Citrus Sinensis ID: 040908
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 790 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGN2 | 1020 | Probable leucine-rich rep | yes | no | 0.955 | 0.740 | 0.566 | 0.0 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.910 | 0.754 | 0.555 | 0.0 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.920 | 0.716 | 0.563 | 0.0 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.937 | 0.713 | 0.545 | 0.0 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.960 | 0.733 | 0.537 | 0.0 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.9 | 0.696 | 0.506 | 0.0 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.888 | 0.688 | 0.493 | 0.0 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.932 | 0.713 | 0.422 | 1e-158 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.863 | 0.660 | 0.436 | 1e-153 | |
| Q9ZP16 | 667 | Cysteine-rich receptor-li | no | no | 0.429 | 0.508 | 0.458 | 6e-81 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 890 bits (2300), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/803 (56%), Positives = 582/803 (72%), Gaps = 48/803 (5%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRT 64
+Q++ L G +P +G L +LTDLRI+DL+GPE+ P LRN T
Sbjct: 237 IQASGLVGPIPSAIGLL------------------GTLTDLRITDLSGPESPFPPLRNMT 278
Query: 65 -FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLL 123
K LILR+CNLTG+LP +LG+ ++K LDLSFNKL+G IP +++ L+DVDFIY T N+L
Sbjct: 279 SMKYLILRNCNLTGDLPAYLGQNRKLKNLDLSFNKLSGPIPATYSGLSDVDFIYFTSNML 338
Query: 124 TGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK-GSNSTGIVSCLRSH 182
G+VP WM +G + ID++YNNF+ + + +CQ +VN F+S+S +N++ VSCL +
Sbjct: 339 NGQVPSWMVDQG-DTIDITYNNFSKDKT-EECQQKSVNTFSSTSPLVANNSSNVSCLSKY 396
Query: 183 TCPKTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHFLDDKSP 242
TCPKT+ +HINCGG+E+T N T ++ DT + + N W S+TG+FLDD
Sbjct: 397 TCPKTFYGLHINCGGNEITSN-ETKYDADTWDTPGY---YDSKNGWVSSNTGNFLDDDRT 452
Query: 243 DTNIQK--NTSRLLMD----DFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTD 296
+ K N+S L + DF+LYT+AR+S ISLTY CL GNY VNLHFAE MF +
Sbjct: 453 NNGKSKWSNSSELKITNSSIDFRLYTQARLSAISLTYQALCLGKGNYTVNLHFAEIMFNE 512
Query: 297 DKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRLYWAGK 356
Y +LGRR FD+Y+QGK E+KDFNI +EA GVGK +VK F +VTNG ++IRL WAGK
Sbjct: 513 KNMYSNLGRRYFDIYVQGKREVKDFNIVDEAKGVGKAVVKKFPVMVTNGKLEIRLQWAGK 572
Query: 357 GTTEIPDRGVYGPLISAISLHNPDF---------EGSSGISVGTVLGIVAAAAVVIILVV 407
GT IP RGVYGPLISA+S+ +PDF G V ++A+ +++L+
Sbjct: 573 GTQAIPVRGVYGPLISAVSV-DPDFIPPKEPGTGTGGGSSVGTVVGSVIASTVFLVLLIG 631
Query: 408 GILWWKGCFRPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLL 467
GILWW+GC RPK E++ + LD Q SF+LRQIK AT++FD ANKIGEGGFGPV+KG++
Sbjct: 632 GILWWRGCLRPKSQMEKDFKNLDFQISSFSLRQIKVATDNFDPANKIGEGGFGPVHKGIM 691
Query: 468 ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527
DGT+IAVKQLSAKSKQGNREF+NEI ISALQHPHLVKLYGCC+EG+QLLL+YEYLENN
Sbjct: 692 TDGTVIAVKQLSAKSKQGNREFLNEIAMISALQHPHLVKLYGCCVEGDQLLLVYEYLENN 751
Query: 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 587
SLARALFGP+E ++ L+WP R IC+GIARGLAYLHEESRLKIVHRDIKATNVLLDK+LN
Sbjct: 752 SLARALFGPQETQIPLNWPMRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKELN 811
Query: 588 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
PKISDFGLAKLDEE+NTHISTRVAGT+GYMAPEYAMRGHLTDKADVYSFG+VALEIV G+
Sbjct: 812 PKISDFGLAKLDEEENTHISTRVAGTYGYMAPEYAMRGHLTDKADVYSFGVVALEIVHGK 871
Query: 648 SNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPT 707
SN ++K + FYLLDW +L+EQ L+E+VDP LG++ +K++ +MI + +LC +P
Sbjct: 872 SNTSSRSKADTFYLLDWVHVLREQNTLLEVVDPRLGTDYNKQEALMMIQIGMLCTSPAPG 931
Query: 708 NRPLMSSVVSMLEGR--VGVPDIVQDSSVSNKDESKSEAMRKYYQFSIENTASTQSVSTD 765
+RP MS+VVSMLEG V V +++ S + KDE AM+++Y +I T + +TD
Sbjct: 932 DRPSMSTVVSMLEGHSTVNVEKLLEASVNNEKDEESVRAMKRHYA-TIGEEEITNTTTTD 990
Query: 766 GPPTGSSTSGV---DLYPFNIDS 785
GP T SSTS DLYP +DS
Sbjct: 991 GPFTSSSTSTANANDLYPVKLDS 1013
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 843 bits (2177), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/768 (55%), Positives = 545/768 (70%), Gaps = 49/768 (6%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRN-R 63
+Q++ L G +P + SL+ L DLRISDLNGPE+ P LRN +
Sbjct: 213 IQASGLVGPIPIAIASLVE------------------LKDLRISDLNGPESPFPQLRNIK 254
Query: 64 TFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLL 123
+ LILR+CNLTG+LP +LG+++ K LDLSFNKL+G IP ++ L D +IY TGN+L
Sbjct: 255 KMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINLRDGGYIYFTGNML 314
Query: 124 TGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIVSCLRSHT 183
G VP WM +G + IDLSYNNF+ + + + C+ ++SC+R++
Sbjct: 315 NGSVPDWMVNKGYK-IDLSYNNFSVDPTNAVCK---------------YNNVLSCMRNYQ 358
Query: 184 CPKTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHFLDDKS-P 242
CPKT++ +HINCGG E+++NG T +E D + + + N W ++ G F+DDK P
Sbjct: 359 CPKTFNALHINCGGDEMSING-TIYESDKYDRLES--WYESRNGWFSNNVGVFVDDKHVP 415
Query: 243 D-TNIQKNTSRLLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTDDKTYK 301
+ I+ N+S L + DF LYT+AR+S ISLTYY CLENGNY VNLHFAE MF + Y+
Sbjct: 416 ERVTIESNSSELNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNGNNNYQ 475
Query: 302 SLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRLYWAGKGTTEI 361
SLGRR FD+YIQ KLE+KDFNI +EA VG ++K F + +G ++IRLYWAG+GTT I
Sbjct: 476 SLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYWAGRGTTVI 535
Query: 362 PDRGVYGPLISAISLH---NPDFEGSSGISVGTVLGIVAAAAVVII-LVVGILWWKGCFR 417
P VYGPLISAIS+ NP +G+S GT+ +V ++ I+ LV G LW KG R
Sbjct: 536 PKERVYGPLISAISVDSSVNPS--PRNGMSTGTLHTLVVILSIFIVFLVFGTLWKKGYLR 593
Query: 418 PKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQ 477
K E++ + L+L SF+LRQIK ATN+FD AN+IGEGGFGPVYKG L DGT+IAVKQ
Sbjct: 594 SKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQ 653
Query: 478 LSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPE 537
LS SKQGNREF+NEIG ISAL HP+LVKLYGCC+EG QLLL+YE++ENNSLARALFGP+
Sbjct: 654 LSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQ 713
Query: 538 EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597
E +L+LDWPTR ICIG+ARGLAYLHEESRLKIVHRDIKATNVLLDK LNPKISDFGLAK
Sbjct: 714 ETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAK 773
Query: 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE 657
LDEED+THISTR+AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIV GRSN + ++K
Sbjct: 774 LDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNN 833
Query: 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717
FYL+DW +L+E+ NL+ELVDP LGS ++E+ MI +A++C P RP MS VV
Sbjct: 834 TFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVK 893
Query: 718 MLEGRVGVP-DIVQDSSV--SNKDESKSEAMRKYYQFSIENTASTQSV 762
MLEG+ V + ++++SV K M+KYY+ + +++ S+
Sbjct: 894 MLEGKKMVEVEKLEEASVHRETKRLENMNTMKKYYEMIGQEISTSMSM 941
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 804 bits (2076), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/752 (56%), Positives = 541/752 (71%), Gaps = 25/752 (3%)
Query: 44 DLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGT 102
DLRISDL G ++ P L+N + K LILR C + G +P ++G++ ++K LDLSFN L+G
Sbjct: 261 DLRISDLGGKPSSFPPLKNLESIKTLILRKCKIIGPIPKYIGDLKKLKTLDLSFNLLSGE 320
Query: 103 IPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESS--GSDCQNGAV 160
IP SF + DFIYLTGN LTG VP + R +N+D+S+NNF DESS DC
Sbjct: 321 IPSSFENMKKADFIYLTGNKLTGGVPNYFVERN-KNVDVSFNNFTDESSIPSHDCNRVTS 379
Query: 161 NLFASSSKGSNSTGIVSC-LRSHTC--PKTYSY--VHINCGGSEVTVNGSTTFEEDTDEA 215
NL S + G+ S +C L+ C PK Y ++INCGG EV V+ T++ D +
Sbjct: 380 NLVESFALGNKSHKGSTCFLQRMPCVHPKRYHLYKLYINCGGGEVKVDKEITYQADDEPK 439
Query: 216 TAARFGFTGTNHWAFSSTGHFLD-DKSPDTNIQKNTSRLLMD----DFQLYTEARVSPIS 270
A+ + WA SSTG+F+D D D +NTSRL ++ F LY ARVSP+S
Sbjct: 440 GASMYVLGANKRWALSSTGNFMDNDDDADEYTVQNTSRLSVNASSPSFGLYRTARVSPLS 499
Query: 271 LTYYVFCLENGNYKVNLHFAETMFTDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGV 330
LTYY CL NGNY VNLHFAE +FTDD T SLG+R+FD+Y+Q +L +K+FNI+E A G
Sbjct: 500 LTYYGICLGNGNYTVNLHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVIKNFNIQEAARGS 559
Query: 331 GKPIVKPFSAVVTNGTMDIRLYWAGKGTTEIPDRGVYGPLISAISLHNPDFEGSSGISVG 390
GKPI+K F VT+ T+ I L WAGKGTT IP RGVYGP+ISAIS+ P+F+
Sbjct: 560 GKPIIKSFLVNVTDHTLKIGLRWAGKGTTGIPIRGVYGPMISAISVE-PNFKPPVYYDTK 618
Query: 391 TVL---GI-VAAAAVVIILVVGILWWKGCFRPKYTSERELRGLDLQTGSFTLRQIKAATN 446
++ G+ VAAA +++ ++VG+ W K R K ++ELRGLDLQTG+FTLRQIKAAT+
Sbjct: 619 DIILKVGVPVAAATLLLFIIVGVFWKKR--RDKNDIDKELRGLDLQTGTFTLRQIKAATD 676
Query: 447 HFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
+FDV KIGEGGFG VYKG L++G LIAVKQLSAKS+QGNREFVNEIG ISALQHP+LVK
Sbjct: 677 NFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMISALQHPNLVK 736
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEH-RLKLDWPTRHNICIGIARGLAYLHEE 565
LYGCC+EGNQL+L+YEYLENN L+RALFG +E RLKLDW TR I +GIA+GL +LHEE
Sbjct: 737 LYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKGLTFLHEE 796
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
SR+KIVHRDIKA+NVLLDKDLN KISDFGLAKL+++ NTHISTR+AGT GYMAPEYAMRG
Sbjct: 797 SRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEYAMRG 856
Query: 626 HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN 685
+LT+KADVYSFG+VALEIVSG+SN + E+ YLLDWA +L+E+G+L+ELVDP L S+
Sbjct: 857 YLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQERGSLLELVDPTLASD 916
Query: 686 VDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDIVQDSSVSNKDESKSEAM 745
+E+ +M+NVAL+C + SPT RP MS VVS++EG+ + +++ D S S + K +A+
Sbjct: 917 YSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEGKTAMQELLSDPSFSTVN-PKLKAL 975
Query: 746 RKYYQFSIENTASTQSVSTDGPPTGSSTSGVD 777
R + F + + S ST GP T S+ S VD
Sbjct: 976 RNH--FWQNELSRSLSFSTSGPRTASANSLVD 1005
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 765 bits (1976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/785 (54%), Positives = 539/785 (68%), Gaps = 44/785 (5%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSES------LTDLRISDLNGPEA-TL 57
+ N LSG++P+ +G+ + S+ S LT+LRI+DL G A +
Sbjct: 216 IDGNSLSGKIPDFIGNWTLLERLDLQGTSMEGPIPPSISNLTNLTELRITDLRGQAAFSF 275
Query: 58 PDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFI 116
PDLRN K L+LR+C + G +P ++G +SE+K LDLS N L G IP++F L +F+
Sbjct: 276 PDLRNLMKMKRLVLRNCLIRGPIPEYIGSMSELKTLDLSSNMLTGVIPDTFRNLDAFNFM 335
Query: 117 YLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIV 176
+L N LTG VPQ++ EN+DLS NNF + S C VNL +S ++++ +
Sbjct: 336 FLNNNSLTGPVPQFIIN-SKENLDLSDNNFTQPPTLS-CNQLDVNLISSYPSVTDNS-VQ 392
Query: 177 SCLRSH-TCPK--TYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSST 233
CLR CP+ S + INCGGS + + G T+ +D + + F + + W +SS+
Sbjct: 393 WCLREGLPCPEDAKQSSLFINCGGSRLKI-GKDTYTDDLNSRGQSTFS-SVSERWGYSSS 450
Query: 234 GHFLDDKSPDTNIQKNTSRLLMDDFQL--------YTEARVSPISLTYYVFCLENGNYKV 285
G +L +++ L D F L Y AR+SP SL YY CL G+YK+
Sbjct: 451 GVWLG--------KEDAGYLATDRFNLINGSTPEYYKTARLSPQSLKYYGLCLRRGSYKL 502
Query: 286 NLHFAETMFTDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNG 345
LHFAE MF++D+T+ SLGRRIFD+Y+QG L +DFNI E AGGVGKP ++ V NG
Sbjct: 503 QLHFAEIMFSNDQTFNSLGRRIFDIYVQGNLLERDFNIAERAGGVGKPFIRQIDGVQVNG 562
Query: 346 -TMDIRLYWAGKGTTEIPDRGVYGPLISAISLHNPDFEGSSG--ISVGTVLGIV-AAAAV 401
T++I L W GKGT IP RGVYGPLISAI++ P+F+ +G +S G V GIV AA AV
Sbjct: 563 STLEIHLQWTGKGTNVIPTRGVYGPLISAITI-TPNFKVDTGKPLSNGAVAGIVIAACAV 621
Query: 402 VIILVVGILWWKGCFRPKYTSE-RELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFG 460
+LV+ IL G K E ELRGLDLQTGSFTL+QIK ATN+FD NKIGEGGFG
Sbjct: 622 FGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFG 681
Query: 461 PVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520
PVYKG+LADG IAVKQLS+KSKQGNREFV EIG ISALQHP+LVKLYGCCIEG +LLL+
Sbjct: 682 PVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLV 741
Query: 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNV 580
YEYLENNSLARALFG E+ RL LDW TR+ ICIGIA+GLAYLHEESRLKIVHRDIKATNV
Sbjct: 742 YEYLENNSLARALFGTEKQRLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNV 801
Query: 581 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVA 640
LLD LN KISDFGLAKL++++NTHISTR+AGT GYMAPEYAMRG+LTDKADVYSFG+V
Sbjct: 802 LLDLSLNAKISDFGLAKLNDDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVC 861
Query: 641 LEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALL 700
LEIVSG+SN + KEE YLLDWA +L+EQG+L+ELVDP+LG++ K++ M+N+ALL
Sbjct: 862 LEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALL 921
Query: 701 CADVSPTNRPLMSSVVSMLEGRVGV-PDIVQDSSVSNKDESKSEAMRKYYQFSIENTAST 759
C + SPT RP MSSVVSMLEG++ V P +V+ + D S S AMR + + + S
Sbjct: 922 CTNPSPTLRPPMSSVVSMLEGKIKVQPPLVKREA----DPSGSAAMR-FKALELLSQDSE 976
Query: 760 QSVST 764
VST
Sbjct: 977 SQVST 981
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 763 bits (1971), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/800 (53%), Positives = 550/800 (68%), Gaps = 41/800 (5%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSES------LTDLRISDLNGPEATLP 58
+ N LSG++P+ +G+ + S+ S LT+LRI+DL GP + P
Sbjct: 214 IDGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNLKNLTELRITDLRGPTSPFP 273
Query: 59 DLRNRT-FKNLILRSCNLTGELPHFLG-EVSEMKVLDLSFNKLNGTIPESFARLADVDFI 116
DL+N T + L+LR+C + +P ++G ++ +K+LDLS N LNGTIP++F L +F+
Sbjct: 274 DLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPDTFRSLNAFNFM 333
Query: 117 YLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIV 176
YL N LTG VPQ++ +NIDLSYNNF + S C VNL +S +N++ +
Sbjct: 334 YLNNNSLTGPVPQFILD-SKQNIDLSYNNFTQPPTLS-CNQLDVNLISSYPSVTNNS-VQ 390
Query: 177 SCLRSH-TCP--KTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSST 233
CLR CP +S + INCGG+ + V+ + +D ++ A+ F + + W +SS+
Sbjct: 391 WCLRKDLPCPGDAHHSSLFINCGGNRLKVD-KDEYADDLNKRGASTFS-SVSERWGYSSS 448
Query: 234 GHFLDDKSPDTNIQKNTSRLLMDDF-QLYTEARVSPISLTYYVFCLENGNYKVNLHFAET 292
G +L + T + +T L+ + + Y AR++ SL YY C+ G+YKV L+FAE
Sbjct: 449 GAWLGNDGA-TYLATDTFNLINESTPEYYKTARLASQSLKYYGLCMRRGSYKVQLYFAEI 507
Query: 293 MFTDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNG-TMDIRL 351
MF++D+TY SLGRR+FD+Y+QG L +DFNI + AGGVGKP ++ V NG T++I L
Sbjct: 508 MFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQVNGSTLEIHL 567
Query: 352 YWAGKGTTEIPDRGVYGPLISAISLHNPDFEGSSG--ISVGTVLGIVAAAAVVI-ILVVG 408
W GKGT IP RGVYGPLISAI++ P+F+ +G +S G V GIV AA V +LV+
Sbjct: 568 KWTGKGTNVIPTRGVYGPLISAITV-TPNFKVDTGKPLSNGVVAGIVIAACVAFGLLVLV 626
Query: 409 ILWWKGCFRPKYTSE-RELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLL 467
IL G K E ELRGLDLQTGSFTL+QIK ATN+FD NKIGEGGFGPVYKG+L
Sbjct: 627 ILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVL 686
Query: 468 ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527
ADG IAVKQLS+KSKQGNREFV EIG ISALQHP+LVKLYGCCIEG +LLL+YEYLENN
Sbjct: 687 ADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENN 746
Query: 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 587
SLARALFG E+ RL LDW TR+ +CIGIA+GLAYLHEESRLKIVHRDIKATNVLLD LN
Sbjct: 747 SLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLN 806
Query: 588 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
KISDFGLAKLDEE+NTHISTR+AGT GYMAPEYAMRG+LTDKADVYSFG+V LEIVSG+
Sbjct: 807 AKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGK 866
Query: 648 SNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPT 707
SN + KEE YLLDWA +L+EQG+L+ELVDP+LG++ K++ M+N+ALLC + SPT
Sbjct: 867 SNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPT 926
Query: 708 NRPLMSSVVSMLEGRVGV-PDIVQDSSVSNKDESKSEAMR----KYYQFSIENTAST--- 759
RP MSSVVSML+G++ V P +V+ + D S S AMR ++ E+ ST
Sbjct: 927 LRPPMSSVVSMLQGKIKVQPPLVKREA----DPSGSAAMRFKALEHLSQDSESQVSTYTR 982
Query: 760 -----QSVSTDGPPTGSSTS 774
S S DGP SS S
Sbjct: 983 NKEHKSSSSMDGPWVDSSFS 1002
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 700 bits (1806), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/735 (50%), Positives = 493/735 (67%), Gaps = 24/735 (3%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRT-FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKL 99
+L +LRISD+ GP P L+N T +IL++CN++G++P +L + E++ LDLSFNKL
Sbjct: 266 NLVNLRISDIRGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNKL 325
Query: 100 NGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSD-CQ-- 156
G IP SFA+ ++ FI L GN+L G P + G +DLSYNN +S S C+
Sbjct: 326 VGGIP-SFAQAENLRFIILAGNMLEGDAPDELLRDG-ITVDLSYNNLKWQSPESRACRPN 383
Query: 157 -NGAVNLFASSSKGSNSTGIVSCLRSHTCPKTYSYVHINCGGSEVTVNGSTT---FEEDT 212
N +NLF S+S S+ + C++ CP+ S +H+NCGGS++ V T +E D
Sbjct: 384 MNLNLNLFQSTST-KKSSKFLPCIKDFKCPRYSSCLHVNCGGSDMYVKEKKTKELYEGDG 442
Query: 213 D-EATAARFGFTGTNHWAFSSTGHFLDDKSPDTNIQKNTSRLLM---DDFQLYTEARVSP 268
+ E AA++ +W FSSTG F+DD N Q + + + LY AR++P
Sbjct: 443 NVEGGAAKYFLKPDANWGFSSTGDFMDD----NNFQNTRFTMFVPASNQSDLYKSARIAP 498
Query: 269 ISLTYYVFCLENGNYKVNLHFAETMFTDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAG 328
+SLTY+ CLENGNY +NL FAE FT+D+ Y LGRR+FD+YIQ KL KDFNI +EA
Sbjct: 499 VSLTYFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNIMDEAK 558
Query: 329 GVGKPIVKPFSAVVTNGTMDIRLYWAGKGTTEIPDRGVYGPLISAISL---HNPDFEGSS 385
G PI+KP +A VTN + IRL WAGKGTT IP RGVYGP+ISAIS+ P +
Sbjct: 559 GAQTPIIKPLTAYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDSKPCERPKT 618
Query: 386 GISVGTVLGIVAAAAVVIILVVGILWWKGCFRPKYTSERELRGLDLQTGSFTLRQIKAAT 445
G+S G + I A +II ++G LW GC ++ +L +G+FTLRQIK AT
Sbjct: 619 GMSPGAYIAIGIGAPCLIIFILGFLWICGCLPRCGRQRKDPYEEELPSGTFTLRQIKFAT 678
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
+ F+ NKIGEGGFG V+KG+LADG ++AVKQLS+KS+QGNREF+NEIG IS LQHP+LV
Sbjct: 679 DDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNLV 738
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
KL+G C+E QLLL YEY+ENNSL+ ALF P+ ++ +DWPTR IC GIA+GLA+LHEE
Sbjct: 739 KLHGFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGLAFLHEE 798
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
S LK VHRDIKATN+LLDKDL PKISDFGLA+LDEE+ THIST+VAGT GYMAPEYA+ G
Sbjct: 799 SPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWG 858
Query: 626 HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN 685
+LT KADVYSFG++ LEIV+G +N + LL++A E G+LM++VD L
Sbjct: 859 YLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGHLMQVVDERLRPE 918
Query: 686 VDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDIVQDSSVSNKDESKSEAM 745
VD+++ +I VAL+C+ SPT+RPLMS VV+MLEG VP+ S N + + +A
Sbjct: 919 VDRKEAEAVIKVALVCSSASPTDRPLMSEVVAMLEGLYPVPESTPGVS-RNAGDIRFKAF 977
Query: 746 RKYYQFSIENTASTQ 760
+ + +EN + TQ
Sbjct: 978 KDLRR-GMENNSKTQ 991
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 679 bits (1753), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/749 (49%), Positives = 487/749 (65%), Gaps = 47/749 (6%)
Query: 56 TLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTI------PESFAR 109
+ P+L ++ K LILR+ L+G +P ++ ++++K+LDLSFNKLNG + P++
Sbjct: 277 SFPNLSSKGLKRLILRNVGLSGPIPSYIWNLTDLKILDLSFNKLNGIVQGVQNPPKN--- 333
Query: 110 LADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGA-VNLFASSSK 168
IYLTGNLL+G + IDLSYNNF+ SS CQ G+ +N + SS
Sbjct: 334 ------IYLTGNLLSGNIESGGLLNSQSYIDLSYNNFSWSSS---CQKGSTINTYQSSYS 384
Query: 169 GSNSTGIVSCLRSHTCPKTYSYVHINCGGSEVTVN---GSTTFEED----TDEATAARFG 221
+N TG+ C C K ++HINCGG EV++ G T++ D T+ A+ +F
Sbjct: 385 KNNLTGLPPCAVPANCKKYQRFLHINCGGEEVSIRNSLGKITYQTDNSRQTNAASNQQF- 443
Query: 222 FTGTNHWAFSSTGHFLDDKSPDTNIQKNTSRLLMDDF-QLYTEARVSPISLTYYVFCLEN 280
++W S+TG F DD S +T+ L D+ LY AR S +SL YY FCLEN
Sbjct: 444 ----DYWGVSNTGDFTDDNSDHDEYYTSTNLTLSGDYPDLYKTARRSALSLVYYAFCLEN 499
Query: 281 GNYKVNLHFAETMFTDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSA 340
GNY V LHF E F+D + Y LGRRIFDVY+QGKL L+DFNI +EA G KP++K +A
Sbjct: 500 GNYNVKLHFMEIQFSDKEVYSRLGRRIFDVYVQGKLFLRDFNINKEANGNMKPVIKEINA 559
Query: 341 VVTNGTMDIRLYWAGKGTTEIPDRGVYGPLISAISL-HNPD-----FEGSSGISVGTVLG 394
VTN ++IRLYWAGKGTT IP RG YGPLISAISL H+ + + I +LG
Sbjct: 560 TVTNHMLEIRLYWAGKGTTLIPKRGNYGPLISAISLCHSQEPLCGVEKTKHHIKYPLILG 619
Query: 395 IVAAAAVVIILVVGILWWKGCFRPKYTSERE-LRGLDLQTGSFTLRQIKAATNHFDVANK 453
A +++L VGI + +G +R LR LQT F+ RQ++ ATN+FD ANK
Sbjct: 620 ASGALVTIVLLAVGI-YARGIYRRDNNRRERDLRAQGLQTVCFSWRQLQTATNNFDQANK 678
Query: 454 IGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIE 513
+GEGGFG V+KG L+DGT+IAVKQLS+KS QGNREFVNEIG IS L HP+LVKLYGCC+E
Sbjct: 679 LGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCCVE 738
Query: 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHR 573
+QLLL+YEY+ENNSLA ALFG ++ LKLDW R IC+GIARGL +LH+ S +++VHR
Sbjct: 739 RDQLLLVYEYMENNSLALALFG--QNSLKLDWAARQKICVGIARGLEFLHDGSAMRMVHR 796
Query: 574 DIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADV 633
DIK TNVLLD DLN KISDFGLA+L E ++THIST+VAGT GYMAPEYA+ G LT+KADV
Sbjct: 797 DIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAGTIGYMAPEYALWGQLTEKADV 856
Query: 634 YSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRV 693
YSFG+VA+EIVSG+SN + + L++WAL L++ G+++E+VD L ++ +
Sbjct: 857 YSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQTGDILEIVDRMLEGEFNRSEAVR 916
Query: 694 MINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDIVQDSSVSNKDESKSEAMRKYYQFSI 753
MI VAL+C + SP+ RP MS V MLEG + + ++ D + D S S K
Sbjct: 917 MIKVALVCTNSSPSLRPTMSEAVKMLEGEIEITQVMSDPGIYGHDWSIS----KLRDIDT 972
Query: 754 ENTASTQSVSTDGPPT-GSSTSGVDLYPF 781
+++ST V+ T SS SG DLYP
Sbjct: 973 HSSSSTSGVTDQTTTTMKSSVSGCDLYPL 1001
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 560 bits (1443), Expect = e-158, Method: Compositional matrix adjust.
Identities = 326/771 (42%), Positives = 459/771 (59%), Gaps = 34/771 (4%)
Query: 41 SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKL 99
SLT+LR+ D++ ++L +++ ++ L+LR+ NLTG +P +GE S ++ LDLSFNKL
Sbjct: 267 SLTELRLGDISNGNSSLEFIKDMKSLSILVLRNNNLTGTIPSNIGEYSSLRQLDLSFNKL 326
Query: 100 NGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADE-----SSGSD 154
+GTIP S L + ++L N L G +P G+ N+D+SYN+ + S +
Sbjct: 327 HGTIPASLFNLRQLTHLFLGNNTLNGSLPT-QKGQSLSNVDVSYNDLSGSLPSWVSLPNL 385
Query: 155 CQNGAVNLFASSSKGSNSTGIVSCLRSH-TCPK---TYSYVHINCGGSEVTVNGSTTFEE 210
N N F + ++CL+ + C + YS INCGG E+ FE
Sbjct: 386 NLNLVANNFTLEGLDNRVLSGLNCLQKNFPCNRGKGIYSDFSINCGGPEIRSVTEAVFER 445
Query: 211 DTDEATAARFGFTGTNHWAFSSTGHFLDDKSPDTNIQKNTSRLLMD-DFQLYTEARVSPI 269
+ ++ A F + WA SS G F S + I + S+ + D +L+ AR+S
Sbjct: 446 EDEDLGPASFVVSAGQRWAASSVGLF-AGSSNNIYISTSQSQFVNTLDSELFQSARLSAS 504
Query: 270 SLTYYVFCLENGNYKVNLHFAETMF--TDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEA 327
SL YY LENG Y V L FAE + T++ LGRR FD+Y+QG+L KDF++ A
Sbjct: 505 SLRYYGLGLENGGYTVTLQFAEIQILGSTSNTWRGLGRRRFDIYVQGRLVEKDFDVRRTA 564
Query: 328 G-GVGKPIVKPFSAVVTNGTMDIRLYWAGKGTTEIPDRGVYGPLISAISLHNPDFEGSSG 386
G + + + + A V+ ++I L+WAGKGT IP +G YGPLISA+ PDF + G
Sbjct: 565 GDSTVRAVQREYKANVSQNHLEIHLFWAGKGTCCIPIQGAYGPLISAVG-ATPDFTPTVG 623
Query: 387 --------ISVGTVLGIVAAAAVVIILVVGILWWKGCFRPKYTSERELRGLDLQTGSFTL 438
GT++G++ ++ I+ +++ R +YT + E+ +D++ +FT
Sbjct: 624 NRPPSKGKSMTGTIVGVIVGVGLLSIISGVVIFIIRKRRKRYTDDEEILSMDVKPYTFTY 683
Query: 439 RQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISA 498
++K+AT FD +NK+GEGGFGPVYKG L DG +AVK LS S+QG +FV EI ISA
Sbjct: 684 SELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISA 743
Query: 499 LQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
+QH +LVKLYGCC EG LL+YEYL N SL +ALFG E L LDW TR+ IC+G+ARG
Sbjct: 744 VQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFG--EKTLHLDWSTRYEICLGVARG 801
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 618
L YLHEE+RL+IVHRD+KA+N+LLD L PK+SDFGLAKL ++ THISTRVAGT GY+A
Sbjct: 802 LVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLA 861
Query: 619 PEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678
PEYAMRGHLT+K DVY+FG+VALE+VSGR N ++EK YLL+WA L E+G +EL+
Sbjct: 862 PEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKGREVELI 921
Query: 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDIVQDSSVSNKD 738
D L + + E+ + MI +ALLC S RP MS VV+ML G V V D+
Sbjct: 922 DHQL-TEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVTSKPGYLTDW 980
Query: 739 ESKSEAMRKYYQFSIENTASTQSVSTDGPPTGSSTSGVDLYPFNIDSERLL 789
F + NT +++S ++ P ++ P N D+ +L
Sbjct: 981 RFDDTTASSISGFPLRNTQASESFTSFVAPRS------EISPRNNDARPML 1025
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 543 bits (1398), Expect = e-153, Method: Compositional matrix adjust.
Identities = 310/710 (43%), Positives = 436/710 (61%), Gaps = 28/710 (3%)
Query: 41 SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKL 99
SLT+LR+ D++ ++L +++ ++ L+LR+ NLTG +P +GE S ++ +DLSFNKL
Sbjct: 268 SLTELRLGDISSGSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKL 327
Query: 100 NGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADE-----SSGSD 154
+G IP S L+ + ++L N L G P + N+D+SYN+ + S S
Sbjct: 328 HGPIPASLFNLSQLTHLFLGNNTLNGSFPT-QKTQSLRNVDVSYNDLSGSLPSWVSLPSL 386
Query: 155 CQNGAVNLFASSSKGSNSTGIVSCL-RSHTCPK---TYSYVHINCGGSEVTVNGSTTFEE 210
N N F + ++CL ++ C + YS INCGG E FE
Sbjct: 387 KLNLVANNFTLEGLDNRVLPGLNCLQKNFPCNRGKGIYSDFSINCGGPEKRSVTGALFER 446
Query: 211 DTDEATAARFGFTGTNHWAFSSTGHFLDDKSPDTNIQKNTSRLLMD-DFQLYTEARVSPI 269
+ ++ A F + WA SS G F S + I + S+ + D +L+ AR+S
Sbjct: 447 EDEDFGPASFFVSAGQRWAASSVGLFAG-SSNNIYIATSQSQFVNTLDSELFQSARLSAS 505
Query: 270 SLTYYVFCLENGNYKVNLHFAETMF--TDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEA 327
S+ YY LENG Y V L FAE + T+K LGRR FD+Y+QG+L KDF++ A
Sbjct: 506 SVRYYGLGLENGGYTVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTA 565
Query: 328 G-GVGKPIVKPFSAVVTNGTMDIRLYWAGKGTTEIPDRGVYGPLISAISLHNPDFEGSSG 386
G + + + + A V+ +++ L+WAGKGT IP +G YGPLISA+S PDF +
Sbjct: 566 GDSTVRAVQRVYKANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVS-ATPDFTPTVA 624
Query: 387 IS--------VGTVLGIVAAAAVVIILVVGILWWKGCFRPKYTSERELRGLDLQTGSFTL 438
GT++G++ ++ IL +++ R +YT + EL G+D++ FT
Sbjct: 625 NKPPSKGKNRTGTIVGVIVGVGLLSILAGVVMFTIRKRRKRYTDDEELLGMDVKPYIFTY 684
Query: 439 RQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISA 498
++K+AT FD +NK+GEGGFGPVYKG L DG ++AVK LS S+QG +FV EI IS+
Sbjct: 685 SELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISS 744
Query: 499 LQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
+ H +LVKLYGCC EG +L+YEYL N SL +ALFG + L LDW TR+ IC+G+ARG
Sbjct: 745 VLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFG--DKTLHLDWSTRYEICLGVARG 802
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 618
L YLHEE+ ++IVHRD+KA+N+LLD L P+ISDFGLAKL ++ THISTRVAGT GY+A
Sbjct: 803 LVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLA 862
Query: 619 PEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678
PEYAMRGHLT+K DVY+FG+VALE+VSGR N +EEK YLL+WA L E+ +EL+
Sbjct: 863 PEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDIELI 922
Query: 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDI 728
D L ++ + E+ + MI +ALLC S RP MS VV+ML G V + D+
Sbjct: 923 DDKL-TDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDV 971
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 302 bits (774), Expect = 6e-81, Method: Compositional matrix adjust.
Identities = 161/351 (45%), Positives = 229/351 (65%), Gaps = 12/351 (3%)
Query: 378 NPDFEGSSGISVGTVLGIVAAA--AVVIILVVGILWW---KGCFRPKYTSERELRGLDLQ 432
NP S GIS G V+ I A++I+LV+G + + K R K SE ++ D
Sbjct: 277 NPTNNDSKGISAGVVVAITVPTVIAILILLVLGFVLFRRRKSYQRTKTESESDISTTD-- 334
Query: 433 TGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNE 492
+ + + I+AATN F +NK+GEGGFG VYKG L++GT +AVK+LS KS QG REF NE
Sbjct: 335 SLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNE 394
Query: 493 IGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNIC 552
++ LQH +LV+L G C+E + +LIYE++ N SL LF PE+ +LDW R+ I
Sbjct: 395 AVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQS-QLDWTRRYKII 453
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST-RVA 611
GIARG+ YLH++SRLKI+HRD+KA+N+LLD D+NPKI+DFGLA + + T +T R+A
Sbjct: 454 GGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGNTNRIA 513
Query: 612 GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY---LLDWALLL 668
GT+ YM+PEYAM G + K+D+YSFG++ LEI+SG+ N +E L+ +A L
Sbjct: 514 GTYAYMSPEYAMHGQYSMKSDIYSFGVLVLEIISGKKNSGVYQMDETSTAGNLVTYASRL 573
Query: 669 KEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719
+ +ELVDP G N +V I++ALLC +P +RP++S+++ ML
Sbjct: 574 WRNKSPLELVDPTFGRNYQSNEVTRCIHIALLCVQENPEDRPMLSTIILML 624
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 790 | ||||||
| 302142829 | 1036 | unnamed protein product [Vitis vinifera] | 0.981 | 0.748 | 0.662 | 0.0 | |
| 359493983 | 1007 | PREDICTED: probable leucine-rich repeat | 0.981 | 0.769 | 0.662 | 0.0 | |
| 359493981 | 1007 | PREDICTED: probable leucine-rich repeat | 0.979 | 0.768 | 0.663 | 0.0 | |
| 359493985 | 1011 | PREDICTED: probable leucine-rich repeat | 0.979 | 0.765 | 0.655 | 0.0 | |
| 255567058 | 985 | ATP binding protein, putative [Ricinus c | 0.929 | 0.745 | 0.633 | 0.0 | |
| 357492929 | 996 | Cysteine-rich receptor-like protein kina | 0.970 | 0.770 | 0.625 | 0.0 | |
| 255567064 | 1007 | ATP binding protein, putative [Ricinus c | 0.977 | 0.766 | 0.636 | 0.0 | |
| 351723187 | 999 | receptor-like protein kinase 2-like prec | 0.975 | 0.771 | 0.624 | 0.0 | |
| 449456691 | 1007 | PREDICTED: probable leucine-rich repeat | 0.958 | 0.751 | 0.628 | 0.0 | |
| 449503668 | 1007 | PREDICTED: probable leucine-rich repeat | 0.958 | 0.751 | 0.628 | 0.0 |
| >gi|302142829|emb|CBI20124.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1028 bits (2659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/799 (66%), Positives = 619/799 (77%), Gaps = 24/799 (3%)
Query: 5 VQSNRLSGELPE------ELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLP 58
V N+ +G++P +L L+ G F +TDLRISDLNG EAT P
Sbjct: 239 VGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 298
Query: 59 DLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIY 117
L + R K LILRSCN+ G LP +LGE++++K LDLSFNKL G IP SF L++ D++Y
Sbjct: 299 PLSDMRNLKTLILRSCNIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSNADYMY 358
Query: 118 LTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIVS 177
TGN+LTG VP WM RG +N DLSYNNF ESS CQ +VNLF SSS G N+ GIVS
Sbjct: 359 FTGNMLTGAVPDWMLKRG-DNYDLSYNNFTSESS-RGCQERSVNLFGSSS-GGNNFGIVS 415
Query: 178 CLRSHTCPKTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHFL 237
CLRS CPK + +HINCGG EV V+G+TT+E+DTD ++F + TN WAFSSTGHF+
Sbjct: 416 CLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKFYQSRTN-WAFSSTGHFM 474
Query: 238 DDKSP-DTNIQKNTSRLLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTD 296
DD P D+ I N SRL M++ LYT AR+S +SLTYY FCLENGNY V LHFAE FTD
Sbjct: 475 DDDRPTDSFIGTNVSRLTMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHFAEITFTD 534
Query: 297 DKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRLYWAGK 356
DKTY SLGRR+FDVY+Q +L LKDF+IE++AGGV K I+K F+AVVTN T++IR YWAGK
Sbjct: 535 DKTYSSLGRRLFDVYVQDELVLKDFDIEDDAGGVSKEIIKYFTAVVTNNTLEIRFYWAGK 594
Query: 357 GTTEIPDRGVYGPLISAISLHNPDF-----EGSSGISVGTVLGIVAAAAVVIILVVGILW 411
GTT IP RGVYGPLISAIS+ +PDF GSS SVG V+G VA +++ LV+GILW
Sbjct: 595 GTTGIPVRGVYGPLISAISV-DPDFIPPTKNGSSSKSVGIVVGHVAGVILLVFLVIGILW 653
Query: 412 WKGCFRPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGT 471
W+GC R K T E+EL+GLDLQTG FTLRQIKAATN+FD ANKIGEGGFG VYKG+L+DGT
Sbjct: 654 WRGCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYKGVLSDGT 713
Query: 472 LIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLAR 531
+IAVKQLS+KSKQGNREFVNE+G ISALQHPHLVKLYGCCIEGNQLLLIYEY+ENNSLAR
Sbjct: 714 IIAVKQLSSKSKQGNREFVNELGMISALQHPHLVKLYGCCIEGNQLLLIYEYMENNSLAR 773
Query: 532 ALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 591
ALFGPEE +L+LDWPTRH IC+GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS
Sbjct: 774 ALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 833
Query: 592 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIM 651
DFGLAKLDEEDNTHISTR+AGTFGYMAPEYAMRG+LTDKADVYSFGIVALEIVSGRSN
Sbjct: 834 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNTT 893
Query: 652 CKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL 711
+ KEE YLLDWAL LKE+GNLM+LVDP LGS+ +KE+V M+N+ALLC ++S RP
Sbjct: 894 YRPKEECTYLLDWALSLKEKGNLMDLVDPRLGSDFNKEEVMAMLNIALLCTNISSAVRPA 953
Query: 712 MSSVVSMLEGRVGVPDIVQDSSVSNKDESKSEAMRKYYQF----SIENTASTQSVSTDGP 767
MSSVVSMLEG V DIV D S + D+ K + M+++Y+ S++ + S DGP
Sbjct: 954 MSSVVSMLEGITAVQDIVSDPSAPS-DDLKLKEMKEHYRHIQEKSMDVSESKAQSMPDGP 1012
Query: 768 PTGSSTSGVDLYPFNIDSE 786
T SS S DLYP +DSE
Sbjct: 1013 WTASS-SITDLYPVTLDSE 1030
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493983|ref|XP_002283596.2| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1028 bits (2657), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/799 (66%), Positives = 619/799 (77%), Gaps = 24/799 (3%)
Query: 5 VQSNRLSGELPE------ELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLP 58
V N+ +G++P +L L+ G F +TDLRISDLNG EAT P
Sbjct: 210 VGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 59 DLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIY 117
L + R K LILRSCN+ G LP +LGE++++K LDLSFNKL G IP SF L++ D++Y
Sbjct: 270 PLSDMRNLKTLILRSCNIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSNADYMY 329
Query: 118 LTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIVS 177
TGN+LTG VP WM RG +N DLSYNNF ESS CQ +VNLF SSS G N+ GIVS
Sbjct: 330 FTGNMLTGAVPDWMLKRG-DNYDLSYNNFTSESS-RGCQERSVNLFGSSS-GGNNFGIVS 386
Query: 178 CLRSHTCPKTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHFL 237
CLRS CPK + +HINCGG EV V+G+TT+E+DTD ++F + TN WAFSSTGHF+
Sbjct: 387 CLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKFYQSRTN-WAFSSTGHFM 445
Query: 238 DDKSP-DTNIQKNTSRLLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTD 296
DD P D+ I N SRL M++ LYT AR+S +SLTYY FCLENGNY V LHFAE FTD
Sbjct: 446 DDDRPTDSFIGTNVSRLTMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHFAEITFTD 505
Query: 297 DKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRLYWAGK 356
DKTY SLGRR+FDVY+Q +L LKDF+IE++AGGV K I+K F+AVVTN T++IR YWAGK
Sbjct: 506 DKTYSSLGRRLFDVYVQDELVLKDFDIEDDAGGVSKEIIKYFTAVVTNNTLEIRFYWAGK 565
Query: 357 GTTEIPDRGVYGPLISAISLHNPDF-----EGSSGISVGTVLGIVAAAAVVIILVVGILW 411
GTT IP RGVYGPLISAIS+ +PDF GSS SVG V+G VA +++ LV+GILW
Sbjct: 566 GTTGIPVRGVYGPLISAISV-DPDFIPPTKNGSSSKSVGIVVGHVAGVILLVFLVIGILW 624
Query: 412 WKGCFRPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGT 471
W+GC R K T E+EL+GLDLQTG FTLRQIKAATN+FD ANKIGEGGFG VYKG+L+DGT
Sbjct: 625 WRGCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYKGVLSDGT 684
Query: 472 LIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLAR 531
+IAVKQLS+KSKQGNREFVNE+G ISALQHPHLVKLYGCCIEGNQLLLIYEY+ENNSLAR
Sbjct: 685 IIAVKQLSSKSKQGNREFVNELGMISALQHPHLVKLYGCCIEGNQLLLIYEYMENNSLAR 744
Query: 532 ALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 591
ALFGPEE +L+LDWPTRH IC+GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS
Sbjct: 745 ALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 804
Query: 592 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIM 651
DFGLAKLDEEDNTHISTR+AGTFGYMAPEYAMRG+LTDKADVYSFGIVALEIVSGRSN
Sbjct: 805 DFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNTT 864
Query: 652 CKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL 711
+ KEE YLLDWAL LKE+GNLM+LVDP LGS+ +KE+V M+N+ALLC ++S RP
Sbjct: 865 YRPKEECTYLLDWALSLKEKGNLMDLVDPRLGSDFNKEEVMAMLNIALLCTNISSAVRPA 924
Query: 712 MSSVVSMLEGRVGVPDIVQDSSVSNKDESKSEAMRKYYQF----SIENTASTQSVSTDGP 767
MSSVVSMLEG V DIV D S + D+ K + M+++Y+ S++ + S DGP
Sbjct: 925 MSSVVSMLEGITAVQDIVSDPSAPS-DDLKLKEMKEHYRHIQEKSMDVSESKAQSMPDGP 983
Query: 768 PTGSSTSGVDLYPFNIDSE 786
T SS S DLYP +DSE
Sbjct: 984 WTASS-SITDLYPVTLDSE 1001
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493981|ref|XP_003634703.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 989 bits (2557), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/800 (66%), Positives = 621/800 (77%), Gaps = 26/800 (3%)
Query: 5 VQSNRLSGELPE------ELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLP 58
V N+ +G++P +L L+ G F +TDLRISDLNG EAT P
Sbjct: 210 VGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 59 DLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIY 117
L + R K LILRSCN+ LP +LGE++++K LDLSFNKL G IP SF L++ D++Y
Sbjct: 270 PLSDMRDLKTLILRSCNIVDPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSNADYMY 329
Query: 118 LTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIVS 177
TGN+LTG VP WM RG +N DLSYNNF ESS CQ +VNLF SSS G+NS IVS
Sbjct: 330 FTGNMLTGAVPDWMLKRG-DNYDLSYNNFTSESS-RGCQERSVNLFGSSSGGNNSG-IVS 386
Query: 178 CLRSHTCPKTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHFL 237
CLRS CPK + +HINCGG EV V+G+TT+E+DTD ++F + TN WAFSSTGHF+
Sbjct: 387 CLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKFYQSRTN-WAFSSTGHFM 445
Query: 238 DDKSP-DTNIQKNTSRLLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTD 296
DD P D+ I N SRL+M++ LYT AR+S +SLTYY FCLENGNY V LHFAE FTD
Sbjct: 446 DDDRPTDSFIGTNVSRLIMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHFAEITFTD 505
Query: 297 DKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRLYWAGK 356
DKTY SLGRR+FDVY+Q KL LKDFNIE+EAGGV K I+K F+AVVTN T++IR YWAGK
Sbjct: 506 DKTYSSLGRRLFDVYVQDKLVLKDFNIEDEAGGVSKEILKYFTAVVTNNTLEIRFYWAGK 565
Query: 357 GTTEIPDRGVYGPLISAISLHNPDF-----EGSSGISVGTVLGIVAAAAVVIILVVGILW 411
GTT IP RGVYGPLISAIS+ +PDF GSS ISVG V+GIVA +++ L++GILW
Sbjct: 566 GTTGIPVRGVYGPLISAISV-DPDFIPPTENGSSSISVGVVVGIVAGVILLVFLLIGILW 624
Query: 412 WKGCFRPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGT 471
W+ C R K T E+EL+GLDLQTG FTLRQIKAATN+FD ANKIGEGGFG VYKG+L+DGT
Sbjct: 625 WRDCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYKGVLSDGT 684
Query: 472 LIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLAR 531
+IAVKQLS+KSKQGNREFVNEIG ISALQHPHLVKLYGCCIEGNQLLLIYEY+ENNSLAR
Sbjct: 685 IIAVKQLSSKSKQGNREFVNEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYMENNSLAR 744
Query: 532 ALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 591
ALFGPEE +L+LDWPTRH IC+GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS
Sbjct: 745 ALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 804
Query: 592 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIM 651
DFGLAKLDEEDNTHISTR+AGT+GYMAPEYAMRG+LTDKADVYSFG+VALEIVSGRSN
Sbjct: 805 DFGLAKLDEEDNTHISTRIAGTYGYMAPEYAMRGYLTDKADVYSFGVVALEIVSGRSNTT 864
Query: 652 CKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL 711
+ KEE YLLD AL LKE+G+LM++VDP LGS+ +KE+V M+N+ALLC +S RP
Sbjct: 865 YRPKEESIYLLDRALSLKEKGSLMDIVDPRLGSDFNKEEVMAMLNIALLCTTISSAVRPA 924
Query: 712 MSSVVSMLEGRVGVPDIVQDSSVSNKDESKSEAMRKYYQFSIENT-----ASTQSVSTDG 766
MSSVVSMLEGR V DIV D S + D+ K E M+++Y+ E + + QS+ DG
Sbjct: 925 MSSVVSMLEGRTAVQDIVSDPSAPS-DDLKLEEMKEHYRHIQEKSMGVSESKAQSMP-DG 982
Query: 767 PPTGSSTSGVDLYPFNIDSE 786
P T SS S DLYP N+DSE
Sbjct: 983 PWTASS-SIPDLYPVNLDSE 1001
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493985|ref|XP_002283578.2| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 980 bits (2534), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 527/804 (65%), Positives = 615/804 (76%), Gaps = 30/804 (3%)
Query: 5 VQSNRLSGELPE------ELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLP 58
V N+ +G++P +L L+ G F +TDLRISDLNG EAT P
Sbjct: 210 VADNQFTGKIPNFIQNWTKLEKLVIHGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 59 DLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIY 117
L + R K LILRSC++ G LP +LGE++++K LDLSFNKL G IP SF L+ D+IY
Sbjct: 270 PLSDMRNLKTLILRSCSIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSKADYIY 329
Query: 118 LTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIVS 177
TGN+LTG VP WM RG +N DLSYNNF ESS CQ +VNLF SSS G+NS IVS
Sbjct: 330 FTGNMLTGAVPDWMLKRG-DNYDLSYNNFTSESS-RGCQERSVNLFGSSSGGNNSG-IVS 386
Query: 178 CLRSHTCPKTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHFL 237
CLRS CPK + +HINCGG EV V+G+TT+E+D D ++F + TN WAFSSTGHF+
Sbjct: 387 CLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDKDSGGPSKFYQSRTN-WAFSSTGHFM 445
Query: 238 DDKSP-DTNIQKNTSRLLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTD 296
DD P D+ I N SRL M++ LYT AR+S +SLTYY FCLENGNY V LHFAE FTD
Sbjct: 446 DDDHPTDSFIGTNVSRLAMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHFAEITFTD 505
Query: 297 DKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRLYWAGK 356
DKTY SLGRR+FDVY+Q +L LKDFNIE+EAGGV K I+K F+A+VTN T++IR YWAGK
Sbjct: 506 DKTYSSLGRRLFDVYVQDELVLKDFNIEDEAGGVSKEILKFFTAIVTNNTLEIRFYWAGK 565
Query: 357 GTTEIPDRGVYGPLISAISLHNPDF---------EGSSGISVGTVLGIVAAAAVVIILVV 407
GTT IP RGVYGPLISAIS+ +PDF S GI VG V+GIVA +++ LV+
Sbjct: 566 GTTGIPVRGVYGPLISAISV-DPDFIPPTENRSSSISVGIVVGVVVGIVAGVILLVFLVI 624
Query: 408 GILWWKGCFRPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLL 467
GILWW+ C R K T E+EL+GLDLQTG FTLRQIKAATN+FD ANKIGEGGFG VYKG+L
Sbjct: 625 GILWWRVCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYKGVL 684
Query: 468 ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527
+DGT+IAVKQLS+KSKQGNREFV EIG ISALQHPHLVKLYGCCIEGNQLLLIYEY+ENN
Sbjct: 685 SDGTIIAVKQLSSKSKQGNREFVTEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYMENN 744
Query: 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 587
SLARALFGPEE +L+LDWPTRH IC+GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN
Sbjct: 745 SLARALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 804
Query: 588 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
PKISDFGLAKLDEE NTHISTR+AGTFGYMAPEYAMRG+LTDKADVYSFG+VALEIVSGR
Sbjct: 805 PKISDFGLAKLDEEYNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGVVALEIVSGR 864
Query: 648 SNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPT 707
SN + KEE YLLD AL LKE+G+LM++VDP LGS+ +KE+V M+N+ALLC +S
Sbjct: 865 SNTTYRPKEESIYLLDRALSLKEKGSLMDIVDPRLGSDFNKEEVMAMLNIALLCTTISSA 924
Query: 708 NRPLMSSVVSMLEGRVGVPDIVQDSSVSNKDESKSEAMRKYYQFSIENT-----ASTQSV 762
RP MSSVVSMLEGR V DIV D S + D+ K E M+++Y+ E + + QS+
Sbjct: 925 VRPAMSSVVSMLEGRTAVQDIVSDPSAPS-DDLKLEEMKEHYRHIQEKSMGVSESKAQSM 983
Query: 763 STDGPPTGSSTSGVDLYPFNIDSE 786
DGP T SS S DLYP N+DSE
Sbjct: 984 P-DGPWTASS-SIPDLYPVNLDSE 1005
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567058|ref|XP_002524511.1| ATP binding protein, putative [Ricinus communis] gi|223536185|gb|EEF37838.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 969 bits (2504), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/792 (63%), Positives = 593/792 (74%), Gaps = 58/792 (7%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDL-NGPEATLPDLRN- 62
+Q + LSG +P +G L GK +TDLRISDL NG E P L N
Sbjct: 234 IQGSGLSGPIPSGIGLL---GK---------------MTDLRISDLSNGTETPFPPLSNM 275
Query: 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL 122
+ K LI R+CN+ GELP +LG ++++KVLDLSFNKL G IP SF+ LA+ D+I
Sbjct: 276 KNLKTLICRTCNIVGELPQYLGGMTKLKVLDLSFNKLTGEIPSSFSGLANTDYI------ 329
Query: 123 LTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIVSCLRSH 182
DLSYNN +SS CQ G++NLF SSS +N + VSCLRS+
Sbjct: 330 -----------------DLSYNNLTFQSS---CQQGSINLFGSSSM-ANVSATVSCLRSY 368
Query: 183 TCPKTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHFLDD-KS 241
CPK + HINCGG E ++G T +E+D D ++F + TN WAFSSTGHFLDD +
Sbjct: 369 RCPKNFYSFHINCGGKEAIISGKT-YEDDIDSGGPSKFYQSRTN-WAFSSTGHFLDDDRQ 426
Query: 242 PDTNIQKNTSRLLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTDDKTYK 301
PD+ I NT++L LY +AR+SPISLTYY FC+ NGNY V+LHFAE MFT+D TY
Sbjct: 427 PDSYIWTNTTKLYAGTSALYMDARLSPISLTYYGFCMGNGNYTVSLHFAEIMFTNDSTYS 486
Query: 302 SLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRLYWAGKGTTEI 361
SLGRRIFD+YIQG+L KDFNI EEAGG GK I+K F+A+V N T++IR YW GKGTT I
Sbjct: 487 SLGRRIFDIYIQGELVKKDFNIAEEAGGAGKAIIKSFAAIVINHTLEIRFYWNGKGTTGI 546
Query: 362 PDRGVYGPLISAISLHN---PDFEGSSGISVGTVLGIVAAAAVVIILVVGILWWKGCFRP 418
P RGVYGPLISAIS+ + P E + IS+GTV+GIVA A VI ++G+LWWKGC
Sbjct: 547 PVRGVYGPLISAISVTSDFVPPSENNKRISIGTVIGIVATAIAVIFFILGVLWWKGCLGR 606
Query: 419 KYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQL 478
K +++LRGL+LQTGSFTL+QIKAATN+FD NKIGEGGFG VYKGLL+DGT IAVKQL
Sbjct: 607 KDILDQDLRGLELQTGSFTLKQIKAATNNFDPDNKIGEGGFGSVYKGLLSDGTAIAVKQL 666
Query: 479 SAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEE 538
S+KSKQGNREF+ EIG ISALQHPHLVKLYGCCI+GNQL L+YEY+ENNSLARALFGPEE
Sbjct: 667 SSKSKQGNREFITEIGMISALQHPHLVKLYGCCIDGNQLFLLYEYMENNSLARALFGPEE 726
Query: 539 HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598
+L LDWPTRH IC+GIARGLA+LHEESRLKIVHRDIKATNVLLDK+L+PKISDFGLAKL
Sbjct: 727 CQLNLDWPTRHKICVGIARGLAFLHEESRLKIVHRDIKATNVLLDKNLDPKISDFGLAKL 786
Query: 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCK--TKE 656
DEE+NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSN + KE
Sbjct: 787 DEEENTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNTSLRQNMKE 846
Query: 657 EKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVV 716
+ FYLLDWAL+LKE+G+L+ELVDP +G+N DK QV MINVAL CA VS RP MSSVV
Sbjct: 847 DCFYLLDWALVLKEKGSLLELVDPRMGTNYDKNQVMTMINVALQCASVSSVARPAMSSVV 906
Query: 717 SMLEGRVGVPDIVQDSSVSNKDESKSEAMRKYYQFSIENTAS---TQSVSTDGPPTGSST 773
S+LEG+ V D+V D S + DE K EAMRK++Q +IE+ S TQS+S DGP TGSS+
Sbjct: 907 SILEGKTTVQDLVLDDSNVSHDEKKIEAMRKHFQHNIESQTSESQTQSMSLDGPWTGSSS 966
Query: 774 SGVDLYPFNIDS 785
S DLYP +DS
Sbjct: 967 SAGDLYPITLDS 978
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357492929|ref|XP_003616753.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355518088|gb|AES99711.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 955 bits (2468), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/798 (62%), Positives = 610/798 (76%), Gaps = 31/798 (3%)
Query: 5 VQSNRLSGELPE------ELGSLIHSGKWFGWANSVWHYFS--ESLTDLRISDLNGPE-A 55
+Q N+ SG++P+ L LI G G + + S E LTDLRISDL+G E +
Sbjct: 212 IQDNQFSGKIPDFIQSWTSLTKLIIEGS--GLSGPIPSGISKLEKLTDLRISDLSGSEFS 269
Query: 56 TLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDF 115
P L++ K LILR+CN+ G LP +LG ++ +K LDLSFNKL+G IP ++ L VD+
Sbjct: 270 PFPQLKDLKLKTLILRNCNINGTLPEYLGTMTTLKNLDLSFNKLSGPIPSNYDPLRKVDY 329
Query: 116 IYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGI 175
IYLTGNLLTG VP W + +N+D+SYNNF CQ+G VN F SSS N +G+
Sbjct: 330 IYLTGNLLTGPVPAWT--QKADNLDISYNNFTISQGSQPCQDGNVNYF-SSSLTRNESGV 386
Query: 176 VSCLRSHTCPKTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGH 235
VSCL+S CPKT + INCGG VTVNGST +++D+D A ARF +GTN W FS+TG+
Sbjct: 387 VSCLKSFVCPKTSYALRINCGGKSVTVNGST-YDDDSDTAAPARFHQSGTN-WGFSTTGN 444
Query: 236 FLDDKSPDTNIQKNTSRLLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFT 295
F+D+ D N S+L + + +LYT ARVSP SLTYY FC+ NGNY VNL FAE MFT
Sbjct: 445 FMDNDGGDYYTWSNRSKLSIANAELYTNARVSPTSLTYYGFCMANGNYTVNLQFAEIMFT 504
Query: 296 DDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRLYWAG 355
+D+T+ SLGRR+FD+YIQGKL KDF+I +EAGGV K + KPF+AVVT+ T++IRLYWAG
Sbjct: 505 NDQTFNSLGRRVFDIYIQGKLVKKDFDIAKEAGGVDKEVTKPFTAVVTDSTLEIRLYWAG 564
Query: 356 KGTTEIPDRGVYGPLISAISLHNPDF----EGSSGISVGTVLGIVAAAAVVIILVVGILW 411
KGTT IP R VYGPLISAIS+ + DF E S IS+G V+GIVAA +VIIL+ GILW
Sbjct: 565 KGTTGIPFRSVYGPLISAISVQS-DFPAPSENGSSISIGAVVGIVAAVVIVIILLFGILW 623
Query: 412 WKGCFRPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGT 471
WKGCF K + E E++GL+LQ F +RQIK ATN+FD++NKIGEGGFGPVYKG L+DGT
Sbjct: 624 WKGCFGKKSSLENEVKGLNLQMSLFNVRQIKGATNNFDISNKIGEGGFGPVYKGRLSDGT 683
Query: 472 LIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLAR 531
LIAVK LS+KSKQGNREF+NEIG ISALQHPHLVKLYGCC+EG+QL+LIYEYLENNSLAR
Sbjct: 684 LIAVKLLSSKSKQGNREFLNEIGMISALQHPHLVKLYGCCVEGDQLMLIYEYLENNSLAR 743
Query: 532 ALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 591
ALFGP EH+++LDWPTR+ IC+GIARGLAYLHEESRLK+VHRDIKATNVLLDKDLNPKIS
Sbjct: 744 ALFGPAEHQIRLDWPTRYKICVGIARGLAYLHEESRLKVVHRDIKATNVLLDKDLNPKIS 803
Query: 592 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIM 651
DFGLAKLDEE+NTHISTR+AGT+GYMAPEYAM G+LTDKADVYSFGIVALEI+ G +N +
Sbjct: 804 DFGLAKLDEEENTHISTRIAGTYGYMAPEYAMHGYLTDKADVYSFGIVALEILHGSNNTI 863
Query: 652 CKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL 711
+ KEE F+LLDWA +LKE+GN +ELVD LGSN +KE+ +MINVALLC +V+ + RP
Sbjct: 864 LRQKEEAFHLLDWAHILKEKGNEIELVDKRLGSNFNKEEAMLMINVALLCTNVTSSLRPA 923
Query: 712 MSSVVSMLEGRVGVPDIVQDSSVSNKDESKSEAMRKYYQFSIENTASTQSVSTDGPPTGS 771
MSSVVSMLEG++ + ++V +SS DE K EAMRK+YQ QS+S +GP T S
Sbjct: 924 MSSVVSMLEGKIAIQELVLESS-EVLDEKKMEAMRKHYQ--------DQSISMEGPWTAS 974
Query: 772 STS-GVDLYPFNIDSERL 788
S+S DLYP N+DS L
Sbjct: 975 SSSVTTDLYPVNLDSSYL 992
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567064|ref|XP_002524514.1| ATP binding protein, putative [Ricinus communis] gi|223536188|gb|EEF37841.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 950 bits (2455), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/800 (63%), Positives = 604/800 (75%), Gaps = 28/800 (3%)
Query: 5 VQSNRLSGELPE------ELGSLIHSGKWFGWANSVWHYFSESLTDLRISDL-NGPEATL 57
+ N+ +G++P+ L L+ G ++TD+RISDL NG E
Sbjct: 210 IGDNKFTGQIPDLIQNWTNLQKLVIQGSGLSGPVPSGISLLANITDMRISDLSNGTETPF 269
Query: 58 PDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFI 116
P L + + K LILRSCN+ G+LP +LG ++ ++ LDLSFNKL G IP F+ + D+I
Sbjct: 270 PALSSMKNLKTLILRSCNIVGQLPLYLGGMTNLRTLDLSFNKLTGGIPSDFSNIQKADYI 329
Query: 117 YLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIV 176
YLTGN L G VP W+ +G NIDLSYNNF D+S+ CQ ++NLF SSS N+T IV
Sbjct: 330 YLTGNRLNGTVPDWILQKG-NNIDLSYNNFIDQST---CQQRSINLFGSSSM-ENATEIV 384
Query: 177 SCLRSHTCPKTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHF 236
SCLRSH CPK + HINCGG E +N T+EED D +RF + TN WAFSSTGHF
Sbjct: 385 SCLRSHRCPKNFYSFHINCGGKEAVIN-RNTYEEDVDSGGPSRFYQSRTN-WAFSSTGHF 442
Query: 237 LDDKSP-DTNIQKNTSRLLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFT 295
LDD P D+ NT++L LYT+AR+SP+SLTYY FC+ NGNY V+LHFAE +FT
Sbjct: 443 LDDDRPTDSYTWTNTTKLSSGISALYTDARLSPLSLTYYGFCMGNGNYTVDLHFAEIIFT 502
Query: 296 DDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRLYWAG 355
D TY SLGRR+FD+YIQGKL KDFNI ++AGGVGK I+K F+A+VTN T++IR YW G
Sbjct: 503 ADNTYSSLGRRMFDIYIQGKLVGKDFNIADDAGGVGKAIIKKFTAIVTNHTLEIRFYWDG 562
Query: 356 KGTTEIPDRGVYGPLISAISLHNPDF-----EGSSGISVGTVLGIVAAAAVVIILVVGIL 410
KGTT IP RG+YGPLISAIS+ P+F SS IS GTV GIV VV+ LV+G+L
Sbjct: 563 KGTTGIPLRGIYGPLISAISV-TPNFVPPSENSSSSISTGTVAGIVIVVVVVVFLVLGVL 621
Query: 411 WWKGCFRPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADG 470
WWKGC K T ++ L+GLDLQTGSFTL+QIKAAT++F++ NKIGEGGFG VYKGLL+DG
Sbjct: 622 WWKGCLGQKDTVDQALKGLDLQTGSFTLKQIKAATHNFNLDNKIGEGGFGSVYKGLLSDG 681
Query: 471 TLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLA 530
T+IAVKQLS+KSKQGNREFVNEIG ISALQHPHLVKLYGCCIE NQLLL+YEY+ENNSLA
Sbjct: 682 TIIAVKQLSSKSKQGNREFVNEIGMISALQHPHLVKLYGCCIEENQLLLVYEYMENNSLA 741
Query: 531 RALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 590
RALFGPEE +L LDWPTRH IC+GIARGLA+LHEESRLKIVHRDIKATNVLLDK+LNPKI
Sbjct: 742 RALFGPEECQLDLDWPTRHKICVGIARGLAFLHEESRLKIVHRDIKATNVLLDKNLNPKI 801
Query: 591 SDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNI 650
SDFGLAKLDEE+NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSN
Sbjct: 802 SDFGLAKLDEEENTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNT 861
Query: 651 MCK--TKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTN 708
+ KE YLLDWAL+LKE+G+L+ELVDP +G+N +K +V +INVAL CA VSP
Sbjct: 862 SYRLNLKENCVYLLDWALVLKEKGSLLELVDPRMGTNYNKAEVMTVINVALQCASVSPGV 921
Query: 709 RPLMSSVVSMLEGRVGVPDIVQDSSVSNKDESKSEAMRKYYQFSIENTAS---TQSVSTD 765
RP MSSVVSMLEG+ V D Q++S S+ DE K EAM K++Q SIE+ S QS+S D
Sbjct: 922 RPAMSSVVSMLEGKTVVQDFTQETS-SSFDEMKDEAMSKHFQHSIEHKTSESQIQSMSLD 980
Query: 766 GPPTGSSTSGVDLYPFNIDS 785
GP SSTS DLYP +DS
Sbjct: 981 GPWVASSTSEQDLYPVTLDS 1000
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351723187|ref|NP_001237014.1| receptor-like protein kinase 2-like precursor [Glycine max] gi|51847838|gb|AAU10526.1| putative receptor-like protein kinase 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 937 bits (2421), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/796 (62%), Positives = 597/796 (75%), Gaps = 25/796 (3%)
Query: 5 VQSNRLSGELPE------ELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATL- 57
+ N+ SG++P L L+ G F E+LTDLRISDLNG E +L
Sbjct: 213 IGDNQFSGKIPNFIQSLTSLQKLVIQGSGLSGPIPSGISFLENLTDLRISDLNGSEHSLF 272
Query: 58 PDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFI 116
P L + K LILR+CN+ G LP +LG ++ +K LDLSFNKL G IP ++ L VD+I
Sbjct: 273 PQLNQMKNLKYLILRNCNINGTLPPYLGNMTTLKNLDLSFNKLTGPIPSTYDALRKVDYI 332
Query: 117 YLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIV 176
YLTGNLL G+VP W +N+D+S+NNF+ S GS CQ G VNLFASS N +G V
Sbjct: 333 YLTGNLLNGQVPAWT--EKSDNVDISFNNFSVTSQGSTCQIGNVNLFASSMT-HNDSGTV 389
Query: 177 SCLRSHTCPKTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHF 236
+CL S C +T +HINCGG VT NGST +++D+D ARF +GT +WA+ +TG+F
Sbjct: 390 ACLGSSVCQETLYSLHINCGGKIVTDNGST-YDDDSDTGGPARFHRSGTKNWAYINTGNF 448
Query: 237 LDDKSPDTNIQKNTSRLLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTD 296
+D+ + I +N + L D+ LY +ARVSPISLTYY FCL NGNY VNLHFAE MF D
Sbjct: 449 MDNDAGAYYIVQNKTLLSTDNVDLYMDARVSPISLTYYGFCLGNGNYTVNLHFAEIMFID 508
Query: 297 DKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRLYWAGK 356
D+T+ SLGRR+FD+YIQG L KDF+I EEAGG+GK ++ F+AVVT+ T++IRLYWAGK
Sbjct: 509 DQTFNSLGRRVFDIYIQGALVKKDFDIVEEAGGIGKAVITSFTAVVTSNTLEIRLYWAGK 568
Query: 357 GTTEIPDRGVYGPLISAISLHNPDFEGSS----GISVGTVLGIVAAAAVVIILVVGILWW 412
GTT +P R VYGPLISAIS+ PDF S ISVG V+G+VAA AVVIILV+GILWW
Sbjct: 569 GTTSLPFRSVYGPLISAISVE-PDFTPPSKNKSSISVGVVVGVVAAGAVVIILVLGILWW 627
Query: 413 KGCFRPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTL 472
KGCF K + EREL+GLDL+TG FTLRQIKAATN+FDVANKIGEGGFGPVYKG +DGTL
Sbjct: 628 KGCFGKKSSLERELQGLDLRTGLFTLRQIKAATNNFDVANKIGEGGFGPVYKGCFSDGTL 687
Query: 473 IAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARA 532
IAVKQLS+KS+QGNREF+NEIG ISALQHPHLVKLYGCC+EG+QLLL+YEY+ENNSLARA
Sbjct: 688 IAVKQLSSKSRQGNREFLNEIGMISALQHPHLVKLYGCCVEGDQLLLVYEYMENNSLARA 747
Query: 533 LFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 592
LFG EEH++KLDW TR+ IC+GIARGLAYLHEESRLKIVHRDIKATNVLLD+DLNPKISD
Sbjct: 748 LFGAEEHQIKLDWTTRYKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDQDLNPKISD 807
Query: 593 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMC 652
FGLAKLDEEDNTHISTR+AGTFGYMAPEYAM G+LTDKADVYSFGIVALEI++GRSN +
Sbjct: 808 FGLAKLDEEDNTHISTRIAGTFGYMAPEYAMHGYLTDKADVYSFGIVALEIINGRSNTIH 867
Query: 653 KTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLM 712
+ KEE F +L+WA LL+E+G++M+LVD LG +KE+ VMI VALLC +V+ RP M
Sbjct: 868 RQKEESFSVLEWAHLLREKGDIMDLVDRRLGLEFNKEEALVMIKVALLCTNVTAALRPTM 927
Query: 713 SSVVSMLEGRVGVPDIVQDSSVSNKDESKSEAMRKYYQFSIENTASTQSVSTDGPPTGSS 772
SSVVSMLEG++ V + + DE K E MR YYQ S S + P T SS
Sbjct: 928 SSVVSMLEGKIVVDEEFSGETTEVLDEKKMEKMRLYYQ--------ELSNSKEEPWTASS 979
Query: 773 TSGVDLYPFNIDSERL 788
TS DLYP +DS L
Sbjct: 980 TSVADLYPVGLDSSYL 995
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449456691|ref|XP_004146082.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 936 bits (2420), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/792 (62%), Positives = 602/792 (76%), Gaps = 35/792 (4%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRT 64
+Q++ LSG +P E+G L LTDLRISDLNG + LP L T
Sbjct: 239 IQASGLSGPIPSEIGLLTK------------------LTDLRISDLNGGSSQLPPLNTLT 280
Query: 65 -FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLL 123
K+LILRSC++TG LP L S+++ LD SFNK+ G IP SF L VD I+LTGNLL
Sbjct: 281 KLKHLILRSCSITGMLPDILAGFSDLRTLDFSFNKITGPIPHSFEALKKVDSIFLTGNLL 340
Query: 124 TGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIVSCLRSHT 183
G VP WM +G ++IDLSYN F +S + CQ +NLFASSS+ SNS G VSCL +
Sbjct: 341 NGSVPNWMLNQG-KSIDLSYNTFT-QSQNTGCQPRNLNLFASSSEDSNS-GTVSCLGA-- 395
Query: 184 CPKTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHFLDD-KSP 242
C KT+ VHINCGG+E +NG+T F+ + + T++ F G +W FS+TG F+DD ++
Sbjct: 396 CEKTWYSVHINCGGNEEFINGTTKFDANPETGTSSFF-LQGRTNWGFSNTGTFMDDGQTS 454
Query: 243 DTNIQKNTSRLLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTDDKTYKS 302
D I +N S L M + +LY AR+SPISLTYY CL GNY ++LHFAE FT+D+TY+S
Sbjct: 455 DDFIARNLSALSMPNPELYVRARISPISLTYYAHCLGTGNYTLSLHFAEIAFTNDETYRS 514
Query: 303 LGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRLYWAGKGTTEIP 362
LGRR+FDVY+QGKLELKDFNI + AGG+GKP+VK F+ V NGT++IRL+WAGKG+ IP
Sbjct: 515 LGRRVFDVYVQGKLELKDFNIADAAGGIGKPLVKKFTVSVINGTVEIRLFWAGKGSNAIP 574
Query: 363 DRGVYGPLISAISLHNPDFE----GSSGISVGTVLGIVAAAAVVIILVVGILWWKGCFRP 418
RGVYGPLISAISL +PDFE G + IS G V GIV A VI+LV+G+LWW+GC R
Sbjct: 575 VRGVYGPLISAISL-DPDFEPPSEGGNAISAGAVAGIVVAVVFVILLVLGVLWWRGCLRK 633
Query: 419 KYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQL 478
T E+EL+GLDL TGSF+LRQI+ ATN+FD ANKIGEGGFGPV+KG+LADGT+IAVKQL
Sbjct: 634 PSTLEQELKGLDLGTGSFSLRQIRDATNNFDAANKIGEGGFGPVFKGVLADGTIIAVKQL 693
Query: 479 SAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEE 538
S+KSKQGNREFVNEIG ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGP E
Sbjct: 694 SSKSKQGNREFVNEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPGE 753
Query: 539 HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598
+LKLDWPTR IC+GIARGLAYLHEESRLKIVHRDIKATNVLLDK+L+ KISDFGLAKL
Sbjct: 754 SQLKLDWPTRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKNLDAKISDFGLAKL 813
Query: 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEK 658
DEE+NTHISTRVAGTFGYMAPEYAMRG+LTDKADVYSFGIVALEIVSGRSN +TK++
Sbjct: 814 DEEENTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNTSYRTKDDC 873
Query: 659 FYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718
FYLLD A LKE+ +L+ELVD LGS+ +K + MIN+ L C +V +RP MSSVVSM
Sbjct: 874 FYLLDHANTLKEKDSLLELVDSRLGSDFNKREAMAMINIGLQCTNVVSADRPAMSSVVSM 933
Query: 719 LEGRVGVPDIVQDSSVSNKDESK--SEAMRKYYQFSIENTASTQSVSTDGPPTGSSTSGV 776
LEG++ V ++V D S+S +D + S+ R+ Q + E + TQS++ DGP TGSST+
Sbjct: 934 LEGKIAVKEVVSDPSISKQDVNAMWSQIYRQKGQTTSE--SQTQSLTMDGPWTGSSTTAS 991
Query: 777 DLYPFNIDSERL 788
DLYP N+DS+ L
Sbjct: 992 DLYPINMDSKYL 1003
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449503668|ref|XP_004162117.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2415), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/792 (62%), Positives = 602/792 (76%), Gaps = 35/792 (4%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRT 64
+Q++ LSG +P E+G L LTDLRISDLNG + LP L T
Sbjct: 239 IQASGLSGPIPSEIGLLTK------------------LTDLRISDLNGGSSQLPPLNTLT 280
Query: 65 -FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLL 123
K+LILRSC++TG LP L S+++ LD SFNK+ G IP SF L VD I+LTGNLL
Sbjct: 281 KLKHLILRSCSITGMLPDNLAGFSDLRTLDFSFNKITGPIPHSFEALKKVDSIFLTGNLL 340
Query: 124 TGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIVSCLRSHT 183
G VP WM +G ++IDLSYN F +S + CQ +NLFASSS+ SNS G VSCL +
Sbjct: 341 NGSVPNWMLNQG-KSIDLSYNTFT-QSQNTGCQPRNLNLFASSSEDSNS-GTVSCLGA-- 395
Query: 184 CPKTYSYVHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHFLDD-KSP 242
C KT+ VHINCGG+E +NG+T F+ + + T++ F G +W FS+TG F+DD ++
Sbjct: 396 CEKTWYSVHINCGGNEEFINGTTKFDANPETGTSSFF-LQGRTNWGFSNTGTFMDDGQTS 454
Query: 243 DTNIQKNTSRLLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTDDKTYKS 302
D I +N S L M + +LY AR+SPISLTYY CL GNY ++LHFAE FT+D+TY+S
Sbjct: 455 DDFIARNLSALSMPNPELYVRARISPISLTYYAHCLGTGNYTLSLHFAEIAFTNDETYRS 514
Query: 303 LGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRLYWAGKGTTEIP 362
LGRR+FDVY+QGKLELKDFNI + AGG+GKP+VK F+ V NGT++IRL+WAGKG+ IP
Sbjct: 515 LGRRVFDVYVQGKLELKDFNIADAAGGIGKPLVKKFTVSVINGTVEIRLFWAGKGSNAIP 574
Query: 363 DRGVYGPLISAISLHNPDFE----GSSGISVGTVLGIVAAAAVVIILVVGILWWKGCFRP 418
RGVYGPLISAISL +PDFE G + IS G V GIV A VI+LV+G+LWW+GC R
Sbjct: 575 VRGVYGPLISAISL-DPDFEPPSEGGNAISAGAVAGIVVAVVFVILLVLGVLWWRGCLRK 633
Query: 419 KYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQL 478
T E+EL+GLDL TGSF+LRQI+ ATN+FD ANKIGEGGFGPV+KG+LADGT+IAVKQL
Sbjct: 634 PSTLEQELKGLDLGTGSFSLRQIRDATNNFDAANKIGEGGFGPVFKGVLADGTIIAVKQL 693
Query: 479 SAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEE 538
S+KSKQGNREFVNEIG ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGP E
Sbjct: 694 SSKSKQGNREFVNEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPGE 753
Query: 539 HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598
+LKLDWPTR IC+GIARGLAYLHEESRLKIVHRDIKATNVLLDK+L+ KISDFGLAKL
Sbjct: 754 SQLKLDWPTRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKNLDAKISDFGLAKL 813
Query: 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEK 658
DEE+NTHISTRVAGTFGYMAPEYAMRG+LTDKADVYSFGIVALEIVSGRSN +TK++
Sbjct: 814 DEEENTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNTSYRTKDDC 873
Query: 659 FYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718
FYLLD A LKE+ +L+ELVD LGS+ +K + MIN+ L C +V +RP MSSVVSM
Sbjct: 874 FYLLDHANTLKEKDSLLELVDSRLGSDFNKREAMAMINIGLQCTNVVSADRPAMSSVVSM 933
Query: 719 LEGRVGVPDIVQDSSVSNKDESK--SEAMRKYYQFSIENTASTQSVSTDGPPTGSSTSGV 776
LEG++ V ++V D S+S +D + S+ R+ Q + E + TQS++ DGP TGSST+
Sbjct: 934 LEGKIAVKEVVSDPSISKQDVNAMWSQIYRQKGQTTSE--SQTQSLTMDGPWTGSSTTAS 991
Query: 777 DLYPFNIDSERL 788
DLYP N+DS+ L
Sbjct: 992 DLYPINMDSKYL 1003
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 790 | ||||||
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.870 | 0.721 | 0.570 | 2.9e-213 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.881 | 0.672 | 0.552 | 3.1e-193 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.898 | 0.695 | 0.490 | 1.7e-178 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.422 | 0.344 | 0.620 | 7.5e-174 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.849 | 0.622 | 0.488 | 6e-167 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.829 | 0.634 | 0.439 | 6.3e-140 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.862 | 0.650 | 0.408 | 5.5e-125 | |
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.391 | 0.792 | 0.530 | 1e-82 | |
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.358 | 0.720 | 0.535 | 8.3e-81 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.365 | 0.462 | 0.442 | 1.2e-77 |
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2061 (730.6 bits), Expect = 2.9e-213, P = 2.9e-213
Identities = 410/719 (57%), Positives = 512/719 (71%)
Query: 42 LTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLN 100
L DLRISDLNGPE+ P LRN + + LILR+CNLTG+LP +LG+++ K LDLSFNKL+
Sbjct: 232 LKDLRISDLNGPESPFPQLRNIKKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLS 291
Query: 101 GTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAV 160
G IP ++ L D +IY TGN+L G VP WM +G + IDLSYNNF+ + + + C
Sbjct: 292 GAIPNTYINLRDGGYIYFTGNMLNGSVPDWMVNKGYK-IDLSYNNFSVDPTNAVC----- 345
Query: 161 NLFASSSKGSNSTGIVSCLRSHTCPKTYSYVHINCGGSEVTVNGSXXXXXXXXXXXXXRF 220
K +N ++SC+R++ CPKT++ +HINCGG E+++NG+
Sbjct: 346 -------KYNN---VLSCMRNYQCPKTFNALHINCGGDEMSINGTIYESDKYDRLESW-- 393
Query: 221 GFTGTNHWAFSSTGHFLDDKS-PD-TNIQKNTSRLLMDDFQLYTEARVSPISLTYYVFCL 278
+ N W ++ G F+DDK P+ I+ N+S L + DF LYT+AR+S ISLTYY CL
Sbjct: 394 -YESRNGWFSNNVGVFVDDKHVPERVTIESNSSELNVVDFGLYTQARISAISLTYYALCL 452
Query: 279 ENGNYKVNLHFAETMFTDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPF 338
ENGNY VNLHFAE MF + Y+SLGRR FD+YIQ KLE+KDFNI +EA VG ++K F
Sbjct: 453 ENGNYNVNLHFAEIMFNGNNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTF 512
Query: 339 SAVVTNGTMDIRLYWAGKGTTEIPDRGVYGPLISAISLH---NPDFEGSSGISXXXXXXX 395
+ +G ++IRLYWAG+GTT IP VYGPLISAIS+ NP +G+S
Sbjct: 513 PVEIKDGKLEIRLYWAGRGTTVIPKERVYGPLISAISVDSSVNPS--PRNGMSTGTLHTL 570
Query: 396 XXXXXXXXXXXXXXXWWK-GCFRPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKI 454
WK G R K E++ + L+L SF+LRQIK ATN+FD AN+I
Sbjct: 571 VVILSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRI 630
Query: 455 GEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEG 514
GEGGFGPVYKG L DGT+IAVKQLS SKQGNREF+NEIG ISAL HP+LVKLYGCC+EG
Sbjct: 631 GEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEG 690
Query: 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRD 574
QLLL+YE++ENNSLARALFGP+E +L+LDWPTR ICIG+ARGLAYLHEESRLKIVHRD
Sbjct: 691 GQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRD 750
Query: 575 IKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVY 634
IKATNVLLDK LNPKISDFGLAKLDEED+THISTR+AGTFGYMAPEYAMRGHLTDKADVY
Sbjct: 751 IKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVY 810
Query: 635 SFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVM 694
SFGIVALEIV GRSN + ++K FYL+DW +L+E+ NL+ELVDP LGS ++E+ M
Sbjct: 811 SFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTM 870
Query: 695 INVALLCADVSPTNRPLMSSVVSMLEGRVGVP-DIVQDSSVSNKDE--SKSEAMRKYYQ 750
I +A++C P RP MS VV MLEG+ V + ++++SV + + M+KYY+
Sbjct: 871 IQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEKLEEASVHRETKRLENMNTMKKYYE 929
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1872 (664.0 bits), Expect = 3.1e-193, P = 3.1e-193
Identities = 397/719 (55%), Positives = 500/719 (69%)
Query: 40 ESLTDLRISDLNGPEATLPDLRNRT-FKNLILRSCNLTGELPHFLG-EVSEMKVLDLSFN 97
++LT+LRI+DL GP + PDL+N T + L+LR+C + +P ++G ++ +K+LDLS N
Sbjct: 255 KNLTELRITDLRGPTSPFPDLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSN 314
Query: 98 KLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQN 157
LNGTIP++F L +F+YL N LTG VPQ++ +NIDLSYNNF + S C
Sbjct: 315 MLNGTIPDTFRSLNAFNFMYLNNNSLTGPVPQFILD-SKQNIDLSYNNFTQPPTLS-CNQ 372
Query: 158 GAVNLFASSSKGSNSTGIVSCLRSHT-CPKT--YSYVHINCGGSEVTVNGSXXXXXXXXX 214
VNL +S +N++ + CLR CP +S + INCGG+ + V+
Sbjct: 373 LDVNLISSYPSVTNNS-VQWCLRKDLPCPGDAHHSSLFINCGGNRLKVDKDEYADDLNKR 431
Query: 215 XXXXRFGFTGTNHWAFSSTGHFLDDKSPDTNIQKNTSRLLMDDF-QLYTEARVSPISLTY 273
F + W +SS+G +L + T + +T L+ + + Y AR++ SL Y
Sbjct: 432 GAST-FSSV-SERWGYSSSGAWLGNDGA-TYLATDTFNLINESTPEYYKTARLASQSLKY 488
Query: 274 YVFCLENGNYKVNLHFAETMFTDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKP 333
Y C+ G+YKV L+FAE MF++D+TY SLGRR+FD+Y+QG L +DFNI + AGGVGKP
Sbjct: 489 YGLCMRRGSYKVQLYFAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKP 548
Query: 334 IVKPFSAVVTNG-TMDIRLYWAGKGTTEIPDRGVYGPLISAISLHNPDFEGSSG--ISXX 390
++ V NG T++I L W GKGT IP RGVYGPLISAI++ P+F+ +G +S
Sbjct: 549 FLRQVDEVQVNGSTLEIHLKWTGKGTNVIPTRGVYGPLISAITV-TPNFKVDTGKPLSNG 607
Query: 391 XXXXXXXXXXXXXXXXXXXXW-WKGCFRPKYTSERE-LRGLDLQTGSFTLRQIKAATNHF 448
G K E E LRGLDLQTGSFTL+QIK ATN+F
Sbjct: 608 VVAGIVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNF 667
Query: 449 DVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLY 508
D NKIGEGGFGPVYKG+LADG IAVKQLS+KSKQGNREFV EIG ISALQHP+LVKLY
Sbjct: 668 DPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLY 727
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
GCCIEG +LLL+YEYLENNSLARALFG E+ RL LDW TR+ +CIGIA+GLAYLHEESRL
Sbjct: 728 GCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRL 787
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLT 628
KIVHRDIKATNVLLD LN KISDFGLAKLDEE+NTHISTR+AGT GYMAPEYAMRG+LT
Sbjct: 788 KIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLT 847
Query: 629 DKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDK 688
DKADVYSFG+V LEIVSG+SN + KEE YLLDWA +L+EQG+L+ELVDP+LG++ K
Sbjct: 848 DKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGTSFSK 907
Query: 689 EQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGV-PDIVQDSSVSNKDESKSEAMR 746
++ M+N+ALLC + SPT RP MSSVVSML+G++ V P +V+ + D S S AMR
Sbjct: 908 KEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKVQPPLVKREA----DPSGSAAMR 962
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1700 (603.5 bits), Expect = 1.7e-178, Sum P(2) = 1.7e-178
Identities = 361/736 (49%), Positives = 477/736 (64%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRT-FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKL 99
+L +LRISD+ GP P L+N T +IL++CN++G++P +L + E++ LDLSFNKL
Sbjct: 266 NLVNLRISDIRGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNKL 325
Query: 100 NGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSD-CQ-- 156
G IP SFA+ ++ FI L GN+L G P + G +DLSYNN +S S C+
Sbjct: 326 VGGIP-SFAQAENLRFIILAGNMLEGDAPDELLRDGI-TVDLSYNNLKWQSPESRACRPN 383
Query: 157 -NGAVNLFASSSKGSNSTGIVSCLRSHTCPKTYSYVHINCGGSEVTVNGSXXXXXXXXXX 215
N +NLF S+S S+ + C++ CP+ S +H+NCGGS++ V
Sbjct: 384 MNLNLNLFQSTST-KKSSKFLPCIKDFKCPRYSSCLHVNCGGSDMYVKEKKTKELYEGDG 442
Query: 216 X----XXRFGFTGTNHWAFSSTGHFLDDKSPDTNIQKNTSRLLM---DDFQLYTEARVSP 268
++ +W FSSTG F+DD N Q + + + LY AR++P
Sbjct: 443 NVEGGAAKYFLKPDANWGFSSTGDFMDDN----NFQNTRFTMFVPASNQSDLYKSARIAP 498
Query: 269 ISLTYYVFCLENGNYKVNLHFAETMFTDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAG 328
+SLTY+ CLENGNY +NL FAE FT+D+ Y LGRR+FD+YIQ KL KDFNI +EA
Sbjct: 499 VSLTYFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNIMDEAK 558
Query: 329 GVGKPIVKPFSAVVTNGTMDIRLYWAGKGTTEIPDRGVYGPLISAISL---HNPDFEGSS 385
G PI+KP +A VTN + IRL WAGKGTT IP RGVYGP+ISAIS+ P +
Sbjct: 559 GAQTPIIKPLTAYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDSKPCERPKT 618
Query: 386 GISXXXXXXXXXXXXXXXXXXXXXXWWKGCFRPKYTSER-ELRGLDLQTGSFTLRQIKAA 444
G+S W GC P+ +R + +L +G+FTLRQIK A
Sbjct: 619 GMSPGAYIAIGIGAPCLIIFILGFLWICGCL-PRCGRQRKDPYEEELPSGTFTLRQIKFA 677
Query: 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL 504
T+ F+ NKIGEGGFG V+KG+LADG ++AVKQLS+KS+QGNREF+NEIG IS LQHP+L
Sbjct: 678 TDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNL 737
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
VKL+G C+E QLLL YEY+ENNSL+ ALF P+ ++ +DWPTR IC GIA+GLA+LHE
Sbjct: 738 VKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGLAFLHE 797
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 624
ES LK VHRDIKATN+LLDKDL PKISDFGLA+LDEE+ THIST+VAGT GYMAPEYA+
Sbjct: 798 ESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALW 857
Query: 625 GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684
G+LT KADVYSFG++ LEIV+G +N + LL++A E G+LM++VD L
Sbjct: 858 GYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGHLMQVVDERLRP 917
Query: 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDIVQDSSVSNKDESKSEA 744
VD+++ +I VAL+C+ SPT+RPLMS VV+MLEG VP+ S N + + +A
Sbjct: 918 EVDRKEAEAVIKVALVCSSASPTDRPLMSEVVAMLEGLYPVPESTPGVS-RNAGDIRFKA 976
Query: 745 MRKYYQFSIENTASTQ 760
+ + +EN + TQ
Sbjct: 977 FKDLRR-GMENNSKTQ 991
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1051 (375.0 bits), Expect = 7.5e-174, Sum P(2) = 7.5e-174
Identities = 209/337 (62%), Positives = 258/337 (76%)
Query: 425 ELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQ 484
+L+G DL+TGSF+LRQ+K ATN FD NKIGEGGFG VYKG L DGTLIAVK+LS+KS Q
Sbjct: 617 KLKGPDLRTGSFSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQ 676
Query: 485 GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLD 544
GN+EFVNEIG I+ LQHP+LVKLYGCC+E NQLLL+YEYLENN L+ ALF LKL+
Sbjct: 677 GNKEFVNEIGMIACLQHPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALFAGRSC-LKLE 735
Query: 545 WPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604
W TRH IC+GIARGLA+LHE+S +KI+HRDIK TNVLLDKDLN KISDFGLA+L E++ +
Sbjct: 736 WGTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQS 795
Query: 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY-LLD 663
HI+TRVAGT GYMAPEYAMRGHLT+KADVYSFG+VA+EIVSG+SN +E LLD
Sbjct: 796 HITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTPDDECCVGLLD 855
Query: 664 WALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723
WA +L+++G++ E++DP L D + MI V+LLCA+ S T RP MS VV MLEG
Sbjct: 856 WAFVLQKKGDIAEILDPRLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQVVKMLEGET 915
Query: 724 GVPDIVQDSSV-SNKDESKSEAMRKYYQFSIENTAST 759
+ I+ D V S+ K ++ Y SI +++ +
Sbjct: 916 EIEQIISDPGVYSDNLHFKPSSLSSDYILSIPSSSES 952
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1624 (576.7 bits), Expect = 6.0e-167, P = 6.0e-167
Identities = 349/715 (48%), Positives = 450/715 (62%)
Query: 40 ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKL 99
E+L DLRISD +P + +++ K L+LR+ NLTG +P L ++ + LDLSFN+L
Sbjct: 266 ENLIDLRISDTAAGLGQVPLITSKSLKFLVLRNMNLTGPIPTSLWDLPNLMTLDLSFNRL 325
Query: 100 NGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGA 159
G +P A + + YL GN+L+GKV F NIDLSYNNF S + N
Sbjct: 326 TGEVP---ADASAPKYTYLAGNMLSGKVESGPFLTASTNIDLSYNNFTWSQSCKERNN-- 380
Query: 160 VNLFASSSKGSNSTGIVSCLRSHTCPKTYSYVHINCGGSEVTVNGSXXXXXXXXXXXXXR 219
+N +ASS ++ T ++ C + C +HINCGG +VT+ S
Sbjct: 381 INTYASSRSTNSLTRLLPCSAINLCQNYNRSLHINCGGPDVTIENSRGRFLYEGD----N 436
Query: 220 FGFTG--TNH----WAFSSTGHFLDDK-SPDTNIQKNTSRLLMDDFQLYTEARVSPISLT 272
+G TG TN+ W FS+TG F+DD + DT + S + LY AR SP+SL
Sbjct: 437 YGLTGSATNYYGKNWGFSNTGDFMDDAITEDTYTVSSESAVSAKYPDLYQNARRSPLSLA 496
Query: 273 YYVFCLENGNYKVNLHFAETMFTDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGK 332
Y+ C ENG+Y V LHFAE F+D++ + L +R+F++Y+QGKL +DF+I EEA G K
Sbjct: 497 YFAICFENGSYNVKLHFAEIQFSDEEPFSRLAKRVFNIYVQGKLIWEDFSIREEANGTHK 556
Query: 333 PIVKPFSAVVTNGTMDIRLYWAGKGTTEIPDRGVYGPLISAISLHNPDFEGSSGI----- 387
++K + VT+ T++IRLYWAGKGTT IP RG YG LISAIS+ P E G+
Sbjct: 557 EVIKEVNTTVTDNTLEIRLYWAGKGTTIIPKRGNYGSLISAISVC-PSSESECGVPVQIH 615
Query: 388 ----------SXXXXXXXXXXXXXXXXXXXXXXWWKGCFRPKYTSERELRGLDLQTGSFT 437
+W+ C ++ E RG SF+
Sbjct: 616 PVTKQQHKQRKYHLILGIAALIVSLSFLILGALYWRICVS---NADGEKRG------SFS 666
Query: 438 LRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTIS 497
LRQ+K AT+ F+ NKIGEGGFG VYKG L +GTLIAVK+LS+KS QGN+EF+NEIG I+
Sbjct: 667 LRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGIIA 726
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
LQHP+LVKLYGCC+E QLLL+YEYLENN LA ALFG LKLDW TRH IC+GIAR
Sbjct: 727 CLQHPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFG--RSGLKLDWRTRHKICLGIAR 784
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 617
GLA+LHE+S +KI+HRDIK TN+LLDKDLN KISDFGLA+L E+D +HI+TRVAGT GYM
Sbjct: 785 GLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTIGYM 844
Query: 618 APEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY-LLDWALLLKEQGNLME 676
APEYAMRGHLT+KADVYSFG+VA+EIVSG+SN E LLDWA +L+++G E
Sbjct: 845 APEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANYTPDNECCVGLLDWAFVLQKKGAFDE 904
Query: 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDIVQD 731
++DP L D + MI V+LLC+ SPT RP MS VV MLEG + +I+ D
Sbjct: 905 ILDPKLEGVFDVMEAERMIKVSLLCSSKSPTLRPTMSEVVKMLEGETEIEEIISD 959
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1286 (457.8 bits), Expect = 6.3e-140, Sum P(2) = 6.3e-140
Identities = 300/682 (43%), Positives = 402/682 (58%)
Query: 68 LILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKV 127
L+LR+ NLTG +P +GE S ++ +DLSFNKL+G IP S L+ + ++L N L G
Sbjct: 296 LVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIPASLFNLSQLTHLFLGNNTLNGSF 355
Query: 128 P----QWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIVSCLRSH- 182
P Q + DLS + + S S N N F + ++CL+ +
Sbjct: 356 PTQKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVANNFTLEGLDNRVLPGLNCLQKNF 415
Query: 183 TCPK---TYSYVHINCGGSEV-TVNGSXXXXXXXXXXXXXRFGFTGTNHWAFSSTGHFLD 238
C + YS INCGG E +V G+ F G WA SS G F
Sbjct: 416 PCNRGKGIYSDFSINCGGPEKRSVTGALFEREDEDFGPASFFVSAG-QRWAASSVGLFAG 474
Query: 239 DKSPDTNIQKNTSRLLMD-DFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMF--T 295
S + I + S+ + D +L+ AR+S S+ YY LENG Y V L FAE +
Sbjct: 475 S-SNNIYIATSQSQFVNTLDSELFQSARLSASSVRYYGLGLENGGYTVTLQFAEIQILGS 533
Query: 296 DDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAG-GVGKPIVKPFSAVVTNGTMDIRLYWA 354
T+K LGRR FD+Y+QG+L KDF++ AG + + + + A V+ +++ L+WA
Sbjct: 534 TSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQRVYKANVSENHLEVHLFWA 593
Query: 355 GKGTTEIPDRGVYGPLISAISLHNPDFEG-------SSGISXXXXXXXXXXXXXXXXXXX 407
GKGT IP +G YGPLISA+S PDF S G +
Sbjct: 594 GKGTCCIPIQGAYGPLISAVSA-TPDFTPTVANKPPSKGKNRTGTIVGVIVGVGLLSILA 652
Query: 408 XXXWWKGCFRPK-YTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL 466
+ R K YT + EL G+D++ FT ++K+AT FD +NK+GEGGFGPVYKG
Sbjct: 653 GVVMFTIRKRRKRYTDDEELLGMDVKPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKGN 712
Query: 467 LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526
L DG ++AVK LS S+QG +FV EI IS++ H +LVKLYGCC EG +L+YEYL N
Sbjct: 713 LNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPN 772
Query: 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 586
SL +ALFG + L LDW TR+ IC+G+ARGL YLHEE+ ++IVHRD+KA+N+LLD L
Sbjct: 773 GSLDQALFG--DKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRL 830
Query: 587 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSG 646
P+ISDFGLAKL ++ THISTRVAGT GY+APEYAMRGHLT+K DVY+FG+VALE+VSG
Sbjct: 831 VPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSG 890
Query: 647 RSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSP 706
R N +EEK YLL+WA L E+ +EL+D L ++ + E+ + MI +ALLC S
Sbjct: 891 RPNSDENLEEEKKYLLEWAWNLHEKSRDIELIDDKL-TDFNMEEAKRMIGIALLCTQTSH 949
Query: 707 TNRPLMSSVVSMLEGRVGVPDI 728
RP MS VV+ML G V + D+
Sbjct: 950 ALRPPMSRVVAMLSGDVEIGDV 971
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1228 (437.3 bits), Expect = 5.5e-125, P = 5.5e-125
Identities = 293/718 (40%), Positives = 411/718 (57%)
Query: 32 NSVWHYFSESLTDLRISDLNGP-EATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMK 90
+++ Y S DL + L+GP A+L +L T +L L + L G LP G+ +
Sbjct: 284 STIGGYTSLQQVDLSFNKLHGPIPASLFNLSRLT--HLFLGNNTLNGSLPTLKGQ--SLS 339
Query: 91 VLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADES 150
LD+S+N L+G++P S+ L D+ + L N T + + R + NF
Sbjct: 340 NLDVSYNDLSGSLP-SWVSLPDLK-LNLVANNFT---LEGLDNRVLSGLHCLQKNFPCNR 394
Query: 151 SGSDCQ-NGAVN---LFA-----SSSKGSNSTGIVSCLRSHTCPKTYSY-VHINCGGSEV 200
C+ N + +F+ + +GSN +C ++ Y INCGG E+
Sbjct: 395 GEGICKCNKKIPSQIMFSMLNVQTYGQGSNVLLEKNCFKTFAIDWCLDYNFSINCGGPEI 454
Query: 201 -TVNGSXXXXXXXXXXXXXRFGFTGTNHWAFSSTGHFLDDKSPDTNIQKNTSRLLMD-DF 258
+V+G+ F + WA SS G+F S + I + ++ + D
Sbjct: 455 RSVSGALFEKEDADLGPAS-FVVSAAKRWAASSVGNFAGS-SNNIYIATSLAQFINTMDS 512
Query: 259 QLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTDDKTYKSLGRRIFDVYIQGKLEL 318
+L+ AR+S SL YY LENG Y V L FAE ++K +GRR F++Y+QG+L
Sbjct: 513 ELFQSARLSASSLRYYGLGLENGGYTVTLQFAEVQIEGSNSWKGIGRRRFNIYVQGRLVE 572
Query: 319 KDFNIEEEAGGVG-KPIVKPFSAVVTNGTMDIRLYWAGKGTTEIPDRGVYGPLISAISLH 377
KDF+I AGG + + + + V+ +++ L+WAGKGT IP +G YGPLI+A+S
Sbjct: 573 KDFDIRRTAGGSSVRAVQREYKTNVSENHLEVHLFWAGKGTCCIPIQGAYGPLIAAVSA- 631
Query: 378 NPDFEGS-SGISXXXXXXXXXXXXXXXXXXXXXXWWKGCF-------RPKYTSERELRGL 429
PDF + + + G R YT + E+ +
Sbjct: 632 TPDFTPTVANRPPSKGKSRTGTIVGVIVGVGLLSIFAGVVILVIRKRRKPYTDDEEILSM 691
Query: 430 DLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREF 489
D++ +FT ++K AT FD++NK+GEGGFG VYKG L DG +AVKQLS S+QG +F
Sbjct: 692 DVKPYTFTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQF 751
Query: 490 VNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRH 549
V EI IS++ H +LVKLYGCC EG+ LL+YEYL N SL +ALFG + L LDW TR+
Sbjct: 752 VAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKS--LHLDWSTRY 809
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609
IC+G+ARGL YLHEE+ ++I+HRD+KA+N+LLD +L PK+SDFGLAKL ++ THISTR
Sbjct: 810 EICLGVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTR 869
Query: 610 VAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669
VAGT GY+APEYAMRGHLT+K DVY+FG+VALE+VSGR N +E K YLL+WA L
Sbjct: 870 VAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLH 929
Query: 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPD 727
E+ +EL+D L S + E+V+ MI +ALLC S RP MS VV+ML G V D
Sbjct: 930 EKNRDVELIDDEL-SEYNMEEVKRMIGIALLCTQSSYALRPPMSRVVAMLSGDAEVND 986
|
|
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 829 (296.9 bits), Expect = 1.0e-82, P = 1.0e-82
Identities = 166/313 (53%), Positives = 216/313 (69%)
Query: 412 WKGCFRPKYTS-ERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADG 470
W C R + T + E+ +D + R+I+ AT+ F NKIGEGGFG VYKG L DG
Sbjct: 5 WLSCHRREATEVDGEIAAID-NVKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDG 63
Query: 471 TLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLA 530
L A+K LSA+S+QG +EF+ EI IS +QH +LVKLYGCC+EGN +L+Y +LENNSL
Sbjct: 64 KLAAIKVLSAESRQGVKEFLTEINVISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLD 123
Query: 531 RALF--GPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 588
+ L G ++ DW +R NIC+G+A+GLA+LHEE R I+HRDIKA+N+LLDK L+P
Sbjct: 124 KTLLAGGYTRSGIQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSP 183
Query: 589 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
KISDFGLA+L + TH+STRVAGT GY+APEYA+RG LT KAD+YSFG++ +EIVSGRS
Sbjct: 184 KISDFGLARLMPPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRS 243
Query: 649 NIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTN 708
N + E YLL+ A L E+ L++LVD L D E+ + + LLC SP
Sbjct: 244 NKNTRLPTEYQYLLERAWELYERNELVDLVDSGLNGVFDAEEACRYLKIGLLCTQDSPKL 303
Query: 709 RPLMSSVVSMLEG 721
RP MS+VV +L G
Sbjct: 304 RPSMSTVVRLLTG 316
|
|
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 787 (282.1 bits), Expect = 8.3e-81, Sum P(2) = 8.3e-81
Identities = 152/284 (53%), Positives = 196/284 (69%)
Query: 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGT 495
F+ +++AT+ F N+IG GG+G V+KG+L DGT +AVK LSA+SKQG REF+ EI
Sbjct: 34 FSYNSLRSATDSFHPTNRIGGGGYGVVFKGVLRDGTQVAVKSLSAESKQGTREFLTEINL 93
Query: 496 ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGI 555
IS + HP+LVKL GCCIEGN +L+YEYLENNSLA L G + LDW R IC+G
Sbjct: 94 ISNIHHPNLVKLIGCCIEGNNRILVYEYLENNSLASVLLGSRSRYVPLDWSKRAAICVGT 153
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 615
A GLA+LHEE +VHRDIKA+N+LLD + +PKI DFGLAKL ++ TH+STRVAGT G
Sbjct: 154 ASGLAFLHEEVEPHVVHRDIKASNILLDSNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVG 213
Query: 616 YMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675
Y+APEYA+ G LT KADVYSFGI+ LE++SG S+ +E L++W L+E+ L+
Sbjct: 214 YLAPEYALLGQLTKKADVYSFGILVLEVISGNSSTRAAFGDEYMVLVEWVWKLREERRLL 273
Query: 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719
E VDP L + ++V I VAL C + RP M V+ ML
Sbjct: 274 ECVDPEL-TKFPADEVTRFIKVALFCTQAAAQKRPNMKQVMEML 316
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 631 (227.2 bits), Expect = 1.2e-77, Sum P(2) = 1.2e-77
Identities = 130/294 (44%), Positives = 187/294 (63%)
Query: 432 QTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNR-EFV 490
Q F+LR+++ A++ F N +G GGFG VYKG LADGTL+AVK+L + G +F
Sbjct: 286 QLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQ 345
Query: 491 NEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHN 550
E+ IS H +L++L G C+ + LL+Y Y+ N S+A L + LDWPTR
Sbjct: 346 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKR 405
Query: 551 ICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 610
I +G ARGL+YLH+ KI+HRD+KA N+LLD++ + DFGLAKL + +TH++T V
Sbjct: 406 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 465
Query: 611 AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS--NIMCKTKEEKFYLLDWAL-L 667
GT G++APEY G ++K DV+ +GI+ LE+++G+ ++ ++ LLDW L
Sbjct: 466 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 525
Query: 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721
LKE+ L LVDP+L +N ++ ++ +I VALLC SP RP MS VV MLEG
Sbjct: 526 LKEK-KLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVRMLEG 578
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGN2 | Y3148_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5666 | 0.9556 | 0.7401 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 790 | |||
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 4e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-39 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-36 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-36 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-32 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-29 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-29 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-27 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-25 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-24 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-19 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-14 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-05 | |
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.003 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 4e-60
Identities = 89/186 (47%), Positives = 109/186 (58%), Gaps = 26/186 (13%)
Query: 191 VHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHFLDDKSPDTNIQKNT 250
+ INCGG E T + T+E DT FTG S +++ D + ++I
Sbjct: 3 LAINCGGPEHTDSDGITYEADT--------YFTG------GSADYYVSDTNGSSSIAG-- 46
Query: 251 SRLLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTDDKTYKSLGRRIFDV 310
D +LY R SP S +YY+ CLENGNY V LHFAE F +D LGRR+FDV
Sbjct: 47 ----TTDPELYQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGED----GLGRRVFDV 98
Query: 311 YIQGKLELKDFNIEEEAGGVGKPIVKPF-SAVVTNGTMDIRLYWAGKGTTEIPDRGVYG- 368
Y+QGKL LKDF+I EAGG GK K + VT+GT++I YWAGKGT IP RGVYG
Sbjct: 99 YVQGKLVLKDFDIVAEAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPFRGVYGN 158
Query: 369 PLISAI 374
P ISAI
Sbjct: 159 PKISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-51
Identities = 74/194 (38%), Positives = 106/194 (54%), Gaps = 11/194 (5%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQHPHLVKLYGCC 511
+GEGGFG VY G +A+K + + E + EI + L HP++VKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571
+ N L L+ EY E SL L +E+ KL I + I GL YLH I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 572 HRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-YAMRGHLTD 629
HRD+K N+LLD D K++DFGL+KL D + + T V GT YMAPE +G+ ++
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 630 KADVYSFGIVALEI 643
K+D++S G++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 88/276 (31%), Positives = 130/276 (47%), Gaps = 33/276 (11%)
Query: 453 KIGEGGFGPVYKGLL-----ADGTLIAVKQLSA-KSKQGNREFVNEIGTISALQHPHLVK 506
K+GEG FG VYKG L +AVK L S+Q EF+ E + L HP++VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
L G C E L ++ EY+E L L ++R KL + + IARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLE--- 119
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH 626
+HRD+ A N L+ ++L KISDFGL++ +D+ + +MAPE G
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 627 LTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLK--EQGNLMELVDPNLG 683
T K+DV+SFG++ EI + G E+ + + +L+ + G +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLG---------EQPYPGMSNEEVLEYLKNGYRLPQPP---- 226
Query: 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719
N E +M L C P +RP S +V +L
Sbjct: 227 -NCPPELYDLM----LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 4e-51
Identities = 93/288 (32%), Positives = 131/288 (45%), Gaps = 45/288 (15%)
Query: 452 NKIGEGGFGPVYKGLLADG----TLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLVK 506
K+GEG FG VYKG L T +AVK L S++ ++F+ E + L HP++V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 507 LYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
L G C E L L+ EY+E L P + L + I IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAP 619
L K VHRD+ A N L+ +DL KISDFGL++ D D+ + + G +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAP 176
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLLDWALLLKEQG 672
E G T K+DV+SFG++ EI + G SN EE L +G
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYL-------RKG 223
Query: 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ P E + + L C + P +RP S +V LE
Sbjct: 224 YRLP--KP---EYCPDE----LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 87/276 (31%), Positives = 129/276 (46%), Gaps = 32/276 (11%)
Query: 453 KIGEGGFGPVYKGLLADG-----TLIAVKQLSA-KSKQGNREFVNEIGTISALQHPHLVK 506
K+GEG FG VYKG L +AVK L S+Q EF+ E + L HP++VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
L G C E L+++ EY+ L L L + + IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS--LSDLLSFALQIARGMEYLE--- 120
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH 626
+HRD+ A N L+ ++L KISDFGL++ +D+ + +MAPE G
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 627 LTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLK--EQGNLMELVDPNLG 683
T K+DV+SFG++ EI + G EE + + A +L+ ++G + P
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLG---------EEPYPGMSNAEVLEYLKKGYRLPK--P--- 226
Query: 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719
N E + + L C P +RP S +V +L
Sbjct: 227 PNCPPE----LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 169 bits (432), Expect = 8e-48
Identities = 73/203 (35%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 453 KIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLVK 506
K+GEG FG VYKG L T +AVK L + + R EF+ E + L HP++V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
L G C +G L ++ EY+ L L +H KL + + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLES-- 120
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG---YMAPEYAM 623
VHRD+ A N L+ ++L KISDFGL++ ED+ + G +MAPE
Sbjct: 121 -KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLK 177
Query: 624 RGHLTDKADVYSFGIVALEIVSG 646
G T K+DV+SFG++ EI +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 68/203 (33%), Positives = 108/203 (53%), Gaps = 11/203 (5%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQHPHLV 505
+++ K+GEG FG VY G L+A+K + K + +RE + EI + L+HP++V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+LY + ++L L+ EY E L L + R +L I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHS- 115
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
IVHRD+K N+LLD+D + K++DFGLA+ + ++T V GT YMAPE +
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 626 HLTDKADVYSFGIVALEIVSGRS 648
D++S G++ E+++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 70/199 (35%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 453 KIGEGGFGPVYKG-LLADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYG 509
K+G G FG VYK G ++AVK L +S + ++ EI + L HP++V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
+ + L L+ EY E L L L I + I RGL YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGG-PLSEDEAKKIALQILRGLEYLHSNG--- 118
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-YAMRGHLT 628
I+HRD+K N+LLD++ KI+DFGLAK + ++ ++T V GT YMAPE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 629 DKADVYSFGIVALEIVSGR 647
K DV+S G++ E+++G+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 4e-43
Identities = 77/205 (37%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 452 NKIGEGGFGPVYKGLLAD-GTLIAVKQ--LSAKSKQGNREFVNEIGTISALQHPHLVKLY 508
+G G FG VY L D G L+AVK LS S++ EI +S+LQHP++V+ Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 509 GCCI--EGNQLLLIYEYLENNSLARAL--FGP-EEHRLKLDWPTRHNICIGIARGLAYLH 563
G E N L + EY+ SL+ L FG E ++ TR I GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK--YTRQ-----ILEGLAYLH 118
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYA 622
IVHRDIK N+L+D D K++DFG AK L + + + V GT +MAPE
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 623 MRGHLTDKADVYSFGIVALEIVSGR 647
AD++S G +E+ +G+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 69/204 (33%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
F++ KIG+GGFG VYK G +A+K + +SK+ + +NEI + +HP++V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
K YG ++ ++L ++ E+ SL L + L +C + +GL YLH
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAM 623
I+HRDIKA N+LL D K+ DFGL+ D + + GT +MAPE
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM----VGTPYWMAPEVIN 170
Query: 624 RGHLTDKADVYSFGIVALEIVSGR 647
KAD++S GI A+E+ G+
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 77/211 (36%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS-AKSKQGN-REFVNEIGTISALQHPH 503
++ + + IG G FG VYKGL L G +A+KQ+S K K+ + + EI + L+HP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIA---RG 558
+VK G + L +I EY EN SL + + FGP L + + + +G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---------VAVYVYQVLQG 111
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFGYM 617
LAYLHE+ ++HRDIKA N+L KD K++DFG+A KL++ V GT +M
Sbjct: 112 LAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWM 166
Query: 618 APE-YAMRGHLTDKADVYSFGIVALEIVSGR 647
APE M G T +D++S G +E+++G
Sbjct: 167 APEVIEMSGAST-ASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 69/205 (33%), Positives = 109/205 (53%), Gaps = 20/205 (9%)
Query: 448 FDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKL 507
F + K+G G FG V++GL + +A+K L + ++F E+ + L+H HL+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIG--IARGLAYLHEE 565
+ C G + +I E +E SL L PE L P I + +A G+AYL E+
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVL----PVASLIDMACQVAEGMAYLEEQ 123
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED-----NTHISTRVAGTFGYMAPE 620
+HRD+ A N+L+ +DL K++DFGLA+L +ED + I + + APE
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPE 174
Query: 621 YAMRGHLTDKADVYSFGIVALEIVS 645
A G + K+DV+SFGI+ E+ +
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 66/204 (32%), Positives = 111/204 (54%), Gaps = 11/204 (5%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH 503
+ KIGEG G VYK A G +A+K++ + + +NEI + +HP+
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL-IINEILIMKDCKHPN 76
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+V Y + G++L ++ EY++ SL + ++ ++++ P +C + +GL YLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYA 622
++HRDIK+ N+LL KD + K++DFG A+L +E + S V GT +MAPE
Sbjct: 134 ---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVI 188
Query: 623 MRGHLTDKADVYSFGIVALEIVSG 646
R K D++S GI+ +E+ G
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 79/201 (39%), Positives = 110/201 (54%), Gaps = 17/201 (8%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGN---REFVNEIGTISALQHPHLVKLYG 509
K+G G FG V+ G T +AVK L K G F+ E + L+H LV+LY
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
C E + ++ EY+ SL L E +L+L P ++ IA G+AYL ESR
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYL--ESR-N 123
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGHL 627
+HRD+ A N+L+ ++L KI+DFGLA+L E+D + R F + APE A G
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKFPIKWTAPEAANYGRF 181
Query: 628 TDKADVYSFGIVALEIVS-GR 647
T K+DV+SFGI+ EIV+ GR
Sbjct: 182 TIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 82/289 (28%), Positives = 128/289 (44%), Gaps = 48/289 (16%)
Query: 454 IGEGGFGPVYKGLLAD------GTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLVK 506
+G+G FG VY+GL T +A+K ++ + R EF+NE + H+V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 507 LYGCCIEGNQLLLIYEYLENNSLA---RALFGPEEHRLKLDWPTR---HNICIGIARGLA 560
L G G L++ E + L R+ E+ L PT + IA G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAP 619
YL K VHRD+ A N ++ +DL KI DFG+ + + E D + +MAP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKF-YLLDWALLLKEQ 671
E G T K+DV+SFG+V E+ + G SN EE +++D
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEVLKFVID-------- 236
Query: 672 GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
G ++L + N + + +M +C +P RP +VS L+
Sbjct: 237 GGHLDLPE-----NCPDKLLELM----RMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 70/203 (34%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
+ IG+G FG V G G +AVK L S F+ E ++ L+HP+LV
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLV 63
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+L G ++GN L ++ EY+ SL L + L + + + G+ YL E+
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK 121
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
VHRD+ A NVL+ +DL K+SDFGLAK E S ++ + APE
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREK 174
Query: 626 HLTDKADVYSFGIVALEIVS-GR 647
+ K+DV+SFGI+ EI S GR
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 452 NKIGEGGFGPVYKG---LLADGT--LIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLV 505
++GEG FG V L D T +AVK L+ +Q +F EI + L H ++V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 506 KLYGCCIE--GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
K G C + G L LI EYL + SL L + HR +++ I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG---TFGYMAPE 620
+ + +HRD+ A N+L++ + KISDFGLAK+ ED + + G F Y APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 621 YAMRGHLTDKADVYSFGIVALEIVS-GRSN 649
+ +DV+SFG+ E+ + G +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
FD+ K+GEG +G VYK + G ++A+K + + +E + EI + P++VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
YG + L ++ EY S++ + + L I +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLH--- 116
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH 626
K +HRDIKA N+LL+++ K++DFG++ + +T V GT +MAPE
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIG 175
Query: 627 LTDKADVYSFGIVALEIVSGR 647
+KAD++S GI A+E+ G+
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 71/205 (34%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 452 NKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN--REFVNEIGTISALQHPHLVKLY 508
NKIG G FG VY + L G L+AVK++ + +E +E+ + L+HP+LVK Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
G + ++ + EY +L L EH LD + + GLAYLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG---YMAPEYAMRG 625
IVHRDIK N+ LD + K+ DFG A + + T + V G YMAPE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 626 HLTDK---ADVYSFGIVALEIVSGR 647
AD++S G V LE+ +G+
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 71/205 (34%), Positives = 113/205 (55%), Gaps = 13/205 (6%)
Query: 448 FDVANKIGEGGFGPVYKGLL-ADGTLIAVKQ--LSAKSKQGNREFVNEIGTISALQHPHL 504
F++ NKIG+G FG V+K + AD + A+KQ LS +++ E ++E ++ L ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLD--WPTRHNICIGIARGLAYL 562
++ Y ++ +L ++ EY EN L + L L D W I I GLA+L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHL 117
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 622
H + KI+HRDIK+ N+ LD N KI D G+AKL DNT+ + + GT Y++PE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTNFANTIVGTPYYLSPELC 173
Query: 623 MRGHLTDKADVYSFGIVALEIVSGR 647
+K+DV++ G+V E +G+
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 67/199 (33%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 454 IGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLVKLY 508
IG G FG V +G L +A+K L A S R +F+ E + HP++++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
G + +++I EY+EN SL + L E+ K + GIA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYL---SEM 125
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG--YMAPEYAMRGH 626
VHRD+ A N+L++ +L K+SDFGL++ E+ +T+ G + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAIAYRK 184
Query: 627 LTDKADVYSFGIVALEIVS 645
T +DV+SFGIV E++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 70/213 (32%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 454 IGEGGFGPVYKGLLA------DGTLIAVKQLS-AKSKQGNREFVNEIGTISALQHPHLVK 506
+GEG FG V+ G D L+AVK L S ++F E ++ QH ++VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTR--------HNICIGIA 556
YG C EG+ ++++EY+E+ L + L GP+ LK I + IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT--- 613
G+ YL + VHRD+ N L+ DL KI DFG+++ D + RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-DVYTTDYY--RVGGHTML 186
Query: 614 -FGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+M PE M T ++DV+SFG+V EI +
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS-AKSKQGNREFV-NEIGTISALQHPH 503
+++ +IG+G FG VY +DG L +K++ + + RE NE+ + L HP+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNI---CIGIARGLA 560
++K Y E +L ++ EY + L++ + ++ + + I + + L
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI---KKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
YLH KI+HRDIK N+ L + K+ DFG++K+ T V GT Y++PE
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
Query: 621 YAMRGHLTDKADVYSFGIVALEIVSGR 647
K+D++S G V E+ + +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 68/203 (33%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLS-----AKSKQGNREFVNEIGTISALQHPHLVKL 507
+G G FG VY+GL L DG AVK++S ++ ++ EI +S LQHP++V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 508 YGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
G E + L + E + SLA+ L +G P I GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGS------FPEPVIRLYTRQILLGLEYLHDR 121
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
VHRDIK N+L+D + K++DFG+AK E + S G+ +MAPE +
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQ 176
Query: 626 HLTD-KADVYSFGIVALEIVSGR 647
AD++S G LE+ +G+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 69/198 (34%), Positives = 109/198 (55%), Gaps = 11/198 (5%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI 512
K+G G FG V++GL + T +AVK L + +F+ E + L+HP L++LY C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 513 EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVH 572
+ ++ E ++ SL L G LKL P ++ +A G+AYL ++ +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 573 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGHLTDK 630
RD+ A NVL+ ++ K++DFGLA++ +ED R F + APE A+ + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDI--YEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 631 ADVYSFGIVALEIVS-GR 647
+DV+SFGI+ EIV+ GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 67/201 (33%), Positives = 109/201 (54%), Gaps = 18/201 (8%)
Query: 454 IGEGGFGPVYKGL---LADGTLI--AVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKL 507
+G G FG VYKG+ + I A+K L ++ + N+E ++E ++++ HPH+V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
G C+ +Q+ LI + + L + H+ + N C+ IA+G++YL EE R
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYV---RNHKDNIGSQYLLNWCVQIAKGMSYL-EEKR 129
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG---TFGYMAPEYAMR 624
L VHRD+ A NVL+ + KI+DFGLAKL + D G +MA E +
Sbjct: 130 L--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALESILH 185
Query: 625 GHLTDKADVYSFGIVALEIVS 645
T K+DV+S+G+ E+++
Sbjct: 186 RIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 62/218 (28%), Positives = 108/218 (49%), Gaps = 37/218 (16%)
Query: 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPH 503
+ + +G+G G VYK G + A+K++ + R + + E+ T+ + + P+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR----GL 559
+VK YG + ++ ++ EY++ SLA L + P + IAR GL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL------KKVGKIP--EPVLAYIARQILKGL 112
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNTHISTRVAGTFG 615
YLH ++ I+HRDIK +N+L++ KI+DFG++K+ ++ NT + GT
Sbjct: 113 DYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVT 165
Query: 616 YMAPE------YAMRGHLTDKADVYSFGIVALEIVSGR 647
YM+PE Y+ AD++S G+ LE G+
Sbjct: 166 YMSPERIQGESYSY------AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 70/211 (33%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 453 KIGEGGFGPVY----KGLL--ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
++GEG FG V+ LL D L+AVK L S+ ++F E ++ LQH H+V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRL---------KLDWPTRHNICIGI 555
YG C EG LL+++EY+ + L R L GP+ L +L I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTF 614
A G+ YL + L VHRD+ N L+ + L KI DFG+++ + D + R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+M PE + T ++D++SFG+V EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 7e-29
Identities = 72/215 (33%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 447 HFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHP- 502
+ + K+GEG FG VY D L+A+K L+ K + F+ EI +++L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
++VKLY + L L+ EY++ SL L + L I I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 563 HEESRLKIVHRDIKATNVLLDKDLN-PKISDFGLAKLDEEDNTHISTR-----VAGTFGY 616
H + I+HRDIK N+LLD+D K+ DFGLAKL + + S GT GY
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 617 MAPEYAM---RGHLTDKADVYSFGIVALEIVSGRS 648
MAPE + + + +D++S GI E+++G
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 93/274 (33%), Positives = 132/274 (48%), Gaps = 34/274 (12%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNRE---FVNEIGTISALQHPHLVKLYG 509
K+G G FG V+ G T +A+K L KQG+ F+ E + LQHP LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
+ + +I EY+EN SL L PE +L + ++ IA G+A++ R
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTI--NKLIDMAAQIAEGMAFIE---RKN 122
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGHL 627
+HRD++A N+L+ + L KI+DFGLA+L E + + R F + APE G
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 628 TDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686
T K+DV+SFGI+ EIV+ GR T E L E+G M D N
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-------ERGYRMPRPD-----NC 228
Query: 687 DKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+E +M LC P RP + S+LE
Sbjct: 229 PEELYELM----RLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN-EIGTISALQHPHLV 505
F + IG+G FG VYK + ++A+K + + + E + EI +S + P++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
K YG ++G++L +I EY S L KLD I + GL YLHEE
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
+HRDIKA N+LL ++ + K++DFG++ + +T V GT +MAPE +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQS 173
Query: 626 HLTDKADVYSFGIVALEIVSG 646
+KAD++S GI A+E+ G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 75/211 (35%), Positives = 110/211 (52%), Gaps = 26/211 (12%)
Query: 454 IGEGGFGPVYKGLLA-DGTLIAVKQL-----SAKSKQGNREFVN----EIGTISALQHPH 503
IG G FG VY G+ A G L+AVKQ+ SA SK R ++ EI + LQH +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARGLAY 561
+V+ G ++ + L + EY+ S+A L +G E L N I +GL Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV------RNFVRQILKGLNY 121
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA-----GTFGY 616
LH I+HRDIK N+L+D KISDFG++K E ++ T A G+ +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
MAPE + T KAD++S G + +E+++G+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 7e-27
Identities = 89/295 (30%), Positives = 135/295 (45%), Gaps = 46/295 (15%)
Query: 454 IGEGGFGPVYKGL------LADGTLIAVKQLSAKSKQGN-REFVNEIGTISALQHPHLVK 506
+GEG FG V K A T +AVK L + R+ ++E + + HPH++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARAL------------FGPEEHRLKLDWPTRHNICIG 554
LYG C + LLLI EY + SL L + LD P + +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 555 --------IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606
I+RG+ YL E +K+VHRD+ A NVL+ + KISDFGL++ E+++++
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 607 S-TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWA 665
++ +MA E T ++DV+SFG++ EIV+ N E+ +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL----FN 240
Query: 666 LLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
LL + G ME + N +E M N+ L C P RP + + LE
Sbjct: 241 LL--KTGYRMERPE-----NCSEE----MYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 16/211 (7%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV-NEIGTISALQHPH 503
+ +++ IG G VY + L + +A+K++ + Q + + + E+ +S HP+
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLK---LDWPTRHNICIGIARGLA 560
+VK Y + G++L L+ YL SL + + LD + + +GL
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIM----KSSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHIS-TRVAGTFGYM 617
YLH + +HRDIKA N+LL +D + KI+DFG++ D D T GT +M
Sbjct: 117 YLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 618 APEYAMRGH-LTDKADVYSFGIVALEIVSGR 647
APE + H KAD++SFGI A+E+ +G
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 74/287 (25%), Positives = 132/287 (45%), Gaps = 41/287 (14%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQ------LSAKSKQGNREFVNEIGTIS 497
+F + KIG+G F VYK + L DG ++A+K+ + AK++Q + + EI +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
L HP+++K IE N+L ++ E + L+R + ++ + + T + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 617
L ++H + +I+HRDIK NV + K+ D GL + T + V GT YM
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 173
Query: 618 APEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677
+PE K+D++S G + E+ + +S FY ++ NL L
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQS---------PFY--------GDKMNLYSL 216
Query: 678 VD-------PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717
P L ++ E++R +++ C + P RP +S V+
Sbjct: 217 CKKIEKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
+++ +IG G +G VYK +A G L+A+K + + EI + +HP++V
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLA---RALFGP-EEHRLKLDWPTRHNICIGIARGLAY 561
+G + ++L ++ EY SL + GP E ++ +C +GLAY
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-------VCRETLKGLAY 116
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA--GTFGYMAP 619
LHE +HRDIK N+LL +D + K++DFG++ + T I+ R + GT +MAP
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSA--QLTAT-IAKRKSFIGTPYWMAP 170
Query: 620 EYA---MRGHLTDKADVYSFGIVALE 642
E A +G K D+++ GI A+E
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 74/273 (27%), Positives = 130/273 (47%), Gaps = 29/273 (10%)
Query: 448 FDVANKIGEGGFGPVYK-GLLADGTLIAVKQ--LSAKSKQGNREFVNEIGTISALQHPHL 504
F V K+G+G +G VYK L+D A+K+ L + S++ + VNEI ++++ HP++
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
+ ++GN+L ++ EY L++A+ ++ R + I I + RGL LHE
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED--NTHISTRVAGTFGYMAPEYA 622
KI+HRD+K+ N+LL + KI D G++K+ +++ T I GT YMAPE
Sbjct: 122 ---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYMAPEVW 173
Query: 623 MRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682
+ K+D++S G + E+ + ++ ++ L K Q P +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--------LRYKVQRGKY----PPI 221
Query: 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSV 715
++ + N V P RP +
Sbjct: 222 PPIYSQD----LQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 452 NKIGEGGFGPVYKG--LLADGTLI--AVKQLSA-KSKQGNREFVNEIGTISALQHPHLVK 506
++G G FG V KG L+ G + AVK L G +EF+ E ++ L HP +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEE---HRLKLDWPTRHNICIGIARGLAYLH 563
L G C +G L+L+ E L + L E LK + +A G+AYL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-LAHQ------VAMGMAYL- 111
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEY 621
E VHRD+ A NVLL KISDFG+++ + + AG + + APE
Sbjct: 112 ESKHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169
Query: 622 AMRGHLTDKADVYSFGIVALEIVS 645
G + K+DV+S+G+ E S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 58/193 (30%), Positives = 100/193 (51%), Gaps = 7/193 (3%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI 512
+IG G FG V+ G + +A+K + + +F+ E + L HP LV+LYG C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 513 EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVH 572
E + + L++E++E+ L+ L R K T +C+ + G+AYL + ++H
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 573 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKAD 632
RD+ A N L+ ++ K+SDFG+ + +D ST + +PE + K+D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 633 VYSFGIVALEIVS 645
V+SFG++ E+ S
Sbjct: 184 VWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 14/211 (6%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS-----AKSKQGNREFVNEIGTISALQ 500
++V IG+G FG V K +DG ++ K++ K KQ + V+E+ + L+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ---QLVSEVNILRELK 57
Query: 501 HPHLVKLYGCCI-EGNQLLLIY-EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
HP++V+ Y I NQ L I EY E LA+ + ++ R ++ I +
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117
Query: 559 LAYLH--EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 616
L H + ++HRD+K N+ LD + N K+ DFGLAK+ D++ T V GT Y
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYY 176
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
M+PE +K+D++S G + E+ +
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 454 IGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIE 513
+G G FG V+ G +A+K + + +F+ E + L HP+LV+LYG C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHR 573
+ ++ EY+ N L L E + KL ++C + + YL +HR
Sbjct: 71 QRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 574 DIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKA 631
D+ A N L+ +D K+SDFGLA+ LD++ + T+ + PE + K+
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFSSKS 182
Query: 632 DVYSFGIVALEIVSG 646
DV+SFG++ E+ S
Sbjct: 183 DVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 72/206 (34%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI 512
K+G G FG V+ G + T +AVK L + + F+ E + LQH LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 513 EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVH 572
+ + +I EY+ SL L E ++ L P + IA G+AY+ R +H
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 573 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGHLTDK 630
RD++A NVL+ + L KI+DFGLA++ E++ + R F + APE G T K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 631 ADVYSFGIVALEIVS-------GRSN 649
+DV+SFGI+ EIV+ G SN
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 85/302 (28%), Positives = 129/302 (42%), Gaps = 62/302 (20%)
Query: 454 IGEGGFGPVYK----GLLA--DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVK 506
IG+G FG V++ GLL T++AVK L + S +F E ++ HP++VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 507 LYGCCIEGNQLLLIYEYLEN---NSLARALFGPEEHRL-------------KLDWPTRHN 550
L G C G + L++EY+ N R + L L
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 551 ICIG--IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA---------KLD 599
+CI +A G+AYL E K VHRD+ N L+ +++ KI+DFGL+ K
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEK 658
E D I +M PE T ++DV+++G+V EI S G EE
Sbjct: 190 ENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
Query: 659 FYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718
Y + GN++ D N E + N+ LC P++RP +S+ +
Sbjct: 242 IYYV-------RDGNVLSCPD-----NCPLE----LYNLMRLCWSKLPSDRPSFASINRI 285
Query: 719 LE 720
L+
Sbjct: 286 LQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 72/212 (33%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 454 IGEGGFGPVYKGLL------ADGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVK 506
+GEG FG VYKG L T +A+K L + +EF E +S LQHP++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALF------------GPEEHRLKLDWPTRHNICIG 554
L G C + +++EYL + L L G E + LD +I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EEDNTHISTRVAGT 613
IA G+ YL S VHRD+ A N L+ + L KISDFGL++ D + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 614 FGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+M PE + G T ++D++SFG+V EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 71/198 (35%), Positives = 109/198 (55%), Gaps = 12/198 (6%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI 512
K+G+G FG V+ G T +A+K L + F+ E + L+H LV+LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 513 EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVH 572
E + ++ EY+ SL L G L+L P ++ IA G+AY+ R+ VH
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 125
Query: 573 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGHLTDK 630
RD++A N+L+ ++L K++DFGLA+L EDN + + R F + APE A+ G T K
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 631 ADVYSFGIVALEIVS-GR 647
+DV+SFGI+ E+ + GR
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQL------SAKSKQGNREFV----NEIGTISALQHP 502
IG+G +G VY L G ++AVKQ+ + + ++ V +EI T+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARGLA 560
++V+ G L + EY+ S+ L +G E +L R + GLA
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL-----VRF-FTEQVLEGLA 122
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE--DNTHISTRVAGTFGYMA 618
YLH + I+HRD+KA N+L+D D KISDFG++K ++ DN + + G+ +MA
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ-NMSMQGSVFWMA 178
Query: 619 PE--YAMRGHLTDKADVYSFGIVALEIVSGR 647
PE ++ + K D++S G V LE+ +GR
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQHPHLVKLYGCC 511
KIG+G FG VYKG+L T +AVK + + F+ E + HP++VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571
++ + ++ E + SL L + RL + + + A G+ YL ES+ +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVK--KLLQMSLDAAAGMEYL--ESK-NCI 115
Query: 572 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGHLTD 629
HRD+ A N L+ ++ KISDFG+++ +EE + + + APE G T
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 630 KADVYSFGIVALEIVSG 646
++DV+S+GI+ E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 10/202 (4%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLV 505
+ ++G G G V K L G ++AVK + + ++ + E+ + P++V
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
YG + + EY++ SL + L +E + ++ I + + +GL YLHE
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHE- 118
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
+ KI+HRD+K +N+L++ K+ DFG++ + N+ ++ GT YMAPE
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNS-LAKTFVGTSSYMAPERIQGN 174
Query: 626 HLTDKADVYSFGIVALEIVSGR 647
+ K+D++S G+ +E+ +GR
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 64/207 (30%), Positives = 112/207 (54%), Gaps = 24/207 (11%)
Query: 448 FDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFV-NEIGTISALQHP 502
D KIGEG G V +A G +AVK++ + KQ RE + NE+ + QHP
Sbjct: 21 LDNFVKIGEGSTGIV---CIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHP 76
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
++V++Y + G++L ++ E+LE +L + +++ +C+ + + L++L
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFL 131
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTR--VAGTFGYMAP 619
H + ++HRDIK+ ++LL D K+SDFG A++ +E + R + GT +MAP
Sbjct: 132 HAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----VPRRKSLVGTPYWMAP 184
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVSG 646
E R + D++S GI+ +E+V G
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 72/198 (36%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI 512
K+G G FG V+ G T +AVK L + F+ E + L+H LV+LY
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 513 EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVH 572
E + ++ EY+ SL L E LKL P ++ +A G+AY+ R+ +H
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 573 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGHLTDK 630
RD+++ N+L+ L KI+DFGLA+L EDN + + R F + APE A+ G T K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLI-EDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 631 ADVYSFGIVALEIVS-GR 647
+DV+SFGI+ E+V+ GR
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 1e-24
Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 454 IGEGGFGPVYK-GLLADGTLIAVKQLSAKSKQGNREFV---NEIGTISALQHPHLVKLYG 509
+G+G FG V G L A+K L K +E E +S + HP +VKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
+L L+ EY L L + I L YLH L
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL----SKEGRFSEERARFYAAEIVLALEYLH---SLG 113
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTD 629
I++RD+K N+LLD D + K++DFGLAK + + +T GT Y+APE +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYGK 172
Query: 630 KADVYSFGIVALEIVSGRS 648
D +S G++ E+++G+
Sbjct: 173 AVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREF----VNEIGTISALQHPHLVKL 507
K+GEG +G VYK G ++A+K++ + + EI + L+HP++VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
+L L++EY + + L + L ++ L +I + RGLAY H S
Sbjct: 64 LDVIHTERKLYLVFEYCDMD-LKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCH--SH 117
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHL 627
+I+HRD+K N+L+++D K++DFGLA+ + V T Y APE +
Sbjct: 118 -RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKH 175
Query: 628 TDKA-DVYSFGIVALEIVSGR 647
A D++S G + E+++G+
Sbjct: 176 YSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 453 KIGEGGFGPVYKG--LLADGTLI--AVKQLSAKSKQGN-REFVNEIGTISALQHPHLVKL 507
K+G+G FG V +G + G +I AVK L + +F+ E + +L H +L++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
YG + + L+++ E SL L + T + + IA G+ YL +
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESK-- 116
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIST---RVAGTFGYMAPEYAM 623
+ +HRD+ A N+LL D KI DFGL + L + ++ ++ +V F + APE
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLR 173
Query: 624 RGHLTDKADVYSFGIVALEIVS 645
+ +DV+ FG+ E+ +
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 82/271 (30%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI 512
K+G G FG V+ T +AVK + S F+ E + LQH LVKL+ +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-V 70
Query: 513 EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVH 572
+ +I E++ SL L E + L P + IA G+A++ + + +H
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 573 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGHLTDK 630
RD++A N+L+ L KI+DFGLA++ EDN + + R F + APE G T K
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVI-EDNEYTA-REGAKFPIKWTAPEAINFGSFTIK 183
Query: 631 ADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKE 689
+DV+SFGI+ +EIV+ GR + E L E+G M + N +E
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------ERGYRMPRPE-----NCPEE 231
Query: 690 QVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+M+ C P RP + S+L+
Sbjct: 232 LYNIMMR----CWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 74/223 (33%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 444 ATNHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISAL-QH 501
T F++ IGEG +G VYK G L+A+K + + E E + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNH 62
Query: 502 PHLVKLYGC------CIEGNQLLLIYEYLENNS---LARALFGPEEHRLKLDWPTRHNIC 552
P++ YG +QL L+ E S L + L + RLK +W I
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAY--IL 119
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHIST 608
RGLAYLHE K++HRDIK N+LL K+ K+ DFG+ A+LD NT I
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-- 174
Query: 609 RVAGTFGYMAPE-----YAMRGHLTDKADVYSFGIVALEIVSG 646
GT +MAPE ++DV+S GI A+E+ G
Sbjct: 175 ---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 68/198 (34%), Positives = 101/198 (51%), Gaps = 19/198 (9%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN---REFVNEIGTISALQHPHLVKLY 508
+IG G FG VY + ++A+K++S KQ N ++ + E+ + L+HP+ ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
GC + + L+ EY L A E H+ L IC G +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEY----CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---H 134
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE--YAM-RG 625
+ +HRDIKA N+LL + K++DFG A L N+ + GT +MAPE AM G
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 626 HLTDKADVYSFGIVALEI 643
K DV+S GI +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-24
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 453 KIGEGGFGPVYKGLL------ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
++GEG FG V+ D L+AVK L S ++F E ++ LQH H+VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRH-------NICIGIAR 557
YG C+EG+ L++++EY+++ L + L GP+ + +I IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGY 616
G+ YL + VHRD+ N L+ ++L KI DFG+++ + D + +
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVS 645
M PE M T ++DV+S G+V EI +
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 71/221 (32%), Positives = 107/221 (48%), Gaps = 18/221 (8%)
Query: 447 HFDVANKIGEGGFGPV----YKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQH 501
H ++G+G FG V Y L + G ++AVK+L + + R+F EI + +LQH
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH 64
Query: 502 PHLVKLYGCCIEG--NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGL 559
++VK G C L L+ EYL SL L ++HR +LD I +G+
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGM 121
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG---TFGY 616
YL + VHRD+ N+L++ + KI DFGL K+ +D + R G F Y
Sbjct: 122 EYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE 657
APE + +DV+SFG+V E+ + S+ C E
Sbjct: 179 -APESLTESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 453 KIGEGGFGPVYKGLLA---------DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH 503
++GEG FG V+ LA D L+AVK L + ++F E ++ LQH H
Sbjct: 12 ELGEGAFGKVF---LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHN----------I 551
+VK YG C +G+ L++++EY+++ L + L GP+ L P + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 552 CIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRV 610
IA G+ YL + VHRD+ N L+ +L KI DFG+++ + D +
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 611 AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+M PE M T ++DV+SFG++ EI +
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 31/226 (13%)
Query: 446 NHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAK--SKQGNREFVN-EIGTISAL-Q 500
+ F IGEG F V A+K L + K+ ++V E ++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
HP ++KLY + L + EY N L + + LD I L
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALE 116
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA--------- 611
YLH I+HRD+K N+LLDKD++ KI+DFG AK+ + +++ S +
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 612 ----------GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
GT Y++PE +D+++ G + ++++G+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 71/235 (30%), Positives = 113/235 (48%), Gaps = 35/235 (14%)
Query: 453 KIGEGGFGPVY----KGLLA-----------DGTLIAVKQLSAK-SKQGNREFVNEIGTI 496
K+GEG FG V+ +GL L+AVK L A +K +F+ EI +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 497 SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNI 551
S L++P++++L G C+ + L +I EY+EN L R + H + + N+
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 552 ---CIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIS 607
+ IA G+ YL + L VHRD+ N L+ KI+DFG+++ L D I
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 608 TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
R +MA E + G T +DV++FG+ E+ + +C KE+ + LL
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT-----LC--KEQPYSLL 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 69/222 (31%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 454 IGEGGFGPVYKG----LLADGT---LIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLV 505
+G G FG VY+G +L G+ +AVK L + Q +EF+ E +S HP++V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLK---LDWPTRHNICIGIARGLAYL 562
KL G C+ +I E +E L L R L +IC+ +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 563 HEESRLKIVHRDIKATNVLL-----DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG-- 615
++ +HRD+ A N L+ D D KI DFGLA+ D + + G
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLPVR 178
Query: 616 YMAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNI 650
+MAPE + G T ++DV+SFG++ EI++ +N
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 71/198 (35%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI 512
K+G+G FG V+ G T +A+K L + F+ E + L+H LV LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 513 EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVH 572
E + ++ E++ SL L + LKL P ++ IA G+AY+ R+ +H
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIE---RMNYIH 125
Query: 573 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGHLTDK 630
RD++A N+L+ +L KI+DFGLA+L EDN + + R F + APE A+ G T K
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLI-EDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 631 ADVYSFGIVALEIVS-GR 647
+DV+SFGI+ E+V+ GR
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 63/199 (31%), Positives = 107/199 (53%), Gaps = 14/199 (7%)
Query: 454 IGEGGFGPVYKGL-LADGTLI----AVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKL 507
+G G FG V+KG+ + +G I A+K + +S +Q +E + + + +L H ++V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
G C G L L+ + SL + +HR LD N C+ IA+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV---RQHRDSLDPQRLLNWCVQIAKGMYYLEEH-- 128
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAMRGH 626
++VHR++ A N+LL D +I+DFG+A L +D + + +MA E + G
Sbjct: 129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 627 LTDKADVYSFGIVALEIVS 645
T ++DV+S+G+ E++S
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREF----VNEIGTISALQHP 502
++ +IGEG +G VYK G L+A+K++ + + F + EI + L+HP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHP 58
Query: 503 HLVKLYGCCIE--GNQLLLIYEYLEN--NSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
++V+L + +++EY+++ L +K + G
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLD------SPEVKFTESQIKCYMKQLLEG 112
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST-RVAGTFGYM 617
L YLH I+HRDIK +N+L++ D K++DFGLA+ + N+ T RV T Y
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYR 168
Query: 618 APEYAMRGHLTD---KADVYSFGIVALEIVSGR 647
PE + T + D++S G + E+ G+
Sbjct: 169 PPELLL--GATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 4e-23
Identities = 90/297 (30%), Positives = 131/297 (44%), Gaps = 59/297 (19%)
Query: 454 IGEGGFGPV--YKGLLA-DGT--LIAVKQLSAKSKQGNRE-FVNEIGTISALQHPHLVKL 507
+GEG FG V Y A DGT ++AVK L + Q N + EI + L H ++VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 508 YGCCIEGNQ--LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIG--------IAR 557
GCC E L LI EY+ SL D+ +H + + I
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSL-------------RDYLPKHKLNLAQLLLFAQQICE 118
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG---TF 614
G+AYLH + +HRD+ A NVLLD D KI DFGLAK E + + R G F
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKE---EKFY-LLDWALLLKE 670
Y A E + +DV+SFG+ E+++ C +K+ +KF ++
Sbjct: 176 WY-AVECLKENKFSYASDVWSFGVTLYELLT-----HCDSKQSPPKKFEEMIGPKQGQMT 229
Query: 671 QGNLMELVD-------PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
L+EL++ P N +E +M N C + RP S++ +L+
Sbjct: 230 VVRLIELLERGMRLPCPK---NCPQEVYILMKN----CWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 66/202 (32%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI 512
+G+G +G VY L+ IA+K++ + + + EI S L+H ++V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 513 EGNQLLLIYEYLENNSLA---RALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
E + E + SL+ R+ +GP LK + T I GL YLH+ +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGP----LKDNEQTIIFYTKQILEGLKYLHD---NQ 128
Query: 570 IVHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTRVAGTFGYMAPE---YAMRG 625
IVHRDIK NVL++ KISDFG +K N T GT YMAPE RG
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRG 187
Query: 626 HLTDKADVYSFGIVALEIVSGR 647
+ AD++S G +E+ +G+
Sbjct: 188 Y-GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQ 500
+H IG G FG V++G+L +A+K L + R +F++E +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
H ++++L G + ++I EY+EN +L + L +H + + GIA G+
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMK 121
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG--YMA 618
YL S + VHRD+ A N+L++ +L K+SDFGL+++ E+D T G + A
Sbjct: 122 YL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 619 PEYAMRGHLTDKADVYSFGIVALEIVS 645
PE T +DV+SFGIV E++S
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 29/206 (14%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV-NEIGTISALQH---PHLVKLY 508
IG G +G VY+G + G ++A+K ++ + + + E+ +S L+ P++ K Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 509 GCCIEGNQLLLIYEYLENNSLARALF--GPEEHRLKLDWPTRHNICIG-IAR----GLAY 561
G ++G +L +I EY E S+ R L GP + I I R L Y
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEK-----------YISVIIREVLVALKY 116
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
+H+ ++HRDIKA N+L+ N K+ DFG+A L ++++ ST V GT +MAPE
Sbjct: 117 IHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEV 172
Query: 622 AMRGHLTD-KADVYSFGIVALEIVSG 646
G D KAD++S GI E+ +G
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 65/201 (32%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN--REFVNEIGTISALQHPHLVKLYG 509
+IGEG G V+K G +A+K+++ + +G + + EI + A QHP++VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
G+ +L+ EY+ + L+ L EE L + + +G+AY+H
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVL-RDEERPLPE--AQVKSYMRMLLKGVAYMHAN---G 119
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRVAGTFGYMAPE--YAMRGH 626
I+HRD+K N+L+ D KI+DFGLA+L EE+ S +VA T Y APE Y R
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGAR-K 177
Query: 627 LTDKADVYSFGIVALEIVSGR 647
D+++ G + E+++G
Sbjct: 178 YDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 77/285 (27%), Positives = 131/285 (45%), Gaps = 32/285 (11%)
Query: 448 FDVANKIGEGGFGPVYKGLLADG--TLIAVKQLS---------AKSKQGN-REFVNEIGT 495
+ V +G G FG VYK + L+A+K+++ + + + + V+E+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 496 I-SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIG 554
I L+HP++V+ Y +E ++L ++ + +E L +E + + NI +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
+ L YLH+E R IVHRD+ N++L +D I+DFGLAK + ++ T V GT
Sbjct: 122 MVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTI 177
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674
Y PE +KADV++FG + + MC T + FY + +L +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQ--------MC-TLQPPFYSTN---MLSLATKI 225
Query: 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719
+E V L + E V +I C RP + V +M+
Sbjct: 226 VEAVYEPLPEGMYSEDVTDVITS---CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 66/212 (31%), Positives = 110/212 (51%), Gaps = 12/212 (5%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCC 511
KIG+G G VY + +A G +A+KQ++ + + +NEI + +HP++V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571
+ G++L ++ EYL SL + +D +C + L +LH +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 572 HRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDK 630
HRDIK+ N+LL D + K++DFG A++ E + ST V GT +MAPE R K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMV-GTPYWMAPEVVTRKAYGPK 195
Query: 631 ADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
D++S GI+A+E+V G + + YL+
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLS----AKSKQGN--REFVNEIGTISALQHPHLVK 506
+G G F Y+ + GTL+AVKQ++ S+Q EI ++ L HPH+++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
+ G E + L E++ S++ L +G + + + N + RGL+YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII------NYTEQLLRGLSYLHE 121
Query: 565 ESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKLDEEDNT---HISTRVAGTFGYMA 618
+I+HRD+K N+L+D + L +I+DFG A T ++ GT +MA
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 619 PEYAMRGHLTDKA-DVYSFGIVALEIVSGR 647
PE +RG ++ DV+S G V +E+ + +
Sbjct: 177 PE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 71/205 (34%), Positives = 108/205 (52%), Gaps = 19/205 (9%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN-EIGTISALQHPHLV 505
F +IG+G FG V+KG+ ++A+K + + + E + EI +S P++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 506 KLYGCCIEGNQLLLIYEYLENNS---LARALFGP-EEHRLKLDWPTRHNICIGIARGLAY 561
K YG ++G +L +I EYL S L RA GP +E ++ + I +GL Y
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIA-------TMLKEILKGLDY 116
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
LH E K +HRDIKA NVLL + + K++DFG+A + +T V F +MAPE
Sbjct: 117 LHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEV 172
Query: 622 AMRGHLTDKADVYSFGIVALEIVSG 646
+ KAD++S GI A+E+ G
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-22
Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 30/292 (10%)
Query: 435 SFTLRQIKAATNHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGNREFVNEI 493
S T+ I ++ N I G G YKG + +G VK++ N +EI
Sbjct: 682 SITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEI----NDVNSIPSSEI 734
Query: 494 GTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICI 553
+ LQHP++VKL G C LI+EY+E +L+ L L W R I I
Sbjct: 735 ADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAI 787
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 613
GIA+ L +LH +V ++ +++D P + L L D +
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS---- 842
Query: 614 FGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR--SNIMCKTKEEKFYLLDWALLLKEQ 671
Y+APE +T+K+D+Y FG++ +E+++G+ ++ +++WA
Sbjct: 843 -AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS---IVEWARYCYSD 898
Query: 672 GNLMELVDPNLGSNV---DKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+L +DP++ +V E V VM N+AL C PT RP + V+ LE
Sbjct: 899 CHLDMWIDPSIRGDVSVNQNEIVEVM-NLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-22
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 10/211 (4%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCC 511
KIG+G G VY + +A G +A+KQ++ + + +NEI + ++P++V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571
+ G++L ++ EYL SL + +D +C + L +LH +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 572 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKA 631
HRDIK+ N+LL D + K++DFG + + ST V GT +MAPE R K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 632 DVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
D++S GI+A+E+V G + + YL+
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 445 TNHFDVANKIGEGGFGPVYK------GLLADGTLIAVKQLSAKSKQGNREFVNEIGTISA 498
+ +++ ++G+G FG VYK GL A A K + +S++ +F+ EI +S
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFA-----AAKIIQIESEEELEDFMVEIDILSE 58
Query: 499 LQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
+HP++V LY N+L ++ E+ + +L + E L P +C +
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEA 115
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYM 617
L +LH K++HRD+KA N+LL D + K++DFG+ AK T + GT +M
Sbjct: 116 LNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWM 170
Query: 618 APEYAMRGHLTD-----KADVYSFGIVALEIVSGR 647
APE D KAD++S GI +E+
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 447 HFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAK---SKQGNREFVNEIGTISALQHP 502
HF++ IG+G FG V D + A+K ++ + K R +NE + L HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIAR 557
LV L+ + + L+ + L L + F E ++K W IC I
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKF--SEEQVKF-W-----IC-EIVL 111
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFGY 616
L YLH + I+HRDIK N+LLD+ + I+DF +A K+ + T T +GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGY 165
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
MAPE R + D +S G+ A E + G+
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 447 HFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
++G G FG V G +A+K + S + EF+ E + L H LV+
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQ 63
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
LYG C + + ++ EY+ N L L EH + +C + G+AYL ES
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYL--ES 118
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAMR 624
+ + +HRD+ A N L+D K+SDFGL++ LD+E + + ++ + PE +
Sbjct: 119 K-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLY 175
Query: 625 GHLTDKADVYSFGIVALEIVS 645
+ K+DV++FG++ E+ S
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 7e-22
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 10/211 (4%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCC 511
KIG+G G V+ + +A G +A+KQ++ + + +NEI + L++P++V
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571
+ G++L ++ EYL SL + +D +C + L +LH +++
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 572 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKA 631
HRDIK+ NVLL D + K++DFG + + ST V GT +MAPE R K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 632 DVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
D++S GI+A+E+V G + + YL+
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 8e-22
Identities = 69/219 (31%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 453 KIGEGGFGPVY----KGLLA-------------DGTLIAVKQLSAKSKQGNR-EFVNEIG 494
K+GEG FG V+ +G+ L+AVK L + + R +F+ EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 495 TISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRH--- 549
+S L+ P++++L CI + L +I EY+EN L + L P+E K D T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 550 --NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHI 606
+ IA G+ YL S L VHRD+ N L+ K+ KI+DFG+++ L D I
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
R +M+ E + G T +DV++FG+ EI++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 69/201 (34%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 448 FDVANKIGEGGFGPVYKGLLADGT-LIAVKQLSAKSKQGNREFVN-EIGTISALQHPHLV 505
F +IG+G FG VYKG+ ++A+K + + + E + EI +S P++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+ YG ++G +L +I EYL S A L P L+ I I +GL YLH E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPG----PLEETYIATILREILKGLDYLHSE 120
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
+ +HRDIKA NVLL + + K++DFG+A + +T V F +MAPE +
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQS 176
Query: 626 HLTDKADVYSFGIVALEIVSG 646
KAD++S GI A+E+ G
Sbjct: 177 AYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 9e-22
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 452 NKIGEGGFGPVYKGLLADGTLIAVKQLS-------AKSKQGNREFVNEIGTISALQHPHL 504
+G+G +G VY GL G LIAVKQ+ A K+ + E+ + +L+H ++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKE-YEKLQEEVDLLKSLKHVNI 64
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARGLAYL 562
V+ G C++ N + + E++ S++ L FGP L P I G+AYL
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP------LPEPVFCKYTKQILDGVAYL 118
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-----TRVAGTFGYM 617
H +VHRDIK NV+L + K+ DFG A+ H + + GT +M
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 618 APEYAMRGHLTDKADVYSFGIVALEIVSGR 647
APE K+D++S G E+ +G+
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 59/196 (30%), Positives = 106/196 (54%), Gaps = 12/196 (6%)
Query: 453 KIGEGGFGPV-YKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCC 511
KIGEG G V + + G L+AVK++ + +Q NE+ + QH ++V++Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571
+ G++L ++ E+LE +L + +++ +C+ + + L+ LH + ++
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQG---VI 138
Query: 572 HRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDK 630
HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE R +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPE 196
Query: 631 ADVYSFGIVALEIVSG 646
D++S GI+ +E+V G
Sbjct: 197 VDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 66/199 (33%), Positives = 109/199 (54%), Gaps = 14/199 (7%)
Query: 454 IGEGGFGPVYKGL-LADGTLI----AVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKL 507
+G G FG VYKG+ + +G + A+K L+ + + N EF++E ++++ HPHLV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
G C+ + L+ + + + L + EH+ + N C+ IA+G+ YL EE R
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYV---HEHKDNIGSQLLLNWCVQIAKGMMYL-EERR 129
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAPEYAMRGH 626
L VHRD+ A NVL+ + KI+DFGLA+L E D + +MA E
Sbjct: 130 L--VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 627 LTDKADVYSFGIVALEIVS 645
T ++DV+S+G+ E+++
Sbjct: 188 FTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 68/275 (24%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 454 IGEGGFGP--VYKGLLADGTLIAVKQ--LSAKSKQGNREFVNEIGTISALQHPHLVKLYG 509
+G+G FG +Y+ D +L+ K+ L+ S++ R+ +NEI +S LQHP+++ Y
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNI--CIGIARGLAYLHEESR 567
++ N LL+ EY +L + + + + I ++Y+H+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKI----VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG- 121
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHL 627
I+HRDIK N+ L K K+ DFG++K+ + + T V GT YM+PE
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKY 178
Query: 628 TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN-- 685
K+D+++ G V E + T + F + N + LV + N
Sbjct: 179 NFKSDIWALGCVLYE--------LL-TLKRTF----------DATNPLNLVVKIVQGNYT 219
Query: 686 -VDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719
V +I++ P RP V+
Sbjct: 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 68/201 (33%), Positives = 113/201 (56%), Gaps = 18/201 (8%)
Query: 454 IGEGGFGPVYKGL-LADGTLI----AVKQL-SAKSKQGNREFVNEIGTISALQHPHLVKL 507
+G G FG VYKGL + +G + A+K+L A S + N+E ++E ++++ +PH+ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
G C+ + + LI + + L + EH+ + N C+ IA+G+ YL EE R
Sbjct: 75 LGICLT-STVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYL-EERR 129
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKL---DEEDNTHISTRVAGTFGYMAPEYAMR 624
L VHRD+ A NVL+ + KI+DFGLAKL DE++ +V +MA E +
Sbjct: 130 L--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP--IKWMALESILH 185
Query: 625 GHLTDKADVYSFGIVALEIVS 645
T ++DV+S+G+ E+++
Sbjct: 186 RIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 2e-21
Identities = 71/202 (35%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN-EIGTISALQHPHLV 505
F KIG+G FG V+KG+ ++A+K + + + E + EI +S P++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
K YG ++ +L +I EYL S A L P LD I I +GL YLH E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPG----PLDETQIATILREILKGLDYLHSE 120
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-TRVAGTFGYMAPEYAMR 624
+ +HRDIKA NVLL + K++DFG+A + +T I GT +MAPE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 625 GHLTDKADVYSFGIVALEIVSG 646
KAD++S GI A+E+ G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 448 FDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
+++ ++G+G FG VYK + G L A K + KS++ +++ EI ++ HP++VK
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
L G +L ++ E+ ++ + E L P IC + L YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIML---ELDRGLTEPQIQVICRQMLEALQYLHS-- 128
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLA----KLDEEDNTHISTRVAGTFGYMAPEYA 622
+KI+HRD+KA NVLL D + K++DFG++ K + ++ I GT +MAPE
Sbjct: 129 -MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVV 182
Query: 623 MRGHLTD-----KADVYSFGIVALEI 643
M + D KAD++S GI +E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 454 IGEGGFGPVYKGLLA----DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLY 508
IG G FG V G L +A+K L A +++ R+F++E + HP+++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
G + ++++ EY+EN SL L +H + + GIA G+ YL S +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMKYL---SDM 125
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG--YMAPEYAMRGH 626
VHRD+ A N+L++ +L K+SDFGL+++ E+D T G + APE
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 627 LTDKADVYSFGIVALEIVS 645
T +DV+S+GIV E++S
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 80/281 (28%), Positives = 122/281 (43%), Gaps = 33/281 (11%)
Query: 454 IGEGGFGPVY----KGLLADG--TLIAVKQLSAKSKQG-NREFVNEIGTISALQHPHLVK 506
+G G FG V+ KG+ +G TL+ VK L + EF E+ L H ++V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALF--GPEEHRLK---LDWPTRHNICIGIARGLAY 561
L G C E +I EY + L + L ++ +LK L + +C IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
L S + VHRD+ A N L+ K+S L+K + ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 622 AMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY-LLDWALLLKEQGNLMELVDP 680
+ K+DV+SFG++ E+ + E FY L D +L + Q +EL P
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFT--------QGELPFYGLSDEEVLNRLQAGKLELPVP 241
Query: 681 -NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
S + K R C V+P +RP S +VS L
Sbjct: 242 EGCPSRLYKLMTR--------CWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 447 HFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
+ IGEG FG V +G G +AVK + K + F+ E ++ L H +LV+
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVR 63
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
L G I N L ++ E + +L F R + + +A G+ YL ES
Sbjct: 64 LLGV-ILHNGLYIVMELMSKGNLVN--FLRTRGRALVSVIQLLQFSLDVAEGMEYL--ES 118
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE--DNTHISTRVAGTFGYMAPEYAMR 624
+ K+VHRD+ A N+L+ +D K+SDFGLA++ DN+ + + + APE
Sbjct: 119 K-KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKH 171
Query: 625 GHLTDKADVYSFGIVALEIVS-GRS 648
+ K+DV+S+G++ E+ S GR+
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 80/290 (27%), Positives = 127/290 (43%), Gaps = 43/290 (14%)
Query: 454 IGEGGFGPVYKGLLAD------GTLIAVKQLSA-KSKQGNREFVNEIGTISAL-QHPHLV 505
+GEG FG V K + +AVK L +++ + V+E+ + + +H +++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 506 KLYGCCIEGNQLLLIYEYLENNSL-----AR-------ALFGPEEHRLKLDWPTRHNICI 553
L G C + L ++ EY + +L AR + P L +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 613
+ARG+ +L S+ K +HRD+ A NVL+ +D KI+DFGLA+ D + G
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR-DIHHIDYYRKTTNGR 195
Query: 614 FGY--MAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKE 670
MAPE T ++DV+SFG++ EI + G S EE F LL +
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-------K 248
Query: 671 QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+G ME P N +E +M + C P+ RP +V L+
Sbjct: 249 EGYRME--KP---QNCTQELYHLMRD----CWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 453 KIGEGGFGPVYKG----LLADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQHPHLVKL 507
IGEG FG VY+G + +AVK + RE F+ E + HPH+VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
G E N + ++ E L L + ++ LD + ++ LAYL ES+
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYL--ESK 126
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHL 627
+ VHRDI A NVL+ K+ DFGL++ E+++ + +++ +MAPE
Sbjct: 127 -RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 628 TDKADVYSFGIVALEIVS 645
T +DV+ FG+ EI+
Sbjct: 186 TSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 6e-21
Identities = 60/212 (28%), Positives = 109/212 (51%), Gaps = 12/212 (5%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCC 511
KIG+G G VY + +A G +A++Q++ + + +NEI + ++P++V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571
+ G++L ++ EYL SL + +D +C + L +LH +++
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 572 HRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDK 630
HRDIK+ N+LL D + K++DFG A++ E + + + GT +MAPE R K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196
Query: 631 ADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
D++S GI+A+E++ G + + YL+
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 28/207 (13%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQG--NREFVNEIGTISALQHPHLVKLYG 509
KIGEG +G VYK G ++A+K++ + + + + EI + L HP+++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 510 CCIEGNQLLLIYEYLENN---SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
L L++E+++ + + G E +K + + +GLA+ H
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIK-------SYLYQLLQGLAFCH--- 115
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN---TH-ISTRVAGTFGYMAPE-- 620
I+HRD+K N+L++ + K++DFGLA+ TH + TR Y APE
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELL 170
Query: 621 YAMRGHLTDKADVYSFGIVALEIVSGR 647
+G+ + D++S G + E++S R
Sbjct: 171 LGDKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN--EIGTISALQ-HPH 503
+ V ++G+G FG VY G L+A+K++ K E +N E+ ++ L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPN 59
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHR--LKLDWPTRHNICIGIARGLAY 561
+VKL E ++L ++EY+E N L+ + R +I I +GLA+
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN-----THISTRVAGTFGY 616
+H + HRD+K N+L+ KI+DFGLA+ E + ++STR Y
Sbjct: 115 IH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WY 164
Query: 617 MAPEYAMR-GHLTDKADVYSFGIVALEIVSGR 647
APE +R + D+++ G + E+ + R
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 79/293 (26%), Positives = 125/293 (42%), Gaps = 52/293 (17%)
Query: 452 NKIGEGGFGPVYKGLLA--DGTL----IAVKQL-SAKSKQGNREFVNEIGTISALQHPHL 504
+G G FG VY+GL DG +AVK L + S+Q +F+ E +S H ++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRH------NICIGIARG 558
V+L G E ++ E + L L E+R + + P+ +A+G
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFL---RENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 559 LAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAK-LDEEDNTHISTRVAGTF 614
YL EE+ +HRDI A N LL KI+DFG+A+ + R
Sbjct: 129 CKYL-EENHF--IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGN 673
+M PE + G T K DV+SFG++ EI S G +T +E
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---------------- 229
Query: 674 LMELVDPNLGSNVDKEQ------VRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ME V G +D + R+M + C +P +RP ++++ ++
Sbjct: 230 VMEFV--TGGGRLDPPKGCPGPVYRIMTD----CWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 29/208 (13%)
Query: 454 IGEGGFGPVYKGLLA----DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLY 508
IG G FG V +G L +A+K L + +++ R+F++E + HP+++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 509 GCCIEGNQLLLIYEYLENNSLARAL------FGPEEHRLKLDWPTRHNICIGIARGLAYL 562
G + +++I E++EN +L L F ++L R GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV----IQLVGMLR-----GIAAGMKYL 122
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG-----YM 617
E + VHRD+ A N+L++ +L K+SDFGL++ E+D + T + G +
Sbjct: 123 SE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSSLGGKIPIRWT 178
Query: 618 APEYAMRGHLTDKADVYSFGIVALEIVS 645
APE T +DV+S+GIV E++S
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 43/230 (18%)
Query: 453 KIGEGGFGPVY--------------------KGLLADGTLIAVKQLSAK-SKQGNREFVN 491
K+GEG FG V+ KG L+AVK L +K +F+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG---RPLLVAVKILRPDANKNARNDFLK 68
Query: 492 EIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARAL---------------FGP 536
E+ +S L+ P++++L G C++ + L +I EY+EN L + L P
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 537 EEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596
+ + + ++ + IA G+ YL S L VHRD+ N L+ ++L KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 597 K-LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+ L D I R +MA E + G T +DV++FG+ EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 452 NKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQG-NREFVNEIGTISALQHPHLVKLYG 509
+++GEG G V K L G + A+K ++ ++ + E+ + + P++VK YG
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 510 CCIE--GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
++ + + + EY E SL ++ ++ I + +GL+YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-- 124
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG----YMAPEYAM 623
KI+HRDIK +N+LL + K+ DFG++ + +AGTF YMAPE
Sbjct: 125 -KIIHRDIKPSNILLTRKGQVKLCDFGVSG-------ELVNSLAGTFTGTSFYMAPERIQ 176
Query: 624 RGHLTDKADVYSFGIVALEIVSGR 647
+ +DV+S G+ LE+ R
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 45/288 (15%)
Query: 447 HFDVANKIGEGGFGPVYKG-LLADGTLIAVKQ------LSAKSKQGNREFVNEIGTISAL 499
+F + KIG G F VY+ L DG +A+K+ + AK++ + + EI + L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59
Query: 500 QHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGL 559
HP+++K Y IE N+L ++ E + L+R + ++ + + T + + L
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 619
++H +++HRDIK NV + K+ D GL + T + V GT YM+P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVSGRSNI---------MCKTKEEKFYLLDWALLLKE 670
E K+D++S G + E+ + +S +CK E+ Y
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY---------- 225
Query: 671 QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718
P L S+ E++R ++N +C + P RP ++ V +
Sbjct: 226 ---------PPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQ-----LSAKSKQGNREFVNEIGTISALQHPHLVKL 507
+G+G FG VY D G +AVKQ S ++K+ EI + LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 508 YGCCIEGNQLLLIYEYLENNSLAR--ALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
YGC + L + EY+ S+ +G + + TR I G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY-TRQ-----ILEGVEYLH-- 121
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS--TRVAGTFGYMAPEYAM 623
IVHRDIK N+L D N K+ DFG +K + + + V GT +M+PE
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 624 RGHLTDKADVYSFGIVALEIVS 645
KADV+S G +E+++
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 29/228 (12%)
Query: 444 ATNHFDVANKIGEGGFGPVY------------KGLLADG-----TLIAVKQLSA-KSKQG 485
+ K+GEG FG V+ K + L+AVK L S
Sbjct: 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA 62
Query: 486 NREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALF-------GPEE 538
+F+ E+ +S L P++ +L G C L +I EY+EN L + L G
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 539 HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK- 597
+ L + T + IA G+ YL L VHRD+ N L+ K+ KI+DFG+++
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRN 179
Query: 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
L D + R +MA E + G T K+DV++FG+ EI++
Sbjct: 180 LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 16/198 (8%)
Query: 453 KIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLY 508
KIGEG G V +A G +AVK + + +Q NE+ + QH ++V++Y
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
+ G +L ++ E+L+ +L + + +L+ +C + + L YLH +
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQG-- 137
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLT 628
++HRDIK+ ++LL D K+SDFG +D + V GT +MAPE R
Sbjct: 138 -VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYG 195
Query: 629 DKADVYSFGIVALEIVSG 646
+ D++S GI+ +E+V G
Sbjct: 196 TEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL 504
+++ ++G+G FG VYK + G L A K + KS++ +++ EI +++ HP++
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
VKL N L ++ E+ ++ + E L P +C L YLHE
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVML---ELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR---VAGTFGYMAPEY 621
KI+HRD+KA N+L D + K++DFG++ NT R GT +MAPE
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEV 174
Query: 622 AMRGHLTD-----KADVYSFGIVALEI 643
M D KADV+S GI +E+
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 454 IGEGGFGPVY---KGLLADGTLIAVKQLSAKSKQGNREF---VNEIGTISALQHPHLVKL 507
I +G +G V+ K D + A+K + + + E +S Q P++VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 508 YGCCIEGNQLLLIYEYLENNSLARAL--FG--PEEHRLKLDWPTRHNICIGIARGLAYLH 563
Y L L+ EYL LA L G E+ I L YLH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA--------RIYIAEIVLALEYLH 110
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-------LDEEDNTHISTRVAGTFGY 616
I+HRD+K N+L+D + + K++DFGL+K ++ D+ R+ GT Y
Sbjct: 111 ---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVSG 646
+APE + + D +S G + E + G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 14/199 (7%)
Query: 454 IGEGGFGPVYKGLLA-DGTLI----AVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKL 507
+G G FG VYKG+ DG + A+K L S + N+E ++E ++ + P++ +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
G C+ + + L+ + + L + E++ ++ N C+ IA+G++YL E
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYV---RENKDRIGSQDLLNWCVQIAKGMSYLEE--- 127
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAPEYAMRGH 626
+++VHRD+ A NVL+ + KI+DFGLA+L + D T +MA E +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 627 LTDKADVYSFGIVALEIVS 645
T ++DV+S+G+ E+++
Sbjct: 188 FTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 7e-20
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGN---REFVNEIGTISALQHPHLVKL 507
++IG G FG VY + ++AVK++S KQ N ++ + E+ + L+HP+ ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
GC ++ + L+ EY L A E H+ L I G +GLAYLH +
Sbjct: 87 KGCYLKEHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN- 141
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM---R 624
++HRDIKA N+LL + K++DFG A N+ + GT +MAPE +
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDE 194
Query: 625 GHLTDKADVYSFGIVALEI 643
G K DV+S GI +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 453 KIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCC 511
KIGEG G V G +AVK++ + +Q NE+ + H ++V +Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571
+ G++L ++ E+LE +L + +++ +C+ + R L+YLH + ++
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VI 140
Query: 572 HRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDK 630
HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE R +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTE 198
Query: 631 ADVYSFGIVALEIVSG 646
D++S GI+ +E++ G
Sbjct: 199 VDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 454 IGEGGFGPVYKGLLA----DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLY 508
+G G FG + +G L +A+ L A S + R F+ E T+ H ++V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
G GN ++++ EY+ N +L L +H +L + G+A G+ YL E +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLT 628
VH+ + A VL++ DL KIS F + D+ + + + + APE H +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 629 DKADVYSFGIVALEIVS 645
+DV+SFGIV E++S
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 19/198 (9%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN---REFVNEIGTISALQHPHLVKLY 508
+IG G FG VY + + ++A+K++S KQ N ++ + E+ + L+HP+ ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
GC + + L+ EY L A E H+ L + G +GLAYLH +
Sbjct: 82 GCYLREHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 135
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM---RG 625
++HRD+KA N+LL + K+ DFG A + N + GT +MAPE + G
Sbjct: 136 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEG 189
Query: 626 HLTDKADVYSFGIVALEI 643
K DV+S GI +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 2e-19
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGN---REFVNEIGTISALQHPH 503
F +IG G FG VY ++A+K++S KQ N ++ + E+ + ++HP+
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
++ GC + + L+ EY L A E H+ L I G +GLAYLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 623
+ ++HRDIKA N+LL + K++DFG A + N+ + GT +MAPE +
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVIL 194
Query: 624 ---RGHLTDKADVYSFGIVALEI 643
G K DV+S GI +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQL--SAKSKQGNREFVNEIGTISALQHP 502
N ++V +GEG +G V K A G ++A+K+ S + + + E+ + L+H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
++V L +L L++EY+E L E L + + + +AY
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEY 621
H I+HRDIK N+L+ + K+ DFG A+ L + ++ VA T Y APE
Sbjct: 117 H---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPEL 172
Query: 622 AMRGHLTDKA-DVYSFGIVALEIVSGR 647
+ K DV++ G + E++ G
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 453 KIGEGGFGPVYKGLL-----ADGTLIAVKQLS-AKSKQGNREFVNEIGTISALQHPHLVK 506
++GE FG +YKG L L+A+K L + Q EF E ++ L HP++V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEH-------------RLKLDWPTRHNICI 553
L G + + +++EYL L L H + LD +I I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAG 612
IA G+ YL S VH+D+ A N+L+ + L+ KISD GL++ + D + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 613 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+M PE M G + +D++SFG+V EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 7e-19
Identities = 71/216 (32%), Positives = 106/216 (49%), Gaps = 28/216 (12%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLV 505
F++ +G G +G VYKG + G L A+K + + E EI + H ++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 506 KLYGCCIEGN------QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGL 559
YG I+ N QL L+ E+ S+ + + + LK +W IC I RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDE---EDNTHISTRVAGTFG 615
++LH+ K++HRDIK NVLL ++ K+ DFG+ A+LD NT I GT
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPY 176
Query: 616 YMAPEYAMRGHLTD-----KADVYSFGIVALEIVSG 646
+MAPE D K+D++S GI A+E+ G
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 20/218 (9%)
Query: 454 IGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLVKLYGCCI 512
+G+G FG V+KG L D T +AVK Q + +F++E + HP++VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 513 EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRH--NICIGIARGLAYLHEESRLKI 570
+ + ++ E + L + K + T+ + A G+AYL ES+
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL-----RKKKDELKTKQLVKFALDAAAGMAYL--ESK-NC 114
Query: 571 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAPEYAMRGHLTD 629
+HRD+ A N L+ ++ KISDFG+++ E+D + S+ + + APE G +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 630 KADVYSFGIVALEIVS-------GRSNIMCKTKEEKFY 660
++DV+S+GI+ E S G +N + + EK Y
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 7/193 (3%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI 512
++G G FG V+ G +A+K ++ + +F+ E + L HP LV+LYG C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 513 EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVH 572
+ L ++ E++EN L L + + KL ++C + G+ YL S +H
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 573 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKAD 632
RD+ A N L+ K+SDFG+ + +D S+ + PE + K+D
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 633 VYSFGIVALEIVS 645
V+SFG++ E+ +
Sbjct: 184 VWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 58/215 (26%), Positives = 106/215 (49%), Gaps = 36/215 (16%)
Query: 448 FDVANKIGEGGFGPVYKGLLADGTL---------IAVKQLSAKSKQGNREFVNEIGTISA 498
+++ KIGEG FG +Y LA I + ++ K K+ ++ E+ ++
Sbjct: 2 YEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAK 55
Query: 499 LQHPHLVKLYGCCIEGNQLLLIYEYLENNSLAR-------ALFGPEEHRLKLDWPTRHNI 551
++HP++V + E +L ++ EY + L + LF E ++ L W
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQI-LSW------ 106
Query: 552 CIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRV 610
+ I+ GL ++H+ KI+HRDIK+ N+ L K+ + K+ DFG+A+ D+ ++
Sbjct: 107 FVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELAYTC 162
Query: 611 AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
GT Y++PE +K D++S G V E+ +
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-18
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 452 NKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQG-NREFVNEIGTISALQHPHLVKLYG 509
N+IG G G VYK + G L A+K + + R+ EI + + HP++VK +
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
++ ++ E+++ SL +E L ++ I G+AYLH R
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIA-DEQFLA-------DVARQILSGIAYLH---RRH 188
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTD 629
IVHRDIK +N+L++ N KI+DFG++++ + ++ V GT YM+PE + L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE-RINTDLNH 246
Query: 630 KA------DVYSFGIVALEIVSGR 647
A D++S G+ LE GR
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLVKLYGCC 511
+G G G V K + GT++A K + +K R + + E+ + + P++V YG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 512 IEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
+ N + + E+++ SL R GP + ++ I + + GL YL+ R
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGP----IPVE--ILGKIAVAVVEGLTYLYNVHR-- 124
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTD 629
I+HRDIK +N+L++ K+ DFG++ E N+ T V GT YM+PE G T
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINSIADTFV-GTSTYMSPERIQGGKYTV 181
Query: 630 KADVYSFGIVALEIVSGR 647
K+DV+S GI +E+ G+
Sbjct: 182 KSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 453 KIGEGGFGPVYKGLLAD------GTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLV 505
++G+G FG VY+G D T +AVK ++ + R EF+NE + H+V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLA---RALFGPEEHRLKLDWPTRHNI---CIGIARGL 559
+L G +G L++ E + + L R+L E+ PT + IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMA 618
AYL+ + K VHRD+ A N ++ D KI DFG+ + + E D + +MA
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 619 PEYAMRGHLTDKADVYSFGIVALEIVS 645
PE G T +D++SFG+V EI S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 39/213 (18%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYG 509
+G+GGFG V + G + A K+L K ++G + +NE + + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 510 CCIEGNQLLLIYEYLENNSL--------------ARALFGPEEHRLKLDWPTRHNICIGI 555
+ L L+ + L ARA+F + I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ----------------I 104
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 615
GL +LH+ +IV+RD+K NVLLD N +ISD GLA ++ + I R AGT G
Sbjct: 105 ICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGR-AGTPG 159
Query: 616 YMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
YMAPE D ++ G E+++GRS
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 450 VANKIGEGGFGPVYKGLLADG-------TLIAVKQLSAKSKQGNR-EFVNEIGTISALQH 501
++ ++G+G FG VY+G+ A G T +A+K ++ + R EF+NE +
Sbjct: 10 MSRELGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 68
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLA---RALFGPEEHRLKLDWPTRH---NICIGI 555
H+V+L G +G L+I E + L R+L E+ P+ + I
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTF 614
A G+AYL+ K VHRD+ A N ++ +D KI DFG+ + + E D +
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+M+PE G T +DV+SFG+V EI +
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 452 NKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGC 510
+K+G G +G VY+G+ +AVK L + + EF+ E + ++HP+LV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 511 CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKI 570
C +I E++ +L L E +R +++ + I+ + YL E +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL--EKK-NF 125
Query: 571 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT---FGYMAPEYAMRGHL 627
+HRD+ A N L+ ++ K++DFGL++L D T AG + APE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 628 TDKADVYSFGIVALEIVS 645
+ K+DV++FG++ EI +
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 75/240 (31%), Positives = 112/240 (46%), Gaps = 35/240 (14%)
Query: 424 RELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKS 482
R L +DL ++ F++ +G G +G VYKG + G L A+K +
Sbjct: 1 RSLDDIDLSA-------LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE 53
Query: 483 KQGNREFVNEIGTISAL-QHPHLVKLYGCCIE------GNQLLLIYEYLENNSLARALFG 535
+ E EI + H ++ YG I+ +QL L+ E+ S+ +
Sbjct: 54 DE-EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN 112
Query: 536 PEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595
+ + LK DW IC I RGLA+LH K++HRDIK NVLL ++ K+ DFG+
Sbjct: 113 TKGNALKEDWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGV 167
Query: 596 -AKLDE---EDNTHISTRVAGTFGYMAPEYAMRGHLTD-----KADVYSFGIVALEIVSG 646
A+LD NT I GT +MAPE D ++D++S GI A+E+ G
Sbjct: 168 SAQLDRTVGRRNTFI-----GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 39/228 (17%)
Query: 439 RQIKAATNHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGNREFVNEIGT-- 495
++ A N + +IG G G VYK G ++AVKQ+ + GN+E I
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDL 64
Query: 496 -ISALQH--PHLVKLYGCCIEGNQLLLIYEYLEN--NSLARALFGP-EEHRLKLDWPTRH 549
+ H P++VK YG I + + + E + + L + + GP E L
Sbjct: 65 DVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG------- 117
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609
+ + I + L YL E+ ++HRD+K +N+LLD N K+ DFG++ + TR
Sbjct: 118 KMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173
Query: 610 VAGTFGYMAPE----------YAMRGHLTDKADVYSFGIVALEIVSGR 647
AG YMAPE Y +R ADV+S GI +E+ +G+
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIR------ADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 60/200 (30%), Positives = 111/200 (55%), Gaps = 13/200 (6%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN-REFVNEIGTISALQHPHLVKLYGC 510
K+GEG + VYKG G ++A+K++ +++G + EI + L+H ++V+L+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 511 CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKI 570
N+L+L++EY++ + L + + R LD T + + +G+A+ HE ++
Sbjct: 67 IHTENKLMLVFEYMDKD-LKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 571 VHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAM--RGHL 627
+HRD+K N+L++K K++DFGLA+ NT + V T Y AP+ + R +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYS 179
Query: 628 TDKADVYSFGIVALEIVSGR 647
T D++S G + E+++GR
Sbjct: 180 T-SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 36/213 (16%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE-----FVNEIGT---ISA 498
++ +IGEG +G VYK L G +A+K++ + E + EI + +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRV---PLSEEGIPLSTLREIALLKQLES 57
Query: 499 LQHPHLVKLYGCCI-----EGNQLLLIYEYLENNSLARAL-----FGPEEHRLKLDWPTR 548
+HP++V+L C +L L++E+++ + LA L G +K
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPPETIK------ 110
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 608
++ + RG+ +LH +IVHRD+K N+L+ D KI+DFGLA++ T
Sbjct: 111 -DLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALT 164
Query: 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFG-IVA 640
V T Y APE ++ D++S G I A
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 454 IGEGGFGPVYKGLLAD--GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCC 511
IG+G FG V +L D G +AVK + K+ + F+ E ++ L+H +LV+L G
Sbjct: 14 IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 512 IEGN-QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKI 570
+E L ++ EY+ SL L R L + + + YL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---F 123
Query: 571 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDK 630
VHRD+ A NVL+ +D K+SDFGL K E +T + ++ + APE + K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 179
Query: 631 ADVYSFGIVALEIVS-GR 647
+DV+SFGI+ EI S GR
Sbjct: 180 SDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGC 510
+G G FG V+ AD L+ +KQ+ + +K NE + L HP++++ Y
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 511 CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKI 570
+E L+++ EY +LA + + LD T + + I L ++H + I
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHTK---LI 122
Query: 571 VHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTD 629
+HRD+K N+LLDK KI DFG++K + + V GT Y++PE
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 630 KADVYSFGIVALEIVS 645
K+D+++ G V E+ S
Sbjct: 181 KSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 55/205 (26%), Positives = 83/205 (40%), Gaps = 16/205 (7%)
Query: 452 NKIGEGGFGPVYKGLLADGTLIA---VKQLSAKSK-QGNREFVNEIGTISALQHPHLVKL 507
++IG G FG V G G A VK+L A + F+ E+ L HP++++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEH-RLKLDWPTRHNICIGIARGLAYLHEES 566
G CIE LL+ E+ L L + +A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EEDNTHISTRVAGTFGYMAPEYAMRG 625
+ +H D+ N L DL+ KI D+GLA ED A ++APE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 626 H-------LTDKADVYSFGIVALEI 643
T K++++S G+ E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 453 KIGEGGFGPVYKG---LLADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLVKLY 508
++G G FG V KG + +A+K L ++++ R E + E + L +P++V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICI---GIARGLAYLHEE 565
G C E L+L+ E L + L G K D T N+ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSG------KKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAM 623
+ VHRD+ A NVLL KISDFGL+K D+++ R AG + + APE
Sbjct: 115 N---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 624 RGHLTDKADVYSFGIVALEIVS 645
+ ++DV+S+GI E S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 454 IGEGGFGPVYKGLLA--DGTL--IAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKL 507
+GEG FG V +G L+ DG+ +AVK + + EF++E + HP+++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 508 YGCCIEGNQL------LLIYEYLENNSLARALFGP--EEHRLKLDWPTRHNICIGIARGL 559
G C E + L ++I ++++ L L KL T + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMA 618
YL S +HRD+ A N +L +D+ ++DFGL+K + + R+A ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 619 PEYAMRGHLTDKADVYSFGIVALEIVS 645
E T K+DV++FG+ EI +
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 454 IGEGGFGPVY------KGLLADGTLIAVKQLSAKSKQGN-REFVNEIGTISALQHPHLVK 506
+GEG FG V +G G +AVK L +S + + EI + L H ++VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 507 LYGCCIE--GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
G C E GN + LI E+L + SL L ++ K++ + + I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLG- 126
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRVAGTFGYMAPEY 621
SR + VHRD+ A NVL++ + KI DFGL K D+E T + F Y APE
Sbjct: 127 -SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APEC 183
Query: 622 AMRGHLTDKADVYSFGIVALEIVS 645
++ +DV+SFG+ E+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 46/218 (21%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQLSAKS-KQGNREFVNEIGTISALQH-PHLVKLYG- 509
IG G FG V K L GT++AVK++ + ++ + + ++ + P++VK YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 510 ------C--CIE--GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGL 559
C C+E L Y+Y+ + PEE K I + + L
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVI---PEEILGK--------IAVATVKAL 120
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFGYMA 618
YL EE LKI+HRD+K +N+LLD++ N K+ DFG++ +L ++ TR AG YMA
Sbjct: 121 NYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMA 175
Query: 619 PE---------YAMRGHLTDKADVYSFGIVALEIVSGR 647
PE Y +R +DV+S GI E+ +G+
Sbjct: 176 PERIDPSARDGYDVR------SDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 81/279 (29%), Positives = 124/279 (44%), Gaps = 34/279 (12%)
Query: 454 IGEGGFGPVYK----GLLADGTLI--AVKQLSAKSKQGNRE-FVNEIGTISAL-QHPHLV 505
+G G FG V + GL ++ AVK L + RE ++E+ +S L H ++V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
L G C G +L+I EY L L E L L+ + +A+G+A+L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE--DLLSFSYQVAKGMAFLASK 160
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRVAGTFGYMAPEYA 622
+ +HRD+ A NVLL KI DFGLA+ D+ ++ + R+ +MAPE
Sbjct: 161 N---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VKWMAPESI 215
Query: 623 MRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681
T ++DV+S+GI+ EI S G + + KFY L+KE + P
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY-----KLIKEG---YRMAQPE 267
Query: 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
E +M C D P RP +V ++
Sbjct: 268 HAP---AEIYDIMKT----CWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV-----NEIGTISALQHPHLVK 506
KIGEG +G VYK G ++A+K++ +++ E V EI + L HP++V+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVR 62
Query: 507 LYGCCIEGNQLLLIYEYLEN------NSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
L N+L L++E+L+ +S P + L + + +G+A
Sbjct: 63 LLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYL-----YQLL----QGIA 113
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRVAGTFGYM 617
Y H S +++HRD+K N+L+D++ K++DFGLA+ + TH V T Y
Sbjct: 114 YCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYR 166
Query: 618 APEYAMRG-HLTDKADVYSFGIVALEIVSGR 647
APE + + D++S G + E+V+ R
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 453 KIGEGGFGPVYKGLL-ADGTLIAVK--------QLSAKSKQGNREFVNEIGTISALQHPH 503
+IG G FG V+ G L AD T +AVK L AK F+ E + HP+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-------FLQEARILKQYSHPN 54
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+V+L G C + + ++ E ++ E RLK+ + + A G+ YL
Sbjct: 55 IVRLIGVCTQKQPIYIVMELVQGGDF-LTFLRTEGPRLKVKELIQ--MVENAAAGMEYL- 110
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT----FGYMAP 619
ES+ +HRD+ A N L+ + KISDFG+++ +EED + ST G + AP
Sbjct: 111 -ESK-HCIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST--GGMKQIPVKWTAP 165
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVS 645
E G + ++DV+SFGI+ E S
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 70/221 (31%), Positives = 103/221 (46%), Gaps = 17/221 (7%)
Query: 438 LRQIKAATNHFDVANKIGEGGFGPVYK-GLLADGTLIAVKQLSAKSKQGNREFVNEIGTI 496
L + T+ +++ IG+G +G VYK DG+L AVK L S + E E +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNIL 72
Query: 497 SAL-QHPHLVKLYGCCIE-----GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHN 550
+L HP++VK YG + G QL L+ E S+ + G +LD
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 551 ICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 610
I G GL +LH +I+HRD+K N+LL + K+ DFG++ +T V
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 611 AGTFGYMAPEYAMRGHLTD-----KADVYSFGIVALEIVSG 646
GT +MAPE D + DV+S GI A+E+ G
Sbjct: 190 -GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 73/220 (33%), Positives = 111/220 (50%), Gaps = 34/220 (15%)
Query: 454 IGEGGFGPVY---KGLLAD-GTLIAVKQLSAKSKQGNREFV---NEIGTISALQHPHLVK 506
+G+G FG V+ K D G L A+K L K+ R+ V E ++ + HP +VK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLK-KATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 507 L-YGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
L Y EG +L LI ++L L +F E+ + L +A L
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---------AELALALD 112
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMA 618
+LH L I++RD+K N+LLD++ + K++DFGL+K +D E + GT YMA
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMA 166
Query: 619 PEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE 657
PE R GH T AD +SFG++ E+++G K ++E
Sbjct: 167 PEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKE 205
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 25/206 (12%)
Query: 454 IGEGGFGPVYKGLLADG----TLIAVKQLSAKSKQGNRE-FVNEIGTISALQHPHLVKLY 508
IG+G FG VY G L D AVK L+ + E F+ E + HP+++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 509 GCCI--EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIG----IARGLAYL 562
G C+ EG+ L+++ Y+++ L R E H PT ++ IG +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVL-PYMKHGDL-RNFIRSETHN-----PTVKDL-IGFGLQVAKGMEYL 114
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEE-DNTHISTRVAGTFGYMAP 619
+ K VHRD+ A N +LD+ K++DFGLA+ D+E + H T +MA
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVS 645
E T K+DV+SFG++ E+++
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 35/229 (15%)
Query: 444 ATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKS-KQGNREF----VNEIGTIS 497
+++ K+GEG FG VYK + G ++A+K++ + K G F + EI +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 498 ALQHPHLVKLYGCCIE-----GNQLLLIY---EYLENNSLARALFGPEEHRLKLDWPTRH 549
L+HP++V L +E + +Y Y++++ L+ L P +KL
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD-LSGLLENP---SVKLTESQIK 118
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED------- 602
+ + G+ YLHE I+HRDIKA N+L+D KI+DFGLA+ +
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 603 ---NTHISTRVAGTFGYMAPEYAM-RGHLTDKADVYSFGIVALEIVSGR 647
T T + T Y PE + T D++ G V E+ + R
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 33/206 (16%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN-----EIGTISALQH 501
++ K+GEG + VYK G ++A+K++ ++ ++ +N EI + L+H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLE--------NNSLARALFGPEEHRLKLDWPTRHNICI 553
P+++ L + + L++E++E + S+ + P + + + +
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIK---------SYML 109
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 613
RGL YLH I+HRD+K N+L+ D K++DFGLA+ N ++ +V T
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165
Query: 614 FGYMAPE--YAMRGHLTDKADVYSFG 637
Y APE + R H D++S G
Sbjct: 166 RWYRAPELLFGAR-HYGVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 72/213 (33%), Positives = 104/213 (48%), Gaps = 35/213 (16%)
Query: 448 FDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLS----AKSKQGNREFV-NEIGTISA 498
F+ +G G FG V +L G A+K LS K KQ E V NE + +
Sbjct: 3 FEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQ--VEHVLNEKRILQS 57
Query: 499 LQHPHLVKLYGCCIEGNQLLLIYEYL---ENNSLARALFGPEEHRLKLDWPTRHNICIGI 555
++HP LV LYG + + L L+ EY+ E S R R + + +
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVL 112
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 615
A L YLH L IV+RD+K N+LLD D KI+DFG AK + T+ + GT
Sbjct: 113 A--LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRTYT---LCGTPE 163
Query: 616 YMAPEYAM-RGHLTDKA-DVYSFGIVALEIVSG 646
Y+APE + +G+ KA D ++ GI+ E+++G
Sbjct: 164 YLAPEIILSKGY--GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 16/196 (8%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCC 511
+G G G VYK L ++AVK + + + ++ ++E+ + P+++ YG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571
N++ + E+++ SL PE I + + +GL YL LKI+
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPE--------HVLGRIAVAVVKGLTYLWS---LKIL 117
Query: 572 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKA 631
HRD+K +N+L++ K+ DFG++ + I+ GT YMAPE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 632 DVYSFGIVALEIVSGR 647
DV+S GI +E+ GR
Sbjct: 175 DVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 34/215 (15%)
Query: 454 IGEGGFGPVYKGLLA-DGTLI--AVKQLSA-KSKQGNREFVNEIGTISAL-QHPHLVKLY 508
IGEG FG V + ++ DG + A+K L S+ +R+F E+ + L HP+++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 509 GCCIEGNQLLLIYEYLENNSL------ARAL-----FGPEEHRLKLDWPTRH--NICIGI 555
G C L + EY +L +R L F +EH ++ +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA-KEHGTASTLTSQQLLQFASDV 128
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 615
A G+ YL E+ + +HRD+ A NVL+ ++L KI+DFGL++ +E V T G
Sbjct: 129 ATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKKTMG 178
Query: 616 -----YMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+MA E T K+DV+SFG++ EIVS
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSA-KSKQG-NREFVNEIGTISALQHPHL 504
F+ N+IGEG +G VY+ G ++A+K++ + G + EI + L+HP++
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 505 VKLYGCCIEGNQL---LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
V+L + G L L+ EY E + LA L + + + + RGL Y
Sbjct: 69 VELKE-VVVGKHLDSIFLVMEYCEQD-LASLL---DNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE- 620
LHE I+HRD+K +N+LL KI+DFGLA+ ++ +V T Y APE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPEL 179
Query: 621 -YAMRGHLTDKADVYSFGIVALEIVSGR 647
+ T D+++ G + E+++ +
Sbjct: 180 LLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQ------LSAKSKQGNREFVNEIGTISALQ 500
F + KIG G F VY+ L D +A+K+ + AK++Q + V EI + L
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQLN 60
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
HP+++K IE N+L ++ E + L++ + ++ + + T + + +
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
++H SR +++HRDIK NV + K+ D GL + T + V GT YM+PE
Sbjct: 121 HMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 621 YAMRGHLTDKADVYSFGIVALEIVSGRS 648
K+D++S G + E+ + +S
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 453 KIGEGGFGPVYKGLLADGT------LIAVKQLSAKSKQGNRE-FVNEIGTISALQHPHLV 505
++GE FG VYKG L +A+K L K++ RE F +E S LQHP++V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEH------------RLKLDWPTRHNICI 553
L G + L +I+ Y ++ L L H + L+ +I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAG 612
IA G+ +L S +VH+D+ NVL+ LN KISD GL + + D +
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 613 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+M+PE M G + +D++S+G+V E+ S
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 27/205 (13%)
Query: 453 KIGEGGFGPVYKGLLA----DGTLIAVKQL--SAKSKQGNREFVNEIGTISALQHPHLVK 506
KIGEG FG K +L DG +K++ S S + E E+ +S ++HP++V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 507 LYGCCIEGNQLLLIYEYLENNSL------ARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
E L ++ +Y E L R + PE+ LDW + IC+ L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ--ILDWFVQ--ICLA----LK 115
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
++H+ KI+HRDIK+ N+ L KD K+ DFG+A++ ++ GT Y++PE
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPE 171
Query: 621 YAMRGHLTDKADVYSFGIVALEIVS 645
+K+D+++ G V E+ +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 32/233 (13%)
Query: 448 FDVANKIGEGGFGPVYKGLL---ADGTLIAVKQLSAKSKQG---NREFVNEIGTISALQH 501
+++ IG G +G VYK DG A+K+ +Q ++ EI + L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 502 PHLVKLYGCCIEGNQ--LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGL 559
++V L +E + L+++Y E++ F + R+ + ++ I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNP----KISDFGLAK--------LDEEDNTHIS 607
YLH ++HRD+K N+L+ + KI D GLA+ L + D
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD----- 173
Query: 608 TRVAGTFGYMAPEYAMRG--HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEK 658
V T Y APE + G H T D+++ G + E+++ + + K
Sbjct: 174 -PVVVTIWYRAPELLL-GARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIK 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 57/207 (27%), Positives = 106/207 (51%), Gaps = 15/207 (7%)
Query: 448 FDVANKIGEGGFGPVYK-GLLADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLV 505
F+ +++G G G V K G ++A K + + K R + + E+ + P++V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
YG ++ + E+++ SL + L E R+ + + + I + RGLAYL E+
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGK--VSIAVLRGLAYLREK 122
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAM 623
+I+HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 123 H--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQ 175
Query: 624 RGHLTDKADVYSFGIVALEIVSGRSNI 650
H + ++D++S G+ +E+ GR I
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 453 KIGEGGFGPVYKG---LLADGTLIAVKQLSAKSKQG--NREFVNEIGTISALQHPHLVKL 507
++G G FG V KG + +AVK L + E + E + L +P++V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNI---CIGIARGLAYLHE 564
G C E +L+ E E L + L K T NI ++ G+ YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL-------QKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYA 622
+ VHRD+ A NVLL KISDFGL+K D + + G + + APE
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 623 MRGHLTDKADVYSFGIVALEIVS 645
+ K+DV+SFG++ E S
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 454 IGEGGFGPVYKGLLADGTL---IAVKQLSA-KSKQGNREFVNEIGTISAL-QHPHLVKLY 508
IGEG FG V K + L A+K++ SK +R+F E+ + L HP+++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 509 GCCIEGNQLLLIYEYLENNSL------ARALFG----PEEHRLKLDWPTRH--NICIGIA 556
G C L L EY + +L +R L + ++ + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG- 615
RG+ YL ++ + +HRD+ A N+L+ ++ KI+DFGL++ E V T G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTMGR 172
Query: 616 ----YMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+MA E T +DV+S+G++ EIVS
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQ--LSAKSKQGNREFVNEIGTISALQHPHL 504
F KIGEG +G VYK G ++A+K+ L +++ + EI + L HP++
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
VKL N+L L++E+L + L + + + L P + + +GLA+ H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCHS 118
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRVAGTFGYMAPEY 621
+++HRD+K N+L++ + K++DFGLA+ + TH V T Y APE
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEI 171
Query: 622 AMRGHLTDKA-DVYSFGIVALEIVSGRS 648
+ A D++S G + E+V+ R+
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN--REFVNEIGTISALQHPHLVKLYG 509
KIGEG +G VYKG G ++A+K++ +S++ + EI + LQHP++V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 510 CCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
++ ++L LI+E+L + L + L ++ +D + I +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSMD-LKKYLDSLPKGQY---MDAELVKSYLYQILQGILFCH---S 119
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV----AGTFGYMAPEYAM 623
+++HRD+K N+L+D K++DFGLA+ I RV T Y APE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRVYTHEVVTLWYRAPEVLL 174
Query: 624 RGHL-TDKADVYSFGIVALEIVSGR 647
+ D++S G + E+ + +
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-15
Identities = 83/293 (28%), Positives = 129/293 (44%), Gaps = 47/293 (16%)
Query: 454 IGEGGFGPVYK----GLLAD----GTLIAVKQLSAKSKQGNREFVNEIGTISALQ----H 501
+GEG FG V + G+ +AVK L K +++ + I + ++ H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML--KDNATDKDLADLISEMELMKLIGKH 77
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSL-----AR-------ALFGPEEHRLKLDWPTRH 549
+++ L G C + L +I EY +L AR + +L +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIST 608
+ +ARG+ YL ESR + +HRD+ A NVL+ +D KI+DFGLA+ + + D ++
Sbjct: 138 SCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALL 667
+MAPE T ++DV+SFGI+ EI + G S EE F LL
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL----- 249
Query: 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+G+ M+ P SN E +M C PT RP +V L+
Sbjct: 250 --REGHRMD--KP---SNCTHELYMLMRE----CWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAK-SKQGNREFVNEIG-TISALQHPHL 504
+V ++G G +G V K + GT++AVK++ A + Q + + ++ ++ ++ P+
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT 62
Query: 505 VKLYGCCI-EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
V YG EG+ + I + + SL + + L + I + I + L YLH
Sbjct: 63 VTFYGALFREGD--VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFG--------LAKLDEEDNTHISTRVAGTFG 615
+L ++HRD+K +NVL++++ K+ DFG +AK T AG
Sbjct: 121 S--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----------TIDAGCKP 168
Query: 616 YMAPE-----YAMRGHLTDKADVYSFGIVALEIVSGR 647
YMAPE +G+ K+DV+S GI +E+ +GR
Sbjct: 169 YMAPERINPELNQKGYDV-KSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLV 505
F+ ++G G G V K L G ++A K + + K R + + E+ + P++V
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 506 KLYGCCIEGNQLLLIYEYLENNSL----ARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
YG ++ + E+++ SL +A PE K I I + RGL Y
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK--------ISIAVLRGLTY 114
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAP 619
L E+ KI+HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+P
Sbjct: 115 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 167
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVSGRSNI 650
E H T ++D++S G+ +E+ GR I
Sbjct: 168 ERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 453 KIGEGGFGPVY----KGLLADGTLIAVKQLSAKSKQGNREFVN---EIGTISALQHPHLV 505
++G+G FG VY K +A+ L +K++ N E V E +S L HP +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPN-ETVQANQEAQLLSKLDHPAIV 65
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNIC---IGIARGLAYL 562
K + +E + +I EY E L L EE + + + +C I + G+ Y+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKL---EELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 622
H+ +I+HRD+KA N+ L +L KI DFG+++L + ++T GT YM+PE
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL-LMGSCDLATTFTGTPYYMSPEAL 177
Query: 623 MRGHLTDKADVYSFGIVALEI 643
K+D++S G + E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-15
Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 31/227 (13%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS---AKSKQGNREFVNEIGTISALQHP 502
+D+ IG+GG G VY +A+K++ +++ + F+ E + L HP
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFG-------PEEHRLKLDWPTRHNICIGI 555
+V +Y C +G+ + Y+E +L L +E K +I I
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEED---------- 602
+ Y+H S+ ++HRD+K N+LL I D+G A L+EED
Sbjct: 123 CATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 603 ----NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+ I ++ GT YMAPE + ++ D+Y+ G++ ++++
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 81/298 (27%), Positives = 131/298 (43%), Gaps = 57/298 (19%)
Query: 454 IGEGGFGPVYKGLLADG-----------TLIAVKQLSAKSKQGN-REFVNEIGTISAL-Q 500
+GEG FG V ++A+ T +AVK L + + + + + ++E+ + + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHN---------- 550
H +++ L G C + L +I EY +L L ++ +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 551 --ICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 608
+ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ D HI
Sbjct: 143 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 195
Query: 609 RVAGTFG-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLL 662
T G +MAPE T ++DV+SFG++ EI + G S EE F LL
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255
Query: 663 DWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
++G+ M+ P SN E +M + C P+ RP +V L+
Sbjct: 256 -------KEGHRMD--KP---SNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLV 505
F+ +++G G G V+K G ++A K + + K R + + E+ + P++V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
YG ++ + E+++ SL + L + ++ + I + +GL YL E+
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAM 623
KI+HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 123 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQ 175
Query: 624 RGHLTDKADVYSFGIVALEIVSGRSNI 650
H + ++D++S G+ +E+ GR I
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
I RGL YLH I+HRDIK N+L++ + KI DFGLA+++E D + T+ T
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 615 GYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGR 647
Y APE M H T D++S G + E++ R
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 453 KIGEGGFGPVYKGLLADGTLIA---VKQL--SAKSKQGNREFVNEIGTISALQHPHLVKL 507
+IG G FG V + T +A VK+L +A SK+ N EF+ + LQHP++++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN-EFLQQGDPYRILQHPNILQC 60
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
G C+E LL++EY E L L + HR + IA G+ ++H +
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EEDNTHISTRVAGTFGYMAPEYAMRGH 626
+H D+ N L DL K+ D+G+ +ED ++APE H
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 627 -------LTDKADVYSFGIVALEI 643
T ++V++ G+ E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 61/222 (27%), Positives = 110/222 (49%), Gaps = 27/222 (12%)
Query: 452 NKIGEGGFGPVYKGL--LADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLVKLY 508
K+GEG + V+KG L + L+A+K++ + ++G + E+ + L+H ++V L+
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLD----WPTRHNICI---GIARGLAY 561
L L++EYL+ ++ + +D + HN+ I I RGLAY
Sbjct: 71 DIVHTDKSLTLVFEYLD-----------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
H R K++HRD+K N+L+++ K++DFGLA+ S V T Y P+
Sbjct: 120 CH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV 175
Query: 622 AM-RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
+ + + D++ G + E+ SGR T E++ +L+
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 67/214 (31%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 454 IGEGGFGPVYK-GLLADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYG 509
+G+GGFG V + A G + A K+L K ++G +NE + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 510 CCIEGNQLLLIYEYLENNSLARALF-----GPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
+ L L+ + L ++ G EE R IC G L LH+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF---YAAEICCG----LEDLHQ 120
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 624
E +IV+RD+K N+LLD + +ISD GLA E T I RV GT GYMAPE
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKN 175
Query: 625 GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEK 658
T D ++ G + E+++G+S + K+ K
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 69/206 (33%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQL--SAKSKQGNREFVN----EIGTISALQHPHLVK 506
+G G FG VY AD G +AVKQ+ S++ ++E VN EI + L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68
Query: 507 LYGCC--IEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARGLAYL 562
YGC E +L + EY+ S+ L +G + + TR I +G++YL
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRY-TRQ-----ILQGVSYL 122
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE---DNTHISTRVAGTFGYMAP 619
H IVHRDIK N+L D N K+ DFG +K + T I + V GT +M+P
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSP 178
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVS 645
E KADV+S +E+++
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 454 IGEGGFGPVYKGLLA--DGTL-IAVK--QLSAKSKQGNREFVNEIGTISALQHPHLVKLY 508
+GEG FG V +G L D L +AVK +++ ++ +F++E + HP++++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 509 GCCIEGNQL------LLIYEYLENNSLARALFGPEEHRLKLDWPTRH--NICIGIARGLA 560
G C++ + ++I ++++ L L PT+ IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAP 619
YL S +HRD+ A N +L++++N ++DFGL+K + + R+A ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVS 645
E T K+DV+SFG+ EI +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 72/265 (27%), Positives = 110/265 (41%), Gaps = 50/265 (18%)
Query: 454 IGEGGFGPVYKGLLAD----GTLIAVKQLSAKSKQGNREFVNEIGTISALQH-----PHL 504
I +G FG VY LA G A+K L KS + V + A+ P++
Sbjct: 4 ISKGAFGSVY---LAKKRSTGDYFAIKVLK-KSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIAR---GL 559
KLY + L L+ EYL A + G L DW IA G+
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG----LPEDW-----AKQYIAEVVLGV 110
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 619
LH+ I+HRDIK N+L+D+ + K++DFGL++ N + + GT Y+AP
Sbjct: 111 EDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAP 162
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF-----YLLDW-----ALLLK 669
E + +D +S G V E + G +T + F ++W
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSP 222
Query: 670 EQGNLME-LVDPN----LGSNVDKE 689
E +L+ L+ + LG+N +E
Sbjct: 223 EAVDLINRLLCMDPAKRLGANGYQE 247
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
F++ +IG G +G VYK + G L A+K + + + EI + +H ++V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARA--LFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
+G + ++L + E+ SL + GP ++ + +R + +GL YLH
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSE-SQIAYVSRETL-----QGLYYLHS 124
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA------GTFGYMA 618
+ ++ HRDIK N+LL + + K++DFG++ I+ +A GT +MA
Sbjct: 125 KGKM---HRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMA 174
Query: 619 PEYAM---RGHLTDKADVYSFGIVALEI 643
PE A +G D+++ GI A+E+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 442 KAATNHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKS-KQGNREF----VNEIGT 495
K + FD+ +IGEG +G VYK D G L+A+K++ + K+G F + EI
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKI 59
Query: 496 ISALQHPHLVKLYGCCIEGNQLL----------LIYEYLENNSLARALFGPEEHRLKLDW 545
+ L H ++V L + L L++EY++++ L G E L + +
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGL-VHF 113
Query: 546 PTRHNICI--GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603
H + GL Y H+++ L HRDIK +N+LL+ K++DFGLA+L +
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 604 THISTRVAGTFGYMAPEYAM-RGHLTDKADVYSFGIVALEIVSGR 647
+ T T Y PE + DV+S G + E+ + +
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
+++ ++G G +G VYK L G L AVK + + EI + +H ++V
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARA--LFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
+G + +L + EY SL + GP L++ + R + +GLAYLH
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSE-LQIAYVCRETL-----QGLAYLHS 124
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA--GTFGYMAPEYA 622
+ ++ HRDIK N+LL + + K++DFG+A + I+ R + GT +MAPE A
Sbjct: 125 KGKM---HRDIKGANILLTDNGDVKLADFGVAA---KITATIAKRKSFIGTPYWMAPEVA 178
Query: 623 M---RGHLTDKADVYSFGIVALEI 643
G D+++ GI A+E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 59/217 (27%), Positives = 111/217 (51%), Gaps = 17/217 (7%)
Query: 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLVKLYG 509
+K+GEG + V+KG L+A+K++ + ++G + E+ + L+H ++V L+
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICI---GIARGLAYLHEES 566
L L++EYL+++ L + L ++ L + HN+ I + RGL+Y H+
Sbjct: 71 IIHTERCLTLVFEYLDSD-LKQYL----DNCGNL--MSMHNVKIFMFQLLRGLSYCHKR- 122
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-RG 625
KI+HRD+K N+L+++ K++DFGLA+ S V T Y P+ +
Sbjct: 123 --KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGST 179
Query: 626 HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
+ D++ G + E+ +GR T +E+ +L+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 448 FDVANKIGEGGFGPVY----KGLLADGTLIAVKQLS-------AKSKQGNREFVNEIGTI 496
F++ +G G +G V+ G G L A+K L AK+ + R E +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR---TERQVL 58
Query: 497 SALQH-PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIG- 554
A++ P LV L+ +L LI +Y+ L L+ E + + I
Sbjct: 59 EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE-----SEVRVYIAE 113
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL---DEEDNTHISTRVA 611
I L +LH+ L I++RDIK N+LLD + + ++DFGL+K +EE+ +
Sbjct: 114 IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFC 167
Query: 612 GTFGYMAPEYAMR---GHLTDKA-DVYSFGIVALEIVSGRS 648
GT YMAPE GH DKA D +S G++ E+++G S
Sbjct: 168 GTIEYMAPEVIRGGSGGH--DKAVDWWSLGVLTFELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYG 509
+G+GGFG V + + G + A K+L K K G + + E + + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
L L+ + L ++ E L+++ ++ I G+ +LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA--QITCGILHLHS---MD 115
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTD 629
IV+RD+K NVLLD N ++SD GLA ++ +D I+ R AGT GYMAPE +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQR-AGTNGYMAPEILKEEPYSY 173
Query: 630 KADVYSFGIVALEIVSGRS 648
D ++ G E+V+GR+
Sbjct: 174 PVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 41/153 (26%), Positives = 80/153 (52%), Gaps = 10/153 (6%)
Query: 448 FDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSK-QGNREF-VNEIGTISALQHPHL 504
++ KIGEG +G V+K + ++A+K++ +G + EI + L+H ++
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
V+LY +L L++EY + + L + + +D + + +GLA+ H
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQD-LKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597
++HRD+K N+L++K+ K++DFGLA+
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 454 IGEGGFGPVYK-GLLADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYG 509
+G+GGFG V + A G L A K+L+ K ++G + E ++ + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
L L+ + L ++ +E P I GL +LH+ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTD 629
I++RD+K NVLLD D N +ISD GLA ++ +D + AGT G+MAPE ++G D
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFMAPEL-LQGEEYD 175
Query: 630 KA-DVYSFGIVALEIVSGRSNIMCK 653
+ D ++ G+ E+++ R +
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRAR 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 21/219 (9%)
Query: 452 NKIGEGGFGPVYKGL--LADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLVKLY 508
+K+GEG + VYKG L D L+A+K++ + ++G + E+ + L+H ++V L+
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEE----HRLKLDWPTRHNICIGIARGLAYLHE 564
L L++EYL+ + L + L H +KL + RGL Y H
Sbjct: 71 DIIHTEKSLTLVFEYLDKD-LKQYLDDCGNSINMHNVKL-------FLFQLLRGLNYCH- 121
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM- 623
R K++HRD+K N+L+++ K++DFGLA+ S V T Y P+ +
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLG 178
Query: 624 RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
+ + D++ G + E+ +GR T EE+ + +
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQLS--AKSKQGNREFVN---EIGTISALQHPHLVKL 507
+G+G FG VY D G +A KQ+ +S + ++E EI + LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 508 YGCCIE-GNQLLLIY-EYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
YGC + + L I+ EY+ S+ L +G + + TR I G++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY-TRQ-----ILEGMSYLH 123
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE---DNTHISTRVAGTFGYMAPE 620
IVHRDIK N+L D N K+ DFG +K + T I + V GT +M+PE
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPE 179
Query: 621 YAMRGHLTDKADVYSFGIVALEIVSGR 647
KADV+S G +E+++ +
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 447 HFDVANKIGEGGFGPVYKG--LLADGTLIAVKQLSAKSKQGNREF--VNEIGTISALQ-- 500
++ +IGEG +G V+K L G +A+K++ ++ + + E+ + L+
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 501 -HPHLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIG 554
HP++V+L+ C +L L++E+++ + PE + T ++
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDMMFQ 118
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
+ RGL +LH ++VHRD+K N+L+ K++DFGLA++ T V T
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTL 173
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
Y APE ++ D++S G + E+ +
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 57/211 (27%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS-AKSKQGNREF----VNEIGTISALQH 501
++ N+I EG +G VY+ G ++A+K+L K K+G F + EI + LQH
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQH 63
Query: 502 PHLVKL----YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
P++V + G + +++ ++ EY+E++ L + E + + + +
Sbjct: 64 PNIVTVKEVVVGSNL--DKIYMVMEYVEHD-LKSLM---ETMKQPFLQSEVKCLMLQLLS 117
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 617
G+A+LH+ I+HRD+K +N+LL+ KI DFGLA+ + T++ T Y
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYR 173
Query: 618 APEYAM-RGHLTDKADVYSFGIVALEIVSGR 647
APE + + D++S G + E+++ +
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 453 KIGEGGFGPVYKGLLAD-GTLIAVKQL--SAKSKQGNREFVNEIGTISALQHPHLVKLYG 509
KIGEG +G V+K + G ++A+K+ S + + EI + L+HP+LV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 510 CCIEGNQLLLIYEYLEN---NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
+L L++EY ++ N L + G EH +K I + + + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCH--- 117
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNTHISTRVAGTFGYMAPEYA 622
+ +HRD+K N+L+ K K+ DFG A++ ++ +++TR Y APE
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL- 171
Query: 623 MRGHLT--DKADVYSFGIVALEIVSG 646
+ G DV++ G V E+++G
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 36/216 (16%)
Query: 454 IGEGGFGPVYK------GLLADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVK 506
IGEG FG V K GL D + +K+ + SK +R+F E+ + L HP+++
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 507 LYGCCIEGNQLLLIYEYLENNSL------ARAL-FGPE---EHRLKLDWPTRHNICIG-- 554
L G C L L EY + +L +R L P + ++ +
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
+ARG+ YL S+ + +HRD+ A N+L+ ++ KI+DFGL++ E V T
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 182
Query: 615 G-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
G +MA E T +DV+S+G++ EIVS
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 454 IGEGGFGPVYKGLLAD--GT--LIAVKQLSAKSKQGNREFVNEIGT---ISALQ--HPHL 504
+G+G FG V LLA+ GT L AVK L K + V T + AL HP L
Sbjct: 3 LGKGSFGKV---LLAELKGTDELYAVKVLK-KDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
+L+ C ++L + EY+ L + R + I + GL +LHE
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAEIVL--GLQFLHE 114
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYA 622
I++RD+K NVLLD + + KI+DFG+ K + T + GT Y+APE
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPE-I 167
Query: 623 MRGHLTDKA-DVYSFGIVALEIVSGRS 648
+ A D ++ G++ E+++G+S
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 13/211 (6%)
Query: 454 IGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGNREF---VNEIGTIS-ALQHPHLVKLY 508
+G+G FG V+ L A+K L + + + E +S A +HP L LY
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
L + EYL L + + K D P I GL +LH +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLHSKG-- 116
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLT 628
IV+RD+K N+LLD D + KI+DFG+ K + + T GT Y+APE +
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKYN 174
Query: 629 DKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
D +SFG++ E++ G+S +EE F
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 29/187 (15%)
Query: 452 NKIGEGGFGPVYKGL-LADGTLIAVKQ-LSAKSKQGNREF----VNEIGTISALQHPHLV 505
KIG+G FG V+K ++A+K+ L K+G F + EI + L+H ++V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVV 74
Query: 506 KLYGCC----IEGN----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
L C N L++E+ E++ LA L +K + +
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNK---NVKFTLSEIKKVMKMLLN 130
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNTHISTRVAGT 613
GL Y+H R KI+HRD+KA N+L+ KD K++DFGLA+ + RV T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 614 FGYMAPE 620
Y PE
Sbjct: 187 LWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQLSAKS---KQGNREFVNE---IGTISALQHPHLVK 506
IG GGFG VY AD G + A+K L K KQG +NE + +S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 507 LYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
+ ++L I + + L +F +E R I GL +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF---------YATEIILGLEH 112
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
+H +V+RD+K N+LLD+ + +ISD GLA + H S GT GYMAPE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 622 AMRGHLTD-KADVYSFGIVALEIVSGRS 648
+G D AD +S G + +++ G S
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 498 ALQHPHLVKLYGCCIEGNQ-LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIA 556
A +HP L L+ C + + L + EYL L + R + I
Sbjct: 52 AWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAA--EII 106
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 616
GL +LH++ I++RD+K NVLLDKD + KI+DFG+ K + ST GT Y
Sbjct: 107 CGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDY 162
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
+APE + D +SFG++ E++ G+S + ++E F
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 42/217 (19%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ----HP 502
+ + KIGEG F V K G A+K + K + E VN + I AL+ HP
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 503 HLVKLYGCCIE--GNQLLLI--------YEYLENNSLARALFGPEEHRLKLDWPTRHNIC 552
++++L + +L L+ YE ++ + E R+K +
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMDMNLYELIKGR---KRPLP--EKRVK-------SYM 106
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNT-HISTR 609
+ + L ++H R I HRDIK N+L+ D+ K++DFG + + T +ISTR
Sbjct: 107 YQLLKSLDHMH---RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTR 162
Query: 610 VAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVS 645
Y APE + G+ K D+++ G V EI+S
Sbjct: 163 -----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 449 DVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN-REFVNEIGTISALQHPHLVK 506
+V +++G+G +G VYK L G +A+K++ + + + + E+ + P++V
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
YG + + EY++ SL + L+ + I + +GL +L EE
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE- 121
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH 626
I+HRD+K TNVL++ + K+ DFG++ ++ G YMAPE G
Sbjct: 122 -HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGG 177
Query: 627 LTD------KADVYSFGIVALEIVSGR 647
++DV+S G+ LE+ GR
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 78/294 (26%), Positives = 132/294 (44%), Gaps = 49/294 (16%)
Query: 454 IGEGGFGPVY--------KGLLADGTLIAVKQLSAKSKQGN-REFVNEIGTISAL-QHPH 503
+GEG FG V K + +AVK L + + + + V+E+ + + +H +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFG---------------PEEHRLKLDWPTR 548
++ L G C + L +I EY +L L P+E ++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE---QMTFKDL 139
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIS 607
+ +ARG+ YL + K +HRD+ A NVL+ ++ KI+DFGLA+ ++ D +
Sbjct: 140 VSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 608 TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWAL 666
T +MAPE T ++DV+SFG++ EI + G S EE F LL
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL---- 252
Query: 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
++G+ M+ P +N E +M + C P++RP +V L+
Sbjct: 253 ---KEGHRMD--KP---ANCTNELYMMMRD----CWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 58/212 (27%), Positives = 108/212 (50%), Gaps = 20/212 (9%)
Query: 443 AATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQG-NREFVNEIGTISALQ 500
AAT++ ++ K+GEG + VYKG+ +G L+A+K +S K+++G + E + L+
Sbjct: 3 AATSYLNL-EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALF----GPEEHRLKLDWPTRHNICIGIA 556
H ++V L+ L ++EY+ + LA+ + G + ++L +
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRL-------FMFQLL 113
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 616
RGLAY+H I+HRD+K N+L+ K++DFGLA+ + S+ V T Y
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWY 169
Query: 617 MAPEYAMRG-HLTDKADVYSFGIVALEIVSGR 647
P+ + + D++ G + +E++ G+
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 51/221 (23%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKS----KQGNREFV-NEIGTISALQH 501
+ +G G FG V+ A+K ++ KQ + V NE + + H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ--EQHVHNEKRVLKEVSH 60
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLE--------------NNSLARALFGPEEHRLKLDWPT 547
P +++L+ + L ++ EY+ +NS + E
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL-FYASE---------- 109
Query: 548 RHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 607
I L YLH +IV+RD+K N+LLDK+ + K++DFG AK D T
Sbjct: 110 -------IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWT- 157
Query: 608 TRVAGTFGYMAPE-YAMRGHLTDKA-DVYSFGIVALEIVSG 646
+ GT Y+APE +GH +KA D ++ GI+ E++ G
Sbjct: 158 --LCGTPEYLAPEVIQSKGH--NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 20/201 (9%)
Query: 454 IGEGGFGPVYKGLL---ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLY 508
+G+G +G V L+ DG +K+L+ + S++ + E +S L+HP++V Y
Sbjct: 8 VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AY 64
Query: 509 GCCIEGN--QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNI--CIGIARGLAYLHE 564
EG L ++ + E L L +E + KL P + + IA L YLHE
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKL---KEQKGKL-LPENQVVEWFVQIAMALQYLHE 120
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 624
+ I+HRD+K NV L + K+ D G+A++ E ST + GT YM+PE
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSN 176
Query: 625 GHLTDKADVYSFGIVALEIVS 645
K+DV++ G E+ +
Sbjct: 177 KPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 453 KIGEGGFGPVYKGLLADG---TLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLVKLY 508
+IG G FG V G + G + VK+L + S Q +F+ E +LQH +L++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEE-HRLKLDWPTRHNICIGIARGLAYLHEESR 567
G C E LL+ E+ L L + + D T + IA GL +LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EEDNTHISTRVAGTFGYMAPEYA--MR 624
+H D+ N LL DL KI D+GL+ +ED ++ ++APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 625 GHL-----TDKADVYSFGIVALEI 643
G+L T +++V+S G+ E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 25/208 (12%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQL--SAKSKQGNREFVN----EIGTISALQHPHLVK 506
+G+G FG VY AD G +AVKQ+ +S + ++E VN EI + L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68
Query: 507 LYGCCIEGNQ--LLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARGLAYL 562
YGC + + L + E++ S+ L +G + + TR I G++YL
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKY-TRQ-----ILEGVSYL 122
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE---DNTHISTRVAGTFGYMAP 619
H IVHRDIK N+L D N K+ DFG +K + T + + V GT +M+P
Sbjct: 123 HSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSP 178
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVSGR 647
E KAD++S G +E+++ +
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQLSAKS---KQGNREFVNE---IGTISALQHPHLVK 506
IG GGFG VY AD G + A+K L K KQG +NE + +S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 507 LYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
+ ++L I + + L +F E R I GL +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF---------YAAEIILGLEH 112
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
+H +V+RD+K N+LLD+ + +ISD GLA + H S GT GYMAPE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 622 AMRGHLTD-KADVYSFGIVALEIVSGRS 648
+G D AD +S G + +++ G S
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 454 IGEGGFGPVYK-GLLADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYG 509
+G+GGFG V + A G + A K+L K ++G +NE + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 510 CCIEGNQLLLIYEYLENNSLARALF-----GPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
+ L L+ + L ++ G EE R I G L LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF---YAAEILCG----LEDLHR 120
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFGYMAPEYAM 623
E+ V+RD+K N+LLD + +ISD GLA K+ E ++ I RV GT GYMAPE
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLN 174
Query: 624 RGHLTDKADVYSFGIVALEIVSGRS 648
T D + G + E++ G+S
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 17/214 (7%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HP 502
++ +++ IG+G +G V+K L +G+ AVK L + E E + AL HP
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHP 75
Query: 503 HLVKLYGC-----CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
++VK YG G+QL L+ E S+ + G + +++ P I
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 617
GL +LH K +HRD+K N+LL + K+ DFG++ +T V GT +M
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 191
Query: 618 APEYAMRGHLTD-----KADVYSFGIVALEIVSG 646
APE D + DV+S GI A+E+ G
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 17/200 (8%)
Query: 454 IGEGGFGPVYK-GLLADGTLIAVKQLSAKSKQGNRE---FVNEIGTISALQHPHLVKLYG 509
+G GGFG V + + A+K + + + +E + HP +VKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
+ + ++ EY L L R D T + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL----RDRGLFDEYTARFYIACVVLAFEYLH---NRG 113
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAM-RGHL 627
I++RD+K N+LLD + K+ DFG AK L T T GT Y+APE + +G+
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGY- 169
Query: 628 TDKADVYSFGIVALEIVSGR 647
D +S GI+ E+++GR
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 454 IGEGGFGPVYKGLLA----DGTLIAVKQLSAKS----KQGNREFVNEIGTISALQHPHLV 505
IG+G FG V LLA DG+ AVK L K+ K+ N + L+HP LV
Sbjct: 3 IGKGSFGKV---LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
L+ +L + +Y+ L F + R L+ P +A + YLH
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLE-PRARFYAAEVASAIGYLHS- 114
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAM 623
L I++RD+K N+LLD + ++DFGL K ++ E+ T + GT Y+APE +
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPE-VL 168
Query: 624 RGHLTDKA-DVYSFGIVALEIVSG 646
R D+ D + G V E++ G
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 454 IGEGGFGPVYKGLLA----DGTLIAVKQLSAKS---KQGNREFVNEIGTI-SALQHPHLV 505
IG+G FG V LLA + AVK L K+ K+ + ++E + ++HP LV
Sbjct: 3 IGKGSFGKV---LLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
L+ ++L + +Y+ L L + R L+ P IA L YLH
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHL---QRERCFLE-PRARFYAAEIASALGYLHS- 114
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
L IV+RD+K N+LLD + ++DFGL K + E N ST GT Y+APE +
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQ 171
Query: 626 HLTDKADVYSFGIVALEIVSG 646
D + G V E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQ--LSAKSKQGNREFVNEIGTISALQHPHLVKLYG 509
KIGEG +G VYK IA+K+ L + + + EI + +QH ++V+L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPE---EHRLKLDWPTRHNICIGIARGLAYLHEES 566
+L L++EYL+ + P+ RL + + I RG+AY H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ------ILRGIAYCHSH- 121
Query: 567 RLKIVHRDIKATNVLLDKDLNP-KISDFGLAK---LDEEDNTHISTRVAGTFGYMAPEYA 622
+++HRD+K N+L+D+ N K++DFGLA+ + TH T Y APE
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEIL 175
Query: 623 MRG-HLTDKADVYSFGIVALEIVSGR 647
+ H + D++S G + E+V+ +
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 80/294 (27%), Positives = 127/294 (43%), Gaps = 49/294 (16%)
Query: 454 IGEGGFGPVY--------KGLLADGTLIAVKQLSAKSKQGN-REFVNEIGTISAL-QHPH 503
+GEG FG V K +AVK L + + + V+E+ + + +H +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFG---------------PEEHRLKLDWPTR 548
++ L G C + L ++ EY +L L PEE +L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE---QLTFKDL 136
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIS 607
+ +ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ + D +
Sbjct: 137 VSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 608 TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWAL 666
T +MAPE T ++DV+SFG++ EI + G S EE F LL
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL---- 249
Query: 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
++G+ M+ P +N E +M C P+ RP +V L+
Sbjct: 250 ---KEGHRMD--KP---ANCTHELYMIMRE----CWHAVPSQRPTFKQLVEDLD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 454 IGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREF---VNEIGTIS-ALQHPHLV 505
+G+G FG V +LA G L AVK L + + + E +S A HP L
Sbjct: 3 LGKGSFGKV---MLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+LY C ++L + E++ L +F ++ R + D I L +LH++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSR-RFDEARARFYAAEITSALMFLHDK 115
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
I++RD+K NVLLD + + K++DFG+ K + ST GT Y+APE
Sbjct: 116 G---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEM 171
Query: 626 HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
D ++ G++ E++ G + + +++ F
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 55/229 (24%), Positives = 102/229 (44%), Gaps = 53/229 (23%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN---------EIGTI 496
+++ IG G +G V + G +A+K++ + F + EI +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLL 53
Query: 497 SALQHPHLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFGP----EEHRLKLDWPT 547
L+H +++ L + N + ++ E +E + L + + P ++H
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETD-LHKVIKSPQPLTDDHI------- 105
Query: 548 RHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 607
++ + I RGL YLH ++HRD+K +N+L++ + + KI DFGLA+ + D
Sbjct: 106 QYFLY-QILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161
Query: 608 -------TRVAGTFGYMAPEYAMRGHLTDKA-DVYSFG-IVALEIVSGR 647
TR Y APE + KA D++S G I A E+++ +
Sbjct: 162 FLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFA-ELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 67/222 (30%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 454 IGEGGFGPVYKGLLAD----GTLIAVKQL------------SAKSKQGNREFVNEIGTIS 497
+G G FG V LLA+ G L A+K L S ++ R F T +
Sbjct: 7 LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEK--RIFE----TAN 57
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
+ +HP LV L+ C + + + EY L + H P +
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVL 112
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 617
GL YLHE KIV+RD+K N+LLD + KI+DFGL K ST GT ++
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFL 168
Query: 618 APEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
APE T D + G++ E++ G S +EE F
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQL--SAKSKQGNREFVNEIGTISALQHP 502
++ +GEG +G V K + G ++A+K+ S K + + EI + L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 503 HLVKLYGCCIEGNQLLLIYEYLEN---NSLARALFGPEEHRLKLDWPTRHNICIGIARGL 559
+LV L +L L++E++++ + L + G +E R++ I RG+
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR-------KYLFQILRGI 113
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 619
+ H + I+HRDIK N+L+ + K+ DFG A+ + VA T Y AP
Sbjct: 114 EFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAP 169
Query: 620 EYAMRGHLTDKA-DVYSFGIVALEIVSG 646
E + +A D+++ G + E+++G
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQ--LSAKSKQGNREFVNEIGTISALQH-PHLVKLY 508
KIGEG +G VYK G L+A+K+ L + + EI + L ++V+L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 509 GCCIEGN-------QLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARGL 559
+E L L++EYL+++ L + + G R L T + + +G+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGR-PLPAKTIKSFMYQLLKGV 123
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK---LDEEDNTHISTRVAGTFG 615
A+ H + ++HRD+K N+L+DK KI+D GL + + + TH T
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLW 176
Query: 616 YMAPEYAMRG-HLTDKADVYSFGIVALEIVSG 646
Y APE + H + D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 454 IGEGGFGPVYKGLLADGT----LIAVKQLS----AKSKQGNREFVNEIGTISALQHPHLV 505
+G+GG+G V++ G + A+K L ++++ E + A++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
L G +L LI EYL L L E + ++ T I+ L +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFME-DTACFYLSEISLALEHLH-- 117
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR- 624
+ I++RD+K N+LLD + K++DFGL K + T T GT YMAPE MR
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILMRS 175
Query: 625 GHLTDKA-DVYSFGIVALEIVSG 646
GH KA D +S G + ++++G
Sbjct: 176 GH--GKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 454 IGEGGFGPVYK-GLLADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYG 509
+G+GGFG V + A G + A K+L K ++G +NE + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 510 CCIEGNQLLLIYEYLENNSLARALF-----GPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
+ L L+ + L ++ G +E R I G L LH
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF---YAAEITCG----LEDLHR 120
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 624
E +IV+RD+K N+LLD + +ISD GLA ++ + I RV GT GYMAPE
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRV-GTVGYMAPEVVKN 175
Query: 625 GHLTDKADVYSFGIVALEIVSGRS 648
T D + G + E++ G+S
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 35/212 (16%)
Query: 456 EGGFGPVYKGLLADGTLIAVKQLSAKS-KQGNRE-----FVNEIGTISALQHPHLVKLYG 509
EG FG ++ G+L D +++ K+ K E + E + L H +++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 510 CCIEGNQL-LLIYEYLENNSLARAL----FGPEEHRLKLDWPTRHNICIG--IARGLAYL 562
CIE + ++Y Y+ +L L G + L T+ + + IA G++YL
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS--TQQLVHMAIQIACGMSYL 133
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---------LDEEDNTHISTRVAGT 613
H + ++H+DI A N ++D++L KI+D L++ L + +N +
Sbjct: 134 H---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK------ 184
Query: 614 FGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+MA E + + +DV+SFG++ E+++
Sbjct: 185 --WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 65/214 (30%), Positives = 92/214 (42%), Gaps = 45/214 (21%)
Query: 454 IGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFVNEIGTISAL----QHPHLV 505
IG+G FG V LA DG AVK L K+ +E + + + L +HP LV
Sbjct: 3 IGKGSFGKVL---LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 506 KLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEHRLKLDWPTRHNICI 553
L+ ++L + +Y+ L RA F E
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE--------------- 104
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 613
IA L YLH L I++RD+K N+LLD + ++DFGL K E + ST GT
Sbjct: 105 -IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGT 159
Query: 614 FGYMAPEYAMRGHLTDKA-DVYSFGIVALEIVSG 646
Y+APE +R D+ D + G V E++ G
Sbjct: 160 PEYLAPE-VLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 448 FDVANKIGEGGFGPVYKGLLA--DGTL--IAVKQLSAK--SKQGNREFVNEIGTISALQH 501
F + +G+G FG V + L DG+ +AVK L A S EF+ E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 502 PHLVKLYGCCIEGNQL------LLIYEYLENNSLARALFGPE--EHRLKLDWPTRHNICI 553
P+++KL G + ++I ++++ L L E L T I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAG 612
IA G+ YL S +HRD+ A N +L++++ ++DFGL+ K+ D
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 613 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
++A E T +DV++FG+ EI++
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 34/231 (14%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQL------SAKSKQGNREFVNEIGTIS 497
TN + +G G FG V G +A+K++ +K+ RE + +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE----LKLLK 64
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNIC----I 553
L+H +++ L I LE+ L G + HRL P
Sbjct: 65 HLRHENIISLSDIFISP---------LEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLY 115
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAG 612
I RGL Y+H +VHRD+K +N+L++++ + KI DFGLA++ + T ++STR
Sbjct: 116 QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-- 170
Query: 613 TFGYMAPEYAMRGHLTD-KADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
Y APE + D + D++S G + E++ G+ K +F ++
Sbjct: 171 ---YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 23/216 (10%)
Query: 454 IGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFVNEIGTISAL----QHPHLV 505
IG+G FG V LLA DG AVK L K +E + + + L +HP LV
Sbjct: 3 IGKGSFGKV---LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
L+ +L + +++ L F + R P IA L YLH
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGEL---FFHLQRER-SFPEPRARFYAAEIASALGYLHS- 114
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAM 623
+ IV+RD+K N+LLD + ++DFGL K + + D T T GT Y+APE
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIR 169
Query: 624 RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
+ + D + G V E++ G C+ E +
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQ--GNREFVNEIGTISALQHPH 503
+ + IGEG +G V G +A+K++S Q R + EI + +H +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHEN 64
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRL-KLDWPTRHNICI---GIARGL 559
++ + + +E + + + L + ++L K + +I I RGL
Sbjct: 65 IIGILDIIRPPS-----FESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGL 119
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD--EEDNTHISTRVAGTFGYM 617
Y+H + ++HRD+K +N+LL+ + + KI DFGLA++ E D+T T T Y
Sbjct: 120 KYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 618 APEYAMRGHLTDKA-DVYSFGIVALEIVSGR 647
APE + KA D++S G + E++S R
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 447 HFDVANKIGEGGFGPVY---KGLLAD-GTLIAVKQLS-------AKSKQGNREFVNEIGT 495
+F++ +G G +G V+ K D G L A+K L AK+ + R +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 496 ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGI 555
I Q P LV L+ +L LI +Y+ L F R + + I
Sbjct: 61 IR--QSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERF---KEQEVQIYS 111
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 615
+ L +L I++RDIK N+LLD + + ++DFGL+K ED + GT
Sbjct: 112 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 616 YMAPEYAMRGHLT-DKA-DVYSFGIVALEIVSGRS 648
YMAP+ G DKA D +S G++ E+++G S
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 24/159 (15%)
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRH------NI 551
A +P LV L+ C ++L L+ EY+ L +F + R KL P H I
Sbjct: 52 ASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQR-KL--PEEHARFYAAEI 105
Query: 552 CIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTR 609
CI L +LHE I++RD+K NVLLD D + K++D+G+ K L D T +
Sbjct: 106 CIA----LNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---ST 155
Query: 610 VAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
GT Y+APE D ++ G++ E+++GRS
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 33/95 (34%), Positives = 56/95 (58%), Gaps = 10/95 (10%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGT 613
I RGL Y+H I+HRD+K +N+ +++D KI DFGLA+ +++ T +++TR
Sbjct: 127 ILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR---- 179
Query: 614 FGYMAPEYAM-RGHLTDKADVYSFGIVALEIVSGR 647
Y APE + H D++S G + E+++G+
Sbjct: 180 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREF----VNEIGTISALQ 500
N F+V +GEG +G V K + ++A+K+ K + N E + E+ + L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
++V+L +L L++EY+E N L EE + + + + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELL----EEMPNGVPPEKVRSYIYQLIKAIH 114
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
+ H+ IVHRDIK N+L+ + K+ DFG A+ E + T T Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 621 YAMRGHLTDKADVYSFGIVALEIVSGR 647
+ D++S G + E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 51/160 (31%), Positives = 78/160 (48%), Gaps = 24/160 (15%)
Query: 497 SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL------ARALFGPEEH-RLKLDWPTRH 549
+A HP LV L+ C ++L + E++ L R L PEEH R
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKL--PEEHARF-----YSA 103
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609
I + L +LHE I++RD+K NVLLD + + K++D+G+ K ST
Sbjct: 104 EISLA----LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST- 155
Query: 610 VAGTFGYMAPEYAMRGHLTD-KADVYSFGIVALEIVSGRS 648
GT Y+APE +RG D ++ G++ E+++GRS
Sbjct: 156 FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 51/155 (32%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHN--ICIGI 555
A HP LV L+ C ++L + EY+ L +F + R KL P H I
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQR-KL--PEEHARFYSAEI 105
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGT 613
+ L YLHE I++RD+K NVLLD + + K++D+G+ K L D T + GT
Sbjct: 106 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGT 159
Query: 614 FGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
Y+APE D ++ G++ E+++GRS
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPH 503
+ ++ K+GEG + VYKG +G L+A+K + + ++G + E + L+H +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+V L+ L L++EY+ + L + + ++H L + RGL+Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTD-LCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 623
+ I+HRD+K N+L+ K++DFGLA+ + S V T Y P+ +
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLL 176
Query: 624 -RGHLTDKADVYSFGIVALEIVSG 646
+ D++ G + +E++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 57/238 (23%), Positives = 91/238 (38%), Gaps = 34/238 (14%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAK---SKQGNREFVNEIGTISALQH 501
F + ++G+GG+G V+ D G ++A+K++ R + E ++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 502 PHLVKLYGCCIEGNQLLLIYEY---------LENNSLARALFGPEEHRLKLDWPTRHNIC 552
LVKL + L L EY L N + E+H R
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS-----EDH-------AR---- 104
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG 612
+A + L +HRD+K N L+D + K++DFGL+K + V G
Sbjct: 105 FYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVG 160
Query: 613 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY-LLDWALLLK 669
+ YMAPE D +S G + E + G T E + L W L+
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ 218
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 36/196 (18%)
Query: 473 IAVKQLSAKSKQGNRE---FVNEIGTISALQHPHLVKLY--GCCIEGNQLLLIYEYLENN 527
+A+K L + + + F E + L HP++V L G G L ++EY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYVPGR 64
Query: 528 SLAR------ALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVL 581
+L AL E RL L + LA H + IVHRD+K N++
Sbjct: 65 TLREVLAADGALPAGETGRLMLQ----------VLDALACAHNQG---IVHRDLKPQNIM 111
Query: 582 L---DKDLNPKISDFGLAKL----DEEDNTHIS--TRVAGTFGYMAPEYAMRGH-LTDKA 631
+ + K+ DFG+ L + D ++ T V GT Y APE +RG +T +
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNS 170
Query: 632 DVYSFGIVALEIVSGR 647
D+Y++G++ LE ++G+
Sbjct: 171 DLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 36/217 (16%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLY---- 508
+G G G V+ + +D +AVK++ Q + + EI I L H ++VK+Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 509 ----------GCCIEGNQLLLIYEYLENNSLARALFG---PEEHRLKLDWPTRHNICIGI 555
G E N + ++ EY+E + LA L EEH +L +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEH-ARL-------FMYQL 123
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTH---ISTRVA 611
RGL Y+H + ++HRD+K NV ++ +DL KI DFGLA++ + +H +S +
Sbjct: 124 LRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 612 GTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGR 647
+ Y +P + + T D+++ G + E+++G+
Sbjct: 181 TKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQH------PHLVK 506
IG+G FG VY+ D + A+K LS K +E + IG + L P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIG-IARGLAYLHEE 565
L + L L+ +Y+ L L +E R D R I + L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSED---RAKFYIAELVLALEHLHKY 115
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-- 623
IV+RD+K N+LLD + + DFGL+K + DN +T GT Y+APE +
Sbjct: 116 D---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDE 171
Query: 624 RGHLTDKADVYSFGIVALEIVSGRS 648
+G+ T D +S G++ E+ G S
Sbjct: 172 KGY-TKHVDFWSLGVLVFEMCCGWS 195
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 24/217 (11%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN------REFVNEIGTISALQHPHLV 505
+IG G +G VYK G +A+K + ++ + RE V + + A HP++V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPNIV 65
Query: 506 KLYGCCIEGN-----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
+L C ++ L++E+++ + L L L + T ++ RGL
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPAE--TIKDLMRQFLRGLD 122
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-TRVAGTFGYMAP 619
+LH IVHRD+K N+L+ K++DFGLA++ + ++ T V T Y AP
Sbjct: 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAP 176
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKE 656
E ++ D++S G + E+ R + C E
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 65/285 (22%), Positives = 113/285 (39%), Gaps = 52/285 (18%)
Query: 470 GTLIAVKQ--LSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527
TL+AVK+ L + SK+ + EI T LQHP+++ I ++L ++ +
Sbjct: 25 NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA-- 82
Query: 528 SLARALFGPEEHRLKLDWPTR------HNICIGIARGLAYLHEESRLKIVHRDIKATNVL 581
+G E LK +P I + L Y+H +HR +KA+++L
Sbjct: 83 ------YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHIL 133
Query: 582 LDKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFG--------YMAPEY---AMRGHLTD 629
L D +S + + + RV F +++PE ++G+ +
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQ---RVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NE 189
Query: 630 KADVYSFGIVALEIVSG-------RSNIMC--KTKEEKFYLLDWALLLKEQGNL----ME 676
K+D+YS GI A E+ +G + M K + LLD + + ++
Sbjct: 190 KSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249
Query: 677 LVDPNLGSNVDKEQVRVMI----NVALLCADVSPTNRPLMSSVVS 717
PN +VD R LC P +RP S +++
Sbjct: 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 437 TLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTL--IAVKQLSA----KSKQGNREFV 490
R+ K F+ +G G FG V + +A+K+ K KQ + F
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF- 79
Query: 491 NEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHN 550
+E ++ + HP V LYG + + L L+ E++ L R +P
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL------RRNKRFPNDVG 133
Query: 551 ICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 610
C A+ + L IV+RD+K N+LLDKD K++DFG AK+ + T T +
Sbjct: 134 -CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD---TRTYT-L 188
Query: 611 AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSG 646
GT Y+APE + AD ++ GI EI+ G
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 447 HFDVANKIGEGGFGPVYK-GLLADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHP 502
H+ V +G+GGFG V + A G + A K+L K ++G +NE + +
Sbjct: 4 HYRV---LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALF-----GPEEHRLKLDWPTRHNICIGIAR 557
+V L + L L+ + L ++ G +E R +C G
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF---YAAELCCG--- 114
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 617
L + R +IV+RD+K N+LLD + +ISD GLA E T + RV GT GYM
Sbjct: 115 ----LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYM 168
Query: 618 APEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
APE T D + G + E++ G+S
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 454 IGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGNRE----FVNEIGTISALQHPHLVKLY 508
+G+G FG V L G AVK L + + V + A ++P L LY
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
L + E+L L + ++ R L T + I GL +LH +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATFY--AAEIVCGLQFLHSKG-- 116
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLT 628
I++RD+K NV+LD+D + KI+DFG+ K + + ST GT Y+APE T
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYT 174
Query: 629 DKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
D +SFG++ E++ G+S ++E F
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 62/248 (25%), Positives = 93/248 (37%), Gaps = 51/248 (20%)
Query: 448 FDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFV------NEIGTIS 497
F+V IG G FG V+ L G + A+K L KS R + +I +
Sbjct: 3 FEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDILADA 58
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
P +VKLY + L L+ EY+ L L + + R IA
Sbjct: 59 D--SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI--RKDVFPEET-AR----FYIAE 109
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-------------------- 597
+ L +L +HRDIK N+L+D D + K++DFGL K
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 598 --------LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSN 649
D + + GT Y+APE + D +S G++ E++ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 650 IMCKTKEE 657
T +E
Sbjct: 230 FYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 65/216 (30%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 454 IGEGGFGPVYKGLL----ADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVK 506
+G+G FG V +L A G A+K L + +K + E + +HP L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
L ++L + EY+ L F R+ + TR I L YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG- 114
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH 626
KIV+RD+K N++LDKD + KI+DFGL K D + T GT Y+APE
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 627 LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
D + G+V E++ GR + E+ F L+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 38/108 (35%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
I L YLH +V+RD+K N++LDKD + KI+DFGL K D + T GT
Sbjct: 104 IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 159
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
Y+APE D + G+V E++ GR + E+ F L+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 28/210 (13%)
Query: 448 FDVANKIGEGGFGPVYKGLLADGTL----IAVKQLS-AKSKQGNREFVNEIGTISALQHP 502
++V +GEG FG + LL A+K++ KS + E ++ ++HP
Sbjct: 2 YNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHP 58
Query: 503 HLVKLYGCCIEGN-QLLLIYEYLENNSL------ARALFGPEEHRLKLDWPTRHNICIGI 555
++V + E + L ++ EY + L R PE+ L W + +C+G+
Sbjct: 59 NIVA-FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED--TILQWFVQ--MCLGV 113
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 615
++HE+ +++HRDIK+ N+ L ++ K+ DFG A+L + T V GT
Sbjct: 114 Q----HIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPY 165
Query: 616 YMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
Y+ PE +K+D++S G + E+ +
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 28/72 (38%), Positives = 46/72 (63%)
Query: 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL 122
R +++ L ++ G +P LG ++ ++VLDLS+N NG+IPES +L + + L GN
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501
Query: 123 LTGKVPQWMFGR 134
L+G+VP + GR
Sbjct: 502 LSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 49/227 (21%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 450 VANKIGEGGFGPVYKGL-LADGTLIAVKQLS----AKSKQGNREFVNEIG---------- 494
+GEG +G V K G ++A+K++ + +R+ V G
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 495 TISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIG 554
++ ++H +++ L +EG+ + L+ + + ++ L + + + +++L I +
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTESQVKCILLQ 127
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-------------KLDEE 601
I GL LH+ +HRD+ N+ ++ KI+DFGLA K +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 602 DNTHISTRVAGTFGYMAPEYAMRGH-LTDKADVYSFGIVALEIVSGR 647
T T Y APE M D++S G + E+++G+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-10
Identities = 60/220 (27%), Positives = 111/220 (50%), Gaps = 38/220 (17%)
Query: 448 FDVANKIGEGGFGPVYKGLLAD---GTLIAVK------QLSAKSKQGNRE--FVNEIGTI 496
+++ K+G+G +G V+K + D ++A+K + + +++ RE F+ E+G
Sbjct: 9 YEILQKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-- 64
Query: 497 SALQHPHLVKLYGC--CIEGNQLLLIYEYLEN--NSLARALFGPEEHRLKLDWPTRHNIC 552
HP++VKL + L++EY+E +++ RA + H+ R+ I
Sbjct: 65 ---DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK-------RY-IM 113
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK----LDEEDNTHIST 608
+ + L Y+H S ++HRD+K +N+LL+ D K++DFGLA+ L+E + T
Sbjct: 114 YQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 609 RVAGTFGYMAPEYAMRGHLTDKA-DVYSFGIVALEIVSGR 647
T Y APE + K D++S G + E++ G+
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 32/178 (17%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT- 613
+A+G+ +L ++ +HRD+ A NVLL KI DFGLA+ D+ ++ V G
Sbjct: 221 VAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNA 274
Query: 614 ---FGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRS---NIMCKTKEEKFYLLDWAL 666
+MAPE T ++DV+S+GI+ EI S G+S I+ + KFY
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFY-----K 326
Query: 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724
++K G M P+ E +M +C ++ PT RP S + +++ ++G
Sbjct: 327 MVKR-GYQMS--RPDFAP---PEIYSIM----KMCWNLEPTERPTFSQISQLIQRQLG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 17/216 (7%)
Query: 454 IGEGGFGPVYKGLL----ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ---HPHLVK 506
+G+G FG V +L A G A+K L + E + + LQ HP L
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
L ++L + EY L F R+ + R I L YLH E
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARF-YGAEIVSALDYLHSEK 115
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH 626
+V+RD+K N++LDKD + KI+DFGL K +D + T GT Y+APE
Sbjct: 116 --NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 627 LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
D + G+V E++ GR + E+ F L+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 7/107 (6%)
Query: 546 PTRHNICI--GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603
P + I I GL YLH + +I+HRD+K N+ ++ I D G A+
Sbjct: 155 PIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211
Query: 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNI 650
+ +AGT APE R KAD++S GIV E+++ S I
Sbjct: 212 AFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256
|
Length = 357 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 448 FDVANKIGEGGFGPV-YKGLLADGTLIAVKQLSA----KSKQGNREFVNEIGTISALQHP 502
F++ +G G FG V G A+K L K KQ + E + L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHP 78
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPT--RHNICIGIARGLA 560
+V + + N++ + E++ L L R +P +
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHL------RKAGRFPNDVAKFYHAELVLAFE 132
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
YLH I++RD+K N+LLD + K++DFG AK D T + GT Y+APE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFT---LCGTPEYLAPE 185
Query: 621 YAM-RGHLTDKA-DVYSFGIVALEIVSG 646
+GH KA D ++ G++ E ++G
Sbjct: 186 VIQSKGH--GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 35/96 (36%), Positives = 56/96 (58%), Gaps = 10/96 (10%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGT 613
I RGL Y+H I+HRD+K +N+ +++D KI DFGLA+ D+E +++TR
Sbjct: 129 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR---- 181
Query: 614 FGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRS 648
Y APE + H D++S G + E+++GR+
Sbjct: 182 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 54/192 (28%), Positives = 85/192 (44%), Gaps = 30/192 (15%)
Query: 536 PEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595
EE L LD + +A+G+++L ++ +HRD+ A N+LL KI DFGL
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGL 260
Query: 596 AKLDEEDNTHISTRVAGT----FGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNI 650
A+ D+ ++ V G +MAPE T ++DV+S+GI+ EI S G S
Sbjct: 261 ARDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
Query: 651 MCKTKEEKFYLLDWALLLKEQGNLM--ELVDPNLGSNVDKEQVRVMINVALLCADVSPTN 708
+ KFY ++KE ++ E M ++ C D P
Sbjct: 318 PGMPVDSKFY-----KMIKEGYRMLSPECAPSE------------MYDIMKSCWDADPLK 360
Query: 709 RPLMSSVVSMLE 720
RP +V ++E
Sbjct: 361 RPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 42/147 (28%)
Query: 4 TVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNR 63
T+ SN+L G++P ELG + +
Sbjct: 194 TLASNQLVGQIPRELGQM-----------------------------------------K 212
Query: 64 TFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLL 123
+ K + L NL+GE+P+ +G ++ + LDL +N L G IP S L ++ +++L N L
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272
Query: 124 TGKVPQWMFG-RGPENIDLSYNNFADE 149
+G +P +F + ++DLS N+ + E
Sbjct: 273 SGPIPPSIFSLQKLISLDLSDNSLSGE 299
|
Length = 968 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 446 NHFDVANKIGEGGFGPVYKGLL---ADGTLIAVKQLSAKSKQGNRE---FVNEIGTISAL 499
FDV + +G G FG V ++ A G + A+K + KS +E F E I ++
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSI 57
Query: 500 QH-PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
+ P + +L + + L L+ EY L L + + D +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLA 114
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 618
+ +H+ + VHRDIK NVL+D+ + K++DFG A + S GT Y+A
Sbjct: 115 IHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 619 PEY--AMRGHLTDKADV----YSFGIVALEIVSGRS 648
PE M G V +S G++A E++ GRS
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 64/216 (29%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 454 IGEGGFGPVYKGLL----ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ---HPHLVK 506
+G+G FG V +L A G A+K L + E + + LQ HP L
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
L ++L + EY L F R+ + R I L YLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIVSALEYLHSRD 115
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH 626
+V+RDIK N++LDKD + KI+DFGL K D + T GT Y+APE
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 627 LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
D + G+V E++ GR + E F L+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
A +HP L L+ C ++L + EY+ L +F + R K D P +
Sbjct: 52 AAKHPFLTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSR-KFDEPRSRFYAAEVTL 107
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 617
L +LH R +++RD+K N+LLD + + K++DFG+ K + N +T GT Y+
Sbjct: 108 ALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYI 163
Query: 618 APEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
APE D ++ G++ E+++G+ +++ F
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 64/251 (25%), Positives = 113/251 (45%), Gaps = 59/251 (23%)
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG--- 615
LA H S+ ++HRDIK+ N+LL + K+ DFG +K+ T +S V TF
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKM--YAAT-VSDDVGRTFCGTP 209
Query: 616 -YMAPEYAMRGHLTDKADVYSFGIVALEIVSGR--------SNIMCKTKEEKFYLLDWAL 666
Y+APE R + KAD++S G++ E+++ + +M KT ++
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------- 262
Query: 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV--- 723
DP L ++ E ++ ALL +D P RP S +++M ++
Sbjct: 263 ------------DP-LPPSISPEMQEIV--TALLSSD--PKRRPSSSKLLNMPICKLFIS 305
Query: 724 GVPDIVQ---------DSSVSNKDESKSEAM---RKYYQFSIENTASTQSVST---DGPP 768
G+ +IVQ ++S + + + + R+ +E + ST + ST +G
Sbjct: 306 GLLEIVQTQPGFSGPLRDTISRQIQQTKQLLQVERRRIVRQMEESLST-AASTTILEGAT 364
Query: 769 TGSSTSGVDLY 779
++ G+ LY
Sbjct: 365 PLTTLGGLTLY 375
|
Length = 496 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 70/222 (31%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 448 FDVANKIGEGGFGPVY---KGLLAD-GTLIAVKQLS-------AKSKQGNREFVNEIGTI 496
F++ +G G +G V+ K D G L A+K L AK+ + R N + +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 497 SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNI 551
Q P LV L+ +L LI +Y+ + R F +E R
Sbjct: 62 R--QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVR----------F 109
Query: 552 CIG-IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHIST 608
G I L +LH +L IV+RDIK N+LLD + + ++DFGL+K L EE S
Sbjct: 110 YSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS- 165
Query: 609 RVAGTFGYMAPEY--AMRGHLTDKADVYSFGIVALEIVSGRS 648
GT YMAPE GH D +S GI+ E+++G S
Sbjct: 166 -FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGAS 205
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 454 IGEGGFGPVYKGL---LADG-----TLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
+G+G F ++KG+ + D T + +K L + + F +S L H HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY-LHE 564
YG C+ G++ +++ EY++ SL L ++ + + W + +A+ LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISWK------LEVAKQLAWALHF 115
Query: 565 ESRLKIVHRDIKATNVLL-----DKDLNP---KISDFGL--AKLDEEDNTHISTRVAGTF 614
+ H ++ A NVLL K NP K+SD G+ L +E + R+
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---ILLERIP--- 169
Query: 615 GYMAPEYAMRG-HLTDKADVYSFGIVALEIVSG 646
++ PE +L+ AD +SFG EI SG
Sbjct: 170 -WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P L +L+ C ++L + EY+ L + + + P IA GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI----QQVGRFKEPHAVFYAAEIAIGLFF 116
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
LH + I++RD+K NV+LD + + KI+DFG+ K + D T GT Y+APE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPEI 172
Query: 622 AMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
D ++FG++ E+++G++ + ++E F
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 438 LRQIKAATNHFDVANKIGEGGFGPV----YKGLLADGTLIAVKQLSAKS--KQGNREFVN 491
+R+++ +DV IG G FG V +K + + A+K LS K+ + F
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 492 EIGTISALQH-PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHN 550
E I A + P +V+L+ + L ++ EY+ L + + + W +
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYT 148
Query: 551 ICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTR 609
+ +A L +H + ++HRD+K N+LLDK + K++DFG K+DE T
Sbjct: 149 AEVVLA--LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA 203
Query: 610 VAGTFGYMAPEYAMR----GHLTDKADVYSFGIVALEIVSG 646
V GT Y++PE G+ + D +S G+ E++ G
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 44/159 (27%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P L +L+ C ++L + EY+ L + + K P I+ GL +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFF 116
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV-AGTFGYMAPE 620
LH I++RD+K NV+LD + + KI+DFG+ K D ++TR GT Y+APE
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPE 171
Query: 621 YAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
D +++G++ E+++G+ + ++E F
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 56/169 (33%), Positives = 83/169 (49%), Gaps = 24/169 (14%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRVA 611
+ARG+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ +D ++ S R+
Sbjct: 183 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 612 GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKE 670
+MAPE T ++DV+SFG++ EI S G S E+F LK+
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-----CQRLKD 292
Query: 671 QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719
G M + N E R+M+ C P RP S++V +L
Sbjct: 293 -GTRMRAPE-----NATPEIYRIMLA----CWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 6/106 (5%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV-AGT 613
IA GL +LH + I++RD+K NV+LD + + KI+DFG+ K E +TR GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164
Query: 614 FGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
Y+APE D ++FG++ E+++G+ + ++E F
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 15/156 (9%)
Query: 5 VQSNRLSGELPEELGSL-------IHSGKWFGWANS-VWHYFSESLTDLRISDLNGPEAT 56
+Q N SGELP E L I + G NS W S + L + G
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG---G 467
Query: 57 LPDL-RNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDF 115
LPD ++ +NL L +G +P LG +SE+ L LS NKL+G IP+ + +
Sbjct: 468 LPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS 527
Query: 116 IYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADE 149
+ L+ N L+G++P F P +DLS N + E
Sbjct: 528 LDLSHNQLSGQIPA-SFSEMPVLSQLDLSQNQLSGE 562
|
Length = 968 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 10/94 (10%)
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFG 615
RGL Y+H I+HRD+K +NV +++D +I DFGLA+ D+E +++TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 616 YMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRS 648
Y APE + H D++S G + E++ G++
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-09
Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 491 NEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTR-H 549
+E+ ++A H +VK + ++LLLI EY L + + + RLK P + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI----KQRLKEHLPFQEY 169
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIST 608
+ + + + L E K++HRD+K+ N+ L K+ DFG +K + + +++
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
GT Y+APE R + KAD++S G++ E+++
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 45/150 (30%), Positives = 82/150 (54%), Gaps = 15/150 (10%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLVKLYGC 510
K+GEG + VYKG G L+A+K++ + ++G + E + L+H ++V L+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 511 CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICI---GIARGLAYLHEESR 567
L L++EYL+ + L + + ++ L HN+ + + RGLAY H+
Sbjct: 72 IHTKKTLTLVFEYLDTD-LKQYM---DDCGGGLS---MHNVRLFLFQLLRGLAYCHQR-- 122
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAK 597
+++HRD+K N+L+ + K++DFGLA+
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-09
Identities = 44/144 (30%), Positives = 77/144 (53%), Gaps = 19/144 (13%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFK 66
+N+LSG +P+++ + S ++ +N+ F+ S+ P ++P+L +
Sbjct: 102 NNQLSGPIPDDIFTTSSSLRYLNLSNN---NFTGSI----------PRGSIPNL-----E 143
Query: 67 NLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGK 126
L L + L+GE+P+ +G S +KVLDL N L G IP S L ++F+ L N L G+
Sbjct: 144 TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQ 203
Query: 127 VPQWMFG-RGPENIDLSYNNFADE 149
+P+ + + + I L YNN + E
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGE 227
|
Length = 968 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
+ARG+ +L ++ VHRD+ A NVLL + KI DFGLA+ D+ ++S TF
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK--GSTF 300
Query: 615 ---GYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+MAPE T +DV+S+GI+ EI S
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 10/95 (10%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGT 613
+ +GL Y+H I+HRD+K N+ +++D KI DFGLA+ D E ++ TR
Sbjct: 127 MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR---- 179
Query: 614 FGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGR 647
Y APE + H T D++S G + E+++G+
Sbjct: 180 -WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 49/221 (22%)
Query: 454 IGEGGFGPVYKGLL-------ADGTLIAVKQLSAKSKQGNR---EFVNEIGTISALQHPH 503
+G+G F +YKG+L G V + +R F +S L H H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 504 LVKLYGCCI-EGNQLLLIYEYLE----NNSLARALFGPEEH-RLKLDWPTRHNICIGIAR 557
LVKLYG C+ + N ++ EY++ + L R H +L + +A
Sbjct: 63 LVKLYGVCVRDENIMVE--EYVKFGPLDVFLHREKNNVSLHWKLDVAK--------QLAS 112
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDK-DLNP------KISDFGLAK---LDEEDNTHIS 607
L YL ++ K+VH ++ N+L+ + LN K+SD G+ EE I
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP 169
Query: 608 TRVAGTFGYMAPEYAMRGH--LTDKADVYSFGIVALEIVSG 646
++APE G LT AD +SFG LEI S
Sbjct: 170 --------WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 4/92 (4%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG-T 613
+ARG+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ +D ++ A
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 614 FGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+MAPE T ++DV+SFG++ EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 12/99 (12%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNTHISTRV 610
+ RGL Y+H ++HRD+K +N+L+++D +I DFG+A+ E ++ V
Sbjct: 116 LLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 611 AGTFGYMAPE--YAMRGHLTDKADVYSFGIVALEIVSGR 647
A T Y APE ++ + T D++S G + E++ GR
Sbjct: 173 A-TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 57/227 (25%), Positives = 103/227 (45%), Gaps = 31/227 (13%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQG---NREFVNEIGTISALQHPHLVKLYG 509
K+G G +G VYK DG K+ + K +G + EI + L+HP+++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 510 CCIEGN--QLLLIYEYLENNSLARALFGPEEHR--------LKLDWPTRHNICIGIARGL 559
+ + ++ L+++Y E++ F HR ++L ++ I G+
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKF----HRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNP-----KISDFGLAKLDEEDNTHIS--TRVAG 612
YLH ++HRD+K N+L+ + P KI+D G A+L ++ V
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 613 TFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEK 658
TF Y APE + H T D+++ G + E+++ C+ ++ K
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 224
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 53/246 (21%)
Query: 446 NHFDVANKIGEGGFGPVYKGLL---ADGTLIAVKQLSAKS----KQGNREFVNEIGTISA 498
F+ I G +G VY L+ A+K+++ ++ Q + FV E ++
Sbjct: 1 EDFETIKLISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTF 57
Query: 499 LQHPHLVKLYGCCIEGNQ-LLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGI 555
++P +V ++ C E + L ++ EY+E A L G L +D +
Sbjct: 58 AENPFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIGA----LPVD----------M 102
Query: 556 AR--------GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---------- 597
AR L YLH IVHRD+K N+L+ + K++DFGL+K
Sbjct: 103 ARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 598 ----LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCK 653
++++ + +V GT Y+APE +R D ++ GI+ E + G
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219
Query: 654 TKEEKF 659
T EE F
Sbjct: 220 TPEELF 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 35/96 (36%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 553 IGIARGL----AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHIS 607
I I R L AYLH I+HRD+K N+ LD+ N + DFG A KLD +T
Sbjct: 188 ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 608 TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEI 643
+GT +PE K D++S G+V E+
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 67/257 (26%), Positives = 95/257 (36%), Gaps = 59/257 (22%)
Query: 447 HFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVN----EIGTISALQH 501
HF +G+G G V+ L G L A+K L K R V E ++ L H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDH 60
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR---- 557
P L LY L L+ +Y L R L L + +AR
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE----------VARFYAA 110
Query: 558 ----GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---------------- 597
L YLH L IV+RD+K N+LL + + +SDF L+K
Sbjct: 111 EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 598 -------------LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKA-DVYSFGIVALEI 643
EE + S GT Y+APE + G A D ++ GI+ E+
Sbjct: 168 SRRSSVNSIPSETFSEEPSF-RSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEM 225
Query: 644 VSGRSNIMCKTKEEKFY 660
+ G + ++E F
Sbjct: 226 LYGTTPFKGSNRDETFS 242
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 10/94 (10%)
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFG 615
GL Y+H I+HRD+K N+ +++D KI DFGLA+ D E ++ TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 616 YMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRS 648
Y APE + H D++S G + E+++G++
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 37/100 (37%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 549 HNICIG--IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606
IC +A+G+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ +D ++
Sbjct: 180 DLICYSFQVAKGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236
Query: 607 STRVAG-TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
A +MAPE T ++DV+SFG++ EI S
Sbjct: 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY--AM- 623
+L VHRDIK NVLLDK+ + +++DFG D T S GT Y++PE AM
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 624 --RGHLTDKADVYSFGIVALEIVSGRS 648
+G + D +S G+ E++ G +
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-08
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 27/155 (17%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNG--PEATLPDLRNRT 64
SN+ SGE+P+ LG N++ ++ DL ++L G PE L
Sbjct: 341 SNKFSGEIPKNLGK----------HNNL------TVLDLSTNNLTGEIPE-GLCS-SGNL 382
Query: 65 FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLT 124
FK LIL S +L GE+P LG ++ + L N +G +P F +L V F+ ++ N L
Sbjct: 383 FK-LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQ 441
Query: 125 GKV--PQWMFGRGPENIDLSYNNFADE---SSGSD 154
G++ +W + + L+ N F S GS
Sbjct: 442 GRINSRKWDMPS-LQMLSLARNKFFGGLPDSFGSK 475
|
Length = 968 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 31/227 (13%)
Query: 453 KIGEGGFGPVYKGLLADG---TLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYG 509
K+G G +G VYK DG A+KQ+ + EI + L+HP+++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 510 CCIE--GNQLLLIYEYLENNSLARALFGPEEHR--------LKLDWPTRHNICIGIARGL 559
+ ++ L+++Y E++ F HR ++L ++ I G+
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKF----HRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNP-----KISDFGLAKLDEEDNTHIS--TRVAG 612
YLH ++HRD+K N+L+ + P KI+D G A+L ++ V
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 613 TFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEK 658
TF Y APE + H T D+++ G + E+++ C+ ++ K
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 67/243 (27%), Positives = 97/243 (39%), Gaps = 50/243 (20%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFV----NEIGTISALQ 500
+ F+ IG G FG V D G + A+K+L KS+ +E V E ++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEAD 59
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
+P +VKLY + N L LI EYL + L +K D T IA +
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL-------MKKDTFTEEETRFYIAETIL 112
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL----------------------AKL 598
+ +L +HRDIK N+LLD + K+SDFGL L
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 599 DEEDNTHISTRVA---------------GTFGYMAPEYAMRGHLTDKADVYSFGIVALEI 643
D S R A GT Y+APE ++ + D +S G++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 644 VSG 646
+ G
Sbjct: 233 LVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
+A G+ +L ++ VHRD+ A NVL+ + KI DFGLA+ D+ +IS TF
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GSTF 302
Query: 615 ---GYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
+MAPE T +DV+SFGI+ EI +
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 6/94 (6%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
+ RGL Y+H + ++HRD+K +N+LL+ + + KI DFGLA+ E ++ V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TR 172
Query: 615 GYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGR 647
Y APE + T DV+S G + E++ GR
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 46/177 (25%), Positives = 71/177 (40%), Gaps = 25/177 (14%)
Query: 483 KQGNRE-FVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRL 541
K G R E + A+ HP +++L G + Y N + + L
Sbjct: 123 KAGQRGGTATEAHILRAINHPSIIQLKG----------TFTY---NKFTCLILPRYKTDL 169
Query: 542 KLDWPTRHNICI--------GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593
+ NI I + R + YLHE I+HRDIKA N+ ++ + + DF
Sbjct: 170 YCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDF 226
Query: 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNI 650
G A + N + AGT APE R D++S GIV E+ + ++
Sbjct: 227 GAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 24/148 (16%)
Query: 8 NRLSGELPE---ELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRT 64
N LSGE+PE +L +L + H FS + T + +LP L
Sbjct: 294 NSLSGEIPELVIQLQNL-----------EILHLFSNNFT----GKIPVALTSLPRL---- 334
Query: 65 FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLT 124
+ L L S +GE+P LG+ + + VLDLS N L G IPE ++ + L N L
Sbjct: 335 -QVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393
Query: 125 GKVPQWMFG-RGPENIDLSYNNFADESS 151
G++P+ + R + L N+F+ E
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELP 421
|
Length = 968 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 33/238 (13%)
Query: 422 SERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS- 479
SE + + +Q T +K + IG G G V G +AVK+LS
Sbjct: 1 SEEDSQFYSVQVADSTFTVLK----RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR 56
Query: 480 -----AKSKQGNREFVNEIGTISALQHPHLVKLYGCCI------EGNQLLLIYEYLENNS 528
+K+ RE V + + H +++ L E + L+ E ++ N
Sbjct: 57 PFQNQTHAKRAYRELV----LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN- 111
Query: 529 LARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 588
L + + +H ++ + +C G+ +LH I+HRD+K +N+++ D
Sbjct: 112 LCQVIHMELDHE-RMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTL 162
Query: 589 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSG 646
KI DFGLA+ + T T Y APE + + D++S G + E+V G
Sbjct: 163 KILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGT----ISALQHP 502
F + I G FG VY G + L AVK + K+ N+ V+++ ++ + P
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVK-KADMINKNMVHQVQAERDALALSKSP 64
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLAR--ALFGPEEHRLKLDWPTRHNICIGIARGLA 560
+V LY N + L+ EYL + ++G D +A L
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALD 118
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599
YLH I+HRD+K N+L+ + + K++DFGL+K+
Sbjct: 119 YLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 47/229 (20%)
Query: 442 KAATNHFDVANKIGEGGFGPVYKGLLADGT-LIAVKQLSAKSKQGNREFVNEIGTISALQ 500
++ + + N IG G FG VY+ + D + +A+K++ + NRE + + L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117
Query: 501 HPHLVKL----YGCCIEGNQ----LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNIC 552
H +++ L Y C + N+ L ++ E++ P+ + R+N
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFI-----------PQTVHKYMKHYARNNHA 166
Query: 553 I----------GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK---L 598
+ + R LAY+H + I HRD+K N+L+D + + K+ DFG AK
Sbjct: 167 LPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223
Query: 599 DEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSG 646
+ ++I +R Y APE + + T D++S G + E++ G
Sbjct: 224 GQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 29/88 (32%), Positives = 50/88 (56%), Gaps = 4/88 (4%)
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 618
L LH+ +++RD+K N+LLD + + DFGL KL+ +D+ +T GT Y+A
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLA 161
Query: 619 PEYAMRGHLTDKADVYSFGIVALEIVSG 646
PE + T D ++ G++ E+++G
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 448 FDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNRE----FVNEIGTISALQHPH 503
F++ IG G FG V L + + ++ K + R F E + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+ L+ + N L L+ +Y L L E RL D + +A + +
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFY-----LAEMVIAID 116
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY-- 621
+L VHRDIK N+L+D + + +++DFG ED T S+ GT Y++PE
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 622 AM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
AM +G + D +S G+ E++ G + ++ E +
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 33/197 (16%)
Query: 470 GTLIAVK--QLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527
GTL+ V+ L +++ + NE+ +HP+++ + G+ L +I ++
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA-- 82
Query: 528 SLARALFGPEEHRLKLDWPTR------HNICIGIARGLAYLHEESRLKIVHRDIKATNVL 581
+G LK +P NI G RGL YLH+ +HR+IKA+++L
Sbjct: 83 ------YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL 133
Query: 582 LDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG--------YMAPEYAMRGHLTD---K 630
+ D +S GL+ L +V F +++PE +R L K
Sbjct: 134 ISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL-LRQDLYGYNVK 190
Query: 631 ADVYSFGIVALEIVSGR 647
+D+YS GI A E+ +GR
Sbjct: 191 SDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 26/178 (14%)
Query: 496 ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGI 555
+S + H HL ++G C+ G++ +++ E++E+ L E+ R+ + W + + +
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--KITVAQQL 126
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDK-----DLNP--KISDFG--LAKLDEEDNTHI 606
A L+YL +++ +VH ++ A N+LL + +P K+SD G L E+
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE- 182
Query: 607 STRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIV-SGRSNIMCKTKEEK--FY 660
R+ ++APE G L+ AD +SFG LEI G + +T EK FY
Sbjct: 183 --RIP----WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 24/221 (10%)
Query: 438 LRQIKAATNHFDVANKIGEGGFGPV----YKGLLADGTLIAVKQLSAKS--KQGNREFVN 491
+ +++ FDV IG G FG V +K + + A+K LS K+ + F
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFW 91
Query: 492 EIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHN 550
E I A +V+L+ + L ++ EY+ L + + + W +
Sbjct: 92 EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYT 148
Query: 551 ICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTR 609
+ +A L +H + +HRD+K N+LLDK + K++DFG K+D T
Sbjct: 149 AEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203
Query: 610 VAGTFGYMAPEYAMR----GHLTDKADVYSFGIVALEIVSG 646
V GT Y++PE G+ + D +S G+ E++ G
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED--NTHISTRVAGTF 614
R L Y+H + + HRD+K N+L + D KI DFGLA++ D T T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 615 GYMAPEY--AMRGHLTDKADVYSFGIVALEIVSGR 647
Y APE + T D++S G + E+++G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 15/148 (10%)
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
+P+ +KLY +LI +Y+++ L F + KL I + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTRVAGTFGYMAP 619
LH + I+H DIK NVL D+ + + D+GL K + GT Y +P
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSP 175
Query: 620 EYAMRGHLTDKA-DVYSFGIVALEIVSG 646
E ++GH D + D ++ G++ E+++G
Sbjct: 176 E-KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 39/126 (30%), Positives = 58/126 (46%), Gaps = 25/126 (19%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEAT---LPDLRNR 63
+N LSGE+P ++GS FS L++ DL G L N
Sbjct: 149 NNMLSGEIPNDIGS-----------------FS----SLKVLDLGGNVLVGKIPNSLTNL 187
Query: 64 T-FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL 122
T + L L S L G++P LG++ +K + L +N L+G IP L ++ + L N
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNN 247
Query: 123 LTGKVP 128
LTG +P
Sbjct: 248 LTGPIP 253
|
Length = 968 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 11/150 (7%)
Query: 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRD 574
N L L+ +Y L L E RL D + IA + +H +L VHRD
Sbjct: 74 NYLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFY-----IAEMVLAIHSIHQLHYVHRD 127
Query: 575 IKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY--AMR---GHLTD 629
IK NVLLD + + +++DFG +D T S+ GT Y++PE AM G
Sbjct: 128 IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGP 187
Query: 630 KADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
+ D +S G+ E++ G + ++ E +
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYAESLVETY 217
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 9/98 (9%)
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK----LDEEDNTHISTRV 610
I GL Y+H + ++HRD+K N+L++ D KI DFGLA+ E+ ++ V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 611 AGTFGYMAPEYAMRGHLTDKA-DVYSFGIVALEIVSGR 647
A T Y APE + KA DV+S G + E++ +
Sbjct: 171 A-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 32/91 (35%), Positives = 45/91 (49%), Gaps = 14/91 (15%)
Query: 260 LYTEARVS---PISLTYYVFCLENGNYKVNLHFAETMFTDDKTYKSLGRRIFDVYIQGKL 316
LY A VS L+Y + N NY V LHFAE D + + G+R+FDV I G
Sbjct: 254 LYQSALVSTDTQPDLSYTMDVDPNRNYSVWLHFAEI----DNSITAEGKRVFDVLINGDT 309
Query: 317 ELKDFNIEEEAGGVGKPIVKPFSAVVTNGTM 347
KD +I + +G ++A+V N T+
Sbjct: 310 AFKDVDIVKMSGE-------RYTALVLNKTV 333
|
Length = 623 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 60/253 (23%), Positives = 112/253 (44%), Gaps = 42/253 (16%)
Query: 454 IGEGGFGPV---YKGLLADGTLIAVKQLS------AKSKQGNREFVNEIGTISALQHPHL 504
IG G G V Y +L +A+K+LS +K+ RE V + + H ++
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNI 78
Query: 505 VKLYGCCI------EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
+ L E + L+ E ++ N L + + +++LD + + G
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCG 131
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 618
+ +LH I+HRD+K +N+++ D KI DFGLA+ + + T T Y A
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 186
Query: 619 PEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN----L 674
PE + + D++S G + E+V R I+ ++ Y+ W ++++ G
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV--RHKILFPGRD---YIDQWNKVIEQLGTPCPEF 241
Query: 675 MELVDPNLGSNVD 687
M+ + P + + V+
Sbjct: 242 MKKLQPTVRNYVE 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 18/218 (8%)
Query: 438 LRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNRE----FVNEI 493
+R ++ ++V IG G FG V + +L +K + R F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 494 GTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICI 553
++ P +V+L+ + L ++ EY+ L + + + W + +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEV 151
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAG 612
+A L +H + +HRD+K N+LLDK + K++DFG K+++E T V G
Sbjct: 152 VLA--LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 205
Query: 613 TFGYMAPEYAMR----GHLTDKADVYSFGIVALEIVSG 646
T Y++PE G+ + D +S G+ E++ G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 4e-06
Identities = 66/243 (27%), Positives = 108/243 (44%), Gaps = 54/243 (22%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNRE-----FVNEIGTISALQ 500
N ++V KIG G FG V+ L+ A S +G +E V E+ + L+
Sbjct: 13 NEYEVIKKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 501 HPHLVKLYGCCI-EGNQ-LLLIYEYLENNSLAR------ALFGP-EEHRLKLDWPTRHNI 551
H ++V+ + + NQ L ++ E+ + L+R +FG EEH + +I
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV-------DI 123
Query: 552 CIGIARGLAYLHE----ESRLKIVHRDIKATNVLLD-------------KDLN----PKI 590
+ LAY H + +++HRD+K N+ L +LN KI
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 591 SDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAMRGHLT----DKADVYSFGIVALEIVS 645
DFGL+K + E H GT Y +PE + H T DK+D+++ G + E+ S
Sbjct: 184 GDFGLSKNIGIESMAH---SCVGTPYYWSPELLL--HETKSYDDKSDMWALGCIIYELCS 238
Query: 646 GRS 648
G++
Sbjct: 239 GKT 241
|
Length = 1021 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 64/283 (22%), Positives = 105/283 (37%), Gaps = 68/283 (24%)
Query: 447 HFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISA------- 498
F IG G FG V D L A+K L K+ R N+ + A
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR-KADVLMR---NQAAHVKAERDILAE 57
Query: 499 LQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIA 556
+ +VKLY + + L + +Y+ + L G E L R I +
Sbjct: 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-----ARFYIA-ELT 111
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-------------------- 596
+ +H ++ +HRDIK N+L+D+D + K++DFGL
Sbjct: 112 CAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQ 168
Query: 597 -------KLDEEDNTHIST---------------RVAGTFGYMAPEYAMRGHLTDKADVY 634
+ E D + + GT Y+APE +R T D +
Sbjct: 169 DSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228
Query: 635 SFGIVALEIVSGRSNIMCKTK-EEKFYLLDW--ALLLKEQGNL 674
S G++ E++ G+ + T E + +++W L + Q L
Sbjct: 229 SVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKL 271
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 44/200 (22%), Positives = 85/200 (42%), Gaps = 30/200 (15%)
Query: 462 VYKGLLADGTLIAVKQL---SAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN--- 515
+YKG+ + + ++ K NEI + + +++K+YG I+
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 516 -QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRD 574
+L LI EY L L ++ L + T+ ++ I +GL L++ + +++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYT--NKPYKN 148
Query: 575 IKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTD----- 629
+ + + L+ ++ KI GL K+ +S+ +M Y L D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKI-------LSSPPFKNVNFMV--YFSYKMLNDIFSEY 199
Query: 630 --KADVYSFGIVALEIVSGR 647
K D+YS G+V EI +G+
Sbjct: 200 TIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 57/256 (22%), Positives = 97/256 (37%), Gaps = 46/256 (17%)
Query: 448 FDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEI----GTISALQHPH 503
F+ IG G FG V D I ++ K+ +E V I +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+VK++ + L LI E+L + L +K D + IA + +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLL-------MKKDTLSEEATQFYIAETVLAID 115
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGL---------------------------- 595
+L +HRDIK N+LLD + K+SDFGL
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 596 ------AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSN 649
A+ +++ ++ GT Y+APE M+ D +S G++ E++ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 650 IMCKTKEEKFY-LLDW 664
+T +E + +++W
Sbjct: 236 FCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 44/155 (28%), Positives = 66/155 (42%), Gaps = 11/155 (7%)
Query: 446 NHFDVANKIGEGGFGPV-YKGLLADGTLIAVKQL--SAKSKQGNREFVN-EIGTISALQH 501
F IG+G FG V G + A+K L S K+ V E ++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P +V LY + L LI E+L L L +K D + +A +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMAECVLA 113
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596
+ +L +HRDIK N+L+D+ + K+SDFGL+
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 57/256 (22%), Positives = 96/256 (37%), Gaps = 46/256 (17%)
Query: 448 FDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEI----GTISALQHPH 503
F+ IG G FG V D + ++ K+ +E V I +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+VK++ + L LI E+L + L +K D T IA + +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLL-------MKKDTLTEEETQFYIAETVLAID 115
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGL---------------------------- 595
+L +HRDIK N+LLD + K+SDFGL
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 596 ------AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSN 649
A+ + + ++ GT Y+APE M+ D +S G++ E++ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 650 IMCKTKEEKFY-LLDW 664
+T +E + +++W
Sbjct: 236 FCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 31/208 (14%)
Query: 454 IGEGGFGPVYKGLLADGTL---IAVKQLS------AKSKQGNREFVNEIGTISALQHPHL 504
IG G G V D L +A+K+LS +K+ RE V + + H ++
Sbjct: 32 IGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNI 85
Query: 505 VKLYGC-----CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGL 559
+ L +E Q + I L + +L + + +++LD + + G+
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGI 139
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 619
+LH I+HRD+K +N+++ D KI DFGLA+ + + T T Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVSGR 647
E + + D++S G + E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 11/93 (11%)
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT---HISTRVAGTF 614
G+ +LH I+HRD+K +N+++ D KI DFGLA+ ++ TR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
Y APE + + D++S G + E++ G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 4/101 (3%)
Query: 545 WPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604
TR I + + Y+H++ K++HRDIK N+ L+ D + DFG A E++
Sbjct: 267 KQTRA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645
GT +PE + D++S G++ L+++S
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 5e-05
Identities = 21/58 (36%), Positives = 30/58 (51%)
Query: 66 KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLL 123
K+L L + LT + +KVLDLS N L PE+F+ L + + L+GN L
Sbjct: 3 KSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 56/236 (23%)
Query: 499 LQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEE---HRLK--LDWPTRHNICI 553
+ H H+V LYG C+ + +++ E++E FGP + HR L P + +
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVE--------FGPLDLFMHRKSDVLTTPWKFKVAK 112
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLL-----DKDLNP--KISDFG--LAKLDEEDNT 604
+A L+YL ++ +VH ++ N+LL D + P K+SD G + L ++
Sbjct: 113 QLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECV 169
Query: 605 HISTRVAGTFGYMAPEYAM-RGHLTDKADVYSFGIVALEIV-SGRSNIMCKT--KEEKFY 660
R+ ++APE +L+ AD +SFG EI +G + KT ++E+FY
Sbjct: 170 E---RIP----WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY 222
Query: 661 LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVV 716
LV P+ KE +M + C + P RP +++
Sbjct: 223 -----------EGQCMLVTPSC-----KELADLMTH----CMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 30/109 (27%), Positives = 44/109 (40%), Gaps = 19/109 (17%)
Query: 267 SPISLTYYVFCLENGNYKVNLHFAETMFTDDKTYKSLGRRIFDVYIQGKLELKDFNIEEE 326
+P++ T+ N Y V LHFAE +SL R FD+YI GK D + +
Sbjct: 240 APLNFTW-DLVDPNFEYYVYLHFAE--------IQSLETREFDIYINGKTVYGDVSP-KY 289
Query: 327 AGGVGKPIVKPFSAVVTNGTMD-IRLYWAGKGTTEIPDRGVYGPLISAI 374
G + F V+ G + I L T PL++A+
Sbjct: 290 LGTDTGALYLDFPVNVSGGGLLNISLVPTSGST--------LPPLLNAL 330
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 54/262 (20%), Positives = 96/262 (36%), Gaps = 58/262 (22%)
Query: 454 IGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVN---EIGTISALQHPHLVKLYG 509
+G G FG V D L A+K L K + + E ++ + +VKLY
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
+ + L + +Y+ + L ++++ IA + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL-------IRMEVFPEVLARFYIAELTLAIESVHKMG 121
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAK---------------------------LDEED 602
+HRDIK N+L+D D + K++DFGL D+
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 603 NTHISTR-------------------VAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEI 643
N R + GT Y+APE +R T D +S G++ E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 644 VSGRSNIMCKT-KEEKFYLLDW 664
+ G+ + T E + +++W
Sbjct: 242 LVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 32/145 (22%), Positives = 61/145 (42%), Gaps = 47/145 (32%)
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLA------------------KLDEEDNTH--- 605
++ +HRDIK N+L+D+D + K++DFGL + D D ++
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 606 -------------------------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVA 640
++ + GT Y+APE +R T D +S G++
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 641 LEIVSGRSNIMCKTK-EEKFYLLDW 664
E++ G+ + +T E + +++W
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 31/149 (20%), Positives = 56/149 (37%), Gaps = 16/149 (10%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLV-KLYGC 510
+ G VY D + +K ++ K +RE E+ + L + V K+
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61
Query: 511 CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKI 570
L+ E++E +L + + + +I +A LA LH+ L +
Sbjct: 62 GESDGWSYLLMEWIEGETL--------DEVSEEEKE---DIAEQLAELLAKLHQLPLLVL 110
Query: 571 VHRDIKATNVLLDKDLNPKISDFGLAKLD 599
H D+ N+L+D I D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 29/83 (34%), Positives = 40/83 (48%), Gaps = 4/83 (4%)
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED-NTHISTRVAGTFGYMAP 619
Y+H E I+HRDIK NVL++ + + DFG A +T +AGT AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 620 EYAMRGHLTDKADVYSFGIVALE 642
E T D++S G+V E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 21/58 (36%), Positives = 30/58 (51%), Gaps = 1/58 (1%)
Query: 90 KVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNF 146
K LDLS N+L +F L ++ + L+GN LT P+ G ++DLS NN
Sbjct: 3 KSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 53/229 (23%), Positives = 84/229 (36%), Gaps = 50/229 (21%)
Query: 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRH---------NICIGIARGLAYLHEESR 567
L+ I Y +N + + P+ LDW +H I L Y H E
Sbjct: 193 LMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE-- 250
Query: 568 LKIVHRDIKATNVLL---DKDLNP-------------KISDFGLAKLDEEDNTHISTRVA 611
L ++H D+K N+L+ D ++P +I D G D H T +
Sbjct: 251 LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC----DERHSRTAIV 306
Query: 612 GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL--------- 662
T Y +PE + D++S G + E+ +G+ E +L+
Sbjct: 307 STRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPS 366
Query: 663 DWA---------LLLKEQGNLMELVDPNLGSNVDKEQ-VRVMINVALLC 701
+WA LL G L DP + + + + VR +I LLC
Sbjct: 367 EWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLC 415
|
Length = 467 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 23/157 (14%)
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSL----ARALFGPEEHRLKLDWPTRHNICIGIAR 557
P++V L+ + + + L+ ++ E L ++ L PEE W +
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEE--CVKRWAAE------MVV 96
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE--DNTHISTRVAGTFG 615
L LH E IV RD+ N+LLD + +++ F E+ D +
Sbjct: 97 ALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------ 147
Query: 616 YMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMC 652
Y APE T+ D +S G + E+++G++ + C
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 30/128 (23%), Positives = 51/128 (39%), Gaps = 41/128 (32%)
Query: 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDL 60
M + N+LSGE+P+EL S + L L +S
Sbjct: 502 MQLKLSENKLSGEIPDELSS------------------CKKLVSLDLSH----------- 532
Query: 61 RNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTG 120
L+G++P E+ + LDLS N+L+G IP++ + + + ++
Sbjct: 533 ------------NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISH 580
Query: 121 NLLTGKVP 128
N L G +P
Sbjct: 581 NHLHGSLP 588
|
Length = 968 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 790 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.46 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.42 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.42 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.34 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.28 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.23 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.22 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.21 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.14 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.13 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.13 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.12 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.01 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.96 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.95 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.93 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.89 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.86 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.85 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.84 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.73 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.68 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.68 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.57 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.49 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.45 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.45 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.42 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.37 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.35 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.34 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.32 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.28 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.18 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.15 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.12 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.07 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.06 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.04 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.01 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.99 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.98 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 97.98 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-60 Score=588.20 Aligned_cols=262 Identities=29% Similarity=0.515 Sum_probs=217.4
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
...|...+.||+|+||.||+|.. .+|..||||++...... ..+|++++++++|||||+++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45677788999999999999996 57899999998643322 23468899999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++|+|.++++ .++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+......
T Consensus 765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 99999999993 38999999999999999999997766789999999999999999988876 6665533221
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
....||+.|+|||++.+..++.|+|||||||++|||+||+.|++.... ....+..|+...........++|+.+.
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence 223688999999999999999999999999999999999999864332 234566777766555566667777664
Q ss_pred C--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 684 S--NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 684 ~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
. ..+.++..++.+++.+||+.+|++||+|.||+++|+....
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 4 3345677789999999999999999999999999987644
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-57 Score=496.11 Aligned_cols=290 Identities=52% Similarity=0.880 Sum_probs=258.9
Q ss_pred CCCCccHHHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEE
Q 040908 432 QTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCC 511 (790)
Q Consensus 432 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 511 (790)
....|++.+++.||++|...+.||+|+||.||+|.+.+|+.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765443256799999999999999999999999
Q ss_pred EeCC-eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEE
Q 040908 512 IEGN-QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 590 (790)
Q Consensus 512 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 590 (790)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999875543 8999999999999999999999999889999999999999999999999
Q ss_pred eecCCccccCC-CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 591 SDFGLAKLDEE-DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 591 ~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
+|||+|+..+. .... .+...||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+.........+++|++...
T Consensus 219 sDFGLa~~~~~~~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999986654 2222 111179999999999999999999999999999999999999988665455556999999999
Q ss_pred hhCCcccccCCCCC-CCCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 670 EQGNLMELVDPNLG-SNVDK-EQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 670 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
..+.+.+++|+.+. ..++. +++..+..++.+|++.+|.+||+|.||+++|+....
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 99999999999987 56664 688999999999999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=406.61 Aligned_cols=255 Identities=34% Similarity=0.542 Sum_probs=209.9
Q ss_pred eeeeecccCcEEEEeeeecCCcEEEEEEccccchhc--HHHHHHHHHHhhccCCCceeeeeeEEEeCC-eEEEEEEeccC
Q 040908 450 VANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQG--NREFVNEIGTISALQHPHLVKLYGCCIEGN-QLLLIYEYLEN 526 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~ 526 (790)
+.+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 446699999999999999755559999997653222 568999999999999999999999999887 79999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-CeEEeecCCccccCCCCcc
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~~~~ 605 (790)
|+|.++++.. ....+++..++++|.|||+||.|||++.. ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 9999999754 34689999999999999999999999852 99999999999999997 99999999998665432 2
Q ss_pred eeeccccCCCcccHHHhh--cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAM--RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~--~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
..+...||+.|||||++. ...|+.|+|||||||++|||+||+.||........ .. ... ....+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---~~---~v~---------~~~~R 264 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---AS---AVV---------VGGLR 264 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---HH---HHH---------hcCCC
Confidence 233467999999999999 66999999999999999999999999976543111 11 111 11112
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
...+......+..++..||+.||..||++.+++..|+....
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 22233356678889999999999999999999999986654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=400.49 Aligned_cols=254 Identities=30% Similarity=0.490 Sum_probs=217.2
Q ss_pred cceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCC
Q 040908 448 FDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 527 (790)
+.+.+.||+|-||.||.|.++....||+|.++.. ......|.+|+.+|++++|+|||+++|+|..++.++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3457899999999999999988789999999765 344578999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCccee
Q 040908 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 607 (790)
Q Consensus 528 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 607 (790)
+|.++|.. ..+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||||+...++.....
T Consensus 287 sLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 287 SLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred cHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 99999965 2346789999999999999999999988 599999999999999999999999999996666555555
Q ss_pred eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 608 TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 608 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
....-++.|.|||.+..+.++.|||||||||+||||+| |+.|+......+.. +.++...+-..
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~----------------~~le~GyRlp~ 425 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL----------------ELLERGYRLPR 425 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH----------------HHHhccCcCCC
Confidence 55566789999999999999999999999999999999 88888655433221 22333333344
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
+..++..+.+|+..||+.+|++|||+..+...|+...
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 5567778999999999999999999999998888754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=367.09 Aligned_cols=204 Identities=31% Similarity=0.550 Sum_probs=182.6
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
..+|.+.+.||+|+||+||+|+++ ++.+||||.+... .+...+....|+.+|+.++|||||++++++..++.++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888899999999999999964 6899999999776 5556677889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC------CCeEEeecCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD------LNPKISDFGL 595 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~------~~~kl~DFGl 595 (790)
|||.+|+|.++++. +..+++.....++.|+|.||++||+++ ||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999953 347899999999999999999999985 9999999999999765 4689999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccc
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE 657 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~ 657 (790)
|+.+.... ...+.+|++-|||||+++..+|+.|+|+||.|+++||+++|+.||+..+..+
T Consensus 162 AR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 162 ARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 99887433 4466889999999999999999999999999999999999999998665443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=365.02 Aligned_cols=253 Identities=29% Similarity=0.456 Sum_probs=208.3
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEe
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
+++.+++ ..+.||+|..|+|||+.++ +++.+|+|++... .....+++.+|++++++.+||+||+++|.|..
T Consensus 76 i~~~dle-------~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLE-------RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhh-------hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 4555555 4578999999999999975 6889999999544 34446789999999999999999999999999
Q ss_pred CC-eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEee
Q 040908 514 GN-QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 592 (790)
Q Consensus 514 ~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 592 (790)
.. ...++||||.+|+|++++.. ...+++...-+|+.+|++||.|||+. +.||||||||+|||++..|++||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecc
Confidence 88 59999999999999999932 25689999999999999999999974 3699999999999999999999999
Q ss_pred cCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC
Q 040908 593 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 593 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
||.++.+... .....+||..|||||.+.+..|+.++||||||++++|+++|+.|+...... ..+|...+.
T Consensus 223 FGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~----~~~~~~Ll~--- 292 (364)
T KOG0581|consen 223 FGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP----YLDIFELLC--- 292 (364)
T ss_pred ccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC----CCCHHHHHH---
Confidence 9999876544 446688999999999999999999999999999999999999999764211 112222211
Q ss_pred CcccccC---CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLMELVD---PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~~~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+++ |.+... ....++..++..|+++||.+||++.|+++
T Consensus 293 ---~Iv~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 293 ---AIVDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ---HHhcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1222 222222 35567889999999999999999999876
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=382.16 Aligned_cols=247 Identities=28% Similarity=0.460 Sum_probs=211.1
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
.+|...+.||+|||..||+++. ..|..||+|++.+. .....+...+||++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999996 78999999999764 2334566889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
|+|.+|+|..++. .+.++++.++..++.||+.||.|||+.+ |||||||..|+||++++++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999993 3478999999999999999999999985 99999999999999999999999999998775
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
+.. ...+.+|||.|+|||++.+...+..+||||+|||||-|+.|++||+.....+...-+. ..+..
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik----------~~~Y~--- 236 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK----------LNEYS--- 236 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH----------hcCcc---
Confidence 433 2345899999999999999999999999999999999999999998665444332111 01111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.....+..+|+..+++.+|.+|||+++|+.
T Consensus 237 ----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 ----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12233446678889999999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=398.82 Aligned_cols=262 Identities=29% Similarity=0.498 Sum_probs=217.6
Q ss_pred HhcCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 516 (790)
.+.+....+.||+|+||+||+|... +.+.||||.++..... ...+|++|+++++.++|||||+|+|.|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3455667889999999999999842 3467999999887665 67899999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCcc----------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC
Q 040908 517 LLLIYEYLENNSLARALFGPEE----------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 586 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 586 (790)
.+||+|||..|+|.++|..... ...+++..+.+.||.|||.||+||-+. .++||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 9999999999999999943211 123488999999999999999999877 499999999999999999
Q ss_pred CeEEeecCCcccc-CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHH
Q 040908 587 NPKISDFGLAKLD-EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDW 664 (790)
Q Consensus 587 ~~kl~DFGla~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 664 (790)
.+||+||||++.. ..+.........-.++||+||.++.+++|.+||||||||+|||++| |+.|+.....++....
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~--- 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC--- 717 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH---
Confidence 9999999999843 3333333334455789999999999999999999999999999999 9999987665543322
Q ss_pred HHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 665 ALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 665 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
...+++. ..+..++.++.+|+..||+..|.+||+++||-..|+....
T Consensus 718 ----i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 718 ----IRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ----HHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 2334432 3455677789999999999999999999999999987543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=354.05 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=210.5
Q ss_pred CcceeeeecccCcEEEEeee-ecCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeee-EEEeCCe-EEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYG-CCIEGNQ-LLLIY 521 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV~ 521 (790)
+|++.++||+|.||+|||+. +.+|..||.|.+.-. .....+....|+.+|++++|||||++++ .+.++.+ +.+||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 56678999999999999998 678999999998743 3334567889999999999999999998 5555555 89999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCC-CcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR-LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||..|+|...+......+..+++..+++++.|++.||..+|++-+ ..|+||||||.||+|+.+|.+||+|||+++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999997666667789999999999999999999998531 139999999999999999999999999999887
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
..... ....+|||.||+||.+....|+.||||||+||++|||+.-++||.+++- ...- ...++++..
T Consensus 180 s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~-~KI~qgd~~----- 246 (375)
T KOG0591|consen 180 SKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLC-KKIEQGDYP----- 246 (375)
T ss_pred chhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHH-HHHHcCCCC-----
Confidence 65443 3457899999999999999999999999999999999999999986521 1111 111222221
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.+ .+.....++.+++..|+..||+.||+...++..+..
T Consensus 247 ~~---p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 PL---PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CC---cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 124566778889999999999999985555544443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=385.99 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=220.1
Q ss_pred cCcceeeeecccCcEEEEeeeecC----CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
....+.+.||.|.||+||+|.++- ...||||.++... .....+|+.|+.+|.+++||||++|-|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 445788999999999999999652 3579999998764 44567899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
.|||+||+|+.+|+.. ...+++.+...++++||.||.||-+. +++||||.++|||++.+..+||+|||++|..+
T Consensus 709 TEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999543 35699999999999999999999876 59999999999999999999999999999887
Q ss_pred CCCcceeecccc--CCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 601 EDNTHISTRVAG--TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 601 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
++.....+...| .++|.|||.+...++|.+||||||||||||.++ |.+|+.....++.. ..
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI----------------ka 846 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI----------------KA 846 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH----------------HH
Confidence 766443333333 569999999999999999999999999999887 99998765544322 22
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcCCCC
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPD 727 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~ 727 (790)
++...+-..+++++..|.+|++.||++|-.+||++.|++..|++....|.
T Consensus 847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 23333344566788899999999999999999999999999988765443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=359.99 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=202.8
Q ss_pred HhcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchh-------cHHHHHHHHHHhhccCCCceeeeeeEEEeCC
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQ-------GNREFVNEIGTISALQHPHLVKLYGCCIEGN 515 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 515 (790)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++.+.... ......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678899999999999999998 557999999999764211 1234579999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC---CCeEEee
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISD 592 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~D 592 (790)
..||||||++||+|.+.+... ..+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999433 34666667889999999999999986 9999999999999766 7799999
Q ss_pred cCCccccCCCCcceeeccccCCCcccHHHhhcCCC---CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 593 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHL---TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 593 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
||+|+..++. ..+.+.+||+.|.|||++.++.. ..|.|+||+||+||-+++|.+||.....+.. +.+ ..
T Consensus 323 FGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~e----QI 394 (475)
T KOG0615|consen 323 FGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKE----QI 394 (475)
T ss_pred cchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHH----HH
Confidence 9999987643 34567899999999999987543 3488999999999999999999976543321 111 00
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..|+... ......+..++.++++.+++..||++||++.|+++
T Consensus 395 ~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 LKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111111 01123355677889999999999999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=370.18 Aligned_cols=272 Identities=29% Similarity=0.504 Sum_probs=214.8
Q ss_pred HHHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC
Q 040908 438 LRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN 515 (790)
Q Consensus 438 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 515 (790)
.+++++..+.+.+.+.||+|.||+||+|.|-+ .||||++... ..+..+.|++|+.++++-+|.||+-+.|||....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 35566666677788999999999999999853 5999999765 4456788999999999999999999999999887
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
. .+|..+|++.+|+.+||..+ ..++..+...||.|||+||.|||.+ +|||||||+.||+|.+++.|||+|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 7 99999999999999998665 4688899999999999999999998 499999999999999999999999999
Q ss_pred ccccCCCC-cceeeccccCCCcccHHHhhc---CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh
Q 040908 596 AKLDEEDN-THISTRVAGTFGYMAPEYAMR---GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ 671 (790)
Q Consensus 596 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 671 (790)
+.....-. .......-|...|||||+++. .+|+..+||||||+|+|||+||..||.....+.....+
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV--------- 605 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV--------- 605 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe---------
Confidence 96432211 111122347889999999974 46899999999999999999999999733322221111
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC-CCCCCC
Q 040908 672 GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG-VPDIVQ 730 (790)
Q Consensus 672 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~-~~~~~~ 730 (790)
|+-.-..| + ......+.++|.+|+..||..++++||.+.+|+.+|+.... .+.+..
T Consensus 606 GrG~l~pd--~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~R 662 (678)
T KOG0193|consen 606 GRGYLMPD--L-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINR 662 (678)
T ss_pred cccccCcc--c-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccccc
Confidence 11111111 1 11223456688899999999999999999999998888765 444433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.65 Aligned_cols=242 Identities=27% Similarity=0.406 Sum_probs=200.3
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||.++.+ .++.+|+|++++.. ....+...+|..+|.+++||.||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 578999999999999999999854 58899999997753 33456688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
+||+.||.|..+|. +...+++..+.-++.+|+.||.|||+++ ||||||||+|||||++|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999993 2356889989999999999999999986 9999999999999999999999999999544
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.... .+.+.+||+.|||||++.+..|+..+|+||+||++|||++|.+||...+..... .... .+++
T Consensus 177 ~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~------~~I~-~~k~------ 242 (357)
T KOG0598|consen 177 KDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY------DKIL-KGKL------ 242 (357)
T ss_pred cCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH------HHHh-cCcC------
Confidence 3332 234589999999999999999999999999999999999999999865433221 1111 1110
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRP 710 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 710 (790)
...+.-...+..+++...++.||++|-
T Consensus 243 ---~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 ---PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 011111234567788889999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=335.51 Aligned_cols=264 Identities=20% Similarity=0.342 Sum_probs=207.7
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
+.|+...++|+|+||.|||++.+ .|+.||||++..... .-.+-.++|+++|++++|+|+|.++.+|.....+.||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788899999999999999965 599999999976433 234557899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
||+..-|.++= .....++.....+++.|+++|+.|+|++ ++|||||||+|||++.++.+||||||+|+.+..
T Consensus 82 ~~dhTvL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDHTVLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecchHHHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 99885554433 3345688899999999999999999998 499999999999999999999999999997764
Q ss_pred CcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH---------HHHhhC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL---------LLKEQG 672 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~ 672 (790)
.....+..+.|..|.|||.+.+ .+|....||||.||++.||++|.+-|.+..+-+..+++.... .+...+
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2334467889999999999987 789999999999999999999998887766555444432211 111111
Q ss_pred CcccccCCCCC-----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLMELVDPNLG-----SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
-+..+.-|... +..-......+++++..|++.||.+|++.+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111112111 1111233457899999999999999999999873
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=358.62 Aligned_cols=250 Identities=28% Similarity=0.495 Sum_probs=211.4
Q ss_pred hcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
...|...++||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3467778899999999999998 557889999999876666666789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
|++|+|.+.+. ...+++.++..|+.++++||+|||.++ |+|||||..|||++.++.+||+|||++.......
T Consensus 352 m~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999982 345899999999999999999999986 9999999999999999999999999998766544
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
. .....+||+.|||||++....|..|.||||||++++||+-|.+||.....-...+++. ..+. |.+
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------~ng~------P~l- 489 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNGT------PKL- 489 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------hcCC------CCc-
Confidence 3 3355789999999999999999999999999999999999999997644433322221 1111 111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+......+.++..+|++.|+.+||++.|+++
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 223344567889999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=360.83 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=204.4
Q ss_pred HhcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccch-hcHHHHHHHHHHhhcc-CCCceeeeeeEEEeC-
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKSK-QGNREFVNEIGTISAL-QHPHLVKLYGCCIEG- 514 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~- 514 (790)
..++|++.++||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 457899999999999999999973 2356899999875432 3346789999999999 899999999998764
Q ss_pred CeEEEEEEeccCCChhhhhcCCccc-------------------------------------------------------
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEH------------------------------------------------------- 539 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~------------------------------------------------------- 539 (790)
+..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4589999999999999998542110
Q ss_pred ---cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce-eeccccCCC
Q 040908 540 ---RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI-STRVAGTFG 615 (790)
Q Consensus 540 ---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~ 615 (790)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......... .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134788899999999999999999875 9999999999999999999999999998654332221 223446789
Q ss_pred cccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHH
Q 040908 616 YMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVM 694 (790)
Q Consensus 616 y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 694 (790)
|+|||++.+..++.++|||||||++|||++ |+.||......+.. .... ..+.. ... +......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~-----~~~~-~~~~~-----~~~----~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-----CQRL-KDGTR-----MRA----PENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH-----HHHH-hcCCC-----CCC----CCCCCHHH
Confidence 999999999999999999999999999997 99998754322211 1111 11111 111 11233468
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 695 INVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 695 ~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.+++.+||+.||.+||++.|++++|+...
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 89999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=338.92 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=207.3
Q ss_pred hcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.+.||.|.-++||+|. ...+..||||++....- ...+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4689999999999999999998 56789999999976433 335789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
||.+|++.+.+...-. ..+++..+..|..++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+-..
T Consensus 105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999954332 45899999999999999999999986 899999999999999999999999997644333
Q ss_pred Cccee---eccccCCCcccHHHhhc--CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 603 NTHIS---TRVAGTFGYMAPEYAMR--GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 603 ~~~~~---~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
..... ...+||++|||||+++. ..|+.|+||||||++..||.+|..||.....-. . ..+.-++.....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-v------Ll~tLqn~pp~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-V------LLLTLQNDPPTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-H------HHHHhcCCCCCc
Confidence 32221 45789999999999654 468999999999999999999999997432211 1 111112222211
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.-..+..+........+.+++..|++.||++|||++++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111222233446888999999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=346.06 Aligned_cols=264 Identities=25% Similarity=0.395 Sum_probs=208.9
Q ss_pred hcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEG--NQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 519 (790)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|++.... ........+||.+|++++||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3457778899999999999999 6689999999997764 34456678999999999999999999998876 68999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
|+|||+. +|.-++. .....++..++..++.|++.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 196 VFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999988 7877773 33467999999999999999999999986 999999999999999999999999999988
Q ss_pred CCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH-----HHhhCC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL-----LKEQGN 673 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~~~~~~ 673 (790)
........+..+-|..|.|||++.+. .|+.+.|+||.||||.||++|++.+.+.++.++...+--... .+...+
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 77666556667789999999999874 799999999999999999999998887765554433211100 000011
Q ss_pred cc--cccCCCCCCCCcH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 LM--ELVDPNLGSNVDK-------EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~~--~~~d~~l~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+. ..+.+. ..+.. ......++|+..+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11 011110 11111 12345678888999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=351.44 Aligned_cols=265 Identities=27% Similarity=0.412 Sum_probs=213.4
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhc-HHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQG-NREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
..+...+.++||+|-||+|..+....+..||||+++...... .++|.+|+++|.+++|||||+++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 345567889999999999999999888999999998775544 4889999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc-CC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EE 601 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~-~~ 601 (790)
||++|+|.+++...... .+.-....+||.|||.||+||.+. +++||||.++|+|+|.++++||+|||+++-+ ..
T Consensus 616 YmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999544321 245566778999999999999886 6999999999999999999999999999943 33
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh--CCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS--GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
+..+...+.+-+++|||+|.+.-+++|.++|||+|||++||+++ ...||.....+.. ++-...+...+....
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~--- 764 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQV--- 764 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcce---
Confidence 34445556677899999999999999999999999999999876 6778765433322 111111111111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.-..+.-++..+.++++.||..|-.+||++.++...|.+.
T Consensus 765 ---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1122345667888999999999999999999999888653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=380.46 Aligned_cols=261 Identities=30% Similarity=0.480 Sum_probs=211.8
Q ss_pred hcCcceeeeecccCcEEEEeeeecC--Cc----EEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD--GT----LIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~--g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
.++.+..+.||+|.||.||+|.+.+ |. .||||.+... +.+...+|.+|..+|+.++|||||+++|.|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4556778999999999999999643 43 4999999775 445567899999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccc---cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 518 LLIYEYLENNSLARALFGPEEH---RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
++++|||++|+|..+|+..+.. ...++....+.+|.|||+|+.||+++. +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999654221 356888999999999999999999984 9999999999999999999999999
Q ss_pred Ccccc-CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhC
Q 040908 595 LAKLD-EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 595 la~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
||+.. ..+.........-..+|||||.+.++.++.|+|||||||++||++| |..||......+... ...+.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCC
Confidence 99933 3222222222234579999999999999999999999999999999 888886554332211 112233
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 673 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
++ +.+..++..+.+|++.||+.+|++||++..+++.+..+..
T Consensus 922 RL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 922 RL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred cc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 22 2334556778899999999999999999999998776554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=344.88 Aligned_cols=253 Identities=29% Similarity=0.447 Sum_probs=199.7
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC--eEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN--QLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 522 (790)
.++...+.||+|+||+||.+... +|...|||.+........+.+.+|+.+|.+++|||||+.+|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45667899999999999999965 48999999987654333567889999999999999999999855444 6899999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC-CCCeEEeecCCccccCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEE 601 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~ 601 (790)
|+++|+|.+++... +..+++..+..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999432 226999999999999999999999885 999999999999999 79999999999986653
Q ss_pred --CCcceeeccccCCCcccHHHhhcCCC-CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 602 --DNTHISTRVAGTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 602 --~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
..........||+.|||||++..+.. ..++|||||||+++||+||+.||.... ....+.........
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~~----- 240 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGREDS----- 240 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccCC-----
Confidence 12222345789999999999986433 349999999999999999999996431 11111111111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
-| .++.....+..+++..|+..+|.+|||+.+++..
T Consensus 241 ~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 241 LP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 12 2233345567888999999999999999999873
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=355.03 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=206.9
Q ss_pred CCccHHHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEe
Q 040908 434 GSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 434 ~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
..+.+++|. .++-||.|+.|.||.|++. ++.||||+++.-. ..+++-|++++|+||+.+.|+|..
T Consensus 119 WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 119 WEIPFEEIS-------ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred ccCCHHHhh-------hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence 445555554 3578999999999999996 5679999885422 246788999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
...+|+|||||..|-|...|. .+.++.-.....|..+||.||.|||.+ .|||||||+-||||..+..+||+||
T Consensus 184 sPcyCIiMEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDF 256 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDF 256 (904)
T ss_pred CceeEEeeeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccc
Confidence 999999999999999999994 345678888899999999999999987 4999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
|-++...+..+ ...++||..|||||++...+.++|.||||||||||||+||..||........
T Consensus 257 GTS~e~~~~ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI--------------- 319 (904)
T KOG4721|consen 257 GTSKELSDKST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI--------------- 319 (904)
T ss_pred cchHhhhhhhh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------
Confidence 99986655432 2347899999999999999999999999999999999999999964332211
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
++-.-...+.-..+..+++.+.-|+++||+-.|.+||++++++.-|+-..
T Consensus 320 IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 320 IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 11111223333455567778888999999999999999999999997543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.23 Aligned_cols=265 Identities=23% Similarity=0.343 Sum_probs=208.2
Q ss_pred HhcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchhc-HHHHHHHHHHhhccC-CCceeeeeeEEEeCC-eEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQG-NREFVNEIGTISALQ-HPHLVKLYGCCIEGN-QLLL 519 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~l 519 (790)
..++|.+.++||.|.||.||+|+ ...|..||||+++.+.... ...=++|+..|++++ |||||++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45788999999999999999999 5678999999998764332 223468999999998 999999999999888 9999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
|||||+. +|.+++.++ +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||..
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 9999976 899999544 468999999999999999999999986 999999999999998889999999999976
Q ss_pred CCCCcceeeccccCCCcccHHHhh-cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh-------
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAM-RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ------- 671 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------- 671 (790)
..... .+.++.|..|.|||++. .+.|+.+.||||+|||++|+.+-++-|.+..+-++..-+.-+..-...
T Consensus 161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 55443 36788999999999875 567899999999999999999998877665544433222111100000
Q ss_pred -------CCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 672 -------GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 672 -------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
-++.+...-.+..-.+ ....+.++++..|+.+||.+|||+.|.++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0011111111111111 245678899999999999999999999873
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=361.18 Aligned_cols=259 Identities=30% Similarity=0.455 Sum_probs=206.9
Q ss_pred cCcceeeeecccCcEEEEeeeecC--C--cE-EEEEEccc---cchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLAD--G--TL-IAVKQLSA---KSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~--g--~~-vAvK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
++..+.++||+|+||.||+|.+.. + .. ||||..+. .......+|++|+++|++++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 444556899999999999999643 2 23 89999885 3466678999999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++|||+|.||+|.++|... ...++..++..++.+.|.||+|||++. +|||||.++|+|++.++.+||+|||+++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999433 236899999999999999999999984 9999999999999999999999999998
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
........ .....-+.+|+|||.+..+.++.++|||||||++||+++ |..|+......+. ..++.
T Consensus 311 ~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---~~kI~---------- 376 (474)
T KOG0194|consen 311 AGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---KAKIV---------- 376 (474)
T ss_pred CCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---HHHHH----------
Confidence 55411111 111235679999999999999999999999999999999 8888876543221 11110
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcCCC
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVP 726 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~ 726 (790)
-...+...+...+.++..++..||..+|++||+|.++.+.|+......
T Consensus 377 --~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 377 --KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred --hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 111111222244556777788999999999999999999998776543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=341.94 Aligned_cols=246 Identities=21% Similarity=0.309 Sum_probs=198.4
Q ss_pred eeeecccCcEEEEeeeecCCcEEEEEEccccchhc---HHHHHHHHHHhhccCCCceeeeeeEEEe----CCeEEEEEEe
Q 040908 451 ANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQG---NREFVNEIGTISALQHPHLVKLYGCCIE----GNQLLLIYEY 523 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey 523 (790)
...||+|++|.||+|.+ +|+.||||++....... .+.|.+|+.+|++++|||||+++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 68899999997653332 4668899999999999999999999977 3468999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++|+|.+++.. ...++|....+++.+++.||+|||+.. +++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999943 246899999999999999999999752 37799999999999999999999999998654322
Q ss_pred cceeeccccCCCcccHHHhhc--CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMR--GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+.. . .....+. .+
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~---~---~i~~~~~-----~~- 241 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY---D---LIINKNN-----SL- 241 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH---H---HHHhcCC-----CC-
Confidence 23458899999999976 68999999999999999999999999754322211 1 1111110 01
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
..+......+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 242 ---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 ---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11222345688999999999999999999999999764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.08 Aligned_cols=265 Identities=26% Similarity=0.422 Sum_probs=203.1
Q ss_pred hcCcceeeeecccCcEEEEeeeecC-----------------CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceee
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD-----------------GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVK 506 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~-----------------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 506 (790)
.++|++.++||+|+||.||+|.+.+ +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999997532 3469999987543 333567999999999999999999
Q ss_pred eeeEEEeCCeEEEEEEeccCCChhhhhcCCc---------------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEE
Q 040908 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPE---------------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571 (790)
Q Consensus 507 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 571 (790)
+++++.+.+..++||||+++|+|.+++.... .....++|..+.+++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999884321 11235788999999999999999999885 99
Q ss_pred eccCCCCcEEecCCCCeEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh--CCC
Q 040908 572 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS--GRS 648 (790)
Q Consensus 572 HrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~ 648 (790)
||||||+|||+++++.+||+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999985543222 12233456889999999998899999999999999999997 456
Q ss_pred CCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 649 NIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 649 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
||......+ .............. .. . ...+......+.+++.+||+.+|.+||||.||.+.|++
T Consensus 241 p~~~~~~~~---~~~~~~~~~~~~~~-~~-~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQ---VIENAGEFFRDQGR-QV-Y----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHH---HHHHHHHHhhhccc-cc-c----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 665433221 12222111111110 00 0 00111234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=337.57 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=204.1
Q ss_pred hcCcceeeeecccCcEEEEeeeec----CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ......|.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457889999999999999999853 35689999987643 2334678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++... ...++|..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999432 346899999999999999999999875 999999999999999999999999987654
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
............++..|+|||++.+..++.++|||||||++||+++ |+.||......+. .. .. ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~---~~-~~~~~---- 226 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IK---AV-EDGFR---- 226 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH---HH-HCCCC----
Confidence 3222111122345678999999999999999999999999999775 9999965432211 11 11 11110
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
. ..+......+.+++..||+.+|.+||++.++.+.|+..
T Consensus 227 -~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 -L----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -C----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 11223345688899999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=345.61 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=205.8
Q ss_pred HHhcCcceeeeecccCcEEEEeee-ecCCcEEEEEEcccc---chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeE
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAK---SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 517 (790)
.-.++|.+.+.||.|+|.+|++|+ ...++++|||++.+. .....+-...|-++|.+| .||.|++|+..|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345688999999999999999999 456899999999654 122234566788999999 899999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
|+|+||+++|+|.++|. +...+++.....+|.+|+.||+|||+.| ||||||||+|||||+||++||+|||-|+
T Consensus 150 YFvLe~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999994 3357899999999999999999999986 9999999999999999999999999998
Q ss_pred ccCCCCcc----------e--eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHH
Q 040908 598 LDEEDNTH----------I--STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 598 ~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 665 (790)
.+...... . ...++||..|.+||++..+..+..+|+|+||||||+|+.|++||...++--. +.
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli-----Fq 297 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI-----FQ 297 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH-----HH
Confidence 76532211 1 1348899999999999999999999999999999999999999976543211 12
Q ss_pred HHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 666 LLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 666 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+.+.-+. .++....+.+.+|+.+.+..||.+|+|..|+.+
T Consensus 298 kI~~l~y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 298 KIQALDY------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHhcc------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 2111111 122223356778888999999999999988866
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=315.43 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=205.3
Q ss_pred cCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchh--cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQ--GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|...++||+|.||.||+|+ .+.|+.||||+++..... -.....+|++.|+.++|+||+.++++|...+.+-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467788999999999999999 567999999999765322 24678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
||+. +|+..+. .....++-..+..++.++++|++|+|++. |+||||||.|+|++++|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9986 8999884 34567899999999999999999999985 999999999999999999999999999987654
Q ss_pred CcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC------cc
Q 040908 603 NTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN------LM 675 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~ 675 (790)
.... +..+-|..|.|||.+.+ ..|+...||||.|||+.||+-|.+-|.+.++-++...+-.+..-..... +.
T Consensus 155 ~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 155 NRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred Cccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 4332 23367899999999987 4689999999999999999998766555444333222211110000111 11
Q ss_pred cc-----cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 EL-----VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ~~-----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+. +.+......-.....+.++++..++..+|.+|++++|+++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 10 0011111122234556789999999999999999999876
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=340.15 Aligned_cols=246 Identities=27% Similarity=0.419 Sum_probs=208.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+. ...+.+.+.+|+++++.++|||||.++++|....++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999844 6789999999764 33445678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+.+ +|..+|. ....+++..+..|+.++..||.|||+.. |+|||+||.|||++..+.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9988 9999993 3457999999999999999999999984 99999999999999999999999999998765
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
+..+.+.+.||+-|||||++.+..|+..+|+||+||++||+++|++||.... ...++ ..... |+.
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv---~~I~~--------d~v- 217 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLV---KSILK--------DPV- 217 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHH---HHHhc--------CCC-
Confidence 4556677899999999999999999999999999999999999999996432 11222 11111 111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.++......+.+++...+..||..|-+..+++.
T Consensus 218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 123355567788888999999999999999875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.21 Aligned_cols=259 Identities=27% Similarity=0.430 Sum_probs=203.0
Q ss_pred hcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 516 (790)
.++|++.+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.++..+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999963 235689999986532 23345688999999999 89999999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCcc----------------------------------------------------------
Q 040908 517 LLLIYEYLENNSLARALFGPEE---------------------------------------------------------- 538 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 538 (790)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999853211
Q ss_pred -------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 539 -------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 539 -------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
....++|..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1125789999999999999999999874 999999999999999999999999999865443221
Q ss_pred -eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 606 -ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 606 -~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
......++..|+|||++.+..++.++|||||||++|||++ |..||........ ...+. ..+.. .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~~----~~~~~--~------ 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKMI----KEGYR--M------ 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHHH----HhCcc--C------
Confidence 1122345678999999999999999999999999999998 8888864332211 11111 11110 0
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
..+.....++.+++.+||+.||.+||+|.||+++|+.
T Consensus 337 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 -LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0011123468899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.28 Aligned_cols=264 Identities=23% Similarity=0.398 Sum_probs=221.5
Q ss_pred HHHHHHhcCcceeeeecccCcEEEEeeeecC-CcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 439 RQIKAATNHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 439 ~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
++++-...+..+.++||.|.||.||.|+|+. .-.||||.++.+. ....+|+.|+.+|+.++|||+|+|+|+|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4455555667788999999999999999875 5679999997643 4478999999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
|+|.|||.+|+|.++|+... +..++-...+.+|.||+.||+||..+ ++|||||.++|.|+.++..+||+|||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999996543 34577778899999999999999876 59999999999999999999999999999
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
++..+.........-.+.|.|||-+....++.|+|||+|||+|||+.| |..|+...+... +.+
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq----------------VY~ 477 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYG 477 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----------------HHH
Confidence 998766554444556789999999999999999999999999999999 777875432211 223
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
++....+.+-+..++..+.+|++.||++.|.+||++.|+-+.+|....
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 333444445566677889999999999999999999999998876543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=330.87 Aligned_cols=252 Identities=26% Similarity=0.459 Sum_probs=203.2
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
++|++.+.||+|+||.||+|.+.++..+|+|.+... ......|.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468889999999999999999888889999988643 2334678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+|+|.++++.. ...++|..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999998532 235899999999999999999999885 999999999999999999999999999865432222
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
......++..|+|||++....++.++||||||+++|||++ |+.||......+. .... .. +. ....+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i---~~-~~--~~~~~~--- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMI---SR-GF--RLYRPK--- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH---HC-CC--CCCCCC---
Confidence 2222345678999999988889999999999999999999 8999865432211 1111 11 11 011111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
.....+.+++.+||+.+|.+||++.++++.|.
T Consensus 225 ----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 ----LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12346789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.83 Aligned_cols=265 Identities=29% Similarity=0.397 Sum_probs=197.8
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhh--ccCCCceeeeeeEEEeCC----eEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTIS--ALQHPHLVKLYGCCIEGN----QLLL 519 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~l 519 (790)
+..++.+.||+|+||.||||.+. ++.||||++.. +..+.|++|-++.+ .++|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34556789999999999999995 48999999965 44456777776655 568999999999977665 8999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhc------CCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE------SRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
|+||.++|+|.++|. ...++|....+|+..+++||+|||+. .+++|+|||||++||||..|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999993 35789999999999999999999975 3678999999999999999999999999
Q ss_pred CCccccCCCCcc-eeeccccCCCcccHHHhhcCC-CC-----ChhhHHHHHHHHHHHHhCCCCCcc--------ccccch
Q 040908 594 GLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGH-LT-----DKADVYSFGIVALEIVSGRSNIMC--------KTKEEK 658 (790)
Q Consensus 594 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDV~S~Gvvl~elltG~~p~~~--------~~~~~~ 658 (790)
|+|..+...... .....+||.+|||||++.+.- +. .+.||||+|.|||||+++-.-++. ..+.+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999876543322 223478999999999997642 22 268999999999999997654421 111000
Q ss_pred ---hhHHHHHHHHHhhCCcccccCCCCCCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 659 ---FYLLDWALLLKEQGNLMELVDPNLGSNV-DKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 659 ---~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
-.+-+ .+... +.+-..|.++... ....+..+.+.+..||+.||+.|-|+.=|.+++.+...
T Consensus 441 G~hPt~e~-mq~~V----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 441 GNHPTLEE-MQELV----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCCCCHHH-HHHHH----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 00000 01000 1111122222211 11456778999999999999999999888887776543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.88 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=200.1
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.|+..+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999985 578999999986532 2233467899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999999888432 2246899999999999999999999985 999999999999999999999999999865432
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||............ .... ...
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~--~~~~-~~~---------- 220 (285)
T cd05631 156 ET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV--DRRV-KED---------- 220 (285)
T ss_pred Ce--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH--HHHh-hcc----------
Confidence 21 23456999999999999999999999999999999999999999764432211100 0000 000
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPL-----MSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 717 (790)
...++......+.+++..||+.||.+||+ +.++++
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01122223456788999999999999997 677654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=331.06 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=207.1
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46789999999999999999998888899999886532 33567899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999985432 346889999999999999999999874 99999999999999999999999999987654332
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.......++..|+|||++....++.++|||||||++|||+| |+.||....... ...+. ..+. .....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~-----~~~~~ 226 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSAL----QRGY-----RMPRM 226 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCC-----CCCCC
Confidence 22233446778999999998889999999999999999998 999986433221 11111 1110 00011
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
. .....+.+++.+|++.+|++||+++++.++|+.
T Consensus 227 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 E----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 223467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.60 Aligned_cols=262 Identities=27% Similarity=0.440 Sum_probs=203.9
Q ss_pred HhcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCC
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGN 515 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 515 (790)
..++|++.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.+ +|+|||+++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 345788999999999999999873 223579999997543 23345688999999999 8999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCcc---------------------------------------------------------
Q 040908 516 QLLLIYEYLENNSLARALFGPEE--------------------------------------------------------- 538 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 538 (790)
..++||||+++|+|.++++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998843210
Q ss_pred ---------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc-eee
Q 040908 539 ---------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-IST 608 (790)
Q Consensus 539 ---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~ 608 (790)
....+++.++.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 1134788899999999999999999875 999999999999999999999999999855433221 122
Q ss_pred ccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCc
Q 040908 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVD 687 (790)
Q Consensus 609 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 687 (790)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......... ... ...+ . . +.. +
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~-----~~~-~~~~-~-~---~~~----~ 337 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF-----YKM-VKRG-Y-Q---MSR----P 337 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH-----HHH-HHcc-c-C---ccC----C
Confidence 2345678999999998899999999999999999997 99998654322111 011 0111 0 0 001 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 688 KEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 688 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.....++.+++.+||+.||.+||++.+|+++|++..
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 112356889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=342.68 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=204.4
Q ss_pred HHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc----ch-hcHHHHHHHHHHhhccC-CCceeeeeeEEEeCC
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK----SK-QGNREFVNEIGTISALQ-HPHLVKLYGCCIEGN 515 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 515 (790)
....+|.+.+.||+|.||.|+.|.. .+|..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999984 46899999977553 11 22445668999999998 999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC-CCeEEeecC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFG 594 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFG 594 (790)
..++||||+.+|+|.+++.. ..++.+..+..++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999943 467888999999999999999999985 9999999999999999 999999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhcCC-CC-ChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH-LT-DKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......... ......-
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~-----ki~~~~~ 240 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR-----KIRKGEF 240 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH-----HHhcCCc
Confidence 999874 2222345678999999999999877 76 68999999999999999999998633221111 0111111
Q ss_pred CcccccCCCCCCCCcHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLMELVDPNLGSNVDKEQ-VRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ++... ..++..++.+|+..+|.+|+++.+++.
T Consensus 241 ~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 241 K------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred c------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 11112 456788999999999999999999984
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=330.82 Aligned_cols=256 Identities=29% Similarity=0.479 Sum_probs=206.8
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..++|++.+.||+|+||.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456789999999999999999998778889999986543 3356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.... ...++|..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999995432 346899999999999999999999885 9999999999999999999999999998665332
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
.........+..|+|||++.+..++.++||||||+++|||+| |+.||........ .. .......
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~---~~~~~~~--------- 222 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV---LQ---QVDQGYR--------- 222 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH---HHHcCCC---------
Confidence 221122223468999999998899999999999999999999 9988864432111 11 0000000
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
...+......+.+++.+|++.+|.+||++.++++.|++
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 -MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01111234568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=340.63 Aligned_cols=200 Identities=26% Similarity=0.432 Sum_probs=175.4
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.+.||+|+||.||++... +|..||+|.+.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999965 68899999987542 2334679999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999842 245889999999999999999999863 5999999999999999999999999999755332
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccc
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCK 653 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~ 653 (790)
. .....||..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 23456999999999999989999999999999999999999999654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.30 Aligned_cols=265 Identities=21% Similarity=0.320 Sum_probs=202.4
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999965 57899999986542 2334568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|++++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999987765542 2246889999999999999999999874 999999999999999999999999999866443
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHH---------HHHHHhhCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDW---------ALLLKEQGN 673 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~---------~~~~~~~~~ 673 (790)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. .........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 33223345689999999999988899999999999999999999999975433221111100 000000111
Q ss_pred cccccCCCCCCC------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 LMELVDPNLGSN------VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~~~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......+..... ........+.+++..|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111111000 01113456899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=330.93 Aligned_cols=256 Identities=30% Similarity=0.521 Sum_probs=210.8
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
...+|++.+.||.|+||.||+|...++..+|+|.+..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678899999999999999999888999999999876655567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999996432 356899999999999999999999875 9999999999999999999999999998654332
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
.. .....++..|+|||++....++.++||||||+++|+|++ |+.||......+.. .... . + .
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~---~~~~---~-~---------~ 221 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY---DQIT---A-G---------Y 221 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH---HHHH---h-C---------C
Confidence 21 223446778999999998899999999999999999998 88898654322211 1111 1 0 0
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
....+......+.+++.+|++.+|.+|||+.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 011112334567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=332.02 Aligned_cols=250 Identities=34% Similarity=0.566 Sum_probs=193.2
Q ss_pred ceeeeecccCcEEEEeeeec-----CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 449 DVANKIGEGGFGPVYKGLLA-----DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 449 ~~~~~LG~G~fG~Vy~g~~~-----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++.+.||.|.||.||+|.+. .+..|+||.++... ....+.|.+|++.+++++||||++++|+|...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35689999999999999976 25689999996543 3346789999999999999999999999998888999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++|+|.++|... ....+++..+..|+.|||+||+|||+.+ ++|+||+++||++++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999999543 2357899999999999999999999974 999999999999999999999999999866322
Q ss_pred Cc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 603 NT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 603 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.. .......+...|+|||.+....++.++||||||+++|||++ |+.|+......+ +.... ..+....
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~~~~~-~~~~~~~---- 225 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------IIEKL-KQGQRLP---- 225 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------HHHHH-HTTEETT----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc-cccccce----
Confidence 22 12223457789999999999999999999999999999999 678875432211 11111 1111111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 719 (790)
.+......+.+++..||+.+|.+||+|.++++.|
T Consensus 226 -----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112345678899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.87 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=205.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
.+|++.+.||+|+||.||+|... .++.||+|.+... .....++.+|++++++++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888999999999999999965 5789999998653 333567899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999984322 346899999999999999999999875 99999999999999999999999999986654332
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.......++..|+|||++.+..++.++|||||||++|||++ |..|+......+. ..... .+ ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~-~~---------~~ 223 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLE-KG---------YR 223 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHH-CC---------CC
Confidence 22222334678999999998899999999999999999998 8888864332211 11111 11 01
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
...+......+.+++.+|++.+|++||++.+++++|+..
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111122345688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=335.87 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=202.1
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
..++|+++..||+|+||.||.|+.+ .|..+|+|++++.. ..+.+....|-.+|...++|.||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999954 69999999998753 4455678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||++||++..+|. ....|+...+..++.+++-|+.-||..| +|||||||.|+|||..|++||+||||+.-.
T Consensus 219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999993 3457888889999999999999999985 999999999999999999999999998421
Q ss_pred CC-----------------------CCc----ce-------------------eeccccCCCcccHHHhhcCCCCChhhH
Q 040908 600 EE-----------------------DNT----HI-------------------STRVAGTFGYMAPEYAMRGHLTDKADV 633 (790)
Q Consensus 600 ~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~s~ksDV 633 (790)
.. +.. .. ....+|||.|||||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 000 00 012579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCccccccch-hhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 040908 634 YSFGIVALEIVSGRSNIMCKTKEEK-FYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL 711 (790)
Q Consensus 634 ~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 711 (790)
||+|||+|||+.|.+||...+..+. ..++.|...+..... .....+..++|.+|+. ||.+|--
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999999988776554 344555433221111 1122567888889998 9999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=312.01 Aligned_cols=236 Identities=25% Similarity=0.373 Sum_probs=196.4
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|+..+.||.|+||+|..++.+ +|..+|+|++.+..- .+.+...+|..+|+.+.||+++++.+.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999954 688999999976532 23455778999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||++||.|..+++ ...+++.+.+.-+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999994 3357899999999999999999999985 99999999999999999999999999997654
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
. +-+.+||+.|+|||++....+...+|.|||||++|||+.|.+||...+..... .+ ++...
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY-----~K----------I~~~~ 257 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY-----EK----------ILEGK 257 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH-----HH----------HHhCc
Confidence 3 35588999999999999999999999999999999999999999876542221 11 11111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNR 709 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 709 (790)
+ .++.-...++.+|+...++.|-.+|
T Consensus 258 v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 V--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred c--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1 1233333456677777888887777
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.00 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=215.2
Q ss_pred HHhcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC-----e
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN-----Q 516 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 516 (790)
...++|++.+.||+|||.-||.+. ..++..+|+|++...+.++.+..++|++.-++++|||++++++++..+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999998 6678899999998888788889999999999999999999999876443 4
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.|++++|...|+|.+.+......+..+++.+.+.|+.+|++||++||+.. ++++||||||.|||+.+++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999999766666678999999999999999999999985 58999999999999999999999999998
Q ss_pred cccCCCCcc--------eeeccccCCCcccHHHhh---cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHH
Q 040908 597 KLDEEDNTH--------ISTRVAGTFGYMAPEYAM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 597 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 665 (790)
+...-.... .......|..|.|||.+. +...++++|||||||+||+|+.|..||+......
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-------- 248 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-------- 248 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC--------
Confidence 754321110 011234789999999885 3467889999999999999999999997543211
Q ss_pred HHHHhhCCcc-cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 666 LLLKEQGNLM-ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 666 ~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
+.+. .+..+.+...-.....+.+.+++.+|++.||.+||+..+++..++..
T Consensus 249 ------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 ------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111 11122222111223567889999999999999999999999988754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=335.86 Aligned_cols=248 Identities=27% Similarity=0.416 Sum_probs=206.8
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..|...++||+|.||.||||.. ..++.||+|++.... .....++++|+.+|.+++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566778999999999999995 468899999997653 44467789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
|.+|++.+.|. ....+++....-|+.++..||.|||++. .+|||||+.|||+..+|.+||+|||.+.......
T Consensus 93 ~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999993 2344577778889999999999999985 9999999999999999999999999998776655
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
... .+++||+-|||||++....|+.|+||||||++.+||++|.+|+....+. ++.-++.....
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~P 228 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAP 228 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCC
Confidence 443 6688999999999999889999999999999999999999998643221 12222222222
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+......+.+++..|++.+|+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2222344556889999999999999999999875
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=341.40 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=203.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999965 58899999987542 223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999942 346889999999999999999999885 99999999999999999999999999985543
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhh-HHHHHHHHHhhCCcccccCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY-LLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~ 680 (790)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... +..|. ..+..
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------~~~~~ 219 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK----------ETLQR 219 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc----------ccccC
Confidence 2234569999999999999999999999999999999999999997544322211 11110 00110
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
............++.+++..|++.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000011234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.01 Aligned_cols=257 Identities=30% Similarity=0.493 Sum_probs=205.4
Q ss_pred cCcceeeeecccCcEEEEeeeecC------CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLAD------GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......|.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998532 2579999986543 233467899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC
Q 040908 519 LIYEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 586 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 586 (790)
++|||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999854211 1145888999999999999999999985 99999999999999999
Q ss_pred CeEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHH
Q 040908 587 NPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDW 664 (790)
Q Consensus 587 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 664 (790)
.+||+|||+++....... .......+++.|+|||++....++.++|||||||++|||++ |+.||......+. ...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~---~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV---IEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH
Confidence 999999999985533221 22233456889999999998899999999999999999998 9999875433221 111
Q ss_pred HHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 665 ALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 665 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
...+.. ...+......+.+++.+||+.+|.+||++.||++.|+.
T Consensus 239 ----i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ----IRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 011111 11223345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.45 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=202.6
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
++|++.+.||+|+||.||+|...++..+|+|.+.... ....+|.+|+.++.+++||||+++++++...+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4678899999999999999998777789999987533 334678999999999999999999999999889999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+|+|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||.++........
T Consensus 83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999998432 236899999999999999999999885 999999999999999999999999999865433222
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
......++..|+|||++....++.++|||||||++|||++ |+.||........ .... ..+... .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~~-----~--- 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEKV----SQGLRL-----Y--- 221 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH----hcCCCC-----C---
Confidence 2222346678999999998889999999999999999999 9999864332211 1110 111100 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
.+......+.+++..||+.+|.+||++.++++.|+
T Consensus 222 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 -RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112356789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=334.84 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=198.5
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999965 68899999986432 223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999842 346889999999999999999999985 99999999999999999999999999986543
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ... ..+..
T Consensus 154 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~------~~i-~~~~~------- 215 (291)
T cd05612 154 RT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY------EKI-LAGKL------- 215 (291)
T ss_pred Cc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-HhCCc-------
Confidence 21 2356899999999999888999999999999999999999999754322111 110 11110
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPL-----MSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 717 (790)
.++......+.+++.+|++.||.+||+ +.|+++
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 111122346788999999999999995 666553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=353.92 Aligned_cols=252 Identities=20% Similarity=0.281 Sum_probs=203.7
Q ss_pred CcceeeeecccCcEEEEeeeec-C-CcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-D-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
.|.+.+.||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++|||||+++++|...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999843 3 6788888876555555567888999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++|+|.+++........++++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988543334457889999999999999999999874 99999999999999999999999999986544322
Q ss_pred -ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 605 -HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 605 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ... .+.. ++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~---~---~~~-~~~~----~~--- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM---Q---QVL-YGKY----DP--- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---HHH-hCCC----CC---
Confidence 2234467999999999999999999999999999999999999999654322111 1 100 1111 00
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+......+.+++..||+.+|.+||++.+++.
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11122346788999999999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.34 Aligned_cols=267 Identities=26% Similarity=0.376 Sum_probs=202.5
Q ss_pred HHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhh--ccCCCceeeeeeEEEeC----Ce
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTIS--ALQHPHLVKLYGCCIEG----NQ 516 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~----~~ 516 (790)
....+..+.+.||+|.||+||+|.|. |..||||++... +++.+.+|.++.+ .++|+||+.+++.-..+ .+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 45678899999999999999999995 678999999643 3455667777765 45999999999987654 36
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhh-----cCCCcEEeccCCCCcEEecCCCCeEEe
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE-----ESRLKIVHRDIKATNVLLDKDLNPKIS 591 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-----~~~~~iiHrDlk~~NILl~~~~~~kl~ 591 (790)
++||.+|.++|||.|+|. +..++....++++..+|.||++||. +++|.|+|||||++|||+..++.+.|+
T Consensus 284 LwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 899999999999999993 3578999999999999999999995 578999999999999999999999999
Q ss_pred ecCCccccCCCCcc---eeeccccCCCcccHHHhhcCC----C--CChhhHHHHHHHHHHHHhC----------CCCCcc
Q 040908 592 DFGLAKLDEEDNTH---ISTRVAGTFGYMAPEYAMRGH----L--TDKADVYSFGIVALEIVSG----------RSNIMC 652 (790)
Q Consensus 592 DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--s~ksDV~S~Gvvl~elltG----------~~p~~~ 652 (790)
|+|+|.....+... .....+||-+|||||++...- + -..+||||||.|+||++.+ +.||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999765544322 223467999999999986431 1 2368999999999999863 245543
Q ss_pred ccccchhhHHHHHHHHHhhCCcccccCCCCCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 653 KTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN-VDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 653 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
..+.+.. ..+ +.+---.+-+.|.+... .+.+.+..|.+++..||..+|.-|-|+-.+-+.|.+...
T Consensus 439 ~Vp~DPs-~ee-----MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDPS-FEE-----MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCC-HHH-----HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2211110 000 00000011122333222 244778899999999999999999999999888877654
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=325.12 Aligned_cols=256 Identities=29% Similarity=0.456 Sum_probs=205.0
Q ss_pred hcCcceeeeecccCcEEEEeeeecC----CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.++|++.+.||+|+||.||+|.+.. ...||+|.+.... .....+|.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578999999999999999998642 3579999987543 3335678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++++|.+++... ...+++..+.+++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999999432 236899999999999999999999874 999999999999999999999999999876
Q ss_pred CCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 600 EEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 600 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ..... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~--- 226 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDGYR--- 226 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCCC---
Confidence 522222 1222345678999999998899999999999999999998 999985432211 11111 11100
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.+ .+......+.+++.+|++.+|++||++.||++.|++.
T Consensus 227 -~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 -LP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 1112345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.26 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=201.6
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCc----EEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGT----LIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.+|++.+.||+|+||.||+|.+. +|. .||+|++.... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999853 333 48999986543 33456789999999999999999999999864 5679
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999532 345889999999999999999999875 999999999999999999999999999876
Q ss_pred CCCCccee-eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 600 EEDNTHIS-TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 600 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
........ ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+ +..........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~--- 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERL--- 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHhCCCCC---
Confidence 54333221 22334678999999999999999999999999999998 999986432211 11111111110
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
..+......+.+++..||+.+|.+||++.+++..|.....
T Consensus 231 -------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0011123457889999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=345.04 Aligned_cols=262 Identities=25% Similarity=0.383 Sum_probs=205.3
Q ss_pred HhcCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccch-hcHHHHHHHHHHhhccC-CCceeeeeeEEEeCC
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQ-HPHLVKLYGCCIEGN 515 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 515 (790)
..++|.+.++||+|+||.||+|+.. .+..||||++..... ...+.|.+|+.+++++. ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3568889999999999999999842 134699999975433 23457899999999996 999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCcc---------------------------------------------------------
Q 040908 516 QLLLIYEYLENNSLARALFGPEE--------------------------------------------------------- 538 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 538 (790)
..++||||+++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998854211
Q ss_pred -----------------------------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec
Q 040908 539 -----------------------------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD 583 (790)
Q Consensus 539 -----------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 583 (790)
....+++..+..++.|+++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0124788899999999999999999874 99999999999999
Q ss_pred CCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhH
Q 040908 584 KDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYL 661 (790)
Q Consensus 584 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 661 (790)
+++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--
Confidence 9999999999999865432221 1223457788999999998899999999999999999997 88888653322111
Q ss_pred HHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 662 LDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 662 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.. . ...+. ....+......+.+++.+||+.+|++||++.+|+++|+...
T Consensus 350 ~~---~-~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 YN---K-IKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HH---H-HhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 00 0 01110 00111233457889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.90 Aligned_cols=244 Identities=21% Similarity=0.323 Sum_probs=198.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999965 58899999986532 223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999842 346788899999999999999999985 99999999999999999999999999986543
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ... ..+.+ .
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-----~~i--~~~~~------~ 233 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-----EKI--LAGRL------K 233 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-----HHH--hcCCc------C
Confidence 22 2356999999999999989999999999999999999999999654321110 000 11111 0
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPL-----MSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 717 (790)
. +......+.+++..||+.||.+||+ +.+++.
T Consensus 234 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 F----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 1112345778999999999999997 566543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.88 Aligned_cols=263 Identities=23% Similarity=0.399 Sum_probs=194.1
Q ss_pred cCcceeeeecccCcEEEEeeee-c-CCcEEEEEEccccch--hcHHHHHHHHHHhhcc---CCCceeeeeeEEEe-----
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-A-DGTLIAVKQLSAKSK--QGNREFVNEIGTISAL---QHPHLVKLYGCCIE----- 513 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----- 513 (790)
++|++.+.||+|+||.||+|.. . +++.||+|++..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4789999999999999999985 3 468899998865322 2234566777777665 69999999999862
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
....++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 346899999997 58998885322 245899999999999999999999985 999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhh-HHHHHHHHHhhC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY-LLDWALLLKEQG 672 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~ 672 (790)
|+++..... .......||+.|+|||++....++.++|||||||++|||++|+.||......+... +.+.... ....
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~-~~~~ 231 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGEE 231 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC-CChh
Confidence 999865433 12234568999999999998899999999999999999999999997654322211 1110000 0000
Q ss_pred Cc-------ccccCCCCCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NL-------MELVDPNLGS---NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~-------~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. .....+.... .........+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 0000000000 000122345778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=330.65 Aligned_cols=264 Identities=21% Similarity=0.319 Sum_probs=198.7
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999854 68899999986543 22345678999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 985 89888842 2245788999999999999999999885 9999999999999999999999999997543322
Q ss_pred cceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH-----H----HhhCC
Q 040908 604 THISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL-----L----KEQGN 673 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~----~~~~~ 673 (790)
. ......|++.|+|||++.+ ..++.++||||+||++|||+||+.||......+.......... . .....
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1 1233468999999999875 5689999999999999999999999976543332211100000 0 00000
Q ss_pred cccccCCCCCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 LMELVDPNLGSNV----DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......+...... ......++.+++..|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111110000 0012345788999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.27 Aligned_cols=241 Identities=24% Similarity=0.306 Sum_probs=194.8
Q ss_pred eeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCC
Q 040908 452 NKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 527 (790)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468899999987542 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCccee
Q 040908 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 607 (790)
Q Consensus 528 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 607 (790)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence 99999842 346899999999999999999999985 99999999999999999999999999975322221 22
Q ss_pred eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCc
Q 040908 608 TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVD 687 (790)
Q Consensus 608 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 687 (790)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ... ..+. .. ++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~~----~~~~------~~----~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELI----LMEE------IR----FP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH---HHH----HcCC------CC----CC
Confidence 3456999999999999999999999999999999999999999654322111 100 0011 11 11
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 688 KEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 688 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
.....++.+++..|++.||.+|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 22345678899999999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.78 Aligned_cols=264 Identities=27% Similarity=0.425 Sum_probs=202.0
Q ss_pred cCcceeeeecccCcEEEEeeee-----cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEe--CCeEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIE--GNQLL 518 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 518 (790)
++|++.+.||+|+||.||+|.. .++..||+|++........+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788899999999999999974 2578999999877666666789999999999999999999998754 34689
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++|+|.+++... ...++|..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999432 346899999999999999999999885 99999999999999999999999999986
Q ss_pred cCCCCccee--eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC----
Q 040908 599 DEEDNTHIS--TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG---- 672 (790)
Q Consensus 599 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---- 672 (790)
......... ....++..|+|||++.+..++.++|||||||++|||++|..++...... +........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 230 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMMGNDKQGQM 230 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhccccccccc
Confidence 654332211 1122445699999999888999999999999999999987765432110 000000000
Q ss_pred ---CcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 673 ---NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 673 ---~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.+.+.+........+.....++.+++.+||+.+|++|||+.||++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00001111100011112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.46 Aligned_cols=251 Identities=26% Similarity=0.440 Sum_probs=201.2
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
.+|++.+.||+|+||.||+|...++..+|+|.+.... .....|.+|++++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577889999999999999998777789999986432 234578899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+++|.+++... ...++|..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999998532 236899999999999999999999985 999999999999999999999999999865432222
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
......++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. . ... .+ ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~---~~~-~~-----~~~---- 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---E---SVS-AG-----YRL---- 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---H---HHH-cC-----CcC----
Confidence 1222234568999999998899999999999999999999 78888644322111 1 000 01 011
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 719 (790)
..+......+.+++.+||+.+|++||+|.|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11112345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=328.73 Aligned_cols=257 Identities=28% Similarity=0.500 Sum_probs=205.8
Q ss_pred hcCcceeeeecccCcEEEEeeeecC------CcEEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD------GTLIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~------g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
.++|.+.+.||+|+||.||+|...+ +..||+|.++..... ..+.|.+|++++++++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999998533 478999998765444 456899999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCc----------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC
Q 040908 518 LLIYEYLENNSLARALFGPE----------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 587 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 587 (790)
++||||+++++|.+++.... .....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999995431 12345789999999999999999999885 999999999999999999
Q ss_pred eEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHH
Q 040908 588 PKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 588 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 665 (790)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ ..+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH
Confidence 99999999975432221 11223446789999999999999999999999999999999 999986543322 11111
Q ss_pred HHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 666 LLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 666 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
. .+.... .+......+.+++..||+.+|.+||++.||++.|+
T Consensus 238 ~----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T----QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 111111 11123456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.66 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=203.7
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN 515 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 515 (790)
.++++|++.+.||+|+||.||+|... .+..||+|++.... .....+|.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999998743 24679999986432 233457899999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCccc------cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeE
Q 040908 516 QLLLIYEYLENNSLARALFGPEEH------RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 589 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 589 (790)
..++||||+++|+|.+++...... ...++|..+..++.|++.||+|||+.+ ++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 999999999999999998532211 234688899999999999999999874 99999999999999999999
Q ss_pred EeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHH
Q 040908 590 ISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 590 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 667 (790)
|+|||+++........ ......+++.|+|||++.++.++.++|||||||++|||++ |..||....... ...+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~--- 233 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRF--- 233 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---
Confidence 9999999755432221 1122345788999999998899999999999999999999 688886443221 1111
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
........ .+......+.+++.+|++.+|++||++.|+++.|++
T Consensus 234 -~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 -VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -HHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 111233568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=323.40 Aligned_cols=254 Identities=30% Similarity=0.494 Sum_probs=203.6
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
.++|++.+.||+|+||.||+|...++..||+|.+..... ....|.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357888999999999999999988888899999875332 3467899999999999999999999885 45689999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999995432 245899999999999999999999885 99999999999999999999999999986544332
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.......++..|+|||++....++.++||||||+++|||++ |+.||......+ ...+ ... + ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~---~~~-~---------~~ 221 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQ---VER-G---------YR 221 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH---HHc-C---------CC
Confidence 22222345678999999988899999999999999999999 888886433211 1111 110 1 01
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
...+......+.+++.+|++.+|.+|||+.++.++|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=336.45 Aligned_cols=262 Identities=27% Similarity=0.457 Sum_probs=217.9
Q ss_pred HHHHHhcCcceeeeecccCcEEEEeeeecC---Cc--EEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEe
Q 040908 440 QIKAATNHFDVANKIGEGGFGPVYKGLLAD---GT--LIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~---g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
+.+...+.....++||.|-||.||+|++.+ |. .||||..+.+ ..+..+.|+.|..+|++++|||||+++|.|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 344445555667899999999999999543 32 5899998774 45556789999999999999999999999986
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
...++|||.++-|.|..+|.. ++..++......++.||+.||+|||+. +++||||..+|||+...-.+|++||
T Consensus 463 -~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred -cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence 568999999999999999953 345788899999999999999999998 5999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
|+++.++++..+..++..-++.|||||.+.-.+++.+||||.|||.+||++. |..||......+
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------------- 600 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------------- 600 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------------
Confidence 9999998877766666667889999999999999999999999999999887 999997543221
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 673 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
+.-.+...-+-..++.++..+..++.+||..+|.+||++.|+...|.....
T Consensus 601 -VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 601 -VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 112222222334455677788999999999999999999999998877654
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=322.94 Aligned_cols=255 Identities=29% Similarity=0.473 Sum_probs=204.5
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
.++|++.++||+|+||.||+|...++..||+|++.... .....|.+|+.++++++|+||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 45789999999999999999998777789999987532 234678999999999999999999998754 5679999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++|+|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999532 2245799999999999999999999875 99999999999999999999999999986654332
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.......++..|+|||+..+..++.++|||||||++|||+| |+.||......+... .. ..+. .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~------~~-~~~~---------~ 221 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD------QV-ERGY---------R 221 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH------HH-hcCC---------C
Confidence 22223446778999999988899999999999999999999 788886443221110 00 0000 0
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.....+....+.+++.+|++.+|++||++.+++++|++.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 111223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=329.06 Aligned_cols=261 Identities=28% Similarity=0.492 Sum_probs=207.9
Q ss_pred hcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
.++|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35788999999999999999974 234568999987766555678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCc---------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeE
Q 040908 519 LIYEYLENNSLARALFGPE---------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 589 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 589 (790)
+||||+++++|.+++.... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999985322 12235899999999999999999999885 99999999999999999999
Q ss_pred EeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHH
Q 040908 590 ISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 590 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 667 (790)
|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||......+. ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~~--- 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IEC--- 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH---
Confidence 999999985543221 11223446788999999998889999999999999999999 8888864432211 110
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
...+.... ... .....+.+++.+||+.+|.+||++.||.+.|+....
T Consensus 235 -i~~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 -ITQGRVLQ-----RPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -HHcCCcCC-----CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11111111 111 123468899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=328.04 Aligned_cols=260 Identities=27% Similarity=0.489 Sum_probs=208.6
Q ss_pred cCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999742 345799999876665556789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCc------------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC
Q 040908 520 IYEYLENNSLARALFGPE------------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 587 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 587 (790)
||||+++++|.+++.... .....++|..++.++.||+.||+|||+.+ ++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985322 11235899999999999999999999885 999999999999999999
Q ss_pred eEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHH
Q 040908 588 PKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 588 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 665 (790)
++|+|||+++....... .......++..|+|||++....++.++|||||||++|||+| |+.||......+ ..+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence 99999999975543221 12233456789999999998899999999999999999999 999986543222 1111
Q ss_pred HHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 666 LLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 666 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
...+...+. .......+.+++.+||+.+|.+||++.+|+++|+....
T Consensus 238 ---~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ---ITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111 11234568899999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=326.59 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=202.7
Q ss_pred cCcceeeeecccCcEEEEeeee-----cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
++|++.+.||+|+||.||+|.. .++..||+|.+.... .+....|.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999984 245789999997533 3344678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCcc-------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC
Q 040908 520 IYEYLENNSLARALFGPEE-------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 586 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 586 (790)
||||+++++|.+++..... ....+++.+...++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999842211 1235789999999999999999999985 99999999999999999
Q ss_pred CeEEeecCCccccCCCC-cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHH
Q 040908 587 NPKISDFGLAKLDEEDN-THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDW 664 (790)
Q Consensus 587 ~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 664 (790)
.+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||........ ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH
Confidence 99999999998553322 112233446778999999988889999999999999999999 8888864332111 111
Q ss_pred HHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 665 ALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 665 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
. ...... ..+......+.+++.+|++.+|.+||++.++.+.|..
T Consensus 239 ~----~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V----RKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 111111 1111223567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.01 Aligned_cols=260 Identities=22% Similarity=0.364 Sum_probs=207.9
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|.. .+++.||||.+... .......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999995 46899999987542 2233456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.........+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988543333456888999999999999999999874 99999999999999999999999999986544
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
.... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..+...... ...+.
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~~~------~~~~~ 227 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQKIEQ------CDYPP 227 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHHHhc------CCCCC
Confidence 3221 123458889999999998889999999999999999999999986432211 111111111 01111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
. ........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 228 ~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 1223446788999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=337.49 Aligned_cols=245 Identities=23% Similarity=0.300 Sum_probs=198.4
Q ss_pred hcCcceeeeecccCcEEEEeeeecC--CcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD--GTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~--g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.++|++.+.||+|+||.||+|...+ +..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578999999999999999998543 3689999986532 2334568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999942 246889999999999999999999985 999999999999999999999999999865
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ... ..+..
T Consensus 182 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-----~~i--~~~~~----- 245 (340)
T PTZ00426 182 DTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY-----QKI--LEGII----- 245 (340)
T ss_pred CCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH-----HHH--hcCCC-----
Confidence 4322 2356999999999999888999999999999999999999999754322111 111 11110
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
.++......+.+++..|++.+|.+|+ ++.++++
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 01111234567889999999999995 7887764
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=327.89 Aligned_cols=266 Identities=28% Similarity=0.384 Sum_probs=201.9
Q ss_pred cceeeeecccCcEEEEeeee-----cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeEEE
Q 040908 448 FDVANKIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEG--NQLLL 519 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 519 (790)
|++.+.||+|+||.||.+.+ .++..||+|.+.... ......|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999987652 357789999987543 23456788999999999999999999998754 45899
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999832 35899999999999999999999885 999999999999999999999999999866
Q ss_pred CCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 600 EEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 600 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
...... ......++..|+|||++....++.++||||||+++|||+||+.|+....... .....+.........+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhh
Confidence 543221 1122345667999999988889999999999999999999999986432110 0011111000000111112
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
++.......+......+.+++..||+.+|++||++++++++|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 222111112223446788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=338.89 Aligned_cols=243 Identities=25% Similarity=0.386 Sum_probs=204.7
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc---chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK---SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 518 (790)
.-++|.+.+.||+|.||.|+.+..+ +++.+|||++++. ..+..+..+.|.+++... +||.+++++.+|...++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578999999999999999999965 5789999999876 344556678888888777 5999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+.||++..+. +...+++..+.-+|..|+.||+|||+++ ||+||||..|||||.+|++||+|||+++.
T Consensus 446 fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 999999999955444 3357899999999999999999999986 99999999999999999999999999985
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
.-.... .+++++||+.|||||++.+..|+...|.|||||+||||+.|..||.++++++.+.-+- .-
T Consensus 518 ~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~-------------~d 583 (694)
T KOG0694|consen 518 GMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV-------------ND 583 (694)
T ss_pred cCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-------------cC
Confidence 432222 4567999999999999999999999999999999999999999998877666543221 01
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
| ..++.....+.++++.+.+..+|++|--+
T Consensus 584 ~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 E----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 12344556677888999999999999977
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=335.14 Aligned_cols=200 Identities=25% Similarity=0.444 Sum_probs=174.4
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.++||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++|+||++++++|...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999965 67889999886542 2334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++|+|.+++.. ...+++..+..++.+++.||+|||+.+ +++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999842 245888999999999999999999753 5999999999999999999999999999754332
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccc
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCK 653 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~ 653 (790)
......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123356899999999999888999999999999999999999999654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.02 Aligned_cols=242 Identities=21% Similarity=0.298 Sum_probs=193.1
Q ss_pred ecccCcEEEEeeeec-CCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCCh
Q 040908 454 IGEGGFGPVYKGLLA-DGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL 529 (790)
Q Consensus 454 LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 529 (790)
||+|+||.||+|... +++.||+|++... .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999964 5789999998653 233345688999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeec
Q 040908 530 ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609 (790)
Q Consensus 530 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 609 (790)
.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccc
Confidence 999842 246899999999999999999999985 99999999999999999999999999985433222 2234
Q ss_pred cccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHH
Q 040908 610 VAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKE 689 (790)
Q Consensus 610 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 689 (790)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ..... .+. . .++..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~-~~~------~----~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKIL-QEP------L----RFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHH-cCC------C----CCCCc
Confidence 6799999999999999999999999999999999999999975432111 11111 010 0 11122
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 690 QVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 690 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
....+.+++..|++.||.+||++.++.+.|+
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 3346788999999999999987544444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=346.33 Aligned_cols=259 Identities=21% Similarity=0.283 Sum_probs=210.3
Q ss_pred hcCcceeeeecccCcEEEEeeeecCC-cEEEEEEccccchhcHHHHHHHHHHhhccC-CCceeeeeeE-EEe------CC
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADG-TLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPHLVKLYGC-CIE------GN 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~------~~ 515 (790)
..++++.+.|.+|||+.||.|....+ ..+|+|++........+...+||++|++|+ |+|||.+++. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34667889999999999999997765 999999998877788889999999999996 9999999993 321 13
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
+.+|.||||++|.|.|++..+.. ..|++.++++|+.++++|+++||.. +++|||||||-+||||+.+++.||||||-
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 67999999999999999954333 4499999999999999999999987 58999999999999999999999999999
Q ss_pred ccccCCCC--cc-e-----eeccccCCCcccHHHh---hcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHH
Q 040908 596 AKLDEEDN--TH-I-----STRVAGTFGYMAPEYA---MRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDW 664 (790)
Q Consensus 596 a~~~~~~~--~~-~-----~~~~~gt~~y~aPE~~---~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 664 (790)
|.-.-... .. . .-...-|+.|+|||++ .+..+++|+|||+|||+||-|+....||+....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------- 263 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------- 263 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence 86321111 10 0 0113468999999987 456889999999999999999999999974321
Q ss_pred HHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcCC
Q 040908 665 ALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGV 725 (790)
Q Consensus 665 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 725 (790)
..+++......-...+...|.+||..||+.+|.+||++.+|+..+..+...
T Consensus 264 ----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 ----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 123333333222346788999999999999999999999999887665543
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=327.64 Aligned_cols=259 Identities=31% Similarity=0.452 Sum_probs=203.5
Q ss_pred CcceeeeecccCcEEEEeeeec------CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
+|++.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+.+++.++||||++++++|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 235789998865432 334678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCc--------------------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCc
Q 040908 520 IYEYLENNSLARALFGPE--------------------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATN 579 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~N 579 (790)
|+||+.+|+|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885321 11235889999999999999999999874 9999999999
Q ss_pred EEecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccc
Q 040908 580 VLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEE 657 (790)
Q Consensus 580 ILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~ 657 (790)
||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999855332221 1223346778999999988889999999999999999999 999886443221
Q ss_pred hhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 658 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
+..+ ...+. .. ..+......+.+++..|++.+|.+||++.|+++.|++...
T Consensus 238 ---~~~~----~~~~~-----~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ---LFNL----LKTGY-----RM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HHHH----HhCCC-----CC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1111 11110 01 1111233568899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=336.75 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=203.1
Q ss_pred hcCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEe-CC
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIE-GN 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~ 515 (790)
.++|++.+.||+|+||.||+|... .++.||+|++.... ....+.+..|+.++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457899999999999999999632 24789999987543 23345678899999999 89999999998865 45
Q ss_pred eEEEEEEeccCCChhhhhcCCcc---------------------------------------------------------
Q 040908 516 QLLLIYEYLENNSLARALFGPEE--------------------------------------------------------- 538 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 538 (790)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999998843211
Q ss_pred ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce-eeccccCCCcc
Q 040908 539 HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI-STRVAGTFGYM 617 (790)
Q Consensus 539 ~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~ 617 (790)
....++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0136899999999999999999999874 9999999999999999999999999998654332221 22345678899
Q ss_pred cHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHH
Q 040908 618 APEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMIN 696 (790)
Q Consensus 618 aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 696 (790)
|||++.+..++.++|||||||++|||++ |+.||......+. ..... ..+.. . ..+.....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-----~~~~~-~~~~~-~--------~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-----FCRRL-KEGTR-M--------RAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-----HHHHH-hccCC-C--------CCCccCCHHHHH
Confidence 9999999999999999999999999998 9999864322211 11111 11110 0 111123356889
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 697 VALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 697 l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
++.+||+.+|++||++.||++.|+...
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=321.39 Aligned_cols=255 Identities=33% Similarity=0.515 Sum_probs=205.3
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..++|++.++||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 356789999999999999999998889999999987543 33467899999999999999999999874 4568999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999985432 346899999999999999999999875 9999999999999999999999999998665333
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
........++..|+|||++....++.++||||||+++|||++ |+.||......+. .. .. ..+. ...
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~---~~-~~~~-----~~~- 223 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ---NL-ERGY-----RMP- 223 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH---HH-HcCC-----CCC-
Confidence 222233446788999999988889999999999999999999 9999965432211 11 11 1110 001
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.+.....++.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 ---RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111223468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.39 Aligned_cols=259 Identities=21% Similarity=0.250 Sum_probs=196.1
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..+|++.+.||+|+||.||++.. ..++.||+|.... ..+.+|+.++++++|||||++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35799999999999999999985 4688999997532 3467899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+. ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 85 688888732 246889999999999999999999985 9999999999999999999999999997543322
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchh--hHHHHHHHHHhhCC--------
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF--YLLDWALLLKEQGN-------- 673 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~-------- 673 (790)
........||+.|+|||++.+..++.++|||||||++|||+||+.|+......... ............+.
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22234467999999999999989999999999999999999999887543211000 00000000000000
Q ss_pred ----ccc---------ccCCCCCCCC--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 ----LME---------LVDPNLGSNV--DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ----~~~---------~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+.+ ...+...... ......++.+++.+|++.||.+|||+.|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000000000 0123457889999999999999999999875
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.50 Aligned_cols=239 Identities=26% Similarity=0.371 Sum_probs=189.7
Q ss_pred cceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHh---hccCCCceeeeeeEEEeCCeEEEE
Q 040908 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTI---SALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
|++.+.||+|+||.||+|... +|+.||||+++... ....+.+..|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999854 68999999987542 22234566666554 567899999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++|+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988832 36899999999999999999999885 9999999999999999999999999987433
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... +. .
T Consensus 153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~i~~-~~------~ 218 (324)
T cd05589 153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DSIVN-DE------V 218 (324)
T ss_pred CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-CC------C
Confidence 2221 223467999999999999989999999999999999999999999754322211 11100 11 0
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
.. +......+.+++.+|++.||.+||++
T Consensus 219 ~~----p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 219 RY----PRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 11 11223457889999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=350.58 Aligned_cols=259 Identities=21% Similarity=0.295 Sum_probs=205.6
Q ss_pred HHHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC-
Q 040908 440 QIKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN- 515 (790)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~- 515 (790)
+.+...++|.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+..+..++|+|++++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3444567999999999999999999984 57899999998653 2334567889999999999999999988775432
Q ss_pred -------eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCe
Q 040908 516 -------QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 588 (790)
Q Consensus 516 -------~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 588 (790)
..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 368999999999999999654444467899999999999999999999974 9999999999999999999
Q ss_pred EEeecCCccccCCCC-cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH
Q 040908 589 KISDFGLAKLDEEDN-THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 589 kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 667 (790)
||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHH
Confidence 999999998654322 1223346799999999999999999999999999999999999999975432211 111
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. .+.. + ..+.....++.+++..||+.+|.+||++.++++
T Consensus 257 ~~-~~~~----~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 257 TL-AGRY----D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred Hh-cCCC----C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 10 1111 1 111223456889999999999999999999976
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.83 Aligned_cols=247 Identities=27% Similarity=0.424 Sum_probs=198.3
Q ss_pred eeecccCcEEEEeeeecCCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCChh
Q 040908 452 NKIGEGGFGPVYKGLLADGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLA 530 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 530 (790)
+.||+|+||.||+|...+++.+|+|.+..... .....|.+|++++++++||||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999876543 23456889999999999999999999999999999999999999999
Q ss_pred hhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeecc
Q 040908 531 RALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 610 (790)
Q Consensus 531 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 610 (790)
+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 998432 245789999999999999999999875 99999999999999999999999999975443222212223
Q ss_pred ccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHH
Q 040908 611 AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKE 689 (790)
Q Consensus 611 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 689 (790)
.++..|+|||++..+.++.++||||||+++||+++ |..||......... . ....+.. ...+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~---~----~~~~~~~---------~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---E----QVEKGYR---------MSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH---H----HHHcCCC---------CCCCCC
Confidence 45678999999998899999999999999999998 99898644322111 0 0111110 011112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 690 QVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 690 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
....+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=336.08 Aligned_cols=263 Identities=21% Similarity=0.357 Sum_probs=194.7
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-----CeEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG-----NQLL 518 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 518 (790)
+|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999995 46899999998643 222345688999999999999999999988643 2579
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+. ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 689888832 246899999999999999999999985 99999999999999999999999999985
Q ss_pred cCCCCc--ceeeccccCCCcccHHHhhc--CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHH---------HH
Q 040908 599 DEEDNT--HISTRVAGTFGYMAPEYAMR--GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLD---------WA 665 (790)
Q Consensus 599 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~ 665 (790)
...... .......||..|+|||++.+ ..++.++|||||||++|||+||+.||............. +.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432221 11234579999999999875 678999999999999999999999996543221111000 00
Q ss_pred HHHH--hhCCcccccCCCCCCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 666 LLLK--EQGNLMELVDPNLGSNVD---KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 666 ~~~~--~~~~~~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.... ........+.+....... ......+.+++..|++.+|++||++.|+++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 000000000000000000 012345788999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.93 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=209.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999965 7899999988642 2233567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.........+++.++..++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998544344456899999999999999999999875 99999999999999999999999999886543
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
.... .....++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+..... ..+.. +.
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~~-----~~ 227 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-EKCDY-----PP 227 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhh-hcCCC-----CC
Confidence 3221 22345889999999999888999999999999999999999998643211 11111110 01111 01
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
. ........+.+++.+||+.+|++||++.+|+++|+..
T Consensus 228 ~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 L---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 1113445688999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=334.06 Aligned_cols=241 Identities=27% Similarity=0.328 Sum_probs=193.7
Q ss_pred eeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCC
Q 040908 452 NKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 527 (790)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999987542 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCccee
Q 040908 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 607 (790)
Q Consensus 528 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 607 (790)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence 99988832 346899999999999999999999885 99999999999999999999999999875322211 12
Q ss_pred eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCc
Q 040908 608 TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVD 687 (790)
Q Consensus 608 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 687 (790)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... .. ..+ +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~-----~~~--~~------~~~----p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-----ILM--EE------IRF----P 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----Hhc--CC------CCC----C
Confidence 335699999999999988999999999999999999999999965432221110 000 00 011 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 688 KEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 688 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
......+.+++..|++.||.+|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 12234677889999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=333.87 Aligned_cols=241 Identities=26% Similarity=0.319 Sum_probs=194.5
Q ss_pred eeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCC
Q 040908 452 NKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 527 (790)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999987542 233467889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCccee
Q 040908 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 607 (790)
Q Consensus 528 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 607 (790)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence 99988842 246899999999999999999999885 99999999999999999999999999875332221 22
Q ss_pred eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCc
Q 040908 608 TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVD 687 (790)
Q Consensus 608 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 687 (790)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ... .. +..+ +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~------~~~-~~------~~~~----p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE------LIL-ME------DIKF----P 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH------Hhc-cC------CccC----C
Confidence 34579999999999998899999999999999999999999996543221110 000 00 1111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 688 KEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 688 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
.....++.+++..|++.||.+|| ++.|+++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 12234678889999999999997 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.40 Aligned_cols=253 Identities=29% Similarity=0.469 Sum_probs=202.5
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688999999999999999998777789999886533 23467889999999999999999999875 456889999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+++|.+++.... ...++|..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999995432 245899999999999999999999875 999999999999999999999999999865443222
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
......++..|+|||+..+..++.++|||||||++|||+| |+.||......+. ..+. .. + . .+
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~---~~-~-~----~~---- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQV---ER-G-Y----RM---- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---Hc-C-C----CC----
Confidence 2223346778999999988899999999999999999999 8888865432211 1111 11 1 0 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
..+......+.+++.+|++.+|.+||++.+|+++|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=332.72 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=196.9
Q ss_pred CcceeeeecccCcEEEEeeee----cCCcEEEEEEccccc----hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL----ADGTLIAVKQLSAKS----KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 517 (790)
+|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999874 357899999986532 12235678899999999 599999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999842 346889999999999999999999885 9999999999999999999999999998
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
..............||+.|+|||++.+. .++.++|||||||++|||+||+.||.......... ........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~------ 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK------ 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc------
Confidence 6543333333346799999999999765 47889999999999999999999996433221111 11111000
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
.++.+.. .....+.+++.+|++.||.+|| ++.++++
T Consensus 226 -~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 -CDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -CCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1122222 2234577889999999999999 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.10 Aligned_cols=263 Identities=23% Similarity=0.370 Sum_probs=196.7
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999965 688999999875432 223467889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+. ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 578777742 2346888999999999999999999985 999999999999999999999999999754322
Q ss_pred CcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC---c---c
Q 040908 603 NTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN---L---M 675 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~---~ 675 (790)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ............. . .
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchh
Confidence 21 1233568999999999875 4578899999999999999999999975422111 0110000000000 0 0
Q ss_pred --cccCCC-CC----CCCcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 --ELVDPN-LG----SNVDK-----EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 --~~~d~~-l~----~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...++. .. ..... .....+.+++..|++.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 00 00000 01245778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.06 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=201.6
Q ss_pred hcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccch--------------hcHHHHHHHHHHhhccCCCceeeeee
Q 040908 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSK--------------QGNREFVNEIGTISALQHPHLVKLYG 509 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~g 509 (790)
-++|++.+.||+|.||.|-+|. ..+++.||+|++.+... ...+...+|+.+|++++|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 4789999999999999999999 45789999999975421 11246789999999999999999999
Q ss_pred EEEe--CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC
Q 040908 510 CCIE--GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 587 (790)
Q Consensus 510 ~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 587 (790)
+-.+ .+.+|||+|||..|.+...= .....++..++++++.++..||+|||.++ ||||||||+|+||+++|+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 9865 46899999999998775432 12223899999999999999999999986 999999999999999999
Q ss_pred eEEeecCCccccCCC----CcceeeccccCCCcccHHHhhcCC----CCChhhHHHHHHHHHHHHhCCCCCccccccchh
Q 040908 588 PKISDFGLAKLDEED----NTHISTRVAGTFGYMAPEYAMRGH----LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659 (790)
Q Consensus 588 ~kl~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~ 659 (790)
+||+|||.+...... ......+.+||+.|+|||.+.++. .+.+.||||+||+||-|+.|+-||......+.+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 999999999866322 111223478999999999998743 345789999999999999999999765432221
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040908 660 YLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719 (790)
Q Consensus 660 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 719 (790)
.+++...+......++.+++.+|+++++++||+.|.+..+|....
T Consensus 329 ---------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 329 ---------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ---------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 123333343333345677889999999999999999999987644
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=336.69 Aligned_cols=246 Identities=26% Similarity=0.416 Sum_probs=191.3
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
+|+..+.||+|+||.||+|... +|+.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4456789999999999999854 689999999865432 33467899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++|+|.+.. ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999986533 3456778889999999999999885 99999999999999999999999999986543221
Q ss_pred ceeeccccCCCcccHHHhhc-----CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 605 HISTRVAGTFGYMAPEYAMR-----GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
......||..|+|||++.. ...+.++|||||||++|||++|+.||......+ |......... . ..
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------~~~~~~~~~~-~--~~ 293 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCAICM-S--QP 293 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHHhc-c--CC
Confidence 1233569999999998743 234568999999999999999999997332221 2111111000 0 00
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+ ........++.+++.+||+.||++||++.|+++
T Consensus 294 ~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 P----EAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 111223456889999999999999999999876
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.34 Aligned_cols=260 Identities=23% Similarity=0.396 Sum_probs=208.1
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|.. .++..+|||.+.... .....++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 578999999876432 223457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++.........+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988543333456899999999999999999999875 99999999999999999999999999886544
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
.... .....|+..|+|||++.+..++.++||||||+++|||++|..||....... . .+... +.....+.
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~---~~~~~------~~~~~~~~ 227 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-Y---SLCKK------IEQCDYPP 227 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-H---HHhhh------hhcCCCCC
Confidence 3321 223468899999999988889999999999999999999999986432211 1 11111 11111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.. .......+.+++.+||+.+|++||||.+|++++++.
T Consensus 228 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 LP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 123445788999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=327.86 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=207.7
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeec------CCcEEEEEEcccc-chhcHHHHHHHHHHhhcc-CCCceeeeeeEEE
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAK-SKQGNREFVNEIGTISAL-QHPHLVKLYGCCI 512 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 512 (790)
++...++|++.+.||+|+||.||+|... ....+|+|.+... ......++.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3445678999999999999999999853 2367999998753 233345688999999999 8999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhcCCc------------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcE
Q 040908 513 EGNQLLLIYEYLENNSLARALFGPE------------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNV 580 (790)
Q Consensus 513 ~~~~~~lV~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 580 (790)
..+..++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 9999999999999999999985321 22356899999999999999999999874 99999999999
Q ss_pred EecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccch
Q 040908 581 LLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEK 658 (790)
Q Consensus 581 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~ 658 (790)
|+++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 9999999999999999865443221 1122345678999999988899999999999999999998 8888864432221
Q ss_pred hhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 659 FYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 659 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.. . ...+.. ...+......+.+++.+|++.+|.+|||+.|+++.|+..
T Consensus 244 ~~------~-~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 FK------L-LKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HH------H-HHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11 0 111110 011122345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.47 Aligned_cols=247 Identities=26% Similarity=0.408 Sum_probs=195.9
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCCh
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL 529 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 529 (790)
+.||+|+||.||+|... +++.||+|.+.... ......|.+|++++++++||||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999964 68899999876543 33456799999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCccee-e
Q 040908 530 ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-T 608 (790)
Q Consensus 530 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~ 608 (790)
.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999842 2346899999999999999999999885 99999999999999999999999999875443211110 1
Q ss_pred ccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCc
Q 040908 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVD 687 (790)
Q Consensus 609 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 687 (790)
...++..|+|||.+.++.++.++|||||||++|||++ |..|+.......... ..... .....+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-------~~~~~---------~~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-------AIEQG---------VRLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-------HHHcC---------CCCCCc
Confidence 1123467999999998899999999999999999998 888886433211110 00000 011112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 688 KEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 688 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
......+.+++.+|++.+|++||++.+|.++|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 223457888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.69 Aligned_cols=255 Identities=28% Similarity=0.434 Sum_probs=199.2
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCc----EEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGT----LIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
++|++.+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46778899999999999999863 344 477888754332 234678888889999999999999998864 55788
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
++||+++|+|.+++.. ....++|..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999953 2346899999999999999999999875 999999999999999999999999999865
Q ss_pred CCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 600 EEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 600 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
...... ......++..|+|||++..+.++.++|||||||++|||++ |+.||........ .++ ...+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~----~~~~~~--~ 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---PDL----LEKGER--L 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----HHCCCc--C
Confidence 433221 2233557789999999998899999999999999999998 9999865432221 111 111111 1
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
..+. .....+.+++..||..+|.+||++.|+++.|....
T Consensus 231 ~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 231 AQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111 12235677889999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=324.66 Aligned_cols=256 Identities=27% Similarity=0.411 Sum_probs=201.7
Q ss_pred CcceeeeecccCcEEEEeeeec------CCcEEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
+|++.+.||+|+||.||+|... +++.||+|++...... ....|.+|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4677889999999999999853 2478999999755433 24568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCc------------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC
Q 040908 520 IYEYLENNSLARALFGPE------------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 587 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 587 (790)
++||+++++|.+++.... .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999984211 11235888999999999999999999875 999999999999999999
Q ss_pred eEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHH
Q 040908 588 PKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 588 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 665 (790)
+||+|||+++....... .......+++.|+|||++..+.++.++|||||||++|||++ |..||......+ +.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------VI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------HH
Confidence 99999999886543222 12223446789999999988899999999999999999998 777876432221 11
Q ss_pred HHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 666 LLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 666 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.... .+... ..+......+.+++..||+.+|.+||++.+|++.|+.
T Consensus 237 ~~i~-~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIR-NRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHH-cCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111 11111 1122334567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=336.05 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=200.5
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||++... +|+.||+|+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999854 688999999975422 23456888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999432 246899999999999999999999985 99999999999999999999999999987654
Q ss_pred CCcceeeccccCCCcccHHHhh------cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 602 DNTHISTRVAGTFGYMAPEYAM------RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||......... ... .......
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-----~~i-~~~~~~~ 228 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY-----NNI-MNFQRFL 228 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH-----HHH-HcCCCcc
Confidence 4433334457999999999986 456788999999999999999999999754322211 111 1111111
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. + ........+.+++..|++ +|.+||++.+++.
T Consensus 229 ~~--~-----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KF--P-----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CC--C-----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11 0 011123457788889997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=340.38 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=199.3
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
..++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999854 68899999986432 2233457889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++.. ..++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999832 34777888889999999999999985 999999999999999999999999999865
Q ss_pred CCCCcceeeccccCCCcccHHHhhcC----CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRG----HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
............||+.|+|||++... .++.++|||||||++|||++|+.||........ +.........+
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~i~~~~~~~- 266 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMDHKNSL- 266 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-----HHHHHcCCCcC-
Confidence 44332222346799999999998653 478899999999999999999999975432211 11111000000
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTN--RPLMSSVVS 717 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~ 717 (790)
.+ + . ......++.+++..|++.+|.+ ||++.|+++
T Consensus 267 ~~--~---~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 TF--P---D--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CC--C---C--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 00 0 0 1122456788899999999987 999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=338.63 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=201.8
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999965 68999999987542 234567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999432 46899999999999999999999974 99999999999999999999999999986543
Q ss_pred CC----------------------------cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccc
Q 040908 602 DN----------------------------THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCK 653 (790)
Q Consensus 602 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~ 653 (790)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223456999999999999999999999999999999999999999754
Q ss_pred cccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 040908 654 TKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL-MSSVVS 717 (790)
Q Consensus 654 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~ev~~ 717 (790)
..... +......... ..-+.. . ....++.+++..|++ +|.+||+ +.|+++
T Consensus 234 ~~~~~-----~~~i~~~~~~---~~~p~~-~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 234 TLQET-----YNKIINWKES---LRFPPD-P----PVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CHHHH-----HHHHhccCCc---ccCCCC-C----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 42211 1111000000 000100 0 134567788889997 9999999 999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=318.03 Aligned_cols=256 Identities=28% Similarity=0.461 Sum_probs=203.9
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CC---cEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DG---TLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
+++|+..+.||+|+||.||+|... ++ ..+|+|.+.... ....+.+.+|++++++++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999964 33 379999987542 3335678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++++|.+++.. ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999843 2346899999999999999999999875 999999999999999999999999999865
Q ss_pred CCCCcceee--ccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 600 EEDNTHIST--RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 600 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
......... ....+..|+|||++....++.++|||||||++|||++ |+.||......+ +..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~i~~~~~~-- 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAINDGFRL-- 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhcCCCC--
Confidence 433222111 1223567999999998889999999999999999998 999986543211 11111111000
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.........+.+++.+|++.+|.+||+|.+|++.|++.
T Consensus 230 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 --------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112345678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=300.04 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=206.6
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
-++|++.+.||+|-||.||.|+. +++-.||+|++.+.. .+....+.+|+++-+.++||||.+++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 36788999999999999999995 467899999986642 23346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
+||.++|++...|..... ..++......+..|+|.||.|+|.+ +||||||||+|+|++.++..|++|||-+...+
T Consensus 101 lEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999964433 5688888999999999999999987 59999999999999999999999999988654
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
. + .....+||..|++||...+..++.+.|+|++|++.||++.|.+||......+...-+ .. .++.+|
T Consensus 176 ~-~--kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI-----~k-----~~~~~p 242 (281)
T KOG0580|consen 176 S-N--KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI-----RK-----VDLKFP 242 (281)
T ss_pred C-C--CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH-----HH-----ccccCC
Confidence 2 2 235578999999999999999999999999999999999999999866533322111 00 112222
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........+++..|+..+|.+|.+..||++
T Consensus 243 -------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 243 -------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 233446788999999999999999999876
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.16 Aligned_cols=258 Identities=28% Similarity=0.476 Sum_probs=204.3
Q ss_pred hcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
.++|...++||+|+||.||++.. .++..+|+|.+..........|.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 35677889999999999999963 235689999987766666678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCcc-----------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC
Q 040908 519 LIYEYLENNSLARALFGPEE-----------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 587 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 587 (790)
+||||+++++|.+++..... ....+++..+..++.|++.|++|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999854321 1135899999999999999999999875 999999999999999999
Q ss_pred eEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHH
Q 040908 588 PKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 588 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 665 (790)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.. .
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~-- 235 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---E-- 235 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---H--
Confidence 99999999975533221 11223345788999999998899999999999999999998 88888643322211 1
Q ss_pred HHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 666 LLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 666 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.. ..+... . .+......+.+++.+||+.||.+||++.||.+.|+.
T Consensus 236 -~~-~~~~~~-----~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 -CI-TQGREL-----E----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -HH-HcCccC-----C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 00 111100 0 111223457899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.51 Aligned_cols=256 Identities=33% Similarity=0.508 Sum_probs=206.9
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..++|++.+.||+|+||.||+|...+++.||||.+.... ....++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 457899999999999999999998888899999987533 3456789999999999999999999999988899999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.... ...+++..+..++.+++.|++|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999995432 246899999999999999999999885 9999999999999999999999999998665432
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
........++..|+|||.+.+..++.++|||||||++|||+| |+.||........ .... .. .. .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~---~~--~~----~--- 222 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQV---ER--GY----R--- 222 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---Hc--CC----C---
Confidence 222222335678999999998889999999999999999999 9999864332111 1110 00 00 0
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
...+......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111224568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.59 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=202.3
Q ss_pred HhcCcceeeeecccCcEEEEeeeecC------CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLAD------GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 516 (790)
.+++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......|..|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35679999999999999999998653 5679999886543 3334578999999999999999999999999899
Q ss_pred EEEEEEeccCCChhhhhcCCcc---ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC---CeEE
Q 040908 517 LLLIYEYLENNSLARALFGPEE---HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKI 590 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl 590 (790)
.++||||+++++|.+++..... ....++|..+.+++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999854321 1235899999999999999999999985 99999999999998754 5999
Q ss_pred eecCCccccCCCCcce-eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHH
Q 040908 591 SDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLL 668 (790)
Q Consensus 591 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 668 (790)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||......+.. . ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~---~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---E---FV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H---HH
Confidence 9999998653322111 112234568999999999999999999999999999997 99998654332211 1 11
Q ss_pred HhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 669 KEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 669 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
..... ...+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 235 ~~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111 1111223456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.51 Aligned_cols=251 Identities=25% Similarity=0.304 Sum_probs=199.7
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
+|++.+.||+|+||.||++.. .+++.||+|++..... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478899999999999999995 4688999999865321 223457889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888532 2246899999999999999999999985 999999999999999999999999999865433
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ..... ....
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~--~~~~~-~~~~---------- 220 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE--EVERR-VKED---------- 220 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH--HHHHH-hhhc----------
Confidence 22 123468999999999998899999999999999999999999997543221110 10000 0000
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
...++......+.+++..|++.||.+|| ++.++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0112223445678999999999999999 6667644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=337.95 Aligned_cols=257 Identities=20% Similarity=0.305 Sum_probs=198.9
Q ss_pred HHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC
Q 040908 440 QIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN 515 (790)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 515 (790)
++....++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 33445678999999999999999999965 57899999986432 223456789999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999999832 35788889999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhcC----CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMRG----HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ 671 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 671 (790)
++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ... ...
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~-----~~i-~~~ 262 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY-----SKI-MDH 262 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH-----HHH-HhC
Confidence 986644333223456799999999999754 3788999999999999999999999754322111 111 110
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 040908 672 GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTN--RPLMSSVVS 717 (790)
Q Consensus 672 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~ 717 (790)
..... . .........+.+++..|++.++.+ ||++.|+++
T Consensus 263 ~~~~~-----~--p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 263 KNSLN-----F--PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred CcccC-----C--CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 00000 0 011122345677788888755543 889999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=337.19 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=196.7
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999964 68999999997532 233456788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999842 246899999999999999999999985 99999999999999999999999999875422
Q ss_pred CCcc-------------------------------------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHH
Q 040908 602 DNTH-------------------------------------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIV 644 (790)
Q Consensus 602 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ell 644 (790)
.... .....+||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246999999999999999999999999999999999
Q ss_pred hCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 040908 645 SGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL---MSSVVS 717 (790)
Q Consensus 645 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~ev~~ 717 (790)
+|+.||......+.. ... ...... ...+ . .......+.+++..|+. +|.+|++ +.|+++
T Consensus 234 ~G~~Pf~~~~~~~~~---~~i--~~~~~~---~~~~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQETY---RKI--INWKET---LQFP---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHHH---HHH--HcCCCc---cCCC---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999754322211 000 000000 0000 0 00123456677788886 9999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.60 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=193.9
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588999999999999999985 467899999996542 2334578899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999843 245888899999999999999999875 999999999999999999999999997532110
Q ss_pred C----------------------------------------------cceeeccccCCCcccHHHhhcCCCCChhhHHHH
Q 040908 603 N----------------------------------------------THISTRVAGTFGYMAPEYAMRGHLTDKADVYSF 636 (790)
Q Consensus 603 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~ 636 (790)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 000123579999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCccccccchh-hHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHH--ccCCCCCCCCCHH
Q 040908 637 GIVALEIVSGRSNIMCKTKEEKF-YLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALL--CADVSPTNRPLMS 713 (790)
Q Consensus 637 Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPt~~ 713 (790)
||++|||+||+.||......+.. ....| ...+ .+ +. ....+ .++.+++.+ |+..+|..||++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~------~~~~-~~--~~-~~~~s----~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINW------ENTL-HI--PP-QVKLS----PEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcc------cccc-CC--CC-CCCCC----HHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999999764432211 11111 0000 00 00 01122 344555554 6677777899999
Q ss_pred HHHH
Q 040908 714 SVVS 717 (790)
Q Consensus 714 ev~~ 717 (790)
|++.
T Consensus 301 ~~l~ 304 (381)
T cd05626 301 DIKA 304 (381)
T ss_pred HHhc
Confidence 9976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=331.94 Aligned_cols=202 Identities=25% Similarity=0.363 Sum_probs=174.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++.+++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999854 58899999996532 223356788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999942 346899999999999999999999985 99999999999999999999999999875432
Q ss_pred CCc----------------------------------ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCC
Q 040908 602 DNT----------------------------------HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647 (790)
Q Consensus 602 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~ 647 (790)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012357999999999999999999999999999999999999
Q ss_pred CCCcccc
Q 040908 648 SNIMCKT 654 (790)
Q Consensus 648 ~p~~~~~ 654 (790)
.||....
T Consensus 234 ~Pf~~~~ 240 (363)
T cd05628 234 PPFCSET 240 (363)
T ss_pred CCCCCCC
Confidence 9997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.08 Aligned_cols=261 Identities=23% Similarity=0.376 Sum_probs=206.8
Q ss_pred HhcCcceeeeecccCcEEEEeeeecC-----CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEe-CCe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLAD-----GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIE-GNQ 516 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~-----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 516 (790)
..++|++.+.||+|+||.||+|...+ +..|++|++.... ......+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999765 6889999887542 3335668899999999999999999999876 467
Q ss_pred EEEEEEeccCCChhhhhcCCccc----cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEee
Q 040908 517 LLLIYEYLENNSLARALFGPEEH----RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 592 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 592 (790)
.++++||+++++|.+++...... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998543221 146899999999999999999999874 99999999999999999999999
Q ss_pred cCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHh
Q 040908 593 FGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKE 670 (790)
Q Consensus 593 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 670 (790)
||+++.+...... ......++..|+|||++....++.++|||||||++||+++ |+.||...... .+..+. ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~---~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYL---KD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHH---Hc
Confidence 9999865433222 1222346778999999988889999999999999999999 99998653321 111111 11
Q ss_pred hCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 671 QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 671 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.... .. .......+.+++.+||..+|++||++.++++.|+...
T Consensus 235 ~~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GYRL------AQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCCC------CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1110 01 1122346789999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.04 Aligned_cols=245 Identities=28% Similarity=0.416 Sum_probs=194.7
Q ss_pred eecccCcEEEEeeee---cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCC
Q 040908 453 KIGEGGFGPVYKGLL---ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527 (790)
Q Consensus 453 ~LG~G~fG~Vy~g~~---~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 527 (790)
.||+|+||.||+|.+ .++..+|+|+++... ....+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 357889999986543 233567899999999999999999999885 45678999999999
Q ss_pred ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCccee
Q 040908 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 607 (790)
Q Consensus 528 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 607 (790)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999842 246899999999999999999999875 99999999999999999999999999986644332211
Q ss_pred --eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 608 --TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 608 --~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
....++..|+|||.+....++.++|||||||++|||++ |+.||......+ +.... +.+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~i-~~~~~~-----~--- 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE------VTQMI-ESGERM-----E--- 218 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH-HCCCCC-----C---
Confidence 22334679999999988889999999999999999998 999986543221 11111 111111 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.+.....++.+++.+||+.+|++||++.+|+..|++
T Consensus 219 -~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 -CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111234567899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.34 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=204.5
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccchh-cHHHHHHHHHHhhccC-CCceeeeeeEEEeC
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKSKQ-GNREFVNEIGTISALQ-HPHLVKLYGCCIEG 514 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 514 (790)
...++|.+.++||+|+||.||+|++. .+..||+|+++..... ..+.+.+|+.++.++. |||||+++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456778899999999999999853 2468999999764332 2456889999999997 99999999999999
Q ss_pred CeEEEEEEeccCCChhhhhcCCcc--------------------------------------------------------
Q 040908 515 NQLLLIYEYLENNSLARALFGPEE-------------------------------------------------------- 538 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 538 (790)
+..++||||+++|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999964321
Q ss_pred --------------------------------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcE
Q 040908 539 --------------------------------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNV 580 (790)
Q Consensus 539 --------------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 580 (790)
....++|..+..++.|++.||+|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 112467888899999999999999987 499999999999
Q ss_pred EecCCCCeEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccch
Q 040908 581 LLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEK 658 (790)
Q Consensus 581 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~ 658 (790)
|+++++.+||+|||+++....... .......++..|+|||++....++.++|||||||++|||++ |+.||......+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999986433221 11223457889999999998889999999999999999998 8888864332211
Q ss_pred hhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 659 FYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 659 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
. . .. ...+. ....+.....++.+++..||+.+|.+||+++||++.|+...
T Consensus 351 ~--~---~~-~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 F--Y---NA-IKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H--H---HH-HHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0 0 00 01110 00111122456888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.70 Aligned_cols=258 Identities=27% Similarity=0.447 Sum_probs=205.0
Q ss_pred hcCcceeeeecccCcEEEEeeeecC------CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD------GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678899999999999999998542 3689999986543 23346788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccc------cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEe
Q 040908 518 LLIYEYLENNSLARALFGPEEH------RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 591 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 591 (790)
++||||+++|+|.+++...... ...++|..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999998543221 234789999999999999999999874 9999999999999999999999
Q ss_pred ecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHH
Q 040908 592 DFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 592 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
|||+++....... .......++..|+|||.+..+.++.++|||||||++|||+| |+.||......+. ..+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~---- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFV---- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHH----
Confidence 9999985543322 12233456789999999998889999999999999999998 8888864432221 1111
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
..+.... ... .....+.+++..||+.+|.+|||+.++++.|+.
T Consensus 235 ~~~~~~~-----~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLD-----LPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCC-----CCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111111 111 224578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.83 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=194.8
Q ss_pred ecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCCh
Q 040908 454 IGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL 529 (790)
Q Consensus 454 LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 529 (790)
||+|+||+||++... +|+.||+|++..... ...+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 688999999865322 2235678899999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeec
Q 040908 530 ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609 (790)
Q Consensus 530 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 609 (790)
.+++.........+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 9888544334457899999999999999999999985 999999999999999999999999999765443221 234
Q ss_pred cccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHH
Q 040908 610 VAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKE 689 (790)
Q Consensus 610 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 689 (790)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... ...... ..++..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~---------~~~~~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQ---------RILNDS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHH---------hhcccC--CCCccc
Confidence 56899999999999999999999999999999999999999754321110 00000 001110 112223
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 690 QVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 690 ~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
....+.+++..|++.||++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 445678899999999999999 5566554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.45 Aligned_cols=241 Identities=26% Similarity=0.381 Sum_probs=192.4
Q ss_pred eeecccCcEEEEeeee----cCCcEEEEEEccccc----hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 452 NKIGEGGFGPVYKGLL----ADGTLIAVKQLSAKS----KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+.||+|+||.||++.. ..++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999984 357899999987532 22334678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999832 345788888999999999999999985 9999999999999999999999999987433222
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ... ..+. ..
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~------~~~-~~~~------~~-- 218 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI------DKI-LKGK------LN-- 218 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH------HHH-HcCC------CC--
Confidence 2 223456999999999999888999999999999999999999999754322110 010 0111 01
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
.+......+.+++.+|++.+|++|| ++.++++
T Consensus 219 --~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 --LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1112234678899999999999999 7777655
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=323.47 Aligned_cols=264 Identities=25% Similarity=0.408 Sum_probs=204.4
Q ss_pred hcCcceeeeecccCcEEEEeeeecC-----------------CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceee
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD-----------------GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVK 506 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~-----------------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 506 (790)
..+|++.+.||+|+||.||+|...+ +..||+|++.... .....++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678899999999999999987542 2468999987543 334567899999999999999999
Q ss_pred eeeEEEeCCeEEEEEEeccCCChhhhhcCCcc-------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCc
Q 040908 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEE-------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATN 579 (790)
Q Consensus 507 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~N 579 (790)
++++|..++..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999854321 1236899999999999999999999875 9999999999
Q ss_pred EEecCCCCeEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh--CCCCCcccccc
Q 040908 580 VLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS--GRSNIMCKTKE 656 (790)
Q Consensus 580 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~p~~~~~~~ 656 (790)
|+++.++.++|+|||+++....... .......+++.|+|||++....++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999975433221 12233456789999999998899999999999999999998 66677543221
Q ss_pred chhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 657 EKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 657 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
. .................. ..+.....++.+++.+|++.+|.+||++.||++.|+
T Consensus 241 ~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q---VIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 112111111111111111 111123357899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=313.55 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=203.2
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|++.+.||+|+||.||+|... +++.|++|.+... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999964 6889999988643 234456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999995432 356899999999999999999999874 9999999999999999999999999998655432
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.. .....|++.|+|||+..+..++.++|||||||++|||++|+.||....... .... ...+..
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~~--------- 218 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILK----IIRGVF--------- 218 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHcCCC---------
Confidence 22 233468899999999999899999999999999999999999997544211 1111 011111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+......+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1111133456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.38 Aligned_cols=256 Identities=25% Similarity=0.447 Sum_probs=200.3
Q ss_pred cceeeeecccCcEEEEeeeecC----CcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe-----
Q 040908 448 FDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ----- 516 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 516 (790)
|.+.+.||+|+||.||+|.... +..||+|+++... ......+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998642 3679999987532 2334678999999999999999999999876554
Q ss_pred -EEEEEEeccCCChhhhhcCCc--cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 517 -LLLIYEYLENNSLARALFGPE--EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 517 -~~lV~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
.++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999885432 12246899999999999999999999874 999999999999999999999999
Q ss_pred CCccccCCCCcce-eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhh
Q 040908 594 GLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQ 671 (790)
Q Consensus 594 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 671 (790)
|+++......... .....++..|+|||++....++.++|||||||++|||++ |..||......+ ..++.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~----~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLR----H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----c
Confidence 9998654332221 122335678999999988889999999999999999999 888885433211 111111 1
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 672 GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 672 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
+... ..+......+.+++.+|++.||.+||++.||++.|++.
T Consensus 231 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 11223345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=322.30 Aligned_cols=264 Identities=26% Similarity=0.423 Sum_probs=201.0
Q ss_pred hcCcceeeeecccCcEEEEeeeecC---------------CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeee
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD---------------GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLY 508 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~---------------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~ 508 (790)
.++|++.+.||+|+||.||++...+ ...||+|.+.... ......|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999987532 2358999987542 33345789999999999999999999
Q ss_pred eEEEeCCeEEEEEEeccCCChhhhhcCCcc--------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcE
Q 040908 509 GCCIEGNQLLLIYEYLENNSLARALFGPEE--------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNV 580 (790)
Q Consensus 509 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 580 (790)
+++...+..++||||+++++|.+++..... ....++|..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999843211 1124789999999999999999999885 99999999999
Q ss_pred EecCCCCeEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh--CCCCCccccccc
Q 040908 581 LLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS--GRSNIMCKTKEE 657 (790)
Q Consensus 581 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~ 657 (790)
++++++.+||+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999975533221 11223345779999999998899999999999999999998 556665433222
Q ss_pred hhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 658 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
.. ................. .+......+.+++.+|++.+|.+||+|.+|++.|+
T Consensus 241 ~~--~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VI--ENTGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HH--HHHHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11 11111111111100010 11112357899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.57 Aligned_cols=252 Identities=28% Similarity=0.535 Sum_probs=202.3
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
.+|++.+.||+|+||.||+|.+.+++.+|+|.+.... .....|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4688899999999999999998778899999886532 234578999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+++|.+++... ...+++..+..++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999998432 245789999999999999999999875 999999999999999999999999998855432221
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
......++.+|+|||++.++.++.++||||||+++|||++ |+.||......+ ......+ + .....+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~-~--~~~~~~~~-- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETINA-G--FRLYKPRL-- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHhC-C--CCCCCCCC--
Confidence 1222335678999999998899999999999999999998 899986433211 1111111 0 11111111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
....+.+++.+||+.+|++||++.||++.|.
T Consensus 226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2356889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=317.41 Aligned_cols=256 Identities=25% Similarity=0.431 Sum_probs=197.4
Q ss_pred cceeeeecccCcEEEEeeeecC-Cc--EEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC------Ce
Q 040908 448 FDVANKIGEGGFGPVYKGLLAD-GT--LIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG------NQ 516 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~~-g~--~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 516 (790)
|.+.+.||+|+||.||+|...+ +. .||+|.++.. .......+.+|+.++++++|+||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467899999999999999654 32 6899988653 234456789999999999999999999988532 24
Q ss_pred EEEEEEeccCCChhhhhcCCc--cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 517 LLLIYEYLENNSLARALFGPE--EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
.++||||+++|+|.+++.... .....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998873221 12345899999999999999999999874 9999999999999999999999999
Q ss_pred CccccCCCCcce-eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhC
Q 040908 595 LAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 595 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
+++......... .....+++.|+|||+.....++.++|||||||++|||++ |+.||......+ +.. . ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---~-~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYD---Y-LRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---H-HHcC
Confidence 998664332211 122346778999999998899999999999999999999 788886432211 111 1 1111
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 673 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.... ........+.+++.+||+.+|++||++.++++.|+..
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1110 1112334678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.47 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=205.0
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..++|++.+.||+|+||.||+|...++..+|+|.+.... .....|.+|+.++++++|+||+++++++.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 356899999999999999999998778889999886532 334678899999999999999999999887 778999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999995432 346889999999999999999999874 9999999999999999999999999998654433
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
........++..|+|||++..+.++.++|||||||++||++| |+.||....... +..+. ..+...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~~~------- 222 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----ERGYRM------- 222 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hCCCCC-------
Confidence 222223346678999999998889999999999999999999 898886433211 11111 111100
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.........+.+++.+|++.+|++||++.++.++|+.
T Consensus 223 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.03 Aligned_cols=255 Identities=28% Similarity=0.453 Sum_probs=203.1
Q ss_pred cCcceeeeecccCcEEEEeeeec----CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.+|++.+.||+|+||.||+|... .+..+|+|.++... ....+.|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999853 23479999986543 23356789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+|||++.++.++++|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999432 246899999999999999999999875 9999999999999999999999999998665
Q ss_pred CCCcceee--ccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 601 EDNTHIST--RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 601 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
........ ...++..|+|||++.+..++.++|||||||++||+++ |+.||......+ ...+. ..+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~--~- 227 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----EEGY--R- 227 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----hCCC--c-
Confidence 43322222 1224568999999998899999999999999999887 999986543221 11111 1110 0
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
... .......+.+++.+|++.+|.+||+|.++++.|++.
T Consensus 228 --~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 --LPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001 112345678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.36 Aligned_cols=241 Identities=24% Similarity=0.343 Sum_probs=192.4
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCC-CceeeeeeEEEeCCeEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQH-PHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 521 (790)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|++++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999865 57899999987542 2334567889999999976 56888999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998842 246889999999999999999999985 99999999999999999999999999874322
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+.. ... . ... ..
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~~i---~-~~~------~~ 219 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---QSI---M-EHN------VS 219 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHH---H-cCC------CC
Confidence 111 223456999999999999989999999999999999999999999754322211 100 0 000 11
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
++......+.+++.+|++.+|.+|++.
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 ----YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111223467889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=334.61 Aligned_cols=263 Identities=22% Similarity=0.339 Sum_probs=198.1
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC-----eEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN-----QLL 518 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 518 (790)
+|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999995 47899999998653 2234467889999999999999999999998766 789
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+|+||+. ++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 578777732 346899999999999999999999985 99999999999999999999999999986
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHH----------HHH
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDW----------ALL 667 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~----------~~~ 667 (790)
.............+|..|+|||++.+. .++.++|||||||++|||++|+.||...........+.. ...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 544333333445689999999998774 478999999999999999999999975543222111100 000
Q ss_pred HHhh-CCc-ccccCC-CCC--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 668 LKEQ-GNL-MELVDP-NLG--SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 668 ~~~~-~~~-~~~~d~-~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.... ..+ .....+ ... .........++.+++.+|++.||.+|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000 000 000000 000 0011122456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=321.17 Aligned_cols=250 Identities=25% Similarity=0.465 Sum_probs=203.4
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..+|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35789999999999999999985 46889999998765555567788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999832 35789999999999999999999885 9999999999999999999999999987544322
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.. .....|++.|+|||++.+..++.++|||||||++|||++|+.||......... . . ....+ . +.+
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~---~-~~~~~-~-----~~~- 236 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--Y---L-IATNG-T-----PEL- 236 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--H---H-HhcCC-C-----CCC-
Confidence 11 22346889999999999888999999999999999999999999654321111 0 0 00000 0 001
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+......+.+++.+|+..+|++||++.|+++
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 112233456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.31 Aligned_cols=258 Identities=28% Similarity=0.420 Sum_probs=201.4
Q ss_pred cCcceeeeecccCcEEEEeeeecC-Cc--EEEEEEcccc-chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLAD-GT--LIAVKQLSAK-SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~-g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 520 (790)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.|.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998653 33 4788888743 333456789999999999 799999999999999999999
Q ss_pred EEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCe
Q 040908 521 YEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 588 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 588 (790)
+||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999954221 1135889999999999999999999874 9999999999999999999
Q ss_pred EEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHH
Q 040908 589 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 589 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 667 (790)
||+|||++........ ......+..|+|||++....++.++|||||||++|||++ |+.||......+.. ..
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~------~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY------EK 230 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH------HH
Confidence 9999999874322111 111223567999999988889999999999999999998 99998654322111 11
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
.. .+ ... ..+......+.+++..|++.+|.+||++.++++.|+....
T Consensus 231 ~~-~~-----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 LP-QG-----YRM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred Hh-cC-----CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 01 001 1111233567899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=314.21 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=194.7
Q ss_pred eecccCcEEEEeeeec---CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCC
Q 040908 453 KIGEGGFGPVYKGLLA---DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNS 528 (790)
Q Consensus 453 ~LG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 528 (790)
.||+|+||.||+|.+. ++..||+|++..... ...++|.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 355799999876533 33467899999999999999999999885 457899999999999
Q ss_pred hhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceee
Q 040908 529 LARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 608 (790)
Q Consensus 529 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 608 (790)
|.+++.. ....+++..+.+++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999843 2346899999999999999999999885 999999999999999999999999999865443322211
Q ss_pred --ccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 040908 609 --RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN 685 (790)
Q Consensus 609 --~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 685 (790)
...++..|+|||++....++.++|||||||++|||++ |+.||......+. ... ...+.. ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~-~~~~~~---------~~ 218 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV------MSF-IEQGKR---------LD 218 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHH-HHCCCC---------CC
Confidence 1234578999999988889999999999999999996 9999865432211 111 111111 11
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 686 VDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 686 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.+.....++.+++..||..+|++||++.+|.+.|+..
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1223345778899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=332.09 Aligned_cols=242 Identities=26% Similarity=0.321 Sum_probs=193.6
Q ss_pred eeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCC
Q 040908 452 NKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 527 (790)
+.||+|+||.||++.. .+|+.||+|++.... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468899999987542 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCccee
Q 040908 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 607 (790)
Q Consensus 528 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 607 (790)
+|.+++.. ...+++..+..++.||+.||+|||+.. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~--~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 99988832 346899999999999999999999731 499999999999999999999999999875332222 12
Q ss_pred eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCc
Q 040908 608 TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVD 687 (790)
Q Consensus 608 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 687 (790)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...........+ .. .. ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-----~~--~~------~~~p~--- 217 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-----LM--EE------IRFPR--- 217 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-----hc--CC------CCCCC---
Confidence 3356999999999999999999999999999999999999999754332211110 00 00 01111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 688 KEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 688 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
....++.+++.+|++.||.+|+ ++.++++
T Consensus 218 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 218 -TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 2234577889999999999996 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=327.04 Aligned_cols=238 Identities=26% Similarity=0.393 Sum_probs=188.1
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 57889999987542 22334556677777654 899999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999998842 246889999999999999999999975 9999999999999999999999999998543322 22
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .... . .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~-~------~~~~---- 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD------SILN-D------RPHF---- 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHc-C------CCCC----
Confidence 334679999999999998899999999999999999999999997543322110 0000 0 0111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMSS 714 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 714 (790)
+.....++.+++..||+.+|.+||++.+
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 1122345678889999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=330.17 Aligned_cols=244 Identities=30% Similarity=0.427 Sum_probs=202.9
Q ss_pred eecccCcEEEEeeeecC-CcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCChhh
Q 040908 453 KIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLAR 531 (790)
Q Consensus 453 ~LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 531 (790)
.||+|.||+||.|+..+ ...+|||.+........+.+.+|+..-++++|+|||+++|.|.+++.+-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999654 56799999988777777788999999999999999999999999999999999999999999
Q ss_pred hhcCCccccCCC--ChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec-CCCCeEEeecCCccccCCCCcceee
Q 040908 532 ALFGPEEHRLKL--DWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHIST 608 (790)
Q Consensus 532 ~l~~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~ 608 (790)
+|... -.++ ++.+.-.+..||++||.|||+.. |+|||||-.|||++ -.|.+||+|||-++.+..-+. .+.
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TE 734 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTE 734 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-ccc
Confidence 99433 3455 67788889999999999999984 99999999999995 678999999999987654333 455
Q ss_pred ccccCCCcccHHHhhcC--CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 609 RVAGTFGYMAPEYAMRG--HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 609 ~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
++-||..|||||++..+ .|..++|||||||++.||.||++||......... +.+-|-. ......
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVGmy------KvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVGMY------KVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhcce------ecCCCC
Confidence 67899999999999875 5888999999999999999999999754322110 0011111 123455
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+.+...+...++++|+..||.+||++.++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 6777888999999999999999999999876
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.69 Aligned_cols=258 Identities=27% Similarity=0.416 Sum_probs=203.9
Q ss_pred HhcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCC
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGN 515 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 515 (790)
..++|.+.+.||+|+||.||+|.. ..+..||+|+++... ....+.+.+|+.+++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 345789999999999999999973 134579999987543 23346789999999999 7999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+|||++.++.++++|||+
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999995322 234899999999999999999999875 99999999999999999999999999
Q ss_pred ccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 596 AKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 596 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
++........ ......++..|+|||++....++.++|||||||++|||++ |+.||......+.. ... ...+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~----~~~~~ 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKL----IKEGY 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHH----HHcCC
Confidence 9865433221 1222346788999999999899999999999999999998 99998644322211 010 11110
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
....+.....++.+++.+|++.+|++||++.|+++.|+.
T Consensus 262 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 ---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 000111123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=332.11 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=206.6
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
-|++.+.||+|+-|.|-.|+. .+|+.+|||++.+... .....+.+|+.+|+-+.|||++++++++.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 366789999999999999994 5799999999976522 223457789999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++|.|++++. .+.+++..+..+++.||+.|+.|+|.. +|+|||+||+|+|||..+++||+|||+|.+..++
T Consensus 93 yv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999993 346799999999999999999999987 5999999999999999999999999999875544
Q ss_pred CcceeeccccCCCcccHHHhhcCCCC-ChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLT-DKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
. ...+.+|++.|.|||++++.+|. .++||||.|||||.|+||+.||+.++- ..+..-+ ..|.+
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV----~~G~f------- 229 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKV----QRGVF------- 229 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHH----HcCcc-------
Confidence 3 33557899999999999998875 699999999999999999999984432 2222211 11211
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCc
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGRV 723 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~~ 723 (790)
+.+.....+..+|+.+|+..||.+|-|+.||.+ +|.+..
T Consensus 230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 122233445678888999999999999999987 454433
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=341.99 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=193.4
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeC--------
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEG-------- 514 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 514 (790)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999999996 468899999885432 2345799999999999999999886432
Q ss_pred CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-CeEEeec
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDF 593 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DF 593 (790)
..+++||||+++ +|.+++.........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999985 677766433333457899999999999999999999985 99999999999999665 6999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH------
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL------ 666 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~------ 666 (790)
|+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+....
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99986543322 2335689999999998764 68999999999999999999999997654322211110000
Q ss_pred HHH-hhCCcccccCCCC-----CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 667 LLK-EQGNLMELVDPNL-----GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 667 ~~~-~~~~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... ......++.-+.. ...++.....++.+++..||+.||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 0000001100111 01111123357889999999999999999999985
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=315.28 Aligned_cols=250 Identities=30% Similarity=0.496 Sum_probs=204.1
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888999999999999999875 78899999976544 4678999999999999999999999999889999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++++|.+++.... ...++|..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999985332 236899999999999999999999885 99999999999999999999999999986533221
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
...++..|+|||++..+.++.++||||||+++|||++ |+.||....... +... ...+. .
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~----~~~~~---------~ 217 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPH----VEKGY---------R 217 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HhcCC---------C
Confidence 2335678999999988899999999999999999997 998886432211 1110 01110 0
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
...+......+.+++.+|++.+|++||++.|++++|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=326.61 Aligned_cols=237 Identities=24% Similarity=0.351 Sum_probs=186.2
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHH-HhhccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIG-TISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 68899999986532 122344555654 57889999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999988832 245788888999999999999999875 9999999999999999999999999987532211 12
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ... ... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~---~i~-~~~--------~--~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---YD---NIL-HKP--------L--QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---HH---HHh-cCC--------C--CC
Confidence 2345799999999999988999999999999999999999999975432111 11 000 010 0 11
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMS 713 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 713 (790)
+......+.+++.+|++.+|.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 122334678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=334.43 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=194.2
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999985 468899999986532 233456888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999842 246788899999999999999999985 99999999999999999999999999863211
Q ss_pred CCc------------c----------------------------------eeeccccCCCcccHHHhhcCCCCChhhHHH
Q 040908 602 DNT------------H----------------------------------ISTRVAGTFGYMAPEYAMRGHLTDKADVYS 635 (790)
Q Consensus 602 ~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S 635 (790)
... . .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 0 001246999999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCccccccchhh-HHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCC---CC
Q 040908 636 FGIVALEIVSGRSNIMCKTKEEKFY-LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNR---PL 711 (790)
Q Consensus 636 ~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt 711 (790)
|||++|||+||+.||......+... +..| ... ..+ +. ......++.+++..|++ +|.+| ++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~------~~~-~~~--p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINW------RET-LYF--PD-----DIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHcc------CCc-cCC--CC-----CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 9999999999999997544322111 0011 000 000 10 00123456778888987 66665 58
Q ss_pred HHHHHH
Q 040908 712 MSSVVS 717 (790)
Q Consensus 712 ~~ev~~ 717 (790)
+.|++.
T Consensus 299 ~~~~l~ 304 (377)
T cd05629 299 AHEIKS 304 (377)
T ss_pred HHHHhc
Confidence 888876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=321.50 Aligned_cols=264 Identities=26% Similarity=0.408 Sum_probs=201.9
Q ss_pred hcCcceeeeecccCcEEEEeeeec-----------------CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceee
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-----------------DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVK 506 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-----------------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 506 (790)
.++|++.+.||+|+||.||++... ++..||+|++.... ......|.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999998532 23469999987543 334567899999999999999999
Q ss_pred eeeEEEeCCeEEEEEEeccCCChhhhhcCCcc-------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCc
Q 040908 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEE-------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATN 579 (790)
Q Consensus 507 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~N 579 (790)
+++++...+..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999854321 1234788899999999999999999885 9999999999
Q ss_pred EEecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh--CCCCCcccccc
Q 040908 580 VLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS--GRSNIMCKTKE 656 (790)
Q Consensus 580 ILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~p~~~~~~~ 656 (790)
||+++++.++|+|||+++........ ......+++.|+|||+...+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999855433221 1222345678999999988899999999999999999998 66777543322
Q ss_pred chhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 657 EKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 657 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
+.. ............ ....+. +..+...+.+++.+||+.+|.+||+|.||++.|+
T Consensus 241 ~~~---~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVI---ENTGEFFRDQGR-QVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHH---HHHHHHHhhccc-cccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 211 111111111100 000011 1123356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.60 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=203.9
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN 515 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 515 (790)
..+++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999743 24579999886443 223456889999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCcc------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeE
Q 040908 516 QLLLIYEYLENNSLARALFGPEE------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 589 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 589 (790)
..++||||+++|+|.+++..... .....++..+.+++.|++.||+|||+.+ |+||||||+|||+++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999953211 1234577788999999999999999874 99999999999999999999
Q ss_pred EeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHH
Q 040908 590 ISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 590 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 667 (790)
|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |+.||......+ ... .
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~---~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK---F 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H
Confidence 9999999854332211 1122345778999999998899999999999999999999 788886433221 111 1
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.. .+.... .+......+.+++.+|++.+|++||++.++++.|++..
T Consensus 234 ~~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VM-DGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HH-cCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11 111110 11122357889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=316.80 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=201.8
Q ss_pred cCcceeeeecccCcEEEEeeeecC-C---cEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLAD-G---TLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~-g---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.+|++.+.||+|+||.||+|.... + ..||+|.+... ......+|..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457889999999999999998643 3 36999998754 333456899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998432 346899999999999999999999875 9999999999999999999999999988654
Q ss_pred CCCcc--eeeccc--cCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 601 EDNTH--ISTRVA--GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 601 ~~~~~--~~~~~~--gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
..... ...... .+..|+|||++....++.++|||||||++|||++ |+.||....... ...+.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~---~~~~-- 229 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE---QDYR-- 229 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH---cCCc--
Confidence 32221 111111 2457999999999999999999999999999887 999986543221 111111 0000
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
...+.+.+..+.+++..||+.+|.+||++.+|+..|+..
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 --------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011112345678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.26 Aligned_cols=238 Identities=26% Similarity=0.364 Sum_probs=191.7
Q ss_pred eeecccCcEEEEeeee----cCCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 452 NKIGEGGFGPVYKGLL----ADGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 3578999999975432 233457789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999999832 346899999999999999999999985 99999999999999999999999999986543322
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN 685 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 685 (790)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ... .... .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~---~i~-~~~~----------~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM---T---MIL-KAKL----------G 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH---H---HHH-cCCC----------C
Confidence 223467999999999999888999999999999999999999999754322111 1 000 0100 1
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 040908 686 VDKEQVRVMINVALLCADVSPTNRPLMSS 714 (790)
Q Consensus 686 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 714 (790)
.+......+.+++.+|++.||.+||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11122346778999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=323.97 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=204.3
Q ss_pred hcCcceeeeecccCcEEEEeeeec--------CCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeC
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA--------DGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEG 514 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 514 (790)
.++|.+.+.||+|+||.||++... ++..+|+|.+.... .....++..|+.+++++ +|+||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999742 23569999997542 33446788999999999 799999999999999
Q ss_pred CeEEEEEEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe
Q 040908 515 NQLLLIYEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL 582 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 582 (790)
+..++||||+++|+|.+++..... ....++|.+++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999954321 1235899999999999999999999874 9999999999999
Q ss_pred cCCCCeEEeecCCccccCCCCcce-eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhh
Q 040908 583 DKDLNPKISDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFY 660 (790)
Q Consensus 583 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 660 (790)
++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~-- 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-- 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--
Confidence 999999999999997554322111 112234578999999998889999999999999999998 8888854332111
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 661 LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 661 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
..... .+.. ...+.....++.+++..|++.+|.+||+|.+|++.|+.+..
T Consensus 252 ----~~~~~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 252 ----FKLLK-EGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred ----HHHHH-cCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11111 1111 11122234577889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.91 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=200.2
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788999999999999999995 56889999998765444556788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998842 246889999999999999999999874 9999999999999999999999999998654322
Q ss_pred cceeeccccCCCcccHHHhh---cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 604 THISTRVAGTFGYMAPEYAM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
. ......|+..|+|||.+. ...++.++|||||||++|||++|+.|+......+... . ..... ...+
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~-----~~~~~---~~~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L-----MSKSN---FQPP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--e-----eecCC---CCCC
Confidence 1 112346889999999884 3457889999999999999999999985432211100 0 00000 0011
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
.... .......+.+++.+||+.+|++||++.++++.
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 1110 11233568899999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=315.29 Aligned_cols=250 Identities=26% Similarity=0.337 Sum_probs=200.0
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc-----hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS-----KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
++|++.+.||+|++|.||+|.. .++++||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999985 468999999886432 1223568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998842 245788999999999999999999885 999999999999999999999999999755
Q ss_pred CCCCccee--eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 600 EEDNTHIS--TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 600 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
........ ....|+..|+|||++.+..++.++||||||+++|||++|+.||......... .. ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~---~~~~~~---- 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FK---IATQPT---- 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HH---HhccCC----
Confidence 43222111 2345788999999999988999999999999999999999998643221111 00 000000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
....+......+.+++..||..+|.+||++.|+++
T Consensus 225 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 225 -----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred -----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 01112223446788999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=329.20 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=210.6
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe-EEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ-LLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 521 (790)
++|..++.+|+|+||.++..+.+ +++.+++|.+.... ....+...+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998854 57789999886542 3334578899999999999999999999999888 99999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
+|++||++.+.+.... +.-++..++..++.|++.|+.|||++ .|+|||||++||+++.+..+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999995443 46789999999999999999999977 599999999999999999999999999998876
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... ....++||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+...-..-+ .+.
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki----------------~~~ 221 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI----------------NRG 221 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH----------------hhc
Confidence 553 335578999999999999999999999999999999999999999765433221100 011
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
.....+.....++..++..|++.+|..||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1122344556678899999999999999999999874
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=326.53 Aligned_cols=241 Identities=24% Similarity=0.358 Sum_probs=192.7
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 521 (790)
+|++.+.||+|+||.||+|... +++.||+|++.... ......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999865 57899999987542 22234567788888777 5899999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998842 245889999999999999999999885 99999999999999999999999999975432
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......... .. ... .. .
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---~~---i~~-~~------~- 218 (323)
T cd05616 154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---QS---IME-HN------V- 218 (323)
T ss_pred CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH---HH---HHh-CC------C-
Confidence 221 223467999999999999999999999999999999999999999754332211 11 010 11 0
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
.++.....++.+++.+|++.+|.+|++.
T Consensus 219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1122234567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.56 Aligned_cols=263 Identities=26% Similarity=0.401 Sum_probs=206.7
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec--------CCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEE
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA--------DGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCI 512 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 512 (790)
...++|.+.+.||+|+||.||+|... ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567889999999999999999731 24579999986542 34456789999999999 8999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcE
Q 040908 513 EGNQLLLIYEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNV 580 (790)
Q Consensus 513 ~~~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 580 (790)
.....++||||+++|+|.+++..... ....++|.++..++.||++||+|||+.+ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999954321 1235788999999999999999999885 99999999999
Q ss_pred EecCCCCeEEeecCCccccCCCCcce-eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccch
Q 040908 581 LLDKDLNPKISDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEK 658 (790)
Q Consensus 581 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~ 658 (790)
++++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..|+......+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 99999999999999998664433221 222346778999999998889999999999999999998 777775432211
Q ss_pred hhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 659 FYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 659 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
+.......... ..+......+.+++.+||+.+|.+||+|.|+++.|+++..
T Consensus 248 -----~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 248 -----LFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred -----HHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 11111111110 1111234568889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=327.55 Aligned_cols=243 Identities=23% Similarity=0.318 Sum_probs=189.5
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|... +++.||+|+++... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 57899999987542 22345677898888776 899999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 999988832 246899999999999999999999985 99999999999999999999999999975322211 2
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccc--hhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE--KFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 234679999999999999999999999999999999999999996321111 11111122111111111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
..+......+.+++.+|++.||.+||+.
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1122233467889999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=316.76 Aligned_cols=257 Identities=25% Similarity=0.435 Sum_probs=201.7
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCc----EEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGT----LIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
.++|++.++||+|+||.||+|.+ .+|. .||+|++.... .....++.+|+.++..++|+||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 45788999999999999999984 3444 48999986543 33456788999999999999999999999754 578
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999999532 346899999999999999999999884 99999999999999999999999999986
Q ss_pred cCCCCcce-eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 599 DEEDNTHI-STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 599 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
........ .....++..|+|||...+..++.++|||||||++|||++ |..||....... +..+.. .+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~~- 230 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----KGERL- 230 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCCcC-
Confidence 65332221 112335678999999998899999999999999999998 888886433211 111111 11100
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
..+......+.+++..||+.||++||++.++++.|+....
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 231 --------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0111233467889999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=327.24 Aligned_cols=242 Identities=22% Similarity=0.306 Sum_probs=189.8
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|... +++.||+|+++... ......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999854 68899999997542 22345678899999888 799999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-T 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-c
Confidence 999988832 246899999999999999999999885 99999999999999999999999999874322111 2
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccc--hhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE--KFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .....++.......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~-- 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CC--
Confidence 234679999999999999999999999999999999999999996422111 11111222111111111 11
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCC
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPL 711 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt 711 (790)
+......+.+++..|++.||.+||+
T Consensus 225 --p~~~~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 225 --PRSLSVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCC
Confidence 1122345788999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=319.38 Aligned_cols=258 Identities=29% Similarity=0.482 Sum_probs=203.6
Q ss_pred hcCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
.++|++.+.||+|+||.||+|... ++..||+|++.... .....+|.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 46789999987543 33456799999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCc------------------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCc
Q 040908 518 LLIYEYLENNSLARALFGPE------------------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATN 579 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~N 579 (790)
++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 11235788999999999999999999885 9999999999
Q ss_pred EEecCCCCeEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccc
Q 040908 580 VLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEE 657 (790)
Q Consensus 580 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~ 657 (790)
|++++++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432221 11122345678999999998899999999999999999998 888885433221
Q ss_pred hhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 658 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
+... ...+.... .+.....++.+++.+|++.+|.+||++.|+++.|+.
T Consensus 241 ------~~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ------VIYY-VRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHH-HhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 11111111 111234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=341.79 Aligned_cols=253 Identities=29% Similarity=0.435 Sum_probs=209.8
Q ss_pred ceeeeecccCcEEEEeeee-cCCc----EEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 449 DVANKIGEGGFGPVYKGLL-ADGT----LIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 449 ~~~~~LG~G~fG~Vy~g~~-~~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
...++||+|+||+||||.| ..|. +||+|++... ..+...++++|+.+|.+++|||+++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3467999999999999985 4443 6899988654 4456789999999999999999999999998766 889999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
||+.|+|.++++ .++..+.-+..+.|+.|||+||.|||.+ .++||||.++|||+.+-..+||.|||+|+....+
T Consensus 778 ~mP~G~LlDyvr---~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVR---EHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHH---HhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999995 3556788899999999999999999987 5999999999999999999999999999988776
Q ss_pred Ccceeec-cccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 603 NTHISTR-VAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 603 ~~~~~~~-~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
....... ..-.+.|||-|.+....++.++|||||||++||++| |..|++....++...+.+ .
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle----------------~ 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE----------------K 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh----------------c
Confidence 6554432 234568999999999999999999999999999999 999998766554432221 1
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
..+-..++.+..++..++..||..|+..||+++++...+.....
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 11123344566778888999999999999999999988865443
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.76 Aligned_cols=237 Identities=24% Similarity=0.378 Sum_probs=189.8
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|... +++.||+|++.... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 58899999987532 23345677888888876 699999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence 999998842 246889999999999999999999875 99999999999999999999999999875332221 2
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ... .+.. . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~---~---~i~-~~~~------~----~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF---E---AIL-NDEV------V----Y 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH---H---HHh-cCCC------C----C
Confidence 23457999999999999889999999999999999999999999754432211 1 100 1110 0 1
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMS 713 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 713 (790)
+.....++.+++..|++.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 112234678899999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=332.59 Aligned_cols=260 Identities=20% Similarity=0.303 Sum_probs=201.1
Q ss_pred HHHHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEe
Q 040908 438 LRQIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 438 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
++++....++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4555666789999999999999999999965 57899999986432 2233457889999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
++..++||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999832 34788888899999999999999985 999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcC----CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG----HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
|+++..............||+.|+|||++... .++.++|||||||++|||++|+.||......... ... .
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-----~~i-~ 260 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-----SKI-M 260 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH-----HHH-H
Confidence 99986654333233456799999999998754 3788999999999999999999999754332111 111 1
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTN--RPLMSSVVSM 718 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~~ 718 (790)
.......+.+ .......+.+++..|+...+.+ ||++.|+++.
T Consensus 261 ~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 261 NHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111111110 1123445778888999843433 7788888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=315.15 Aligned_cols=256 Identities=26% Similarity=0.354 Sum_probs=202.0
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4556777777889999999999999954 578899999877666666789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCC--ChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC-CCCeEEeecCCc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKL--DWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLA 596 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla 596 (790)
|+||+++++|.+++... ...+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999999532 1234 78888899999999999999874 999999999999986 678999999998
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhcCC--CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMRGH--LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
........ ......|+..|+|||++.... ++.++|||||||++|||++|+.|+........ ..|......
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~---- 228 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK---- 228 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc----
Confidence 76543222 122345889999999986643 78899999999999999999999864322111 111110000
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 675 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+ ..+.....++.+++.+||+.+|.+||++.|+++
T Consensus 229 ---~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ---IHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---cCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011 122233456788999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.36 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=197.1
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|+||.||+|.. .+++.||+|.+... ......++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4678899999999999999985 56889999998654 233456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999986543 4678888999999999999999885 9999999999999999999999999998553321
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchh-hHHHHHHHHHhhCCcccccCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF-YLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......... ....+...... . ..+.+
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~ 220 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-E-----DPPVL 220 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-c-----CCCCC
Confidence 23356899999999999888999999999999999999999999653322111 00111110000 0 01111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ......++.+++.+|++.+|.+||++.|+++
T Consensus 221 ~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 221 P---VGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred C---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1 1112346788999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.90 Aligned_cols=241 Identities=21% Similarity=0.365 Sum_probs=191.9
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|... +++.||+|++.... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 57899999987542 23345677888888866 799999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 999988842 246899999999999999999999985 99999999999999999999999999875332221 2
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . .... +. .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~---~---~i~~-~~---~~-------~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF---E---SILH-DD---VL-------Y 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH---H---HHHc-CC---CC-------C
Confidence 23456999999999999889999999999999999999999999755432211 1 0000 11 00 1
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRP-------LMSSVVS 717 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RP-------t~~ev~~ 717 (790)
+.....++.+++..|++.||.+|| ++.++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 111234678899999999999999 6666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=312.61 Aligned_cols=252 Identities=29% Similarity=0.453 Sum_probs=200.3
Q ss_pred cceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcH--HHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGN--REFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
|++.+.||+|+||+||++... +++.+|+|++........ ....+|+.++++++||||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678999999999999999965 567899999977543332 23456999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++++|.+++. ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred cccccccccc----cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-cc
Confidence 9999999994 3467899999999999999999999985 99999999999999999999999999986422 22
Q ss_pred ceeeccccCCCcccHHHhh-cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAM-RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.......++..|+|||++. ....+.++||||+|+++|+|++|+.|+................. ...... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~----~- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK----RPLPSS----S- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH----THHHHH----T-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc----cccccc----c-
Confidence 2334567899999999998 78899999999999999999999999976522222211111111 000000 0
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.........+.+++..|++.||++||++.++++
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011267889999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=323.95 Aligned_cols=240 Identities=27% Similarity=0.411 Sum_probs=190.3
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|... +++.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999987542 22345567788888764 899999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999999842 246889999999999999999999885 99999999999999999999999999874322221 2
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ... ... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~---~~i----~~~------~~~~---- 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF---QSI----RMD------NPCY---- 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH---HHH----HhC------CCCC----
Confidence 23456999999999999889999999999999999999999999754322111 110 000 1111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMS-SVV 716 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-ev~ 716 (790)
+.....++.+++..|++.+|.+||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111234577889999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=334.23 Aligned_cols=201 Identities=23% Similarity=0.375 Sum_probs=171.7
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999985 468899999986542 2334568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999843 245788888999999999999999985 999999999999999999999999997532100
Q ss_pred C----------------------------------------------cceeeccccCCCcccHHHhhcCCCCChhhHHHH
Q 040908 603 N----------------------------------------------THISTRVAGTFGYMAPEYAMRGHLTDKADVYSF 636 (790)
Q Consensus 603 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~ 636 (790)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000123469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCcccc
Q 040908 637 GIVALEIVSGRSNIMCKT 654 (790)
Q Consensus 637 Gvvl~elltG~~p~~~~~ 654 (790)
||++|||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.70 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=200.0
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|++++.+++||||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47899999999999999999854 578899998865422 3345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.. ...+++..+..++.|+++||.|||+.. +++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999942 246889999999999999999999742 59999999999999999999999999987543321
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC-C---------
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG-N--------- 673 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~--------- 673 (790)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...................... .
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 233568999999999988889999999999999999999999986433211110000000000000 0
Q ss_pred -----------ccccc---CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 674 -----------LMELV---DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 674 -----------~~~~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
...+. .+.+. ......++.+++.+|+..+|++||++.||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00000 00123468899999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=335.34 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=192.9
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
.+|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|++++++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999985 468899999986532 223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999943 245788888999999999999999985 99999999999999999999999999753210
Q ss_pred C------------------------------------------CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHH
Q 040908 602 D------------------------------------------NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIV 639 (790)
Q Consensus 602 ~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvv 639 (790)
. .........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 0000123569999999999999999999999999999
Q ss_pred HHHHHhCCCCCccccccchhh-HHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCC---CHHHH
Q 040908 640 ALEIVSGRSNIMCKTKEEKFY-LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP---LMSSV 715 (790)
Q Consensus 640 l~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~ev 715 (790)
+|||++|+.||......+... ...|. .....+. .... ...+.+++.+|+ .+|.+|+ ++.|+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~---------~~~~~~~-~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWE---------TTLHIPS-QAKL----SREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccC---------ccccCCC-CCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999997554322110 00100 0000010 1112 234455666665 4999999 77887
Q ss_pred HH
Q 040908 716 VS 717 (790)
Q Consensus 716 ~~ 717 (790)
++
T Consensus 299 l~ 300 (376)
T cd05598 299 KA 300 (376)
T ss_pred hC
Confidence 65
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=314.86 Aligned_cols=255 Identities=26% Similarity=0.453 Sum_probs=201.6
Q ss_pred CcceeeeecccCcEEEEeeeecC--CcEEEEEEcccc----------chhcHHHHHHHHHHhhc-cCCCceeeeeeEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLLAD--GTLIAVKQLSAK----------SKQGNREFVNEIGTISA-LQHPHLVKLYGCCIE 513 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~~--g~~vAvK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 513 (790)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999754 678999987532 12233557788888865 799999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+.. +++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988543333456899999999999999999999642 5999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
|++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||........ .... ..+.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~~~~-~~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------ATKI-VEAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------HHHH-hhcc
Confidence 9998654433 22345689999999999988899999999999999999999999864322111 1111 0111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
.. +.. .......+.+++.+||+.||.+||++.||.++++
T Consensus 230 ~~----~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YE----PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CC----cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 100 1112356788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=320.21 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=201.6
Q ss_pred cCcceeeeecccCcEEEEeeee-----cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEG--NQL 517 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 517 (790)
+.|++.+.||+|+||.||.+.+ .++..||+|.+.... ......+.+|+.++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3567889999999999999974 357889999987543 33346789999999999999999999999875 568
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+++++|.+++... ...++|..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999998422 235899999999999999999999885 9999999999999999999999999998
Q ss_pred ccCCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCcccccc---------chhhHHHHHH
Q 040908 598 LDEEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKE---------EKFYLLDWAL 666 (790)
Q Consensus 598 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~~ 666 (790)
........ ......++..|+|||++.+..++.++|||||||++|||+|++.|....... .......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65433221 122345677899999998888999999999999999999987765322110 0000111111
Q ss_pred HHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 667 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
. ...+.. ..........+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 238 ~-~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 V-LEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred H-HHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1 111110 011112345788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=322.73 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=200.7
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCc--EEEEEEcccc-chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGT--LIAVKQLSAK-SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 519 (790)
.++|++.+.||+|+||.||+|... ++. .+|+|.+... .......+.+|++++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357889999999999999999864 454 4678877643 334456788999999999 89999999999999999999
Q ss_pred EEEeccCCChhhhhcCCc------------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC
Q 040908 520 IYEYLENNSLARALFGPE------------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 587 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 587 (790)
||||+++|+|.+++.... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999995332 11235889999999999999999999875 999999999999999999
Q ss_pred eEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHH
Q 040908 588 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWAL 666 (790)
Q Consensus 588 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 666 (790)
+||+|||+++...... ......++..|+|||++....++.++|||||||++|||+| |..||......+.. .
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------E 234 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH------H
Confidence 9999999987432111 1111234678999999988889999999999999999998 99998644322111 1
Q ss_pred HHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 667 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
... .+ ... ..+......+.+++.+|++.+|++||++.++++.|+...
T Consensus 235 ~~~-~~-----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 235 KLP-QG-----YRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHh-cC-----CcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 110 00 000 011112346788999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.71 Aligned_cols=248 Identities=28% Similarity=0.432 Sum_probs=198.4
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEE-eCCeEEEEEEec
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI-EGNQLLLIYEYL 524 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey~ 524 (790)
++|++.+.||+|+||.||+|... |..||+|.++... ..+.|.+|+.++++++|+|++++++++. ..+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47888999999999999999874 7789999886432 3467899999999999999999999865 456789999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999985322 235889999999999999999999875 9999999999999999999999999987543322
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
....++..|+|||++....++.++|||||||++|||++ |+.||......+ +..+. . .+. .
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~---~-~~~---------~ 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV---E-KGY---------K 217 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---h-cCC---------C
Confidence 22335678999999998889999999999999999998 998886432211 11111 1 110 0
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
..........+.+++.+|++.+|.+||++.++++.|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=332.57 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=205.7
Q ss_pred ceeeeecccCcEEEEeeeec--CCc--EEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 449 DVANKIGEGGFGPVYKGLLA--DGT--LIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 449 ~~~~~LG~G~fG~Vy~g~~~--~g~--~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.+.++||+|.||.|++|.|. +|+ .||||.++..... ...+|++|+.+|.+|+|||+++|+|...+ ....||||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 35689999999999999975 343 6899999876544 56789999999999999999999999987 778999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
++.|+|.+.|+. ..+..+-......+|.|||.||.||.++. +|||||.++|+||-....+||+|||+.+.+....
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999965 34567888889999999999999999884 9999999999999999999999999999776544
Q ss_pred cce-e-eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 604 THI-S-TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 604 ~~~-~-~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
... . ....-.+.|+|||.+....++.++|||+|||++|||+| |..||.+-.... +.+.+|.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~ 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDA 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhccc
Confidence 332 2 22335678999999999999999999999999999999 778886543322 1223333
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.-+-..+..+.+++.++++.||..+|.+|||+..+.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 3233345567889999999999999999999999974
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.86 Aligned_cols=246 Identities=24% Similarity=0.318 Sum_probs=192.6
Q ss_pred ecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCCh
Q 040908 454 IGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL 529 (790)
Q Consensus 454 LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 529 (790)
||+|+||.||++... +|+.||+|++.... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999854 68999999986432 12234566799999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeec
Q 040908 530 ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609 (790)
Q Consensus 530 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 609 (790)
.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9888532 2345899999999999999999999875 9999999999999999999999999998654332 2234
Q ss_pred cccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHH
Q 040908 610 VAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKE 689 (790)
Q Consensus 610 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 689 (790)
..|+..|+|||++.+..++.++|||||||++|||++|+.||......... ........ ... .... ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~-~~~--------~~~~-~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTL-EDE--------VKFE-HQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhh-ccc--------cccc-ccc
Confidence 56899999999999888999999999999999999999998643221111 11111100 000 0000 012
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 690 QVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 690 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
...++.+++..|++.||.+||++.|+++.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 23467889999999999999999887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.09 Aligned_cols=250 Identities=27% Similarity=0.454 Sum_probs=203.5
Q ss_pred hcCcceeeeecccCcEEEEeeeecC-CcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|++.+.||+|+||.||+|...+ ++.+++|.+..... ..++.+|++++++++|+||+++++++...+..++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678899999999999999999764 78999999865433 67899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999999842 2357899999999999999999999885 9999999999999999999999999998654432
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.|+........... ......+..
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------------~~~~~~~~~- 219 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------------IPNKPPPTL- 219 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------------hccCCCCCC-
Confidence 2 22334588999999999988999999999999999999999999865432211100 000000011
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+......+.+++..|++.+|.+||++.||++
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 -SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112223456888999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.19 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=202.8
Q ss_pred hcCcceeeeecccCcEEEEeeeecC----CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.++|.+.+.||+|+||.||+|...+ ...||+|...... ....+.+.+|+.++++++||||+++++++.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568889999999999999998643 2468999887654 3445679999999999999999999999875 45789
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++... ...+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999999432 235899999999999999999999874 999999999999999999999999999866
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
............++..|+|||.+....++.++|||||||++|||++ |+.||......+.. .+. ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~----~~~~~~--- 227 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRI----ENGERL--- 227 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH----HcCCcC---
Confidence 5443222223345678999999988889999999999999999996 99998654322211 111 111100
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.. +......+.+++.+|+..+|.+||++.++++.|++..
T Consensus 228 --~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 --PM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred --CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 1122346888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=326.15 Aligned_cols=237 Identities=25% Similarity=0.346 Sum_probs=187.3
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHH-HhhccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIG-TISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986532 222344555555 56789999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999998842 346889999999999999999999985 9999999999999999999999999987532222 12
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .+. ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~-~~~------~~~~~-- 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY------DNIL-NKP------LRLKP-- 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH------HHHH-cCC------CCCCC--
Confidence 23456999999999999999999999999999999999999999754322111 0000 011 01111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMS 713 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 713 (790)
.....+.+++..|++.||.+||++.
T Consensus 218 --~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 --NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1244678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.61 Aligned_cols=250 Identities=28% Similarity=0.421 Sum_probs=194.3
Q ss_pred eeecccCcEEEEeeeecC-Cc--EEEEEEcccc-chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLAD-GT--LIAVKQLSAK-SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~-g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|...+ +. .+|+|.++.. .......+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999653 43 4788888743 234456788999999999 899999999999999999999999999
Q ss_pred CChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 527 NSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 527 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
|+|.+++..... ....+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999854321 1235789999999999999999999874 9999999999999999999999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
++........ ......+..|+|||++....++.++|||||||++|||++ |+.||......+.. ..... +.
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~------~~~~~-~~ 228 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQ-GY 228 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH------HHHhC-CC
Confidence 9863221111 111224568999999988889999999999999999997 99998643322111 11111 10
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
....+......+.+++.+|++.+|.+||++.+++..|+..
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0011112234678999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=316.17 Aligned_cols=239 Identities=23% Similarity=0.385 Sum_probs=187.5
Q ss_pred eecccCcEEEEeeeecC-------------------------CcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeee
Q 040908 453 KIGEGGFGPVYKGLLAD-------------------------GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKL 507 (790)
Q Consensus 453 ~LG~G~fG~Vy~g~~~~-------------------------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 507 (790)
.||+|+||.||+|.+.. ...||+|++.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876555555678899999999999999999
Q ss_pred eeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-
Q 040908 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL- 586 (790)
Q Consensus 508 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~- 586 (790)
+++|.+....++||||+++|+|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999843 2346889999999999999999999874 99999999999998654
Q ss_pred ------CeEEeecCCccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHH-hCCCCCccccccch
Q 040908 587 ------NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIV-SGRSNIMCKTKEEK 658 (790)
Q Consensus 587 ------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~ 658 (790)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+.
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999998643221 12347888999998865 56889999999999999995 68988865432221
Q ss_pred hhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 659 FYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 659 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
. .+ ..... ..... ....+.+++..||+.+|++||+|.+|++.|+
T Consensus 231 ~---~~---~~~~~--------~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 E---RF---YEKKH--------RLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---HH---HHhcc--------CCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 11 00000 01111 1235788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=314.05 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=197.5
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC-----eEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN-----QLLLI 520 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV 520 (790)
.|...+++|.|+||.||+|.+. .+..||||++..+.+.. -+|+++|++++|||||+|+-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667899999999999999954 57899999986654322 25889999999999999998886432 34689
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC-CCeEEeecCCcccc
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLD 599 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~~~ 599 (790)
||||+. +|.++++.....+..++...+.-++.||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999997 89998864434456788888888999999999999997 49999999999999977 89999999999987
Q ss_pred CCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHh--h-----
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKE--Q----- 671 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~----- 671 (790)
...... .....|.-|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.++...++ +....+.+-. .
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHhh
Confidence 665544 23456888999999987 4799999999999999999999988876543332 2222221110 0
Q ss_pred --CCcccccCCCCCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 672 --GNLMELVDPNLGS-----NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 672 --~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
....+.-.|.+.. -+......+.++++.++++.+|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111111222211 122344567889999999999999999999875
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=323.94 Aligned_cols=241 Identities=24% Similarity=0.371 Sum_probs=192.4
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|... +++.||+|+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 57899999997542 23345677888888887 799999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 999988832 246899999999999999999999885 99999999999999999999999999874322221 1
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... . ... ... .. +
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~---~---~i~-~~~------~~----~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF---Q---SIL-EDE------VR----Y 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH---H---HHH-cCC------CC----C
Confidence 23356899999999999999999999999999999999999999754322111 0 000 011 01 1
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLM-----SSVVS 717 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~ev~~ 717 (790)
+......+.+++.+||+.||.+||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11233567889999999999999999 77654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=319.67 Aligned_cols=261 Identities=26% Similarity=0.399 Sum_probs=204.4
Q ss_pred cCcceeeeecccCcEEEEeeeec-----CCcEEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEe--CCeE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-----DGTLIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIE--GNQL 517 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-----~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 517 (790)
++|++.+.||+|+||.||+|.+. ++..||||.+...... ....|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999853 3678999999765443 46789999999999999999999999987 5678
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999532 235899999999999999999999885 9999999999999999999999999998
Q ss_pred ccCCCCcce--eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchh---------hHHHHHH
Q 040908 598 LDEEDNTHI--STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF---------YLLDWAL 666 (790)
Q Consensus 598 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~---------~l~~~~~ 666 (790)
......... .....++..|+|||+.....++.++||||||+++|||+||+.|+......... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 665322211 11234566799999998889999999999999999999999987643221100 0011111
Q ss_pred HHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 667 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.+........+......+.+++.+|++.+|.+||+|.||+++|+.+
T Consensus 238 ----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 ----------LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ----------HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111111222345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=324.01 Aligned_cols=243 Identities=23% Similarity=0.309 Sum_probs=191.0
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 57899999997542 22345688899999888 699999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence 999988832 246899999999999999999999985 99999999999999999999999999874322111 2
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............++.......... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~----~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------R----I 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------C----C
Confidence 23467999999999999999999999999999999999999999643322221112222221111110 1 1
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
+......+.+++..|++.||.+||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11223456788999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=311.61 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=192.6
Q ss_pred eeecccCcEEEEeeeecC---CcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCC
Q 040908 452 NKIGEGGFGPVYKGLLAD---GTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~---g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 527 (790)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998543 35799998865432 33457889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCcc-ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 528 SLARALFGPEE-HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 528 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
+|.+++..... .....++..+..++.|++.||+|||+.+ ++||||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999954322 2235677888899999999999999875 9999999999999999999999999997543332211
Q ss_pred -eeccccCCCcccHHHhhcC-------CCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 607 -STRVAGTFGYMAPEYAMRG-------HLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 607 -~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
.....++..|+|||++... .++.++|||||||++|||++ |+.||......+.. .+ ...+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~----~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TY----TVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HH----HhhcccCCC
Confidence 1234578899999998642 35789999999999999996 99999654322211 11 011111222
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
.++.+... ....+.+++..|+ .+|++|||+.||++.|+
T Consensus 231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22322222 2234677888998 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.53 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=195.9
Q ss_pred eeecccCcEEEEeeeecC----CcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
++||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 26899999876543 24567899999999999999999999876 4568999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999432 36899999999999999999999874 9999999999999999999999999998664433322
Q ss_pred ee--ccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 607 ST--RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 607 ~~--~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.. ...++..|+|||.+....++.++|||||||++|||++ |+.||......+ +..+.. .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----~~~~~-------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----SGERL-------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----cCCcC--------
Confidence 11 1224568999999998899999999999999999998 999986543211 111111 11100
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
..+......+.+++.+|++.+|.+||++.++++.|++.
T Consensus 218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11112335678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=349.48 Aligned_cols=261 Identities=23% Similarity=0.364 Sum_probs=202.6
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.++||+|+||.||+|... +|+.||+|++.... ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999854 58899999986532 223457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCc-------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 522 EYLENNSLARALFGPE-------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
||+++|+|.+++.... .....+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 11234677888999999999999999985 9999999999999999999999999
Q ss_pred CccccCCCCc-----------------ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccc
Q 040908 595 LAKLDEEDNT-----------------HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE 657 (790)
Q Consensus 595 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~ 657 (790)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01123569999999999999999999999999999999999999996532211
Q ss_pred hhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCc
Q 040908 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP-LMSSVVSMLEGRV 723 (790)
Q Consensus 658 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~L~~~~ 723 (790)
.. +. .. ..++.... ........+.+++.+|++.||++|| ++.++.+.|+...
T Consensus 239 i~----~~------~~---i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 IS----YR------DV---ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hh----hh------hh---ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 10 00 00 00110000 0112334678899999999999996 5677777776543
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.49 Aligned_cols=240 Identities=23% Similarity=0.403 Sum_probs=188.7
Q ss_pred eeecccCcEEEEeeeecC-------------CcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 452 NKIGEGGFGPVYKGLLAD-------------GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~-------------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
+.||+|+||.||+|.+.. ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887655555567889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC-------eEEe
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-------PKIS 591 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-------~kl~ 591 (790)
+||||+++|+|..++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999988843 2346899999999999999999999874 999999999999987664 8999
Q ss_pred ecCCccccCCCCcceeeccccCCCcccHHHhh-cCCCCChhhHHHHHHHHHHHH-hCCCCCccccccchhhHHHHHHHHH
Q 040908 592 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-RGHLTDKADVYSFGIVALEIV-SGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 592 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
|||++...... ....++..|+|||++. ...++.++|||||||++|||+ +|+.|+......+.. . ..
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~-~~ 222 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE------R-FY 222 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH------H-HH
Confidence 99998754322 2245788999999886 466889999999999999998 588777543221110 0 00
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
. +.. .. .. .....+.+++..||+.||.+||++.++++.++
T Consensus 223 ~-~~~-~~-----~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 E-GQC-ML-----VT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred h-cCc-cC-----CC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 110 01 01 12346788999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=325.25 Aligned_cols=202 Identities=25% Similarity=0.353 Sum_probs=173.2
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999954 58899999986422 223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999942 2346889999999999999999999985 99999999999999999999999999876544
Q ss_pred CCcceeeccccCCCcccHHHhhc-----CCCCChhhHHHHHHHHHHHHhCCCCCccc
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMR-----GHLTDKADVYSFGIVALEIVSGRSNIMCK 653 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~ 653 (790)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 33322333569999999999873 45788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=316.16 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=198.4
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeC------
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEG------ 514 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------ 514 (790)
.+++.|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46778899999999999999999854 57899999986543 3456788999999998 799999999998753
Q ss_pred CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
...++||||+++++|.+++.... ...++|..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 46899999999999999985322 246899999999999999999999985 9999999999999999999999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
+++....... ......|+..|+|||++. +..++.++|||||||++|||++|+.||......... ...
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~~-- 228 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FLI-- 228 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HHH--
Confidence 9986543222 223456899999999986 345788999999999999999999998643221111 000
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..... +... .......+.+++.+||..+|.+||++.|+++
T Consensus 229 ~~~~~-----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNPA-----PRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCCC-----CCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00111 1111 1122346788999999999999999999865
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=322.22 Aligned_cols=263 Identities=22% Similarity=0.353 Sum_probs=197.9
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999854 678899999865432 2344678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 985 78887732 2345788999999999999999999885 9999999999999999999999999997543322
Q ss_pred cceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHH----------HHHHHHhhC
Q 040908 604 THISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLD----------WALLLKEQG 672 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~----------~~~~~~~~~ 672 (790)
. ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||......+...... |..... ..
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 236 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS-ND 236 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc-hh
Confidence 1 1223457899999999865 467899999999999999999999997554332221111 100000 00
Q ss_pred CcccccCCCCCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLMELVDPNLGS----NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.....-.+.... ........++.+++..|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 000112346788999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.41 Aligned_cols=250 Identities=25% Similarity=0.441 Sum_probs=203.4
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999995 57899999998765555556788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999832 35788999999999999999999875 9999999999999999999999999987654332
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........... . .......
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------------~--~~~~~~~ 234 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------------I--ATNGTPE 234 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------------e--ccCCCCC
Confidence 21 2234688999999999988899999999999999999999999965432211100 0 0000000
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+......+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112233456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.34 Aligned_cols=248 Identities=27% Similarity=0.460 Sum_probs=198.9
Q ss_pred eeecccCcEEEEeeeecC--C--cEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLAD--G--TLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~--g--~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999987655 556789999999999999999999999988 889999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc-
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH- 605 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~- 605 (790)
++|.+++..... ..++|..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999954322 46899999999999999999999885 999999999999999999999999999866443221
Q ss_pred -eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 606 -ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 606 -~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
......++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. . ........ .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~---~~~~~~~~--~------ 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL---K---KIDKEGER--L------ 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---HHHhcCCc--C------
Confidence 1123457889999999998899999999999999999999 99998644322211 1 11111110 0
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
..+......+.+++.+|++.+|.+||++.++++.|.
T Consensus 221 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 -ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123456888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.23 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=201.3
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999854 6889999988543 2334567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 999999988432 2245788999999999999999999875 99999999999999999999999999986543222
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||........ .... ..+...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~-~~~~~~--------- 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKV-CQGSYK--------- 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHH-hcCCCC---------
Confidence 22345689999999999888899999999999999999999999975322111 0111 111111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
..+......+.+++.+||+.+|.+||++.+++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0111233467889999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=322.63 Aligned_cols=240 Identities=25% Similarity=0.383 Sum_probs=190.1
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|... +|+.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999987542 22344567788888754 899999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999998842 246889999999999999999999885 9999999999999999999999999987432221 12
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... . .. .. . .+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~---~--~~-~~-~------~~~~~~-- 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF---E--SI-RV-D------TPHYPR-- 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---H--HH-Hh-C------CCCCCC--
Confidence 34467999999999999999999999999999999999999999754322111 1 00 00 0 111111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMS-SVV 716 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-ev~ 716 (790)
....++.+++..|++.||.+||++. ++.
T Consensus 218 --~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 --WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1234577899999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.70 Aligned_cols=247 Identities=24% Similarity=0.307 Sum_probs=195.2
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.|+..+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|++++++++|+|++++.+++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367789999999999999985 468899999986532 2223457889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999888532 2246899999999999999999999875 999999999999999999999999999765432
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ..+..... .. ..
T Consensus 156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~~~~~-~~--~~------ 222 (285)
T cd05632 156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVDRRVL-ET--EE------ 222 (285)
T ss_pred Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhhh-cc--cc------
Confidence 21 12356899999999999889999999999999999999999999754322111 11111100 00 00
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMS 713 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 713 (790)
.+.......+.+++..|++.+|.+||++.
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 --VYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred --ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 11112234568899999999999999944
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=348.14 Aligned_cols=262 Identities=23% Similarity=0.377 Sum_probs=201.5
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEe--CC
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIE--GN 515 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~ 515 (790)
.+...++|++.+.||+|+||.||+|... .+..||+|.+... .......|..|+.++++++|||||+++++|.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445678999999999999999999954 5778999988643 22335678999999999999999999998864 35
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCC----CcEEeccCCCCcEEecCC------
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR----LKIVHRDIKATNVLLDKD------ 585 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~iiHrDlk~~NILl~~~------ 585 (790)
.+++||||+++|+|.++|.........+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999995433333579999999999999999999998541 359999999999999642
Q ss_pred -----------CCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhc--CCCCChhhHHHHHHHHHHHHhCCCCCcc
Q 040908 586 -----------LNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR--GHLTDKADVYSFGIVALEIVSGRSNIMC 652 (790)
Q Consensus 586 -----------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~ 652 (790)
..+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||+||||+||+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 348999999998654322 2234569999999999864 4588999999999999999999999964
Q ss_pred ccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 040908 653 KTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLE 720 (790)
Q Consensus 653 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~ 720 (790)
..... ........ . +.+.. .....++.+++..||+.+|.+||++.|++. .+.
T Consensus 246 ~~~~~-----qli~~lk~-~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 246 ANNFS-----QLISELKR-G-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred CCcHH-----HHHHHHhc-C-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 33211 11111111 1 11100 012346788999999999999999999984 454
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=327.38 Aligned_cols=261 Identities=27% Similarity=0.406 Sum_probs=200.6
Q ss_pred hcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeC-C
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEG-N 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 515 (790)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46789999999999999999973 346789999997543 23345788999999999 789999999988654 4
Q ss_pred eEEEEEEeccCCChhhhhcCCcc---------------------------------------------------------
Q 040908 516 QLLLIYEYLENNSLARALFGPEE--------------------------------------------------------- 538 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 538 (790)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999853211
Q ss_pred ------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc-eeeccc
Q 040908 539 ------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVA 611 (790)
Q Consensus 539 ------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~ 611 (790)
....++|..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124788899999999999999999875 999999999999999999999999999865332221 112234
Q ss_pred cCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHH
Q 040908 612 GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQ 690 (790)
Q Consensus 612 gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 690 (790)
+++.|+|||++.+..++.++||||||+++|||++ |..||......... .... ..+.... .... .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----~~~~-~~~~~~~-----~~~~----~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRL-KEGTRMR-----APDY----T 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-----HHHH-hccCCCC-----CCCC----C
Confidence 6678999999998899999999999999999997 88888643222111 1111 1111100 1111 1
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 691 VRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 691 ~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
..++.+++..||+.+|.+||++.||++.|+...
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 235788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=303.51 Aligned_cols=259 Identities=23% Similarity=0.331 Sum_probs=198.7
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchh-c-HHHHHHHHHHhhccCCCceeeeeeEEEe--CCeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQ-G-NREFVNEIGTISALQHPHLVKLYGCCIE--GNQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 520 (790)
+.|+.+++|++|.||.||+|+. ++++.||+|+++..... + -..-++|+.+|.+++|||||.+-.+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4577789999999999999995 46889999999764322 1 2346799999999999999999887764 3579999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
||||+. +|..++..- ..++...++.-++.|+++|++|||... |+|||||++|+|+...|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 888888432 357888899999999999999999985 9999999999999999999999999999876
Q ss_pred CCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
.... ..+..+-|..|.|||.+.+. .|+...|+||+|||+.||+++++-|.+..+-++.+.+- ..-|...+.+-
T Consensus 229 sp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If-----~llGtPte~iw 302 (419)
T KOG0663|consen 229 SPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIF-----KLLGTPSEAIW 302 (419)
T ss_pred CCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHH-----HHhCCCccccC
Confidence 5433 34556779999999999874 68999999999999999999998887665443332221 11111111111
Q ss_pred CC-------------------CCCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PN-------------------LGSNVDKE-QVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~-------------------l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
|. ++..+... ..+.-.+++...+..||.+|-|+.|.++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11 11111111 2244567778889999999999999765
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.15 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=203.1
Q ss_pred hcCcceeeeecccCcEEEEeeeec--------CCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeC
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA--------DGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEG 514 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 514 (790)
.++|.+.+.||+|+||.||+|... ....+|+|.++... .....++.+|+.+++++ +||||++++++|...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 467889999999999999999742 24579999987542 33456788999999999 699999999999998
Q ss_pred CeEEEEEEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe
Q 040908 515 NQLLLIYEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL 582 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 582 (790)
+..++||||+++|+|.+++..... ....++|.++.+++.|++.||+|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999954221 1245899999999999999999999875 9999999999999
Q ss_pred cCCCCeEEeecCCccccCCCCcce-eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhh
Q 040908 583 DKDLNPKISDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFY 660 (790)
Q Consensus 583 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 660 (790)
++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~- 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF- 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 999999999999998654322211 112234568999999998899999999999999999999 88888643322211
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 661 LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 661 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
. . ...+... ..+.....++.+++.+|++.+|.+||++.|+++.|++..
T Consensus 247 --~---~-~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 247 --K---L-LREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred --H---H-HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1 1 1111111 111122346778999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.86 Aligned_cols=249 Identities=26% Similarity=0.473 Sum_probs=203.2
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
.+|++.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999984 578999999987655555677899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++++|.+++. ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999883 235899999999999999999999985 99999999999999999999999999886543322
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... .... ......
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~------~~~~-~~~~~~------- 235 (296)
T cd06655 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT-NGTPEL------- 235 (296)
T ss_pred c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh-cCCccc-------
Confidence 1 223468899999999998889999999999999999999999997543322111 0000 110011
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+......+.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011122346778899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.36 Aligned_cols=247 Identities=28% Similarity=0.466 Sum_probs=198.0
Q ss_pred eeecccCcEEEEeeeecCCcEEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCChh
Q 040908 452 NKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLA 530 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 530 (790)
++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999777999999998765433 4567999999999999999999999999999999999999999999
Q ss_pred hhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCccee-ec
Q 040908 531 RALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-TR 609 (790)
Q Consensus 531 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~ 609 (790)
+++... ...+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998432 235789999999999999999999885 99999999999999999999999999986543221111 11
Q ss_pred cccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcH
Q 040908 610 VAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDK 688 (790)
Q Consensus 610 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 688 (790)
..++..|+|||++.++.++.++|||||||++|||+| |..||......... . ... .. .....+.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~---~---~~~-~~---------~~~~~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---E---RIE-SG---------YRMPAPQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH---H---HHh-cC---------CCCCCCc
Confidence 234667999999988899999999999999999999 78887544321111 1 100 00 0001122
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 689 EQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 689 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
.....+.+++.+|++.+|.+||++.||++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 23457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=308.13 Aligned_cols=250 Identities=35% Similarity=0.556 Sum_probs=202.0
Q ss_pred eeecccCcEEEEeeeecC----CcEEEEEEccccchhc-HHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKSKQG-NREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|.... +..||+|.+....... .+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 7889999997654333 67889999999999999999999999999999999999999
Q ss_pred CChhhhhcCCccc-----cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 527 NSLARALFGPEEH-----RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 527 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
++|.+++...... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999543211 367899999999999999999999975 99999999999999999999999999986654
Q ss_pred CCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 602 DNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 602 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
... .......++..|+|||.+....++.++|||||||++|||++ |+.||......+ +.. .... +..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~~~~-~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLE---YLRK-GYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHH---HHHc-CCC-----
Confidence 321 12234557889999999988889999999999999999999 688887542211 111 1111 110
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
...+.....++.+++..|++.+|.+||++.|+++.|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112223457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.63 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=202.5
Q ss_pred cCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
++|++.+.||+|+||.||+|+.. +.+.|++|.+...... ...++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999853 2467999988654433 4567999999999999999999999999989999
Q ss_pred EEEEeccCCChhhhhcCCccc-----cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 519 LIYEYLENNSLARALFGPEEH-----RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
+||||+++|+|.+++...... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999543311 126899999999999999999999885 999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
|+++..............++..|+|||.+.+...+.++||||||+++|||++ |..||....... .... ...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~----~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNR----LQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHH----HHcC
Confidence 9987543322222233456778999999988888999999999999999999 777875332211 1111 1111
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 673 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
..... ........+.+++.+|++.+|.+||++.|+++.|+
T Consensus 235 ~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11100 11123346888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.14 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=198.0
Q ss_pred cceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|||++++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677889999999999999965 5778899998765555567889999999999999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 999988743 2346899999999999999999999975 99999999999999999999999999875433221 1
Q ss_pred eeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 607 STRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
.....++..|+|||++. +..++.++|||||||++|||++|+.||......+.. ... .. .......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~----~~-~~~~~~~--- 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKI----AK-SEPPTLA--- 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHH----hh-cCCCCCC---
Confidence 23356899999999984 345778999999999999999999998643321110 110 00 1000110
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+......+.+++.+||+.+|.+||++.++++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 ----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11123356789999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.39 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=192.6
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhcc---CCCceeeeeeEEEe-----CC
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISAL---QHPHLVKLYGCCIE-----GN 515 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 515 (790)
+|++.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999854 688999998865322 2234566777777665 79999999998864 34
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999985 8888884322 245899999999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchh-hHHHHHHHHHhhCC-
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF-YLLDWALLLKEQGN- 673 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~- 673 (790)
++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||......... ....+.........
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 986543221 23356899999999999889999999999999999999999998654332211 11110000000000
Q ss_pred ----c-ccccCCCCCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 ----L-MELVDPNLGS---NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ----~-~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. .....+.... .........+.+++.+|++.||.+|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000000 011123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=321.62 Aligned_cols=241 Identities=24% Similarity=0.359 Sum_probs=192.0
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 521 (790)
+|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999985 468899999987542 223456778899988885 577888999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998832 246899999999999999999999885 99999999999999999999999999875432
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .... ...
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~---~i~~-~~~------- 218 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---FQ---SIME-HNV------- 218 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH---HHHh-CCC-------
Confidence 221 12335699999999999988999999999999999999999999975432211 11 1010 110
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
.++.....++.+++.+|++.+|.+|++.
T Consensus 219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111223467889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.83 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=197.6
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.|+..+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++++++|++++++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999854 688999998865322 223457789999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999884322 24589999999999999999999987 4999999999999999999999999999765433
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
... ....|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ....... ... .
T Consensus 156 ~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~--~~~~~~~---~~~----~-- 222 (285)
T cd05630 156 QTI--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVERLVK---EVQ----E-- 222 (285)
T ss_pred ccc--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH--HHHhhhh---hhh----h--
Confidence 221 23468999999999999899999999999999999999999997543211100 0000000 000 0
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPL-----MSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 717 (790)
.........+.+++..|++.||.+||+ +.|+++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 --EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111122345788999999999999999 777664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=324.17 Aligned_cols=193 Identities=24% Similarity=0.324 Sum_probs=164.9
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
...+|++.+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999965 5678999975432 23569999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+. ++|.+++.. ....++|..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 995 588888842 2356899999999999999999999985 999999999999999999999999999754322
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCc
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIM 651 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~ 651 (790)
. ......||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 P--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred c--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 2 1234569999999999999999999999999999999999766553
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.19 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=203.2
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999954 68899999876543 23356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.. ...+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999998832 246899999999999999999999742 59999999999999999999999999987542221
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccc-----hhhHHHHHHHHHhhCCccccc
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE-----KFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~~ 678 (790)
.....|+..|+|||++.+..++.++|||||||++|||+||+.||......+ ...+.++........
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 123568999999999988899999999999999999999999997543321 111112211111100
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 719 (790)
.+.+. ......++.+++.+|++.||.+||++.|+++..
T Consensus 230 ~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 01111 112345688999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.65 Aligned_cols=251 Identities=29% Similarity=0.482 Sum_probs=196.7
Q ss_pred eeecccCcEEEEeeeecC-------CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 452 NKIGEGGFGPVYKGLLAD-------GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~-------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.+++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886543 23456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCcc---ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-----CeEEeecCC
Q 040908 524 LENNSLARALFGPEE---HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-----NPKISDFGL 595 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-----~~kl~DFGl 595 (790)
+++++|.+++..... ....++|.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999954321 1245789999999999999999999874 99999999999999887 899999999
Q ss_pred ccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 596 AKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 596 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
++....... .......++..|+|||++.++.++.++|||||||++|||+| |+.||......+ ..... ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH----hcCC
Confidence 975432221 11122346789999999999999999999999999999998 999986433211 11110 1111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
. ...+......+.+++.+||+.+|.+||++.+|++.|++
T Consensus 231 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 R---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred c---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 01122334578899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.14 Aligned_cols=254 Identities=20% Similarity=0.260 Sum_probs=193.6
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999965 47889999986432 222345888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999943 2346889999999999999999999875 99999999999999999999999999975543
Q ss_pred CCcceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 602 DNTHISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. ........ .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~--~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKE--R 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------HHHhCCCc--c
Confidence 3333333457999999999986 346788999999999999999999999754322111 11111000 0
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCC--CCCCCCCHHHHHH
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADV--SPTNRPLMSSVVS 717 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPt~~ev~~ 717 (790)
.--+.... ....++.+++.+|+.. ++..|+++.|+++
T Consensus 227 ~~~p~~~~----~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 227 FQFPAQVT----DVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred ccCCCccc----cCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 00011111 1234566677776654 4444788888865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.41 Aligned_cols=263 Identities=27% Similarity=0.408 Sum_probs=205.6
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEe
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIE 513 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 513 (790)
+++.++..++++|++.+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 55667777899999999999999999999996 468899999986532 2345677899999998 89999999999875
Q ss_pred C-----CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCe
Q 040908 514 G-----NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 588 (790)
Q Consensus 514 ~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 588 (790)
. +..++||||+++++|.+++.........+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3589999999999999988543333456899999999999999999999874 9999999999999999999
Q ss_pred EEeecCCccccCCCCcceeeccccCCCcccHHHhhcC-----CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHH
Q 040908 589 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-----HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLD 663 (790)
Q Consensus 589 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~ 663 (790)
||+|||+++........ .....|+..|+|||++... .++.++|||||||++|||++|+.||........ +..
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFK 244 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHH
Confidence 99999998865432211 1234688999999998643 368899999999999999999999865432111 111
Q ss_pred HHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 664 WALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 664 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+ .......+.+ +......+.+++.+|++.+|++||++.|+++
T Consensus 245 ~-----~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 I-----PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred H-----hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 0111111111 1123346889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.91 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=194.9
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999954 57889999986532 223345788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999432 246889999999999999999999874 99999999999999999999999999986654
Q ss_pred CCcceeeccccCCCcccHHHhhc-----CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMR-----GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+.. .......... .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-----~~i~~~~~~~-~ 228 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-----GKIMNHEERF-Q 228 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH-----HHHHcCCCcc-c
Confidence 43333334569999999999875 46788999999999999999999999754322111 1111000000 0
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTN--RPLMSSVVS 717 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~ 717 (790)
+.+.. . ....++.+++.+|+..++.+ |+++.++++
T Consensus 229 -~p~~~-~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 -FPSHI-T----DVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -CCCcc-c----cCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00101 1 12345677788888765443 467777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=324.02 Aligned_cols=263 Identities=21% Similarity=0.287 Sum_probs=197.0
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-----
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEG----- 514 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 514 (790)
...++|++.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999854 58899999986532 23345678899999999999999999988643
Q ss_pred -CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 515 -NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 515 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
...++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence 357999999975 5666662 24788899999999999999999985 999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH-----------
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL----------- 662 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~----------- 662 (790)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+.....
T Consensus 164 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred cccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9998654322 223456899999999999889999999999999999999999999754321111000
Q ss_pred -----HHHHHHHh-hCCcccccCCCC--------CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 663 -----DWALLLKE-QGNLMELVDPNL--------GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 663 -----~~~~~~~~-~~~~~~~~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.......+ .........+.. ...........+.+++.+|++.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 00000000 000000000000 00111122456789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=329.28 Aligned_cols=195 Identities=24% Similarity=0.304 Sum_probs=167.6
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
....|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+|||++++++..++..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3557999999999999999999965 478899996432 345689999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
++. ++|.+++.. ....++|..+..|+.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 688888742 2246899999999999999999999885 999999999999999999999999999865432
Q ss_pred Cc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCc
Q 040908 603 NT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIM 651 (790)
Q Consensus 603 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~ 651 (790)
.. .......||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 22 12234679999999999999999999999999999999999887654
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.92 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=191.3
Q ss_pred eeecccCcEEEEeeeec----CCcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEE-eCCeEEEEEEecc
Q 040908 452 NKIGEGGFGPVYKGLLA----DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCI-EGNQLLLIYEYLE 525 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~----~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey~~ 525 (790)
+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2357999998543 2334567889999999999999999999876 4556899999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+|+|.+++... ....++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999432 234678888999999999999999874 999999999999999999999999999754332111
Q ss_pred ---eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCC-CCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 606 ---ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR-SNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 606 ---~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
......++..|+|||++....++.++|||||||++|||++|. .|+..... ..+..+ ... +. .+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~---~~~-~~-----~~~ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVY---LLQ-GR-----RLL 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH---Hhc-CC-----CCC
Confidence 112334677899999998889999999999999999999964 45543221 111111 111 10 000
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
. +...+..+.+++..||+.+|++||++.||++.|+...
T Consensus 223 ~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 Q----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1 1112346889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=337.27 Aligned_cols=266 Identities=19% Similarity=0.272 Sum_probs=193.3
Q ss_pred HHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCC------CceeeeeeEEE
Q 040908 440 QIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQH------PHLVKLYGCCI 512 (790)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~ 512 (790)
++...+++|++.++||+|+||.||+|... .++.||||+++... ....++..|+.++..++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34456789999999999999999999854 57889999986432 223445667777766654 45889999887
Q ss_pred eC-CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-----
Q 040908 513 EG-NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----- 586 (790)
Q Consensus 513 ~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----- 586 (790)
.. ...++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++. +||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccc
Confidence 54 5788999987 6788888842 246899999999999999999999742 499999999999998765
Q ss_pred -----------CeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccc
Q 040908 587 -----------NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTK 655 (790)
Q Consensus 587 -----------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~ 655 (790)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998864322 22346799999999999999999999999999999999999999976543
Q ss_pred cchhhHHH---------HHHHH---------HhhCCcccccCCCC----CC-C-C-cHHHHHHHHHHHHHccCCCCCCCC
Q 040908 656 EEKFYLLD---------WALLL---------KEQGNLMELVDPNL----GS-N-V-DKEQVRVMINVALLCADVSPTNRP 710 (790)
Q Consensus 656 ~~~~~l~~---------~~~~~---------~~~~~~~~~~d~~l----~~-~-~-~~~~~~~l~~l~~~Cl~~dP~~RP 710 (790)
.+....+. |.... ...+.+....++.. .. . . .......+.+++..||+.||.+||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 32222111 11000 00000000011000 00 0 0 001234578999999999999999
Q ss_pred CHHHHHH
Q 040908 711 LMSSVVS 717 (790)
Q Consensus 711 t~~ev~~ 717 (790)
|+.|+++
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999986
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=306.36 Aligned_cols=254 Identities=26% Similarity=0.449 Sum_probs=205.0
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367999999999999999999864 5788999999766555667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999998843 2246899999999999999999999874 9999999999999999999999999997654322
Q ss_pred cceeeccccCCCcccHHHhhcC---CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRG---HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
. ......++..|+|||.+... .++.++|||||||++|||+||+.|+........... ..... ...+
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------~~~~~---~~~~ 224 (262)
T cd06613 156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------ISKSN---FPPP 224 (262)
T ss_pred h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhcc---CCCc
Confidence 1 12335688899999999776 889999999999999999999999865432221110 00010 0011
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+ .........+.+++.+||+.+|.+||++.+|+.
T Consensus 225 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 112234567889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.08 Aligned_cols=238 Identities=26% Similarity=0.449 Sum_probs=188.4
Q ss_pred eeecccCcEEEEeeeecCCc-----------EEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 452 NKIGEGGFGPVYKGLLADGT-----------LIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~g~-----------~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
+.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999975432 5788877654333 6788999999999999999999999988 778999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-------CeEEeec
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-------NPKISDF 593 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-------~~kl~DF 593 (790)
|||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999432 236899999999999999999999874 99999999999999888 7999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcC--CCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHh
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG--HLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKE 670 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 670 (790)
|+++.... .....++..|+|||++... .++.++|||||||++|||++ |..|+......+ +......
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~~~~~~~ 221 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KERFYQD 221 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------HHHHHhc
Confidence 99986543 1224467789999999876 78999999999999999999 466665432211 1111110
Q ss_pred hCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 671 QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 671 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
... . + . .....+.+++.+||+.+|.+||++.+|++.|+
T Consensus 222 -~~~--~--~---~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 -QHR--L--P---M----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -CCC--C--C---C----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0 0 0 01157889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=325.22 Aligned_cols=242 Identities=25% Similarity=0.338 Sum_probs=189.3
Q ss_pred eeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHH-HhhccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIG-TISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|.. .+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 468999999986542 223345566655 46778999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence 99998883 2346899999999999999999999885 99999999999999999999999999874322111 2
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... ...+ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~~~~-~~~~------~~~~-- 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY------DNIL-HKPL------VLRP-- 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH------HHHH-cCCc------cCCC--
Confidence 23467999999999999999999999999999999999999999754322111 0100 0110 0111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
.....+.+++..|++.+|.+||++.+.++.
T Consensus 218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 218 --GASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred --CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 123456788899999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=315.04 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=203.9
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEE-
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCI- 512 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~- 512 (790)
+.++.+..+.++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 455667778899999999999999999999854 57899999876432 2245678899999999 6999999999885
Q ss_pred ----eCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCe
Q 040908 513 ----EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 588 (790)
Q Consensus 513 ----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 588 (790)
.++..++||||+++++|.+++.........+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345689999999999999988543333456889999999999999999999874 9999999999999999999
Q ss_pred EEeecCCccccCCCCcceeeccccCCCcccHHHhhc-----CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHH
Q 040908 589 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-----GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLD 663 (790)
Q Consensus 589 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~ 663 (790)
||+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+......... ..
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FK 240 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hh
Confidence 9999999986543221 1223468999999998753 45788999999999999999999998644321110 00
Q ss_pred HHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 664 WALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 664 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
. .........++. .....+.+++.+|++.+|++||++.|+++.
T Consensus 241 ~-----~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 I-----PRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred c-----cccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000001111111 123457889999999999999999999763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.04 Aligned_cols=263 Identities=21% Similarity=0.356 Sum_probs=197.6
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999864 57899999986443 22345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
++ ++|.+++... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5888888432 345789999999999999999999875 9999999999999999999999999997543322
Q ss_pred cceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH----------HHHHHHHhhC
Q 040908 604 THISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL----------DWALLLKEQG 672 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~----------~~~~~~~~~~ 672 (790)
.. .....+++.|+|||++.+. .++.++|||||||++|||+||+.||......+..... .|.... ...
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL-SNE 236 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh-ccc
Confidence 11 1234578899999998754 5788999999999999999999999754432211100 010000 000
Q ss_pred CcccccCCCCCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLMELVDPNLGSNV----DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.....-.+...... .......+.+++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000001110000 0112346788999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=310.55 Aligned_cols=248 Identities=30% Similarity=0.466 Sum_probs=201.8
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999954 68899999986543 33456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999842 27899999999999999999999875 9999999999999999999999999998665432
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
. ......|+..|+|||++.+..++.++|||||||++|||+||+.||........ ... ..... .+.+.
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~-~~~~~-----~~~~~ 219 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFL-IPKNN-----PPSLE 219 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHH-hhhcC-----CCCCc
Confidence 1 12335688899999999988899999999999999999999999965432111 000 00111 11111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. .....+.+++..|+..+|++||+++++++
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 03346788999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.15 Aligned_cols=247 Identities=29% Similarity=0.461 Sum_probs=199.6
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+.|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34667788999999999999854 57899999986443 33456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++. ...+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999883 246889999999999999999999874 9999999999999999999999999998654332
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.. .....|+..|+|||++.+..++.++|||||||++|||+||+.|+......... ... . ....+.+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~~-~-----~~~~~~~- 221 (277)
T cd06642 156 IK-RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------FLI-P-----KNSPPTL- 221 (277)
T ss_pred hh-hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------hhh-h-----cCCCCCC-
Confidence 21 12345888999999999888999999999999999999999998643221111 000 0 0011111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.......+.+++.+|++.+|.+||+|.+|+.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ---CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2233456789999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=308.30 Aligned_cols=254 Identities=25% Similarity=0.430 Sum_probs=203.0
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEe--CCeEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIE--GNQLLLIY 521 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 521 (790)
+|++.+.||.|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 578899999999999999985 46789999988643 23345678899999999999999999998764 45679999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC--CCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||+++++|.+++.........+++..++.++.|++.||+|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999544333567899999999999999999999443 346999999999999999999999999999876
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
...... .....|+..|+|||++....++.++||||||+++|+|++|+.||....... +... ...+..
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~~----- 227 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASK----IKEGKF----- 227 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHH----HhcCCC-----
Confidence 543321 233568999999999998889999999999999999999999997543211 1111 111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+......+.+++.+|++.+|.+||++.+|++
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1122234467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=310.46 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=189.1
Q ss_pred eecccCcEEEEeeeecC---CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCC
Q 040908 453 KIGEGGFGPVYKGLLAD---GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNS 528 (790)
Q Consensus 453 ~LG~G~fG~Vy~g~~~~---g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 528 (790)
.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+.+++.++|+||++++++|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3578888876543 2334578899999999999999999999999999999999999999
Q ss_pred hhhhhcCCccc-cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc-e
Q 040908 529 LARALFGPEEH-RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-I 606 (790)
Q Consensus 529 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 606 (790)
|.+++...... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999543321 233567888999999999999999884 999999999999999999999999998754332211 1
Q ss_pred eeccccCCCcccHHHhhc-------CCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 607 STRVAGTFGYMAPEYAMR-------GHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||......+. .. . ... .....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~--~-~~~-~~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LK--Q-VVR-EQDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HH--H-Hhh-ccCccCC
Confidence 123346778999999753 356789999999999999999 7778754332211 00 0 011 1111222
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
++.+.. .....+.+++..|+ .||++||++.||+++|.
T Consensus 232 ~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222 23345567778898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.52 Aligned_cols=262 Identities=27% Similarity=0.417 Sum_probs=204.7
Q ss_pred HhcCcceeeeecccCcEEEEeeeec--------CCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA--------DGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIE 513 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 513 (790)
...+|++.+.||+|+||.||+|... .+..||+|.+.... ....+++.+|+.+++++ +||||++++++|..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3457889999999999999999742 12368999887542 33456789999999999 89999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEE
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVL 581 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 581 (790)
.+..+++|||+++|+|.+++..... ....++|.++..++.|++.||+|||+.+ ++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 9999999999999999999854211 1235889999999999999999999875 999999999999
Q ss_pred ecCCCCeEEeecCCccccCCCCcce-eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchh
Q 040908 582 LDKDLNPKISDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKF 659 (790)
Q Consensus 582 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 659 (790)
+++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 244 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 244 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence 9999999999999998654322211 122334568999999999899999999999999999998 888886433222
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 660 YLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 660 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
+...... +... ..+......+.+++.+|++.+|.+||++.|+++.|+....
T Consensus 245 ----~~~~~~~-~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 245 ----LFKLLKE-GHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ----HHHHHHc-CCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1111111 1111 1111233568899999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=308.59 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=199.2
Q ss_pred CcceeeeecccCcEEEEeeeecCCcEEEEEEccccc------hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKS------KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
+|++.+.||+|+||.||+|...+|+.+|+|.+.... ......+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998788999999886432 12235688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999942 245789999999999999999999875 9999999999999999999999999987543
Q ss_pred CCC-----cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 601 EDN-----THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 601 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
... ........|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~-- 226 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-----YIGAHRGL-- 226 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-----HhhhccCC--
Confidence 211 111223568999999999998889999999999999999999999996543221110 00000011
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.+.. .....+.+++.+|++.+|.+||++.|++.
T Consensus 227 ---~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ---MPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111212 23456788999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=305.24 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=203.0
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|+..+.||.|+||.||.+.. .++..+++|.+... .....+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588999999999999999884 46889999987643 334456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999995332 346899999999999999999999875 9999999999999999999999999998664433
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+.. ... ..+....
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~-~~~~~~~------- 220 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------VKI-VQGNYTP------- 220 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHH-HcCCCCC-------
Confidence 2 223456899999999998888899999999999999999999998653322111 111 1111111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
.......++.+++.+|++.+|.+||++.++++.
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 112234568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=322.19 Aligned_cols=262 Identities=21% Similarity=0.301 Sum_probs=195.7
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC-----
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN----- 515 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 515 (790)
..++|++.+.||+|+||.||++.. .+|..||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999985 45889999998643 2233567889999999999999999999986443
Q ss_pred -eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 516 -QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 516 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
..++||||+.+ +|.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999976 5665552 24788889999999999999999985 9999999999999999999999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhH-------------
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYL------------- 661 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l------------- 661 (790)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 997543322 22345689999999999998999999999999999999999999975432111000
Q ss_pred ---HHHHHHHHhh-CCc-----ccccCCCC---CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 662 ---LDWALLLKEQ-GNL-----MELVDPNL---GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 662 ---~~~~~~~~~~-~~~-----~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.......... ... .+...... ...........+.+++.+|++.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 000 00000000 00011122356789999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.01 Aligned_cols=203 Identities=25% Similarity=0.374 Sum_probs=174.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999864 68899999986532 233456888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999842 346889999999999999999999885 99999999999999999999999999874422
Q ss_pred CCc----------------------------------ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCC
Q 040908 602 DNT----------------------------------HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647 (790)
Q Consensus 602 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~ 647 (790)
... .......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0112356999999999999999999999999999999999999
Q ss_pred CCCccccc
Q 040908 648 SNIMCKTK 655 (790)
Q Consensus 648 ~p~~~~~~ 655 (790)
.||.....
T Consensus 234 ~Pf~~~~~ 241 (360)
T cd05627 234 PPFCSETP 241 (360)
T ss_pred CCCCCCCH
Confidence 99975543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=306.30 Aligned_cols=248 Identities=23% Similarity=0.416 Sum_probs=206.3
Q ss_pred hcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
..+|++.+.||+|.||.|-+|. ...|+.||||.+++.. .++.-.+.+|+++|+.++||||+.++.+|...+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3578888999999999999998 4679999999997753 34445678999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||..+|.|.+++ ..+..+++.+...++.||..|+.|+|.+. ++|||||.+|||||+++++||+|||++-++.
T Consensus 132 MEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999 34567999999999999999999999884 9999999999999999999999999998776
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCC-ChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLT-DKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
... ..++++|++-|.+||++.+..|. +..|-||+||+||-|+.|.+||++.+. ..++ ++. ..|.. ..
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lv---rQI-s~GaY---rE 272 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLV---RQI-SRGAY---RE 272 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHH---HHh-hcccc---cC
Confidence 543 34668999999999999998875 689999999999999999999986432 1111 111 11111 11
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 719 (790)
| +.+....-+++||+..+|++|.|+.+|..-.
T Consensus 273 P--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 P--------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred C--------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 2 1223456688899999999999999998743
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=307.79 Aligned_cols=248 Identities=29% Similarity=0.452 Sum_probs=197.9
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchh---------cHHHHHHHHHHhhccCCCceeeeeeEEEeCCe
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQ---------GNREFVNEIGTISALQHPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 516 (790)
+|.+.+.||+|+||.||+|.. .+++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999985 45789999988653221 12468889999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999932 246889999999999999999999875 999999999999999999999999999
Q ss_pred cccCCCCc-----ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh
Q 040908 597 KLDEEDNT-----HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ 671 (790)
Q Consensus 597 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 671 (790)
+....... .......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---------~~- 223 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI---------FK- 223 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH---------HH-
Confidence 86542211 1112345889999999999888999999999999999999999999653221110 00
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 672 GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 672 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......+.+ +......+.+++.+||+.+|.+||++.|+++
T Consensus 224 --~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 --IGENASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --HhccCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 001111122 2223456788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=312.12 Aligned_cols=252 Identities=25% Similarity=0.439 Sum_probs=201.9
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|++.+.||+|+||.||+|... ++..||+|.+..........|..|++++++++|+||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467899999999999999999964 6889999998766555667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999842 2346899999999999999999999985 9999999999999999999999999987543322
Q ss_pred cceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 604 THISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
. ......|++.|+|||++. ...++.++||||||+++|||++|+.||........ ...+ ..+..
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~-----~~~~~---- 225 (280)
T cd06611 158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKI-----LKSEP---- 225 (280)
T ss_pred c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHH-----hcCCC----
Confidence 2 123356899999999985 34467799999999999999999999865432111 1111 11110
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+.+ ..+......+.+++..||+.+|.+||++.++++
T Consensus 226 -~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 -PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred -CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 111 011122346788999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.49 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=200.0
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+|++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47889999999999999999965 58899999886432 2234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|++++.|..++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999988887632 235899999999999999999999974 999999999999999999999999999866543
Q ss_pred CcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH----------hh
Q 040908 603 NTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK----------EQ 671 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----------~~ 671 (790)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+... ....... ..
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY--LIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCChHHhhhccc
Confidence 32 1223457889999999876 457899999999999999999999997544322211 1111000 00
Q ss_pred CC-cccccCCCCCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 672 GN-LMELVDPNLGSNVD-----KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 672 ~~-~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ......+......+ ......+.+++.+|++.+|++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 00001111111111 112356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.93 Aligned_cols=253 Identities=24% Similarity=0.407 Sum_probs=189.0
Q ss_pred eecccCcEEEEeeeecCC---cEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCC
Q 040908 453 KIGEGGFGPVYKGLLADG---TLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNS 528 (790)
Q Consensus 453 ~LG~G~fG~Vy~g~~~~g---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 528 (790)
.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975433 346677665432 3345689999999999999999999999999999999999999999
Q ss_pred hhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC-ccee
Q 040908 529 LARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN-THIS 607 (790)
Q Consensus 529 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~-~~~~ 607 (790)
|.+++..........++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999643322345677778899999999999999874 9999999999999999999999999986432211 1122
Q ss_pred eccccCCCcccHHHhhc-------CCCCChhhHHHHHHHHHHHHhC-CCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 608 TRVAGTFGYMAPEYAMR-------GHLTDKADVYSFGIVALEIVSG-RSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 608 ~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
....++..|+|||++.. ..++.++|||||||++|||+++ ..||......+. .. ... .+......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~---~~~-~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV---LN---HVI-KDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHH-hhcccccCC
Confidence 33567899999998743 2457899999999999999974 667653322111 11 111 122223344
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
+.+...++ ..+.+++..|| .+|++||++.+|++.|.
T Consensus 232 ~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 44433333 35667888899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.70 Aligned_cols=244 Identities=25% Similarity=0.337 Sum_probs=189.3
Q ss_pred eeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHH-HhhccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIG-TISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|... +++.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 57889999986532 122334455544 56788999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. ...+++.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 999999842 245778888899999999999999985 99999999999999999999999999975322221 2
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ... . .. ... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~--i-~~-~~~------~----~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDN--I-LN-KPL------Q----L 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHH--H-Hh-CCc------C----C
Confidence 2346799999999999999999999999999999999999999975432221 111 1 00 110 0 1
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
.......+.+++..|++.+|.+||++.+.+..+.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 1122345778889999999999999875544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.81 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=199.1
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
++|++.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4678889999999999999985 468899999987655455567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++++|.+++.. ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999999842 246899999999999999999999985 99999999999999999999999999875543221
Q ss_pred ceeeccccCCCcccHHHhh---cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 605 HISTRVAGTFGYMAPEYAM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
......|+..|+|||++. ...++.++|||||||++|||++|+.|+.......... .. ..... ..+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~~-~~~~~---~~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LM-TKSNF---QPPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------hh-hccCC---CCCc
Confidence 123356899999999974 4568889999999999999999999986433211110 00 00110 0011
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.... ......+.+++.+|++.+|++||++.+|++
T Consensus 231 ~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1100 012345788999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.68 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=202.2
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCc----EEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGT----LIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.+|++.+.||+|+||.||+|... +|. .+|+|.+.... .....++.+|+.++++++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56788999999999999999854 232 58999886553 3345678999999999999999999999987 78899
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999532 34589999999999999999999987 4999999999999999999999999999866
Q ss_pred CCCCccee-eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 600 EEDNTHIS-TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 600 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
........ ....++..|+|||.+....++.++||||||+++||+++ |+.||......+ +...... +.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~-~~~--~ 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IPDLLEK-GER--L 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhC-CCC--C
Confidence 54332211 12224678999999988889999999999999999999 999986543221 1111111 110 0
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
..+......+.+++..||..+|.+||++.++++.|+....
T Consensus 231 -------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 -------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0111122457788999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.05 Aligned_cols=240 Identities=24% Similarity=0.408 Sum_probs=188.8
Q ss_pred eeecccCcEEEEeeeecC--------CcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 452 NKIGEGGFGPVYKGLLAD--------GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888888665555567889999999999999999999999998999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC--------eEEeecCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--------PKISDFGL 595 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~--------~kl~DFGl 595 (790)
+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999533 236899999999999999999999874 999999999999988765 59999998
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCC-CCCccccccchhhHHHHHHHHHhhCC
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGR-SNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
+...... ....++..|+|||++.+. .++.++|||||||++|||++|. .|+........ ........
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~~~- 222 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK------LQFYEDRH- 222 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH------HHHHHccc-
Confidence 8744321 224578899999999864 5789999999999999999995 45433221111 11111100
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
. .+.....++.+++..||+.+|++|||++++++.|+
T Consensus 223 -------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 -------Q----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------c----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 11112346789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.13 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=199.4
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEe-CCeEEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIE-GNQLLLIYE 522 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 522 (790)
+|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999954 57889999986532 2344578899999999999999999998764 446799999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++++|.+++... ....+++.++..++.+++.|++|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999532 2346899999999999999999999885 999999999999999999999999999866433
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
.. ......|++.|+|||++.+..++.++||||||++++||++|+.||....... +..... .+.+ +
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~-~~~~-----~-- 220 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRII-EGKL-----P-- 220 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHH-hcCC-----C--
Confidence 22 2234568899999999999899999999999999999999999986433211 111111 1111 1
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+......+.+++.+|++.+|++||++.++++
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 112233456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=310.90 Aligned_cols=264 Identities=23% Similarity=0.352 Sum_probs=196.5
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788999999999999999964 68899999986532 22346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
++ ++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 68888874322 2356899999999999999999999874 9999999999999999999999999997553322
Q ss_pred cceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhh-HH---------HHHHHHHhhC
Q 040908 604 THISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY-LL---------DWALLLKEQG 672 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~---------~~~~~~~~~~ 672 (790)
.......+++.|+|||++.+. .++.++|||||||++|||+||+.||.......... .. .|.... ...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT-SLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch-hhH
Confidence 112234578899999988654 57889999999999999999999997543221110 00 000000 000
Q ss_pred CcccccCCCCCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLMELVDPNLGS---NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......+..... ........++.+++.+|++.||.+|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 000112346778999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=312.80 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=200.3
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.+.|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367889999999999999999964 5889999999876666677899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 91 CPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999998887422 346899999999999999999999874 9999999999999999999999999987543221
Q ss_pred cceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 604 THISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
. ......++..|+|||++. ...++.++|||||||++|||++|+.||........ ..... ...
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~-~~~----- 231 (292)
T cd06644 165 Q-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIA-KSE----- 231 (292)
T ss_pred c-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHh-cCC-----
Confidence 1 122345888999999884 34567899999999999999999999864332111 00110 011
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.. ..+.....++.+++.+||+.+|++||++.|+++
T Consensus 232 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0111 011123346788999999999999999999865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.86 Aligned_cols=247 Identities=29% Similarity=0.451 Sum_probs=201.9
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677889999999999999964 58899999886542 34456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++|+|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999999832 35788999999999999999999874 9999999999999999999999999997654332
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
. ......++..|+|||++.+..++.++|||||||++|||+||+.|+.......... .+.....
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~~~~~~~ 218 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF----------------LIPKNNP 218 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----------------hhhcCCC
Confidence 2 1223458889999999988889999999999999999999999986443221110 0011111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..........+.+++..||+.+|.+||++.+++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 2223345667889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=308.05 Aligned_cols=273 Identities=21% Similarity=0.311 Sum_probs=205.0
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccc--cchhcHHHHHHHHHHhhccCCCceeeeeeEEEe-----CC
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSA--KSKQGNREFVNEIGTISALQHPHLVKLYGCCIE-----GN 515 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~ 515 (790)
+...|...+.||+|+||.|+++.. .+|+.||+|++.. ...-..++..+|+.+|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 445566678999999999999985 4789999999973 344456778899999999999999999998865 45
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..|+|+|+| .-+|...++ .+..++......++.|+++||.|+|+. +|+||||||+|+|++.+...||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 789999999 458988883 234588889999999999999999998 499999999999999999999999999
Q ss_pred ccccCCC-CcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH-----
Q 040908 596 AKLDEED-NTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL----- 668 (790)
Q Consensus 596 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~----- 668 (790)
|+..... .....+..+-|..|.|||++.. ..|+...||||.|||+.||++|++-|.+...-.+..++-.....
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 9977542 1223466778999999998865 57999999999999999999999988766544333222111000
Q ss_pred ---HhhCCcccccC---CCCCCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCcC
Q 040908 669 ---KEQGNLMELVD---PNLGSNVD---KEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGRVG 724 (790)
Q Consensus 669 ---~~~~~~~~~~d---~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~~~ 724 (790)
.........+. ...+..+. +......++++.+|+..||.+|+|++|.++ .|+....
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 00000011110 00011110 122345788899999999999999999886 4554443
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=325.20 Aligned_cols=259 Identities=18% Similarity=0.211 Sum_probs=196.4
Q ss_pred hcCcceeeeecccCcEEEEeeeec---CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA---DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
..+|++.+.||+|+||.||++... .+..||+|.+... ..+.+|++++++++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999743 3578999988542 23568999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 166 e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9986 68888882 2356899999999999999999999885 99999999999999999999999999976544
Q ss_pred CCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchh-hHHHHHHHHHhhCC------
Q 040908 602 DNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF-YLLDWALLLKEQGN------ 673 (790)
Q Consensus 602 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~------ 673 (790)
... .......||+.|+|||++....++.++|||||||++|||++|+.||......... .+..-... .....
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~-~~~~~~~~~~~ 316 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC-MQVHPLEFPQN 316 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH-hccCccccCCc
Confidence 322 1223467999999999999989999999999999999999999999754322111 11110000 00000
Q ss_pred -----------cccccCCCCC--CCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 -----------LMELVDPNLG--SNV-DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 -----------~~~~~d~~l~--~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......+... ... ......++.+++.+|++.||++||++.|++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 000 0011345678889999999999999999876
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.32 Aligned_cols=256 Identities=28% Similarity=0.480 Sum_probs=199.3
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCc----EEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGT----LIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
.++|+..+.||+|+||.||+|... +|. .||+|.+..... ....++.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356778899999999999999853 443 578888865432 2345788999999999999999999998754 467
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+++||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999843 2346889999999999999999999874 99999999999999999999999999986
Q ss_pred cCCCCcce-eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 599 DEEDNTHI-STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 599 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
........ .....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ...+. ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~-- 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLL----EKGER-- 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCCCC--
Confidence 54332221 122345778999999998899999999999999999998 888886432211 11111 11110
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.. .+......+.+++..||..+|++||++.++++.|+...
T Consensus 230 ~~-------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 LP-------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 01112346788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=306.56 Aligned_cols=247 Identities=27% Similarity=0.446 Sum_probs=197.4
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
++|++.+.||+|+||.||+|.. .++.||+|.+.... ....+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999985 57789999986532 345788999999999999999999998764 4799999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 999999995432 245889999999999999999999874 9999999999999999999999999987543221
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
.....+..|+|||++.+..++.++|||||||++|||++ |+.||......+. .... ..+...
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~~~~-~~~~~~--------- 216 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV------KECV-EKGYRM--------- 216 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH------HHHH-hCCCCC---------
Confidence 12234578999999988899999999999999999998 8988865432211 1111 111100
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.........+.+++.+|++.+|.+||++.++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111234567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.91 Aligned_cols=269 Identities=23% Similarity=0.323 Sum_probs=199.9
Q ss_pred hcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchh--cHHHHHHHHHHhhccCCCc-eeeeeeEEEeCC-----
Q 040908 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQ--GNREFVNEIGTISALQHPH-LVKLYGCCIEGN----- 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~----- 515 (790)
...|+.+++||+|.||+||+|+ ..+|+.||+|++.....+ .-....+|+.+|++++|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456677889999999999999 457899999999766442 2345689999999999999 999999998877
Q ss_pred -eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 516 -QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 516 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
.+++||||+.. +|.+++.........++-..+..++.||++||+|||+++ |+||||||.|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78999999976 899998543322134666789999999999999999985 9999999999999999999999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH-hhC
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK-EQG 672 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-~~~ 672 (790)
+|+...-... ..+..++|..|.|||++.+. .|+...||||+|||++||++++.-|.+..+.+....+--..... ++.
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9995542222 23456789999999999886 78999999999999999999998887665432221110000000 000
Q ss_pred Cc--ccccCC--CCC-----CCCcHHHH---HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 673 NL--MELVDP--NLG-----SNVDKEQV---RVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 673 ~~--~~~~d~--~l~-----~~~~~~~~---~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
+- ....+- ... ........ ....+++.+|++.+|.+|.|++..++.
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 000000 000 00111111 367889999999999999999988763
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.36 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=201.0
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|++.+.||+|+||.||++.. .+|+.||+|++... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999985 46889999998643 233446789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999884321 235789999999999999999999875 9999999999999999999999999998654322
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.. .....|++.|+|||+..+...+.++|||||||+++||++|+.|+......+. ..... .+.. +
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~~-----~--- 219 (256)
T cd08218 156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKII-RGSY-----P--- 219 (256)
T ss_pred hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHh-cCCC-----C---
Confidence 21 2234588899999999988899999999999999999999999864322111 11110 1111 1
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+......+.+++.+|++.+|.+||+|.+|++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 112223456889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=312.08 Aligned_cols=265 Identities=22% Similarity=0.370 Sum_probs=202.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46899999999999999999965 57899999886542 2334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877776652 2245899999999999999999999885 999999999999999999999999999876554
Q ss_pred CcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH---------HHHhhC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL---------LLKEQG 672 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~ 672 (790)
.........++..|+|||++... .++.++||||||+++|||++|+.||......+......... ......
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 43233445688999999999887 88999999999999999999999986543222111100000 000000
Q ss_pred Ccc--cccCCCCC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLM--ELVDPNLG----SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~--~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... +..+.... ..++.....++.+++..||..+|++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 00000000 0111123567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=313.22 Aligned_cols=264 Identities=21% Similarity=0.357 Sum_probs=199.1
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47889999999999999999975 588999998865322 234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++++|.++... ...++|..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999887632 235899999999999999999999875 999999999999999999999999999865443
Q ss_pred CcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchh-hHHHHHH-------HHHhhCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF-YLLDWAL-------LLKEQGN 673 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~-------~~~~~~~ 673 (790)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.. .+..+.. .......
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 32 2233557899999999875 45788999999999999999999888644321111 0000000 0000000
Q ss_pred -cccccCCCCCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 -LMELVDPNLGSNV-----DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 -~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......+...... .......+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000011110000 1122456889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=316.81 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=211.1
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh---cHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeE
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ---GNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 517 (790)
...+.|++.+.||+|.||.||+++.. +|+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+.+.+......
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567889999999999999999965 4999999999765433 3457899999999998 99999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC----CCeEEeec
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD----LNPKISDF 593 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~DF 593 (790)
++|||++.+|.|.+.+... .+++..+..++.|++.|++|||+.+ |+||||||+|+|+... +.+|++||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999433 2899999999999999999999975 9999999999999643 57999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
|++..... .......+||+.|+|||++....|+..+||||.||++|.|++|.+||...........+ ..++
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-------~~~~ 254 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-------LRGD 254 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-------HcCC
Confidence 99998776 33456688999999999999999999999999999999999999999876654433211 1111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ......-......+.+++..|+..||.+|+|+.++++
T Consensus 255 ~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 F------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred C------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1 1122222344567889999999999999999999988
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.03 Aligned_cols=251 Identities=33% Similarity=0.557 Sum_probs=199.7
Q ss_pred cceeeeecccCcEEEEeeeecC-----CcEEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 448 FDVANKIGEGGFGPVYKGLLAD-----GTLIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~~-----g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
|++.+.||+|+||.||++...+ +..||+|++...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999653 378999999765433 4678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999953221 12899999999999999999999885 99999999999999999999999999986654
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
..........+++.|+|||.+....++.++||||+|++++||++ |+.||....... ..... ..+...
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~~----- 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYL----KKGYRL----- 223 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcCCCC-----
Confidence 42222212337889999999988889999999999999999999 778876432211 11111 111110
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 719 (790)
.........+.+++.+|++.+|++|||+.|+++.|
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01112345688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.00 Aligned_cols=262 Identities=19% Similarity=0.284 Sum_probs=196.2
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC------
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEG------ 514 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 514 (790)
..++|++.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999854 57899999986532 23346788999999999999999999987543
Q ss_pred CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 6776662 24788899999999999999999885 9999999999999999999999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH---------HHH
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL---------DWA 665 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~ 665 (790)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+ .+.
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 998654322 223456899999999999999999999999999999999999999754322211100 000
Q ss_pred H-------HHH-hhCCcccc----cCCCCC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 666 L-------LLK-EQGNLMEL----VDPNLG----SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 666 ~-------~~~-~~~~~~~~----~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ... ........ ..+... ..........+.+++.+|++.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 000 00000000 000000 0011112346789999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.47 Aligned_cols=249 Identities=26% Similarity=0.363 Sum_probs=192.6
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc-----hhcHHHHHHHHHHhhccCCCceeeeeeEEEe--CCeE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS-----KQGNREFVNEIGTISALQHPHLVKLYGCCIE--GNQL 517 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 517 (790)
.+|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788899999999999999985 458899999886432 1233568889999999999999999998875 3578
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999842 235889999999999999999999874 9999999999999999999999999997
Q ss_pred ccCCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 598 LDEEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 598 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
........ ......++..|+|||++.+..++.++|||||||++|||++|+.||........ ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~----- 223 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIAT----- 223 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhc-----
Confidence 54321111 11234588999999999988899999999999999999999999864321111 000000
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
....+. .+......+.+++ .|+..+|++||+++||++
T Consensus 224 ~~~~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 QPTNPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 001111 1222233445555 688899999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.89 Aligned_cols=247 Identities=29% Similarity=0.439 Sum_probs=199.1
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-----hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-----KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999965 78999999886533 23456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999842 235889999999999999999999885 9999999999999999999999999988654
Q ss_pred CCCcceeeccccCCCcccHHHhhcCC-CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGH-LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
... ......|+..|+|||.+.... ++.++|+|||||++|||++|+.||........ ...........
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~---- 221 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFKIGRSKELP---- 221 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHHHHhcccCC----
Confidence 332 223456889999999987766 89999999999999999999999864431111 11111101111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+......+.+++.+|++.+|.+||++.+++.
T Consensus 222 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 -----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111123356788999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=309.74 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=199.6
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|+||.||++... +|..||+|.+... .......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999965 6899999988653 233346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.... ....+++..+..++.|++.||.|||+.. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999885421 1246899999999999999999999742 59999999999999999999999999997553221
Q ss_pred cceeeccccCCCcccHHHhhcCC------CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 604 THISTRVAGTFGYMAPEYAMRGH------LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
.....++..|+|||++.+.. ++.++|||||||++|||++|+.||.......... ... .+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~------~~~------~~ 222 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA------QLS------AI 222 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH------HHH------HH
Confidence 22345888999999985543 4789999999999999999999996432211110 000 01
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.. ....+.....++.+++.+|++.+|.+||++.+++.
T Consensus 223 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 223 VDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1100 01122234566788999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=305.78 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=201.8
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEG--NQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 521 (790)
++|+..+.||.|++|.||+|... +++.+|+|.+..... .....+.+|++++++++||||++++++|... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46889999999999999999964 578999999875432 3456789999999999999999999998653 4689999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++.........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887433333456889999999999999999999875 99999999999999999999999999875432
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccc--cchhhHHHHHHHHHhhCCcccccC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTK--EEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
... ....++..|+|||.+.+..++.++|||||||++|||++|+.||..... .....+..+... .....+ .
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~-~ 229 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL-K 229 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-c
Confidence 221 234578899999999988999999999999999999999999975532 111122222111 011111 1
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.... ........+.+++.+||+.+|.+|||+.|+++
T Consensus 230 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1110 01123456889999999999999999999877
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.90 Aligned_cols=256 Identities=19% Similarity=0.287 Sum_probs=192.5
Q ss_pred eeeeeccc--CcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 450 VANKIGEG--GFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 450 ~~~~LG~G--~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
+.++||+| +||+||++.. .+|+.||+|++.... ......+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999985 578999999987542 223456778999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999984322 235899999999999999999999875 99999999999999999999999987543221111
Q ss_pred c------eeeccccCCCcccHHHhhc--CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 605 H------ISTRVAGTFGYMAPEYAMR--GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 605 ~------~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... ... ..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~-----~~~~~~~ 229 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEK-----LNGTVPC 229 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHH-----hcCCccc
Confidence 0 1112346778999999976 45889999999999999999999999643221110 000 0000000
Q ss_pred ccC-------------------CCC-----------------CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 677 LVD-------------------PNL-----------------GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 677 ~~d-------------------~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.++ ... ...........+.+++.+|++.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 000 00111223457889999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=309.69 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=194.1
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHH-hhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGT-ISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|++.+.||+|+||.||+|... +|+.||+|++.... ......+..|+.. ++..+||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999964 68999999986542 2234456667665 566789999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|++ |+|.+++.........+++..+..++.|++.||+|||++. +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 6888877543333457899999999999999999999863 5999999999999999999999999999865432
Q ss_pred CcceeeccccCCCcccHHHhhc----CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 603 NTHISTRVAGTFGYMAPEYAMR----GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
. ..+...|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+. .. . .+ .
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~---~~-~-~~-----~ 224 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLK---QV-V-EE-----P 224 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHH---HH-H-hc-----C
Confidence 2 1233568899999998864 456889999999999999999999986322110 0000 00 0 01 1
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.... .....++.+++..|+..+|.+||++.++++
T Consensus 225 ~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 SPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111110 112356888999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.86 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=196.9
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch----------hcHHHHHHHHHHhhccCCCceeeeeeEEEeCC
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK----------QGNREFVNEIGTISALQHPHLVKLYGCCIEGN 515 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 515 (790)
+|.+.+.||+|+||.||+|.. .+|+.||+|.+..... ...+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467789999999999999985 4688999998753211 11245788999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999432 46899999999999999999999874 99999999999999999999999999
Q ss_pred ccccCCCCcc-eeeccccCCCcccHHHhhcCC--CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC
Q 040908 596 AKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGH--LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 596 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
++........ ......|+..|+|||++.... ++.++||||||+++||+++|+.|+......+. +. .. .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~---~~-~~-~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MF---KL-GN-K 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HH---Hh-hc-c
Confidence 9865432211 123356889999999987654 78999999999999999999999853321111 00 00 00 0
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.....++ ..........+.+++..|++.+|.+||++.+|++
T Consensus 228 ~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 228 RSAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111111 1111223457888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=312.34 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=199.5
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47889999999999999999965 489999999875432 23456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998532 2356899999999999999999999875 99999999999999999999999999875432
Q ss_pred CCcc----------------------------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccc
Q 040908 602 DNTH----------------------------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCK 653 (790)
Q Consensus 602 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~ 653 (790)
.... ......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 111246889999999999888999999999999999999999999654
Q ss_pred cccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 654 TKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 654 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...... ... .+..............+.+++.+|++.+|++||++...++
T Consensus 236 ~~~~~~-----~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 236 NRDETF-----SNI----------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred chHHHH-----HHH----------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 332211 110 1111111111114567899999999999999999444333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.03 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=203.0
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999954 67899999986532 23457789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++..... ...+++.....++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999953221 246899999999999999999999875 9999999999999999999999999987554332
Q ss_pred cc---eeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 604 TH---ISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 604 ~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
.. ......|+..|+|||++... .++.++|||||||++|||++|+.||........ ..... . . ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~---~--~-----~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTL---Q--N-----DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHh---c--C-----CC
Confidence 22 22335689999999999877 789999999999999999999999965432211 11100 0 0 01
Q ss_pred CCCCCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNV-DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+...... .......+.+++..|++.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111111 1133456789999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.37 Aligned_cols=260 Identities=20% Similarity=0.328 Sum_probs=194.2
Q ss_pred HHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-----
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEG----- 514 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 514 (790)
...++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4568899999999999999999985 467899999986532 22345678899999999999999999987543
Q ss_pred -CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 515 -NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 515 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
...++++|++ +++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 3578999987 778988773 245899999999999999999999985 999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHh--
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKE-- 670 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-- 670 (790)
|+++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......... ..+......
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~ 236 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL--KRIMEVVGTPS 236 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCC
Confidence 999865432 233568999999999876 56889999999999999999999999653321110 000000000
Q ss_pred --------hCCcccccC--CCCCCC-C---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 671 --------QGNLMELVD--PNLGSN-V---DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 671 --------~~~~~~~~d--~~l~~~-~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.......+. +..... . .......+.+++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000000 0 0011234678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.80 Aligned_cols=247 Identities=25% Similarity=0.419 Sum_probs=197.9
Q ss_pred cceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
|+....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344568999999999999854 6889999998665445556788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
++|.+++. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 103 ~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~- 173 (297)
T cd06659 103 GALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK- 173 (297)
T ss_pred CCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-
Confidence 99998872 245899999999999999999999885 999999999999999999999999998755433221
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......+.. .. . ....... .. .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~---~-~~~~~~~-----~~--~ 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KR---L-RDSPPPK-----LK--N 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH---H-hccCCCC-----cc--c
Confidence 22356899999999999888999999999999999999999999754322211 10 0 0010000 00 0
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.......+.+++..|++.+|.+||++.++++
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 1112345778899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=302.26 Aligned_cols=249 Identities=24% Similarity=0.303 Sum_probs=194.2
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-----hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-----KQGNREFVNEIGTISALQHPHLVKLYGCCIEG--NQL 517 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 517 (790)
++|++.+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999854 58899999875321 12245788899999999999999999998763 467
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+++++|.+++.. ...+++....+++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999842 235788889999999999999999885 9999999999999999999999999987
Q ss_pred ccCCCCc--ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 598 LDEEDNT--HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 598 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......... .. .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-----~~-~~--~~-- 224 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-----FK-IA--TQ-- 224 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-----HH-Hh--cC--
Confidence 5432111 1122345889999999998888999999999999999999999998643211110 00 00 00
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... ...+......+.+++..|+. +|.+||+++||++
T Consensus 225 -~~~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 -PTN----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCC----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 001 11233444567778888884 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=302.20 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=204.2
Q ss_pred cCcceeeeecccCcEEEEeeeecC-CcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
+.|++++.||+|.-|+||.+.+.+ +..+|+|++.+.. .....+...|-+||+.++||.++.|++.+..++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345567899999999999999764 5889999997753 334556788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
|||+||+|..+++.+.. ..++...+.-+|.+|+-||+|||-.| ||.|||||+||||-++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999865543 67899999999999999999999886 99999999999999999999999998642210
Q ss_pred ---------------------------------CCc----------------------ceeeccccCCCcccHHHhhcCC
Q 040908 602 ---------------------------------DNT----------------------HISTRVAGTFGYMAPEYAMRGH 626 (790)
Q Consensus 602 ---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~ 626 (790)
... ..+...+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 0112267999999999999999
Q ss_pred CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCC
Q 040908 627 LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSP 706 (790)
Q Consensus 627 ~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP 706 (790)
.+.+.|+|+|||++|||+.|+.||.+.+..+... .++-..+...........+.+||...+.+||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~---------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR---------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH---------------HHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 9999999999999999999999998876554432 1222222222222445678899999999999
Q ss_pred CCCCC----HHHHHH
Q 040908 707 TNRPL----MSSVVS 717 (790)
Q Consensus 707 ~~RPt----~~ev~~ 717 (790)
.+|-. +.||-+
T Consensus 377 ~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhccccchHHhhc
Confidence 99998 666643
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.62 Aligned_cols=248 Identities=25% Similarity=0.433 Sum_probs=198.3
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
.|.....||+|+||.||++.. .++..||||++........+.+.+|+.++++++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 344456799999999999985 4688999999876555556678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+++|.+++. ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 103 ~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 103 GGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 999999883 235889999999999999999999985 999999999999999999999999998754332221
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN 685 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 685 (790)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........... . .....+.+..
T Consensus 175 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------~-----~~~~~~~~~~- 240 (292)
T cd06658 175 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-------I-----RDNLPPRVKD- 240 (292)
T ss_pred -CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------H-----HhcCCCcccc-
Confidence 2234588999999999888899999999999999999999999865432211110 0 0011111111
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 686 VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 686 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.......+.+++..|+..+|.+|||+.|+++
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1122345778889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.53 Aligned_cols=251 Identities=30% Similarity=0.496 Sum_probs=200.2
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788999999999999999854 688999999875543 2567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.. ...+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999843 235789999999999999999999885 9999999999999999999999999998665433
Q ss_pred cceee---ccccCCCcccHHHhhcCC---CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 604 THIST---RVAGTFGYMAPEYAMRGH---LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 604 ~~~~~---~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
..... ...++..|+|||++.... .+.++||||||+++|||++|+.||...... |.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~---- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFHVGAG---- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHHHhcC----
Confidence 32211 356788999999998766 889999999999999999999999643211 1111110000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+.+... ......+.+++.+|++.+|.+||++.|++.
T Consensus 223 ~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01111111 112455678999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.33 Aligned_cols=246 Identities=28% Similarity=0.412 Sum_probs=205.5
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
-|+++++||+|.||.||||.++ .|+++|+|.+... .+.+++..|+.++++.+.|++|+++|.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3677899999999999999954 6999999998754 346789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
.|+..+.++ ..+.++++.++..|+...++||+|||.. .-||||||+.||||+.+|.+||+|||.|-.+.+.- .
T Consensus 112 AGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-A 184 (502)
T KOG0574|consen 112 AGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-A 184 (502)
T ss_pred CCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-H
Confidence 999999994 4457899999999999999999999986 46899999999999999999999999997554322 2
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC--CCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD--PNLG 683 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d--~~l~ 683 (790)
...++.||+-|||||++..-.|..++||||+|++..||..|++|+..--+-. ..-++. |...
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------------AIFMIPT~PPPT 248 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------------AIFMIPTKPPPT 248 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------------eeEeccCCCCCC
Confidence 2345789999999999999999999999999999999999999985321110 011111 1112
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+..-..++-++++.|+-..|++|-|+.++++
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 2334455678899999999999999999988765
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.57 Aligned_cols=249 Identities=25% Similarity=0.452 Sum_probs=202.1
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
++|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6888999999999999999985 467899999986554445567899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999832 35789999999999999999999885 99999999999999999999999999875543322
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
. .....|++.|+|||++....++.++|||||||++||+++|+.||........... ... .+....
T Consensus 171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~--------~~~~~~ 235 (293)
T cd06647 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IAT--------NGTPEL 235 (293)
T ss_pred c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhc--------CCCCCC
Confidence 1 2234688999999999888899999999999999999999999965432211100 000 000001
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.........+.+++..||+.+|++||++.+++.
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112223456788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=301.09 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=199.2
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|+..+.||+|+||.||++.. .+++.+|+|.+... .......+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588899999999999999985 46789999998654 233456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-CeEEeecCCccccCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDEED 602 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~ 602 (790)
+++++|.+++.... ...+++..+.+++.++++||+|||+.+ ++|+||||+||+++++. .+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999995322 345899999999999999999999874 99999999999998654 5899999999866443
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
.. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ .... . .+....
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~---~-~~~~~~------ 220 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKI---M-SGTFAP------ 220 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHH---H-hcCCCC------
Confidence 22 2235688999999999988889999999999999999999999865432211 1111 0 011111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+......+.+++..||+.+|.+|||+.|+++
T Consensus 221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11123446789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=319.60 Aligned_cols=244 Identities=30% Similarity=0.471 Sum_probs=200.7
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.|..++.||.|+||.||-|.. .+..+||||++....+ ..+.+++.||..|++++|||++.+-|||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355678899999999999994 4678999999976543 345789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
||-| +-.|++ .-++.++....+..|+.+.+.||+|||+.. .||||||+.||||++.|.+||+|||.|......
T Consensus 107 YClG-SAsDll---eVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCLG-SASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHhc-cHHHHH---HHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9965 777777 445678999999999999999999999984 899999999999999999999999999876554
Q ss_pred CcceeeccccCCCcccHHHhh---cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 603 NTHISTRVAGTFGYMAPEYAM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
+ .++|||.|||||++. .+.|+-|+||||+|++..||.-+++|....+.-... .+..+. -.
T Consensus 180 n-----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-------YHIAQN-----es 242 (948)
T KOG0577|consen 180 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YHIAQN-----ES 242 (948)
T ss_pred h-----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-------HHHHhc-----CC
Confidence 3 478999999999985 578999999999999999999999998765432111 111111 11
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
|.+. ..+-...+.+++-.|++.-|.+|||..+++.
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2232 2244566788899999999999999988765
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.97 Aligned_cols=256 Identities=24% Similarity=0.408 Sum_probs=197.7
Q ss_pred cceeeeecccCcEEEEeeeec----CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC------
Q 040908 448 FDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN------ 515 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 515 (790)
|.+.+.||+|+||.||+|.+. .+..||+|++.... ....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 36789999986542 334567889999999999999999999886532
Q ss_pred eEEEEEEeccCCChhhhhcCCc--cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 516 QLLLIYEYLENNSLARALFGPE--EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
..++++||+.+|+|.+++.... .....+++....+++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999998874321 12235788999999999999999999875 999999999999999999999999
Q ss_pred CCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhh
Q 040908 594 GLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQ 671 (790)
Q Consensus 594 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 671 (790)
|+++........ ......++..|++||.+....++.++|||||||++|||++ |+.||......+ +..+.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---cC
Confidence 999865432211 1122345678999999998889999999999999999999 888886433221 111111 11
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 672 GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 672 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
... . .+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~------~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRL------K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcC------C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 0 0112335788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.75 Aligned_cols=197 Identities=26% Similarity=0.446 Sum_probs=159.9
Q ss_pred eeeecccCcEEEEeeeec---CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEe--CCeEEEEEEecc
Q 040908 451 ANKIGEGGFGPVYKGLLA---DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIE--GNQLLLIYEYLE 525 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 525 (790)
.++||+|+||.||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 45789999986432 23457889999999999999999998864 456899999986
Q ss_pred CCChhhhhcCCc-----cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe----cCCCCeEEeecCCc
Q 040908 526 NNSLARALFGPE-----EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLA 596 (790)
Q Consensus 526 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla 596 (790)
+ +|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 7877763211 11235888999999999999999999985 9999999999999 45678999999999
Q ss_pred cccCCCCcc--eeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccc
Q 040908 597 KLDEEDNTH--ISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCK 653 (790)
Q Consensus 597 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~ 653 (790)
+........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 865433221 12346789999999999774 5889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=304.08 Aligned_cols=252 Identities=25% Similarity=0.447 Sum_probs=200.0
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc------hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS------KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
+|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999984 568899999986432 1124678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-CeEEeecCCccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKL 598 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~ 598 (790)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999842 246889999999999999999999985 99999999999998776 599999999876
Q ss_pred cCCCCcc---eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 599 DEEDNTH---ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 599 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
....... ......|+..|+|||++.+..++.++||||+|+++|||++|+.||............ ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~------ 224 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIA------ 224 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHh------
Confidence 5432211 122356889999999998888999999999999999999999998643322211111 0000
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........+.....++.+++.+|++.+|.+||++.|++.
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 ---SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000112233344567888999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=291.60 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=201.5
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++.|++.+.||+|.|+.||+... ..|+.+|+|.+... +..+.+++.+|+.+-+.++|||||++.+...+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999984 57889999887533 334677889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC---CCCeEEeecCCcc
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAK 597 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla~ 597 (790)
+|+|.|++|..-+.. +...++..+-..+.||++||.|+|.++ |+|||+||+|+||-. ..-+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999999876632 245677788889999999999999985 999999999999943 3458999999999
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
... ........+||++|||||++...+|+..+|||+-||+||-|+.|..||...+....+ + +. ..+.. -
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly---e--~I--~~g~y--d 230 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---E--QI--KAGAY--D 230 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH---H--HH--hcccc--C
Confidence 776 233445678999999999999999999999999999999999999999764332211 1 11 11111 1
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+++ ..-....++..+++.+|+..||.+|.|+.|.+.
T Consensus 231 ~~~----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 YPS----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCC----cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111 111123346788899999999999999998764
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=317.83 Aligned_cols=240 Identities=24% Similarity=0.316 Sum_probs=184.6
Q ss_pred ecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhcc---CCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 454 IGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISAL---QHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 454 LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
||+|+||.||+|... +++.||+|++..... .....+..|..++.+. +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999854 689999999865322 2223455677776655 699999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 999998842 346899999999999999999999985 99999999999999999999999999875332221 2
Q ss_pred eeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN 685 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 685 (790)
.....||+.|+|||++.+. .++.++|||||||++|||+||+.||......+.. .. ...+.. .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~------~~-i~~~~~------~~~~~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY------RN-IAFGKV------RFPKN 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH------HH-HHcCCC------CCCCc
Confidence 2346799999999998764 4789999999999999999999999754322111 00 011111 11110
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 040908 686 VDKEQVRVMINVALLCADVSPTNRPL----MSSVVS 717 (790)
Q Consensus 686 ~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~ev~~ 717 (790)
.....+.+++.+|++.+|.+||+ +.++++
T Consensus 220 ---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 ---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 12345678899999999999995 555443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.53 Aligned_cols=261 Identities=24% Similarity=0.363 Sum_probs=199.9
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999964 68999999987543 23346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+ +++|.+++... ...+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998432 256899999999999999999999875 9999999999999999999999999998665433
Q ss_pred cceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh---------CC
Q 040908 604 THISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ---------GN 673 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---------~~ 673 (790)
........|+..|+|||++.+. .++.++||||+||++|||+||+.||........ ..+....... ..
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccC
Confidence 2223345689999999988654 468899999999999999999877754332111 1111100000 00
Q ss_pred c---ccccCCCCC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 L---MELVDPNLG----SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~---~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+ ..+..+... .+...+....+.+++.+|++.+|.+||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 000000000 0000122467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.44 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=202.3
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEe
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIE 513 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 513 (790)
.++.++..+.+.|++.+.||+|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 35667777888999999999999999999996 468899999885533 3345688899999998 79999999999853
Q ss_pred ------CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC
Q 040908 514 ------GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 587 (790)
Q Consensus 514 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 587 (790)
.+..+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 457899999999999999985322 245788889999999999999999875 999999999999999999
Q ss_pred eEEeecCCccccCCCCcceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH
Q 040908 588 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662 (790)
Q Consensus 588 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 662 (790)
++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||...........
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~- 237 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL- 237 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-
Confidence 99999999875432211 122356899999999875 34678899999999999999999999864332111100
Q ss_pred HHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 663 DWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 663 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......+... .......+.+++.+||+.+|.+||++.|+++
T Consensus 238 -----------~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 -----------IPRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----------HhhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000111111 1123456889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.40 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=200.7
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCC-----
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGN----- 515 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~----- 515 (790)
.++++|++.+.||+|+||.||+|... +++.+++|++..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45789999999999999999999964 578899998865433 346789999999999 7999999999997644
Q ss_pred -eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 516 -QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 516 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
..++||||+++++|.+++.........+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999998543323457899999999999999999999875 9999999999999999999999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhc-----CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMR-----GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||........ +.. .
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~-----~ 230 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK-----I 230 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH-----h
Confidence 9875543222 1223458899999998753 3467899999999999999999999964321111 000 0
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.... .+.+ .........+.+++.+|+..||++|||+.|+++
T Consensus 231 ~~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0011 1111 112224557889999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=305.95 Aligned_cols=263 Identities=22% Similarity=0.313 Sum_probs=198.2
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh-----cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ-----GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
+|++.+.||+|+||.||+|... +|+.||+|++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999964 6899999998754322 245677899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+ +|+|.+++.... ..+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999994322 36899999999999999999999985 9999999999999999999999999998665
Q ss_pred CCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH-HHHH-----HHHhhCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL-DWAL-----LLKEQGN 673 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~~-----~~~~~~~ 673 (790)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||......+..... .... .......
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 43221 123356788999999865 45788999999999999999997777543321111000 0000 0000000
Q ss_pred cccccCCCCCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 LMELVDPNLGSNVD-----KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.............+ ......+.+++..|++.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 10111100001111 122457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.00 Aligned_cols=260 Identities=20% Similarity=0.315 Sum_probs=194.9
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788999999999999999964 688999999865322 2235678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+. ++|.+++.. ....+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 478877742 2346899999999999999999999885 9999999999999999999999999998554322
Q ss_pred cceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchh-hH----------HHHHHHHHhh
Q 040908 604 THISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF-YL----------LDWALLLKEQ 671 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l----------~~~~~~~~~~ 671 (790)
.. .....++..|+|||++.+. .++.++|||||||++|||+||+.|+......... .. ..|.... ..
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 231 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS-KL 231 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhh-hc
Confidence 21 1234578899999998764 4689999999999999999999987543321110 00 0010000 00
Q ss_pred CCcccccCCCCCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 672 GNLMELVDPNLGSN-----VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 672 ~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...... +..... .......++.+++..|++.||.+|||+.|+++
T Consensus 232 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPY--PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccc--CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 000000 01123456788999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=290.24 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=201.6
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch----hcH----HHHHHHHHHhhcc-CCCceeeeeeEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK----QGN----REFVNEIGTISAL-QHPHLVKLYGCCIE 513 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~----~~~----~~~~~E~~~l~~l-~H~niv~l~g~~~~ 513 (790)
.-+.|+..+.||.|..+.|-++.. ..|+..|+|++..... ... +.-..|+.+|+++ .||+|+++.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345677889999999999999885 4688999999865321 112 3345799999998 69999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
....++|+|.|+.|.|.|+| .+...++++...+|+.|+.+|++|||.. +|+||||||+|||+|++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999 3457899999999999999999999987 5999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhc------CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMR------GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 667 (790)
|+|+..+.+.. ....+||++|+|||.+.. ..|+...|+|+.||+||-|+.|.+||..... ..+. .
T Consensus 168 GFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---mlML----R 238 (411)
T KOG0599|consen 168 GFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---MLML----R 238 (411)
T ss_pred ceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---HHHH----H
Confidence 99998776543 255789999999998853 3578899999999999999999999964211 1111 1
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+..+|+. ++- ...-.+......+++.+|++.||++|-|.+|+++
T Consensus 239 ~ImeGky-qF~-----speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 MIMEGKY-QFR-----SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHhccc-ccC-----CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1112221 111 1111234556789999999999999999999986
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=303.16 Aligned_cols=247 Identities=30% Similarity=0.465 Sum_probs=199.3
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+-|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3467789999999999999985 468899999876432 33346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++. ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999999983 235899999999999999999999875 9999999999999999999999999987654322
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.. .....++..|+|||++....++.++|||||||++|||++|+.|+....... +.... .... .+.
T Consensus 156 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~~-----~~~-- 220 (277)
T cd06641 156 IK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLI-PKNN-----PPT-- 220 (277)
T ss_pred hh-hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHH-hcCC-----CCC--
Confidence 11 223468889999999988889999999999999999999999986432211 11110 0111 011
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........+.+++.+|++.+|.+||++.+++.
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 221 --LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred --CCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11223456788999999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=305.22 Aligned_cols=266 Identities=22% Similarity=0.326 Sum_probs=195.8
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+|+.+++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999985 46889999998654332 2346788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+. +++.+++... ...+.+..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 6777766322 245788889999999999999999885 99999999999999999999999999975433
Q ss_pred CCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH----------Hh
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL----------KE 670 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~----------~~ 670 (790)
.... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||.............|.... ..
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 2211 1234578899999998753 5788999999999999999999999754332111111111000 00
Q ss_pred -hCCcccccCCCCCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 671 -QGNLMELVDPNLGSNVD-----KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 671 -~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.....+........... ......+.+++.+|++.||.+|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000 011346778899999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=306.98 Aligned_cols=263 Identities=22% Similarity=0.361 Sum_probs=194.9
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999965 6889999998654322 234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+.+ +|.+++... ...+++.....++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 899988432 236889999999999999999999874 9999999999999999999999999987543211
Q ss_pred cceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccc-hhhHHH----------HHHHHHhh
Q 040908 604 THISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE-KFYLLD----------WALLLKEQ 671 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~l~~----------~~~~~~~~ 671 (790)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...... |......
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 235 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN- 235 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc-
Confidence 1 1122346889999999875 457899999999999999999999996443111 110000 0000000
Q ss_pred CCcccc----c-CCCCCCCCc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 672 GNLMEL----V-DPNLGSNVD-KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 672 ~~~~~~----~-d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...... . ...+..... ......+.+++..|++.+|++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0 000000000 011256778999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=298.77 Aligned_cols=251 Identities=27% Similarity=0.461 Sum_probs=205.0
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|++|.||+|... +++.|++|++..... .....+.+|+.++.+++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46889999999999999999966 589999999876543 4457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhh-cCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
+++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999432 568999999999999999999998 74 999999999999999999999999999866443
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
... .....++..|+|||.+....++.++||||||+++|||+||+.|+.............+.. ... .+..
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~-----~~~~ 223 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGP-----PPSL 223 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCC-----CCCC
Confidence 322 123568899999999998889999999999999999999999986553211111111111 010 1111
Q ss_pred CCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 683 GSNVDKE-QVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 683 ~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+.. ....+.+++..|++.+|++||++.|+++
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 112 3457889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=311.12 Aligned_cols=197 Identities=26% Similarity=0.449 Sum_probs=159.5
Q ss_pred eeeecccCcEEEEeeeec---CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEe--CCeEEEEEEecc
Q 040908 451 ANKIGEGGFGPVYKGLLA---DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIE--GNQLLLIYEYLE 525 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 525 (790)
..+||+|+||.||+|... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999864 35789999886532 23467889999999999999999999854 457899999987
Q ss_pred CCChhhhhcCCc-----cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe----cCCCCeEEeecCCc
Q 040908 526 NNSLARALFGPE-----EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLA 596 (790)
Q Consensus 526 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla 596 (790)
+ +|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7777663211 12235888999999999999999999985 9999999999999 56678999999999
Q ss_pred cccCCCCcc--eeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccc
Q 040908 597 KLDEEDNTH--ISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCK 653 (790)
Q Consensus 597 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~ 653 (790)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 865433221 1233568999999999876 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=308.76 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=200.6
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||++... .++.||+|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47889999999999999999964 57899999986543 223457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999932 246899999999999999999999874 99999999999999999999999999874211
Q ss_pred CC--------------cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH
Q 040908 602 DN--------------THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 602 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 667 (790)
.. ........|+..|+|||++....++.++|||||||++|||++|+.||......+ +...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH
Confidence 00 001122457889999999988889999999999999999999999996443221 1111
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
... +. ...+.... .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 228 ~~~-~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VIS-DD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHh-cc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 110 11 11111111 223457899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.74 Aligned_cols=253 Identities=24% Similarity=0.422 Sum_probs=201.6
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788899999999999999965 68899999987653 34456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhh-cCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
+++++|.+++... ...+++..+..++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999998432 2568889999999999999999998 5 5999999999999999999999999998754322
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
... ...++..|+|||++.+..++.++||||||+++|+|++|+.||........ ...+....... .. .+.+
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~-~~-----~~~~ 224 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVN-EP-----PPRL 224 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhc-CC-----CCCC
Confidence 211 15688999999999998999999999999999999999999865422111 11111111111 10 0111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ......+.+++..|+..+|.+||++.+++.
T Consensus 225 ~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 PS---GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred Ch---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11 114456889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=303.15 Aligned_cols=247 Identities=26% Similarity=0.450 Sum_probs=198.5
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc-chhcHHHHHHHHHHhhccC---CCceeeeeeEEEeCCeEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK-SKQGNREFVNEIGTISALQ---HPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 521 (790)
.|+..+.||+|+||.||+|.. .+++.||+|.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999995 56899999998654 2334567889999999996 999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998832 26899999999999999999999885 99999999999999999999999999986654
Q ss_pred CCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.... .....|+..|+|||++.++ .++.++|||||||++|+|++|+.||.......... .......+
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------------~~~~~~~~ 220 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------------LIPKSKPP 220 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------------ccccCCCC
Confidence 3322 2335689999999998754 46889999999999999999999996543211110 00001111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+... ....++.+++..|++.+|.+||++.|++.
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111 13456888999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.55 Aligned_cols=247 Identities=29% Similarity=0.488 Sum_probs=196.2
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.+.|++.+.||+|+||.||+|... +|+.||+|++.... ....+++.+|+++++.++||||++++++|.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999864 68899999886432 23345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+. |++.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 577776632 2346899999999999999999999875 9999999999999999999999999987654
Q ss_pred CCCcceeeccccCCCcccHHHhh---cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
.. ....++..|+|||++. ...++.++||||||+++|||+||+.||.......... .. ....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~~-~~~~---- 230 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HI-AQND---- 230 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------HH-hcCC----
Confidence 32 2345788999999874 4568889999999999999999999986543221110 00 0000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
.+.+ ........+.+++.+||+.+|.+||++.+|+..
T Consensus 231 -~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 -SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0111 112344578899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=305.59 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=198.0
Q ss_pred cceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeEEEEEE
Q 040908 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEG--NQLLLIYE 522 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 522 (790)
|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999965 58899999997653 33346788999999999999999999999987 88999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++ +|.+++... ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 888888432 246899999999999999999999875 999999999999999999999999999866544
Q ss_pred CcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC---Ccccc-
Q 040908 603 NTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG---NLMEL- 677 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~- 677 (790)
.........++..|+|||.+.+ ..++.++||||||+++|||+||+.||...................... ...+.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 3222233457889999997764 457899999999999999999999997554322111100000000000 00000
Q ss_pred ----cCC------CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 ----VDP------NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ----~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+ .+...+...+...+.+++..|++.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 0000001112557889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=304.43 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=197.2
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47899999999999999999964 68999999986532 223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999843 246899999999999999999999975 99999999999999999999999999986544
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
. .....|++.|+|||.+.....+.++||||||+++|||++|+.||........ +... ..+. ..
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~--~~~~------~~ 216 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-----YEKI--LEGK------VR 216 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHH--hcCC------cc
Confidence 3 2335689999999999888889999999999999999999999864431110 0110 0111 11
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVV 716 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~ 716 (790)
+ +......+.+++.+||+.+|.+|| +..|++
T Consensus 217 ~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 F----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred C----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1 112235678899999999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=313.07 Aligned_cols=201 Identities=25% Similarity=0.375 Sum_probs=170.2
Q ss_pred cCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchhcHHHHHHHHHHhhccC-C-----CceeeeeeEEEeCCeEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-H-----PHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~ 518 (790)
-+|++.+.||+|.||.|-+|. ..+++.||||+++... .-..+...|+.+|..++ | -|+|++++||...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 388999999999999999999 4568999999997643 33455678999999997 4 48999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC--CCeEEeecCCc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD--LNPKISDFGLA 596 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~kl~DFGla 596 (790)
||+|.+.. +|.+++.... ...++...+..|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||.|
T Consensus 265 iVfELL~~-NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhhh-hHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 99998765 8999996543 356899999999999999999999875 9999999999999754 36999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccc
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE 657 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~ 657 (790)
+.....-. ...-+.-|.|||++.+.+|+.+.||||||||++||++|.+-|.+..+.+
T Consensus 339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 96554322 3445678999999999999999999999999999999987776555444
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=307.61 Aligned_cols=267 Identities=22% Similarity=0.305 Sum_probs=196.5
Q ss_pred CcceeeeecccCcEEEEeeeec---CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA---DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEG--NQLL 518 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 518 (790)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788999999999999999964 47899999997633 33346678899999999999999999999988 7899
Q ss_pred EEEEeccCCChhhhhcCCccc-cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC----CCCeEEeec
Q 040908 519 LIYEYLENNSLARALFGPEEH-RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK----DLNPKISDF 593 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~----~~~~kl~DF 593 (790)
+||||+++ +|.+++...... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 666666322222 236889999999999999999999885 999999999999999 999999999
Q ss_pred CCccccCCCCc--ceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccch-------hhHHH
Q 040908 594 GLAKLDEEDNT--HISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEK-------FYLLD 663 (790)
Q Consensus 594 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-------~~l~~ 663 (790)
|+++....... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 112235678999999988764 578999999999999999999999975443220 00110
Q ss_pred HHHHHH-----------hhCCcccccCCCCCCCCc-----H------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 664 WALLLK-----------EQGNLMELVDPNLGSNVD-----K------EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 664 ~~~~~~-----------~~~~~~~~~d~~l~~~~~-----~------~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
....+. +........+......++ . .....+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000000000000000011 0 22346889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=302.49 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=199.4
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
+|...+.||+|++|.||+|.. .+++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 345567999999999999985 4688999999865554555678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999999843 35889999999999999999999985 99999999999999999999999999875543322
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN 685 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 685 (790)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ...... .. .+....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~-~~-----~~~~~~- 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRD-NL-----PPKLKN- 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHh-cC-----CCCCcc-
Confidence 12235689999999999888899999999999999999999999865332111 111111 11 111110
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 686 VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 686 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.......+.+++.+|++.+|++||++.++++
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1113356889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=298.18 Aligned_cols=249 Identities=23% Similarity=0.431 Sum_probs=199.1
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|++.+.||+|+||.||+|... +|..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999965 57899999986532 23345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-CeEEeecCCccccCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDEED 602 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~ 602 (790)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998532 2245799999999999999999999875 99999999999999885 4699999999865433
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
.. ......|++.|+|||+..+..++.++|||||||++|||++|+.||....... +..... .+....
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~------ 221 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC-QGYFAP------ 221 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-cccCCC------
Confidence 22 2223458999999999988889999999999999999999999986432211 111111 111111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........+.+++.+|++.+|++||++.|+++
T Consensus 222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11122346788899999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.90 Aligned_cols=249 Identities=29% Similarity=0.497 Sum_probs=203.1
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
+|+..+.||+|++|.||++... ++..+++|++..........+.+|++++++++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999965 688999999977655556789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+++|.+++... ...+++..+..++.|++.||+|||.. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998432 24689999999999999999999987 499999999999999999999999999986654332
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN 685 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 685 (790)
.....++..|+|||++....++.++||||||+++|+|++|+.|+.......... . ..........+
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~-~~~~~~~~~~~------ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------K-IATNGPPGLRN------ 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------H-HHhcCCCCcCc------
Confidence 234568899999999988889999999999999999999999986542211110 0 01111111111
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 686 VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 686 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.......+.+++..|++.+|++|||+.|+++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112456888999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=305.32 Aligned_cols=264 Identities=21% Similarity=0.336 Sum_probs=198.1
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh--cHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ--GNREFVNEIGTISALQHPHLVKLYGCCIEG--NQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 520 (790)
++|++.+.||+|+||.||+|... +++.+|+|.++..... ....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888999999999999999965 5889999998654322 234577899999999999999999999877 889999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+.+ +|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 898888432 236899999999999999999999885 9999999999999999999999999998655
Q ss_pred CCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH----------HHHHHHH
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL----------DWALLLK 669 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~----------~~~~~~~ 669 (790)
..... .....+++.|+|||++.+. .++.++|+||||+++|||++|+.||...........+ .|.....
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 43221 1234578899999998764 4688999999999999999999999754332211100 0110000
Q ss_pred ----hhCCcccccCCCCCCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 670 ----EQGNLMELVDPNLGSNVDKE-QVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 670 ----~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......+.....+...++.. ....+.+++..|++.+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000011111111112221 3456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.99 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=200.5
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEcccc--chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAK--SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 520 (790)
....|++.++||+||...||++.-.+.+.+|+|++... ..+...-|.+|+..|.++ .|.+||+|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34568899999999999999999888888998887543 445567899999999999 499999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||- .-+|..+|..... ....| .+..+..|++.|+.++|..+ |||.||||.|+|+-. |.+||+|||+|....
T Consensus 439 mE~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9964 5599999954322 33445 77789999999999999985 999999999999865 589999999999877
Q ss_pred CCCcce-eeccccCCCcccHHHhhcC-----------CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH
Q 040908 601 EDNTHI-STRVAGTFGYMAPEYAMRG-----------HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL 668 (790)
Q Consensus 601 ~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 668 (790)
.+.+.+ ....+||+.||+||.+... +.+.++||||+|||||+|+.|+.||..- ...|++
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-------~n~~aK-- 581 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-------INQIAK-- 581 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-------HHHHHH--
Confidence 765543 3457899999999998543 2567999999999999999999999521 112333
Q ss_pred HhhCCcccccCCCCCCCCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 669 KEQGNLMELVDPNLGSNVDK-EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 669 ~~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+..+.||...-+++. ....++++++..|++.||.+||+..|+++
T Consensus 582 -----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 -----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 334555544333322 11223899999999999999999999876
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=304.51 Aligned_cols=263 Identities=23% Similarity=0.359 Sum_probs=195.9
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|++.+.||.|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999864 68899999886542 22335788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+. ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 68888885332 356899999999999999999999875 9999999999999999999999999987554322
Q ss_pred cceeeccccCCCcccHHHhhcCC-CCChhhHHHHHHHHHHHHhCCCCCccccccchh-hHHHHHH------------HHH
Q 040908 604 THISTRVAGTFGYMAPEYAMRGH-LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF-YLLDWAL------------LLK 669 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~------------~~~ 669 (790)
.. .....++..|+|||++.+.. ++.++|||||||++|||+||+.||......... ....+.. ...
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 11 22345788999999886644 588999999999999999999998654322111 0000000 000
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
............. ..........+.+++.+|++.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 0000112345678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=296.86 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=203.5
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|++.+.||+|+||.||++.. .+++.+|+|.+.... .....++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588899999999999999984 467899999986532 33356788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.........+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999998543333457899999999999999999999885 9999999999999999999999999998665431
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.....++..|+|||...+..++.++|+||||+++|||++|+.||......+. .. . ...+..
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~---~-~~~~~~--------- 218 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RY---K-VQRGKY--------- 218 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---H-HhcCCC---------
Confidence 2234588899999999998899999999999999999999999965432211 10 0 011111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+.....++.+++..|++.+|.+||++.|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1122244567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=304.52 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=193.6
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556789999999999999854 68999999986543 234567889999999996 99999999999999999999999
Q ss_pred ccCCChhhhhcC-CccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 524 LENNSLARALFG-PEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 524 ~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
+.. ++.++... .......+++..+..++.+++.||+|||+.. +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 874 55443311 1112256899999999999999999999752 5999999999999999999999999999754432
Q ss_pred CcceeeccccCCCcccHHHhhcC---CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRG---HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
.. .....|+..|+|||++... .++.++|||||||++|||++|+.||..... ...-... ......
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~------~~~~~~ 228 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQ------VVKGDP 228 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhh------hcCCCC
Confidence 21 1334588999999999776 688999999999999999999999864321 0000000 000011
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+.+..........++.+++.+|++.+|.+||++.+|+.
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12222222234557889999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.51 Aligned_cols=253 Identities=26% Similarity=0.473 Sum_probs=204.0
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
..++.|+..+.||+|+||.||+|... +++.|++|++..... ....+.+|++++++++|+|++++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35677888899999999999999976 688999999876544 4567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999432 237899999999999999999999874 99999999999999999999999999875443
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... ......++..|+|||++.+..++.++|||||||++|||++|+.|+......... ..+ .........
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~-----~~~~~~~~~--- 237 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLI-----TTKGIPPLK--- 237 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH-----HhcCCCCCc---
Confidence 221 122345788999999998888999999999999999999999998643322111 000 011111110
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........+.+++.+|++.+|.+||++.+++.
T Consensus 238 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 ----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01113456888999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=305.51 Aligned_cols=265 Identities=23% Similarity=0.358 Sum_probs=197.6
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC----
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN---- 515 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 515 (790)
...++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999965 58899999986543 223356788999999999999999999987654
Q ss_pred ------eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeE
Q 040908 516 ------QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 589 (790)
Q Consensus 516 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 589 (790)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999986 677766322 346899999999999999999999885 99999999999999999999
Q ss_pred EeecCCccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH
Q 040908 590 ISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL 668 (790)
Q Consensus 590 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 668 (790)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+. +.......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~~~~~~~~ 234 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--LELISRLC 234 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHh
Confidence 99999998665433222223346788999998865 3578899999999999999999999975432211 11111100
Q ss_pred Hhh--CCcccc--------cCC------CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 669 KEQ--GNLMEL--------VDP------NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 669 ~~~--~~~~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... ....++ .++ ...... ......+.+++..|++.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 000000 000 000000 012456889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.53 Aligned_cols=268 Identities=23% Similarity=0.344 Sum_probs=197.2
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-----CeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEG-----NQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 517 (790)
+++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 57899999999999999999985 468999999986432 23345688899999999999999999987654 357
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++|+||+.+ +|.+.+. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 999999975 7877773 246899999999999999999999985 9999999999999999999999999997
Q ss_pred ccCCCCcc--eeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHh--hC
Q 040908 598 LDEEDNTH--ISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKE--QG 672 (790)
Q Consensus 598 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~ 672 (790)
........ ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..+...... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~--~~~~~~~~~~~~~ 232 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL--NLILGVLGTPSQE 232 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHcCCCCHH
Confidence 65432211 1123568999999998765 46889999999999999999999999643221110 000000000 00
Q ss_pred CcccccCCC-------C--CCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCc
Q 040908 673 NLMELVDPN-------L--GSNVD-----KEQVRVMINVALLCADVSPTNRPLMSSVVSM--LEGRV 723 (790)
Q Consensus 673 ~~~~~~d~~-------l--~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~--L~~~~ 723 (790)
.+..+.+.. . ....+ .....++.+++.+|++.+|.+||++.|+++. ++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000000 0 00000 1123568899999999999999999999874 54433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.21 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=194.6
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCe-----
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQ----- 516 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 516 (790)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47899999999999999999964 689999998765432 23457888999999995 6999999999987665
Q ss_pred EEEEEEeccCCChhhhhcCCccc-cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC-CCCeEEeecC
Q 040908 517 LLLIYEYLENNSLARALFGPEEH-RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFG 594 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFG 594 (790)
.++||||+++ +|.+++...... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 788887543222 346899999999999999999999885 999999999999998 8899999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC-
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG- 672 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 672 (790)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||......... ...........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHHhCCCCh
Confidence 9875432211 1122346889999998865 45789999999999999999999998654322111 00000000000
Q ss_pred ----CcccccC----CCCCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 ----NLMELVD----PNLGS----NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ----~~~~~~d----~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+..+ +.... ........++.+++..|++.+|.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 00000 000123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.95 Aligned_cols=257 Identities=22% Similarity=0.287 Sum_probs=192.9
Q ss_pred cceeeeecccCcEEEEeeee-cCCcEEEEEEccccch-hcHHHHHHHHHHhhccC-CCceeeeeeEEEeC--CeEEEEEE
Q 040908 448 FDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK-QGNREFVNEIGTISALQ-HPHLVKLYGCCIEG--NQLLLIYE 522 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 522 (790)
|++.+.||+|+||.||+|.. .+++.||+|+++.... .......+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67789999999999999985 4688999999875422 22334567899999885 99999999999987 88999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|++ |+|.+.+... ...++|..+..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5888877432 246899999999999999999999885 999999999999999 99999999999865433
Q ss_pred CcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH-----------Hh
Q 040908 603 NTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL-----------KE 670 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-----------~~ 670 (790)
... ....++..|+|||++.. +.++.++|||||||++|||++|+.||......+. ..+.... ..
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhc
Confidence 221 23457899999998754 5578899999999999999999999965443221 1111100 00
Q ss_pred hCCcccccCCCCCC-C---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 671 QGNLMELVDPNLGS-N---VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 671 ~~~~~~~~d~~l~~-~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.........+.... . ........+.+++..|++.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000110111000 0 01123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.58 Aligned_cols=248 Identities=27% Similarity=0.455 Sum_probs=195.4
Q ss_pred cceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 448 FDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
|+..+.||+|+||.||+|+. .++..||+|++.... ......+.+|+.++++++|+|++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66778999999999999995 468899999986432 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+. |+|.+.+.. ....++|.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 97 477777632 2356899999999999999999999885 999999999999999999999999998754332
Q ss_pred cceeeccccCCCcccHHHhh---cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 604 THISTRVAGTFGYMAPEYAM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||......... ..+. .... +
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~----~~~~------~ 242 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIA----QNES------P 242 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHH----hccC------C
Confidence 2345888999999974 456889999999999999999999998653221111 0110 0000 0
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.. ........+.+++.+|++.+|.+||++.++++.+.-.
T Consensus 243 ~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 243 TL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 01 1112345678899999999999999999999855433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=297.96 Aligned_cols=247 Identities=26% Similarity=0.359 Sum_probs=200.4
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
+|++.+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999965 58899999987542 2345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+.+++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999832 247899999999999999999999875 999999999999999999999999998865443
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
. ......|+..|+|||++....++.++||||||+++|+|++|+.||......... +...... ..
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~--~~-------- 217 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAKQE--TA-------- 217 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HHHHHhc--cc--------
Confidence 2 123356888999999998888999999999999999999999999765432111 1111000 00
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLM--SSVV 716 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~ev~ 716 (790)
....+......+.+++.+||+.+|.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011122234678899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.00 Aligned_cols=264 Identities=23% Similarity=0.382 Sum_probs=198.2
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
+|++.+.||.|++|.||+|+.. +|+.||+|++...... ....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999964 6889999998765332 3456788999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++ +|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 88888743321 346899999999999999999999875 99999999999999999999999999975533221
Q ss_pred ceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhH-HH---------HHHHHHhhCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYL-LD---------WALLLKEQGN 673 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~---------~~~~~~~~~~ 673 (790)
......++..|++||++.+. .++.++|||||||++|||++|+.||......+.... .. |.... ....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cCch
Confidence 11234578899999998664 568899999999999999999999975543221110 00 00000 0000
Q ss_pred cccccCCCCC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 LMELVDPNLG---SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.......... ..........+.+++..|++.+|.+||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 0011122456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.99 Aligned_cols=250 Identities=30% Similarity=0.422 Sum_probs=203.3
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEG--NQLLLIY 521 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 521 (790)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+++++.+... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999965 688999999866542 4467889999999999999999999999988 8899999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998422 37899999999999999999999974 99999999999999999999999999986654
Q ss_pred CCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.... ......++..|+|||.......+.++||||||+++++|++|+.||........ ..+ . ....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~-----~------~~~~ 219 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALY-----K------IGSS 219 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHH-----h------cccc
Confidence 4321 12335688999999999888899999999999999999999999975431110 000 0 0001
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......+......+.+++.+|++.+|.+||++.|++.
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111222233567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=292.78 Aligned_cols=251 Identities=24% Similarity=0.439 Sum_probs=204.7
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|++.+.||.|+||.||++... ++..+|+|++..... .....+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788999999999999999965 588999999876533 4556789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++.........+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999544323467999999999999999999999884 9999999999999999999999999998665433
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.......|++.|+|||......++.++||||+|+++++|++|+.||....... ...... .... +.+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~-~~~~-----~~~- 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKIL-KGQY-----PPI- 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHh-cCCC-----CCC-
Confidence 22333568899999999988889999999999999999999999986543211 111111 1111 111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+......+.+++.+|+..+|++||++.|+++
T Consensus 224 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 ---PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1123356788999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=301.51 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=195.2
Q ss_pred cceeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 448 FDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
|++.+.||.|++|.||+|.. .+|+.||+|++.... ......+.+|+++++.++|||++++++++..++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56789999999999999985 478999999986543 223356889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
+ ++|.+++..... ..+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689998843321 36899999999999999999999874 99999999999999999999999999975543221
Q ss_pred ceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchh-hHHHHH---------HHHHh---
Q 040908 605 HISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF-YLLDWA---------LLLKE--- 670 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~---------~~~~~--- 670 (790)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||......... ....+. .....
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1 1223468899999987664 5688999999999999999999998654322111 100000 00000
Q ss_pred hCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 671 QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 671 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.........+.. ..........+.+++.+|++.+|.+||++.|+++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000 0001112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=332.84 Aligned_cols=265 Identities=30% Similarity=0.471 Sum_probs=210.7
Q ss_pred HHHHHhcCcceeeeecccCcEEEEeeeec----C----CcEEEEEEccccch-hcHHHHHHHHHHhhcc-CCCceeeeee
Q 040908 440 QIKAATNHFDVANKIGEGGFGPVYKGLLA----D----GTLIAVKQLSAKSK-QGNREFVNEIGTISAL-QHPHLVKLYG 509 (790)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~----~----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g 509 (790)
.++...++..+.+.||+|.||.||+|... . ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34455566667779999999999999842 1 35799999986533 4567899999999999 6999999999
Q ss_pred EEEeCCeEEEEEEeccCCChhhhhcCCc---cc-------c--CCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCC
Q 040908 510 CCIEGNQLLLIYEYLENNSLARALFGPE---EH-------R--LKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKA 577 (790)
Q Consensus 510 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~ 577 (790)
+|...+..++|+||+..|+|.++|+..+ .- . ..++....+.++.|||.||+||++. +++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999996544 00 0 2388899999999999999999987 599999999
Q ss_pred CcEEecCCCCeEEeecCCccccCCCCcceeecccc--CCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCcccc
Q 040908 578 TNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG--TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKT 654 (790)
Q Consensus 578 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~ 654 (790)
+|||++++..+||+|||+|+..............| ...|||||.+....|+.|+|||||||+||||+| |..|+....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999655544443332333 457999999999999999999999999999999 777875421
Q ss_pred ccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 655 KEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 655 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
... .+.. ..+.|. +.+.+..+..++.++++.||+.+|++||++.++++.++..
T Consensus 527 ~~~--~l~~----~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PTE--ELLE----FLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cHH--HHHH----HHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111 1111 122222 2233444567888999999999999999999999999874
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=298.95 Aligned_cols=257 Identities=19% Similarity=0.247 Sum_probs=183.6
Q ss_pred HhcCcceeeeecccCcEEEEeeeecC----CcEEEEEEccccchhcH-----------HHHHHHHHHhhccCCCceeeee
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKSKQGN-----------REFVNEIGTISALQHPHLVKLY 508 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~ 508 (790)
..++|++.++||+|+||.||+|...+ +..+|+|+......... .....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34689999999999999999999654 34566665432221110 1122344456677899999999
Q ss_pred eEEEeCC----eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC
Q 040908 509 GCCIEGN----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK 584 (790)
Q Consensus 509 g~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~ 584 (790)
+++.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 9876543 34677777644 55555521 123578888999999999999999874 999999999999999
Q ss_pred CCCeEEeecCCccccCCCCcc------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccch
Q 040908 585 DLNPKISDFGLAKLDEEDNTH------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEK 658 (790)
Q Consensus 585 ~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~ 658 (790)
++.++|+|||+|+........ ......||+.|+|||+..+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999865322211 11224699999999999999999999999999999999999999976532221
Q ss_pred h-hH--HHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 659 F-YL--LDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 659 ~-~l--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
. .. .++..... .+. .. .......+.+++..|++.+|++||++.++.+.|+
T Consensus 242 ~~~~~~~~~~~~~~-~~~--------~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLH-EGK--------IK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhh-hhh--------hc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 10 11111111 010 00 0112356888999999999999999999998763
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=305.99 Aligned_cols=262 Identities=20% Similarity=0.298 Sum_probs=196.9
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC------
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG------ 514 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 514 (790)
..++|++.+.||+|+||.||+|.. .+|+.||+|.+... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999995 46899999998643 223345678899999999999999999988643
Q ss_pred CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
...++||||+.+ +|.+.+. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999964 7888773 12788899999999999999999985 9999999999999999999999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH---------HHH
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL---------DWA 665 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~ 665 (790)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+ ++.
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9986543221 23345889999999999999999999999999999999999999654321110000 000
Q ss_pred HH-------HHhhC------CcccccCC----CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 666 LL-------LKEQG------NLMELVDP----NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 666 ~~-------~~~~~------~~~~~~d~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ..... .+.+.... .............+.+++.+|++.||.+||++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 00000 00011100 0001111233556789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.72 Aligned_cols=262 Identities=25% Similarity=0.369 Sum_probs=195.3
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh--cHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ--GNREFVNEIGTISALQHPHLVKLYGCCIEG--NQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 519 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999964 6899999998654322 233567899999999999999999998755 56899
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+.+ +|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 788887432 256899999999999999999999985 999999999999999999999999999865
Q ss_pred CCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh--CCcc-
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ--GNLM- 675 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~- 675 (790)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+...... ..... ....
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII---QLLGTPNESIWP 234 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCChhhch
Confidence 433211 122345788999999875 457899999999999999999999997544322211110 00000 0000
Q ss_pred ---------cc-cCCCCCCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 ---------EL-VDPNLGSNVD---KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ---------~~-~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. +......... ......+.+++..|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0000000000 012456788999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=300.14 Aligned_cols=265 Identities=23% Similarity=0.354 Sum_probs=194.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|++.+.||+|++|.||+|... +|+.||+|.+..... .....+.+|+.++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999964 688999999865432 234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC-CCCeEEeecCCccccCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEE 601 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~ 601 (790)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 57877774322 234678888899999999999999874 999999999999985 55799999999975543
Q ss_pred CCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH-HHHHHHHhh-----CCc
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL-DWALLLKEQ-----GNL 674 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~~~~~~~-----~~~ 674 (790)
... ......+++.|+|||++.+. .++.++|||||||++|||+||+.||......+..... .+....... ..+
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 221 12234578899999998764 5789999999999999999999999754332211100 000000000 000
Q ss_pred cccc--CCCCCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 675 MELV--DPNLGSN----VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 675 ~~~~--d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.. -+..... .......++.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0000000 01112345788999999999999999999876
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=323.88 Aligned_cols=270 Identities=19% Similarity=0.242 Sum_probs=187.5
Q ss_pred HhcCcceeeeecccCcEEEEeeeecC--CcEEEEEE--------------ccc---cchhcHHHHHHHHHHhhccCCCce
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLAD--GTLIAVKQ--------------LSA---KSKQGNREFVNEIGTISALQHPHL 504 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~--g~~vAvK~--------------~~~---~~~~~~~~~~~E~~~l~~l~H~ni 504 (790)
..++|++.+.||+|+||.||++..+. +..+++|. +.+ ........+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987532 22222221 111 111223568899999999999999
Q ss_pred eeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccc-cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec
Q 040908 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEH-RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD 583 (790)
Q Consensus 505 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 583 (790)
|++++++...+..++|+|++. ++|.+++...... ...........++.||+.||+|||+.+ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 4677776432211 122345567789999999999999885 99999999999999
Q ss_pred CCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCcc-ccccchhhHH
Q 040908 584 KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMC-KTKEEKFYLL 662 (790)
Q Consensus 584 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~-~~~~~~~~l~ 662 (790)
.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.++.. ........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987654433333456799999999999999999999999999999999998854332 2211111111
Q ss_pred HHHHHHHh-hC-------CcccccCCC----CCCCCcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 663 DWALLLKE-QG-------NLMELVDPN----LGSNVDK-----EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 663 ~~~~~~~~-~~-------~~~~~~d~~----l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........ .. .+.+.++.. ....... .....+.+++.+|++.||.+|||+.|+++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11110000 00 000111000 0000000 01234667788999999999999999976
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.51 Aligned_cols=264 Identities=20% Similarity=0.324 Sum_probs=196.8
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-----Ce
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG-----NQ 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 516 (790)
.++|.+.+.||+|+||.||+|.. .+++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999985 46899999998653 233345678899999999999999999988644 34
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 688888832 246899999999999999999999885 999999999999999999999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH--------H
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL--------L 667 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~ 667 (790)
+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||.............-.. .
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 8654332 12233467889999998865 468899999999999999999999996543221111000000 0
Q ss_pred HHhhCCcccc-------cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 668 LKEQGNLMEL-------VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 668 ~~~~~~~~~~-------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
........+. .++... ........++.+++.+|++.+|.+||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 000000 0011234567899999999999999999999873
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=296.57 Aligned_cols=241 Identities=25% Similarity=0.293 Sum_probs=185.0
Q ss_pred eecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhc---cCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 453 KIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISA---LQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 453 ~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~---l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 688999998865321 122334455544433 479999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+|+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 9999998842 246899999999999999999999985 99999999999999999999999999875433221
Q ss_pred eeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
....||..|+|||.+.+ ..++.++|||||||++|||++|+.||..........+... . ......
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~------~~~~~~--- 217 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----T------LTVNVE--- 217 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH----h------hcCCcC---
Confidence 23468999999999864 5578999999999999999999999965432221111100 0 001111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
.+.....++.+++..|++.||.+|| ++.|+++
T Consensus 218 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 218 -LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred -CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 2223345678889999999999999 5888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.69 Aligned_cols=260 Identities=22% Similarity=0.348 Sum_probs=198.4
Q ss_pred cceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh--cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ--GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
|++.+.||+|++|.||+|... +++.+++|++...... ....+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999864 6889999998654322 3567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++ +|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 88888743 2257899999999999999999999885 99999999999999999999999999986654331
Q ss_pred ceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHh--hCCcccccC--
Q 040908 605 HISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKE--QGNLMELVD-- 679 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~d-- 679 (790)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+...... ..... ........+
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF--RTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHcCCCchHhcccchhhh
Confidence 12234578899999998876 78899999999999999999999986544322111100 00000 000000000
Q ss_pred -------CCC----CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 -------PNL----GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 -------~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+.. ..........++.+++..||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00111234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=301.95 Aligned_cols=266 Identities=22% Similarity=0.324 Sum_probs=193.1
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC------
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN------ 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 515 (790)
-++|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999964 68899999886432 222345678999999999999999999987654
Q ss_pred --eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 516 --QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 516 --~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
..++||||+.+ +|.+.+.. ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 45999999975 78877732 2246899999999999999999999884 999999999999999999999999
Q ss_pred CCccccCCCCc---ceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 594 GLAKLDEEDNT---HISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 594 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
|++........ .......++..|+|||++.+. .++.++||||||+++|||+||+.||...........+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99975533221 112234578899999988664 46889999999999999999999986544322211111100000
Q ss_pred hhCCc-----ccccCC-CCCCCC---------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 670 EQGNL-----MELVDP-NLGSNV---------DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 670 ~~~~~-----~~~~d~-~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..... .+..+. ...... .......+.+++.+|++.+|.+||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 000000 000000 0011235678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=289.64 Aligned_cols=247 Identities=29% Similarity=0.478 Sum_probs=201.3
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|++.+.||+|++|.||+|... +++.|++|.+..... .....+.+|++++++++|+|++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999854 578999999976543 3456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998422 56899999999999999999999885 9999999999999999999999999998665433
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.|+....... ..|... ... .+..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~~---~~~-----~~~~- 219 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRIV---QDD-----HPPL- 219 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHh---ccC-----CCCC-
Confidence 32 233568899999999988888999999999999999999999986433111 111110 011 1111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+......+.+++.+|+..+|++||++.+++.
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122456788999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=292.06 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=194.9
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc-----chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK-----SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG--NQL 517 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 517 (790)
.+|++.+.||+|+||.||+|.. .++..||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5789999999999999999985 46889999987432 123345788999999999999999999998764 468
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999842 235788999999999999999999885 9999999999999999999999999998
Q ss_pred ccCCCC--cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 598 LDEEDN--THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 598 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
...... ........|+..|+|||++.+..++.++|||||||++|||++|+.||......... . .... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~~-~~-- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI--F----KIAT-QP-- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH--H----HHHc-CC--
Confidence 543211 11112356899999999998888999999999999999999999999643221111 0 0000 00
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.....+......+.+++..|++ +|..||+..+++.
T Consensus 226 ------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111233344568888999998 5799999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.61 Aligned_cols=265 Identities=18% Similarity=0.309 Sum_probs=197.5
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEe----CCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIE----GNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 517 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999954 68999999987542 2334667889999999999999999998763 3568
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 589888842 245899999999999999999999875 9999999999999999999999999997
Q ss_pred ccCCCCc---ceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH------H
Q 040908 598 LDEEDNT---HISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL------L 667 (790)
Q Consensus 598 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~------~ 667 (790)
....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||.............-.. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 5533221 11234578999999999865 468899999999999999999999996543222111000000 0
Q ss_pred H--HhhCCcccccC---CCCCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 668 L--KEQGNLMELVD---PNLGSN---VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 668 ~--~~~~~~~~~~d---~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. .....+.+..+ ...... ........+.+++..|++.+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 00000000000 000000 01123467899999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.28 Aligned_cols=242 Identities=22% Similarity=0.283 Sum_probs=193.5
Q ss_pred ecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCCh
Q 040908 454 IGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL 529 (790)
Q Consensus 454 LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 529 (790)
||.|+||.||+|+.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 48899999986532 23346789999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeec
Q 040908 530 ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609 (790)
Q Consensus 530 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 609 (790)
.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999432 35889999999999999999999874 9999999999999999999999999998665432 1233
Q ss_pred cccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHH
Q 040908 610 VAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKE 689 (790)
Q Consensus 610 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 689 (790)
..|+..|+|||.+....++.++|+||||+++|||++|+.||.....+.. . ..... .+......++..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~---~~~~~---------~~~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-E---IYNDI---------LKGNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-H---HHHHH---------hccCCCCCCCcc
Confidence 4688999999999888899999999999999999999999975542111 1 11110 000001112222
Q ss_pred HHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040908 690 QVRVMINVALLCADVSPTNRPL-----MSSVVS 717 (790)
Q Consensus 690 ~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 717 (790)
....+.+++..||+.+|.+||+ +.|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2557899999999999999999 566544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=298.15 Aligned_cols=244 Identities=25% Similarity=0.428 Sum_probs=195.6
Q ss_pred eeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCCh
Q 040908 451 ANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL 529 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 529 (790)
..+||+|+||.||+|.. .++..||+|++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 36799999999999986 46899999998655555566789999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeec
Q 040908 530 ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609 (790)
Q Consensus 530 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 609 (790)
.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 998732 35789999999999999999999985 99999999999999999999999999875543221 1223
Q ss_pred cccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHH
Q 040908 610 VAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKE 689 (790)
Q Consensus 610 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 689 (790)
..|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ... . . ..+.... ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~---~~~---~--~----~~~~~~~--~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIR---D--N----LPPKLKN--LHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH---h--h----CCcccCC--ccc
Confidence 458899999999988888999999999999999999999986433221111 000 0 0 0111100 011
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 690 QVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 690 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
....+.+++.+|++.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2345678889999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.64 Aligned_cols=265 Identities=21% Similarity=0.355 Sum_probs=196.4
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc--chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeC--CeE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK--SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEG--NQL 517 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~ 517 (790)
..++|++.+.||+|+||.||+|... +|+.+|+|++... .......+.+|+.+++++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578899999999999999999965 5789999988542 223345677899999999 999999999998653 468
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||++ ++|.+++.. ..++|..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 589888832 26789999999999999999999874 9999999999999999999999999998
Q ss_pred ccCCCCc----ceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH-HH-------
Q 040908 598 LDEEDNT----HISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL-DW------- 664 (790)
Q Consensus 598 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~------- 664 (790)
....... .......||..|+|||++.+ ..++.++||||||+++|||+||+.||............ .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 5543321 12234568999999998755 45788999999999999999999998654322111100 00
Q ss_pred --HHHH-HhhCCcccccCCCCC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 665 --ALLL-KEQGNLMELVDPNLG---SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 665 --~~~~-~~~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.... .....+.+.+...-. ..........+.+++.+|++.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 0000 000000000000000 0000113457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=296.89 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=199.5
Q ss_pred CcceeeeecccCcEEEEeeee----cCCcEEEEEEccccc----hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL----ADGTLIAVKQLSAKS----KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 517 (790)
+|++.+.||+|+||.||++.. .+++.||||.++... ....+.+.+|+.++.++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999974 356889999986432 12345688999999999 599999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999842 245889999999999999999999874 9999999999999999999999999988
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcCC--CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGH--LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||........ ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~----- 226 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILK----- 226 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHc-----
Confidence 65443322233356889999999987655 78899999999999999999999864321111 1111111110
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.++.... .....+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 227 --~~~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 --SKPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --cCCCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0111111 223457888999999999999999999887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=295.97 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=194.2
Q ss_pred cceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh--cHHHHHHHHHHhhcc---CCCceeeeeeEEEeCCe-----
Q 040908 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ--GNREFVNEIGTISAL---QHPHLVKLYGCCIEGNQ----- 516 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 516 (790)
|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999976 4899999998743222 234566788777665 69999999999988776
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.+++|||+.+ +|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 7888884322 235899999999999999999999975 999999999999999999999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc--
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL-- 674 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-- 674 (790)
......... ....++..|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+..........
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCCCChHhc
Confidence 865433221 2345788999999999989999999999999999999999988754432211 1111100000000
Q ss_pred -------ccccCCCCC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 675 -------MELVDPNLG---SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 675 -------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......... ..........+.+++.+||+.||.+||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 0111133466789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=292.05 Aligned_cols=249 Identities=20% Similarity=0.268 Sum_probs=191.5
Q ss_pred HHHHHHhcCcceeeee--cccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeC
Q 040908 439 RQIKAATNHFDVANKI--GEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEG 514 (790)
Q Consensus 439 ~~~~~~~~~y~~~~~L--G~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 514 (790)
.++....++|++.+.+ |+|+||.||++.. .++..+|+|.+....... .|+.....+ +||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444455677777777 9999999999985 467889999986432111 122222222 799999999999999
Q ss_pred CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-CeEEeec
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDF 593 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DF 593 (790)
+..++||||+++++|.+++.. ...++|..+..++.|+++||+|||+.+ ++||||||+||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence 999999999999999999942 237899999999999999999999985 99999999999999998 9999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
|+++..... ....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......|.... ..
T Consensus 155 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~---~~ 225 (267)
T PHA03390 155 GLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ---QK 225 (267)
T ss_pred ccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh---cc
Confidence 998765432 2245889999999999889999999999999999999999999743322 22222222211 00
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL-MSSVVS 717 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~ev~~ 717 (790)
.. .........+.+++..|++.+|.+||+ ++|+++
T Consensus 226 ~~---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 KL---------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cC---------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 111133456788999999999999996 688763
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=299.64 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=192.8
Q ss_pred hcCcceeeeecccCcEEEEeeeecC-CcEEEEEEccccc-hhcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKS-KQGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 521 (790)
-++|++.+.||+|+||.||+|...+ ++.||||.+.... .....++..|+.++.+.. |+||++++++|......++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3668889999999999999999764 8899999986542 233456777887777774 999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+.+ ++.+++.. ....+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++.....
T Consensus 94 e~~~~-~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99854 67766632 2247899999999999999999999742 599999999999999999999999999976543
Q ss_pred CCcceeeccccCCCcccHHHhhcCC----CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGH----LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
.... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... ..... .... .....
T Consensus 168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~---~~~~-~~~~~- 238 (296)
T cd06618 168 SKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLT---KILQ-EEPPS- 238 (296)
T ss_pred CCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHH---HHhc-CCCCC-
Confidence 2221 2345788999999987543 788999999999999999999998642211 11111 0000 11000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... .......+.+++.+|++.+|.+||++.++++
T Consensus 239 ----~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 239 ----LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred ----CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 100 0123456889999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=294.32 Aligned_cols=246 Identities=27% Similarity=0.387 Sum_probs=195.6
Q ss_pred ecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCCh
Q 040908 454 IGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL 529 (790)
Q Consensus 454 LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 529 (790)
||+|+||.||++... +|+.+++|.+..... .....+.+|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999865433 3456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc-----
Q 040908 530 ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT----- 604 (790)
Q Consensus 530 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~----- 604 (790)
.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998422 36899999999999999999999875 99999999999999999999999999875433211
Q ss_pred --ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 605 --HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 605 --~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
.......++..|+|||.......+.++||||||+++|||++|+.||......+.. ..... +.. . .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~-~~~----~--~ 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF------QNILN-GKI----E--W 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhc-CCc----C--C
Confidence 1223355788999999998888899999999999999999999999654322211 11110 111 0 0
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.... .....+.+++..|++.+|.+||++.++.+.|+.
T Consensus 221 ~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 221 PEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred Cccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0000 124567899999999999999999777766653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.01 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=201.2
Q ss_pred cCcceeeeecccCcEEEEeeeecC-CcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
+.|+++..||.|+||.||+|+.++ +-..|.|++...+.....+|+-|+++|+..+||+||+|++.|...+.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 456678899999999999999654 4456788888778888889999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
.||-.+..+.. -...+...++..+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+...... .
T Consensus 112 ~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-R 184 (1187)
T ss_pred CCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-H
Confidence 99999888743 346799999999999999999999998 5999999999999999999999999997532211 1
Q ss_pred ceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 605 HISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
.....+.||+.|||||+++ ..+|+.++||||||++|.||..+.+|....+.-. +...........++-
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-------VllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSEPPTLLQ 257 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-------HHHHHhhcCCCcccC
Confidence 1223478999999999875 4678999999999999999999999875432211 111111111111211
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+..-...+.++...|+..+|..||++.++++
T Consensus 258 -------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 -------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2233456788999999999999999999875
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=291.47 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=188.9
Q ss_pred eeecccCcEEEEeeee-cCCcEEEEEEccccch---hcHHHHHHHHHHh-hccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK---QGNREFVNEIGTI-SALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|.. .+|+.||+|++..... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999986 4688999999865422 2223445555544 455899999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999842 246888999999999999999999874 99999999999999999999999999875433
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||......... ... ..+... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~--~~~~~~------~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF-----DNI--LSRRIN------WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-----HHH--HhcccC------CCCcc
Confidence 12345889999999998888899999999999999999999999654322111 110 111110 00111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
.......+.+++.+|++.+|++||++.++.+.|+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1123456889999999999999998876666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=295.66 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=194.2
Q ss_pred CcceeeeecccCcEEEEeeee----cCCcEEEEEEccccch----hcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeE
Q 040908 447 HFDVANKIGEGGFGPVYKGLL----ADGTLIAVKQLSAKSK----QGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 517 (790)
+|++.+.||+|+||.||++.. .+|..||+|++..... ...+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999985 3688999999865321 2345678899999999 699999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999842 246788899999999999999999875 9999999999999999999999999998
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcC--CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRG--HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
..............|+..|+|||++... .++.++||||||+++|||++|+.||........ ...+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~---- 227 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS---- 227 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc----
Confidence 6544332223345689999999998753 467899999999999999999999864322111 11111111110
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVV 716 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~ 716 (790)
.+. ++......+.+++..|++.+|.+|| +..+++
T Consensus 228 ---~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 228 ---EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred ---CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 111 1222345678899999999999998 455543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=294.33 Aligned_cols=262 Identities=24% Similarity=0.365 Sum_probs=196.2
Q ss_pred cceeeeecccCcEEEEeeeec-CCcEEEEEEccccch-hcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEEEEEec
Q 040908 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
|++.+.||+|+||.||+|... +++.||+|++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567899999999999999975 478899999865432 22334567999999998 999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889998885332 246899999999999999999999885 99999999999999999999999999986543322
Q ss_pred ceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhH----------HHHHHHHHhhCC
Q 040908 605 HISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYL----------LDWALLLKEQGN 673 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l----------~~~~~~~~~~~~ 673 (790)
.....++..|+|||++.. ..++.++||||||+++|||++|+.||......+.... ..|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 133558889999998754 4578999999999999999999999865433221110 011111111111
Q ss_pred cccccCCCCCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 LMELVDPNLGS---NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
....+...... .........+.+++.+|++.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 11111000000 000111356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=306.08 Aligned_cols=266 Identities=19% Similarity=0.331 Sum_probs=195.2
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC------C
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEG------N 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 515 (790)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999995 468999999986532 22235688999999999999999999998754 3
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++|+||+.. +|.+++ ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999974 676654 135889999999999999999999885 99999999999999999999999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH--------
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL-------- 666 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-------- 666 (790)
++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98543321 23457889999999876 468899999999999999999999997543221111000000
Q ss_pred HHHhhCCcccccC--CCC-CCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCcC
Q 040908 667 LLKEQGNLMELVD--PNL-GSNVD---KEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGRVG 724 (790)
Q Consensus 667 ~~~~~~~~~~~~d--~~l-~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~~~ 724 (790)
...........+. +.. ..... ......+.+++..|++.||.+||++.|++. .++....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000000000000 000 00000 012345789999999999999999999984 4555443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=300.60 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=191.0
Q ss_pred eeeccc--CcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEG--GFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G--~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+| +||+||++.. .+|+.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999985 478999999986532 23346788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999985432 235889999999999999999999875 9999999999999999999999998654222111100
Q ss_pred ------eeccccCCCcccHHHhhcC--CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH------------
Q 040908 607 ------STRVAGTFGYMAPEYAMRG--HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL------------ 666 (790)
Q Consensus 607 ------~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~------------ 666 (790)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||........ ......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCcccccc
Confidence 0112356679999999763 478899999999999999999999965432111 000000
Q ss_pred --H--H-------Hh---------hCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 667 --L--L-------KE---------QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 667 --~--~-------~~---------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. . .. ........+..+...........+.+++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 0 00 00000111111112223345677899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.98 Aligned_cols=241 Identities=26% Similarity=0.329 Sum_probs=188.9
Q ss_pred ecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCCh
Q 040908 454 IGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL 529 (790)
Q Consensus 454 LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 529 (790)
||+|+||+||++.. .+|+.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 468899999986532 22344577899999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeec
Q 040908 530 ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609 (790)
Q Consensus 530 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 609 (790)
.+++.... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++........ ...
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccc
Confidence 99985332 246899999999999999999999985 99999999999999999999999999886543221 223
Q ss_pred cccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHH
Q 040908 610 VAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKE 689 (790)
Q Consensus 610 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 689 (790)
..++..|+|||++.+..++.++|||||||++|+|++|+.||............ .. ... . .. ...+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~-~~~-~-~~----~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL------KR-RTL-E-MA----VEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH------Hh-ccc-c-cc----ccCCcc
Confidence 45788999999998888999999999999999999999999654321111000 00 000 0 00 111222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHH
Q 040908 690 QVRVMINVALLCADVSPTNRPLMSS 714 (790)
Q Consensus 690 ~~~~l~~l~~~Cl~~dP~~RPt~~e 714 (790)
....+.+++..||+.+|.+||+..+
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCc
Confidence 3456788999999999999995444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=298.61 Aligned_cols=246 Identities=27% Similarity=0.455 Sum_probs=193.5
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
+.|+..+.||+|+||.||+|... ++..+|+|.+... ......++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34677789999999999999954 6788999988642 2233456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+. |++.+.+.. ....+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9997 578777632 2345889999999999999999999875 99999999999999999999999999875543
Q ss_pred CCcceeeccccCCCcccHHHhh---cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 602 DNTHISTRVAGTFGYMAPEYAM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
. ....|+..|+|||++. ...++.++|||||||++|||++|+.|+......... .... .+..
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~-~~~~---- 231 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIA-QNES---- 231 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HHHh-hcCC----
Confidence 2 2345888999999985 356788999999999999999999998643221111 1101 1111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
+.. ........+.+++.+||+.+|.+||++.+++..
T Consensus 232 -~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 -PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred -CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 111 111234567889999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=294.48 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=208.8
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchh--cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQ--GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.-|++.+.||+|.|..|-.|++ -.|..||||++.+..-+ ....+.+|++.|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4467778999999999999984 37999999999765332 34568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec-CCCCeEEeecCCccccCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~~~ 601 (790)
.-.+|+|++++- .+...+.+....+++.||..|+.|+|+.. ++||||||+||.+- .-|-+||.|||++-.+..
T Consensus 98 LGD~GDl~DyIm---KHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIM---KHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHH---hhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999994 34457899999999999999999999874 99999999999774 568899999999976655
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCC-hhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTD-KADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
... .++.+|+..|.|||++.+..|+. +.||||+|||||.|++|+.||...++.+.. ..++|-
T Consensus 172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDC 234 (864)
T KOG4717|consen 172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDC 234 (864)
T ss_pred cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcc
Confidence 432 35678999999999999988865 789999999999999999999866554432 223332
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEG 721 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~ 721 (790)
. -..+.....++.+++..|+..||.+|.+..|++. +|+.
T Consensus 235 K--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 235 K--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred c--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 2 2345667788999999999999999999999986 5544
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=300.39 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=193.8
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh--cHHHHHHHHHHhhccCCCceeeeeeEEEeC-------
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ--GNREFVNEIGTISALQHPHLVKLYGCCIEG------- 514 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 514 (790)
.++|++.+.||+|+||.||+|... +++.+|+|++...... ....+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999954 6889999988654322 234677899999999999999999987543
Q ss_pred -CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 515 -NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 515 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
...++|+||+.. +|...+.. ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 346999999975 67666643 2346899999999999999999999985 999999999999999999999999
Q ss_pred CCccccCCCCcc----------eeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH
Q 040908 594 GLAKLDEEDNTH----------ISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662 (790)
Q Consensus 594 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 662 (790)
|+++........ ..+...+++.|+|||++.+. .++.++|||||||++|||++|+.||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999754332211 11234578899999988654 5789999999999999999999998754432221111
Q ss_pred HHHHH------HHhhCCccccc----CCCCCCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 663 DWALL------LKEQGNLMELV----DPNLGSNVD---KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 663 ~~~~~------~~~~~~~~~~~----d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..... ......+.... ......... ......+.+++.+|++.+|.+|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000 00000000100 000000000 012256889999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=294.03 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=200.1
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc---chhcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK---SKQGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 520 (790)
++|.+.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999964 6899999998653 2233467889999999998 99999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999942 236999999999999999999999875 9999999999999999999999999987554
Q ss_pred CCCc-------------------ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhH
Q 040908 601 EDNT-------------------HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYL 661 (790)
Q Consensus 601 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l 661 (790)
.... .......++..|+|||......++.++||||||++++|+++|+.||.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-- 231 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF-- 231 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH--
Confidence 3221 1122345789999999998888999999999999999999999999754321110
Q ss_pred HHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 040908 662 LDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLM----SSVVS 717 (790)
Q Consensus 662 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~ev~~ 717 (790)
. .. .. . ....+......+.+++..|++.+|.+||++ .++++
T Consensus 232 -~--~~-~~-------~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 -Q--KI-LK-------L----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -H--HH-Hh-------c----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 00 00 0 011122224567899999999999999999 66643
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.38 Aligned_cols=269 Identities=21% Similarity=0.301 Sum_probs=202.7
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC-----eEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN-----QLL 518 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 518 (790)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999965 48899999987643 344567899999999999999999999998765 789
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++ +|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999984 88888842 237899999999999999999999985 99999999999999999999999999986
Q ss_pred cCCCCc--ceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH-----H--
Q 040908 599 DEEDNT--HISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL-----L-- 668 (790)
Q Consensus 599 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~-- 668 (790)
...... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....+.-... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 554321 112334578899999999887 789999999999999999999999976543221111000000 0
Q ss_pred -HhhCCcccccC---CCCCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCc
Q 040908 669 -KEQGNLMELVD---PNLGSN---VDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGRV 723 (790)
Q Consensus 669 -~~~~~~~~~~d---~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~~ 723 (790)
.......+.+. ...... ........+.+++.+||+.+|.+||++.+++. .+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000000 000000 01113456789999999999999999999987 455443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=290.21 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=194.4
Q ss_pred CcceeeeecccCcEEEEeeeecC-CcEEEEEEcccc-----chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAK-----SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
+|.+.+.||+|+||.||++.... +..+++|.++.. .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57889999999999999998543 444555555432 122334577899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988543334467899999999999999999999875 999999999999976 569999999997654
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...... .+. .+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~-~~~-----~~ 223 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIV-EGP-----TP 223 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHH-cCC-----CC
Confidence 3222 2233568899999999988888999999999999999999999985432111 111100 111 11
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. .+.....++.+++.+|++.+|++||++.|+++
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 22334457888999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.00 Aligned_cols=260 Identities=20% Similarity=0.250 Sum_probs=192.2
Q ss_pred eeeeecccCcEEEEeeeecCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCC
Q 040908 450 VANKIGEGGFGPVYKGLLADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 527 (790)
+.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|+.++++++|+||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445566667777777666 6889999998654 3344567999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc---
Q 040908 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT--- 604 (790)
Q Consensus 528 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~--- 604 (790)
+|.+++.... ...+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999995332 245788899999999999999999885 99999999999999999999999999874432111
Q ss_pred ---ceeeccccCCCcccHHHhhc--CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH-----------H
Q 040908 605 ---HISTRVAGTFGYMAPEYAMR--GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL-----------L 668 (790)
Q Consensus 605 ---~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----------~ 668 (790)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.+.... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchh
Confidence 11123457789999999876 357889999999999999999999997532211 11110000 0
Q ss_pred HhhCCccc----ccCCCC----CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 669 KEQGNLME----LVDPNL----GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 669 ~~~~~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........ ..++.. ..........++.+++..||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000000 001100 01112233457889999999999999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=295.66 Aligned_cols=243 Identities=28% Similarity=0.453 Sum_probs=191.2
Q ss_pred cceeeeecccCcEEEEeeee-cCCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 448 FDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
|...+.||+|+||.||+|+. .+|+.||+|++..... .....+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55667899999999999985 4688999999864322 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+. |++.+++.. ....+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 577777732 2346899999999999999999999885 999999999999999999999999998643221
Q ss_pred cceeeccccCCCcccHHHhh---cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 604 THISTRVAGTFGYMAPEYAM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
....|+..|+|||++. ...++.++|||||||++|||++|+.|+......... ... .. .....
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~~~---~~-~~~~~---- 239 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHI---AQ-NDSPT---- 239 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHH---Hh-cCCCC----
Confidence 2356889999999984 456888999999999999999999998654321111 110 00 11111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. .......+.+++.+|++.+|.+||++.+++.
T Consensus 240 -~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 -LQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 1112245788999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=303.79 Aligned_cols=269 Identities=21% Similarity=0.321 Sum_probs=198.8
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEE
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCI 512 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 512 (790)
....++..++++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34566777889999999999999999999984 578899999986532 223456888999999999999999999886
Q ss_pred eC------CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC
Q 040908 513 EG------NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 586 (790)
Q Consensus 513 ~~------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 586 (790)
.. ...+++++++ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 43 3467888876 779988873 235899999999999999999999885 99999999999999999
Q ss_pred CeEEeecCCccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH-HH
Q 040908 587 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL-DW 664 (790)
Q Consensus 587 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~ 664 (790)
.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ ..
T Consensus 158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999999999854332 123568899999999866 56788999999999999999999998643322111000 00
Q ss_pred H-------HHHHhhC---CcccccCCCCCCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 665 A-------LLLKEQG---NLMELVDPNLGSNVD---KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 665 ~-------~~~~~~~---~~~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ....... .....++......+. .....++.+++..|++.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0 0000000 000000000000000 012346789999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=293.21 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=200.9
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.+.|+.-++||+||||.||-+... .|+.+|.|++.++ .+++..-.++|-.+|.+++.+.||.+--.|...+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356888899999999999999854 6899999988654 344556678999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
+..|.||+|.-+|+.... ..+++..+.-+|.+|+.||++||.. .|+.||+||+|||||+.|+++|+|.|+|..+.
T Consensus 264 LtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999999964432 5689999999999999999999987 49999999999999999999999999999777
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
+.... ...+||.+|||||++.+..|+...|.||+||++|||+.|+.||....+.. .|... +... .-|
T Consensus 339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-----k~eEv---drr~--~~~- 405 (591)
T KOG0986|consen 339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-----KREEV---DRRT--LED- 405 (591)
T ss_pred CCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-----hHHHH---HHHH--hcc-
Confidence 65543 33489999999999999999999999999999999999999996432211 11000 0000 001
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMS 713 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 713 (790)
..+++....++..++....++.||.+|--.+
T Consensus 406 --~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 406 --PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1233444556677777788899999987443
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=308.14 Aligned_cols=268 Identities=24% Similarity=0.403 Sum_probs=199.9
Q ss_pred cceeeeecccCcEEEEeee-ecCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC------CeEEE
Q 040908 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEG------NQLLL 519 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 519 (790)
+...+.||+|+||.||+|+ ...|+.||||.+.... ....+...+|+++|++++|+|||++++.-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3456789999999999999 5679999999997754 33345678999999999999999999876543 35789
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec--CCC--CeEEeecCC
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD--KDL--NPKISDFGL 595 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~~--~~kl~DFGl 595 (790)
|||||.+|||...|..+++ ...++..+.+.+..+++.||.|||+++ |+||||||.||++- ++| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999987765 467999999999999999999999885 99999999999983 334 369999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
|+..+++. ..+.++||..|++||++.. +.|+..+|.|||||++||.+||..||..........-+.|...-.....+
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 99877655 4466889999999999985 88999999999999999999999999764433222223333322221111
Q ss_pred ccccCCCC------------CCCCcHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHhc
Q 040908 675 MELVDPNL------------GSNVDKEQVRVMINVALLCADVSPTNRP--LMSSVVSMLEG 721 (790)
Q Consensus 675 ~~~~d~~l------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RP--t~~ev~~~L~~ 721 (790)
.-..++.. ...........+-.....++..+|.+|. ...+....+..
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d 309 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD 309 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence 11111111 1112223344455555667777888888 55444444433
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=298.31 Aligned_cols=263 Identities=23% Similarity=0.334 Sum_probs=196.7
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEe-CCe
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIE-GNQ 516 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 516 (790)
+..++++|++.+.||.|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 345788999999999999999999984 47899999987542 22234668899999999999999999999875 567
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++|+||+ +++|.+++. ...+++.....++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||++
T Consensus 85 ~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 89999998 568888873 235788888899999999999999985 999999999999999999999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhH-HH--------HHH
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYL-LD--------WAL 666 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~--------~~~ 666 (790)
....... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||........... .+ |..
T Consensus 156 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 156 RIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 8543321 23457889999998765 5689999999999999999999999865432211110 00 000
Q ss_pred HHHhhCCcccccC-CCCCCCCcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 667 LLKEQGNLMELVD-PNLGSNVDK-----EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 667 ~~~~~~~~~~~~d-~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
....... .+.+. -......+. .....+.+++.+|++.+|++||++.+++.
T Consensus 232 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 232 TICSENT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hccchhh-HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00000 000011111 12357889999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=289.99 Aligned_cols=241 Identities=26% Similarity=0.311 Sum_probs=185.1
Q ss_pred eecccCcEEEEeeee-cCCcEEEEEEccccch---hcHHHHHHHHHH---hhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 453 KIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK---QGNREFVNEIGT---ISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 453 ~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
.||+|+||.||+|.. .+++.||+|.+..... .....+..|..+ ++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4588999998865321 222234445443 444579999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+|+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999998832 346899999999999999999999875 99999999999999999999999999875433221
Q ss_pred eeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
....|+..|+|||++.++ .++.++|||||||++|||++|+.||........... . .. ....++.+
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~--~~-------~~~~~~~~-- 218 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-D--RM-------TLTMAVEL-- 218 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-H--HH-------hhccCCCC--
Confidence 234689999999999754 688999999999999999999999975422211110 0 00 00011111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
+......+.+++.+|+..+|.+|| ++.++++
T Consensus 219 --~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 112245678889999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=296.69 Aligned_cols=268 Identities=21% Similarity=0.362 Sum_probs=197.9
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC--
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN-- 515 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-- 515 (790)
+....++|++.+.||+|+||.||+|.. .+|..||||++... .......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 334578899999999999999999984 47899999998543 2223456889999999999999999999987543
Q ss_pred ----eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEe
Q 040908 516 ----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 591 (790)
Q Consensus 516 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 591 (790)
..++||||+ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 458999998 678988873 236899999999999999999999875 9999999999999999999999
Q ss_pred ecCCccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhh-HH-------
Q 040908 592 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY-LL------- 662 (790)
Q Consensus 592 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~------- 662 (790)
|||++....... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... ..
T Consensus 161 dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 161 DFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred ecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999998654322 23457889999999876 458899999999999999999999997543211100 00
Q ss_pred -HHHHHHHhhCCcccccC--CCCCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 040908 663 -DWALLLKEQGNLMELVD--PNLGS----NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGR 722 (790)
Q Consensus 663 -~~~~~~~~~~~~~~~~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~ 722 (790)
.|...... ........ +.... .........+.+++.+|++.||.+|||+.+++. .++..
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 237 KEFVQKLQS-EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHhhcc-hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00000000 00000000 00000 000122345789999999999999999999984 44443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.60 Aligned_cols=243 Identities=23% Similarity=0.393 Sum_probs=189.4
Q ss_pred eeeeecccCcEEEEeeeec-CCcEEEEEEcc--c--cchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe--EEEEEE
Q 040908 450 VANKIGEGGFGPVYKGLLA-DGTLIAVKQLS--A--KSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ--LLLIYE 522 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~E 522 (790)
..+.||+|+|-+||||... +|..||=-.++ . .+....+.|..|+.+|+.|+|||||+++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4578999999999999964 46666632222 1 134445789999999999999999999999987654 789999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC-CCCeEEeecCCccccCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEE 601 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~ 601 (790)
.|..|+|..|+.. .+.++......||.||++||.|||++ .|||||||||-.||+|+. -|.+||+|.|+|.....
T Consensus 124 L~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999942 34678889999999999999999998 589999999999999976 48999999999997755
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCcc-ccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMC-KTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
... ..+.|||.|||||++. ..|.+..||||||+.|+||+|+.-||.. ......+ .-+..-.....+..+-
T Consensus 199 s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY---KKV~SGiKP~sl~kV~-- 269 (632)
T KOG0584|consen 199 SHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY---KKVTSGIKPAALSKVK-- 269 (632)
T ss_pred ccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH---HHHHcCCCHHHhhccC--
Confidence 432 2378999999999887 6899999999999999999999999853 2222111 1111100111111111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..++.+++..|+.. ..+|||+.|++.
T Consensus 270 ----------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 ----------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 23567888999998 999999999986
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=299.50 Aligned_cols=261 Identities=20% Similarity=0.312 Sum_probs=193.3
Q ss_pred cCcc-eeeeecccCcEEEEeeeec-CCcEEEEEEccccchhc--------------HHHHHHHHHHhhccCCCceeeeee
Q 040908 446 NHFD-VANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQG--------------NREFVNEIGTISALQHPHLVKLYG 509 (790)
Q Consensus 446 ~~y~-~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g 509 (790)
++|. +.+.||+|+||.||+|... +++.||+|++....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 3577999999999999954 68999999986532211 125778999999999999999999
Q ss_pred EEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeE
Q 040908 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 589 (790)
Q Consensus 510 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 589 (790)
++..++..++||||+. |+|.+++. ....+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9999999999999997 68998883 2345889999999999999999999875 99999999999999999999
Q ss_pred EeecCCccccCCCC-------------cceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccc
Q 040908 590 ISDFGLAKLDEEDN-------------THISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTK 655 (790)
Q Consensus 590 l~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~ 655 (790)
|+|||+++...... ........++..|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997654110 1111223468899999998764 468899999999999999999999975543
Q ss_pred cchhhHHHHHHHHHhhC---Ccccc--------cCCCCCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 656 EEKFYLLDWALLLKEQG---NLMEL--------VDPNLGSN---VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 656 ~~~~~l~~~~~~~~~~~---~~~~~--------~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.. .......... ...+. ..+..... .......++.+++..|++.+|++||++.|++.
T Consensus 240 ~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 2211 1110000000 00000 00000000 01122456789999999999999999999976
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=303.11 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=193.3
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeC---------
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEG--------- 514 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------- 514 (790)
..+|++.+.||.|+||.||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36899999999999999999985 46889999998766555667789999999999999999999776543
Q ss_pred -----CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec-CCCCe
Q 040908 515 -----NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNP 588 (790)
Q Consensus 515 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ 588 (790)
...++||||++ ++|.+++. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999997 58888873 235889999999999999999999875 99999999999997 45678
Q ss_pred EEeecCCccccCCCCcc--eeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHH
Q 040908 589 KISDFGLAKLDEEDNTH--ISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 589 kl~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 665 (790)
|++|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999765332111 1123457889999998755 46788999999999999999999999654322211100000
Q ss_pred HHHH---hhCC----ccc-ccCCCCCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 666 LLLK---EQGN----LME-LVDPNLGSNVD-----KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 666 ~~~~---~~~~----~~~-~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.... .... ... ..........+ .....++.+++..|++.||.+||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 0000 000 00000000000 112356788999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=283.99 Aligned_cols=265 Identities=20% Similarity=0.281 Sum_probs=208.5
Q ss_pred HHHHHHhcCcceeeeecccCcEEEEeeeecC------CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEE
Q 040908 439 RQIKAATNHFDVANKIGEGGFGPVYKGLLAD------GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCC 511 (790)
Q Consensus 439 ~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 511 (790)
+++..-..+++....+-+|.||+||+|.|.+ .+.|.||.++... .-+...++.|...+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4455566778888999999999999997543 3457788776653 33456788999999999999999999999
Q ss_pred EeC-CeEEEEEEeccCCChhhhhcCC----ccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC
Q 040908 512 IEG-NQLLLIYEYLENNSLARALFGP----EEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 586 (790)
Q Consensus 512 ~~~-~~~~lV~Ey~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 586 (790)
.+. +..+++|.++.-|+|..+|... ......++-.+...++.|++.|++|||..+ +||.||.++|.++|+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 864 5678999999999999999622 122356777888999999999999999885 99999999999999999
Q ss_pred CeEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHH
Q 040908 587 NPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDW 664 (790)
Q Consensus 587 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 664 (790)
++||+|=.++|-+-..+. ........+..||+||.+....|+..+|||||||+||||+| |+.|+..-++.+..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----- 508 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----- 508 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-----
Confidence 999999999984433332 22233345679999999999999999999999999999999 88888654433221
Q ss_pred HHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 665 ALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 665 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
....+..++ .-+..++.++..++..||...|++||++.|++.-|.+.
T Consensus 509 -~ylkdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 509 -HYLKDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -HHHhcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 111111222 22335667889999999999999999999999988753
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=276.41 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=193.0
Q ss_pred ceeeeecccCcEEEEeeeec-CCcEEEEEEcccc-chhcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEEEEEecc
Q 040908 449 DVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 449 ~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
+.+..||.|.-|.||+++.. .|..+|||.+... .++..++++..++++.+-+ +|.||+-+|||......++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 35678999999999999965 5899999999764 4556678888888877764 8999999999999999999999885
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
. -++.++ ..-..++++.-+-++...+..||.||.++. +|||||+||+|||+|+.|++|+||||++-.+-+..
T Consensus 175 ~-C~ekLl---krik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 175 T-CAEKLL---KRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred H-HHHHHH---HHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 4 344444 223456888888899999999999998875 79999999999999999999999999997665433
Q ss_pred eeeccccCCCcccHHHhhc---CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMR---GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
..++.+|.+.|||||.+.- ..|+.++||||||+.++||.||+.||..-..+ +....-+. . . ..|.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvl--n---~----ePP~L 315 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVL--N---E----EPPLL 315 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHH--h---c----CCCCC
Confidence 3466789999999998853 46888999999999999999999999753322 11111111 1 1 11223
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.... .....+.+++..|++.|+.+||...++++
T Consensus 316 ~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 316 PGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred Cccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2211 13456788888999999999999998865
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=289.94 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=197.2
Q ss_pred cceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|+.++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567789999999999999965 58999999987653 333467889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
+ ++|.+++... ...+++..+..++.+++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 5899999432 146899999999999999999999985 99999999999999999999999999986544322
Q ss_pred ceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhh-HHHHH-----HHHHhhCCcc--
Q 040908 605 HISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY-LLDWA-----LLLKEQGNLM-- 675 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~-----~~~~~~~~~~-- 675 (790)
. .....++..|+|||++... .++.++|||||||++|||++|+.||......+... ..... ........+.
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 1 1223467789999998776 78999999999999999999999986543221110 00000 0000000000
Q ss_pred cccCCCCCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 ELVDPNLGSN----VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+..-+..... ........+.+++..|++.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 00112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-34 Score=329.53 Aligned_cols=250 Identities=31% Similarity=0.455 Sum_probs=198.9
Q ss_pred hcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
+-++.-..+||.|.||.||.|. ..+|.-.|+|.++... ........+|..++..++|||+|+++|+-.+.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4456667899999999999999 5678899999886543 233456788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
|||++|+|.+.+. ++...++.....+..|++.|++|||+.| ||||||||.||+|+.+|.+|++|||.|.....
T Consensus 1314 EyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999993 3445677777778999999999999986 99999999999999999999999999986654
Q ss_pred CCcc---eeeccccCCCcccHHHhhcC---CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH-hhCCc
Q 040908 602 DNTH---ISTRVAGTFGYMAPEYAMRG---HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK-EQGNL 674 (790)
Q Consensus 602 ~~~~---~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-~~~~~ 674 (790)
.... .....+||+.|||||++.+. ....++||||+|||++||+||++||...+. +|+-.+. ..|.-
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHK 1459 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCC
Confidence 3211 12346799999999999764 345689999999999999999999975432 2333221 11221
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 675 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..++.....+-.+++..|++.||++|.++.|+++
T Consensus 1460 ---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 ---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1223334555678888999999999988887654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=296.43 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=190.3
Q ss_pred CcceeeeecccCcEEEEeeeec-C--CcEEEEEEccccc--hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeC----Ce
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-D--GTLIAVKQLSAKS--KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEG----NQ 516 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~--g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 516 (790)
+|++.+.||+|+||.||++... . +..||+|++.... ....+.+.+|+.+++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999954 3 7789999986432 22345688899999999 599999999876532 45
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++++||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788888886 689888842 346899999999999999999999885 999999999999999999999999999
Q ss_pred cccCCCCcc---eeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhH-H--------H
Q 040908 597 KLDEEDNTH---ISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYL-L--------D 663 (790)
Q Consensus 597 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~--------~ 663 (790)
+........ ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||........... . +
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 855432211 1233568999999998865 4688999999999999999999999865432111100 0 0
Q ss_pred HHHHHHhhC--CcccccCCCCCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 664 WALLLKEQG--NLMELVDPNLGSN---VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 664 ~~~~~~~~~--~~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+........ ............. ........+.+++.+|++.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 0000000000000 00012346889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-33 Score=319.66 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=187.1
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC------
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG------ 514 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 514 (790)
.-..+|+..+.||+||||.|||++.+ ||+.+|||++... +......+.+|+..|++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567899999999999999999954 8999999999765 334456788999999999999999987652210
Q ss_pred --------------------------------------------------------------------------------
Q 040908 515 -------------------------------------------------------------------------------- 514 (790)
Q Consensus 515 -------------------------------------------------------------------------------- 514 (790)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHH
Q 040908 515 ---------------------------------NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561 (790)
Q Consensus 515 ---------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~y 561 (790)
..+|+-||||+...+.+++....- .-.-...++++.+|++||+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~---~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF---NSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc---chhhHHHHHHHHHHHHHHHH
Confidence 124667888888777777732211 11356778999999999999
Q ss_pred hhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC-----------------CCCcceeeccccCCCcccHHHhhc
Q 040908 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE-----------------EDNTHISTRVAGTFGYMAPEYAMR 624 (790)
Q Consensus 562 LH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~ 624 (790)
+|++| ||||||||.||+||++..+||+|||+|+... ..+....+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99986 9999999999999999999999999997511 001112355789999999999976
Q ss_pred C---CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHc
Q 040908 625 G---HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLC 701 (790)
Q Consensus 625 ~---~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 701 (790)
. .|+.|+|+||+|||++||+. ||.... +....+ ...+.+.+..- ..+.......=..++.++
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL----~~LR~g~iP~~------~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASIL----TNLRKGSIPEP------ADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHH----HhcccCCCCCC------cccccccchHHHHHHHHH
Confidence 4 59999999999999999995 443211 111110 11112222211 122333444457889999
Q ss_pred cCCCCCCCCCHHHHHH
Q 040908 702 ADVSPTNRPLMSSVVS 717 (790)
Q Consensus 702 l~~dP~~RPt~~ev~~ 717 (790)
++.||.+|||+.|++.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999865
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=297.46 Aligned_cols=261 Identities=20% Similarity=0.354 Sum_probs=196.0
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe---
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ--- 516 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--- 516 (790)
...++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++|+|++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999965 5789999998643 22334567789999999999999999998876554
Q ss_pred ---EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 517 ---LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 517 ---~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 5699998832 46899999999999999999999875 999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhh-HHHH-------
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY-LLDW------- 664 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~------- 664 (790)
|++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +...
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 999865432 223467889999999865 367889999999999999999999996543221110 0000
Q ss_pred -HHHHHhhCCcccccC---CCCCCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 665 -ALLLKEQGNLMELVD---PNLGSNVD---KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 665 -~~~~~~~~~~~~~~d---~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..... .......+. ......+. ......+.+++.+|++.+|.+|||+.||+.
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKIS-SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhcc-chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000 000000000 00000000 012457889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=278.35 Aligned_cols=241 Identities=28% Similarity=0.354 Sum_probs=196.3
Q ss_pred hcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
-++|+.++.||+|.||.|-.++ ...|+.+|+|++++.. +.....-+.|-++|+..+||.+..+--.|...+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3678889999999999999998 4578999999998753 33344456788999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||..||.|.-+|. ....+++....-+-.+|..||.|||+. +|+.||||.+|.|||.+|++||+|||+++.--
T Consensus 247 MeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999998883 235678888888899999999999997 49999999999999999999999999998432
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.. ......++||+.|+|||++....|....|.|.+|||+|||++|+.||...+.+.-+.++- .++ +
T Consensus 320 ~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----~ed-----~--- 385 (516)
T KOG0690|consen 320 KY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----MED-----L--- 385 (516)
T ss_pred cc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----hhh-----c---
Confidence 22 223456899999999999999999999999999999999999999998665444333221 111 1
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRP 710 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 710 (790)
.++.....+...+....+..||.+|-
T Consensus 386 ----kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 ----KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ----cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 12233334556777788899999997
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=296.80 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=201.2
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchh--cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQ--GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
...|.+...||+|.|+.|..|+. ..+..||+|.+.+..-. ....+.+|+++|..++|||||+++.+......+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 45788999999999999999995 46899999999775332 2345889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+.+|.+++++... ..+....+..++.|+.+|++|+|+++ |+|||||++||||+.++++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999432 23444788889999999999999985 99999999999999999999999999998764
Q ss_pred CCcceeeccccCCCcccHHHhhcCCC-CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.. .....+|++.|.|||++.+.++ .+.+|+||+|+++|-|+.|..||+...-. ++-++
T Consensus 208 ~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr~r 266 (596)
T KOG0586|consen 208 GL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELRPR 266 (596)
T ss_pred cc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------cccch
Confidence 33 3456889999999999998766 56999999999999999999999754321 11122
Q ss_pred CCCCC--CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSN--VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+... .+.-...++.++++..+-.+|.+|++++++.+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 22111 12222345667888899999999999999876
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-33 Score=315.46 Aligned_cols=257 Identities=22% Similarity=0.292 Sum_probs=206.1
Q ss_pred HHHHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEe
Q 040908 438 LRQIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 438 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
..++..-.++|++++.||+|+||.|..++.+ .++++|.|++.+. ......-|..|-.+|..-+.+-||.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4555666789999999999999999999964 5889999999874 23345678899999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
.+.+|+|||||+||+|..++. ... +++...+..++..|.-||.-||+.| +|||||||.|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlS---k~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLS---KFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHh---hcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999993 222 5788888889999999999999985 999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhc-----CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-----GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL 668 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 668 (790)
|-+-.+..+..-.+...+|||.|++||++.. +.|...+|+||+||++|||+.|..||..+...+.+ .+.+
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY-----~KIm 294 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY-----GKIM 294 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH-----HHHh
Confidence 9998888777767777889999999999852 57899999999999999999999999865433322 1111
Q ss_pred HhhCCcccccCCCCCCCCc--HHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 040908 669 KEQGNLMELVDPNLGSNVD--KEQVRVMINVALLCADVSPTNRPL---MSSVVS 717 (790)
Q Consensus 669 ~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPt---~~ev~~ 717 (790)
..... -.+| .+...+..+++..-+. +|+.|-. ..++-.
T Consensus 295 ~hk~~----------l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 NHKES----------LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred chhhh----------cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 11111 1111 1234456666665554 7777777 777654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=313.19 Aligned_cols=145 Identities=30% Similarity=0.449 Sum_probs=129.4
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|.+.++||+|+||.||+|... +++.||+|++.... ......+..|+.++..++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 68999999999999999999965 68899999986532 222456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
||+.+++|.+++.. ...+++..++.++.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999842 235788999999999999999999874 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=277.14 Aligned_cols=236 Identities=25% Similarity=0.348 Sum_probs=190.7
Q ss_pred ecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCCh
Q 040908 454 IGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL 529 (790)
Q Consensus 454 LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 529 (790)
||+|+||.||++... +++.+|+|.+..... .....+..|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 588999999865432 2345788999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeec
Q 040908 530 ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609 (790)
Q Consensus 530 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 609 (790)
.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence 9999422 3689999999999999999999987 499999999999999999999999999986544321 2234
Q ss_pred cccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHH
Q 040908 610 VAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKE 689 (790)
Q Consensus 610 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 689 (790)
..++..|+|||...+...+.++|+||||+++|||++|+.||....... ... .... . .. ..+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~---~~~~-~------~~----~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYE---KILK-D------PL----RFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHhc-C------CC----CCCCC
Confidence 568889999999988888999999999999999999999996443211 111 1000 0 01 11112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHH
Q 040908 690 QVRVMINVALLCADVSPTNRPLMSS 714 (790)
Q Consensus 690 ~~~~l~~l~~~Cl~~dP~~RPt~~e 714 (790)
....+.+++..|+..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2456788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-34 Score=277.85 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=195.5
Q ss_pred CCCccHHHHHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch-hcHHHHHHHHHHhhcc-CCCceeeeee
Q 040908 433 TGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK-QGNREFVNEIGTISAL-QHPHLVKLYG 509 (790)
Q Consensus 433 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g 509 (790)
...|+-..++. ...||.|+||+|+|-.. +.|+..|||+++.... .+.++++.|.+...+- +.||||+++|
T Consensus 58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 34555555543 46899999999999985 4699999999987644 5567888898876554 7999999999
Q ss_pred EEEeCCeEEEEEEeccCCChhhhhc-CCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCe
Q 040908 510 CCIEGNQLLLIYEYLENNSLARALF-GPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 588 (790)
Q Consensus 510 ~~~~~~~~~lV~Ey~~~gsL~~~l~-~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 588 (790)
.+..++.+|+.||.|.- ||+.+-. .....+..+++.-.-.|+.-..+||.||-.. ..|||||+||+|||||..|.+
T Consensus 131 a~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCE
Confidence 99999999999999964 5554331 1112335678888888888899999999876 479999999999999999999
Q ss_pred EEeecCCccccCCCCcceeeccccCCCcccHHHhhc--CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH
Q 040908 589 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR--GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL 666 (790)
Q Consensus 589 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 666 (790)
||||||++-.+.+.- ..+.-+|...|||||.+.. ..|+-+|||||+|++|||+.||+.|+.. |..
T Consensus 208 KLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~-----------w~s 274 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK-----------WDS 274 (361)
T ss_pred eeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch-----------HHH
Confidence 999999987554322 2345678899999998853 3588899999999999999999999853 222
Q ss_pred HHHh-----hCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 667 LLKE-----QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 667 ~~~~-----~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.+ .++...+..+ ....+....+..++..|+..|-.+||...++.+
T Consensus 275 vfeql~~Vv~gdpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 275 VFEQLCQVVIGDPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHHHHcCCCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 2211 1222222111 111234567888999999999999999999865
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=272.62 Aligned_cols=205 Identities=26% Similarity=0.408 Sum_probs=169.4
Q ss_pred hcCcceeeeecccCcEEEEeeeecC-----CcEEEEEEccccchh--cHHHHHHHHHHhhccCCCceeeeeeEEEe-CCe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD-----GTLIAVKQLSAKSKQ--GNREFVNEIGTISALQHPHLVKLYGCCIE-GNQ 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~-----g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 516 (790)
-..|+....||+|.||.||+|+-.+ .+.+|+|+++..... -.....+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568889999999999999996322 236899999765332 23567899999999999999999999887 778
Q ss_pred EEEEEEeccCCChhhhhcCCc-cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC----CCeEEe
Q 040908 517 LLLIYEYLENNSLARALFGPE-EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD----LNPKIS 591 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~ 591 (790)
.+|++||.+. +|...++-.+ .....++-..+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 7888874322 22357888899999999999999999985 9999999999999877 899999
Q ss_pred ecCCccccCCCCcce--eeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccc
Q 040908 592 DFGLAKLDEEDNTHI--STRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCK 653 (790)
Q Consensus 592 DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~ 653 (790)
|||+++.+...-... ...++-|+.|.|||.+.+. .||.+.|||+.|||+.||+|-++-|.+.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999776533322 2346779999999999875 6899999999999999999988777553
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=267.95 Aligned_cols=264 Identities=20% Similarity=0.285 Sum_probs=199.8
Q ss_pred cHHHHHHHhcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeC
Q 040908 437 TLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEG 514 (790)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 514 (790)
+++++-..| .+.||+|+|+.|-.++ +.+|..+|||++.+..........+|++++.+. .|+||+.|+++|.++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 456666665 3789999999999988 778999999999887666677889999999988 599999999999999
Q ss_pred CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC---CeEEe
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKIS 591 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~ 591 (790)
+.+|||||.|.||+|..+++. +..+++.++.++..+||.||.|||.+| |.|||+||+|||...-. -+|||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 999999999999999999943 356899999999999999999999986 99999999999996544 38999
Q ss_pred ecCCccccCC--C----CcceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhh
Q 040908 592 DFGLAKLDEE--D----NTHISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY 660 (790)
Q Consensus 592 DFGla~~~~~--~----~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~ 660 (790)
||.+..-... + ........+|+..|||||++. ...|+.+.|.||+|||||-|++|..||.+....+..
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG- 300 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG- 300 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC-
Confidence 9998753221 1 111223467888999999873 235788999999999999999999999765432211
Q ss_pred HHHHHHHH---HhhCCcccccCCCCCCCCcHHH----HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 661 LLDWALLL---KEQGNLMELVDPNLGSNVDKEQ----VRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 661 l~~~~~~~---~~~~~~~~~~d~~l~~~~~~~~----~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
|.... .-+..+.+-+.. -.-+++.++ ..+..+++...+..|+.+|-++.+++.
T Consensus 301 ---WdrGe~Cr~CQ~~LFesIQE-GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 ---WDRGEVCRVCQNKLFESIQE-GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ---ccCCCccHHHHHHHHHHHhc-cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11000 000011111110 011233333 345567777788899999999999876
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=271.99 Aligned_cols=221 Identities=21% Similarity=0.210 Sum_probs=175.2
Q ss_pred cCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCChhhhhcC
Q 040908 457 GGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFG 535 (790)
Q Consensus 457 G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 535 (790)
|.||.||++.. .+++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999995 468899999986543 233455555666799999999999999999999999999999999842
Q ss_pred CccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeeccccCCC
Q 040908 536 PEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 615 (790)
Q Consensus 536 ~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~ 615 (790)
...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++++|||.+....... ....++..
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~ 147 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENM 147 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcc
Confidence 235899999999999999999999875 9999999999999999999999999886544321 22346778
Q ss_pred cccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHH
Q 040908 616 YMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMI 695 (790)
Q Consensus 616 y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 695 (790)
|+|||.+....++.++||||+|+++|||++|+.|+....... ..... ...+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTT----LNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccc----cCCcccCCHHHH
Confidence 999999988889999999999999999999998764321100 00000 011122335678
Q ss_pred HHHHHccCCCCCCCCCHHH
Q 040908 696 NVALLCADVSPTNRPLMSS 714 (790)
Q Consensus 696 ~l~~~Cl~~dP~~RPt~~e 714 (790)
+++.+|++.||.+||++.+
T Consensus 207 ~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 207 SLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHccCCHHHhcCCCc
Confidence 8999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=278.04 Aligned_cols=256 Identities=25% Similarity=0.404 Sum_probs=195.8
Q ss_pred HhcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccc--hhc-----HHHHHHHHHHhhccCCCceeeeeeEEE-eC
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKS--KQG-----NREFVNEIGTISALQHPHLVKLYGCCI-EG 514 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~--~~~-----~~~~~~E~~~l~~l~H~niv~l~g~~~-~~ 514 (790)
..++|-++++||+|||+.||||. +...+.||||+-.... ++. .+...+|.++-+.+.||.||++++|+. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34678889999999999999998 5567889999864321 111 244778999999999999999999997 55
Q ss_pred CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec---CCCCeEEe
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKIS 591 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~ 591 (790)
+.+|-|+|||+|.+|+-+|.. ..-+++.++..|+.||+.||.||.+. +++|||-||||.||||- .-|.+||.
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 678999999999999999943 35689999999999999999999887 58999999999999995 45789999
Q ss_pred ecCCccccCCCCc------ceeeccccCCCcccHHHhhcC----CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhH
Q 040908 592 DFGLAKLDEEDNT------HISTRVAGTFGYMAPEYAMRG----HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYL 661 (790)
Q Consensus 592 DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l 661 (790)
|||+++.++.+.. ..+....||+.|++||.+.-+ +++.|.||||.|||+|..+.|+.||.........
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI-- 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI-- 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--
Confidence 9999998876543 244567899999999987543 5788999999999999999999999754332211
Q ss_pred HHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 040908 662 LDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSV 715 (790)
Q Consensus 662 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev 715 (790)
... ..+.... .+.....+....+...++++|++..-++|...-++
T Consensus 694 Lqe-------NTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 694 LQE-------NTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred Hhh-------hchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 111 1111110 01111111233456788999999998988766554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=298.06 Aligned_cols=261 Identities=21% Similarity=0.265 Sum_probs=170.1
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-C----CcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeE------EE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-D----GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGC------CI 512 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~----g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 512 (790)
..++|++.+.||+|+||.||+|++. + +..||+|++..... .+.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999964 4 68999998754321 1111111 1222222333322221 24
Q ss_pred eCCeEEEEEEeccCCChhhhhcCCccc----------------cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCC
Q 040908 513 EGNQLLLIYEYLENNSLARALFGPEEH----------------RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIK 576 (790)
Q Consensus 513 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk 576 (790)
.+...++||||+.+++|.+++...... ........+..++.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566899999999999999988532110 001122345679999999999999874 9999999
Q ss_pred CCcEEecC-CCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcC----------------------CCCChhhH
Q 040908 577 ATNVLLDK-DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG----------------------HLTDKADV 633 (790)
Q Consensus 577 ~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDV 633 (790)
|+|||+++ ++.+||+|||+|+..............+|++|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986654443444557789999999976422 23456799
Q ss_pred HHHHHHHHHHHhCCCCCcccccc-------chhhHHHHHHHHHhhCCcccccCCCCCCCC--cHHHHHHHHHHHHHccCC
Q 040908 634 YSFGIVALEIVSGRSNIMCKTKE-------EKFYLLDWALLLKEQGNLMELVDPNLGSNV--DKEQVRVMINVALLCADV 704 (790)
Q Consensus 634 ~S~Gvvl~elltG~~p~~~~~~~-------~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~ 704 (790)
|||||++|||+++..+.+..... ....+..|....... ..+.+...+ .........+++.+|++.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999977654321000 001112222111100 000000000 001122345899999999
Q ss_pred CCCCCCCHHHHHH
Q 040908 705 SPTNRPLMSSVVS 717 (790)
Q Consensus 705 dP~~RPt~~ev~~ 717 (790)
||.+|||+.|+++
T Consensus 437 dP~kR~ta~e~L~ 449 (566)
T PLN03225 437 KGRQRISAKAALA 449 (566)
T ss_pred CcccCCCHHHHhC
Confidence 9999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=290.45 Aligned_cols=261 Identities=20% Similarity=0.238 Sum_probs=180.6
Q ss_pred HhcCcceeeeecccCcEEEEeeee-----------------cCCcEEEEEEccccchhcHHH--------------HHHH
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-----------------ADGTLIAVKQLSAKSKQGNRE--------------FVNE 492 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-----------------~~g~~vAvK~~~~~~~~~~~~--------------~~~E 492 (790)
..++|++.++||+|+||.||+|.+ .+++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235679999986543322223 3447
Q ss_pred HHHhhccCCCce-----eeeeeEEEe--------CCeEEEEEEeccCCChhhhhcCCcc--------------------c
Q 040908 493 IGTISALQHPHL-----VKLYGCCIE--------GNQLLLIYEYLENNSLARALFGPEE--------------------H 539 (790)
Q Consensus 493 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------~ 539 (790)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 678888753 3568999999999999999864211 0
Q ss_pred cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeeccccCCCcccH
Q 040908 540 RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 619 (790)
Q Consensus 540 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aP 619 (790)
...++|..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123577889999999999999999875 99999999999999999999999999975543222211223357899999
Q ss_pred HHhhcCCC----------------------CChhhHHHHHHHHHHHHhCCC-CCccccccc------hhhHHHHHHHHHh
Q 040908 620 EYAMRGHL----------------------TDKADVYSFGIVALEIVSGRS-NIMCKTKEE------KFYLLDWALLLKE 670 (790)
Q Consensus 620 E~~~~~~~----------------------s~ksDV~S~Gvvl~elltG~~-p~~~~~~~~------~~~l~~~~~~~~~ 670 (790)
|.+..... ..+.||||+||+++||++|.. |+....... ...+..|... .
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--K 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--c
Confidence 98754321 235799999999999999875 554211000 1111122211 0
Q ss_pred hCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCC---CCCCCHHHHHH
Q 040908 671 QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSP---TNRPLMSSVVS 717 (790)
Q Consensus 671 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~ev~~ 717 (790)
.... + ............+++..++..+| .+|+|+.|+++
T Consensus 458 ~~~~----~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQKY----D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccCC----C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0110 0 00111223456778888888765 68999999865
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=282.20 Aligned_cols=243 Identities=26% Similarity=0.338 Sum_probs=191.0
Q ss_pred eeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCC
Q 040908 451 ANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 527 (790)
.+.||.|.||+||-|+. ++|+.||||++.+. .......+.+|+.+|++++||.||.+-..|...+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999995 47999999999753 3444577899999999999999999999999999999999999765
Q ss_pred ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC---CCeEEeecCCccccCCCCc
Q 040908 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 528 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla~~~~~~~~ 604 (790)
-|+-.| . ....+++......+..||+.||.|||.+ +|+|+||||+||||... .++||||||+|++.++..-
T Consensus 649 MLEMIL-S--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 649 MLEMIL-S--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred HHHHHH-H--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 555555 2 3346788888888999999999999998 59999999999999643 4799999999998876543
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
...++||+.|+|||++..+.|...-|+||.|||+|--++|..||..+.+-. .-+ ....-+..+..
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQI---------QNAaFMyPp~P-- 787 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQI---------QNAAFMYPPNP-- 787 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHh---------hccccccCCCc--
Confidence 345889999999999999999999999999999999999999996432211 111 11111111111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVV 716 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 716 (790)
-.+.....++++...++..-.+|-+.++-+
T Consensus 788 --W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 --WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred --hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 123334556777777788888888776553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=289.01 Aligned_cols=240 Identities=22% Similarity=0.307 Sum_probs=191.5
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 521 (790)
.++.|++...+|.|+|+.|-++.. .+++..+||++..... +-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356788888899999999988884 5688899999976522 234567666555 7999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe-cCCCCeEEeecCCccccC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL-DKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl-~~~~~~kl~DFGla~~~~ 600 (790)
|++.++-+.+.+... +..-..+..|+.+|+.|+.|||++| ++||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999888877322 2222677789999999999999985 9999999999999 689999999999999766
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.. ....+-|..|.|||+.....+++++|+||||++||+|++|+.||.....+.. +. ....
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e--i~----~~i~---------- 527 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE--IH----TRIQ---------- 527 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH--HH----Hhhc----------
Confidence 54 1223457899999999999999999999999999999999999976543311 10 1111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+.........+|+.+|++.||.+||+|.++..
T Consensus 528 --~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 --MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred --CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11122344556788999999999999999999865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=265.52 Aligned_cols=238 Identities=26% Similarity=0.391 Sum_probs=191.8
Q ss_pred CcEEEEeeeec-CCcEEEEEEccccchhc-HHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCChhhhhcC
Q 040908 458 GFGPVYKGLLA-DGTLIAVKQLSAKSKQG-NREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFG 535 (790)
Q Consensus 458 ~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 535 (790)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997665444 67899999999999999999999999999999999999999999999843
Q ss_pred CccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeeccccCCC
Q 040908 536 PEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 615 (790)
Q Consensus 536 ~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~ 615 (790)
. ..+++..+..++.+++++++|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 2 23889999999999999999999874 9999999999999999999999999998665432 2234568889
Q ss_pred cccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHH
Q 040908 616 YMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMI 695 (790)
Q Consensus 616 y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 695 (790)
|++||......++.++||||||+++++|++|+.||...... .....+.. ..... . ..........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~----~~~~~-~------~~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG----KPKPP-F------PPPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh----ccCCC-C------ccccccCCHHHH
Confidence 99999999888999999999999999999999998652211 11111111 01000 0 000000345788
Q ss_pred HHHHHccCCCCCCCCCHHHHHH
Q 040908 696 NVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 696 ~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+++.+|+..+|.+||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=271.03 Aligned_cols=242 Identities=25% Similarity=0.359 Sum_probs=193.4
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 519 (790)
..+|..+..||+|+||.|..|.-+ ....+|||+++++.- ++.+--+.|-++|+.- +-|.++.++.+|..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357889999999999999999854 456799999987532 2222334577777766 67899999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+.+|+|--+++. -..+.++.+.-+|.+||-||-+||+++ ||.||||..|||||.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999988842 245777888899999999999999986 999999999999999999999999999832
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
-.+. ..+.+.+||+.|+|||++...+|...+|.|||||+||||+.|++||+..++++.+..+ .+
T Consensus 501 i~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI---------------~e 564 (683)
T KOG0696|consen 501 IFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI---------------ME 564 (683)
T ss_pred ccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---------------HH
Confidence 2211 2334588999999999999999999999999999999999999999887665543211 11
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPL 711 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 711 (790)
.. ..++.....+...+...-+...|.+|-.
T Consensus 565 hn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 HN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11 1344445556677777888899998864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=289.64 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=207.9
Q ss_pred HHHHHHHhcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEe--
Q 040908 438 LRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIE-- 513 (790)
Q Consensus 438 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-- 513 (790)
+..+...++.|++.+.||+|.+|.||+++ .++|+.+|+|+..... ...++...|.++++.. +|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 44444567889999999999999999999 5578899999886543 3456777899999888 79999999999874
Q ss_pred ---CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEE
Q 040908 514 ---GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 590 (790)
Q Consensus 514 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 590 (790)
++++|||||||.+|+..|++.+.. +..+.|..+.-|+++++.|+.+||.. .++|||||-.|||++.++.+|+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 578999999999999999997654 56799999999999999999999987 4999999999999999999999
Q ss_pred eecCCccccCCCCcceeeccccCCCcccHHHhhc-----CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHH
Q 040908 591 SDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-----GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 591 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 665 (790)
+|||++........ ...+..||+.|||||++.. ..|+..+|+||+|++..||.-|.+|+...-.-..
T Consensus 165 vDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------- 236 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------- 236 (953)
T ss_pred eeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-------
Confidence 99999986654322 2345679999999999854 3467799999999999999999999864321110
Q ss_pred HHHHhhCCcccc-cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 666 LLLKEQGNLMEL-VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 666 ~~~~~~~~~~~~-~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+..+ -.|...-..+..-.+++.+++..|+..|-.+||++.++++
T Consensus 237 --------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 --------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0011 1122222334556778999999999999999999998765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-31 Score=259.82 Aligned_cols=265 Identities=24% Similarity=0.388 Sum_probs=192.9
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhc-HHHHHHHHHHhhccCCCceeeeeeEEEe--------C
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQG-NREFVNEIGTISALQHPHLVKLYGCCIE--------G 514 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 514 (790)
..|+-..+||+|.||+||+|+.+ .|+.||+|++--.. +.+ -....+|+++|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45566789999999999999954 57888988764322 222 3457899999999999999999998863 2
Q ss_pred CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
..+++||.+|+. +|.-+|. .....++..++.+++.++..||.|+|.. .|+|||+|+.|+|++.++.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 358999999987 7777772 2336788999999999999999999987 49999999999999999999999999
Q ss_pred CccccCCCCc---ceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH---
Q 040908 595 LAKLDEEDNT---HISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL--- 667 (790)
Q Consensus 595 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--- 667 (790)
+++.+..... ...+..+-|..|.+||.+.+ ..++++.|||+-|||+.||+||.+-+....+.....++.-...
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9975533221 12233456899999999876 5789999999999999999999877766555444433321110
Q ss_pred -----HHhhCCccccc--CCCCCCCCcH--HH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 668 -----LKEQGNLMELV--DPNLGSNVDK--EQ------VRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 668 -----~~~~~~~~~~~--d~~l~~~~~~--~~------~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+.-.+.+.+ .|-....+.. +. ..+.++++..++..||.+|+..++++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00011111111 1111111100 11 124567888899999999999999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=257.71 Aligned_cols=262 Identities=21% Similarity=0.244 Sum_probs=196.5
Q ss_pred HhcCccee-eeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEe----CCe
Q 040908 444 ATNHFDVA-NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIE----GNQ 516 (790)
Q Consensus 444 ~~~~y~~~-~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~ 516 (790)
.+++|.+. ++||-|-.|.|-.+..+ .++.+|+|++... ....+|++.--+. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666653 57999999999998854 6889999998653 3346788875555 69999999998753 456
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC---CCCeEEeec
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDF 593 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DF 593 (790)
+++|||.|+||.|...+.... ...+++.++-.|+.||+.|+.|||+. +|.||||||+|+|... |..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 789999999999999995433 35689999999999999999999987 6999999999999964 556999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
|+|+...... .....+-|+.|.|||++-..+|+...|+||+||++|-|++|.+||...-.... ..=.+.....+.
T Consensus 209 GFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~gq 283 (400)
T KOG0604|consen 209 GFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTGQ 283 (400)
T ss_pred ccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhccC
Confidence 9999665432 22445689999999999988999999999999999999999999975422110 000000001111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCcCCC
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGRVGVP 726 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~~~~~ 726 (790)
.++ ....-....+...++++..++.+|++|-|+.|+++ .+......+
T Consensus 284 -y~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 284 -YEF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred -ccC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 011 11111244567788999999999999999999986 444443333
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=236.00 Aligned_cols=197 Identities=23% Similarity=0.413 Sum_probs=165.8
Q ss_pred CcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchh--cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQ--GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+|+..++||+|.||+||||+ .+.++.||+|+++.+..+ --....+|+.+++.++|+|||++++....+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999 556889999998764332 245688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
|.. +|..+.. .-...++......++.|+++||.++|+. ++.|||+||.|.|++.+|+.|++|||+++.++-.-
T Consensus 83 cdq-dlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 7777763 2335688889999999999999999987 59999999999999999999999999999766433
Q ss_pred cceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCc
Q 040908 604 THISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIM 651 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~ 651 (790)
... ...+-|..|.+|.++.+. -|+...|+||-||++.|+.....|..
T Consensus 156 rcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 156 RCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred Eee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 322 334568999999999875 47889999999999999998555544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=267.78 Aligned_cols=275 Identities=20% Similarity=0.305 Sum_probs=206.0
Q ss_pred CCCCccHHHHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccC-C-C----ce
Q 040908 432 QTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-H-P----HL 504 (790)
Q Consensus 432 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----ni 504 (790)
..|.+-++.-...+++|.++..+|+|.||.|-++... .+..||||+++...+. .+..+-|+++|.++. + | -+
T Consensus 75 ~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 75 KDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred CCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEE
Confidence 3444555545555899999999999999999999843 4789999999875443 344567999999994 2 2 36
Q ss_pred eeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC
Q 040908 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK 584 (790)
Q Consensus 505 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~ 584 (790)
|.+.+||.-.++.|+|+|.+ |-|+.++|.. ++..+++...+..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvs 227 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVS 227 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEec
Confidence 88889999999999999977 5599999953 34467888999999999999999999984 999999999999932
Q ss_pred --------------------CCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHH
Q 040908 585 --------------------DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIV 644 (790)
Q Consensus 585 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ell 644 (790)
+..+||+|||-|++..+.. ..++.|..|.|||++.+-.++.++||||+||||+|+.
T Consensus 228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 3458999999999765544 4467889999999999999999999999999999999
Q ss_pred hCCCCCccccccchhhHHHHH--------------HHHHhhCCcc-----------cccCCCC----CCCCcHHHHHHHH
Q 040908 645 SGRSNIMCKTKEEKFYLLDWA--------------LLLKEQGNLM-----------ELVDPNL----GSNVDKEQVRVMI 695 (790)
Q Consensus 645 tG~~p~~~~~~~~~~~l~~~~--------------~~~~~~~~~~-----------~~~d~~l----~~~~~~~~~~~l~ 695 (790)
||..-|......+..-+.+.. ......+.+. ...++.. .......+..++.
T Consensus 304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 999887654433322111111 0111111110 0111100 0112335667899
Q ss_pred HHHHHccCCCCCCCCCHHHHHH
Q 040908 696 NVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 696 ~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+|+..++..||.+|+|++|++.
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHccCccccccHHHHhc
Confidence 9999999999999999999865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=244.68 Aligned_cols=205 Identities=26% Similarity=0.410 Sum_probs=167.9
Q ss_pred HHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc-chhcHHHHHHHHHHhhc-cCCCceeeeeeEEEeCCeEEE
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK-SKQGNREFVNEIGTISA-LQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~l 519 (790)
...+...-...||+|++|.|-+-++ .+|+..|+|++... ..+..+..++|+.+..+ ..+|.+|.++|...+....++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 3344445567899999999988874 47999999999765 34456678889887655 479999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
.||.|.- ||+.+-..--..+..+++...-+||..+.+||.|||++ ..+||||+||+|||++.+|++|+||||++-.+
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999865 77766533334456788999999999999999999997 47999999999999999999999999999876
Q ss_pred CCCCcceeeccccCCCcccHHHhhc----CCCCChhhHHHHHHHHHHHHhCCCCCcc
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMR----GHLTDKADVYSFGIVALEIVSGRSNIMC 652 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~S~Gvvl~elltG~~p~~~ 652 (790)
.+.-. .+-..|.-.|||||.+.. ..|+-|+||||+|+++.||.+++.|++.
T Consensus 200 ~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 200 VDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 54322 222457789999998853 4788999999999999999999999863
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=270.47 Aligned_cols=223 Identities=23% Similarity=0.398 Sum_probs=179.6
Q ss_pred cHHHHHHH---hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeee
Q 040908 437 TLRQIKAA---TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYG 509 (790)
Q Consensus 437 ~~~~~~~~---~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g 509 (790)
.|-.++.+ ..-|..++.||-|+||+|..+... ....+|.|.+.+.. +........|-+||.....+-||+|+-
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 34444444 345788899999999999999844 45678999987653 334456788999999999999999999
Q ss_pred EEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeE
Q 040908 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 589 (790)
Q Consensus 510 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 589 (790)
.|.+.+.+|+||+|++||++-.+|- ....+.+..+..++.+++.|+++.|..| +|||||||.|||||.+|++|
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIK 769 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIK 769 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCcee
Confidence 9999999999999999999999983 2245777777788889999999999875 99999999999999999999
Q ss_pred EeecCCccc---------cCCCC-----------------cc---------------eeeccccCCCcccHHHhhcCCCC
Q 040908 590 ISDFGLAKL---------DEEDN-----------------TH---------------ISTRVAGTFGYMAPEYAMRGHLT 628 (790)
Q Consensus 590 l~DFGla~~---------~~~~~-----------------~~---------------~~~~~~gt~~y~aPE~~~~~~~s 628 (790)
|+||||+.- +.+.+ .. .....+||+.|+|||++....++
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~ 849 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT 849 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence 999999742 11110 00 01125799999999999999999
Q ss_pred ChhhHHHHHHHHHHHHhCCCCCccccccch-hhHHHHHH
Q 040908 629 DKADVYSFGIVALEIVSGRSNIMCKTKEEK-FYLLDWAL 666 (790)
Q Consensus 629 ~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~ 666 (790)
.-+|+||.|||||||+.|+.||......+. ..++.|..
T Consensus 850 q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 850 QLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred ccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh
Confidence 999999999999999999999987665433 34445543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=271.35 Aligned_cols=241 Identities=22% Similarity=0.289 Sum_probs=194.8
Q ss_pred CcceeeeecccCcEEEEeeeecCCc-EEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLADGT-LIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~~g~-~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
+++.+..||-||||.|=.+...... .+|+|.+++. ...+.+....|-.+|...+.|.||+++-.|.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4455678999999999988865433 4888888764 23345567889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
-|-||.|+..|. .+..++..+..-++..+.+|++|||.++ ||.|||||+|.+||.+|-+||.|||+|+.....
T Consensus 501 aClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 501 ACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999994 3456888888889999999999999985 999999999999999999999999999987655
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
... -+++||+.|.|||++..+..+..+|.||+|+++|||++|++||...++-...+++--. +..
T Consensus 574 ~KT--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG--------id~------ 637 (732)
T KOG0614|consen 574 RKT--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG--------IDK------ 637 (732)
T ss_pred Cce--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh--------hhh------
Confidence 433 4588999999999999999999999999999999999999999876654443332110 000
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPL 711 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 711 (790)
-.++........++++.....+|.+|--
T Consensus 638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 -IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1123333444566776777889999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=281.17 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=186.2
Q ss_pred cceeeeecccCcEE-EEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 448 FDVANKIGEGGFGP-VYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 448 y~~~~~LG~G~fG~-Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
|.-.+.+|.|+.|+ ||+|.++ |+.||||++-. +......+|+..|+.- +|||||++++.-.+....|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34456789999887 6999994 78999999853 3344667899999887 69999999999889999999999996
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC---C--CCeEEeecCCccccC
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK---D--LNPKISDFGLAKLDE 600 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~--~~~kl~DFGla~~~~ 600 (790)
. +|.+++...........-...+.+..|+++||++||+. .||||||||.||||+. + .+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 99999965311111112145577899999999999996 4999999999999976 3 579999999999776
Q ss_pred CCCcce--eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhC-CCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 601 EDNTHI--STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSG-RSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 601 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
.+.... .....||-||+|||++....-+.++||||+|||+|+.++| +.||......+.. .......+..+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-------Il~~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-------ILTGNYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-------hhcCccceeee
Confidence 654432 3356799999999999988888899999999999999996 8899754322211 01111111111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ..++ +..+++.+|++.+|..||++.+|+.
T Consensus 736 -----~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 -----EP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----cc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 01 1111 6778899999999999999999863
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=245.17 Aligned_cols=200 Identities=26% Similarity=0.389 Sum_probs=173.8
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc---chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK---SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 519 (790)
-++|++++.||+|+|..|..+.++ ..+.+|+|++++. ..+.....+.|-.+..+. +||.+|-++.+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999864 5788999998764 233455677788888776 79999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
|.||+++|+|--++.. ...+++..+.-+..+|+-||.|||+.| ||.||||..|||+|.+|++|++|+|+++.-
T Consensus 329 vieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999877732 356888888889999999999999986 999999999999999999999999999843
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCcc
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMC 652 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~ 652 (790)
-.. ...+.+++||+.|+|||++.+..|....|.|++||+++||+.|+.||+.
T Consensus 402 l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 402 LGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 222 2234668999999999999999999999999999999999999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-27 Score=234.43 Aligned_cols=210 Identities=35% Similarity=0.576 Sum_probs=181.3
Q ss_pred ecccCcEEEEeeeecC-CcEEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCChhh
Q 040908 454 IGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLAR 531 (790)
Q Consensus 454 LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 531 (790)
||+|.+|.||++...+ ++.+++|++...... ....+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999998765432 34678999999999999999999999999899999999999999999
Q ss_pred hhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC-CCCeEEeecCCccccCCCCcceeecc
Q 040908 532 ALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEEDNTHISTRV 610 (790)
Q Consensus 532 ~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 610 (790)
++.... ..+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 984221 46899999999999999999999985 999999999999999 89999999999986654321 12234
Q ss_pred ccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHH
Q 040908 611 AGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKE 689 (790)
Q Consensus 611 ~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 689 (790)
.+...|++||..... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999877 788999999999999998
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 690 QVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 690 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356788889999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=242.40 Aligned_cols=262 Identities=22% Similarity=0.310 Sum_probs=192.5
Q ss_pred eeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-----CeEEEEE
Q 040908 450 VANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEG-----NQLLLIY 521 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~ 521 (790)
-.+.||.|+||.||.++. ++|+.||.|++.... -...+.+.+|+.+|..++|.|++..++.-.-. ++.|++.
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 357899999999999985 479999999986542 23457788999999999999999888775432 3567888
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
|.|.. +|.+.+. ....++-..+.-+.+||++||.|||+.+ |.||||||.|.|++.+...||||||+|+..+.
T Consensus 137 ELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 137 ELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 87754 7777774 3356788888889999999999999984 99999999999999999999999999998776
Q ss_pred CCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHH--------HHHHhhC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWA--------LLLKEQG 672 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~ 672 (790)
+...-.+..+-|-.|.|||++++. .|+.+.||||.||++.||+.++.-|.....-+...++.-. ....-+|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 665555666678899999999985 6899999999999999999988777655443333222110 0000011
Q ss_pred CcccccC-----CCCCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040908 673 NLMELVD-----PNLGS----NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML 719 (790)
Q Consensus 673 ~~~~~~d-----~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 719 (790)
.-..++. |.... .-+.....+.+.+...++..||.+|.+..+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111 11100 00112223455666778899999999988877644
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=235.06 Aligned_cols=199 Identities=35% Similarity=0.520 Sum_probs=171.8
Q ss_pred cceeeeecccCcEEEEeeeecC-CcEEEEEEccccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 448 FDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
|++.+.||.|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5678899999999999999765 889999999765544 56788999999999999999999999999899999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+++|.+++.... ..+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999984321 12789999999999999999999884 999999999999999999999999999866544211
Q ss_pred eeeccccCCCcccHHHh-hcCCCCChhhHHHHHHHHHHHHhCCCCCcc
Q 040908 606 ISTRVAGTFGYMAPEYA-MRGHLTDKADVYSFGIVALEIVSGRSNIMC 652 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~S~Gvvl~elltG~~p~~~ 652 (790)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22335578899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=241.91 Aligned_cols=131 Identities=25% Similarity=0.439 Sum_probs=109.8
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccC-----C---CceeeeeeEEEe---
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-----H---PHLVKLYGCCIE--- 513 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~--- 513 (790)
.+|.+.++||-|.|++||.+.. .+.+.||+|+.+... .-.+..+.|+++|++++ | ..||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6899999999999999999984 467899999986532 22455788999999984 2 469999999974
Q ss_pred -CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe
Q 040908 514 -GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL 582 (790)
Q Consensus 514 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 582 (790)
+.+.|||+|++. -+|..+|... ..+.++...+.+|+.||+.||.|||.+| +|||.||||+|||+
T Consensus 157 NG~HVCMVfEvLG-dnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLG-DNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhh-hHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 568999999884 4788887433 3356888999999999999999999998 79999999999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=225.32 Aligned_cols=257 Identities=17% Similarity=0.299 Sum_probs=189.8
Q ss_pred hcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchhcHHHHHHHHHHhhccC-CCceeeeeeEEEeC--CeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPHLVKLYGCCIEG--NQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV 520 (790)
.++|++.+++|+|-+++||.|. ..+..+++||+++.. ..+.+.+|+.+|..+. ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4789999999999999999998 567788999999653 3456889999999997 99999999998754 467999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC-CCeEEeecCCcccc
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLD 599 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~~~ 599 (790)
+||+.+-+...+- ..++...+...+.+++.||.|+|+.| |+|||+||.|+++|.. -.++|+|+|+|.+.
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998776655 35677788889999999999999986 9999999999999865 46999999999987
Q ss_pred CCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH--------h
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK--------E 670 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--------~ 670 (790)
...... .-.+.+..|--||.+..- .|+-.-|+|||||++.+|+..+.||...... ...++.-+..+- .
T Consensus 184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHH
Confidence 654322 112345678889988764 5677889999999999999999999753322 122222222110 0
Q ss_pred h------CCcccccCCCCCCCC-------cH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 671 Q------GNLMELVDPNLGSNV-------DK-EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 671 ~------~~~~~~~d~~l~~~~-------~~-~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. .....++....+..+ .. -...+.++++-..+..|-++|||++|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0 111111111111000 00 11246677888889999999999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=257.60 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=200.1
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|+....+|.|.||.|||++. ..+...|+|+++........-.++|+-+++..+|+|||.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46788999999999999999994 57899999999987777778888999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
|.+|+|.+.-+. ..++++.++..++++..+||+|||+.+ =+|||||-.|||+++.+.+|++|||.+......-
T Consensus 94 cgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999987753 367899999999999999999999986 5899999999999999999999999986543322
Q ss_pred cceeeccccCCCcccHHHh---hcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 604 THISTRVAGTFGYMAPEYA---MRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
. ....+.||+.|||||+. ..+.|..++|||+.|+...|+---+.|....-... +..++.. ...+|
T Consensus 167 ~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTk----S~~qp 234 (829)
T KOG0576|consen 167 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTK----SGFQP 234 (829)
T ss_pred h-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhc----cCCCC
Confidence 1 12346799999999987 45789999999999999999987776654221111 1111110 11111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVV 716 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 716 (790)
.-..+ ...-.+-+-++++.|+..+|.+||+...++
T Consensus 235 p~lkD-k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 235 PTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CcccC-CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 11111 112344577889999999999999987654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=245.74 Aligned_cols=196 Identities=24% Similarity=0.367 Sum_probs=165.6
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh--------cHHHHHHHHHHhhccC---CCceeeeeeEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ--------GNREFVNEIGTISALQ---HPHLVKLYGCCIE 513 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 513 (790)
.+|...+.+|.|+||.|+.|.++ +...|+||.+.+..-- ..-..-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45889999999999999999965 4668999988653211 1112456999999997 9999999999999
Q ss_pred CCeEEEEEEeccC-CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEee
Q 040908 514 GNQLLLIYEYLEN-NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 592 (790)
Q Consensus 514 ~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 592 (790)
.+.++|+||-... -+|.+++ +.+..+++..+..|+.||+.|+++||+.+ |||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 9999999998654 4888888 23457899999999999999999999986 99999999999999999999999
Q ss_pred cCCccccCCCCcceeeccccCCCcccHHHhhcCCCC-ChhhHHHHHHHHHHHHhCCCCCc
Q 040908 593 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLT-DKADVYSFGIVALEIVSGRSNIM 651 (790)
Q Consensus 593 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~ 651 (790)
||.|.+.....- ..++||.+|.|||++.+.+|- ..-|||++|++||-++....||.
T Consensus 714 fgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999987654332 346799999999999987764 45799999999999998888874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=230.03 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=193.0
Q ss_pred hcCcceeeeecccCcEEEEeee-ecCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC------C
Q 040908 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG------N 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 515 (790)
..+|.-...+|.|.- .|-.+. .-.+++||+|++... .....+...+|...+..++|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356667788999988 565555 335789999988543 344567788999999999999999999998643 3
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
+.++|||||.. +|...++ ..++-.+...|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 57999999965 7887774 35677888999999999999999986 99999999999999999999999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc-
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL- 674 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~- 674 (790)
|+....+ ...+..+.|.-|.|||++.+..+.+.+||||.||++.||++|+.-|.+.. .+-.|.+....-|..
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPD 237 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCC
Confidence 9854443 45567788999999999999889999999999999999999998775332 222332221111110
Q ss_pred --------------------------cccc-CCCCC--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 675 --------------------------MELV-DPNLG--SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 675 --------------------------~~~~-d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.+ |.... .+.+.-......+++..|+-.+|++|-+.+++++
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0000 00000 0111223445678889999999999999999886
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=216.14 Aligned_cols=252 Identities=17% Similarity=0.273 Sum_probs=183.3
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeE-EEeCCeEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGC-CIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~ 521 (790)
.+.|.+.+.||+|.||.+-.+.++ ..+.+++|.+... ....++|.+|...--.+ .|.||+.-++. |...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 467889999999999999999975 4678999988653 33467899998876666 59999987764 56667889999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec--CCCCeEEeecCCcccc
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD--KDLNPKISDFGLAKLD 599 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGla~~~ 599 (790)
||++.|+|.+-+. ...+.+....+++.|++.|+.|||++ +++|||||.+|||+- +..++||||||+.+..
T Consensus 102 E~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999998882 24567778889999999999999998 599999999999993 3457999999998744
Q ss_pred CCCCcceeeccccCCCcccHHHhhcC-----CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRG-----HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
+.. .....-+..|.+||..... ...+.+|||.||++++.++||+.||......+ .....| ..+..+..
T Consensus 174 g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~--~~w~~rk~ 246 (378)
T KOG1345|consen 174 GTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEW--EQWLKRKN 246 (378)
T ss_pred Cce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHH--HHHhcccC
Confidence 321 1223346689999987543 34567899999999999999999998433222 222233 23333332
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 675 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
. .+...+. .....+.++..+-+..+|++|-...++.++
T Consensus 247 ~-----~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 247 P-----ALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred c-----cCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 2 1211111 122345566667788999999666555543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=271.01 Aligned_cols=195 Identities=18% Similarity=0.226 Sum_probs=138.9
Q ss_pred ccCC-CceeeeeeEE-------EeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCc
Q 040908 498 ALQH-PHLVKLYGCC-------IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569 (790)
Q Consensus 498 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 569 (790)
.++| +||++++++| .+.+.+++++||+ +++|.++|... ...+++.++..++.||++||+|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4456 6888888887 2334577888987 56999999532 346899999999999999999999885
Q ss_pred EEeccCCCCcEEecC-------------------CCCeEEeecCCccccCCCC---------------cceeeccccCCC
Q 040908 570 IVHRDIKATNVLLDK-------------------DLNPKISDFGLAKLDEEDN---------------THISTRVAGTFG 615 (790)
Q Consensus 570 iiHrDlk~~NILl~~-------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~ 615 (790)
|+||||||+||||+. ++.+|++|||+++...... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 4456677777765321100 000112458899
Q ss_pred cccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHH
Q 040908 616 YMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMI 695 (790)
Q Consensus 616 y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 695 (790)
|||||++.+..++.++|||||||+||||++|..|+..... ....... . ...+.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~-----~----~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH-----R----VLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH-----h----hcChhh-----hhcCHHHH
Confidence 9999999999999999999999999999999887642110 0001100 0 111111 01123356
Q ss_pred HHHHHccCCCCCCCCCHHHHHH
Q 040908 696 NVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 696 ~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+++.+||+.+|.+||+|.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7788999999999999999976
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-25 Score=236.05 Aligned_cols=277 Identities=20% Similarity=0.270 Sum_probs=205.9
Q ss_pred CCCCccHHHHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccC------CCce
Q 040908 432 QTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQ------HPHL 504 (790)
Q Consensus 432 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------H~ni 504 (790)
..+.|.+.--+....+|.+....|+|-|++|.+|... .|..||||++..... -.+.=+.|+++|.+|+ .-|.
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHH
Confidence 4567777777788899999999999999999999954 578999999976432 2344568999999995 3588
Q ss_pred eeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC
Q 040908 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK 584 (790)
Q Consensus 505 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~ 584 (790)
++|+-.|...+++|||||-+. -+|.++|... +....|....+..++.|+.-||..|-.. +|+|.||||.|||+++
T Consensus 497 lrl~r~F~hknHLClVFE~Ls-lNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPLS-LNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHhhhcceeEEEehhhh-chHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence 999999999999999999764 4888888543 2346688889999999999999999876 4999999999999998
Q ss_pred CC-CeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhH-H
Q 040908 585 DL-NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYL-L 662 (790)
Q Consensus 585 ~~-~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~ 662 (790)
.. .+||||||-|....+... +.+.-+.-|.|||++.+..|+...|+||.||.||||.||+.-|.+.+......+ .
T Consensus 572 ~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred CcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 65 589999999986654332 222234569999999999999999999999999999999988865543221111 0
Q ss_pred HHH----HHHHhhCCcc---------------------------cccCC------CCC-----CCCcHHHHHHHHHHHHH
Q 040908 663 DWA----LLLKEQGNLM---------------------------ELVDP------NLG-----SNVDKEQVRVMINVALL 700 (790)
Q Consensus 663 ~~~----~~~~~~~~~~---------------------------~~~d~------~l~-----~~~~~~~~~~l~~l~~~ 700 (790)
+.. ..+...+.+. ..+.| .+. .+-....+..+.+|+-.
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 000 0011111110 00111 000 11123446678899999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 040908 701 CADVSPTNRPLMSSVVS 717 (790)
Q Consensus 701 Cl~~dP~~RPt~~ev~~ 717 (790)
|+..||++|-|..+.+.
T Consensus 729 ml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALK 745 (752)
T ss_pred HhccChhhcCCHHHHhc
Confidence 99999999999998754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=227.68 Aligned_cols=265 Identities=25% Similarity=0.393 Sum_probs=195.3
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeec----CCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCC
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGN 515 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 515 (790)
+....+.|..+++||.|.|++||++.+. ..+.||+|.+...+.. ....+|+++|..+ -+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445677889999999999999999843 4678999999765433 4578999999999 5999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC-CCCeEEeecC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFG 594 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFG 594 (790)
...+|+||++.-...++. ..++...+..+++.+..||+++|.+| ||||||||+|+|.+. -+.-.|.|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 999999999999888887 35678889999999999999999996 999999999999975 4567899999
Q ss_pred CccccCCC----------------------------------C---------cceeeccccCCCcccHHHhhc-CCCCCh
Q 040908 595 LAKLDEED----------------------------------N---------THISTRVAGTFGYMAPEYAMR-GHLTDK 630 (790)
Q Consensus 595 la~~~~~~----------------------------------~---------~~~~~~~~gt~~y~aPE~~~~-~~~s~k 630 (790)
+|...+.. . .......+||+||.|||++.. ..-+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 98611000 0 000112579999999999876 457889
Q ss_pred hhHHHHHHHHHHHHhCCCCCccccccch-----hhHHHHHHHH---HhhCC--ccc---------------ccC-CCCCC
Q 040908 631 ADVYSFGIVALEIVSGRSNIMCKTKEEK-----FYLLDWALLL---KEQGN--LME---------------LVD-PNLGS 684 (790)
Q Consensus 631 sDV~S~Gvvl~elltG~~p~~~~~~~~~-----~~l~~~~~~~---~~~~~--~~~---------------~~d-~~l~~ 684 (790)
+||||-|||++-+++++.||.....+-. ..+..|.... .-.+. +.+ -++ ..+..
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 9999999999999999999975432221 1111111110 00112 111 010 00000
Q ss_pred ---------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 685 ---------NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 685 ---------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.........++++..+|++.+|.+|-|+++.+.
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 011112336789999999999999999998764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=208.22 Aligned_cols=166 Identities=22% Similarity=0.192 Sum_probs=124.5
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++.. .+..++|..++.|+.||++||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999842 2356999999999999999999999873 999999999999999 99998654422
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
..||+.|||||++.+..++.++|||||||++|||+||+.||........ .+..+.... ... ++.. ...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~------~~~-~~~~-~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGM------PAD-DPRD-RSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHh------ccC-Cccc-ccc
Confidence 2589999999999999999999999999999999999999864332111 111111110 000 0000 011
Q ss_pred cHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 687 DKEQVR--VMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 687 ~~~~~~--~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
...... .+.+++..|++.+|.+||++.|+++.+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 112222 68999999999999999999999987754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=211.89 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=188.6
Q ss_pred eeeeecccCcEEEEeeeecCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCC
Q 040908 450 VANKIGEGGFGPVYKGLLADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 527 (790)
+..+|.+...|+.|+|++..+ .+++|++... +....++|..|.-.|+-+.||||.+++|.|.....+.++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 445788999999999999754 4556766432 3344578999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEe--ecCCccccCCCCcc
Q 040908 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS--DFGLAKLDEEDNTH 605 (790)
Q Consensus 528 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~--DFGla~~~~~~~~~ 605 (790)
+|...||.... ..++-.++.++|.++|+|++|||+.. +-|.---|.++.|++|++.+++|+ |--++. ++
T Consensus 273 slynvlhe~t~--vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--qe---- 343 (448)
T KOG0195|consen 273 SLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE---- 343 (448)
T ss_pred HHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--ec----
Confidence 99999986543 66788899999999999999999975 334455789999999999998875 221111 11
Q ss_pred eeeccccCCCcccHHHhhcCCCC---ChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLT---DKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s---~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
....-.+.||+||.++.++.+ ..+|+|||.+++|||.|+..||..-..-+... ++.-..+
T Consensus 344 --~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialegl 406 (448)
T KOG0195|consen 344 --VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGL 406 (448)
T ss_pred --cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhccc
Confidence 112235789999999887644 47899999999999999999997543322211 1111122
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
+..+++.....+.+++.-|++.||.+||.++.|+-.||..
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 3333444556678889999999999999999999988753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=221.70 Aligned_cols=169 Identities=22% Similarity=0.212 Sum_probs=130.9
Q ss_pred HHHHHhcCcceeeeecccCcEEEEeeeec--CCcEEEEEEcccc-----chhcHHHHHHHHHHhhccCCCceeeeeeEEE
Q 040908 440 QIKAATNHFDVANKIGEGGFGPVYKGLLA--DGTLIAVKQLSAK-----SKQGNREFVNEIGTISALQHPHLVKLYGCCI 512 (790)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~--~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 512 (790)
......++|++.+.||+|+||.||+|... +++.||||++... .......|.+|+++|++++|+|+++.+..
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 34456788999999999999999999854 5788899986532 12234568999999999999999853322
Q ss_pred eCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccC-CCCcEEecCCCCeEEe
Q 040908 513 EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDI-KATNVLLDKDLNPKIS 591 (790)
Q Consensus 513 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDl-k~~NILl~~~~~~kl~ 591 (790)
.+..++||||+++++|.... .. . ...++.++++||+|||+.+ |+|||| ||+|||++.++.+||+
T Consensus 90 -~~~~~LVmE~~~G~~L~~~~----~~----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHLAR----PH----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred -cCCcEEEEEccCCCCHHHhC----cc----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence 24579999999999996321 00 0 1467889999999999985 999999 9999999999999999
Q ss_pred ecCCccccCCCCcce-------eeccccCCCcccHHHhhcC
Q 040908 592 DFGLAKLDEEDNTHI-------STRVAGTFGYMAPEYAMRG 625 (790)
Q Consensus 592 DFGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 625 (790)
|||+|+......... .+...+++.|+|||++...
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999998665433111 1346788999999998543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-21 Score=210.78 Aligned_cols=260 Identities=19% Similarity=0.204 Sum_probs=191.6
Q ss_pred CcceeeeecccCcEEEEeeeecCC--cEEEEEEccccchhcHHHHHHHHHHhhccCC----CceeeeeeEE-EeCCeEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLADG--TLIAVKQLSAKSKQGNREFVNEIGTISALQH----PHLVKLYGCC-IEGNQLLL 519 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~~g--~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 519 (790)
+|.+.+.||+|+||.||.+..... ..+|+|............+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999996543 4788888766433333367889999988863 6888888888 47778899
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC-----CCeEEeecC
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-----LNPKISDFG 594 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-----~~~kl~DFG 594 (790)
||+.+ +.+|.++..... ...++..+...|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99965 779999774332 367899999999999999999999986 9999999999999865 468999999
Q ss_pred Ccc--ccC-CCCc---ce---eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHH
Q 040908 595 LAK--LDE-EDNT---HI---STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 595 la~--~~~-~~~~---~~---~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 665 (790)
+++ ... .... .. .....||.+|.+++...+...+.+.|+||++.++.|++.|..||.......... ...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~--~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS--KFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH--HHH
Confidence 998 321 2111 11 223569999999999999999999999999999999999999996543221111 000
Q ss_pred HHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 666 LLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 666 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
.. ........ .......++.++...+-..+..++|....+...|+....
T Consensus 251 ~~-----~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 251 KD-----PRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HH-----hhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 00 00001110 111122345555555666899999999999888766543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-20 Score=199.89 Aligned_cols=260 Identities=30% Similarity=0.433 Sum_probs=195.9
Q ss_pred cceeeeecccCcEEEEeeeecCCcEEEEEEccccchh---cHHHHHHHHHHhhccCCC-ceeeeeeEEEeCCeEEEEEEe
Q 040908 448 FDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQ---GNREFVNEIGTISALQHP-HLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey 523 (790)
|.+.+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677899999999999999976 77899998765332 367799999999999988 799999999777778999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-CeEEeecCCccccCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDEED 602 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~ 602 (790)
+.++++.+++...... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++... .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999776322111 26888899999999999999999986 99999999999999988 6999999999855443
Q ss_pred Ccc-----eeeccccCCCcccHHHhhc---CCCCChhhHHHHHHHHHHHHhCCCCCcccccc-chhhHHHHHHHHHhhCC
Q 040908 603 NTH-----ISTRVAGTFGYMAPEYAMR---GHLTDKADVYSFGIVALEIVSGRSNIMCKTKE-EKFYLLDWALLLKEQGN 673 (790)
Q Consensus 603 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~ 673 (790)
... ......||..|+|||.+.. .......|+||+|++++++++|..|+...... .......... .....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~ 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL--ELPTP 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH--hcCCc
Confidence 322 2355779999999999987 57888999999999999999999997654321 0011111111 11111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000001111011223467788889999999999999887653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-20 Score=187.50 Aligned_cols=172 Identities=16% Similarity=0.150 Sum_probs=134.3
Q ss_pred HHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHH---------HHHHHHHhhccCCCceeeeeeEEEe
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNRE---------FVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
...++|+..+.+|.|+||.||.... ++..+|+|.+........+. +.+|+..+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3478999999999999999999665 56789999997543332222 6789999999999999999888653
Q ss_pred C--------CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC
Q 040908 514 G--------NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD 585 (790)
Q Consensus 514 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 585 (790)
. ...++||||++|.+|.++.. ++. ....+++.++..+|..+ ++|||+||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 3 35799999999999988741 121 24669999999999985 9999999999999998
Q ss_pred CCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHH
Q 040908 586 LNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIV 644 (790)
Q Consensus 586 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ell 644 (790)
+ ++|+|||........... ..++....+..++|+|+||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988754322111 11444555667999999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-20 Score=177.96 Aligned_cols=258 Identities=20% Similarity=0.239 Sum_probs=190.3
Q ss_pred hcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchhcHHHHHHHHHHhhccCC-CceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQH-PHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 522 (790)
..+|.++++||.|+||.+|.|. ..+|..||+|+-+...+. ..+.-|..+...++| ..|..+..|..+.+.-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999998 678999999987655433 345678888888865 677778888888888899999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC---CCeEEeecCCcccc
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISDFGLAKLD 599 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla~~~ 599 (790)
.. +.+|+++..-. ...++..+.+-+|-|++.-++|+|..+ +|||||||.|+|..-+ ..+.++|||+|+.+
T Consensus 92 LL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 76 67999988332 246888999999999999999999986 9999999999999754 35889999999855
Q ss_pred CCCCcc------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 600 EEDNTH------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 600 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
.+..+. ......||.+|.+-....+...+.+.|+-|+|.+|..+--|..||..........-.+... .. +
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~--Ek--K 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS--EK--K 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH--Hh--h
Confidence 432211 2234679999999988888888899999999999999999999998654333221111110 00 0
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
+... -..+...+ +.++...+..|-..--++-|...-+-+++.
T Consensus 241 ~s~~-ie~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 241 MSTP-IEVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred cCCC-HHHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 0000 01112223 335556667788888888888665554443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-21 Score=220.18 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=184.3
Q ss_pred eeeeecccCcEEEEeeeec-CCcEEEEEEcc-----ccchh-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 450 VANKIGEGGFGPVYKGLLA-DGTLIAVKQLS-----AKSKQ-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~-----~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
..+.+|.|++|.|+..... .....+.|... ..... ....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999988777632 33334444332 11111 11226678888889999999888877777666666699
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
||+. +|..++.. ...+....+..++.|+..|++|||+.| |.|||+|++|++++.++.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99999832 235778888999999999999999986 999999999999999999999999998754332
Q ss_pred C---cceeeccccCCCcccHHHhhcCCCCC-hhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 603 N---THISTRVAGTFGYMAPEYAMRGHLTD-KADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 603 ~---~~~~~~~~gt~~y~aPE~~~~~~~s~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
. .......+|+-.|+|||++....|.+ ..||||.|+++..|++|+.||......+... .......+.-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccccccc
Confidence 2 24556788999999999999999887 5799999999999999999997654333211 0000000000
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+..-........+.....++..+++.+|.+|-|+.+|++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000111122244566788899999999999999999976
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=182.63 Aligned_cols=201 Identities=25% Similarity=0.351 Sum_probs=165.3
Q ss_pred cCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
-.|.+.++||+|.||.++.|+ +-+++.||||.-..++.. -.+..|.+..+.+ ..++|..++-+..++..-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468889999999999999999 567899999987654432 3456677777777 578999888888888888999997
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC-----CCeEEeecCCccc
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-----LNPKISDFGLAKL 598 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-----~~~kl~DFGla~~ 598 (790)
+ |.+|+|+.. --++.++.+++..||.|++.-++|+|++. +|.|||||+|+||..- ..+.++|||+|+.
T Consensus 106 L-GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 6 668888772 23467899999999999999999999984 9999999999999643 3589999999986
Q ss_pred cCCCCcc------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccc
Q 040908 599 DEEDNTH------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTK 655 (790)
Q Consensus 599 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~ 655 (790)
+.+..+. .....-||.+||+-....+.+-+.+.|+-|+|-|+...+-|..||.+...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 6433221 12335699999999999999999999999999999999999999986543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.7e-20 Score=181.61 Aligned_cols=139 Identities=16% Similarity=0.184 Sum_probs=107.5
Q ss_pred eeeecccCcEEEEeeeecCCcEEEEEEccccchh--c-------HHH-----------------HHHHHHHhhccCCCce
Q 040908 451 ANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQ--G-------NRE-----------------FVNEIGTISALQHPHL 504 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni 504 (790)
...||+|+||.||+|...+|+.||||+++..... . ... ...|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999998654211 1 111 2349999999988877
Q ss_pred eeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHh-hhcCCCcEEeccCCCCcEEec
Q 040908 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL-HEESRLKIVHRDIKATNVLLD 583 (790)
Q Consensus 505 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiHrDlk~~NILl~ 583 (790)
.....+.. ...++||||++++++..... ....+++.....++.|++.+|+|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333222 22389999999987765431 124688899999999999999999 566 499999999999998
Q ss_pred CCCCeEEeecCCcccc
Q 040908 584 KDLNPKISDFGLAKLD 599 (790)
Q Consensus 584 ~~~~~kl~DFGla~~~ 599 (790)
+ +.++|+|||+|...
T Consensus 153 ~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 D-GKLYIIDVSQSVEH 167 (190)
T ss_pred C-CcEEEEEccccccC
Confidence 4 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=197.37 Aligned_cols=218 Identities=27% Similarity=0.368 Sum_probs=164.4
Q ss_pred hhccCCCceeeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccC
Q 040908 496 ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDI 575 (790)
Q Consensus 496 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDl 575 (790)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....++|.....+..+|+.||+|||+.. -..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence 4678999999999999999999999999999999999953 4578999999999999999999999863 2399999
Q ss_pred CCCcEEecCCCCeEEeecCCccccCCCC-cceeeccccCCCcccHHHhhcC-------CCCChhhHHHHHHHHHHHHhCC
Q 040908 576 KATNVLLDKDLNPKISDFGLAKLDEEDN-THISTRVAGTFGYMAPEYAMRG-------HLTDKADVYSFGIVALEIVSGR 647 (790)
Q Consensus 576 k~~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~S~Gvvl~elltG~ 647 (790)
+++|.++|....+|++|||+........ ........-..-|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987664311 1111112234579999998753 1467899999999999999999
Q ss_pred CCCccccccch-hhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcCC
Q 040908 648 SNIMCKTKEEK-FYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGV 725 (790)
Q Consensus 648 ~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 725 (790)
.||........ ..++.++.. .....+.|.+.... +....+..++..||..+|.+||++++|-..++.....
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99976432221 122222111 11122223322111 3334688999999999999999999999988876543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-20 Score=213.02 Aligned_cols=248 Identities=22% Similarity=0.272 Sum_probs=180.6
Q ss_pred CcceeeeecccCcEEEEeeeecCCcEEEEEEccccc-hhcHHHHHHHHHHh--hccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 447 HFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKS-KQGNREFVNEIGTI--SALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l--~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++...+.||.+.|=.|.+|+.+.|. |+||++-+.. .-..+.|.++++-+ ..++|||.+++.-+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998887 8889886544 33455666555444 445899999988776666667888888
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc--ccCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEE 601 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~--~~~~ 601 (790)
..+ +|.|.| ..+.-+...+..-||.|++.||..+|..+ |+|||||.+|||++.-.-+.|+||.-.+ ++++
T Consensus 103 vkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 876 788888 33345677788889999999999999985 9999999999999999999999998776 4455
Q ss_pred CCcceeeccccC----CCcccHHHhhcC-----------CCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHH
Q 040908 602 DNTHISTRVAGT----FGYMAPEYAMRG-----------HLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 602 ~~~~~~~~~~gt----~~y~aPE~~~~~-----------~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 665 (790)
++....+-+..| .+|+|||.+... ..+++.||||+||++.||++ |+++|.-. .+..+.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr 248 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYR 248 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHh
Confidence 554433322222 479999987542 26778999999999999998 67777421 111111
Q ss_pred HH-H-HhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 666 LL-L-KEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 666 ~~-~-~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.. . ..+.-+.++-| ..+.++++.|++.||.+|-++++.++.-.+
T Consensus 249 ~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 249 SGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred ccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 10 0 00001111211 146788999999999999999999876444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.2e-19 Score=175.41 Aligned_cols=141 Identities=18% Similarity=0.211 Sum_probs=110.5
Q ss_pred eeeecccCcEEEEeeeecCCcEEEEEEccccchh---------------------c-----HHHHHHHHHHhhccCCCce
Q 040908 451 ANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQ---------------------G-----NREFVNEIGTISALQHPHL 504 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~ni 504 (790)
...||+|+||.||+|...+|+.||||++...... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998754211 0 1124578999999999987
Q ss_pred eeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhh-cCCCcEEeccCCCCcEEec
Q 040908 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE-ESRLKIVHRDIKATNVLLD 583 (790)
Q Consensus 505 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~ 583 (790)
.....+... ..++||||++++++..... ....++......++.|++.++.++|+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 554444333 2489999999886544321 12356778889999999999999999 64 99999999999999
Q ss_pred CCCCeEEeecCCccccCC
Q 040908 584 KDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 584 ~~~~~kl~DFGla~~~~~ 601 (790)
++.++|+|||+++..+.
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=170.37 Aligned_cols=188 Identities=17% Similarity=0.098 Sum_probs=141.4
Q ss_pred ceeeeecccCcEEEEeeeecCCcEEEEEEccccchhc----HHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEEEEEe
Q 040908 449 DVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQG----NREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 449 ~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.+...|++|+||+||.+.- .+.+++.+.+....... ...|.+|+++|++++ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999996655 57778877776543211 125789999999995 5889999886 346999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccC-CCCcEEecCCCCeEEeecCCccccCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDI-KATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDl-k~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
+.+.+|.+.+. . ....++.|++++|+++|+.+ |+|||| ||+|||++.++.++|+|||+|......
T Consensus 80 I~G~~L~~~~~---~--------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPP---R--------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhh---h--------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 99999875541 0 11347789999999999985 999999 799999999999999999999855443
Q ss_pred Ccc----e--------eeccccCCCcccHHHhhcC-CCC-ChhhHHHHHHHHHHHHhCCCCCccccc
Q 040908 603 NTH----I--------STRVAGTFGYMAPEYAMRG-HLT-DKADVYSFGIVALEIVSGRSNIMCKTK 655 (790)
Q Consensus 603 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~ 655 (790)
... . ......++.|++|+...-- ..+ ...+.++-|..+|.++||+.+...+.+
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 310 0 1123468899999865322 233 467999999999999999988765443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-19 Score=194.62 Aligned_cols=224 Identities=26% Similarity=0.313 Sum_probs=172.9
Q ss_pred ecccCcEEEEeeee----cCCcEEEEEEccccchhc--HHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 454 IGEGGFGPVYKGLL----ADGTLIAVKQLSAKSKQG--NREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 454 LG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+|+|.||.|+.+.. +.|..+|.|+.++..... ......|..++...+ ||.+|++...+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 69999999998762 346778888876543211 114556788888886 99999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|.|...+.. ...++..........++-|++++|..+ |+|||+|++||+++.+|++++.|||+++..-+....
T Consensus 82 g~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988832 244566666677788999999999885 999999999999999999999999999855433221
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
+||..|||||++. .....+|.||||++++||+||-.||.. +... . +. ...-..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~------~---------Il--~~~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMK------R---------IL--KAELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHH------H---------Hh--hhccCC
Confidence 7999999999997 567889999999999999999999975 1100 0 00 011223
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
+.+......++.......+|.+|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 44555566677777888888888765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-17 Score=173.13 Aligned_cols=233 Identities=21% Similarity=0.259 Sum_probs=149.3
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCC-----------CceeeeeeEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQH-----------PHLVKLYGCC 511 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H-----------~niv~l~g~~ 511 (790)
.+...+.||.|+++.||.++.. .|+++|||++.... ....+.+.+|.-....+.+ +-++++ +..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEE
Confidence 3456789999999999999965 58999999885432 3345667777765555332 222222 211
Q ss_pred ---------EeC---C-----eEEEEEEeccCCChhhhhc---CCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEE
Q 040908 512 ---------IEG---N-----QLLLIYEYLENNSLARALF---GPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571 (790)
Q Consensus 512 ---------~~~---~-----~~~lV~Ey~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 571 (790)
... . ..+++|+-+ .++|.+++. ........+....++.+..|+++.+++||+.| ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 111 1 236677766 458887752 11111223455677788899999999999986 99
Q ss_pred eccCCCCcEEecCCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcC--------CCCChhhHHHHHHHHHHH
Q 040908 572 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG--------HLTDKADVYSFGIVALEI 643 (790)
Q Consensus 572 HrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~ksDV~S~Gvvl~el 643 (790)
|+||||+|++++++|.++|+||+.....+.. ... ...+..|.+||..... .++.+.|.|++|+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCce---eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999887644331 111 3356789999987542 478899999999999999
Q ss_pred HhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 040908 644 VSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNR 709 (790)
Q Consensus 644 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 709 (790)
++|+.||.......... | + . ..+. +.++.+..++...++.+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~---~-----------~-----f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPE---W-----------D-----F-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSG---G-----------G-----G-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccc---c-----------c-----c-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999997653322111 0 0 1 1233 566778889999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=165.64 Aligned_cols=135 Identities=17% Similarity=0.243 Sum_probs=104.2
Q ss_pred eeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhcc-----CCCceeeeeeEEEeCC---e-EEEE
Q 040908 450 VANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-----QHPHLVKLYGCCIEGN---Q-LLLI 520 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~lV 520 (790)
-.+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 457899999999996 3234444 68888665444567799999999999 5799999999998763 3 3478
Q ss_pred EEe--ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHH-HHhhhcCCCcEEeccCCCCcEEecC----CCCeEEeec
Q 040908 521 YEY--LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGL-AYLHEESRLKIVHRDIKATNVLLDK----DLNPKISDF 593 (790)
Q Consensus 521 ~Ey--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~iiHrDlk~~NILl~~----~~~~kl~DF 593 (790)
+|| +.+|+|.+++.. ..+++. ..++.+++.++ +|||+.+ |+||||||+|||++. +..++|+||
T Consensus 84 ~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred ecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 999 558999999932 124444 35677888777 9999985 999999999999974 347999995
Q ss_pred CCc
Q 040908 594 GLA 596 (790)
Q Consensus 594 Gla 596 (790)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.8e-18 Score=174.77 Aligned_cols=196 Identities=24% Similarity=0.372 Sum_probs=134.6
Q ss_pred CCCceeeeeeEEEe---------------------------CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHH
Q 040908 500 QHPHLVKLYGCCIE---------------------------GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNIC 552 (790)
Q Consensus 500 ~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 552 (790)
+|||||++.++|.+ ...+|+||...+. +|..++... ..+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence 59999999988754 2357888887655 888888432 34556677789
Q ss_pred HHHHHHHHHhhhcCCCcEEeccCCCCcEEec--CCC--CeEEeecCCccccCCCCcc-----eeeccccCCCcccHHHhh
Q 040908 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLD--KDL--NPKISDFGLAKLDEEDNTH-----ISTRVAGTFGYMAPEYAM 623 (790)
Q Consensus 553 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~ 623 (790)
.|+++|+.|||.++ |.|||+|+.|||+. +|. ...|+|||.+-..+...-. ......|.-.-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999885 99999999999993 343 4689999987533321111 111234777899999986
Q ss_pred cCC------CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHH
Q 040908 624 RGH------LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINV 697 (790)
Q Consensus 624 ~~~------~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 697 (790)
..+ --.|+|.|+.|.+.||+++...||....+ ..+ +-.. .++.++ |.+.+.. ...+.++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---m~L-~~r~--Yqe~qL-----Palp~~v----pp~~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---MLL-DTRT--YQESQL-----PALPSRV----PPVARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch---hee-chhh--hhhhhC-----CCCcccC----ChHHHHH
Confidence 432 13599999999999999999999975211 111 1000 111111 2333333 3456677
Q ss_pred HHHccCCCCCCCCCHHHHHHHH
Q 040908 698 ALLCADVSPTNRPLMSSVVSML 719 (790)
Q Consensus 698 ~~~Cl~~dP~~RPt~~ev~~~L 719 (790)
+...++.||.+|++..-....|
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 7788999999999976555544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.4e-17 Score=205.43 Aligned_cols=168 Identities=23% Similarity=0.301 Sum_probs=108.1
Q ss_pred CEEEccCCcCcccCChhhh-cccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEecccc
Q 040908 1 MYRTVQSNRLSGELPEELG-SLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCN 74 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~-~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~ 74 (790)
++|+|++|+++|.+|..+. .+++|++|+|++|++++..| .+|+.|++++|.+....+..+.. ++|++|+|++|.
T Consensus 96 ~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~ 175 (968)
T PLN00113 96 QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175 (968)
T ss_pred CEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCc
Confidence 3566666666666666544 66666666666666665444 25666666666655443333443 667777777777
Q ss_pred ccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCC
Q 040908 75 LTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGS 153 (790)
Q Consensus 75 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~ 153 (790)
+.+.+|..|+++++|++|+|++|++++.+|..++++++|+.|+|++|++++.+|..+.. ++|+.|+|++|++++.+|..
T Consensus 176 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 255 (968)
T PLN00113 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS 255 (968)
T ss_pred ccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChh
Confidence 76667777777777777777777776666766777777777777777766666666655 66666666666666666666
Q ss_pred CCCCCcceeeecCCC
Q 040908 154 DCQNGAVNLFASSSK 168 (790)
Q Consensus 154 ~~~~~~l~~~~~~~~ 168 (790)
+..+++|+.+..+.+
T Consensus 256 l~~l~~L~~L~L~~n 270 (968)
T PLN00113 256 LGNLKNLQYLFLYQN 270 (968)
T ss_pred HhCCCCCCEEECcCC
Confidence 666666666655443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=186.58 Aligned_cols=249 Identities=19% Similarity=0.228 Sum_probs=180.2
Q ss_pred HHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccC---CCceeeeeeEEEeCCe
Q 040908 440 QIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ---HPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~ 516 (790)
+.+.-.+.|.+.+.||+|+||.||+|...+|+.||+|+-+...... |.-=.+++.+|+ -+-|..+..+..-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 4445567899999999999999999998889999999977655442 111122333443 2445555555566778
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec-------CCCCeE
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD-------KDLNPK 589 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-------~~~~~k 589 (790)
.+||+||.+.|+|.+++. ....++|.-.+.++.|+++-++.||..+ |||+||||.|.||. +...++
T Consensus 769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 899999999999999994 4467999999999999999999999985 99999999999994 234589
Q ss_pred EeecCCccc---cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH
Q 040908 590 ISDFGLAKL---DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL 666 (790)
Q Consensus 590 l~DFGla~~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 666 (790)
|+|||.+-- +++. ..-...++|-.+-.+|+..+...+..+|.|.++.+++-|+.|+.- .
T Consensus 842 lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------------q 903 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------------E 903 (974)
T ss_pred EEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------------H
Confidence 999999853 3332 233456789999999999999999999999999999999998631 0
Q ss_pred HHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 667 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
...+. ...++..++..+..+...++.++++ +.|-..=|...++...+++.
T Consensus 904 --~~~g~-~~~~~~~~~Ry~~~~~W~~~F~~lL---N~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 904 --VKNGS-SWMVKTNFPRYWKRDMWNKFFDLLL---NPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred --hcCCc-ceeccccchhhhhHHHHHHHHHHHh---CcCcccchhHHHHHHHHHHH
Confidence 01111 1223333444444455555555444 44445556666666666654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=184.42 Aligned_cols=143 Identities=17% Similarity=0.235 Sum_probs=114.1
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEcccc-c------hhcHHHHHHHHHHhhccCCCceeeeeeEEEe
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAK-S------KQGNREFVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
.......|...+.||+|+||.||+|.+.+...++.+++... . ......+.+|++++.+++|++++....++..
T Consensus 328 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 328 EEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred ccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 33344556678999999999999998765443333222221 1 1123568899999999999999988888887
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
.+..++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 778899999999999999883 35678999999999999985 9999999999999 5779999999
Q ss_pred CCcccc
Q 040908 594 GLAKLD 599 (790)
Q Consensus 594 Gla~~~ 599 (790)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999853
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=161.31 Aligned_cols=134 Identities=20% Similarity=0.291 Sum_probs=112.5
Q ss_pred eeecccCcEEEEeeeecCCcEEEEEEccccchh--------cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 452 NKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQ--------GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
+.||+|++|.||+|.. .|..|++|+....... ....+.+|+.++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5677889976532211 124578899999999999998887787777888999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998321 22 78899999999999999985 99999999999999 78899999999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=164.21 Aligned_cols=143 Identities=18% Similarity=0.189 Sum_probs=110.3
Q ss_pred CcceeeeecccCcEEEEeee--ecCCcEEEEEEccccchh------------------------cHHHHHHHHHHhhccC
Q 040908 447 HFDVANKIGEGGFGPVYKGL--LADGTLIAVKQLSAKSKQ------------------------GNREFVNEIGTISALQ 500 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~--~~~g~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 500 (790)
.|++.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999998643210 0123568999999997
Q ss_pred CCc--eeeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCC
Q 040908 501 HPH--LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKAT 578 (790)
Q Consensus 501 H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~ 578 (790)
+.. +.+++++ ...++||||+++++|...... ...+.......++.|++.++++||+.+ .++||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 633 3344443 235899999999888765421 123455567789999999999999874 3999999999
Q ss_pred cEEecCCCCeEEeecCCccccC
Q 040908 579 NVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 579 NILl~~~~~~kl~DFGla~~~~ 600 (790)
||+++ ++.++|+|||.+....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=158.14 Aligned_cols=131 Identities=23% Similarity=0.308 Sum_probs=106.4
Q ss_pred eecccCcEEEEeeeecCCcEEEEEEccccch--------hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSK--------QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 453 ~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
.||+|+||.||+|.+ +|..|++|+...... .....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 567899998643221 11255778999999999988766655666667779999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
++++|.+++.... . .++.+++.+|++||+.+ ++|+|++|+||+++ ++.+++.|||+++..
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998873211 0 78999999999999985 99999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.4e-16 Score=157.71 Aligned_cols=144 Identities=21% Similarity=0.231 Sum_probs=111.0
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchh----------------------cHHHHHHHHHHhhc
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQ----------------------GNREFVNEIGTISA 498 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~----------------------~~~~~~~E~~~l~~ 498 (790)
+......|.+.+.||+|+||.||+|...+|+.||||++...... ....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333347788999999999999999888999999986542100 01236678889999
Q ss_pred cCCCc--eeeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCC
Q 040908 499 LQHPH--LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIK 576 (790)
Q Consensus 499 l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk 576 (790)
+.|++ +.+.++. ...++||||+++++|.+.... .....++.+++.++.++|+.+ ++|||||
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 98874 4444432 345899999999998765410 245678999999999999974 9999999
Q ss_pred CCcEEecCCCCeEEeecCCccccCC
Q 040908 577 ATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 577 ~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
|+||++++++.++|+|||++.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.5e-17 Score=176.13 Aligned_cols=123 Identities=27% Similarity=0.447 Sum_probs=107.1
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
.+++.|++|...+|.+||.+++. ....+|.....++.|++.|++| + +.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 47889999999999999964432 3567889999999999999999 4 389999999999999999999999999
Q ss_pred ccccCCCC-----cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh
Q 040908 596 AKLDEEDN-----THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645 (790)
Q Consensus 596 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt 645 (790)
........ ....+...||..||+||.+.+..|+.|+||||+|++|+||++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87665544 223456789999999999999999999999999999999997
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.5e-16 Score=155.57 Aligned_cols=169 Identities=38% Similarity=0.627 Sum_probs=109.0
Q ss_pred EEeecCCceeEecCCeeeecCCCcccccceeccCCCceeeeccccccCCCCCCceeeeccccccCCchhhhhhhhcCCcc
Q 040908 191 VHINCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHFLDDKSPDTNIQKNTSRLLMDDFQLYTEARVSPIS 270 (790)
Q Consensus 191 ~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 270 (790)
+.++||+...+...+..++.|..-.++.. .+... ................+.+..||+|+|.++.+
T Consensus 3 ~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~---------~y~~~-----~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~ 68 (174)
T PF11721_consen 3 LRINAGGPAYTDSSGIVWEADQYYTGGSW---------GYYVS-----SDNNGSTSSTNSSIPGTTDDPLYQTERYGPSS 68 (174)
T ss_dssp EEEEETSSSEEETTTEEE-SSSSSTTSS-------------------------SSTTS--TTS-HHHHHTTT-----SSS
T ss_pred EEEECCCCcccCCCCCEEcCCCCCCCCCc---------ccccc-----cccccccccccccccCCCchhhhHhhcCCCCc
Confidence 46899999887778888888885433332 11000 00000012234455678899999999999999
Q ss_pred cceEEeeccCCeeeeeeecceeeeccccccccccceEEEEEecCccccccCCcchhcCCCCCcceece-eeeeecCeeEE
Q 040908 271 LTYYVFCLENGNYKVNLHFAETMFTDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPF-SAVVTNGTMDI 349 (790)
Q Consensus 271 l~~~~~~~~~g~~~~~~~~a~~~~~~~~~~~~~~~~~~~i~i~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~ 349 (790)
++|...|+.||.|.|+|||||+++..+..+.+.|+|+|||+++++.++++|+|..++++..+++...+ .+.++++.+.+
T Consensus 69 f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i 148 (174)
T PF11721_consen 69 FSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNI 148 (174)
T ss_dssp EEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEET
T ss_pred eEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEE
Confidence 99999999999999999999999999999999999999999999999999999999999887766554 88899999999
Q ss_pred EEEecCCcceecCCCCCCC-Ccccc
Q 040908 350 RLYWAGKGTTEIPDRGVYG-PLISA 373 (790)
Q Consensus 350 ~~~~ag~~~~~~p~~~~~g-p~~s~ 373 (790)
++.|++++.+++|..+..+ |.+++
T Consensus 149 ~f~~~~~~~~~i~~~~~~~~p~Isa 173 (174)
T PF11721_consen 149 QFVWAGKGTLCIPFIGSYGNPLISA 173 (174)
T ss_dssp TEEEE--SEEEEEEESSSSSSSEEE
T ss_pred EEEecCCCcEEeeccccCCCcEEee
Confidence 9999999999998766666 66654
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-14 Score=138.96 Aligned_cols=135 Identities=21% Similarity=0.218 Sum_probs=114.5
Q ss_pred eeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCC--CceeeeeeEEEeCCeEEEEEEeccCC
Q 040908 450 VANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQH--PHLVKLYGCCIEGNQLLLIYEYLENN 527 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~g 527 (790)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999855 7899999865433 4678899999999976 58899998888878899999999987
Q ss_pred ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 528 SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 528 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
.+..+ ++.....++.++++++++||.....+++|+|++|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 4566778899999999999986545699999999999999989999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.6e-15 Score=174.72 Aligned_cols=210 Identities=24% Similarity=0.325 Sum_probs=139.3
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..+|+.++.|..|+||.||..+++ ..+++|.| +.+.. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee------------------
Confidence 467888999999999999999865 35677873 32211 00000 22222333333
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC-
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED- 602 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~- 602 (790)
|+-.+.+... ..++. +++.+++|||+.+ |+|||+||.|.+|+.-|++|+.|||+.+..-..
T Consensus 136 ---gDc~tllk~~----g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNI----GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccC----CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 4444444211 22322 2277899999985 999999999999999999999999998632110
Q ss_pred -------------CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 603 -------------NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 603 -------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
.......++||+.|+|||++....|....|+|++|+|+||.+-|+.||+.++.++-+..+ ..
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v-----is 272 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV-----IS 272 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh-----hh
Confidence 011223478999999999999999999999999999999999999999988766543211 01
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
......|- | .....+..+++...++.+|..|--.
T Consensus 273 d~i~wpE~-d--------ea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 273 DDIEWPEE-D--------EALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hhcccccc-C--------cCCCHHHHHHHHHHHHhChHhhccc
Confidence 11111111 1 1222345566667788888888643
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-16 Score=171.41 Aligned_cols=172 Identities=19% Similarity=0.211 Sum_probs=128.3
Q ss_pred EEEccCCcCcccCChh-hhcccccCcccccCccccccccc-----cccceeccccCCCCCCCccccc-CcccEEEecccc
Q 040908 2 YRTVQSNRLSGELPEE-LGSLIHSGKWFGWANSVWHYFSE-----SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCN 74 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~-~~~L~~L~~L~l~~N~l~~~~~~-----~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~ 74 (790)
.|+||+|+|. .||.. |.+|+-|-.|+|++|++...+|. .|+.|.|++|.+.-..+-.+.. ++|+.|.+++.+
T Consensus 130 VLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~Tq 208 (1255)
T KOG0444|consen 130 VLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQ 208 (1255)
T ss_pred EEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccccc
Confidence 5788888887 77775 56788888888888888887775 7788888888776544444333 667778887754
Q ss_pred c-cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCC
Q 040908 75 L-TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSG 152 (790)
Q Consensus 75 l-~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~ 152 (790)
= ...+|.++..|.+|..+|||.|+|. .+|+.+.++.+|+.|+||+|+++ .+...... .+|+.|+||.|+|+ .+|.
T Consensus 209 RTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~ 285 (1255)
T KOG0444|consen 209 RTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPD 285 (1255)
T ss_pred chhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchH
Confidence 2 2368888888888888888888888 88888888888888888888887 33333333 67888888888887 5788
Q ss_pred CCCCCCcceeeecCCCCCCCCcccc
Q 040908 153 SDCQNGAVNLFASSSKGSNSTGIVS 177 (790)
Q Consensus 153 ~~~~~~~l~~~~~~~~~~~~~~~~~ 177 (790)
.+|.++.|+.+-..++.-+..|+++
T Consensus 286 avcKL~kL~kLy~n~NkL~FeGiPS 310 (1255)
T KOG0444|consen 286 AVCKLTKLTKLYANNNKLTFEGIPS 310 (1255)
T ss_pred HHhhhHHHHHHHhccCcccccCCcc
Confidence 8888888877776666555555543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.6e-14 Score=143.95 Aligned_cols=137 Identities=22% Similarity=0.262 Sum_probs=97.5
Q ss_pred eeeecccCcEEEEeeeecCCcEEEEEEccccchh--cHHH----------------------HHHHHHHhhccCCCc--e
Q 040908 451 ANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQ--GNRE----------------------FVNEIGTISALQHPH--L 504 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 504 (790)
.+.||+|+||.||+|...+|+.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999987643211 1111 134566666664443 3
Q ss_pred eeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhh-cCCCcEEeccCCCCcEEec
Q 040908 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE-ESRLKIVHRDIKATNVLLD 583 (790)
Q Consensus 505 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~ 583 (790)
.+.+++ ...++||||++++.+....... .... .....++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~----~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD----VRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh----hhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 344433 2458999999996543221100 0011 5677899999999999998 5 599999999999999
Q ss_pred CCCCeEEeecCCccccC
Q 040908 584 KDLNPKISDFGLAKLDE 600 (790)
Q Consensus 584 ~~~~~kl~DFGla~~~~ 600 (790)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999997443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.5e-16 Score=169.60 Aligned_cols=161 Identities=22% Similarity=0.264 Sum_probs=108.4
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccc----cccc---------------------------cccceecccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWH----YFSE---------------------------SLTDLRISDL 50 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~----~~~~---------------------------~L~~L~l~~n 50 (790)
|||||+|+|. .+|+.+..|.+|+.|.|++|.+.. .+|. +|..++++.|
T Consensus 154 fLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N 232 (1255)
T KOG0444|consen 154 FLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSEN 232 (1255)
T ss_pred hhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhcccccc
Confidence 7999999998 999999999999999999998741 1121 5555566666
Q ss_pred CCCCCCCcccccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccc-cCCc
Q 040908 51 NGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTG-KVPQ 129 (790)
Q Consensus 51 ~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g-~~p~ 129 (790)
++...|.-.....+|+.|+||+|+|+ .+.-..+...+|+.|+||+|+|+ .+|+.++.|++|+.|++.+|+|+- -||+
T Consensus 233 ~Lp~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPS 310 (1255)
T KOG0444|consen 233 NLPIVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPS 310 (1255)
T ss_pred CCCcchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCcc
Confidence 66666555555566666777777666 56556666666666777777776 667777777777777777666542 2455
Q ss_pred cccC-CCCcEEeccCCccccCCCCCCCCCCcceeeecC
Q 040908 130 WMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFASS 166 (790)
Q Consensus 130 ~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~ 166 (790)
.+.. .+|+.+..++|+|. .+|.++|.+..|+.+.++
T Consensus 311 GIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~ 347 (1255)
T KOG0444|consen 311 GIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLD 347 (1255)
T ss_pred chhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccc
Confidence 5544 55666666666654 456666666555555443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=143.26 Aligned_cols=134 Identities=19% Similarity=0.236 Sum_probs=103.3
Q ss_pred eeec-ccCcEEEEeeeecCCcEEEEEEccccc-------------hhcHHHHHHHHHHhhccCCCce--eeeeeEEEeCC
Q 040908 452 NKIG-EGGFGPVYKGLLADGTLIAVKQLSAKS-------------KQGNREFVNEIGTISALQHPHL--VKLYGCCIEGN 515 (790)
Q Consensus 452 ~~LG-~G~fG~Vy~g~~~~g~~vAvK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~ 515 (790)
..|| .||.|+||++... +..++||.+.... ......+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8899999998875 6678888875311 1123457889999999998885 66777654322
Q ss_pred ----eEEEEEEeccC-CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEE
Q 040908 516 ----QLLLIYEYLEN-NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 590 (790)
Q Consensus 516 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 590 (790)
..++||||+++ .+|.+++.. ..++. ..+.+++.+|.+||+.+ |+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-----APLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-----CCCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 23599999997 689888732 23333 23678999999999986 999999999999999889999
Q ss_pred eecCCccc
Q 040908 591 SDFGLAKL 598 (790)
Q Consensus 591 ~DFGla~~ 598 (790)
+|||.++.
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998874
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1e-14 Score=157.76 Aligned_cols=165 Identities=16% Similarity=0.105 Sum_probs=85.8
Q ss_pred EEccCCcCcccCCh-hhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEecccc
Q 040908 3 RTVQSNRLSGELPE-ELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCN 74 (790)
Q Consensus 3 L~Ls~N~l~g~iP~-~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~ 74 (790)
||||.|.|+ +||. .|..=.+++.|+|++|+|+.... .+|..|.|++|.++..+.-.|.. ++|+.|+|..|+
T Consensus 154 lDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ 232 (873)
T KOG4194|consen 154 LDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNR 232 (873)
T ss_pred hhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccc
Confidence 455555555 4443 34444455555555555543221 14444555555555555444442 445555554444
Q ss_pred c------------------------cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCcc
Q 040908 75 L------------------------TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQW 130 (790)
Q Consensus 75 l------------------------~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~ 130 (790)
| +..-...|-.|.++++|+|+.|+++..--.++.+|++|+.||||+|.+...-++.
T Consensus 233 irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~ 312 (873)
T KOG4194|consen 233 IRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS 312 (873)
T ss_pred eeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch
Confidence 4 4333334445555556666666665444455556666666666666665554444
Q ss_pred ccC-CCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 131 MFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 131 ~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
+.- .+|+.||||+|+|+..-++.+..+.+|..+.++.+
T Consensus 313 WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~N 351 (873)
T KOG4194|consen 313 WSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHN 351 (873)
T ss_pred hhhcccceeEeccccccccCChhHHHHHHHhhhhccccc
Confidence 333 55666666666666555555555555555555443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=7.3e-15 Score=158.96 Aligned_cols=164 Identities=20% Similarity=0.140 Sum_probs=138.5
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
.+|+|+.|++...--.++.+|+.|+.|+|++|.|..+.+. .|+.|+|++|+++..+...|.. ..|++|+|++|
T Consensus 272 e~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~N 351 (873)
T KOG4194|consen 272 EHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHN 351 (873)
T ss_pred ceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccccc
Confidence 3689999999966666788999999999999999876654 8999999999999998888877 88999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCcCcch---hccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccC
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPE---SFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADE 149 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~---~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~ 149 (790)
.|+-.--..|..|++|+.|||++|.|++.|-+ .|..|++|+.|+|.+|+|..+.-..|.. .+|+.|||.+|.|-..
T Consensus 352 si~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSI 431 (873)
T KOG4194|consen 352 SIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASI 431 (873)
T ss_pred chHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceee
Confidence 99855555788899999999999999988765 5788999999999999999655566766 8899999999999988
Q ss_pred CCCCCCCCCcceeeec
Q 040908 150 SSGSDCQNGAVNLFAS 165 (790)
Q Consensus 150 ~p~~~~~~~~l~~~~~ 165 (790)
-|..|..+ .|+.+..
T Consensus 432 q~nAFe~m-~Lk~Lv~ 446 (873)
T KOG4194|consen 432 QPNAFEPM-ELKELVM 446 (873)
T ss_pred cccccccc-hhhhhhh
Confidence 88888877 6665544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.1e-14 Score=168.37 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=183.1
Q ss_pred hcCcceeeeecccCcEEEEeeeecC--CcEEEEEEccccc--hhcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD--GTLIAVKQLSAKS--KQGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~--g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 519 (790)
...|.+.+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3457777889999999998877533 3456667665443 222233445777777775 9999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhh-hcCCCcEEeccCCCCcEEecCCC-CeEEeecCCcc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH-EESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAK 597 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~ 597 (790)
+.+|..++++.+.+.. ......+.........|+..++.|+| .. .+.||||||+|.+++..+ ..+++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999888831 11114455666778999999999999 66 499999999999999999 99999999998
Q ss_pred ccCC--CCcceeecccc-CCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 598 LDEE--DNTHISTRVAG-TFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 598 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
.... .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ....|.... +.
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~~ 249 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---GR 249 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---cc
Confidence 6655 33333445678 9999999998874 456688999999999999999999986543331 111121110 00
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVV 716 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 716 (790)
.. ............++...++..+|..|.+.+++.
T Consensus 250 ~~--------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 FT--------QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cc--------cCccccCChhhhhcccccccCCchhcccccccc
Confidence 00 000111122345666678889999999988764
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.4e-15 Score=155.21 Aligned_cols=163 Identities=20% Similarity=0.239 Sum_probs=120.4
Q ss_pred EEccCCcCcccCChhhhcccccCcccccCccccccccc-----cccceeccccCCCCCCCcccccCcccEEEeccccccc
Q 040908 3 RTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE-----SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTG 77 (790)
Q Consensus 3 L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~-----~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~ 77 (790)
|+++.|++. ++|++++.+..|+.|+..+|+++..++. ++..|.+..|.+...+......+.|+.||...|-+.
T Consensus 119 l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~- 196 (565)
T KOG0472|consen 119 LDCSSNELK-ELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE- 196 (565)
T ss_pred hhcccccee-ecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-
Confidence 455555555 5555555555555555555555555443 455566666666666666666677888888888886
Q ss_pred cCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCcccc-C-CCCcEEeccCCccccCCCCCCC
Q 040908 78 ELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMF-G-RGPENIDLSYNNFADESSGSDC 155 (790)
Q Consensus 78 ~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~-~~L~~l~ls~N~l~g~~p~~~~ 155 (790)
.+|+.++.|.+|+-|+|.+|+|. .+| +|.++..|+.|+++.|++. .+|.... . .++..|||..|+++ +.|.++|
T Consensus 197 tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c 272 (565)
T KOG0472|consen 197 TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC 272 (565)
T ss_pred cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHH
Confidence 88888888888888888888887 777 7888888888888888887 5565554 4 78899999999997 7899999
Q ss_pred CCCcceeeecCCCCCC
Q 040908 156 QNGAVNLFASSSKGSN 171 (790)
Q Consensus 156 ~~~~l~~~~~~~~~~~ 171 (790)
.+++|.+++.|++...
T Consensus 273 lLrsL~rLDlSNN~is 288 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDIS 288 (565)
T ss_pred HhhhhhhhcccCCccc
Confidence 9999999999887543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.4e-15 Score=136.63 Aligned_cols=143 Identities=17% Similarity=0.135 Sum_probs=91.7
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccc-----cccceeccccCCCCCCCcccccCcccEEEecccccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE-----SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLT 76 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~-----~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~ 76 (790)
.|-||+|+|+ .+|+.+..|.+|+.|++++|++...+++ .|+.|++.-|.+...+-...+.+.|+.|||+.|+++
T Consensus 37 rLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldltynnl~ 115 (264)
T KOG0617|consen 37 RLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYNNLN 115 (264)
T ss_pred hhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhccccccc
Confidence 3667888888 7888888888888888888888765543 455555555555555544444456666666666655
Q ss_pred c-cCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccc
Q 040908 77 G-ELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFA 147 (790)
Q Consensus 77 ~-~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~ 147 (790)
. .+|..|..|+-|+-|.|+.|.+. .+|..+++|++|+.|.+..|.+- .+|..+.. ..|+.|.+.+|+|+
T Consensus 116 e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 116 ENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred cccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 3 35555666666666666666665 66666666666666666666665 45555554 55666666666665
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.4e-12 Score=151.17 Aligned_cols=93 Identities=19% Similarity=0.328 Sum_probs=84.8
Q ss_pred cccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEecc
Q 040908 64 TFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLS 142 (790)
Q Consensus 64 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls 142 (790)
.++.|+|++|.++|.+|..|++|++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..+.. .+|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 3778999999999999999999999999999999999999999999999999999999999999998877 889999999
Q ss_pred CCccccCCCCCCCC
Q 040908 143 YNNFADESSGSDCQ 156 (790)
Q Consensus 143 ~N~l~g~~p~~~~~ 156 (790)
+|+|+|.+|..+..
T Consensus 499 ~N~l~g~iP~~l~~ 512 (623)
T PLN03150 499 GNSLSGRVPAALGG 512 (623)
T ss_pred CCcccccCChHHhh
Confidence 99999998877653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.9e-12 Score=143.99 Aligned_cols=140 Identities=21% Similarity=0.239 Sum_probs=99.8
Q ss_pred eeecccCcEEEEeeeecCCcEEEEEEccccchhc----------------------------------------HHHHHH
Q 040908 452 NKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQG----------------------------------------NREFVN 491 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~----------------------------------------~~~~~~ 491 (790)
+.||.|++|.||+|++.+|+.||||+.+...... +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999999999999999999975431110 012555
Q ss_pred HHHHhhccC----CCceeeeeeEEE-eCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHH-HHHHhhhc
Q 040908 492 EIGTISALQ----HPHLVKLYGCCI-EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR-GLAYLHEE 565 (790)
Q Consensus 492 E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-aL~yLH~~ 565 (790)
|+..+.+++ |.+-+.+-..+. .....++||||++|++|.+...... ... .+.+++..+++ .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC
Confidence 666665552 333333333332 2345799999999999988763211 112 34567777776 46788877
Q ss_pred CCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 566 ~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
+ ++|+|+||.||+++++++++++|||++....
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 4 9999999999999999999999999987554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.6e-14 Score=146.23 Aligned_cols=158 Identities=22% Similarity=0.168 Sum_probs=139.1
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccc-----cccceeccccCCCCCCCcccccCcccEEEecccccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE-----SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLT 76 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~-----~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~ 76 (790)
.|+..+|+|+ .+|+.++++.+|..|++.+|++...+|. .|+.|+...|.+...|.......+|.-|+|..|+|.
T Consensus 141 dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~ 219 (565)
T KOG0472|consen 141 DLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR 219 (565)
T ss_pred hhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc
Confidence 4788999999 9999999999999999999999988875 788899999888888776666689999999999999
Q ss_pred ccCCccccCCCCCCEEEccCCcCCcCcchhcc-CCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 77 GELPHFLGEVSEMKVLDLSFNKLNGTIPESFA-RLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 77 ~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
.+| +|++|..|.+|+++.|+|. .+|.+.. +|.+|..|||..|+++ ..|+.+.. ++|+.||||+|.|++ .|.++
T Consensus 220 -~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sL 294 (565)
T KOG0472|consen 220 -FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSL 294 (565)
T ss_pred -cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCccc
Confidence 889 7999999999999999998 9999877 8999999999999999 67776666 889999999999996 56677
Q ss_pred CCCCcceeeecC
Q 040908 155 CQNGAVNLFASS 166 (790)
Q Consensus 155 ~~~~~l~~~~~~ 166 (790)
+++ .|..+...
T Consensus 295 gnl-hL~~L~le 305 (565)
T KOG0472|consen 295 GNL-HLKFLALE 305 (565)
T ss_pred ccc-eeeehhhc
Confidence 777 66666553
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=9.7e-14 Score=150.38 Aligned_cols=172 Identities=21% Similarity=0.242 Sum_probs=152.5
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCcccccccc-----ccccceeccccCCCCCCCcccccCcccEEEecccccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLT 76 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~ 76 (790)
..||+.|++. ++|.++..+..|+.|.|..|.+..+++ +.|+.|+|+.|.+...+.+.... -|+.|.+++|+++
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~l-pLkvli~sNNkl~ 156 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLSHLPDGLCDL-PLKVLIVSNNKLT 156 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccchhhcCChhhhcC-cceeEEEecCccc
Confidence 5799999999 999999999999999999999987665 37888899999988877665543 5999999999998
Q ss_pred ccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCCCC
Q 040908 77 GELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQ 156 (790)
Q Consensus 77 ~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~ 156 (790)
.+|+.++.+..|..||.+.|++. .+|..+++|.+|+.|.+..|++. .+|..+....|..||+|.|+++ .+|-.|+.
T Consensus 157 -~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis-~iPv~fr~ 232 (722)
T KOG0532|consen 157 -SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKIS-YLPVDFRK 232 (722)
T ss_pred -cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCcee-ecchhhhh
Confidence 99999999999999999999998 89999999999999999999999 5666666778999999999998 68999999
Q ss_pred CCcceeeecCCCCCCCCcccccc
Q 040908 157 NGAVNLFASSSKGSNSTGIVSCL 179 (790)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~~~ 179 (790)
++.|+.+.+.++.-.++.+-.|.
T Consensus 233 m~~Lq~l~LenNPLqSPPAqIC~ 255 (722)
T KOG0532|consen 233 MRHLQVLQLENNPLQSPPAQICE 255 (722)
T ss_pred hhhheeeeeccCCCCCChHHHHh
Confidence 99999999999988777665553
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.4e-12 Score=131.21 Aligned_cols=154 Identities=22% Similarity=0.331 Sum_probs=118.9
Q ss_pred HHhhccCCCceeeeeeEEEeC-----CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCC
Q 040908 494 GTISALQHPHLVKLYGCCIEG-----NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568 (790)
Q Consensus 494 ~~l~~l~H~niv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 568 (790)
.-|-++-|-|||+++.|+.+. ....++.|||..|++..+|+........+......+|+.||..||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 445667799999999998653 356899999999999999976666666777778889999999999999986 68
Q ss_pred cEEeccCCCCcEEecCCCCeEEeecCCccccC---CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh
Q 040908 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDE---EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS 645 (790)
Q Consensus 569 ~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt 645 (790)
+|+|+++.-.-|++..++-+|+.----..... ...........+-++|.|||+-.....+..+|||+||+-.+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999888875211110000 000111122346789999998777777889999999999999988
Q ss_pred CCC
Q 040908 646 GRS 648 (790)
Q Consensus 646 G~~ 648 (790)
+..
T Consensus 278 lEi 280 (458)
T KOG1266|consen 278 LEI 280 (458)
T ss_pred hee
Confidence 764
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.4e-12 Score=147.56 Aligned_cols=77 Identities=22% Similarity=0.277 Sum_probs=44.1
Q ss_pred cccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccC
Q 040908 64 TFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSY 143 (790)
Q Consensus 64 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~ 143 (790)
+|+.|+|++|+|+ .+|... .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ +|... .+|+.|+|++
T Consensus 343 ~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-LP~l~--s~L~~LdLS~ 411 (788)
T PRK15387 343 GLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVLP--SELKELMVSG 411 (788)
T ss_pred ccceEecCCCccC-CCCCCC---cccceehhhccccc-cCccc---ccccceEEecCCcccC-CCCcc--cCCCEEEccC
Confidence 5666666666666 455422 34445555555555 34532 2456777777777774 44322 4567777777
Q ss_pred CccccCCCC
Q 040908 144 NNFADESSG 152 (790)
Q Consensus 144 N~l~g~~p~ 152 (790)
|+|++ +|.
T Consensus 412 N~Lss-IP~ 419 (788)
T PRK15387 412 NRLTS-LPM 419 (788)
T ss_pred CcCCC-CCc
Confidence 77764 443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.1e-13 Score=128.47 Aligned_cols=144 Identities=18% Similarity=0.163 Sum_probs=102.0
Q ss_pred hhcccccCcccccCccccccccc-----cccceeccccCCCCCCCcccccCcccEEEeccccccccCCccccCCCCCCEE
Q 040908 18 LGSLIHSGKWFGWANSVWHYFSE-----SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVL 92 (790)
Q Consensus 18 ~~~L~~L~~L~l~~N~l~~~~~~-----~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 92 (790)
+.++.+.+.|.|++|+++..+|. +|+.|++.+|.+...+....+.+.|+.|+++-|++. .+|..||.++.|++|
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 45567778888889888877764 666677777777777666666677777777777777 777777777777777
Q ss_pred EccCCcCC-cCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcceeee
Q 040908 93 DLSFNKLN-GTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFA 164 (790)
Q Consensus 93 ~Ls~N~l~-g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~ 164 (790)
||++|+|. ..+|..|..|+.|+.|+|+.|.|. .+|..+.. ++|+.|.+..|.|- ..|.+++.+.+|.-+-
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelh 179 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELH 179 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHh
Confidence 77777775 356777777777777777777776 44444444 67777777777765 4677776666665543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.8e-11 Score=119.65 Aligned_cols=130 Identities=22% Similarity=0.142 Sum_probs=97.3
Q ss_pred eeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceee-eeeEEEeCCeEEEEEEeccCCCh
Q 040908 451 ANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK-LYGCCIEGNQLLLIYEYLENNSL 529 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~Ey~~~gsL 529 (790)
.+.|+.|.++.||++... +..+++|....... ....+..|+.++..+.+.++++ ++.+. .+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999875 67899998755432 2234678999999987666554 44433 3345899999999877
Q ss_pred hhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC--CCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 530 ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 530 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
.+.- .....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5431 011345678999999999875 23479999999999999 6689999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.3e-11 Score=145.70 Aligned_cols=133 Identities=17% Similarity=0.234 Sum_probs=69.4
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCcccccccc---ccccceeccccCCCCCCCcccccCcccEEEecccccccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS---ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGE 78 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~---~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~ 78 (790)
.|+|+++.|+ .+|..+. ++|+.|+|++|+|+..+. .+|+.|++++|++...+.. ...+|+.|+|++|+|. .
T Consensus 182 ~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~~nL~~L~Ls~N~LtsLP~~--l~~~L~~L~Ls~N~L~-~ 255 (754)
T PRK15370 182 ELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPENLQGNIKTLYANSNQLTSIPAT--LPDTIQEMELSINRIT-E 255 (754)
T ss_pred EEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChhhccCCCEEECCCCccccCChh--hhccccEEECcCCccC-c
Confidence 3566666666 5555443 345666666666654332 3566666666655543221 1134666666666665 5
Q ss_pred CCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccc
Q 040908 79 LPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFA 147 (790)
Q Consensus 79 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~ 147 (790)
+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. .+|+.|+|++|+|+
T Consensus 256 LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp-~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 256 LPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP-SGITHLNVQSNSLT 317 (754)
T ss_pred CChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch-hhHHHHHhcCCccc
Confidence 555443 35666666666665 4555443 356666666666653 332221 24555555555555
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=7.6e-13 Score=150.89 Aligned_cols=125 Identities=25% Similarity=0.321 Sum_probs=103.7
Q ss_pred cccceeccccCCCCCCCccccc-CcccEEEeccccccccCCc-cccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEe
Q 040908 41 SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPH-FLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYL 118 (790)
Q Consensus 41 ~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l 118 (790)
.|..|.+-+|.++..-.|.+.+ ++|+.|+|++|+|. .+|+ .+.++..|++|+||+|+|+ .+|..+.++..|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 5677778888888877777777 88999999999998 7776 4688999999999999998 89999999999999999
Q ss_pred eCCcccccCCccccCCCCcEEeccCCcccc-CCCCCCCCCCcceeeecCCCC
Q 040908 119 TGNLLTGKVPQWMFGRGPENIDLSYNNFAD-ESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 119 s~N~l~g~~p~~~~~~~L~~l~ls~N~l~g-~~p~~~~~~~~l~~~~~~~~~ 169 (790)
.+|+|. .+|.....+.|+.+|||.|+|+- .+|...+. ++|++|+.+.+.
T Consensus 438 hsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 438 HSNQLL-SFPELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNT 487 (1081)
T ss_pred cCCcee-echhhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCc
Confidence 999998 67755555899999999999975 34444443 788899887664
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.2e-11 Score=143.95 Aligned_cols=153 Identities=18% Similarity=0.234 Sum_probs=118.8
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccc---cccccceeccccCCCCCCCcccccCcccEEEeccccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYF---SESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTG 77 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~ 77 (790)
..|+|++|+|+ .+|..+. .+|+.|++++|+++..+ |.+|+.|++++|++...+.. ...+|+.|+|++|+|+
T Consensus 202 ~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~~~L~~L~Ls~N~L~~LP~~--l~s~L~~L~Ls~N~L~- 275 (754)
T PRK15370 202 TTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLPDTIQEMELSINRITELPER--LPSALQSLDLFHNKIS- 275 (754)
T ss_pred cEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhhccccEEECcCCccCcCChh--HhCCCCEEECcCCccC-
Confidence 36999999999 7898765 58999999999998654 45899999999998865432 2368999999999999
Q ss_pred cCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCCCCC
Q 040908 78 ELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQN 157 (790)
Q Consensus 78 ~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~~ 157 (790)
.+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+. +|..+. .+|+.|++++|.|++ +|..++
T Consensus 276 ~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~-~sL~~L~Ls~N~Lt~-LP~~l~-- 345 (754)
T PRK15370 276 CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLP-PGLKTLEAGENALTS-LPASLP-- 345 (754)
T ss_pred ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-CCcccc-ccceeccccCCcccc-CChhhc--
Confidence 6888775 58999999999998 5776543 468888888888885 454332 578888888888875 666655
Q ss_pred CcceeeecCCCC
Q 040908 158 GAVNLFASSSKG 169 (790)
Q Consensus 158 ~~l~~~~~~~~~ 169 (790)
..|..++.+++.
T Consensus 346 ~sL~~L~Ls~N~ 357 (754)
T PRK15370 346 PELQVLDVSKNQ 357 (754)
T ss_pred CcccEEECCCCC
Confidence 467777776653
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.9e-11 Score=143.70 Aligned_cols=132 Identities=20% Similarity=0.215 Sum_probs=100.4
Q ss_pred cCcccccCccccccc--cccccceeccccCCCCCCCcccccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCCc
Q 040908 24 SGKWFGWANSVWHYF--SESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNG 101 (790)
Q Consensus 24 L~~L~l~~N~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 101 (790)
|+.|++++|.+++.+ |.+|+.|++++|.+...+. + ..+|+.|++++|+|+ .+|... .+|+.|+|++|+|+
T Consensus 324 L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~LP~--l-p~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt- 395 (788)
T PRK15387 324 LCKLWAYNNQLTSLPTLPSGLQELSVSDNQLASLPT--L-PSELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT- 395 (788)
T ss_pred ccccccccCccccccccccccceEecCCCccCCCCC--C-Ccccceehhhccccc-cCcccc---cccceEEecCCccc-
Confidence 444455555554322 3467888888888776543 1 257999999999999 688643 57999999999998
Q ss_pred CcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCCCCCCcceeeecCCCCC
Q 040908 102 TIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 102 ~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~~ 170 (790)
.+|.. .++|+.|+|++|+|++ +|... .+|+.|+|++|+|+ .+|..++.+..|..++.+.|.-
T Consensus 396 ~LP~l---~s~L~~LdLS~N~Lss-IP~l~--~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~L 457 (788)
T PRK15387 396 SLPVL---PSELKELMVSGNRLTS-LPMLP--SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 457 (788)
T ss_pred CCCCc---ccCCCEEEccCCcCCC-CCcch--hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCC
Confidence 57754 3679999999999995 66533 46889999999998 6899999999999999876643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=3e-11 Score=137.25 Aligned_cols=147 Identities=14% Similarity=0.183 Sum_probs=93.7
Q ss_pred hcCcceeeeecccCcEEEEeeeecC-CcEEEEEEccccchh----------------------------------cH---
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQ----------------------------------GN--- 486 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~----------------------------------~~--- 486 (790)
-..|+. +.||+|++|.||+|++.+ |+.||||+.+..-.. -.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999887 999999998643110 00
Q ss_pred ---HHHHHHHHHhhccC----CCceeeeeeEEEe-CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHH
Q 040908 487 ---REFVNEIGTISALQ----HPHLVKLYGCCIE-GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558 (790)
Q Consensus 487 ---~~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~a 558 (790)
-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.-.- .. ...+ +..++...++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~--~g~d---~~~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RA--AGTD---MKLLAERGVEV 271 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-Hh--cCCC---HHHHHHHHHHH
Confidence 12444555444442 3333443333332 3567899999999999874210 01 1111 12222222221
Q ss_pred -HHHhhhcCCCcEEeccCCCCcEEecCCC----CeEEeecCCccccCC
Q 040908 559 -LAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDFGLAKLDEE 601 (790)
Q Consensus 559 -L~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFGla~~~~~ 601 (790)
+..++.. +++|+|+||.||+++.++ ++++.|||++...+.
T Consensus 272 ~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 FFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2223344 499999999999999988 999999999876543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.8e-11 Score=131.64 Aligned_cols=247 Identities=22% Similarity=0.229 Sum_probs=174.5
Q ss_pred Ccceeeeecc--cCcEEEEeeee---cCCcEEEEEEccccc--hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEE
Q 040908 447 HFDVANKIGE--GGFGPVYKGLL---ADGTLIAVKQLSAKS--KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 447 ~y~~~~~LG~--G~fG~Vy~g~~---~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 518 (790)
.|.+...+|. |.+|.||++.. .++..+|+|+-+... ......=.+|+..-.++ .|+|.|+....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556788999 99999999986 357889999844322 23233334677777777 4999999888899999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHH----HHHHhhhcCCCcEEeccCCCCcEEecCC-CCeEEeec
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR----GLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDF 593 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DF 593 (790)
+-.|++. .+|.++.+... ..++....+.+..+... ||.++|+. +++|-|+||.||++..+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999886 68888775432 23566667777777777 99999997 49999999999999999 88999999
Q ss_pred CCccccCCCCc----ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 594 GLAKLDEEDNT----HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 594 Gla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
|+........- ....+..|...|++||...+ .++.++|+|++|.+..|..++........ ...|...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~~W~~~-- 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK------NSSWSQL-- 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC------CCCcccc--
Confidence 99986655431 12223368889999997654 67889999999999999998865543221 0112211
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.... +..++...-...+..++..+++.+|..|++...+..
T Consensus 339 -----r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 -----RQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----cccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000 011111111123344777899999999999877654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.1e-12 Score=137.94 Aligned_cols=155 Identities=19% Similarity=0.216 Sum_probs=139.2
Q ss_pred EEccCCcCcccCChhhhcccccCcccccCccccccccc----cccceeccccCCCCCCCcccccCcccEEEecccccccc
Q 040908 3 RTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE----SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGE 78 (790)
Q Consensus 3 L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~----~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~ 78 (790)
|.|+.|.|. .||..+++|..|++|+|+.|+++..++. -|+.|-+++|++..++.+.-....|..||.+.|.|. .
T Consensus 103 liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lpLkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-s 180 (722)
T KOG0532|consen 103 LILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDLPLKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-S 180 (722)
T ss_pred HHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcCcceeEEEecCccccCCcccccchhHHHhhhhhhhhh-h
Confidence 568899999 9999999999999999999999977664 788999999999998887775588999999999998 9
Q ss_pred CCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCC
Q 040908 79 LPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQN 157 (790)
Q Consensus 79 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~ 157 (790)
+|..+++|.+|+.|.+..|++. .+|.+++.| .|..||+|.|+++ .+|-.|.. +.|++|-|.+|.|+ ..|..+|..
T Consensus 181 lpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~k 256 (722)
T KOG0532|consen 181 LPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEK 256 (722)
T ss_pred chHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhc
Confidence 9999999999999999999998 899999966 6999999999999 67877766 89999999999998 568899988
Q ss_pred Ccceee
Q 040908 158 GAVNLF 163 (790)
Q Consensus 158 ~~l~~~ 163 (790)
+.+-.|
T Consensus 257 GkVHIF 262 (722)
T KOG0532|consen 257 GKVHIF 262 (722)
T ss_pred cceeee
Confidence 876544
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.9e-12 Score=145.21 Aligned_cols=165 Identities=24% Similarity=0.289 Sum_probs=124.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----------------------------ccccceeccccCC
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----------------------------ESLTDLRISDLNG 52 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----------------------------~~L~~L~l~~n~~ 52 (790)
|++|+|.|+++ .+|.+++.+.+|+.|...+|+++..+. ..|+.|+|..|++
T Consensus 244 ~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L 322 (1081)
T KOG0618|consen 244 QYLDISHNNLS-NLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNL 322 (1081)
T ss_pred eeeecchhhhh-cchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccc
Confidence 68899999998 788889999999999999988853321 1566667776666
Q ss_pred CCCCCccc--------------------------ccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchh
Q 040908 53 PEATLPDL--------------------------RNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPES 106 (790)
Q Consensus 53 ~~~~~~~~--------------------------~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~ 106 (790)
...+...+ ....|+.|.|.+|.|+...=+.|-+.+.|++|+|++|+|. .+|++
T Consensus 323 ~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas 401 (1081)
T KOG0618|consen 323 PSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPAS 401 (1081)
T ss_pred cccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHH
Confidence 54432211 1134677788888888766666778888888888888887 67764
Q ss_pred -ccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcceeeecCCCCC
Q 040908 107 -FARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 107 -~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~~ 170 (790)
+.++..|+.|+||+|+|+ .+|..+.. ..|++|...+|+|. ..| .+.++++|..+|.+.+.-
T Consensus 402 ~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L 464 (1081)
T KOG0618|consen 402 KLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNL 464 (1081)
T ss_pred HHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchh
Confidence 788888888888888888 56777766 78888888888886 455 788888899999887643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.4e-11 Score=139.15 Aligned_cols=104 Identities=29% Similarity=0.542 Sum_probs=67.5
Q ss_pred ccceeccccCCCCCCCccccc-CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeC
Q 040908 42 LTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTG 120 (790)
Q Consensus 42 L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~ 120 (790)
+..|+|++|.+....+..+.. ++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..+++|++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 555666666665544444444 6677777777777777777677777777777777777777777777777777777777
Q ss_pred CcccccCCccccC--CCCcEEeccCCc
Q 040908 121 NLLTGKVPQWMFG--RGPENIDLSYNN 145 (790)
Q Consensus 121 N~l~g~~p~~~~~--~~L~~l~ls~N~ 145 (790)
|+|+|.+|..+.. .++..+++++|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCc
Confidence 7777777765543 234455555554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.1e-10 Score=123.19 Aligned_cols=166 Identities=17% Similarity=0.222 Sum_probs=124.5
Q ss_pred ecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChh
Q 040908 467 LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWP 546 (790)
Q Consensus 467 ~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~ 546 (790)
..++.+|.|+..+...........+-++.|+.+|||||++++..+...+..|+|+|.+. .|..++. .+...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk-------~l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK-------ELGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH-------HhHHH
Confidence 45788899988876655434556677889999999999999999999999999999875 4555552 12234
Q ss_pred hHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCC
Q 040908 547 TRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH 626 (790)
Q Consensus 547 ~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 626 (790)
...-.+.||+.||.|||++| +++|++|.-.-|++++.|..||++|-++......... .....--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-AKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-cccchhhhcccChhhcCccc
Confidence 45557899999999999887 7999999999999999999999999887643322210 01111222466776543222
Q ss_pred CCChhhHHHHHHHHHHHHhC
Q 040908 627 LTDKADVYSFGIVALEIVSG 646 (790)
Q Consensus 627 ~s~ksDV~S~Gvvl~elltG 646 (790)
-..|.|.||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999998
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.5e-11 Score=126.75 Aligned_cols=87 Identities=21% Similarity=0.229 Sum_probs=75.3
Q ss_pred cccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcc
Q 040908 82 FLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAV 160 (790)
Q Consensus 82 ~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l 160 (790)
.|..|++|+.|+|++|+|++.-+.+|..+..|+.|+|..|+|...-...|.+ .+|+.|+|.+|+||...|..|..+..|
T Consensus 269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l 348 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL 348 (498)
T ss_pred HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence 4778899999999999999888999999999999999999998554445555 789999999999999999999998888
Q ss_pred eeeecCCC
Q 040908 161 NLFASSSK 168 (790)
Q Consensus 161 ~~~~~~~~ 168 (790)
..+..-++
T Consensus 349 ~~l~l~~N 356 (498)
T KOG4237|consen 349 STLNLLSN 356 (498)
T ss_pred eeeehccC
Confidence 88766544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-09 Score=111.95 Aligned_cols=142 Identities=20% Similarity=0.282 Sum_probs=109.9
Q ss_pred eeecccCcEEEEeeeecCCcEEEEEEccccch-hcHHHHHHHHHHhhccCCC--ceeeeeeEEEeCC---eEEEEEEecc
Q 040908 452 NKIGEGGFGPVYKGLLADGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHP--HLVKLYGCCIEGN---QLLLIYEYLE 525 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~---~~~lV~Ey~~ 525 (790)
+.|+.|..+.||++...+|..+++|....... .....+..|++++..+++. ++.+++.++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999987778899998765322 1345788999999999764 4566777766532 5689999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES--------------------------------------- 566 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------- 566 (790)
+.++.+.+.. ..++...+..++.+++++|++||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988776521 24667777888888888888888521
Q ss_pred --------------CCcEEeccCCCCcEEecC--CCCeEEeecCCccc
Q 040908 567 --------------RLKIVHRDIKATNVLLDK--DLNPKISDFGLAKL 598 (790)
Q Consensus 567 --------------~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~ 598 (790)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2e-10 Score=127.36 Aligned_cols=244 Identities=20% Similarity=0.184 Sum_probs=170.2
Q ss_pred HhcCcceeeeecccCcEEEEeeeec--CCcEEEEEEccccchhcH--HHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA--DGTLIAVKQLSAKSKQGN--REFVNEIGTISAL-QHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~g~~vAvK~~~~~~~~~~--~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 518 (790)
...+|..+..||.|.|+.|++...+ ++..+++|.+........ ..-..|+.+...+ .|.++++....+..-+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567889999999999999998743 578899998876543322 2234566666666 5899999888887777888
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC-CCeEEeecCCcc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAK 597 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~ 597 (790)
+--||++++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||.+.
T Consensus 343 ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 999999999888766 22345777888999999999999999874 9999999999999886 788999999986
Q ss_pred ccCCCCcceeeccccCCCcc--cHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 598 LDEEDNTHISTRVAGTFGYM--APEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
.+.-.. .....+-++. +++......+..+.|+||||.-+.|.++|..--... ..|... ..+..
T Consensus 416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~~i--~~~~~- 480 (524)
T KOG0601|consen 416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSLTI--RSGDT- 480 (524)
T ss_pred ccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccc--------ccceee--ecccc-
Confidence 322111 1111223444 555555667888999999999999999986422110 011100 00100
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSM 718 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 718 (790)
+.+ +..- .++..++..+...++..||.+.++...
T Consensus 481 ----p~~----~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 481 ----PNL----PGLK-LQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred ----cCC----CchH-HhhhhhhhhhcCCccccchhhhhhccc
Confidence 111 1111 344455566788999999988876543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.7e-09 Score=104.82 Aligned_cols=135 Identities=16% Similarity=0.129 Sum_probs=96.2
Q ss_pred eeecccCcEEEEeeeecC-------CcEEEEEEccccc------------h----------hcHHH----HHHHHHHhhc
Q 040908 452 NKIGEGGFGPVYKGLLAD-------GTLIAVKQLSAKS------------K----------QGNRE----FVNEIGTISA 498 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~-------g~~vAvK~~~~~~------------~----------~~~~~----~~~E~~~l~~ 498 (790)
..||.|--+.||.|...+ +..+|||+.+... . ...+. ..+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998543 4789999875310 0 00112 3379999999
Q ss_pred cCC--CceeeeeeEEEeCCeEEEEEEeccCCChhh-hhcCCccccCCCChhhHHHHHHHHHHHHHHh-hhcCCCcEEecc
Q 040908 499 LQH--PHLVKLYGCCIEGNQLLLIYEYLENNSLAR-ALFGPEEHRLKLDWPTRHNICIGIARGLAYL-HEESRLKIVHRD 574 (790)
Q Consensus 499 l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiHrD 574 (790)
+.. -++.+++++ ..-++||||+.+..+.. .+. ...++..+...+..+++.+|..| |.. +++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 854 455566654 45689999998754422 221 12334455667889999999999 665 499999
Q ss_pred CCCCcEEecCCCCeEEeecCCcccc
Q 040908 575 IKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 575 lk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
|++.|||+++ +.++|+|||.+...
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 67999999988744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.3e-10 Score=126.01 Aligned_cols=147 Identities=19% Similarity=0.172 Sum_probs=67.8
Q ss_pred EEEccCCcCc------ccCChhhhcccccCcccccCccccccccc------c---ccceeccccCCCCCCCccc-----c
Q 040908 2 YRTVQSNRLS------GELPEELGSLIHSGKWFGWANSVWHYFSE------S---LTDLRISDLNGPEATLPDL-----R 61 (790)
Q Consensus 2 ~L~Ls~N~l~------g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~---L~~L~l~~n~~~~~~~~~~-----~ 61 (790)
+|++++|.+. ..++..+..+++|+.|++++|.+....+. . |+.|++++|.+.......+ .
T Consensus 55 ~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~ 134 (319)
T cd00116 55 ELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKD 134 (319)
T ss_pred EEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHh
Confidence 3455555554 12333444555555555555555422111 1 5555555555442111110 1
Q ss_pred c-CcccEEEeccccccc----cCCccccCCCCCCEEEccCCcCCc----CcchhccCCCCCcEEEeeCCcccccCCc---
Q 040908 62 N-RTFKNLILRSCNLTG----ELPHFLGEVSEMKVLDLSFNKLNG----TIPESFARLADVDFIYLTGNLLTGKVPQ--- 129 (790)
Q Consensus 62 ~-~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~ls~N~l~g~~p~--- 129 (790)
. ++|+.|+|++|.+++ .++..+..+.+|++|+|++|.+++ .++..+..+++|+.|+|++|.+++....
T Consensus 135 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 214 (319)
T cd00116 135 LPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALA 214 (319)
T ss_pred CCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHH
Confidence 1 345556666665552 223334445555566665555552 1233344445555566655555432211
Q ss_pred -cccC-CCCcEEeccCCcccc
Q 040908 130 -WMFG-RGPENIDLSYNNFAD 148 (790)
Q Consensus 130 -~~~~-~~L~~l~ls~N~l~g 148 (790)
.+.. ++|+.|++++|++++
T Consensus 215 ~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 215 ETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHhcccCCCCEEecCCCcCch
Confidence 1222 445555555555553
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.5e-09 Score=134.82 Aligned_cols=163 Identities=15% Similarity=0.100 Sum_probs=88.2
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc-----ccccceeccccCCC---------------------C
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGP---------------------E 54 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~---------------------~ 54 (790)
+.|+|++|.....+|..|++|++|+.|++++|.....+| .+|+.|.+++|... .
T Consensus 660 e~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~~ 739 (1153)
T PLN03210 660 ETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEE 739 (1153)
T ss_pred cEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCCcccc
Confidence 468888887666888888888888888888864332222 24555555554322 1
Q ss_pred CCCcc------------------------------cccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcc
Q 040908 55 ATLPD------------------------------LRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIP 104 (790)
Q Consensus 55 ~~~~~------------------------------~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip 104 (790)
.+... ...++|+.|+|++|...+.+|..+++|++|+.|+|++|...+.+|
T Consensus 740 lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP 819 (1153)
T PLN03210 740 FPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP 819 (1153)
T ss_pred ccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeC
Confidence 11000 000234455555554444555555555555555555543333455
Q ss_pred hhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCCCCCCcceeeecCC
Q 040908 105 ESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSS 167 (790)
Q Consensus 105 ~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~ 167 (790)
..+ ++++|+.|+|++|.....+|... .+|+.|+|++|.++ .+|.++..+++|..++.+.
T Consensus 820 ~~~-~L~sL~~L~Ls~c~~L~~~p~~~--~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 820 TGI-NLESLESLDLSGCSRLRTFPDIS--TNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred CCC-CccccCEEECCCCCccccccccc--cccCEeECCCCCCc-cChHHHhcCCCCCEEECCC
Confidence 443 45555555555544333333321 34666666666665 4566666666666665543
|
syringae 6; Provisional |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.4e-08 Score=110.21 Aligned_cols=170 Identities=19% Similarity=0.320 Sum_probs=129.4
Q ss_pred cEEEEeee-ecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEE----eCCeEEEEEEeccC-CChhhh
Q 040908 459 FGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI----EGNQLLLIYEYLEN-NSLARA 532 (790)
Q Consensus 459 fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~~ 532 (790)
-.+.||+. ..||..+++|++.....+.......-+++++++.|.|+|++..++. .+..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35679998 4589999999995443333323345678899999999999998876 34568999999996 577776
Q ss_pred hcCCcc-----------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 533 LFGPEE-----------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 533 l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
-+.... .....++..+|.++.|++.||.++|+.| +.-+-|.+++||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 543322 2245677899999999999999999986 88899999999999999999998888776655
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSN 649 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p 649 (790)
+... | +. --.+-|.=.||.+++.|.||...
T Consensus 446 d~~~-------------~--le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTE-------------P--LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCc-------------c--hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 4411 0 11 12367888999999999999643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-08 Score=97.97 Aligned_cols=132 Identities=21% Similarity=0.280 Sum_probs=101.7
Q ss_pred eeecccCcEEEEeeeecCCcEEEEEEccccchh--------cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 452 NKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQ--------GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..+++|+-..+|.+.+.+ ..+.+|.-..+... ....-.+|+.++.+++--.|...+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 467899999999997743 34666654332111 123467899999999877776666677778888999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
+++-.|.+.+... +..++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||++...
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999998888321 3567788888889999986 99999999999998875 999999998843
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.5e-09 Score=131.01 Aligned_cols=162 Identities=15% Similarity=0.144 Sum_probs=99.2
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCcccccccc-----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
+|++.+|.++ .+|..| .+.+|+.|+|.+|++..... .+|+.|+++++..... .+.+.. ++|+.|+|++|..
T Consensus 593 ~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~-ip~ls~l~~Le~L~L~~c~~ 669 (1153)
T PLN03210 593 LLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKE-IPDLSMATNLETLKLSDCSS 669 (1153)
T ss_pred EEEecCCCCC-CCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCc-CCccccCCcccEEEecCCCC
Confidence 4666666665 666665 35667777777766654322 3566666665433221 123333 6677777766655
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEee---------------------CCcccccCCccc---
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLT---------------------GNLLTGKVPQWM--- 131 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls---------------------~N~l~g~~p~~~--- 131 (790)
...+|..+++|++|+.|+|++|...+.+|..+ ++++|+.|+|+ +|.+. .+|..+
T Consensus 670 L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~ 747 (1153)
T PLN03210 670 LVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLE 747 (1153)
T ss_pred ccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCccc-ccccccccc
Confidence 55666666667777777776654334566543 44445444444 44443 233211
Q ss_pred ---------------------------c-CCCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 132 ---------------------------F-GRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 132 ---------------------------~-~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
. .++|+.|+|++|+..+.+|.+++.+++|..+..+++
T Consensus 748 ~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C 812 (1153)
T PLN03210 748 NLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENC 812 (1153)
T ss_pred ccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCC
Confidence 0 136788899999888889999999999999998765
|
syringae 6; Provisional |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.2e-08 Score=95.44 Aligned_cols=143 Identities=19% Similarity=0.269 Sum_probs=103.6
Q ss_pred eeeeecccCcEEEEeeeecCCcEEEEEEc-ccc-------chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 450 VANKIGEGGFGPVYKGLLADGTLIAVKQL-SAK-------SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~-~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
....|-+|+-+.|+++.+. |+...||.- .+. .+-..+...+|++.|.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999985 566666643 221 1122356788999999987666655555666666778999
Q ss_pred EeccC-CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC---CeEEeecCCcc
Q 040908 522 EYLEN-NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKISDFGLAK 597 (790)
Q Consensus 522 Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGla~ 597 (790)
||+++ .++.+++...-. ..........++..|-+.+.-||..+ |||+||..+||+|..++ .+.+.|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 477777743211 11222233678899999999999985 99999999999997654 35899999986
Q ss_pred c
Q 040908 598 L 598 (790)
Q Consensus 598 ~ 598 (790)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.5e-09 Score=103.93 Aligned_cols=120 Identities=20% Similarity=0.272 Sum_probs=40.0
Q ss_pred ccCCcCcccCChhhhcccccCcccccCcccccccccccc-ceeccccCCCCCCCcccccCcccEEEeccccccccCCccc
Q 040908 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLT-DLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFL 83 (790)
Q Consensus 5 Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~-~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~ 83 (790)
|+.|.|. .+|. +.+..+++.|+|.+|.|+.+ ++|. .| .+|+.|+|++|.|+ .++ .+
T Consensus 4 lt~~~i~-~~~~-~~n~~~~~~L~L~~n~I~~I--e~L~~~l-----------------~~L~~L~Ls~N~I~-~l~-~l 60 (175)
T PF14580_consen 4 LTANMIE-QIAQ-YNNPVKLRELNLRGNQISTI--ENLGATL-----------------DKLEVLDLSNNQIT-KLE-GL 60 (175)
T ss_dssp ------------------------------------S--TT------------------TT--EEE-TTS--S---T-T-
T ss_pred ccccccc-cccc-cccccccccccccccccccc--cchhhhh-----------------cCCCEEECCCCCCc-ccc-Cc
Confidence 4555555 5554 44555778888888887642 1222 12 47899999999999 555 58
Q ss_pred cCCCCCCEEEccCCcCCcCcchhc-cCCCCCcEEEeeCCcccccCC-ccccC-CCCcEEeccCCcccc
Q 040908 84 GEVSEMKVLDLSFNKLNGTIPESF-ARLADVDFIYLTGNLLTGKVP-QWMFG-RGPENIDLSYNNFAD 148 (790)
Q Consensus 84 ~~l~~L~~L~Ls~N~l~g~ip~~~-~~l~~L~~L~ls~N~l~g~~p-~~~~~-~~L~~l~ls~N~l~g 148 (790)
..|+.|++|+|++|+|+ .++..+ ..+++|+.|+|++|++...-- ..+.. ++|+.|+|.+|+++.
T Consensus 61 ~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 61 PGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp ---TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred cChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 88999999999999998 666555 468999999999999975322 12333 889999999999874
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.1e-10 Score=122.04 Aligned_cols=169 Identities=18% Similarity=0.158 Sum_probs=125.0
Q ss_pred CEEEccCCcCccc----CChhhhcccccCcccccCccccc------cc------cccccceeccccCCCCCCCccccc-C
Q 040908 1 MYRTVQSNRLSGE----LPEELGSLIHSGKWFGWANSVWH------YF------SESLTDLRISDLNGPEATLPDLRN-R 63 (790)
Q Consensus 1 ~~L~Ls~N~l~g~----iP~~~~~L~~L~~L~l~~N~l~~------~~------~~~L~~L~l~~n~~~~~~~~~~~~-~ 63 (790)
++|+|++|.++.. ++..+..+++|+.|++++|.+.+ .+ ..+|+.|++++|.+.......+.. .
T Consensus 26 ~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~ 105 (319)
T cd00116 26 QVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLL 105 (319)
T ss_pred cEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHh
Confidence 4789999999543 66667777889999999998763 11 127889999998887544443333 3
Q ss_pred ---cccEEEeccccccc----cCCccccCC-CCCCEEEccCCcCCcC----cchhccCCCCCcEEEeeCCcccccC----
Q 040908 64 ---TFKNLILRSCNLTG----ELPHFLGEV-SEMKVLDLSFNKLNGT----IPESFARLADVDFIYLTGNLLTGKV---- 127 (790)
Q Consensus 64 ---~L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~~---- 127 (790)
+|++|++++|++++ .+...+..+ ++|+.|+|++|++++. ++..+..+++|+.|+|++|.+++..
T Consensus 106 ~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l 185 (319)
T cd00116 106 RSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRAL 185 (319)
T ss_pred ccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHH
Confidence 49999999999983 344566677 8999999999999843 4456778889999999999998532
Q ss_pred CccccC-CCCcEEeccCCccccC----CCCCCCCCCcceeeecCCCC
Q 040908 128 PQWMFG-RGPENIDLSYNNFADE----SSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 128 p~~~~~-~~L~~l~ls~N~l~g~----~p~~~~~~~~l~~~~~~~~~ 169 (790)
+..+.. .+|+.|+|++|.+++. ++..+..++.|+.++.+.+.
T Consensus 186 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~ 232 (319)
T cd00116 186 AEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNN 232 (319)
T ss_pred HHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCc
Confidence 222322 6899999999998754 34456677889999887654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.1e-09 Score=119.02 Aligned_cols=161 Identities=20% Similarity=0.185 Sum_probs=120.8
Q ss_pred EEEccCCcCcccCChhhhccc-ccCcccccCccccccc-----cccccceeccccCCCCCCCcccccCcccEEEeccccc
Q 040908 2 YRTVQSNRLSGELPEELGSLI-HSGKWFGWANSVWHYF-----SESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNL 75 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~-~L~~L~l~~N~l~~~~-----~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l 75 (790)
.|++.+|+++ .||...+.+. +|+.|++++|++...+ +.+|+.|++++|.+...+......+.|+.|++++|++
T Consensus 120 ~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls~N~i 198 (394)
T COG4886 120 SLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKI 198 (394)
T ss_pred EEecCCcccc-cCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhhhhhhhhhhhhhhhheeccCCcc
Confidence 5788888888 7888777775 8888888888887652 3478888888888887766544447788888888888
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
+ .+|..++.+..|++|.+++|++. .++..+.++.++..|.+.+|++.. ++..+.. .+++.|++++|.++-. +. +
T Consensus 199 ~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~~i-~~-~ 273 (394)
T COG4886 199 S-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISSI-SS-L 273 (394)
T ss_pred c-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccceecccccccccc-cc-c
Confidence 8 88877767777888888888655 577778888888888888888763 2445555 5688888888888743 33 7
Q ss_pred CCCCcceeeecCCC
Q 040908 155 CQNGAVNLFASSSK 168 (790)
Q Consensus 155 ~~~~~l~~~~~~~~ 168 (790)
+....+..++.+.+
T Consensus 274 ~~~~~l~~L~~s~n 287 (394)
T COG4886 274 GSLTNLRELDLSGN 287 (394)
T ss_pred cccCccCEEeccCc
Confidence 77777777777654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.8e-09 Score=83.36 Aligned_cols=61 Identities=28% Similarity=0.469 Sum_probs=53.1
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcc
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLL 123 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l 123 (790)
++|+.|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.+|++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4689999999999955557889999999999999999866677899999999999999975
|
... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.4e-09 Score=117.72 Aligned_cols=161 Identities=23% Similarity=0.233 Sum_probs=81.8
Q ss_pred EEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCcccccCcccEEEecccccc
Q 040908 3 RTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLT 76 (790)
Q Consensus 3 L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~ 76 (790)
|+++.|++. .-+..+..++.+..|++.+|.++.+.+ .+|+.|++++|.+...+.+....++|+.|++++|+++
T Consensus 98 l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~ 176 (394)
T COG4886 98 LDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS 176 (394)
T ss_pred eeccccccc-cCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh
Confidence 455555553 223334444555566666665554333 1455555555555554333333355666666666665
Q ss_pred ccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCC
Q 040908 77 GELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDC 155 (790)
Q Consensus 77 ~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~ 155 (790)
.+|...+.+++|+.|++++|+++ .+|..+..+..|+.|.+++|.+. .++..+.. .++..+.+++|++.. ++..+.
T Consensus 177 -~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~ 252 (394)
T COG4886 177 -DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIG 252 (394)
T ss_pred -hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhc
Confidence 55555545566666666666665 55555555555666666666422 12222333 445555555555542 134444
Q ss_pred CCCcceeeecCCC
Q 040908 156 QNGAVNLFASSSK 168 (790)
Q Consensus 156 ~~~~l~~~~~~~~ 168 (790)
.+..+..++.+.+
T Consensus 253 ~l~~l~~L~~s~n 265 (394)
T COG4886 253 NLSNLETLDLSNN 265 (394)
T ss_pred cccccceeccccc
Confidence 4444555555444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.5e-09 Score=123.27 Aligned_cols=209 Identities=20% Similarity=0.278 Sum_probs=145.6
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
...+.+.+.+-+-+|.++.++-+.-. .|...+.|...... ....+....+-.++-..+||-++...--+.-.....
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567788888999999999987732 34334444433221 111122222222333334566666555555567789
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
||++|..+++|...|+... ..+..........+..+++|||+. .+.|||++|.|+|...+++.+++|||....
T Consensus 881 L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 9999999999999986432 334444445566678899999986 389999999999999999999999984321
Q ss_pred cC---------------------C---------CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCC
Q 040908 599 DE---------------------E---------DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648 (790)
Q Consensus 599 ~~---------------------~---------~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~ 648 (790)
.. . +.........||+.|.+||...+......+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 10 0 00011233679999999999999999999999999999999999999
Q ss_pred CCccccccch
Q 040908 649 NIMCKTKEEK 658 (790)
Q Consensus 649 p~~~~~~~~~ 658 (790)
||.....+..
T Consensus 1034 p~na~tpq~~ 1043 (1205)
T KOG0606|consen 1034 PFNAETPQQI 1043 (1205)
T ss_pred CCCCcchhhh
Confidence 9987665543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.4e-08 Score=95.67 Aligned_cols=125 Identities=24% Similarity=0.304 Sum_probs=82.3
Q ss_pred EEEeeeecCCcEEEEEEccccc--------------h-------h-----cHHHHHHHHHHhhccCCCc--eeeeeeEEE
Q 040908 461 PVYKGLLADGTLIAVKQLSAKS--------------K-------Q-----GNREFVNEIGTISALQHPH--LVKLYGCCI 512 (790)
Q Consensus 461 ~Vy~g~~~~g~~vAvK~~~~~~--------------~-------~-----~~~~~~~E~~~l~~l~H~n--iv~l~g~~~ 512 (790)
.||.|...+|..+|||..+... . . ......+|.+.|.++..-+ +.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999875320 0 0 0134678999999997664 45555442
Q ss_pred eCCeEEEEEEecc--CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHh-hhcCCCcEEeccCCCCcEEecCCCCeE
Q 040908 513 EGNQLLLIYEYLE--NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL-HEESRLKIVHRDIKATNVLLDKDLNPK 589 (790)
Q Consensus 513 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiHrDlk~~NILl~~~~~~k 589 (790)
.-.+||||++ +..+..+.. ..++......++.+++..+..+ |.. +|+|+|+.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~------~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD------VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH------CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHh------ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999999 544544331 1122445667888888866665 555 59999999999999988 999
Q ss_pred EeecCCcccc
Q 040908 590 ISDFGLAKLD 599 (790)
Q Consensus 590 l~DFGla~~~ 599 (790)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.68 E-value=9.3e-09 Score=100.00 Aligned_cols=118 Identities=20% Similarity=0.220 Sum_probs=49.6
Q ss_pred CEEEccCCcCcccCChhhh-cccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccC
Q 040908 1 MYRTVQSNRLSGELPEELG-SLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGEL 79 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~-~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~ 79 (790)
++|+|++|+|+ .|. .++ .|.+|+.|+|++|.|+... .|..| +.|+.|+|++|+|+ .+
T Consensus 22 ~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L-----------------~~L~~L~L~~N~I~-~i 79 (175)
T PF14580_consen 22 RELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKLE--GLPGL-----------------PRLKTLDLSNNRIS-SI 79 (175)
T ss_dssp ----------------S--TT-TT--EEE-TTS--S--T--T---------------------TT--EEE--SS----S-
T ss_pred ccccccccccc-ccc-chhhhhcCCCEEECCCCCCcccc--CccCh-----------------hhhhhcccCCCCCC-cc
Confidence 36999999999 564 576 5889999999999987531 23322 68999999999999 66
Q ss_pred Cccc-cCCCCCCEEEccCCcCCcCc-chhccCCCCCcEEEeeCCcccccCCc----cccC-CCCcEEec
Q 040908 80 PHFL-GEVSEMKVLDLSFNKLNGTI-PESFARLADVDFIYLTGNLLTGKVPQ----WMFG-RGPENIDL 141 (790)
Q Consensus 80 p~~~-~~l~~L~~L~Ls~N~l~g~i-p~~~~~l~~L~~L~ls~N~l~g~~p~----~~~~-~~L~~l~l 141 (790)
++.+ ..+++|++|+|++|+|...- =..+..+++|+.|+|.+|.++.. +. .+.. ++|+.||-
T Consensus 80 ~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 80 SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 6655 46999999999999997321 14678899999999999999843 32 1223 77888773
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.2e-07 Score=97.38 Aligned_cols=140 Identities=18% Similarity=0.044 Sum_probs=99.0
Q ss_pred eecccCcEEEEeeeecCCcEEEEEEccccchh-----------cHHHHHHHHHHhhccCCCce--eeeeeEEEe-----C
Q 040908 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQ-----------GNREFVNEIGTISALQHPHL--VKLYGCCIE-----G 514 (790)
Q Consensus 453 ~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~-----~ 514 (790)
.+-.-....|.+..+ +|+.+.||+....... ....+.+|...+.++...+| .+++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333344667666 5778999977443211 11247899999988854444 445666543 2
Q ss_pred CeEEEEEEeccCC-ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC-------CC
Q 040908 515 NQLLLIYEYLENN-SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-------DL 586 (790)
Q Consensus 515 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-------~~ 586 (790)
...++|+|++++- +|.+++.... ....+...+..++.+++..++-||..+ |+|+|++++|||++. +.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 3578999999986 8888873211 123455667789999999999999986 999999999999985 46
Q ss_pred CeEEeecCCccc
Q 040908 587 NPKISDFGLAKL 598 (790)
Q Consensus 587 ~~kl~DFGla~~ 598 (790)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998763
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.1e-08 Score=78.44 Aligned_cols=60 Identities=35% Similarity=0.474 Sum_probs=54.1
Q ss_pred CCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCcc
Q 040908 87 SEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNF 146 (790)
Q Consensus 87 ~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l 146 (790)
++|++|+|++|+|+...+..|.++++|+.|+|++|+++...|..+.. ++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 57999999999999555578999999999999999999888888877 8999999999986
|
... |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.4e-08 Score=102.60 Aligned_cols=126 Identities=17% Similarity=0.094 Sum_probs=77.8
Q ss_pred hcccccCcccccCcccccccc-----ccccceeccccCCCCCCCccccc-CcccEEEeccccccccCCccccCCCCCCEE
Q 040908 19 GSLIHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVL 92 (790)
Q Consensus 19 ~~L~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 92 (790)
.....|+.|+|++|.|+..-. ..++.|+++.|.+..... +.. .+|+.||||+|.++ .+-.+=..|-+++.|
T Consensus 281 dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred chHhhhhhccccccchhhhhhhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 334445555555555543221 245555555555544332 222 67888888888888 555555567778888
Q ss_pred EccCCcCCcCcchhccCCCCCcEEEeeCCcccccCC-ccccC-CCCcEEeccCCccccC
Q 040908 93 DLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVP-QWMFG-RGPENIDLSYNNFADE 149 (790)
Q Consensus 93 ~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~-~~L~~l~ls~N~l~g~ 149 (790)
.|+.|.|. .+ ..+..|-+|..||+++|++...-. ..+.. +-|+.|.|.+|+|.+.
T Consensus 358 ~La~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 358 KLAQNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred ehhhhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 88888876 33 356777778888888888763211 12233 5578888888888764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.3e-06 Score=87.36 Aligned_cols=258 Identities=15% Similarity=0.180 Sum_probs=152.2
Q ss_pred eeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeE------EE-eCCeEEEEE
Q 040908 450 VANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGC------CI-EGNQLLLIY 521 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~------~~-~~~~~~lV~ 521 (790)
..+.||+|+-+.+|..--- +..| .|+.......... +.+..|... .||-+-.=+.+ .- .+...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hchh-heeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4578999999999964322 1223 4665543332222 223344444 45543321111 11 122356777
Q ss_pred EeccCCChhhhhcCC---ccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 522 EYLENNSLARALFGP---EEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
..+.+--=-..++.. +.+....+|...++++..+|.+.+-||..| ..-+|+.++|+|+.+++.+.|.|=.-...
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 777664222222222 223345799999999999999999999986 78899999999999999999987554443
Q ss_pred cCCCCcceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhC-CCCCcccccc--c-hhhHHHHHHHHH
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSG-RSNIMCKTKE--E-KFYLLDWALLLK 669 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~--~-~~~l~~~~~~~~ 669 (790)
...+ ......+|...|.+||.-. +..-+...|-|.+||++++++.| +.||.+.... . .-...+-+
T Consensus 167 ~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia---- 240 (637)
T COG4248 167 NANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA---- 240 (637)
T ss_pred ccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh----
Confidence 3222 2334467889999999754 23456789999999999999886 8898643211 0 00000000
Q ss_pred hhCCcccccCCCC-----CCCCcHH-HHHHHHHHHHHccCCC--CCCCCCHHHHHHHHhcC
Q 040908 670 EQGNLMELVDPNL-----GSNVDKE-QVRVMINVALLCADVS--PTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 670 ~~~~~~~~~d~~l-----~~~~~~~-~~~~l~~l~~~Cl~~d--P~~RPt~~ev~~~L~~~ 722 (790)
.+.....-|... ....+-. ....+-.+..+|+... +.-||+.+-.+..|...
T Consensus 241 -~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 241 -HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred -cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 011111111000 1112211 1233445566788653 56899999888777543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=9.5e-07 Score=89.84 Aligned_cols=134 Identities=24% Similarity=0.240 Sum_probs=95.5
Q ss_pred cceeeeecccCcEEEEeeeecCCcEEEEEEccccc----------------------hhcHHHHHHHHHHhhccCCC--c
Q 040908 448 FDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKS----------------------KQGNREFVNEIGTISALQHP--H 503 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~----------------------~~~~~~~~~E~~~l~~l~H~--n 503 (790)
+.+.+.||-|--+.||.|...+|.++|||.-+... ........+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34678999999999999999999999999754321 00112467899999999655 6
Q ss_pred eeeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec
Q 040908 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD 583 (790)
Q Consensus 504 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 583 (790)
+.+.+++ +...+||||+++-.|...- ++-...-.|+..|++-+.-+-.. +++|+|+.+-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 6666654 4568999999986554322 12223334444555444444344 499999999999999
Q ss_pred CCCCeEEeecCCcc
Q 040908 584 KDLNPKISDFGLAK 597 (790)
Q Consensus 584 ~~~~~kl~DFGla~ 597 (790)
+||.+.++||--+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999996554
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.1e-08 Score=104.42 Aligned_cols=145 Identities=14% Similarity=0.075 Sum_probs=100.7
Q ss_pred EEEccCCcCcccCCh--hhhcccccCcccccCccccccc-------cccccceeccccCCCCCCCccccc--CcccEEEe
Q 040908 2 YRTVQSNRLSGELPE--ELGSLIHSGKWFGWANSVWHYF-------SESLTDLRISDLNGPEATLPDLRN--RTFKNLIL 70 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~--~~~~L~~L~~L~l~~N~l~~~~-------~~~L~~L~l~~n~~~~~~~~~~~~--~~L~~L~L 70 (790)
.||||.|-|+.--|- -...|++|+.|+|+.|++.... ...|+.|.|+.+.++.-....+.. ++|+.|+|
T Consensus 150 ~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L 229 (505)
T KOG3207|consen 150 DLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYL 229 (505)
T ss_pred eecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhh
Confidence 578888888733222 2456888888888888886322 237888888888777433333222 78888999
Q ss_pred ccccccccCCccccCCCCCCEEEccCCcCCcCcc--hhccCCCCCcEEEeeCCccccc-CCcc-----ccC-CCCcEEec
Q 040908 71 RSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIP--ESFARLADVDFIYLTGNLLTGK-VPQW-----MFG-RGPENIDL 141 (790)
Q Consensus 71 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip--~~~~~l~~L~~L~ls~N~l~g~-~p~~-----~~~-~~L~~l~l 141 (790)
..|...+.-......+..|+.|||++|++- ..+ ...+.++.|..|.++.+.+... +|+. ... ++|++|++
T Consensus 230 ~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i 308 (505)
T KOG3207|consen 230 EANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNI 308 (505)
T ss_pred hcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeec
Confidence 888643344444556788899999998887 555 4678888888998888887744 3433 122 67899999
Q ss_pred cCCccc
Q 040908 142 SYNNFA 147 (790)
Q Consensus 142 s~N~l~ 147 (790)
+.|++.
T Consensus 309 ~~N~I~ 314 (505)
T KOG3207|consen 309 SENNIR 314 (505)
T ss_pred ccCccc
Confidence 999885
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.1e-08 Score=90.51 Aligned_cols=132 Identities=22% Similarity=0.266 Sum_probs=93.2
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccccccceeccccCCCCCCCccccc-CcccEEEeccccccccCC
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELP 80 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p 80 (790)
+||||+++|- .+++....+... ..|+..+|++|.+...+...... +.++.|+|++|.|+ .+|
T Consensus 31 ~ldLssc~lm-~i~davy~l~~~---------------~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvP 93 (177)
T KOG4579|consen 31 FLDLSSCQLM-YIADAVYMLSKG---------------YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVP 93 (177)
T ss_pred hcccccchhh-HHHHHHHHHhCC---------------ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hch
Confidence 4677777775 677766555332 12333444444444333322222 47889999999999 899
Q ss_pred ccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCC
Q 040908 81 HFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSG 152 (790)
Q Consensus 81 ~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~ 152 (790)
.++..++.|+.|++++|.|. ..|.-|..|.+|..|+..+|.+. .+|..+.. ..+...++.+|.+.+.-+.
T Consensus 94 eE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 94 EELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred HHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 99999999999999999998 88988888999999999999987 55644444 4445567788888765543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.3e-07 Score=106.62 Aligned_cols=152 Identities=18% Similarity=0.298 Sum_probs=100.2
Q ss_pred HHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC--------cceeeccccCCCcccHHHhh
Q 040908 552 CIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN--------THISTRVAGTFGYMAPEYAM 623 (790)
Q Consensus 552 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~--------~~~~~~~~gt~~y~aPE~~~ 623 (790)
+.+++.||.|+|... .+||++|.|++|.++..+..||+.|+.+....... .....-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345569999999764 79999999999999999999999999875433211 11111123456899999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccC
Q 040908 624 RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCAD 703 (790)
Q Consensus 624 ~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 703 (790)
....+.++|+||+||++|.+..|..+........... ... . ..+..-...+....+.++.+=+.+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--~~~------~----~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--SFS------R----NLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchh--hhh------h----cccccccccccccCcHHHHHHHHHHhc
Confidence 9888999999999999999995544432221111000 000 0 011111111223344556666677899
Q ss_pred CCCCCCCCHHHHHH
Q 040908 704 VSPTNRPLMSSVVS 717 (790)
Q Consensus 704 ~dP~~RPt~~ev~~ 717 (790)
.++..||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998887754
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.34 E-value=8.7e-08 Score=97.06 Aligned_cols=102 Identities=23% Similarity=0.254 Sum_probs=61.1
Q ss_pred cccceeccccCCCCCCCcccccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeC
Q 040908 41 SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTG 120 (790)
Q Consensus 41 ~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~ 120 (790)
.|+.|+|+.|.+.......-..+.++.|+||+|.|. .+-+ +..|.+|+.||||+|.|+ .+-.+=..|-+++.|.|+.
T Consensus 285 ~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 285 ELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhhccccccchhhhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence 566677777666644332222256677777777776 4443 666677777777777776 5555555666667777777
Q ss_pred CcccccCCccccC-CCCcEEeccCCccc
Q 040908 121 NLLTGKVPQWMFG-RGPENIDLSYNNFA 147 (790)
Q Consensus 121 N~l~g~~p~~~~~-~~L~~l~ls~N~l~ 147 (790)
|.+.. +.. +.. -+|.+||+++|+|.
T Consensus 362 N~iE~-LSG-L~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 362 NKIET-LSG-LRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhHhh-hhh-hHhhhhheeccccccchh
Confidence 76652 111 222 45677777777764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.9e-06 Score=84.93 Aligned_cols=107 Identities=23% Similarity=0.243 Sum_probs=83.3
Q ss_pred HHHHHHHHHHhhccCCCc--eeeeeeEEEeC----CeEEEEEEeccCC-ChhhhhcCCccccCCCChhhHHHHHHHHHHH
Q 040908 486 NREFVNEIGTISALQHPH--LVKLYGCCIEG----NQLLLIYEYLENN-SLARALFGPEEHRLKLDWPTRHNICIGIARG 558 (790)
Q Consensus 486 ~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~----~~~~lV~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~a 558 (790)
...+.+|...+..+.... ..+.+++.... ...++|+|++++. +|.+++.... ..+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 346788988888885444 45667766543 2458999999984 7988884311 15556778899999999
Q ss_pred HHHhhhcCCCcEEeccCCCCcEEecCCC---CeEEeecCCcccc
Q 040908 559 LAYLHEESRLKIVHRDIKATNVLLDKDL---NPKISDFGLAKLD 599 (790)
Q Consensus 559 L~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGla~~~ 599 (790)
++-||..+ |+|+|++++|||++.+. .+.++||+-++..
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999986 99999999999999887 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.2e-05 Score=80.25 Aligned_cols=136 Identities=15% Similarity=0.129 Sum_probs=100.3
Q ss_pred cccCcEEEEeeeecCCcEEEEEEccccc------hhcHHHHHHHHHHhhccCCCc--eeeeeeEEE-e----CCeEEEEE
Q 040908 455 GEGGFGPVYKGLLADGTLIAVKQLSAKS------KQGNREFVNEIGTISALQHPH--LVKLYGCCI-E----GNQLLLIY 521 (790)
Q Consensus 455 G~G~fG~Vy~g~~~~g~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~-~----~~~~~lV~ 521 (790)
|+||-+.|++-.+. |..+-+|+-...- +-+...|.+|...|.++...+ +.+++ ++. . .-..+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 66899999987774 4468888765221 335678999999999996433 44444 332 1 12468999
Q ss_pred EeccC-CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC--eEEeecCCcc
Q 040908 522 EYLEN-NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--PKISDFGLAK 597 (790)
Q Consensus 522 Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGla~ 597 (790)
|-+++ -+|.+++.... ..+.+...+..+..+++++++-||..+ +.|+|+.+.||+++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98774 48888873321 124566677899999999999999985 999999999999986666 9999997665
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.4e-05 Score=82.06 Aligned_cols=138 Identities=17% Similarity=0.229 Sum_probs=85.0
Q ss_pred eeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCce--eeeeeEEEeCCeEEEEEEeccCCC-
Q 040908 452 NKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL--VKLYGCCIEGNQLLLIYEYLENNS- 528 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~lV~Ey~~~gs- 528 (790)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-.+ .+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24467788876432 23456889999999865444 667778777778889999999963
Q ss_pred hhhhh---------------------cCCccccCCCChhhHHH-HHH----------HHHH-HHHHhhh-cCCCcEEecc
Q 040908 529 LARAL---------------------FGPEEHRLKLDWPTRHN-ICI----------GIAR-GLAYLHE-ESRLKIVHRD 574 (790)
Q Consensus 529 L~~~l---------------------~~~~~~~~~l~~~~~~~-i~~----------~ia~-aL~yLH~-~~~~~iiHrD 574 (790)
+...+ |..... ......... +-. .+.+ ...+|.. ...+.++|+|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 22111 111000 001111000 000 0011 1122211 1233578999
Q ss_pred CCCCcEEecCCCCeEEeecCCcc
Q 040908 575 IKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 575 lk~~NILl~~~~~~kl~DFGla~ 597 (790)
+.|.||++++++ +.|.||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999988 9999999776
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.9e-05 Score=79.83 Aligned_cols=156 Identities=19% Similarity=0.228 Sum_probs=102.6
Q ss_pred CCccHHHHHHHhcCcceeeeec---ccCcEEEEeeeecCCcEEEEEEccccchhc------------------------H
Q 040908 434 GSFTLRQIKAATNHFDVANKIG---EGGFGPVYKGLLADGTLIAVKQLSAKSKQG------------------------N 486 (790)
Q Consensus 434 ~~~~~~~~~~~~~~y~~~~~LG---~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~------------------------~ 486 (790)
...++..+....++..+.+..| .|--..||+|.-.++..+|||+++...... .
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 3456777777777777666655 555667999998889999999986432111 0
Q ss_pred HHHHHHHHHhhccC--CCceeeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhh
Q 040908 487 REFVNEIGTISALQ--HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564 (790)
Q Consensus 487 ~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~ 564 (790)
....+|+.-|.++. +-.+.+.+++. .-.|||||+..... -.+.-...++.......+..++++.+.-|-.
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC----CCCCcccCCcCchhHHHHHHHHHHHHHHHHH
Confidence 12345677777663 33344444443 34789999976411 1111112223333566677778888888776
Q ss_pred cCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 565 ~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
.+ +++|+||..-|||+. ++.+.++|||-|....
T Consensus 185 ~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 43 599999999999999 7899999999887443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.7e-07 Score=98.61 Aligned_cols=124 Identities=15% Similarity=0.169 Sum_probs=94.9
Q ss_pred cccccceeccccCCCCCCCccccc-CcccEEEeccccccccCCccccCCCCCCEEEccC-CcCCcCcc-hhccCCCCCcE
Q 040908 39 SESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSF-NKLNGTIP-ESFARLADVDF 115 (790)
Q Consensus 39 ~~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~ip-~~~~~l~~L~~ 115 (790)
|.....++|..|.+..++...|.. .+|+.||||+|+|+-+-|+.|.+|++|..|-|-+ |+|+ .+| ..|++|.+|+.
T Consensus 66 P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 66 PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQR 144 (498)
T ss_pred CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHH
Confidence 455666666666666666666666 7899999999999988899999999988765555 9998 555 56999999999
Q ss_pred EEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcceee
Q 040908 116 IYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLF 163 (790)
Q Consensus 116 L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~ 163 (790)
|.+.-|++.-...+.+.. ++|..|.|-.|.+....-..+..+..++.+
T Consensus 145 LllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tl 193 (498)
T KOG4237|consen 145 LLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTL 193 (498)
T ss_pred HhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchH
Confidence 999999999777777766 788889999999874333355555554443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.7e-05 Score=76.24 Aligned_cols=137 Identities=18% Similarity=0.229 Sum_probs=92.3
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHH---------HHHHHHhhccCC---CceeeeeeEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREF---------VNEIGTISALQH---PHLVKLYGCC 511 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~l~g~~ 511 (790)
...+|.+.+.+-......|.+-.. +|+.+.+|..+......++.| .+++..+.+++. -..+.++.++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 467788888888777776766655 567899998876543333322 234444444432 2333333333
Q ss_pred Ee-----CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC
Q 040908 512 IE-----GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 586 (790)
Q Consensus 512 ~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 586 (790)
.. ....+++|||++|-.|.+... ++. .++..+++++.-||..| +.|+|..|+|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 22 245678999999988766541 111 25567788899999986 99999999999999664
Q ss_pred CeEEeecCCcc
Q 040908 587 NPKISDFGLAK 597 (790)
Q Consensus 587 ~~kl~DFGla~ 597 (790)
+++.||+..+
T Consensus 173 -i~iID~~~k~ 182 (229)
T PF06176_consen 173 -IRIIDTQGKR 182 (229)
T ss_pred -EEEEECcccc
Confidence 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.5e-05 Score=90.47 Aligned_cols=140 Identities=17% Similarity=0.251 Sum_probs=91.8
Q ss_pred eeecccCcEEEEeeeecCCcEEEEEEccccchhc------------------------------HH----------HHHH
Q 040908 452 NKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQG------------------------------NR----------EFVN 491 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~------------------------------~~----------~~~~ 491 (790)
+-|+.++-|-||+|++.+|+.||||+.+..-... .+ ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999976321000 01 1334
Q ss_pred HHHHhhccC-----CCceeeeeeEE-EeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHH-HHHhhh
Q 040908 492 EIGTISALQ-----HPHLVKLYGCC-IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG-LAYLHE 564 (790)
Q Consensus 492 E~~~l~~l~-----H~niv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~a-L~yLH~ 564 (790)
|..-+.+++ .+++ ++=..+ .-.....|+|||++|-.+.+...-.. ...+ +..++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence 555554442 2333 232233 23467799999999988887742111 2233 33444444443 222222
Q ss_pred cCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 565 ~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
. ++.|.|..|.||+++.++++.+.|||+....++
T Consensus 284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred c---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3 499999999999999999999999999875543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=5e-07 Score=100.69 Aligned_cols=190 Identities=18% Similarity=0.143 Sum_probs=136.3
Q ss_pred HHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCc-eeeeeeEEEeCCeEEEEE
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH-LVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 521 (790)
..+.-+...+-.++|+++.+||.+-...+....+.+... .+..-++++|.+++||| .+..++-+..++..++++
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 334444555678899999999988443444446655432 34456889999999999 777777777788889999
Q ss_pred EeccCC-ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 522 EYLENN-SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 522 Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
+++..+ +-.... ......+...+...++..-+++++|+|+.. =+|+| ||+..+ ...+..||+....+.
T Consensus 314 ~i~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 314 RICSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhcCCccccccC---ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccC
Confidence 999887 222211 111122333444556667778999999762 37998 887766 578999999987665
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNI 650 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~ 650 (790)
+.. ......+|+.|+|||+.....+..+.|+|+.|+-..++.-|-+|-
T Consensus 383 ~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 383 RTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 543 224467999999999999999999999999998777777776654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.04 E-value=4e-05 Score=78.65 Aligned_cols=144 Identities=17% Similarity=0.141 Sum_probs=85.2
Q ss_pred eeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCc--eeeeeeEEEe---CCeEEEEEEecc
Q 040908 451 ANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH--LVKLYGCCIE---GNQLLLIYEYLE 525 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~---~~~~~lV~Ey~~ 525 (790)
++.|+.|..+.||+....+ ..+++|..... .....+..|+.+++.+.... +.+++.++.. ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4689999999999999877 58999987554 34567778999988885433 4566665533 335799999999
Q ss_pred CCChhh----------------hh---cCCccccCCCChhh---------HHHH------------HHHHHH-HHHHhhh
Q 040908 526 NNSLAR----------------AL---FGPEEHRLKLDWPT---------RHNI------------CIGIAR-GLAYLHE 564 (790)
Q Consensus 526 ~gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~ia~-aL~yLH~ 564 (790)
+..+.. .+ +..........+.. .... ...+.+ .++.++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 11100001111110 0000 111222 2333332
Q ss_pred ----cCCCcEEeccCCCCcEEec-CCCCeEEeecCCcc
Q 040908 565 ----ESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAK 597 (790)
Q Consensus 565 ----~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~ 597 (790)
.....++|+|+.++|||++ +++.+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1345699999999999999 55666799998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.2e-05 Score=78.02 Aligned_cols=105 Identities=23% Similarity=0.247 Sum_probs=82.9
Q ss_pred HHHHHHhhccCC-CceeeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCC
Q 040908 490 VNEIGTISALQH-PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568 (790)
Q Consensus 490 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 568 (790)
..|.-+++.+++ +++.+++|+|- .++|.||...+++...- ..-..-..-+|..|.+||.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888876 69999999994 37799999987664220 0001123469999999999999999999986544
Q ss_pred cEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 569 ~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
.+.-.|++++|+-+++++++|+.|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5899999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.6e-06 Score=61.02 Aligned_cols=36 Identities=28% Similarity=0.479 Sum_probs=17.5
Q ss_pred cccEEEeccccccccCCccccCCCCCCEEEccCCcCC
Q 040908 64 TFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLN 100 (790)
Q Consensus 64 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 100 (790)
+|++|+|++|+|+ .+|..|++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 3455555555555 44444555555555555555554
|
... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.2e-05 Score=77.78 Aligned_cols=141 Identities=16% Similarity=0.110 Sum_probs=85.3
Q ss_pred eecccCc-EEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEEEEEeccCCChh
Q 040908 453 KIGEGGF-GPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLLIYEYLENNSLA 530 (790)
Q Consensus 453 ~LG~G~f-G~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 530 (790)
.|-.|.. ..||+.... +..+.||...... .....+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 778998765 4678888875432 335667999888884 444557787777666789999999998776
Q ss_pred hhh-------------------cCCccccCCCC--hhhHHHHHH--------------------HHHHHHHHhhh----c
Q 040908 531 RAL-------------------FGPEEHRLKLD--WPTRHNICI--------------------GIARGLAYLHE----E 565 (790)
Q Consensus 531 ~~l-------------------~~~~~~~~~l~--~~~~~~i~~--------------------~ia~aL~yLH~----~ 565 (790)
... |.-.....++. +..+..... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11110001111 000000000 01111222211 1
Q ss_pred CCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 566 ~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
..+.++|+|+.|.|||++++....|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23458999999999999998778899998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=3e-07 Score=103.18 Aligned_cols=120 Identities=22% Similarity=0.158 Sum_probs=75.6
Q ss_pred EccCCcCcccCChhhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccCCc-c
Q 040908 4 TVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPH-F 82 (790)
Q Consensus 4 ~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~-~ 82 (790)
+.+.|+|. .+-.++.-|+.|+.|+|++|+++..- +|+.| ..|+.|||+.|.+. .+|. .
T Consensus 170 ~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l-----------------~~LkhLDlsyN~L~-~vp~l~ 228 (1096)
T KOG1859|consen 170 SFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRL-----------------PKLKHLDLSYNCLR-HVPQLS 228 (1096)
T ss_pred hcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhc-----------------ccccccccccchhc-cccccc
Confidence 45667776 66666777777777777777776543 44444 46777777777777 5554 2
Q ss_pred ccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCcc-ccC-CCCcEEeccCCccc
Q 040908 83 LGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQW-MFG-RGPENIDLSYNNFA 147 (790)
Q Consensus 83 ~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~-~~L~~l~ls~N~l~ 147 (790)
...++ |+.|.|++|.++ .+ ..+.+|.+|+.|||++|-|++.-.-. +.. ..|..|+|.+|++.
T Consensus 229 ~~gc~-L~~L~lrnN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 229 MVGCK-LQLLNLRNNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhh-heeeeecccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 33444 777777777776 33 24567777777777777766432110 111 45667777777764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 790 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-65 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-63 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-62 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-62 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-37 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-22 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-22 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-22 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-22 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-21 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-09 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-09 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 536 bits (1384), Expect = 0.0
Identities = 131/305 (42%), Positives = 185/305 (60%), Gaps = 4/305 (1%)
Query: 421 TSERELRGLDL-QTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLS 479
E + L Q F+LR+++ A+++F N +G GGFG VYKG LADGTL+AVK+L
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 63
Query: 480 AKSKQGN-REFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEE 538
+ QG +F E+ IS H +L++L G C+ + LL+Y Y+ N S+A L E
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 539 HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598
+ LDWP R I +G ARGLAYLH+ KI+HRD+KA N+LLD++ + DFGLAKL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCK--TKE 656
+ +TH++T V GT G++APEY G ++K DV+ +G++ LE+++G+ +
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 657 EKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVV 716
+ LLDW L ++ L LVD +L N E+V +I VALLC SP RP MS VV
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 717 SMLEG 721
MLEG
Sbjct: 304 RMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 485 bits (1252), Expect = e-167
Identities = 131/300 (43%), Positives = 187/300 (62%), Gaps = 8/300 (2%)
Query: 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGT 495
L ++ ATN+FD IG G FG VYKG+L DG +A+K+ + +S QG EF EI T
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 496 ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGI 555
+S +HPHLV L G C E N+++LIY+Y+EN +L R L+G + + + W R ICIG
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRVAGTF 614
ARGL YLH + I+HRD+K+ N+LLD++ PKI+DFG++K E D TH+ST V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674
GY+ PEY ++G LT+K+DVYSFG+V E++ RS I+ E L +WA+ G L
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDIVQDSSV 734
++VDPNL + E +R + A+ C +S +RP M V+ LE + +Q+S +
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL----RLQESVI 321
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 477 bits (1231), Expect = e-165
Identities = 111/313 (35%), Positives = 169/313 (53%), Gaps = 21/313 (6%)
Query: 423 ERELRGLDLQTGSFTLRQIKAATNHFD------VANKIGEGGFGPVYKGLLADGTLIAVK 476
+ L D + SF+ ++K TN+FD NK+GEGGFG VYKG + + T +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 477 QLSA----KSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARA 532
+L+A +++ ++F EI ++ QH +LV+L G +G+ L L+Y Y+ N SL
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 533 LFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 592
L + L W R I G A G+ +LHE +HRDIK+ N+LLD+ KISD
Sbjct: 121 LSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 593 FGLAKL-DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIM 651
FGLA+ ++ T +++R+ GT YMAPE +RG +T K+D+YSFG+V LEI++G +
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV- 234
Query: 652 CKTKEEKFYLLDWAL-LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP 710
E LLD + E+ + + +D + + D V M +VA C RP
Sbjct: 235 -DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 711 LMSSVVSMLEGRV 723
+ V +L+
Sbjct: 293 DIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 1e-88
Identities = 74/308 (24%), Positives = 116/308 (37%), Gaps = 30/308 (9%)
Query: 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGT 495
+ + + G FG V+K L +AVK + KQ + E+ +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 496 ISALQHPHLVKLYGCCIEGN----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNI 551
+ ++H ++++ G G L LI + E SL+ L + W +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHI 126
Query: 552 CIGIARGLAYLHEE-------SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604
+ARGLAYLHE+ + I HRDIK+ NVLL +L I+DFGLA E +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 605 HI-STRVAGTFGYMAPEYAMRGHLTD-----KADVYSFGIVALEIVSGRSNIMCKTKEEK 658
+ GT YMAPE + D+Y+ G+V E+ S + E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 659 FYLLDWALLLKEQGNLMELV-----DPNLGSNVDK-EQVRVMINVALLCADVSPTNRPLM 712
+ ++ E+V P L K + ++ C D R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 713 SSVVSMLE 720
V +
Sbjct: 307 GCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 3e-73
Identities = 72/314 (22%), Positives = 115/314 (36%), Gaps = 47/314 (14%)
Query: 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNE--IGTISALQH 501
++ + IG G +G VYKG L D +AVK S ++Q F+NE I + ++H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66
Query: 502 PHLVKLYGCCIEGN-----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIA 556
++ + + LL+ EY N SL + L DW + + +
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVT 121
Query: 557 RGLAYLHEE------SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-------DEEDN 603
RGLAYLH E + I HRD+ + NVL+ D ISDFGL+ +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 604 THISTRVAGTFGYMAPEYAM-------RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKE 656
+ + GT YMAPE + D+Y+ G++ EI R + +
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDLFPGES 240
Query: 657 EKFYLLDWALLLKEQGNLMELVD--------PNLGSNV--DKEQVRVMINVALLCADVSP 706
Y + + + ++ P + VR + C D
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 707 TNRPLMSSVVSMLE 720
R +
Sbjct: 301 EARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 4e-62
Identities = 76/280 (27%), Positives = 131/280 (46%), Gaps = 27/280 (9%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGN--REFVNEIGTISALQHPH 503
++ KIG G FG V++ G+ +AVK L + EF+ E+ + L+HP+
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+V G + L ++ EYL SL R L +LD R ++ +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNYLH 154
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 623
+ IVHR++K+ N+L+DK K+ DFGL++L + S AGT +MAPE
Sbjct: 155 NRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLR 212
Query: 624 RGHLTDKADVYSFGIVALEIVSGR---SNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680
+K+DVYSFG++ E+ + + N+ + + +E+ P
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNP---------AQVVAAVGFKCKRLEI--P 261
Query: 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
N++ + ++ C P RP ++++ +L
Sbjct: 262 ---RNLNPQVAAIIEG----CWTNEPWKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-61
Identities = 80/279 (28%), Positives = 127/279 (45%), Gaps = 31/279 (11%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
+V +G G FG V K +A+KQ+ +S+ + F+ E+ +S + HP++V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
KLYG C+ N + L+ EY E SL L G E + C+ ++G+AYLH
Sbjct: 65 KLYGACL--NPVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 566 SRLKIVHRDIKATNVLLDKDLN-PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 624
++HRD+K N+LL KI DFG A D T G+ +MAPE
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 625 GHLTDKADVYSFGIVALEIVSGR---SNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681
+ ++K DV+S+GI+ E+++ R I + + WA+ + P
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEI-----GGPAFRIMWAVHNGTR--------PP 224
Query: 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
L N+ K +M C P+ RP M +V ++
Sbjct: 225 LIKNLPKPIESLMTR----CWSKDPSQRPSMEEIVKIMT 259
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-59
Identities = 73/290 (25%), Positives = 128/290 (44%), Gaps = 42/290 (14%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGN----REFVNEIGTISALQH 501
+ IG GGFG VY+ G +AVK + E + L+H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P+++ L G C++ L L+ E+ L R L ++ N + IARG+ Y
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNY 120
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNP--------KISDFGLAKLDEEDNTHISTRVAGT 613
LH+E+ + I+HRD+K++N+L+ + + KI+DFGLA+ E T + AG
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA-AGA 177
Query: 614 FGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR---SNIMCKTKEEKFYLLDWALLLKE 670
+ +MAPE + +DV+S+G++ E+++G I L A +
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---------LAVAYGVAM 228
Query: 671 QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ + P S + ++M + C + P +RP ++++ L
Sbjct: 229 NKLALPI--P---STCPEPFAKLMED----CWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-59
Identities = 77/293 (26%), Positives = 134/293 (45%), Gaps = 44/293 (15%)
Query: 446 NHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGN-------REFVNEIGTIS 497
N + +IG+GGFG V+KG L+ D +++A+K L +G +EF E+ +S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
L HP++VKLYG N ++ E++ L L + W + + + IA
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIAL 133
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDK-----DLNPKISDFGLAKLDEEDNTHISTRVAG 612
G+ Y+ ++ IVHRD+++ N+ L + K++DFGL++ + H + + G
Sbjct: 134 GIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLG 188
Query: 613 TFGYMAPE--YAMRGHLTDKADVYSFGIVALEIVSGR---SNIMCKTKEEKFYLLDWALL 667
F +MAPE A T+KAD YSF ++ I++G + + + +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-------SYGKIKFINM 241
Query: 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
++E+G + P + + V+ C P RP S +V L
Sbjct: 242 IREEG-----LRPTIPEDCPPRLRNVIEL----CWSGDPKKRPHFSYIVKELS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-58
Identities = 80/284 (28%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGN--REFVNEIGTISALQHPH 503
V +IG G FG VYKG G +AVK L+ + + F NE+G + +H +
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
++ G L ++ ++ E +SL L E K + +I ARG+ YLH
Sbjct: 82 ILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLH 137
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRVAGTFGYMAPE-- 620
I+HRD+K+ N+ L +D KI DFGLA +H +++G+ +MAPE
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 621 -YAMRGHLTDKADVYSFGIVALEIVSGR---SNIMCKTKEEKFYLLDWALLLKEQGNLME 676
+ ++DVY+FGIV E+++G+ SNI D + + +G+L
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---------RDQIIEMVGRGSLS- 244
Query: 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ SN K R+M C RP +++ +E
Sbjct: 245 PDLSKVRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEIE 284
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-57
Identities = 77/339 (22%), Positives = 126/339 (37%), Gaps = 49/339 (14%)
Query: 416 FRPKYTSERELRGLDLQTGS-----FTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADG 470
+ P S R+L +GS +++ A + +IG+G +G V+ G G
Sbjct: 4 YIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIA--KQIQMVKQIGKGRYGEVWMGKW-RG 60
Query: 471 TLIAVKQLSAKSKQGNREFVNE--IGTISALQHPHLVKLYGCCIEGN----QLLLIYEYL 524
+AVK + E I ++H +++ I+G QL LI +Y
Sbjct: 61 EKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117
Query: 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE-----SRLKIVHRDIKATN 579
EN SL L LD + + GL +LH E + I HRD+K+ N
Sbjct: 118 ENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
Query: 580 VLLDKDLNPKISDFGLAKLDEEDNTHI---STRVAGTFGYMAPE------YAMRGHLTDK 630
+L+ K+ I+D GLA D + GT YM PE
Sbjct: 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232
Query: 631 ADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD--------PNL 682
AD+YSFG++ E+ + Y L + L+ + ++ + P+
Sbjct: 233 ADMYSFGLILWEVARR----CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF 288
Query: 683 GSNVDKEQV-RVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ ++ R M + C +P +R V L
Sbjct: 289 PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-57
Identities = 66/298 (22%), Positives = 117/298 (39%), Gaps = 42/298 (14%)
Query: 452 NKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNE--IGTISALQHPHLVKLYG 509
+G+G +G V++G G +AVK S+ + + + E + L+H +++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 510 CCIEGN----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+ QL LI Y E SL L LD + I + IA GLA+LH E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 566 -----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRVAGTFGYM 617
+ I HRD+K+ N+L+ K+ I+D GLA + + + + GT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 618 APE------YAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ 671
APE + D+++FG+V E+ M + Y + ++
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR----MVSNGIVEDYKPPFYDVVPND 240
Query: 672 GNLMELVD--------PNLGSNVDKEQV-RVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ ++ PN+ + + + + C +P+ R + L
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-57
Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 40/286 (13%)
Query: 452 NKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGC 510
+G+G FG K G ++ +K+L ++ R F+ E+ + L+HP+++K G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 511 CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKI 570
+ +L I EY++ +L + + + W R + IA G+AYLH + I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 571 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-------------ISTRVAGTFGYM 617
+HRD+ + N L+ ++ N ++DFGLA+L ++ T V G +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 618 APEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDW---ALLLKEQGNL 674
APE +K DV+SFGIV EI+ + L +G L
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEII---------GRVNADPDYLPRTMDFGLNVRGFL 240
Query: 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
D N + + C D+ P RP + LE
Sbjct: 241 ----DRYCPPNCPPS----FFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 1e-56
Identities = 58/286 (20%), Positives = 114/286 (39%), Gaps = 40/286 (13%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPH 503
+ K+ E G ++KG G I VK L + S + +R+F E + HP+
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 504 LVKLYGCCIE--GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
++ + G C LI ++ SL L E +D + +ARG+A+
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAF 126
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
LH I + + +V++D+D+ +IS + + S ++APE
Sbjct: 127 LHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE- 178
Query: 622 AMRG----HLTDKADVYSFGIVALEIVSGR---SNIMCKTKEEKFYLLDWALLLKEQGNL 674
A++ AD++SF ++ E+V+ +++ ++ + + +G
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---------MEIGMKVALEG-- 227
Query: 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ P + + ++M C + P RP +V +LE
Sbjct: 228 ---LRPTIPPGISPHVSKLMKI----CMNEDPAKRPKFDMIVPILE 266
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 9e-55
Identities = 76/299 (25%), Positives = 121/299 (40%), Gaps = 44/299 (14%)
Query: 452 NKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNE--IGTISALQHPHLVKLYG 509
IG+G FG V++G G +AVK S+ + R + E I L+H +++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 510 CCIEGN----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+ N QL L+ +Y E+ SL L +R + + + A GLA+LH E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 566 -----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRVAGTFGYM 617
+ I HRD+K+ N+L+ K+ I+D GLA + I GT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 618 APEYAMRGHL-------TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKE 670
APE + + +AD+Y+ G+V EI S Y L + L+
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED----YQLPYYDLVPS 273
Query: 671 QGNLMELVD--------PNLGSNVDK-EQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
++ E+ PN+ + E +RVM + C + R + L
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-53
Identities = 58/293 (19%), Positives = 105/293 (35%), Gaps = 45/293 (15%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGN--REFVNEIGTISALQHPH 503
++ IG+G FG VY G G +A++ + + + + F E+ +H +
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+V G C+ L +I + +L + + LD I I +G+ YLH
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLH 147
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNTHISTRVAGTFGYMAP 619
+ I+H+D+K+ NV D I+DFGL + G ++AP
Sbjct: 148 AK---GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 620 E---------YAMRGHLTDKADVYSFGIVALEIVSGR---SNIMCKTKEEKFYLLDWALL 667
E + + +DV++ G + E+ + + +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP----------AEAIIW 253
Query: 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
G L + KE ++ L C RP + ++ MLE
Sbjct: 254 QMGTGMKPNLSQ----IGMGKEISDIL----LFCWAFEQEERPTFTKLMDMLE 298
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-46
Identities = 70/286 (24%), Positives = 114/286 (39%), Gaps = 40/286 (13%)
Query: 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQL-SAKSKQGNREFVNEIGTISALQHPH 503
+ +IG G FG V+ G L AD TL+AVK +F+ E + HP+
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+V+L G C + + ++ E ++ L +L T + A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEY 621
+ +HRD+ A N L+ + KISDFG+++ +E D + ++ APE
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEA 286
Query: 622 AMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLLDWALLLKEQGNL 674
G + ++DV+SFGI+ E S SN ++ E+G
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN------QQ-------TREFVEKGGR 333
Query: 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ P R+M C P RP S++ L+
Sbjct: 334 LPC--P---ELCPDAVFRLM----EQCWAYEPGQRPSFSTIYQELQ 370
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI 512
+G+G +G VY G L++ IA+K++ + + ++ EI L+H ++V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 513 EGNQLLLIYEYLENNSLA---RALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
E + + E + SL+ R+ +GP LK + T I GL YLH+ +
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGP----LKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 570 IVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE---YAMRG 625
IVHRDIK NVL++ KISDFG +K N T GT YMAPE RG
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRG 201
Query: 626 HLTDKADVYSFGIVALEIVSGR 647
+ AD++S G +E+ +G+
Sbjct: 202 Y-GKAADIWSLGCTIIEMATGK 222
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 452 NKIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
++G+G FG V G ++AVK+L +++ R+F EI + +LQH ++VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 507 LYGCCIEGNQ--LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
G C + L LI EYL SL L ++H+ ++D I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYA 622
++ + +HRD+ N+L++ + KI DFGL K+ +D + G + APE
Sbjct: 131 GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 623 MRGHLTDKADVYSFGIVALEIVS 645
+ +DV+SFG+V E+ +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 33/287 (11%)
Query: 452 NKIGEGGFGPVYKGLLA-----DGTLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLV 505
+GEG FG V G +AVK L + EI + L H ++V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 506 KLYGCCIE--GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
K G C E GN + LI E+L + SL L +++ K++ + + I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEY 621
+ VHRD+ A NVL++ + KI DFGL K E D + + + + APE
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 622 AMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYL-----LDWALLLK--EQGN 673
M+ +DV+SFG+ E+++ S+ K + L+ ++G
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK 260
Query: 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ P N E ++M C + P+NR +++ E
Sbjct: 261 RLPC--P---PNCPDEVYQLM----RKCWEFQPSNRTSFQNLIEGFE 298
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 452 NKIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
++G+G FG V G ++AVK+L +++ R+F EI + +LQH ++VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 507 LYGCCIEGNQ--LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
G C + L LI EYL SL L ++H+ ++D I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYA 622
++ + +HRD+ N+L++ + KI DFGL K+ +D + + G + APE
Sbjct: 162 GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 623 MRGHLTDKADVYSFGIVALEIVS 645
+ +DV+SFG+V E+ +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 78/309 (25%), Positives = 122/309 (39%), Gaps = 58/309 (18%)
Query: 452 NKIGEGGFGPVYKGLLADG------TLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
++GEG FG V+ + L+AVK L S+ ++F E ++ LQH H+V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 506 KLYGCCIEGNQLLLIYEYLENNSL-----------ARALFGPEEHRLKLDWPTRHNICIG 554
+ +G C EG LL+++EY+ + L G + L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
+A G+ YL + L VHRD+ N L+ + L KI DFG+++ + RV G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGR- 219
Query: 615 G-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLL 662
+M PE + T ++DV+SFG+V EI + SN E +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TEAIDCI 273
Query: 663 DWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722
QG +E P E +M C P R + V + L+
Sbjct: 274 -------TQGRELE--RP---RACPPEVYAIM----RGCWQREPQQRHSIKDVHARLQAL 317
Query: 723 VGVPDIVQD 731
P + D
Sbjct: 318 AQAPPVYLD 326
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 67/203 (33%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 452 NKIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
+++G+G FG V G L+AVKQL R+F EI + AL +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 507 LYGCCIEGNQ--LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
G + L L+ EYL + L L + HR +LD I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYL-- 143
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYA 622
SR + VHRD+ A N+L++ + + KI+DFGLAKL D + R G + APE
Sbjct: 144 GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 623 MRGHLTDKADVYSFGIVALEIVS 645
+ ++DV+SFG+V E+ +
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-43
Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQL--SAKSKQGNREFVNEIGTISALQHPHLVKLYGC 510
++G G FG V G +AVK + + S+ EF E T+ L HP LVK YG
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 511 CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKI 570
C + + ++ EY+ N L L H L+ +C + G+A+L +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQF 125
Query: 571 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRGHLT 628
+HRD+ A N L+D+DL K+SDFG+ + +D + V F APE +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 629 DKADVYSFGIVALEIVS 645
K+DV++FGI+ E+ S
Sbjct: 184 SKSDVWAFGILMWEVFS 200
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-43
Identities = 71/306 (23%), Positives = 129/306 (42%), Gaps = 36/306 (11%)
Query: 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGN---REFVNEIGTISALQH 501
+ +K+G G +G VY+G+ +AVK L K+ EF+ E + ++H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 275
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P+LV+L G C +I E++ +L L + + I+ + Y
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEY 333
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
L E + +HR++ A N L+ ++ K++DFGL++L D + APE
Sbjct: 334 L--EKK-NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 390
Query: 622 AMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680
+ K+DV++FG++ EI + G S + + LL E+ ME P
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDYRMER--P 441
Query: 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDIVQDSSVSNKDES 740
++ +M C +P++RP + + E + Q+SS+S++ E
Sbjct: 442 ---EGCPEKVYELMRA----CWQWNPSDRPSFAEIHQAFE------TMFQESSISDEVEK 488
Query: 741 KSEAMR 746
+
Sbjct: 489 ELGKRG 494
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-43
Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 453 KIGEGGFGPVYKGLL-----ADGTLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLVK 506
IG G FG VYKG+L +A+K L + +++ +F+ E G + H ++++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
L G + +++I EY+EN +L + L E + + GIA G+ YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYL---A 164
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMR 624
+ VHRD+ A N+L++ +L K+SDFGL+++ E+D T G APE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 625 GHLTDKADVYSFGIVALEIVS 645
T +DV+SFGIV E+++
Sbjct: 225 RKFTSASDVWSFGIVMWEVMT 245
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 76/299 (25%), Positives = 123/299 (41%), Gaps = 59/299 (19%)
Query: 452 NKIGEGGFGPVYKGLLADG------TLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
++GEG FG V+ + L+AVK L + ++F E ++ LQH H+V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 506 KLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEHRLKLDWPTRHNICI 553
K YG C +G+ L++++EY+++ L P + + +L +I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 613
IA G+ YL + VHRD+ N L+ +L KI DFG+++ + + G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGG 193
Query: 614 FG-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYL 661
+M PE M T ++DV+SFG++ EI + SN E
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TEVIEC 247
Query: 662 LDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ QG ++E P KE VM L C P R + + +L
Sbjct: 248 I-------TQGRVLE--RP---RVCPKEVYDVM----LGCWQREPQQRLNIKEIYKILH 290
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-43
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 452 NKIGEGGFGPVYKGLLADGTLIAVKQL--SAKSKQGNREFVNEIGTISALQHPHLVKLYG 509
++G G FG V G +A+K + + S+ EF+ E + L H LV+LYG
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
C + + +I EY+ N L L E R + +C + + YL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQ 140
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT---FGYMAPEYAMRGH 626
+HRD+ A N L++ K+SDFGL++ +D T G+ + PE M
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSK 197
Query: 627 LTDKADVYSFGIVALEIVS 645
+ K+D+++FG++ EI S
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 452 NKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGC 510
++G G FG V++ G AVK++ + + V E+ + L P +V LYG
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 511 CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKI 570
EG + + E LE SL + + + L GL YLH +I
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 571 VHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTR----VAGTFGYMAPEYAMRG 625
+H D+KA NVLL D + + DFG A + D S + GT +MAPE M
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 626 HLTDKADVYSFGIVALEIVSGR 647
K D++S + L +++G
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGC 253
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 452 NKIGEGGFGPVYKGLL----ADGTLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLVK 506
+G G FG V G L +A+K L +++ R+F+ E + HP++++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
L G + ++++ EY+EN SL L +H + + GIA G+ YL S
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMR 624
+ VHRD+ A N+L++ +L K+SDFGL ++ E+D T G +PE
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 625 GHLTDKADVYSFGIVALEIVS 645
T +DV+S+GIV E++S
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 452 NKIGEGGFGPVYKGLL----ADGTLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLVK 506
IG G G V G L +A+K L + +++ R+F++E + HP++++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
L G G +++ EY+EN SL L H + + G+ G+ YL S
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMR 624
L VHRD+ A NVL+D +L K+SDFGL+++ E+D T G APE
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 625 GHLTDKADVYSFGIVALEIVS 645
+ +DV+SFG+V E+++
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA 249
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 79/287 (27%), Positives = 116/287 (40%), Gaps = 35/287 (12%)
Query: 452 NKIGEGGFGPVYKGLL-----ADGTLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLV 505
+GEG FG V G ++AVK L + Q + EI + L H H++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 506 KLYGCCIE--GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
K GCC + L L+ EY+ SL L H + L I G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGL--AQLLLFAQQICEGMAYLH 151
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEY 621
+HRD+ A NVLLD D KI DFGLAK E + + R G + APE
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 622 AMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDW-------ALLLKEQGN 673
+DV+SFG+ E+++ S+ TK + + L E+G
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ P E +M C + + RP +++ +L+
Sbjct: 269 RLPR--P---DKCPAEVYHLM----KNCWETEASFRPTFENLIPILK 306
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQ--LSAKSKQGNREFVNEIGTISALQHPHLVKLYG 509
+IG G F VYKGL +A + +K + F E + LQHP++V+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 510 CCI----EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
++L+ E + + +L L + + + + C I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFK-VMKIKVLRSWCRQILKGLQFLHTR 148
Query: 566 SRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 624
+ I+HRD+K N+ + + KI D GLA L V GT +MAPE
Sbjct: 149 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 625 GHLTDKADVYSFGIVALEIVSGR 647
+ + DVY+FG+ LE+ +
Sbjct: 205 KY-DESVDVYAFGMCMLEMATSE 226
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 452 NKIGEGGFGPVYKGLLADGTLIAVKQL--SAKSKQGNREFVNEIGTISALQHPHLVKLYG 509
+IG G FG V+ G + +A+K + A S++ +F+ E + L HP LV+LYG
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70
Query: 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLK 569
C+E + L+ E++E+ L+ L R T +C+ + G+AYL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYL---EEAC 124
Query: 570 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRGHL 627
++HRD+ A N L+ ++ K+SDFG+ + +D ++ F +PE
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRY 182
Query: 628 TDKADVYSFGIVALEIVS 645
+ K+DV+SFG++ E+ S
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 14/201 (6%)
Query: 452 NKIGEGGFGPVYKGLLADG-----TLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLV 505
+G G FG VYKGL +A+K+L A S + N+E ++E ++++ +PH+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+L G C+ + + LI + + L + EH+ + N C+ IA+G+ YL E
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYL--E 134
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAPEYAMR 624
R ++VHRD+ A NVL+ + KI+DFGLAKL + +MA E +
Sbjct: 135 DR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 625 GHLTDKADVYSFGIVALEIVS 645
T ++DV+S+G+ E+++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 7e-42
Identities = 70/288 (24%), Positives = 110/288 (38%), Gaps = 50/288 (17%)
Query: 452 NKIGEGGFGPVYKGLLADG----TLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLVK 506
IG G FG VY G L D AVK L+ + G +F+ E + HP+++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 507 LYGCCIEG-NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
L G C+ L++ Y+++ L + + +A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS- 146
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG------YMAP 619
K VHRD+ A N +LD+ K++DFGLA+ + + V G +MA
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMAL 201
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLLDWALLLKEQG 672
E T K+DV+SFG++ E+++ + + L QG
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYL-------LQG 248
Query: 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ P VM L C RP S +VS +
Sbjct: 249 RRLLQ--PE---YCPDPLYEVM----LKCWHPKAEMRPSFSELVSRIS 287
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-42
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 453 KIGEGGFGPVYKGLLADG---TLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLVKLY 508
++G G FG V +G+ +A+K L K E + E + L +P++V+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
G C + L+L+ E L + L R ++ + ++ G+ YL
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---EEK 129
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGH 626
VHRD+ A NVLL KISDFGL+K D+++ + R AG + + APE
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 627 LTDKADVYSFGIVALEIVS 645
+ ++DV+S+G+ E +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 73/320 (22%), Positives = 120/320 (37%), Gaps = 58/320 (18%)
Query: 452 NKIGEGGFGPVYKGLLADG----TLIAVKQL--SAKSKQGNREFVNEIGTISALQHPHLV 505
+G+G FG V + L +AVK L + EF+ E + HPH+
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 506 KLYGCCIEG------NQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIAR 557
KL G + ++I ++++ L L E+ L T + IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG-- 615
G+ YL SR +HRD+ A N +L +D+ ++DFGL++ + + G
Sbjct: 149 GMEYL--SSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKL 201
Query: 616 ---YMAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLLDWA 665
++A E T +DV++FG+ EI++ G N E + L
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN------AEIYNYL--- 252
Query: 666 LLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE---GR 722
GN ++ P +E +M C P RP + + LE G
Sbjct: 253 ----IGGNRLKQ--P---PECMEEVYDLM----YQCWSADPKQRPSFTCLRMELENILGH 299
Query: 723 VGVPDIVQDSSVSNKDESKS 742
+ V QD N + +
Sbjct: 300 LSVLSTSQDPLYINIERAHH 319
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 72/300 (24%), Positives = 117/300 (39%), Gaps = 60/300 (20%)
Query: 452 NKIGEGGFGPVYKGLLADG------TLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHL 504
++GE FG VYKG L +A+K L K EF +E + LQHP++
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEHRLKLDWPTRHNIC 552
V L G + L +I+ Y + L + + L+ P ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG 612
IA G+ YL S +VH+D+ NVL+ LN KISD GL + + +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY----KLL 187
Query: 613 TFG-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFY 660
+MAPE M G + +D++S+G+V E+ S G SN ++
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVVE 241
Query: 661 LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
++ ++ P + +M + C + P+ RP + S L
Sbjct: 242 MI-------RNRQVLP--CP---DDCPAWVYALM----IECWNEFPSRRPRFKDIHSRLR 285
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 73/308 (23%), Positives = 130/308 (42%), Gaps = 52/308 (16%)
Query: 452 NKIGEGGFGPVYKGLLADGTL-IAVKQLSAKSKQGN---REFVNEIGTISALQHPHLVKL 507
+K+G G +G VY+G+ +L +AVK L K+ EF+ E + ++HP+LV+L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
G C +I E++ +L L + + I+ + YL E +
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYL--EKK 130
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRG 625
+HRD+ A N L+ ++ K++DFGL++L D + F APE
Sbjct: 131 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYN 187
Query: 626 HLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678
+ K+DV++FG++ EI + G + + LL E+ ME
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELL-------EKDYRMER- 233
Query: 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDIVQDSSVSNKD 738
P ++ +M C +P++RP + + E + Q+SS+S++
Sbjct: 234 -PE---GCPEKVYELM----RACWQWNPSDRPSFAEIHQAFE------TMFQESSISDEV 279
Query: 739 ESKSEAMR 746
E +
Sbjct: 280 EKELGKRG 287
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 72/203 (35%), Positives = 106/203 (52%), Gaps = 18/203 (8%)
Query: 452 NKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGN---REFVNEIGTISALQHPHLVKLY 508
++G G FG V+ G T +AVK L KQG+ F+ E + LQH LV+LY
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
+ + +I EY+EN SL L P +L + ++ IA G+A++
Sbjct: 75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTI--NKLLDMAAQIAEGMAFI---EER 128
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRGH 626
+HRD++A N+L+ L+ KI+DFGLA+L E++ + R F APE G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGT 186
Query: 627 LTDKADVYSFGIVALEIVS-GRS 648
T K+DV+SFGI+ EIV+ GR
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI 209
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 64/285 (22%), Positives = 111/285 (38%), Gaps = 44/285 (15%)
Query: 452 NKIGEGGFGPVYKGLLADG----TLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHLVK 506
IG+G FG VY G D A+K LS ++ F+ E + L HP+++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 507 LYGCCIEGN-QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
L G + ++ Y+ + L + + + + + +ARG+ YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTF--GYMAPEYA 622
+ K VHRD+ A N +LD+ K++DFGLA+ + + + + + A E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 623 MRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675
T K+DV+SFG++ E+++ + + L QG +
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP------FDLTHFL-------AQGRRL 247
Query: 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
P +VM C + P RP +V +E
Sbjct: 248 PQ--P---EYCPDSLYQVM----QQCWEADPAVRPTFRVLVGEVE 283
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 80/316 (25%), Positives = 133/316 (42%), Gaps = 56/316 (17%)
Query: 452 NKIGEGGFGPVYKGLLADG------TLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHL 504
++G+G FG VY+G+ T +A+K ++ + R EF+NE + H+
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLA---RALFGPEEHRLKLDWPTRH---NICIGIARG 558
V+L G +G L+I E + L R+L + L P+ + IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY-- 616
+AYL+ K VHRD+ A N ++ +D KI DFG+ + E + + G G
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLP 203
Query: 617 ---MAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLLDWAL 666
M+PE G T +DV+SFG+V EI + G SN E+ +
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFV---- 253
Query: 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVP 726
+G L++ P N +M +C +P RP ++S ++ +
Sbjct: 254 ---MEGGLLDK--P---DNCPDMLFELM----RMCWQYNPKMRPSFLEIISSIKEE--ME 299
Query: 727 DIVQDSSVSNKDESKS 742
++ S +E+K
Sbjct: 300 PGFREVSFYYSEENKL 315
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-41
Identities = 57/316 (18%), Positives = 114/316 (36%), Gaps = 67/316 (21%)
Query: 453 KIGEGGFGPVYKGLL--------ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL 504
+G+G F ++KG+ T + +K L + + F +S L H HL
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
V YG C+ G++ +L+ E+++ SL L ++++ ++ + + +A + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMHFL-- 129
Query: 565 ESRLKIVHRDIKATNVLLDKDLNP--------KISDFGLAK-LDEEDNTHISTRVAGTFG 615
E ++H ++ A N+LL ++ + K+SD G++ + +D
Sbjct: 130 EEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------ 182
Query: 616 YMAPE-YAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLLDWALL 667
++ PE +L D +SFG EI S + + K
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS------QRKLQFY----- 231
Query: 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPD 727
E + + E ++ C D P +RP +++ L
Sbjct: 232 --EDRHQLPAPKA-------AELANLI----NNCMDYEPDHRPSFRAIIRDLN------S 272
Query: 728 IVQDSSVSNKDESKSE 743
+ V
Sbjct: 273 LFTPDLVPRGSHHHHH 288
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-41
Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 453 KIGEGGFGPVYKGLLADG----TLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKL 507
IGEG FG V++G+ +A+K S +F+ E T+ HPH+VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
G E N + +I E L L + + LD + ++ LAYL
Sbjct: 82 IGVITE-NPVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYL---ES 134
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHL 627
+ VHRDI A NVL+ + K+ DFGL++ E+ + +++ +MAPE
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 628 TDKADVYSFGIVALEIVS 645
T +DV+ FG+ EI+
Sbjct: 195 TSASDVWMFGVCMWEILM 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-41
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 452 NKIGEGGFGPVYKGLLADG-----TLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLV 505
+G G FG V+KG+ + +K + KS +Q + + + I +L H H+V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+L G C + L L+ +YL SL + +HR L N + IA+G+ YL E
Sbjct: 79 RLLGLCPG-SSLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAKGMYYL--E 132
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAPEYAMR 624
+VHR++ A NVLL +++DFG+A L D+ + A T +MA E
Sbjct: 133 EH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 625 GHLTDKADVYSFGIVALEIVS 645
G T ++DV+S+G+ E+++
Sbjct: 192 GKYTHQSDVWSYGVTVWELMT 212
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 75/310 (24%), Positives = 111/310 (35%), Gaps = 60/310 (19%)
Query: 452 NKIGEGGFGPVYKGLLADG------TLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHL 504
+G G FG VY+G ++ +AVK L + + +F+ E IS H ++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLA---RALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
V+ G ++ ++ E + L R L ++ IA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 562 LHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKLDEEDNTHISTRVAGTFGY-- 616
L +HRDI A N LL KI DFG+A+ + R G
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKGGC-AMLP 208
Query: 617 ---MAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLLDWAL 666
M PE M G T K D +SFG++ EI S +SN +E +
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFV---- 258
Query: 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVP 726
G M+ P N R+M C P +RP + ++ +E
Sbjct: 259 ---TSGGRMDP--P---KNCPGPVYRIM----TQCWQHQPEDRPNFAIILERIE------ 300
Query: 727 DIVQDSSVSN 736
QD V N
Sbjct: 301 YCTQDPDVIN 310
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 453 KIGEGGFGPVYKGLL----ADGTLIAVKQL---SAKSKQGNREFVNEIGTISALQHPHLV 505
K+G+G FG V +G +AVK L + +F+ E+ + +L H +L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+LYG + + ++ E SL L +H+ T + +A G+ YL E
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYL-ES 139
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAM 623
R +HRD+ A N+LL KI DFGL + +++ H + + APE
Sbjct: 140 KRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 624 RGHLTDKADVYSFGIVALEIVS 645
+ +D + FG+ E+ +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-40
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGN---REFVNEIGTISALQHP 502
+ K+G+G FG V+ G T +A+K L K G F+ E + L+H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHE 239
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
LV+LY E + ++ EY+ SL L G L+L P ++ IA G+AY+
Sbjct: 240 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYV 296
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 622
R+ VHRD++A N+L+ ++L K++DFGLA+L E++ + APE A
Sbjct: 297 ---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 623 MRGHLTDKADVYSFGIVALEIVS 645
+ G T K+DV+SFGI+ E+ +
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTT 376
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQL---SAKSKQGNREFVNEIGTISALQH 501
+F + KIG G F VY+ L DG +A+K++ + + + EI + L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P+++K Y IE N+L ++ E + L+R + ++ + + T + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
+H +++HRDIK NV + K+ D GL + T + V GT YM+PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 622 AMRGHLTDKADVYSFGIVALEIVSGR 647
K+D++S G + E+ + +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 54/294 (18%)
Query: 452 NKIGEGGFGPVYKGLLADG----TLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLV 505
+GEG FG V +G L +AVK + S++ EF++E + HP+++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 506 KLYGCCIEGN-----QLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARG 558
+L G CIE + + ++I +++ L L E + T + IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG--- 615
+ YL S +HRD+ A N +L D+ ++DFGL+K + + G
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212
Query: 616 --YMAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLLDWAL 666
++A E T K+DV++FG+ EI + G N E + L
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN------HEMYDYL---- 262
Query: 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
G+ ++ P + E +M C P +RP S + LE
Sbjct: 263 ---LHGHRLKQ--P---EDCLDELYEIM----YSCWRTDPLDRPTFSVLRLQLE 304
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-40
Identities = 66/285 (23%), Positives = 111/285 (38%), Gaps = 44/285 (15%)
Query: 452 NKIGEGGFGPVYKGLLADG----TLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVK 506
IG G FG VY G L D AVK L+ +F+ E + HP+++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 507 LYGCCIEG-NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
L G C+ L++ Y+++ L + + +A+G+ +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTF--GYMAPEYA 622
+ K VHRD+ A N +LD+ K++DFGLA+ + +++ + + +MA E
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 623 MRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675
T K+DV+SFG++ E+++ + + L QG +
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYL-------LQGRRL 315
Query: 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
P VM L C RP S +VS +
Sbjct: 316 LQ--PE---YCPDPLYEVM----LKCWHPKAEMRPSFSELVSRIS 351
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-40
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGN---REFVNEIGTISALQHP 502
+ K+G G FG V+ T +AVK + K G+ F+ E + LQH
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHD 243
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
LVKL+ + + +I E++ SL L E + L P + IA G+A++
Sbjct: 244 KLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFI 300
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPE 620
+ +HRD++A N+L+ L KI+DFGLA++ E++ + R F APE
Sbjct: 301 ---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPE 355
Query: 621 YAMRGHLTDKADVYSFGIVALEIVS 645
G T K+DV+SFGI+ +EIV+
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-40
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 453 KIGEGGFGPVYKGLLADG---TLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLVKLY 508
++G G FG V +G+ +A+K L K E + E + L +P++V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
G C + L+L+ E L + L R ++ + ++ G+ YL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---EEK 455
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRGH 626
VHR++ A NVLL KISDFGL+K D+++ + R AG + APE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 627 LTDKADVYSFGIVALEIVS 645
+ ++DV+S+G+ E +S
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 14/201 (6%)
Query: 452 NKIGEGGFGPVYKGLLADG-----TLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLV 505
+G G FG VYKGL +A+K+L A S + N+E ++E ++++ +PH+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+L G C+ + + LI + + L + EH+ + N C+ IA+G+ YL E
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYL--E 134
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAPEYAMR 624
R ++VHRD+ A NVL+ + KI+DFGLAKL + +MA E +
Sbjct: 135 DR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 625 GHLTDKADVYSFGIVALEIVS 645
T ++DV+S+G+ E+++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-40
Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 15/215 (6%)
Query: 437 TLRQIKAATN---HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNE 492
LR + + D KIGEG G V G +AVK + + +Q NE
Sbjct: 33 ALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNE 92
Query: 493 IGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNIC 552
+ + QH ++V++Y + G +L ++ E+L+ +L + +++L+ +C
Sbjct: 93 VVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVC 147
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVA 611
+ + LAYLH + ++HRDIK+ ++LL D K+SDFG A++ ++ S +
Sbjct: 148 EAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LV 202
Query: 612 GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSG 646
GT +MAPE R + D++S GI+ +E+V G
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 453 KIGEGGFGPVYKGLL----ADGTLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLVKL 507
+GEG FG VY+G+ + +AVK + +F++E + L HPH+VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
G E +I E L L E ++ L T + I + +AYL
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYL---ES 131
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT---FGYMAPEYAMR 624
+ VHRDI N+L+ K+ DFGL++ E+++ + + T +M+PE
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINF 188
Query: 625 GHLTDKADVYSFGIVALEIVS 645
T +DV+ F + EI+S
Sbjct: 189 RRFTTASDVWMFAVCMWEILS 209
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 452 NKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCC 511
IG+G FG V G G +AVK + K+ + F+ E ++ L+H +LV+L G
Sbjct: 27 QTIGKGEFGDVMLGD-YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 512 IEGN-QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKI 570
+E L ++ EY+ SL L L + + + YL E
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYL--EGN-NF 138
Query: 571 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRGHLT 628
VHRD+ A NVL+ +D K+SDFGL K T+ G APE +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASS------TQDTGKLPVKWTAPEALREKKFS 192
Query: 629 DKADVYSFGIVALEIVS-GRS 648
K+DV+SFGI+ EI S GR
Sbjct: 193 TKSDVWSFGILLWEIYSFGRV 213
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-40
Identities = 74/310 (23%), Positives = 109/310 (35%), Gaps = 60/310 (19%)
Query: 452 NKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHL 504
+G G FG VY+G + +AVK L + + +F+ E IS H ++
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLA---RALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
V+ G ++ ++ E + L R L ++ IA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 562 LHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKLDEEDNTHISTRVAGTFGY-- 616
L +HRDI A N LL KI DFG+A+ + G
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAMLP 249
Query: 617 ---MAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYLLDWAL 666
M PE M G T K D +SFG++ EI S +SN +E +
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFV---- 299
Query: 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVP 726
G M+ P N R+M C P +RP + ++ +E
Sbjct: 300 ---TSGGRMDP--P---KNCPGPVYRIM----TQCWQHQPEDRPNFAIILERIE------ 341
Query: 727 DIVQDSSVSN 736
QD V N
Sbjct: 342 YCTQDPDVIN 351
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-40
Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 15/215 (6%)
Query: 437 TLRQIKAATN---HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNE 492
LR I + + + KIG+G G VY + +A G +A++Q++ + + +NE
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 493 IGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNIC 552
I + ++P++V + G++L ++ EYL SL + +D +C
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVC 122
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVA 611
+ L +LH +++HRDIK+ N+LL D + K++DFG A++ E + + +
Sbjct: 123 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MV 177
Query: 612 GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSG 646
GT +MAPE R K D++S GI+A+E++ G
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-40
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 453 KIGEGGFGPVYKGLL---ADGTLIAVKQL--SAKSKQGNREFVNEIGTISALQHPHLVKL 507
++G G FG V KG +AVK L A E + E + L +P++V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
G C E +L+ E E L + L +++R + + ++ G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL---QQNR-HVKDKNIIELVHQVSMGMKYL---EE 135
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRG 625
VHRD+ A NVLL KISDFGL+K D + + G + + APE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 626 HLTDKADVYSFGIVALEIVS 645
+ K+DV+SFG++ E S
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-40
Identities = 60/255 (23%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH 503
+ F+ +G+G FG V K D A+K++ +++ ++E+ +++L H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 504 LVKLYGCCIEGNQLLL----------IY---EYLENNSLARALFGPEEHRLKLDWPTRHN 550
+V+ Y +E + ++ EY EN +L + L
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWR 120
Query: 551 ICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED-------- 602
+ I L+Y+H + I+HRD+K N+ +D+ N KI DFGLAK
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 603 ------NTHISTRVAGTFGYMAPE-YAMRGHLTDKADVYSFGIVALEIVSG------RSN 649
+ ++++ + GT Y+A E GH +K D+YS GI+ E++ R N
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236
Query: 650 IMCKTKEEKFYLLDW 664
I+ K +
Sbjct: 237 ILKKLRSVSIEFPPD 251
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-39
Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 7/200 (3%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
+ K+G+G FG V+ G T +A+K L + F+ E + L+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLV 325
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+LY E + ++ EY+ SL L G L+L P ++ IA G+AY+ E
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYV--E 380
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
VHRD++A N+L+ ++L K++DFGLA+L E++ + APE A+ G
Sbjct: 381 RM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 626 HLTDKADVYSFGIVALEIVS 645
T K+DV+SFGI+ E+ +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-39
Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGN--REFVNEIGTISALQHPH 503
+ IG+G FG V G G +AVK + K + F+ E ++ L+H +
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSN 247
Query: 504 LVKLYGCCIEGN-QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
LV+L G +E L ++ EY+ SL L L + + + YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYL 305
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 622
E VHRD+ A NVL+ +D K+SDFGL K E +T + ++ + APE
Sbjct: 306 --EGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEAL 358
Query: 623 MRGHLTDKADVYSFGIVALEIVS-GRS 648
+ K+DV+SFGI+ EI S GR
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRV 385
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-39
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 453 KIGEGGFGPVYKGLLADG----TLIAVKQL-SAKSKQGNREFVNEIGTISALQHPHLVKL 507
IGEG FG V++G+ +A+K + S +F+ E T+ HPH+VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 508 YGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESR 567
G E N + +I E L L + + LD + ++ LAYL
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYL---ES 509
Query: 568 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHL 627
+ VHRDI A NVL+ + K+ DFGL++ E+ + +++ +MAPE
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 628 TDKADVYSFGIVALEIVS 645
T +DV+ FG+ EI+
Sbjct: 570 TSASDVWMFGVCMWEILM 587
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 76/301 (25%), Positives = 111/301 (36%), Gaps = 37/301 (12%)
Query: 417 RPKYTSERELRGLDLQTGSFT-LRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIA 474
+P+ S R LQ+ + R F +++G G +G V+K DG L A
Sbjct: 27 QPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYA 86
Query: 475 VKQLSAKSKQGNRE---FVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLENNSLA 530
VK+ S +G ++ + E+G+ + QHP V+L EG L L E SL
Sbjct: 87 VKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGP-SLQ 144
Query: 531 RALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 590
+ E L LA+LH + +VH D+K N+ L K+
Sbjct: 145 QHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKL 198
Query: 591 SDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSN 649
DFGL L + G YMAPE + ADV+S G+ LE
Sbjct: 199 GDFGLLVELGTAGAGE--VQE-GDPRYMAPELLQGSY-GTAADVFSLGLTILE------- 247
Query: 650 IMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNR 709
+ E W L QG L L S+ + + +M+ P R
Sbjct: 248 -VACNMELPHGGEGWQQLR--QGYLPPEFTAGL-SSELRSVLVMMLE-------PDPKLR 296
Query: 710 P 710
Sbjct: 297 A 297
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 52/228 (22%), Positives = 85/228 (37%), Gaps = 34/228 (14%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQ--LSAKSKQGNREFVNEIGTISAL-Q 500
T F KIG G FG V+K + DG + A+K+ + + E+ + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
H H+V+ + E + +L+ EY SLA A+ ++ + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNP-------------------KISDFGLAKLDEE 601
Y+H +VH DIK +N+ + + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 602 DNTHISTRVAGTFGYMAPEYAM--RGHLTDKADVYSFGIVALEIVSGR 647
G ++A E HL KAD+++ + +
Sbjct: 187 PQVEE-----GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE 228
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQ--LSAKSKQGNREFVNEIGTISALQHP 502
+ KIGEG FG DG +K+ +S S + E E+ ++ ++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARAL------FGPEEHRLKLDWPTRHNICIGIA 556
++V+ E L ++ +Y E L + + E+ L + I
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD--------WFVQIC 135
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 616
L ++H+ KI+HRDIK+ N+ L KD ++ DFG+A++ + GT Y
Sbjct: 136 LALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYY 191
Query: 617 MAPE-YAMRGHLTDKADVYSFGIVALEIVSGR 647
++PE + + +K+D+++ G V E+ + +
Sbjct: 192 LSPEICENKPY-NNKSDIWALGCVLYELCTLK 222
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 35/187 (18%), Positives = 61/187 (32%), Gaps = 31/187 (16%)
Query: 193 INCGGSEVTVNGSTTFEEDTDEATAARFGFTGTNHWAFSSTGHFLDDKSPDTNIQKNTSR 252
+N GG + +D G D ++ N
Sbjct: 10 VNAGGESHVDVHGIHYRKDPL----------------EGRVGRASDYGMKLPILRSNP-- 51
Query: 253 LLMDDFQLYTEARVSPISLTYYVFCLENGNYKVNLHFAETMFTDDKTYKSLGRRIFDVYI 312
+D LY R + S Y + E G Y + L FAE F +++FDV +
Sbjct: 52 ---EDQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAEVYFA------QSQQKVFDVRV 102
Query: 313 QGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMDIRL---YWAGKGTTEIPDRGVYGP 369
G +KD +I + G + + G + ++ + GK + E P
Sbjct: 103 NGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNP 161
Query: 370 LISAISL 376
+ A+ +
Sbjct: 162 KVCALFI 168
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 81/329 (24%), Positives = 127/329 (38%), Gaps = 69/329 (20%)
Query: 452 NKIGEGGFGPVYKGLLADG---TLIAVKQL--SAKSKQGNREFVNEIGTISAL-QHPHLV 505
+ IGEG FG V K + A+K++ A +R+F E+ + L HP+++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-HRDFAGELEVLCKLGHHPNII 89
Query: 506 KLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEHRLKLDWPTRHNICI 553
L G C L L EY + +L A L +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 613
+ARG+ YL S+ + +HRD+ A N+L+ ++ KI+DFGL++ E V T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 199
Query: 614 FG-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEEKFYL 661
G +MA E T +DV+S+G++ EIVS G + E +
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEK 253
Query: 662 LDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721
L QG +E P N D E +M C P RP + ++ L
Sbjct: 254 L-------PQGYRLE--KP---LNCDDEVYDLM----RQCWREKPYERPSFAQILVSLNR 297
Query: 722 RVGVP------DIVQDSSVSNKDESKSEA 744
+ + + + + D S EA
Sbjct: 298 MLEERKTYVNTTLYEKFTYAGIDCSAEEA 326
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH 503
+++ ++G+G FG VYK G L A K + KS++ +++ EI ++ HP+
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+VKL G +L ++ E+ ++ + E L P +C + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRVAGTFGYMAP 619
+ +I+HRD+KA NVL+ + + +++DFG+ AK + ++ I GT +MAP
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAP 186
Query: 620 EYAMRGHLTD-----KADVYSFGIVALEIVSG 646
E M + D KAD++S GI +E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 84/308 (27%), Positives = 127/308 (41%), Gaps = 68/308 (22%)
Query: 452 NKIGEGGFGPVYKGLLADG------TLIAVKQLSAKSKQGNR-EFVNEIGTISALQHPHL 504
+GEG FG V K T +AVK L + + ++E + + HPH+
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSL--------------------ARALFGPEEHRLKLD 544
+KLYG C + LLLI EY + SL + L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 545 WPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604
+ I++G+ YL K+VHRD+ A N+L+ + KISDFGL++ E+++
Sbjct: 149 MGDLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 605 HISTRVAGTFG-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMC 652
+ V + G +MA E T ++DV+SFG++ EIV+ G
Sbjct: 206 Y----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP--- 258
Query: 653 KTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLM 712
E F LL + G+ ME P N +E R+M L C P RP+
Sbjct: 259 ---ERLFNLL-------KTGHRMER--P---DNCSEEMYRLM----LQCWKQEPDKRPVF 299
Query: 713 SSVVSMLE 720
+ + LE
Sbjct: 300 ADISKDLE 307
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 74/303 (24%), Positives = 124/303 (40%), Gaps = 63/303 (20%)
Query: 452 NKIGEGGFGPVYKGLLAD--------GTLIAVKQLSAKSKQGNR-EFVNEIGTISAL-QH 501
+GEG FG V +AVK L + + + + V+E+ + + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEHRLKLDWPTRH 549
+++ L G C + L +I EY +L + ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609
+ +ARG+ YL S+ K +HRD+ A NVL+ ++ KI+DFGLA+ + +
Sbjct: 161 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213
Query: 610 VAGTFG-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEE 657
T G +MAPE T ++DV+SFG++ EI + G EE
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------EE 267
Query: 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717
F LL ++G+ M+ P +N E +M C P+ RP +V
Sbjct: 268 LFKLL-------KEGHRMD--KP---ANCTNELYMMM----RDCWHAVPSQRPTFKQLVE 311
Query: 718 MLE 720
L+
Sbjct: 312 DLD 314
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 76/309 (24%), Positives = 119/309 (38%), Gaps = 70/309 (22%)
Query: 452 NKIGEGGFGPVYKGLLADG------TLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHL 504
IGEG FG V++ T++AVK L + S +F E ++ +P++
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSL--------------------ARALFGPEEHRLKLD 544
VKL G C G + L++EY+ L + L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 545 WPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDN 603
+ I +A G+AYL S K VHRD+ N L+ +++ KI+DFGL+ + D
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 604 THISTRVAGTFGY-----MAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIM 651
M PE T ++DV+++G+V EI S G ++
Sbjct: 230 YKADGN-----DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-- 282
Query: 652 CKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL 711
EE Y + GN++ P N E +M LC P +RP
Sbjct: 283 ----EEVIYYV-------RDGNILAC--P---ENCPLELYNLM----RLCWSKLPADRPS 322
Query: 712 MSSVVSMLE 720
S+ +L+
Sbjct: 323 FCSIHRILQ 331
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
FDV K+GEG +G VYK + G ++A+KQ+ +S +E + EI + PH+VK
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
YG + L ++ EY S++ + L I +GL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFM- 144
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRVAGTFGYMAPEYA 622
+ +HRDIKA N+LL+ + + K++DFG+ +L + NT I GT +MAPE
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEVI 197
Query: 623 MRGHLTDKADVYSFGIVALEIVSG 646
AD++S GI A+E+ G
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEG 221
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-38
Identities = 74/303 (24%), Positives = 124/303 (40%), Gaps = 63/303 (20%)
Query: 452 NKIGEGGFGPVYKGLLAD--------GTLIAVKQLSAKSKQGNR-EFVNEIGTISAL-QH 501
+GEG FG V +AVK L + + + + V+E+ + + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEHRLKLDWPTRH 549
+++ L G C + L +I EY +L + ++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609
+ +ARG+ YL S+ K +HRD+ A NVL+ ++ KI+DFGLA+ + +
Sbjct: 207 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 259
Query: 610 VAGTFG-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEE 657
T G +MAPE T ++DV+SFG++ EI + G EE
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------EE 313
Query: 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717
F LL ++G+ M+ P +N E +M C P+ RP +V
Sbjct: 314 LFKLL-------KEGHRMDK--P---ANCTNELYMMM----RDCWHAVPSQRPTFKQLVE 357
Query: 718 MLE 720
L+
Sbjct: 358 DLD 360
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 75/310 (24%), Positives = 121/310 (39%), Gaps = 60/310 (19%)
Query: 452 NKIGEGGFGPVYKGLLAD------GTLIAVKQL--SAKSKQGNREFVNEIGTISAL-QHP 502
+G G FG V + +AVK L +A + + ++E+ +S L QH
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-KEALMSELKIMSHLGQHE 110
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSL----------ARALFGPEEHRLKLDWPTRHNIC 552
++V L G C G +L+I EY L +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG 612
+A+G+A+L S+ +HRD+ A NVLL KI DFGLA+ D+ + +
Sbjct: 171 SQVAQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVK 223
Query: 613 TFG-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRS---NIMCKTKEEKFYLLD 663
+MAPE T ++DV+S+GI+ EI S G + I+ + + L+
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL--VNSKFYKLV- 280
Query: 664 WALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723
+ G M P + K +M C + PT+RP + S L+
Sbjct: 281 ------KDGYQMA--QP---AFAPKNIYSIM----QACWALEPTHRPTFQQICSFLQ--- 322
Query: 724 GVPDIVQDSS 733
+ Q+
Sbjct: 323 ---EQAQEDR 329
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 34/237 (14%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL 504
F IG GGFG V+K DG +K++ K N + E+ ++ L H ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 505 VKLYGCCIE----------------GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTR 548
V GC L + E+ + +L + + + KLD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLA 124
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 608
+ I +G+ Y+H + K+++RD+K +N+ L KI DFGL + D T
Sbjct: 125 LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSG------RSNIMCKTKEEKF 659
R GT YM+PE + D+Y+ G++ E++ S ++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGII 236
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 73/303 (24%), Positives = 116/303 (38%), Gaps = 62/303 (20%)
Query: 452 NKIGEGGFGPVYKGLLAD------GTLIAVKQLSAKSKQGNR-EFVNEIGTISAL-QHPH 503
+G G FG V + +AVK L + R ++E+ +S L H +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSL--------------ARALFGPEEHRLKLDWPTRH 549
+V L G C G L+I EY L + E+ L LD
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609
+ +A+G+A+L + +HRD+ A N+LL KI DFGLA+ + D+ +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY---- 201
Query: 610 VAGTFG-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEE 657
V +MAPE T ++DV+S+GI E+ S G +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-----VDSK 256
Query: 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717
+ ++ ++G M P + E +M C D P RP +V
Sbjct: 257 FYKMI-------KEGFRML--SP---EHAPAEMYDIM----KTCWDADPLKRPTFKQIVQ 300
Query: 718 MLE 720
++E
Sbjct: 301 LIE 303
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 83/349 (23%), Positives = 138/349 (39%), Gaps = 75/349 (21%)
Query: 452 NKIGEGGFGPVYKGLLAD--------GTLIAVKQLSAKSKQGNR-EFVNEIGTISAL-QH 501
+GEG FG V T +AVK L + + + + + ++E+ + + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEHRLKLDWPTRH 549
+++ L G C + L +I EY +L + +L
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 609
+ +ARG+ YL S+ K +HRD+ A NVL+ +D KI+DFGLA+ + +
Sbjct: 195 SCAYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY---- 247
Query: 610 VAGTFG-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-------GRSNIMCKTKEE 657
T G +MAPE T ++DV+SFG++ EI + G EE
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EE 301
Query: 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717
F LL ++G+ M+ P SN E +M C P+ RP +V
Sbjct: 302 LFKLL-------KEGHRMD--KP---SNCTNELYMMM----RDCWHAVPSQRPTFKQLVE 345
Query: 718 MLEGRVGVPDIVQDSSVSNKDESKSEAMRKYYQFSIENTASTQSVSTDG 766
L+ IV +S Y + +T+++ +G
Sbjct: 346 DLD------RIVALTSNQEMGYYHHHHHHDY------DIPTTENLYFNG 382
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 19/226 (8%)
Query: 439 RQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTIS 497
+ H+ K+GEGGF V L DG A+K++ +Q E E
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 498 ALQHPHLVKLYGCCIE----GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICI 553
HP++++L C+ ++ L+ + + +L + ++ L + +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA-- 611
GI RGL +H + HRD+K TN+LL + P + D G +
Sbjct: 142 GICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 612 ------GTFGYMAPE---YAMRGHLTDKADVYSFGIVALEIVSGRS 648
T Y APE + ++ DV+S G V ++ G
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQHPHL 504
F KIG+G FG V+KG+ ++A+K + + + E EI +S P++
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
K YG ++ +L +I EYL S L LD I I +GL YLH
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 137
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRVAGTFGYMAPE 620
E K +HRDIKA NVLL + K++DFG+ +L + NT + GT +MAPE
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPE 189
Query: 621 YAMRGHLTDKADVYSFGIVALEIVSG 646
+ KAD++S GI A+E+ G
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARG 215
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQG-NREFVNEIGTISALQHPH 503
+ F+ +++G G G V+K G ++A K + + K + + E+ + P+
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARAL--FGP-EEHRLKLDWPTRHNICIGIARGLA 560
+V YG ++ + E+++ SL + L G E L + I + +GL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-------VSIAVIKGLT 145
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
YL E+ KI+HRD+K +N+L++ K+ DFG++ + ++ ++ V GT YM+PE
Sbjct: 146 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GTRSYMSPE 200
Query: 621 YAMRGHLTDKADVYSFGIVALEIVSGR 647
H + ++D++S G+ +E+ GR
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQHPH 503
+ +++ IG G V +A+K+++ + Q + + + EI +S HP+
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLA----RALFGPEEHRLKLDWPTRHNICIGIARGL 559
+V Y + ++L L+ + L S+ + E LD T I + GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKL-DEEDNTHISTR--VAGTFG 615
YLH+ +HRD+KA N+LL +D + +I+DFG+ A L D T R GT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 616 YMAPEYAMRGHLTD-KADVYSFGIVALEIVSGR 647
+MAPE + D KAD++SFGI A+E+ +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 55/236 (23%), Positives = 97/236 (41%), Gaps = 25/236 (10%)
Query: 428 GLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQ--LSAKSKQG 485
G+DL T + + + + + +IG GG V++ L + A+K L Q
Sbjct: 10 GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 69
Query: 486 NREFVNEIGTISALQHP--HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKL 543
+ NEI ++ LQ +++LY I + ++ E N L L + + +
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSI 124
Query: 544 DWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603
D R + + + +H+ IVH D+K N L+ K+ DFG+A + D
Sbjct: 125 DPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 180
Query: 604 THISTR-VAGTFGYMAPE-----------YAMRGHLTDKADVYSFGIVALEIVSGR 647
T + GT YM PE + ++ K+DV+S G + + G+
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 12/209 (5%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSK-QGNREFVNEIGTI-SALQHP 502
+ + ++G G +G V K + G ++AVK++ A Q + + ++ + P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
V YG + + E + + SL + + + I + I + L +L
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-- 620
H + L ++HRD+K +NVL++ K+ DFG++ + AG YMAPE
Sbjct: 126 HSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERI 181
Query: 621 --YAMRGHLTDKADVYSFGIVALEIVSGR 647
+ + K+D++S GI +E+ R
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 53/245 (21%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQHPH 503
F+ +G GGFG V++ D A+K++ +++ RE + E+ ++ L+HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 504 LVKLYGCCIEGNQ------------LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNI 551
+V+ + +E N L + + +L + G + + +I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHI 123
Query: 552 CIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA 611
+ IA + +LH + ++HRD+K +N+ D K+ DFGL ++D +
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 612 -----------GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIV------SGRSNIMCKT 654
GT YM+PE + K D++S G++ E++ R +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDV 240
Query: 655 KEEKF 659
+ KF
Sbjct: 241 RNLKF 245
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 73/299 (24%), Positives = 117/299 (39%), Gaps = 55/299 (18%)
Query: 452 NKIGEGGFGPVYKGLLAD------GTLIAVKQLSAKSKQGNR-EFVNEIGTISAL-QHPH 503
+G G FG V + +AVK L + ++E+ + + H +
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 504 LVKLYGCC-IEGNQLLLIYEYLENNSL------------ARALFGPEEHRLKLDWPTRHN 550
+V L G C G L++I E+ + +L + + ++ L
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 551 ICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 610
+A+G+ +L + K +HRD+ A N+LL + KI DFGLA+ +D + V
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----V 205
Query: 611 AGTFG-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRS---NIMCKTKEEKFYL 661
+MAPE T ++DV+SFG++ EI S G S + K EE
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV--KIDEEFCRR 263
Query: 662 LDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
L ++G M P E + M L C P+ RP S +V L
Sbjct: 264 L-------KEGTRMR--AP---DYTTPEMYQTM----LDCWHGEPSQRPTFSELVEHLG 306
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 8/209 (3%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQ--LSAKSKQGNREFVNEIGTISALQHP 502
++V IG G +G K +DG ++ K+ + ++ + V+E+ + L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 503 HLVKLYGCCIE--GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
++V+ Y I+ L ++ EY E LA + + R LD + + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 561 YLHE--ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 618
H + ++HRD+K NV LD N K+ DFGLA++ D + T V GT YM+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 619 PEYAMRGHLTDKADVYSFGIVALEIVSGR 647
PE R +K+D++S G + E+ +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 25/218 (11%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQ--LSAKSKQGNREFVNEIGTISALQHP- 502
+ + +IG GG V++ L + A+K L Q + NEI ++ LQ
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 503 -HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
+++LY I + ++ E N L L + + +D R + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHT 123
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR-VAGTFGYMAPE 620
+H+ IVH D+K N L+ K+ DFG+A + D T + GT YM PE
Sbjct: 124 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 621 -----------YAMRGHLTDKADVYSFGIVALEIVSGR 647
+ ++ K+DV+S G + + G+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREF---VNEIGTISALQ 500
F +IG G FG VY + + ++A+K++S KQ N ++ + E+ + L+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
HP+ ++ GC + + L+ EY S + L E H+ L + G +GLA
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLG-SASDLL---EVHKKPLQEVEIAAVTHGALQGLA 168
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
YLH ++HRD+KA N+LL + K+ DFG A + N+ + GT +MAPE
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 220
Query: 621 ---YAMRGHLTDKADVYSFGIVALEIVSG 646
G K DV+S GI +E+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-36
Identities = 74/305 (24%), Positives = 111/305 (36%), Gaps = 61/305 (20%)
Query: 452 NKIGEGGFGPVYKGLLADG------TLIAVKQLSAKSKQGNR-EFVNEIGTISAL-QHPH 503
+G G FG V +AVK L K+ R ++E+ ++ L H +
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSL-------------------ARALFGPEEHRLKLD 544
+V L G C + LI+EY L + EE L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 545 WPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604
+ +A+G+ +L VHRD+ A NVL+ KI DFGLA+ D+
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 605 HISTRVAGTFG-----YMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRS---NIMCKTK 655
+ V +MAPE G T K+DV+S+GI+ EI S G + I
Sbjct: 228 Y----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI--PVD 281
Query: 656 EEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSV 715
+ L+ + G M+ P +E +M C RP ++
Sbjct: 282 ANFYKLI-------QNGFKMD--QP---FYATEEIYIIM----QSCWAFDSRKRPSFPNL 325
Query: 716 VSMLE 720
S L
Sbjct: 326 TSFLG 330
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSK-QGNREFVNEIGTI-SALQHP 502
+IG G +G V K + G ++AVK++ + + ++ + ++ + + P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARAL---FGPEEHRLKLDWPTRHNICIGIARGL 559
++V+ YG + E + + S + + + + + + I + + L
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKAL 138
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 619
+L E LKI+HRDIK +N+LLD+ N K+ DFG++ + ++ TR AG YMAP
Sbjct: 139 NHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRPYMAP 194
Query: 620 E----YAMRGHLTDKADVYSFGIVALEIVSGR 647
E A R ++DV+S GI E+ +GR
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 25/218 (11%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQ--LSAKSKQGNREFVNEIGTISALQHP- 502
+ + +IG GG V++ L + A+K L Q + NEI ++ LQ
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 503 -HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
+++LY I + ++ E N L L + + +D R + + +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHT 170
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR-VAGTFGYMAPE 620
+H+ IVH D+K N L+ K+ DFG+A + D T + G YM PE
Sbjct: 171 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 621 -----------YAMRGHLTDKADVYSFGIVALEIVSGR 647
+ ++ K+DV+S G + + G+
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 22/220 (10%)
Query: 439 RQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSA-KSKQGNREFVNEIGTI 496
++ +A N + ++G G G V+K G +IAVKQ+ +K+ N+ + ++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 497 -SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLA--RALFGP-EEHRLKLDWPTRHNIC 552
+ P++V+ +G I + + E + + + + GP E L +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-------KMT 130
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG 612
+ I + L YL E+ ++HRD+K +N+LLD+ K+ DFG++ + R AG
Sbjct: 131 VAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAG 186
Query: 613 TFGYMAPE-----YAMRGHLTDKADVYSFGIVALEIVSGR 647
YMAPE + +ADV+S GI +E+ +G+
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 68/219 (31%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHP 502
F++ +G G +G VYKG + G L A+K + E EI + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 503 HLVKLYGC------CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIA 556
++ YG +QL L+ E+ S+ + + + LK +W IC I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREIL 139
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRVAG 612
RGL++LH+ K++HRDIK NVLL ++ K+ DFG+ A+LD NT G
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-----FIG 191
Query: 613 TFGYMAPEYAMRGHLTD-----KADVYSFGIVALEIVSG 646
T +MAPE D K+D++S GI A+E+ G
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 2e-34
Identities = 42/222 (18%), Positives = 78/222 (35%), Gaps = 30/222 (13%)
Query: 445 TNHFDVANKIGEG--GFGPVYKGL-LADGTLIAVKQ--LSAKSKQGNREFVNEIGTISAL 499
+++ IG+G V G + V++ L A S + E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 500 QHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHN------ICI 553
HP++V I N+L ++ ++ S + + N I
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAK--------DLICTHFMDGMNELAIAYILQ 135
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG-LAKLDEEDN-----THIS 607
G+ + L Y+H VHR +KA+++L+ D +S +
Sbjct: 136 GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 608 TRVAGTFGYMAPEYAMRGHL--TDKADVYSFGIVALEIVSGR 647
+++PE + K+D+YS GI A E+ +G
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 450 VANKIGEGGFGPVYKGLLADGTL---IAVKQLSAKSKQGNREFV----NEIGTISALQHP 502
+ +K+G GG VY D L +A+K + + E + E+ S L H
Sbjct: 15 IVDKLGGGGMSTVYLAE--DTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQ 71
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
++V + E + L+ EY+E +L+ + E L T N I G+ +
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHA 127
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEY 621
H ++IVHRDIK N+L+D + KI DFG+AK L E T + V GT Y +PE
Sbjct: 128 H---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQ 183
Query: 622 AMRGHLTDKADVYSFGIVALEIVSGR 647
A + D+YS GIV E++ G
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-33
Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 26/234 (11%)
Query: 424 RELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSK 483
E D +T + +I F + +G G G + + D +AVK++
Sbjct: 7 LEQDDGDEETSVVIVGKIS-----FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---P 58
Query: 484 QGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLK 542
+ E+ + +HP++++ + + + E +L + E+
Sbjct: 59 ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYV---EQKDFA 114
Query: 543 LDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL-----DKDLNPKISDFGLAK 597
+ GLA+LH L IVHRD+K N+L+ + ISDFGL K
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 598 LDEEDNTHISTR--VAGTFGYMAPEY---AMRGHLTDKADVYSFGIVALEIVSG 646
S R V GT G++APE + + T D++S G V ++S
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 59/205 (28%), Positives = 83/205 (40%), Gaps = 23/205 (11%)
Query: 453 KIGEGGFGPVYKGLLADGTL---IAVKQLSAKSKQGNREFV----NEIGTISALQHPHLV 505
+G GG G VY+ D +A+K +S + + F E T LQ PH+V
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
++ QL + + LA L GP L P I I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP------LAPPRAVAIVRQIGSALDAAH 151
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYA 622
HRD+K N+L+ D + DFG+A +E T + GT YMAPE
Sbjct: 152 ---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERF 207
Query: 623 MRGHLTDKADVYSFGIVALEIVSGR 647
H T +AD+Y+ V E ++G
Sbjct: 208 SESHATYRADIYALTCVLYECLTGS 232
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 44/210 (20%), Positives = 80/210 (38%), Gaps = 24/210 (11%)
Query: 446 NHFDVANKIGEGGFGPVYKG--LLADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQHP 502
++V I GG G +Y +G + +K L + + E ++ + HP
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHP 139
Query: 503 HLVKLY--GCCIEGNQLLLIY---EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
+V+++ + + + Y EY+ SL R+ L + I
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILP 193
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 617
L+YLH + +V+ D+K N++L ++ K+ D G + GT G+
Sbjct: 194 ALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQ 244
Query: 618 APEYAMRGHLTDKADVYSFGIVALEIVSGR 647
APE R T D+Y+ G +
Sbjct: 245 APEIV-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 71/286 (24%), Positives = 113/286 (39%), Gaps = 32/286 (11%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV-NEIGTISALQHPHL 504
+++ ++G GGFG V + + G +A+KQ + NRE EI + L HP++
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 505 VKLYGCCIE-------GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
V + + LL EY E L + L E + L + I+
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISS 132
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
L YLHE +I+HRD+K N++L + L KI D G AK + + + V GT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFV-GTL 187
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR-------SNIMCKTKEEKFYLLDWALL 667
Y+APE + T D +SFG +A E ++G + K + +
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 668 LKEQGNL---MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP 710
G + L PN S + ++ + L R
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRG 290
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 25/209 (11%)
Query: 453 KIGEGGFGPVYKGLLADGTL---IAVKQLSAKSKQGNREFV----NEIGTISALQHPHLV 505
+G GG V+ D +AVK L A + F E +AL HP +V
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 506 KLY--GCCIEGNQLLLIY---EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
+Y G E L Y EY++ +L + + + + L
Sbjct: 76 AVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALN 130
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI--STRVAGTFGYMA 618
+ H + I+HRD+K N+++ K+ DFG+A+ + + + V GT Y++
Sbjct: 131 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 619 PEYAMRGHLTDKADVYSFGIVALEIVSGR 647
PE A + ++DVYS G V E+++G
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 60/289 (20%), Positives = 108/289 (37%), Gaps = 38/289 (13%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQHPH 503
+ + +++ +G+G V++G G L A+K + S + + E + L H +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 504 LVKLYGC--CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
+VKL+ +LI E+ SL L P + L + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNH 127
Query: 562 LHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 617
L E IVHR+IK N++ D K++DFG A+ ED+ + GT Y+
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYL 182
Query: 618 APEYAMRGHLTD--------KADVYSFGIVALEIVSGR------------SNIMCKTKEE 657
P+ R L D++S G+ +G +M K
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 658 KFYLLDWALLLKEQGNL---MELVDPNLGSNVDKEQVRVMINVALLCAD 703
K + E G + ++ S + + ++ +L AD
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA-NILEAD 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 28/243 (11%)
Query: 429 LDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNR 487
L G F + + + K+G G +G V A+K + K+
Sbjct: 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR-KTSVSTS 78
Query: 488 E---FVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEH 539
+ E+ + L HP+++KLY + L+ E + L R F +
Sbjct: 79 SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA 138
Query: 540 RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLA 596
I + G+ YLH+ IVHRD+K N+LL +KD KI DFGL+
Sbjct: 139 A---------VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 597 KLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKE 656
+ E GT Y+APE +R +K DV+S G++ +++G +T +
Sbjct: 187 AVFENQKKM--KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ 243
Query: 657 EKF 659
E
Sbjct: 244 EIL 246
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 447 HFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKS--KQGNRE-FVNEIGTISALQHP 502
+ +G+GGF ++ + A K + K RE EI +L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
H+V +G + + + ++ E SL + R L P I G YL
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYL 131
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 622
H R +++HRD+K N+ L++DL KI DFGLA E D + GT Y+APE
Sbjct: 132 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL 187
Query: 623 M-RGHLTDKADVYSFGIVALEIVSGR 647
+GH + + DV+S G + ++ G+
Sbjct: 188 SKKGH-SFEVDVWSIGCIMYTLLVGK 212
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 4e-30
Identities = 32/228 (14%), Positives = 66/228 (28%), Gaps = 22/228 (9%)
Query: 439 RQIKAATNHFDVANKIGEGGFGPVYKG------LLADGTLIAVKQLSAKSKQGNREFVNE 492
+ + + V + +GEG F VY+ + +K +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 493 IGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-ARALFGPEEHRLKLDWPTRHNI 551
+ + +K Y + N +L+ E +L + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 552 CIGIARGLAYLHEESRLKIVHRDIKATNVLL-----------DKDLNPKISDFGLAK-LD 599
+ + + +H+ +I+H DIK N +L D + D G + +
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
I T T G+ E + D + ++ G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 447 HFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKS--KQGNRE-FVNEIGTISALQHP 502
+ +G+GGF ++ + A K + K RE EI +L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
H+V +G + + + ++ E SL + R L P I G YL
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYL 157
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 622
H R +++HRD+K N+ L++DL KI DFGLA E D + GT Y+APE
Sbjct: 158 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL 213
Query: 623 M-RGHLTDKADVYSFGIVALEIVSGR 647
+GH + + DV+S G + ++ G+
Sbjct: 214 SKKGH-SFEVDVWSIGCIMYTLLVGK 238
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-30
Identities = 58/289 (20%), Positives = 107/289 (37%), Gaps = 38/289 (13%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQHPH 503
+ + +++ +G+G V++G G L A+K + S + + E + L H +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 504 LVKLYGC--CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
+VKL+ +LI E+ SL L P + L + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNH 127
Query: 562 LHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 617
L E IVHR+IK N++ D K++DFG A+ ED+ + GT Y+
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYL 182
Query: 618 APE--------YAMRGHLTDKADVYSFGIVALEIVSGR------------SNIMCKTKEE 657
P+ + D++S G+ +G +M K
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 658 KFYLLDWALLLKEQGNL---MELVDPNLGSNVDKEQVRVMINVALLCAD 703
K + E G + ++ S + + ++ +L AD
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA-NILEAD 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 50/240 (20%), Positives = 86/240 (35%), Gaps = 25/240 (10%)
Query: 432 QTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV 490
F + ++ V + EGGF VY+ + G A+K+L + ++ NR +
Sbjct: 14 DQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII 73
Query: 491 NEIGTISALQ-HPHLVKLYGCCI-------EGNQLLLIYEYLENNSLARALFGPEEHRLK 542
E+ + L HP++V+ G L+ L L E R
Sbjct: 74 QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLV-EFLKKMESRGP 132
Query: 543 LDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602
L T I R + ++H + I+HRD+K N+LL K+ DFG A
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191
Query: 603 NTHISTRVA-----------GTFGYMAPE---YAMRGHLTDKADVYSFGIVALEIVSGRS 648
+ + T Y PE + +K D+++ G + + +
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 11/212 (5%)
Query: 440 QIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKS--KQGNRE-FVNEIGT 495
I F V N +G+G F VY+ + G +A+K + K+ K G + NE+
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 496 ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGI 555
L+HP +++LY + N + L+ E N + R L + + I
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQI 121
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 615
G+ YLH I+HRD+ +N+LL +++N KI+DFGLA + + T + GT
Sbjct: 122 ITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPN 177
Query: 616 YMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
Y++PE A R ++DV+S G + ++ GR
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 63/244 (25%), Positives = 98/244 (40%), Gaps = 29/244 (11%)
Query: 429 LDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNR 487
L G F ++ + +G+G FG V G AVK +S K + +
Sbjct: 9 LHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQK 67
Query: 488 EFV----NEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEE 538
E+ + L HP+++KLY + L+ E L +R F +
Sbjct: 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 127
Query: 539 HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGL 595
I + G+ Y+H+ KIVHRD+K N+LL KD N +I DFGL
Sbjct: 128 AA---------RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175
Query: 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTK 655
+ E GT Y+APE + G +K DV+S G++ ++SG +
Sbjct: 176 STHFEASKKM--KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANE 232
Query: 656 EEKF 659
+
Sbjct: 233 YDIL 236
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 47/227 (20%), Positives = 91/227 (40%), Gaps = 33/227 (14%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLA--DGTLIAVKQLSAKSKQGNREFV------------- 490
N + + + +G F + L D A+K+ + R+F
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 491 ----NEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLEN----NSLARALFGPEEHRLK 542
NE+ I+ +++ + + G +++ +IYEY+EN + +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 543 LDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602
+ I + +Y+H + I HRD+K +N+L+DK+ K+SDFG ++ +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 603 NTHISTRVAGTFGYMAPEYAMRGHLTD--KADVYSFGIVALEIVSGR 647
S GT+ +M PE+ + K D++S GI +
Sbjct: 206 KIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-29
Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 42/232 (18%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHL 504
N +G G G V G +AVK++ + EI ++ HP++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALF-------GPEEHRLKLDWPTRHNICIGIAR 557
++ Y L + E N L +E+ ++ IA
Sbjct: 72 IRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLD-------------KDLNPKISDFGLAKLDEEDNT 604
G+A+LH LKI+HRD+K N+L+ ++L ISDFGL K + +
Sbjct: 127 GVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 605 HISTR---VAGTFGYMAPE-------YAMRGHLTDKADVYSFGIVALEIVSG 646
T +GT G+ APE + LT D++S G V I+S
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 448 FDVANKIGEGGFGPVYKG-LLADGTLIAVKQLS----AKSKQGNREFVNEIGTISALQHP 502
F++ +G+G FG VY ++A+K L K+ ++ E+ S L+HP
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHP 69
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
++++LYG + ++ LI EY ++ R L + K D +A L+Y
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYC 125
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 622
H +++HRDIK N+LL KI+DFG + + GT Y+ PE
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMI 179
Query: 623 MRGHLTDKADVYSFGIVALEIVSGR 647
+K D++S G++ E + G+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 57/331 (17%), Positives = 111/331 (33%), Gaps = 84/331 (25%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV-NEIGTISALQHPH 503
F+ +G GGFG V++ D A+K++ +++ RE V E+ ++ L+HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 504 LVKLYGCCIEGNQLLL-----------------------IYEYLENNSLARALFGPEEHR 540
+V+ + +E +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 541 LKLDWPTRHNICIG------------IARGLAYLHEESRL------------------KI 570
+ + I + R + E + +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 571 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-----------TRVAGTFGYMAP 619
+HRD+K +N+ D K+ DFGL ++D + T GT YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679
E + + K D++S G++ E++ T+ E+ ++ ++ L
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYS-----FSTQMERVRIIT---------DVRNLKF 291
Query: 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRP 710
P L + ++ +M+ +L PT RP
Sbjct: 292 PLLFTQKYPQE-HMMVQ-DMLSPS--PTERP 318
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-28
Identities = 63/255 (24%), Positives = 104/255 (40%), Gaps = 39/255 (15%)
Query: 428 GLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN 486
G+ + G + ++ + K+G G +G V + A+K + KS+
Sbjct: 18 GIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIK-KSQFDK 76
Query: 487 REFV--------------NEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL--- 529
+ NEI + +L HP+++KL+ + L+ E+ E L
Sbjct: 77 GRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ 136
Query: 530 --ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DK 584
R F + NI I G+ YLH+ IVHRDIK N+LL +
Sbjct: 137 IINRHKFDECDAA---------NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNS 184
Query: 585 DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIV 644
LN KI DFGL+ +D GT Y+APE ++ +K DV+S G++ ++
Sbjct: 185 LLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILL 241
Query: 645 SGRSNIMCKTKEEKF 659
G + ++
Sbjct: 242 CGYPPFGGQNDQDII 256
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE---FVNEIGTISALQ 500
+++ +G+G FG V K AVK ++ K+ N++ + E+ + L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGI 555
HP+++KL+ + + ++ E L R F + I +
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---------RIIKQV 130
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAG 612
G+ Y+H+ IVHRD+K N+LL +KD + KI DFGL+ +++ G
Sbjct: 131 FSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIG 185
Query: 613 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
T Y+APE +RG +K DV+S G++ ++SG K + +
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 446 NHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGNREFV----NEIGTISALQ 500
+ FD+ +G+G FG VY + ++A+K L KS+ EI S L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHLR 72
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
HP+++++Y + ++ L+ E+ L + L + R + + + +A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFD-EQRSATFME-ELADALH 128
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
Y H K++HRDIK N+L+ KI+DFG + T + GT Y+ PE
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPE 182
Query: 621 YAMRGHLTDKADVYSFGIVALEIVSGR 647
+K D++ G++ E + G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 26/205 (12%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV-NEIGTISALQHP 502
F +G G F V+ G L A+K + KS + NEI + ++H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHE 66
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIAR 557
++V L L+ + + L R ++ ++ + +
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS---------LVIQQVLS 117
Query: 558 GLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
+ YLHE IVHRD+K N+L +++ I+DFGL+K+++ + GT
Sbjct: 118 AVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTP 171
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIV 639
GY+APE + + D +S G++
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVI 196
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 445 TNHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGNREFV-NEIGTISALQHP 502
+ F K+G G FG V+ + G +K ++ Q E + EI + +L HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHN--------ICIG 554
+++K++ + + + ++ E E L R+ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----L----ERIVSAQARGKALSEGYVAELMKQ 132
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVA 611
+ LAY H +VH+D+K N+L KI DFGLA+L + D T A
Sbjct: 133 MMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAA 187
Query: 612 GTFGYMAPEYAMRGHLTDKADVYSFGIV 639
GT YMAPE + +T K D++S G+V
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVV 214
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-27
Identities = 26/233 (11%), Positives = 58/233 (24%), Gaps = 41/233 (17%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREF----------------------- 489
+G+ + G V + +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 490 --VNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL-------ENNSLARALFGPEEHR 540
+ I ++ P K+ ++ + ++ + + L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 541 LKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600
L R + + + R LA LH +VH ++ +++LD+ ++ F D
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 601 EDNTHISTRVAGTFGYMAPE-----YAMRGHLTDKADVYSFGIVALEIVSGRS 648
R A +T D ++ G+ I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 9e-27
Identities = 24/235 (10%), Positives = 48/235 (20%), Gaps = 41/235 (17%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE---FVNEIGTISALQHP 502
+ + G V+ + A+K + ++ E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 503 HLVKLYGCC--------------------------IEGNQLLLIYEYLENN--SLARALF 534
+ LL+ + L L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 535 GPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594
R H + + R A L +VH N+ + D + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHL--TDKADVYSFGIVALEIVSGR 647
+ Y E+ T + + G+ +
Sbjct: 240 ALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 46/205 (22%), Positives = 82/205 (40%), Gaps = 26/205 (12%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV-NEIGTISALQHP 502
++ + N IG G +G V + A K++ K + + EI + +L HP
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVEDVDRFKQEIEIMKSLDHP 66
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIAR 557
++++LY + + L+ E L + +F + I +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLS 117
Query: 558 GLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
+AY H+ L + HRD+K N L D K+ DFGLA + GT
Sbjct: 118 AVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTP 172
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIV 639
Y++P+ + G + D +S G++
Sbjct: 173 YYVSPQ-VLEGLYGPECDEWSAGVM 196
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 28/207 (13%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE---FVNEIGTISALQ 500
+++ +G+G FG V K AVK ++ K+ N++ + E+ + L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGI 555
HP+++KL+ + + ++ E L R F + I +
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---------RIIKQV 130
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAG 612
G+ Y+H+ IVHRD+K N+LL +KD + KI DFGL+ +++ G
Sbjct: 131 FSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIG 185
Query: 613 TFGYMAPEYAMRGHLTDKADVYSFGIV 639
T Y+APE +RG +K DV+S G++
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVI 211
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 30/238 (12%), Positives = 66/238 (27%), Gaps = 52/238 (21%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE------------------------ 488
+G+ + G V + +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 489 ----FVNEIGTISALQHPHLVKLYGCC--IEGNQLLLIYEYLENN--SLARALFGPEEHR 540
F+ + Q ++++ + +Y +++N + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 541 LKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600
L R + + + R LA LH +VH ++ +++LD+ ++ F D
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 601 EDNTHISTRVAGTFGYMAPEY-----------AMRGHLTDKADVYSFGIVALEIVSGR 647
+ + G+ PE R +T D ++ G+V I
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 74/245 (30%), Positives = 105/245 (42%), Gaps = 25/245 (10%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN-EIGTISALQHPHLVKLYGCC 511
+GEG +G V + +AVK + K E + EI L H ++VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571
EGN L EY L F E + + P + G+ YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 572 HRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRVAGTFGYMAPE-YAMRGHLT 628
HRDIK N+LLD+ N KISDFGLA + ++ GT Y+APE R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHA 186
Query: 629 DKADVYSFGIVALEIVSGR------SNIM---CKTKEEKFYLLDWALLLKEQGNL---ME 676
+ DV+S GIV +++G S+ KE+K YL W + L +
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 677 LVDPN 681
+ +P+
Sbjct: 247 VENPS 251
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 56/293 (19%)
Query: 434 GSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN- 491
GS N + + ++IG+G +G V D T A+K LS K K +
Sbjct: 1 GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLS-KKKLIRQAGFPR 59
Query: 492 --------------------------EIGTISALQHPHLVKLYGCCIEG---NQLLLIYE 522
EI + L HP++VKL ++ + L +++E
Sbjct: 60 RPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFE 118
Query: 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL 582
+ + + L + +G+ YLH KI+HRDIK +N+L+
Sbjct: 119 LVNQGPV----MEVPTLK-PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLV 170
Query: 583 DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE---YAMRGHLTDKADVYSFGIV 639
+D + KI+DFG++ + + +S GT +MAPE + DV++ G+
Sbjct: 171 GEDGHIKIADFGVSNEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
Query: 640 ALEIVSGR-----SNIMC---KTKEEKFYLLDWALLLKEQGNLME---LVDPN 681
V G+ IMC K K + D + ++ +L+ +P
Sbjct: 230 LYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPE 282
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 50/266 (18%), Positives = 89/266 (33%), Gaps = 54/266 (20%)
Query: 432 QTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVK-----QLSAKSKQG 485
+ F + + + IG+G +G V + + A+K ++ + +
Sbjct: 12 ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71
Query: 486 NREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHR 540
E+ + L HP++ +LY + + L+ E L +
Sbjct: 72 VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131
Query: 541 LKLDWPTRH-------------------------------NICIGIARGLAYLHEESRLK 569
+ + NI I L YLH
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QG 188
Query: 570 IVHRDIKATNVLL--DKDLNPKISDFGLAKL----DEEDNTHISTRVAGTFGYMAPE--Y 621
I HRDIK N L +K K+ DFGL+K + + ++T+ GT ++APE
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLN 247
Query: 622 AMRGHLTDKADVYSFGIVALEIVSGR 647
K D +S G++ ++ G
Sbjct: 248 TTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 49/205 (23%), Positives = 82/205 (40%), Gaps = 15/205 (7%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV------NEIGTIS 497
+ +++ IG+G F V + + G AVK + +K + + E
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVD-VAKFTSSPGLSTEDLKREASICH 81
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
L+HPH+V+L L +++E+++ L + + + I
Sbjct: 82 MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 558 GLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
L Y H+ I+HRD+K VLL + K+ FG+A E RV GT
Sbjct: 142 ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTP 197
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIV 639
+MAPE R DV+ G++
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-25
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH 503
+++D+ ++G G FG V++ + A G + K ++ NEI ++ L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 504 LVKLYGCCIEGNQLLLIYEYL---ENNSLARALF---GPEEHRLKLDWPTRH---NICIG 554
L+ L+ + +++LI E+L E LF E++++ + N
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE-------LFDRIAAEDYKM-----SEAEVINYMRQ 157
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLL-DKDLNP-KISDFGLAKLDEEDNTHISTRVAG 612
GL ++HE IVH DIK N++ K + KI DFGLA D
Sbjct: 158 ACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTA 212
Query: 613 TFGYMAPEYAMRGHLTDKADVYSFGIVA 640
T + APE R + D+++ G++
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 74/245 (30%), Positives = 105/245 (42%), Gaps = 25/245 (10%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN-EIGTISALQHPHLVKLYGCC 511
+GEG +G V + +AVK + K E + EI L H ++VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIV 571
EGN L EY L F E + + P + G+ YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 572 HRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRVAGTFGYMAPE-YAMRGHLT 628
HRDIK N+LLD+ N KISDFGLA + ++ GT Y+APE R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHA 186
Query: 629 DKADVYSFGIVALEIVSGR------SNIM---CKTKEEKFYLLDWALLLKEQGNL---ME 676
+ DV+S GIV +++G S+ KE+K YL W + L +
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 677 LVDPN 681
+ +P+
Sbjct: 247 VENPS 251
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE---FVNEIGTISALQ 500
++++DV ++G+G F V + + G A K ++ K R+ E LQ
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQ 63
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGI 555
HP++V+L+ E + L+++ + L AR + + + I
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---------HCIQQI 114
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAG 612
+AY H IVHR++K N+LL K K++DFGLA + AG
Sbjct: 115 LESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAG 169
Query: 613 TFGYMAPEYAMRGHLTDKADVYSFGIV 639
T GY++PE + + D+++ G++
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVI 196
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 21/223 (9%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV-NEIGTISALQHP 502
+H+D+ ++G G FG V++ A G A K + + ++E V EI T+S L+HP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHP 214
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR----G 558
LV L+ + N++++IYE++ L + + + + R G
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE-------AVEYMRQVCKG 267
Query: 559 LAYLHEESRLKIVHRDIKATNVLL-DKDLNP-KISDFGLAKLDEEDNTHISTRVAGTFGY 616
L ++HE VH D+K N++ K N K+ DFGL + + GT +
Sbjct: 268 LCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEF 322
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659
APE A + D++S G+++ ++SG S + +E
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 365
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 45/221 (20%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN---EIGTISALQHP 502
++ + IG+G F V + G +A+K + K++ E+ + L HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIID-KTQLNPTSLQKLFREVRIMKILNHP 74
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSL--------------ARALFGPEEHRLKLDWPTR 548
++VKL+ L LI EY + AR+ F
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ------------ 122
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 608
I + Y H + +IVHRD+KA N+LLD D+N KI+DFG + +
Sbjct: 123 ------IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE-FTVGGKLDA 172
Query: 609 RVAGTFGYMAPEYAMRGHLTD--KADVYSFGIVALEIVSGR 647
G Y APE +G D + DV+S G++ +VSG
Sbjct: 173 FC-GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 47/216 (21%), Positives = 81/216 (37%), Gaps = 37/216 (17%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV---------NEIG 494
+ + ++ +G G G V +A++ +S K K EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIE 192
Query: 495 TISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRH 549
+ L HP ++K+ + ++ E +E L +
Sbjct: 193 ILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--------- 242
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHI 606
+ + YLHE I+HRD+K NVLL ++D KI+DFG +K+ + + +
Sbjct: 243 LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLM 298
Query: 607 STRVAGTFGYMAPE---YAMRGHLTDKADVYSFGIV 639
T GT Y+APE D +S G++
Sbjct: 299 RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 51/244 (20%), Positives = 97/244 (39%), Gaps = 35/244 (14%)
Query: 417 RPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAV 475
+PK T + + + K +D + IG G V + + A G AV
Sbjct: 65 QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAV 124
Query: 476 KQLSAKSKQGNREFV--------NEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLEN 526
K + +++ + E + E + + HPH++ L + + L+++ +
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK 184
Query: 527 NSL-----ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVL 581
L + +E R +I + +++LH IVHRD+K N+L
Sbjct: 185 GELFDYLTEKVALSEKETR---------SIMRSLLEAVSFLHA---NNIVHRDLKPENIL 232
Query: 582 LDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE------YAMRGHLTDKADVYS 635
LD ++ ++SDFG + E + GT GY+APE + D+++
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWA 290
Query: 636 FGIV 639
G++
Sbjct: 291 CGVI 294
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 22/213 (10%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN---------EIGTI 496
+ + +G G FG V+ + + VK + K K ++ EI +
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 497 SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIA 556
S ++H +++K+ L+ E + LF + +LD P I +
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGS---GLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 616
+ YL I+HRDIK N+++ +D K+ DFG A E T GT Y
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FCGTIEY 195
Query: 617 MAPEYAMRGHLTD--KADVYSFGIVALEIVSGR 647
APE + G+ + +++S G+ +V
Sbjct: 196 CAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 432 QTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE-- 488
+ F + ++++DV ++G+G F V + + G A K ++ K R+
Sbjct: 15 RGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQ 73
Query: 489 -FVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLK 542
E LQHP++V+L+ E + L+++ + L AR + +
Sbjct: 74 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-- 131
Query: 543 LDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 599
+ I +AY H IVHR++K N+LL K K++DFGLA
Sbjct: 132 -------HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-- 179
Query: 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIV 639
E +++ AGT GY++PE + + D+++ G++
Sbjct: 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 48/216 (22%), Positives = 81/216 (37%), Gaps = 37/216 (17%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV---------NEIG 494
+ + ++ +G G G V +A+K +S K K EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIE 67
Query: 495 TISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRH 549
+ L HP ++K+ + ++ E +E L +
Sbjct: 68 ILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--------- 117
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHI 606
+ + YLHE I+HRD+K NVLL ++D KI+DFG +K+ + + +
Sbjct: 118 LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLM 173
Query: 607 STRVAGTFGYMAPE---YAMRGHLTDKADVYSFGIV 639
T GT Y+APE D +S G++
Sbjct: 174 RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTI-SALQHP 502
T+ ++V IG G + + + A AVK + KSK+ E EI + QHP
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTE---EIEILLRYGQHP 76
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIAR 557
+++ L +G + ++ E ++ L + F E + I +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS---------AVLFTITK 127
Query: 558 GLAYLHEESRLKIVHRDIKATNVLL-DKDLNP---KISDFGLAKLDEEDNTHISTRVAGT 613
+ YLH +VHRD+K +N+L D+ NP +I DFG AK +N + T T
Sbjct: 128 TVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YT 183
Query: 614 FGYMAPEYAMRGHLTDKADVYSFGIV 639
++APE R D++S G++
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 45/206 (21%), Positives = 88/206 (42%), Gaps = 24/206 (11%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS-AKSKQGNREFV-NEIGTISALQH 501
T + + ++G+G F V + + + G A ++ K + + + E L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIA 556
P++V+L+ E LI++ + L AR + + + I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---------HCIQQIL 120
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGT 613
+ + H+ + +VHR++K N+LL K K++DFGLA E + GT
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GT 176
Query: 614 FGYMAPEYAMRGHLTDKADVYSFGIV 639
GY++PE + D+++ G++
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVI 202
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 27/205 (13%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV-NEIGTISALQHP 502
++ F+V +++G G VY+ A+K L K +++ V EIG + L HP
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHP 108
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIAR 557
+++KL ++ L+ E + L + + + + I
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA---------DAVKQILE 159
Query: 558 GLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
+AYLHE IVHRD+K N+L D KI+DFGL+K+ E V GT
Sbjct: 160 AVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTP 214
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIV 639
GY APE + D++S GI+
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGII 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 59/238 (24%), Positives = 104/238 (43%), Gaps = 39/238 (16%)
Query: 417 RPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANK--IGEGGFGPVYKGL-LADGTLI 473
P + + R + + G+ + + V+ +G G FG V+K A G +
Sbjct: 66 IPAPPAPFDHRIVTAKQGAVN--------SFYTVSKTEILGGGRFGQVHKCEETATGLKL 117
Query: 474 AVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL---ENNSLA 530
A K + + + E NEI ++ L H +L++LY N ++L+ EY+ E
Sbjct: 118 AAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE----- 172
Query: 531 RALFG---PEEHRLKLDWPTRH---NICIGIARGLAYLHEESRLKIVHRDIKATNVLL-D 583
LF E + L T I G+ ++H+ + I+H D+K N+L +
Sbjct: 173 --LFDRIIDESYNL-----TELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVN 222
Query: 584 KDLNP-KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVA 640
+D KI DFGLA+ + + GT ++APE ++ D++S G++A
Sbjct: 223 RDAKQIKIIDFGLARR-YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 26/216 (12%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTI--------- 496
+ + +G+GGFG V+ G L D +A+K + +++ +++ T
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 497 --SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIG 554
+ HP +++L +L+ E A+ LF + L
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLP---AQDLFDYITEKGPLGEGPSRCFFGQ 147
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTRVAGT 613
+ + + H +VHRDIK N+L+D K+ DFG L ++ GT
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGT 201
Query: 614 FGYMAPEYAMRGHLTD--KADVYSFGIVALEIVSGR 647
Y PE+ + H A V+S GI+ ++V G
Sbjct: 202 RVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 48/223 (21%), Positives = 86/223 (38%), Gaps = 36/223 (16%)
Query: 439 RQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVK--------QLSAKSKQGNREF 489
+++ +G G V + + AVK SA+ Q RE
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 490 V-NEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLK 542
E+ + + HP++++L L+++ ++ L + +E R
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-- 127
Query: 543 LDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602
I + + LH+ L IVHRD+K N+LLD D+N K++DFG + +
Sbjct: 128 -------KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 603 NTHISTRVAGTFGYMAPE------YAMRGHLTDKADVYSFGIV 639
+ GT Y+APE + D++S G++
Sbjct: 178 EK-LREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 68/230 (29%), Positives = 96/230 (41%), Gaps = 42/230 (18%)
Query: 439 RQIKAATNHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLS---AKSKQGNREFVNE-- 492
I N F V IG GGFG VY AD G + A+K L K KQG +NE
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 493 -IGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEH 539
+ +S P +V + ++L I + + L A F E
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE- 300
Query: 540 RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599
I GL ++H +V+RD+K N+LLD+ + +ISD GLA
Sbjct: 301 ---------------IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKA-DVYSFGIVALEIVSGRS 648
+ H V GT GYMAPE +G D + D +S G + +++ G S
Sbjct: 343 SKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 33/238 (13%)
Query: 420 YTSERELRGLDLQTGSFTLRQIKAATNHFDVANK-IGEGGFGPVYKGL-LADGTLIAVKQ 477
+ G+DL T + + ++ N + + +K +G G F V + + + G A K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF 61
Query: 478 LS-AKSKQGNREFV-NEIGTISALQH-PHLVKLYGCCIEGNQLLLIYEYL---ENNSLAR 531
L + Q R + +EI + + P ++ L+ ++++LI EY E
Sbjct: 62 LKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE------ 115
Query: 532 ALFGPEEHRLKLDWPTRH------NICIGIARGLAYLHEESRLKIVHRDIKATNVLL--- 582
+F + + I G+ YLH+ IVH D+K N+LL
Sbjct: 116 -IF----SLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSI 167
Query: 583 DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVA 640
+ KI DFG+++ + + GT Y+APE +T D+++ GI+A
Sbjct: 168 YPLGDIKIVDFGMSRK-IGHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVK-----QLSAKSKQGNREFV-NEIGTIS 497
+H+++ ++G G F V K G A K +LS+ + +RE + E+ +
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNIC 552
++HP+++ L+ ++LI E + L + +E
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT---------QFL 114
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHIST 608
I G+ YLH +I H D+K N++L + K+ DFG+A E N
Sbjct: 115 KQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--K 169
Query: 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVA 640
+ GT ++APE L +AD++S G++
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 38/206 (18%), Positives = 81/206 (39%), Gaps = 26/206 (12%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV-NEIGTISALQHP 502
+ +A +G G FG V++ + + K + K ++ V EI ++ +H
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHR 61
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPE------EHRLKLDWPTRHNICIGIA 556
+++ L+ +L++I+E++ G + +L+ + +
Sbjct: 62 NILHLHESFESMEELVMIFEFIS---------GLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLL--DKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
L +LH I H DI+ N++ + KI +FG A+ + + +
Sbjct: 113 EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAP 167
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVA 640
Y APE ++ D++S G +
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN-------EIGTISA 498
+ V +G GGFG VY G+ ++D +A+K + K + + + E+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKK 102
Query: 499 LQH--PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIA 556
+ +++L + +LI E E + LF R L + +
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVL 159
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRVAGTFG 615
+ + H ++HRDIK N+L+D + K+ DFG L ++ GT
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRV 213
Query: 616 YMAPEYAMRGHLTD--KADVYSFGIVALEIVSGR 647
Y PE+ +R H A V+S GI+ ++V G
Sbjct: 214 YSPPEW-IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 26/197 (13%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPHLVKLYGC 510
+GEG F K + AVK +S K + N + EI + + HP++VKL+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQ--KEITALKLCEGHPNIVKLHEV 74
Query: 511 CIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+ L+ E L L + F E I + ++++H+
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS---------YIMRKLVSAVSHMHD- 124
Query: 566 SRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 622
+ +VHRD+K N+L + +L KI DFG A+L DN + T T Y APE
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 623 MRGHLTDKADVYSFGIV 639
+ + D++S G++
Sbjct: 182 NQNGYDESCDLWSLGVI 198
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 437 TLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVK-----QLSAKSKQGNREFV 490
T+ + + +++D ++G G F V K + G A K + + + +RE +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 491 -NEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLD 544
E+ + +QHP+++ L+ ++LI E + L + EE
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT---- 117
Query: 545 WPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDE 600
I G+ YLH L+I H D+K N++L KI DFGLA +
Sbjct: 118 -----EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVA 640
N + GT ++APE L +AD++S G++
Sbjct: 170 FGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-23
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVK-----QLSAKSKQGNREFV-NEIGTIS 497
+ +D+ ++G G F V K + G A K Q A + +RE + E+ +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNIC 552
+ H +++ L+ ++LI E + L + EE +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------SFI 121
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLL-DKDLNP---KISDFGLAKLDEEDNTHIST 608
I G+ YLH KI H D+K N++L DK++ K+ DFGLA E+
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--K 176
Query: 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVA 640
+ GT ++APE L +AD++S G++
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-23
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 30/212 (14%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVK-----QLSAKSKQGNREFV-NEIGTIS 497
+ +D+ ++G G F V K + G A K Q A + RE + E+ +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNIC 552
+ HP+++ L+ ++LI E + L + EE +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------SFI 121
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHIST 608
I G+ YLH KI H D+K N++L + K+ DFGLA E+
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--K 176
Query: 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVA 640
+ GT ++APE L +AD++S G++
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 42/156 (26%), Positives = 81/156 (51%), Gaps = 13/156 (8%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN-----EIGTISALQH 501
++ + +GEG F VYK ++A+K++ + ++ +N EI + L H
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P+++ L + + L+++++E + L + +++ L L + +GL Y
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMETD-LEVII---KDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597
LH+ I+HRD+K N+LLD++ K++DFGLAK
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 56/222 (25%), Positives = 83/222 (37%), Gaps = 39/222 (17%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN-----EIGTISALQHPHLVKL 507
+GEG +G V + L AVK L K K EI + L+H ++++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILK-KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 508 YG--CCIEGNQLLLIYEYLENNSLARALFGPEE-------HRLKLDWPTRHNICIGIARG 558
E ++ ++ EY G +E R + H + G
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVC--------GMQEMLDSVPEKRFPVC--QAHGYFCQLIDG 121
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE--DNTHISTRVAGTFGY 616
L YLH IVH+DIK N+LL KIS G+A+ + T G+ +
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAF 177
Query: 617 MAPEYAMRGHLTD--KADVYSFGIVALEIVSGR-----SNIM 651
PE A K D++S G+ I +G NI
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY 219
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 50/179 (27%), Positives = 87/179 (48%), Gaps = 18/179 (10%)
Query: 448 FDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGN-REFVN-----EIGTISALQH 501
+ K+GEG +G VYK + G ++A+K + + E + EI + L H
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALK----RIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P++V L L L++E++E + L + L +E++ L + RG+A+
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
H+ +I+HRD+K N+L++ D K++DFGLA+ + V T Y AP+
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPD 189
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 47/177 (26%), Positives = 87/177 (49%), Gaps = 10/177 (5%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQG-NREFVNEIGTISALQHPH 503
+ +K+GEG + VYKG L+A+K++ + ++G + E+ + L+H +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+V L+ L L++EYL+ + L + L ++ ++ + RGLAY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
+ K++HRD+K N+L+++ K++DFGLA+ V T Y P+
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPD 170
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-22
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL 504
+ IG G FG V++ L + +A+K++ + NR E+ + ++HP++
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94
Query: 505 VKLYGCCIEGNQ------LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
V L L L+ EY+ + RA + + + + R
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK--LDEEDNTH-ISTRVAGTF 614
LAY+H + I HRDIK N+LLD K+ DFG AK + E N I +R
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY---- 206
Query: 615 GYMAPEYAMRG--HLTDKADVYSFGIVALEIVSGR 647
Y APE + G + T D++S G V E++ G+
Sbjct: 207 -YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 18/179 (10%)
Query: 448 FDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGN-REFVN-----EIGTISALQH 501
+ KIGEG +G VYK G A+K K + E + EI + L+H
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALK----KIRLEKEDEGIPSTTIREISILKELKH 59
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
++VKLY +L+L++E+L+ + L + L + L+ T + + + G+AY
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
H+ +++HRD+K N+L++++ KI+DFGLA+ + + T Y AP+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN-REFVN-----EIGTISA 498
++ +GEG +G V K G ++A+K K + + + V EI +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 499 LQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
L+H +LV L C + + L++E++++ + L E LD+ I G
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDL---ELFPNGLDYQVVQKYLFQIING 136
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 618
+ + H I+HRDIK N+L+ + K+ DFG A+ VA T Y A
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRA 192
Query: 619 PEYAMRGHLTDKA-DVYSFG-IVALEIVSGR 647
PE + KA DV++ G +V E+ G
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVT-EMFMGE 222
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN----EIGTISALQHPHLVKLY 508
+G G FG V G G +AVK L+ + K + + V EI + +HPH++KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 509 GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRL 568
++ EY+ LF +++ + I + Y H R
Sbjct: 78 QVISTPTDFFMVMEYVSGGE----LFDYICKHGRVEEMEARRLFQQILSAVDYCH---RH 130
Query: 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLT 628
+VHRD+K NVLLD +N KI+DFGL+ + D + T G+ Y APE + G L
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRT-SCGSPNYAAPE-VISGRLY 187
Query: 629 D--KADVYSFGIVALEIVSGR 647
+ D++S G++ ++ G
Sbjct: 188 AGPEVDIWSCGVILYALLCGT 208
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 445 TNHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH 503
+ F V G+G FG V G G +A+K++ + NRE + + ++ L HP+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 504 LVKLYGCCIEGNQ-------LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICI--- 553
+V+L + L ++ EY+ + L R ++ P I +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAP--PPIL-IKVFLF 136
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKL--DEEDNTH-IS 607
+ R + LH S + + HRDIK NVL+++ L K+ DFG AK E N I
Sbjct: 137 QLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYIC 193
Query: 608 TRVAGTFGYMAPEYAMRG--HLTDKADVYSFGIVALEIVSGR 647
+R Y APE + G H T D++S G + E++ G
Sbjct: 194 SRY-----YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 47/158 (29%), Positives = 83/158 (52%), Gaps = 8/158 (5%)
Query: 443 AATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQG-NREFVNEIGTISALQ 500
++++ F K+G G + VYKGL G +A+K++ S++G + EI + L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRH--NICIGIARG 558
H ++V+LY N+L L++E+++N+ L + + + +G
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596
LA+ HE KI+HRD+K N+L++K K+ DFGLA
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 46/182 (25%), Positives = 82/182 (45%), Gaps = 19/182 (10%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN-REFVN-----EIGTISA 498
++ KIGEG +G V+K G ++A+K K + + EI +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 499 LQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
L+HP+LV L +L L++EY ++ + L + ++ + +I +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHEL---DRYQRGVPEHLVKSITWQTLQA 114
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 618
+ + H+ +HRD+K N+L+ K K+ DFG A+L + + VA T Y +
Sbjct: 115 VNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRS 170
Query: 619 PE 620
PE
Sbjct: 171 PE 172
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 43/180 (23%), Positives = 84/180 (46%), Gaps = 19/180 (10%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN-REFVN-----EIGTISALQ 500
++ KIGEG +G V+K ++A+K + + + E V EI + L+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALK----RVRLDDDDEGVPSSALREICLLKELK 59
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
H ++V+L+ +L L++E+ + + L + + LD + + +GL
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
+ H ++HRD+K N+L++++ K+++FGLA+ S V T Y P+
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPD 171
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-21
Identities = 38/147 (25%), Positives = 58/147 (39%), Gaps = 30/147 (20%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG--PEATLPDLRN 62
N+LSG+ + + L L IS G P L L+
Sbjct: 232 GNKLSGDFSRAISTC------------------TELKLLNISSNQFVGPIPPLPLKSLQY 273
Query: 63 RTFKNLILRSCNLTGELPHFL-GEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGN 121
L L TGE+P FL G + LDLS N G +P F + ++ + L+ N
Sbjct: 274 -----LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 122 LLTGKVPQWMFGRGP--ENIDLSYNNF 146
+G++P + + +DLS+N F
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEF 355
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-20
Identities = 46/148 (31%), Positives = 66/148 (44%), Gaps = 29/148 (19%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLP-DLRNR 63
N SGELPE L +L S SL L +S +GP + +L
Sbjct: 352 FNEFSGELPESLTNL-----------------SASLLTLDLSSNNFSGP---ILPNLCQN 391
Query: 64 TFKNL---ILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTG 120
L L++ TG++P L SE+ L LSFN L+GTIP S L+ + + L
Sbjct: 392 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451
Query: 121 NLLTGKVPQWMFGRGP--ENIDLSYNNF 146
N+L G++PQ E + L +N+
Sbjct: 452 NMLEGEIPQE-LMYVKTLETLILDFNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-18
Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 32/150 (21%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG--PE--ATLP 58
+Q+N +G++P L + L L +S L+G P +L
Sbjct: 401 LQNNGFTGKIPPTLSNCS------------------ELVSLHLSFNYLSGTIPSSLGSLS 442
Query: 59 DLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYL 118
LR+ L L L GE+P L V ++ L L FN L G IP + ++++I L
Sbjct: 443 KLRD-----LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497
Query: 119 TGNLLTGKVPQWMFGRGPE--NIDLSYNNF 146
+ N LTG++P+W GR + LS N+F
Sbjct: 498 SNNRLTGEIPKW-IGRLENLAILKLSNNSF 526
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-17
Identities = 31/145 (21%), Positives = 64/145 (44%), Gaps = 30/145 (20%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLPDLRNRT 64
N++SG++ + + +L L +S + +P L + +
Sbjct: 187 GNKISGDVD--VSRCV------------------NLEFLDVSSNNFSTG---IPFLGDCS 223
Query: 65 F-KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLL 123
++L + L+G+ + +E+K+L++S N+ G IP L + ++ L N
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKF 281
Query: 124 TGKVPQWMFGRGP--ENIDLSYNNF 146
TG++P ++ G +DLS N+F
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHF 306
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-17
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 32/153 (20%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG--PEATLPDLRN 62
N LSG +P LGSL L DL++ L G P+ L ++
Sbjct: 427 FNYLSGTIPSSLGSL------------------SKLRDLKLWLNMLEGEIPQ-ELMYVKT 467
Query: 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL 122
+ LIL +LTGE+P L + + + LS N+L G IP+ RL ++ + L+ N
Sbjct: 468 --LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 123 LTGKVPQWMFGRGP--ENIDLSYNNFADESSGS 153
+G +P G +DL+ N F +G+
Sbjct: 526 FSGNIPAE-LGDCRSLIWLDLNTNLF----NGT 553
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-16
Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 29/148 (19%)
Query: 6 QSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG--PEATLPDLR 61
SN+ G +P SL L +++ G P+
Sbjct: 255 SSNQFVGPIPPLPLK--------------------SLQYLSLAENKFTGEIPDFLSGACD 294
Query: 62 NRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIP-ESFARLADVDFIYLTG 120
L L + G +P F G S ++ L LS N +G +P ++ ++ + + L+
Sbjct: 295 T--LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352
Query: 121 NLLTGKVPQWMFGRGP--ENIDLSYNNF 146
N +G++P+ + +DLS NNF
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNF 380
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-16
Identities = 40/149 (26%), Positives = 64/149 (42%), Gaps = 29/149 (19%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLPD-LRN- 62
N+ +GE+P+ L + LT L +S G +P +
Sbjct: 278 ENKFTGEIPDFLSGACDT-----------------LTGLDLSGNHFYGA---VPPFFGSC 317
Query: 63 RTFKNLILRSCNLTGELP-HFLGEVSEMKVLDLSFNKLNGTIPESFARL-ADVDFIYLTG 120
++L L S N +GELP L ++ +KVLDLSFN+ +G +PES L A + + L+
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 121 NLLTGKVPQWMFGRGPEN---IDLSYNNF 146
N +G + + + L N F
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGF 406
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-16
Identities = 30/152 (19%), Positives = 54/152 (35%), Gaps = 14/152 (9%)
Query: 5 VQSNRLSGELPEELGSL-------IHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATL 57
+ +N +G +P + +GK + + + + + + L
Sbjct: 545 LNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVY---IKNDGMKKECHGAGNLLEFQGIRS 601
Query: 58 PDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFI 116
L T + S G M LD+S+N L+G IP+ + + +
Sbjct: 602 EQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFIL 661
Query: 117 YLTGNLLTGKVPQWMFG--RGPENIDLSYNNF 146
L N ++G +P G RG +DLS N
Sbjct: 662 NLGHNDISGSIPD-EVGDLRGLNILDLSSNKL 692
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-15
Identities = 43/179 (24%), Positives = 70/179 (39%), Gaps = 32/179 (17%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLPD-LR 61
+ N L GE+P+EL + ++L L + L G +P L
Sbjct: 449 LWLNMLEGEIPQELMYV------------------KTLETLILDFNDLTGE---IPSGLS 487
Query: 62 NRTFKNLI---LRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYL 118
N NL L + LTGE+P ++G + + +L LS N +G IP + ++ L
Sbjct: 488 N--CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 545
Query: 119 TGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGSNSTGIVS 177
NL G +P MF + + ++ N A + +G + GI S
Sbjct: 546 NTNLFNGTIPAAMFKQ---SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS 601
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-14
Identities = 33/154 (21%), Positives = 66/154 (42%), Gaps = 16/154 (10%)
Query: 6 QSNRLSGELPEELGSLIHSGKWFGWAN----------SVWHYFSESLTDLRISDLNGPE- 54
+N ++G+ + + + G N + + + ++ G
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625
Query: 55 ATLPDLRNRTFKNLILRSCN-LTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADV 113
T + + F ++ S N L+G +P +G + + +L+L N ++G+IP+ L +
Sbjct: 626 PTFDNNGSMMFLDM---SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682
Query: 114 DFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNF 146
+ + L+ N L G++PQ M IDLS NN
Sbjct: 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 8e-11
Identities = 26/109 (23%), Positives = 47/109 (43%), Gaps = 7/109 (6%)
Query: 44 DLRISDLNGPEATLPD-LRNRTF-KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNG 101
DL LN + + L + T ++L L + ++ G + F + + LDLS N L+G
Sbjct: 56 DLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF-KCSASLTSLDLSRNSLSG 114
Query: 102 TIPE--SFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNF 146
+ S + + F+ ++ N L + E +DLS N+
Sbjct: 115 PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-10
Identities = 34/149 (22%), Positives = 61/149 (40%), Gaps = 31/149 (20%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLPDLRNRT 64
++ ++G + SLT L +S L+GP TL L + +
Sbjct: 86 NSHINGSVSG-FKCS------------------ASLTSLDLSRNSLSGPVTTLTSLGSCS 126
Query: 65 F-KNLILRSCNLTGELP-HFLGEVSEMKVLDLSFNKLNGTIPESFAR---LADVDFIYLT 119
K L + S L +++ ++VLDLS N ++G + ++ + ++
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186
Query: 120 GNLLTGKVPQWMFGRGP--ENIDLSYNNF 146
GN ++G V R E +D+S NNF
Sbjct: 187 GNKISGDVD---VSRCVNLEFLDVSSNNF 212
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-08
Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 7/96 (7%)
Query: 68 LILRSCNLT---GELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLT 124
+ L S L + L ++ ++ L LS + +NG++ F A + + L+ N L+
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLS 113
Query: 125 GKVPQWM-FGRGP--ENIDLSYNNFADESSGSDCQN 157
G V G + +++S N S
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK 149
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-08
Identities = 34/122 (27%), Positives = 52/122 (42%), Gaps = 32/122 (26%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRIS--DLNG--PEATLPDLRN 62
N LSG +P+E+GS+ L L + D++G P+ + DLR
Sbjct: 641 YNMLSGYIPKEIGSM------------------PYLFILNLGHNDISGSIPD-EVGDLRG 681
Query: 63 RTFKNLILRSCN-LTGELPHFLGEVSEMKVLDLSFNKLNGTIPES--FARLADVDFIYLT 119
+L S N L G +P + ++ + +DLS N L+G IPE F F+
Sbjct: 682 LNILDL---SSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFL--- 735
Query: 120 GN 121
N
Sbjct: 736 NN 737
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAK---SKQGNREFVNEIGTISALQH 501
+ F +G GGFG V+ + G L A K+L+ K ++G + + E ++ +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 502 PHLVKLYGCCIEGNQLLLIYEY---------LENNSLARALFGPEEHRLKLDWPTRHNIC 552
+V L L L+ + N F +E R
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF--QEPR------AIFYTA 296
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG 612
I GL +LH+ I++RD+K NVLLD D N +ISD GLA + T G
Sbjct: 297 -QIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-G 351
Query: 613 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
T G+MAPE + D ++ G+ E+++ R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 56/212 (26%), Positives = 82/212 (38%), Gaps = 44/212 (20%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
+D IG G FG L+AVK + + + EI +L+HP++V
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIV 79
Query: 506 KLYGCCIEGNQLLLIYEYLENNSL--------------ARALFGPEEHRLKLDWPTRHNI 551
+ + L +I EY L AR F + +
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF-------------QQLL 126
Query: 552 CIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP--KISDFGLAKLDEEDNTHISTR 609
G++Y H ++I HRD+K N LLD P KI DFG +K + +
Sbjct: 127 S-----GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 177
Query: 610 VAGTFGYMAPEYAMRGHLTD--KADVYSFGIV 639
V GT Y+APE + D ADV+S G+
Sbjct: 178 V-GTPAYIAPE-VLLRQEYDGKIADVWSCGVT 207
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 445 TNHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH 503
+ IG G FG VY+ L D G L+A+K++ + NRE + + L H +
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCN 108
Query: 504 LVKLYGCCIEGNQ------LLLIYEYLENNSLARALFGPEEHRLKLDWPTRH--NICIGI 555
+V+L + L L+ +Y+ + R + L P + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTL--PVIYVKLYMYQL 165
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK--LDEEDNTH-ISTRVA 611
R LAY+H I HRDIK N+LLD D K+ DFG AK + E N I +R
Sbjct: 166 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 221
Query: 612 GTFGYMAPEYAMRG--HLTDKADVYSFGIVALEIVSGR 647
Y APE + G T DV+S G V E++ G+
Sbjct: 222 ----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 23/201 (11%), Positives = 48/201 (23%), Gaps = 45/201 (22%)
Query: 453 KIGEGGFGPVYKGLLADGTL---IAVKQL---SAKSKQGNREFVNEIGTISALQHPHLVK 506
G ++ L D L +A+ + +E ++ +S + P + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
+ L++ E++ SL +A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAH--- 146
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH 626
R + + V + D G L M
Sbjct: 147 RAGVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA------ 179
Query: 627 LTDKADVYSFGIVALEIVSGR 647
+ D+ G ++ R
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFV----NEIGTISALQ 500
+HF++ IG+G FG V D + A+K ++ K K R V E+ + L+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQGLE 73
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLEN----NSLARALFGPEEHRLKLDWPTRHNIC-IGI 555
HP LV L+ + + ++ + L L + + EE + IC + +
Sbjct: 74 HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-------VKLFICELVM 126
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 615
A L YL +I+HRD+K N+LLD+ + I+DF +A + + + +AGT
Sbjct: 127 A--LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKP 179
Query: 616 YMAPE----YAMRGHLTDKA-DVYSFGIVALEIVSGRS 648
YMAPE G+ A D +S G+ A E++ GR
Sbjct: 180 YMAPEMFSSRKGAGY--SFAVDWWSLGVTAYELLRGRR 215
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 71/267 (26%), Positives = 114/267 (42%), Gaps = 59/267 (22%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN----EIGTISALQH 501
H+ + + +G G FG V G G +AVK L+ + K + + V EI + +H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSL--------------ARALFGPEEHRLKLDWPT 547
PH++KLY + + ++ EY+ L +R LF
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF------------- 122
Query: 548 RHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 607
+ + G+ Y H R +VHRD+K NVLLD +N KI+DFGL+ + D +
Sbjct: 123 QQILS-----GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLR 173
Query: 608 TRVAGTFGYMAPEYAMRGHLTD--KADVYSFGIVALEIVSGR-----SNIMC---KTKEE 657
T G+ Y APE + G L + D++S G++ ++ G ++ K +
Sbjct: 174 TSC-GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG 231
Query: 658 KFYLLDWALLLKEQGNL---MELVDPN 681
FY + L +L M VDP
Sbjct: 232 IFYTPQY--LNPSVISLLKHMLQVDPM 256
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 71/248 (28%), Positives = 107/248 (43%), Gaps = 36/248 (14%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN----EIGTISALQHPHLVKLY 508
+GEG FG V +A+K +S + + EI + L+HPH++KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 509 GCCIEGNQLLLIYEYL--ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
++++ EY E LF + ++ I + Y H
Sbjct: 76 DVITTPTDIVMVIEYAGGE-------LFDYIVEKKRMTEDEGRRFFQQIICAIEYCH--- 125
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH 626
R KIVHRD+K N+LLD +LN KI+DFGL+ + D + T G+ Y APE + G
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKT-SCGSPNYAAPE-VINGK 182
Query: 627 LTD--KADVYSFGIVALEIVSGR-----SNIMC---KTKEEKFYLLDWALLLKEQGNL-- 674
L + DV+S GIV ++ GR I K + + D+ L +L
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF--LSPGAQSLIR 240
Query: 675 -MELVDPN 681
M + DP
Sbjct: 241 RMIVADPM 248
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN-REFVN-----EIGTISALQ 500
F KIGEG +G VYK G ++A+K K + E V EI + L
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALK----KIRLDTETEGVPSTAIREISLLKELN 60
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLK-LDWPTRHNICIGIARGL 559
HP++VKL N+L L++E+L + L + + + L + P + + +GL
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 619
A+ H +++HRD+K N+L++ + K++DFGLA+ + V T Y AP
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 172
Query: 620 E 620
E
Sbjct: 173 E 173
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 63/234 (26%), Positives = 97/234 (41%), Gaps = 36/234 (15%)
Query: 431 LQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLS----AKS 482
LQ + K F +GEG F V LA A+K L K
Sbjct: 15 LQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVV---LARELATSREYAIKILEKRHIIKE 71
Query: 483 KQGNREFVN-EIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARAL-----FGP 536
+ +V E +S L HP VKLY + +L Y +N L + + F
Sbjct: 72 NK--VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-D 128
Query: 537 EEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596
E TR I L YLH I+HRD+K N+LL++D++ +I+DFG A
Sbjct: 129 ETC-------TRFYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTA 177
Query: 597 KLDEEDNTHISTR-VAGTFGYMAPEYAM-RGHLTDKA-DVYSFGIVALEIVSGR 647
K+ ++ GT Y++PE + K+ D+++ G + ++V+G
Sbjct: 178 KVLSPESKQARANSFVGTAQYVSPELLTEKSA--CKSSDLWALGCIIYQLVAGL 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 24/162 (14%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN-REFVN-----EIGTISALQ 500
+ K+GEG +G VYK + +A+K + + + E V E+ + LQ
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIK----RIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
H ++++L ++L LI+EY EN+ L + + + + + + G+
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEND-LKKYM----DKNPDVSMRVIKSFLYQLINGVN 146
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNP-----KISDFGLAK 597
+ H + +HRD+K N+LL KI DFGLA+
Sbjct: 147 FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 35/196 (17%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS-AKSKQGNREF----VNEIGTISAL 499
+ ++ KIG+G FG V+K G +A+K++ K+G F + EI + L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 500 QHPHLVKLYGCCIE--------GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNI 551
+H ++V L C + L++++ E++ LA L +K +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRV 129
Query: 552 CIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-------KLDEEDNT 604
+ GL Y+H KI+HRD+KA NVL+ +D K++DFGLA T
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 605 HISTRVAGTFGYMAPE 620
+ RV T Y PE
Sbjct: 187 N---RVV-TLWYRPPE 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 5e-20
Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 22/184 (11%)
Query: 453 KIGEGGFGPVYKG---LLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYG 509
K+G G +G VYK D A+KQ+ + + EI + L+HP+++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELKHPNVISLQK 85
Query: 510 CCIE--GNQLLLIYEYLEN--NSLARALFGPEEHRLKLDWPTRHNICIG--IARGLAYLH 563
+ ++ L+++Y E+ + + + ++ + P + I G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 564 EESRLKIVHRDIKATNVLLDKDLNP----KISDFGLAKL---DEEDNTHISTRVAGTFGY 616
++HRD+K N+L+ + KI+D G A+L + + V TF Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 617 MAPE 620
APE
Sbjct: 202 RAPE 205
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 6e-20
Identities = 64/221 (28%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAK---SKQGNREFVNEIGTISALQH 501
N F +G+GGFG V + G + A K+L K ++G +NE + +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSL--------------ARALFGPEEHRLKLDWPT 547
+V L + L L+ + L ARA+F E
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE--------- 294
Query: 548 RHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 607
I GL LH E +IV+RD+K N+LLD + +ISD GLA + I
Sbjct: 295 -------ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIK 343
Query: 608 TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
RV GT GYMAPE T D ++ G + E+++G+S
Sbjct: 344 GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 45/185 (24%), Positives = 69/185 (37%), Gaps = 32/185 (17%)
Query: 454 IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFV-NEIGTISALQ-HPHLVKLYGC 510
+GEG V + L AVK + K R V E+ + Q H ++++L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 511 CIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
E ++ L++E + S+ R F E + +A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---------VVVQDVASALDFLHN- 129
Query: 566 SRLKIVHRDIKATNVLL---DKDLNPKISDFGLAK-------LDEEDNTHISTRVAGTFG 615
I HRD+K N+L ++ KI DF L + T G+
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAE 186
Query: 616 YMAPE 620
YMAPE
Sbjct: 187 YMAPE 191
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 52/229 (22%), Positives = 86/229 (37%), Gaps = 39/229 (17%)
Query: 425 ELRGLDLQTGSFTLRQIKAATNHFDVANK-IGEGGFGPVYKGL-LADGTLIAVKQLSAKS 482
+G + + + T + + ++ + +G G G V + G A+K L S
Sbjct: 15 LFQGPEPKKYAVT--------DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-DS 65
Query: 483 KQGNREFVNEIGTISALQHPHLVKLYGCC----IEGNQLLLIYEYLENNSL-----ARAL 533
+ +E + A PH+V + LL+I E +E L R
Sbjct: 66 PKARQEV--DH-HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD 122
Query: 534 FGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKI 590
E I I + +LH I HRD+K N+L +KD K+
Sbjct: 123 QAFTEREAA-------EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 591 SDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIV 639
+DFG AK ++ + T T Y+APE D++S G++
Sbjct: 173 TDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 5e-19
Identities = 65/241 (26%), Positives = 101/241 (41%), Gaps = 35/241 (14%)
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRH---NICIGIAR 557
P +K I +Q ++E SL+ L D+ T +A+
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGY 616
G+ +L SR K +HRD+ A N+LL + KI DFGLA+ +D ++ A +
Sbjct: 205 GMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVS-GRS---NIMCKTKEEKFYLLDWALLLKEQG 672
MAPE T ++DV+SFG++ EI S G S + K EE L ++G
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV--KIDEEFCRRL-------KEG 312
Query: 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDIVQDS 732
M P+ E + M L C P+ RP S +V L +++Q +
Sbjct: 313 TRMR--APD---YTTPEMYQTM----LDCWHGEPSQRPTFSELVEHLG------NLLQAN 357
Query: 733 S 733
+
Sbjct: 358 A 358
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 30/155 (19%), Positives = 57/155 (36%), Gaps = 20/155 (12%)
Query: 452 NKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKSKQG-NREFVNEIGTISAL-QHPH 503
+G G FG V + A +AVK L + +R ++E+ + + H +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 504 LVKLYGCCI-EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
+V L G C G L++I E+ + +L+ L R+ +G +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----------RSKRNEFVPYKTKGARFR 136
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597
+ + + D+K + + S F K
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 9e-19
Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 23/224 (10%)
Query: 438 LRQIKAATNHFDVANKIGEGGFGPVY----KGLLADGTLIAVKQLSAKS--KQGNREFVN 491
++Q++ F++ IG G FG V K + A+K L+ K+
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFR 122
Query: 492 EIGTI-SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHN 550
E + + L+ + N L L+ +Y L L E RL + R
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEM-ARFY 180
Query: 551 ICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 610
+ + + +H+ L VHRDIK N+L+D + + +++DFG ED T S+
Sbjct: 181 LA-EMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 611 AGTFGYMAPE------YAMRGHLTDKADVYSFGIVALEIVSGRS 648
GT Y++PE + + D +S G+ E++ G +
Sbjct: 237 VGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGET 279
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 9e-19
Identities = 65/250 (26%), Positives = 96/250 (38%), Gaps = 41/250 (16%)
Query: 418 PKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLA----DGTLI 473
+ S + G + S + + N F+ +G+G FG V +L G
Sbjct: 120 FRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYY 176
Query: 474 AVKQLSAKSKQGNREF---VNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL- 529
A+K L + E + E + +HP L L ++L + EY L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236
Query: 530 -----------ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKAT 578
RA F E I L YLH S +V+RD+K
Sbjct: 237 FHLSRERVFSEDRARFYGAE----------------IVSALDYLH--SEKNVVYRDLKLE 278
Query: 579 NVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGI 638
N++LDKD + KI+DFGL K +D + T GT Y+APE D + G+
Sbjct: 279 NLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337
Query: 639 VALEIVSGRS 648
V E++ GR
Sbjct: 338 VMYEMMCGRL 347
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 32/154 (20%), Positives = 54/154 (35%), Gaps = 33/154 (21%)
Query: 6 QSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLPD---- 59
N LSG LP + SL +L + ++G +PD
Sbjct: 133 SYNALSGTLPPSISSLP------------------NLVGITFDGNRISGA---IPDSYGS 171
Query: 60 LRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLT 119
F ++ + LTG++P ++ + +DLS N L G F + I+L
Sbjct: 172 FSKL-FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 120 GNLLTGKVPQWMFGRGPENIDLSYNNFADESSGS 153
N L + + + +DL N G+
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRI----YGT 259
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 34/158 (21%), Positives = 61/158 (38%), Gaps = 32/158 (20%)
Query: 4 TVQSNRLSGE--LPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPD-- 59
+ L +P L +L L L I +N +P
Sbjct: 56 DLSGLNLPKPYPIPSSLANLP------------------YLNFLYIGGINNLVGPIPPAI 97
Query: 60 --LRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIY 117
L + L + N++G +P FL ++ + LD S+N L+GT+P S + L ++ I
Sbjct: 98 AKLTQLHY--LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 118 LTGNLLTGKVPQWMFG--RGPENIDLSYNNFADESSGS 153
GN ++G +P + ++ +S N +G
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRL----TGK 189
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 29/143 (20%), Positives = 58/143 (40%), Gaps = 27/143 (18%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLPDL--RN 62
NRL+G++P +L +L + +S L G L +
Sbjct: 183 RNRLTGKIPPTFANL-------------------NLAFVDLSRNMLEGD---ASVLFGSD 220
Query: 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL 122
+ + + L +L +L +G + LDL N++ GT+P+ +L + + ++ N
Sbjct: 221 KNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 123 LTGKVPQWMFGRGPENIDLSYNN 145
L G++PQ + + + N
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 22/86 (25%), Positives = 35/86 (40%), Gaps = 10/86 (11%)
Query: 73 CNLTGELPHFLGEVSEMKVLDLSFNKLNGT--IPESFARLADVDFIYLTG-NLLTGKVPQ 129
G L + + LDLS L IP S A L ++F+Y+ G N L G +P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 130 WMFGRGP--ENIDLSYNNFADESSGS 153
+ + +++ N SG+
Sbjct: 96 A-IAKLTQLHYLYITHTNV----SGA 116
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 64/244 (26%), Positives = 98/244 (40%), Gaps = 46/244 (18%)
Query: 430 DLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVY----KGLLADGTLIAVKQLSAKSKQG 485
+L+T + T K +F++ +G G +G V+ G L A+K L +
Sbjct: 38 ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 97
Query: 486 NREFVNEIGT-----ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL----------- 529
+ T Q P LV L+ +L LI +Y+ L
Sbjct: 98 KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT 157
Query: 530 -ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 588
E I L +LH+ L I++RDIK N+LLD + +
Sbjct: 158 EHEVQIYVGE----------------IVLALEHLHK---LGIIYRDIKLENILLDSNGHV 198
Query: 589 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPE---YAMRGHLTDKA-DVYSFGIVALEIV 644
++DFGL+K D T + GT YMAP+ GH DKA D +S G++ E++
Sbjct: 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELL 256
Query: 645 SGRS 648
+G S
Sbjct: 257 TGAS 260
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 444 ATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS-AKSKQGNREF----VNEIGT-- 495
AT+ ++ +IG G +G VYK G +A+K + G V E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 496 -ISALQHPHLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFGPEEHRLK-LDWPTR 548
+ A +HP++V+L C ++ L++E+++ + L L ++ L T
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAETI 122
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597
++ RGL +LH IVHRD+K N+L+ K++DFGLA+
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 64/250 (25%), Positives = 106/250 (42%), Gaps = 51/250 (20%)
Query: 423 ERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVY----KGLLADGTLIAVKQL 478
E ++ + + T KA + F++ +G+G FG V+ L A+K L
Sbjct: 2 EGSIKEIAI-THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 479 SAKSKQGNREFVNEIGTIS------ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL--- 529
K+ R + + T + HP +VKL+ +L LI ++L L
Sbjct: 61 K-KATLKVR---DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR 116
Query: 530 ---------ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNV 580
F E +A L +LH L I++RD+K N+
Sbjct: 117 LSKEVMFTEEDVKFYLAE----------------LALALDHLHS---LGIIYRDLKPENI 157
Query: 581 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKA-DVYSFGI 638
LLD++ + K++DFGL+K + + GT YMAPE R GH ++ D +SFG+
Sbjct: 158 LLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGH--TQSADWWSFGV 214
Query: 639 VALEIVSGRS 648
+ E+++G
Sbjct: 215 LMFEMLTGTL 224
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 54/234 (23%), Positives = 88/234 (37%), Gaps = 41/234 (17%)
Query: 438 LRQIKAATNHFDVANKIGEGGFGPVY----KGLLADGTLIAVKQLSAKSKQGNRE----F 489
L++++ + F++ IG G F V K G + A+K ++ K R F
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMN-KWDMLKRGEVSCF 108
Query: 490 VNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRH 549
E + + +L+ + N L L+ EY L L R+ +
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEM---- 163
Query: 550 NICIGIAR--------GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601
AR + +H L VHRDIK N+LLD+ + +++DFG
Sbjct: 164 ------ARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214
Query: 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVY-------SFGIVALEIVSGRS 648
D T S GT Y++PE Y + G+ A E+ G++
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 50/200 (25%), Positives = 76/200 (38%), Gaps = 29/200 (14%)
Query: 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYG-- 509
+G G G V + A+K L + RE E+ A Q PH+V++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVY 124
Query: 510 --CCIEGNQLLLIYEYLENNSL-----ARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
LL++ E L+ L R E I I + YL
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------EIMKSIGEAIQYL 177
Query: 563 HEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 619
H + I HRD+K N+L + K++DFG AK N+ ++T T Y+AP
Sbjct: 178 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAP 232
Query: 620 EYAMRGHLTDKADVYSFGIV 639
E D++S G++
Sbjct: 233 EVLGPEKYDKSCDMWSLGVI 252
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 66/275 (24%), Positives = 107/275 (38%), Gaps = 40/275 (14%)
Query: 438 LRQIKAATNHFDVANKIGEGGFGPVY----KGLLADGTLIAVKQLSAKS--KQGNREFVN 491
+R ++ ++V IG G FG V K + A+K LS K+ + F
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFW 117
Query: 492 EIGTI-SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHN 550
E I + P +V+L+ + L ++ EY+ L + + + W R
Sbjct: 118 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKW-ARFY 173
Query: 551 ICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 610
+ L +H + +HRD+K N+LLDK + K++DFG ++
Sbjct: 174 TA-EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 229
Query: 611 AGTFGYMAPE----YAMRGHLTDKADVYSFGIVALEIVSGR------------SNIMCKT 654
GT Y++PE G+ + D +S G+ E++ G S IM
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289
Query: 655 KEEKFYLLDWALLLKEQGNLME--LVDP--NLGSN 685
F D + KE NL+ L D LG N
Sbjct: 290 NSLTFP--DDNDISKEAKNLICAFLTDREVRLGRN 322
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 52/247 (21%), Positives = 87/247 (35%), Gaps = 57/247 (23%)
Query: 445 TNHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH 503
+ + + +G G FG V + + G A+K++ + NRE + + L H +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPT---------------- 547
++KL ++ +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 548 -------RHNICIG--------------IARGLAYLHEESRLKIVHRDIKATNVLLD-KD 585
+ I G + R + ++H L I HRDIK N+L++ KD
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178
Query: 586 LNPKISDFGLAK--LDEEDNTH-ISTRVAGTFGYMAPEYAMRG--HLTDKADVYSFGIVA 640
K+ DFG AK + E + I +R Y APE M G T D++S G V
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL-MLGATEYTPSIDLWSIGCVF 232
Query: 641 LEIVSGR 647
E++ G+
Sbjct: 233 GELILGK 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 63/239 (26%), Positives = 97/239 (40%), Gaps = 44/239 (18%)
Query: 432 QTGSFTLRQIKAATNHFDVANKIGEGGFGPVY----KGLLADGTLIAVKQLSAKSKQGNR 487
S K F++ +G+GG+G V+ G + A+K L N
Sbjct: 3 SETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA 62
Query: 488 EFVNEIGT----ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL------------AR 531
+ + ++HP +V L G +L LI EYL L
Sbjct: 63 KDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT 122
Query: 532 ALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 591
A F E I+ L +LH+ I++RD+K N++L+ + K++
Sbjct: 123 ACFYLAE----------------ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLT 163
Query: 592 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKA-DVYSFGIVALEIVSGRS 648
DFGL K D T T GT YMAPE MR GH ++A D +S G + ++++G
Sbjct: 164 DFGLCKESIHDGTVTHT-FCGTIEYMAPEILMRSGH--NRAVDWWSLGALMYDMLTGAP 219
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 44/170 (25%), Positives = 84/170 (49%), Gaps = 34/170 (20%)
Query: 448 FDVANKIGEGGFGPVYKG--LLADGTLIAVKQLS-AKSKQGN-----REFVNEIGTISAL 499
++ +IGEG +G V+K L G +A+K++ ++G RE ++ L
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-------VAVL 65
Query: 500 Q------HPHLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFGPEEHR-LKLDWPT 547
+ HP++V+L+ C +L L++E+++ + L L ++ + T
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVPTET 121
Query: 548 RHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597
++ + RGL +LH ++VHRD+K N+L+ K++DFGLA+
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 80.7 bits (198), Expect = 2e-16
Identities = 44/272 (16%), Positives = 76/272 (27%), Gaps = 68/272 (25%)
Query: 432 QTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQL--------SAKSK 483
Q G T KIGEG FG V++ +AD T +A+K + + +
Sbjct: 7 QKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 484 QGNREFVNEIGTISALQ---------HPHLVKLYGCCI---------------------- 512
+ E + EI L + L
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 513 --------EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
+ +QL ++ E+ + T +I + LA
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEA 179
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP--EYA 622
L+ HRD+ NVLL K K+ K + + G +Y
Sbjct: 180 --SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK----------SSTIPSCGLQVSIIDYT 227
Query: 623 MRGHLTDKADVYSFGIVALEIVSGRSNIMCKT 654
+ D V+ + ++ +G +
Sbjct: 228 LSRLERDGIVVFCDVSMDEDLFTGDGDYQFDI 259
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 65/227 (28%), Positives = 88/227 (38%), Gaps = 44/227 (19%)
Query: 442 KAATNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFVNEIGT-- 495
K N FD +G+G FG V +L G A+K L K ++ V T
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTES 56
Query: 496 --ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEHRL 541
+ +HP L L ++L + EY L RA F E
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--- 113
Query: 542 KLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601
I L YLH +V+RDIK N++LDKD + KI+DFGL K
Sbjct: 114 -------------IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157
Query: 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
D + T GT Y+APE D + G+V E++ GR
Sbjct: 158 DGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 21/242 (8%)
Query: 416 FRPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLA----DGT 471
F+ S E + T FD+ IG G + V LL
Sbjct: 22 FQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKV---LLVRLKKTDR 78
Query: 472 LIAVKQLSAKSKQGNREFVNEIGT-----ISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526
+ A++ + K + E ++ + T A HP LV L+ C ++L + EY+
Sbjct: 79 IYAMRVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 137
Query: 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 586
L + + +L + ++ I +A L YLHE I++RD+K NVLLD +
Sbjct: 138 GDLMFHMQ--RQRKLPEEHARFYSAEISLA--LNYLHE---RGIIYRDLKLDNVLLDSEG 190
Query: 587 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSG 646
+ K++D+G+ K ST GT Y+APE D ++ G++ E+++G
Sbjct: 191 HIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249
Query: 647 RS 648
RS
Sbjct: 250 RS 251
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFVNEIGT-----I 496
FD+ IG G + V LL + A+K + K + E ++ + T
Sbjct: 9 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFE 64
Query: 497 SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIA 556
A HP LV L+ C ++L + EY+ L + + +L + ++ I +A
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLA 122
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 616
L YLHE I++RD+K NVLLD + + K++D+G+ K ST GT Y
Sbjct: 123 --LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNY 176
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
+APE D ++ G++ E+++GRS
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 65/230 (28%), Positives = 93/230 (40%), Gaps = 49/230 (21%)
Query: 442 KAATNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFVNEIGT-- 495
A + F IG+G FG V LLA + AVK L K ++ I +
Sbjct: 34 HAKPSDFHFLKVIGKGSFGKV---LLARHKAEEVFYAVKVLQ-KKAILKKKEEKHIMSER 89
Query: 496 ---ISALQHPHLVKLYGCCIEGNQLLLIYEYLENN--------------SLARALFGPEE 538
+ ++HP LV L+ ++L + +Y+ N RA F E
Sbjct: 90 NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI--NGGELFYHLQRERCFLEPRARFYAAE 147
Query: 539 HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598
IA L YLH L IV+RD+K N+LLD + ++DFGL K
Sbjct: 148 ----------------IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188
Query: 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
+ E N+ ST GT Y+APE + D + G V E++ G
Sbjct: 189 NIEHNSTTST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 4e-16
Identities = 58/253 (22%), Positives = 96/253 (37%), Gaps = 45/253 (17%)
Query: 417 RPKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLA----DGTL 472
+ E + + + F+ +G+G FG V +L+ L
Sbjct: 312 GQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKV---MLSERKGTDEL 368
Query: 473 IAVKQLSAKSKQGNREFVNEIGT-----ISALQHPHLVKLYGCCIEGNQLLLIYEYLENN 527
AVK L K + V + P L +L+ C ++L + EY+
Sbjct: 369 YAVKILK-KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427
Query: 528 SL------------ARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDI 575
L A+F E IA GL +L I++RD+
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAE----------------IAIGLFFLQS---KGIIYRDL 468
Query: 576 KATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYS 635
K NV+LD + + KI+DFG+ K + D T GT Y+APE D ++
Sbjct: 469 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWA 527
Query: 636 FGIVALEIVSGRS 648
FG++ E+++G++
Sbjct: 528 FGVLLYEMLAGQA 540
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 65/231 (28%), Positives = 93/231 (40%), Gaps = 45/231 (19%)
Query: 439 RQIKAATNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFVNEIG 494
QIK F + +G+G FG V LA A+K L K + V
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALK-KDVVLMDDDVECTM 65
Query: 495 T-----ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPE 537
A +HP L ++ L + EYL L +RA F
Sbjct: 66 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 125
Query: 538 EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597
E I GL +LH IV+RD+K N+LLDKD + KI+DFG+ K
Sbjct: 126 E----------------IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166
Query: 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
+ + +T GT Y+APE + D +SFG++ E++ G+S
Sbjct: 167 ENMLGDAKTNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 53/230 (23%)
Query: 442 KAATNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLS----AKSKQGNREFV-NE 492
K + F + +G G FG V+ L +G A+K L + KQ E +E
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQ--VEHTNDE 56
Query: 493 IGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEHR 540
+S + HP +++++G + Q+ +I +Y+E L A F E
Sbjct: 57 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-- 114
Query: 541 LKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600
+ L YLH I++RD+K N+LLDK+ + KI+DFG AK
Sbjct: 115 --------------VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV- 156
Query: 601 EDNTHISTRVAGTFGYMAPEYAMR-GHLTDKA-DVYSFGIVALEIVSGRS 648
D T+ T + GT Y+APE + +K+ D +SFGI+ E+++G +
Sbjct: 157 PDVTY--T-LCGTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYT 201
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 51/229 (22%)
Query: 442 KAATNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFV----NEI 493
A + FD +G G FG V L G A+K L K K + + NE
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVM---LVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEK 92
Query: 494 GTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEHRL 541
+ A+ P LVKL + + L ++ EY+ + A F +
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ--- 149
Query: 542 KLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601
I YLH L +++RD+K N+L+D+ +++DFG AK +
Sbjct: 150 -------------IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-K 192
Query: 602 DNTHISTRVAGTFGYMAPEYAM-RGHLTDKA-DVYSFGIVALEIVSGRS 648
T T + GT +APE + +G+ +KA D ++ G++ E+ +G
Sbjct: 193 GRTW--T-LCGTPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGYP 236
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 25/229 (10%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQH-PH 503
N + + KIG G FG +Y G +A G +A+K K+K E +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+ + C EG+ +++ E L SL LF + L T + + + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPK---ISDFGLAK--LDEEDNTHISTR----VAGTF 614
++ +HRD+K N L+ I DFGLAK D + HI R + GT
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 615 GYMAPEYAMRGH-LTDKADVYSFGIVALEIVSGR---SNIMCKTKEEKF 659
Y A G + + D+ S G V + G + TK +K+
Sbjct: 180 RY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 45/224 (20%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFVNEIGT-----I 496
++F+ +G+G FG V +LA G L AVK L K + V T
Sbjct: 23 DNFEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLK-KDVILQDDDVECTMTEKRILS 78
Query: 497 SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEHRLKLD 544
A HP L +L+ C ++L + E++ L ARA F E
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE------ 132
Query: 545 WPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604
I L +LH+ I++RD+K NVLLD + + K++DFG+ K +
Sbjct: 133 ----------IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179
Query: 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
+T GT Y+APE D ++ G++ E++ G +
Sbjct: 180 TTAT-FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 45/228 (19%)
Query: 442 KAATNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFVNEIGT-- 495
+ F+ +G+G FG V +L+ L AVK L K + V
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILK-KDVVIQDDDVECTMVEK 71
Query: 496 ---ISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSL------------ARALFGPEEHR 540
+ P L +L+ C ++L + EY+ L A+F E
Sbjct: 72 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-- 129
Query: 541 LKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600
IA GL +L I++RD+K NV+LD + + KI+DFG+ K +
Sbjct: 130 --------------IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172
Query: 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648
D T GT Y+APE D ++FG++ E+++G++
Sbjct: 173 WDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 35/219 (15%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN---------EIG 494
+ IG G G V +A+K+LS R F N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 495 TISALQHPHLVKLY------GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTR 548
+ + H +++ L E + ++ E ++ N L + + +++LD
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI------QMELDHERM 129
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 608
+ + G+ +LH I+HRD+K +N+++ D KI DFGLA+ + + T
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 184
Query: 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
T Y APE + + D++S G + E++ G
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 46/217 (21%), Positives = 93/217 (42%), Gaps = 37/217 (17%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS-AKSKQGNREFVNEIGTISALQ-- 500
+ + + K+G G + V++ + + + + VK L K K+ RE I L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-------IKILENL 87
Query: 501 --HPHLVKLYGCCI--EGNQLLLIYEYLENNSLARAL--FGPEEHRLKLDWPTRHNICIG 554
P+++ L L++E++ N + + R + + I
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-----YEIL-- 140
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKLDEEDNTHISTRVA 611
+ L Y H S I+HRD+K NV++D + L ++ D+GLA+ + + RVA
Sbjct: 141 --KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKL--RLIDWGLAEFYHPGQEY-NVRVA 192
Query: 612 GTFGYMAPEYAMRGHLTDKA-DVYSFGIVALEIVSGR 647
+ + PE + + D + D++S G + ++ +
Sbjct: 193 -SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 55/234 (23%), Positives = 98/234 (41%), Gaps = 33/234 (14%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQH-PH 503
H+ V +IGEG FG +++G L + +A+K +S + +E T L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTG 67
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+ +Y EG +L+ + L SL L + + T + + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL-GPSLE-DLLDLCGRKFSV--KTVAMAAKQMLARVQSIH 123
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPK-----ISDFGLAK--LDEEDNTHISTR----VAG 612
E+S +V+RDIK N L+ + + + DFG+ K D HI R ++G
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 613 TFGYMAPEYAMRGHL----TDKADVYSFGIVALEIVSGR---SNIMCKTKEEKF 659
T YM ++ HL + + D+ + G V + + G + T ++K+
Sbjct: 181 TARYM----SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 58/234 (24%), Positives = 95/234 (40%), Gaps = 33/234 (14%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQH-PH 503
+F V KIG G FG + G L +A+K KS+ E L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+ ++Y G ++ E L SL LF + L T I I + + Y+H
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSL--KTVLMIAIQLISRMEYVH 122
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPK-----ISDFGLAK--LDEEDNTHISTR----VAG 612
++ +++RD+K N L+ + N I DF LAK +D E HI R + G
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 613 TFGYMAPEYAMRGHL----TDKADVYSFGIVALEIVSGR---SNIMCKTKEEKF 659
T YM ++ HL + + D+ + G + + + G + T +E++
Sbjct: 180 TARYM----SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY 229
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPH 503
N F + KIG G FG +Y G + +A+K + K+K + + + E LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTG 64
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+ + +EG+ +L+ + L SL LF +L L T + + + ++H
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSL--KTVLMLADQMINRVEFVH 120
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPK---ISDFGLAKL--DEEDNTHISTR----VAGTF 614
+S +HRDIK N L+ I DFGLAK D + HI R + GT
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 615 GYMAPEYAMRGH-LTDKADVYSFGIVALEIVSGR---SNIMCKTKEEKF 659
Y A G + + D+ S G V + + G + TK++K+
Sbjct: 178 RY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 50/219 (22%), Positives = 89/219 (40%), Gaps = 35/219 (15%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN---------EIG 494
+ IG G G V +A+K+LS R F N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 495 TISALQHPHLVKLY------GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTR 548
+ + H +++ L E + L+ E ++ N L + + +++LD
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERM 166
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 608
+ + G+ +LH I+HRD+K +N+++ D KI DFGLA+ + + T
Sbjct: 167 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 221
Query: 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
T Y APE + + D++S G + E+V +
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 38/226 (16%)
Query: 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLS--AKSKQGNREFVN---------EI 493
+ + V I G +G V G+ ++G +A+K++ + + EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 494 GTISALQHPHLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTR 548
++ HP+++ L + ++L L+ E + + LA+ + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVI------HDQRIVISP 133
Query: 549 HNICI---GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT- 604
+I I GL LHE +VHRD+ N+LL + + I DF LA+ D D
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 605 --HISTRVAGTFGYMAPEYAMRGHLTDKA-DVYSFGIVALEIVSGR 647
+++ R Y APE M+ K D++S G V E+ + +
Sbjct: 191 THYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 49/221 (22%), Positives = 94/221 (42%), Gaps = 40/221 (18%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN---------EIG 494
+ +G G +G V + G +A+K+LS R F + E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 495 TISALQHPHLVKLY------GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTR 548
+ +QH +++ L L+ +++ + L + + LK
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIM------GLKFSEEKI 128
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-IS 607
+ + +GL Y+H +VHRD+K N+ +++D KI DFGLA+ + + T +
Sbjct: 129 QYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185
Query: 608 TRVAGTFGYMAPEYAMRGHLTDKA-DVYSFGIVALEIVSGR 647
TR Y APE + ++ D++S G + E+++G+
Sbjct: 186 TRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-13
Identities = 24/146 (16%), Positives = 43/146 (29%), Gaps = 26/146 (17%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD----LNGPEATLPDLRN 62
L SL L+++ N +LRN
Sbjct: 430 HTHTRVAFNGIFNGL------------------SSLEVLKMAGNSFQENFLPDIFTELRN 471
Query: 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL 122
L L C L P +S ++VL++S N + L + + + N
Sbjct: 472 --LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 123 LTGKVPQWMFGRGP--ENIDLSYNNF 146
+ Q + ++L+ N+F
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-10
Identities = 19/90 (21%), Positives = 33/90 (36%), Gaps = 3/90 (3%)
Query: 66 KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTG 125
KNL L L + E++VLDLS ++ ++ L+ + + LTGN +
Sbjct: 31 KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 126 KVPQWMFGRGP--ENIDLSYNNFADESSGS 153
F + + N A +
Sbjct: 91 LALGA-FSGLSSLQKLVAVETNLASLENFP 119
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 17/124 (13%), Positives = 37/124 (29%), Gaps = 8/124 (6%)
Query: 39 SESLTDLRISD--LNG-PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLS 95
S +L +S L + + L L C + +S + L L+
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPE--LQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 96 FNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADESSGS 153
N + +F+ L+ + + L G + +++++N
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENF-PIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 154 DCQN 157
N
Sbjct: 144 YFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 17/111 (15%), Positives = 33/111 (29%), Gaps = 8/111 (7%)
Query: 46 RISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPH-FLGEVSEMKVLDLSFNKLNGTIP 104
+ ++ L L + L + NL + + LD+S
Sbjct: 384 GVITMSSNFLGLEQLEH-----LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 105 ESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADESSGS 153
F L+ ++ + + GN +F +DLS S +
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 9e-09
Identities = 22/150 (14%), Positives = 48/150 (32%), Gaps = 29/150 (19%)
Query: 6 QSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG-PEATLPDLRN 62
+ SL L+ L ++ + L +
Sbjct: 60 SRCEIQTIEDGAYQSL------------------SHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGT-IPESFARLADVDFIYLTGN 121
+ L+ NL +G + +K L+++ N + +PE F+ L +++ + L+ N
Sbjct: 102 --LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 122 LLTGKVPQWMFG-----RGPENIDLSYNNF 146
+ + ++DLS N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 25/120 (20%), Positives = 46/120 (38%), Gaps = 4/120 (3%)
Query: 37 YFSESLTDLRISDLNGPEA-TLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLS 95
+SL L + G A + DL + F +L + G + +K LDLS
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 96 FNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADESSGS 153
FN + T+ +F L ++ + + L +F +D+S+ + +G
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 24/160 (15%), Positives = 43/160 (26%), Gaps = 28/160 (17%)
Query: 6 QSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG-PEATLPDLRN 62
N + L SL L + L + L+
Sbjct: 84 TGNPIQSLALGAFSGLS------------------SLQKLVAVETNLASLENFPIGHLKT 125
Query: 63 RTFKNLILRSCNLTG-ELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLA----DVDFIY 117
K L + + +LP + ++ ++ LDLS NK+ L +
Sbjct: 126 --LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 118 LTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQN 157
L+ N + P + L N + + Q
Sbjct: 184 LSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 21/122 (17%), Positives = 47/122 (38%), Gaps = 6/122 (4%)
Query: 38 FSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFN 97
++ L + + P L+ ++ K L + G ++ ++ LDLS N
Sbjct: 302 YNFGWQHLELVNCKF--GQFPTLKLKSLKRLTF--TSNKGGNAFSEVDLPSLEFLDLSRN 357
Query: 98 KLN--GTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDC 155
L+ G +S + ++ L+ N + ++ E++D ++N S S
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 156 QN 157
+
Sbjct: 418 LS 419
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 15/156 (9%), Positives = 39/156 (25%), Gaps = 21/156 (13%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNG----PEATLPDLRN 62
+N S + + + + L + ++ L L N
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVH------------RLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 63 RTFKNLILRSCNL-TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGN 121
T + L + ++ ++ + L + S+ + L
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNC 314
Query: 122 LLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQN 157
P + + + + N + S D +
Sbjct: 315 KFGQ-FPTLKL-KSLKRLTFTSNKGGNAFSEVDLPS 348
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 21/143 (14%), Positives = 41/143 (28%), Gaps = 26/143 (18%)
Query: 6 QSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG-PEATLPDLRN 62
+L P SL SL L +S L +
Sbjct: 478 SQCQLEQLSPTAFNSL------------------SSLQVLNMSHNNFFSLDTFPYKCLNS 519
Query: 63 RTFKNLILRSCNLTGELPHFLGEV-SEMKVLDLSFNKLNGTIP-ESFAR-LADVDFIYLT 119
+ L ++ L S + L+L+ N T +SF + + D + +
Sbjct: 520 --LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVE 577
Query: 120 GNLLTGKVPQWMFGRGPENIDLS 142
+ P G +++++
Sbjct: 578 VERMECATPSDKQGMPVLSLNIT 600
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 47/221 (21%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN---------EIG 494
+ +G G +G V + G +A+K+L R F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 495 TISALQHPHLVKLY------GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTR 548
+ ++H +++ L + L+ ++ + L + + KL
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLM-----KHEKLGEDRI 130
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HIS 607
+ + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ + + T ++
Sbjct: 131 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 187
Query: 608 TRVAGTFGYMAPEYAMRGHLTDKA-DVYSFGIVALEIVSGR 647
TR Y APE + + D++S G + E+++G+
Sbjct: 188 TRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN--REFVNEIGTISALQH 501
+ + IGEG +G V + +A+K++S Q R EI + +H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 84
Query: 502 PHLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFGP---EEHRLKLDWPTRHNICI 553
+++ + + + ++ + +E + L + L +H
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHI--------CYFLY 135
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRVA 611
I RGL Y+H + ++HRD+K +N+LL+ + KI DFGLA++ + D+T T
Sbjct: 136 QILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 612 GTFGYMAPEYAMRGHLTDKA-DVYSFGIVALEIVSGR 647
T Y APE + K+ D++S G + E++S R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 42/183 (22%), Positives = 69/183 (37%), Gaps = 28/183 (15%)
Query: 428 GLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN 486
G +++G +++ ++ + +G G G V + A+K L +
Sbjct: 1 GPHVKSG-LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKAR 58
Query: 487 REFVNEIGTISALQHPHLVKLYGCC----IEGNQLLLIYEYLENNSL-----ARALFGPE 537
RE E+ A Q PH+V++ LL++ E L+ L R
Sbjct: 59 REV--EL-HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 115
Query: 538 EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFG 594
E I I + YLH + I HRD+K N+L + K++DFG
Sbjct: 116 EREAS-------EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG 165
Query: 595 LAK 597
AK
Sbjct: 166 FAK 168
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 39/205 (19%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN---------EIG 494
+++ + + IG G +G VY +A+K+++ R F + EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 495 TISALQHPHLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFGP----EEHRLKLDW 545
++ L+ ++++LY I + ++L ++ E +++ L + P EEH
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLFKTPIFLTEEHI----- 131
Query: 546 PTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNT 604
I + G ++HE I+HRD+K N LL++D + K+ DFGLA ++ E +T
Sbjct: 132 ---KTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 605 HISTRVAGTFGYMAPEYAMRGHLTD 629
+I + ++ LT
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 39/221 (17%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN---------EIG 494
+ + +G G +G V G +AVK+LS R F + E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 495 TISALQHPHLVKLY------GCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTR 548
+ ++H +++ L E N + L+ + + L + KL
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIV-----KCQKLTDDHV 134
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HIS 607
+ I RGL Y+H I+HRD+K +N+ +++D KI DFGLA+ ++ T +++
Sbjct: 135 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA 191
Query: 608 TRVAGTFGYMAPEYAMRGHLTDKA-DVYSFGIVALEIVSGR 647
TR Y APE + ++ D++S G + E+++GR
Sbjct: 192 TRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 32/220 (14%)
Query: 450 VANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSK---QGNRE-----FVNEIGTI--SA 498
+ K+G G F V+ + + T +A+K + E VN+ +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 499 LQHPHLVKLYGC----CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIG 554
+ H++KL G +++++E L N L + E + L + + I
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN-LLALIKKYEHRGIPLIY-VKQ-ISKQ 139
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLD------KDLNPKISDFGLA-KLDEEDNTHIS 607
+ GL Y+H I+H DIK NVL++ + KI+D G A DE I
Sbjct: 140 LLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 608 TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
TR Y +PE + AD++S + E+++G
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 43/210 (20%), Positives = 84/210 (40%), Gaps = 44/210 (20%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN---------EIG 494
+ +++ + IG G +G V + + ++A+K++ R F + EI
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 495 TISALQHPHLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFGP----EEHRLKLDW 545
++ L H H+VK+ I + ++L ++ E +++ + P E H L +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLFRTPVYLTELHIKTLLY 163
Query: 546 PTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA------KLD 599
N+ G+ Y+H I+HRD+K N L+++D + K+ DFGLA +
Sbjct: 164 ----NLL----VGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTD 629
++ LT
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 43/254 (16%), Positives = 87/254 (34%), Gaps = 55/254 (21%)
Query: 446 NHFDVANKIGEGGFGPVYKGL------LADGTLIAVKQLSAKSKQ-----------GNRE 488
+ V IG+GGFG +Y + VK + + E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 489 FVNEIGTISALQHPHLVKLYGCCIEGNQLL----LIYEYLENNSLARALFGPEEHRLKLD 544
+ + L++ + K +G + +I + + L + ++ R
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRFSR- 151
Query: 545 WPTRHNICIG---IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI--SDFGLAK-- 597
+ + + + L Y+HE VH DIKA+N+LL+ ++ D+GLA
Sbjct: 152 ---KTVLQLSLRILDI-LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
Query: 598 LDEEDNTHISTR----VAGTFGYMAPEYA-MRGHL----TDKADVYSFGIVALEIVSGR- 647
E + + GT E+ + H + + D+ G ++ ++G
Sbjct: 205 CPEGVHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL 259
Query: 648 --SNIMCKTKEEKF 659
+ + K +
Sbjct: 260 PWEDNLKDPKYVRD 273
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 48/231 (20%), Positives = 95/231 (41%), Gaps = 48/231 (20%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVN---------EIG 494
++ F + + +GEG +G V G ++A+K++ F EI
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 495 TISALQHPHLVKLY-----GCCIEGNQLLLIYEYLENNSLARALFGP---EEHRLKLDWP 546
+ +H +++ ++ N++ +I E ++ + L R + ++H
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVISTQMLSDDHI------ 114
Query: 547 TRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606
R + LH + ++HRD+K +N+L++ + + K+ DFGLA++ +E
Sbjct: 115 --QYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 607 STRVAGTFG---------YMAPEYAMRGHLTDKA-DVYSFGIVALEIVSGR 647
S G Y APE + +A DV+S G + E+ R
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-10
Identities = 25/161 (15%), Positives = 53/161 (32%), Gaps = 28/161 (17%)
Query: 6 QSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG-PEATLPDLRN 62
+ +L L E+L + + S+ +L +S+ L+ T L+
Sbjct: 203 NNVQLGPSLTEKLCLELAN---------------TSIRNLSLSNSQLSTTSNTTFLGLKW 247
Query: 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL 122
L L NL + +++ L +N + S L +V ++ L +
Sbjct: 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSF 307
Query: 123 LTG--------KVPQWMFGRGP--ENIDLSYNNFADESSGS 153
K+ + F E++++ N+ S
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-10
Identities = 28/155 (18%), Positives = 50/155 (32%), Gaps = 28/155 (18%)
Query: 6 QSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG-PEATLPDLRN 62
N +S PE L L L + L+ + T N
Sbjct: 57 GFNTISKLEPELCQKLPM------------------LKVLNLQHNELSQLSDKTFAFCTN 98
Query: 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL 122
L L S ++ + + + LDLS N L+ T + +L ++ + L+ N
Sbjct: 99 --LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 123 LTGKVPQWMFGRGP----ENIDLSYNNFADESSGS 153
+ + + ++LS N + S G
Sbjct: 157 IQA-LKSEELDIFANSSLKKLELSSNQIKEFSPGC 190
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 30/122 (24%), Positives = 44/122 (36%), Gaps = 16/122 (13%)
Query: 40 ESLTDLRISDLNG------PEATLPDLRNRTFKNLI------LRSCNLTGELPHFLGEVS 87
E L L I DL + P K L L S ++
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560
Query: 88 EMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPEN---IDLSYN 144
E+K++DL N LN F + + L NL+T V + +FG N +D+ +N
Sbjct: 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELDMRFN 619
Query: 145 NF 146
F
Sbjct: 620 PF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 23/115 (20%), Positives = 46/115 (40%), Gaps = 18/115 (15%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLN 100
L +L+ L+ +L L N TF +L + +L+L+ NK++
Sbjct: 351 GLINLKYLSLSNSFTSLRTLTNETFVSLAHSP----------------LHILNLTKNKIS 394
Query: 101 GTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADESSGS 153
++F+ L ++ + L N + ++ + I LSYN + + S
Sbjct: 395 KIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 28/165 (16%), Positives = 53/165 (32%), Gaps = 29/165 (17%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG-PEATLPDLRNR 63
SN + ++L L +S L+ T L N
Sbjct: 106 SNSIQKIKNNPFVKQ------------------KNLITLDLSHNGLSSTKLGTQVQLEN- 146
Query: 64 TFKNLILRSCNLTGELPHFLGEV--SEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGN 121
+ L+L + + L S +K L+LS N++ P F + + ++L
Sbjct: 147 -LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 122 LLTGKVPQWMFGRGP----ENIDLSYNNFADESSGSDCQNGAVNL 162
L + + + N+ LS + + S+ + NL
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNL 250
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 9e-09
Identities = 19/114 (16%), Positives = 40/114 (35%), Gaps = 10/114 (8%)
Query: 42 LTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNG 101
+ L+++ + P+ ++ L L L S++ LD+ FN ++
Sbjct: 11 CSHLKLTQV--PDDLPTNI-----TVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 102 TIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADESSGS 153
PE +L + + L N L+ + F + L N+ +
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 25/163 (15%), Positives = 49/163 (30%), Gaps = 35/163 (21%)
Query: 6 QSNRLSGELP-EELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG-PEATLPDLR 61
N + EL +E L E++ ++ +S + +
Sbjct: 413 GLNEIGQELTGQEWRGL------------------ENIFEIYLSYNKYLQLTRNSFALVP 454
Query: 62 NRTFKNLILRSCNLTG--ELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLT 119
+ + L+LR L P + + +LDLS N + + L ++ + L
Sbjct: 455 S--LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ 512
Query: 120 GNLLT-------GKVPQWMFGRGP--ENIDLSYNNFADESSGS 153
N L P + ++L N F +
Sbjct: 513 HNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 19/163 (11%), Positives = 50/163 (30%), Gaps = 33/163 (20%)
Query: 6 QSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEAT----LPD 59
N L+ + L L + + + L +
Sbjct: 256 SYNNLNVVGNDSFAWL------------------PQLEYFFLEYNNIQHLFSHSLHGLFN 297
Query: 60 LR----NRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDF 115
+R R+F + +L + ++ L++ N + G F L ++ +
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY 357
Query: 116 IYLTGNLLTGK-VPQWMFGRGPEN----IDLSYNNFADESSGS 153
+ L+ + + + + F + ++L+ N + S +
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 44/230 (19%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH 503
+ + +G GG G V+ + +A+K++ Q + + EI I L H +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 504 LVKLY--------------GCCIEGNQLLLIYEYLENNSLARALFG---PEEHRLKLDWP 546
+VK++ G E N + ++ EY+E + LA L EEH
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPLLEEHA------ 122
Query: 547 TRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTH 605
+ RGL Y+H + ++HRD+K N+ ++ +DL KI DFGLA++ + +H
Sbjct: 123 --RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 606 -------ISTRVAGTFGYMAPEYAMRGHLTDKA-DVYSFGIVALEIVSGR 647
+ T+ Y +P + + KA D+++ G + E+++G+
Sbjct: 178 KGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 56/230 (24%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSK---QGNREFVNEIGTISALQ 500
++V IG+G FG V K +A+K + + + Q E I L+
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-------IRILE 148
Query: 501 H---------PHLVKLYGC-------CI--EGNQLLLI--YEYLENNSLARALFGPEEHR 540
H +++ + C+ E LL + YE ++ N F
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFE---LLSMNLYELIKKNK-----FQG---- 196
Query: 541 LKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP--KISDFGLA-K 597
P I + L LH + +I+H D+K N+LL + K+ DFG +
Sbjct: 197 --FSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251
Query: 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
+ T+I +R F Y APE + D++S G + E+++G
Sbjct: 252 EHQRVYTYIQSR----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 54/249 (21%), Positives = 96/249 (38%), Gaps = 58/249 (23%)
Query: 428 GLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSK--- 483
G D + ++ + + +++ + IG+G FG V K + +A+K + K
Sbjct: 36 GYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN 95
Query: 484 QGNREFVNEIGTISALQH---------PHLVKLYGC-------CI--EGNQLLL---IYE 522
Q E + L+ ++V L C+ E +L +Y+
Sbjct: 96 QAQIE-------VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----MLSYNLYD 144
Query: 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL 582
L N + F + + L +L L I+H D+K N+LL
Sbjct: 145 LLRNTN-----FRG------VSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILL 192
Query: 583 DKDLNP--KISDFGLA-KLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKA-DVYSFGI 638
KI DFG + +L + +I +R F Y +PE + G D A D++S G
Sbjct: 193 CNPKRSAIKIVDFGSSCQLGQRIYQYIQSR----F-YRSPEVLL-GMPYDLAIDMWSLGC 246
Query: 639 VALEIVSGR 647
+ +E+ +G
Sbjct: 247 ILVEMHTGE 255
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 25/154 (16%), Positives = 53/154 (34%), Gaps = 32/154 (20%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLPDLRN 62
V + +LP L +L + + ++ E D +
Sbjct: 256 VYNCPNLTKLPTFLKAL------------------PEMQLINVACNRGISGEQLKDDWQA 297
Query: 63 RTF-------KNLILRSCNL-TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVD 114
+ + + NL T + L ++ ++ +L+ +N+L G +P F +
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLA 356
Query: 115 FIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNF 146
+ L N +T +P G EN+ ++N
Sbjct: 357 SLNLAYNQITE-IPANFCGFTEQVENLSFAHNKL 389
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 15/154 (9%), Positives = 35/154 (22%), Gaps = 18/154 (11%)
Query: 6 QSNRLSGELPEELGSL------------IHSGKWFGWANSVWHYFSESLTDLRISDLNGP 53
+ SG +P+ +G L + + S+
Sbjct: 89 EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKT 148
Query: 54 E-ATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLAD 112
P + S + + + N + + ++ RL
Sbjct: 149 FVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTK 207
Query: 113 VDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNF 146
+ Y+ + + EN + Y
Sbjct: 208 LRQFYMGNSPFVAENIC----EAWENENSEYAQQ 237
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 27/183 (14%), Positives = 49/183 (26%), Gaps = 62/183 (33%)
Query: 6 QSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG-PEATLPDLRN 62
N+L G GS I L L ++ + P
Sbjct: 338 LYNQLEG-KLPAFGSEI------------------KLASLNLAYNQITEIPANFCGFTEQ 378
Query: 63 --------------------RTFKNLI---LRSCNLTG-------ELPHFLGEVSEMKVL 92
++ + + L + + +
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 93 DLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENI---------DLSY 143
+LS N+++ E F+ + + I L GN+LT +P+ EN DL +
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFKNTYLLTSIDLRF 497
Query: 144 NNF 146
N
Sbjct: 498 NKL 500
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 13/140 (9%), Positives = 31/140 (22%), Gaps = 40/140 (28%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFK 66
N S P + + +L I +
Sbjct: 522 YNSFSK-FPTQPLNS------------------STLKGFGIRN----------------- 545
Query: 67 NLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGK 126
+ E P + + L + N + + E ++ + + N
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISI 602
Query: 127 VPQWMFGRGPENI-DLSYNN 145
++ + L Y+
Sbjct: 603 DLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 13/152 (8%), Positives = 35/152 (23%), Gaps = 36/152 (23%)
Query: 6 QSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLPDLRNR 63
SN ++ + + + L L + +
Sbjct: 191 LSNNITF-VSKAVMRL------------------TKLRQFYMGNSPFVAENICE------ 225
Query: 64 TFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLL 123
++N + ++ +++ +P L ++ I + N
Sbjct: 226 AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285
Query: 124 TGKVPQWMFGRGP---------ENIDLSYNNF 146
+ + I + YNN
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 19/174 (10%), Positives = 52/174 (29%), Gaps = 36/174 (20%)
Query: 7 SNRLSG----ELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDL-------NGPEA 55
S+ P+ + + + + F + SDL + +
Sbjct: 114 SHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQK 173
Query: 56 TLPDLRNRTFKN--LILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNG------------ 101
++ T K+ + S N+T + + +++++ + +
Sbjct: 174 SIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS 232
Query: 102 -------TIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNF 146
T + L D+ + + K+P + P + I+++ N
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF-LKALPEMQLINVACNRG 285
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 24/158 (15%), Positives = 44/158 (27%), Gaps = 39/158 (24%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLPDLRNRT 64
+N++S E + L+ + + L N
Sbjct: 442 NNQISKFPKELFSTG------------------SPLSSINLMGNMLTEIPKNSLKDENEN 483
Query: 65 FKN------LILRSCNLTGELP--HFLGEVSEMKVLDLSFNKLNGTIPESFARLAD---- 112
FKN + LR LT L + + +DLS+N + P +
Sbjct: 484 FKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGF 541
Query: 113 --VDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNF 146
+ GN + P+ P + + N+
Sbjct: 542 GIRNQRDAQGNRTLREWPEG-ITLCPSLTQLQIGSNDI 578
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 12/90 (13%), Positives = 28/90 (31%), Gaps = 6/90 (6%)
Query: 66 KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNG----TIPESFARLADVDFIYLTGN 121
L L +G +P +G+++E++VL L + P+ + +
Sbjct: 84 TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRM 143
Query: 122 LLTGKVPQWMFGRGPENIDLSYNNFADESS 151
+ + DL + +
Sbjct: 144 HYQKTFVDYDPRE--DFSDLIKDCINSDPQ 171
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 16/96 (16%), Positives = 28/96 (29%), Gaps = 26/96 (27%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG-PEATLPDLRNR 63
NR E PE + SLT L+I + E P++
Sbjct: 551 GNRTLREWPEGITLC------------------PSLTQLQIGSNDIRKVNEKITPNI--- 589
Query: 64 TFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKL 99
L ++ ++ E + L ++K
Sbjct: 590 --SVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 39/250 (15%), Positives = 78/250 (31%), Gaps = 47/250 (18%)
Query: 446 NHFDVANKIGEGGFGPVYKGL---------LADGTLIAVKQLSAKSKQGNREFVNEIGTI 496
+ + + G +Y+ ++K L AK + E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 497 SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARAL----FGP-------EEHRLKLDW 545
LQ KLY + + + + R L G + L
Sbjct: 101 KPLQVNKWKKLYSTPLLA--IPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSE 158
Query: 546 PTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI--SDFGLAKLDEEDN 603
+ + + L +LHE VH ++ A N+ +D + ++ + +G A
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 604 THISTR------VAGTFGYMAPEYA-MRGHL----TDKADVYSFGIVALEIVSGR---SN 649
H++ G E+ M H + ++D+ S G L+ + G +N
Sbjct: 216 KHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270
Query: 650 IMCKTKEEKF 659
+ T++
Sbjct: 271 CLPNTEDIMK 280
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 39/201 (19%), Positives = 79/201 (39%), Gaps = 35/201 (17%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISAL---- 499
+++ K+G+G +G V+K + G ++AVK++ F N
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 500 ------QHPHLVKLYGCCI--EGNQLLLIYEYLENNSLARALFGP---EEHRLKLDWPTR 548
H ++V L + L+++Y+E + L + H+
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVIRANILEPVHK-------- 111
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 608
+ + + + YLH S ++HRD+K +N+LL+ + + K++DFGL++ +
Sbjct: 112 QYVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 609 RVAGTFGYMAPEYAMRGHLTD 629
+ LTD
Sbjct: 169 IPLSINENTENFDDDQPILTD 189
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 51/267 (19%), Positives = 93/267 (34%), Gaps = 74/267 (27%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ--- 500
+ V K+G G F V+ + +A+K + + ++EI + +++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSD 94
Query: 501 --HP---HLVKLYGC----CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNI 551
P +V+L + G + +++E L + L + + L L P I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPL--PCVKKI 151
Query: 552 CIGIARGLAYLHEESRLKIVHRDIKATNVLL----------------------------- 582
+ +GL YLH ++ +I+H DIK N+LL
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 583 --------------------DKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFGYMAPEY 621
+ L KI+D G A + + I TR Y + E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEV 264
Query: 622 AMRGHLTDKADVYSFGIVALEIVSGRS 648
+ AD++S +A E+ +G
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDY 291
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 35/179 (19%), Positives = 64/179 (35%), Gaps = 23/179 (12%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL 504
N + + KIG GGFG +Y A + + ++ F +E+ +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDC 95
Query: 505 VKLYGCCIEGNQL---------LLIYEYLENNSLARALFGP------EEHRLKLDWPTRH 549
+K + + + L L ++ + G ++ T
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVL 154
Query: 550 NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI--SDFGLAKLDEEDNTHI 606
+ I + L Y+HE VH DIKA N+LL ++ +D+GL+ + H
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 19/123 (15%), Positives = 41/123 (33%), Gaps = 14/123 (11%)
Query: 41 SLTDLRISD----LNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSF 96
SL L+++ N + N L L C L + +++L++S
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTTN--LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH 506
Query: 97 NKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADESSGSD 154
N L + +L + + + N + + +L+ N+ A
Sbjct: 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVA-----CI 560
Query: 155 CQN 157
C++
Sbjct: 561 CEH 563
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 20/114 (17%), Positives = 39/114 (34%), Gaps = 10/114 (8%)
Query: 41 SLTDLRISDLNG------PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDL 94
+ ++L+ DL+ + L + NLIL + P ++ ++ L
Sbjct: 54 NFSELQWLDLSRCEIETIEDKAWHGLHH--LSNLILTGNPIQSFSPGSFSGLTSLENLVA 111
Query: 95 SFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNF 146
KL +L + + + N + F ++DLSYN
Sbjct: 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI 165
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 21/90 (23%), Positives = 34/90 (37%), Gaps = 3/90 (3%)
Query: 66 KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTG 125
KN+ L L + SE++ LDLS ++ +++ L + + LTGN +
Sbjct: 35 KNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94
Query: 126 KVPQWMFGRGP--ENIDLSYNNFADESSGS 153
P F EN+ A S
Sbjct: 95 FSPGS-FSGLTSLENLVAVETKLASLESFP 123
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 18/116 (15%), Positives = 36/116 (31%), Gaps = 8/116 (6%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELP-HFLGEVSEMKVLDLSFNKL 99
L+ ++ L +L++ L + L + ++ LD+S+
Sbjct: 382 DLSFNGAIIMSANFMGLEELQH-----LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436
Query: 100 NGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADESSGS 153
F L ++ + + GN +F +DLS S G
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 13/151 (8%), Positives = 41/151 (27%), Gaps = 12/151 (7%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFK 66
N S + + + + + + +L I + + + L + T
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHV----HRLILGEFKDERNLEIFEPS----IMEGLCDVTID 264
Query: 67 NLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGK 126
L N + ++ + + L+ + E + + + L
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQF 322
Query: 127 VPQWMFGRGPENIDLSYNNFADESSGSDCQN 157
+ +++ L+ N + +
Sbjct: 323 PTLDL--PFLKSLTLTMNKGSISFKKVALPS 351
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 21/127 (16%), Positives = 44/127 (34%), Gaps = 14/127 (11%)
Query: 41 SLTDLRISD--LNG-PEATLPDLRNRTFKNLILRSCNLTG-ELPHFLGEVSEMKVLDLSF 96
SL +L + L + L K L + + +LP + ++ + +DLS+
Sbjct: 105 SLENLVAVETKLASLESFPIGQLIT--LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 97 NKLNGTIPESFARLADVDF----IYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADES 150
N + L + + ++ N + + F +G + L N +
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAF-QGIKLHELTLRGNFNSSNI 220
Query: 151 SGSDCQN 157
+ QN
Sbjct: 221 MKTCLQN 227
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 29/180 (16%), Positives = 52/180 (28%), Gaps = 29/180 (16%)
Query: 6 QSNRLSGELPEELGSL------------IHSGKWFGWANSVWHYFSESLTDLRISDLNG- 52
+ +LP+ L L S + ++ ++I +
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558
Query: 53 ------PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPES 106
A+L + L + L F G ++ L L +N++ IPE
Sbjct: 559 NLEEFPASASLQKMVK--LGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIE-EIPED 613
Query: 107 -FARLADVDFIYLTGNLLTGKVPQWMFGRGPEN---IDLSYNNFADESSGSDCQNGAVNL 162
A V+ + + N L +P + +D SYN E C
Sbjct: 614 FCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 13/152 (8%), Positives = 37/152 (24%), Gaps = 37/152 (24%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLPDLRNRT 64
+NR++ + + + L L + ++ +
Sbjct: 434 TNRITF-ISKAIQRL------------------TKLQIIYFANSPFTYDNIAVDWE---- 470
Query: 65 FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLT 124
+ + ++ ++L +P+ L ++ + + N
Sbjct: 471 --DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGI 528
Query: 125 GKVPQWM--------FGRGP--ENIDLSYNNF 146
GP + + YNN
Sbjct: 529 SAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 24/160 (15%), Positives = 51/160 (31%), Gaps = 39/160 (24%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG--PEATLPDL 60
+ N++ E+PE+ + ++ + L S L +
Sbjct: 602 LDYNQIE-EIPEDFCAF-----------------TDQVEGLGFSHNKLKYIPNIFNAKSV 643
Query: 61 RNRTFKNLILRSCNLTGELPHFLGEVSE-----MKVLDLSFNKLNGTIPESFARLADVDF 115
++ + E + + + + LS+N++ E FA + +
Sbjct: 644 YV--MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIST 701
Query: 116 IYLTGNLLTGKVPQWMFGRGPENI---------DLSYNNF 146
I L+ NL+T +P+ N DL +N
Sbjct: 702 IILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 14/82 (17%), Positives = 28/82 (34%), Gaps = 4/82 (4%)
Query: 68 LILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKV 127
L L G +P +G+++E+KVL + + D + +
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387
Query: 128 PQWMFGRGPENI---DLSYNNF 146
+ MF + + DL +
Sbjct: 388 KK-MFLDYDQRLNLSDLLQDAI 408
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 21/161 (13%), Positives = 40/161 (24%), Gaps = 18/161 (11%)
Query: 6 QSNRLSGELPEELGSLIH-------------SGKWFGWANSVWHYFSESLTDLRISDLNG 52
G +P+ +G L SG+ FG E +R+
Sbjct: 331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390
Query: 53 PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLAD 112
L + + + + N++ I ++ RL
Sbjct: 391 FLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI-TFISKAIQRLTK 449
Query: 113 VDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGS 153
+ IY + T E+ + Y + S
Sbjct: 450 LQIIYFANSPFTYDNIA----VDWEDANSDYAKQYENEELS 486
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 13/140 (9%), Positives = 28/140 (20%), Gaps = 40/140 (28%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFK 66
N S P + + L I
Sbjct: 762 YNCFS-SFPTQPLNS------------------SQLKAFGIRH----------------- 785
Query: 67 NLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGN-LLTG 125
+ + P + + L + N + + E + + + N ++
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISI 842
Query: 126 KVPQWMFGRGPENIDLSYNN 145
V L Y+
Sbjct: 843 DVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 15/151 (9%), Positives = 45/151 (29%), Gaps = 23/151 (15%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLN 100
L I+ + D R I N + + +++++++ + +
Sbjct: 402 DLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFT 461
Query: 101 G-------------------TIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENID 140
S++ L D+ + L ++P +++ ++++
Sbjct: 462 YDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521
Query: 141 LSYNNFADESSGSDCQNGAVNLFASSSKGSN 171
++ N S + + L G
Sbjct: 522 IACNRG---ISAAQLKADWTRLADDEDTGPK 549
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 7/73 (9%), Positives = 22/73 (30%)
Query: 73 CNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMF 132
+ L + L L+ G +P++ +L ++ + + T +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 133 GRGPENIDLSYNN 145
++ +
Sbjct: 369 EELTPDMSEERKH 381
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 17/108 (15%), Positives = 39/108 (36%), Gaps = 6/108 (5%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLN 100
+ D+ D+ A L + +++ L+ + S ++ LDL+ L+
Sbjct: 234 TFEDMDDEDI--SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291
Query: 101 GTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNF 146
+P L+ + + L+ N + Q P ++ + N
Sbjct: 292 -ELPSGLVGLSTLKKLVLSANKFEN-LCQISASNFPSLTHLSIKGNTK 337
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 18/120 (15%), Positives = 32/120 (26%), Gaps = 11/120 (9%)
Query: 42 LTDLRISDLNG------PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLS 95
L +L DL E T L+L + L L +K L
Sbjct: 56 LINLTFLDLTRCQIYWIHEDTFQSQHR--LDTLVLTANPLIFMAETALSGPKALKHLFFI 113
Query: 96 FNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADESSGS 153
++ ++ +YL N ++ + + +D N S
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISS-IKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 24/130 (18%), Positives = 47/130 (36%), Gaps = 14/130 (10%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRTFKN------LILRSCNLTGELPHFLGEVSEMKVLDL 94
S+ + + ++ + TF L L + +L+ ELP L +S +K L L
Sbjct: 255 SVESINLQKHY-----FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308
Query: 95 SFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADESSG 152
S NK S + + + + GN ++ +DLS+++
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 153 SDCQNGAVNL 162
+ +L
Sbjct: 369 NLQLRNLSHL 378
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 24/125 (19%), Positives = 45/125 (36%), Gaps = 17/125 (13%)
Query: 41 SLTDLRISD------LNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDL 94
+L L + +L L + L+L C+L+ H + M +DL
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGR--LEILVLSFCDLSSIDQHAFTSLKMMNHVDL 507
Query: 95 SFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADESSG 152
S N+L + E+ + L + ++ L N ++ + + I+L N
Sbjct: 508 SHNRLTSSSIEALSHLKGI-YLNLASNHISI-ILPSLLPILSQQRTINLRQNPLD----- 560
Query: 153 SDCQN 157
C N
Sbjct: 561 CTCSN 565
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 11/90 (12%), Positives = 27/90 (30%), Gaps = 3/90 (3%)
Query: 66 KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTG 125
+ L L + + LDL+ ++ ++F +D + LT N L
Sbjct: 36 ECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF 95
Query: 126 KVPQWMFGRGP--ENIDLSYNNFADESSGS 153
+ + +++ +
Sbjct: 96 -MAETALSGPKALKHLFFIQTGISSIDFIP 124
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 26/123 (21%), Positives = 44/123 (35%), Gaps = 14/123 (11%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRTFKNLI------LRSCNLT--GELPHFLGEVSEMKVL 92
SLT L I N L +NL L ++ L +S ++ L
Sbjct: 326 SLTHLSIKG-NTKRLELGT---GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381
Query: 93 DLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFADES 150
+LS+N+ E+F ++ + L L K Q F + ++LS++ S
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS 441
Query: 151 SGS 153
Sbjct: 442 EQL 444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 22/162 (13%), Positives = 47/162 (29%), Gaps = 25/162 (15%)
Query: 6 QSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNG-PEATLPDLRN 62
+N L L ++L L ++ L + +
Sbjct: 89 TANPLIFMAETALSGP------------------KALKHLFFIQTGISSIDFIPLHNQKT 130
Query: 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLA--DVDFIYLTG 120
++L L S +++ ++KVLD N ++ E + L + L G
Sbjct: 131 --LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 121 NLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNL 162
N + G P ++++ + +L
Sbjct: 189 NDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 17/124 (13%), Positives = 42/124 (33%), Gaps = 12/124 (9%)
Query: 41 SLTDLRISDLNG------PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDL 94
L++ D + + L+ T +L L ++ + + + + L+
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNF 209
Query: 95 SFNKLNGTIPESFA-----RLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADE 149
+ I + L F + ++ V + + E+I+L + F +
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI 269
Query: 150 SSGS 153
SS +
Sbjct: 270 SSNT 273
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 25/124 (20%), Positives = 42/124 (33%), Gaps = 16/124 (12%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRTFKN------LILRSCNLTG-ELPHFLGEVSEMKVLD 93
L L +S N L+ FK L L L + + +KVL+
Sbjct: 377 HLQSLNLSY-NE----PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 94 LSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQW--MFGRGP--ENIDLSYNNFADE 149
LS + L+ + + F L + + L GN Q E + LS+ + +
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 150 SSGS 153
+
Sbjct: 492 DQHA 495
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 32/151 (21%), Positives = 59/151 (39%), Gaps = 6/151 (3%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRT 64
V N + ++ + I + F + H I D + T L +
Sbjct: 211 VSGNGWTVDITGNFSNAISKSQAFSLILAH-HIMGAGFGFHNIKDP--DQNTFAGLARSS 267
Query: 65 FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLT 124
++L L + + ++KVL+L++NK+N E+F L ++ + L+ NLL
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327
Query: 125 GKVPQWMFGRGP--ENIDLSYNNFADESSGS 153
++ F P IDL N+ A +
Sbjct: 328 -ELYSSNFYGLPKVAYIDLQKNHIAIIQDQT 357
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 28/123 (22%), Positives = 44/123 (35%), Gaps = 15/123 (12%)
Query: 36 HYFSESLTDLRISDLNG-------PEATLPDLRNRTFKNLILRSCNLTGE-----LPHFL 83
YF + L+I LN + T + + + L L L
Sbjct: 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS--LEQLFLGENMLQLAWETELCWDVF 476
Query: 84 GEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSY 143
+S ++VL L+ N LN P F+ L + + L N LT + E +D+S
Sbjct: 477 EGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISR 535
Query: 144 NNF 146
N
Sbjct: 536 NQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 21/117 (17%), Positives = 40/117 (34%), Gaps = 12/117 (10%)
Query: 40 ESLTDLRISDLNG------PEATLPDLRNRTFKNLILRSCNLTGEL-PHFLGEVSEMKVL 92
+ L L+ ++ P L + L L S + + +++L
Sbjct: 21 QVLNTTERLLLSFNYIRTVTASSFPFLEQ--LQLLELGSQYTPLTIDKEAFRNLPNLRIL 78
Query: 93 DLSFNKLNGTIPESFARLADVDFIYLTGNLLTGK-VPQWMFGRGP--ENIDLSYNNF 146
DL +K+ P++F L + + L L+ + F +DLS N
Sbjct: 79 DLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 20/83 (24%), Positives = 32/83 (38%), Gaps = 6/83 (7%)
Query: 66 KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTG 125
+ R CNLT ++P L + + L LSFN + SF L + + L
Sbjct: 7 RIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 126 KVPQWMFGRGP--ENIDLSYNNF 146
+ + F P +DL +
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKI 85
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 26/120 (21%), Positives = 42/120 (35%), Gaps = 12/120 (10%)
Query: 36 HYFSESLTDLRISDLNGPEATLPDLRNRTFKN------LILRSCNLTGEL-PHFLGEVSE 88
SL +L D++ N F L + + P E+
Sbjct: 414 FSVFLSLRNLIYLDISHTH--TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471
Query: 89 MKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNF 146
+ LDLS +L P +F L+ + + + N L VP +F R + I L N +
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 20/114 (17%), Positives = 36/114 (31%), Gaps = 10/114 (8%)
Query: 41 SLTDLRISDLNG------PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDL 94
S +L++ DL+ + L + LIL + +S ++ L
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSH--LSTLILTGNPIQSLALGAFSGLSSLQKLVA 107
Query: 95 SFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNF 146
L L + + + NL+ F E++DLS N
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 16/117 (13%), Positives = 40/117 (34%), Gaps = 11/117 (9%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRTFKN------LILRSCNLTGELPHFLGEVSEMKVLDL 94
L L DL+ + +++ L L + + + +++ LD
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 403
Query: 95 SFNKLNGTIPES-FARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFAD 148
+ L S F L ++ ++ ++ +F E + ++ N+F +
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQE 459
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 53/254 (20%), Positives = 84/254 (33%), Gaps = 88/254 (34%)
Query: 445 TNHFDVANKIGEGGFGPVYKG--LLADGTLIAVKQLSAKSK---QGNREFVNEIGTISAL 499
+++ +GEG FG V + + +A+K + K E I+ L
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-------INVL 70
Query: 500 QH---------PHLVKLYGC-------CI--EGNQLLL---IYEYLENNSLARALFGPEE 538
+ V + CI E LL +E+L+ N+ F P
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEFLKENN-----FQPYP 121
Query: 539 HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP---------- 588
RH + + L +LHE ++ H D+K N+L
Sbjct: 122 LPH-----VRH-MAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172
Query: 589 ---------KISDFGLAKLDEED-NTHISTRVAGTFGYMAPE------YAMRGHLTDKAD 632
+++DFG A D E T ++TR Y PE +A D
Sbjct: 173 EKSVKNTSIRVADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQ------PCD 221
Query: 633 VYSFGIVALEIVSG 646
V+S G + E G
Sbjct: 222 VWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 56/256 (21%), Positives = 91/256 (35%), Gaps = 92/256 (35%)
Query: 445 TNHFDVANKIGEGGFGPVYKG--LLADGTLIAVKQLSAKSK---QGNREFVNEIGTISAL 499
+ +++ + +GEG FG V + A G +AVK + + E I L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-------IQVL 65
Query: 500 QH---------PHLVKLYGC-------CI--EGNQLLL---IYEYLENNSLARALFGPEE 538
+H V++ CI E LL Y++++ N F P
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE----LLGLSTYDFIKENG-----FLP-- 114
Query: 539 HRLKLDWPTRH--NICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP-------- 588
+ H + I + + +LH K+ H D+K N+L +
Sbjct: 115 ------FRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIK 165
Query: 589 -----------KISDFGLAKLDEED-NTHISTRVAGTFGYMAPE------YAMRGHLTDK 630
K+ DFG A D+E +T +STR Y APE ++
Sbjct: 166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------P 214
Query: 631 ADVYSFGIVALEIVSG 646
DV+S G + +E G
Sbjct: 215 CDVWSIGCILIEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 56/258 (21%), Positives = 88/258 (34%), Gaps = 92/258 (35%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSK---QGNREFVNEIGTISALQ 500
N F V K+G+G FG V + + AVK + K E L+
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-------ADILK 86
Query: 501 H--------PHLVKLYGC-------CI--EGNQLLL---IYEYLENNSLARALFGPEEHR 540
++VK +G C+ E L +YE + N+ +
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFE----PLGPSLYEIITRNN-----YNGFHIE 137
Query: 541 LKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP------------ 588
+ CI I + L YL + + + H D+K N+LLD
Sbjct: 138 D-----IKL-YCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188
Query: 589 -------------KISDFGLAKLDEED-NTHISTRVAGTFGYMAPE------YAMRGHLT 628
K+ DFG A + + I+TR Y APE + +
Sbjct: 189 KKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTR----Q-YRAPEVILNLGWDV----- 238
Query: 629 DKADVYSFGIVALEIVSG 646
+D++SFG V E+ +G
Sbjct: 239 -SSDMWSFGCVLAELYTG 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 1e-06
Identities = 64/374 (17%), Positives = 113/374 (30%), Gaps = 110/374 (29%)
Query: 418 PKYTSERELRGLDLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQ 477
KY R L L+ LR K G G G K +A ++ K
Sbjct: 127 AKYNVSRLQPYLKLRQALLELRPAKNVLID-------GVLGSG---KTWVALDVCLSYKV 176
Query: 478 LSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPE 537
+ +I + L C +L E L+ L
Sbjct: 177 Q--------CKMDFKI---------FWLNL-KNCNSPETVL---EMLQK------LL--- 206
Query: 538 EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVL--LDKDL-NPKISD-F 593
+++ +W +R + I + + E R + + + N L L ++ N K + F
Sbjct: 207 -YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE--NCLLVLL-NVQNAKAWNAF 262
Query: 594 GL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMC 652
L K ++TR +TD + ++L+ S
Sbjct: 263 NLSCK------ILLTTRFKQ--------------VTDFLSAATTTHISLDHHSMTL---- 298
Query: 653 KTKEE-KFYLLDWALL----LKEQ---GNLMEL--------VDPNLGSN---VDKEQVRV 693
T +E K LL + L + N L N V+ +++
Sbjct: 299 -TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT 357
Query: 694 MINVALLCAD------------VSPTNRPLMSSVVSMLEGRVGVPDIVQDSSVSNKDESK 741
+I +L + V P + + + ++S++ V + V V NK
Sbjct: 358 IIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV-IKSDVMV--VVNKLHKY 414
Query: 742 SEAMR--KYYQFSI 753
S + K SI
Sbjct: 415 SLVEKQPKESTISI 428
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 25/167 (14%), Positives = 48/167 (28%), Gaps = 29/167 (17%)
Query: 4 TVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPE-----ATLP 58
T+++ ++G P L L L + +++ A L
Sbjct: 101 TLENLEVTGTAPPPLLEATGP----------------DLNILNLRNVSWATRDAWLAELQ 144
Query: 59 DLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFA----RLADVD 114
K L + + + + LDLS N G A + +
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204
Query: 115 FIYLTGNLLT--GKVPQWMFGRGP--ENIDLSYNNFADESSGSDCQN 157
+ L + V + + +DLS+N+ D + C
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 22/124 (17%), Positives = 41/124 (33%), Gaps = 26/124 (20%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPD----L 60
++++ LS L + L L +L + P
Sbjct: 213 IRNSPLS-ALGPAIHHL------------------PKLEELDLRGCTALR-NYPPIFGGR 252
Query: 61 RNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTG 120
K LIL+ C+ LP + +++++ LDL +P A+L I +
Sbjct: 253 AP--LKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310
Query: 121 NLLT 124
+L
Sbjct: 311 HLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 22/122 (18%), Positives = 43/122 (35%), Gaps = 7/122 (5%)
Query: 7 SNRLSGELPEELGSL-IHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTF 65
S L + L H +S W + + + +AT L + T
Sbjct: 22 STALR-PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQ 80
Query: 66 KNLI---LRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL 122
+ LRS L + P +S ++ + + L +P++ + A ++ + L N
Sbjct: 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNP 138
Query: 123 LT 124
L
Sbjct: 139 LR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 26/131 (19%), Positives = 46/131 (35%), Gaps = 33/131 (25%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLPD--- 59
++ + LP + +L +L L+I + L+ L
Sbjct: 190 LEWTGIR-SLPASIANLQ------------------NLKSLKIRNSPLS----ALGPAIH 226
Query: 60 -LRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLS-FNKLNGTIPESFARLADVDFIY 117
L + L LR C P G + +K L L + L T+P RL ++ +
Sbjct: 227 HLPK--LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL-LTLPLDIHRLTQLEKLD 283
Query: 118 LTGNLLTGKVP 128
L G + ++P
Sbjct: 284 LRGCVNLSRLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 4e-04
Identities = 22/146 (15%), Positives = 38/146 (26%), Gaps = 46/146 (31%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISD--LNGPEATLPD----L 60
S L + P++ L L + I L LPD
Sbjct: 90 SVPLP-QFPDQAFRL------------------SHLQHMTIDAAGLM----ELPDTMQQF 126
Query: 61 RNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTG 120
+ L L L LP + ++ ++ L + +PE A
Sbjct: 127 AG--LETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV 183
Query: 121 NLLTGKVPQWMFGRGPENIDLSYNNF 146
NL +++ L +
Sbjct: 184 NL--------------QSLRLEWTGI 195
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 30/144 (20%), Positives = 50/144 (34%), Gaps = 14/144 (9%)
Query: 4 TVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNG-PEATLPDLRN 62
+V N+L+ LP L N+ + L+ ++G +LP L +
Sbjct: 187 SVSDNQLA-SLPTLPSEL----YKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPS 241
Query: 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL 122
K L++ LT LP + L + N+L +PES L+ + L GN
Sbjct: 242 E-LKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295
Query: 123 LTGKVPQWMFGRGPENIDLSYNNF 146
L+ R +
Sbjct: 296 LS--ERTLQALREITSAPGYSGPI 317
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 29/112 (25%), Positives = 49/112 (43%), Gaps = 11/112 (9%)
Query: 40 ESLTDLRISDLNG----PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLS 95
SL L + +L E L N + L L CNL E+P+ + ++ LDLS
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSN--LRYLNLAMCNLR-EIPNLTP-LIKLDELDLS 215
Query: 96 FNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNN 145
N L+ P SF L + +++ + + + + F I+L++NN
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNN 266
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 18/118 (15%), Positives = 34/118 (28%), Gaps = 14/118 (11%)
Query: 38 FSESLTDLRISDLNG-------PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMK 90
+ S L +L + L K L L S L + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIYDVKGQVVFAKL-----KTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 91 VLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFAD 148
+ L NKL I ++ +++ L GN + F + ++
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 18/117 (15%), Positives = 34/117 (29%), Gaps = 14/117 (11%)
Query: 38 FSESLTDLRISDLNG-------PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMK 90
+ S L +L + L K L L S L + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIYDVKGQVVFAKL-----KTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 91 VLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFA 147
+ L NKL I ++ +++ L GN + F + ++
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 17/85 (20%), Positives = 29/85 (34%), Gaps = 5/85 (5%)
Query: 66 KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTG 125
K + +L L +K LDLS N L+ A ++ + L+ N+L
Sbjct: 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE 72
Query: 126 KVPQWMFGRGP--ENIDLSYNNFAD 148
+DL+ N +
Sbjct: 73 -TLD--LESLSTLRTLDLNNNYVQE 94
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 24/111 (21%), Positives = 49/111 (44%), Gaps = 11/111 (9%)
Query: 41 SLTDLRISDLNG----PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSF 96
SL L + +L E L N K L L CN+ ++P+ + ++ L++S
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFN--LKYLNLGMCNIK-DMPNLTP-LVGLEELEMSG 227
Query: 97 NKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNN 145
N P SF L+ + +++ + ++ + + F ++L++NN
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNN 277
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 29/146 (19%), Positives = 49/146 (33%), Gaps = 7/146 (4%)
Query: 4 TVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNR 63
+ N + + I K S + S D T L
Sbjct: 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP--DNFTFKGLEAS 275
Query: 64 TFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPE-SFARLADVDFIYLTGNL 122
K L + L ++++ L L+ N++N I + +F L + + L+ N
Sbjct: 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNF 334
Query: 123 LTGKVPQWMFGRGP--ENIDLSYNNF 146
L + MF E +DLSYN+
Sbjct: 335 LG-SIDSRMFENLDKLEVLDLSYNHI 359
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 22/142 (15%), Positives = 50/142 (35%), Gaps = 6/142 (4%)
Query: 27 WFGWANSVWHYFSESLTDLRISDLNGPEA--TLPDLRNRTFKNLILRSCNLTGELPHFLG 84
+ S + +L L + + + L + T + L + L +L
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307
Query: 85 EVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWM--FGRGP--ENID 140
+ ++K + + +K+ L ++F+ L+ NL+ + + G P + +
Sbjct: 308 LLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367
Query: 141 LSYNNFADESSGSDCQNGAVNL 162
LS N+ + NL
Sbjct: 368 LSQNHLRSMQKTGEILLTLKNL 389
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 27/132 (20%), Positives = 48/132 (36%), Gaps = 13/132 (9%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNG-PEATLPDLRNR 63
V +N+L+ LPE L ++ N+ E T L + + LP+L
Sbjct: 127 VDNNQLT-MLPELPALL----EYINADNNQLTMLPELPTSLEVLSVRNNQLTFLPELPES 181
Query: 64 TFKNLILRSCNLTGELPHFLGEVSEMK----VLDLSFNKLNGTIPESFARLADVDFIYLT 119
+ L + + L LP + N++ IPE+ L I L
Sbjct: 182 -LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILE 238
Query: 120 GNLLTGKVPQWM 131
N L+ ++ + +
Sbjct: 239 DNPLSSRIRESL 250
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 21/113 (18%), Positives = 44/113 (38%), Gaps = 12/113 (10%)
Query: 40 ESLTDLRISDLNG------PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLD 93
+ L DL+ ++ + L + + L L + + +KVLD
Sbjct: 245 LNYPGLVEVDLSYNELEKIMYHPFVKMQR--LERLYISNNRLV-ALNLYGQPIPTLKVLD 301
Query: 94 LSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNF 146
LS N L + + + ++ +YL N + + +N+ LS+N++
Sbjct: 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTH-HTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 16/108 (14%), Positives = 40/108 (37%), Gaps = 9/108 (8%)
Query: 41 SLTDLRISDLNGPEA-TLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKL 99
+ G E TL + + + ++ + L ++++L+L+ ++
Sbjct: 27 HIDMQTQDVYFGFEDITLNNQKI-----VTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 81
Query: 100 NGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNN 145
+FA + +Y+ N + +P +F P + L N+
Sbjct: 82 EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 128
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 11/116 (9%)
Query: 41 SLTDLRISDLNG------PEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDL 94
S + + +LN + L + + PH V + VL L
Sbjct: 67 SFRQVELLNLNDLQIEEIDTYAFAYAHT--IQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124
Query: 95 SFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNFAD 148
N L+ F + + ++ N L ++ F +N+ LS N
Sbjct: 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH 179
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 19/106 (17%), Positives = 43/106 (40%), Gaps = 8/106 (7%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLN 100
L+ + + ++ + L + + L L + + +KVLDLS N L
Sbjct: 260 DLSYNELEKI--MYHPFVKMQR--LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314
Query: 101 GTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNF 146
+ + + ++ +YL N + + +N+ LS+N++
Sbjct: 315 -HVERNQPQFDRLENLYLDHNSIV-TLKLSTH-HTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 16/110 (14%), Positives = 40/110 (36%), Gaps = 8/110 (7%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRTFKN---LILRSCNLTGELPHFLGEVSEMKVLDLSFN 97
D+ I + + T N + ++ + L ++++L+L+
Sbjct: 28 VFYDVHIDMQ--TQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 85
Query: 98 KLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNN 145
++ +FA + +Y+ N + +P +F P + L N+
Sbjct: 86 QIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 16/81 (19%), Positives = 39/81 (48%), Gaps = 6/81 (7%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLN 100
++ ++ ++ N P + L +L + L + ++T + L ++ + +LD+S + +
Sbjct: 72 TINNIHATNYN-PISGLSNL-----ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
Query: 101 GTIPESFARLADVDFIYLTGN 121
+I L V+ I L+ N
Sbjct: 126 DSILTKINTLPKVNSIDLSYN 146
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 12/89 (13%), Positives = 26/89 (29%), Gaps = 11/89 (12%)
Query: 58 PDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIY 117
++ N + + S NLT E+P V ++++ P ++
Sbjct: 6 RNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64
Query: 118 LTGNLLTGKVPQWMFGRGPENIDLSYNNF 146
L L ++L+
Sbjct: 65 LRDCLDRQA----------HELELNNLGL 83
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 9e-04
Identities = 27/175 (15%), Positives = 52/175 (29%), Gaps = 44/175 (25%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFK 66
S+ L+ E+P E ++ +++ + + R ++ L D +R
Sbjct: 20 SSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS----RLRDCLDRQAH 74
Query: 67 NLILRSCNLTG-------------------ELPHFLGEVSEMKVLDLSFNKLNG------ 101
L L + L+ ELP + + V + + L+
Sbjct: 75 ELELNNLGLSSLPELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKALSDLPPLLE 134
Query: 102 ----------TIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNF 146
+PE + + I + N L K+P E I N
Sbjct: 135 YLGVSNNQLEKLPE-LQNSSFLKIIDVDNNSLK-KLPDLP--PSLEFIAAGNNQL 185
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 22/114 (19%), Positives = 41/114 (35%), Gaps = 15/114 (13%)
Query: 41 SLTDLRISDLNGPEATLPDLRNRTFKN------LILRSCN-LTGELPHFLGEVSEMKVLD 93
+L L IS + N F L + + LP E+ + LD
Sbjct: 127 NLIYLDISHTH-----TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181
Query: 94 LSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNN 145
LS +L P +F L+ + + ++ N + + + + +D S N+
Sbjct: 182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNH 234
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 6/111 (5%)
Query: 40 ESLTDLRISDLNGPEATLPD-LRNRTFKNLILRSCNLTGELPHF-LGEVSEMKVLDLSFN 97
L L IS + P+ L +L + CNLT +P+ + + ++ L+LS+N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYN 258
Query: 98 KLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGP--ENIDLSYNNF 146
++ L + I L G L V + F +++S N
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQL 308
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 790 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.83 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.83 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.8 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.8 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.79 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.79 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.77 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.76 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.76 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.76 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.75 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.74 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.74 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.73 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.72 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.71 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.71 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.71 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.71 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.71 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.71 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.71 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.7 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.7 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.7 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.7 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.7 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.7 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.69 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.69 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.69 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.69 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.68 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.68 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.68 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.68 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.68 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.67 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.67 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.67 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.66 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.66 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.66 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.66 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.65 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.65 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.64 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.64 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.64 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.64 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.63 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.63 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.63 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.63 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.63 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.62 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.62 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.62 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.61 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.61 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.61 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.61 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.61 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.61 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.6 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.6 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.6 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.59 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.59 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.58 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.58 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.58 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.58 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.58 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.57 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.57 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.57 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.57 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.56 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.56 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.55 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.55 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.55 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.55 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.55 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.55 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.54 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.54 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.54 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.52 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.51 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.5 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.5 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.49 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.49 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.48 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.48 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.48 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.48 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.48 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.47 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.47 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.46 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.45 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.45 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.44 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.44 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.42 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.42 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.41 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.41 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.41 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.41 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.41 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.4 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.39 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.39 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.38 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.34 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.32 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.26 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.26 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.26 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.21 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.08 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.72 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.63 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.63 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.58 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.44 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.35 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.34 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.33 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.25 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.24 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.23 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.17 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.13 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.08 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.04 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.87 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.81 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.8 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.73 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.37 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.33 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.16 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.97 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.94 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.89 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.62 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.6 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.55 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.31 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.3 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.17 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.87 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.79 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.64 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.55 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.45 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.36 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.09 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.0 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.31 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.13 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 93.98 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.91 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.78 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.5 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=456.71 Aligned_cols=261 Identities=27% Similarity=0.445 Sum_probs=208.6
Q ss_pred cCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
++|.+.++||+|+||.||+|.+. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778899999999999999864 478899999987766667889999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCcc-----------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCe
Q 040908 520 IYEYLENNSLARALFGPEE-----------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 588 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 588 (790)
|||||++|+|.++++.... ...+++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999965321 2346999999999999999999999874 9999999999999999999
Q ss_pred EEeecCCccccCCCC-cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHH
Q 040908 589 KISDFGLAKLDEEDN-THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWAL 666 (790)
Q Consensus 589 kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 666 (790)
||+|||+|+...... ....+...||+.|||||++.+..++.++|||||||++|||+| |+.||......+. ....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~i- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---IDCI- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HHHH-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HHHH-
Confidence 999999998664433 223345779999999999999999999999999999999999 8999976543221 1111
Q ss_pred HHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcCC
Q 040908 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGV 725 (790)
Q Consensus 667 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 725 (790)
..+.. +. .+.....++.+++.+||+.||++||||.||++.|+.....
T Consensus 274 ---~~g~~-----~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 ---TQGRE-----LE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---HHTCC-----CC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HcCCC-----CC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11211 11 1222345688999999999999999999999999886543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=453.21 Aligned_cols=259 Identities=27% Similarity=0.491 Sum_probs=213.2
Q ss_pred cCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
++|.+.+.||+|+||.||+|.+. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57889999999999999999853 477899999987766667889999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCc---------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEE
Q 040908 520 IYEYLENNSLARALFGPE---------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 590 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 590 (790)
|||||++|+|.++|+... .....++|.++..|+.|||+||+|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999995432 12357999999999999999999999974 999999999999999999999
Q ss_pred eecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHH
Q 040908 591 SDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLL 668 (790)
Q Consensus 591 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 668 (790)
+|||+|+........ ......||++|||||++.+..++.|+|||||||++|||+| |+.||......+. ...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~---- 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IEC---- 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHH----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----
Confidence 999999865443322 2234569999999999999999999999999999999999 8999976543221 111
Q ss_pred HhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 669 KEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 669 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
...+... ..+...+.++.+++..||+.||++||||.||+++|+...
T Consensus 243 i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 243 ITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1112211 112233456889999999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=452.15 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=212.0
Q ss_pred cCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
+++++.++||+|+||.||+|.+. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45678899999999999999863 467899999976533 34578999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC
Q 040908 519 LIYEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 586 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 586 (790)
+|||||++|+|.++|+.... ....++|..+..|+.|||+||+|||+.+ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 2356999999999999999999999985 99999999999999999
Q ss_pred CeEEeecCCccccCCCC-cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHH
Q 040908 587 NPKISDFGLAKLDEEDN-THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDW 664 (790)
Q Consensus 587 ~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 664 (790)
++||+|||+|+...... ....+...||++|||||++.++.++.++|||||||++|||+| |+.||......+ +...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence 99999999998654332 223345679999999999999999999999999999999999 899997654322 1111
Q ss_pred HHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 665 ALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 665 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
. ..+... ..+..++..+.+++..||+.||.+||||.||++.|+...
T Consensus 260 i----~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 260 I----RNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp H----HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred H----HcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1 112111 122234457889999999999999999999999998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=442.63 Aligned_cols=259 Identities=27% Similarity=0.476 Sum_probs=203.5
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
..+++++.++||+|+||+||+|++.+ .||||+++.. .....+.|.+|+.++++++|||||+++|+|.+ +..++||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34678899999999999999999753 5999998643 33445789999999999999999999999865 5689999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
|||++|+|.++|+.. ...++|.++..|+.|||+||+|||+.+ ||||||||+||||++++++||+|||+|+....
T Consensus 111 Ey~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp ECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999543 346999999999999999999999974 99999999999999999999999999987654
Q ss_pred CC-cceeeccccCCCcccHHHhhc---CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 602 DN-THISTRVAGTFGYMAPEYAMR---GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 602 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
.. .......+||+.|||||++.+ +.|+.|+|||||||+||||+||+.||......... ......+ .
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~----~ 254 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRG----Y 254 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTT----C
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcC----C
Confidence 32 223445789999999999964 46899999999999999999999999754332211 1111111 1
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
..|.+ ...+......+.+++..||+.||++||||.||++.|+..
T Consensus 255 ~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 255 ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11211 112223445788999999999999999999999988764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=436.67 Aligned_cols=266 Identities=26% Similarity=0.324 Sum_probs=203.2
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC----eEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN----QLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 521 (790)
++|.+.++||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++|+|.+.+ .+++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5688899999999999999998 5899999999654322 223345667778899999999999998754 689999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC-----CCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES-----RLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
|||++|+|.++|+ ...++|..+.+++.|+|+||+|||+++ .++|+||||||+||||+.++++||+|||+|
T Consensus 81 Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999994 246899999999999999999999862 457999999999999999999999999999
Q ss_pred cccCCCCcc---eeeccccCCCcccHHHhhcC------CCCChhhHHHHHHHHHHHHhCCCCCccccccchh--------
Q 040908 597 KLDEEDNTH---ISTRVAGTFGYMAPEYAMRG------HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF-------- 659 (790)
Q Consensus 597 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-------- 659 (790)
+........ .....+||+.|||||++.+. .++.|+|||||||++|||+||+.|+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876543322 12346799999999999764 3677999999999999999998877543221100
Q ss_pred -hHHHHHHHHHhhCCcccccCCCCCCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 660 -YLLDWALLLKEQGNLMELVDPNLGSNV-DKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 660 -~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
........ . ..+.++|.+.... +.+....+.+++.+||+.||.+||||.||++.|+.+.
T Consensus 236 ~~~~~~~~~-~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 236 PSVEEMRKV-V----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHH-H----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHHH-H----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 00111111 1 1112233332222 2356678999999999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=433.18 Aligned_cols=249 Identities=24% Similarity=0.430 Sum_probs=208.5
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
+.|++.++||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 57999999999999999999964 68999999997665555667899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++|+|.+++. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.......
T Consensus 154 ~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 9999999983 246899999999999999999999985 99999999999999999999999999997654332
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+ . .. ..+.+
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i------~-~~-----~~~~~-- 290 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------R-DN-----LPPRL-- 290 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------H-HS-----SCCCC--
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------H-cC-----CCCCC--
Confidence 234578999999999999999999999999999999999999999765432221111 1 11 11111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........++.+++.+||+.||.+|||+.|+++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223456788999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=441.25 Aligned_cols=270 Identities=25% Similarity=0.363 Sum_probs=217.5
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeeecC------CcEEEEEEccccch-hcHHHHHHHHHHhhccCC-Cceeee
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLLAD------GTLIAVKQLSAKSK-QGNREFVNEIGTISALQH-PHLVKL 507 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l 507 (790)
+...+++...++|++.+.||+|+||.||+|.+.. ++.||||++..... ...+.|.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4455667778899999999999999999998532 36899999976533 345679999999999965 899999
Q ss_pred eeEEEeC-CeEEEEEEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEecc
Q 040908 508 YGCCIEG-NQLLLIYEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRD 574 (790)
Q Consensus 508 ~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrD 574 (790)
+|+|.+. +.+++|||||++|+|.++|+.... ....++|..+..++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 568999999999999999964322 1345899999999999999999999984 99999
Q ss_pred CCCCcEEecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCcc
Q 040908 575 IKATNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMC 652 (790)
Q Consensus 575 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~ 652 (790)
|||+|||+++++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999976554433 3345679999999999999999999999999999999998 8999976
Q ss_pred ccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 653 KTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 653 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
....+.. ......+.. +.. +.....++.+++..||+.||.+||||.||++.|+...
T Consensus 291 ~~~~~~~------~~~i~~g~~-----~~~----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 291 VKIDEEF------CRRLKEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CCCSHHH------HHHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHH------HHHHHcCCC-----CCC----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 4432211 111112211 111 2223456788999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=434.54 Aligned_cols=250 Identities=22% Similarity=0.389 Sum_probs=201.3
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.|.+|+.+|++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999995 46899999998654 23345679999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
||++|+|.++|... ....+++.++..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999432 2345788999999999999999999985 999999999999999999999999999866432
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
. ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......+.. ... ..+.. +..
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~------~~i-~~~~~-----~~~ 245 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV------LKI-ISGSF-----PPV 245 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHH-HHTCC-----CCC
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------HHH-HcCCC-----CCC
Confidence 2 1234467999999999999999999999999999999999999999765432211 111 11111 111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... ...++.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLH----YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Ccc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122 2346788999999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=419.57 Aligned_cols=247 Identities=25% Similarity=0.408 Sum_probs=196.9
Q ss_pred cceeeeecccCcEEEEeeeec-CCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEe----CCeEEEE
Q 040908 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIE----GNQLLLI 520 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV 520 (790)
|++.++||+|+||.||+|... ++..||+|++... .....+.|.+|+.+|++++|||||+++++|.. .+.+++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367788999999999999964 6889999998654 23345679999999999999999999999865 3468999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC-CCCeEEeecCCcccc
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLD 599 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~ 599 (790)
||||++|+|.+++. ....+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999994 2357999999999999999999999874 46999999999999984 799999999999865
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
... .....+||+.|||||++.+ .++.++|||||||++|||+||+.||........ +. .. ...+.....
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~---~~-i~~~~~~~~-- 250 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY---RR-VTSGVKPAS-- 250 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH---HH-HTTTCCCGG--
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HH---HH-HHcCCCCCC--
Confidence 432 2345789999999998864 699999999999999999999999964332211 11 11 111111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.....++.+++.+||+.||.+|||+.|+++
T Consensus 251 ------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 ------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112245788999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=428.33 Aligned_cols=253 Identities=24% Similarity=0.271 Sum_probs=204.4
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.+.|++.++||+|+||.||+|+. .+|+.||||+++.... +.+|+.++++++|||||++++++.+++..++||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35688899999999999999995 4689999999965322 24799999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-CeEEeecCCccccCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDEED 602 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~ 602 (790)
|++|+|.+++. ....+++..+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.....
T Consensus 132 ~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999994 2357999999999999999999999985 99999999999999987 6999999999976543
Q ss_pred Ccc----eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 603 NTH----ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 603 ~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
... .....+||+.|||||++.+..++.++|||||||++|||+||+.||......+....+ ........+
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-----~~~~~~~~~-- 277 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI-----ASEPPPIRE-- 277 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH-----HHSCCGGGG--
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-----HcCCCCchh--
Confidence 221 123367999999999999999999999999999999999999999765443322111 111111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
+ +......+.+++.+||+.||.+|||+.|+++.|....
T Consensus 278 ---~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 278 ---I----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp ---S----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---c----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1 1223456788999999999999999999998876543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=421.68 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=206.9
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999995 56899999999753 2334567999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
|||++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999993 2357999999999999999999999985 99999999999999999999999999997654
Q ss_pred CCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+..+... ... .+..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-----~i~--~~~~------ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA-----KII--KLEY------ 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHH--HTCC------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHH--cCCC------
Confidence 332 23455789999999999999999999999999999999999999997654322211 111 1111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVV 716 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 716 (790)
.....+ ..++.+++.+|++.||.+|||+.|+.
T Consensus 252 ~~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 111222 34678899999999999999998864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=434.45 Aligned_cols=250 Identities=24% Similarity=0.422 Sum_probs=208.6
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.+.|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 367999999999999999999964 6899999999766555566789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
|++|+|.+++. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 230 ~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 99999999983 246899999999999999999999985 9999999999999999999999999998765433
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+ ... ..+.+.
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------~~~-----~~~~~~ 368 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDN-----LPPRLK 368 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHS-----CCCCCS
T ss_pred c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HcC-----CCCCCc
Confidence 2 234578999999999999999999999999999999999999999765432221111 111 111111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.......++.+++.+||+.||.+|||+.|+++
T Consensus 369 --~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01122346788999999999999999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=408.80 Aligned_cols=245 Identities=26% Similarity=0.413 Sum_probs=189.7
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999985 468999999986532 233567999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+ +|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 689999983 2357999999999999999999999985 99999999999999999999999999986554
Q ss_pred CCcceeeccccCCCcccHHHhhcCCC-CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||......... ... ..+..
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~------~~i-~~~~~------ 229 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF------KNI-SNGVY------ 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH-HHTCC------
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHH-HcCCC------
Confidence 32 2345689999999999998776 57999999999999999999999754332211 111 11111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+... ...++.+++.+|++.||++|||+.|+++
T Consensus 230 ~~p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 TLPKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCC----CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11112 2346788999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=415.66 Aligned_cols=242 Identities=26% Similarity=0.364 Sum_probs=193.0
Q ss_pred cCcceeeeecccCcEEEEeeeec----CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
++|++.+.||+|+||+||+|+.. .++.||||++.... ......+.+|+++|++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999742 46799999986542 2234468899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
|||||++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999993 2357999999999999999999999985 999999999999999999999999999865
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
..... .....+||+.|||||++.+..++.++|||||||++|||+||+.||...+..+.... . ..+..
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~------i-~~~~~----- 243 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM------I-LKAKL----- 243 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------H-HHCCC-----
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHH------H-HcCCC-----
Confidence 43322 23457899999999999999999999999999999999999999976543322111 1 11111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
.... ....++.+++.+||+.||.+|||+
T Consensus 244 -~~p~----~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 -GMPQ----FLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -CCCT----TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -CCCC----cCCHHHHHHHHHHcccCHHHCCCC
Confidence 1111 223467889999999999999984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=402.87 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=187.4
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCC--------
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGN-------- 515 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 515 (790)
++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999995 4689999999875433 33467899999999999999999999987644
Q ss_pred ----eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEe
Q 040908 516 ----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 591 (790)
Q Consensus 516 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 591 (790)
.+++|||||++|+|.+++..... ....++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 36999999999999999954322 234567778899999999999999985 9999999999999999999999
Q ss_pred ecCCccccCCCCcc-----------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhh
Q 040908 592 DFGLAKLDEEDNTH-----------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY 660 (790)
Q Consensus 592 DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~ 660 (790)
|||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||.... +...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence 99999876543211 1234679999999999999999999999999999999996 664321 1110
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 661 LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 661 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. . . ....... .........+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~--~-~-~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TL--T-D-VRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH--H-H-HHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH--H-H-HhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0 0 0111110 011123345678999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=401.97 Aligned_cols=287 Identities=45% Similarity=0.787 Sum_probs=250.7
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN 515 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 515 (790)
+++.+++.++++|++.+.||+|+||.||+|...+|+.||||++........+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445566789999999999999999999998889999999998766666778999999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++||||+++|+|.+++.........++|..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999999655444456999999999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCC-cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 596 AKLDEEDN-THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 596 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
++...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+......|.......+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98654322 22234456899999999999999999999999999999999999999876665556667777766677778
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcCC
Q 040908 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGV 725 (790)
Q Consensus 675 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 725 (790)
.+.+++.+......+....+.+++.+||+.||.+|||+.||++.|+.....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 888888888888888999999999999999999999999999999976543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=401.37 Aligned_cols=291 Identities=44% Similarity=0.764 Sum_probs=252.6
Q ss_pred CCCccHHHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEE
Q 040908 433 TGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCC 511 (790)
Q Consensus 433 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~ 511 (790)
...++++++..++++|++.+.||+|+||.||+|...+|+.||||++..... .....+.+|+.++++++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456889999999999999999999999999999988899999999976432 2234689999999999999999999999
Q ss_pred EeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEe
Q 040908 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 591 (790)
Q Consensus 512 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 591 (790)
...+..++||||+++|+|.+++.........++|..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997665555679999999999999999999999854569999999999999999999999
Q ss_pred ecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCcccc--ccchhhHHHHHHHHH
Q 040908 592 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKT--KEEKFYLLDWALLLK 669 (790)
Q Consensus 592 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~--~~~~~~l~~~~~~~~ 669 (790)
|||+++..............||+.|+|||++.+..++.++|||||||++|||+||+.||.... ........+|.....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999999776555555556779999999999999899999999999999999999999996422 223344556666666
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
....+....+..+.......+...+.+++..||+.||.+|||+.||++.|++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 667777888888888888899999999999999999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=396.06 Aligned_cols=260 Identities=19% Similarity=0.305 Sum_probs=200.9
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEe------CC
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIE------GN 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~ 515 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36899999999999999999995 479999999996542 2334678899999999999999999998764 35
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..|+|||||+ |+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 689999943 357999999999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCC---cceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh
Q 040908 596 AKLDEEDN---THISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ 671 (790)
Q Consensus 596 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 671 (790)
|+...... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+..+....+. ...
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~-----~~~ 279 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM-----MVL 279 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH-----HHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH-----Hhc
Confidence 98654321 2233457899999999998875 56899999999999999999999997655433222111 011
Q ss_pred CCcccc----------------cCCCCCCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 672 GNLMEL----------------VDPNLGSNVD---KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 672 ~~~~~~----------------~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+..... +.+....... .....++.+++.+||+.||.+|||+.|+++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 110000 0000000000 011346788999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=390.63 Aligned_cols=200 Identities=27% Similarity=0.435 Sum_probs=171.3
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec----CCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeE
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 517 (790)
...++|++.+.||+|+||.||+|+.+ .++.||+|++.... ....+.+|+++|+.+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45688999999999999999999742 46789999986542 345688999999988 699999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC-CCeEEeecCCc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLA 596 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla 596 (790)
++||||+++|+|.+++ ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 9999999999999998 24889999999999999999999985 9999999999999877 79999999999
Q ss_pred cccCCCCc---------------------------ceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCC
Q 040908 597 KLDEEDNT---------------------------HISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRS 648 (790)
Q Consensus 597 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~ 648 (790)
+....... ...+..+||+.|+|||++.+. .++.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 85443211 112335799999999999875 58999999999999999999999
Q ss_pred CCcccc
Q 040908 649 NIMCKT 654 (790)
Q Consensus 649 p~~~~~ 654 (790)
||....
T Consensus 246 Pf~~~~ 251 (361)
T 4f9c_A 246 PFYKAS 251 (361)
T ss_dssp SSSCCS
T ss_pred CCCCCC
Confidence 996543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=409.72 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=208.4
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|++.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.+|+.++|||||++++++.+.+.+++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999995 46899999999776555567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC--CCeEEeecCCccccCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD--LNPKISDFGLAKLDEE 601 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~kl~DFGla~~~~~ 601 (790)
|++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999943 2346899999999999999999999985 9999999999999854 8999999999997755
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+....+ ......+ ++.
T Consensus 310 ~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i-----~~~~~~~----~~~ 378 (573)
T 3uto_A 310 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSCDWNM----DDS 378 (573)
T ss_dssp TSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-----HTTCCCC----CSG
T ss_pred CCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-----HhCCCCC----Ccc
Confidence 432 34467999999999999999999999999999999999999999765433221110 0111111 111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... ....++.+++..||+.||.+|||+.|+++
T Consensus 379 ~~~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFS----GISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 12346788999999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=403.78 Aligned_cols=248 Identities=26% Similarity=0.309 Sum_probs=198.9
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHH---HHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVN---EIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+.+ ++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999954 68999999996532 222233334 466777889999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+|||||+||+|.++|. ....+++..+..++.||+.||+|||+.+ ||||||||+||||+.+|++||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999993 2357999999999999999999999985 99999999999999999999999999987
Q ss_pred cCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
..... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||..........+.... ....
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i----~~~~---- 410 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----LTMA---- 410 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH----HHCC----
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh----cCCC----
Confidence 65433 234689999999999975 57999999999999999999999999765433322111111 0111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL-----MSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 717 (790)
..... ....++.+++..|++.||.+|++ +.||.+
T Consensus 411 --~~~p~----~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 --VELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --CCCCT----TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --CCCCc----cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11112 22346788999999999999998 677754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=371.31 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=210.4
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|.+.+.||+|+||.||+|... +++.||+|++........+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367899999999999999999964 6899999998776666678899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++|+|.+++.. ....++|..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999943 2356899999999999999999999985 9999999999999999999999999998654332
Q ss_pred cce-------------eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHh
Q 040908 604 THI-------------STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKE 670 (790)
Q Consensus 604 ~~~-------------~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 670 (790)
... .....||+.|+|||++.+..++.++|||||||++|||++|..|+.................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~--- 239 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF--- 239 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH---
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc---
Confidence 211 1145799999999999999999999999999999999999998865332221110000000
Q ss_pred hCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 671 QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 671 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.+...... ....+.+++..||+.||.+|||+.|+++.|+...
T Consensus 240 -------~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 240 -------LDRYCPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -------HHHTCCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------ccccCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00011111 1235788999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.61 Aligned_cols=250 Identities=25% Similarity=0.467 Sum_probs=208.3
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999984 57899999999776666677899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++|+|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999993 235899999999999999999999985 9999999999999999999999999998665433
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......... .....+.. ..
T Consensus 171 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~~~~~~~-~~------ 236 (297)
T 3fxz_A 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTP-EL------ 236 (297)
T ss_dssp CC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCSC-CC------
T ss_pred cc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCCC-CC------
Confidence 32 334679999999999999999999999999999999999999997543322111 11111110 00
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+......+.+++..||+.||.+|||+.|+++
T Consensus 237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 112233456788999999999999999999876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=360.05 Aligned_cols=282 Identities=38% Similarity=0.627 Sum_probs=231.4
Q ss_pred CCCccHHHHHHHhcCccee------eeecccCcEEEEeeeecCCcEEEEEEccccc----hhcHHHHHHHHHHhhccCCC
Q 040908 433 TGSFTLRQIKAATNHFDVA------NKIGEGGFGPVYKGLLADGTLIAVKQLSAKS----KQGNREFVNEIGTISALQHP 502 (790)
Q Consensus 433 ~~~~~~~~~~~~~~~y~~~------~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~ 502 (790)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4678999999999999877 8999999999999987 57899999986532 23356799999999999999
Q ss_pred ceeeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe
Q 040908 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL 582 (790)
Q Consensus 503 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 582 (790)
||+++++++.+.+..++||||+++|+|.+++.... ....++|..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999995432 2356999999999999999999999985 9999999999999
Q ss_pred cCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhH
Q 040908 583 DKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYL 661 (790)
Q Consensus 583 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l 661 (790)
++++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||........ +
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence 99999999999999866543322 2334679999999998764 588999999999999999999999976543321 2
Q ss_pred HHHHHHHH-hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 662 LDWALLLK-EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 662 ~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
..+..... ....+.+.+++.+ ...+......+.+++..||+.+|.+||++.+|++.|+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 22222222 2233445555544 3456677888999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=364.19 Aligned_cols=263 Identities=27% Similarity=0.441 Sum_probs=215.3
Q ss_pred CCCCccHHHHHHHhcC----------cceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccC
Q 040908 432 QTGSFTLRQIKAATNH----------FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQ 500 (790)
Q Consensus 432 ~~~~~~~~~~~~~~~~----------y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~ 500 (790)
..+.++.++++.+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence 4567888998888764 788889999999999999965 79999999997666666778999999999999
Q ss_pred CCceeeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcE
Q 040908 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNV 580 (790)
Q Consensus 501 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 580 (790)
||||+++++++...+..++||||+++++|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+||
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NI 172 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSI 172 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHE
Confidence 9999999999999999999999999999999983 246899999999999999999999985 99999999999
Q ss_pred EecCCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhh
Q 040908 581 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY 660 (790)
Q Consensus 581 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~ 660 (790)
|++.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-- 249 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-- 249 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--
T ss_pred EECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 9999999999999999866543222 2346799999999999999999999999999999999999999975432211
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 661 LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 661 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. .. .... .+.+. ........+.+++.+||+.||.+|||+.|+++
T Consensus 250 -~~---~~-~~~~-----~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 250 -MK---RL-RDSP-----PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -HH---HH-HHSS-----CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HH---HH-hcCC-----CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 11 1111 11111 11122346788999999999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=355.50 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=213.5
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..++|++.+.||+|+||.||+|...++..||+|++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 356899999999999999999998888899999997543 3356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++. .....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHH---HHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999994 23346899999999999999999999985 9999999999999999999999999998766554
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......... .... .+. ....+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~-~~~--~~~~~-- 227 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVS-QGH--RLYRP-- 227 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHH-TTC--CCCCC--
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HHHH-cCC--CCCCC--
Confidence 443444557788999999999899999999999999999999 99999754332211 1111 111 11111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
. .....+.+++..||+.+|.+|||+.|+++.|+....
T Consensus 228 -~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 -H----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -T----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -C----cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1 123467889999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=369.05 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=208.1
Q ss_pred hcCcceeeeecccCcEEEEeeeec----CCcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.++|++.+.||+|+||.||+|... .+..||||++... .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467899999999999999999964 3556999999764 33445679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999432 346899999999999999999999985 999999999999999999999999999876
Q ss_pred CCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 600 EEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 600 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. .... .+.
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~------~~~~-~~~--- 271 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI------SSVE-EGY--- 271 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HHHH-TTC---
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH------HHHH-cCC---
Confidence 543322 2223456789999999999999999999999999999999 99999654332211 1111 110
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
. ...+......+.+++..||+.||.+||++.||++.|+....
T Consensus 272 --~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 272 --R----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp --C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --C----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 11122234568899999999999999999999999998654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=369.47 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=205.9
Q ss_pred hcCcceeeeecccCcEEEEeeee-----cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEG--NQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 517 (790)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999984 36889999999876666677899999999999999999999998653 458
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 999999999999999943 2345899999999999999999999985 9999999999999999999999999998
Q ss_pred ccCCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccch---------hhHHHHHH
Q 040908 598 LDEEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEK---------FYLLDWAL 666 (790)
Q Consensus 598 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~---------~~l~~~~~ 666 (790)
........ ......+|..|+|||++.+..++.++||||||+++|||+||..|+........ ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 76543321 22334577889999999999999999999999999999999998864321100 00000111
Q ss_pred HHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 667 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.... .......+......+.+++..||+.||.+|||+.|+++.|+...
T Consensus 243 ~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 243 ELLK---------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHH---------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHh---------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111 11111122233457889999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=367.34 Aligned_cols=270 Identities=27% Similarity=0.427 Sum_probs=206.0
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEe
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
+...++....++|++.+.||+|+||.||+|.. +|+.||||++.... ....+.|.+|+.++++++||||+++++++..
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 33444445567899999999999999999987 57899999986543 3334678999999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCC
Confidence 9999999999999999999954321 234899999999999999999999874 34999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
|+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .. .....
T Consensus 184 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~---~~---~~~~~ 256 (309)
T 3p86_A 184 GLSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA---AV---GFKCK 256 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH---HH---HHSCC
T ss_pred CCCcccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH---HhcCC
Confidence 99985543321 2234679999999999999999999999999999999999999997544322111 11 01111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
. .. .+......+.+++.+||+.+|.+|||+.|+++.|+....
T Consensus 257 ~-----~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 257 R-----LE----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp C-----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred C-----CC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1 11 112233467889999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=368.90 Aligned_cols=267 Identities=27% Similarity=0.351 Sum_probs=206.8
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC----eEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN----QLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 520 (790)
.++|++.+.||+|+||.||+|... ++.||||++..... ....+..|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999875 78999999965433 3345667999999999999999999998743 47999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC-------CCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES-------RLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-------~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
|||+++|+|.+++. ...++|..+..++.|++.||+|||+.. .++|+||||||+|||++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 99999999999993 235899999999999999999999861 124999999999999999999999999
Q ss_pred CCccccCCCCcc-eeeccccCCCcccHHHhhcC-----CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH-----
Q 040908 594 GLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRG-----HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL----- 662 (790)
Q Consensus 594 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~----- 662 (790)
|+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||............
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999866543322 22335799999999999863 4556889999999999999999999764432211111
Q ss_pred -----HHHHHHHhhCCcccccCCCCCCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 663 -----DWALLLKEQGNLMELVDPNLGSNV-DKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 663 -----~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.+...... ....+.+.... .......+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 256 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 256 HPSLEDMQEVVVH-----KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SCCHHHHHHHHTT-----SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCchhhhhhhhhc-----ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111100 11111111111 2245667999999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=373.31 Aligned_cols=260 Identities=26% Similarity=0.409 Sum_probs=210.3
Q ss_pred hcCcceeeeecccCcEEEEeeee--------cCCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeC
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL--------ADGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEG 514 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~--------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 514 (790)
.++|++.+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.+++++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 47899999999999999999975 235679999997653 33456799999999999 899999999999999
Q ss_pred CeEEEEEEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe
Q 040908 515 NQLLLIYEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL 582 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 582 (790)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999953221 1235899999999999999999999985 9999999999999
Q ss_pred cCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhh
Q 040908 583 DKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFY 660 (790)
Q Consensus 583 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 660 (790)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999999865443221 2233457889999999999999999999999999999999 999997544332211
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 661 LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 661 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
. ...+.. + ..+......+.+++..||+.+|.+||++.|+++.|+.+.
T Consensus 317 ------~-~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 317 ------L-LKEGHR-----M----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ------H-HHTTCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------H-HhcCCC-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111111 1 112223456888999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=356.84 Aligned_cols=256 Identities=26% Similarity=0.469 Sum_probs=210.9
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 46799999999999999999998888999999997543 33567999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 88 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99999999943 2346899999999999999999999985 99999999999999999999999999986654332
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.......+|+.|+|||++....++.++||||||+++|||++ |+.||......+.. ..... + .....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~------~~~~~-~-----~~~~~- 228 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------EDIST-G-----FRLYK- 228 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHT-T-----CCCCC-
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH------HHHhc-C-----ccCCC-
Confidence 22334557889999999999999999999999999999999 99999754332211 11111 1 00111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
+......+.+++..|++.+|.+||++.|+++.|++..
T Consensus 229 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 229 ---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 1112346788999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=360.71 Aligned_cols=262 Identities=26% Similarity=0.361 Sum_probs=206.4
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999985 468899999985432 23346789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999993 2356899999999999999999999985 9999999999999999999999999998765
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
...........||+.|+|||.+.+..++.++|||||||++|||+||+.||......... .... ....... ..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~-~~~~~~~-~~ 234 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHI-QDSVPNV-TT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHH-SSCCCCH-HH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHh-hccCCCc-ch
Confidence 54433344567999999999999999999999999999999999999999754322110 0101 1111100 00
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCcCC
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRP-LMSSVVSMLEGRVGV 725 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~L~~~~~~ 725 (790)
.... .....+.+++.+|++.||.+|| ++.++.+.|+.....
T Consensus 235 ~~~~----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 235 DVRK----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HSCT----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred hccc----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 1111 2235688899999999999999 899999999876653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=383.92 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=213.4
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
++...++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++|||||++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 445567899999999999999999999888999999997643 34678999999999999999999999986 5678999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp ECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999995332 246889999999999999999999985 9999999999999999999999999998764
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
...........+|+.|+|||++....++.++|||||||++|||+| |+.||......+.. . .......+
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~---~i~~~~~~----- 404 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R---ALERGYRM----- 404 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H---HHHHTCCC-----
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---H---HHHcCCCC-----
Confidence 432222233457789999999999999999999999999999999 99999754332211 1 11111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
..+......+.+++..||+.||.+|||+.+|++.|+....
T Consensus 405 -----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 -----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1112234568899999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=362.31 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=204.7
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999996 57899999998654 2334567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999993 2356899999999999999999999985 99999999999999999999999999986654
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCC-ChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLT-DKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
... .....||+.|+|||++.+..+. .++|||||||++|||++|+.||......+.. ... ..+..
T Consensus 167 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~i-~~~~~------ 231 (328)
T 3fe3_A 167 GGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR------ERV-LRGKY------ 231 (328)
T ss_dssp SCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH-HHCCC------
T ss_pred CCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH------HHH-HhCCC------
Confidence 332 2456799999999999988775 7899999999999999999999765432211 111 11111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. +......+.+++..|++.||.+|||+.|+++
T Consensus 232 ~~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 RI----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CC----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CC----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11 1122345778999999999999999999976
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=376.30 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=208.3
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ......|.+|+.++++++||||++++++|...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3568899999999999999999975 68999999987543 233456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 192 e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHH---HHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999994 23346899999999999999999999985 99999999999999999999999999986443
Q ss_pred CCccee-eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 602 DNTHIS-TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 602 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
...... ....+++.|+|||++..+.++.++|||||||++|||+| |+.||......+.. . ....+..
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~---~----~~~~~~~----- 333 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---E----FVEKGGR----- 333 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH---H----HHHTTCC-----
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHHcCCC-----
Confidence 221111 11235778999999999999999999999999999999 99998754322211 1 1111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
...+......+.+++..||+.||.+|||+.++++.|+.+
T Consensus 334 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 ----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111122345678899999999999999999999999865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=373.67 Aligned_cols=258 Identities=26% Similarity=0.472 Sum_probs=198.2
Q ss_pred hcCcceeeeecccCcEEEEeeeec----CCcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.++|++.+.||+|+||.||+|... ++..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999999999999864 5678999999764 33345679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999953 2346899999999999999999999985 999999999999999999999999999876
Q ss_pred CCCCcce--eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 600 EEDNTHI--STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 600 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
....... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. . .. ..+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~---~---~i-~~~~--- 267 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI---K---AV-DEGY--- 267 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH---H---HH-HTTE---
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---HH-HcCC---
Confidence 5433221 122345788999999999999999999999999999998 99999654322211 1 11 1110
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
....+......+.+++..||+.||.+||++.||+++|+....
T Consensus 268 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 268 ------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 001112234568899999999999999999999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=381.48 Aligned_cols=263 Identities=21% Similarity=0.272 Sum_probs=211.2
Q ss_pred cHHHHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEE
Q 040908 437 TLRQIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCI 512 (790)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 512 (790)
.++++...+++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45566677899999999999999999999965 478999999965321 22334889999999999999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEee
Q 040908 513 EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 592 (790)
Q Consensus 513 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 592 (790)
+.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999532 356899999999999999999999985 99999999999999999999999
Q ss_pred cCCccccCCCCcceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH
Q 040908 593 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 593 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 667 (790)
||+|+.............+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+ ..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~ 295 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---MN 295 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HT
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh---hh
Confidence 9999876655544445578999999999997 467899999999999999999999999765433222111 00
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTN--RPLMSSVVS 717 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~ 717 (790)
....-.. |...... ..++.+++..|+..+|.+ ||++.|+++
T Consensus 296 ~~~~~~~-----p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 296 HKERFQF-----PTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHCCC-----CSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccccccC-----CcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0000111 1111112 345778888999888888 999999876
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=361.85 Aligned_cols=252 Identities=28% Similarity=0.406 Sum_probs=201.8
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999865 789999999865432 234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999942 346899999999999999999999985 999999999999999999999999999865433
Q ss_pred Cc-ceeeccccCCCcccHHHhhcCCC-CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 603 NT-HISTRVAGTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 603 ~~-~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....|.. ... ..
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~----~~~---~~-- 228 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----KKT---YL-- 228 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHT----TCT---TS--
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhc----ccc---cC--
Confidence 22 22335679999999999988765 7799999999999999999999975443221 1111111 000 00
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.........+.+++.+|++.||.+|||+.|+++
T Consensus 229 ----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 001123346778999999999999999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=355.16 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=208.4
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..++|++.+.||+|+||.||+|...++..||+|++.... ...+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 457899999999999999999999888899999997543 2356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999532 346899999999999999999999985 9999999999999999999999999998664433
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
........+|+.|+|||++.+..++.++||||||+++|||+| |+.||......... ..... + .....
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~------~~~~~-~-----~~~~~ 242 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIAQ-G-----LRLYR 242 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHT-T-----CCCCC
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH------HHHhc-c-----cCCCC
Confidence 222233457888999999999999999999999999999998 99999754332211 11111 1 01111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
+......+.+++..||+.+|.+|||+.|+++.|+...
T Consensus 243 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 243 ----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 1112346788999999999999999999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=384.40 Aligned_cols=260 Identities=23% Similarity=0.410 Sum_probs=214.2
Q ss_pred HHhcCcceeeeecccCcEEEEeeeecC-CcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
...++|++.+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+.+|++++|||||+++++|...+..++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345679999999999999999999764 8899999997643 34678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 296 E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 296 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 999999999999532 2346899999999999999999999985 99999999999999999999999999997654
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
..........+|+.|+|||++....++.++|||||||++|||+| |+.||......+.. . . ...+
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~---~---~-~~~~-------- 435 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---E---L-LEKD-------- 435 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H---H-HHTT--------
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH---H---H-HHcC--------
Confidence 43333334457789999999999999999999999999999999 99999754432211 1 1 1111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
.....+......+.+++.+||+.||.+||++.+|++.|+....
T Consensus 436 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 436 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1111222334568889999999999999999999999998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=371.98 Aligned_cols=271 Identities=25% Similarity=0.373 Sum_probs=215.8
Q ss_pred CccHHHHHHHhcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceee
Q 040908 435 SFTLRQIKAATNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVK 506 (790)
Q Consensus 435 ~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~ 506 (790)
.+...+++...++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 456667777889999999999999999999973 346789999997643 33456799999999999 7999999
Q ss_pred eeeEEEeCC-eEEEEEEeccCCChhhhhcCCccc----------------------------------------------
Q 040908 507 LYGCCIEGN-QLLLIYEYLENNSLARALFGPEEH---------------------------------------------- 539 (790)
Q Consensus 507 l~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~---------------------------------------------- 539 (790)
++++|.+.+ ..++||||+++|+|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998755 489999999999999999654321
Q ss_pred ----------------cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 540 ----------------RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 540 ----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122889999999999999999999985 9999999999999999999999999998654433
Q ss_pred c-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 604 T-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 604 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. ......+.. ..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~~~-----~~ 316 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTR-----MR 316 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHTCC-----CC
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHHcCCC-----CC
Confidence 2 23344668999999999999999999999999999999999 99999765433211 111111111 11
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
... ....++.+++..||+.||.+|||+.|+++.|+...
T Consensus 317 ~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 317 APD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111 22346788999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=355.43 Aligned_cols=264 Identities=25% Similarity=0.371 Sum_probs=201.7
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhc--cCCCceeeeeeEEEeC----CeE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISA--LQHPHLVKLYGCCIEG----NQL 517 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~ 517 (790)
..++|++.+.||+|+||.||+|.. +|+.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 357899999999999999999998 6889999998653 33455667666665 7999999999997653 458
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC-----CCcEEeccCCCCcEEecCCCCeEEee
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES-----RLKIVHRDIKATNVLLDKDLNPKISD 592 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDlk~~NILl~~~~~~kl~D 592 (790)
++||||+++|+|.+++. ...+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999993 246899999999999999999999211 23699999999999999999999999
Q ss_pred cCCccccCCCCcce---eeccccCCCcccHHHhhcC------CCCChhhHHHHHHHHHHHHhC----------CCCCccc
Q 040908 593 FGLAKLDEEDNTHI---STRVAGTFGYMAPEYAMRG------HLTDKADVYSFGIVALEIVSG----------RSNIMCK 653 (790)
Q Consensus 593 FGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDV~S~Gvvl~elltG----------~~p~~~~ 653 (790)
||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998654433322 2234799999999999876 445699999999999999999 7777543
Q ss_pred cccchhhHHHHHHHHHhhCCcccccCCCCCC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 654 TKEEKFYLLDWALLLKEQGNLMELVDPNLGS-NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 654 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
...... ............ ..+.... .........+.+++..||+.||.+|||+.||++.|+.+
T Consensus 237 ~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPS-FEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCC-HHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcc-hhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 222111 111111111111 1111111 12335678899999999999999999999999999853
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.88 Aligned_cols=253 Identities=26% Similarity=0.457 Sum_probs=197.0
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccch----hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSK----QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||+|... |+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999975 88999999875432 2346789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC--------CCCeEEee
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK--------DLNPKISD 592 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--------~~~~kl~D 592 (790)
|||+++++|.+++. ...+++..+..++.|++.||+|||+.+..+|+||||||+|||++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999983 246899999999999999999999986555999999999999986 77899999
Q ss_pred cCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC
Q 040908 593 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 593 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
||+++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ... ...
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~-~~~ 229 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YGV-AMN 229 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HHH-HTS
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------Hhh-hcC
Confidence 999986543322 2356999999999999999999999999999999999999999754322111 000 111
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 673 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.. ....+......+.+++..||+.||.+|||+.|+++.|+.
T Consensus 230 ~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 KL--------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CC--------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 111122234568899999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=378.15 Aligned_cols=260 Identities=29% Similarity=0.463 Sum_probs=206.9
Q ss_pred HHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 442 KAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
+...++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34567899999999999999999999888889999997643 335689999999999999999999999876 6789999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 258 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999999999999422 2346899999999999999999999985 99999999999999999999999999987654
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
..........+|+.|+|||++..+.++.++|||||||++|||+| |+.||......+.. ... ..+.
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~------~~i-~~~~------- 398 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQV-ERGY------- 398 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------HHH-HTTC-------
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH------HHH-HcCC-------
Confidence 33323334557889999999999999999999999999999999 99999754332211 111 1111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
....+......+.+++..||+.||.+|||+.++++.|+....
T Consensus 399 --~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 399 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 011122334568899999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.98 Aligned_cols=272 Identities=20% Similarity=0.258 Sum_probs=213.0
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC--eEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN--QLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 520 (790)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367999999999999999999965 58999999997543 334567889999999999999999999998765 78999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe----cCCCCeEEeecCCc
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLA 596 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla 596 (790)
|||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999964322 234899999999999999999999985 9999999999999 78888999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhh--------cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchh-hHHHHHHH
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAM--------RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF-YLLDWALL 667 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~ 667 (790)
+........ ....||+.|+|||++. +..++.++|||||||++|||+||+.||......... ....-...
T Consensus 164 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 164 RELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp EECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred eecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 876554322 3456999999999986 467899999999999999999999999753322211 11111111
Q ss_pred HHhhCCccccc-----------CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 668 LKEQGNLMELV-----------DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 668 ~~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.........+. +-.............+.+++..||+.||++|||+.|+++...+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 00000000000 01112245567788899999999999999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=359.22 Aligned_cols=260 Identities=20% Similarity=0.188 Sum_probs=208.5
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999995 5789999999865432 34588999999999 99999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC-----eEEeecCCcc
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-----PKISDFGLAK 597 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DFGla~ 597 (790)
|+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999999422 357999999999999999999999985 999999999999998887 9999999998
Q ss_pred ccCCCCcc------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh
Q 040908 598 LDEEDNTH------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ 671 (790)
Q Consensus 598 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 671 (790)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 65433221 123567999999999999999999999999999999999999999865433322222211111111
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 672 GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 672 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
...... ... .. ++.+++..||+.+|.+||++.+|.+.|+...
T Consensus 239 ~~~~~~-----~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 239 TPIEVL-----CEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp SCHHHH-----TTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCHHHH-----hcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 111000 011 12 6889999999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=361.67 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=205.1
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh------cHHHHHHHHHHhhccCCCceeeeeeEEEeCCe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ------GNREFVNEIGTISALQHPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 516 (790)
..++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3578999999999999999999964 6899999998764321 24678999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC----CeEEee
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISD 592 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~D 592 (790)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999942 346899999999999999999999985 99999999999998877 799999
Q ss_pred cCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC
Q 040908 593 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 593 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .. ..+
T Consensus 163 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~-----~i--~~~ 233 (361)
T 2yab_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-----NI--TAV 233 (361)
T ss_dssp CSSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-----HH--HTT
T ss_pred cCCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HH--Hhc
Confidence 999987654322 234679999999999999899999999999999999999999997654322111 00 001
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. . .++.. .......+.+++..|+..||.+|||+.|+++
T Consensus 234 ~~-~-~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SY-D-FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC-C-CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC-C-CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0 00000 0112346788999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=350.97 Aligned_cols=262 Identities=20% Similarity=0.240 Sum_probs=210.0
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46899999999999999999995 578999999986432 234578899999999 79999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC-----eEEeecCCcc
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-----PKISDFGLAK 597 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DFGla~ 597 (790)
|+ +++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 87 ~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 9999999942 2346899999999999999999999885 999999999999987776 9999999998
Q ss_pred ccCCCCcc------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh
Q 040908 598 LDEEDNTH------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ 671 (790)
Q Consensus 598 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 671 (790)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 66543221 224467999999999999999999999999999999999999999865433222222211111111
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 672 GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 672 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
....+. ... ....+.+++..||+.||.+||++.+|++.|+....
T Consensus 240 ~~~~~~-----~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 240 TPLREL-----CAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp SCHHHH-----TTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccHHHH-----Hhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 111111 111 23567899999999999999999999999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=359.89 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=201.4
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCc----EEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGT----LIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
.++|++.+.||+|+||.||+|... +++ +||+|.+... .....+.|.+|+.++++++||||++++++|...+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357999999999999999999853 444 4688887543 3345678999999999999999999999998765 78
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+|+||+.+|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999943 3356899999999999999999999985 99999999999999999999999999986
Q ss_pred cCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 599 DEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 599 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||........... ...+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------~~~~~--- 236 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGE--- 236 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTTC---
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-------HHcCC---
Confidence 6543322 2233557889999999999999999999999999999999 9999976543322111 11111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
....+......+.+++.+||+.+|.+||++.|+++.|+....
T Consensus 237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111122234568889999999999999999999999987543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=362.71 Aligned_cols=265 Identities=28% Similarity=0.465 Sum_probs=212.4
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEe
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
+....++|++.+.||+|+||.||+|... +++.||||++.... ....+.|.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445688999999999999999999964 34789999997643 3345679999999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccc--------------------cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEH--------------------RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHR 573 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHr 573 (790)
.+..++||||+++|+|.+++...... ...+++..++.++.||++||+|||+.+ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 99999999999999999999542211 256899999999999999999999985 9999
Q ss_pred cCCCCcEEecCCCCeEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCc
Q 040908 574 DIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIM 651 (790)
Q Consensus 574 Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~ 651 (790)
||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999986543221 22234568999999999999999999999999999999999 999997
Q ss_pred cccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 652 CKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 652 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
.....+.. . ....+.... .+......+.+++..||+.||.+||++.++++.|+....
T Consensus 279 ~~~~~~~~------~-~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 279 GMAHEEVI------Y-YVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TSCHHHHH------H-HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCChHHHH------H-HHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 54322211 1 111121111 111233468889999999999999999999999998654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=356.85 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=204.2
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh------cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ------GNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999964 6899999998654321 356799999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC----CeEEeec
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDF 593 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DF 593 (790)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999942 346899999999999999999999985 99999999999999887 8999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ........
T Consensus 163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-----~~~~~~~~ 235 (326)
T 2y0a_A 163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-----NVSAVNYE 235 (326)
T ss_dssp TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-----HHHHTCCC
T ss_pred CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-----HHHhcCCC
Confidence 99987654322 234579999999999998999999999999999999999999997543322111 00000000
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... .........+.+++..||+.||.+|||+.|+++
T Consensus 236 ~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 FED--------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCH--------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCc--------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 000112346788999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=358.29 Aligned_cols=248 Identities=26% Similarity=0.337 Sum_probs=204.5
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999964 6899999999754 234456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999983 2356899999999999999999999985 9999999999999999999999999998543
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ... .+..
T Consensus 157 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------~i~-~~~~------ 222 (337)
T 1o6l_A 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------LIL-MEEI------ 222 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-HCCC------
T ss_pred cCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH------HHH-cCCC------
Confidence 3222 2344679999999999999999999999999999999999999997543322111 111 1111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
.. +.....++.+++..|++.||.+|| ++.|+++
T Consensus 223 ~~----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 RF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11 112234678899999999999999 8998865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=355.42 Aligned_cols=264 Identities=22% Similarity=0.334 Sum_probs=202.1
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
..++|++.+.||+|+||.||+|...+|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3478999999999999999999988899999999875432 22467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99985 78888743 2346899999999999999999999985 99999999999999999999999999987653
Q ss_pred CCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh--CCccc--
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ--GNLME-- 676 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~-- 676 (790)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ ....... .....
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI--FSILGTPNPREWPQVQ 248 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH--HHHHCCCCTTTSGGGT
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHHCCCChHHhhhhh
Confidence 322 2234568999999999876 56899999999999999999999999765443322111 1100000 00000
Q ss_pred ----ccCCCC--CCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 677 ----LVDPNL--GSNVD-----KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 677 ----~~d~~l--~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+... ..... .....++.+++..|++.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 00000 112346789999999999999999999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.67 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=196.0
Q ss_pred HhcCcceeeeecccCcEEEEeeeecC----CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
..++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 35689999999999999999998642 4579999987543 334567899999999999999999999984 56789
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 99999999999999942 2346899999999999999999999985 99999999999999999999999999987
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
.............+|+.|+|||++....++.++|||||||++|||++ |+.||......+.. . .. ..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~---~i-~~~~~--- 235 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G---RI-ENGER--- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H---HH-HTTCC---
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---H---HH-HcCCC---
Confidence 65443333334557889999999999999999999999999999997 99999755433211 1 11 11111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
... +......+.+++..|++.||.+||++.|+++.|+...
T Consensus 236 --~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 236 --LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp --CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011 1223456788999999999999999999999998653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=366.65 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=211.4
Q ss_pred HhcCcceeeeecccCcEEEEeeeec--------CCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA--------DGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIE 513 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 513 (790)
..++|.+.+.||+|+||.||+|... .+..||||++.... ......+.+|+++++++ +||||++++++|..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3578999999999999999999842 24679999997643 33456789999999999 99999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEE
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVL 581 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 581 (790)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999953321 1245899999999999999999999985 999999999999
Q ss_pred ecCCCCeEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchh
Q 040908 582 LDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKF 659 (790)
Q Consensus 582 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 659 (790)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~- 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999986654332 22234567889999999999999999999999999999999 9999975432221
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 660 YLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 660 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
.... ..+.. .. .+.....++.+++..||+.||.+||++.||++.|+....
T Consensus 303 -----~~~~-~~~~~-----~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 303 -----FKLL-KEGHR-----MD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp -----HHHH-HTTCC-----CC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHH-HcCCC-----CC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111 11111 11 111233568889999999999999999999999988764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=356.84 Aligned_cols=251 Identities=18% Similarity=0.253 Sum_probs=205.1
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 578999999999999999999964 6889999998653 23345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC--CCCeEEeecCCccccCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK--DLNPKISDFGLAKLDEE 601 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~~~~ 601 (790)
+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999943 2346899999999999999999999985 999999999999987 78999999999987654
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... +... .++.
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~-~~~~--~~~~ 225 (321)
T 1tki_A 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII------ENIMN-AEYT--FDEE 225 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHH-TCCC--CCHH
T ss_pred CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH------HHHHc-CCCC--CChh
Confidence 432 24466999999999999888899999999999999999999999765432211 11111 1100 0000
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ......++.+++..|++.||.+|||+.|+++
T Consensus 226 ~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 226 A----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0012356789999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=361.61 Aligned_cols=273 Identities=28% Similarity=0.390 Sum_probs=211.9
Q ss_pred hcCcceeeeecccCcEEEEeeee-----cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEE--eCCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI--EGNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 517 (790)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36899999999999999999983 467899999998766666678999999999999999999999987 45678
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 102 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999999942 2346899999999999999999999985 9999999999999999999999999998
Q ss_pred ccCCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 598 LDEEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 598 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+.........+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLL 254 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHHHHH
Confidence 76544332 223356888999999999988999999999999999999999998643221100 000000000000001
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
+.+........+......+.+++..||+.||.+|||+.|+++.|+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111112223344578899999999999999999999999998654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=372.57 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=205.8
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC-eEEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN-QLLLIYE 522 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E 522 (790)
..++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3567899999999999999999985 7899999997543 4578999999999999999999999988765 7999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999532 2234799999999999999999999985 999999999999999999999999999854322
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
. ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+... . ...+.
T Consensus 343 ~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~------~-i~~~~-------- 403 (450)
T 1k9a_A 343 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP------R-VEKGY-------- 403 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH------H-HHTTC--------
T ss_pred c----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------H-HHcCC--------
Confidence 1 22357889999999999999999999999999999999 999997544332111 1 11111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
....+......+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 404 -~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 404 -KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11112233457888999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=368.07 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=207.8
Q ss_pred hcCcceeeeecccCcEEEEeeeec------CCcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
.++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.++++++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999843 4678999999654 334456789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCc---cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC---CeEEe
Q 040908 518 LLIYEYLENNSLARALFGPE---EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKIS 591 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~ 591 (790)
++||||+++|+|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999995322 12245899999999999999999999985 99999999999999554 59999
Q ss_pred ecCCccccCCCC-cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHH
Q 040908 592 DFGLAKLDEEDN-THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 592 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. . ..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~---~---~i- 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---E---FV- 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H---HH-
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---HH-
Confidence 999997542211 122234568999999999999999999999999999999998 99999754332211 1 11
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
..+.. ...+......+.+++..||+.||.+||++.||++.|+....
T Consensus 300 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 300 TSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11111 01111233467889999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=362.56 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=206.5
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999864 6889999999766555566789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC--CCCeEEeecCCccccCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK--DLNPKISDFGLAKLDEE 601 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~~~~ 601 (790)
+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999943 2346899999999999999999999985 999999999999974 47799999999987654
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ... .... ..++.
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~---~i~-~~~~--~~~~~ 272 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---Q---NVK-RCDW--EFDED 272 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H---HHH-HCCC--CCCSS
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---H---HHH-hCCC--CCCcc
Confidence 332 23456999999999999989999999999999999999999999754322211 1 111 1111 01111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... ....++.+++..||+.||.+|||+.|+++
T Consensus 273 ~~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 273 AFS----SVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111 22346789999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=356.87 Aligned_cols=267 Identities=24% Similarity=0.419 Sum_probs=197.1
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeecCC-c---EEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLADG-T---LIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG 514 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g-~---~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 514 (790)
+....++|++.+.||+|+||.||+|..... . .||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 334567899999999999999999986543 2 7999999764 334467899999999999999999999999877
Q ss_pred CeE------EEEEEeccCCChhhhhcCCc--cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC
Q 040908 515 NQL------LLIYEYLENNSLARALFGPE--EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 586 (790)
Q Consensus 515 ~~~------~lV~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 586 (790)
+.. ++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 655 99999999999999984322 12236899999999999999999999985 99999999999999999
Q ss_pred CeEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHH
Q 040908 587 NPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDW 664 (790)
Q Consensus 587 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 664 (790)
.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+...
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---- 250 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN---- 250 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH----
Confidence 999999999986544322 12233457889999999999999999999999999999999 899997654332211
Q ss_pred HHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcCCC
Q 040908 665 ALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVP 726 (790)
Q Consensus 665 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~ 726 (790)
.... +.. ...+......+.+++..||+.||.+|||+.++++.|++....+
T Consensus 251 --~~~~-~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 251 --YLIG-GNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp --HHHT-TCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred --HHhc-CCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 110 0111223356889999999999999999999999999876543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.49 Aligned_cols=256 Identities=26% Similarity=0.456 Sum_probs=209.7
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 46799999999999999999998888999999997643 23467899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 99999999942 2346899999999999999999999985 99999999999999999999999999986543222
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.......+|..|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..... +. ....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~i~~-~~-----~~~~- 226 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------EDIST-GF-----RLYK- 226 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHT-TC-----CCCC-
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH------HHHhc-CC-----cCCC-
Confidence 22233457889999999999999999999999999999999 89998754322111 11111 10 0011
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
+......+.+++.+||+.+|.+||++.|+++.|+...
T Consensus 227 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 227 ---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1112346788999999999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=354.61 Aligned_cols=261 Identities=30% Similarity=0.453 Sum_probs=210.7
Q ss_pred HhcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 516 (790)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 357899999999999999999985 245789999997543 3345678999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCcc--------------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCC
Q 040908 517 LLLIYEYLENNSLARALFGPEE--------------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIK 576 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk 576 (790)
.++||||+++|+|.+++..... ....+++..++.++.||++||+|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999953321 1234889999999999999999999985 9999999
Q ss_pred CCcEEecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCcccc
Q 040908 577 ATNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKT 654 (790)
Q Consensus 577 ~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~ 654 (790)
|+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999866543322 2233457889999999999899999999999999999999 999997654
Q ss_pred ccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 655 KEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 655 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
....... ...+.. + ..+......+.+++..||+.||.+||++.|+++.|+...
T Consensus 258 ~~~~~~~-------~~~~~~-----~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 258 PERLFNL-------LKTGHR-----M----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGGHHHH-------HHTTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHH-------hhcCCc-----C----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3322111 111111 1 111223456889999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=361.26 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=204.3
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc-----hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS-----KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999985 468999999986432 123567999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC---eEEeecCC
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKISDFGL 595 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGl 595 (790)
+||||+++|+|.+++.........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888543333456899999999999999999999985 999999999999987654 99999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +. ... ..+...
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~--~~i--~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LF--EGI--IKGKYK 250 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HH--HHH--HHTCCC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HH--HHH--HcCCCC
Confidence 987654332 233467999999999999989999999999999999999999999753211 11 111 111110
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.++.... .....+.+++..||+.||.+|||+.|+++
T Consensus 251 --~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000 12356789999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=368.60 Aligned_cols=259 Identities=19% Similarity=0.306 Sum_probs=208.6
Q ss_pred HHHHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEe
Q 040908 438 LRQIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 438 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
+++++...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++|||||+++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455566789999999999999999999965 58899999986532 2223458899999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
.+..++||||+++|+|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999999983 235899999999999999999999985 999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCC----CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH----LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
|+++.............+||+.|+|||++.... ++.++|||||||++|||++|+.||......+....+ ..
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-----~~ 287 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI-----MN 287 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----HT
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH-----Hh
Confidence 999876654443444678999999999998765 788999999999999999999999765433221111 00
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTN--RPLMSSVVS 717 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~ 717 (790)
.... ..-+. ... ...++.+++..|++.+|.+ ||++.||++
T Consensus 288 ~~~~---~~~p~-~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 288 HKNS---LTFPD-DND----ISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHH---CCCCT-TCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cccc---ccCCC-ccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0000 00010 011 2346788899999999988 999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.09 Aligned_cols=261 Identities=23% Similarity=0.403 Sum_probs=215.1
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.+...++|++.+.||+|+||.||+|... ++..||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3345678999999999999999999965 4889999998753 3345778999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999432 2356899999999999999999999985 999999999999999999999999999877
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......... .... . .
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~------~~~~-~-----~ 229 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE------LLEK-D-----Y 229 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH------HHHT-T-----C
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHhc-c-----C
Confidence 6554444445567889999999999999999999999999999999 999987544322111 1111 1 0
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
. ...+......+.+++..|++.||.+||++.|+++.|+...
T Consensus 230 ~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 230 R----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 1 1111223356889999999999999999999999998653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=363.79 Aligned_cols=268 Identities=19% Similarity=0.250 Sum_probs=205.7
Q ss_pred HhcCcceeeeecccCcEEEEeeeecC------CcEEEEEEccccchhc-----------HHHHHHHHHHhhccCCCceee
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLAD------GTLIAVKQLSAKSKQG-----------NREFVNEIGTISALQHPHLVK 506 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~------g~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~ 506 (790)
..++|++.+.||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998654 4789999986543211 123445667778889999999
Q ss_pred eeeEEEeC----CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe
Q 040908 507 LYGCCIEG----NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL 582 (790)
Q Consensus 507 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 582 (790)
+++++... ...++||||+ +++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 99999865 4589999999 9999999942 3357999999999999999999999985 9999999999999
Q ss_pred c--CCCCeEEeecCCccccCCCCcc------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCcccc
Q 040908 583 D--KDLNPKISDFGLAKLDEEDNTH------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKT 654 (790)
Q Consensus 583 ~--~~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~ 654 (790)
+ .++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999865432211 1123559999999999999999999999999999999999999998543
Q ss_pred ccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 655 KEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 655 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
..... ..+.... ....+.+++++.+... ....++.+++..||+.+|.+||++.+|++.|+....
T Consensus 266 ~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 266 KDPKY--VRDSKIR-YRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp TCHHH--HHHHHHH-HHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCHHH--HHHHHHH-hhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 32221 1111111 1122333333332211 123467889999999999999999999999987654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=349.25 Aligned_cols=257 Identities=32% Similarity=0.497 Sum_probs=209.7
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..++|++.+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 457899999999999999999998888899999986543 345779999999999999999999999864 568999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999532 2236899999999999999999999985 9999999999999999999999999998765544
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
........+|..|+|||++.+..++.++||||||+++|||++ |+.||......+. . ... ..+. ....
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~---~~~-~~~~-----~~~~ 231 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---I---QNL-ERGY-----RMVR 231 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H---HHH-HTTC-----CCCC
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---H---HHH-hccc-----CCCC
Confidence 333334557889999999998899999999999999999999 8999865432211 1 111 1110 0111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
+......+.+++..|++.+|.+|||+.++++.|+...
T Consensus 232 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 1122356888999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=356.54 Aligned_cols=267 Identities=27% Similarity=0.372 Sum_probs=205.8
Q ss_pred cceeeeecccCcEEEEeeee-----cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEe--CCeEEE
Q 040908 448 FDVANKIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIE--GNQLLL 519 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 519 (790)
|++.+.||+|+||.||++.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999988764 267899999997653 3345679999999999999999999999987 467899
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999932 35899999999999999999999985 999999999999999999999999999876
Q ss_pred CCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 600 EEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 600 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
...... ......||..|+|||++.+..++.++||||||+++|||+||+.||........ ....+.........+.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHH
Confidence 554322 22345688899999999998999999999999999999999999864321100 000000000000011111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
++.......+......+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111112222233457889999999999999999999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=359.86 Aligned_cols=264 Identities=26% Similarity=0.390 Sum_probs=209.6
Q ss_pred HHhcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeC
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEG 514 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 514 (790)
...++|++.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999985 245689999997542 33456789999999999 899999999999999
Q ss_pred CeEEEEEEeccCCChhhhhcCCccc-------------------cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccC
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEH-------------------RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDI 575 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDl 575 (790)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999999999643211 134899999999999999999999985 999999
Q ss_pred CCCcEEecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccc
Q 040908 576 KATNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCK 653 (790)
Q Consensus 576 k~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~ 653 (790)
||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999866443332 2334567889999999999999999999999999999998 99999765
Q ss_pred cccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 654 TKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 654 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
...... . .....+. .. ..+......+.+++..||+.||.+||++.|+++.|+....
T Consensus 279 ~~~~~~--~----~~~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 279 PVDANF--Y----KLIQNGF-----KM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCSHHH--H----HHHHTTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CcHHHH--H----HHHhcCC-----CC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 432211 1 1111111 11 1111224568889999999999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=359.83 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=199.3
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc---chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK---SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 518 (790)
..++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999964 6899999999754 233456688999999988 7999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 9999999999999993 2356999999999999999999999985 99999999999999999999999999985
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .. . .+..
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~-----~i-~-~~~~---- 241 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE-----AI-L-NDEV---- 241 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HH-H-HCCC----
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH-----HH-H-cCCC----
Confidence 43322 22345679999999999999899999999999999999999999997654332111 11 1 1111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLM------SSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~ev~~ 717 (790)
.++......+.+++..|++.||.+||++ .|+++
T Consensus 242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111223457889999999999999998 66654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.27 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=205.7
Q ss_pred cCcceeeeecccCcEEEEeeee-----cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEG--NQL 517 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 517 (790)
+.|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.++++++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5688999999999999999983 468899999997543 33457789999999999999999999999876 668
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+++|+|.+++. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 101 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHH---HHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHH---hccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999993 23356899999999999999999999985 9999999999999999999999999998
Q ss_pred ccCCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCcccccc---------chhhHHHHHH
Q 040908 598 LDEEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKE---------EKFYLLDWAL 666 (790)
Q Consensus 598 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~~ 666 (790)
........ ......||..|+|||++.+..++.++||||||+++|||+||+.|+...... ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 76554332 223456888999999999999999999999999999999999886432110 0001111111
Q ss_pred HHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 667 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.. ..+ .....+......+.+++..||+.||.+|||+.|+++.|+..
T Consensus 255 ~~-~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 255 TL-KEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HH-HTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-hcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11 111 11112223345788999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=368.46 Aligned_cols=263 Identities=21% Similarity=0.276 Sum_probs=208.9
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEE
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCC 511 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 511 (790)
+.+++++...++|++.+.||+|+||.||+|... +|+.||+|++.+.. ......+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566667889999999999999999999964 68999999996532 22234588999999999999999999999
Q ss_pred EeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEe
Q 040908 512 IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 591 (790)
Q Consensus 512 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 591 (790)
.+.+..++||||+++|+|.+++. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLS---KFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHH---HHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEe
Confidence 99999999999999999999994 22346899999999999999999999985 9999999999999999999999
Q ss_pred ecCCccccCCCCcceeeccccCCCcccHHHhh-------cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHH
Q 040908 592 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-------RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDW 664 (790)
Q Consensus 592 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 664 (790)
|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i-- 282 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI-- 282 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence 99999876554443334568999999999997 356899999999999999999999999765433221111
Q ss_pred HHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 040908 665 ALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNR---PLMSSVVS 717 (790)
Q Consensus 665 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~ev~~ 717 (790)
......-. .+..... ...++.+++.+|++ +|.+| |++.|+++
T Consensus 283 -~~~~~~~~-----~p~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 -VHYKEHLS-----LPLVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -HTHHHHCC-----CC----C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -HhcccCcC-----CCccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00000011 1111111 23467889999999 99998 58888875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.93 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=204.7
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
...++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999864 6899999998654 23345678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC---CCeEEeecCCc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISDFGLA 596 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla 596 (790)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 106 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999999843 246899999999999999999999985 9999999999999865 45999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .. ..+...
T Consensus 179 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~---~i-~~~~~~- 248 (362)
T 2bdw_A 179 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YA---QI-KAGAYD- 248 (362)
T ss_dssp BCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HH-HHTCCC-
T ss_pred eEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HH---HH-HhCCCC-
Confidence 86654322 2346799999999999998999999999999999999999999975432211 11 11 111110
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ..........++.+++..||+.||.+||++.|+++
T Consensus 249 ~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 249 Y-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp C-----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred C-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00001122356788999999999999999999976
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=349.95 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=195.7
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch--------------------------hcHHHHHHHHHHhh
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK--------------------------QGNREFVNEIGTIS 497 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~--------------------------~~~~~~~~E~~~l~ 497 (790)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36899999999999999999985 4688999999865321 11246889999999
Q ss_pred ccCCCceeeeeeEEEe--CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccC
Q 040908 498 ALQHPHLVKLYGCCIE--GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDI 575 (790)
Q Consensus 498 ~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDl 575 (790)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.||++||+|||+.+ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999986 568999999999999988762 246899999999999999999999985 999999
Q ss_pred CCCcEEecCCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCC---CCChhhHHHHHHHHHHHHhCCCCCcc
Q 040908 576 KATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH---LTDKADVYSFGIVALEIVSGRSNIMC 652 (790)
Q Consensus 576 k~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvvl~elltG~~p~~~ 652 (790)
||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 234467999999999987654 36789999999999999999999975
Q ss_pred ccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 653 KTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 653 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..... +..... ..... . + .... ....+.+++.+||+.||.+||++.|+++
T Consensus 243 ~~~~~------~~~~~~-~~~~~-~--~-~~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIMC------LHSKIK-SQALE-F--P-DQPD----IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHHH------HHHHHH-HCCCC-C--C-SSSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHHH------HHHHHh-cccCC-C--C-Cccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 43211 111111 11110 0 0 0111 2346788999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=381.06 Aligned_cols=261 Identities=29% Similarity=0.457 Sum_probs=212.4
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
++...++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++|
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 344567899999999999999999999888889999997643 345689999999999999999999999876 678999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++|+|.+++... ....+++..++.|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 340 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp ECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999999999432 2346899999999999999999999985 9999999999999999999999999998664
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
...........++..|+|||++....++.++|||||||++|||+| |+.||......+.. ... ..+..
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~------~~i-~~~~~----- 482 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQV-ERGYR----- 482 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH------HHH-HTTCC-----
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHH-HcCCC-----
Confidence 322222233457889999999999999999999999999999999 99999754332211 111 11110
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
...+......+.+++..||+.||.+|||+.+|+++|+....
T Consensus 483 ----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 11122234568899999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=354.42 Aligned_cols=245 Identities=26% Similarity=0.331 Sum_probs=192.9
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.++||+|+||+||+|... +|+.||||++.... ......+..|+..+.++ +||||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999965 78999999876532 23334556666666665 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+ +++|.+++. .....++|..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~-~~~L~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCE---AWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHH---HHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 679998884 23356999999999999999999999985 9999999999999999999999999998664
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
... ......||++|+|||++.+ .++.++|||||||++|||++|..|+.... .|... ..+....
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~~~~--~~~~~~~---- 271 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GWQQL--RQGYLPP---- 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HHHHH--TTTCCCH----
T ss_pred cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHH--hccCCCc----
Confidence 432 2234569999999998875 78999999999999999999977664321 11111 1111110
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.........+.+++.+|++.||.+|||+.|+++
T Consensus 272 ----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 ----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011122356889999999999999999999876
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=354.29 Aligned_cols=251 Identities=22% Similarity=0.362 Sum_probs=198.0
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC-------
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN------- 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 515 (790)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||++++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999965 78999999987543 334567999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEeccCCChhhhhcCCccccCCCCh
Q 040908 516 --------------------------------------------------QLLLIYEYLENNSLARALFGPEEHRLKLDW 545 (790)
Q Consensus 516 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~ 545 (790)
..++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 37999999999999999965432 234677
Q ss_pred hhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc-----------ceeeccccCC
Q 040908 546 PTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-----------HISTRVAGTF 614 (790)
Q Consensus 546 ~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~ 614 (790)
..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 788999999999999999985 99999999999999999999999999987654321 1223456999
Q ss_pred CcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHH
Q 040908 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVM 694 (790)
Q Consensus 615 ~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 694 (790)
.|+|||++.+..++.++|||||||++|||++|..|+... .... .. ...... ..........+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~---~~-~~~~~~---------~~~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRII---TD-VRNLKF---------PLLFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHH---HH-HHTTCC---------CHHHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHH---HH-hhccCC---------CcccccCChhH
Confidence 999999999999999999999999999999997764311 0000 00 011111 01112334567
Q ss_pred HHHHHHccCCCCCCCCCHHHHHH
Q 040908 695 INVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 695 ~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+++..||+.||.+||++.|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 89999999999999999999976
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=348.01 Aligned_cols=262 Identities=26% Similarity=0.378 Sum_probs=199.4
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|+||.||+|...+|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998889999999986543 22346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 899888432 246899999999999999999999985 9999999999999999999999999998654322
Q ss_pred cceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh--CC---ccc-
Q 040908 604 THISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ--GN---LME- 676 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~---~~~- 676 (790)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+... ......... .. ..+
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--RIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGGGS
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHHCCCChhhchhhhcc
Confidence 2 22335689999999999764 58999999999999999999999997544322111 111100000 00 000
Q ss_pred -ccCCCCCC-------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 677 -LVDPNLGS-------NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 677 -~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..++.... .........+.+++.+|++.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01111100 011123456789999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=344.31 Aligned_cols=254 Identities=21% Similarity=0.355 Sum_probs=204.8
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC--CeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEG--NQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 520 (790)
.++|++.+.||+|+||.||+|... ++.||||++.... ....+.|.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 367899999999999999999985 8899999987542 34456799999999999999999999999876 788999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++++||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999995432 236899999999999999999999873 359999999999999999999999999876433
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCC---hhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTD---KADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
. ....||+.|+|||++.+...+. ++|||||||++|||++|+.||......... ......+
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~----- 227 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVALEG----- 227 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHHHSC-----
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHHhcC-----
Confidence 2 2245899999999998765544 899999999999999999999754322211 1111111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
..+.... .....+.+++..||+.||.+|||+.|+++.|+...
T Consensus 228 ~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 228 LRPTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111222 23346888999999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.39 Aligned_cols=254 Identities=30% Similarity=0.541 Sum_probs=202.8
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhc-------HHHHHHHHHHhhccCCCceeeeeeEEEeCCe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQG-------NREFVNEIGTISALQHPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 516 (790)
.++|++.+.||+|+||.||+|.. .+++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46899999999999999999996 478999999986543221 167899999999999999999999987655
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC-----eEEe
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-----PKIS 591 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~ 591 (790)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||||+|||++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999998843 2357899999999999999999999874 34999999999999988776 9999
Q ss_pred ecCCccccCCCCcceeeccccCCCcccHHHhh--cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 592 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM--RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 592 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
|||+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||......... +.....
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~ 243 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FINMIR 243 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HHHHHH
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HHHHHh
Confidence 9999985433 234467999999999983 456788999999999999999999999754433211 111111
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
..+ . .+.. +......+.+++..||+.||.+||++.|+++.|++
T Consensus 244 ~~~-~----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEG-L----RPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSC-C----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccC-C----CCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111 1 1111 22234568899999999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=353.16 Aligned_cols=262 Identities=27% Similarity=0.440 Sum_probs=210.9
Q ss_pred HhcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccch-hcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCC
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKSK-QGNREFVNEIGTISAL-QHPHLVKLYGCCIEGN 515 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 515 (790)
..++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 456899999999999999999974 3467899999975433 3356789999999999 9999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCcc--------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEE
Q 040908 516 QLLLIYEYLENNSLARALFGPEE--------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVL 581 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 581 (790)
..++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+.+ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999953321 1235899999999999999999999985 999999999999
Q ss_pred ecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchh
Q 040908 582 LDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKF 659 (790)
Q Consensus 582 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 659 (790)
++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999999876554332 2234557889999999999999999999999999999999 99999754432211
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 660 YLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 660 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
. .. ...+. .... +......+.+++.+|++.||.+||++.|+++.|+...
T Consensus 258 --~---~~-~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 --Y---KM-IKEGF-----RMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp --H---HH-HHHTC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --H---HH-hccCC-----CCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1 11 11110 1111 1122356788999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=358.39 Aligned_cols=250 Identities=23% Similarity=0.377 Sum_probs=196.3
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCC--CceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQH--PHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.++.+++| +||+++++++...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999888999999998643 23345678999999999976 9999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|| +.+++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 56889999994 2356899999999999999999999985 99999999999997 5689999999998665
Q ss_pred CCCcc-eeeccccCCCcccHHHhhc-----------CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH
Q 040908 601 EDNTH-ISTRVAGTFGYMAPEYAMR-----------GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL 668 (790)
Q Consensus 601 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 668 (790)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~---- 230 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KL---- 230 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----HH----
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH----HH----
Confidence 43322 2335679999999999875 6788999999999999999999999964322110 00
Q ss_pred HhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 669 KEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 669 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+++.....++......+.+++..||+.||.+|||+.|+++
T Consensus 231 ------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 231 ------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp ------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 1111222222222222346788999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=350.58 Aligned_cols=274 Identities=25% Similarity=0.343 Sum_probs=205.4
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhc--cCCCceeeeeeEEEe
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISA--LQHPHLVKLYGCCIE 513 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~ 513 (790)
.....-....++|++.+.||+|+||.||+|... |+.||||++.... ...+..|.+++.. ++||||+++++++..
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 344444556689999999999999999999985 8999999985432 3344555555554 499999999999988
Q ss_pred C----CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC-----CCcEEeccCCCCcEEecC
Q 040908 514 G----NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES-----RLKIVHRDIKATNVLLDK 584 (790)
Q Consensus 514 ~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDlk~~NILl~~ 584 (790)
. ...++||||+++|+|.+++. ...+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCCCCceEEEEeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 7 78999999999999999993 236899999999999999999999871 235999999999999999
Q ss_pred CCCeEEeecCCccccCCCCcce---eeccccCCCcccHHHhhcCCCCCh------hhHHHHHHHHHHHHhC---------
Q 040908 585 DLNPKISDFGLAKLDEEDNTHI---STRVAGTFGYMAPEYAMRGHLTDK------ADVYSFGIVALEIVSG--------- 646 (790)
Q Consensus 585 ~~~~kl~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~k------sDV~S~Gvvl~elltG--------- 646 (790)
++.+||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||+||
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999997654433221 124579999999999988766665 9999999999999999
Q ss_pred -CCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 647 -RSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV-DKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 647 -~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
+.||......... ...+... .... ...+...... ......++.+++..||+.||.+|||+.||++.|+....
T Consensus 258 ~~~p~~~~~~~~~~-~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 258 YQLPYHDLVPSDPS-YEDMREI-VCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CCCTTTTTSCSSCC-HHHHHHH-HTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccHhhhcCCCCc-hhhhHHH-Hhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 5555432221111 0111111 1111 1111111111 22667889999999999999999999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=365.19 Aligned_cols=253 Identities=20% Similarity=0.318 Sum_probs=203.8
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
..++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 467899999999999999999985 478999999986542 23456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec---CCCCeEEeecCCcc
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAK 597 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGla~ 597 (790)
|||+++|+|.+.+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 89 ~E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999984 2356899999999999999999999985 99999999999998 46789999999998
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... . ...+.. ..
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~-----~--i~~~~~-~~ 232 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ-----Q--IKAGAY-DF 232 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----H--HHHTCC-CC
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHH-----H--HHhCCC-CC
Confidence 6654332 2234679999999999999899999999999999999999999997544322111 1 111111 11
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+. .......+.+++..|++.||.+|||+.|+++
T Consensus 233 ~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 PSPE-----WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Cccc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111 0122346788999999999999999999987
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=359.24 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=197.8
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 519 (790)
.++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+..|..++.++ +|||||++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999965 57899999997643 22234578899999887 89999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999984 2356999999999999999999999985 999999999999999999999999999853
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchh--hHHHHHHHHHhhCCcccc
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF--YLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~ 677 (790)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....+.........+
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence 3222 2234567999999999999999999999999999999999999999643221110 001111111111111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
. ++.....++.+++..||+.||.+||++
T Consensus 280 ---~----~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ---R----IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---C----CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---C----CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 111233467889999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=356.28 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=201.5
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCc----EEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGT----LIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
++|++.+.||+|+||.||+|... +++ +||+|.+.... ......+.+|+.++++++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57899999999999999999854 444 37888775432 233456788999999999999999999986 466899
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999533 346899999999999999999999985 999999999999999999999999999876
Q ss_pred CCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 600 EEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 600 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
...... ......||..|+|||++.+..++.++|||||||++|||+| |+.||......+.... ...+...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~-- 236 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-------LEKGERL-- 236 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-------HHTTCBC--
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-------HHcCCCC--
Confidence 544322 2344668889999999999999999999999999999999 9999976543322111 1111110
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.. +......+.+++..||+.||.+||++.|+++.|+...
T Consensus 237 ~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 AQ-------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CC-------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CC-------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 1112234678899999999999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.20 Aligned_cols=263 Identities=20% Similarity=0.303 Sum_probs=200.2
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999964 68999999986543 2334678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++ ++.+.+. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 5555552 22356899999999999999999999985 999999999999999999999999999866433
Q ss_pred CcceeeccccCCCcccHHHhhcCC-CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh--CC---ccc
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGH-LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ--GN---LME 676 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~---~~~ 676 (790)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|+.|+........ .+.......... .. ..+
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGG
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhcc
Confidence 22 223457899999999998765 79999999999999999999888654332211 111111110000 00 000
Q ss_pred ccC---------CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 677 LVD---------PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 677 ~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+ ..............+.+++..|++.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 00001111223456789999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=358.40 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=203.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67999999999999999999954 58899999986532 334567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999943 346899999999999999999999985 99999999999999999999999999987654
Q ss_pred CCcceeeccccCCCcccHHHhhc---CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMR---GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+.... . ...
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~-~~~----- 236 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF---E-TTV----- 236 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH---H-HCC-----
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH---h-hcc-----
Confidence 32 2345679999999999864 45889999999999999999999999754433222211111 1 110
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPL-MSSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~ev~~ 717 (790)
. .++......+.+++..||+.||.+||+ +.++.+
T Consensus 237 -~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -V----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -C----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -c----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 111223356789999999999999998 777654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.52 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=203.1
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999964 68999999997542 23456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999994 2346899999999999999999999885 9999999999999999999999999998654
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... +..
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~i~~--~~~------ 220 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-----EKILN--AEL------ 220 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----HHHHH--CCC------
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-----HHHHh--CCC------
Confidence 32 23467999999999999999999999999999999999999999754322211 11111 111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
.... ....++.+++..|++.||.+|| ++.|+++
T Consensus 221 ~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 RFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1111 2234678899999999999999 8888864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=344.78 Aligned_cols=252 Identities=22% Similarity=0.392 Sum_probs=203.8
Q ss_pred hcCcceeeeecccCcEEEEeeeecC-C-------cEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD-G-------TLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~-g-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 516 (790)
.++|++.+.||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4679999999999999999998542 3 5799999987666667889999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC--------e
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--------P 588 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~--------~ 588 (790)
.++||||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999943 2345899999999999999999999985 999999999999998887 9
Q ss_pred EEeecCCccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH
Q 040908 589 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 589 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 667 (790)
||+|||+++..... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+......... ...
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-----~~~ 230 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-----LQF 230 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----HHH
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-----HHH
Confidence 99999998754321 23458899999999987 67899999999999999999966554332221110 111
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
......+. ... ..++.+++..||+.||.+|||+.|+++.|+....
T Consensus 231 ~~~~~~~~--------~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YEDRHQLP--------APK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHTTCCCC--------CCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhccCCCC--------CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111111 111 2346789999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=358.78 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=196.6
Q ss_pred eeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccCCC
Q 040908 450 VANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNS 528 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 528 (790)
..+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 367899999999999985 4689999999987655566789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe--cCCCCeEEeecCCccccCCCCcce
Q 040908 529 LARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL--DKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 529 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl--~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 173 L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 9998842 2346899999999999999999999985 9999999999999 5677899999999987654332
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV 686 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 686 (790)
.....||+.|+|||++....++.++|||||||++|||++|+.||......+.. . ......... .+..
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~---~i~~~~~~~----~~~~---- 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL--N---NILACRWDL----EDEE---- 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--H---HHHHTCCCS----CSGG----
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H---HHHhccCCC----Chhh----
Confidence 23356999999999999889999999999999999999999999765432211 1 111110010 0000
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 687 DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 687 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......++.+++..|++.||.+||++.|+++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0122356788999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.47 Aligned_cols=256 Identities=30% Similarity=0.501 Sum_probs=198.7
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
.++|++.+.||+|+||.||+|... ++.||||++... ...+.|.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 357899999999999999999975 788999998643 34567999999999999999999999886 3478999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC-eEEeecCCccccCCCC
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-PKISDFGLAKLDEEDN 603 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-~kl~DFGla~~~~~~~ 603 (790)
++|+|.+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999964322 235788999999999999999999943346999999999999998887 799999999754432
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||........ ...|.. ..+.. +...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~---~~~~~-----~~~~ 226 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAV---HNGTR-----PPLI 226 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHH---HTTCC-----CCCB
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHH---hcCCC-----CCcc
Confidence 1234699999999999999999999999999999999999999975332211 111111 11111 1111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
.. ....+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 227 ~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 227 KN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred cc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 12 23467889999999999999999999999987643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.42 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=203.6
Q ss_pred HhcCcceeeeecccCcEEEEeeeecC----CcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
..++|++.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998543 346999998765 33345679999999999999999999999865 4568
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++++|.+++. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHH---HHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHH---hccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999994 23356899999999999999999999985 99999999999999999999999999987
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
.............+|+.|+|||++.+..++.++||||||+++|||+| |+.||.......... .... +...
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~------~~~~-~~~~-- 233 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG------VLEK-GDRL-- 233 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH------HHHH-TCCC--
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH------HHhc-CCCC--
Confidence 65543333344567889999999999999999999999999999998 999997543332111 1111 1110
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.... .....+.+++..||+.||.+||++.|+++.|+...
T Consensus 234 ---~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 234 ---PKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ---CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 0111 12346788999999999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=356.11 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=201.8
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999995 578999999986532 22345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+ +|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 88 ~E~~-~g~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 789999883 2356999999999999999999999985 9999999999999999999999999998665
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCC-CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
.... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... +.+.
T Consensus 160 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~ 221 (336)
T 3h4j_B 160 DGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVN 221 (336)
T ss_dssp TSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCC
T ss_pred CCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHH
Confidence 4322 234579999999999987765 67999999999999999999999754322111 1111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ....+......+.+++..|++.||.+|||+.|+++
T Consensus 222 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00 01112223456788999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.54 Aligned_cols=265 Identities=19% Similarity=0.218 Sum_probs=198.6
Q ss_pred hcCcceeeeecccCcEEEEeeeec----CCcEEEEEEccccchh-----------cHHHHHHHHHHhhccCCCceeeeee
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKSKQ-----------GNREFVNEIGTISALQHPHLVKLYG 509 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g 509 (790)
.++|++.+.||+|+||.||+|... .+..||+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999964 5678999998654321 1234678889999999999999999
Q ss_pred EEEe----CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC
Q 040908 510 CCIE----GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD 585 (790)
Q Consensus 510 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 585 (790)
++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9988 67899999999 9999999942 237999999999999999999999985 9999999999999988
Q ss_pred C--CeEEeecCCccccCCCCcc------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccc
Q 040908 586 L--NPKISDFGLAKLDEEDNTH------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE 657 (790)
Q Consensus 586 ~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~ 657 (790)
+ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999865432111 1134579999999999999999999999999999999999999996432222
Q ss_pred hhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 658 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
... ........ ..+...+...... .....++.+++..||+.||.+||++.+|++.|+...
T Consensus 268 ~~~-~~~~~~~~--~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 VAV-QTAKTNLL--DELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHH-HHHHHHHH--HTTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHH-HHHHHhhc--ccccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111 11111111 0111111000000 012346888999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.15 Aligned_cols=260 Identities=29% Similarity=0.490 Sum_probs=196.0
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
..++|++.+.||+|+||.||+|...+ .||+|+++... ....+.|.+|+.++++++||||+++++++ ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 45789999999999999999998743 59999986543 33456799999999999999999999966 455689999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999432 356899999999999999999999985 99999999999999999999999999985543
Q ss_pred CC-cceeeccccCCCcccHHHhh---cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 602 DN-THISTRVAGTFGYMAPEYAM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 602 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
.. ........||+.|+|||++. ...++.++||||||+++|||++|+.||........ +.. ....+.....
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~----~~~~~~~~~~ 246 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIE----MVGRGSLSPD 246 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHH----HHHHTSCCCC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHH----HhcccccCcc
Confidence 22 22223456999999999986 56788899999999999999999999975433221 111 1111221111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
. ..........+.+++..||+.+|.+||++.|+++.|+...
T Consensus 247 ~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 247 L-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp T-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred h-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1 1111223457889999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=352.73 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=209.4
Q ss_pred HhcCcceeeeecccCcEEEEeeee--------cCCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL--------ADGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIE 513 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~--------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 513 (790)
..++|++.+.||+|+||.||+|.. .++..||||++.... ......+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 357899999999999999999985 346789999997643 33456789999999999 89999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEE
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVL 581 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 581 (790)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999964322 1234899999999999999999999985 999999999999
Q ss_pred ecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchh
Q 040908 582 LDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKF 659 (790)
Q Consensus 582 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 659 (790)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 999999999999999866543322 2233457889999999999899999999999999999999 99999754322211
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 660 YLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 660 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
... ..+.. ..... .....+.+++..||+.+|.+||++.|+++.|+....
T Consensus 270 ------~~~-~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 270 ------KLL-KEGHR-----MDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp ------HHH-HHTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHH-hcCCC-----CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111 11111 11111 223467889999999999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=342.54 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=206.9
Q ss_pred hcCcceee-eecccCcEEEEeeeec---CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVAN-KIGEGGFGPVYKGLLA---DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~-~LG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.++|.+.+ .||+|+||.||+|... ++..||||++.... ....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35677776 9999999999999853 57889999997643 34456799999999999999999999999 5567899
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999943 2356899999999999999999999985 999999999999999999999999999876
Q ss_pred CCCCcce--eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 600 EEDNTHI--STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 600 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
....... .....||+.|+|||++.+..++.++||||||+++|||+| |+.||......+.. .. ...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~----i~~~~~-- 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AF----IEQGKR-- 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HH----HHTTCC--
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---HH----HhcCCc--
Confidence 5433222 223457889999999998899999999999999999999 99999754432211 11 111111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
+ ..+......+.+++..||+.+|.+||++.|+++.|+...
T Consensus 232 ---~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 232 ---M----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp ---C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---C----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 112223457888999999999999999999999998654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=357.53 Aligned_cols=263 Identities=25% Similarity=0.387 Sum_probs=207.5
Q ss_pred hcCcceeeeecccCcEEEEeeee-----cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC--eE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-----ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN--QL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 517 (790)
.++|++.+.||+|+||.||+|.+ .+|+.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45789999999999999999983 368899999998766666678999999999999999999999987644 67
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+++++|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 120 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 999999999999999942 2346899999999999999999999985 9999999999999999999999999998
Q ss_pred ccCCCCcce--eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccc---------hhhHHHHHH
Q 040908 598 LDEEDNTHI--STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE---------KFYLLDWAL 666 (790)
Q Consensus 598 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~---------~~~l~~~~~ 666 (790)
......... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+....... .........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 765543321 223457788999999999889999999999999999999999886431100 000000000
Q ss_pred HHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 667 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
+.+........+......+.+++..||+.||.+||++.|+++.|+..
T Consensus 274 ---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 274 ---------ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp ---------HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111111222345688899999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=356.53 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=203.1
Q ss_pred HHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCe
Q 040908 442 KAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 516 (790)
....++|++.+.||+|+||.||+|... +|+.||+|+++... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445689999999999999999999965 68999999997642 33456688899999887 99999999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999993 2356899999999999999999999985 999999999999999999999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ... .+.
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-----~i~--~~~--- 234 (345)
T 1xjd_A 166 KENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH-----SIR--MDN--- 234 (345)
T ss_dssp BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHH--HCC---
T ss_pred hhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHH-----HHH--hCC---
Confidence 85432222 2345679999999999999999999999999999999999999997654322111 111 111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMS-SVV 716 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-ev~ 716 (790)
+.... ....++.+++..|++.||.+||++. |+.
T Consensus 235 ---~~~p~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ---PFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---CCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CCCCc----ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11111 2234678899999999999999987 554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=361.60 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=196.2
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEcccc--chhcHHHHHHHHHHhhccC--CCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQ--HPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|...+++.||||++... .......+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999878999999998653 2334567999999999996 599999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
| +.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 678899999942 346899999999999999999999985 99999999999995 57999999999987654
Q ss_pred CCcc-eeeccccCCCcccHHHhhc-----------CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 602 DNTH-ISTRVAGTFGYMAPEYAMR-----------GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 602 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~~---- 277 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KL---- 277 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HH----
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-----HH----
Confidence 3322 2345679999999999875 4688999999999999999999999964322110 00
Q ss_pred hhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 670 EQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 670 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..++++.....++......+.+++..||+.||.+||++.|+++
T Consensus 278 -----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 278 -----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp -----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1111221111112122346788999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=354.87 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=188.9
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
..++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999965 57899999987542 34568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC---CCCeEEeecCCcccc
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKLD 599 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla~~~ 599 (790)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999943 246899999999999999999999985 999999999999975 889999999999865
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ + +... ..... ....
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~--~~~i--~~~~~-~~~~ 272 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M--FRRI--LNCEY-YFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H--HHHH--HTTCC-CCCT
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H--HHHH--HhCCC-ccCC
Confidence 4332 22346799999999999999999999999999999999999999965433221 0 1111 11111 0111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.........+.+++..|++.||.+|||+.|+++
T Consensus 273 -----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 -----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111123356789999999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=379.34 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=202.7
Q ss_pred hcCcceee-eecccCcEEEEeeeec---CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVAN-KIGEGGFGPVYKGLLA---DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~-~LG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....++|.+|+.+|++++|||||+++++|.. +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34555555 8999999999999864 45679999997653 3356789999999999999999999999976 56899
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 413 v~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 99999999999999532 356899999999999999999999985 999999999999999999999999999876
Q ss_pred CCCCccee--eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 600 EEDNTHIS--TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 600 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
........ ....+|+.|+|||++....++.++|||||||++|||+| |+.||......+.. . ....+..
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~----~i~~~~~-- 557 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A----FIEQGKR-- 557 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---H----HHHTTCC--
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---H----HHHcCCC--
Confidence 54332221 22346789999999999999999999999999999998 99999765433211 1 1111111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
...+......+.+++..||+.+|.+||++.+|++.|+...
T Consensus 558 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 558 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1122233457889999999999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=353.18 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=201.1
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc-----chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK-----SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG 514 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 514 (790)
+....++|++.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 456678999999999999999999985 46889999998654 234456799999999999999999999999999
Q ss_pred CeEEEEEEeccCCChhhhhcCCcc------------------------------------ccCCCChhhHHHHHHHHHHH
Q 040908 515 NQLLLIYEYLENNSLARALFGPEE------------------------------------HRLKLDWPTRHNICIGIARG 558 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~ia~a 558 (790)
+..++||||+++|+|.+++..... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999842110 01223567788899999999
Q ss_pred HHHhhhcCCCcEEeccCCCCcEEecCCC--CeEEeecCCccccCCCC---cceeeccccCCCcccHHHhhc--CCCCChh
Q 040908 559 LAYLHEESRLKIVHRDIKATNVLLDKDL--NPKISDFGLAKLDEEDN---THISTRVAGTFGYMAPEYAMR--GHLTDKA 631 (790)
Q Consensus 559 L~yLH~~~~~~iiHrDlk~~NILl~~~~--~~kl~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~s~ks 631 (790)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++...... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999985 99999999999998776 89999999998653322 112344679999999999975 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 040908 632 DVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL 711 (790)
Q Consensus 632 DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 711 (790)
|||||||++|||++|+.||......+.. ..... ... ....+ ........+.+++..|++.||.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~~-~~~-~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTI------SQVLN-KKL-CFENP-----NYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH-CCC-CTTSG-----GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHH------HHHHh-ccc-ccCCc-----ccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999755432211 11111 110 00000 01112356788999999999999999
Q ss_pred HHHHHH
Q 040908 712 MSSVVS 717 (790)
Q Consensus 712 ~~ev~~ 717 (790)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.13 Aligned_cols=264 Identities=22% Similarity=0.321 Sum_probs=206.2
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEe----CCeEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIE----GNQLL 518 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 518 (790)
..++|++.+.||+|+||.||++.. .+|+.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346899999999999999999995 5789999999876666667789999999999999999999999973 34789
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++|+|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999543334467999999999999999999999985 99999999999999999999999999875
Q ss_pred cCCCCcc--------eeeccccCCCcccHHHhhcCC---CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH
Q 040908 599 DEEDNTH--------ISTRVAGTFGYMAPEYAMRGH---LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 599 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 667 (790)
....... ......||+.|+|||++.... ++.++|||||||++|||++|+.||.......... . ..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~---~~ 259 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-A---LA 259 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-H---HH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-h---HH
Confidence 4321110 012245799999999987543 6889999999999999999999986422111100 0 00
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
. . ... . ..........+.+++..||+.||.+||++.|+++.|+....
T Consensus 260 ~-~-~~~-~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 V-Q-NQL-S-------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp H-H-CC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred h-h-ccC-C-------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 0 000 0 00111223468899999999999999999999999998654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=341.94 Aligned_cols=262 Identities=22% Similarity=0.267 Sum_probs=202.1
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEE-EeCCeEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCC-IEGNQLLLIY 521 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 521 (790)
..++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+.+++.++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999995 5789999998654322 23578899999999988877776665 5677889999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe---cCCCCeEEeecCCccc
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKL 598 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~ 598 (790)
||+ +++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 9999999842 2346999999999999999999999985 9999999999999 8899999999999986
Q ss_pred cCCCCcc------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC
Q 040908 599 DEEDNTH------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 599 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 6543321 2234679999999999999999999999999999999999999997644332221111111111111
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 673 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
..... ...+ ...+.+++..||+.||.+||++.+|++.|+...
T Consensus 238 ~~~~~-----~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 238 PIEVL-----CKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp CHHHH-----TTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhh-----hccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 11000 0111 346889999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=353.03 Aligned_cols=244 Identities=22% Similarity=0.318 Sum_probs=203.0
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999964 68999999986542 234567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999994 2346899999999999999999999985 99999999999999999999999999986643
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ... ..+.. .
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i-~~~~~------~ 256 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY------EKI-VSGKV------R 256 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH-HHCCC------C
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH------HHH-HcCCC------C
Confidence 2 23457999999999999999999999999999999999999999754332211 111 11111 1
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPL-----MSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 717 (790)
... .....+.+++..|++.||.+||+ +.|+++
T Consensus 257 ~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 FPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111 22346788999999999999998 777764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=341.12 Aligned_cols=262 Identities=22% Similarity=0.265 Sum_probs=205.5
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEE-EeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCC-IEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 522 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+.+++.++|++++..++++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999995 5789999999865432 34688999999999988877766665 56778899999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe---cCCCCeEEeecCCcccc
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 599 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~ 599 (790)
|+ +++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 9999999942 2346899999999999999999999985 9999999999999 58899999999999866
Q ss_pred CCCCcc------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 600 EEDNTH------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 600 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 543321 12346799999999999999999999999999999999999999976433222111111111111111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
... +...+ ...+.+++..||+.||.+||++.+|++.|+....
T Consensus 239 ~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 239 IEV-----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHH-----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hHH-----HHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 100 01112 2468889999999999999999999999987543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.52 Aligned_cols=270 Identities=24% Similarity=0.415 Sum_probs=214.7
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeee
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLY 508 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~ 508 (790)
+..++++...++|++.+.||+|+||.||+|... .++.||+|++.... ......+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455667789999999999999999999854 36789999997543 23345789999999999999999999
Q ss_pred eEEEeCCeEEEEEEeccCCChhhhhcCCcc------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe
Q 040908 509 GCCIEGNQLLLIYEYLENNSLARALFGPEE------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL 582 (790)
Q Consensus 509 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 582 (790)
+++.+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 999999999999999999999999953211 1145789999999999999999999985 9999999999999
Q ss_pred cCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhh
Q 040908 583 DKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFY 660 (790)
Q Consensus 583 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 660 (790)
+.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||........
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 249 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-- 249 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH--
Confidence 99999999999999855432221 1223457889999999999999999999999999999999 8888865432211
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 661 LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 661 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
. .. ...+.... .+......+.+++..||+.||.+||++.|+++.|+....
T Consensus 250 -~---~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 -L---RF-VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -H---HH-HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -H---HH-HHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1 11 11111111 111233567889999999999999999999999988654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=350.53 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=198.2
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 520 (790)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999965 58899999997542 23345688999999988 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999983 2346899999999999999999999985 9999999999999999999999999998543
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchh--hHHHHHHHHHhhCCccccc
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF--YLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~ 678 (790)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...............
T Consensus 162 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 162 RPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 2221 234567999999999999999999999999999999999999999643211100 001111111111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
.+ +......+.+++..||+.||.+||++
T Consensus 237 --~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 --RI----PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CC----CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --CC----CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 11223467889999999999999995
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=343.18 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=199.1
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 46799999999999999999995 468899999987653 3345789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe---cCCCCeEEeecCCcccc
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 599 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~ 599 (790)
|+++|+|.+++.........+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998544334467999999999999999999999985 9999999999999 45678999999999865
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
..... .....||+.|+|||++. +.++.++|||||||++|||++|+.||......+... .... .......
T Consensus 178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~------~~~~-~~~~~~~- 246 (285)
T 3is5_A 178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ------KATY-KEPNYAV- 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH-CCCCCCC-
T ss_pred CCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh------hhcc-CCccccc-
Confidence 44322 24466999999999875 578999999999999999999999997543222111 1011 1100000
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.... ....+.+++..|++.||.+|||+.|+++
T Consensus 247 --~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 --ECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011 2346778999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=354.97 Aligned_cols=246 Identities=26% Similarity=0.454 Sum_probs=199.4
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.+.|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35589999999999999999995 578999999986532 23346789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+. |+|.+++. .....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 133 ~e~~~-g~l~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 68888873 23457899999999999999999999985 9999999999999999999999999998654
Q ss_pred CCCcceeeccccCCCcccHHHhh---cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
.. ....||+.|+|||++. .+.++.++|||||||++|||++|+.||......... ..... +..
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~-~~~--- 270 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-NES--- 270 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-SCC---
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHh-cCC---
Confidence 32 2356999999999985 567899999999999999999999999654322111 11111 111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+... .......+.+++..||+.||.+|||+.++++
T Consensus 271 --~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 271 --PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp --CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1111 1112345788999999999999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=358.24 Aligned_cols=272 Identities=19% Similarity=0.250 Sum_probs=213.0
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC--eEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN--QLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 520 (790)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999965 58999999997543 334567889999999999999999999998755 78999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe----cCCCCeEEeecCCc
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLA 596 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla 596 (790)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999954322 234899999999999999999999985 9999999999999 77788999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhc--------CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMR--------GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL 668 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 668 (790)
+....... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ......
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~~ 239 (396)
T 4eut_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKI 239 (396)
T ss_dssp EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHHH
T ss_pred eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHHH
Confidence 86654322 234569999999999875 467789999999999999999999997533221111 111111
Q ss_pred HhhC---Ccccc----------c-CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 669 KEQG---NLMEL----------V-DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 669 ~~~~---~~~~~----------~-d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
.... .+... . +..............+.+++..||+.||++||++.|+++.++.+..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1111 00000 0 0111223456778889999999999999999999999999887654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.09 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=203.7
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999854 68899999986542 334567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC---eEEeecCCccc
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKISDFGLAKL 598 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGla~~ 598 (790)
||+++++|.+.+. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999998883 2356899999999999999999999985 999999999999987655 99999999986
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .. ..+.. ...
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~------~~-~~~~~-~~~ 227 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA------QI-KAGAY-DYP 227 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH-HHTCC-CCC
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH------HH-Hhccc-cCC
Confidence 654332 234679999999999999999999999999999999999999997543322111 11 11111 010
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+. .......+.+++..|++.||.+|||+.|+++
T Consensus 228 ~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 110 0122346788999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=356.74 Aligned_cols=252 Identities=22% Similarity=0.310 Sum_probs=192.5
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|++.+.||+|+||.||++... +++.||||++.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999965 78999999986533 2346688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC--eEEeecCCccccCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--PKISDFGLAKLDEE 601 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGla~~~~~ 601 (790)
+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERIC----NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999983 2346899999999999999999999985 999999999999987765 99999999984332
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCCh-hhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDK-ADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.. ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.......... ........ ... .
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~~~~~~~-~~~-~---- 240 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KTIQRILS-VKY-S---- 240 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HHHHHHHT-TCC-C----
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HHHHHHhc-CCC-C----
Confidence 22 2234569999999999988887766 899999999999999999997644322211 11111110 000 0
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... .......+.+++.+||+.||.+|||+.|+++
T Consensus 241 -~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 241 -IPD--DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp -CCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred -CCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 000 0012346788999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=359.45 Aligned_cols=274 Identities=24% Similarity=0.316 Sum_probs=209.5
Q ss_pred CCCccHHHHHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccC-----CCceee
Q 040908 433 TGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-----HPHLVK 506 (790)
Q Consensus 433 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~ 506 (790)
...+++++.....++|++.++||+|+||.||+|.. .+++.||||++... ......+..|+.+++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34556666667789999999999999999999996 46889999998642 334456788999999886 999999
Q ss_pred eeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC--
Q 040908 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-- 584 (790)
Q Consensus 507 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-- 584 (790)
+++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence 999999999999999999 999999995322 235899999999999999999999985 999999999999975
Q ss_pred -----------------------CCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHH
Q 040908 585 -----------------------DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVAL 641 (790)
Q Consensus 585 -----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ 641 (790)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 7899999999998654322 3457999999999999999999999999999999
Q ss_pred HHHhCCCCCccccccchhhHHHHH--------HHHHhhCCcccccCCC-----CCCCC-cH---------------HHHH
Q 040908 642 EIVSGRSNIMCKTKEEKFYLLDWA--------LLLKEQGNLMELVDPN-----LGSNV-DK---------------EQVR 692 (790)
Q Consensus 642 elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~~~~~~d~~-----l~~~~-~~---------------~~~~ 692 (790)
||+||+.||......+........ ............++.. ..... .. ....
T Consensus 251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 999999999765433222111100 0000000000000000 00000 00 0115
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 693 VMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 693 ~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.+++..||+.||.+|||+.|+++
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhc
Confidence 6779999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.80 Aligned_cols=264 Identities=24% Similarity=0.344 Sum_probs=198.6
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch-----hcHHHHHHHHHHhhccC---CCceeeeeeEEEeC
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK-----QGNREFVNEIGTISALQ---HPHLVKLYGCCIEG 514 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 514 (790)
..++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999995 5689999999864321 12346677888777765 99999999999875
Q ss_pred C-----eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeE
Q 040908 515 N-----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 589 (790)
Q Consensus 515 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 589 (790)
. ..++||||+. |+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 5 5899999997 59999995432 234899999999999999999999985 99999999999999999999
Q ss_pred EeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 590 ISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 590 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ......
T Consensus 161 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~--i~~~~~ 236 (308)
T 3g33_A 161 LADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK--IFDLIG 236 (308)
T ss_dssp ECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH--HHHHHC
T ss_pred EeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhC
Confidence 999999986643322 2446799999999999999999999999999999999999999976543322111 111000
Q ss_pred h--hCCcccc-------cCCCCCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 670 E--QGNLMEL-------VDPNLGSN---VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 670 ~--~~~~~~~-------~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ....... ..+..... ...+....+.+++..|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0 0000000 00000000 00122356788999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=349.41 Aligned_cols=266 Identities=24% Similarity=0.403 Sum_probs=189.1
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999854 689999999865432 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCc--cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 523 YLENNSLARALFGPE--EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 523 y~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|++ |+|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999884321 11245899999999999999999999985 9999999999999999999999999998664
Q ss_pred CCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh-CCcccc-
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ-GNLMEL- 677 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~- 677 (790)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ ....... ......
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI--FDIMGTPNESLWPSV 236 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCSCCTTTCGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCChhHhhhh
Confidence 3322 1234568999999999976 46899999999999999999999999765433221111 0000000 000000
Q ss_pred -----cCCCCC----CCC--------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 -----VDPNLG----SNV--------DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 -----~d~~l~----~~~--------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+... ... .......+.+++..|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000 000 0012346889999999999999999999865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=350.52 Aligned_cols=257 Identities=26% Similarity=0.443 Sum_probs=199.9
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCc----EEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGT----LIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
.++|++.+.||+|+||.||+|... +++ +||+|.+... .....+.+.+|+.++++++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999853 444 3577777543 3345678999999999999999999999998765 78
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+|+||+.+|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999943 2356899999999999999999999985 99999999999999999999999999986
Q ss_pred cCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 599 DEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 599 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.... . ..+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~------~-~~~~--- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI------L-EKGE--- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH------H-HTTC---
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH------H-HcCC---
Confidence 6433222 2233457889999999999999999999999999999999 9999976543332111 1 1111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
....+......+.+++..||+.||.+||++.|+++.|+....
T Consensus 237 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 ------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 011112233467889999999999999999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=366.66 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=194.2
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.+++.++||||++++++|...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999995 46899999999754 233345678999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhh-cCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999983 23578999999999999999999998 5 4999999999999999999999999999854
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... ...
T Consensus 300 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-----i~~--~~~----- 366 (446)
T 4ejn_A 300 IKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----ILM--EEI----- 366 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHH--CCC-----
T ss_pred cCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH-----HHh--CCC-----
Confidence 33222 23446799999999999999999999999999999999999999975443221111 111 110
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
.... ....++.+++..||+.||.+|| ++.|+++
T Consensus 367 -~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -RFPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCc----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1111 2234678899999999999999 9999865
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=339.24 Aligned_cols=247 Identities=21% Similarity=0.320 Sum_probs=204.5
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
..++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3567999999999999999999965 577899999987666667889999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe---cCCCCeEEeecCCcccc
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 599 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~ 599 (790)
|+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999883 2356899999999999999999999985 9999999999999 78899999999999866
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
..... .....||+.|+|||++.+ .++.++||||||+++|||++|+.||......+.. ... ..+..
T Consensus 160 ~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~-~~~~~----- 224 (277)
T 3f3z_A 160 KPGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM------LKI-REGTF----- 224 (277)
T ss_dssp CTTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH-HHCCC-----
T ss_pred cCccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH------HHH-HhCCC-----
Confidence 54332 234569999999998865 4899999999999999999999999764432211 011 11111
Q ss_pred CCCCCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDK----EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+. .....+.+++..|++.||.+||++.|+++
T Consensus 225 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 -----TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 12356788999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=351.51 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=202.4
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 518 (790)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ......+..|..++..+ +||||+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999965 47899999997642 23456788999999988 8999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999993 2346899999999999999999999985 99999999999999999999999999985
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... +..
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~-~~~---- 238 (353)
T 2i0e_A 171 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QSIME-HNV---- 238 (353)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH-CCC----
T ss_pred cccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH------HHHHh-CCC----
Confidence 432222 234567999999999999999999999999999999999999999764432211 11111 111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPL-----MSSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 717 (790)
. ++.....++.+++..|++.||.+||+ +.|+++
T Consensus 239 --~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 --A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --C----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --C----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 11123356788999999999999996 466653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=349.79 Aligned_cols=258 Identities=27% Similarity=0.447 Sum_probs=201.3
Q ss_pred hcCcceeeeecccCcEEEEeeeecC-----CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD-----GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~-----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
.++|++.+.||+|+||.||+|.... +..||||++.... ......+.+|+.++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3578889999999999999998642 2469999987543 334557899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999942 2356899999999999999999999985 99999999999999999999999999986
Q ss_pred cCCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 599 DEEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 599 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. ... ..+..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~------~~~-~~~~~- 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM------KAI-NDGFR- 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHH-HTTCC-
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH------HHH-HCCCc-
Confidence 6543221 1223446889999999999999999999999999999999 99999654322111 111 11110
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
.. .+......+.+++.+||+.+|.+||++.|+++.|+....
T Consensus 269 ----~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 269 ----LP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ----CC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01 111234567889999999999999999999999987654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=350.12 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=193.5
Q ss_pred hcCcceeeeecccCcEEEEeeee----cCCcEEEEEEccccc----hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL----ADGTLIAVKQLSAKS----KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 516 (790)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999986 468999999987542 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999993 2346899999999999999999999985 999999999999999999999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... ..
T Consensus 169 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~~-~~--- 237 (327)
T 3a62_A 169 KESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI------DKILK-CK--- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHH-TC---
T ss_pred cccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHh-CC---
Confidence 85433222 234467999999999999999999999999999999999999999754332211 11111 11
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
..+ +......+.+++.+||+.||.+|| ++.|+++
T Consensus 238 ---~~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 ---LNL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---CCC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CCC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011 112235678899999999999999 6777765
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=347.21 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=204.3
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh------cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ------GNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999964 6899999998754321 356799999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC----CeEEeec
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDF 593 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DF 593 (790)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999943 346899999999999999999999985 99999999999999888 7999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... ...
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~i~-~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANIT-SVS 234 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHH-TTC
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-hcc
Confidence 99986654322 23456999999999999999999999999999999999999999754332211 0000 000
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ..++.. .......+.+++..|++.||.+|||+.|+++
T Consensus 235 ~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y--DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C--CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c--ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 000000 0112346789999999999999999999976
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=355.88 Aligned_cols=267 Identities=17% Similarity=0.255 Sum_probs=202.4
Q ss_pred hcCcceeeeeccc--CcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEG--GFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G--~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.++|++.+.||+| +||.||+|... +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999965 68999999997543 3334678889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999994321 246899999999999999999999985 999999999999999999999999998643
Q ss_pred CCCCc------ceeeccccCCCcccHHHhhc--CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHh-
Q 040908 600 EEDNT------HISTRVAGTFGYMAPEYAMR--GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKE- 670 (790)
Q Consensus 600 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~- 670 (790)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ +......
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~ 257 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCL 257 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-hcCCCCcc
Confidence 22111 11122468999999999987 57899999999999999999999999754332221100 0000000
Q ss_pred --------------------hCCcccccC---CC------CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 671 --------------------QGNLMELVD---PN------LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 671 --------------------~~~~~~~~d---~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.....+.+. +. ............+.+++.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000000000 00 000112223456889999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=338.98 Aligned_cols=246 Identities=25% Similarity=0.430 Sum_probs=199.9
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999854 57799999986532 22356788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999983 2356899999999999999999999875 9999999999999999999999999986543
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... ... .. ..
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~-~~------~~ 224 (279)
T 3fdn_A 161 SSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK------RIS-RV------EF 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHH-HT------CC
T ss_pred ccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH------HHH-hC------CC
Confidence 322 234578999999999999999999999999999999999999997543222111 101 11 11
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. +......+.+++..|++.||.+||++.|+++
T Consensus 225 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 225 TF----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 1122346788999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=346.41 Aligned_cols=264 Identities=22% Similarity=0.343 Sum_probs=199.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999965 589999998865432 234668899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998742 346899999999999999999999985 999999999999999999999999999866533
Q ss_pred CcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHH--------HHHHhhCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWA--------LLLKEQGN 673 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~ 673 (790)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+........ ........
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22 2234568999999999976 67899999999999999999999999765443322211110 00000010
Q ss_pred c-c--cccCCCCCCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 L-M--ELVDPNLGSNVD---KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~-~--~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. . ...++....... ......+.+++..||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0 011110000000 122345789999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=345.19 Aligned_cols=262 Identities=23% Similarity=0.388 Sum_probs=199.0
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5799999999999999999995 57899999998753 2334567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++.........+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999998543333466899999999999999999999985 99999999999999999999999999986544
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....... ........
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~---- 258 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKI-EQCDYPPL---- 258 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHHHH-HTTCSCCC----
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHHHh-hcccCCCC----
Confidence 322 2233568999999999999999999999999999999999999996533211 1111111 11111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
... .....+.+++..||+.||.+||++.+|++.|+....
T Consensus 259 ~~~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 259 PSD----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp CTT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccc----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 011 223467889999999999999999999999987653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=349.43 Aligned_cols=267 Identities=27% Similarity=0.416 Sum_probs=198.0
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHH--HHHhhccCCCceeeeeeEEEe-----CCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNE--IGTISALQHPHLVKLYGCCIE-----GNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E--~~~l~~l~H~niv~l~g~~~~-----~~~~ 517 (790)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..| +..+..++||||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999987 68899999986533 2334444 444556899999999986643 2367
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC------CCcEEeccCCCCcEEecCCCCeEEe
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES------RLKIVHRDIKATNVLLDKDLNPKIS 591 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~iiHrDlk~~NILl~~~~~~kl~ 591 (790)
++||||+++|+|.+++. ....++..+..++.||++||+|||+.. .++|+||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHh-----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 89999999999999993 234589999999999999999999871 1259999999999999999999999
Q ss_pred ecCCccccCCCC-------cceeeccccCCCcccHHHhhc-------CCCCChhhHHHHHHHHHHHHhCCCCCccccccc
Q 040908 592 DFGLAKLDEEDN-------THISTRVAGTFGYMAPEYAMR-------GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE 657 (790)
Q Consensus 592 DFGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~ 657 (790)
|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998654322 112234569999999999976 355678999999999999999988775432211
Q ss_pred hhh------------HHHHHHHHHhhCCcccccCCCCCCC--CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 658 KFY------------LLDWALLLKEQGNLMELVDPNLGSN--VDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 658 ~~~------------l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
... ..++.... ..... .+.+... ........+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLV-SREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHH-TTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhh-ccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 100 00111111 11111 1111111 12246678999999999999999999999999999876
Q ss_pred CC
Q 040908 724 GV 725 (790)
Q Consensus 724 ~~ 725 (790)
..
T Consensus 318 ~~ 319 (336)
T 3g2f_A 318 MI 319 (336)
T ss_dssp HC
T ss_pred HH
Confidence 43
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.48 Aligned_cols=260 Identities=22% Similarity=0.264 Sum_probs=199.1
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999964 688999999976432 2246789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999994 2346899999999999999999999985 9999999999999999999999999998665
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
...........||+.|+|||++.+..++.++||||||+++|||++|+.||....... + ..............
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~~~~~~~~~~~~-- 257 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---M---GAHINQAIPRPSTV-- 257 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---H---HHHHHSCCCCGGGT--
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---H---HHHhccCCCCcccc--
Confidence 443333344679999999999998899999999999999999999999997543211 0 01111111100111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCcCC
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRP-LMSSVVSMLEGRVGV 725 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~L~~~~~~ 725 (790)
.......+.+++.+||+.||.+|| ++.++++.|+.....
T Consensus 258 ------~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 258 ------RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ------STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ------CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 112234578899999999999999 999999999987653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.16 Aligned_cols=270 Identities=26% Similarity=0.383 Sum_probs=214.2
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccch-hcHHHHHHHHHHhhcc-CCCceeee
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKSK-QGNREFVNEIGTISAL-QHPHLVKL 507 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l 507 (790)
+.........++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45556666778999999999999999999973 3568899999976433 3346789999999999 79999999
Q ss_pred eeEEEeCC-eEEEEEEeccCCChhhhhcCCccc------------cCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEecc
Q 040908 508 YGCCIEGN-QLLLIYEYLENNSLARALFGPEEH------------RLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRD 574 (790)
Q Consensus 508 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrD 574 (790)
++++...+ ..++||||+++|+|.+++...... ...+++..+..++.|+++||+|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99998754 589999999999999999643321 123789999999999999999999985 99999
Q ss_pred CCCCcEEecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCcc
Q 040908 575 IKATNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMC 652 (790)
Q Consensus 575 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~ 652 (790)
|||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999866543332 2334568899999999999999999999999999999998 9999975
Q ss_pred ccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 653 KTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 653 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
....... .... ..+.. ..... .....+.+++..||+.||.+||++.|+++.|+...
T Consensus 254 ~~~~~~~-----~~~~-~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 254 VKIDEEF-----CRRL-KEGTR-----MRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCCSHHH-----HHHH-HHTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhHHH-----HHHh-ccCcc-----CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 4432211 1111 11111 11111 12346788999999999999999999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=356.23 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=193.9
Q ss_pred CcceeeeecccCcEEEEeeeec--CC--cEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEe-CCeEEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA--DG--TLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIE-GNQLLLI 520 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~--~g--~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV 520 (790)
.|++.+.||+|+||.||+|.+. ++ ..||||.+.... ....+.|.+|+.++++++||||++++++|.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4778899999999999999853 22 368999986543 3445789999999999999999999999764 4578999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999943 2346889999999999999999999985 9999999999999999999999999998654
Q ss_pred CCCcc---eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 601 EDNTH---ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 601 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
..... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||......+.. . .. ..+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---~---~~-~~~~~-- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---V---YL-LQGRR-- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH---H---HH-HTTCC--
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH---H---HH-HcCCC--
Confidence 32211 1233557889999999999999999999999999999999 66677544332211 1 11 11111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
... +......+.+++..||+.||.+||++.|+++.|+....
T Consensus 315 ~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 315 LLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 11223468889999999999999999999999987653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.07 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=194.6
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC----e
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN----Q 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 516 (790)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999995 578999999997642 223457899999999999999999999987654 3
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 499999999999999994 2346899999999999999999999985 999999999999999999999999999
Q ss_pred cccCCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 597 KLDEEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 597 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
+........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||......... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCC
Confidence 865443221 223456999999999999999999999999999999999999999754432211 111111111
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-HHh
Q 040908 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS-MLE 720 (790)
Q Consensus 675 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~-~L~ 720 (790)
... .... .....+.+++.+||+.||.+||++.+++. .+.
T Consensus 238 ~~~---~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 238 PPS---ARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CHH---HHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred Ccc---cccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 000 0001 12346788999999999999997666553 443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.69 Aligned_cols=264 Identities=27% Similarity=0.416 Sum_probs=210.1
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeecC-C-----cEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEE
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLAD-G-----TLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCI 512 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~-g-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 512 (790)
.+...++|++.+.||+|+||.||+|.... + ..||+|.+.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 44456889999999999999999998532 2 479999987643 23456789999999999 8999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhcCCcc----------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe
Q 040908 513 EGNQLLLIYEYLENNSLARALFGPEE----------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL 582 (790)
Q Consensus 513 ~~~~~~lV~Ey~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 582 (790)
..+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 99999999999999999999853211 1245799999999999999999999985 9999999999999
Q ss_pred cCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhh
Q 040908 583 DKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFY 660 (790)
Q Consensus 583 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 660 (790)
+.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~- 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF- 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-
Confidence 99999999999999865443322 2234557889999999999999999999999999999999 99998754332211
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 661 LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 661 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
.. ....+. .... +......+.+++..||+.||.+||++.||++.|+..
T Consensus 277 -~~----~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 -YK----LVKDGY-----QMAQ----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -HH----HHHHTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HH----HHhcCC-----CCCC----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11 111111 0011 111235678899999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=346.88 Aligned_cols=270 Identities=21% Similarity=0.332 Sum_probs=209.2
Q ss_pred ccCCCCCCccHHHHHHHhcCccee-eeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhcc-CCC
Q 040908 428 GLDLQTGSFTLRQIKAATNHFDVA-NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISAL-QHP 502 (790)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~y~~~-~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~H~ 502 (790)
+.+...+...++..+...++|.+. +.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++.++ +||
T Consensus 10 ~~~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 89 (327)
T 3lm5_A 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89 (327)
T ss_dssp ------CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCT
T ss_pred cccccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCC
Confidence 344445556667777788889888 89999999999999865 689999999875432 3357889999999999 569
Q ss_pred ceeeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe
Q 040908 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL 582 (790)
Q Consensus 503 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 582 (790)
||+++++++...+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~ 164 (327)
T 3lm5_A 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILL 164 (327)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEE
Confidence 9999999999999999999999999999998533 2356899999999999999999999985 9999999999999
Q ss_pred cC---CCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchh
Q 040908 583 DK---DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659 (790)
Q Consensus 583 ~~---~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~ 659 (790)
+. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus 165 ~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 242 (327)
T 3lm5_A 165 SSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY 242 (327)
T ss_dssp SCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ecCCCCCcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 98 78999999999986654322 23457999999999999999999999999999999999999999765432211
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 660 YLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 660 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ........ ............+.+++..|++.||.+|||+.|+++
T Consensus 243 ~-----~i~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 243 L-----NISQVNVD--------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp H-----HHHHTCCC--------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred H-----HHHhcccc--------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1 00000000 011111123356788999999999999999999865
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=355.26 Aligned_cols=263 Identities=14% Similarity=0.168 Sum_probs=205.2
Q ss_pred hcCcceeeeecccCcEEEEeeeecC---------CcEEEEEEccccchhcHHHHHHHHHHhhccCCCceee---------
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD---------GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK--------- 506 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~---------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 506 (790)
.++|++.+.||+|+||.||+|.... ++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999653 789999998643 46789999999999999988
Q ss_pred ------eeeEEEe-CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCc
Q 040908 507 ------LYGCCIE-GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATN 579 (790)
Q Consensus 507 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~N 579 (790)
+++++.. .+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6777776 67899999999 999999995321 357999999999999999999999985 9999999999
Q ss_pred EEecCCC--CeEEeecCCccccCCCCcc------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCc
Q 040908 580 VLLDKDL--NPKISDFGLAKLDEEDNTH------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIM 651 (790)
Q Consensus 580 ILl~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~ 651 (790)
||++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999865432211 1233579999999999999999999999999999999999999997
Q ss_pred cccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 652 CKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 652 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
....... .+........ .....+.+.... .......+.+++..||+.||.+||++.+|+++|+....
T Consensus 270 ~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 270 NCLPNTE-DIMKQKQKFV--DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GGTTCHH-HHHHHHHHHH--HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCCcCHH-HHHHHHHhcc--CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 6542221 1111111111 111222221111 00123568889999999999999999999999987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=359.49 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=205.8
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67999999999999999999965 78999999996542 223467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999942 346899999999999999999999985 99999999999999999999999999987654
Q ss_pred CCcceeeccccCCCcccHHHhhcCCC-CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ... ..+..
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~------~~i-~~~~~------ 233 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF------KKI-CDGIF------ 233 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH------HHH-HTTCC------
T ss_pred cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH------HHH-hcCCc------
Confidence 32 2234679999999999988765 67999999999999999999999754332211 111 11110
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGR 722 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~ 722 (790)
.... .....+.+++..|++.||.+|||+.|+++ .+...
T Consensus 234 ~~p~----~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 YTPQ----YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCCc----cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0111 12346788999999999999999999987 55543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=348.01 Aligned_cols=258 Identities=28% Similarity=0.418 Sum_probs=203.6
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcE--EEEEEcccc-chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTL--IAVKQLSAK-SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~--vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 520 (790)
++|++.+.||+|+||.||+|... +|.. ||+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68899999999999999999954 5654 499988653 233456789999999999 999999999999999999999
Q ss_pred EEeccCCChhhhhcCCc------------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCe
Q 040908 521 YEYLENNSLARALFGPE------------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 588 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 588 (790)
|||+++|+|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996443 22347899999999999999999999985 9999999999999999999
Q ss_pred EEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHH
Q 040908 589 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 589 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 667 (790)
||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||......+.. ..
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~------~~ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EK 253 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH------HH
Confidence 999999997433211 1223457889999999998889999999999999999998 99999754322111 11
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
...+ ..... +......+.+++.+||+.+|.+||++.|+++.|+....
T Consensus 254 -~~~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 254 -LPQG-----YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp -GGGT-----CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hhcC-----CCCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111 11111 11233568899999999999999999999999987554
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.06 Aligned_cols=266 Identities=25% Similarity=0.416 Sum_probs=200.4
Q ss_pred HHHHHHhcCcceeeeecccCcEEEEeeeec----CCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEE
Q 040908 439 RQIKAATNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCI 512 (790)
Q Consensus 439 ~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 512 (790)
.++....++|.+.+.||+|+||.||+|... .+..||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344445678999999999999999999854 3458999998754 2334567999999999999999999999998
Q ss_pred eCC-----eEEEEEEeccCCChhhhhcCCc--cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC
Q 040908 513 EGN-----QLLLIYEYLENNSLARALFGPE--EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD 585 (790)
Q Consensus 513 ~~~-----~~~lV~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 585 (790)
+.+ ..++||||+++|+|.+++.... .....+++..++.++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 755 3599999999999999984221 23356999999999999999999999985 9999999999999999
Q ss_pred CCeEEeecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHH
Q 040908 586 LNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLD 663 (790)
Q Consensus 586 ~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~ 663 (790)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......... .
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~ 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---D 260 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---H
Confidence 9999999999986543322 12233457889999999999999999999999999999999 88888654432211 1
Q ss_pred HHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 664 WALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 664 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
... .+.. + ..+......+.+++..||+.+|.+||++.++++.|+...
T Consensus 261 ---~~~-~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 261 ---YLL-HGHR-----L----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp ---HHH-TTCC-----C----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHH-cCCC-----C----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 1111 1 111223356889999999999999999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.87 Aligned_cols=256 Identities=28% Similarity=0.391 Sum_probs=204.1
Q ss_pred HhcCcceee-eecccCcEEEEeeee---cCCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 444 ATNHFDVAN-KIGEGGFGPVYKGLL---ADGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 444 ~~~~y~~~~-~LG~G~fG~Vy~g~~---~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
..++|++.+ .||+|+||.||+|.+ ..++.||||++..... ...+++.+|+.++++++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 356788888 999999999999964 3468899999875432 2356799999999999999999999999 56778
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999999942 346899999999999999999999985 9999999999999999999999999998
Q ss_pred ccCCCCccee--eccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 598 LDEEDNTHIS--TRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 598 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
.......... ....+|+.|+|||++.+..++.++||||||+++|||+| |+.||......+. .. ....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~----~~~~~~~ 238 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TA----MLEKGER 238 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH----HHHTTCC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH----HHHcCCC
Confidence 7654433222 22446789999999998889999999999999999999 9999975433221 11 1111111
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 675 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
+ ..+......+.+++..||+.||.+||++.++++.|+...
T Consensus 239 -----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 -----M----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp -----C----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 112223456889999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=350.80 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=179.7
Q ss_pred Cccee---eeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEEEE
Q 040908 447 HFDVA---NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 447 ~y~~~---~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 521 (790)
+|++. +.||+|+||.||+|... +|+.||||++... ....+.+|+.++..+. ||||+++++++.+.+..++||
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 45543 78999999999999964 6899999998543 3456788999999997 999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC---CeEEeecCCccc
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKISDFGLAKL 598 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGla~~ 598 (790)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.
T Consensus 86 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 86 ELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp CCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999999999942 356999999999999999999999985 99999999999998765 799999999986
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....................+..
T Consensus 159 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~---- 233 (325)
T 3kn6_A 159 KPPDNQP-LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF---- 233 (325)
T ss_dssp CCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC----
T ss_pred cCCCCCc-ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC----
Confidence 6543322 23456899999999999999999999999999999999999999754321110000001111111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
............++.+++..|++.||.+|||+.|+++
T Consensus 234 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 234 --SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp --CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred --CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0000001123457889999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=338.83 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=183.0
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999995 578999999986542 22346789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999943 2356899999999999999999999985 9999999999999999999999999998654
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ......
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~ 227 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLA 227 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhc
Confidence 3222 123356899999999999888999999999999999999999999754322211 000000
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ..+.....++.+++.+|++.||.+||++.++++
T Consensus 228 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 DY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 111123346788999999999999999999865
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=351.14 Aligned_cols=242 Identities=20% Similarity=0.315 Sum_probs=200.4
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch--------hcHHHHHHHHHHhhccCCCceeeeeeEEEeC
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK--------QGNREFVNEIGTISALQHPHLVKLYGCCIEG 514 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 514 (790)
..++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999984 5689999999875421 1234577899999999999999999999999
Q ss_pred CeEEEEEEeccCC-ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 515 NQLLLIYEYLENN-SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 515 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
+..++||||+.+| +|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999877 99999842 346899999999999999999999985 999999999999999999999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCC-CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
|+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 99987654432 234569999999999988776 78999999999999999999999642110
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......+ .. .....+.+++..||+.||.+|||+.|+++
T Consensus 237 -~~~~~~~--~~----~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 -VEAAIHP--PY----LVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp -TTTCCCC--SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HhhccCC--Cc----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000110 11 12346788999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.81 Aligned_cols=274 Identities=26% Similarity=0.359 Sum_probs=211.1
Q ss_pred CccHHHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhc--cCCCceeeeeeEEE
Q 040908 435 SFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISA--LQHPHLVKLYGCCI 512 (790)
Q Consensus 435 ~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~ 512 (790)
...+..-....++|++.+.||+|+||.||+|.. +|+.||||++... ....+.+|++++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344444556678999999999999999999998 5899999998643 34567888888877 79999999999998
Q ss_pred eCC----eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC-----CCcEEeccCCCCcEEec
Q 040908 513 EGN----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES-----RLKIVHRDIKATNVLLD 583 (790)
Q Consensus 513 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDlk~~NILl~ 583 (790)
..+ ..++||||+++|+|.+++. ...+++..++.++.|++.||+|||... ..+|+||||||+|||++
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred ccCCccceeEEEEeecCCCcHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 776 7899999999999999993 246899999999999999999999310 12599999999999999
Q ss_pred CCCCeEEeecCCccccCCCCcc---eeeccccCCCcccHHHhhcCC------CCChhhHHHHHHHHHHHHhC--------
Q 040908 584 KDLNPKISDFGLAKLDEEDNTH---ISTRVAGTFGYMAPEYAMRGH------LTDKADVYSFGIVALEIVSG-------- 646 (790)
Q Consensus 584 ~~~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~S~Gvvl~elltG-------- 646 (790)
.++.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999866544322 123457999999999997652 33689999999999999999
Q ss_pred --CCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 647 --RSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNV-DKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 647 --~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
+.||........ ....+...... ....+.+...+ ..+....+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 262 ~~~~p~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 262 DYQLPYYDLVPSDP-SVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCCTTTTTSCSSC-CHHHHHHHHTT-----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCccccCcCcc-cHHHHHHHHHH-----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 677754322111 11111111111 11122222111 2356778999999999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.55 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=200.9
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch------hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK------QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 367999999999999999999965 689999999865421 1357799999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC----CeEEeec
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDF 593 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DF 593 (790)
++||||+++++|.+++. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLA----EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999993 2356899999999999999999999985 99999999999998877 8999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
|+++....... .....||+.|+|||++....++.++||||||+++|||++|+.||......+.. ... ....
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~--~~~~ 227 (283)
T 3bhy_A 157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-----TNI--SAVN 227 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----HHH--HTTC
T ss_pred ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH-----HHh--Hhcc
Confidence 99986644322 23456999999999999999999999999999999999999999754332211 000 0000
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. .............+.+++.+|++.||.+||++.|+++
T Consensus 228 ~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 Y------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 0000000112346788999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=347.36 Aligned_cols=256 Identities=18% Similarity=0.262 Sum_probs=197.2
Q ss_pred hcCccee-eeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEE
Q 040908 445 TNHFDVA-NKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~-~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 521 (790)
.+.|++. +.||+|+||.||+|.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3578875 7899999999999984 47899999999766555667899999999885 7999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC---eEEeecCCccc
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKISDFGLAKL 598 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGla~~ 598 (790)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999942 356899999999999999999999985 999999999999998776 99999999975
Q ss_pred cCCCCc------ceeeccccCCCcccHHHhhc-----CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhH------
Q 040908 599 DEEDNT------HISTRVAGTFGYMAPEYAMR-----GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYL------ 661 (790)
Q Consensus 599 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l------ 661 (790)
...... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 532211 11223569999999999875 5678999999999999999999999976432210000
Q ss_pred --HHHHHHHHhhCCcccccCCCCCCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 662 --LDWALLLKEQGNLMELVDPNLGSNVDK----EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 662 --~~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..........+.. ..+. .....+.+++.+|++.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCc----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0000000111110 1111 12346889999999999999999999977
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=348.81 Aligned_cols=254 Identities=15% Similarity=0.152 Sum_probs=202.6
Q ss_pred HHhcCcceeeeecccCcEEEEeee------ecCCcEEEEEEccccchhcHHHHHHHHHHhhccC---CCceeeeeeEEEe
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGL------LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ---HPHLVKLYGCCIE 513 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~------~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 513 (790)
...++|.+.+.||+|+||.||+|. ..+++.||||++.... ..++..|+.++.+++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 4468899999996543 446777777777775 9999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCcc-ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC--------
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEE-HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-------- 584 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-------- 584 (790)
.+..++||||+++|+|.+++..... ....++|..+..|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999953211 2356999999999999999999999985 999999999999998
Q ss_pred ---CCCeEEeecCCccccCC-CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhh
Q 040908 585 ---DLNPKISDFGLAKLDEE-DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY 660 (790)
Q Consensus 585 ---~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~ 660 (790)
++.+||+|||+|+.... ..........||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 89999999999975432 222334557799999999999999999999999999999999999999864322110
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhcCc
Q 040908 661 LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNR-PLMSSVVSMLEGRV 723 (790)
Q Consensus 661 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~ev~~~L~~~~ 723 (790)
.+......... .+.+.+++..|++.+|.+| |++.++.+.|+...
T Consensus 294 ----------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 294 ----------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ----------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ----------------eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 01111111112 3455677889999999998 57888888887654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=353.36 Aligned_cols=248 Identities=26% Similarity=0.358 Sum_probs=192.6
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHH-hhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGT-ISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999965 57899999997643 2234456777776 577899999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999993 2356889999999999999999999985 999999999999999999999999999854
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .... ..+
T Consensus 190 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~-----~i~~--~~~----- 256 (373)
T 2r5t_A 190 IEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD-----NILN--KPL----- 256 (373)
T ss_dssp BCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH-----HHHH--SCC-----
T ss_pred ccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH-----HHHh--ccc-----
Confidence 33222 2345679999999999999999999999999999999999999997544322111 1111 111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..... ....+.+++..|++.||.+||++.+.++
T Consensus 257 -~~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 257 -QLKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp -CCCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred -CCCCC----CCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 11112 2346788999999999999999864333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=341.08 Aligned_cols=256 Identities=26% Similarity=0.367 Sum_probs=201.3
Q ss_pred CcceeeeecccCcEEEEeeeecC----CcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE-EEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQL-LLI 520 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 520 (790)
.|++.+.||+|+||.||+|...+ +..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667999999999999998532 23799999875433 3456789999999999999999999999876655 999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+.+|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999953 2356899999999999999999999985 9999999999999999999999999998554
Q ss_pred CCC---cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 601 EDN---THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 601 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+........ +... .. .+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~---~~-~~~~--- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHF---LA-QGRR--- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHH---HH-TTCC---
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHH---hh-cCCC---
Confidence 322 1122345688999999999999999999999999999999996666543322211 1111 11 1110
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.. .+......+.+++..|++.||.+|||+.++++.|+...
T Consensus 247 --~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 247 --LP----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp --CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CC----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01 11122346888999999999999999999999998754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.96 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=204.1
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEe---------
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIE--------- 513 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 513 (790)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999975 78999999986543 356789999999999999999998864
Q ss_pred -------CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC
Q 040908 514 -------GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 586 (790)
Q Consensus 514 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 586 (790)
....++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 44589999999999999999532 2357899999999999999999999985 99999999999999999
Q ss_pred CeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH
Q 040908 587 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL 666 (790)
Q Consensus 587 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 666 (790)
.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|..|+.... .+..
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~ 229 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFT 229 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHH
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHH
Confidence 999999999986654332 234569999999999999999999999999999999999998874211 1111
Q ss_pred HHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcCC
Q 040908 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGV 725 (790)
Q Consensus 667 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 725 (790)
. ...+. +...++ ..+.+++..||+.||.+||++.|+++.|+.....
T Consensus 230 ~-~~~~~--------~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 D-LRDGI--------ISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp H-HHTTC--------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred H-hhccc--------ccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1 11111 112222 3567889999999999999999999999876543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=352.69 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=201.7
Q ss_pred hcCcceeeeecccCcEEEEeeee----cCCcEEEEEEccccc----hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCC
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL----ADGTLIAVKQLSAKS----KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGN 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 515 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+.++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999986 368999999987532 22345677899999999 6999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999994 2346899999999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhc--CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMR--GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..........
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~-- 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS-- 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC--
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhcc--
Confidence 98654433333445679999999999985 34789999999999999999999999754332211 1111111110
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
.+.. +......+.+++.+||+.||.+|| ++.|+++
T Consensus 282 -----~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 282 -----EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp -----CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 1111 122334678899999999999999 8888876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=341.48 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=204.9
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEe--CCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIE--GNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 519 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999964 68999999986542 3345678999999999999999999998864 568999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC--CCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
||||+++++|.+++.........+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999644333456999999999999999999999974 1239999999999999999999999999998
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ +.. . ...+...
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~-i~~~~~~-- 234 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAG---K-IREGKFR-- 234 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHHTCCC--
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHH---H-Hhhcccc--
Confidence 6654322 1233568999999999999899999999999999999999999997543221 111 1 1112211
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.+.. ....++.+++.+||+.||.+||++.|+++.+..
T Consensus 235 ---~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 ---RIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---cCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1111 223567889999999999999999999886543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=356.24 Aligned_cols=204 Identities=25% Similarity=0.450 Sum_probs=164.3
Q ss_pred HHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccC-CCceeeeeeEEEeCC--e
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQ-HPHLVKLYGCCIEGN--Q 516 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~ 516 (790)
...++|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3467899999999999999999985 46899999998643 2334567889999999997 999999999997544 7
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||++ ++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 86 ~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999998 58998883 246899999999999999999999985 999999999999999999999999999
Q ss_pred cccCCC--------------------CcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccc
Q 040908 597 KLDEED--------------------NTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTK 655 (790)
Q Consensus 597 ~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~ 655 (790)
+..... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 865321 1112344679999999999986 6789999999999999999999999976543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.23 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=200.8
Q ss_pred hcCcceeeeecccCcEEEEeeeecC----CcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEe-CCeEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIE-GNQLL 518 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 518 (790)
..+|++.+.||+|+||.||+|...+ ...||+|.+.... ....+.+.+|+.++++++||||++++++|.. ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468899999999999999998543 2368999987543 3345679999999999999999999999754 55789
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999943 2356899999999999999999999985 99999999999999999999999999986
Q ss_pred cCCCCc---ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhC-CCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 599 DEEDNT---HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSG-RSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 599 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
...... .......||+.|+|||.+.+..++.++||||||+++|||++| ..||......+.. .... .+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~------~~~~-~~~~ 250 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT------VYLL-QGRR 250 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH------HHHH-TTCC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH------HHHh-cCCC
Confidence 543221 122345678899999999999999999999999999999995 4555433222211 1111 1110
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 675 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
. .... .....+.+++..||+.+|.+||++.|+++.|+....
T Consensus 251 --~---~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 251 --L---LQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp --C---CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --C---CCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 0111 123468889999999999999999999999987653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=365.70 Aligned_cols=254 Identities=26% Similarity=0.320 Sum_probs=206.5
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+|++++|||||++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999964 68999999996542 3345678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999995432 245899999999999999999999985 999999999999999999999999999876
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..... ...
T Consensus 337 ~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i--~~~i~-~~~------ 405 (576)
T 2acx_A 337 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV--ERLVK-EVP------ 405 (576)
T ss_dssp CTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH--HHHHH-HCC------
T ss_pred ccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH--HHHhh-ccc------
Confidence 54332 23457999999999999989999999999999999999999999765432111111 11111 110
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
. .++.....++.+++..|++.||.+|| ++.||++
T Consensus 406 ~----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 E----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred c----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1 11122235678899999999999999 7788874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=339.78 Aligned_cols=247 Identities=24% Similarity=0.385 Sum_probs=199.2
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc--chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK--SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 519 (790)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3578999999999999999999965 7899999998753 233456788999999999 99999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC---------------
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK--------------- 584 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--------------- 584 (790)
||||+++++|.+++.........+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999543333356899999999999999999999985 999999999999984
Q ss_pred ----CCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchh
Q 040908 585 ----DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659 (790)
Q Consensus 585 ----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~ 659 (790)
...+||+|||+++...... ...||+.|+|||++.+. .++.++|||||||++|||++|+.++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 4479999999998665432 23589999999999875 566799999999999999999877643211
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 660 YLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 660 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+.. ...+.. +.+... ....+.+++..||+.||.+|||+.|+++
T Consensus 237 ----~~~--~~~~~~-----~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ----WHE--IRQGRL-----PRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HHH--HHTTCC-----CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHH--HHcCCC-----CCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111 111211 111222 2346788999999999999999999865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=376.34 Aligned_cols=247 Identities=28% Similarity=0.394 Sum_probs=197.2
Q ss_pred eeecccCcEEEEeeeec---CCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLA---DGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
+.||+|+||.||+|.+. .++.||||+++.... ...++|.+|+.++++++|||||+++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 467899999976433 335789999999999999999999999964 568899999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc-
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH- 605 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~- 605 (790)
|+|.+++. ....+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999993 2356899999999999999999999985 999999999999999999999999999876543321
Q ss_pred -eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 606 -ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 606 -~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
......+|+.|+|||++....++.++|||||||++|||++ |+.||......+... ....+..
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-------~i~~~~~--------- 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-------MLEKGER--------- 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HHHTTCC---------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCC---------
Confidence 2233457889999999999999999999999999999998 999997654322111 1111111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
...+.....++.+++..||+.||.+||++.+|++.|+..
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111223345788999999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=361.25 Aligned_cols=262 Identities=22% Similarity=0.269 Sum_probs=207.3
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCC-CceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQH-PHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.++||+|+||.||+|.. .+++.||||++..... ...+..|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999995 5689999998765432 2357889999999976 556666667778889999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe---cCCCCeEEeecCCcccc
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 599 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~ 599 (790)
|+ +++|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 9999999942 2356999999999999999999999985 9999999999999 68899999999999866
Q ss_pred CCCCcc------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 600 EEDNTH------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 600 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 543321 12256799999999999999999999999999999999999999986544333222222222111111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
+..+. .. ...++.+++..||+.+|.+||++.+|+++|+....
T Consensus 237 ~~~l~-----~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 237 IEALC-----RG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHHH-----TT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHh-----cC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111 11 13468899999999999999999999999987643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.78 Aligned_cols=252 Identities=20% Similarity=0.334 Sum_probs=199.5
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 521 (790)
..++|++.+.||+|+||.||+|... +|+.||||++..... .+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4578999999999999999999964 688999999865432 234688888888 7999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC----CCeEEeecCCcc
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD----LNPKISDFGLAK 597 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGla~ 597 (790)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999843 246899999999999999999999985 9999999999998543 349999999998
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+... ...+...
T Consensus 169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~~~~-- 241 (342)
T 2qr7_A 169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR----IGSGKFS-- 241 (342)
T ss_dssp ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH----HHHCCCC--
T ss_pred cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH----HccCCcc--
Confidence 6654332 22346789999999999888889999999999999999999999975432222211111 1112111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
............+.+++..|++.||.+||++.|+++
T Consensus 242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111123356788999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=340.00 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=197.5
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-CeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEG-NQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 523 (790)
.++|++.+.||+|+||.||+|... |+.||||++.... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 468999999999999999999874 8899999997542 456789999999999999999999997654 468999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 9999999999422 1234889999999999999999999985 9999999999999999999999999998544321
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
....+++.|+|||.+.+..++.++||||||+++|||+| |+.||......+.. ... ..+. ....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~------~~~-~~~~-----~~~~ 235 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRV-EKGY-----KMDA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH------HHH-TTTC-----CCCC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHH-hcCC-----CCCC
Confidence 22357889999999999999999999999999999998 99999754332211 111 1110 1111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
+......+.+++..||+.||.+||++.|+++.|+...
T Consensus 236 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 236 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 1223456888999999999999999999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.23 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=203.5
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999965 68999999986543 3345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999842 346899999999999999999999985 999999999999999999999999999865432
Q ss_pred Cc-ceeeccccCCCcccHHHhhcCCC-CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 603 NT-HISTRVAGTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 603 ~~-~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.. .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....|.. ... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----~~~---~~~- 229 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----KKT---YLN- 229 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT----TCT---TST-
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh----ccc---ccC-
Confidence 21 12234678999999999987665 6799999999999999999999976543221 1111111 000 000
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........+.+++..|++.||.+|||+.|+++
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 -----PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01122346788999999999999999999865
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=341.76 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=187.6
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch-h-cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK-Q-GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
..++|++.+.||+|+||.||+|.. .+|+.||+|++..... . ..+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 357899999999999999999995 5789999999875422 2 223345555568888999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||++ |+|.+++.........+++..+..++.|++.||+|||+.. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99998 5888887443334567999999999999999999999972 39999999999999999999999999998664
Q ss_pred CCCcceeeccccCCCcccHHHh----hcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 601 EDNTHISTRVAGTFGYMAPEYA----MRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
.... .....||+.|+|||++ .+..++.++|||||||++|||+||+.||........ ..... .... ...
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~-~~~~-~~~ 233 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ----QLKQV-VEEP-SPQ 233 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH----HHHHH-HHSC-CCC
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH----HHHHH-hccC-CCC
Confidence 4322 2334699999999996 456788999999999999999999999964322111 11111 1111 111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. .......+.+++..|++.||.+|||+.|+++
T Consensus 234 -----~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 -----LP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----cc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 10 1122346788999999999999999999976
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=359.22 Aligned_cols=261 Identities=20% Similarity=0.283 Sum_probs=195.1
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC------C
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG------N 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 515 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999985 46899999999754 333456788999999999999999999999654 4
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++||||++++ |.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 679999999865 666662 24899999999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHH-----------
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDW----------- 664 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~----------- 664 (790)
|+...... ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.-
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98664432 23456799999999999999999999999999999999999999976543221111000
Q ss_pred -----HHHHHhh-CC-----cccccCCCC-CC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 665 -----ALLLKEQ-GN-----LMELVDPNL-GS--NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 665 -----~~~~~~~-~~-----~~~~~d~~l-~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
....... .. +.......+ .. ........++.+++.+||+.||.+|||+.|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00 000000000 00 011122567899999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.70 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=203.9
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999965 57899999986542 23456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++. ....+++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999883 2356899999999999999999999985 9999999999999999999999999998664
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ... .... .
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~--~~~~------~ 232 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-----LRI--KKNE------Y 232 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----HHH--HTTC------C
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHH--hhcc------C
Confidence 3322 223456999999999999888999999999999999999999999754332211 111 1111 0
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+... ....+.+++.+|++.||.+||++.|+++
T Consensus 233 ~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 SIPKH----INPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCccc----cCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11112 2346788999999999999999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=362.73 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=204.4
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999964 68999999996542 23456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++|+|.+++.........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999654433457999999999999999999999985 9999999999999999999999999998765
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......... ...
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~~-~~~------ 410 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVLE-QAV------ 410 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHHH-CCC------
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHhh-ccc------
Confidence 43322 23457999999999999999999999999999999999999999765322111 111111111 110
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLM 712 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 712 (790)
.++......+.+++..|++.||.+||++
T Consensus 411 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 ----TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ----CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 1112233567889999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.38 Aligned_cols=248 Identities=30% Similarity=0.454 Sum_probs=205.0
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.+.|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 46799999999999999999985 468899999986543 3445789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++++|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999983 246899999999999999999999985 999999999999999999999999999865443
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... . . ..... .+.+
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~-~~~~~-----~~~~ 239 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---F---L-IPKNN-----PPTL 239 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H---H-HHHSC-----CCCC
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---H---H-hhcCC-----CCCC
Confidence 22 223456899999999999999999999999999999999999999654322111 1 1 11111 1112
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+ ...+.+++..||+.||.+|||+.|+++
T Consensus 240 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 240 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccc----CHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 2222 345788999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=350.71 Aligned_cols=264 Identities=22% Similarity=0.356 Sum_probs=202.4
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999965 68999999987642 3345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++++|.+++. ....+++..+..++.|++.||+|||+.. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999993 2346899999999999999999999852 3999999999999999999999999999754321
Q ss_pred CcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH---------HHHh---
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL---------LLKE--- 670 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~--- 670 (790)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+......... ....
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 1234579999999999999999999999999999999999999997544322111100000 0000
Q ss_pred -----------hCCcccc----cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 671 -----------QGNLMEL----VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 671 -----------~~~~~~~----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.....+. ................+.+++..||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000 0000000001112346889999999999999999999976
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=350.00 Aligned_cols=261 Identities=21% Similarity=0.360 Sum_probs=194.1
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhc-HHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQG-NREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999965 68999999986543221 22456799999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
++ |+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 98 589888842 2346899999999999999999999985 9999999999999999999999999998654332
Q ss_pred cceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh---CCcccccC
Q 040908 604 THISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ---GNLMELVD 679 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d 679 (790)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ ...... ........
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI---FRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTTSTTGGG
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChHhchhhhc
Confidence 2 2234568999999999876 56899999999999999999999999765433221111 110000 00000000
Q ss_pred ---------CCCCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 ---------PNLGSNV----DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ---------~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+...... ......++.+++..|++.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 0112346789999999999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=334.74 Aligned_cols=245 Identities=22% Similarity=0.365 Sum_probs=202.7
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999965 57899999986542 223467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999842 246899999999999999999999885 99999999999999999999999999976543
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. .... .. +..
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~-~~------~~~ 230 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------RRIV-NV------DLK 230 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH-TT------CCC
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------HHHh-cc------ccC
Confidence 22 23456899999999999989999999999999999999999999754322211 0101 11 111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... .....+.+++..|++.||.+||++.|+++
T Consensus 231 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 FPP----FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111 22346788999999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.03 Aligned_cols=269 Identities=22% Similarity=0.334 Sum_probs=199.9
Q ss_pred cHHHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchh-----------cHHHHHHHHHHhhccCCCcee
Q 040908 437 TLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQ-----------GNREFVNEIGTISALQHPHLV 505 (790)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv 505 (790)
.+.++....++|++.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456788889999999999999999999999888999999998653221 136789999999999999999
Q ss_pred eeeeEEEeC-----CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcE
Q 040908 506 KLYGCCIEG-----NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNV 580 (790)
Q Consensus 506 ~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 580 (790)
++++++... ...++||||+. |+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 999998543 36899999998 688888843 2346899999999999999999999985 99999999999
Q ss_pred EecCCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchh
Q 040908 581 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659 (790)
Q Consensus 581 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~ 659 (790)
|++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999998544332 2234568999999999887 67899999999999999999999999765432211
Q ss_pred hHHHHHHHHHhhCC-----------cccccCCCCC---CC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 660 YLLDWALLLKEQGN-----------LMELVDPNLG---SN----VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 660 ~l~~~~~~~~~~~~-----------~~~~~d~~l~---~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+ ... ..... ..+.+..... .. ........+.+++..|++.||.+|||+.|+++
T Consensus 244 ~~i--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 244 NKI--VEV-VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHH--HHH-HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH--HHH-cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 100 000 00000 0000000000 00 01112346889999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.46 Aligned_cols=263 Identities=20% Similarity=0.308 Sum_probs=192.9
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchh--cHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQ--GNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
..++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 457899999999999999999984 47899999999754322 245678999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec-----CCCCeEEeecCC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD-----KDLNPKISDFGL 595 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-----~~~~~kl~DFGl 595 (790)
|||+++ +|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999984 9999983 2346899999999999999999999985 99999999999994 455699999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh--C
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ--G 672 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~ 672 (790)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. .......... .
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCTT
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HHHHHHhCCCchh
Confidence 986643322 22345689999999999874 4899999999999999999999999765432211 1111110000 0
Q ss_pred Ccc------ccc--CCCCCCCCcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLM------ELV--DPNLGSNVDK-----EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~------~~~--d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... ... .+........ ....++.+++..|++.||.+|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 000 0000010000 12356789999999999999999999876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=347.65 Aligned_cols=262 Identities=26% Similarity=0.390 Sum_probs=204.1
Q ss_pred HhcCcceeeeecccCcEEEEeeee------cCCcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 516 (790)
..++|++.+.||+|+||.||+|.+ .++..||||++... .......+.+|+.++++++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 357899999999999999999984 24678999999654 33445678999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCcc---ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC---CCCeEE
Q 040908 517 LLLIYEYLENNSLARALFGPEE---HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKI 590 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl 590 (790)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999953321 1245899999999999999999999985 999999999999984 456999
Q ss_pred eecCCccccCCCCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHH
Q 040908 591 SDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLL 668 (790)
Q Consensus 591 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 668 (790)
+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+| |+.||......+. ..+ .
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~---~ 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEF---V 258 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHH---H
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHH---H
Confidence 99999975433221 22234568999999999999999999999999999999998 9999865432211 111 1
Q ss_pred HhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 669 KEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 669 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
..+.. +.. +......+.+++..||+.||.+||++.|+++.|+....
T Consensus 259 -~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 259 -TSGGR-----MDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -HTTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hcCCC-----CCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11111 111 11223467889999999999999999999999986543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=357.33 Aligned_cols=243 Identities=14% Similarity=0.120 Sum_probs=189.1
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc---chhcHHHHHHHH---HHhhccCCCceeeee-------eE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK---SKQGNREFVNEI---GTISALQHPHLVKLY-------GC 510 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 510 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+ .++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999995 56899999998743 333457789999 555666899999998 55
Q ss_pred EEeCC-----------------eEEEEEEeccCCChhhhhcCCcc---ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcE
Q 040908 511 CIEGN-----------------QLLLIYEYLENNSLARALFGPEE---HRLKLDWPTRHNICIGIARGLAYLHEESRLKI 570 (790)
Q Consensus 511 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 570 (790)
+...+ ..++||||+ +|+|.+++..... ....++|..++.|+.||+.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 55443 278999999 6899999943211 1123446888899999999999999985 9
Q ss_pred EeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcC-----------CCCChhhHHHHHHH
Q 040908 571 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-----------HLTDKADVYSFGIV 639 (790)
Q Consensus 571 iHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~S~Gvv 639 (790)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 2344567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 640 ALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 640 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+|||+||+.||......... ..+.. .. ..+ ...+.+++..||+.||.+||++.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~~---------------~~~~~-~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS---------------EWIFR-SC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCS---------------GGGGS-SC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccch---------------hhhhh-hc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999654322111 11111 00 122 346788999999999999999999976
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=352.25 Aligned_cols=252 Identities=21% Similarity=0.250 Sum_probs=190.3
Q ss_pred hcCccee-eeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhc-cCCCceeeeeeEEEe----CCeE
Q 040908 445 TNHFDVA-NKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISA-LQHPHLVKLYGCCIE----GNQL 517 (790)
Q Consensus 445 ~~~y~~~-~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~ 517 (790)
.++|.+. +.||+|+||.||+|... +|+.||||++.. ...+.+|+.++.+ .+||||+++++++.. .+..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567776 78999999999999964 688999999853 2456788888754 489999999999875 5678
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC---CCCeEEeecC
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFG 594 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFG 594 (790)
++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 99999999999999995432 246899999999999999999999985 999999999999998 7899999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... ....+..
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~-~i~~~~~ 284 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKT-RIRMGQY 284 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS--HHH-HHHHTCC
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH--HHH-HHHcCcc
Confidence 998654332 22346789999999999999999999999999999999999999975433221000 000 0111111
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 675 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. .-.+. ......++.+++..||+.||.+|||+.|+++
T Consensus 285 ~-~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 285 E-FPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp C-CCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-CCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00000 0122356789999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=343.88 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=204.0
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367999999999999999999965 57899999986542 23456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999883 2356899999999999999999999985 9999999999999999999999999998664
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... ....
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~--~~~~------ 258 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-----LRIK--KNEY------ 258 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----HHHH--HTCC------
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-----HHHh--cCCC------
Confidence 3322 223456999999999999989999999999999999999999999754322211 1111 1110
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+...+ ...+.+++.+||+.||.+||++.|+++
T Consensus 259 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122 245778999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.43 Aligned_cols=264 Identities=22% Similarity=0.326 Sum_probs=197.0
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchh-----cHHHHHHHHHHhhccCCCceeeeeeEEEeC
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQ-----GNREFVNEIGTISALQHPHLVKLYGCCIEG 514 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 514 (790)
+....++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3445678999999999999999999964 6899999999753221 124688999999999999999999999999
Q ss_pred CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
+..++||||+++ +|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred CceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence 999999999986 88888843 2356899999999999999999999985 9999999999999999999999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. . ......+.
T Consensus 158 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~--~---~i~~~~~~ 231 (346)
T 1ua2_A 158 LAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL--T---RIFETLGT 231 (346)
T ss_dssp GGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--H---HHHHHHCC
T ss_pred cceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--H---HHHHHcCC
Confidence 9986644332 23346789999999999764 5788999999999999999999998755432211 1 11111111
Q ss_pred c-----c------cccCCCCCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 L-----M------ELVDPNLGSNVD-----KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~-----~------~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. . +.+........+ ......+.+++..|++.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0 000000000011 122357889999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=342.60 Aligned_cols=265 Identities=22% Similarity=0.396 Sum_probs=200.3
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367999999999999999999965 589999999865432 23456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999888632 346899999999999999999999985 99999999999999999999999999986544
Q ss_pred CCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHH---------HHHHHHhh
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLD---------WALLLKEQ 671 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~~~~~~ 671 (790)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+...... +.......
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 322 22345689999999999875 78999999999999999999999997654332211100 00001111
Q ss_pred CCcccccCCCCCCCCcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 672 GNLMELVDPNLGSNVDK-----EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 672 ~~~~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........+......+. .....+.+++..||+.||.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111111222111111 22457889999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=339.92 Aligned_cols=257 Identities=24% Similarity=0.424 Sum_probs=197.0
Q ss_pred hcCcceeeeecccCcEEEEeeeec--CCc--EEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA--DGT--LIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~--~g~--~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
.++|++.+.||+|+||.||+|.+. +++ .||||++... .....+.+.+|+.++++++||||+++++++...+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999853 333 6899998654 2334567899999999999999999999998765 8
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 96 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999942 2356899999999999999999999985 9999999999999999999999999998
Q ss_pred ccCCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 598 LDEEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 598 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.. .........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~~~ 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEGER 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTSCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH------HHHHccCCC
Confidence 76544332 1233557889999999998889999999999999999999 99999754332211 111111110
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 675 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
. ..+......+.+++..|++.||.+||++.++++.|++..
T Consensus 244 -----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 244 -----L----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp -----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----C----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0 111123456889999999999999999999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.45 Aligned_cols=265 Identities=21% Similarity=0.305 Sum_probs=197.4
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-----
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEG----- 514 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 514 (790)
++...++|++.+.||+|+||.||+|.. .+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678999999999999999999985 57899999998654322 23799999999999999999998543
Q ss_pred ---------------------------------CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHH
Q 040908 515 ---------------------------------NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561 (790)
Q Consensus 515 ---------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~y 561 (790)
...++||||++ |+|.+.+.........+++..+..++.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 34889999998 58888775433345679999999999999999999
Q ss_pred hhhcCCCcEEeccCCCCcEEec-CCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHH
Q 040908 562 LHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIV 639 (790)
Q Consensus 562 LH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvv 639 (790)
||+.+ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||+
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99885 99999999999998 688999999999986644332 2345689999999998875 48999999999999
Q ss_pred HHHHHhCCCCCccccccchhhHHHHHHHH---------HhhCCcccccCCCCCCC-----CcHHHHHHHHHHHHHccCCC
Q 040908 640 ALEIVSGRSNIMCKTKEEKFYLLDWALLL---------KEQGNLMELVDPNLGSN-----VDKEQVRVMINVALLCADVS 705 (790)
Q Consensus 640 l~elltG~~p~~~~~~~~~~~l~~~~~~~---------~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~d 705 (790)
+|||++|+.||......+.. ....... .......+..-+..... .+......+.+++..||+.|
T Consensus 232 l~ell~g~~pf~~~~~~~~~--~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQL--VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChHHHH--HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 99999999999765433221 1111100 00011111111111110 11123456889999999999
Q ss_pred CCCCCCHHHHHH
Q 040908 706 PTNRPLMSSVVS 717 (790)
Q Consensus 706 P~~RPt~~ev~~ 717 (790)
|.+|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.02 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=199.4
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEe--------
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIE-------- 513 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 513 (790)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999996 5789999999865432 234578899999999999999999999987
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
.+..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 4468999999985 777777332 346899999999999999999999985 999999999999999999999999
Q ss_pred CCccccCCCC---cceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 594 GLAKLDEEDN---THISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 594 Gla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
|+++...... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+. .
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~-- 243 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS---Q-- 243 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---H--
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---H--
Confidence 9998654322 112234678999999999876 457999999999999999999999997654332221111 1
Q ss_pred hhCCcccccCCC-------------CCCCCc-HHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 670 EQGNLMELVDPN-------------LGSNVD-KEQ------VRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 670 ~~~~~~~~~d~~-------------l~~~~~-~~~------~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+......-+. ...... .+. ...+.+++.+|++.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 011110000000 000000 111 235789999999999999999999876
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=358.08 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=191.2
Q ss_pred HHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch--------hcHHHHHHHHHHhhccCCCceeeeeeEEEe
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK--------QGNREFVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
...++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4568999999999999999999985 4688999999865321 11234889999999999999999999975
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC---CCeEE
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKI 590 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl 590 (790)
.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ +.+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 4568999999999999999843 346899999999999999999999985 9999999999999654 45999
Q ss_pred eecCCccccCCCCcceeeccccCCCcccHHHhhc---CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH
Q 040908 591 SDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR---GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 591 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 667 (790)
+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......... ...
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~--- 356 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQ--- 356 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHH---
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHH---
Confidence 9999998765432 2344679999999999853 56788999999999999999999999754332211 110
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+.... . +.. .......+.+++.+|++.||.+||++.|+++
T Consensus 357 -i~~~~~~~-~-~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 -ITSGKYNF-I-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HHTTCCCC-C-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HhcCCCCC-C-chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 01111100 0 000 0012356889999999999999999999876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=334.34 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=197.9
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEe----CCeEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIE----GNQLL 518 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 518 (790)
+.|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3478889999999999999985 46789999998654 23345678999999999999999999999875 35689
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec-CCCCeEEeecCCcc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAK 597 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~ 597 (790)
+||||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ .+|+||||||+|||++ +++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999993 2356899999999999999999999874 3499999999999998 78999999999997
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
...... .....||+.|+|||++. +.++.++|||||||++|||++|+.||......... .... ..+.....
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~-~~~~~~~~ 250 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRV-TSGVKPAS 250 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHH-TTTCCCGG
T ss_pred cccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----HHHH-hccCCccc
Confidence 554332 23456999999999876 46899999999999999999999999653322111 1111 11111111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+......+.+++..||+.||.+|||+.|+++
T Consensus 251 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 --------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11112246889999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=348.02 Aligned_cols=259 Identities=23% Similarity=0.295 Sum_probs=189.5
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccC-CCceeeeeeEEE--------e
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPHLVKLYGCCI--------E 513 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~--------~ 513 (790)
...+|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++.++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 346899999999999999999995 468999999987666666678999999999996 999999999994 3
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
....++||||+. |+|.+++.... ....+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 345899999996 79999884321 2346999999999999999999999873 34999999999999999999999999
Q ss_pred CCccccCCCCcc-----------eeeccccCCCcccHHHh---hcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchh
Q 040908 594 GLAKLDEEDNTH-----------ISTRVAGTFGYMAPEYA---MRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF 659 (790)
Q Consensus 594 Gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~ 659 (790)
|+++........ ......||+.|+|||++ .+..++.++|||||||++|||+||+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 999866543221 11134589999999998 566788999999999999999999999964322110
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 660 YLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 660 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
+...............+.+++..||+.||.+||++.|+++.|+....
T Consensus 262 ------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 262 ------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00000000011112346789999999999999999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=333.90 Aligned_cols=252 Identities=27% Similarity=0.366 Sum_probs=197.6
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
+|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 344556999999999999995 5688999999977655556789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC-CCCeEEeecCCccccCCCCc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~~~ 604 (790)
+++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999995321 1245678899999999999999999985 999999999999997 89999999999986544322
Q ss_pred ceeeccccCCCcccHHHhhcCC--CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGH--LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||......... .+... ... ..+.+
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~--~~~-----~~~~~ 247 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MFKVG--MFK-----VHPEI 247 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HHHHH--HHC-----CCCCC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HHhhc--ccc-----ccccc
Confidence 223456999999999997653 789999999999999999999999643322111 00000 000 11122
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. .....+.+++..||+.||.+||++.|+++
T Consensus 248 ~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 PE----SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CT----TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22 22346788999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.33 Aligned_cols=259 Identities=20% Similarity=0.362 Sum_probs=206.2
Q ss_pred cHHHHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--------hcHHHHHHHHHHhhcc-CCCceee
Q 040908 437 TLRQIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--------QGNREFVNEIGTISAL-QHPHLVK 506 (790)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~ 506 (790)
.........++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34455566788999999999999999999975 789999999865321 1134678999999999 7999999
Q ss_pred eeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC
Q 040908 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 586 (790)
Q Consensus 507 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 586 (790)
+++++...+..++||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 9999999999999999999999999994 2356899999999999999999999985 99999999999999999
Q ss_pred CeEEeecCCccccCCCCcceeeccccCCCcccHHHhhc------CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhh
Q 040908 587 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR------GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY 660 (790)
Q Consensus 587 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~ 660 (790)
.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 238 ~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-- 313 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM-- 313 (365)
T ss_dssp CEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--
T ss_pred CEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH--
Confidence 999999999986654332 234679999999999864 3578899999999999999999999975432211
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 661 LLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 661 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... ...+... ...+.. . .....+.+++..|++.||.+||++.|+++
T Consensus 314 -~~~----i~~~~~~-~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 -LRM----IMEGQYQ-FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HHH----HHHTCCC-CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHH----HHhCCCC-CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 110 0111110 000000 0 12345788999999999999999999976
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.33 Aligned_cols=256 Identities=21% Similarity=0.371 Sum_probs=204.2
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
..++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3568999999999999999999964 689999999976544455678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe---cCCCCeEEeecCCcccc
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 599 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~ 599 (790)
|+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++..
T Consensus 87 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRIL----ERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999983 2346899999999999999999999985 9999999999999 78899999999999854
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ... ..+.. .. .
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~i-~~~~~-~~-~ 227 (304)
T 2jam_A 160 QNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF------EKI-KEGYY-EF-E 227 (304)
T ss_dssp CCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHH-HHCCC-CC-C
T ss_pred CCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH------HHH-HcCCC-CC-C
Confidence 4321 23356899999999999889999999999999999999999999754322111 111 11111 00 1
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGR 722 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~ 722 (790)
... .......+.+++..|++.||.+||++.|+++ .+++.
T Consensus 228 ~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 SPF----WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp TTT----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 111 1123356788999999999999999999986 45543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.35 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=186.6
Q ss_pred HHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 442 KAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
....++|++.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34467899999999999999999985 468899999986543 3345678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCC----ccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 520 IYEYLENNSLARALFGP----EEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
||||+++++|.+++... ......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998421 112346899999999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCCc----ceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHh
Q 040908 596 AKLDEEDNT----HISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKE 670 (790)
Q Consensus 596 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 670 (790)
++....... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||.......... .. .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~--~ 240 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-----LT--L 240 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-----HH--H
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-----HH--h
Confidence 976543221 11234569999999999876 568999999999999999999999997544322110 00 1
Q ss_pred hCCccc----ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 671 QGNLME----LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 671 ~~~~~~----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...... ..++.....+ ...+.+++..||+.||.+||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TSSCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111 1111111222 346788999999999999999999876
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=338.81 Aligned_cols=256 Identities=17% Similarity=0.276 Sum_probs=199.1
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccC-CCceeeeeeEEEe--CCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPHLVKLYGCCIE--GNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|.. .+++.||||++... ..+.+.+|+.++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999985 57899999998643 3467889999999997 9999999999987 66789999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-CeEEeecCCccccC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDE 600 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~ 600 (790)
||+.+++|.+++ ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999988 24788999999999999999999985 99999999999999776 89999999998665
Q ss_pred CCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH--------Hhh
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL--------KEQ 671 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~ 671 (790)
.... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||........ .+....... ...
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHH
Confidence 4332 234568999999999987 6789999999999999999999999964332211 111111000 000
Q ss_pred CC------cccccC--------CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 672 GN------LMELVD--------PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 672 ~~------~~~~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ..+... ..............+.+++..|++.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000000 00111111123467889999999999999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=331.68 Aligned_cols=247 Identities=23% Similarity=0.398 Sum_probs=194.6
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999965 78999999986542 23356789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999932 346899999999999999999999985 9999999999999999999999999998664
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCC-CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
.... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .. .. ..+..
T Consensus 163 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~---~~-~~~~~----- 228 (276)
T 2h6d_A 163 DGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FK---KI-RGGVF----- 228 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HH-HHCCC-----
T ss_pred CCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HH---Hh-hcCcc-----
Confidence 4322 234568999999999987665 5799999999999999999999965432211 11 11 11110
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..... ....+.+++.+|++.||.+||++.|+++
T Consensus 229 -~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 -YIPEY----LNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cCchh----cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 01111 2345788999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=336.09 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=199.7
Q ss_pred HHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 443 AATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 443 ~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
...++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+|+.++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34678999999999999999999965 5899999998653 23467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++++|.+++. .....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999999983 23457899999999999999999999985 99999999999999999999999999986544
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ... ........
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~-~~~~~~~~---- 245 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMI-PTNPPPTF---- 245 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHH-HHSCCCCC----
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HHH-hcCCCccc----
Confidence 322 223456899999999999989999999999999999999999999754322111 011 11111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+......+.+++..||+.||.+||++.++++
T Consensus 246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111122356789999999999999999999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.95 Aligned_cols=254 Identities=11% Similarity=0.035 Sum_probs=182.7
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhcc--CCCceeeee-------eEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISAL--QHPHLVKLY-------GCC 511 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~ 511 (790)
..+|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346899999999999999999954 789999999976432 3345677885555444 699988754 444
Q ss_pred EeC-----------------CeEEEEEEeccCCChhhhhcCCccccCCCChhhH------HHHHHHHHHHHHHhhhcCCC
Q 040908 512 IEG-----------------NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTR------HNICIGIARGLAYLHEESRL 568 (790)
Q Consensus 512 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~ 568 (790)
... ...++||||++ |+|.+++... ...+.+..+ ..++.||+.||+|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 432 34899999999 8999999432 234577777 788899999999999985
Q ss_pred cEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhc--CCCCChhhHHHHHHHHHHHHhC
Q 040908 569 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR--GHLTDKADVYSFGIVALEIVSG 646 (790)
Q Consensus 569 ~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG 646 (790)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999865431 224567799999999987 6799999999999999999999
Q ss_pred CCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 647 RSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 647 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+.||........... ........................+.+++..||+.||.+|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999976532211000 000000001111111111133457888999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.25 Aligned_cols=253 Identities=24% Similarity=0.407 Sum_probs=198.6
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
..++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999965 588999999987666667889999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999998842 2356899999999999999999999985 999999999999999999999999997532211
Q ss_pred CcceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 603 NTHISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
. .......||+.|+|||++. ...++.++||||||+++|||++|+.||........ ...... ......
T Consensus 171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~~~ 242 (302)
T 2j7t_A 171 L-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAK-SDPPTL 242 (302)
T ss_dssp H-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-SCCCCC
T ss_pred c-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhc-cCCccc
Confidence 1 1122356899999999984 56788999999999999999999999975432211 111111 111111
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+......+.+++..||+.||.+|||+.|+++
T Consensus 243 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 -------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011222356788999999999999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=356.83 Aligned_cols=194 Identities=24% Similarity=0.430 Sum_probs=153.5
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-----Ce
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG-----NQ 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 516 (790)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+|++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999854 6899999998653 233456789999999999999999999999543 56
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+. |+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 132 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 899999984 689998842 356899999999999999999999985 999999999999999999999999999
Q ss_pred cccCCCCc--------------------------ceeeccccCCCcccHHHh-hcCCCCChhhHHHHHHHHHHHHhC
Q 040908 597 KLDEEDNT--------------------------HISTRVAGTFGYMAPEYA-MRGHLTDKADVYSFGIVALEIVSG 646 (790)
Q Consensus 597 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~S~Gvvl~elltG 646 (790)
+....... ...+..+||+.|+|||++ ....++.++|||||||++|||+||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 86542211 122446789999999987 456799999999999999999994
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=357.73 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=197.8
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++|||||+++++|.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999964 68899999987542 334567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC---CCCeEEeecCCccc
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKL 598 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla~~ 598 (790)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999883 2356899999999999999999999985 999999999999976 45599999999987
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
..... ......||+.|+|||++. +.++.++|||||||++|||++|+.||......+... .. ..+... ..
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~i-~~~~~~-~~ 257 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR------KV-EKGKYT-FD 257 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH-HHTCCC-CC
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-HhCCCC-CC
Confidence 65432 224467999999999886 578999999999999999999999997654322111 11 111110 00
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.. . .....+.+++..||+.||.+|||+.|+++
T Consensus 258 ~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0100 1 12346788999999999999999999885
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.96 Aligned_cols=252 Identities=20% Similarity=0.338 Sum_probs=202.7
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---------hhcHHHHHHHHHHhhccC-CCceeeeeeEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---------KQGNREFVNEIGTISALQ-HPHLVKLYGCCI 512 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~ 512 (790)
..++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999964 68999999986432 122356889999999995 999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEee
Q 040908 513 EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 592 (790)
Q Consensus 513 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 592 (790)
..+..++||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999993 2357899999999999999999999985 99999999999999999999999
Q ss_pred cCCccccCCCCcceeeccccCCCcccHHHhh------cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH
Q 040908 593 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAM------RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL 666 (790)
Q Consensus 593 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 666 (790)
||+++....... .....||+.|+|||++. ...++.++||||||+++|||++|+.||......... .
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~ 239 (298)
T 1phk_A 168 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML------R 239 (298)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------H
T ss_pred ccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH------H
Confidence 999986654332 23456899999999985 456789999999999999999999999654322111 1
Q ss_pred HHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 667 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ..+... . ...........+.+++..|++.||.+||++.|+++
T Consensus 240 ~~-~~~~~~-~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MI-MSGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HH-HHTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HH-hcCCcc-c-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 111110 0 00111123456889999999999999999999865
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.87 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=201.5
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccC--------CCceeeeeeEEE---
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ--------HPHLVKLYGCCI--- 512 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 512 (790)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999985 46889999999653 334567889999999986 788999999987
Q ss_pred -eCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-----
Q 040908 513 -EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----- 586 (790)
Q Consensus 513 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----- 586 (790)
.....++||||+ +++|.+.+... ....+++..+..++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence 456789999999 55666666322 2246899999999999999999999972 499999999999999775
Q ss_pred --------------------------------------------CeEEeecCCccccCCCCcceeeccccCCCcccHHHh
Q 040908 587 --------------------------------------------NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 622 (790)
Q Consensus 587 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 622 (790)
.+||+|||+++..... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 8999999999866543 2335689999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHH-HHHHHhhCCc-----------ccccCCC-----C---
Q 040908 623 MRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDW-ALLLKEQGNL-----------MELVDPN-----L--- 682 (790)
Q Consensus 623 ~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~-~~~~~~~~~~-----------~~~~d~~-----l--- 682 (790)
.+..++.++|||||||++|||+||+.||............+. .......+.. .+..... +
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999975443221110100 0110000110 0000000 0
Q ss_pred -----------CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 683 -----------GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 683 -----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
....+......+.+++.+||+.||.+|||+.|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01235667788999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=341.95 Aligned_cols=258 Identities=21% Similarity=0.321 Sum_probs=203.9
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhc-----------------HHHHHHHHHHhhccCCCceeee
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQG-----------------NREFVNEIGTISALQHPHLVKL 507 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l 507 (790)
.++|++.+.||+|+||.||+|.. +|+.||+|++....... ...+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999987543221 1789999999999999999999
Q ss_pred eeEEEeCCeEEEEEEeccCCChhhh------hcCCccccCCCChhhHHHHHHHHHHHHHHhhh-cCCCcEEeccCCCCcE
Q 040908 508 YGCCIEGNQLLLIYEYLENNSLARA------LFGPEEHRLKLDWPTRHNICIGIARGLAYLHE-ESRLKIVHRDIKATNV 580 (790)
Q Consensus 508 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NI 580 (790)
++++.+.+..++||||+++|+|.++ +.. .....+++..+..++.|++.||+|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 532 124679999999999999999999998 6 499999999999
Q ss_pred EecCCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcC-CCCC-hhhHHHHHHHHHHHHhCCCCCccccccch
Q 040908 581 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTD-KADVYSFGIVALEIVSGRSNIMCKTKEEK 658 (790)
Q Consensus 581 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~ 658 (790)
|++.++.+||+|||+++..... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||........
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999999999999999865443 23446799999999999877 5666 99999999999999999999976543211
Q ss_pred hhHHHHHHHHHhhCCccccc------CCCCC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 659 FYLLDWALLLKEQGNLMELV------DPNLG---SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 659 ~~l~~~~~~~~~~~~~~~~~------d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... . ...+...... .+... ..........+.+++..||+.||.+||++.|+++
T Consensus 261 --~~~---~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 --LFN---N-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHH---H-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHH---H-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 1 1111110000 00000 0001223457889999999999999999999876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.70 Aligned_cols=265 Identities=24% Similarity=0.317 Sum_probs=197.1
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeC------CeEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEG------NQLL 518 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 518 (790)
.+|++.+.||+|+||.||+|... +|+.||||++..... .+.+|++++++++|||||+++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999975 589999999864322 234799999999999999999998642 2367
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC-CCeEEeecCCcc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAK 597 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~ 597 (790)
+||||+++ +|.+.+.........+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 666665332233467999999999999999999999985 9999999999999965 568999999998
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH--------
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL-------- 668 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-------- 668 (790)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. .......
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHHH
Confidence 6644332 2345789999999999765 7899999999999999999999999765432221 1111110
Q ss_pred -HhhCCcccccCCCCCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 040908 669 -KEQGNLMELVDPNLGSN-----VDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGR 722 (790)
Q Consensus 669 -~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~ 722 (790)
.......+...+.+... +......++.+++.+||+.||.+||++.|+++ .+++.
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 00111111111111110 11122357889999999999999999999986 44443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=347.81 Aligned_cols=201 Identities=22% Similarity=0.323 Sum_probs=172.3
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhcc------CCCceeeeeeEEEeCCe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISAL------QHPHLVKLYGCCIEGNQ 516 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~ 516 (790)
...+|++.+.||+|+||.||+|... +++.||||++... ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3467999999999999999999854 5899999999753 23345677888888777 57799999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC--eEEeecC
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--PKISDFG 594 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFG 594 (790)
.++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 68999884322 245899999999999999999999985 999999999999999987 9999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccc
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTK 655 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~ 655 (790)
+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99865432 2345789999999999999999999999999999999999999976543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=339.99 Aligned_cols=259 Identities=20% Similarity=0.349 Sum_probs=196.5
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC------
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN------ 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 515 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999996 46899999998653 2233467889999999999999999999997653
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 7899999832 46899999999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+ ....+..
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i-----~~~~g~~ 245 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI-----MKVTGTP 245 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHHHCCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HHhcCCC
Confidence 9865432 234678999999999987 68999999999999999999999999765432221111 0000000
Q ss_pred --------------------ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 040908 675 --------------------MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGR 722 (790)
Q Consensus 675 --------------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~ 722 (790)
.+....... .........+.+++.+|++.||.+|||+.|+++ .++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000000000 011122356788999999999999999999987 45543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=356.50 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=203.8
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3568999999999999999999964 68999999986532 33457789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec---CCCCeEEeecCCcc
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAK 597 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGla~ 597 (790)
|||+.+|+|.+.+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999883 2356899999999999999999999985 99999999999995 55679999999998
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
...... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.. . . ...+.....
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~---~-i~~~~~~~~ 242 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---K---R-VETGKYAFD 242 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---H-HHHTCCCSC
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---H-HHhCCCCCC
Confidence 665432 2234579999999999875 6899999999999999999999999765432211 1 1 111111100
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEG 721 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~ 721 (790)
..........+.+++..||+.||.+|||+.|+++ .++.
T Consensus 243 ------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 243 ------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp ------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred ------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 0001122356789999999999999999999987 4444
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=358.17 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=204.3
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
..++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999965 78999999986432 3446779999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe---cCCCCeEEeecCCc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLA 596 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla 596 (790)
||||+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999999843 346899999999999999999999985 9999999999999 56789999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
+....... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.. .. ...+....
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~----i~~~~~~~ 246 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL---KK----VEKGKYTF 246 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH----HHHCCCCC
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH---HH----HHcCCCCC
Confidence 86654332 234569999999999866 7899999999999999999999999765432211 11 11111110
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ..........+.+++..|++.+|.+|||+.|+++
T Consensus 247 ~------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 E------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp C------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 0001123456789999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=349.67 Aligned_cols=199 Identities=24% Similarity=0.406 Sum_probs=166.5
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-----Ce
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG-----NQ 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 516 (790)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999854 6889999999753 233456789999999999999999999999766 57
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+. |+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999987 599999842 356899999999999999999999985 999999999999999999999999999
Q ss_pred cccCCCCc---------------------ceeeccccCCCcccHHHh-hcCCCCChhhHHHHHHHHHHHHhCCCCCc
Q 040908 597 KLDEEDNT---------------------HISTRVAGTFGYMAPEYA-MRGHLTDKADVYSFGIVALEIVSGRSNIM 651 (790)
Q Consensus 597 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~S~Gvvl~elltG~~p~~ 651 (790)
+....... ...+..+||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 86543221 123457799999999986 45679999999999999999998655543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=357.87 Aligned_cols=255 Identities=26% Similarity=0.365 Sum_probs=202.0
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch-------------hcHHHHHHHHHHhhccCCCceeeeee
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-------------QGNREFVNEIGTISALQHPHLVKLYG 509 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g 509 (790)
..++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999964 578999999865321 23467899999999999999999999
Q ss_pred EEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC---
Q 040908 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL--- 586 (790)
Q Consensus 510 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~--- 586 (790)
++.+.+..++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999883 2356999999999999999999999985 99999999999998776
Q ss_pred CeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH
Q 040908 587 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL 666 (790)
Q Consensus 587 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 666 (790)
.+||+|||+++....... .....||+.|+|||++. +.++.++|||||||++|||++|+.||......+...
T Consensus 187 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------ 257 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK------ 257 (504)
T ss_dssp SEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------
T ss_pred cEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------
Confidence 699999999987654332 23457999999999986 568999999999999999999999997654332111
Q ss_pred HHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 040908 667 LLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEG 721 (790)
Q Consensus 667 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~ 721 (790)
. ...+.... +... ......++.+++..|++.||.+|||+.|+++ .+.+
T Consensus 258 ~-i~~~~~~~--~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 258 K-VEKGKYYF--DFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp H-HHHCCCCC--CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred H-HHcCCCCC--Cccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 1 11111100 0000 0012356889999999999999999999986 4444
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=340.74 Aligned_cols=261 Identities=19% Similarity=0.277 Sum_probs=192.1
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC------
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN------ 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 515 (790)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999985 46889999998653 2334567889999999999999999999997654
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999975 7888773 35889999999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH-------------
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL------------- 662 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~------------- 662 (790)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654322 223467999999999999999999999999999999999999999765432211000
Q ss_pred ---HHHHHHHhh-CC-----cccccCCCC-C--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 663 ---DWALLLKEQ-GN-----LMELVDPNL-G--SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 663 ---~~~~~~~~~-~~-----~~~~~d~~l-~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
......... .. +.+...... . ..........+.+++.+|++.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000000 00 000000000 0 0011233567899999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=341.25 Aligned_cols=260 Identities=22% Similarity=0.361 Sum_probs=198.4
Q ss_pred CccHHHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEcccc--chhcHHHHHHHHHHhhccC--CCceeeeeeE
Q 040908 435 SFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQ--HPHLVKLYGC 510 (790)
Q Consensus 435 ~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~ 510 (790)
.+.++.+....++|++.+.||+|+||.||+|...+++.||||++... .......+.+|+.++.+++ |+||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34444445566789999999999999999999888999999998643 2334567899999999997 5999999999
Q ss_pred EEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEE
Q 040908 511 CIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 590 (790)
Q Consensus 511 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 590 (790)
+...+..++||| +.+++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++ +.+||
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEE
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEE
Confidence 999999999999 678899999942 346899999999999999999999985 999999999999975 78999
Q ss_pred eecCCccccCCCCcc-eeeccccCCCcccHHHhhc-----------CCCCChhhHHHHHHHHHHHHhCCCCCccccccch
Q 040908 591 SDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMR-----------GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEK 658 (790)
Q Consensus 591 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~ 658 (790)
+|||+++........ ......||+.|+|||++.. ..++.++|||||||++|||++|+.||........
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 999999866443322 2234569999999999875 4688899999999999999999999964332111
Q ss_pred hhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 659 FYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 659 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. .. ..+++......+......+.+++..||+.||.+||++.|+++
T Consensus 248 ----~-~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 248 ----K-LH---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp ----H-HH---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----H-HH---------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 0 01 111111111111122346788999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=369.90 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=205.3
Q ss_pred HHHHHhcCcceeeeecccCcEEEEeeeec----CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC
Q 040908 440 QIKAATNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEG 514 (790)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 514 (790)
+.+...++|++.+.||+|+||.||+|.+. .+..||+|++.... ....+.|.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 33444678999999999999999999863 24679999987543 333467999999999999999999999985 4
Q ss_pred CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
+..++||||+++|+|.+++. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHH---HTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEcCCCCcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 56899999999999999994 22346899999999999999999999985 9999999999999999999999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
+++..............+|+.|+|||++....++.++|||||||++|||++ |+.||......+. .. ... .+.
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~---~i~-~~~ 609 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG---RIE-NGE 609 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH---HHH-HTC
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HH---HHH-cCC
Confidence 998765544333344567889999999999999999999999999999997 9999975433221 11 111 111
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
. ... +......+.+++..||+.||.+||++.|+++.|+...
T Consensus 610 ~-----~~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 610 R-----LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp C-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-----CCC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 111 1123356788999999999999999999999998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=368.80 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=203.8
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc---chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK---SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 518 (790)
..++|++.+.||+|+||.||+|... +++.||||+++.. .......+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999954 6889999999753 233456788899999988 7999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+|+.
T Consensus 419 lV~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999994 2346999999999999999999999985 99999999999999999999999999985
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ... ...
T Consensus 492 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~------~i~-~~~----- 558 (674)
T 3pfq_A 492 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ------SIM-EHN----- 558 (674)
T ss_dssp CCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-SSC-----
T ss_pred cccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH------HHH-hCC-----
Confidence 433222 2345779999999999999999999999999999999999999997654322111 101 111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLM-----SSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~ev~~ 717 (790)
+ .++.....++.+++..||+.||.+||++ .||.+
T Consensus 559 ---~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 ---V--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---C--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---C--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0 1122234567889999999999999997 66653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.55 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=199.1
Q ss_pred ccHHHHHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEe
Q 040908 436 FTLRQIKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIE 513 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 513 (790)
+++.++....++|++.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 34444555678999999999999999999996 478999999986532 3456788999999999 89999999999987
Q ss_pred ------CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC
Q 040908 514 ------GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 587 (790)
Q Consensus 514 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 587 (790)
.+..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence 468899999999999999995332 356899999999999999999999985 999999999999999999
Q ss_pred eEEeecCCccccCCCCcceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH
Q 040908 588 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662 (790)
Q Consensus 588 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 662 (790)
+||+|||++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||..........
T Consensus 168 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-- 244 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-- 244 (326)
T ss_dssp EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--
T ss_pred EEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH--
Confidence 99999999986543221 123456999999999987 5678999999999999999999999996543221110
Q ss_pred HHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 663 DWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 663 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ......... ...+ ...+.+++..||+.||.+||++.|+++
T Consensus 245 ----~~-~~~~~~~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 245 ----LI-PRNPAPRLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ----HH-HHSCCCCCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----Hh-hcCccccCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 01 111111111 1112 346788999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.51 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=192.5
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEe---------
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIE--------- 513 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 513 (790)
..++|++.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356899999999999999999995 47899999998643 3445678999999999999999999999865
Q ss_pred ----CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeE
Q 040908 514 ----GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 589 (790)
Q Consensus 514 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 589 (790)
.+..++||||+++|+|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 4578999999999999999942 2345788899999999999999999985 99999999999999999999
Q ss_pred EeecCCccccCCCC-------------cceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccc
Q 040908 590 ISDFGLAKLDEEDN-------------THISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTK 655 (790)
Q Consensus 590 l~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~ 655 (790)
|+|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++ |+.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 99999998654321 1122345689999999999864 78999999999999999998 4432111
Q ss_pred cchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 656 EEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 656 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ........ . .......++......+.+++..|++.||.+|||+.|+++
T Consensus 234 --~~---~~~~~~~~-~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 --RV---NILKKLRS-V------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HH---HHHHHHHS-T------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HH---HHHHhccc-c------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11 11111110 0 111122233334456789999999999999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=331.13 Aligned_cols=262 Identities=19% Similarity=0.310 Sum_probs=202.3
Q ss_pred hcCcceeeeecccCcEEEEeeee--cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCc------eeeeeeEEEeCCe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL--ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH------LVKLYGCCIEGNQ 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~--~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 516 (790)
.++|++.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.+++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999985 36889999998653 233567889999999987664 9999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC------------
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK------------ 584 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~------------ 584 (790)
.++||||+ +++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 88999998432 2246889999999999999999999985 999999999999987
Q ss_pred -------CCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccc
Q 040908 585 -------DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE 657 (790)
Q Consensus 585 -------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~ 657 (790)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6789999999998654322 34578999999999999999999999999999999999999997654332
Q ss_pred hhhHHHHHH-----HHHhhCCccccc---------------------CCCC-CCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 040908 658 KFYLLDWAL-----LLKEQGNLMELV---------------------DPNL-GSNVDKEQVRVMINVALLCADVSPTNRP 710 (790)
Q Consensus 658 ~~~l~~~~~-----~~~~~~~~~~~~---------------------d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 710 (790)
......... ............ .+.. ...........+.+++..||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 221111000 000000000000 0000 0011234567889999999999999999
Q ss_pred CHHHHHH
Q 040908 711 LMSSVVS 717 (790)
Q Consensus 711 t~~ev~~ 717 (790)
|+.|+++
T Consensus 322 t~~ell~ 328 (339)
T 1z57_A 322 TLREALK 328 (339)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999865
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=338.75 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=195.5
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch--------hcHHHHHHHHHHhhccCCCceeeeeeEEEeC
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK--------QGNREFVNEIGTISALQHPHLVKLYGCCIEG 514 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 514 (790)
..++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4568999999999999999999864 588999999865321 1224588999999999999999999998765
Q ss_pred CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC---eEEe
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKIS 591 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~ 591 (790)
+ .++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 8999999999999999843 346899999999999999999999985 999999999999987654 9999
Q ss_pred ecCCccccCCCCcceeeccccCCCcccHHHhh---cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH
Q 040908 592 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL 668 (790)
Q Consensus 592 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 668 (790)
|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ +....
T Consensus 160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~--- 232 (322)
T 2ycf_A 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI--- 232 (322)
T ss_dssp CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH---
T ss_pred cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH---
Confidence 999998664322 223456999999999974 46788999999999999999999999975433221 11111
Q ss_pred HhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 669 KEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 669 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+.... .+.. .......+.+++..|++.||.+||++.|+++
T Consensus 233 -~~~~~~~--~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 -TSGKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHTCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HhCcccc--Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111100 0000 0112356789999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.55 Aligned_cols=264 Identities=22% Similarity=0.377 Sum_probs=202.3
Q ss_pred HHHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC
Q 040908 438 LRQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN 515 (790)
Q Consensus 438 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 515 (790)
.++.+...++|++.+.||+|+||.||+|...+ .||+|++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34444556889999999999999999998754 49999986542 223456788999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999943 2346899999999999999999999985 99999999999998 67999999999
Q ss_pred ccccCCCC----cceeeccccCCCcccHHHhhc---------CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH
Q 040908 596 AKLDEEDN----THISTRVAGTFGYMAPEYAMR---------GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662 (790)
Q Consensus 596 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 662 (790)
++...... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||.........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--- 252 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII--- 252 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH---
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 87543211 111223458999999999864 45788999999999999999999999754332211
Q ss_pred HHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcCC
Q 040908 663 DWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGV 725 (790)
Q Consensus 663 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 725 (790)
... ..+........ . ....+.+++..||+.+|.+|||+.+++++|+.....
T Consensus 253 ---~~~-~~~~~~~~~~~----~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 253 ---WQM-GTGMKPNLSQI----G----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ---HHH-HTTCCCCCCCS----S----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ---HHh-ccCCCCCCCcC----C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111 11111111111 1 123578899999999999999999999999987653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=337.90 Aligned_cols=262 Identities=21% Similarity=0.311 Sum_probs=200.1
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-----Ce
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEG-----NQ 516 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 516 (790)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999854 68899999987533 23346789999999999999999999999754 36
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+. |+|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999998 58999883 246899999999999999999999985 999999999999999999999999999
Q ss_pred cccCCCCcc--eeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 597 KLDEEDNTH--ISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 597 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+. .. .....
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~-~~~~~ 252 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL--GI-LGSPS 252 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH--HH-HCSCC
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH--HH-hCCCC
Confidence 866433221 1234579999999998765 458999999999999999999999997654333221110 00 00000
Q ss_pred ---ccc--------ccCC-CCCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 ---LME--------LVDP-NLGSNVD-----KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ---~~~--------~~d~-~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+.. .... ......+ ......+.+++..|++.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000 0000000 112346789999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=330.83 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=196.8
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc----hhcHHHHHHHHHHhhccCCCceeeeeeEEE--eCCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS----KQGNREFVNEIGTISALQHPHLVKLYGCCI--EGNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 517 (790)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999996 468899999997642 234567999999999999999999999984 45578
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
++||||++++ |.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999987 66666322 2356899999999999999999999985 9999999999999999999999999998
Q ss_pred ccCCCC-cceeeccccCCCcccHHHhhcCC--CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 598 LDEEDN-THISTRVAGTFGYMAPEYAMRGH--LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 598 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
...... ........||+.|+|||++.+.. .+.++||||||+++|||++|+.||......+.. ... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~i-~~~~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF------ENI-GKGSY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHH-HHCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH------HHH-hcCCC
Confidence 654322 22233466999999999997644 377999999999999999999999754322111 111 11111
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 675 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..... ....+.+++.+|++.||.+||++.|+++
T Consensus 231 ------~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 ------AIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ------CCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------CCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11112 2346788999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=338.30 Aligned_cols=264 Identities=22% Similarity=0.379 Sum_probs=199.5
Q ss_pred HhcCcceeeeecccCcEEEEeeee--cCCcEEEEEEccccchh--cHHHHHHHHHHhhcc---CCCceeeeeeEEE----
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL--ADGTLIAVKQLSAKSKQ--GNREFVNEIGTISAL---QHPHLVKLYGCCI---- 512 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~--~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~g~~~---- 512 (790)
+.++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999996 46889999998654321 223566788777766 8999999999987
Q ss_pred -eCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEe
Q 040908 513 -EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 591 (790)
Q Consensus 513 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 591 (790)
.....++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 69999984322 235899999999999999999999985 9999999999999999999999
Q ss_pred ecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh
Q 040908 592 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ 671 (790)
Q Consensus 592 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 671 (790)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .........
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~i~~~~~~~ 238 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG--KILDVIGLP 238 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHHHHcCCC
Confidence 999998654322 2234568999999999999999999999999999999999999997654322111 100000000
Q ss_pred --CCccc-------ccCCC---CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 672 --GNLME-------LVDPN---LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 672 --~~~~~-------~~d~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..... ..... ............+.+++.+||+.||.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 00000 000111123456788999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=338.95 Aligned_cols=270 Identities=20% Similarity=0.285 Sum_probs=191.8
Q ss_pred HHHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe-
Q 040908 439 RQIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ- 516 (790)
Q Consensus 439 ~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~- 516 (790)
.......++|++.+.||+|+||.||+|... +|+.||||++.... .....+.+|+..++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667789999999999999999999964 68999999885532 233456788888999999999999999976443
Q ss_pred ------EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhh--hcCCCcEEeccCCCCcEEecC-CCC
Q 040908 517 ------LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH--EESRLKIVHRDIKATNVLLDK-DLN 587 (790)
Q Consensus 517 ------~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~iiHrDlk~~NILl~~-~~~ 587 (790)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999986 555444322223457899999999999999999999 66 5999999999999997 899
Q ss_pred eEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCC-CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH
Q 040908 588 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGH-LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL 666 (790)
Q Consensus 588 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 666 (790)
+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......... ....
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--~~~~ 246 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH--EIVR 246 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH--HHHH
Confidence 99999999986654332 23456899999999987654 8999999999999999999999997654332211 1111
Q ss_pred HH-----------HhhCCcccccCCC-C-----CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 667 LL-----------KEQGNLMELVDPN-L-----GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 667 ~~-----------~~~~~~~~~~d~~-l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ..........+.. . ...........+.+++..||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 0000000000000 0 00111124567899999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=341.24 Aligned_cols=255 Identities=22% Similarity=0.359 Sum_probs=182.6
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC------C
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG------N 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 515 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999984 56899999998653 233456788999999999999999999998754 5
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 6899988832 46899999999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ .. ..+..
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i--~~---~~g~p 249 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI--LR---LVGTP 249 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HH---HHCSC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HH---HhCCC
Confidence 9865432 234679999999999987 67899999999999999999999999765432221111 00 00000
Q ss_pred -cc------------ccC--CCC-CCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 675 -ME------------LVD--PNL-GSNVD---KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 675 -~~------------~~d--~~l-~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+ .+. +.. ...+. ......+.+++.+|++.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 000 000 00000 011346789999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=347.83 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=194.2
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe------EE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ------LL 518 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~ 518 (790)
..+|++.+.||+|+||.||+|....+..||+|++...... ..+|+.+++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3579999999999999999999877777999988543222 2369999999999999999999965433 78
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec-CCCCeEEeecCCcc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAK 597 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~ 597 (790)
+||||++++.+. .+.........+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPETVYR-ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEEHHH-HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCccHHH-HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 999999875443 33221223457899999999999999999999985 99999999999999 79999999999998
Q ss_pred ccCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH--------
Q 040908 598 LDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL-------- 668 (790)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-------- 668 (790)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. .......
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l--~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL--VEIIKVLGTPSREQI 266 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHH
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHHH
Confidence 7644332 2345789999999999765 5899999999999999999999999765433221 1111100
Q ss_pred -HhhCCcccccCCCCCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 669 -KEQGNLMELVDPNLGSN-----VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 669 -~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.......+..-+..... +......++.+++.+||+.||.+|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000000000111100 11123357889999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.55 Aligned_cols=210 Identities=22% Similarity=0.290 Sum_probs=175.1
Q ss_pred cHHHHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccC-CC-----ceeeeee
Q 040908 437 TLRQIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HP-----HLVKLYG 509 (790)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g 509 (790)
.+...+...++|++.+.||+|+||.||+|... +++.||||++... .....++..|+.++..++ |+ +|+++++
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 33444455789999999999999999999854 6889999999753 233466778888888885 54 4999999
Q ss_pred EEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec--CCCC
Q 040908 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD--KDLN 587 (790)
Q Consensus 510 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~~~ 587 (790)
++...+..++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+. ..+|+||||||+|||++ .++.
T Consensus 124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEEETTEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCC
T ss_pred eeccCCceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCc
Confidence 9999999999999996 59999985322 24589999999999999999999963 23699999999999994 5788
Q ss_pred eEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccc
Q 040908 588 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTK 655 (790)
Q Consensus 588 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~ 655 (790)
+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 200 ~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp EEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999876432 2346789999999999999999999999999999999999999976543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=332.23 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=193.7
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEE-----------
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI----------- 512 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------- 512 (790)
.++|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999965 48999999997766666778999999999999999999999873
Q ss_pred ---eCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec-CCCCe
Q 040908 513 ---EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNP 588 (790)
Q Consensus 513 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ 588 (790)
+.+..++||||++ |+|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 4467899999998 69999983 246899999999999999999999985 99999999999997 56799
Q ss_pred EEeecCCccccCCCCc--ceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHH
Q 040908 589 KISDFGLAKLDEEDNT--HISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 589 kl~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 665 (790)
||+|||+++....... .......+|..|+|||.+.. ..++.++|||||||++|||++|+.||......+....+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999986543221 11233567999999998876 67899999999999999999999999765432211110000
Q ss_pred -------HHHHhhCCcccccCCCCC-CCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 666 -------LLLKEQGNLMELVDPNLG-SNV-----DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 666 -------~~~~~~~~~~~~~d~~l~-~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........+...+..... ... .......+.+++..|++.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000000000000000 000 0112456889999999999999999999976
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=344.77 Aligned_cols=204 Identities=26% Similarity=0.446 Sum_probs=155.7
Q ss_pred hcCcce-eeeecccCcEEEEeeeec---CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEe--CCeEE
Q 040908 445 TNHFDV-ANKIGEGGFGPVYKGLLA---DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIE--GNQLL 518 (790)
Q Consensus 445 ~~~y~~-~~~LG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 518 (790)
.+.|++ .++||+|+||.||+|... +++.||||++.... ....+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 344665 458999999999999965 57889999996532 23568899999999999999999999965 67899
Q ss_pred EEEEeccCCChhhhhcCCc-----cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe----cCCCCeE
Q 040908 519 LIYEYLENNSLARALFGPE-----EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPK 589 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~k 589 (790)
+||||+.+ +|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 7887773211 11235899999999999999999999985 9999999999999 7788999
Q ss_pred EeecCCccccCCCCc--ceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCcccc
Q 040908 590 ISDFGLAKLDEEDNT--HISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKT 654 (790)
Q Consensus 590 l~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~ 654 (790)
|+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999999986653221 222346799999999999874 58999999999999999999999997543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.23 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=178.5
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHH-HhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIG-TISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368899999999999999999964 68999999987543 233445666666 777889999999999999999999999
Q ss_pred EeccCCChhhhhcCCc-cccCCCChhhHHHHHHHHHHHHHHhhhc-CCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 522 EYLENNSLARALFGPE-EHRLKLDWPTRHNICIGIARGLAYLHEE-SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||+++ +|.+++.... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 7877763211 1135689999999999999999999997 5 999999999999999999999999999865
Q ss_pred CCCCcceeeccccCCCcccHHHh----hcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYA----MRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
..... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||........ ......
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----------~~~~~~ 243 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----------QLTQVV 243 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCC
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----------HHHHHh
Confidence 44322 2334699999999998 456789999999999999999999999964321100 000111
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
....+.+...........+.+++..||+.||.+||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111111111123456889999999999999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=337.51 Aligned_cols=254 Identities=20% Similarity=0.323 Sum_probs=195.1
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE----
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQL---- 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 517 (790)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 47899999999999999999985 468999999987542 23356788999999999999999999999876654
Q ss_pred --EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 518 --LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 518 --~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
++||||+. ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 68888872 34899999999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.... ... ..+..
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--i~~---~~~~~ 261 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ--ILK---VTGVP 261 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHH---HHCCC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHH---HhCCC
Confidence 9855432 234678999999999987 6889999999999999999999999976543221110 000 00000
Q ss_pred -cc---------------ccCCCCCCCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 675 -ME---------------LVDPNLGSNV---DKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 675 -~~---------------~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+ .+.......+ .......+.+++..|++.||.+|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 0000000000 0112456889999999999999999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=338.29 Aligned_cols=263 Identities=20% Similarity=0.324 Sum_probs=198.1
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-----Ce
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEG-----NQ 516 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 516 (790)
..++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999964 68999999986533 33356788999999999999999999998754 67
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+. |+|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999997 58999883 246899999999999999999999985 999999999999999999999999999
Q ss_pred cccCCCCcc---------eeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHH
Q 040908 597 KLDEEDNTH---------ISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL 666 (790)
Q Consensus 597 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 666 (790)
+........ ......||+.|+|||++.. ..++.++|||||||++|||++|+.||............ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~ 237 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI--FG 237 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH--HH
Confidence 865432211 1123568999999998765 67899999999999999999999999765432211100 00
Q ss_pred HHHhhC---Ccc--------cccC--CCCCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 667 LLKEQG---NLM--------ELVD--PNLGSN----VDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 667 ~~~~~~---~~~--------~~~d--~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...... ... +.+. +..... ........+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 000 0000 000000 00122356789999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=343.62 Aligned_cols=253 Identities=25% Similarity=0.290 Sum_probs=188.2
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEec
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +|||||++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445667899999999998766667999999998643 235678899999887 8999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCC---CChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC-------------CCe
Q 040908 525 ENNSLARALFGPEEHRLK---LDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-------------LNP 588 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-------------~~~ 588 (790)
. |+|.+++......... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999999644322111 244567889999999999999985 9999999999999754 489
Q ss_pred EEeecCCccccCCCCcc---eeeccccCCCcccHHHhhc-------CCCCChhhHHHHHHHHHHHHh-CCCCCccccccc
Q 040908 589 KISDFGLAKLDEEDNTH---ISTRVAGTFGYMAPEYAMR-------GHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEE 657 (790)
Q Consensus 589 kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~ 657 (790)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543322 1234579999999999975 678999999999999999999 999996443221
Q ss_pred hhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 658 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. . ........ +............++.+++.+|++.||.+|||+.||++
T Consensus 248 ~-~------i~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 S-N------IIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H-H------HHHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-H------HhcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 0 00111111 11111224456678999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.56 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=202.4
Q ss_pred HHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 442 KAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
....++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999965 68999999986542 234677999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC---CCeEEeecCC
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISDFGL 595 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGl 595 (790)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.+ +.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999999998832 346899999999999999999999985 9999999999999754 4799999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
++....... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+. .... ..+...
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~-~~~~~~ 240 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LKRV-ETGKYA 240 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH-HHCCCC
T ss_pred ceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH------HHHH-HcCCCC
Confidence 986544322 123458999999998865 589999999999999999999999975432211 1111 111111
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
... + ... .....+.+++..|++.||.+|||+.|+++
T Consensus 241 ~~~-~-~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDL-P-QWR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCS-G-GGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCc-h-hhh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 0 001 12346788999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=328.19 Aligned_cols=262 Identities=19% Similarity=0.305 Sum_probs=199.4
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CC-cEEEEEEccccchhcHHHHHHHHHHhhccCCCc------eeeeeeEEEeCCe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DG-TLIAVKQLSAKSKQGNREFVNEIGTISALQHPH------LVKLYGCCIEGNQ 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 516 (790)
.++|++.+.||+|+||.||+|... ++ +.||+|++... ......+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 578999999999999999999853 34 78999999653 233567888999999998766 8999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEe--------------
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLL-------------- 582 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl-------------- 582 (790)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 99999999 66777776322 2246899999999999999999999885 9999999999999
Q ss_pred -----cCCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccc
Q 040908 583 -----DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE 657 (790)
Q Consensus 583 -----~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~ 657 (790)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 678899999999998654322 34579999999999999999999999999999999999999997654332
Q ss_pred hhhHHHHHH-----HHHhhCCccc-ccCCCC---------------------CCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 040908 658 KFYLLDWAL-----LLKEQGNLME-LVDPNL---------------------GSNVDKEQVRVMINVALLCADVSPTNRP 710 (790)
Q Consensus 658 ~~~l~~~~~-----~~~~~~~~~~-~~d~~l---------------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 710 (790)
......... .......... ...... .......+...+.+++..||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 211111000 0000000000 000000 0011223456788999999999999999
Q ss_pred CHHHHHH
Q 040908 711 LMSSVVS 717 (790)
Q Consensus 711 t~~ev~~ 717 (790)
|+.|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=336.08 Aligned_cols=263 Identities=21% Similarity=0.274 Sum_probs=198.7
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccC-----------CCceeeeeeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-----------HPHLVKLYGCCI 512 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~ 512 (790)
.++|++.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999995 57899999998743 233567889999998886 899999999998
Q ss_pred eCC----eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec-----
Q 040908 513 EGN----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD----- 583 (790)
Q Consensus 513 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~----- 583 (790)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 654 789999999 889999984322 245899999999999999999999972 399999999999995
Q ss_pred -CCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHH
Q 040908 584 -KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662 (790)
Q Consensus 584 -~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 662 (790)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 34479999999998665432 3356899999999999999999999999999999999999999754321110000
Q ss_pred H-HHHHHHhhCCcc--------------------cccCC-C---------CCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 040908 663 D-WALLLKEQGNLM--------------------ELVDP-N---------LGSNVDKEQVRVMINVALLCADVSPTNRPL 711 (790)
Q Consensus 663 ~-~~~~~~~~~~~~--------------------~~~d~-~---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 711 (790)
+ ........+.+. ..+.. . -...++......+.+++..||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 0 000000001000 00000 0 011345567788999999999999999999
Q ss_pred HHHHHH
Q 040908 712 MSSVVS 717 (790)
Q Consensus 712 ~~ev~~ 717 (790)
+.|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=334.82 Aligned_cols=256 Identities=20% Similarity=0.326 Sum_probs=195.0
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe-----
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ----- 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 516 (790)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999995 468999999986532 2334678899999999999999999999987653
Q ss_pred -EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 517 -LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 517 -~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
.++||||+. ++|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 58888772 24899999999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh---
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ--- 671 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--- 671 (790)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.... ........
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~--i~~~~~~~~~~ 246 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ--ILKVTGVPGTE 246 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHH--HHHHHCBCCHH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhCCCCHH
Confidence 9865432 234568999999999987 6789999999999999999999999976543221110 00000000
Q ss_pred --------------CCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 672 --------------GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 672 --------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+.....+.. ..........+.+++.+|++.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000001 0111223457889999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=330.99 Aligned_cols=245 Identities=22% Similarity=0.359 Sum_probs=189.9
Q ss_pred HHHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchh------cHHHHHHHHHHhhcc----CCCceeeee
Q 040908 440 QIKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQ------GNREFVNEIGTISAL----QHPHLVKLY 508 (790)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~ 508 (790)
+.+...++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3445568899999999999999999985 46889999999654321 223456799999988 899999999
Q ss_pred eEEEeCCeEEEEEEe-ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec-CCC
Q 040908 509 GCCIEGNQLLLIYEY-LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDL 586 (790)
Q Consensus 509 g~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~ 586 (790)
+++...+..++|||| +.+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence 999998999999999 789999999942 346899999999999999999999985 99999999999999 889
Q ss_pred CeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCC-ChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHH
Q 040908 587 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLT-DKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 587 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 665 (790)
.+||+|||+++...... .....||..|+|||++.+..+. .++|||||||++|||++|+.||.....
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------- 244 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------- 244 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------
Confidence 99999999998765432 2345699999999999877664 489999999999999999999864210
Q ss_pred HHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 666 LLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 666 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. .... .... .....+.+++..||+.||.+||++.|+++
T Consensus 245 -~~--~~~~------~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 -IL--EAEL------HFPA----HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HH--HTCC------CCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -Hh--hhcc------CCcc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0000 1111 22346788999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.37 Aligned_cols=245 Identities=22% Similarity=0.374 Sum_probs=198.2
Q ss_pred HHHHHhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchh------cHHHHHHHHHHhhccC--CCceeeeeeE
Q 040908 440 QIKAATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQ------GNREFVNEIGTISALQ--HPHLVKLYGC 510 (790)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~ 510 (790)
+.+...++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3344567899999999999999999984 57899999998654321 1245678999999996 5999999999
Q ss_pred EEeCCeEEEEEEeccC-CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec-CCCCe
Q 040908 511 CIEGNQLLLIYEYLEN-NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNP 588 (790)
Q Consensus 511 ~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ 588 (790)
+...+..++||||+.+ ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence 9999999999999986 89999983 2356899999999999999999999985 99999999999999 78899
Q ss_pred EEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCC-CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH
Q 040908 589 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 589 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 667 (790)
||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 190 kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----------~ 255 (320)
T 3a99_A 190 KLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------I 255 (320)
T ss_dssp EECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------H
T ss_pred EEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----------h
Confidence 999999998765432 234569999999999987765 6789999999999999999999964211 0
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+.. . ....+ ..++.+++.+||+.||.+||++.|+++
T Consensus 256 --~~~~~--~----~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 --IRGQV--F----FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --HHCCC--C----CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hcccc--c----ccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00110 0 11122 346788999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.99 Aligned_cols=258 Identities=21% Similarity=0.267 Sum_probs=174.9
Q ss_pred HhcCcceee-eecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHH-HHhhccCCCceeeeeeEEEe----CCe
Q 040908 444 ATNHFDVAN-KIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEI-GTISALQHPHLVKLYGCCIE----GNQ 516 (790)
Q Consensus 444 ~~~~y~~~~-~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~----~~~ 516 (790)
..++|.+.+ .||+|+||.||+|... +|+.||||++.... ...+|+ ..++.++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 357899855 6999999999999965 68999999986431 122333 34566799999999999876 455
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC---CCCeEEeec
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDF 593 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DF 593 (790)
.++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 899999999999999995432 246899999999999999999999985 999999999999976 455999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
|+++...... .....||+.|+|||++....++.++|||||||++|||++|+.||........... .... ...+
T Consensus 176 g~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~-~~~~- 248 (336)
T 3fhr_A 176 GFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRR-IRLG- 248 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred ccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHh-hhcc-
Confidence 9998654322 2345689999999999888889999999999999999999999965432221000 0000 0000
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCc
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGRV 723 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~~ 723 (790)
.. .............+.+++..|++.||.+|||+.|+++ .+....
T Consensus 249 --~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 249 --QY---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred --cc---ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 00 0000111123456788999999999999999999998 555543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=323.84 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=177.7
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch-hcH-HHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-QGN-REFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
.++|++.+.||+|+||.||+|... +|+.||||++..... ... +.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999964 689999999865432 222 33445556788889999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+ ++.+..+.. .....+++..+..++.|+++||+|||+.. +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 e~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 445544442 22356899999999999999999999851 399999999999999999999999999976544
Q ss_pred CCcceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 602 DNTHISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||........ . +... .. +...
T Consensus 178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~--~~~~-~~-~~~~- 248 (318)
T 2dyl_A 178 DKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--V--LTKV-LQ-EEPP- 248 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--H--HHHH-HH-SCCC-
T ss_pred Ccc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--H--HHHH-hc-cCCC-
Confidence 322 23456999999999994 55788999999999999999999999975322111 1 1111 11 1111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.... .......+.+++..||+.||.+||++.|+++
T Consensus 249 ----~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 ----LLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1110 0012346788999999999999999999876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=337.41 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=186.5
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..+|++.+.||+|+||+||.....+|+.||||++..... ..+.+|+.+++++ +|||||++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 456889999999999996655555789999999865332 2356799999999 899999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC-----CCCeEEeecCCccc
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-----DLNPKISDFGLAKL 598 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGla~~ 598 (790)
+. |+|.+++... .....+..+..++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 100 ~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 97 5999999533 234566677899999999999999985 999999999999943 34688999999986
Q ss_pred cCCCCc--ceeeccccCCCcccHHHhh---cCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhC
Q 040908 599 DEEDNT--HISTRVAGTFGYMAPEYAM---RGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 599 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
...... .......||+.|+|||++. ...++.++|||||||++|||+| |+.||........ .......
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~~~ 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLGAC 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTTCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhccC
Confidence 654321 2234467999999999997 4567889999999999999999 8888854322111 0111111
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. .... .........+.+++..||+.||.+|||+.||++
T Consensus 246 ~-~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 S-LDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-CTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-cccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 1111 111234456788999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=349.41 Aligned_cols=238 Identities=21% Similarity=0.307 Sum_probs=192.2
Q ss_pred hcCcceeeeecccCcEEEEeeeec--CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCe-----
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA--DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQ----- 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~--~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 516 (790)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999964 68999999986532 3345678999999999999999999999987655
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+++++|.+++. ..++|..++.++.||+.||+|||+.+ |+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 799999999999998773 26899999999999999999999985 9999999999999986 8999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
+..... ....||+.|+|||++.++. +.++|||||||++|||++|..|+....... +
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~-- 284 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------L-- 284 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------C--
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------c--
Confidence 866543 3456999999999987754 889999999999999999988875321110 0
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhc
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL-MSSVVSMLEG 721 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~ev~~~L~~ 721 (790)
............+.+++.+||+.||.+||+ +.++...|.+
T Consensus 285 -----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 -----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000111123356889999999999999995 5566655544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=348.24 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=197.9
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEe------CCe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIE------GNQ 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 516 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999996 46899999998754 33445679999999999999999999998765 667
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC---eEEeec
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKISDF 593 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DF 593 (790)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999964322 246899999999999999999999985 999999999999997765 899999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh--
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ-- 671 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-- 671 (790)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..|.......
T Consensus 169 G~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred ccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence 99987654332 24467999999999999999999999999999999999999999653211 1111100000
Q ss_pred --CCcccccCC--------CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 040908 672 --GNLMELVDP--------NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSS 714 (790)
Q Consensus 672 --~~~~~~~d~--------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 714 (790)
....+.... .............+.+++..|++.||.+|||+.|
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000111110 1112234456778999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.03 Aligned_cols=230 Identities=10% Similarity=0.043 Sum_probs=182.6
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch---hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK---QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999965 589999999976432 2346799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++.. .....++.+|+.|++.||+|||+.+ |+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999932 1345578889999999999999985 9999999999999999999998543
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
|++ .++.++|||||||++|||+||+.||.......... .....+..
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~ 220 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAG 220 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTS
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhcc
Confidence 333 36889999999999999999999997654322110 00000000
Q ss_pred CCC--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 681 NLG--SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 681 ~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
... ..........+.+++.+||+.||.+| |+.|+++.|+....
T Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000 00011223568899999999999999 99999999987654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=330.47 Aligned_cols=243 Identities=13% Similarity=0.092 Sum_probs=179.9
Q ss_pred hcCcceeeeecccCcEEEEeee-ecCCcEEEEEEccccch---hcHHHHHHHHHHhhccCC-Cceee-------------
Q 040908 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSK---QGNREFVNEIGTISALQH-PHLVK------------- 506 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv~------------- 506 (790)
+.+|...+.||+|+||.||+|. ..+|+.||||++..... ...+.|.+|+.+++.++| +|...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4567888999999999999999 45789999999874322 235679999999999987 32211
Q ss_pred --e------eeEEEe-----CCeEEEEEEeccCCChhhhhcCC---ccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcE
Q 040908 507 --L------YGCCIE-----GNQLLLIYEYLENNSLARALFGP---EEHRLKLDWPTRHNICIGIARGLAYLHEESRLKI 570 (790)
Q Consensus 507 --l------~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 570 (790)
+ ..++.. ....+++|++ .+++|.+++... ......++|..++.++.||++||+|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 1 111111 1235666665 468999888311 112345788999999999999999999985 9
Q ss_pred EeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHh----------hcCCCCChhhHHHHHHHH
Q 040908 571 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA----------MRGHLTDKADVYSFGIVA 640 (790)
Q Consensus 571 iHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDV~S~Gvvl 640 (790)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999865432 344567 999999999 445578899999999999
Q ss_pred HHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 641 LEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 641 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
|||+||+.||......+.. ..++... ..+ ...+.+++..||+.||.+||++.|+++
T Consensus 308 ~elltg~~Pf~~~~~~~~~---------------~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGS---------------EWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCS---------------GGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhhH---------------HHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999754322211 1111100 122 256888999999999999999888754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.58 Aligned_cols=233 Identities=19% Similarity=0.263 Sum_probs=179.9
Q ss_pred hcCccee-eeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHh-hccCCCceeeeeeEEEe----CCeE
Q 040908 445 TNHFDVA-NKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTI-SALQHPHLVKLYGCCIE----GNQL 517 (790)
Q Consensus 445 ~~~y~~~-~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~ 517 (790)
.++|.+. +.||+|+||.||+|.. .+++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567777 7899999999999985 5689999999853 24567888888 55699999999999987 6778
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC---CCCeEEeecC
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFG 594 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFG 594 (790)
++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 9999999999999999532 2246899999999999999999999985 999999999999998 7899999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
+++.... ..++.++|||||||++|||+||+.||......... ...
T Consensus 166 ~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~ 210 (299)
T 3m2w_A 166 FAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGM 210 (299)
T ss_dssp TCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCS
T ss_pred ccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHH
Confidence 9874331 24577999999999999999999999654321100 001
Q ss_pred ccccCCCCCCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCc
Q 040908 675 MELVDPNLGSNVDK----EQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGRV 723 (790)
Q Consensus 675 ~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~~ 723 (790)
...+... ....+. .....+.+++..||+.||.+|||+.|+++ .+....
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 211 KTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CCSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 1111000 001111 23457889999999999999999999987 454433
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.42 Aligned_cols=240 Identities=19% Similarity=0.216 Sum_probs=183.2
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccc--------hhcHHHHHHHHHHhhccC---------CCceeee
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKS--------KQGNREFVNEIGTISALQ---------HPHLVKL 507 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 507 (790)
.++|++.+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.+++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 68999999997542 222377889999998886 7777777
Q ss_pred eeEEE-----------------e-------------CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHH
Q 040908 508 YGCCI-----------------E-------------GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557 (790)
Q Consensus 508 ~g~~~-----------------~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 557 (790)
.+.+. + .+..++||||+++|++.+.+.. ..+++..+..++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 66543 2 6789999999999987776622 45899999999999999
Q ss_pred HHHHhh-hcCCCcEEeccCCCCcEEecCCC--------------------CeEEeecCCccccCCCCcceeeccccCCCc
Q 040908 558 GLAYLH-EESRLKIVHRDIKATNVLLDKDL--------------------NPKISDFGLAKLDEEDNTHISTRVAGTFGY 616 (790)
Q Consensus 558 aL~yLH-~~~~~~iiHrDlk~~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y 616 (790)
||+||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 775 99999999999999887 8999999999866432 24699999
Q ss_pred ccHHHhhcCCCCChhhHHHHHHH-HHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc-c-ccCCCCCCCCcHHHHHH
Q 040908 617 MAPEYAMRGHLTDKADVYSFGIV-ALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM-E-LVDPNLGSNVDKEQVRV 693 (790)
Q Consensus 617 ~aPE~~~~~~~s~ksDV~S~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-~-~~d~~l~~~~~~~~~~~ 693 (790)
+|||++.+.. +.++||||+|++ .+++++|..||... .|...... .+. . ................+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTD--KMLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHH--HHHHTCCCSSCCCSHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHH--hhhhhhccCcccchhhhhhcCHH
Confidence 9999998665 889999998777 77888899887421 12111100 000 0 00111111123356778
Q ss_pred HHHHHHHccCCCCCCCCCHHHHH
Q 040908 694 MINVALLCADVSPTNRPLMSSVV 716 (790)
Q Consensus 694 l~~l~~~Cl~~dP~~RPt~~ev~ 716 (790)
+.+++.+|++.| |+.|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999966 888886
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-28 Score=286.23 Aligned_cols=185 Identities=18% Similarity=0.130 Sum_probs=129.5
Q ss_pred eecccCcEEEEeee-ecCCcEEEEEEccccc----------hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEE
Q 040908 453 KIGEGGFGPVYKGL-LADGTLIAVKQLSAKS----------KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 453 ~LG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 520 (790)
..+.|++|.+..++ .--|+.+|||++.... ....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777776655 3357889999986431 22345799999999999 799999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||++|++|.++|.. ..+++. .+|+.||+.||+|+|+++ ||||||||+||||++++++||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~---~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDR---EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCH---HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCH---HHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999943 234554 358999999999999986 9999999999999999999999999998765
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSN 649 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p 649 (790)
.... .....+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4332 2344679999999999865 567789999999998887766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.2e-26 Score=260.50 Aligned_cols=184 Identities=17% Similarity=0.198 Sum_probs=144.7
Q ss_pred ceeeeecccCcEEEEeeeecCCcEEEEEEccccch--------hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 449 DVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSK--------QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 449 ~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
...+.||+|+||.||+|.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999965 467788887643211 1134589999999999999999777777788888999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++++|.+++.. +..++.|+++||+|||+.+ |+||||||+|||++. ++||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999942 4579999999999999985 999999999999999 99999999999765
Q ss_pred CCCcce------eeccccCCCcccHHHhhc--CCCCChhhHHHHHHHHHHHHhCCCCC
Q 040908 601 EDNTHI------STRVAGTFGYMAPEYAMR--GHLTDKADVYSFGIVALEIVSGRSNI 650 (790)
Q Consensus 601 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~ 650 (790)
...... .....||+.|||||++.. ..|+.++|+|+..+-.++-+.++.++
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 432211 234679999999999976 56788899999999998888777655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=214.28 Aligned_cols=152 Identities=18% Similarity=0.101 Sum_probs=122.9
Q ss_pred HHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccch------------------hcHHHHHHHHHHhhccC
Q 040908 439 RQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSK------------------QGNREFVNEIGTISALQ 500 (790)
Q Consensus 439 ~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 500 (790)
..+......|++.+.||+|+||.||+|...+|+.||+|+++.... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344445566888899999999999999997799999999864321 12456899999999999
Q ss_pred CCceeeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcE
Q 040908 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNV 580 (790)
Q Consensus 501 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 580 (790)
| +++.+++.. +..++||||+++|+|.+ +. ......++.|++.||+|||+.+ |+||||||+||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 5 777776544 55699999999999988 51 1234579999999999999885 99999999999
Q ss_pred EecCCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhh
Q 040908 581 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 623 (790)
Q Consensus 581 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 623 (790)
|++ ++.+||+|||+|+. +..|+|||++.
T Consensus 225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 999 99999999999872 34578999874
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=9.6e-21 Score=228.37 Aligned_cols=168 Identities=21% Similarity=0.254 Sum_probs=103.1
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|+|.+|..|+++++|+.|+|++|++++..|. +|+.|++++|.+....+..+.. ++|+.|+|++|
T Consensus 469 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 548 (768)
T 3rgz_A 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548 (768)
T ss_dssp CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSS
T ss_pred eEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCC
Confidence 3566667777666666666666666666666666655543 4566666666665444444444 56666666666
Q ss_pred cccccCCccc----------------------------------------------------------------------
Q 040908 74 NLTGELPHFL---------------------------------------------------------------------- 83 (790)
Q Consensus 74 ~l~~~~p~~~---------------------------------------------------------------------- 83 (790)
+++|.+|..+
T Consensus 549 ~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~ 628 (768)
T 3rgz_A 549 LFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628 (768)
T ss_dssp EEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSC
T ss_pred ccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhh
Confidence 6665555432
Q ss_pred cCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCccee
Q 040908 84 GEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNL 162 (790)
Q Consensus 84 ~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~ 162 (790)
+++++|+.|||++|+|+|.+|.+|++|++|+.|+|++|+++|.+|..+.. ++|+.|||++|+|+|.+|..+..++.|+.
T Consensus 629 ~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~ 708 (768)
T 3rgz_A 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708 (768)
T ss_dssp SSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSE
T ss_pred hccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE
Confidence 22345666666666666666666666666666666666666666666655 56666666666666666666666666666
Q ss_pred eecCCC
Q 040908 163 FASSSK 168 (790)
Q Consensus 163 ~~~~~~ 168 (790)
++.+.+
T Consensus 709 L~ls~N 714 (768)
T 3rgz_A 709 IDLSNN 714 (768)
T ss_dssp EECCSS
T ss_pred EECcCC
Confidence 666544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-20 Score=226.80 Aligned_cols=103 Identities=24% Similarity=0.250 Sum_probs=48.7
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEecccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCN 74 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~ 74 (790)
+|+|++|+++|.+|..|+.+++|+.|++++|++++..|. +|+.|++++|.+....+..+.. ++|+.|+|++|+
T Consensus 446 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 525 (768)
T 3rgz_A 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525 (768)
T ss_dssp EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred EEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCc
Confidence 344555555544555455555555555555554443332 3444444444444333333332 445555555555
Q ss_pred ccccCCccccCCCCCCEEEccCCcCCcCcc
Q 040908 75 LTGELPHFLGEVSEMKVLDLSFNKLNGTIP 104 (790)
Q Consensus 75 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip 104 (790)
++|.+|..++++++|++|+|++|+++|.+|
T Consensus 526 l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip 555 (768)
T 3rgz_A 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555 (768)
T ss_dssp CEEECCGGGGGCTTCCEEECCSSEEESBCC
T ss_pred ccCcCCHHHcCCCCCCEEECCCCccCCcCC
Confidence 554555555555555555555554444444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.80 E-value=7.4e-20 Score=196.56 Aligned_cols=168 Identities=20% Similarity=0.216 Sum_probs=152.7
Q ss_pred EEEccCCcCcc--cCChhhhcccccCcccccC-ccccccccc------cccceeccccCCCCCCCccccc-CcccEEEec
Q 040908 2 YRTVQSNRLSG--ELPEELGSLIHSGKWFGWA-NSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILR 71 (790)
Q Consensus 2 ~L~Ls~N~l~g--~iP~~~~~L~~L~~L~l~~-N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~ 71 (790)
.|+|++|+|+| .+|..|+++++|++|++++ |.+.+..|. +|+.|++++|.+....+..+.. ++|++|+|+
T Consensus 54 ~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls 133 (313)
T 1ogq_A 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133 (313)
T ss_dssp EEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECC
T ss_pred EEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCC
Confidence 69999999999 9999999999999999995 999877764 7889999999998555555555 899999999
Q ss_pred cccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCC-CCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCC
Q 040908 72 SCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLA-DVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADES 150 (790)
Q Consensus 72 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~-~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~ 150 (790)
+|+|++.+|..|+++++|++|+|++|+++|.+|..+.+++ +|+.|+|++|++++.+|..+....|+.|+|++|++++.+
T Consensus 134 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~ 213 (313)
T 1ogq_A 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDA 213 (313)
T ss_dssp SSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECC
T ss_pred CCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcC
Confidence 9999999999999999999999999999999999999998 999999999999999999888856999999999999999
Q ss_pred CCCCCCCCcceeeecCCCC
Q 040908 151 SGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 151 p~~~~~~~~l~~~~~~~~~ 169 (790)
|..+..++.|+.++.+.+.
T Consensus 214 ~~~~~~l~~L~~L~L~~N~ 232 (313)
T 1ogq_A 214 SVLFGSDKNTQKIHLAKNS 232 (313)
T ss_dssp GGGCCTTSCCSEEECCSSE
T ss_pred CHHHhcCCCCCEEECCCCc
Confidence 9999999999999887653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.80 E-value=8.2e-20 Score=196.21 Aligned_cols=167 Identities=20% Similarity=0.300 Sum_probs=126.9
Q ss_pred CEEEccC-CcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEecc
Q 040908 1 MYRTVQS-NRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRS 72 (790)
Q Consensus 1 ~~L~Ls~-N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~ 72 (790)
++|+|++ |++++.+|..|+++++|++|+|++|.+++..|. +|+.|++++|.+....+..+.. ++|++|+|++
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 4688884 888888888888888888888888888766553 6777788888777555555554 7788888888
Q ss_pred ccccccCCccccCCC-CCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCC
Q 040908 73 CNLTGELPHFLGEVS-EMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADES 150 (790)
Q Consensus 73 N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~ 150 (790)
|+|+|.+|..+++++ +|++|+|++|+++|.+|..|..++ |+.|+|++|++++.+|..+.. ++|+.|+|++|++++.+
T Consensus 159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (313)
T 1ogq_A 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence 888888888888887 788888888888878888887776 888888888887777776666 77777777777777666
Q ss_pred CCCCCCCCcceeeecCCCC
Q 040908 151 SGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 151 p~~~~~~~~l~~~~~~~~~ 169 (790)
|. +..+++|+.++.+.+.
T Consensus 238 ~~-~~~l~~L~~L~Ls~N~ 255 (313)
T 1ogq_A 238 GK-VGLSKNLNGLDLRNNR 255 (313)
T ss_dssp GG-CCCCTTCCEEECCSSC
T ss_pred Cc-ccccCCCCEEECcCCc
Confidence 55 6666777777776553
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.8e-19 Score=192.28 Aligned_cols=166 Identities=14% Similarity=0.086 Sum_probs=145.9
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc-----ccccceeccccCCCCCCCcccc----------cCcc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGPEATLPDLR----------NRTF 65 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~~~~~~~~~----------~~~L 65 (790)
++|+|++|+|+ .+|..|+++++|++|+|++|.++..++ .+|+.|++++|+.....+..+. .++|
T Consensus 107 ~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L 185 (328)
T 4fcg_A 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185 (328)
T ss_dssp SEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTC
T ss_pred CEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCC
Confidence 58999999999 999999999999999999999985433 2788999999776655444332 4889
Q ss_pred cEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCC
Q 040908 66 KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYN 144 (790)
Q Consensus 66 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N 144 (790)
++|+|++|+|+ .+|..++++++|++|+|++|+++ .+|..+.++++|+.|+|++|++.+.+|..+.. ++|+.|+|++|
T Consensus 186 ~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n 263 (328)
T 4fcg_A 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263 (328)
T ss_dssp CEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTC
T ss_pred CEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCC
Confidence 99999999999 89999999999999999999999 57778999999999999999999999998877 89999999999
Q ss_pred ccccCCCCCCCCCCcceeeecCCCC
Q 040908 145 NFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 145 ~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
++.+.+|..+..+++|+.++.+.+.
T Consensus 264 ~~~~~~p~~~~~l~~L~~L~L~~n~ 288 (328)
T 4fcg_A 264 SNLLTLPLDIHRLTQLEKLDLRGCV 288 (328)
T ss_dssp TTCCBCCTTGGGCTTCCEEECTTCT
T ss_pred CchhhcchhhhcCCCCCEEeCCCCC
Confidence 9999999999999999999988653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.79 E-value=5.4e-19 Score=191.07 Aligned_cols=165 Identities=15% Similarity=0.176 Sum_probs=146.9
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc-----ccccceeccccCCCCCCCccccc-CcccEEEecccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCN 74 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~ 74 (790)
+.|+|++|+|+ .+|..+++|++|++|+|++|.++..+. .+|+.|++++|.+...+. .+.. ++|++|+|++|+
T Consensus 84 ~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp~-~l~~l~~L~~L~L~~n~ 161 (328)
T 4fcg_A 84 VALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPA-SIASLNRLRELSIRACP 161 (328)
T ss_dssp CEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCCG-GGGGCTTCCEEEEEEET
T ss_pred eEEEccCCCch-hcChhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCcH-HHhcCcCCCEEECCCCC
Confidence 47999999999 999999999999999999999994433 389999999999985543 4444 899999999999
Q ss_pred ccccCCccccC---------CCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCC
Q 040908 75 LTGELPHFLGE---------VSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYN 144 (790)
Q Consensus 75 l~~~~p~~~~~---------l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N 144 (790)
+.+.+|..++. +++|++|+|++|+|+ .+|..+.++++|+.|+|++|++++ +|..+.. ++|+.|+|++|
T Consensus 162 ~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n 239 (328)
T 4fcg_A 162 ELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGC 239 (328)
T ss_dssp TCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTC
T ss_pred CccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCC
Confidence 99999998765 999999999999999 999999999999999999999996 5555655 89999999999
Q ss_pred ccccCCCCCCCCCCcceeeecCCCC
Q 040908 145 NFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 145 ~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
++.+.+|..+..+.+|+.++.+.+.
T Consensus 240 ~~~~~~p~~~~~l~~L~~L~L~~n~ 264 (328)
T 4fcg_A 240 TALRNYPPIFGGRAPLKRLILKDCS 264 (328)
T ss_dssp TTCCBCCCCTTCCCCCCEEECTTCT
T ss_pred cchhhhHHHhcCCCCCCEEECCCCC
Confidence 9999999999999999999998753
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.8e-18 Score=180.02 Aligned_cols=166 Identities=16% Similarity=0.156 Sum_probs=95.0
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEecccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCN 74 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~ 74 (790)
+|+|++|+|++..|..|.++++|++|+|++|.++..++ .+|+.|++++|.+...+...+.. ++|++|+|++|+
T Consensus 41 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 120 (270)
T 2o6q_A 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQ 120 (270)
T ss_dssp EEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSC
T ss_pred EEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCc
Confidence 45666666664333456666666666666666654433 24556666666665555444443 556666666666
Q ss_pred ccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCC
Q 040908 75 LTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGS 153 (790)
Q Consensus 75 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~ 153 (790)
|++..|..|+++++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..+.. ++|+.|+|++|+|++..+..
T Consensus 121 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 200 (270)
T 2o6q_A 121 LKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200 (270)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred cCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHH
Confidence 66555555566666666666666666443444566666666666666666554444444 55666666666666555555
Q ss_pred CCCCCcceeeecCC
Q 040908 154 DCQNGAVNLFASSS 167 (790)
Q Consensus 154 ~~~~~~l~~~~~~~ 167 (790)
+..+..|+.++.+.
T Consensus 201 ~~~l~~L~~L~l~~ 214 (270)
T 2o6q_A 201 FDSLEKLKMLQLQE 214 (270)
T ss_dssp TTTCTTCCEEECCS
T ss_pred hccccCCCEEEecC
Confidence 55555555555543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.9e-18 Score=181.29 Aligned_cols=169 Identities=16% Similarity=0.161 Sum_probs=147.2
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccC-CCCCCCccccc-CcccEEEecc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLN-GPEATLPDLRN-RTFKNLILRS 72 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~-~~~~~~~~~~~-~~L~~L~L~~ 72 (790)
++|+|++|+|++..|..|.++++|+.|++++|.+++..+ .+|+.|++++|. +.......+.. ++|++|+|++
T Consensus 35 ~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~ 114 (285)
T 1ozn_A 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114 (285)
T ss_dssp SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTT
T ss_pred eEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCC
Confidence 479999999997666789999999999999999987755 378899999997 77666666665 8999999999
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCC
Q 040908 73 CNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESS 151 (790)
Q Consensus 73 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p 151 (790)
|++++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|++|++++..+..+.. ++|+.|+|++|++++..|
T Consensus 115 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 194 (285)
T 1ozn_A 115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194 (285)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCH
Confidence 9999888889999999999999999999766677999999999999999999777766766 899999999999999999
Q ss_pred CCCCCCCcceeeecCCCC
Q 040908 152 GSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 152 ~~~~~~~~l~~~~~~~~~ 169 (790)
..+..+++|+.++.+.+.
T Consensus 195 ~~~~~l~~L~~L~l~~n~ 212 (285)
T 1ozn_A 195 HAFRDLGRLMTLYLFANN 212 (285)
T ss_dssp TTTTTCTTCCEEECCSSC
T ss_pred hHccCcccccEeeCCCCc
Confidence 999999999999887663
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=181.14 Aligned_cols=137 Identities=18% Similarity=0.157 Sum_probs=106.7
Q ss_pred CcceeeeecccCcEEEEeeee-cCCcE--EEEEEccccchh------------------------cHHHHHHHHHHhhcc
Q 040908 447 HFDVANKIGEGGFGPVYKGLL-ADGTL--IAVKQLSAKSKQ------------------------GNREFVNEIGTISAL 499 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~-~~g~~--vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l 499 (790)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999997 68888 999986532111 113688999999999
Q ss_pred CCCce--eeeeeEEEeCCeEEEEEEeccC-C----ChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhh-hcCCCcEE
Q 040908 500 QHPHL--VKLYGCCIEGNQLLLIYEYLEN-N----SLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH-EESRLKIV 571 (790)
Q Consensus 500 ~H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ii 571 (790)
+|+++ ..++++ +..++||||+.+ | +|.++.. ..++..+..++.|++.||+||| +.+ |+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 98865 333332 356899999953 4 5655541 1235677899999999999999 764 99
Q ss_pred eccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 572 HRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 572 HrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||||+|||+++ .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999754
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.76 E-value=6e-18 Score=175.55 Aligned_cols=166 Identities=15% Similarity=0.088 Sum_probs=143.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
.++++++|.++ .+|..+. ++|+.|+|++|.+++..+ .+|+.|++++|.+...+...+.. ++|++|+|++|
T Consensus 17 ~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 93 (251)
T 3m19_A 17 KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN 93 (251)
T ss_dssp TEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred eEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCC
Confidence 36899999998 8888766 689999999999987765 37888999999998877776666 89999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCC
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSG 152 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~ 152 (790)
+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..+.. ++|+.|+|++|+|++..+.
T Consensus 94 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 173 (251)
T 3m19_A 94 QLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHG 173 (251)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHH
Confidence 999777788899999999999999999666667899999999999999999877767766 8999999999999988888
Q ss_pred CCCCCCcceeeecCCCC
Q 040908 153 SDCQNGAVNLFASSSKG 169 (790)
Q Consensus 153 ~~~~~~~l~~~~~~~~~ 169 (790)
.+..++.|+.++.+.+.
T Consensus 174 ~~~~l~~L~~L~l~~N~ 190 (251)
T 3m19_A 174 AFDRLGKLQTITLFGNQ 190 (251)
T ss_dssp TTTTCTTCCEEECCSCC
T ss_pred HHhCCCCCCEEEeeCCc
Confidence 89899999999886553
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.9e-18 Score=180.22 Aligned_cols=164 Identities=15% Similarity=-0.009 Sum_probs=98.1
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCcccccCcccEEEeccccccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTG 77 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~ 77 (790)
+|+|++|+|++..|..|..+++|+.|+|++|.+++..+ .+|+.|++++|.+...+......++|++|+|++|+|++
T Consensus 35 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~ 114 (290)
T 1p9a_G 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS 114 (290)
T ss_dssp EEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCC
T ss_pred EEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCCCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcc
Confidence 56666666665555566666666666666666665433 35666666666666444322222566666666666665
Q ss_pred cCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCC
Q 040908 78 ELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQ 156 (790)
Q Consensus 78 ~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~ 156 (790)
..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+.. ++|+.|+|++|+|+ .+|..+..
T Consensus 115 l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~ 193 (290)
T 1p9a_G 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193 (290)
T ss_dssp CCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTT
T ss_pred cCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcc
Confidence 54556666666666666666666544455666666666666666666444444443 56666666666666 45555555
Q ss_pred CCcceeeecC
Q 040908 157 NGAVNLFASS 166 (790)
Q Consensus 157 ~~~l~~~~~~ 166 (790)
...|+.+..+
T Consensus 194 ~~~L~~l~L~ 203 (290)
T 1p9a_G 194 SHLLPFAFLH 203 (290)
T ss_dssp TCCCSEEECC
T ss_pred cccCCeEEeC
Confidence 5555555544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=181.42 Aligned_cols=168 Identities=15% Similarity=0.069 Sum_probs=149.8
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcc-cccccc------ccccceeccccCCCCCCCccccc-CcccEEEecc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANS-VWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRS 72 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~-l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~ 72 (790)
++|+|++|+|++..|..|..+++|+.|++++|. +....+ .+|+.|++++|.+.......+.. ++|++|+|++
T Consensus 59 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 138 (285)
T 1ozn_A 59 TILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138 (285)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCC
Confidence 579999999998889999999999999999997 776644 37999999999999887777765 8999999999
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCC
Q 040908 73 CNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESS 151 (790)
Q Consensus 73 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p 151 (790)
|++++..+..|+++++|++|+|++|++++..+..|.++++|+.|+|++|++++..|..+.. ++|+.|+|++|+|++..+
T Consensus 139 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 218 (285)
T 1ozn_A 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218 (285)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred CcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCH
Confidence 9999777777999999999999999999666667999999999999999999998988877 899999999999998777
Q ss_pred CCCCCCCcceeeecCCC
Q 040908 152 GSDCQNGAVNLFASSSK 168 (790)
Q Consensus 152 ~~~~~~~~l~~~~~~~~ 168 (790)
..+..++.|+.++.+.+
T Consensus 219 ~~~~~l~~L~~L~l~~N 235 (285)
T 1ozn_A 219 EALAPLRALQYLRLNDN 235 (285)
T ss_dssp HHHTTCTTCCEEECCSS
T ss_pred HHcccCcccCEEeccCC
Confidence 77888999999888655
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.75 E-value=6e-18 Score=175.52 Aligned_cols=149 Identities=17% Similarity=0.101 Sum_probs=134.2
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|++..|..|.++++|+.|+|++|.+++..+. +|+.|++++|.+...+...+.. ++|++|+|++|
T Consensus 38 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 117 (251)
T 3m19_A 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGN 117 (251)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCC
Confidence 4799999999988888899999999999999999987663 7999999999999888777766 89999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccC
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADE 149 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~ 149 (790)
+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..+.. ++|+.|+|++|++++.
T Consensus 118 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 118 QLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 999766777899999999999999999766668999999999999999999888877766 8999999999999864
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2e-17 Score=173.81 Aligned_cols=166 Identities=13% Similarity=0.077 Sum_probs=145.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
+.|++++|.++ .++ .+..+++|+.|++++|.+++... .+|+.|++++|.+...+...+.. ++|++|+|++|+|
T Consensus 44 ~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 121 (272)
T 3rfs_A 44 DQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL 121 (272)
T ss_dssp CEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCCCGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred eeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCCchhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcC
Confidence 46899999998 555 58999999999999999987532 38999999999998877766665 8999999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
++..|..|+++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..+.. ++|+.|+|++|+|++..|..+
T Consensus 122 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 201 (272)
T 3rfs_A 122 QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVF 201 (272)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred CccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHH
Confidence 9777778999999999999999999777777899999999999999999887777666 899999999999999888888
Q ss_pred CCCCcceeeecCCC
Q 040908 155 CQNGAVNLFASSSK 168 (790)
Q Consensus 155 ~~~~~l~~~~~~~~ 168 (790)
..++.|+.++.+.+
T Consensus 202 ~~l~~L~~L~l~~N 215 (272)
T 3rfs_A 202 DRLTSLQYIWLHDN 215 (272)
T ss_dssp TTCTTCCEEECCSS
T ss_pred hCCcCCCEEEccCC
Confidence 99999999988765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.9e-18 Score=181.43 Aligned_cols=170 Identities=18% Similarity=0.121 Sum_probs=135.3
Q ss_pred CEEEccCCcCc--ccCChhhhcccccCcccccCcccccccc-----ccccceeccccCCCCCCC-ccccc-CcccEEEec
Q 040908 1 MYRTVQSNRLS--GELPEELGSLIHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGPEATL-PDLRN-RTFKNLILR 71 (790)
Q Consensus 1 ~~L~Ls~N~l~--g~iP~~~~~L~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~~~~~-~~~~~-~~L~~L~L~ 71 (790)
++|+|++|+|+ +.+|..+..+++|++|++++|.+...++ .+|+.|++++|.+...+. ..+.. ++|++|+|+
T Consensus 55 ~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~ 134 (306)
T 2z66_A 55 TKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134 (306)
T ss_dssp SEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECT
T ss_pred CEEECCCCccCcccCcccccccccccCEEECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECC
Confidence 47889999887 3347778888889999999988876543 378888888888776654 34444 788888888
Q ss_pred cccccccCCccccCCCCCCEEEccCCcCCc-CcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccC
Q 040908 72 SCNLTGELPHFLGEVSEMKVLDLSFNKLNG-TIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADE 149 (790)
Q Consensus 72 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~ 149 (790)
+|++++..|..|.++++|++|+|++|++++ .+|..+..+++|+.|+|++|++++..|..+.. ++|+.|+|++|++++.
T Consensus 135 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 214 (306)
T 2z66_A 135 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 214 (306)
T ss_dssp TSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC
T ss_pred CCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc
Confidence 888888888888888888888888888876 57888888888888888888888877777766 7888888888888887
Q ss_pred CCCCCCCCCcceeeecCCCCC
Q 040908 150 SSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 150 ~p~~~~~~~~l~~~~~~~~~~ 170 (790)
.+..+..+.+|+.++.+.+..
T Consensus 215 ~~~~~~~l~~L~~L~L~~N~l 235 (306)
T 2z66_A 215 DTFPYKCLNSLQVLDYSLNHI 235 (306)
T ss_dssp CSGGGTTCTTCCEEECTTSCC
T ss_pred ChhhccCcccCCEeECCCCCC
Confidence 777778888888888876643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-17 Score=175.54 Aligned_cols=168 Identities=15% Similarity=0.095 Sum_probs=135.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|++..+..|.++++|+.|++++|.++...+ .+|+.|++++|.+...+...+.. ++|++|+|++|
T Consensus 31 ~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 110 (276)
T 2z62_A 31 KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110 (276)
T ss_dssp CEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCC
Confidence 479999999996666689999999999999999987665 37888999999888777666665 88999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCc-CcchhccCCCCCcEEEeeCCcccccCCccccC-CCCc----EEeccCCccc
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNG-TIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPE----NIDLSYNNFA 147 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~----~l~ls~N~l~ 147 (790)
++++..+..++++++|++|+|++|++++ .+|..|.++++|+.|+|++|++++..+..+.. .+|+ .|+|++|+++
T Consensus 111 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~ 190 (276)
T 2z62_A 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190 (276)
T ss_dssp CCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCC
T ss_pred CccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCccc
Confidence 9997767689999999999999999986 36889999999999999999998877666654 4555 7888888887
Q ss_pred cCCCCCCCCCCcceeeecCCCC
Q 040908 148 DESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 148 g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
+..+..+.. .+|+.++.+.+.
T Consensus 191 ~~~~~~~~~-~~L~~L~L~~n~ 211 (276)
T 2z62_A 191 FIQPGAFKE-IRLKELALDTNQ 211 (276)
T ss_dssp EECTTSSCS-CCEEEEECCSSC
T ss_pred ccCccccCC-CcccEEECCCCc
Confidence 665555443 367777776553
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=9.8e-18 Score=168.61 Aligned_cols=143 Identities=17% Similarity=0.082 Sum_probs=76.0
Q ss_pred EEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 3 RTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 3 L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
+++++|.++ .+|..+ .++|++|++++|.+++..+ .+|+.|++++|.+...+...+.. ++|++|+|++|+|
T Consensus 12 v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 88 (208)
T 2o6s_A 12 VECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL 88 (208)
T ss_dssp EECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcC
Confidence 455555555 455433 2355555555555554333 14555555555555444443333 5566666666666
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCcccc
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFAD 148 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g 148 (790)
++..+..|+++++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+..+.. ++|+.|+|++|++++
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 89 QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 5444444555666666666666665444444555666666666666665544443443 556666666665543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.71 E-value=5.4e-17 Score=170.49 Aligned_cols=149 Identities=17% Similarity=0.137 Sum_probs=132.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|++ + +.++.+++|++|+|++|.+++..+ .+|+.|++++|.+...+...+.. ++|++|+|++|
T Consensus 66 ~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 143 (272)
T 3rfs_A 66 RYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHN 143 (272)
T ss_dssp CEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCC
Confidence 579999999995 4 479999999999999999997765 37899999999999887776665 89999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCC
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESS 151 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p 151 (790)
+|++..|..|+++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..+.. ++|+.|+|++|++++..|
T Consensus 144 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 144 QLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 999777778899999999999999999777777899999999999999999988877766 899999999999986544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=7.5e-17 Score=169.16 Aligned_cols=166 Identities=14% Similarity=0.125 Sum_probs=146.7
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
..+++++|+|+ .+|..+. ++|+.|+|++|.++...+ .+|+.|++++|.+...+...+.. ++|++|+|++|
T Consensus 19 ~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n 95 (270)
T 2o6q_A 19 NSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDN 95 (270)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSS
T ss_pred CEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCC
Confidence 36899999999 7898665 689999999999997765 37899999999999887777665 89999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCC
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSG 152 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~ 152 (790)
+|++..+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..+.. ++|+.|+|++|++++..+.
T Consensus 96 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 175 (270)
T 2o6q_A 96 KLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEG 175 (270)
T ss_dssp CCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChh
Confidence 999766778899999999999999999877888999999999999999999877766666 8999999999999998888
Q ss_pred CCCCCCcceeeecCCCC
Q 040908 153 SDCQNGAVNLFASSSKG 169 (790)
Q Consensus 153 ~~~~~~~l~~~~~~~~~ 169 (790)
.+..+++|+.++.+.+.
T Consensus 176 ~~~~l~~L~~L~L~~N~ 192 (270)
T 2o6q_A 176 AFDKLTELKTLKLDNNQ 192 (270)
T ss_dssp TTTTCTTCCEEECCSSC
T ss_pred HhccCCCcCEEECCCCc
Confidence 89999999999987663
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=4.2e-17 Score=184.12 Aligned_cols=108 Identities=19% Similarity=0.161 Sum_probs=95.9
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEec
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDL 141 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~l 141 (790)
++|+.|+|++|++++.+|..|+++++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..+.. ++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 46888888888888888999999999999999999999888889999999999999999998888887776 88999999
Q ss_pred cCCccccCCCCCCCCCCcceeeecCCCCC
Q 040908 142 SYNNFADESSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 142 s~N~l~g~~p~~~~~~~~l~~~~~~~~~~ 170 (790)
++|++++..|..+..+++|+.++.+.+.-
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l 383 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQL 383 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCcccccChhhccccccccEEECCCCcc
Confidence 99999998899999999999999877643
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.71 E-value=5.7e-17 Score=164.73 Aligned_cols=147 Identities=13% Similarity=0.115 Sum_probs=116.0
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccCCc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPH 81 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~ 81 (790)
.+++++|+|+ .+|..+. ++|+.|+|++|.|+...+..+..+ ++|+.|+|++|+|++..|.
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l-----------------~~L~~L~Ls~N~i~~~~~~ 74 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPY-----------------KKLRRIDLSNNQISELAPD 74 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTC-----------------TTCCEEECCSSCCCEECTT
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCC-----------------CCCCEEECCCCcCCCcCHH
Confidence 5788888888 7887664 577788888887776665544443 5788888888888877788
Q ss_pred cccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcc
Q 040908 82 FLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAV 160 (790)
Q Consensus 82 ~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l 160 (790)
.|.++++|++|+|++|+|++..+..|.++++|+.|+|++|++++..|..+.. ++|+.|+|++|+|++..+..+..+..|
T Consensus 75 ~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 154 (220)
T 2v9t_B 75 AFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154 (220)
T ss_dssp TTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred HhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCC
Confidence 8888888888888888888544455788888888888888888887877766 788888888888888877778888888
Q ss_pred eeeecCCC
Q 040908 161 NLFASSSK 168 (790)
Q Consensus 161 ~~~~~~~~ 168 (790)
..++.+.+
T Consensus 155 ~~L~L~~N 162 (220)
T 2v9t_B 155 QTMHLAQN 162 (220)
T ss_dssp CEEECCSS
T ss_pred CEEEeCCC
Confidence 88777544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-17 Score=176.48 Aligned_cols=169 Identities=18% Similarity=0.144 Sum_probs=147.0
Q ss_pred CEEEccCCcCcccCChh-hhcccccCcccccCccccccc--------cccccceeccccCCCCCCCcccccCcccEEEec
Q 040908 1 MYRTVQSNRLSGELPEE-LGSLIHSGKWFGWANSVWHYF--------SESLTDLRISDLNGPEATLPDLRNRTFKNLILR 71 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~-~~~L~~L~~L~l~~N~l~~~~--------~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~ 71 (790)
++|+|++|+|+ .+|.. |.++++|+.|+|++|.++... ..+|+.|++++|.+...+......++|++|+|+
T Consensus 31 ~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~ 109 (306)
T 2z66_A 31 TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQ 109 (306)
T ss_dssp CEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEEEEEEEETCTTCCEEECT
T ss_pred CEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccccChhhcCCCCCCCEEECC
Confidence 47999999999 66664 799999999999999998442 248999999999887654443334899999999
Q ss_pred cccccccCC-ccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccc-cCCccccC-CCCcEEeccCCcccc
Q 040908 72 SCNLTGELP-HFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTG-KVPQWMFG-RGPENIDLSYNNFAD 148 (790)
Q Consensus 72 ~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~-~~L~~l~ls~N~l~g 148 (790)
+|++++..+ ..+.++++|++|+|++|++++..|..|.++++|+.|+|++|.+++ .+|..+.. ++|+.|+|++|++++
T Consensus 110 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 189 (306)
T 2z66_A 110 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 189 (306)
T ss_dssp TSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE
T ss_pred CCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCC
Confidence 999996554 589999999999999999999999999999999999999999997 57877777 899999999999999
Q ss_pred CCCCCCCCCCcceeeecCCCCC
Q 040908 149 ESSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 149 ~~p~~~~~~~~l~~~~~~~~~~ 170 (790)
..|..+..+++|+.++.+.+..
T Consensus 190 ~~~~~~~~l~~L~~L~L~~N~l 211 (306)
T 2z66_A 190 LSPTAFNSLSSLQVLNMSHNNF 211 (306)
T ss_dssp ECTTTTTTCTTCCEEECTTSCC
T ss_pred cCHHHhcCCCCCCEEECCCCcc
Confidence 9999999999999999987643
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.71 E-value=7.2e-18 Score=198.77 Aligned_cols=165 Identities=13% Similarity=0.133 Sum_probs=110.5
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccc------cc---------------------------ccccc-------
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSV------WH---------------------------YFSES------- 41 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l------~~---------------------------~~~~~------- 41 (790)
.|+|++|+|+|.+|++|++|++|+.|+|++|.+ .+ .++..
T Consensus 85 ~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~ 164 (636)
T 4eco_A 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD 164 (636)
T ss_dssp EEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHH
T ss_pred EEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHH
Confidence 699999999999999999999999999999965 11 00110
Q ss_pred ------------------ccceecc--ccCCCCCCCccccc-CcccEEEecccccccc-----------------CCccc
Q 040908 42 ------------------LTDLRIS--DLNGPEATLPDLRN-RTFKNLILRSCNLTGE-----------------LPHFL 83 (790)
Q Consensus 42 ------------------L~~L~l~--~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~-----------------~p~~~ 83 (790)
++.+.+. .|.+.. .+..+.. ++|++|+|++|+|+|. +|+.+
T Consensus 165 l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l 243 (636)
T 4eco_A 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDL 243 (636)
T ss_dssp HHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCC
T ss_pred HhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhh
Confidence 1111111 223333 2223333 6677777777777764 77777
Q ss_pred c--CCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCc-ccc-cCCccccC-------CCCcEEeccCCccccCCCC
Q 040908 84 G--EVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL-LTG-KVPQWMFG-------RGPENIDLSYNNFADESSG 152 (790)
Q Consensus 84 ~--~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~-l~g-~~p~~~~~-------~~L~~l~ls~N~l~g~~p~ 152 (790)
+ +|++|++|+|++|++.|.+|..|+++++|+.|+|++|+ ++| .+|..+.. ++|+.|+|++|+|+ .+|.
T Consensus 244 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~ 322 (636)
T 4eco_A 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV 322 (636)
T ss_dssp CGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred hhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence 6 77777777777777777777777777777777777776 776 66665543 56777777777776 6666
Q ss_pred --CCCCCCcceeeecCCC
Q 040908 153 --SDCQNGAVNLFASSSK 168 (790)
Q Consensus 153 --~~~~~~~l~~~~~~~~ 168 (790)
.+..++.|+.++.+.+
T Consensus 323 ~~~l~~l~~L~~L~L~~N 340 (636)
T 4eco_A 323 ETSLQKMKKLGMLECLYN 340 (636)
T ss_dssp HHHHTTCTTCCEEECCSC
T ss_pred hhhhccCCCCCEEeCcCC
Confidence 6677777777766544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=6.2e-17 Score=164.44 Aligned_cols=147 Identities=13% Similarity=0.117 Sum_probs=108.7
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccc-cccceeccccCCCCCCCcccccCcccEEEeccccccccCC
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE-SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELP 80 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p 80 (790)
.|++++|+|+ .+|..+.. .++.|+|++|++++..+. .+..+ ++|+.|+|++|+|++..|
T Consensus 15 ~l~~s~n~l~-~iP~~~~~--~~~~L~L~~N~l~~~~~~~~~~~l-----------------~~L~~L~L~~N~i~~i~~ 74 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKL-----------------PQLRKINFSNNKITDIEE 74 (220)
T ss_dssp EEECCSSCCS-SCCSCCCT--TCSEEECCSSCCCEECCCCCGGGC-----------------TTCCEEECCSSCCCEECT
T ss_pred EeEeCCCCcc-cCccCCCC--CCCEEEcCCCcCCccCchhhhccC-----------------CCCCEEECCCCcCCEECH
Confidence 6888899988 68876643 457788888877765432 22222 577888888888886666
Q ss_pred ccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCc
Q 040908 81 HFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGA 159 (790)
Q Consensus 81 ~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~ 159 (790)
..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..+.. .+|+.|+|++|+|++..|..+..+.+
T Consensus 75 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 154 (220)
T 2v70_A 75 GAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154 (220)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTT
T ss_pred HHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCC
Confidence 67888888888888888887666667788888888888888888777776666 77888888888888777777777777
Q ss_pred ceeeecCCC
Q 040908 160 VNLFASSSK 168 (790)
Q Consensus 160 l~~~~~~~~ 168 (790)
|..++.+.+
T Consensus 155 L~~L~L~~N 163 (220)
T 2v70_A 155 LSTLNLLAN 163 (220)
T ss_dssp CCEEECCSC
T ss_pred CCEEEecCc
Confidence 777776544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=4.9e-17 Score=171.01 Aligned_cols=155 Identities=15% Similarity=0.098 Sum_probs=83.3
Q ss_pred EEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 3 RTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 3 L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++.++.+++ .+|..+. ++|+.|++++|.+++..+ .+|+.|++++|.+...+...+.. ++|++|+|++|+|
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 344455555 5555443 345566666665554443 24555555555555444444443 5566666666666
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCccccc-CCccccC-CCCcEEeccCCccccCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGK-VPQWMFG-RGPENIDLSYNNFADESSGS 153 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~-~p~~~~~-~~L~~l~ls~N~l~g~~p~~ 153 (790)
++..|..|.++++|++|+|++|++++..+..+.++++|+.|+|++|++++. +|..+.. ++|+.|+|++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 555555555666666666666666544444555666666666666665542 3555544 55666666666665554444
Q ss_pred CCCCCcc
Q 040908 154 DCQNGAV 160 (790)
Q Consensus 154 ~~~~~~l 160 (790)
+..+..+
T Consensus 169 ~~~l~~L 175 (276)
T 2z62_A 169 LRVLHQM 175 (276)
T ss_dssp GHHHHTC
T ss_pred hhhhhhc
Confidence 4443333
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.70 E-value=6.4e-17 Score=171.62 Aligned_cols=165 Identities=19% Similarity=0.232 Sum_probs=143.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCcccccCcccEEEecccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCN 74 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~ 74 (790)
+.|++++|+|+ .+|..+. ++|+.|+|++|.+++..+. +|+.|++++|.+...+.. ...++|+.|+|++|+
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~~L~Ls~N~ 88 (290)
T 1p9a_G 13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLGTLDLSHNQ 88 (290)
T ss_dssp CEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCCEEECCSSC
T ss_pred cEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCCEEECCCCc
Confidence 47899999999 8888775 6899999999999877653 789999999998865543 233899999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCC
Q 040908 75 LTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGS 153 (790)
Q Consensus 75 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~ 153 (790)
|+ .+|..+.++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..+..+.. ++|+.|+|++|+|++..+..
T Consensus 89 l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~ 167 (290)
T 1p9a_G 89 LQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167 (290)
T ss_dssp CS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTT
T ss_pred CC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHH
Confidence 98 89999999999999999999999777788999999999999999999877776665 89999999999999877777
Q ss_pred CCCCCcceeeecCCCCC
Q 040908 154 DCQNGAVNLFASSSKGS 170 (790)
Q Consensus 154 ~~~~~~l~~~~~~~~~~ 170 (790)
+..+.+|+.++.+.+.-
T Consensus 168 ~~~l~~L~~L~L~~N~l 184 (290)
T 1p9a_G 168 LNGLENLDTLLLQENSL 184 (290)
T ss_dssp TTTCTTCCEEECCSSCC
T ss_pred hcCcCCCCEEECCCCcC
Confidence 88899999999876643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.8e-17 Score=177.75 Aligned_cols=164 Identities=15% Similarity=0.058 Sum_probs=82.9
Q ss_pred EEEccCCcCcccCChhh--hcccccCcccccCcccccccc----------ccccceeccccCCCCCCCccccc-CcccEE
Q 040908 2 YRTVQSNRLSGELPEEL--GSLIHSGKWFGWANSVWHYFS----------ESLTDLRISDLNGPEATLPDLRN-RTFKNL 68 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~--~~L~~L~~L~l~~N~l~~~~~----------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L 68 (790)
+|+|++|+|++.+|..+ +.+++|+.|+|++|++++.+. .+|+.|++++|.+...+...+.. ++|++|
T Consensus 99 ~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 178 (312)
T 1wwl_A 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178 (312)
T ss_dssp EEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEE
T ss_pred EEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEE
Confidence 45555555555555544 555555555555555554311 34555555555555554444443 555555
Q ss_pred Eecccccccc--CCccc--cCCCCCCEEEccCCcCCc--Ccc-hhccCCCCCcEEEeeCCcccccCCc-cccC-CCCcEE
Q 040908 69 ILRSCNLTGE--LPHFL--GEVSEMKVLDLSFNKLNG--TIP-ESFARLADVDFIYLTGNLLTGKVPQ-WMFG-RGPENI 139 (790)
Q Consensus 69 ~L~~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~g--~ip-~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~-~~L~~l 139 (790)
+|++|++.+. +|..+ +++++|++|+|++|+|++ .++ ..+.++++|+.|+|++|++++.+|. .+.. ++|+.|
T Consensus 179 ~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 258 (312)
T 1wwl_A 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL 258 (312)
T ss_dssp ECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEE
T ss_pred ECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEE
Confidence 5555555443 22233 555555555555555551 112 2234555555555555555554432 1222 455555
Q ss_pred eccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 140 DLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 140 ~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
+|++|+|+ .+|..+. .+|+.++.+.+
T Consensus 259 ~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N 284 (312)
T 1wwl_A 259 NLSFTGLK-QVPKGLP--AKLSVLDLSYN 284 (312)
T ss_dssp ECTTSCCS-SCCSSCC--SEEEEEECCSS
T ss_pred ECCCCccC-hhhhhcc--CCceEEECCCC
Confidence 55555555 4454444 45555555443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=6.1e-17 Score=182.29 Aligned_cols=166 Identities=13% Similarity=0.099 Sum_probs=126.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|++..|..|.++++|+.|+|++|+++..++ .+|+.|++++|.+...+...+.. ++|+.|+|++|
T Consensus 91 ~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~ 170 (440)
T 3zyj_A 91 EILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL 170 (440)
T ss_dssp CEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC
T ss_pred CEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCC
Confidence 478999999997667789999999999999999987665 37888889998888766655555 77888888874
Q ss_pred cccccCCc-cccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCC
Q 040908 74 NLTGELPH-FLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESS 151 (790)
Q Consensus 74 ~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p 151 (790)
+..+.+|. .|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|++++..|..+.. ++|+.|+|++|+|++..|
T Consensus 171 ~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 248 (440)
T 3zyj_A 171 KRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER 248 (440)
T ss_dssp TTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred CCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEECh
Confidence 43334443 6777888888888888777 566 4777777888888888777777776666 777777787777777777
Q ss_pred CCCCCCCcceeeecCCC
Q 040908 152 GSDCQNGAVNLFASSSK 168 (790)
Q Consensus 152 ~~~~~~~~l~~~~~~~~ 168 (790)
..+..+.+|+.++.+.+
T Consensus 249 ~~~~~l~~L~~L~L~~N 265 (440)
T 3zyj_A 249 NAFDNLQSLVEINLAHN 265 (440)
T ss_dssp TSSTTCTTCCEEECTTS
T ss_pred hhhcCCCCCCEEECCCC
Confidence 77777777777777665
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.5e-17 Score=185.18 Aligned_cols=168 Identities=15% Similarity=0.043 Sum_probs=152.2
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|++..|..|.++++|+.|+|++|.+++..|. +|+.|++++|.+...+...+.. ++|++|+|++|
T Consensus 35 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 114 (477)
T 2id5_A 35 RLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISEN 114 (477)
T ss_dssp SEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTS
T ss_pred cEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCC
Confidence 4799999999987788999999999999999999987653 7899999999999888777666 89999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCC
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSG 152 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~ 152 (790)
++++..|..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..+.. ++|+.|+|++|++++..+.
T Consensus 115 ~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~ 194 (477)
T 2id5_A 115 KIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194 (477)
T ss_dssp CCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTT
T ss_pred ccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChh
Confidence 999888999999999999999999999888899999999999999999999776666766 8999999999999998888
Q ss_pred CCCCCCcceeeecCCC
Q 040908 153 SDCQNGAVNLFASSSK 168 (790)
Q Consensus 153 ~~~~~~~l~~~~~~~~ 168 (790)
.+..+.+|+.++.+.+
T Consensus 195 ~~~~l~~L~~L~l~~~ 210 (477)
T 2id5_A 195 SFKRLYRLKVLEISHW 210 (477)
T ss_dssp CSCSCTTCCEEEEECC
T ss_pred hcccCcccceeeCCCC
Confidence 9999999999988764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.70 E-value=7.3e-17 Score=182.26 Aligned_cols=166 Identities=10% Similarity=0.054 Sum_probs=123.2
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|++..|..|.++++|++|+|++|+++..++. +|+.|++++|.+...+...+.. ++|+.|+|++|
T Consensus 102 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~ 181 (452)
T 3zyi_A 102 EVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL 181 (452)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC
T ss_pred CEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCC
Confidence 4789999999977778899999999999999999876653 7888899999888766655555 77777777774
Q ss_pred cccccCCc-cccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCC
Q 040908 74 NLTGELPH-FLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESS 151 (790)
Q Consensus 74 ~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p 151 (790)
+..+.+|. .|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|++++..|..+.. ++|+.|+|++|+|++..|
T Consensus 182 ~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 259 (452)
T 3zyi_A 182 KKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER 259 (452)
T ss_dssp TTCCEECTTTTTTCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECT
T ss_pred CCccccChhhccCCCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECH
Confidence 33334443 5677777777777777776 344 4677777777777777777766766665 677777777777777777
Q ss_pred CCCCCCCcceeeecCCC
Q 040908 152 GSDCQNGAVNLFASSSK 168 (790)
Q Consensus 152 ~~~~~~~~l~~~~~~~~ 168 (790)
..+..+.+|+.++.+.+
T Consensus 260 ~~~~~l~~L~~L~L~~N 276 (452)
T 3zyi_A 260 NAFDGLASLVELNLAHN 276 (452)
T ss_dssp TTTTTCTTCCEEECCSS
T ss_pred HHhcCCCCCCEEECCCC
Confidence 77777777777777655
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.8e-17 Score=165.24 Aligned_cols=132 Identities=17% Similarity=0.125 Sum_probs=119.0
Q ss_pred CEEEccCCcCcccCCh-hhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccC
Q 040908 1 MYRTVQSNRLSGELPE-ELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGEL 79 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~-~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~ 79 (790)
++|+|++|+|++..|. .|..+++|+.|+|++|++++..+..+..+ ++|++|+|++|+|++..
T Consensus 35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l-----------------~~L~~L~Ls~N~l~~~~ 97 (220)
T 2v70_A 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA-----------------SGVNEILLTSNRLENVQ 97 (220)
T ss_dssp SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTC-----------------TTCCEEECCSSCCCCCC
T ss_pred CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCC-----------------CCCCEEECCCCccCccC
Confidence 4799999999976554 58999999999999999998777666655 58999999999999887
Q ss_pred CccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccC
Q 040908 80 PHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADE 149 (790)
Q Consensus 80 p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~ 149 (790)
|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+.. ++|+.|+|++|++++.
T Consensus 98 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 98 HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp GGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred HhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 888999999999999999999888999999999999999999999988988877 8999999999999853
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.4e-17 Score=194.27 Aligned_cols=167 Identities=20% Similarity=0.198 Sum_probs=149.1
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcc-ccc-ccc------------ccccceeccccCCCCCCC-ccccc-Cc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANS-VWH-YFS------------ESLTDLRISDLNGPEATL-PDLRN-RT 64 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~-l~~-~~~------------~~L~~L~l~~n~~~~~~~-~~~~~-~~ 64 (790)
++|+|++|++.|.+|..|+++++|+.|++++|+ +++ .+| .+|+.|++++|.+...+. ..+.. ++
T Consensus 252 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~ 331 (636)
T 4eco_A 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK 331 (636)
T ss_dssp CEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTT
T ss_pred CEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCC
Confidence 589999999999999999999999999999998 887 555 689999999999994443 14544 89
Q ss_pred ccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCC-CcEEEeeCCcccccCCccccC-C--CCcEEe
Q 040908 65 FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLAD-VDFIYLTGNLLTGKVPQWMFG-R--GPENID 140 (790)
Q Consensus 65 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~-L~~L~ls~N~l~g~~p~~~~~-~--~L~~l~ 140 (790)
|+.|+|++|+++|.+| .|+++++|++|+|++|+++ .+|..|.++++ |+.|+|++|+++ .+|..+.. . +|+.|+
T Consensus 332 L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~ 408 (636)
T 4eco_A 332 LGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAID 408 (636)
T ss_dssp CCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEE
T ss_pred CCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEE
Confidence 9999999999999999 9999999999999999999 99999999999 999999999999 78887765 3 799999
Q ss_pred ccCCccccCCCCCCC-------CCCcceeeecCCCCC
Q 040908 141 LSYNNFADESSGSDC-------QNGAVNLFASSSKGS 170 (790)
Q Consensus 141 ls~N~l~g~~p~~~~-------~~~~l~~~~~~~~~~ 170 (790)
|++|++++.+|..++ .+.+|+.++.+.+..
T Consensus 409 Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l 445 (636)
T 4eco_A 409 FSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI 445 (636)
T ss_dssp CCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCC
T ss_pred CcCCcCCCcchhhhcccccccccCCCCCEEECcCCcc
Confidence 999999999999998 778899999877644
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=9.1e-17 Score=181.36 Aligned_cols=170 Identities=17% Similarity=0.075 Sum_probs=135.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc--------ccccceeccccCCCCCCCcc-ccc-CcccEEEe
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS--------ESLTDLRISDLNGPEATLPD-LRN-RTFKNLIL 70 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~--------~~L~~L~l~~n~~~~~~~~~-~~~-~~L~~L~L 70 (790)
++|+|++|+|++..|..|+++++|++|+|++|.+++..+ .+|+.|++++|.+....+.. +.. ++|++|+|
T Consensus 82 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L 161 (455)
T 3v47_A 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDL 161 (455)
T ss_dssp CEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEEC
T ss_pred CEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeC
Confidence 478888888887778888888888888888888875322 36778888888877665443 433 77788888
Q ss_pred ccccccccCCccccCC----------------------------------------------------------------
Q 040908 71 RSCNLTGELPHFLGEV---------------------------------------------------------------- 86 (790)
Q Consensus 71 ~~N~l~~~~p~~~~~l---------------------------------------------------------------- 86 (790)
++|++++..|..+.++
T Consensus 162 ~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L 241 (455)
T 3v47_A 162 TFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKI 241 (455)
T ss_dssp TTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCE
T ss_pred CCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccce
Confidence 8877776666554432
Q ss_pred ---------------------------------CCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC
Q 040908 87 ---------------------------------SEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG 133 (790)
Q Consensus 87 ---------------------------------~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~ 133 (790)
++|++|+|++|++++.+|..|.++++|+.|+|++|++++..|..+..
T Consensus 242 ~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 321 (455)
T 3v47_A 242 QSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWG 321 (455)
T ss_dssp EEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred eeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcC
Confidence 35777777777777778999999999999999999999988888877
Q ss_pred -CCCcEEeccCCccccCCCCCCCCCCcceeeecCCCCC
Q 040908 134 -RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 134 -~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~~ 170 (790)
++|+.|+|++|++++..|..+..+..|+.++.+.+..
T Consensus 322 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 359 (455)
T 3v47_A 322 LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359 (455)
T ss_dssp CTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCC
T ss_pred cccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcc
Confidence 8999999999999998899999999999999987643
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.69 E-value=5.4e-17 Score=166.91 Aligned_cols=166 Identities=16% Similarity=0.139 Sum_probs=140.8
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcc-cccccc------ccccceeccc-cCCCCCCCccccc-CcccEEEec
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANS-VWHYFS------ESLTDLRISD-LNGPEATLPDLRN-RTFKNLILR 71 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~-l~~~~~------~~L~~L~l~~-n~~~~~~~~~~~~-~~L~~L~L~ 71 (790)
++|+|++|+|++..+..|.++++|+.|++++|+ ++...+ .+|+.|++++ |.+...+...+.. ++|++|+|+
T Consensus 34 ~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~ 113 (239)
T 2xwt_C 34 QTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113 (239)
T ss_dssp CEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEE
T ss_pred cEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCC
Confidence 479999999996666689999999999999997 876654 3789999998 8888877777766 899999999
Q ss_pred cccccccCCccccCCCCCC---EEEccCC-cCCcCcchhccCCCCCc-EEEeeCCcccccCCcc-ccCCCCcEEeccCCc
Q 040908 72 SCNLTGELPHFLGEVSEMK---VLDLSFN-KLNGTIPESFARLADVD-FIYLTGNLLTGKVPQW-MFGRGPENIDLSYNN 145 (790)
Q Consensus 72 ~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~g~ip~~~~~l~~L~-~L~ls~N~l~g~~p~~-~~~~~L~~l~ls~N~ 145 (790)
+|+|++ +|. |+++++|+ +|+|++| ++++..+..|.++++|+ .|+|++|+++ .+|.. +...+|+.|+|++|+
T Consensus 114 ~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 114 NTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred CCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 999995 887 88999998 9999999 99866666799999999 9999999999 55544 444789999999995
Q ss_pred -cccCCCCCCCCC-CcceeeecCCCC
Q 040908 146 -FADESSGSDCQN-GAVNLFASSSKG 169 (790)
Q Consensus 146 -l~g~~p~~~~~~-~~l~~~~~~~~~ 169 (790)
+++..+..+..+ .+|+.++.+.+.
T Consensus 191 ~l~~i~~~~~~~l~~~L~~L~l~~N~ 216 (239)
T 2xwt_C 191 YLTVIDKDAFGGVYSGPSLLDVSQTS 216 (239)
T ss_dssp TCCEECTTTTTTCSBCCSEEECTTCC
T ss_pred CcccCCHHHhhccccCCcEEECCCCc
Confidence 998778888888 899999887653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-16 Score=180.83 Aligned_cols=168 Identities=18% Similarity=0.133 Sum_probs=147.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|++..|..|.++++|+.|+|++|.+++..+. +|+.|+|++|.+...+...+.. ++|++|+|++|
T Consensus 78 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 157 (452)
T 3zyi_A 78 RYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN 157 (452)
T ss_dssp SEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSC
T ss_pred cEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCC
Confidence 4799999999988889999999999999999999987653 8999999999999888777776 89999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCcCcch-hccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCC
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPE-SFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSG 152 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~ 152 (790)
+|+...+..|.++++|++|+|++|+..+.+|. .|.++++|+.|+|++|++++ +|......+|+.|+|++|+|++..|.
T Consensus 158 ~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~ 236 (452)
T 3zyi_A 158 PIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFPEIRPG 236 (452)
T ss_dssp CCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CCCCTTCTTCCEEECTTSCCSEECGG
T ss_pred CcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cccccccccccEEECcCCcCcccCcc
Confidence 99976677899999999999999554446655 69999999999999999996 46544448999999999999999999
Q ss_pred CCCCCCcceeeecCCCC
Q 040908 153 SDCQNGAVNLFASSSKG 169 (790)
Q Consensus 153 ~~~~~~~l~~~~~~~~~ 169 (790)
.+..+.+|+.+..+.+.
T Consensus 237 ~~~~l~~L~~L~L~~n~ 253 (452)
T 3zyi_A 237 SFHGLSSLKKLWVMNSQ 253 (452)
T ss_dssp GGTTCTTCCEEECTTSC
T ss_pred cccCccCCCEEEeCCCc
Confidence 99999999999987664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=3e-17 Score=197.85 Aligned_cols=166 Identities=11% Similarity=0.068 Sum_probs=115.0
Q ss_pred EEEccCCcCcccCChhhhcccccCcccc-cCcccccccccc---------------------------------------
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFG-WANSVWHYFSES--------------------------------------- 41 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l-~~N~l~~~~~~~--------------------------------------- 41 (790)
.|+|++|+|+|.+|++|++|++|+.|+| ++|.+++..+-.
T Consensus 327 ~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~ 406 (876)
T 4ecn_A 327 GLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406 (876)
T ss_dssp EEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHH
T ss_pred EEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHH
Confidence 6999999999999999999999999999 888776552211
Q ss_pred ------------------ccceeccc--cCCCCCCCccccc-CcccEEEeccccccc-----------------cCCccc
Q 040908 42 ------------------LTDLRISD--LNGPEATLPDLRN-RTFKNLILRSCNLTG-----------------ELPHFL 83 (790)
Q Consensus 42 ------------------L~~L~l~~--n~~~~~~~~~~~~-~~L~~L~L~~N~l~~-----------------~~p~~~ 83 (790)
+..+.+.. |.+...+ ..+.. ++|+.|+|++|+|+| .+|+.+
T Consensus 407 ~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP-~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l 485 (876)
T 4ecn_A 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITFIS-KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEEL 485 (876)
T ss_dssp HHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEEC-GGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCC
T ss_pred HhhhCccccccccccccchhhceeccccCcccchh-HHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhh
Confidence 11111111 2222222 23333 677777777777776 377776
Q ss_pred c--CCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCc-ccc-cCCccccC-C-------CCcEEeccCCccccCCC
Q 040908 84 G--EVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL-LTG-KVPQWMFG-R-------GPENIDLSYNNFADESS 151 (790)
Q Consensus 84 ~--~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~-l~g-~~p~~~~~-~-------~L~~l~ls~N~l~g~~p 151 (790)
+ +|++|++|+|++|++.|.+|..|++|++|+.|+|++|+ ++| .+|..+.. . +|+.|+|++|+|+ .+|
T Consensus 486 ~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip 564 (876)
T 4ecn_A 486 SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFP 564 (876)
T ss_dssp CGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCC
T ss_pred hhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccC
Confidence 6 77777777777777777777777777777777777776 776 66654433 2 6777777777777 667
Q ss_pred C--CCCCCCcceeeecCCCC
Q 040908 152 G--SDCQNGAVNLFASSSKG 169 (790)
Q Consensus 152 ~--~~~~~~~l~~~~~~~~~ 169 (790)
. .+..+++|+.++.+.+.
T Consensus 565 ~~~~l~~L~~L~~L~Ls~N~ 584 (876)
T 4ecn_A 565 ASASLQKMVKLGLLDCVHNK 584 (876)
T ss_dssp CHHHHTTCTTCCEEECTTSC
T ss_pred ChhhhhcCCCCCEEECCCCC
Confidence 6 67777777777776553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.3e-16 Score=172.45 Aligned_cols=167 Identities=15% Similarity=0.103 Sum_probs=114.2
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCcccccCcccEEEecccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCN 74 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~ 74 (790)
++|+|++|+|++..|..|.++++|++|+|++|.+++..|. +|+.|++++|.+...+...+ ++|++|+|++|+
T Consensus 57 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~--~~L~~L~l~~n~ 134 (332)
T 2ft3_A 57 TLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP--SSLVELRIHDNR 134 (332)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSCC--TTCCEEECCSSC
T ss_pred eEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCcccc--ccCCEEECCCCc
Confidence 3577777777755566777777777777777777766442 56677777776665443333 567777777777
Q ss_pred ccccCCccccCCCCCCEEEccCCcCC--cCcchhccCC--------------------CCCcEEEeeCCcccccCCcccc
Q 040908 75 LTGELPHFLGEVSEMKVLDLSFNKLN--GTIPESFARL--------------------ADVDFIYLTGNLLTGKVPQWMF 132 (790)
Q Consensus 75 l~~~~p~~~~~l~~L~~L~Ls~N~l~--g~ip~~~~~l--------------------~~L~~L~ls~N~l~g~~p~~~~ 132 (790)
|++..+..|.++++|++|+|++|+++ +..|..+..+ ++|+.|+|++|++++..|..+.
T Consensus 135 i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~ 214 (332)
T 2ft3_A 135 IRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLL 214 (332)
T ss_dssp CCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSST
T ss_pred cCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhc
Confidence 76444455666777777777777664 2444444433 4677777777778777766666
Q ss_pred C-CCCcEEeccCCccccCCCCCCCCCCcceeeecCCCC
Q 040908 133 G-RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 133 ~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
. ++|+.|+|++|++++..|..+..+++|+.++.+.+.
T Consensus 215 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 252 (332)
T 2ft3_A 215 RYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252 (332)
T ss_dssp TCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSC
T ss_pred CCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCc
Confidence 6 788888888888888777778888888888877653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.4e-17 Score=187.98 Aligned_cols=166 Identities=17% Similarity=0.097 Sum_probs=96.3
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCc-----------------c
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLP-----------------D 59 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~-----------------~ 59 (790)
++|+|++|+|++..|..|+.+++|+.|+|++|.+++.+| .+|+.|++++|.+...+.. .
T Consensus 37 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~ 116 (487)
T 3oja_A 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSC 116 (487)
T ss_dssp CEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEECTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEE
T ss_pred cEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcccccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCc
Confidence 468888888887667788888888888888888875543 3566666666655432211 0
Q ss_pred cccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhcc-CCCCCcEEEeeCCcccccCCccccCCCCcE
Q 040908 60 LRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFA-RLADVDFIYLTGNLLTGKVPQWMFGRGPEN 138 (790)
Q Consensus 60 ~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~ 138 (790)
...++|+.|+|++|.|++..|..|+++++|++|+|++|+|++.+|..+. ++++|+.|+|++|.|++.. .....++|+.
T Consensus 117 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~-~~~~l~~L~~ 195 (487)
T 3oja_A 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKT 195 (487)
T ss_dssp CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCE
T ss_pred cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccc-ccccCCCCCE
Confidence 0113455555555555555555555556666666666666555555554 4555666666666655442 2222355556
Q ss_pred EeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 139 IDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 139 l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
|+|++|+|++..| .+..++.|..++.+.+
T Consensus 196 L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N 224 (487)
T 3oja_A 196 LDLSSNKLAFMGP-EFQSAAGVTWISLRNN 224 (487)
T ss_dssp EECCSSCCCEECG-GGGGGTTCSEEECTTS
T ss_pred EECCCCCCCCCCH-hHcCCCCccEEEecCC
Confidence 6666666655333 3555555555555443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=2e-16 Score=178.11 Aligned_cols=169 Identities=17% Similarity=0.088 Sum_probs=147.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|++..|..|.++++|+.|+|++|.++...+ .+|+.|++++|.+...+...+.. ++|++|+|++|
T Consensus 67 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 146 (440)
T 3zyj_A 67 RLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNN 146 (440)
T ss_dssp SEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSC
T ss_pred cEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCC
Confidence 479999999998778899999999999999999987765 37999999999999888777766 89999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCcCcch-hccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCC
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPE-SFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSG 152 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~ 152 (790)
+|+...+..|.++++|++|+|++|+..+.+|. .|.++++|+.|+|++|+++ .+|......+|+.|+|++|+|++..|.
T Consensus 147 ~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 225 (440)
T 3zyj_A 147 PIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPG 225 (440)
T ss_dssp CCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTT
T ss_pred cccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccccCCCcccCEEECCCCccCccChh
Confidence 99977777899999999999999554446654 7999999999999999999 567544448999999999999999999
Q ss_pred CCCCCCcceeeecCCCCC
Q 040908 153 SDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 153 ~~~~~~~l~~~~~~~~~~ 170 (790)
.+..+..|+.+..+.+..
T Consensus 226 ~~~~l~~L~~L~L~~n~l 243 (440)
T 3zyj_A 226 SFQGLMHLQKLWMIQSQI 243 (440)
T ss_dssp TTTTCTTCCEEECTTCCC
T ss_pred hhccCccCCEEECCCCce
Confidence 999999999999876643
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.2e-16 Score=161.43 Aligned_cols=145 Identities=18% Similarity=0.197 Sum_probs=83.2
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccCCc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPH 81 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~ 81 (790)
.+++++|+++ .+|..+. ++|+.|+|++|.+++..|..+..+ ++|+.|+|++|+|++..+.
T Consensus 23 ~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l-----------------~~L~~L~L~~N~l~~i~~~ 82 (229)
T 3e6j_A 23 TVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSL-----------------INLKELYLGSNQLGALPVG 82 (229)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTC-----------------TTCCEEECCSSCCCCCCTT
T ss_pred EeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCc-----------------cCCcEEECCCCCCCCcChh
Confidence 4788888887 7887554 778888888888877665433322 3455555555555533333
Q ss_pred cccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcc
Q 040908 82 FLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAV 160 (790)
Q Consensus 82 ~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l 160 (790)
.|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+.. ++|+.|+|++|+|++..+..+..++.|
T Consensus 83 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 161 (229)
T 3e6j_A 83 VFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161 (229)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTC
T ss_pred hcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCC
Confidence 4455555555555555555444444555555555555555555 34444433 555555555555555444445555555
Q ss_pred eeeecCC
Q 040908 161 NLFASSS 167 (790)
Q Consensus 161 ~~~~~~~ 167 (790)
+.+..+.
T Consensus 162 ~~L~l~~ 168 (229)
T 3e6j_A 162 THAYLFG 168 (229)
T ss_dssp CEEECTT
T ss_pred CEEEeeC
Confidence 5555443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-16 Score=158.82 Aligned_cols=129 Identities=20% Similarity=0.238 Sum_probs=109.7
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc-cccceeccccCCCCCCCcccccCcccEEEeccccccccC
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE-SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGEL 79 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~ 79 (790)
++|++++|+|+ .+|..+.. +|+.|++++|.+++..+. .+..+ ++|+.|+|++|+|++..
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l-----------------~~L~~L~Ls~N~l~~~~ 70 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRL-----------------PHLVKLELKRNQLTGIE 70 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGC-----------------TTCCEEECCSSCCCCBC
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccC-----------------CCCCEEECCCCCCCCcC
Confidence 46889999997 88876653 777778887777665543 23333 68999999999999888
Q ss_pred CccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccC
Q 040908 80 PHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADE 149 (790)
Q Consensus 80 p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~ 149 (790)
|..|+++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.+|..+.. ++|+.|+|++|++++.
T Consensus 71 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 71 PNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp TTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred HhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 999999999999999999999888888999999999999999999998988877 8999999999999864
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=6e-17 Score=173.70 Aligned_cols=164 Identities=18% Similarity=0.130 Sum_probs=136.6
Q ss_pred CEEEccCCcCcccCChhhhcc-----cccCcccccCccccccccc------cccceeccccCCCCC--CCccc--c-cCc
Q 040908 1 MYRTVQSNRLSGELPEELGSL-----IHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEA--TLPDL--R-NRT 64 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L-----~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~--~~~~~--~-~~~ 64 (790)
++|+|++|+|++. |..++.+ ++|++|+|++|++.+..+. +|+.|++++|.+... .+..+ . .++
T Consensus 124 ~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~ 202 (312)
T 1wwl_A 124 NILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT 202 (312)
T ss_dssp SEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTT
T ss_pred cEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCC
Confidence 5799999999966 9999988 9999999999999987753 789999999986532 11122 2 289
Q ss_pred ccEEEeccccccc--cCC-ccccCCCCCCEEEccCCcCCcCcc-hhccCCCCCcEEEeeCCcccccCCccccCCCCcEEe
Q 040908 65 FKNLILRSCNLTG--ELP-HFLGEVSEMKVLDLSFNKLNGTIP-ESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENID 140 (790)
Q Consensus 65 L~~L~L~~N~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ 140 (790)
|++|+|++|+|++ .++ ..+.++++|++|+|++|+|++.+| ..+..+++|+.|+|++|+|+ .+|..+. ++|+.||
T Consensus 203 L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-~~L~~L~ 280 (312)
T 1wwl_A 203 LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-AKLSVLD 280 (312)
T ss_dssp CCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-SEEEEEE
T ss_pred CCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-CCceEEE
Confidence 9999999999983 333 345689999999999999998776 56778999999999999999 7787776 8899999
Q ss_pred ccCCccccCCCCCCCCCCcceeeecCCCC
Q 040908 141 LSYNNFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 141 ls~N~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
|++|+|++. |. +..+++|+.++.+.+.
T Consensus 281 Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~ 307 (312)
T 1wwl_A 281 LSYNRLDRN-PS-PDELPQVGNLSLKGNP 307 (312)
T ss_dssp CCSSCCCSC-CC-TTTSCEEEEEECTTCT
T ss_pred CCCCCCCCC-hh-HhhCCCCCEEeccCCC
Confidence 999999987 65 8889999999887653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=2.1e-16 Score=170.65 Aligned_cols=165 Identities=16% Similarity=0.156 Sum_probs=135.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCcccccCcccEEEecccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCN 74 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~ 74 (790)
++|+|++|+|++..+..|+++++|++|+|++|.+++..|. +|+.|++++|.+...+...+ ++|++|+|++|+
T Consensus 55 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~--~~L~~L~l~~n~ 132 (330)
T 1xku_A 55 ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP--KTLQELRVHENE 132 (330)
T ss_dssp CEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCC--TTCCEEECCSSC
T ss_pred eEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhhc--ccccEEECCCCc
Confidence 4789999999966666899999999999999999887553 78889999998886554433 689999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcCC--cCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCC
Q 040908 75 LTGELPHFLGEVSEMKVLDLSFNKLN--GTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSG 152 (790)
Q Consensus 75 l~~~~p~~~~~l~~L~~L~Ls~N~l~--g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~ 152 (790)
+++..+..|.++++|++|+|++|++. +..|..|.++++|+.|++++|+++. +|..+. ++|+.|+|++|++++..|.
T Consensus 133 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~-~~L~~L~l~~n~l~~~~~~ 210 (330)
T 1xku_A 133 ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP-PSLTELHLDGNKITKVDAA 210 (330)
T ss_dssp CCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC-TTCSEEECTTSCCCEECTG
T ss_pred ccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc-ccCCEEECCCCcCCccCHH
Confidence 99777777899999999999999985 3677888999999999999998885 554443 6788888888888888888
Q ss_pred CCCCCCcceeeecCCCC
Q 040908 153 SDCQNGAVNLFASSSKG 169 (790)
Q Consensus 153 ~~~~~~~l~~~~~~~~~ 169 (790)
.+..+.+|+.++.+.+.
T Consensus 211 ~~~~l~~L~~L~Ls~n~ 227 (330)
T 1xku_A 211 SLKGLNNLAKLGLSFNS 227 (330)
T ss_dssp GGTTCTTCCEEECCSSC
T ss_pred HhcCCCCCCEEECCCCc
Confidence 88888888888887653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.7e-16 Score=161.12 Aligned_cols=131 Identities=17% Similarity=0.184 Sum_probs=117.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccCC
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELP 80 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p 80 (790)
+.|+|++|+|++..|..|..+++|+.|+|++|++++..|..+..| ++|++|+|++|+|+...+
T Consensus 35 ~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l-----------------~~L~~L~Ls~N~l~~l~~ 97 (220)
T 2v9t_B 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL-----------------RSLNSLVLYGNKITELPK 97 (220)
T ss_dssp CEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTC-----------------SSCCEEECCSSCCCCCCT
T ss_pred CEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCC-----------------cCCCEEECCCCcCCccCH
Confidence 479999999997666689999999999999999998877777766 589999999999995555
Q ss_pred ccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCcccc
Q 040908 81 HFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFAD 148 (790)
Q Consensus 81 ~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g 148 (790)
..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+.. ++|+.|+|++|++..
T Consensus 98 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 98 SLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred hHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 56899999999999999999888999999999999999999999888877776 899999999999973
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=187.32 Aligned_cols=169 Identities=15% Similarity=0.031 Sum_probs=131.9
Q ss_pred CEEEccCCcCccc--CChhhhcccccCcccccCcccccccc-----ccccceeccccCCCCCCC-ccccc-CcccEEEec
Q 040908 1 MYRTVQSNRLSGE--LPEELGSLIHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGPEATL-PDLRN-RTFKNLILR 71 (790)
Q Consensus 1 ~~L~Ls~N~l~g~--iP~~~~~L~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~~~~~-~~~~~-~~L~~L~L~ 71 (790)
++|+|++|++++. +|..+..+++|+.|++++|.+++.+. .+|+.|++++|.+..... ..+.. ++|+.|+|+
T Consensus 353 ~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~ 432 (606)
T 3vq2_A 353 SYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432 (606)
T ss_dssp CEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECT
T ss_pred CEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECc
Confidence 4678888888755 37788888888888888888776442 377788888887776554 44444 788888888
Q ss_pred cccccccCCccccCCCCCCEEEccCCcCCc-CcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccC
Q 040908 72 SCNLTGELPHFLGEVSEMKVLDLSFNKLNG-TIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADE 149 (790)
Q Consensus 72 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~ 149 (790)
+|++++.+|..|+++++|++|+|++|++++ .+|..|.++++|+.|+|++|++++.+|..+.. ++|+.|+|++|++++.
T Consensus 433 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 512 (606)
T 3vq2_A 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512 (606)
T ss_dssp TSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCE
T ss_pred CCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCc
Confidence 888888888888888888888888888886 36778888888888888888888877777766 7888888888888888
Q ss_pred CCCCCCCCCcceeeecCCCC
Q 040908 150 SSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 150 ~p~~~~~~~~l~~~~~~~~~ 169 (790)
+|..++.+++|+.++.+.+.
T Consensus 513 ~~~~~~~l~~L~~L~l~~N~ 532 (606)
T 3vq2_A 513 DSSHYNQLYSLSTLDCSFNR 532 (606)
T ss_dssp EGGGTTTCTTCCEEECTTSC
T ss_pred CHHHccCCCcCCEEECCCCc
Confidence 88888888888888877653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=6.6e-16 Score=166.78 Aligned_cols=161 Identities=14% Similarity=0.131 Sum_probs=87.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCC--CCCccccc-CcccEEEec
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPE--ATLPDLRN-RTFKNLILR 71 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~--~~~~~~~~-~~L~~L~L~ 71 (790)
++|+|++|+|+ .+|..+. ++|+.|++++|.+++..+ .+|+.|++++|.+.. .....+.. ++|+.|+|+
T Consensus 103 ~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~ 179 (330)
T 1xku_A 103 ERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179 (330)
T ss_dssp CEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECC
T ss_pred CEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECC
Confidence 35666666666 5555443 456666666666654443 245555555555542 22223333 555666666
Q ss_pred cccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCC
Q 040908 72 SCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADES 150 (790)
Q Consensus 72 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~ 150 (790)
+|+++ .+|..+. ++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..+.. ++|+.|+|++|+|+ .+
T Consensus 180 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l 255 (330)
T 1xku_A 180 DTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV 255 (330)
T ss_dssp SSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SC
T ss_pred CCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cC
Confidence 66655 4444433 55566666666655555555555666666666666655555544444 55566666666555 45
Q ss_pred CCCCCCCCcceeeecCCC
Q 040908 151 SGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 151 p~~~~~~~~l~~~~~~~~ 168 (790)
|..+..++.|+.++.+.+
T Consensus 256 p~~l~~l~~L~~L~l~~N 273 (330)
T 1xku_A 256 PGGLADHKYIQVVYLHNN 273 (330)
T ss_dssp CTTTTTCSSCCEEECCSS
T ss_pred ChhhccCCCcCEEECCCC
Confidence 555555555555555443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.66 E-value=4e-16 Score=168.72 Aligned_cols=161 Identities=16% Similarity=0.147 Sum_probs=101.1
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEecccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCN 74 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~ 74 (790)
.|++++|.++ .+|..+. ++|+.|++++|.+.+..+. +|+.|++++|.+....+..+.. ++|++|+|++|+
T Consensus 37 ~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 113 (332)
T 2ft3_A 37 VVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113 (332)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSC
T ss_pred EEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCc
Confidence 4667777776 6666553 4667777777777655442 5666677777666555555554 667777777777
Q ss_pred ccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccc--cCCccccC-------------------
Q 040908 75 LTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTG--KVPQWMFG------------------- 133 (790)
Q Consensus 75 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~------------------- 133 (790)
|+ .+|..+. ++|++|+|++|++++..+..|.++++|+.|+|++|.++. ..|..+..
T Consensus 114 l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~ 190 (332)
T 2ft3_A 114 LV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKD 190 (332)
T ss_dssp CC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSS
T ss_pred CC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCcc
Confidence 76 5665554 667777777777765444556777777777777776642 33332211
Q ss_pred --CCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 134 --RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 134 --~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
.+|+.|+|++|++++..|..+..+..|+.++.+.+
T Consensus 191 ~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N 227 (332)
T 2ft3_A 191 LPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN 227 (332)
T ss_dssp SCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSS
T ss_pred ccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC
Confidence 24566666666666666666666677776666554
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.6e-16 Score=182.07 Aligned_cols=167 Identities=16% Similarity=0.125 Sum_probs=98.8
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEecccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCN 74 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~ 74 (790)
+|+|++|+|++..|..|+.+++|+.|+|++|.+++.+|. +|+.|++++|.+...+...+.. ++|+.|+|++|.
T Consensus 79 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~ 158 (597)
T 3oja_B 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 158 (597)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCc
Confidence 456666666654455566666666666666665554442 4555556666555554444433 556666666666
Q ss_pred ccccCCccccCCCCCCEEEccCCcCCcCcchhccCC-------------------------------------CCCcEEE
Q 040908 75 LTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARL-------------------------------------ADVDFIY 117 (790)
Q Consensus 75 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l-------------------------------------~~L~~L~ 117 (790)
|++..|..|+++++|++|+|++|+|++..+..+.+| ++|+.|+
T Consensus 159 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~ 238 (597)
T 3oja_B 159 LERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILK 238 (597)
T ss_dssp CCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEE
T ss_pred CCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEE
Confidence 665555556666666666666666554322222111 1233333
Q ss_pred eeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcceeeecCCCCC
Q 040908 118 LTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 118 ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~~ 170 (790)
|++|.+++ +.++.. ++|+.|+|++|.|++.+|..+..++.|..++.+.+..
T Consensus 239 L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 290 (597)
T 3oja_B 239 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 290 (597)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCC
T ss_pred CCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCC
Confidence 33344333 123444 7899999999999999999999999999999887643
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-16 Score=171.49 Aligned_cols=166 Identities=16% Similarity=0.084 Sum_probs=134.8
Q ss_pred CEEEccCCcCcccCChhh--hcccccCcccccCccccccc----------cccccceeccccCCCCCCCccccc-CcccE
Q 040908 1 MYRTVQSNRLSGELPEEL--GSLIHSGKWFGWANSVWHYF----------SESLTDLRISDLNGPEATLPDLRN-RTFKN 67 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~--~~L~~L~~L~l~~N~l~~~~----------~~~L~~L~l~~n~~~~~~~~~~~~-~~L~~ 67 (790)
++|+|++|++++.+|..+ ..+++|+.|+|++|.+++.. ..+|+.|++++|.+...+...+.. ++|++
T Consensus 94 ~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 173 (310)
T 4glp_A 94 KELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTS 173 (310)
T ss_dssp CEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCE
T ss_pred eEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCE
Confidence 579999999999999988 89999999999999998633 348899999999998777777765 88999
Q ss_pred EEecccccccc--C--CccccCCCCCCEEEccCCcCCcCcch----hccCCCCCcEEEeeCCcccccCCccccC----CC
Q 040908 68 LILRSCNLTGE--L--PHFLGEVSEMKVLDLSFNKLNGTIPE----SFARLADVDFIYLTGNLLTGKVPQWMFG----RG 135 (790)
Q Consensus 68 L~L~~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~g~ip~----~~~~l~~L~~L~ls~N~l~g~~p~~~~~----~~ 135 (790)
|+|++|++.+. + +..++++++|++|+|++|+|+ .+|. .+.++++|+.|+|++|++++..|..+.. ++
T Consensus 174 L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~ 252 (310)
T 4glp_A 174 LDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSA 252 (310)
T ss_dssp EECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTT
T ss_pred EECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCc
Confidence 99999998753 3 233478899999999999997 4554 3578899999999999999887765544 48
Q ss_pred CcEEeccCCccccCCCCCCCCCCcceeeecCCCCC
Q 040908 136 PENIDLSYNNFADESSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 136 L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~~ 170 (790)
|+.|+|++|+|+ .+|..++ ++|+.++.+.+.-
T Consensus 253 L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l 284 (310)
T 4glp_A 253 LNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRL 284 (310)
T ss_dssp CCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCC
T ss_pred CCEEECCCCCCC-chhhhhc--CCCCEEECCCCcC
Confidence 999999999998 6777775 6788888876643
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=8.9e-16 Score=154.20 Aligned_cols=152 Identities=19% Similarity=0.192 Sum_probs=119.7
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|++..+..|..+++|+.|++++|+++..++ .+|+.|++++|.+...+...+.. ++|++|+|++|
T Consensus 31 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N 110 (208)
T 2o6s_A 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTN 110 (208)
T ss_dssp SEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCC
Confidence 478888888885555567888888888888888886654 26788888888888776665554 78888888888
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCC
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGS 153 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~ 153 (790)
+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|.+.+..| +|+.|+++.|+++|.+|..
T Consensus 111 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~------~l~~L~~~~n~~~g~ip~~ 184 (208)
T 2o6s_A 111 QLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP------GIRYLSEWINKHSGVVRNS 184 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT------TTHHHHHHHHHCTTTBBCT
T ss_pred cCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC------CHHHHHHHHHhCCceeecc
Confidence 8886666667888888888888888886666668888888888888888876554 5788888888888888887
Q ss_pred CCCCC
Q 040908 154 DCQNG 158 (790)
Q Consensus 154 ~~~~~ 158 (790)
++.+.
T Consensus 185 ~~~l~ 189 (208)
T 2o6s_A 185 AGSVA 189 (208)
T ss_dssp TSSBC
T ss_pred Ccccc
Confidence 76543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=4e-16 Score=177.37 Aligned_cols=169 Identities=12% Similarity=0.007 Sum_probs=148.1
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|++..|..|.+|++|+.|+|++|.++..++ .+|+.|++++|.+.......+.. ++|+.|+|++|
T Consensus 59 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n 138 (477)
T 2id5_A 59 EELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN 138 (477)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCT
T ss_pred CEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCC
Confidence 579999999998889999999999999999999987765 37899999999998777666666 89999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCC
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSG 152 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~ 152 (790)
.+++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|++|.+.+..+..+.. .+|+.|+|++|++.+.+|.
T Consensus 139 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~ 218 (477)
T 2id5_A 139 DLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP 218 (477)
T ss_dssp TCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT
T ss_pred ccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc
Confidence 999888999999999999999999999766678999999999999999999887777766 8899999999888888887
Q ss_pred CCCCCCcceeeecCCCC
Q 040908 153 SDCQNGAVNLFASSSKG 169 (790)
Q Consensus 153 ~~~~~~~l~~~~~~~~~ 169 (790)
.......|+.++.+.+.
T Consensus 219 ~~~~~~~L~~L~l~~n~ 235 (477)
T 2id5_A 219 NCLYGLNLTSLSITHCN 235 (477)
T ss_dssp TTTTTCCCSEEEEESSC
T ss_pred ccccCccccEEECcCCc
Confidence 77777778888776653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.4e-16 Score=184.74 Aligned_cols=169 Identities=15% Similarity=0.070 Sum_probs=143.7
Q ss_pred CEEEccCCcCcccC--ChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCcc-ccc-CcccEEEe
Q 040908 1 MYRTVQSNRLSGEL--PEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPD-LRN-RTFKNLIL 70 (790)
Q Consensus 1 ~~L~Ls~N~l~g~i--P~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~-~~~-~~L~~L~L 70 (790)
++|+|++|++++.. |..++.+++|+.|++++|.+.+..|. +|+.|++++|.+.....+. +.. ++|+.|+|
T Consensus 353 ~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 432 (606)
T 3t6q_A 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432 (606)
T ss_dssp CEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEEC
T ss_pred CEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEEC
Confidence 57999999999765 77899999999999999998876553 7888899999887655443 444 88999999
Q ss_pred ccccccccCCccccCCCCCCEEEccCCcCCcC---cchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCcc
Q 040908 71 RSCNLTGELPHFLGEVSEMKVLDLSFNKLNGT---IPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNF 146 (790)
Q Consensus 71 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~---ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l 146 (790)
++|.+++..|..|+++++|++|+|++|++++. .+..+..+++|+.|+|++|++++..|..+.. ++|+.|+|++|++
T Consensus 433 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 512 (606)
T 3t6q_A 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512 (606)
T ss_dssp TTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCcc
Confidence 99999988899999999999999999999863 3367899999999999999999888888877 8899999999999
Q ss_pred ccCCCCCCCCCCcceeeecCCCCC
Q 040908 147 ADESSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 147 ~g~~p~~~~~~~~l~~~~~~~~~~ 170 (790)
++..|..+..+..| .++.+.+.-
T Consensus 513 ~~~~~~~l~~l~~L-~L~L~~N~l 535 (606)
T 3t6q_A 513 TSSSIEALSHLKGI-YLNLASNHI 535 (606)
T ss_dssp CGGGGGGGTTCCSC-EEECCSSCC
T ss_pred CcCChhHhCccccc-EEECcCCcc
Confidence 99999999999999 888776643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=5.4e-16 Score=184.29 Aligned_cols=167 Identities=15% Similarity=0.073 Sum_probs=144.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|++..|..|+++++|+.|+|++|.+++..|. +|+.|++++|.+...+...+.. ++|++|+|++|
T Consensus 28 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n 107 (680)
T 1ziw_A 28 TVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSN 107 (680)
T ss_dssp SEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSS
T ss_pred cEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCC
Confidence 4799999999976666799999999999999999987764 7899999999988877766666 89999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCcccc--C-CCCcEEeccCCccccCC
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMF--G-RGPENIDLSYNNFADES 150 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~--~-~~L~~l~ls~N~l~g~~ 150 (790)
++++..|..|+++++|++|+|++|++++..|..+.++++|+.|+|++|++++..|..+. . .+|+.|+|++|++++..
T Consensus 108 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~ 187 (680)
T 1ziw_A 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS 187 (680)
T ss_dssp CCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBC
T ss_pred ccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccC
Confidence 99977778899999999999999999988888999999999999999999987776543 2 78999999999999999
Q ss_pred CCCCCCCCcceeeecCC
Q 040908 151 SGSDCQNGAVNLFASSS 167 (790)
Q Consensus 151 p~~~~~~~~l~~~~~~~ 167 (790)
|..+..+..|..+..+.
T Consensus 188 ~~~~~~l~~L~~L~l~~ 204 (680)
T 1ziw_A 188 PGCFHAIGRLFGLFLNN 204 (680)
T ss_dssp TTGGGGSSEECEEECTT
T ss_pred hhhhhhhhhhhhhhccc
Confidence 98888888877776543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.4e-16 Score=180.87 Aligned_cols=168 Identities=15% Similarity=0.105 Sum_probs=130.7
Q ss_pred CEEEccCCcCcccC--ChhhhcccccCcccccCcccccccc-----ccccceeccccCCCCCCC-ccccc-CcccEEEec
Q 040908 1 MYRTVQSNRLSGEL--PEELGSLIHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGPEATL-PDLRN-RTFKNLILR 71 (790)
Q Consensus 1 ~~L~Ls~N~l~g~i--P~~~~~L~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~~~~~-~~~~~-~~L~~L~L~ 71 (790)
++|+|++|++++.. |..+..+++|+.|++++|.+.+.++ .+|+.|++++|.+..... ..+.. ++|++|+|+
T Consensus 350 ~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~ 429 (570)
T 2z63_A 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429 (570)
T ss_dssp CEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECT
T ss_pred CEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCc
Confidence 46788888887543 6778888888888888888776554 377788888877765543 33443 778888888
Q ss_pred cccccccCCccccCCCCCCEEEccCCcCC-cCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccC
Q 040908 72 SCNLTGELPHFLGEVSEMKVLDLSFNKLN-GTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADE 149 (790)
Q Consensus 72 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~ 149 (790)
+|++.+.+|..|.++++|++|+|++|+++ +.+|..|..+++|+.|+|++|++++..|..+.. ++|+.|+|++|+|++.
T Consensus 430 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 509 (570)
T 2z63_A 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSV 509 (570)
T ss_dssp TSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCC
Confidence 88888888888888888888888888887 578888888888888888888888877877766 7888888888888887
Q ss_pred CCCCCCCCCcceeeecCCC
Q 040908 150 SSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 150 ~p~~~~~~~~l~~~~~~~~ 168 (790)
.|..+..+++|+.++.+.+
T Consensus 510 ~~~~~~~l~~L~~L~l~~N 528 (570)
T 2z63_A 510 PDGIFDRLTSLQKIWLHTN 528 (570)
T ss_dssp CTTTTTTCTTCCEEECCSS
T ss_pred CHHHhhcccCCcEEEecCC
Confidence 7777888888888877655
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=6.1e-16 Score=181.23 Aligned_cols=167 Identities=12% Similarity=0.054 Sum_probs=118.1
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|+|++|+|++..|..|.++++|+.|+|++|.+++..|. +|+.|++++|.+....+..+.. ++|++|+|++|
T Consensus 35 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 114 (606)
T 3vq2_A 35 KNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114 (606)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTS
T ss_pred CEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCC
Confidence 3677888888766666777788888888888877766553 6777777777777665555655 77777788777
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCc-CcchhccCCCCCcEEEeeCCcccccCCccccC-CC----CcEEeccCCccc
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNG-TIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RG----PENIDLSYNNFA 147 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~----L~~l~ls~N~l~ 147 (790)
++++..|..|+++++|++|+|++|++++ .+|..|+++++|+.|+|++|++++..|..+.. .+ +..|++++|+++
T Consensus 115 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~ 194 (606)
T 3vq2_A 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194 (606)
T ss_dssp CCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCC
T ss_pred ccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcc
Confidence 7776666677777778888887777765 56777777777888888777777766665544 22 447777777777
Q ss_pred cCCCCCCCCCCcceeeecCCC
Q 040908 148 DESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 148 g~~p~~~~~~~~l~~~~~~~~ 168 (790)
+..+..+... +|+.++.+.+
T Consensus 195 ~~~~~~~~~~-~L~~L~L~~n 214 (606)
T 3vq2_A 195 FIQDQAFQGI-KLHELTLRGN 214 (606)
T ss_dssp EECTTTTTTC-EEEEEEEESC
T ss_pred eeCcccccCc-eeeeeeccCC
Confidence 6555554443 6777766554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.63 E-value=6.2e-16 Score=186.49 Aligned_cols=166 Identities=18% Similarity=0.179 Sum_probs=139.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcc-ccc-cccc-------------cccceeccccCCCCCCC-ccccc-C
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANS-VWH-YFSE-------------SLTDLRISDLNGPEATL-PDLRN-R 63 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~-l~~-~~~~-------------~L~~L~l~~n~~~~~~~-~~~~~-~ 63 (790)
++|+|++|++.|.+|..|++|++|+.|+|++|+ +++ .+|. +|+.|++++|.+...+. ..+.. +
T Consensus 494 ~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~ 573 (876)
T 4ecn_A 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573 (876)
T ss_dssp CEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCT
T ss_pred CEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCC
Confidence 579999999999999999999999999999998 887 5553 79999999999984443 13544 8
Q ss_pred cccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCC-CcEEEeeCCcccccCCccccC---CCCcEE
Q 040908 64 TFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLAD-VDFIYLTGNLLTGKVPQWMFG---RGPENI 139 (790)
Q Consensus 64 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~-L~~L~ls~N~l~g~~p~~~~~---~~L~~l 139 (790)
+|+.|+|++|+|+ .+| .|+++++|+.|+|++|+|+ .+|..+.++++ |+.|+|++|+++ .+|..+.. .+|+.|
T Consensus 574 ~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L 649 (876)
T 4ecn_A 574 KLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSV 649 (876)
T ss_dssp TCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEE
T ss_pred CCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEE
Confidence 9999999999999 899 8999999999999999999 89999999999 999999999999 77877655 349999
Q ss_pred eccCCccccCCCCCCC-----CCCcceeeecCCCCC
Q 040908 140 DLSYNNFADESSGSDC-----QNGAVNLFASSSKGS 170 (790)
Q Consensus 140 ~ls~N~l~g~~p~~~~-----~~~~l~~~~~~~~~~ 170 (790)
+|++|+|+|.+|...+ ...+|+.++.+.+..
T Consensus 650 ~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L 685 (876)
T 4ecn_A 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEI 685 (876)
T ss_dssp ECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCC
T ss_pred ECcCCcCCCccccchhhhccccCCCcCEEEccCCcC
Confidence 9999999997775432 234688888776543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-15 Score=168.14 Aligned_cols=166 Identities=16% Similarity=0.130 Sum_probs=88.0
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEecccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCN 74 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~ 74 (790)
+|+|++|+|++..|..|..+++|+.|+|++|.+++.+|. +|+.|++++|.+...+...+.. ++|++|+|++|+
T Consensus 73 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~ 152 (390)
T 3o6n_A 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 152 (390)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCc
Confidence 445555555533333455555555555555555444332 3444555555554444333332 455555555555
Q ss_pred ccccCCccccCCCCCCEEEccCCcCCcCcchhccCC-------------------------------------CCCcEEE
Q 040908 75 LTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARL-------------------------------------ADVDFIY 117 (790)
Q Consensus 75 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l-------------------------------------~~L~~L~ 117 (790)
+++..|..|+++++|++|+|++|++++.-...+.+| ++|+.|+
T Consensus 153 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~ 232 (390)
T 3o6n_A 153 LERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILK 232 (390)
T ss_dssp CCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEE
T ss_pred cCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEE
Confidence 554444445555555555555555543211111111 1233333
Q ss_pred eeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcceeeecCCCC
Q 040908 118 LTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 118 ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
|++|++++. ..+.. ++|+.|+|++|.+++..|..+..+++|+.++.+.+.
T Consensus 233 l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 283 (390)
T 3o6n_A 233 LQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283 (390)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSC
T ss_pred CCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCc
Confidence 333333321 22333 788999999999999889999999999999987764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=5.2e-16 Score=169.29 Aligned_cols=149 Identities=13% Similarity=0.030 Sum_probs=74.7
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCC-ccccc-CcccEEEeccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATL-PDLRN-RTFKNLILRSC 73 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~-~~~~~-~~L~~L~L~~N 73 (790)
+|+|++|+|++..|..|+++++|++|+|++|++++.++. +|+.|++++|.+...+. ..+.. ++|++|+|++|
T Consensus 80 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n 159 (353)
T 2z80_A 80 ALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159 (353)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEES
T ss_pred EEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCC
Confidence 445555555544444455555555555555555443321 45555555555544333 22332 45555555555
Q ss_pred -cccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCC
Q 040908 74 -NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADES 150 (790)
Q Consensus 74 -~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~ 150 (790)
.+.+..|..|+++++|++|+|++|++++..|..|.++++|+.|+|++|++....+..+.. ++|+.|+|++|++++..
T Consensus 160 ~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~ 238 (353)
T 2z80_A 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH 238 (353)
T ss_dssp SSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCC
T ss_pred ccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccc
Confidence 244333445555555555555555555555555555555555555555543221111222 56777777777777643
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-15 Score=175.81 Aligned_cols=118 Identities=18% Similarity=0.096 Sum_probs=84.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCcccccCcccEEEecccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCN 74 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~ 74 (790)
++|+|++|+|++..|..|.++++|++|+|++|++++..|. +|+.|++++|.+...+.. ..++|++|+|++|+
T Consensus 24 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~~N~ 101 (520)
T 2z7x_B 24 TILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNA 101 (520)
T ss_dssp SEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECCSSC
T ss_pred cEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEeccCCc
Confidence 4688888888866667888888888888888888877553 678888888887754433 44788888888888
Q ss_pred ccc-cCCccccCCCCCCEEEccCCcCCcCcchhccCCCCC--cEEEeeCCcc
Q 040908 75 LTG-ELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADV--DFIYLTGNLL 123 (790)
Q Consensus 75 l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L--~~L~ls~N~l 123 (790)
|++ .+|..|+++++|++|+|++|++++ ..+..+++| +.|+|++|++
T Consensus 102 l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 102 FDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGET 150 (520)
T ss_dssp CSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTT
T ss_pred cccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccc
Confidence 886 477888888888888888887764 223333343 4444444444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=8.2e-16 Score=180.17 Aligned_cols=170 Identities=16% Similarity=0.076 Sum_probs=150.4
Q ss_pred CEEEccCCcCcccCChh-hhcccccCcccccCccccccc--c------ccccceeccccCCCCCCCccccc-CcccEEEe
Q 040908 1 MYRTVQSNRLSGELPEE-LGSLIHSGKWFGWANSVWHYF--S------ESLTDLRISDLNGPEATLPDLRN-RTFKNLIL 70 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~-~~~L~~L~~L~l~~N~l~~~~--~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L 70 (790)
++|+|++|.+.+.+|.. +..+++|+.|++++|.+++.. + .+|+.|++++|.+.......+.. ++|+.|+|
T Consensus 328 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 407 (606)
T 3t6q_A 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407 (606)
T ss_dssp SEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEEC
T ss_pred CEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEEC
Confidence 57999999999888875 999999999999999998764 2 38999999999988776666665 89999999
Q ss_pred ccccccccCCcc-ccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCccccc---CCccccC-CCCcEEeccCCc
Q 040908 71 RSCNLTGELPHF-LGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGK---VPQWMFG-RGPENIDLSYNN 145 (790)
Q Consensus 71 ~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~---~p~~~~~-~~L~~l~ls~N~ 145 (790)
++|++++..|.. |.++++|++|+|++|++++..|..|.++++|+.|+|++|++++. .+..+.. ++|+.|+|++|+
T Consensus 408 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~ 487 (606)
T 3t6q_A 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487 (606)
T ss_dssp TTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred CCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence 999999887765 89999999999999999999999999999999999999999873 2345555 899999999999
Q ss_pred cccCCCCCCCCCCcceeeecCCCCC
Q 040908 146 FADESSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 146 l~g~~p~~~~~~~~l~~~~~~~~~~ 170 (790)
+++..|..+..++.|+.++.+.+.-
T Consensus 488 l~~~~~~~~~~l~~L~~L~Ls~N~l 512 (606)
T 3t6q_A 488 LSSIDQHAFTSLKMMNHVDLSHNRL 512 (606)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCC
T ss_pred cCccChhhhccccCCCEEECCCCcc
Confidence 9999999999999999999987743
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-16 Score=169.99 Aligned_cols=166 Identities=17% Similarity=0.095 Sum_probs=91.3
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCc-----------------c
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLP-----------------D 59 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~-----------------~ 59 (790)
++|+|++|+|++..|..|..+++|+.|+|++|.+++..+ .+|+.|++++|.+...+.. .
T Consensus 37 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~ 116 (317)
T 3o53_A 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSC 116 (317)
T ss_dssp SEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEEETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEE
T ss_pred CEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchhhhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCc
Confidence 468888888886666788888888888888888875443 3667777777655432211 0
Q ss_pred cccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhcc-CCCCCcEEEeeCCcccccCCccccCCCCcE
Q 040908 60 LRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFA-RLADVDFIYLTGNLLTGKVPQWMFGRGPEN 138 (790)
Q Consensus 60 ~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~ 138 (790)
...++|+.|+|++|+|++..|..++.+++|++|+|++|++++..|..+. .+++|+.|+|++|++++. |.....++|+.
T Consensus 117 ~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~ 195 (317)
T 3o53_A 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKT 195 (317)
T ss_dssp CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCE
T ss_pred cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCE
Confidence 0013455555555555544444555555555555555555544444442 455555555555555533 22222345555
Q ss_pred EeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 139 IDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 139 l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
|+|++|+|++. |..+..++.|+.++.+.+
T Consensus 196 L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N 224 (317)
T 3o53_A 196 LDLSSNKLAFM-GPEFQSAAGVTWISLRNN 224 (317)
T ss_dssp EECCSSCCCEE-CGGGGGGTTCSEEECTTS
T ss_pred EECCCCcCCcc-hhhhcccCcccEEECcCC
Confidence 55555555543 223444455555554433
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.4e-16 Score=170.06 Aligned_cols=137 Identities=13% Similarity=0.166 Sum_probs=99.3
Q ss_pred CcceeeeecccCcEEEEeeeecCCcEEEEEEccccch--------------hcHHH--------HHHHHHHhhccCCCce
Q 040908 447 HFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSK--------------QGNRE--------FVNEIGTISALQHPHL 504 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~H~ni 504 (790)
-|++.+.||+|+||.||+|...+|+.||||+++.... ..... ...|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3999999999999999999988999999998753210 00111 2345666666654443
Q ss_pred eeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC
Q 040908 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK 584 (790)
Q Consensus 505 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~ 584 (790)
.-..-+... ..++||||+++++|.++.. ......++.|++.+|.|||..+ ||||||||.|||+++
T Consensus 176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQS--RHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEEE--TTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCCeeeecc--CceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 221111111 2379999999988876541 1234568899999999999885 999999999999988
Q ss_pred CCC----------eEEeecCCccc
Q 040908 585 DLN----------PKISDFGLAKL 598 (790)
Q Consensus 585 ~~~----------~kl~DFGla~~ 598 (790)
++. +.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 773 89999997763
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-16 Score=173.34 Aligned_cols=163 Identities=15% Similarity=0.078 Sum_probs=121.8
Q ss_pred EEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 3 RTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 3 L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
.++++|+++ .+|..+. ++|+.|++++|.+++..+ .+|+.|++++|.+.......+.. ++|++|+|++|+|
T Consensus 36 c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (353)
T 2z80_A 36 CKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112 (353)
T ss_dssp EECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence 577788887 7777655 478888888888876655 26777788888777665555555 7888888888888
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcch--hccCCCCCcEEEeeCCc-ccccCCccccC-CCCcEEeccCCccccCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPE--SFARLADVDFIYLTGNL-LTGKVPQWMFG-RGPENIDLSYNNFADESS 151 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~--~~~~l~~L~~L~ls~N~-l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p 151 (790)
++..+..|+++++|++|+|++|+++ .+|. .|.++++|+.|+|++|+ +.+..|..+.. ++|+.|+|++|++++..|
T Consensus 113 ~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 191 (353)
T 2z80_A 113 SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191 (353)
T ss_dssp SSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred CcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCH
Confidence 8443344788888888888888887 5554 67888888888888884 66555666655 778888888888888888
Q ss_pred CCCCCCCcceeeecCCCC
Q 040908 152 GSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 152 ~~~~~~~~l~~~~~~~~~ 169 (790)
..+..+.+|+.++.+.+.
T Consensus 192 ~~l~~l~~L~~L~l~~n~ 209 (353)
T 2z80_A 192 KSLKSIQNVSHLILHMKQ 209 (353)
T ss_dssp TTTTTCSEEEEEEEECSC
T ss_pred HHHhccccCCeecCCCCc
Confidence 888888888888776554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.5e-16 Score=171.35 Aligned_cols=156 Identities=16% Similarity=0.088 Sum_probs=124.8
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc-------ccccceeccccCCCCCCCccccc-CcccEEEecc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS-------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRS 72 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~-------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~ 72 (790)
+.+++++|+|+ .+|..+. ..|+.|+|++|+|++..+ .+|+.|+|++|.+...+...+.. ++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 36899999998 7898765 458899999999987654 36788889888888777666666 8899999999
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccc---cC-CCCcEEeccCCcccc
Q 040908 73 CNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWM---FG-RGPENIDLSYNNFAD 148 (790)
Q Consensus 73 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~---~~-~~L~~l~ls~N~l~g 148 (790)
|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+ .. ++|+.|||++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99997777788999999999999999997778889999999999999999986544444 23 789999999999986
Q ss_pred CCCCCCCCCCc
Q 040908 149 ESSGSDCQNGA 159 (790)
Q Consensus 149 ~~p~~~~~~~~ 159 (790)
..+..+..+..
T Consensus 178 l~~~~~~~l~~ 188 (361)
T 2xot_A 178 LPLTDLQKLPA 188 (361)
T ss_dssp CCHHHHHHSCH
T ss_pred cCHHHhhhccH
Confidence 55455544443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=3e-16 Score=167.99 Aligned_cols=164 Identities=18% Similarity=0.076 Sum_probs=131.3
Q ss_pred CEEEccCCcCcccCC----hhhhcccccCcccccCccccccccc------cccceeccccCCCC---CCCccc--ccCcc
Q 040908 1 MYRTVQSNRLSGELP----EELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPE---ATLPDL--RNRTF 65 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP----~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~---~~~~~~--~~~~L 65 (790)
++|+|++|+|++..| ..+..+++|+.|+|++|.+.+.++. +|+.|++++|.+.. .+.... ..++|
T Consensus 120 ~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L 199 (310)
T 4glp_A 120 SSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAI 199 (310)
T ss_dssp SSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCC
T ss_pred CEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCC
Confidence 468999999998766 3556799999999999999877653 78999999998753 222221 23789
Q ss_pred cEEEeccccccccCCc----cccCCCCCCEEEccCCcCCcCcchhccCC---CCCcEEEeeCCcccccCCccccCCCCcE
Q 040908 66 KNLILRSCNLTGELPH----FLGEVSEMKVLDLSFNKLNGTIPESFARL---ADVDFIYLTGNLLTGKVPQWMFGRGPEN 138 (790)
Q Consensus 66 ~~L~L~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l---~~L~~L~ls~N~l~g~~p~~~~~~~L~~ 138 (790)
++|+|++|+|+ .+|. .++++++|++|+|++|+|++.+|..+..+ ++|+.|+|++|+|+ .+|..+. ++|+.
T Consensus 200 ~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-~~L~~ 276 (310)
T 4glp_A 200 QNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-AKLRV 276 (310)
T ss_dssp CSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC-SCCSC
T ss_pred CEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc-CCCCE
Confidence 99999999997 4444 25789999999999999998889888887 69999999999999 6676664 78999
Q ss_pred EeccCCccccCCCCCCCCCCcceeeecCCCC
Q 040908 139 IDLSYNNFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 139 l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
|||++|+|++. |. +..++.|+.++.+.+.
T Consensus 277 L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~ 305 (310)
T 4glp_A 277 LDLSSNRLNRA-PQ-PDELPEVDNLTLDGNP 305 (310)
T ss_dssp EECCSCCCCSC-CC-TTSCCCCSCEECSSTT
T ss_pred EECCCCcCCCC-ch-hhhCCCccEEECcCCC
Confidence 99999999974 32 4566778887776553
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-15 Score=176.99 Aligned_cols=167 Identities=13% Similarity=0.022 Sum_probs=135.9
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
..|+|++|.++...+..|.++++|+.|+|++|.+++.++. +|+.|++++|.+...++..+.. ++|++|+|++|
T Consensus 54 ~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 133 (597)
T 3oja_B 54 KIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133 (597)
T ss_dssp SEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCC
Confidence 3689999999854444578999999999999999987763 7999999999999888777766 89999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC--------------------
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-------------------- 133 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-------------------- 133 (790)
.|++..+..|+++++|++|+|++|+|++..|..|+++++|+.|+|++|.+++..+..+..
T Consensus 134 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L 213 (597)
T 3oja_B 134 DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAV 213 (597)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTC
T ss_pred CCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchh
Confidence 999555556799999999999999999888889999999999999999998753222110
Q ss_pred ------------------CCCcEEeccCCccccCCCCCCCCCCcceeeecCCCC
Q 040908 134 ------------------RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 134 ------------------~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
.+|+.|+|++|+|++ +..+..++.|..++.+.+.
T Consensus 214 ~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~ 265 (597)
T 3oja_B 214 EELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNE 265 (597)
T ss_dssp SEEECCSSCCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSC
T ss_pred heeeccCCcccccccccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCc
Confidence 245666666666665 3567778888888887654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.61 E-value=7.4e-16 Score=175.59 Aligned_cols=162 Identities=16% Similarity=0.054 Sum_probs=134.5
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----------------------ccccceeccccCCCCCCCc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----------------------ESLTDLRISDLNGPEATLP 58 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----------------------~~L~~L~l~~n~~~~~~~~ 58 (790)
++|+|++|+|++.+| |+.+++|+.|+|++|.+++.++ .+|+.|++++|.+....+.
T Consensus 61 ~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~ 138 (487)
T 3oja_A 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDL 138 (487)
T ss_dssp CEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCSGGGB
T ss_pred CEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCCCCch
Confidence 479999999997666 8889999999998888876543 2567777777777766555
Q ss_pred cccc-CcccEEEeccccccccCCcccc-CCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CC
Q 040908 59 DLRN-RTFKNLILRSCNLTGELPHFLG-EVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RG 135 (790)
Q Consensus 59 ~~~~-~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~ 135 (790)
.+.. ++|+.|+|++|.|++.+|..+. ++++|++|+|++|+|++. |. +..+++|+.|+|++|+|++.+|. +.. ++
T Consensus 139 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~ 215 (487)
T 3oja_A 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPE-FQSAAG 215 (487)
T ss_dssp CGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGG-GGGGTT
T ss_pred hhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHh-HcCCCC
Confidence 5555 8999999999999999999886 799999999999999965 43 45699999999999999987666 544 89
Q ss_pred CcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 136 PENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 136 L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
|+.|+|++|+|++ +|..+..++.|..++.+.+
T Consensus 216 L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N 247 (487)
T 3oja_A 216 VTWISLRNNKLVL-IEKALRFSQNLEHFDLRGN 247 (487)
T ss_dssp CSEEECTTSCCCE-ECTTCCCCTTCCEEECTTC
T ss_pred ccEEEecCCcCcc-cchhhccCCCCCEEEcCCC
Confidence 9999999999996 6778888888988887654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.3e-15 Score=174.90 Aligned_cols=118 Identities=14% Similarity=0.052 Sum_probs=86.5
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCcccccCcccEEEecccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCN 74 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~ 74 (790)
++|+|++|+|++..|..|.++++|++|+|++|++++..|. +|+.|++++|.+...+.. ..++|++|+|++|+
T Consensus 55 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~Ls~N~ 132 (562)
T 3a79_B 55 KALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMASLRHLDLSFND 132 (562)
T ss_dssp CEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCTTCSEEECCSSC
T ss_pred CEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccccCCEEECCCCC
Confidence 4688888888866667888888888888888888877653 678888888888755544 44788888888888
Q ss_pred ccc-cCCccccCCCCCCEEEccCCcCCcCcchhccCCCCC--cEEEeeCCcc
Q 040908 75 LTG-ELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADV--DFIYLTGNLL 123 (790)
Q Consensus 75 l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L--~~L~ls~N~l 123 (790)
|++ .+|..|+++++|++|+|++|++++. .+..+++| +.|+|++|++
T Consensus 133 l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 133 FDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp CSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSC
T ss_pred ccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccc
Confidence 886 4567888888888888888887642 23333333 5555555555
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.5e-15 Score=147.06 Aligned_cols=128 Identities=16% Similarity=0.093 Sum_probs=101.0
Q ss_pred CEEEccCCcCc-ccCChhhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccC
Q 040908 1 MYRTVQSNRLS-GELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGEL 79 (790)
Q Consensus 1 ~~L~Ls~N~l~-g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~ 79 (790)
++|+|++|+|+ +.+|..+..+++|+.|++++|.+++. ..+..+ ++|++|+|++|+|++.+
T Consensus 27 ~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l-----------------~~L~~L~Ls~N~l~~~~ 87 (168)
T 2ell_A 27 RELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKL-----------------PKLKKLELSENRIFGGL 87 (168)
T ss_dssp SEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCC-----------------SSCCEEEEESCCCCSCC
T ss_pred CEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccC-----------------CCCCEEECcCCcCchHH
Confidence 46788888887 67787778888888888877777653 222222 68999999999999778
Q ss_pred CccccCCCCCCEEEccCCcCCcCcc--hhccCCCCCcEEEeeCCcccccCC---ccccC-CCCcEEeccCCcccc
Q 040908 80 PHFLGEVSEMKVLDLSFNKLNGTIP--ESFARLADVDFIYLTGNLLTGKVP---QWMFG-RGPENIDLSYNNFAD 148 (790)
Q Consensus 80 p~~~~~l~~L~~L~Ls~N~l~g~ip--~~~~~l~~L~~L~ls~N~l~g~~p---~~~~~-~~L~~l~ls~N~l~g 148 (790)
|..+.++++|++|+|++|+|++ +| ..+..+++|+.|+|++|.+++..+ ..+.. ++|+.|++++|.++.
T Consensus 88 ~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 88 DMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp CHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred HHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 8888889999999999999984 44 788999999999999999987665 35555 889999999998863
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.6e-15 Score=176.23 Aligned_cols=167 Identities=14% Similarity=0.091 Sum_probs=141.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|||++|+|++..|..|.++++|+.|+|++|++++..+. +|+.|++++|.+...+...+.. ++|++|+|++|
T Consensus 31 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 110 (570)
T 2z63_A 31 KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110 (570)
T ss_dssp CEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccccc
Confidence 4799999999977777899999999999999999877653 7888899999888777666766 88999999999
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCc-CcchhccCCCCCcEEEeeCCcccccCCccccC-CCC----cEEeccCCccc
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNG-TIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGP----ENIDLSYNNFA 147 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L----~~l~ls~N~l~ 147 (790)
++++..+..|+++++|++|+|++|++++ .+|..|+++++|+.|++++|++++..|..+.. .+| ..|++++|.++
T Consensus 111 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~ 190 (570)
T 2z63_A 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190 (570)
T ss_dssp CCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC
T ss_pred ccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCce
Confidence 9996555579999999999999999986 47999999999999999999999887777665 666 78999999999
Q ss_pred cCCCCCCCCCCcceeeecCCC
Q 040908 148 DESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 148 g~~p~~~~~~~~l~~~~~~~~ 168 (790)
+..|..+... .|+.++.+.+
T Consensus 191 ~~~~~~~~~~-~L~~L~l~~n 210 (570)
T 2z63_A 191 FIQPGAFKEI-RLHKLTLRNN 210 (570)
T ss_dssp EECTTTTTTC-EEEEEEEESC
T ss_pred ecCHHHhccC-cceeEecccc
Confidence 8888777665 7888877654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.6e-15 Score=178.17 Aligned_cols=154 Identities=16% Similarity=0.092 Sum_probs=105.5
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEeccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSC 73 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N 73 (790)
++|||++|+|++..|..|.+|++|++|+|++|+|+++++. +|+.|+|++|.+...+...|.. ++|++|+|++|
T Consensus 55 ~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N 134 (635)
T 4g8a_A 55 KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 134 (635)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTS
T ss_pred CEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCC
Confidence 4688888888855556788888888888888888876653 5666677777776666655555 67777777777
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCc-CcchhccCCCCCcEEEeeCCcccccCCccccC-----CCCcEEeccCCccc
Q 040908 74 NLTGELPHFLGEVSEMKVLDLSFNKLNG-TIPESFARLADVDFIYLTGNLLTGKVPQWMFG-----RGPENIDLSYNNFA 147 (790)
Q Consensus 74 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-----~~L~~l~ls~N~l~ 147 (790)
+|++..+..|++|++|++|+|++|++++ .+|..++++++|+.|+|++|++++..|..+.. ..+..++++.|.++
T Consensus 135 ~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~ 214 (635)
T 4g8a_A 135 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 214 (635)
T ss_dssp CCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC
T ss_pred cCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccc
Confidence 7775555567777777777777777754 35666777777777777777777666655433 12345677777776
Q ss_pred cCCCCCC
Q 040908 148 DESSGSD 154 (790)
Q Consensus 148 g~~p~~~ 154 (790)
...+..+
T Consensus 215 ~i~~~~~ 221 (635)
T 4g8a_A 215 FIQPGAF 221 (635)
T ss_dssp EECTTTT
T ss_pred ccCcccc
Confidence 5444433
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.7e-15 Score=149.42 Aligned_cols=145 Identities=13% Similarity=0.129 Sum_probs=108.5
Q ss_pred hcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccccccCCccccCCCCCCEEE
Q 040908 19 GSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLD 93 (790)
Q Consensus 19 ~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 93 (790)
+.+++|+.|++++|.+...+. .+|+.|++++|.+... +.+.. ++|++|+|++|++++..|..|++|++|++|+
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~~l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCTTGGGCTTCSEEEEESCCCSCC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred hhcCCccEEeccCCCccChHHHhcCCCCCEEEccCCCCCcc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 555566666666666653221 2566666666644332 23333 7899999999999988888999999999999
Q ss_pred ccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 94 LSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 94 Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
|++|++++..|..+..+++|+.|+|++|++.+.+|. +.. ++|+.|+|++|++++. + .+..+++|+.++.+.+
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~-l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGG-GGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHh-hcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCc
Confidence 999999988899999999999999999984445664 444 8899999999999863 3 6777888888877654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.60 E-value=2.8e-15 Score=160.32 Aligned_cols=159 Identities=14% Similarity=0.158 Sum_probs=127.7
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|+|++|+|+ .+| .+..+++|+.|+|++|.+.+..+ .+|+.|++++|.+...+ .+.. ++|+.|+|++|+|
T Consensus 44 ~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~l~~n~l 119 (308)
T 1h6u_A 44 TTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLTSTQI 119 (308)
T ss_dssp CEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECTTSCC
T ss_pred CEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChhHccCCCCCEEEccCCcCCCch--hhcCCCCCCEEECCCCCC
Confidence 47899999998 677 68889999999999999886553 47888899999877653 4444 8899999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
++ +|. +.++++|++|+|++|++++ +|. +.++++|+.|+|++|++++..+ +.. ++|+.|+|++|++++..+ +
T Consensus 120 ~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l 191 (308)
T 1h6u_A 120 TD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--L 191 (308)
T ss_dssp CC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--G
T ss_pred CC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--h
Confidence 85 554 8899999999999999985 443 8899999999999999986544 444 889999999999987544 7
Q ss_pred CCCCcceeeecCCCCCC
Q 040908 155 CQNGAVNLFASSSKGSN 171 (790)
Q Consensus 155 ~~~~~l~~~~~~~~~~~ 171 (790)
..++.|+.++.+.+.-.
T Consensus 192 ~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 192 ASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp GGCTTCCEEECTTSCCC
T ss_pred cCCCCCCEEEccCCccC
Confidence 78888888888776443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=4.4e-15 Score=176.48 Aligned_cols=168 Identities=15% Similarity=0.141 Sum_probs=132.0
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc-------ccccceeccccCCCCCCCccccc-CcccEEEecc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS-------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRS 72 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~-------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~ 72 (790)
++|+|++|+|++..|..|..+++|+.|++++|.+.+.+| .+|+.|++++|.+.......+.. ++|+.|+|++
T Consensus 384 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~ 463 (680)
T 1ziw_A 384 HILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463 (680)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTT
T ss_pred ceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcc
Confidence 468888899988888889999999999999999876544 37888888888877666666665 7888888888
Q ss_pred cccc--ccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCc--------cccC-CCCcEEec
Q 040908 73 CNLT--GELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQ--------WMFG-RGPENIDL 141 (790)
Q Consensus 73 N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~--------~~~~-~~L~~l~l 141 (790)
|.++ +.+|..|+++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..+. .+.. ++|+.|+|
T Consensus 464 n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L 543 (680)
T 1ziw_A 464 VALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543 (680)
T ss_dssp SCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEEC
T ss_pred ccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEEC
Confidence 8886 56788888888888888888888876677788888888888888888764221 2344 77888888
Q ss_pred cCCccccCCCCCCCCCCcceeeecCCC
Q 040908 142 SYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 142 s~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
++|+|+...+..+..+.+|+.++.+.+
T Consensus 544 ~~N~l~~i~~~~~~~l~~L~~L~Ls~N 570 (680)
T 1ziw_A 544 ESNGFDEIPVEVFKDLFELKIIDLGLN 570 (680)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCCCCCCCHHHcccccCcceeECCCC
Confidence 888888555556788888888887655
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.2e-15 Score=183.43 Aligned_cols=168 Identities=13% Similarity=0.015 Sum_probs=140.3
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccc-c------ccccceeccccCCCCCCCccccc-CcccEEEecc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYF-S------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRS 72 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~-~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~ 72 (790)
++|||++|+|++..|..|.+|++|++|+|++|.+.+.+ | .+|+.|+|++|.+....+..+.. ++|++|+|++
T Consensus 27 ~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 106 (844)
T 3j0a_A 27 ERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYF 106 (844)
T ss_dssp CEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTT
T ss_pred CEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcC
Confidence 47999999999888889999999999999999655443 3 37888899999988777777766 8899999999
Q ss_pred ccccccCCcc--ccCCCCCCEEEccCCcCCcCcc-hhccCCCCCcEEEeeCCcccccCCccccC---CCCcEEeccCCcc
Q 040908 73 CNLTGELPHF--LGEVSEMKVLDLSFNKLNGTIP-ESFARLADVDFIYLTGNLLTGKVPQWMFG---RGPENIDLSYNNF 146 (790)
Q Consensus 73 N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~---~~L~~l~ls~N~l 146 (790)
|.+++.+|.. |++|++|++|+|++|++++..| ..|++|++|+.|+|++|++++..|..+.. ++|+.|+|++|.+
T Consensus 107 n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l 186 (844)
T 3j0a_A 107 CGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL 186 (844)
T ss_dssp CCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBS
T ss_pred CCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCcc
Confidence 9999877765 8999999999999999987655 57899999999999999999888877654 6899999999999
Q ss_pred ccCCCCCCCCCCc------ceeeecCCC
Q 040908 147 ADESSGSDCQNGA------VNLFASSSK 168 (790)
Q Consensus 147 ~g~~p~~~~~~~~------l~~~~~~~~ 168 (790)
++..|..+..+.. |+.++.+.+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~L~~L~Ls~n 214 (844)
T 3j0a_A 187 YSRVSVDWGKCMNPFRNMVLEILDVSGN 214 (844)
T ss_dssp CCCCCCCCCSSSCTTTTCCBSEEBCSSC
T ss_pred ccccccchhhcCCccccCceeEEecCCC
Confidence 9888877766554 778877655
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.59 E-value=5e-15 Score=163.74 Aligned_cols=165 Identities=16% Similarity=0.108 Sum_probs=132.3
Q ss_pred CEEEccCCcCcccCChh-hhcccccCcccccCcccccccc------ccccceeccccCCCCCCCccccc-CcccEEEecc
Q 040908 1 MYRTVQSNRLSGELPEE-LGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRS 72 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~-~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~ 72 (790)
++|++++|.++ .+|.. |..+++|+.|++++|.+....+ .+|+.|++++|.+...++..+.. ++|++|+|++
T Consensus 48 ~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 126 (390)
T 3o6n_A 48 KIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 126 (390)
T ss_dssp SEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred eEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCC
Confidence 47999999998 66665 7899999999999999997765 37999999999999887777666 8999999999
Q ss_pred ccccccCCc-cccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC------------------
Q 040908 73 CNLTGELPH-FLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG------------------ 133 (790)
Q Consensus 73 N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~------------------ 133 (790)
|+|+ .+|. .|+++++|++|+|++|++++..|..|.++++|+.|+|++|++++.....+..
T Consensus 127 n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 205 (390)
T 3o6n_A 127 NDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPI 205 (390)
T ss_dssp SCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCS
T ss_pred CccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCC
Confidence 9999 5555 4699999999999999999888888999999999999999998642221110
Q ss_pred --------------------CCCcEEeccCCccccCCCCCCCCCCcceeeecCCCC
Q 040908 134 --------------------RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 134 --------------------~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
.+|+.|+|++|++++. ..+..++.|+.++.+.+.
T Consensus 206 ~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~ 259 (390)
T 3o6n_A 206 AVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNE 259 (390)
T ss_dssp SCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred cceEEECCCCeeeeccccccccccEEECCCCCCccc--HHHcCCCCccEEECCCCc
Confidence 1455566666666543 456677788888887664
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=3.7e-15 Score=172.40 Aligned_cols=164 Identities=15% Similarity=0.088 Sum_probs=114.1
Q ss_pred CEEEccCCcCcccCChhh-hcccccCcccccCcccccccc---------ccccceeccccCCCCCCC--ccccc-CcccE
Q 040908 1 MYRTVQSNRLSGELPEEL-GSLIHSGKWFGWANSVWHYFS---------ESLTDLRISDLNGPEATL--PDLRN-RTFKN 67 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~-~~L~~L~~L~l~~N~l~~~~~---------~~L~~L~l~~n~~~~~~~--~~~~~-~~L~~ 67 (790)
++|+|++|+++ .+|..+ ..+++|+.|++++|++++..| .+|+.|++++|.+...+. ..+.. ++|++
T Consensus 313 ~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~ 391 (549)
T 2z81_A 313 KRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391 (549)
T ss_dssp CEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCE
T ss_pred eEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCE
Confidence 36788888887 788876 468888888888888876432 368888888888776542 22333 78888
Q ss_pred EEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhc------------------cCCCCCcEEEeeCCcccccCCc
Q 040908 68 LILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESF------------------ARLADVDFIYLTGNLLTGKVPQ 129 (790)
Q Consensus 68 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~------------------~~l~~L~~L~ls~N~l~g~~p~ 129 (790)
|+|++|+|+ .+|..++.+++|++|+|++|+|+ .+|..+ .++++|+.|+|++|+|+ .+|.
T Consensus 392 L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~ 468 (549)
T 2z81_A 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPD 468 (549)
T ss_dssp EECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCC
T ss_pred EECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCC
Confidence 888888888 78888888888888888888876 444433 25666666666666666 4554
Q ss_pred cccCCCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 130 WMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 130 ~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
....++|+.|||++|+|++.+|..+..+.+|+.++.+.+
T Consensus 469 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 507 (549)
T 2z81_A 469 ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507 (549)
T ss_dssp GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSS
T ss_pred cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCC
Confidence 333366666666666666666666666666666665544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.4e-15 Score=174.91 Aligned_cols=165 Identities=16% Similarity=0.133 Sum_probs=134.8
Q ss_pred CEEEccCCcCcccCChhh-----hcccccCcccccCcccccccc----------ccccceeccccCCCCCCCcccccCcc
Q 040908 1 MYRTVQSNRLSGELPEEL-----GSLIHSGKWFGWANSVWHYFS----------ESLTDLRISDLNGPEATLPDLRNRTF 65 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~-----~~L~~L~~L~l~~N~l~~~~~----------~~L~~L~l~~n~~~~~~~~~~~~~~L 65 (790)
++|+|++|+|+|.+|..+ +++++|+.|++++|.+ ..| .+|+.|++++|.+.....+ ...++|
T Consensus 250 ~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~l~~L 326 (520)
T 2z7x_B 250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP-SKISPF 326 (520)
T ss_dssp SEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCC-SSCCCC
T ss_pred cEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccch-hhCCcc
Confidence 478999999999999988 8999999999999998 334 3588999998887655432 123789
Q ss_pred cEEEeccccccccCCccccCCCCCCEEEccCCcCCc--CcchhccCCCCCcEEEeeCCcccccCCcc-ccC-CCCcEEec
Q 040908 66 KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNG--TIPESFARLADVDFIYLTGNLLTGKVPQW-MFG-RGPENIDL 141 (790)
Q Consensus 66 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g--~ip~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~-~~L~~l~l 141 (790)
++|+|++|++++.+|..++++++|++|+|++|++++ .+|..+.++++|+.|+|++|++++.+|.. +.. ++|+.|+|
T Consensus 327 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L 406 (520)
T 2z7x_B 327 LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406 (520)
T ss_dssp CEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEEC
T ss_pred cEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEEC
Confidence 999999999998889999999999999999999986 66788999999999999999999866654 444 78999999
Q ss_pred cCCccccCCCCCCCCCCcceeeecCCCCC
Q 040908 142 SYNNFADESSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 142 s~N~l~g~~p~~~~~~~~l~~~~~~~~~~ 170 (790)
++|++++.+|..++ ..|+.++.+.+.-
T Consensus 407 s~N~l~~~~~~~l~--~~L~~L~Ls~N~l 433 (520)
T 2z7x_B 407 SSNILTDTIFRCLP--PRIKVLDLHSNKI 433 (520)
T ss_dssp CSSCCCGGGGGSCC--TTCCEEECCSSCC
T ss_pred cCCCCCcchhhhhc--ccCCEEECCCCcc
Confidence 99999888777665 6778888776643
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.2e-15 Score=146.95 Aligned_cols=126 Identities=14% Similarity=0.174 Sum_probs=96.6
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccCCc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPH 81 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~ 81 (790)
.+++++|+|+ .+|..+. .+|+.|+|++|.++.. |..+..+ ++|+.|+|++|+|++..|.
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~i-p~~~~~l-----------------~~L~~L~Ls~N~i~~i~~~ 72 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLV-PKELSNY-----------------KHLTLIDLSNNRISTLSNQ 72 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSC-CGGGGGC-----------------TTCCEEECCSSCCCCCCTT
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchh-HHHhhcc-----------------cCCCEEECCCCcCCEeCHh
Confidence 5778888887 7776543 4566666666666532 2333332 6789999999999977777
Q ss_pred cccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCcccc
Q 040908 82 FLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFAD 148 (790)
Q Consensus 82 ~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g 148 (790)
.|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+.. ++|+.|+|++|++..
T Consensus 73 ~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 73 SFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp TTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred HccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 8899999999999999998777778999999999999999998766666655 789999999998863
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.2e-15 Score=144.63 Aligned_cols=129 Identities=16% Similarity=0.121 Sum_probs=99.7
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccCCc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPH 81 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~ 81 (790)
.+++++|+++ .+|..+. ++|+.|++++|++++.++..+..+ ++|++|+|++|+|++..+.
T Consensus 11 ~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l-----------------~~L~~L~l~~n~l~~~~~~ 70 (177)
T 2o6r_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKL-----------------TQLTKLSLSQNQIQSLPDG 70 (177)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTC-----------------TTCSEEECCSSCCCCCCTT
T ss_pred EEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCc-----------------ccccEEECCCCcceEeChh
Confidence 5777888887 6775443 566667777666665444433333 6899999999999966666
Q ss_pred cccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCC
Q 040908 82 FLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADES 150 (790)
Q Consensus 82 ~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~ 150 (790)
.|+++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..+..+.. ++|+.|+|++|++++..
T Consensus 71 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 71 VFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred HccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 7899999999999999999766667899999999999999999766655555 88999999999988643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=2e-15 Score=174.68 Aligned_cols=164 Identities=12% Similarity=0.066 Sum_probs=130.9
Q ss_pred EEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 3 RTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 3 L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
.|+++|+++ .+|..+. ++|+.|+|++|++++..|. +|+.|++++|.+...+...+.. ++|++|+|++|+|
T Consensus 10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence 467778887 7777654 6788888888888766553 6777788888777766666655 8899999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCc-CcchhccCCCCCcEEEeeCCcccccCC-ccccC-CCCcEEeccCCccccCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNG-TIPESFARLADVDFIYLTGNLLTGKVP-QWMFG-RGPENIDLSYNNFADESSG 152 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~-~~L~~l~ls~N~l~g~~p~ 152 (790)
++..|..|+++++|++|+|++|++++ .+|..|+++++|+.|+|++|++.+.+| ..+.. ++|+.|+|++|++++.+|.
T Consensus 87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 166 (549)
T 2z81_A 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ 166 (549)
T ss_dssp CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChh
Confidence 97777779999999999999999986 467788999999999999998655565 45555 7899999999999998899
Q ss_pred CCCCCCcceeeecCCCC
Q 040908 153 SDCQNGAVNLFASSSKG 169 (790)
Q Consensus 153 ~~~~~~~l~~~~~~~~~ 169 (790)
.+..+..|+.++.+.+.
T Consensus 167 ~l~~l~~L~~L~l~~n~ 183 (549)
T 2z81_A 167 SLKSIRDIHHLTLHLSE 183 (549)
T ss_dssp TTTTCSEEEEEEEECSB
T ss_pred hhhccccCceEecccCc
Confidence 99888888888876543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.5e-14 Score=147.80 Aligned_cols=126 Identities=15% Similarity=0.050 Sum_probs=106.1
Q ss_pred ccceeccccCCCCCCCcccccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCC
Q 040908 42 LTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGN 121 (790)
Q Consensus 42 L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N 121 (790)
.+.++++++.+...+... .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 21 ~~~v~c~~~~l~~ip~~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TTEEECTTSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEeEccCCCcCccCCCC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 445666666555554322 278999999999999888999999999999999999998555567899999999999999
Q ss_pred cccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcceeeecCCCCC
Q 040908 122 LLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 122 ~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~~ 170 (790)
+|++..+..+.. ++|+.|+|++|+|+ .+|..+..+.+|+.++.+.+.-
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l 147 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCC
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcC
Confidence 999877777666 89999999999999 7899999999999999987643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-14 Score=155.80 Aligned_cols=156 Identities=14% Similarity=0.207 Sum_probs=108.7
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|+|++|+|+ .+|. +..+++|+.|+|++|.+++... .+|+.|++++|.+...+ .+.. ++|+.|+|++|++
T Consensus 66 ~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l 141 (308)
T 1h6u_A 66 IGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQI 141 (308)
T ss_dssp CEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred CEEEccCCcCC-CChh-HccCCCCCEEEccCCcCCCchhhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCcc
Confidence 46788888887 4444 7778888888888887775432 36777788887776543 2443 7788888888888
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
++. |. ++++++|++|+|++|++++ +|. +.++++|+.|+|++|++++..+ +.. ++|+.|+|++|++++..| +
T Consensus 142 ~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l 213 (308)
T 1h6u_A 142 TNI-SP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--L 213 (308)
T ss_dssp CCC-GG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--G
T ss_pred CcC-cc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--c
Confidence 743 33 7778888888888888874 444 7788888888888888875443 333 778888888888876543 6
Q ss_pred CCCCcceeeecCCC
Q 040908 155 CQNGAVNLFASSSK 168 (790)
Q Consensus 155 ~~~~~l~~~~~~~~ 168 (790)
..+++|+.++.+.+
T Consensus 214 ~~l~~L~~L~l~~N 227 (308)
T 1h6u_A 214 ANTSNLFIVTLTNQ 227 (308)
T ss_dssp TTCTTCCEEEEEEE
T ss_pred cCCCCCCEEEccCC
Confidence 66666766665433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.58 E-value=4.1e-15 Score=152.77 Aligned_cols=160 Identities=15% Similarity=0.012 Sum_probs=129.8
Q ss_pred CEEEccCCc-CcccCChhhhcccccCcccccC-ccccccccc------cccceeccccCCCCCCCccccc-Cccc---EE
Q 040908 1 MYRTVQSNR-LSGELPEELGSLIHSGKWFGWA-NSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFK---NL 68 (790)
Q Consensus 1 ~~L~Ls~N~-l~g~iP~~~~~L~~L~~L~l~~-N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~---~L 68 (790)
++|+|++|+ +++..+..|.++++|+.|++++ |+++...+. +|+.|++++|.+...+. +.. ++|+ .|
T Consensus 58 ~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~lp~--~~~l~~L~~L~~L 135 (239)
T 2xwt_C 58 SRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPD--LTKVYSTDIFFIL 135 (239)
T ss_dssp CEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCSCCC--CTTCCBCCSEEEE
T ss_pred cEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCccccc--cccccccccccEE
Confidence 579999997 8855555899999999999999 999877653 78999999999887553 444 6777 99
Q ss_pred Eeccc-cccccCCccccCCCCCC-EEEccCCcCCcCcchhccCCCCCcEEEeeCCc-ccccCCccccC--CCCcEEeccC
Q 040908 69 ILRSC-NLTGELPHFLGEVSEMK-VLDLSFNKLNGTIPESFARLADVDFIYLTGNL-LTGKVPQWMFG--RGPENIDLSY 143 (790)
Q Consensus 69 ~L~~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~-l~g~~p~~~~~--~~L~~l~ls~ 143 (790)
+|++| ++++..+..|.++++|+ +|+|++|+++ .+|......++|+.|+|++|+ +++..+..+.. ++|+.|+|++
T Consensus 136 ~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~ 214 (239)
T 2xwt_C 136 EITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQ 214 (239)
T ss_dssp EEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTT
T ss_pred ECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCC
Confidence 99999 99976677899999999 9999999999 777765555899999999995 99766666654 5899999999
Q ss_pred CccccCCCCCCCCCCcceeeecC
Q 040908 144 NNFADESSGSDCQNGAVNLFASS 166 (790)
Q Consensus 144 N~l~g~~p~~~~~~~~l~~~~~~ 166 (790)
|+|++..+. .+..|+.+..+
T Consensus 215 N~l~~l~~~---~~~~L~~L~l~ 234 (239)
T 2xwt_C 215 TSVTALPSK---GLEHLKELIAR 234 (239)
T ss_dssp CCCCCCCCT---TCTTCSEEECT
T ss_pred CccccCChh---HhccCceeecc
Confidence 999965444 34455555543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.7e-15 Score=161.67 Aligned_cols=147 Identities=16% Similarity=0.022 Sum_probs=126.7
Q ss_pred cCcccccCccccccc---cccccceeccccCCCCCCCcccc-c-CcccEEEeccccccccCCccccCCCCCCEEEccCCc
Q 040908 24 SGKWFGWANSVWHYF---SESLTDLRISDLNGPEATLPDLR-N-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNK 98 (790)
Q Consensus 24 L~~L~l~~N~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~-~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 98 (790)
-+.+++++|.++..+ |..++.|+|++|.+...+...+. . ++|+.|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 20 ~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~ 99 (361)
T 2xot_A 20 SNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99 (361)
T ss_dssp TTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCc
Confidence 468999999998654 45899999999999988877774 4 899999999999998778889999999999999999
Q ss_pred CCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC---CCCCcceeeecCCCCC
Q 040908 99 LNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD---CQNGAVNLFASSSKGS 170 (790)
Q Consensus 99 l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~---~~~~~l~~~~~~~~~~ 170 (790)
|++..+..|.++++|+.|+|++|++++..|..+.. .+|+.|+|++|+|++..+..+ ..+..|..++.+.+.-
T Consensus 100 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 100 LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred CCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence 99777778999999999999999999888888877 899999999999997555545 5688899998876643
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.57 E-value=3.3e-15 Score=160.47 Aligned_cols=163 Identities=17% Similarity=0.074 Sum_probs=132.2
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----------------------ccccceeccccCCCCCCCc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----------------------ESLTDLRISDLNGPEATLP 58 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----------------------~~L~~L~l~~n~~~~~~~~ 58 (790)
++|+|++|+|++..| |..+++|++|++++|.+++..+ .+|+.|++++|.+......
T Consensus 61 ~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~~~~~ 138 (317)
T 3o53_A 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDL 138 (317)
T ss_dssp CEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCCSGGGB
T ss_pred CEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCCCccch
Confidence 578999999986555 8888888888888888875432 2466777777777766555
Q ss_pred cccc-CcccEEEeccccccccCCccc-cCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CC
Q 040908 59 DLRN-RTFKNLILRSCNLTGELPHFL-GEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RG 135 (790)
Q Consensus 59 ~~~~-~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~ 135 (790)
.+.. ++|++|+|++|+|++..|..+ ..+++|++|+|++|+|++ +|. ...+++|+.|+|++|++++..+. +.. ++
T Consensus 139 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~~l~~~-~~~l~~ 215 (317)
T 3o53_A 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLAFMGPE-FQSAAG 215 (317)
T ss_dssp CTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCCEECGG-GGGGTT
T ss_pred hhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCCcchhh-hcccCc
Confidence 5554 899999999999998888877 479999999999999984 453 44699999999999999976555 555 99
Q ss_pred CcEEeccCCccccCCCCCCCCCCcceeeecCCCC
Q 040908 136 PENIDLSYNNFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 136 L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
|+.|+|++|+|++ +|..+..+++|+.++.+.+.
T Consensus 216 L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~ 248 (317)
T 3o53_A 216 VTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNG 248 (317)
T ss_dssp CSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCC
T ss_pred ccEEECcCCcccc-hhhHhhcCCCCCEEEccCCC
Confidence 9999999999995 68888899999999887653
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.1e-14 Score=168.04 Aligned_cols=149 Identities=20% Similarity=0.158 Sum_probs=116.2
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccc--cccccceeccccCCCCCCCcccccCcccEEEecccccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYF--SESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGE 78 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~ 78 (790)
++|+|++|+|++ +|..+. ++|+.|+|++|+|+.++ +.+|+.|++++|.+...+. +. .+|+.|+|++|+|++
T Consensus 62 ~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~ip~~l~~L~~L~Ls~N~l~~ip~--l~-~~L~~L~Ls~N~l~~- 134 (571)
T 3cvr_A 62 SELQLNRLNLSS-LPDNLP--PQITVLEITQNALISLPELPASLEYLDACDNRLSTLPE--LP-ASLKHLDVDNNQLTM- 134 (571)
T ss_dssp SEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCC--CC-TTCCEEECCSSCCSC-
T ss_pred cEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcccccccCCCCEEEccCCCCCCcch--hh-cCCCEEECCCCcCCC-
Confidence 468999999985 887664 78999999999988544 3578888999998887544 33 389999999999985
Q ss_pred CCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCCCCCC
Q 040908 79 LPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNG 158 (790)
Q Consensus 79 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~ 158 (790)
+|. .+++|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. +. .+|+.|+|++|+|+ .+|. ++.
T Consensus 135 lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~-~~L~~L~Ls~N~L~-~lp~-~~~-- 200 (571)
T 3cvr_A 135 LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP-ESLEALDVSTNLLE-SLPA-VPV-- 200 (571)
T ss_dssp CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC-TTCCEEECCSSCCS-SCCC-CC---
T ss_pred CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh-CCCCEEECcCCCCC-chhh-HHH--
Confidence 777 68899999999999985 776 67889999999999987 666 44 88999999999998 5666 554
Q ss_pred cc-------eeeecCCCCC
Q 040908 159 AV-------NLFASSSKGS 170 (790)
Q Consensus 159 ~l-------~~~~~~~~~~ 170 (790)
.| ..++.+.+..
T Consensus 201 ~L~~~~~~L~~L~Ls~N~l 219 (571)
T 3cvr_A 201 RNHHSEETEIFFRCRENRI 219 (571)
T ss_dssp -------CCEEEECCSSCC
T ss_pred hhhcccccceEEecCCCcc
Confidence 66 7787776543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.2e-14 Score=154.19 Aligned_cols=156 Identities=19% Similarity=0.231 Sum_probs=119.1
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|++++|.|+ .+|. +..+++|+.|+|++|++++..+ .+|+.|++++|.+...+ .+.. ++|+.|+|++|+|
T Consensus 49 ~~L~l~~~~i~-~~~~-~~~l~~L~~L~L~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~L~~n~i 124 (291)
T 1h6t_A 49 DQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLSLEHNGI 124 (291)
T ss_dssp CEEECTTSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEECTTSCC
T ss_pred cEEEccCCCcc-cChh-HhcCCCCCEEEccCCccCCCcccccCCCCCEEECCCCcCCCCh--hhccCCCCCEEECCCCcC
Confidence 46888999888 5554 8888899999999998887654 47888888888876632 3444 7888888888888
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
++ + +.+.++++|++|+|++|++++. ..+..+++|+.|+|++|++++..| +.. ++|+.|+|++|+|++. | .+
T Consensus 125 ~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l 196 (291)
T 1h6t_A 125 SD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-AL 196 (291)
T ss_dssp CC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GG
T ss_pred CC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hh
Confidence 85 3 4688888888888888888854 578888888888888888887655 444 7888888888888763 3 36
Q ss_pred CCCCcceeeecCCC
Q 040908 155 CQNGAVNLFASSSK 168 (790)
Q Consensus 155 ~~~~~l~~~~~~~~ 168 (790)
..+++|+.++.+.+
T Consensus 197 ~~l~~L~~L~l~~n 210 (291)
T 1h6t_A 197 AGLKNLDVLELFSQ 210 (291)
T ss_dssp TTCTTCSEEEEEEE
T ss_pred ccCCCCCEEECcCC
Confidence 77777777766543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-15 Score=176.86 Aligned_cols=160 Identities=18% Similarity=0.148 Sum_probs=82.7
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCcc-------------ccccccc------ccccee-ccccCCCCCC-----
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANS-------------VWHYFSE------SLTDLR-ISDLNGPEAT----- 56 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~-------------l~~~~~~------~L~~L~-l~~n~~~~~~----- 56 (790)
.|+|++|+|+ .+|.+|++|++|+.|++++|. +.+.+|. +|+.|+ ++.|.+....
T Consensus 353 ~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l~l~ 431 (567)
T 1dce_A 353 RCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431 (567)
T ss_dssp SCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHH
T ss_pred eccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhhhhhh
Confidence 5788888887 888888888888888887664 2333322 222222 1111110000
Q ss_pred ---CcccccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC
Q 040908 57 ---LPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG 133 (790)
Q Consensus 57 ---~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~ 133 (790)
...+....|+.|+|++|+|++ +|. |++|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .+..
T Consensus 432 ~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~ 506 (567)
T 1dce_A 432 ENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVAN 506 (567)
T ss_dssp HHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTT
T ss_pred cccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCC
Confidence 000111235555555555552 444 555555555555555555 455555555555555555555554 34 2333
Q ss_pred -CCCcEEeccCCccccCC-CCCCCCCCcceeeecCC
Q 040908 134 -RGPENIDLSYNNFADES-SGSDCQNGAVNLFASSS 167 (790)
Q Consensus 134 -~~L~~l~ls~N~l~g~~-p~~~~~~~~l~~~~~~~ 167 (790)
++|+.|+|++|+|++.+ |..+..+++|..++.+.
T Consensus 507 l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~ 542 (567)
T 1dce_A 507 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542 (567)
T ss_dssp CSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTT
T ss_pred CCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecC
Confidence 45555555555555544 55555555555555543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.56 E-value=2.5e-15 Score=142.45 Aligned_cols=122 Identities=16% Similarity=0.107 Sum_probs=62.7
Q ss_pred EEEccCCcCc-ccCChhhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccCC
Q 040908 2 YRTVQSNRLS-GELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELP 80 (790)
Q Consensus 2 ~L~Ls~N~l~-g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p 80 (790)
+|+|++|+|+ +.+|..+..+++|+.|++++|.+++. ..+..+ ++|++|+|++|+|++.+|
T Consensus 21 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l-----------------~~L~~L~Ls~n~i~~~~~ 81 (149)
T 2je0_A 21 ELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKL-----------------NKLKKLELSDNRVSGGLE 81 (149)
T ss_dssp EEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCC-----------------TTCCEEECCSSCCCSCTH
T ss_pred EEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcC-----------------CCCCEEECCCCcccchHH
Confidence 4555555555 45555555555555555555544432 111111 355556666666555455
Q ss_pred ccccCCCCCCEEEccCCcCCcC-cchhccCCCCCcEEEeeCCcccccCC---ccccC-CCCcEEecc
Q 040908 81 HFLGEVSEMKVLDLSFNKLNGT-IPESFARLADVDFIYLTGNLLTGKVP---QWMFG-RGPENIDLS 142 (790)
Q Consensus 81 ~~~~~l~~L~~L~Ls~N~l~g~-ip~~~~~l~~L~~L~ls~N~l~g~~p---~~~~~-~~L~~l~ls 142 (790)
..++++++|++|+|++|++++. .|..+.++++|+.|+|++|.+++..+ ..+.. ++|+.||++
T Consensus 82 ~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 82 VLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp HHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred HHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 5555555566666666665531 23555555556666666665554443 23333 555555554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.2e-14 Score=170.75 Aligned_cols=128 Identities=16% Similarity=0.170 Sum_probs=104.6
Q ss_pred cccceeccccCCCCCCCccccc-CcccEEEeccccc-cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEe
Q 040908 41 SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL-TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYL 118 (790)
Q Consensus 41 ~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l 118 (790)
++..++++.|.+.......+.. +.|+.|+|++|++ .+.+|..|..+++|++|+|++|+|++..|..|.+|++|+.|+|
T Consensus 446 ~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~L 525 (635)
T 4g8a_A 446 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 525 (635)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEEC
Confidence 5566667777776666555555 7889999998874 4457888899999999999999999888888999999999999
Q ss_pred eCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCC-CcceeeecCCC
Q 040908 119 TGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQN-GAVNLFASSSK 168 (790)
Q Consensus 119 s~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~-~~l~~~~~~~~ 168 (790)
++|+|++..|..+.. ++|+.|||++|+|++..|..+..+ .+|+.++.+.+
T Consensus 526 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~N 577 (635)
T 4g8a_A 526 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 577 (635)
T ss_dssp TTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTC
T ss_pred CCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCC
Confidence 999999888877776 889999999999999888888877 57888877654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.55 E-value=8.7e-15 Score=169.97 Aligned_cols=163 Identities=12% Similarity=0.031 Sum_probs=125.5
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCC--ccccc-CcccEEEec
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATL--PDLRN-RTFKNLILR 71 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~--~~~~~-~~L~~L~L~ 71 (790)
++|++++|++. .++- ...+++|+.|++++|.+++..|. +|+.|++++|.+...+. ..+.. ++|+.|+|+
T Consensus 334 ~~L~l~~n~~~-~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~ 411 (562)
T 3a79_B 334 KMLSISDTPFI-HMVC-PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVS 411 (562)
T ss_dssp SEEEEESSCCC-CCCC-CSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECT
T ss_pred eEEEccCCCcc-cccC-ccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECC
Confidence 46888888886 3321 26778888899999988875543 78888888888876542 22333 789999999
Q ss_pred cccccccCCcc-ccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccC
Q 040908 72 SCNLTGELPHF-LGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADE 149 (790)
Q Consensus 72 ~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~ 149 (790)
+|++++.+|.. +..+++|++|+|++|+|++.+|..+. ++|+.|+|++|+++ .+|..+.. ++|+.|+|++|+|++
T Consensus 412 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~- 487 (562)
T 3a79_B 412 LNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS- 487 (562)
T ss_dssp TSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-
T ss_pred CCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-
Confidence 99999767764 78899999999999999888887655 78999999999998 56655555 889999999999985
Q ss_pred CCCC-CCCCCcceeeecCCCC
Q 040908 150 SSGS-DCQNGAVNLFASSSKG 169 (790)
Q Consensus 150 ~p~~-~~~~~~l~~~~~~~~~ 169 (790)
+|.. +..++.|+.++.+.+.
T Consensus 488 l~~~~~~~l~~L~~L~l~~N~ 508 (562)
T 3a79_B 488 VPDGVFDRLTSLQYIWLHDNP 508 (562)
T ss_dssp CCTTSTTTCTTCCCEECCSCC
T ss_pred CCHHHHhcCCCCCEEEecCCC
Confidence 5554 8888888888876653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.55 E-value=8e-16 Score=183.52 Aligned_cols=142 Identities=18% Similarity=0.093 Sum_probs=111.7
Q ss_pred cCChhhhcccccCcccccCcccccccc-----ccccceeccccCCCCCCCccccc-CcccEEEeccccccccCCccccCC
Q 040908 13 ELPEELGSLIHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEV 86 (790)
Q Consensus 13 ~iP~~~~~L~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l 86 (790)
..|..|..+.+|+.|+|++|.+..+++ .+|+.|+|++|.+...+ ..+.. ++|+.|+|++|+|+ .+|..|++|
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~~lp-~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 292 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLTELP-AEIKNLSNLRVLDLSHNRLT-SLPAELGSC 292 (727)
T ss_dssp -------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCSCCC-GGGGGGTTCCEEECTTSCCS-SCCSSGGGG
T ss_pred cChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCcccC-hhhhCCCCCCEEeCcCCcCC-ccChhhcCC
Confidence 457778889999999999999885543 37888999999888554 33444 89999999999999 889999999
Q ss_pred CCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC--CCCcEEeccCCccccCCCCCCCCC
Q 040908 87 SEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG--RGPENIDLSYNNFADESSGSDCQN 157 (790)
Q Consensus 87 ~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~--~~L~~l~ls~N~l~g~~p~~~~~~ 157 (790)
++|++|+|++|+|+ .+|..|++|++|+.|+|++|.|++.+|..+.. ..+..|+|++|.++|.+|..+..+
T Consensus 293 ~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l 364 (727)
T 4b8c_D 293 FQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFI 364 (727)
T ss_dssp TTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----
T ss_pred CCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccccee
Confidence 99999999999997 88999999999999999999999999987765 233457899999999998876543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.5e-14 Score=174.19 Aligned_cols=169 Identities=17% Similarity=0.158 Sum_probs=122.1
Q ss_pred CEEEccCCcCcccCC-hhhhcccccCcccccCcccccccc--------cc------------------------------
Q 040908 1 MYRTVQSNRLSGELP-EELGSLIHSGKWFGWANSVWHYFS--------ES------------------------------ 41 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP-~~~~~L~~L~~L~l~~N~l~~~~~--------~~------------------------------ 41 (790)
++|||++|++++..| ..|++|++|+.|+|++|.+++..+ .+
T Consensus 126 ~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~ 205 (844)
T 3j0a_A 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMV 205 (844)
T ss_dssp CEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCC
T ss_pred CEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCc
Confidence 478888888886654 468888888888888888765433 23
Q ss_pred ccceeccccCCCCCCCccc---------------------------------------ccCcccEEEeccccccccCCcc
Q 040908 42 LTDLRISDLNGPEATLPDL---------------------------------------RNRTFKNLILRSCNLTGELPHF 82 (790)
Q Consensus 42 L~~L~l~~n~~~~~~~~~~---------------------------------------~~~~L~~L~L~~N~l~~~~p~~ 82 (790)
|+.|++++|.+.......+ ..++|+.|+|++|.+.+..|..
T Consensus 206 L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~ 285 (844)
T 3j0a_A 206 LEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV 285 (844)
T ss_dssp BSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCC
T ss_pred eeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhh
Confidence 4444444443221111000 0146788888888888777778
Q ss_pred ccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcce
Q 040908 83 LGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVN 161 (790)
Q Consensus 83 ~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~ 161 (790)
|+++++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+.. ++|+.|+|++|++++..+..+..+++|+
T Consensus 286 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 365 (844)
T 3j0a_A 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ 365 (844)
T ss_dssp SSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCC
T ss_pred hhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCC
Confidence 888888888888888888777788888888888888888888777777766 7888888888888877777788888888
Q ss_pred eeecCCCC
Q 040908 162 LFASSSKG 169 (790)
Q Consensus 162 ~~~~~~~~ 169 (790)
.++.+.+.
T Consensus 366 ~L~Ls~N~ 373 (844)
T 3j0a_A 366 TLDLRDNA 373 (844)
T ss_dssp EEEEETCC
T ss_pred EEECCCCC
Confidence 88776653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.55 E-value=3.6e-15 Score=148.01 Aligned_cols=137 Identities=15% Similarity=0.101 Sum_probs=111.2
Q ss_pred CEEEccCCcCcccCCh-hhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccC
Q 040908 1 MYRTVQSNRLSGELPE-ELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGEL 79 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~-~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~ 79 (790)
++|+|++|+|++..|. .|+.+++|+.|+|++|+|++..|..+..+ ++|++|+|++|+|++..
T Consensus 32 ~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----------------~~L~~L~Ls~N~l~~~~ 94 (192)
T 1w8a_A 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA-----------------SHIQELQLGENKIKEIS 94 (192)
T ss_dssp SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTC-----------------TTCCEEECCSCCCCEEC
T ss_pred CEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCc-----------------ccCCEEECCCCcCCccC
Confidence 4799999999965554 49999999999999999998888777766 58999999999999888
Q ss_pred CccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCC
Q 040908 80 PHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 80 p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~ 154 (790)
|..|.++++|++|+|++|+|++.+|..|..+++|+.|+|++|.+++..+-......++...+..+......|..+
T Consensus 95 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~l 169 (192)
T 1w8a_A 95 NKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV 169 (192)
T ss_dssp SSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTT
T ss_pred HHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChHH
Confidence 888999999999999999999999999999999999999999999877632222223333444455444445443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.7e-14 Score=168.07 Aligned_cols=156 Identities=19% Similarity=0.227 Sum_probs=126.1
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|+|++|.|+ .+| .|..|++|+.|+|++|.+.+..+ .+|+.|+|++|.+...+ .+.. ++|+.|+|++|+|
T Consensus 46 ~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~l~--~l~~l~~L~~L~Ls~N~l 121 (605)
T 1m9s_A 46 DQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKDLS--SLKDLKKLKSLSLEHNGI 121 (605)
T ss_dssp CCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCCCT--TSTTCTTCCEEECTTSCC
T ss_pred CEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChhhccCCCCCEEECcCCCCCCCh--hhccCCCCCEEEecCCCC
Confidence 36889999998 666 58889999999999999887664 47888889998887644 3444 8899999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
++ + +.+.+|++|+.|+|++|+|++. ..|..|++|+.|+|++|+|++..| +.. ++|+.|+|++|+|++. ..+
T Consensus 122 ~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l 193 (605)
T 1m9s_A 122 SD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RAL 193 (605)
T ss_dssp CC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGG
T ss_pred CC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHH
Confidence 85 4 4588899999999999999854 578899999999999999988766 444 8899999999999874 357
Q ss_pred CCCCcceeeecCCC
Q 040908 155 CQNGAVNLFASSSK 168 (790)
Q Consensus 155 ~~~~~l~~~~~~~~ 168 (790)
..++.|..|+.+.+
T Consensus 194 ~~l~~L~~L~L~~N 207 (605)
T 1m9s_A 194 AGLKNLDVLELFSQ 207 (605)
T ss_dssp TTCTTCSEEECCSE
T ss_pred ccCCCCCEEEccCC
Confidence 78888888887654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.7e-14 Score=164.61 Aligned_cols=128 Identities=19% Similarity=0.136 Sum_probs=78.7
Q ss_pred ccCcccccCcccccccc---ccccceeccccCCCCCCCcccccCcccEEEeccccccccCCccccCCCCCCEEEccCCcC
Q 040908 23 HSGKWFGWANSVWHYFS---ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKL 99 (790)
Q Consensus 23 ~L~~L~l~~N~l~~~~~---~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 99 (790)
+|+.|+|++|.++++++ .+|+.|++++|.+...+ -..++|+.|+|++|+|++ +|. |++ +|++|+|++|+|
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l 132 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLPPQITVLEITQNALISLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQL 132 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCCTTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCC
T ss_pred CccEEEeCCCCCCccCHhHcCCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcC
Confidence 66667777776665332 35666667666666444 112566777777777764 665 544 667777777777
Q ss_pred CcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 100 NGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 100 ~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
++ +|. .+++|+.|+|++|+|++ +|. ..++|+.|+|++|+|++ +|. ++ .+|+.++.+.+
T Consensus 133 ~~-lp~---~l~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N 190 (571)
T 3cvr_A 133 TM-LPE---LPALLEYINADNNQLTM-LPE--LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTN 190 (571)
T ss_dssp SC-CCC---CCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSS
T ss_pred CC-CCC---cCccccEEeCCCCccCc-CCC--cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCC
Confidence 64 555 56667777777777665 444 22566677777777665 454 44 56666666554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=2.2e-16 Score=182.83 Aligned_cols=138 Identities=20% Similarity=0.084 Sum_probs=121.0
Q ss_pred CcccCChhhhcccccCccc-ccCc-------------cccccccccccceeccccCCCCCCCccccc-CcccEEEecccc
Q 040908 10 LSGELPEELGSLIHSGKWF-GWAN-------------SVWHYFSESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCN 74 (790)
Q Consensus 10 l~g~iP~~~~~L~~L~~L~-l~~N-------------~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~ 74 (790)
+.+.+|..++.|++|+.|+ ++.| .+....+..|+.|++++|.+...+. +.. ++|+.|+|++|+
T Consensus 397 ~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~lp~--~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 397 PLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp TGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHHHHHTTCSEEECTTSCCSSCCC--GGGGTTCCEEECCSSC
T ss_pred cccCCHHHHHHHHhcccCcchhhcccchhhhhhhhcccccccCccCceEEEecCCCCCCCcC--ccccccCcEeecCccc
Confidence 6778888999999988888 4544 4555566689999999999988653 554 899999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccC-CccccC-CCCcEEeccCCccccCCCC
Q 040908 75 LTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKV-PQWMFG-RGPENIDLSYNNFADESSG 152 (790)
Q Consensus 75 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~-p~~~~~-~~L~~l~ls~N~l~g~~p~ 152 (790)
|+ .+|..|++|++|+.|+|++|+|++ +| .|++|++|+.|+|++|+|++.+ |..+.. ++|+.|+|++|+|++.+|.
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 99 999999999999999999999995 88 8999999999999999999987 888877 8999999999999987653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.1e-14 Score=149.85 Aligned_cols=153 Identities=16% Similarity=0.188 Sum_probs=92.8
Q ss_pred EEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccccc
Q 040908 3 RTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTG 77 (790)
Q Consensus 3 L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~ 77 (790)
|+|++|.++ .++ .+..+++|+.|++++|.++.... .+|+.|++++|.+...+. +.. ++|+.|+|++|+|++
T Consensus 24 l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~~l~~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~ 99 (263)
T 1xeu_A 24 QNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN 99 (263)
T ss_dssp HHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC
T ss_pred HHhcCCCcc-ccc-chhhcCcCcEEECcCCCcccchHHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC
Confidence 355666666 344 46666666667776666654331 256666666666665443 333 667777777777763
Q ss_pred cCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCC
Q 040908 78 ELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQ 156 (790)
Q Consensus 78 ~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~ 156 (790)
+|... . ++|++|+|++|+|++ +| .+.++++|+.|+|++|++++. | .+.. ++|+.|+|++|+|++. ..+..
T Consensus 100 -l~~~~-~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~ 170 (263)
T 1xeu_A 100 -LNGIP-S-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTR 170 (263)
T ss_dssp -CTTCC-C-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTT
T ss_pred -cCccc-c-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhcc
Confidence 44322 2 667777777777763 33 466777777777777777653 3 2333 6677777777777665 45666
Q ss_pred CCcceeeecCCC
Q 040908 157 NGAVNLFASSSK 168 (790)
Q Consensus 157 ~~~l~~~~~~~~ 168 (790)
++.|+.++.+.+
T Consensus 171 l~~L~~L~l~~N 182 (263)
T 1xeu_A 171 LKKVNWIDLTGQ 182 (263)
T ss_dssp CCCCCEEEEEEE
T ss_pred CCCCCEEeCCCC
Confidence 666666665443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.9e-14 Score=153.78 Aligned_cols=159 Identities=14% Similarity=0.145 Sum_probs=119.1
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|++++|.+++ ++. +..+++|+.|++++|.+.+..+ .+|+.|++++|.+..... +.. ++|+.|+|++|++
T Consensus 158 ~~L~l~~~~~~~-~~~-~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l 233 (347)
T 4fmz_A 158 NYLTVTESKVKD-VTP-IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233 (347)
T ss_dssp CEEECCSSCCCC-CGG-GGGCTTCSEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred cEEEecCCCcCC-chh-hccCCCCCEEEccCCcccccccccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCcc
Confidence 478888888884 443 8888888888888888876543 477778888877765543 333 7788888888888
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
++ +|. +..+++|++|+|++|++++ + ..+..+++|+.|+|++|++++. |. +.. ++|+.|+|++|++++..|..+
T Consensus 234 ~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~~~l 307 (347)
T 4fmz_A 234 TD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SV-LNNLSQLNSLFLNNNQLGNEDMEVI 307 (347)
T ss_dssp CC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GG-GGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred CC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hh-hcCCCCCCEEECcCCcCCCcChhHh
Confidence 74 444 7888888888888888874 4 4678888888888888888764 43 333 778888888888888777777
Q ss_pred CCCCcceeeecCCCC
Q 040908 155 CQNGAVNLFASSSKG 169 (790)
Q Consensus 155 ~~~~~l~~~~~~~~~ 169 (790)
..++.|+.++.+.+.
T Consensus 308 ~~l~~L~~L~L~~n~ 322 (347)
T 4fmz_A 308 GGLTNLTTLFLSQNH 322 (347)
T ss_dssp HTCTTCSEEECCSSS
T ss_pred hccccCCEEEccCCc
Confidence 788888888877654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2e-14 Score=162.16 Aligned_cols=156 Identities=16% Similarity=0.180 Sum_probs=86.2
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccccc-------------------ccceeccccCCCCCCCcccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSES-------------------LTDLRISDLNGPEATLPDLR 61 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~-------------------L~~L~l~~n~~~~~~~~~~~ 61 (790)
++|++++|+| |.+|.+|++|++|++|++++|.+.+..|.. ++.|++++|.+...+. +
T Consensus 14 ~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~--~- 89 (454)
T 1jl5_A 14 QEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE--L- 89 (454)
T ss_dssp ---------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS--C-
T ss_pred hhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC--C-
Confidence 4678888888 688888888888888888888887666642 3556666666654332 1
Q ss_pred cCcccEEEeccccccccCCccccC----------------C-CCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCccc
Q 040908 62 NRTFKNLILRSCNLTGELPHFLGE----------------V-SEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLT 124 (790)
Q Consensus 62 ~~~L~~L~L~~N~l~~~~p~~~~~----------------l-~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~ 124 (790)
.++|+.|+|++|++++ +|..+.+ + ++|++|+|++|++++ +| +|+++++|+.|++++|+++
T Consensus 90 ~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~ 166 (454)
T 1jl5_A 90 PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK 166 (454)
T ss_dssp CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS
T ss_pred cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCc
Confidence 2456666666666664 4433211 1 467777777777764 66 4777777777777777777
Q ss_pred ccCCccccCCCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 125 GKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 125 g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
+ +|... .+|+.|+|++|++++ +| .+..++.|+.++.+.+
T Consensus 167 ~-lp~~~--~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N 205 (454)
T 1jl5_A 167 K-LPDLP--PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNN 205 (454)
T ss_dssp C-CCCCC--TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSS
T ss_pred c-cCCCc--ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCC
Confidence 5 45432 367777777777776 45 4667777777766554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.50 E-value=6.2e-14 Score=163.27 Aligned_cols=142 Identities=18% Similarity=0.265 Sum_probs=121.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|+|++|+|++. |. |..|++|+.|+|++|.+.+... .+|+.|+|++|.+... +.+.. ++|+.|+|++|+|
T Consensus 68 ~~L~Ls~N~l~~~-~~-l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l 143 (605)
T 1m9s_A 68 TKLFLNGNKLTDI-KP-LTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKI 143 (605)
T ss_dssp CEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCTTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred CEEEeeCCCCCCC-hh-hccCCCCCEEECcCCCCCCChhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCcc
Confidence 5799999999954 44 9999999999999999987542 4899999999998864 34544 8999999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSG 152 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~ 152 (790)
++. ..|+.|++|+.|+|++|+|++..| +..|++|+.|+|++|+|++. |. +.. ++|+.|+|++|+|++....
T Consensus 144 ~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~-l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 144 TDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RA-LAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp CCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GG-GTTCTTCSEEECCSEEEECCCCC
T ss_pred CCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hH-HccCCCCCEEEccCCcCcCCccc
Confidence 965 679999999999999999997666 99999999999999999974 54 444 8999999999999875433
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.50 E-value=5.6e-14 Score=148.92 Aligned_cols=139 Identities=19% Similarity=0.300 Sum_probs=119.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|+|++|+|++ +|. +..+++|+.|++++|.+++... .+|+.|++++|.+... +.+.. ++|+.|+|++|+|
T Consensus 71 ~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l 146 (291)
T 1h6t_A 71 TKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKI 146 (291)
T ss_dssp CEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCGGGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCC
T ss_pred CEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCCChhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcC
Confidence 479999999995 554 9999999999999999987543 4899999999998875 44444 8999999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADE 149 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~ 149 (790)
++. ..++.+++|++|+|++|++++..| +..+++|+.|+|++|++++ +|. +.. ++|+.|+|++|+++..
T Consensus 147 ~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 147 TDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEEEEEEEEECC
T ss_pred Ccc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Chh-hccCCCCCEEECcCCcccCC
Confidence 954 679999999999999999996544 9999999999999999996 454 444 8999999999999863
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.49 E-value=2e-13 Score=154.15 Aligned_cols=153 Identities=14% Similarity=0.104 Sum_probs=123.1
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc---ccccceeccccCCCCCCCccccc-CcccEEEecccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS---ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLT 76 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~---~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~ 76 (790)
++|+|++|+|++ +| .|+.+++|++|+|++|.+++... .+|+.|++++|.+...+ +.. ++|++|+|++|+|+
T Consensus 45 ~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~~~~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~~L~L~~N~l~ 119 (457)
T 3bz5_A 45 TSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTLDLSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCDTNKLT 119 (457)
T ss_dssp CEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCCCCTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECCSSCCS
T ss_pred CEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeEccccCCCCCEEECcCCCCceee---cCCCCcCCEEECCCCcCC
Confidence 479999999995 56 69999999999999999987643 47888999999888764 333 78999999999999
Q ss_pred ccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCC
Q 040908 77 GELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDC 155 (790)
Q Consensus 77 ~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~ 155 (790)
+ +| ++++++|++|+|++|+|++ +| ++++++|+.|++++|+..+.++ +.. ++|+.|+|++|+|++ +| +.
T Consensus 120 ~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~--~~~l~~L~~L~ls~n~l~~-l~--l~ 188 (457)
T 3bz5_A 120 K-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE-LD--VS 188 (457)
T ss_dssp C-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCC--CTTCTTCCEEECCSSCCCC-CC--CT
T ss_pred e-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcccccc--cccCCcCCEEECCCCccce-ec--cc
Confidence 6 55 8899999999999999986 44 7888888999988887666663 334 788888888888887 34 66
Q ss_pred CCCcceeeecCCCC
Q 040908 156 QNGAVNLFASSSKG 169 (790)
Q Consensus 156 ~~~~l~~~~~~~~~ 169 (790)
.++.|+.+..+.+.
T Consensus 189 ~l~~L~~L~l~~N~ 202 (457)
T 3bz5_A 189 QNKLLNRLNCDTNN 202 (457)
T ss_dssp TCTTCCEEECCSSC
T ss_pred cCCCCCEEECcCCc
Confidence 77777777776553
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.49 E-value=1.2e-13 Score=156.52 Aligned_cols=158 Identities=18% Similarity=0.209 Sum_probs=127.0
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccc----cccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYF----SESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~----~~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|+|++|++++..| ++.+++|+.|++++|.+.+.. ..+|+.|++++|.+..... +.. ++|+.|+|++|++
T Consensus 202 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l 277 (466)
T 1o6v_A 202 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 277 (466)
T ss_dssp SEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCC
T ss_pred CEEEecCCccccccc--ccccCCCCEEECCCCCcccchhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCcc
Confidence 478999999996555 788999999999999988642 2478899999988876543 433 8899999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
++..| +..+++|++|+|++|++++..| +..+++|+.|+|++|++++..| +.. ++|+.|++++|++++. ..+
T Consensus 278 ~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l 349 (466)
T 1o6v_A 278 SNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSL 349 (466)
T ss_dssp CCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGG
T ss_pred Ccccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhh
Confidence 85443 8889999999999999986444 8889999999999999998766 334 8899999999999875 467
Q ss_pred CCCCcceeeecCCCCC
Q 040908 155 CQNGAVNLFASSSKGS 170 (790)
Q Consensus 155 ~~~~~l~~~~~~~~~~ 170 (790)
..++.|+.++.+.+..
T Consensus 350 ~~l~~L~~L~l~~n~l 365 (466)
T 1o6v_A 350 ANLTNINWLSAGHNQI 365 (466)
T ss_dssp TTCTTCCEEECCSSCC
T ss_pred ccCCCCCEEeCCCCcc
Confidence 7888888888876643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.9e-13 Score=154.22 Aligned_cols=134 Identities=17% Similarity=0.160 Sum_probs=67.5
Q ss_pred cccCcccccCcccccc--ccccccceeccccCCCCCCCccccc-CcccEEEeccccccccCCccccCCCCCCEEEccCCc
Q 040908 22 IHSGKWFGWANSVWHY--FSESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNK 98 (790)
Q Consensus 22 ~~L~~L~l~~N~l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 98 (790)
++|+.|++++|.+++. .|.+|+.|++++|.+...+ .+.. ++|++|+|++|++++ +|..+ .+|++|+|++|+
T Consensus 111 ~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~lp--~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~ 184 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLP--ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQ 184 (454)
T ss_dssp TTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSC
T ss_pred CCCcEEECCCCccCcccCCCCCCCEEECcCCCCCCCc--ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCc
Confidence 3445555555554432 2234555555555544432 2332 455555555555552 44332 355555555555
Q ss_pred CCcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 99 LNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 99 l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
+++ +| .|+++++|+.|++++|++++ +|... .+|+.|++++|+++ .+| .+..++.|+.++.+.+
T Consensus 185 l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N 247 (454)
T 1jl5_A 185 LEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP--LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNN 247 (454)
T ss_dssp CSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSS
T ss_pred CCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCC
Confidence 553 44 45556666666666666554 33221 35666666666665 445 3556666666665543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.48 E-value=6.6e-14 Score=146.10 Aligned_cols=139 Identities=16% Similarity=0.149 Sum_probs=109.5
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCcccccCcccEEEecccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLT 76 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~ 76 (790)
++|+|++|+|+ .+| .+..+++|+.|+|++|++++..+ .+|+.|++++|.+...+.... ++|+.|+|++|+|+
T Consensus 44 ~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~L~~N~l~~l~~~~~--~~L~~L~L~~N~l~ 119 (263)
T 1xeu_A 44 QNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLKNLNGIPS--ACLSRLFLDNNELR 119 (263)
T ss_dssp SEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSCCSCCTTCCC--SSCCEEECCSSCCS
T ss_pred cEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChhhccCCCCCEEECCCCccCCcCcccc--CcccEEEccCCccC
Confidence 46888899888 677 68888889999999998887654 478888888888876543222 78889999999888
Q ss_pred ccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccC
Q 040908 77 GELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADE 149 (790)
Q Consensus 77 ~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~ 149 (790)
+ +| .++++++|++|+|++|+|++ +| .+..+++|+.|+|++|++++. ..+.. ++|+.|+|++|++++.
T Consensus 120 ~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 120 D-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp B-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred C-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 5 44 58888899999999999884 45 688888899999999988876 33444 7888899999988765
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.48 E-value=4.8e-14 Score=140.31 Aligned_cols=143 Identities=12% Similarity=0.114 Sum_probs=120.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|+|++|+|+ .+| .+..+++|+.|++++|.++.... .+|+.|++++|.+....+..+.. ++|++|+|++|++
T Consensus 47 ~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i 124 (197)
T 4ezg_A 47 TYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124 (197)
T ss_dssp CEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBC
T ss_pred cEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCcc
Confidence 47999999999 888 79999999999999998875432 48999999999988655555555 8999999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCcccc
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFAD 148 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g 148 (790)
++..|..++++++|++|+|++|++.+.+| .+.++++|+.|+|++|++++ ++ .+.. ++|+.|++++|++.+
T Consensus 125 ~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 125 DDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp BGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 98899999999999999999999434777 79999999999999999996 44 3444 899999999999864
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.48 E-value=2.5e-15 Score=165.99 Aligned_cols=104 Identities=18% Similarity=0.203 Sum_probs=48.2
Q ss_pred CcccEEEecccccc--c---cCCccccCCCCCCEEEccCCcCC----cCcchhccCCCCCcEEEeeCCccccc----CCc
Q 040908 63 RTFKNLILRSCNLT--G---ELPHFLGEVSEMKVLDLSFNKLN----GTIPESFARLADVDFIYLTGNLLTGK----VPQ 129 (790)
Q Consensus 63 ~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----g~ip~~~~~l~~L~~L~ls~N~l~g~----~p~ 129 (790)
++|+.|+|++|+|+ | .+|..+.++++|++|+|++|+|+ +.+|..+..+++|+.|+|++|++++. +|.
T Consensus 187 ~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 266 (386)
T 2ca6_A 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266 (386)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHH
Confidence 34555555555554 1 23334445555555555555553 34455555555555555555555443 233
Q ss_pred ccc---CCCCcEEeccCCcccc----CCCCCC-CCCCcceeeecC
Q 040908 130 WMF---GRGPENIDLSYNNFAD----ESSGSD-CQNGAVNLFASS 166 (790)
Q Consensus 130 ~~~---~~~L~~l~ls~N~l~g----~~p~~~-~~~~~l~~~~~~ 166 (790)
.+. .++|+.|+|++|+|++ .+|..+ ..+++|+.++.+
T Consensus 267 ~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~ 311 (386)
T 2ca6_A 267 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 311 (386)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECT
T ss_pred HHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEcc
Confidence 321 2445555555555554 244333 223444444443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.6e-13 Score=153.18 Aligned_cols=152 Identities=16% Similarity=0.067 Sum_probs=93.1
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc---ccccceeccccCCCCCCCcccccCcccEEEeccccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS---ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTG 77 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~---~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~ 77 (790)
++|+|++|+|++ +| ++.+++|++|++++|.+++... .+|+.|++++|.+...+ ....++|++|+|++|+|++
T Consensus 67 ~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~ 141 (457)
T 3bz5_A 67 TKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLTKLD--VSQNPLLTYLNCARNTLTE 141 (457)
T ss_dssp SEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECCSSCCSCCC--CTTCTTCCEEECTTSCCSC
T ss_pred CEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCceeecCCCCcCCEEECCCCcCCeec--CCCCCcCCEEECCCCccce
Confidence 467888888874 45 7777778888888887776532 36777777777776643 1122677777777777775
Q ss_pred cCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCC
Q 040908 78 ELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQ 156 (790)
Q Consensus 78 ~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~ 156 (790)
+| ++++++|++|+|++|+..+.+ .+..+++|+.|+|++|++++ +| +.. ++|+.|++++|+|++. .+..
T Consensus 142 -l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~ 210 (457)
T 3bz5_A 142 -ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQ 210 (457)
T ss_dssp -CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTT
T ss_pred -ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---cccc
Confidence 33 666666666666666554455 35566666666666666665 33 222 5555555555555543 2445
Q ss_pred CCcceeeecCCC
Q 040908 157 NGAVNLFASSSK 168 (790)
Q Consensus 157 ~~~l~~~~~~~~ 168 (790)
++.|+.++.+.+
T Consensus 211 l~~L~~L~Ls~N 222 (457)
T 3bz5_A 211 NIQLTFLDCSSN 222 (457)
T ss_dssp CTTCSEEECCSS
T ss_pred CCCCCEEECcCC
Confidence 555555555443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.47 E-value=2e-13 Score=154.61 Aligned_cols=157 Identities=18% Similarity=0.238 Sum_probs=134.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|+|++|+++ .++ .+..+++|+.|++++|.+.+..+ .+|+.|++++|.+... +.+.. ++|+.|+|++|++
T Consensus 180 ~~L~l~~n~l~-~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l 255 (466)
T 1o6v_A 180 ERLDISSNKVS-DIS-VLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQI 255 (466)
T ss_dssp CEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred CEEECcCCcCC-CCh-hhccCCCCCEEEecCCcccccccccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCcc
Confidence 57999999998 454 48999999999999999987764 5899999999988765 34444 8999999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
++..| +.++++|++|+|++|++++..| +..+++|+.|+|++|++++..| +.. ++|+.|+|++|++++..| +
T Consensus 256 ~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~ 327 (466)
T 1o6v_A 256 SNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--V 327 (466)
T ss_dssp CCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--G
T ss_pred ccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--h
Confidence 96655 8999999999999999996444 8999999999999999997655 444 899999999999998776 7
Q ss_pred CCCCcceeeecCCCC
Q 040908 155 CQNGAVNLFASSSKG 169 (790)
Q Consensus 155 ~~~~~l~~~~~~~~~ 169 (790)
..++.|+.++.+.+.
T Consensus 328 ~~l~~L~~L~l~~n~ 342 (466)
T 1o6v_A 328 SSLTKLQRLFFYNNK 342 (466)
T ss_dssp GGCTTCCEEECCSSC
T ss_pred ccCccCCEeECCCCc
Confidence 788999999987764
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=7.1e-14 Score=135.89 Aligned_cols=157 Identities=22% Similarity=0.290 Sum_probs=115.2
Q ss_pred EEeecCCceeEecCCeeeecCCCcc--cccceeccCCCceeeeccccccCCCCCCceeeeccccccCCchhhhhhhhcCC
Q 040908 191 VHINCGGSEVTVNGSTTFEEDTDEA--TAARFGFTGTNHWAFSSTGHFLDDKSPDTNIQKNTSRLLMDDFQLYTEARVSP 268 (790)
Q Consensus 191 ~~~~c~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 268 (790)
..++|||...+-.++..++.|..-. +.+.. + +. .. ......+.+++||+|||.+|
T Consensus 8 ~~INcGg~~~~d~~gr~w~~D~~~~~~g~~~~-------~-----~~-------~~----~~~~~~~~~~~lY~TaR~~~ 64 (174)
T 2jwp_A 8 WAVNAGGESHVDVHGIHYRKDPLEGRVGRASD-------Y-----GM-------KL----PILRSNPEDQVLYQTERYNE 64 (174)
T ss_dssp EEEEETSSSEEETTTEEECSSCSSTTCCCCCC-------C-----CT-------TS----CCSSSCHHHHHTTTCCCCCC
T ss_pred EEEECCCCCccCCCCCEEcCCcCcccCCcccc-------c-----cc-------ce----EecccCCCCchhhhhhccCC
Confidence 4689999887656677888775321 11110 0 00 00 01123556789999999999
Q ss_pred cccceEEeeccCCeeeeeeecceeeeccccccccccceEEEEEecCccccccCCcchhcCCCCCcceeceeeeeecCeeE
Q 040908 269 ISLTYYVFCLENGNYKVNLHFAETMFTDDKTYKSLGRRIFDVYIQGKLELKDFNIEEEAGGVGKPIVKPFSAVVTNGTMD 348 (790)
Q Consensus 269 ~~l~~~~~~~~~g~~~~~~~~a~~~~~~~~~~~~~~~~~~~i~i~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (790)
.+++|+..|..||.|.|+|||||+.+.+ .++|+|+|||++...+++|+|...+++ ..|..+.+.+.++++.+.
T Consensus 65 ~~~tY~f~v~~~G~Y~VrLhF~ei~~~~------~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~~~~~~v~~~~l~ 137 (174)
T 2jwp_A 65 DSFGYDIPIKEEGEYVLVLKFAEVYFAQ------SQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLS 137 (174)
T ss_dssp SCEEEEEECCSCEEEEEEEEEECCSCCC------SSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEEEEEEEEETTEEE
T ss_pred CCeEEEEEeCCCeEEEEEEEEeccccCC------CCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEEEEEEEEecCcee
Confidence 9999999999999999999999998653 799999999999999999999998877 677888899999998888
Q ss_pred EEEEec-CCcceecCC--CCCCCCcccccccC
Q 040908 349 IRLYWA-GKGTTEIPD--RGVYGPLISAISLH 377 (790)
Q Consensus 349 ~~~~~a-g~~~~~~p~--~~~~gp~~s~~~~~ 377 (790)
++.+|+ +.|...+.- ....+|.++++.+.
T Consensus 138 i~~~~~~~~g~L~I~f~p~~~~~a~inaIEI~ 169 (174)
T 2jwp_A 138 VQGEVSTFTGKLSVEFVKGYYDNPKVCALFIM 169 (174)
T ss_dssp ETTEEEECCSEEEEEEECSSSCSSSEEEEEEE
T ss_pred eeeeecccCCeEEEEEeccCCCCcEEEEEEEE
Confidence 887665 455544321 12456777766554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=3.2e-13 Score=133.93 Aligned_cols=122 Identities=20% Similarity=0.197 Sum_probs=104.4
Q ss_pred ceeccccCCCCCCCcccccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcc
Q 040908 44 DLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLL 123 (790)
Q Consensus 44 ~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l 123 (790)
.+++++|.+...+... ..+|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|
T Consensus 14 ~l~~~~~~l~~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 14 VVRCSNKGLKVLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EEECTTSCCSSCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEEcCCCCCCcCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 4555555555444221 257999999999998 8999999999999999999999987788899999999999999999
Q ss_pred cccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 124 TGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 124 ~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
++..|..+.. ++|+.|+|++|+|++..+..+..+.+|..++.+.+
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 136 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSS
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCC
Confidence 9988887877 89999999999999877778999999999887654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.45 E-value=4.7e-14 Score=133.58 Aligned_cols=126 Identities=12% Similarity=0.067 Sum_probs=100.2
Q ss_pred cccCcccccCcccc-ccccccccceeccccCCCCCCCcccccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCC
Q 040908 22 IHSGKWFGWANSVW-HYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLN 100 (790)
Q Consensus 22 ~~L~~L~l~~N~l~-~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 100 (790)
++|+.|++++|.++ +..|..+..+ ++|+.|+|++|+|++. ..++++++|++|+|++|+++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l-----------------~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~ 77 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEF-----------------EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVS 77 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTC-----------------TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhc-----------------CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCccc
Confidence 45566666666655 3333333322 6899999999999965 78999999999999999999
Q ss_pred cCcchhccCCCCCcEEEeeCCccccc-CCccccC-CCCcEEeccCCccccCCC---CCCCCCCcceeeecC
Q 040908 101 GTIPESFARLADVDFIYLTGNLLTGK-VPQWMFG-RGPENIDLSYNNFADESS---GSDCQNGAVNLFASS 166 (790)
Q Consensus 101 g~ip~~~~~l~~L~~L~ls~N~l~g~-~p~~~~~-~~L~~l~ls~N~l~g~~p---~~~~~~~~l~~~~~~ 166 (790)
+.+|..+.++++|+.|+|++|++++. .|..+.. ++|+.|+|++|++++..+ ..+..+++|+.++.+
T Consensus 78 ~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 78 GGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp SCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred chHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 88999999999999999999999974 3455666 899999999999998765 467777888777653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.9e-13 Score=148.39 Aligned_cols=159 Identities=11% Similarity=0.112 Sum_probs=129.2
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|+|++|.....++ .+..+++|+.|++++|.+....+ .+|+.|++++|.+...+. +.. ++|+.|++++|.+
T Consensus 135 ~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l 211 (347)
T 4fmz_A 135 YSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI 211 (347)
T ss_dssp CEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred eEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchhhccCCCCCEEEccCCccccccc--ccCCCccceeecccCCC
Confidence 479999997764544 49999999999999999886653 489999999998876544 444 8899999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
++..+ +..+++|++|+|++|++++ +|. +..+++|+.|+|++|++++. + .+.. ++|+.|+|++|++++. ..+
T Consensus 212 ~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~~--~~~ 283 (347)
T 4fmz_A 212 TDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISDI-N-AVKDLTKLKMLNVGSNQISDI--SVL 283 (347)
T ss_dssp CCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC--GGG
T ss_pred CCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCCC-h-hHhcCCCcCEEEccCCccCCC--hhh
Confidence 85544 8899999999999999984 454 89999999999999999864 4 3444 8999999999999875 457
Q ss_pred CCCCcceeeecCCCCC
Q 040908 155 CQNGAVNLFASSSKGS 170 (790)
Q Consensus 155 ~~~~~l~~~~~~~~~~ 170 (790)
..+++|+.++.+.+..
T Consensus 284 ~~l~~L~~L~L~~n~l 299 (347)
T 4fmz_A 284 NNLSQLNSLFLNNNQL 299 (347)
T ss_dssp GGCTTCSEEECCSSCC
T ss_pred cCCCCCCEEECcCCcC
Confidence 7888899998877643
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.9e-13 Score=155.97 Aligned_cols=128 Identities=16% Similarity=0.132 Sum_probs=61.7
Q ss_pred ccCcccccCcccccc--ccccccceeccccCCCCCCCcccccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCC
Q 040908 23 HSGKWFGWANSVWHY--FSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLN 100 (790)
Q Consensus 23 ~L~~L~l~~N~l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 100 (790)
+|+.|+|++|++++. .+.+|+.|++++|.+...+ ...++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+
T Consensus 142 ~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~---~~~~~L~~L~Ls~N~l~-~l~~~---~~~L~~L~L~~N~l~ 214 (622)
T 3g06_A 142 GLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLP---MLPSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT 214 (622)
T ss_dssp TCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred CCCEEECcCCcCCCcCCccCCCCEEECCCCCCCCCc---ccCCCCcEEECCCCCCC-CCCCc---cchhhEEECcCCccc
Confidence 344444444444432 1234444444444444332 11145666666666665 34432 234444444444444
Q ss_pred cCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 101 GTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 101 g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
.+|. .+++|+.|+|++|+|++ +|.. .++|+.|+|++|+|+. +|. .+.+|..++.+.+
T Consensus 215 -~l~~---~~~~L~~L~Ls~N~L~~-lp~~--l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N 271 (622)
T 3g06_A 215 -SLPA---LPSGLKELIVSGNRLTS-LPVL--PSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRN 271 (622)
T ss_dssp -SCCC---CCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSS
T ss_pred -ccCC---CCCCCCEEEccCCccCc-CCCC--CCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCC
Confidence 3332 13556667777776664 4411 1556667777776663 443 3345555655544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.7e-13 Score=132.59 Aligned_cols=128 Identities=14% Similarity=0.145 Sum_probs=100.2
Q ss_pred cccccceeccccCCC--CCCCccccc-CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcE
Q 040908 39 SESLTDLRISDLNGP--EATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDF 115 (790)
Q Consensus 39 ~~~L~~L~l~~n~~~--~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 115 (790)
|.+|+.|++++|.+. ..+ ..+.. ++|++|+|++|.|++. ..++.+++|++|+|++|++++.+|..+.++++|+.
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIE-GLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCS-SCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred cccCCEEECCCCCCChhhHH-HHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 344555555555444 121 11222 7899999999999965 78999999999999999999889999999999999
Q ss_pred EEeeCCcccccCC-ccccC-CCCcEEeccCCccccCCC---CCCCCCCcceeeecCCCC
Q 040908 116 IYLTGNLLTGKVP-QWMFG-RGPENIDLSYNNFADESS---GSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 116 L~ls~N~l~g~~p-~~~~~-~~L~~l~ls~N~l~g~~p---~~~~~~~~l~~~~~~~~~ 169 (790)
|+|++|++++..+ ..+.. ++|+.|+|++|++++..+ ..+..+++|+.++.+.+.
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~ 158 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRE 158 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETT
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCC
Confidence 9999999997532 55555 899999999999997655 478888899888876553
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.5e-14 Score=158.38 Aligned_cols=169 Identities=18% Similarity=0.120 Sum_probs=131.3
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc-----------ccccceeccccCCCCCCCccccc------C
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS-----------ESLTDLRISDLNGPEATLPDLRN------R 63 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~-----------~~L~~L~l~~n~~~~~~~~~~~~------~ 63 (790)
++++|+.|+++|.+|..+....+|+.|+|++|.++...+ .+|+.|++++|.+.......+.. +
T Consensus 1 ~~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp CEEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred CccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 578999999999999888877789999999999986553 27899999999888766554443 6
Q ss_pred cccEEEeccccccccCCccccC----C-CCCCEEEccCCcCCcCcchhcc----C-CCCCcEEEeeCCcccccCCc----
Q 040908 64 TFKNLILRSCNLTGELPHFLGE----V-SEMKVLDLSFNKLNGTIPESFA----R-LADVDFIYLTGNLLTGKVPQ---- 129 (790)
Q Consensus 64 ~L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~Ls~N~l~g~ip~~~~----~-l~~L~~L~ls~N~l~g~~p~---- 129 (790)
+|++|+|++|+|++..+..++. + ++|++|+|++|+|++..+..+. . .++|+.|+|++|++++..+.
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 8999999999999777765444 4 8999999999999876665543 3 36899999999999864433
Q ss_pred cccC--CCCcEEeccCCccccCCCCCCCC----C-CcceeeecCCCC
Q 040908 130 WMFG--RGPENIDLSYNNFADESSGSDCQ----N-GAVNLFASSSKG 169 (790)
Q Consensus 130 ~~~~--~~L~~l~ls~N~l~g~~p~~~~~----~-~~l~~~~~~~~~ 169 (790)
.+.. .+|+.|+|++|+|++..+..++. + ..|+.++.+.+.
T Consensus 161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 207 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANL 207 (362)
T ss_dssp HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSC
T ss_pred HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCC
Confidence 3333 38999999999998876654443 3 578888887664
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=3.1e-13 Score=131.20 Aligned_cols=87 Identities=21% Similarity=0.184 Sum_probs=70.3
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEec
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDL 141 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~l 141 (790)
++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+.. ++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 46888888888888777888888888888888888888666666788888888888888888776666665 78888888
Q ss_pred cCCccccC
Q 040908 142 SYNNFADE 149 (790)
Q Consensus 142 s~N~l~g~ 149 (790)
++|+++..
T Consensus 110 ~~N~~~c~ 117 (170)
T 3g39_A 110 LNNPWDCA 117 (170)
T ss_dssp CSSCBCTT
T ss_pred CCCCCCCC
Confidence 88888743
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.8e-14 Score=156.24 Aligned_cols=172 Identities=16% Similarity=0.039 Sum_probs=123.8
Q ss_pred CEEEccCCcCcccCC----hhhhccc-ccCcccccCcccccccc-----------ccccceeccccCCCCCCCccccc--
Q 040908 1 MYRTVQSNRLSGELP----EELGSLI-HSGKWFGWANSVWHYFS-----------ESLTDLRISDLNGPEATLPDLRN-- 62 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP----~~~~~L~-~L~~L~l~~N~l~~~~~-----------~~L~~L~l~~n~~~~~~~~~~~~-- 62 (790)
++|||++|+|++..+ ..|..++ +|+.|+|++|.+....+ .+|+.|++++|.+.......+..
T Consensus 25 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l 104 (362)
T 3goz_A 25 TSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTL 104 (362)
T ss_dssp CEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHH
T ss_pred eEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHH
Confidence 478999999986555 6677787 89999999999886543 57888999998887655442221
Q ss_pred ----CcccEEEeccccccccCCcccc----C-CCCCCEEEccCCcCCc----CcchhccCCC-CCcEEEeeCCcccccCC
Q 040908 63 ----RTFKNLILRSCNLTGELPHFLG----E-VSEMKVLDLSFNKLNG----TIPESFARLA-DVDFIYLTGNLLTGKVP 128 (790)
Q Consensus 63 ----~~L~~L~L~~N~l~~~~p~~~~----~-l~~L~~L~Ls~N~l~g----~ip~~~~~l~-~L~~L~ls~N~l~g~~p 128 (790)
++|+.|+|++|+|++..+..+. . .++|++|+|++|+|+. .++..+..++ +|+.|+|++|++++..+
T Consensus 105 ~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~ 184 (362)
T 3goz_A 105 AAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC 184 (362)
T ss_dssp HTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred HhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhH
Confidence 5799999999999866655543 3 3689999999999885 3444556665 89999999999887766
Q ss_pred cccc----C--CCCcEEeccCCccccC----CCCCCCC-CCcceeeecCCCCCCC
Q 040908 129 QWMF----G--RGPENIDLSYNNFADE----SSGSDCQ-NGAVNLFASSSKGSNS 172 (790)
Q Consensus 129 ~~~~----~--~~L~~l~ls~N~l~g~----~p~~~~~-~~~l~~~~~~~~~~~~ 172 (790)
..+. . .+|+.|||++|+|++. ++..+.. .+.|+.++.+.+.-..
T Consensus 185 ~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 239 (362)
T 3goz_A 185 AELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG 239 (362)
T ss_dssp HHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCC
T ss_pred HHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCc
Confidence 4332 2 4789999999998864 3333333 3478888887765443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.2e-12 Score=127.61 Aligned_cols=124 Identities=15% Similarity=0.138 Sum_probs=102.3
Q ss_pred cceeccccCCCCCCCcccccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCc
Q 040908 43 TDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL 122 (790)
Q Consensus 43 ~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~ 122 (790)
+.++++++.+...+... .++|+.|+|++|+|++..+..|+++++|++|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus 10 ~~l~~~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 10 TEIRCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp TEEECCSSCCSSCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEecCCCCccCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 44555555555444222 2689999999999997667778999999999999999996666778999999999999999
Q ss_pred ccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 123 LTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 123 l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
+++..+..+.. ++|+.|+|++|+|++..+..+..+..|..++.+.+
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 134 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCC
Confidence 99887777766 89999999999999877767788999999988665
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.41 E-value=4.5e-14 Score=168.37 Aligned_cols=137 Identities=13% Similarity=0.070 Sum_probs=110.7
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc-----ccccceeccccCCCCCCCcccccCcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l 75 (790)
+.|+|++|+|. .+|..+.+|++|+.|+|++|.|+.+++ .+|+.|+|++|.+..++......++|++|+|++|.|
T Consensus 227 ~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l 305 (727)
T 4b8c_D 227 HALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMV 305 (727)
T ss_dssp CEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCC
T ss_pred cEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCC
Confidence 47999999999 999999999999999999999995443 279999999999996644433348999999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCC-CcEEEeeCCcccccCCccccCCCCcEEeccCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLAD-VDFIYLTGNLLTGKVPQWMFGRGPENIDLSYN 144 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~-L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N 144 (790)
+ .+|..|++|++|++|+|++|+|+|.+|..+..+.. +..|+|++|.++|.+|.. |..|+++.|
T Consensus 306 ~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~-----l~~l~l~~n 369 (727)
T 4b8c_D 306 T-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE-----RRFIEINTD 369 (727)
T ss_dssp C-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--------------
T ss_pred C-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc-----cceeEeecc
Confidence 8 89999999999999999999999999998876543 335899999999999864 566777777
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.41 E-value=1.7e-14 Score=159.26 Aligned_cols=171 Identities=13% Similarity=0.043 Sum_probs=124.8
Q ss_pred CEEEccCCcCcccCChh----hhcccccCcccccCccc---ccccc-------------ccccceeccccCCCCCC----
Q 040908 1 MYRTVQSNRLSGELPEE----LGSLIHSGKWFGWANSV---WHYFS-------------ESLTDLRISDLNGPEAT---- 56 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~----~~~L~~L~~L~l~~N~l---~~~~~-------------~~L~~L~l~~n~~~~~~---- 56 (790)
++|+|++|+|++..+.. |..+++|+.|+|++|.+ .+..| .+|+.|++++|.+....
T Consensus 35 ~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l 114 (386)
T 2ca6_A 35 KEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPL 114 (386)
T ss_dssp CEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHH
T ss_pred cEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHH
Confidence 47899999998765544 56788899999988643 33322 47888888888877632
Q ss_pred Cccccc-CcccEEEeccccccccCCcccc----CC---------CCCCEEEccCCcCC-cCcc---hhccCCCCCcEEEe
Q 040908 57 LPDLRN-RTFKNLILRSCNLTGELPHFLG----EV---------SEMKVLDLSFNKLN-GTIP---ESFARLADVDFIYL 118 (790)
Q Consensus 57 ~~~~~~-~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~Ls~N~l~-g~ip---~~~~~l~~L~~L~l 118 (790)
+..+.. ++|+.|+|++|.|++..+..+. .+ ++|++|+|++|+|+ +.+| ..+..+++|+.|+|
T Consensus 115 ~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 194 (386)
T 2ca6_A 115 IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM 194 (386)
T ss_dssp HHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEEC
T ss_pred HHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEEC
Confidence 223333 7899999999998754444443 33 88999999999987 5566 46778889999999
Q ss_pred eCCccc--c---cCCccccC-CCCcEEeccCCccc----cCCCCCCCCCCcceeeecCCCCCC
Q 040908 119 TGNLLT--G---KVPQWMFG-RGPENIDLSYNNFA----DESSGSDCQNGAVNLFASSSKGSN 171 (790)
Q Consensus 119 s~N~l~--g---~~p~~~~~-~~L~~l~ls~N~l~----g~~p~~~~~~~~l~~~~~~~~~~~ 171 (790)
++|+++ | .+|..+.. ++|+.|+|++|.|+ +.+|..+..++.|+.++.+.+...
T Consensus 195 ~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~ 257 (386)
T 2ca6_A 195 VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257 (386)
T ss_dssp CSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred cCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCc
Confidence 999887 3 34434544 78999999999986 667777888888888888766543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.41 E-value=2.7e-14 Score=154.29 Aligned_cols=168 Identities=15% Similarity=0.139 Sum_probs=132.0
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccc-cc------ccccceeccccCCCCCCCccccc-CcccEEEecc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHY-FS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRS 72 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~-~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~ 72 (790)
++|+|++|.+++..|. +..+++|+.|++++|.++.. .+ .+|+.|++++|.+....+..+.. ++|++|+|++
T Consensus 73 ~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~ 151 (336)
T 2ast_B 73 IAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 151 (336)
T ss_dssp SEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred eEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCC
Confidence 4688999999866555 66789999999999988753 33 37888889888766443334444 7899999999
Q ss_pred c-ccccc-CCccccCCCCCCEEEccCC-cCCcC-cchhccCCC-CCcEEEeeCC--ccc-ccCCccccC-CCCcEEeccC
Q 040908 73 C-NLTGE-LPHFLGEVSEMKVLDLSFN-KLNGT-IPESFARLA-DVDFIYLTGN--LLT-GKVPQWMFG-RGPENIDLSY 143 (790)
Q Consensus 73 N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~g~-ip~~~~~l~-~L~~L~ls~N--~l~-g~~p~~~~~-~~L~~l~ls~ 143 (790)
| .+++. +|..+.++++|++|+|++| ++++. +|..+..++ +|+.|+|++| .++ +.+|..+.. ++|+.|+|++
T Consensus 152 ~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~ 231 (336)
T 2ast_B 152 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 231 (336)
T ss_dssp CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTT
T ss_pred CCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCC
Confidence 9 68763 7777888999999999999 88864 688888899 9999999999 455 455665555 8899999999
Q ss_pred Cc-cccCCCCCCCCCCcceeeecCCCC
Q 040908 144 NN-FADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 144 N~-l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
|. +++..+..+..+++|+.++.+.+.
T Consensus 232 ~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 232 SVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp CTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred CCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 98 777777888888899999887764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.41 E-value=2e-13 Score=133.23 Aligned_cols=83 Identities=14% Similarity=0.251 Sum_probs=47.7
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcch--hccCCCCCcEEEeeCCcccccCCcc----ccC-CC
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPE--SFARLADVDFIYLTGNLLTGKVPQW----MFG-RG 135 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~--~~~~l~~L~~L~ls~N~l~g~~p~~----~~~-~~ 135 (790)
++|++|+|++|+|++..|..|+++++|++|+|++|+|+ .+|. .+..+++|+.|+|++|.++. +|.. +.. ++
T Consensus 64 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~ 141 (176)
T 1a9n_A 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQ 141 (176)
T ss_dssp SSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTT
T ss_pred CCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCc
Confidence 45666666666666333333466666666666666664 4554 56666666666666666653 3332 333 56
Q ss_pred CcEEeccCCccc
Q 040908 136 PENIDLSYNNFA 147 (790)
Q Consensus 136 L~~l~ls~N~l~ 147 (790)
|+.||+++|.+.
T Consensus 142 L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 142 VRVLDFQKVKLK 153 (176)
T ss_dssp CSEETTEECCHH
T ss_pred cceeCCCcCCHH
Confidence 666666666553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.41 E-value=1.9e-14 Score=155.45 Aligned_cols=166 Identities=15% Similarity=0.055 Sum_probs=130.1
Q ss_pred CEEEccCCcCcccCChhhhcc--cccCcccccCcccccccc-----ccccceeccccCCCCC-CCccccc-CcccEEEec
Q 040908 1 MYRTVQSNRLSGELPEELGSL--IHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGPEA-TLPDLRN-RTFKNLILR 71 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L--~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~~~-~~~~~~~-~~L~~L~L~ 71 (790)
+.|||++|++. |..+..+ ++|+.|++++|.+.+..+ .+|+.|++++|.+... ....+.. ++|++|+|+
T Consensus 50 ~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~ 126 (336)
T 2ast_B 50 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 126 (336)
T ss_dssp SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred eeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCc
Confidence 36889998887 5667777 889999999999887665 4788889988876543 2223333 789999999
Q ss_pred cccccccCCccccCCCCCCEEEccCC-cCCc-CcchhccCCCCCcEEEeeCC-ccccc-CCccccC-C-CCcEEeccCC-
Q 040908 72 SCNLTGELPHFLGEVSEMKVLDLSFN-KLNG-TIPESFARLADVDFIYLTGN-LLTGK-VPQWMFG-R-GPENIDLSYN- 144 (790)
Q Consensus 72 ~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~g-~ip~~~~~l~~L~~L~ls~N-~l~g~-~p~~~~~-~-~L~~l~ls~N- 144 (790)
+|.+++..|..++++++|++|+|++| .+++ .+|..+.++++|+.|+|++| .+++. ++..+.. + +|+.|+|++|
T Consensus 127 ~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~ 206 (336)
T 2ast_B 127 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 206 (336)
T ss_dssp TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred CcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence 99998888888999999999999999 6775 37777888999999999999 88864 5555555 7 8999999999
Q ss_pred -ccc-cCCCCCCCCCCcceeeecCCCC
Q 040908 145 -NFA-DESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 145 -~l~-g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
.++ +.+|..+..+++|+.++.+.+.
T Consensus 207 ~~~~~~~l~~~~~~~~~L~~L~l~~~~ 233 (336)
T 2ast_B 207 KNLQKSDLSTLVRRCPNLVHLDLSDSV 233 (336)
T ss_dssp GGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred ccCCHHHHHHHHhhCCCCCEEeCCCCC
Confidence 565 4556666677888888887664
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.40 E-value=3.8e-13 Score=146.46 Aligned_cols=167 Identities=13% Similarity=0.045 Sum_probs=103.8
Q ss_pred CEEEccCCcCcccCCh-hhhcccccCcccccCccccccccc-------ccc-ceeccccCCCCCCCccccc-CcccEEEe
Q 040908 1 MYRTVQSNRLSGELPE-ELGSLIHSGKWFGWANSVWHYFSE-------SLT-DLRISDLNGPEATLPDLRN-RTFKNLIL 70 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~-~~~~L~~L~~L~l~~N~l~~~~~~-------~L~-~L~l~~n~~~~~~~~~~~~-~~L~~L~L 70 (790)
++|+|++|+|+ .||. .|.+|++|++|+|++|++.+.+|. ++. .+.+..|++...+...+.. ++|++|++
T Consensus 33 ~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l 111 (350)
T 4ay9_X 33 IELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 111 (350)
T ss_dssp SEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEE
T ss_pred CEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccc
Confidence 46788888887 5554 577888888888888877654432 222 2344556666666666655 77788888
Q ss_pred ccccccccCCccccCCCCCCEEEccC-CcCCcCcchhccCCC-CCcEEEeeCCcccccCCccccCCCCcEEeccC-Cccc
Q 040908 71 RSCNLTGELPHFLGEVSEMKVLDLSF-NKLNGTIPESFARLA-DVDFIYLTGNLLTGKVPQWMFGRGPENIDLSY-NNFA 147 (790)
Q Consensus 71 ~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~-~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~-N~l~ 147 (790)
++|+|++..+..+..+.++..|++++ |++....+..|..+. .|+.|+|++|+|+...+..+...+|+.|++++ |.++
T Consensus 112 ~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~ 191 (350)
T 4ay9_X 112 SNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE 191 (350)
T ss_dssp EEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCC
T ss_pred cccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCccc
Confidence 88877755555566666666777754 455533334555554 46777777777775444444446677777764 4444
Q ss_pred cCCCCCCCCCCcceeeecCCC
Q 040908 148 DESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 148 g~~p~~~~~~~~l~~~~~~~~ 168 (790)
...+..|..+.+|+.++.+.+
T Consensus 192 ~i~~~~f~~l~~L~~LdLs~N 212 (350)
T 4ay9_X 192 ELPNDVFHGASGPVILDISRT 212 (350)
T ss_dssp CCCTTTTTTEECCSEEECTTS
T ss_pred CCCHHHhccCcccchhhcCCC
Confidence 333345566777777777655
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.39 E-value=2.6e-15 Score=149.65 Aligned_cols=141 Identities=15% Similarity=0.204 Sum_probs=102.7
Q ss_pred EEEccCCcCcccCCh------hhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccc
Q 040908 2 YRTVQSNRLSGELPE------ELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNL 75 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~------~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l 75 (790)
.++|+.|.|+|.+|. .|+.+++|+.|+|++|.+++. | .+..+ ++|+.|+|++|+|
T Consensus 22 ~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-~-~~~~l-----------------~~L~~L~l~~n~l 82 (198)
T 1ds9_A 22 ATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-S-SLSGM-----------------ENLRILSLGRNLI 82 (198)
T ss_dssp CTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCC-C-CHHHH-----------------TTCCEEEEEEEEE
T ss_pred CcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccc-c-ccccC-----------------CCCCEEECCCCCc
Confidence 356777777777776 788888888888888877662 2 33322 6788888888888
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCC-ccccC-CCCcEEeccCCccccCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVP-QWMFG-RGPENIDLSYNNFADESSGS 153 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~-~~L~~l~ls~N~l~g~~p~~ 153 (790)
+ .+|..+..+++|++|+|++|+|++ +| .+.++++|+.|+|++|++++..+ ..+.. ++|+.|++++|++++.+|..
T Consensus 83 ~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~ 159 (198)
T 1ds9_A 83 K-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159 (198)
T ss_dssp C-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTT
T ss_pred c-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccc
Confidence 8 778777778888888888888884 66 67888888888888888875432 24444 78888888888888776653
Q ss_pred ----------CCCCCcceeee
Q 040908 154 ----------DCQNGAVNLFA 164 (790)
Q Consensus 154 ----------~~~~~~l~~~~ 164 (790)
+..+++|+.++
T Consensus 160 ~~~~~~~~~~~~~l~~L~~Ld 180 (198)
T 1ds9_A 160 NATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp TTHHHHHHHHHHHCSSCSEEC
T ss_pred cchHHHHHHHHHhCCCcEEEC
Confidence 55556666554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=6.4e-13 Score=129.47 Aligned_cols=86 Identities=19% Similarity=0.176 Sum_probs=68.6
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEec
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDL 141 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~l 141 (790)
++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..+.. ++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 56888888888888777888888888888888888888654555788888888888888888766655655 78888888
Q ss_pred cCCcccc
Q 040908 142 SYNNFAD 148 (790)
Q Consensus 142 s~N~l~g 148 (790)
++|++..
T Consensus 113 ~~N~~~c 119 (174)
T 2r9u_A 113 YNNPWDC 119 (174)
T ss_dssp CSSCBCT
T ss_pred CCCCccc
Confidence 8888864
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.39 E-value=1.2e-12 Score=127.11 Aligned_cols=101 Identities=17% Similarity=0.093 Sum_probs=63.0
Q ss_pred ccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccC
Q 040908 65 FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSY 143 (790)
Q Consensus 65 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~ 143 (790)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+.. ++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456666666666 4665553 66666666666666555666666666666666666666555554444 6666666666
Q ss_pred CccccCCCCCCCCCCcceeeecCCC
Q 040908 144 NNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 144 N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
|+|++..+..+..+.+|+.++.+.+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N 112 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNN 112 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCC
Confidence 6666655555666666666666544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.38 E-value=1e-12 Score=153.27 Aligned_cols=151 Identities=21% Similarity=0.223 Sum_probs=122.2
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccc--cccccceeccccCCCCCCCcccccCcccEEEecccccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYF--SESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGE 78 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~ 78 (790)
++|+|++|+|+ .+|. .+.+|+.|++++|.++..+ +.+|+.|++++|.+...+.. .++|+.|+|++|+|+ .
T Consensus 144 ~~L~Ls~N~l~-~l~~---~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~-~ 215 (622)
T 3g06_A 144 QELSVSDNQLA-SLPA---LPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-S 215 (622)
T ss_dssp CEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS-S
T ss_pred CEEECcCCcCC-CcCC---ccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCccc-c
Confidence 46788888887 4664 3467889999999998754 35899999999988865431 268999999999998 6
Q ss_pred CCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCCCCCC
Q 040908 79 LPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNG 158 (790)
Q Consensus 79 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~ 158 (790)
+|.. +++|+.|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. ..++|+.|+|++|+|+ .+|..+..++
T Consensus 216 l~~~---~~~L~~L~Ls~N~L~-~lp---~~l~~L~~L~Ls~N~L~~-lp~--~~~~L~~L~Ls~N~L~-~lp~~l~~l~ 284 (622)
T 3g06_A 216 LPAL---PSGLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLTS-LPM--LPSGLLSLSVYRNQLT-RLPESLIHLS 284 (622)
T ss_dssp CCCC---CTTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCC-SCCGGGGGSC
T ss_pred cCCC---CCCCCEEEccCCccC-cCC---CCCCcCcEEECCCCCCCc-CCc--ccccCcEEeCCCCCCC-cCCHHHhhcc
Confidence 7753 488999999999998 477 567889999999999994 565 3478999999999999 7788899999
Q ss_pred cceeeecCCCCC
Q 040908 159 AVNLFASSSKGS 170 (790)
Q Consensus 159 ~l~~~~~~~~~~ 170 (790)
+|..++.+.+.-
T Consensus 285 ~L~~L~L~~N~l 296 (622)
T 3g06_A 285 SETTVNLEGNPL 296 (622)
T ss_dssp TTCEEECCSCCC
T ss_pred ccCEEEecCCCC
Confidence 999999876643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.34 E-value=3.1e-12 Score=124.63 Aligned_cols=102 Identities=16% Similarity=0.146 Sum_probs=80.0
Q ss_pred ccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccC
Q 040908 65 FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSY 143 (790)
Q Consensus 65 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~ 143 (790)
-+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+.. ++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 357888888886 7787664 78888888888888777888888888888888888888766655555 7888888888
Q ss_pred CccccCCCCCCCCCCcceeeecCCCC
Q 040908 144 NNFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 144 N~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
|+|++..+..+..+.+|..++.+.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~ 116 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNP 116 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSC
T ss_pred CccceeCHHHhccccCCCEEEeCCCC
Confidence 88887666668888888888876553
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.1e-12 Score=140.51 Aligned_cols=163 Identities=18% Similarity=0.082 Sum_probs=126.5
Q ss_pred CEEEccCCcCcccCCh-hhhcccccCc-ccccCccccccccc------cccceeccccCCCCCCCccccc-CcccEEEec
Q 040908 1 MYRTVQSNRLSGELPE-ELGSLIHSGK-WFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILR 71 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~-~~~~L~~L~~-L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~ 71 (790)
++|+|++|+|.+.+|. .|.+|++|.. +.+..|+++...|. +|+.|++++|.+...+...+.. .++..|++.
T Consensus 57 ~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~ 136 (350)
T 4ay9_X 57 EKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 136 (350)
T ss_dssp CEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEE
T ss_pred CEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhc
Confidence 5899999999878886 5788988775 67778999887663 7888999999998776655444 778899997
Q ss_pred c-ccccccCCccccCCC-CCCEEEccCCcCCcCcchhccCCCCCcEEEeeC-CcccccCC-ccccC-CCCcEEeccCCcc
Q 040908 72 S-CNLTGELPHFLGEVS-EMKVLDLSFNKLNGTIPESFARLADVDFIYLTG-NLLTGKVP-QWMFG-RGPENIDLSYNNF 146 (790)
Q Consensus 72 ~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~-N~l~g~~p-~~~~~-~~L~~l~ls~N~l 146 (790)
+ |++....+..|..+. .|+.|+|++|+|+ .+|.......+|+.|++++ |.++ .+| ..+.. .+|+.|||++|+|
T Consensus 137 ~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l 214 (350)
T 4ay9_X 137 DNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRI 214 (350)
T ss_dssp SCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCC
T ss_pred cccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCc
Confidence 6 677755555777765 6899999999998 6777777778999999986 5555 555 45555 8999999999999
Q ss_pred ccCCCCCCCCCCcceeeec
Q 040908 147 ADESSGSDCQNGAVNLFAS 165 (790)
Q Consensus 147 ~g~~p~~~~~~~~l~~~~~ 165 (790)
+...+..+..+.+|..+..
T Consensus 215 ~~lp~~~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 215 HSLPSYGLENLKKLRARST 233 (350)
T ss_dssp CCCCSSSCTTCCEEECTTC
T ss_pred CccChhhhccchHhhhccC
Confidence 9766666766666655443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=2.8e-11 Score=125.76 Aligned_cols=147 Identities=14% Similarity=0.095 Sum_probs=115.6
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEE
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 519 (790)
+...-+.|++...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. |..+.++++++...+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3344567888899999999999999864 6789999986532233346889999999884 6778889999998889999
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhc----------------------------------
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE---------------------------------- 565 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------------------------------- 565 (790)
||||++|.+|.+.+. +......++.+++++|+.||+.
T Consensus 88 v~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999999887641 1223457889999999999981
Q ss_pred ----------------------CCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 566 ----------------------SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 566 ----------------------~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
....++|+|+++.|||++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11458999999999999876666799998765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.26 E-value=4.7e-12 Score=123.38 Aligned_cols=102 Identities=12% Similarity=0.053 Sum_probs=84.4
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCc--cccC-CCCcEE
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQ--WMFG-RGPENI 139 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~--~~~~-~~L~~l 139 (790)
++|+.|+|++|+|++. +.|+++++|++|+|++|+|++..|..|..+++|+.|+|++|+++ .+|. .+.. ++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 4899999999999965 67999999999999999999544455699999999999999996 4555 5555 899999
Q ss_pred eccCCccccCCCCC----CCCCCcceeeecCCC
Q 040908 140 DLSYNNFADESSGS----DCQNGAVNLFASSSK 168 (790)
Q Consensus 140 ~ls~N~l~g~~p~~----~~~~~~l~~~~~~~~ 168 (790)
+|++|+++. +|.. +..++.|+.++.+.+
T Consensus 119 ~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n 150 (176)
T 1a9n_A 119 CILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKV 150 (176)
T ss_dssp ECCSSGGGG-STTHHHHHHHHCTTCSEETTEEC
T ss_pred EecCCCCCC-cHhHHHHHHHHCCccceeCCCcC
Confidence 999999984 4553 777788888776543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=7.4e-12 Score=135.87 Aligned_cols=85 Identities=18% Similarity=0.135 Sum_probs=51.2
Q ss_pred CcccEEEecc-ccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEec
Q 040908 63 RTFKNLILRS-CNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDL 141 (790)
Q Consensus 63 ~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~l 141 (790)
++|+.|+|++ |+|++..|..|++|++|++|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..+....|+.|+|
T Consensus 31 ~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l 110 (347)
T 2ifg_A 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVL 110 (347)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEEC
T ss_pred CCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCCceEEEe
Confidence 4566666664 666655555666666666666666666665555666666666666666666654444444444666666
Q ss_pred cCCccc
Q 040908 142 SYNNFA 147 (790)
Q Consensus 142 s~N~l~ 147 (790)
++|+|.
T Consensus 111 ~~N~~~ 116 (347)
T 2ifg_A 111 SGNPLH 116 (347)
T ss_dssp CSSCCC
T ss_pred eCCCcc
Confidence 666664
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.26 E-value=2.2e-13 Score=153.75 Aligned_cols=167 Identities=16% Similarity=0.057 Sum_probs=83.3
Q ss_pred EEEccCCcCccc----CChhhhcccccCcccccCcccccc-----------ccccccceeccccCCCCCC----Ccccc-
Q 040908 2 YRTVQSNRLSGE----LPEELGSLIHSGKWFGWANSVWHY-----------FSESLTDLRISDLNGPEAT----LPDLR- 61 (790)
Q Consensus 2 ~L~Ls~N~l~g~----iP~~~~~L~~L~~L~l~~N~l~~~-----------~~~~L~~L~l~~n~~~~~~----~~~~~- 61 (790)
+|+|++|++++. +|..+..+++|+.|++++|.+... ...+|+.|++++|.+.... ...+.
T Consensus 203 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 282 (461)
T 1z7x_W 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282 (461)
T ss_dssp EEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHH
T ss_pred EEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhh
Confidence 455555555532 344455555555555555555421 0234555555555444321 11111
Q ss_pred cCcccEEEeccccccccCCccccC-----CCCCCEEEccCCcCCcC----cchhccCCCCCcEEEeeCCcccccCCcccc
Q 040908 62 NRTFKNLILRSCNLTGELPHFLGE-----VSEMKVLDLSFNKLNGT----IPESFARLADVDFIYLTGNLLTGKVPQWMF 132 (790)
Q Consensus 62 ~~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~ 132 (790)
.++|+.|+|++|.|++..+..+.. .++|++|+|++|++++. +|..+..+++|+.|+|++|++++..+..+.
T Consensus 283 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 362 (461)
T 1z7x_W 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362 (461)
T ss_dssp CTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred CCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHH
Confidence 145555566555555433332222 24556666666655543 445555556666666666666544333222
Q ss_pred ------CCCCcEEeccCCcccc----CCCCCCCCCCcceeeecCCC
Q 040908 133 ------GRGPENIDLSYNNFAD----ESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 133 ------~~~L~~l~ls~N~l~g----~~p~~~~~~~~l~~~~~~~~ 168 (790)
.++|+.|+|++|++++ .+|..+..+++|+.++.+.+
T Consensus 363 ~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N 408 (461)
T 1z7x_W 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 408 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSS
T ss_pred HHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCC
Confidence 2356666666666654 45555555555666555443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.21 E-value=6.4e-13 Score=149.92 Aligned_cols=166 Identities=14% Similarity=0.059 Sum_probs=77.5
Q ss_pred EEEccCCcCcc----cCChhhhcccccCcccccCcccccccc-----------ccccceeccccCCCCCCCc----cccc
Q 040908 2 YRTVQSNRLSG----ELPEELGSLIHSGKWFGWANSVWHYFS-----------ESLTDLRISDLNGPEATLP----DLRN 62 (790)
Q Consensus 2 ~L~Ls~N~l~g----~iP~~~~~L~~L~~L~l~~N~l~~~~~-----------~~L~~L~l~~n~~~~~~~~----~~~~ 62 (790)
+|+|++|+|+. .+|..|..+++|+.|+|++|.+....+ .+|+.|++++|.+...... .+..
T Consensus 89 ~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 168 (461)
T 1z7x_W 89 KLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168 (461)
T ss_dssp EEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHH
T ss_pred EEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhh
Confidence 45555555552 345555555555555555555542111 1355555555544432211 1111
Q ss_pred -CcccEEEeccccccccCCcccc-----CCCCCCEEEccCCcCCcC----cchhccCCCCCcEEEeeCCcccccC-----
Q 040908 63 -RTFKNLILRSCNLTGELPHFLG-----EVSEMKVLDLSFNKLNGT----IPESFARLADVDFIYLTGNLLTGKV----- 127 (790)
Q Consensus 63 -~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~~----- 127 (790)
++|+.|+|++|.+++..+..+. .+++|++|+|++|++++. +|..+..+++|+.|+|++|++++..
T Consensus 169 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~ 248 (461)
T 1z7x_W 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELC 248 (461)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH
T ss_pred CCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHH
Confidence 4555555555555543333332 234555555555555532 4555555555556666555554321
Q ss_pred CccccC-CCCcEEeccCCccccC----CCCCCCCCCcceeeecCC
Q 040908 128 PQWMFG-RGPENIDLSYNNFADE----SSGSDCQNGAVNLFASSS 167 (790)
Q Consensus 128 p~~~~~-~~L~~l~ls~N~l~g~----~p~~~~~~~~l~~~~~~~ 167 (790)
+..... ++|+.|+|++|+++.. ++..+..++.|+.++.+.
T Consensus 249 ~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~ 293 (461)
T 1z7x_W 249 PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTT
T ss_pred HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCC
Confidence 111111 4555666666655543 333343445555555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.2e-12 Score=130.36 Aligned_cols=123 Identities=15% Similarity=0.121 Sum_probs=100.2
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccCC
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELP 80 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p 80 (790)
++|+|++|+|++ +| .+..+++|+.|++++|.++.. |..+..+ ++|+.|+|++|+|++ +|
T Consensus 51 ~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l-~~~~~~~-----------------~~L~~L~L~~N~l~~-l~ 109 (198)
T 1ds9_A 51 KHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKI-ENLDAVA-----------------DTLEELWISYNQIAS-LS 109 (198)
T ss_dssp SEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSC-SSHHHHH-----------------HHCSEEEEEEEECCC-HH
T ss_pred CEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccc-cchhhcC-----------------CcCCEEECcCCcCCc-CC
Confidence 579999999995 88 899999999999999988742 2222221 579999999999995 66
Q ss_pred ccccCCCCCCEEEccCCcCCcCcc--hhccCCCCCcEEEeeCCcccccCCcc----------ccC-CCCcEEeccCCccc
Q 040908 81 HFLGEVSEMKVLDLSFNKLNGTIP--ESFARLADVDFIYLTGNLLTGKVPQW----------MFG-RGPENIDLSYNNFA 147 (790)
Q Consensus 81 ~~~~~l~~L~~L~Ls~N~l~g~ip--~~~~~l~~L~~L~ls~N~l~g~~p~~----------~~~-~~L~~l~ls~N~l~ 147 (790)
.++++++|++|+|++|+++ .+| ..+..+++|+.|+|++|.+++.+|.. +.. ++|+.|| +|.++
T Consensus 110 -~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 110 -GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp -HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred -ccccCCCCCEEECCCCcCC-chhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 6899999999999999998 444 47999999999999999999887652 334 8899887 77776
Q ss_pred c
Q 040908 148 D 148 (790)
Q Consensus 148 g 148 (790)
.
T Consensus 186 ~ 186 (198)
T 1ds9_A 186 V 186 (198)
T ss_dssp T
T ss_pred H
Confidence 3
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=6.6e-11 Score=122.41 Aligned_cols=138 Identities=16% Similarity=0.124 Sum_probs=102.0
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCce--eeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL--VKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~lV~E 522 (790)
...+.+....+.|..+.||++...+|+.+++|..... ....+..|+.+++.+.+.++ .++++++..++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3455554443456669999998777888999987543 22457789999999865554 558888888788999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC------------------------------------
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES------------------------------------ 566 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------------ 566 (790)
|++|.+|. ... . ....++.++++.|+.||+..
T Consensus 96 ~i~G~~l~--~~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 96 EVPGQDLL--SSH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CCSSEETT--TSC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred ecCCcccC--cCc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99998884 210 1 12357778888888888642
Q ss_pred -------------------CCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 567 -------------------RLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 567 -------------------~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
...++|+|++|.|||++++..+.|+|||.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999876
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.08 E-value=8.7e-12 Score=136.64 Aligned_cols=148 Identities=12% Similarity=-0.013 Sum_probs=106.5
Q ss_pred CEEEccCCcCcccCChhhhcc-----cccCcccccCcccccccc-------ccccceeccccCCCCCCCccc------cc
Q 040908 1 MYRTVQSNRLSGELPEELGSL-----IHSGKWFGWANSVWHYFS-------ESLTDLRISDLNGPEATLPDL------RN 62 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L-----~~L~~L~l~~N~l~~~~~-------~~L~~L~l~~n~~~~~~~~~~------~~ 62 (790)
++|+|++|+|+..-...|..+ .+|+.|+|++|.++.... .+|+.|+|++|.+.......+ ..
T Consensus 75 ~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~ 154 (372)
T 3un9_A 75 RQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQ 154 (372)
T ss_dssp CEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTT
T ss_pred CEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcC
Confidence 478999999986555556554 689999999998863221 368888888887764433332 12
Q ss_pred CcccEEEeccccccc----cCCccccCCCCCCEEEccCCcCCc----CcchhccCCCCCcEEEeeCCcccccC----Ccc
Q 040908 63 RTFKNLILRSCNLTG----ELPHFLGEVSEMKVLDLSFNKLNG----TIPESFARLADVDFIYLTGNLLTGKV----PQW 130 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~ls~N~l~g~~----p~~ 130 (790)
.+|+.|+|++|.|+. .++..+..+++|++|+|++|+|+. .++..+..+++|+.|+|++|.++..- +..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 678899999998874 345556778889999999998864 23566777888999999999887532 222
Q ss_pred ccC-CCCcEEeccCCcccc
Q 040908 131 MFG-RGPENIDLSYNNFAD 148 (790)
Q Consensus 131 ~~~-~~L~~l~ls~N~l~g 148 (790)
+.. ++|+.|||++|.|+.
T Consensus 235 L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHCSSCCEEECTTSSCCH
T ss_pred HHhCCCCCEEeccCCCCCH
Confidence 322 778899999998864
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.08 E-value=2.6e-10 Score=123.67 Aligned_cols=100 Identities=15% Similarity=0.085 Sum_probs=87.9
Q ss_pred EEEeccc-cccccCCccccCCCCCCEEEccC-CcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccC
Q 040908 67 NLILRSC-NLTGELPHFLGEVSEMKVLDLSF-NKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSY 143 (790)
Q Consensus 67 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~ 143 (790)
.++++++ +|+ .+|. |..+++|++|+|++ |+|++..|..|.+|++|+.|+|++|+|++.+|..|.. ++|+.|||++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4688988 898 6999 99999999999996 9999877789999999999999999999999988877 8999999999
Q ss_pred CccccCCCCCCCCCCcceeeecCCCC
Q 040908 144 NNFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 144 N~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
|+|++..+..+..+. |..+....+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~ 114 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNP 114 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCC
Confidence 999987766666655 8888876553
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.00 E-value=9.1e-10 Score=118.51 Aligned_cols=98 Identities=11% Similarity=0.023 Sum_probs=51.9
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCc-EEEeeCCcccccCCccccC-CCCcEEe
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVD-FIYLTGNLLTGKVPQWMFG-RGPENID 140 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~-~L~ls~N~l~g~~p~~~~~-~~L~~l~ 140 (790)
++|+.|+|++|+++..-+..|.+|.+|+.|+|++| ++..-+..|.+|++|+ .|+|.+ +++..-+..|.. .+|+.|+
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 35556666655555333334555666666666555 4433334455666665 666655 444333444444 5566666
Q ss_pred ccCCccccCCCCCCCCCCccee
Q 040908 141 LSYNNFADESSGSDCQNGAVNL 162 (790)
Q Consensus 141 ls~N~l~g~~p~~~~~~~~l~~ 162 (790)
|+.|+++...+..|..+.+|+.
T Consensus 304 l~~n~i~~I~~~aF~~~~~L~~ 325 (329)
T 3sb4_A 304 ATGDKITTLGDELFGNGVPSKL 325 (329)
T ss_dssp ECSSCCCEECTTTTCTTCCCCE
T ss_pred eCCCccCccchhhhcCCcchhh
Confidence 6666655555555555554443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.3e-09 Score=116.74 Aligned_cols=142 Identities=18% Similarity=0.257 Sum_probs=106.6
Q ss_pred eeeeecccCcEEEEeeeecCCcEEEEEEcc--ccc-hhcHHHHHHHHHHhhccC--CCceeeeeeEEEeC---CeEEEEE
Q 040908 450 VANKIGEGGFGPVYKGLLADGTLIAVKQLS--AKS-KQGNREFVNEIGTISALQ--HPHLVKLYGCCIEG---NQLLLIY 521 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 521 (790)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 46789999999999998765 568888775 322 122346788999999986 45678889888766 4479999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC-----------------------------------
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES----------------------------------- 566 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------- 566 (790)
||+++..+.+.. ...++...+..++.+++++|+.||+..
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999998775422 124677888899999999999999731
Q ss_pred --------------------CCcEEeccCCCCcEEecCCCC--eEEeecCCccc
Q 040908 567 --------------------RLKIVHRDIKATNVLLDKDLN--PKISDFGLAKL 598 (790)
Q Consensus 567 --------------------~~~iiHrDlk~~NILl~~~~~--~kl~DFGla~~ 598 (790)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.1e-09 Score=116.42 Aligned_cols=187 Identities=18% Similarity=0.217 Sum_probs=121.9
Q ss_pred eeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccC-CCc--eeeeeeEEEeCC---eEEEEEEec
Q 040908 451 ANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPH--LVKLYGCCIEGN---QLLLIYEYL 524 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~Ey~ 524 (790)
.+.++.|....||+.. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999864 45888876432 33467889999998883 333 334444433332 348899999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhc---------------------------------------
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE--------------------------------------- 565 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------------------------------------- 565 (790)
+|.++.+... ..++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988865431 2456667778888888888888851
Q ss_pred ----------------CCCcEEeccCCCCcEEecC--CCCeEEeecCCccccCCCCccee-------------eccccCC
Q 040908 566 ----------------SRLKIVHRDIKATNVLLDK--DLNPKISDFGLAKLDEEDNTHIS-------------TRVAGTF 614 (790)
Q Consensus 566 ----------------~~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~~~~~~~~~~-------------~~~~gt~ 614 (790)
..+.++|+|+++.||++++ +..+.|.||+.+...+....-.. ......+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1235899999999999998 45678999999875432110000 0000111
Q ss_pred Cccc-HHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCc
Q 040908 615 GYMA-PEYAMRGHLTDKADVYSFGIVALEIVSGRSNIM 651 (790)
Q Consensus 615 ~y~a-PE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~ 651 (790)
+... |+..... ....+.|+++.++|++.+|+.++.
T Consensus 253 ~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence 2222 3322211 123689999999999999987653
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.72 E-value=5.1e-10 Score=122.53 Aligned_cols=149 Identities=17% Similarity=0.099 Sum_probs=110.0
Q ss_pred ccccCcccccCccccccc-----------cccccceeccccCCCCCCCccccc--CcccEEEeccccccccCCccc----
Q 040908 21 LIHSGKWFGWANSVWHYF-----------SESLTDLRISDLNGPEATLPDLRN--RTFKNLILRSCNLTGELPHFL---- 83 (790)
Q Consensus 21 L~~L~~L~l~~N~l~~~~-----------~~~L~~L~l~~n~~~~~~~~~~~~--~~L~~L~L~~N~l~~~~p~~~---- 83 (790)
+++|+.|+|++|.++... +.+|+.|+|++|.+.......+.. .+|+.|+|++|+|+..-...+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 357999999999997321 258999999999876543333332 679999999999985544444
Q ss_pred -cCCCCCCEEEccCCcCCc----CcchhccCCCCCcEEEeeCCcccccC----CccccC-CCCcEEeccCCccccC----
Q 040908 84 -GEVSEMKVLDLSFNKLNG----TIPESFARLADVDFIYLTGNLLTGKV----PQWMFG-RGPENIDLSYNNFADE---- 149 (790)
Q Consensus 84 -~~l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~ls~N~l~g~~----p~~~~~-~~L~~l~ls~N~l~g~---- 149 (790)
...++|++|+|++|+|+. .++..+..+++|+.|+|++|.|+..- +..+.. .+|+.|+|++|.|+..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 356889999999999974 35566688999999999999998532 334444 7899999999999753
Q ss_pred CCCCCCCCCcceeeecCCCC
Q 040908 150 SSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 150 ~p~~~~~~~~l~~~~~~~~~ 169 (790)
++..+..++.|+.++.+.+.
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~ 250 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNE 250 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSS
T ss_pred HHHHHHhCCCCCEEeccCCC
Confidence 22333345678888876653
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.63 E-value=1.2e-09 Score=127.03 Aligned_cols=107 Identities=9% Similarity=0.014 Sum_probs=64.7
Q ss_pred CcccEEEeccccccccCCccccC-CCCCCEEEcc----CCcCCcC-----cchhccCCCCCcEEEeeCC--cccccCCcc
Q 040908 63 RTFKNLILRSCNLTGELPHFLGE-VSEMKVLDLS----FNKLNGT-----IPESFARLADVDFIYLTGN--LLTGKVPQW 130 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~g~-----ip~~~~~l~~L~~L~ls~N--~l~g~~p~~ 130 (790)
++|++|+|+.|++++..+..++. +++|+.|+|+ .|++++. ++..+.++++|+.|+|+++ .+++..+..
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 56777777777777666666654 7777777775 5666642 4444566777777777643 355444433
Q ss_pred ccC--CCCcEEeccCCccccC-CCCCCCCCCcceeeecCCCC
Q 040908 131 MFG--RGPENIDLSYNNFADE-SSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 131 ~~~--~~L~~l~ls~N~l~g~-~p~~~~~~~~l~~~~~~~~~ 169 (790)
+.. ++|+.|+|++|++++. ++..+..+++|+.++.+.+.
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~ 499 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCC 499 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCC
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCC
Confidence 322 5677777777777652 33333455666666665554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.63 E-value=6.2e-08 Score=104.02 Aligned_cols=100 Identities=14% Similarity=0.123 Sum_probs=86.4
Q ss_pred ccccceeccccCCCCCCCccccc-CcccEEEeccccccccCCccccCCCCCC-EEEccCCcCCcCcchhccCCCCCcEEE
Q 040908 40 ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMK-VLDLSFNKLNGTIPESFARLADVDFIY 117 (790)
Q Consensus 40 ~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 117 (790)
.+|+.|++++|++...+...|.. .+|+.|+|.+| ++..-+..|.+|.+|+ .|+|.+ +++..-+..|.+|++|+.|+
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 47888899999999888888888 89999999998 7755566899999999 999999 78755568999999999999
Q ss_pred eeCCcccccCCccccC-CCCcEEec
Q 040908 118 LTGNLLTGKVPQWMFG-RGPENIDL 141 (790)
Q Consensus 118 ls~N~l~g~~p~~~~~-~~L~~l~l 141 (790)
|++|+++...+..|.. .+|+.|+.
T Consensus 304 l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 304 ATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp ECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred eCCCccCccchhhhcCCcchhhhcc
Confidence 9999999777777777 78998864
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.58 E-value=1.1e-08 Score=118.83 Aligned_cols=147 Identities=11% Similarity=0.050 Sum_probs=97.9
Q ss_pred cccccCcccccCcccccc--------ccccccceeccccCCCC-CCCccc--ccCcccEEEecccccccc----CCcccc
Q 040908 20 SLIHSGKWFGWANSVWHY--------FSESLTDLRISDLNGPE-ATLPDL--RNRTFKNLILRSCNLTGE----LPHFLG 84 (790)
Q Consensus 20 ~L~~L~~L~l~~N~l~~~--------~~~~L~~L~l~~n~~~~-~~~~~~--~~~~L~~L~L~~N~l~~~----~p~~~~ 84 (790)
.+++|+.|+|++|.++.. .+.+|+.|+++++.... .....+ ..++|++|+|++|.+++. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 678888888888877633 22348888887765311 111111 127788888888888765 444556
Q ss_pred CCCCCCEEEccCCcCC----cCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccc---cCCCCCCCC
Q 040908 85 EVSEMKVLDLSFNKLN----GTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFA---DESSGSDCQ 156 (790)
Q Consensus 85 ~l~~L~~L~Ls~N~l~----g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~---g~~p~~~~~ 156 (790)
++++|++|+|++|.++ +.++..+.++++|+.|+|++|.+.+ +|..+.. ++|+.|+++.+... +..+..+..
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence 7888888888888887 3555666788888888888888876 5555555 77888888754332 233345555
Q ss_pred CCcceeeecCC
Q 040908 157 NGAVNLFASSS 167 (790)
Q Consensus 157 ~~~l~~~~~~~ 167 (790)
+.+|+.+..+.
T Consensus 269 ~~~L~~L~l~~ 279 (592)
T 3ogk_B 269 PRKLCRLGLSY 279 (592)
T ss_dssp CTTCCEEEETT
T ss_pred cccccccCccc
Confidence 66666665544
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.35 E-value=6.4e-08 Score=112.46 Aligned_cols=168 Identities=11% Similarity=-0.024 Sum_probs=104.8
Q ss_pred CEEEccCCcCccc-CChhhhcccccCcccc---------cCccccccc-------cccccceeccccCCCCCCCcccc--
Q 040908 1 MYRTVQSNRLSGE-LPEELGSLIHSGKWFG---------WANSVWHYF-------SESLTDLRISDLNGPEATLPDLR-- 61 (790)
Q Consensus 1 ~~L~Ls~N~l~g~-iP~~~~~L~~L~~L~l---------~~N~l~~~~-------~~~L~~L~l~~n~~~~~~~~~~~-- 61 (790)
++|+|++| ++.. ++.-...+++|+.|++ ..|.++... -.+|+.|.+..|.+.......+.
T Consensus 317 ~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~ 395 (594)
T 2p1m_B 317 QRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARN 395 (594)
T ss_dssp CEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHH
T ss_pred CEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhh
Confidence 46788877 4433 2222345788888877 334554221 23677777766666543333332
Q ss_pred cCcccEEEec--c----ccccc-----cCCccccCCCCCCEEEccCCcCCcCcchhccC-CCCCcEEEeeCCcccccCCc
Q 040908 62 NRTFKNLILR--S----CNLTG-----ELPHFLGEVSEMKVLDLSFNKLNGTIPESFAR-LADVDFIYLTGNLLTGKVPQ 129 (790)
Q Consensus 62 ~~~L~~L~L~--~----N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-l~~L~~L~ls~N~l~g~~p~ 129 (790)
.++|+.|+|+ + |++++ .++..+.++++|+.|+|++ ++++..+..++. +++|+.|+|++|.+++..+.
T Consensus 396 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~ 474 (594)
T 2p1m_B 396 RPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH 474 (594)
T ss_dssp CTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHH
T ss_pred CCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHH
Confidence 2678888888 4 55652 1222256778888888876 666655666665 78888888888888765444
Q ss_pred cc-cC-CCCcEEeccCCccccCCCC-CCCCCCcceeeecCCCCC
Q 040908 130 WM-FG-RGPENIDLSYNNFADESSG-SDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 130 ~~-~~-~~L~~l~ls~N~l~g~~p~-~~~~~~~l~~~~~~~~~~ 170 (790)
.+ .. ++|+.|+|++|++++.... .+..+++|+.++.+.+..
T Consensus 475 ~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 475 HVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 44 22 7788888888888654333 333466777777766543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.34 E-value=4.1e-08 Score=114.07 Aligned_cols=116 Identities=10% Similarity=0.077 Sum_probs=53.3
Q ss_pred EEEccCCcCcccCChhhh-cccccCcccccCc-ccccc-c------cccccceeccccCCCCCCCcccc-----cCcccE
Q 040908 2 YRTVQSNRLSGELPEELG-SLIHSGKWFGWAN-SVWHY-F------SESLTDLRISDLNGPEATLPDLR-----NRTFKN 67 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~-~L~~L~~L~l~~N-~l~~~-~------~~~L~~L~l~~n~~~~~~~~~~~-----~~~L~~ 67 (790)
+|+|++|.+++..+..+. .+++|+.|+|++| .++.. + -.+|+.|++++|.+.......+. .++|+.
T Consensus 109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~ 188 (594)
T 2p1m_B 109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188 (594)
T ss_dssp EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence 455566655555555554 4556666666555 33211 0 12555555555543332211111 145555
Q ss_pred EEecccc--ccc-cCCccccCCCCCCEEEccCC-cCCcCcchhccCCCCCcEEEe
Q 040908 68 LILRSCN--LTG-ELPHFLGEVSEMKVLDLSFN-KLNGTIPESFARLADVDFIYL 118 (790)
Q Consensus 68 L~L~~N~--l~~-~~p~~~~~l~~L~~L~Ls~N-~l~g~ip~~~~~l~~L~~L~l 118 (790)
|+|++|. ++. .++.-+.++++|++|+|++| .+. .+|..+.++++|+.|++
T Consensus 189 L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l 242 (594)
T 2p1m_B 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGT 242 (594)
T ss_dssp EECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEEC
T ss_pred EEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEccc
Confidence 5555554 111 01111233455666666555 233 25555555555555553
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.33 E-value=2.1e-06 Score=94.69 Aligned_cols=160 Identities=10% Similarity=0.010 Sum_probs=110.0
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccc-----cccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE-----SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~-----~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
.++|.+ .++..-+..|.+|.+|+.++|++|+++.+... +|+.+.+.+ ++.......|.. .+|+.|+|..| +
T Consensus 161 ~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l 237 (401)
T 4fdw_A 161 EIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-V 237 (401)
T ss_dssp EEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-C
T ss_pred EEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-c
Confidence 466664 66634445788899999999999888765543 677777764 355555566666 68888888875 5
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCccc-----ccCCccccC-CCCcEEeccCCccccC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLT-----GKVPQWMFG-RGPENIDLSYNNFADE 149 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~-----g~~p~~~~~-~~L~~l~ls~N~l~g~ 149 (790)
+..-...|.+ .+|+.+.| .|+++..-+..|.+|++|+.+++.+|.+. ...+..|.. .+|+.++|. |.++..
T Consensus 238 ~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I 314 (401)
T 4fdw_A 238 STIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRIL 314 (401)
T ss_dssp CEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEE
T ss_pred cCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEE
Confidence 5344456666 77888888 45566344567888888888888887765 233344544 778888888 457766
Q ss_pred CCCCCCCCCcceeeecCC
Q 040908 150 SSGSDCQNGAVNLFASSS 167 (790)
Q Consensus 150 ~p~~~~~~~~l~~~~~~~ 167 (790)
....|..+..|+.+...+
T Consensus 315 ~~~aF~~c~~L~~l~lp~ 332 (401)
T 4fdw_A 315 GQGLLGGNRKVTQLTIPA 332 (401)
T ss_dssp CTTTTTTCCSCCEEEECT
T ss_pred hhhhhcCCCCccEEEECc
Confidence 667777777777776643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=4.5e-06 Score=88.54 Aligned_cols=137 Identities=16% Similarity=0.149 Sum_probs=93.4
Q ss_pred eeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCC---ceeeeeeEEE-eCCeEEEEEEeccC
Q 040908 451 ANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHP---HLVKLYGCCI-EGNQLLLIYEYLEN 526 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~ 526 (790)
.+.++.|....||+. |..+++|+... ......+..|+.+|+.+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 467888999999987 45678887432 23346788999999999653 3456666664 34557899999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhc-----------------------------------------
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE----------------------------------------- 565 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------------------------------------- 565 (790)
..+.+... ..++...+..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88866321 1223344444555555555555532
Q ss_pred ----------------CCCcEEeccCCCCcEEecC---CCCe-EEeecCCcccc
Q 040908 566 ----------------SRLKIVHRDIKATNVLLDK---DLNP-KISDFGLAKLD 599 (790)
Q Consensus 566 ----------------~~~~iiHrDlk~~NILl~~---~~~~-kl~DFGla~~~ 599 (790)
..+.++|+|+++.|||++. ++.+ .|.||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235799999999999987 4554 89999988743
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=8.9e-06 Score=84.25 Aligned_cols=140 Identities=15% Similarity=0.112 Sum_probs=98.4
Q ss_pred cCcceeeeecccCcE-EEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFG-PVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG-~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 522 (790)
..|+. +.+..|..| .||+.... ++..+++|+-.. .....+.+|...|+.+. +--+.++++++.+.+..++|||
T Consensus 25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 34443 455556655 68987754 456788887643 23456788999998884 3346778999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhc-------------------------------------
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE------------------------------------- 565 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------------------------------------- 565 (790)
++++.++.+.... .......++.++++.|+.||..
T Consensus 101 ~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 101 AIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp CCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred eeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 9999887765411 1123344566666666666642
Q ss_pred ------------------CCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 566 ------------------SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 566 ------------------~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
..+.++|+|+.+.|||+++++.+-|.||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 11238999999999999988777799999876
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.24 E-value=4.6e-06 Score=91.94 Aligned_cols=159 Identities=9% Similarity=-0.002 Sum_probs=117.6
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCcccccCcccEEEeccccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNL 75 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l 75 (790)
.++|.+| ++..-...|.++ +|+.+.+.. .+..+.. .+|+.+.+.+|.+...+...|...+|+.+.|.+| +
T Consensus 139 ~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l 214 (401)
T 4fdw_A 139 KVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT-L 214 (401)
T ss_dssp EEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT-C
T ss_pred EEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeCCc-h
Confidence 4666665 763334467774 799999986 5553332 3788899999988888888888889999999855 7
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccc-----cC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFA-----DE 149 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~-----g~ 149 (790)
+..-...|.+|++|+.|+|..| ++..-...|.+ .+|+.+.|. |.++..-+..|.. .+|+.++|.+|.+. ..
T Consensus 215 ~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I 291 (401)
T 4fdw_A 215 KEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMI 291 (401)
T ss_dssp CEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEE
T ss_pred heehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEE
Confidence 7455668899999999999875 66344456777 789999994 5566555666666 89999999998875 34
Q ss_pred CCCCCCCCCcceeeecCC
Q 040908 150 SSGSDCQNGAVNLFASSS 167 (790)
Q Consensus 150 ~p~~~~~~~~l~~~~~~~ 167 (790)
.+..|..+.+|+.+...+
T Consensus 292 ~~~aF~~c~~L~~l~l~~ 309 (401)
T 4fdw_A 292 HPYCLEGCPKLARFEIPE 309 (401)
T ss_dssp CTTTTTTCTTCCEECCCT
T ss_pred CHHHhhCCccCCeEEeCC
Confidence 567788888888887653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.23 E-value=1.9e-07 Score=96.54 Aligned_cols=82 Identities=18% Similarity=0.194 Sum_probs=58.7
Q ss_pred EEecccccc---ccCCccccCCCCCCEEEccCCcCCc--CcchhccCCCCCcEEEeeCCcccccCCccccC---CCCcEE
Q 040908 68 LILRSCNLT---GELPHFLGEVSEMKVLDLSFNKLNG--TIPESFARLADVDFIYLTGNLLTGKVPQWMFG---RGPENI 139 (790)
Q Consensus 68 L~L~~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~g--~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~---~~L~~l 139 (790)
++++.|+.. +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+.. .+|+.|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 667777433 2222233567888999999999887 5567778888899999999988865 12222 278889
Q ss_pred eccCCccccCCC
Q 040908 140 DLSYNNFADESS 151 (790)
Q Consensus 140 ~ls~N~l~g~~p 151 (790)
+|++|++++.+|
T Consensus 226 ~L~~Npl~~~~~ 237 (267)
T 3rw6_A 226 WLDGNSLCDTFR 237 (267)
T ss_dssp ECTTSTTGGGCS
T ss_pred EccCCcCccccC
Confidence 999999887666
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.17 E-value=7.6e-07 Score=96.64 Aligned_cols=154 Identities=14% Similarity=0.081 Sum_probs=101.3
Q ss_pred CChhhhcccccCcccccCcccc-------------cc--ccccccceeccccCCCCCCCcccccCcccEEEecccccccc
Q 040908 14 LPEELGSLIHSGKWFGWANSVW-------------HY--FSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGE 78 (790)
Q Consensus 14 iP~~~~~L~~L~~L~l~~N~l~-------------~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~ 78 (790)
+...+.++++|+.|.+..+... .. .+.+|+.|++..+..... +.+...+|+.|+|..|.++..
T Consensus 131 L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~l--~~~~~~~L~~L~L~~~~l~~~ 208 (362)
T 2ra8_A 131 IVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSI--GKKPRPNLKSLEIISGGLPDS 208 (362)
T ss_dssp HHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCBC--CSCBCTTCSEEEEECSBCCHH
T ss_pred HHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCcee--ccccCCCCcEEEEecCCCChH
Confidence 3445677888888888655321 11 124899999877632222 224458899999999888754
Q ss_pred CCcccc--CCCCCCEEEccC--CcCCcC-----cchhc--cCCCCCcEEEeeCCcccccCCcccc----CCCCcEEeccC
Q 040908 79 LPHFLG--EVSEMKVLDLSF--NKLNGT-----IPESF--ARLADVDFIYLTGNLLTGKVPQWMF----GRGPENIDLSY 143 (790)
Q Consensus 79 ~p~~~~--~l~~L~~L~Ls~--N~l~g~-----ip~~~--~~l~~L~~L~ls~N~l~g~~p~~~~----~~~L~~l~ls~ 143 (790)
.-..++ .+++|+.|+|+. |...|. +...+ ..+++|+.|+|++|.+....+..+. .++|+.|||+.
T Consensus 209 ~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~ 288 (362)
T 2ra8_A 209 VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA 288 (362)
T ss_dssp HHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCS
T ss_pred HHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCC
Confidence 444454 789999999864 332221 11122 3578999999999998754443332 26899999999
Q ss_pred CccccC----CCCCCCCCCcceeeecCCCC
Q 040908 144 NNFADE----SSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 144 N~l~g~----~p~~~~~~~~l~~~~~~~~~ 169 (790)
|.|+.. ++..+..++.|+.++.+.+.
T Consensus 289 n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~ 318 (362)
T 2ra8_A 289 GVLTDEGARLLLDHVDKIKHLKFINMKYNY 318 (362)
T ss_dssp SCCBHHHHHHHHTTHHHHTTCSEEECCSBB
T ss_pred CCCChHHHHHHHhhcccCCcceEEECCCCc
Confidence 999874 34444456778888886553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.16 E-value=1e-06 Score=90.97 Aligned_cols=76 Identities=18% Similarity=0.289 Sum_probs=62.7
Q ss_pred CcccEEEeccccccc--cCCccccCCCCCCEEEccCCcCCcCcchhccCCC--CCcEEEeeCCcccccCCc-------cc
Q 040908 63 RTFKNLILRSCNLTG--ELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLA--DVDFIYLTGNLLTGKVPQ-------WM 131 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~--~L~~L~ls~N~l~g~~p~-------~~ 131 (790)
++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+.+.+|. .+
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il 247 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIR 247 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHH
Confidence 689999999999998 6678888999999999999999964 3455555 999999999999988773 12
Q ss_pred cC-CCCcEEe
Q 040908 132 FG-RGPENID 140 (790)
Q Consensus 132 ~~-~~L~~l~ 140 (790)
.. ++|+.||
T Consensus 248 ~~~P~L~~LD 257 (267)
T 3rw6_A 248 ERFPKLLRLD 257 (267)
T ss_dssp HHCTTCCEES
T ss_pred HHCcccCeEC
Confidence 33 7788776
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=4.4e-06 Score=90.51 Aligned_cols=82 Identities=9% Similarity=0.024 Sum_probs=57.2
Q ss_pred eeeee-cccCcEEEEeeeec-------CCcEEEEEEccccc---hhcHHHHHHHHHHhhccC-C--CceeeeeeEEEeC-
Q 040908 450 VANKI-GEGGFGPVYKGLLA-------DGTLIAVKQLSAKS---KQGNREFVNEIGTISALQ-H--PHLVKLYGCCIEG- 514 (790)
Q Consensus 450 ~~~~L-G~G~fG~Vy~g~~~-------~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~- 514 (790)
..+.| +.|....+|+.... ++..+++|+..... ......+..|+.+++.+. + -.+.++++++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34677 88889999998764 26678888865432 101245678888888884 3 3466788877655
Q ss_pred --CeEEEEEEeccCCChhh
Q 040908 515 --NQLLLIYEYLENNSLAR 531 (790)
Q Consensus 515 --~~~~lV~Ey~~~gsL~~ 531 (790)
+..++||||++|..+.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.13 E-value=4e-07 Score=89.11 Aligned_cols=117 Identities=10% Similarity=0.039 Sum_probs=79.1
Q ss_pred hhhcccccCcccccCc-cccccccccccceeccccCCCCCCCcccc-cCcccEEEecccccccc----CCccccCCCCCC
Q 040908 17 ELGSLIHSGKWFGWAN-SVWHYFSESLTDLRISDLNGPEATLPDLR-NRTFKNLILRSCNLTGE----LPHFLGEVSEMK 90 (790)
Q Consensus 17 ~~~~L~~L~~L~l~~N-~l~~~~~~~L~~L~l~~n~~~~~~~~~~~-~~~L~~L~L~~N~l~~~----~p~~~~~l~~L~ 90 (790)
.+...++|+.|+|++| .+...-...|.. .+. .++|++|+|++|+|... +...+...+.|+
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~--------------~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~ 96 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAE--------------ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLK 96 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHH--------------HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCC
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHH--------------HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcC
Confidence 3445567777777777 665321111111 111 15788999999998742 445566668899
Q ss_pred EEEccCCcCCcC----cchhccCCCCCcEEEe--eCCcccccC----CccccC-CCCcEEeccCCccc
Q 040908 91 VLDLSFNKLNGT----IPESFARLADVDFIYL--TGNLLTGKV----PQWMFG-RGPENIDLSYNNFA 147 (790)
Q Consensus 91 ~L~Ls~N~l~g~----ip~~~~~l~~L~~L~l--s~N~l~g~~----p~~~~~-~~L~~l~ls~N~l~ 147 (790)
+|+|++|+|... +...+...++|+.|+| ++|.+...- ...+.. .+|+.|+|++|.+.
T Consensus 97 ~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 97 SLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp EEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred EEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 999999998743 5667788888999999 889887542 222333 78999999999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.2e-06 Score=95.05 Aligned_cols=134 Identities=14% Similarity=0.170 Sum_probs=64.4
Q ss_pred CChhhhcccccCcccccCcc-cc--ccccccccceeccccCCCCCCCcccc---cCcccEEEecc--cccccc-----CC
Q 040908 14 LPEELGSLIHSGKWFGWANS-VW--HYFSESLTDLRISDLNGPEATLPDLR---NRTFKNLILRS--CNLTGE-----LP 80 (790)
Q Consensus 14 iP~~~~~L~~L~~L~l~~N~-l~--~~~~~~L~~L~l~~n~~~~~~~~~~~---~~~L~~L~L~~--N~l~~~-----~p 80 (790)
++..+..+++|+.|+|++|. +. .....+|+.|++..+.+.......+. .++|+.|+|+. |...+. +.
T Consensus 164 L~~ll~~~P~L~~L~L~g~~~l~l~~~~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~ 243 (362)
T 2ra8_A 164 LSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR 243 (362)
T ss_dssp CHHHHHTCTTCCEEEEECCBTCBCCSCBCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG
T ss_pred HHHHHhcCCCCcEEEEeCCCCceeccccCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH
Confidence 44445555666666666652 11 11123566666655554322222221 25666666642 221111 11
Q ss_pred ccc--cCCCCCCEEEccCCcCCcCcchhcc---CCCCCcEEEeeCCccccc----CCccccC-CCCcEEeccCCccc
Q 040908 81 HFL--GEVSEMKVLDLSFNKLNGTIPESFA---RLADVDFIYLTGNLLTGK----VPQWMFG-RGPENIDLSYNNFA 147 (790)
Q Consensus 81 ~~~--~~l~~L~~L~Ls~N~l~g~ip~~~~---~l~~L~~L~ls~N~l~g~----~p~~~~~-~~L~~l~ls~N~l~ 147 (790)
..+ ..+++|++|+|++|.+....+..+. .+++|+.|+|+.|.+.+. ++..+.. ++|+.|+|++|.|+
T Consensus 244 ~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 112 2356666666666666543333332 355666666666666542 2222222 56666666666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.04 E-value=9.1e-07 Score=86.55 Aligned_cols=111 Identities=14% Similarity=0.026 Sum_probs=81.0
Q ss_pred CEEEccCC-cCccc----CChhhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccc
Q 040908 1 MYRTVQSN-RLSGE----LPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N-~l~g~----iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l 75 (790)
++|+|++| +|... +...+...++|++|+|++|.|...-...|... .-.+++|++|+|++|.|
T Consensus 39 ~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~-------------L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 39 EEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEM-------------LKVNNTLKSLNVESNFI 105 (185)
T ss_dssp CEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHH-------------HHHCSSCCEEECCSSCC
T ss_pred CEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHH-------------HHhCCCcCEEECcCCcC
Confidence 47999999 99743 34455566889999999998864222111110 00115799999999999
Q ss_pred ccc----CCccccCCCCCCEEEc--cCCcCCcC----cchhccCCCCCcEEEeeCCccc
Q 040908 76 TGE----LPHFLGEVSEMKVLDL--SFNKLNGT----IPESFARLADVDFIYLTGNLLT 124 (790)
Q Consensus 76 ~~~----~p~~~~~l~~L~~L~L--s~N~l~g~----ip~~~~~l~~L~~L~ls~N~l~ 124 (790)
... +...+...+.|++|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 854 5677888899999999 88999743 4456667799999999999885
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.87 E-value=5.6e-05 Score=80.86 Aligned_cols=142 Identities=15% Similarity=0.216 Sum_probs=81.0
Q ss_pred eeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCC--Cceeeeee------EEEeCCeEEEEEE
Q 040908 451 ANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQH--PHLVKLYG------CCIEGNQLLLIYE 522 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g------~~~~~~~~~lV~E 522 (790)
.+.|+.|..+.||+....+| .+++|+.... ...+..|+.++..+.. -.+.+++. +....+..+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 35566677889999987655 4888988642 2333445555555531 12333433 2234667899999
Q ss_pred eccCCChh-----------h---hhcCCcc----c------cCCCChhhHH-----------------------------
Q 040908 523 YLENNSLA-----------R---ALFGPEE----H------RLKLDWPTRH----------------------------- 549 (790)
Q Consensus 523 y~~~gsL~-----------~---~l~~~~~----~------~~~l~~~~~~----------------------------- 549 (790)
|++|..+. + .+|.... . ...-.|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986543 0 1111000 0 0012332211
Q ss_pred --HHHHHHHHHHHHhhh----------cCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 550 --NICIGIARGLAYLHE----------ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 550 --~i~~~ia~aL~yLH~----------~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
.+...+.+++++|+. .....++|+|+++.|||++.++.+.|.||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123445666763 124579999999999999888899999999765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00011 Score=76.98 Aligned_cols=80 Identities=20% Similarity=0.197 Sum_probs=58.7
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCC---ceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHP---HLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lV~E 522 (790)
....-++.+|.|..+.||+..+.||+.|++|+...........|..|+..|+.+.-. -+.+++++. .-++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 345667889999999999999999999999987654444445678899999888422 234445432 2378999
Q ss_pred eccCCCh
Q 040908 523 YLENNSL 529 (790)
Q Consensus 523 y~~~gsL 529 (790)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=6.6e-05 Score=82.48 Aligned_cols=75 Identities=19% Similarity=0.246 Sum_probs=49.4
Q ss_pred eeeecccCcEEEEeeeec-CCcEEEEEEccccch-------hcHHHHHHHHHHhhccCC--Ccee-eeeeEEEeCCeEEE
Q 040908 451 ANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-------QGNREFVNEIGTISALQH--PHLV-KLYGCCIEGNQLLL 519 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~niv-~l~g~~~~~~~~~l 519 (790)
.+.||.|..+.||++... +++.++||....... .....+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 578999999999999754 467899997643211 123456778888887742 3444 45543 3445689
Q ss_pred EEEeccCC
Q 040908 520 IYEYLENN 527 (790)
Q Consensus 520 V~Ey~~~g 527 (790)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.0002 Score=75.75 Aligned_cols=140 Identities=15% Similarity=0.136 Sum_probs=92.8
Q ss_pred eeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccC---CCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 450 VANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ---HPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
..+.|+.|....+|+... ++..+++|+.... ....|..|+..|+.+. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 457899999999999886 4567888886532 3456888999998884 35678889888888889999999999
Q ss_pred CChhh-----------hhcCCcc-c-----------------cCCCChhhHH---HHHH----------------HHHHH
Q 040908 527 NSLAR-----------ALFGPEE-H-----------------RLKLDWPTRH---NICI----------------GIARG 558 (790)
Q Consensus 527 gsL~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~~----------------~ia~a 558 (790)
..+.. .||.... . ...-+|.... ++.. .+++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 86531 1221110 0 0012454321 1111 11111
Q ss_pred -HHHhhh-cCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 559 -LAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 559 -L~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
...|.. ...+.++|+|+.+.||+++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123321 2356799999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00081 Score=71.23 Aligned_cols=159 Identities=16% Similarity=0.153 Sum_probs=88.4
Q ss_pred ccHHHHHHHhcCcce-----eeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCc--eeeee
Q 040908 436 FTLRQIKAATNHFDV-----ANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH--LVKLY 508 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~-----~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~ 508 (790)
++.+++...-..|.+ .+.|+.|....+|+....+| .+++|...... ....+..|+.++..+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 455566665555654 35577788899999987666 57788876421 1234556777777764222 23333
Q ss_pred eE------EEeCCeEEEEEEeccCCChhh--------------hhcCC----cccc----CCCChhhHHH----------
Q 040908 509 GC------CIEGNQLLLIYEYLENNSLAR--------------ALFGP----EEHR----LKLDWPTRHN---------- 550 (790)
Q Consensus 509 g~------~~~~~~~~lV~Ey~~~gsL~~--------------~l~~~----~~~~----~~l~~~~~~~---------- 550 (790)
.. ....+..+++|+|++|..+.. .+|.. .... ....|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 123456789999999865421 01110 0000 0012322111
Q ss_pred --HHHHHHHHHHHhhhc----CCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 551 --ICIGIARGLAYLHEE----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 551 --i~~~ia~aL~yLH~~----~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
+...+.+.+++++.. ....++|+|+.+.|||++++..+.|.||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234445555432 23469999999999999987656899998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00056 Score=75.67 Aligned_cols=78 Identities=9% Similarity=0.070 Sum_probs=47.6
Q ss_pred CCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcceeecc-ccCCCcccHHHhhcCC---CCChhhHHHHHHHHHH
Q 040908 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV-AGTFGYMAPEYAMRGH---LTDKADVYSFGIVALE 642 (790)
Q Consensus 567 ~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvvl~e 642 (790)
...++|+|+++.|||++.++ ++|.||+.+........- .... .-...|++|+...... .....++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45699999999999999876 999999988753321100 0000 0012456665543111 1123556678888888
Q ss_pred HHhC
Q 040908 643 IVSG 646 (790)
Q Consensus 643 lltG 646 (790)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00082 Score=74.54 Aligned_cols=73 Identities=21% Similarity=0.264 Sum_probs=50.5
Q ss_pred eeeecccCcEEEEeeeecC--------CcEEEEEEccccchhcHHHHHHHHHHhhccCCCce-eeeeeEEEeCCeEEEEE
Q 040908 451 ANKIGEGGFGPVYKGLLAD--------GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL-VKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 521 (790)
.+.|+.|....||+....+ +..+++|+.... .....+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678888889999998653 478889987432 112456689999988854444 556665532 2899
Q ss_pred EeccCCCh
Q 040908 522 EYLENNSL 529 (790)
Q Consensus 522 Ey~~~gsL 529 (790)
||+++.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.002 Score=69.99 Aligned_cols=142 Identities=20% Similarity=0.246 Sum_probs=82.5
Q ss_pred eeeecccCcEEEEeeeec--------CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCce-eeeeeEEEeCCeEEEEE
Q 040908 451 ANKIGEGGFGPVYKGLLA--------DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL-VKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~--------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 521 (790)
.+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.+.-.++ .++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888889998864 2468999986432 2234566789999988853333 456666543 2899
Q ss_pred EeccCCChhhh-----------------hcCCcc-ccCCCC--hhhHHHHHHHHHH-------------------HHHHh
Q 040908 522 EYLENNSLARA-----------------LFGPEE-HRLKLD--WPTRHNICIGIAR-------------------GLAYL 562 (790)
Q Consensus 522 Ey~~~gsL~~~-----------------l~~~~~-~~~~l~--~~~~~~i~~~ia~-------------------aL~yL 562 (790)
||++|.+|..- ||.... ...... |.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665421 121100 011122 3444444433321 22333
Q ss_pred h----h-cCCCcEEeccCCCCcEEecCC----CCeEEeecCCcc
Q 040908 563 H----E-ESRLKIVHRDIKATNVLLDKD----LNPKISDFGLAK 597 (790)
Q Consensus 563 H----~-~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGla~ 597 (790)
. . .....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 1 123468999999999999887 789999998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.009 Score=63.24 Aligned_cols=159 Identities=13% Similarity=0.092 Sum_probs=88.5
Q ss_pred ccHHHHHHHhcCcce-----eeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCc--eeeee
Q 040908 436 FTLRQIKAATNHFDV-----ANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH--LVKLY 508 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~-----~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~ 508 (790)
.+.+++..+-+.|.+ ...++ |....||+....+|+.+++|...... .....+..|..++..+.... +.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 344445444333322 34576 78889999887778789999875321 22345667888887774222 34444
Q ss_pred eE-----EEeCCeEEEEEEeccCCChhh-----------h---hcCC----c-cccCCCChhhH----HH----------
Q 040908 509 GC-----CIEGNQLLLIYEYLENNSLAR-----------A---LFGP----E-EHRLKLDWPTR----HN---------- 550 (790)
Q Consensus 509 g~-----~~~~~~~~lV~Ey~~~gsL~~-----------~---l~~~----~-~~~~~l~~~~~----~~---------- 550 (790)
.. ....+..+++|||++|..+.. . +|.. . ......++... ..
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 43 223456788999999865421 0 1110 0 00111222111 00
Q ss_pred -----HHHHHHHHHHHhhh----cCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 551 -----ICIGIARGLAYLHE----ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 551 -----i~~~ia~aL~yLH~----~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+...+.+.++.+.. .....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 01111122223221 1234589999999999999 4 899999988763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0035 Score=66.69 Aligned_cols=144 Identities=17% Similarity=0.138 Sum_probs=73.3
Q ss_pred eeeecccCcEE-EEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCC--CceeeeeeEEEeCCeEEEEEEeccCC
Q 040908 451 ANKIGEGGFGP-VYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQH--PHLVKLYGCCIEGNQLLLIYEYLENN 527 (790)
Q Consensus 451 ~~~LG~G~fG~-Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~g 527 (790)
.+.|+.|+... +|+....+|..+++|....... ..+..|+.++..+.. -.+.+++.+..+.+ +++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34566665444 6677654466777776543211 233456777766642 23455666644333 6899999876
Q ss_pred ChhhhhcCCcc---------------------cc-CCCChhhHH-------H-------------HHHHHHHHHHHhh--
Q 040908 528 SLARALFGPEE---------------------HR-LKLDWPTRH-------N-------------ICIGIARGLAYLH-- 563 (790)
Q Consensus 528 sL~~~l~~~~~---------------------~~-~~l~~~~~~-------~-------------i~~~ia~aL~yLH-- 563 (790)
.+.+++.+... .. ..++..... . ....+.+.++.+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 66544321100 00 001110000 0 0001112222221
Q ss_pred -hcCCCcEEeccCCCCcEEecCC----CCeEEeecCCcccc
Q 040908 564 -EESRLKIVHRDIKATNVLLDKD----LNPKISDFGLAKLD 599 (790)
Q Consensus 564 -~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGla~~~ 599 (790)
......++|+|+.+.|||++.+ ..+.|.||+.+...
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123469999999999999875 67899999988743
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.002 Score=67.55 Aligned_cols=71 Identities=7% Similarity=0.051 Sum_probs=44.3
Q ss_pred eeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCce-eeeeeEEEeCCeEEEEEEec-cCCC
Q 040908 451 ANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL-VKLYGCCIEGNQLLLIYEYL-ENNS 528 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs 528 (790)
.+.|+.|....+|+. ..+++|+....... ......|+.+++.+...++ .++++++ .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 578999999999998 45788877543211 1123468888877753334 3555443 33347899999 5544
Q ss_pred h
Q 040908 529 L 529 (790)
Q Consensus 529 L 529 (790)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0025 Score=57.98 Aligned_cols=56 Identities=21% Similarity=0.142 Sum_probs=34.5
Q ss_pred EEEecccccc-ccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCccc
Q 040908 67 NLILRSCNLT-GELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLT 124 (790)
Q Consensus 67 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~ 124 (790)
.++.+++.|+ ..+|..+. .+|++|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666677665 35565432 45777777777776433445666777777777766553
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0083 Score=66.83 Aligned_cols=74 Identities=16% Similarity=0.084 Sum_probs=48.3
Q ss_pred eeeecccCcEEEEeeeecC-CcEEEEEEccccchhcHHHHHHHHHHhhccCCCce-eeeeeEEEeCCeEEEEEEeccCCC
Q 040908 451 ANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL-VKLYGCCIEGNQLLLIYEYLENNS 528 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gs 528 (790)
.+.|+.|-...+|+....+ +..+++|+....... ...-..|..++..+...++ .++++++. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4678888889999998765 477888887433211 1112478888888865555 45676663 2 25999999855
Q ss_pred h
Q 040908 529 L 529 (790)
Q Consensus 529 L 529 (790)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.60 E-value=0.001 Score=63.76 Aligned_cols=83 Identities=10% Similarity=-0.030 Sum_probs=56.8
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCc-CCcCcchhccCC----CCCcEEEeeCCc-ccccCCccccC-CC
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNK-LNGTIPESFARL----ADVDFIYLTGNL-LTGKVPQWMFG-RG 135 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~g~ip~~~~~l----~~L~~L~ls~N~-l~g~~p~~~~~-~~ 135 (790)
..|+.|||+++.|+..-=..+.+|++|++|+|+++. ++..-=..++.+ ++|+.|+|+++. ++..-=..+.. ++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 468899999988876544567788899999999885 653322345554 368899998874 65321122333 78
Q ss_pred CcEEeccCCc
Q 040908 136 PENIDLSYNN 145 (790)
Q Consensus 136 L~~l~ls~N~ 145 (790)
|+.|+|++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888888764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0036 Score=67.72 Aligned_cols=74 Identities=14% Similarity=0.150 Sum_probs=44.7
Q ss_pred eeeecccCcEEEEeeeecC---------CcEEEEEEccccchhcHHHHHHHHHHhhccCCCce-eeeeeEEEeCCeEEEE
Q 040908 451 ANKIGEGGFGPVYKGLLAD---------GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL-VKLYGCCIEGNQLLLI 520 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~---------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV 520 (790)
.+.|+.|..-.+|+....+ +..+++|+....... ......|..+++.+...++ .++++.. .+ ++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 4577888888999988654 267888887543221 1123578888888754444 3566543 22 689
Q ss_pred EEeccCCCh
Q 040908 521 YEYLENNSL 529 (790)
Q Consensus 521 ~Ey~~~gsL 529 (790)
|||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999997544
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0011 Score=63.45 Aligned_cols=82 Identities=7% Similarity=0.163 Sum_probs=57.3
Q ss_pred cccceeccccCCCCCCCccccc-CcccEEEecccc-ccccCCccccCC----CCCCEEEccCCc-CCcCcchhccCCCCC
Q 040908 41 SLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCN-LTGELPHFLGEV----SEMKVLDLSFNK-LNGTIPESFARLADV 113 (790)
Q Consensus 41 ~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~g~ip~~~~~l~~L 113 (790)
.|+.|+++++.++......+.. ++|+.|+|++|. |+..-=..++.+ ++|++|+|+++. ++..==..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 4566666665554444444444 789999999995 775433445554 479999999974 774333467889999
Q ss_pred cEEEeeCCc
Q 040908 114 DFIYLTGNL 122 (790)
Q Consensus 114 ~~L~ls~N~ 122 (790)
+.|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 999999985
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.013 Score=62.61 Aligned_cols=32 Identities=31% Similarity=0.427 Sum_probs=28.1
Q ss_pred CCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 567 ~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
...++|+|+.+.||++++++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999987764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.87 E-value=0.031 Score=54.92 Aligned_cols=102 Identities=15% Similarity=0.099 Sum_probs=65.5
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
-+|.+.|. ..+.++++.++|.++.|.+.+|.-+-... .+ ..+=+-|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc---------
Confidence 37888883 44578999999999999999987762110 01 1233346899999999888764 1111
Q ss_pred eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCC
Q 040908 607 STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS 648 (790)
Q Consensus 607 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~ 648 (790)
.....+.+||... ...+.+.=|||+|+++|.-+--..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0112456777653 345678999999999999886443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.79 E-value=0.012 Score=53.49 Aligned_cols=57 Identities=21% Similarity=0.191 Sum_probs=40.3
Q ss_pred ceeccccCCCCCCCcccccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCC
Q 040908 44 DLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLN 100 (790)
Q Consensus 44 ~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 100 (790)
.++.+++.++...+|.....+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 344445555411222222367999999999999555567889999999999999875
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.64 E-value=0.021 Score=62.22 Aligned_cols=81 Identities=12% Similarity=0.175 Sum_probs=46.1
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEec
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDL 141 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~l 141 (790)
..|+.+.+. +.++..-...|.+|.+|+.++|..| ++..-..+|.++.+|+.+.|..+ ++..-...|.. .+|+.+++
T Consensus 288 ~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~ 364 (394)
T 4gt6_A 288 PALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEY 364 (394)
T ss_dssp TTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEE
T ss_pred cccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEE
Confidence 566666664 3444233345666777777777643 44223445677777777777544 44332334444 66777777
Q ss_pred cCCcc
Q 040908 142 SYNNF 146 (790)
Q Consensus 142 s~N~l 146 (790)
.+|..
T Consensus 365 ~~~~~ 369 (394)
T 4gt6_A 365 SGSRS 369 (394)
T ss_dssp SSCHH
T ss_pred CCcee
Confidence 66654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.55 E-value=0.0018 Score=63.14 Aligned_cols=59 Identities=12% Similarity=0.162 Sum_probs=29.7
Q ss_pred CcccEEEecccccccc----CCccccCCCCCCEEEccCCcCCcC----cchhccCCCCCcEEEeeCC
Q 040908 63 RTFKNLILRSCNLTGE----LPHFLGEVSEMKVLDLSFNKLNGT----IPESFARLADVDFIYLTGN 121 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~ls~N 121 (790)
+.|+.|+|++|+|... |.+.+..=+.|++|+|+.|.|... +-..+..-+.|+.|+|++|
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence 4566666666666532 222233335566666666666421 2223444445666666544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.45 E-value=0.031 Score=60.83 Aligned_cols=97 Identities=12% Similarity=0.012 Sum_probs=53.0
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEec
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDL 141 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~l 141 (790)
..|+.+.+..+.+. ...|.++.+|+.+.+..+ ++..-...|.++++|+.++|.++ ++..-...|.. .+|+.++|
T Consensus 276 ~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~l 350 (394)
T 4fs7_A 276 SGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINF 350 (394)
T ss_dssp TTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECC
T ss_pred cccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEE
Confidence 55666655554322 224566666666666544 44222345666666666666543 44333344444 66666666
Q ss_pred cCCccccCCCCCCCCCCcceeeec
Q 040908 142 SYNNFADESSGSDCQNGAVNLFAS 165 (790)
Q Consensus 142 s~N~l~g~~p~~~~~~~~l~~~~~ 165 (790)
..| ++..-...|..+.+|+.+..
T Consensus 351 p~~-l~~I~~~aF~~C~~L~~i~l 373 (394)
T 4fs7_A 351 PLS-LRKIGANAFQGCINLKKVEL 373 (394)
T ss_dssp CTT-CCEECTTTBTTCTTCCEEEE
T ss_pred Ccc-ccEehHHHhhCCCCCCEEEE
Confidence 655 55444556666666665544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.36 E-value=0.076 Score=57.25 Aligned_cols=99 Identities=7% Similarity=0.071 Sum_probs=51.2
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEec
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDL 141 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~l 141 (790)
..|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|.++++|+.+.+.+|.++..-...|.. .+|+.++|
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 45666666544 43233345556666666666433 43222334566666666666666555433444444 56666666
Q ss_pred cCCccccCCCCCCCCCCcceeee
Q 040908 142 SYNNFADESSGSDCQNGAVNLFA 164 (790)
Q Consensus 142 s~N~l~g~~p~~~~~~~~l~~~~ 164 (790)
..+ ++..-..+|..+.+|+.+.
T Consensus 318 p~~-l~~I~~~aF~~C~~L~~i~ 339 (379)
T 4h09_A 318 PTA-LKTIQVYAFKNCKALSTIS 339 (379)
T ss_dssp CTT-CCEECTTTTTTCTTCCCCC
T ss_pred Ccc-ccEEHHHHhhCCCCCCEEE
Confidence 543 4433444555555554443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.09 E-value=0.0055 Score=59.73 Aligned_cols=103 Identities=10% Similarity=-0.019 Sum_probs=65.9
Q ss_pred cccCcccccCc-ccccc----------ccccccceeccccCCCCCCCccc----c-cCcccEEEecccccccc----CCc
Q 040908 22 IHSGKWFGWAN-SVWHY----------FSESLTDLRISDLNGPEATLPDL----R-NRTFKNLILRSCNLTGE----LPH 81 (790)
Q Consensus 22 ~~L~~L~l~~N-~l~~~----------~~~~L~~L~l~~n~~~~~~~~~~----~-~~~L~~L~L~~N~l~~~----~p~ 81 (790)
+.|+.|+|++| .|... .-..|+.|+|++|.+.......+ . ++.|+.|+|++|.|... +-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 55777777775 65411 12367778887777763322222 2 27899999999999853 334
Q ss_pred cccCCCCCCEEEccCCc---CCc----CcchhccCCCCCcEEEeeCCccc
Q 040908 82 FLGEVSEMKVLDLSFNK---LNG----TIPESFARLADVDFIYLTGNLLT 124 (790)
Q Consensus 82 ~~~~l~~L~~L~Ls~N~---l~g----~ip~~~~~l~~L~~L~ls~N~l~ 124 (790)
.+..=+.|++|+|++|. +.. .+-..+..-+.|+.|+|+.|.+-
T Consensus 121 aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 55555679999999763 331 13344555677888888777543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.00 E-value=0.14 Score=55.49 Aligned_cols=157 Identities=11% Similarity=-0.039 Sum_probs=71.2
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCcccccccc------ccccceeccccCCCCCCCcccccCcccEEEeccccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNL 75 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l 75 (790)
.+.|.++-.+ .-...|.++.+|+.+.+..| ++.+.. ..|+.+.+.++.... ....+....|+.+.+..+.
T Consensus 166 ~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i-~~~~~~~~~l~~i~ip~~~- 241 (394)
T 4fs7_A 166 YVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYL-GDFALSKTGVKNIIIPDSF- 241 (394)
T ss_dssp EEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEE-CTTTTTTCCCCEEEECTTC-
T ss_pred EEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEe-ehhhcccCCCceEEECCCc-
Confidence 4556544332 33446888889999988776 322111 134444333322111 1111222445555554322
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcch---------------------hccCCCCCcEEEeeCCcccccCCccccC-
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPE---------------------SFARLADVDFIYLTGNLLTGKVPQWMFG- 133 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~---------------------~~~~l~~L~~L~ls~N~l~g~~p~~~~~- 133 (790)
+..-...|.++..|+.+.+..|... .-.. .|..+.+|+.+.+.++ ++..-...|..
T Consensus 242 ~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c 319 (394)
T 4fs7_A 242 TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESC 319 (394)
T ss_dssp CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC
T ss_pred eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccccccccccccccccc-cceechhhhcCC
Confidence 2122234445555555555444332 2223 3455555555555443 33222333333
Q ss_pred CCCcEEeccCCccccCCCCCCCCCCcceeeec
Q 040908 134 RGPENIDLSYNNFADESSGSDCQNGAVNLFAS 165 (790)
Q Consensus 134 ~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~ 165 (790)
.+|+.++|..+ ++..-...|..+.+|+.+..
T Consensus 320 ~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~l 350 (394)
T 4fs7_A 320 TSLVSIDLPYL-VEEIGKRSFRGCTSLSNINF 350 (394)
T ss_dssp TTCCEECCCTT-CCEECTTTTTTCTTCCEECC
T ss_pred CCCCEEEeCCc-ccEEhHHhccCCCCCCEEEE
Confidence 55666665433 44334445555555554433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.31 E-value=0.11 Score=56.97 Aligned_cols=74 Identities=11% Similarity=0.086 Sum_probs=48.3
Q ss_pred eeeecccCcEEEEeeeecC--------CcEEEEEEccccchhcHHHHHHHHHHhhccCCCce-eeeeeEEEeCCeEEEEE
Q 040908 451 ANKIGEGGFGPVYKGLLAD--------GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL-VKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 521 (790)
.+.+..|-...+|+....+ +..+++|+...... ......+|..+++.+...++ .++++.+ .+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 4677778888899988653 57788988754321 11223578888888753334 4455433 22 6899
Q ss_pred EeccCCCh
Q 040908 522 EYLENNSL 529 (790)
Q Consensus 522 Ey~~~gsL 529 (790)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.13 E-value=0.18 Score=54.22 Aligned_cols=101 Identities=5% Similarity=-0.028 Sum_probs=74.6
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEec
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDL 141 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~l 141 (790)
.+|+.+.+..+ +...-...|.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ +.......+.. .+|+.+++
T Consensus 217 ~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 217 KNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEE
T ss_pred cccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccc
Confidence 67888888665 44345567888999999999776 65344567888999999998655 54333444555 88999999
Q ss_pred cCCccccCCCCCCCCCCcceeeecC
Q 040908 142 SYNNFADESSGSDCQNGAVNLFASS 166 (790)
Q Consensus 142 s~N~l~g~~p~~~~~~~~l~~~~~~ 166 (790)
.+|.++......|..+.+|+.+...
T Consensus 294 ~~~~i~~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 294 DNSAIETLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp CCTTCCEECTTTTTTCTTCCEEECC
T ss_pred cccccceehhhhhcCCCCCCEEEcC
Confidence 9888887777788888888887764
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=93.98 E-value=0.1 Score=56.67 Aligned_cols=106 Identities=10% Similarity=0.095 Sum_probs=79.9
Q ss_pred ccccc-CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CC
Q 040908 58 PDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RG 135 (790)
Q Consensus 58 ~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~ 135 (790)
..|.. ..|+.+.+.++..+ .-...|.++.+|+.+.+. +.++..-...|.++.+|+.++|..| ++..-...|.. .+
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~ 335 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ 335 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence 34555 78999999876654 556678999999999996 5666344467999999999999865 55444556666 89
Q ss_pred CcEEeccCCccccCCCCCCCCCCcceeeecCC
Q 040908 136 PENIDLSYNNFADESSGSDCQNGAVNLFASSS 167 (790)
Q Consensus 136 L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~ 167 (790)
|+.+.|..+ ++..-...|..+.+|+.+....
T Consensus 336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~ 366 (394)
T 4gt6_A 336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSG 366 (394)
T ss_dssp CCEEEECTT-CCBCCGGGGTTCTTCCEEEESS
T ss_pred CCEEEECcc-cCEEhHhHhhCCCCCCEEEECC
Confidence 999999755 7666667888888898887654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.91 E-value=0.48 Score=51.53 Aligned_cols=29 Identities=24% Similarity=0.407 Sum_probs=24.6
Q ss_pred cEEeccCCCCcEEe------cCCCCeEEeecCCcc
Q 040908 569 KIVHRDIKATNVLL------DKDLNPKISDFGLAK 597 (790)
Q Consensus 569 ~iiHrDlk~~NILl------~~~~~~kl~DFGla~ 597 (790)
.++|+|+.+.|||+ +++..++++||-+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36799999999999 456779999998876
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.78 E-value=4.3 Score=39.63 Aligned_cols=116 Identities=7% Similarity=0.080 Sum_probs=78.5
Q ss_pred CCCceeeeeeEEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCc
Q 040908 500 QHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATN 579 (790)
Q Consensus 500 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~N 579 (790)
.||++++. ..-...+.+.+.|+.-+.+-=...+ ..++...+++++..|+....+++.. +|--+.|.|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 58888766 4555666666666644322111122 4578889999999999888777643 788999999
Q ss_pred EEecCCCCeEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCc
Q 040908 580 VLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIM 651 (790)
Q Consensus 580 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~ 651 (790)
|+++.++.+++.-.|+-..+.+. ..+...=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P~-----------------------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDPL-----------------------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSCC-----------------------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCCCC-----------------------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999877764322221 11122223357788899999988775
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.50 E-value=0.17 Score=56.35 Aligned_cols=61 Identities=10% Similarity=0.106 Sum_probs=18.6
Q ss_pred eeeeecccCcEEEEeeeecC-CcEEEE------EEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEe
Q 040908 450 VANKIGEGGFGPVYKGLLAD-GTLIAV------KQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~~~-g~~vAv------K~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
+.+.|| ||.||+|.+.. ..+||| |..+.. +.+....|.+|..++...+|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 456676 99999999864 367888 766542 22334568889999999999999999888653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 790 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 4e-71
Identities = 72/279 (25%), Positives = 126/279 (45%), Gaps = 22/279 (7%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
V +IG G FG VYKG + + ++A + Q + F NE+G + +H +++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
G QL ++ ++ E +SL L E K + +I A+G+ YLH +
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK 123
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRVAGTFGYMAPEYAM- 623
I+HRD+K+ N+ L +DL KI DFGLA + +H +++G+ +MAPE
Sbjct: 124 ---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 624 --RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681
+ + ++DVY+FGIV E+++G+ + ++ +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-------QIIFMVGRGYLSPDLSK 233
Query: 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ SN K M + C RPL +++ +E
Sbjct: 234 VRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 7e-69
Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 22/275 (8%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
+ ++G G FG V+ G T +AVK L + F+ E + LQH LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+LY + + +I EY+EN SL L P +KL ++ IA G+A++ E
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
+HRD++A N+L+ L+ KI+DFGLA+L E++ + APE G
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 626 HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN 685
T K+DV+SFGI+ EIV+ + + +++ +V P N
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP--------YPGMTNPEVIQNLERGYRMVRP---DN 234
Query: 686 VDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+E + + LC P +RP + S+LE
Sbjct: 235 CPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-67
Identities = 67/275 (24%), Positives = 119/275 (43%), Gaps = 22/275 (8%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
+ +IG G FG V+ G + +A+K + + +F+ E + L HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+LYG C+E + L++E++E+ L+ R T +C+ + G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
++HRD+ A N L+ ++ K+SDFG+ + +D ST + +PE
Sbjct: 121 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 626 HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN 685
+ K+DV+SFG++ E+ S + ++++ L P L S
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYKPRLAST 229
Query: 686 VDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ + C P +RP S ++ L
Sbjct: 230 -------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 2e-66
Identities = 66/276 (23%), Positives = 108/276 (39%), Gaps = 24/276 (8%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
++G G FG V G +A+K + + EF+ E + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+LYG C + + +I EY+ N L L E R + +C + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
+ +HRD+ A N L++ K+SDFGL++ +D S + PE M
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 626 HLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684
+ K+D+++FG++ EI S G+ T E + L L P+L S
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---------RLYRPHLAS 227
Query: 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ + C RP ++S +
Sbjct: 228 -------EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (551), Expect = 5e-65
Identities = 65/297 (21%), Positives = 127/297 (42%), Gaps = 28/297 (9%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL 504
+ +K+G G +G VY+G+ +AVK L + EF+ E + ++HP+L
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
V+L G C +I E++ +L L E +R ++ + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE- 132
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 624
+ +HRD+ A N L+ ++ K++DFGL++L D + APE
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 625 GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684
+ K+DV++FG++ EI + + + + EL++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEKDYRM 235
Query: 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDIVQDSSVSNKDESK 741
+ + + C +P++RP + + E + Q+SS+S++ E +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE------TMFQESSISDEVEKE 286
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 9e-65
Identities = 73/291 (25%), Positives = 119/291 (40%), Gaps = 30/291 (10%)
Query: 453 KIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCI 512
IG+G FG V++G G +AVK S++ ++ + EI L+H +++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 513 EGN----QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE--- 565
+ N QL L+ +Y E+ SL L +R + + + A GLA+LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 566 --SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS---TRVAGTFGYMAPE 620
+ I HRD+K+ N+L+ K+ I+D GLA + I GT YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 621 Y------AMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY----LLDWALLLKE 670
+AD+Y+ G+V EI S + Y D ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 671 QGNLMELVDPNLGSNVD-KEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ + + PN+ + E +RVM + C + R + L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 4e-64
Identities = 60/281 (21%), Positives = 117/281 (41%), Gaps = 11/281 (3%)
Query: 444 ATNHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQH 501
+ F+ +++G G G V+K G ++A K + + K R + E+ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P++V YG ++ + E+++ SL + L + ++ + I + +GL Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTY 119
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
L + KI+HRD+K +N+L++ K+ DFG++ + GT YM+PE
Sbjct: 120 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPER 174
Query: 622 AMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681
H + ++D++S G+ +E+ GR I +E + + P
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722
+ R + + L + P + S V LE +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-63
Identities = 72/275 (26%), Positives = 119/275 (43%), Gaps = 22/275 (8%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
+ K+G+G FG V+ G T +A+K L F+ E + L+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
+LY + ++ EY+ SL L G E L P ++ IA G+AY+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE-- 130
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
R+ VHRD++A N+L+ ++L K++DFGLA+L E++ + APE A+ G
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 626 HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSN 685
T K+DV+SFGI+ E+ + + +++ V+
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQVERGYRMP 234
Query: 686 VDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
E + ++ C P RP + + LE
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-62
Identities = 71/290 (24%), Positives = 130/290 (44%), Gaps = 29/290 (10%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGT-----LIAVKQLSAKSKQGNR-EFVNEIGTISAL 499
+ IG G FG VYKG+L + +A+K L A + R +F+ E G +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 500 QHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGL 559
H ++++L G + +++I EY+EN +L + E + + GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLRGIAAGM 123
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRVAGTFGYM 617
YL + VHRD+ A N+L++ +L K+SDFGL+++ D+ + T+ ++ +
Sbjct: 124 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 618 APEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677
APE T +DV+SFGIV E+++ + + +M+
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKA 225
Query: 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPD 727
++ + + + + C RP + +VS+L+ + PD
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (532), Expect = 3e-62
Identities = 71/310 (22%), Positives = 129/310 (41%), Gaps = 39/310 (12%)
Query: 436 FTLRQIKAATNHFD---------VANKIGEGGFGPVYKGLLA----DGTLIAVKQL-SAK 481
FT A F + IG G FG V G L +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 482 SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRL 541
+++ R+F++E + HP+++ L G + +++I E++EN SL ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL---DSFLRQNDG 123
Query: 542 KLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601
+ + GIA G+ YL + VHRD+ A N+L++ +L K+SDFGL++ E+
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 602 DNTHISTRVA----GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE 657
D + + A + APE T +DV+S+GIV E++S +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717
+++ ++ + + + + L C +RP +V+
Sbjct: 241 ---------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 718 MLEGRVGVPD 727
L+ + P+
Sbjct: 286 TLDKMIRNPN 295
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-61
Identities = 72/311 (23%), Positives = 117/311 (37%), Gaps = 46/311 (14%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKSKQGNRE-FVNEIGTISA 498
N +G G FG V + +AVK L + RE ++E+ +S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 499 L-QHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFG--------------PEEHRLKL 543
L H ++V L G C G L+I EY L L E+ L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 544 DWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEED 602
D + +A+G+A+L + +HRD+ A N+LL KI DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 603 NTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
N + +MAPE T ++DV+S+GI E+ S S+ +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255
Query: 663 DWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722
+++ + M ++ C D P RP +V ++E
Sbjct: 256 ----------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK- 304
Query: 723 VGVPDIVQDSS 733
+ +S+
Sbjct: 305 -----QISEST 310
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (526), Expect = 2e-61
Identities = 76/311 (24%), Positives = 127/311 (40%), Gaps = 46/311 (14%)
Query: 438 LRQIKAATNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKSKQGNR-EFV 490
L ++ N+ + IGEG FG V++ T++AVK L ++ + +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 491 NEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRL--------- 541
E ++ +P++VKL G C G + L++EY+ L L H +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 542 -----------KLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 590
L + I +A G+AYL E K VHRD+ N L+ +++ KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181
Query: 591 SDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSN 649
+DFGL++ + D A +M PE T ++DV+++G+V EI S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 650 IMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNR 709
E + GN++ + N E + N+ LC P +R
Sbjct: 242 PYYGMAHE------EVIYYVRDGNILACPE-----NCPLE----LYNLMRLCWSKLPADR 286
Query: 710 PLMSSVVSMLE 720
P S+ +L+
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-60
Identities = 66/276 (23%), Positives = 102/276 (36%), Gaps = 28/276 (10%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
+ IG+G FG V G G +AVK + K+ + F+ E ++ L+H +LV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63
Query: 506 KLYGCCIEG-NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
+L G +E L ++ EY+ SL L R L + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 565 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 624
VHRD+ A NVL+ +D K+SDFGL K + APE
Sbjct: 122 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALRE 174
Query: 625 GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684
+ K+DV+SFGI+ EI S + + + + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----------RVEKGYKMDAPD 223
Query: 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ V C + RP + LE
Sbjct: 224 GCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-60
Identities = 68/290 (23%), Positives = 121/290 (41%), Gaps = 31/290 (10%)
Query: 439 RQIKAATNHFDVAN-KIGEGGFGPVYKGLLA---DGTLIAVKQLSAKSKQGNRE-FVNEI 493
+++ ++ +A+ ++G G FG V +G+ +A+K L +++ + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 494 GTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICI 553
+ L +P++V+L G C + L+L+ E L + L G E + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR--VA 611
++ G+ YL VHRD+ A NVLL KISDFGL+K D+++ + R
Sbjct: 117 QVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 612 GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKE 670
+ APE + ++DV+S+G+ E +S G+ E + E
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------E 226
Query: 671 QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
QG ME E + + C +RP +V +
Sbjct: 227 QGKRMECPP-----ECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 4e-59
Identities = 72/277 (25%), Positives = 110/277 (39%), Gaps = 32/277 (11%)
Query: 452 NKIGEGGFGPVYKGLLAD---GTLIAVKQLSAKSKQGN--REFVNEIGTISALQHPHLVK 506
++G G FG V KG +AVK L ++ E + E + L +P++V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES 566
+ G C E +L+ E E L + L + + ++ G+ YL E
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES- 126
Query: 567 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR--VAGTFGYMAPEYAMR 624
VHRD+ A NVLL KISDFGL+K D + + + APE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 625 GHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683
+ K+DV+SFG++ E S G+ E +L E+G M
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGCPA---- 233
Query: 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+E M ++ LC NRP ++V L
Sbjct: 234 -GCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (510), Expect = 7e-59
Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 34/280 (12%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGN---REFVNEIGTISALQ 500
F +IG G FG VY + + ++A+K++S KQ N ++ + E+ + L+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
HP+ ++ GC + + L+ EY ++ H+ L + G +GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLA 129
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
YLH ++HRD+KA N+LL + K+ DFG A + N+ + GT +MAPE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 181
Query: 621 YAM---RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677
+ G K DV+S GI +E+ + + Y ++ +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------------HIAQN 229
Query: 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717
P L S E R N C P +RP ++
Sbjct: 230 ESPALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 9e-59
Identities = 63/276 (22%), Positives = 117/276 (42%), Gaps = 24/276 (8%)
Query: 448 FDVANKIGEGGFGPVYKG-LLADGTLIAVKQL--SAKSKQGNREFVNEIGTISALQHPHL 504
++V IG G +G K +DG ++ K+L + ++ + V+E+ + L+HP++
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 505 VKLYGCCIE--GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
V+ Y I+ L ++ EY E LA + + R LD + + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 563 HEESR--LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
H S ++HRD+K NV LD N K+ DFGLA++ D + + GT YM+PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSPE 184
Query: 621 YAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680
R +K+D++S G + E+ + +++E + E
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------------KIREGKFR 232
Query: 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVV 716
+ E + + ++ +RP + ++
Sbjct: 233 RIPYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 9e-59
Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 32/283 (11%)
Query: 447 HFDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKSKQGN-REFVNEIGTISALQH 501
HF+ IG G FG VY G L D AVK L+ + G +F+ E + H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 502 PHLVKLYGCCIEG-NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
P+++ L G C+ L++ Y+++ L + +A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL---DEEDNTHISTRVAGTFGYM 617
+L K VHRD+ A N +LD+ K++DFGLA+ E D+ H T +M
Sbjct: 145 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 618 APEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677
A E T K+DV+SFG++ E+++ + + ++ + L
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYLLQGRRL 253
Query: 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ P + V L C RP S +VS +
Sbjct: 254 LQP---EYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-58
Identities = 70/303 (23%), Positives = 109/303 (35%), Gaps = 45/303 (14%)
Query: 446 NHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKSKQGNRE-FVNEIGTISA 498
+ + +G G FG V +AVK L K+ RE ++E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 499 L-QHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFG-------------------PEE 538
L H ++V L G C + LI+EY L L EE
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 539 HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK- 597
L + +A+G+ +L + VHRD+ A NVL+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 598 LDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEE 657
+ + N + +MAPE G T K+DV+S+GI+ EI S N +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 658 KFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717
N +L+ + + + C RP ++ S
Sbjct: 274 A--------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 718 MLE 720
L
Sbjct: 320 FLG 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-57
Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 31/290 (10%)
Query: 438 LRQIKAATNHFDVANKIGEGGFGPVYKGLLAD-----GTLIAVKQLS-AKSKQGNREFVN 491
LR +K F +G G FG VYKGL +A+K+L A S + N+E ++
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 492 EIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNI 551
E ++++ +PH+ +L G C+ + LI + + L L EH+ + N
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCL---LDYVREHKDNIGSQYLLNW 116
Query: 552 CIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRV 610
C+ IA+G+ YL + ++VHRD+ A NVL+ + KI+DFGLAK L E+ + +
Sbjct: 117 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 611 AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKE 670
+MA E + T ++DV+S+G+ E+++ S +
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------------ 221
Query: 671 QGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ +++ + + + C + +RP ++
Sbjct: 222 ---ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-57
Identities = 64/277 (23%), Positives = 111/277 (40%), Gaps = 27/277 (9%)
Query: 445 TNHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH 503
+ +++ ++G+G FG VYK L A K + KS++ +++ EI +++ HP+
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+VKL N L ++ E+ ++ + E L +C L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH 127
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 623
+ KI+HRD+KA N+L D + K++DFG++ + + + GT +MAPE M
Sbjct: 128 D---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183
Query: 624 -----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678
KADV+S GI +E+ + + L
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-------AKSEPPTLA 236
Query: 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSV 715
P S + C + + R S +
Sbjct: 237 QP---SRWSSN----FKDFLKKCLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 5e-57
Identities = 72/276 (26%), Positives = 111/276 (40%), Gaps = 25/276 (9%)
Query: 446 NHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQHPH 503
+D+ +GEG +G V +AVK + K E EI L H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+VK YG EGN L EY L + E + + P + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYA 622
+ I HRDIK N+LLD+ N KISDFGLA + + ++ GT Y+APE
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 623 MRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681
R + DV+S GIV +++G + + Y KE+ +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-----SDWKEKKTYLNPWK-- 230
Query: 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717
+D + ++ +L + P+ R + +
Sbjct: 231 ---KIDSAPLALLH--KILVEN--PSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-56
Identities = 67/280 (23%), Positives = 110/280 (39%), Gaps = 27/280 (9%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKSKQGNRE-FVNEIGTISALQ 500
++ IGEG FG V++G+ +A+K + RE F+ E T+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
HPH+VKL G E N + +I E L + + LD + ++ LA
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
YL + VHRDI A NVL+ + K+ DFGL++ E+ + +++ +MAPE
Sbjct: 123 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 621 YAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680
T +DV+ FG+ EI+ K G +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-----------GRIENGERL 228
Query: 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ N + ++ C P+ RP + + + L
Sbjct: 229 PMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 3e-56
Identities = 72/292 (24%), Positives = 114/292 (39%), Gaps = 37/292 (12%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTL---IAVKQLS-AKSKQGNREFVNEIGTISAL-Q 500
N + IGEG FG V K + L A+K++ SK +R+F E+ + L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFG------------PEEHRLKLDWPTR 548
HP+++ L G C L L EY + +L L L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 608
+ +ARG+ YL + + +HRD+ A N+L+ ++ KI+DFGL++ E T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL 668
+MA E T +DV+S+G++ EIVS C + Y
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------- 237
Query: 669 KEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
L + N D E + ++ C P RP + ++ L
Sbjct: 238 ----KLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 8e-56
Identities = 62/274 (22%), Positives = 107/274 (39%), Gaps = 31/274 (11%)
Query: 452 NKIGEGGFGPVYKGLLAD-GTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLY 508
+IG G F VYKGL + +A +L + +K + F E + LQHP++V+ Y
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 509 GCCIE----GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
++L+ E + + +L L + + C I +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 565 ESRLKIVHRDIKATNVLL-DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 623
+ I+HRD+K N+ + + KI D GLA L V GT +MAPE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEM-Y 185
Query: 624 RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683
+ DVY+FG+ LE+ + + Y +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--------------RRVTSGVKP 231
Query: 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717
++ DK + + + C + R + +++
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 8e-56
Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 27/282 (9%)
Query: 438 LRQIKAA---TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEI 493
LR I + + KIG+G G VY + +A G +A++Q++ + + +NEI
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 494 GTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICI 553
+ ++P++V + G++L ++ EYL SL + +D +C
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCR 123
Query: 554 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 613
+ L +LH +++HRDIK+ N+LL D + K++DFG + + ST V GT
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 179
Query: 614 FGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673
+MAPE R K D++S GI+A+E++ G + + Y L
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-------LIATNG 232
Query: 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSV 715
EL +P + + C D+ R +
Sbjct: 233 TPELQNP---EKLSAI----FRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-55
Identities = 60/285 (21%), Positives = 113/285 (39%), Gaps = 32/285 (11%)
Query: 446 NHFDVANKIGEGGFGPVYKGLL----ADGTLIAVKQLS---AKSKQGNREFVNEIGTISA 498
+ K+G+G FG V +G +AVK L + +F+ E+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 499 LQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
L H +L++LYG + + ++ E SL L +H+ T + +A G
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH--ISTRVAGTFGY 616
+ YL + + +HRD+ A N+LL KI DFGL + +++ H + F +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675
APE + +D + FG+ E+ + G+ + + + +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-----------DK 229
Query: 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
E + ++ + NV + C P +RP ++ L
Sbjct: 230 EGERLPRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 7e-55
Identities = 61/276 (22%), Positives = 111/276 (40%), Gaps = 31/276 (11%)
Query: 446 NHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLS---AKSKQGNREFVNEIGTISALQH 501
F++ +G+G FG VY ++A+K L + + E+ S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P++++LYG + ++ LI EY ++ R L K D +A L+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSY 121
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
H +++HRDIK N+LL KI+DFG + + GT Y+ PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175
Query: 622 AMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681
+K D++S G++ E + G+ T +E + + + + + V
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-----RISRVEFTFPDFVTEG 230
Query: 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717
++ +P+ RP++ V+
Sbjct: 231 A------------RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-54
Identities = 71/290 (24%), Positives = 118/290 (40%), Gaps = 32/290 (11%)
Query: 446 NHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLS-AKSKQGNREFVNEIGTISA 498
++ ++G+G FG VY+G+ T +A+K ++ A S + EF+NE +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 499 LQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALF------GPEEHRLKLDWPTRHNIC 552
H+V+L G +G L+I E + L L +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 553 IGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVA 611
IA G+AYL+ K VHRD+ A N ++ +D KI DFG+ + + E D +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 612 GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ 671
+M+PE G T +DV+SFG+V EI + E L +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVME 250
Query: 672 GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721
G L++ D N + + +C +P RP ++S ++
Sbjct: 251 GGLLDKPD-----NCPDM----LFELMRMCWQYNPKMRPSFLEIISSIKE 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-52
Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 45/310 (14%)
Query: 446 NHFDVANKIGEGGFGPVYKGL------LADGTLIAVKQLSAKSKQG-NREFVNEIGTISA 498
+ + +G G FG V + A +AVK L + +R ++E+ +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 499 -LQHPHLVKLYGCCIE-GNQLLLIYEYLENNSLARALFG------------PEEHRLKLD 544
H ++V L G C + G L++I E+ + +L+ L + ++ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 545 WPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDN 603
+A+G+ +L K +HRD+ A N+LL + KI DFGLA+ + ++ +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLD 663
+MAPE T ++DV+SFG++ EI S + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GASPYPGVKIDE 244
Query: 664 WALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723
++G M D E M L C P+ RP S +V L
Sbjct: 245 EFCRRLKEGTRMRAPD-----YTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG--- 292
Query: 724 GVPDIVQDSS 733
+++Q ++
Sbjct: 293 ---NLLQANA 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 183 bits (465), Expect = 3e-52
Identities = 58/268 (21%), Positives = 108/268 (40%), Gaps = 24/268 (8%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL 504
+H+D+ ++G G FG V++ A G A K + + EI T+S L+HP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
V L+ + N++++IYE++ L + + K+ + +GL ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 565 ESRLKIVHRDIKATNVLLDKDLNP--KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 622
VH D+K N++ + K+ DFGL + + T GT + APE A
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVA 197
Query: 623 MRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682
+ D++S G+++ ++SG S + +E + N+ + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-----NVKSCDWNMDDSAFSGI 252
Query: 683 GSNVDKEQVRVMINVALLCADVSPTNRP 710
+ + P R
Sbjct: 253 SED--------GKDFIRKLLLADPNTRM 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 7e-51
Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 41/298 (13%)
Query: 446 NHFDVANKIGEGGFGPVYKGLL--------ADGTLIAVKQLSAKSKQGN-REFVNEIGTI 496
+ + +GEG FG V T +AVK L + + + + + ++E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 497 SAL-QHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALF------------GPEEHRLKL 543
+ +H +++ L G C + L +I EY +L L +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 544 DWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603
+ +ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 604 THISTRVA-GTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
+ T +MAPE T ++DV+SFG++ EI + + E+ + L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 663 DWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
L E + SN E + + C P+ RP +V L+
Sbjct: 250 -----------LKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (451), Expect = 3e-50
Identities = 63/268 (23%), Positives = 104/268 (38%), Gaps = 24/268 (8%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL 504
+++D+ ++G G FG V++ + A G + K ++ NEI ++ L HP L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 505 VKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE 564
+ L+ + +++LI E+L L + K+ N GL ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 565 ESRLKIVHRDIKATNVLLDKDLNP--KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 622
IVH DIK N++ + KI DFGLA D T T + APE
Sbjct: 146 ---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIV 200
Query: 623 MRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682
R + D+++ G++ ++SG S F D L+ D +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS---------PFAGEDDLETLQNVKRCDWEFDEDA 251
Query: 683 GSNVDKEQVRVMINVALLCADVSPTNRP 710
S+V E + P R
Sbjct: 252 FSSVSPE----AKDFIKNLLQKEPRKRL 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 67/274 (24%), Positives = 103/274 (37%), Gaps = 29/274 (10%)
Query: 442 KAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS---AKSKQGNREFVNEIGTIS 497
K F +GEG F V LA A+K L + E +S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 498 ALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIAR 557
L HP VKLY + +L Y +N L + + D I
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVS 119
Query: 558 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRVAGTFGY 616
L YLH I+HRD+K N+LL++D++ +I+DFG AK+ E + GT Y
Sbjct: 120 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676
++PE +D+++ G + ++V+G + F ++K + + E
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ-----KIIKLEYDFPE 231
Query: 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP 710
P V+K LL D T R
Sbjct: 232 KFFPKARDLVEK----------LLVLD--ATKRL 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 7e-47
Identities = 59/281 (20%), Positives = 112/281 (39%), Gaps = 12/281 (4%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE-FVNEIGTISALQHP 502
+ + IGEG +G V + +A+K++S Q + + EI + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
+++ + + YL + + L+ + + L I RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRVAGTFGYMAPE 620
H ++HRD+K +N+LL+ + KI DFGLA++ + D+T T T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 621 YAMRGHLTD-KADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679
+ D++S G + E++S R K ++ + L Q +L +++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
+ + + + L + L+ ML
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLT 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 2e-46
Identities = 57/286 (19%), Positives = 94/286 (32%), Gaps = 29/286 (10%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL 504
N + + KIG G FG +Y G +A G +A+K K+K + E +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 505 VKLYG-CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+ C EG+ +++ E L + K T + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLE----DLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 564 EESRLKIVHRDIKATNVL---LDKDLNPKISDFGLAKLDEEDNTHI------STRVAGTF 614
+HRD+K N L K I DFGLAK + TH + + GT
Sbjct: 121 S---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674
Y + + + + D+ S G V + G K + +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-----RISEKK 232
Query: 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
M L E C + ++P S + +
Sbjct: 233 MSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 2e-46
Identities = 62/277 (22%), Positives = 111/277 (40%), Gaps = 27/277 (9%)
Query: 439 RQIKAATNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE-FVNEIGTI 496
+Q + + +D + +G G F V L+A+K ++ K+ +G NEI +
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 497 SALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIA 556
++HP++V L G L LI + + L + + + +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVL 117
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGT 613
+ YLH+ IVHRD+K N+L D+D ISDFGL+K+ ED + + GT
Sbjct: 118 DAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGT 172
Query: 614 FGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673
GY+APE + + D +S G++A ++ G + + F +LK +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE-----QILKAEYE 227
Query: 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP 710
++ + + + P R
Sbjct: 228 FDSPYWDDISDS--------AKDFIRHLMEKDPEKRF 256
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-46
Identities = 50/331 (15%), Positives = 115/331 (34%), Gaps = 32/331 (9%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLV 505
+ +A +G G FG V++ + + K + K EI ++ +H +++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNIL 64
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
L+ +L++I+E++ + + +L+ + + L +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 566 SRLKIVHRDIKATNVLLDKDLNP--KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 623
I H DI+ N++ + KI +FG A+ + + Y APE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQ 176
Query: 624 RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683
++ D++S G + ++SG + + +T ++ ++ + E +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE-----NIMNAEYTFDEEAFKEIS 231
Query: 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVGVPDIVQDSSVSNKDESKSE 743
++ +R S + P + Q + ++
Sbjct: 232 IEA--------MDFVDRLLVKERKSRMTASEALQH-------PWLKQKIERVSTKVIRTL 276
Query: 744 AMRKYYQFSIENTASTQSVSTDGPPTGSSTS 774
R+YY I+ + + G+ S
Sbjct: 277 KHRRYYHTLIKKDLNMVVSAARISCGGAIRS 307
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (420), Expect = 6e-46
Identities = 66/229 (28%), Positives = 96/229 (41%), Gaps = 18/229 (7%)
Query: 446 NHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLS---AKSKQGNREFVNEIGTISALQ- 500
N F V IG GGFG VY G + A+K L K KQG +NE +S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 501 --HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
P +V + ++L I + + L L I G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILG 119
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 618
L ++H +V+RD+K N+LLD+ + +ISD GLA + H S GT GYMA
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 173
Query: 619 PEYAMRGHLTD-KADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWAL 666
PE +G D AD +S G + +++ G S ++K + L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (409), Expect = 4e-45
Identities = 51/288 (17%), Positives = 98/288 (34%), Gaps = 31/288 (10%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQH-PH 503
H+ V +IGEG FG +++G L + +A+K +S + +E T L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+ +Y EG +L+ + L + + K T + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 564 EESRLKIVHRDIKATNVLLDKDLNP-----KISDFGLAKLDEEDNTHI------STRVAG 612
E +V+RDIK N L+ + + + DFG+ K + T ++G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 613 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG 672
T YM+ + + + D+ + G V + + G + K+
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720
L EL +E +++ P + +
Sbjct: 236 PLRELCA-----GFPEE----FYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (403), Expect = 5e-44
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 446 NHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLS---AKSKQGNREFVNEIGTISALQH 501
F + +G G FG V+ +G A+K L + +E +S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P +++++G + Q+ +I +Y+E L F + P + L Y
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
LH I++RD+K N+LLDK+ + KI+DFG AK + + GT Y+APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEV 172
Query: 622 AMRGHLTDKADVYSFGIVALEIVSGRS 648
D +SFGI+ E+++G +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-44
Identities = 51/219 (23%), Positives = 102/219 (46%), Gaps = 9/219 (4%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQL--SAKSKQGNREFVNEIGTISALQHPH 503
+F KIGEG +G VYK G ++A+K++ +++ + EI + L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+VKL N+L L++E+L + F + P + + +GLA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 623
+++HRD+K N+L++ + K++DFGLA+ + V +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 624 RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL 662
+ + D++S G + E+V+ R+ ++ ++ + +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (398), Expect = 7e-44
Identities = 60/276 (21%), Positives = 109/276 (39%), Gaps = 30/276 (10%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS---AKSKQGNREFVNEIGTISALQ 500
++ +++ +G GG V+ L +AVK L A+ F E +AL
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 501 HPHLVKLYGCCIE----GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIA 556
HP +V +Y G ++ EY++ +L + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADAC 121
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRVAGTF 614
+ L + H+ I+HRD+K N+++ K+ DFG+A+ D ++ + V GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674
Y++PE A + ++DVYS G V E+++G + Y ++E
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-----QHVREDPIP 233
Query: 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP 710
L +++D V L +P NR
Sbjct: 234 PSARHEGLSADLD--------AVVLKALAKNPENRY 261
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 157 bits (397), Expect = 1e-43
Identities = 56/279 (20%), Positives = 113/279 (40%), Gaps = 21/279 (7%)
Query: 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQL--SAKSKQGNREFVNEIGTISALQHPH 503
+ KIGEG +G VYK G A+K++ + + + EI + L+H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 504 LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLH 563
+VKLY +L+L++E+L+ + L+ T + + + G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 564 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 623
+ +++HRD+K N+L++++ KI+DFGLA+ + + +
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 624 RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL------------LKEQ 671
+ D++S G + E+V+G ++ ++ + L L +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 672 GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP 710
+ +P + K I++ + P R
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 156 bits (396), Expect = 2e-43
Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 26/218 (11%)
Query: 447 HFDVANKIGEGGFGPVYKGL-LADGTLIAVKQL--------SAKSKQGNRE-FVNEIGTI 496
+++ +G G V + + AVK + SA+ Q RE + E+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 497 SALQ-HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGI 555
+ HP++++L L+++ ++ L L ++ L I +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRAL 119
Query: 556 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 615
+ LH+ L IVHRD+K N+LLD D+N K++DFG + + V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPS 174
Query: 616 YMAPEYAM------RGHLTDKADVYSFGIVALEIVSGR 647
Y+APE + D++S G++ +++G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-43
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 13/220 (5%)
Query: 446 NHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGNRE---FVNEIGTIS-ALQ 500
F + +G+G FG V+ A+K L + + + E +S A +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 501 HPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
HP L ++ L + EYL L + + K D I GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQ 117
Query: 561 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
+LH IV+RD+K N+LLDKD + KI+DFG+ K + + +T GT Y+APE
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 621 YAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY 660
+ D +SFG++ E++ G+S + +EE F+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-43
Identities = 57/291 (19%), Positives = 112/291 (38%), Gaps = 24/291 (8%)
Query: 444 ATNHFDVANKIGEGGFGPVYKG--LLADGTLIAVKQLSAKSKQGN--REFVNEIGTISAL 499
A ++ +IGEG +G V+K L G +A+K++ ++ + + E+ + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 500 ---QHPHLVKLYGCCIEGNQLLLIYEYLENNSLAR--ALFGPEEHRLKLDWPTRHNICIG 554
+HP++V+L+ C L + + + + + T ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 614
+ RGL +LH ++VHRD+K N+L+ K++DFGLA++ T V T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLL----------DW 664
Y APE ++ D++S G + E+ + + ++ + DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 665 ALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSV 715
+ + + ++ L C +P R S
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 6e-42
Identities = 59/278 (21%), Positives = 116/278 (41%), Gaps = 25/278 (8%)
Query: 452 NKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQG-----NREFVNEIGTISALQHPHLV 505
+ +GEG F VYK ++A+K++ + NR + EI + L HP+++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 506 KLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEE 565
L + + L+++++E + +++ L L + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE----VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 566 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 625
I+HRD+K N+LLD++ K++DFGLAK N + +V T Y APE
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 626 HLTD-KADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684
+ D+++ G + E++ + + ++ + + G E P++ S
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT-----RIFETLGTPTEEQWPDMCS 230
Query: 685 NVDKEQVRVMINVAL--LCADVSPTNRPLMSSVVSMLE 720
D + + L + + L+ +
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFL 265
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 20/226 (8%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNR------EFVNEIGTISA 498
+++D ++G G F V K + G A K + + + +R + E+ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 499 LQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARG 558
+QHP+++ L+ ++LI E + LF + L I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILNG 125
Query: 559 LAYLHEESRLKIVHRDIKATNVLLDKDLNP----KISDFGLAKLDEEDNTHISTRVAGTF 614
+ YLH L+I H D+K N++L P KI DFGLA + N + GT
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTP 180
Query: 615 GYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY 660
++APE L +AD++S G++ ++SG S + TK+E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-40
Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 20/214 (9%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE------FVNEIGTISA 498
+ + V +G GGFG VY G+ ++D +A+K + E E+ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 499 LQHPH--LVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIA 556
+ +++L + +LI E E R L + +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVL 120
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRVAGTFG 615
+ + H ++HRDIK N+L+D + K+ DFG L ++ T GT
Sbjct: 121 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRV 174
Query: 616 YMAPEYAMRGHLTDK-ADVYSFGIVALEIVSGRS 648
Y PE+ + A V+S GI+ ++V G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-39
Identities = 68/338 (20%), Positives = 116/338 (34%), Gaps = 31/338 (9%)
Query: 448 FDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
+ IG G FG VY+ L G L+A+K++ + NRE + + L H ++V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVR 77
Query: 507 LYGCCIEGNQ------LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLA 560
L + L L+ +Y+ A + L + R LA
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSLA 136
Query: 561 YLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 619
Y+H I HRDIK N+LLD D K+ DFG AK + + +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAPE 192
Query: 620 EYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679
T DV+S G V E++ G+ + ++ + L + + E+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML----EGRVGVPDIVQDS--- 732
+ Q++ + P L S +L R+ + S
Sbjct: 253 NY--TEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACAHSFFD 307
Query: 733 --SVSNKDESKSEAMRKYYQFSIENTASTQSVSTDGPP 768
N + F+ + +S ++T P
Sbjct: 308 ELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIP 345
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-39
Identities = 64/220 (29%), Positives = 86/220 (39%), Gaps = 12/220 (5%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS---AKSKQGNREFVNEIGTISALQH 501
N FD +G+G FG V A G A+K L +K V E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P L L ++L + EY L L I L Y
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEY 120
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
LH +V+RDIK N++LDKD + KI+DFGL K D + T GT Y+APE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEV 176
Query: 622 AMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYL 661
D + G+V E++ GR + E F L
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 9e-39
Identities = 59/262 (22%), Positives = 115/262 (43%), Gaps = 27/262 (10%)
Query: 446 NHFDVANKIGEGGFGPVYKG-LLADGTLIAVKQLSAKSKQGN--REFVNEIGTISALQHP 502
+ ++ KIG+G FG V+K G +A+K++ ++++ + EI + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 503 HLVKLYGCCIEG--------NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIG 554
++V L C + L++++ E++ +K +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQM 125
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRVA 611
+ GL Y+H KI+HRD+KA NVL+ +D K++DFGLA+ L + + T
Sbjct: 126 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 612 GTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKE 670
T Y PE + D++ G + E+ + + T++ + AL+ +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL-----ALISQL 237
Query: 671 QGNLMELVDPNLGSNVDKEQVR 692
G++ V PN+ + E++
Sbjct: 238 CGSITPEVWPNVDNYELYEKLE 259
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-38
Identities = 41/206 (19%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQL--SAKSKQGNREFVNEIGTISALQHP 502
++ KIGEG +G V+K ++A+K++ + + EI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 503 HLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYL 562
++V+L+ +L L++E+ + + + LD + + +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLK----KYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 563 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 622
H ++HRD+K N+L++++ K+++FGLA+ S V +
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 623 MRGHLTDKADVYSFGIVALEIVSGRS 648
+ D++S G + E+ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-38
Identities = 56/335 (16%), Positives = 122/335 (36%), Gaps = 20/335 (5%)
Query: 436 FTLRQIKAAT----NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQL--SAKSKQGNRE 488
F +++ + +G G +G V + G +A+K+L +S+ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 489 FVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTR 548
E+ + ++H +++ L L ++ G KL
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 549 HNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 608
+ + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ + ++ ++
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTG 177
Query: 609 RVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL 668
V + T D++S G + E+++G++ ++ +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 669 KEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML----EGRVG 724
+ L + + + A + + SP L+ ML E RV
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVT 294
Query: 725 VPDIVQDSSVSNKDESKSEAMRKYYQFSIENTAST 759
+ + + +++ E + Y S ++ T
Sbjct: 295 AGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRT 329
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 9e-38
Identities = 56/274 (20%), Positives = 95/274 (34%), Gaps = 29/274 (10%)
Query: 446 NHFDVANK-IGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPH 503
+ + V ++ +G G G V + A+K L + RE A Q PH
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHW---RASQCPH 66
Query: 504 LVKLYGCC----IEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGL 559
+V++ LL++ E L+ L + + I I +
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAI 124
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNP---KISDFGLAKLDEEDNTHISTRVAGTFGY 616
YLH + I HRD+K N+L K++DFG AK N+ + T Y
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYY 179
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676
+APE D++S G++ ++ G + + + + E
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----YE 235
Query: 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP 710
+P S V +E + + PT R
Sbjct: 236 FPNPEW-SEVSEE----VKMLIRNLLKTEPTQRM 264
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 2e-36
Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 15/219 (6%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNRE---FVNEIGTISALQH 501
+ FD +G G FG V G A+K L + ++ +NE + A+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
P LVKL + + L ++ EY+ + L + P I Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEY 156
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
LH L +++RD+K N+L+D+ +++DFG AK + + GT +APE
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEI 209
Query: 622 AMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY 660
+ D ++ G++ E+ +G + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-34
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 18/229 (7%)
Query: 430 DLQTGSFTLRQIKAATNHFDVANKIGEGGFGPVYKGLLA----DGTLIAVKQLS----AK 481
+L+T + T K +F++ +G G +G V+ G L A+K L +
Sbjct: 8 ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 67
Query: 482 SKQGNREFVNEIGTISALQH-PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHR 540
+ E + ++ P LV L+ +L LI +Y+ L L R
Sbjct: 68 KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQR 123
Query: 541 LKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600
+ I L +LH+ L I++RDIK N+LLD + + ++DFGL+K
Sbjct: 124 ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180
Query: 601 EDNTHISTRVAGTFGYMAPEYAMRGH--LTDKADVYSFGIVALEIVSGR 647
D T + GT YMAP+ G D +S G++ E+++G
Sbjct: 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 3e-34
Identities = 46/224 (20%), Positives = 90/224 (40%), Gaps = 21/224 (9%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS--AKSKQGNREFVNEIGTISALQHP 502
+ IG G G V +A+K+LS +++ + E+ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 503 HLVKLYGCCI------EGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIA 556
+++ L E + L+ E ++ N + +++LD + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-------QVIQMELDHERMSYLLYQML 129
Query: 557 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 616
G+ +LH I+HRD+K +N+++ D KI DFGLA+ T T Y
Sbjct: 130 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYY 184
Query: 617 MAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFY 660
APE + + D++S G + E+V + + +++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 2e-33
Identities = 61/318 (19%), Positives = 119/318 (37%), Gaps = 16/318 (5%)
Query: 445 TNHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLS--AKSKQGNREFVNEIGTISALQH 501
+ + +G G +G V G +AVK+LS +S + E+ + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 502 PHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
+++ L L + L A KL + I RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 562 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 621
+H I+HRD+K +N+ +++D KI DFGLA+ + ++ VA +
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 190
Query: 622 AMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681
H D++S G + E+++GR+ ++ L+ + L ++ +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSML----EGRVGVPDIVQDSSVSNK 737
+ + +N A + +P L+ ML + R+ + + +
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQALAHAYFAQY 307
Query: 738 DESKSEAMRKYYQFSIEN 755
+ E + Y S E+
Sbjct: 308 HDPDDEPVADPYDQSFES 325
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (320), Expect = 7e-33
Identities = 41/232 (17%), Positives = 90/232 (38%), Gaps = 21/232 (9%)
Query: 446 NHFDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPH 503
+ + + K+G G + V++ + + + + VK L K+ + EI + L+ P+
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 504 LVKLYGCCIE--GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAY 561
++ L + L++E++ N ++ L I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYEILKALDY 144
Query: 562 LHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 620
H + I+HRD+K NV++D + ++ D+GLA+ + + + PE
Sbjct: 145 CHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 199
Query: 621 YAMRGHLTD-KADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ 671
+ + D D++S G + ++ + + +L E
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 1e-26
Identities = 41/215 (19%), Positives = 73/215 (33%), Gaps = 18/215 (8%)
Query: 448 FDVANKIGEGGFGPVYKGL-LADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVK 506
+ + K+G G F V+ + + T +A+K + K +EI + + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 507 LYGCCIEGNQLLLIYEYLENNSLARALFGPEEH------------RLKLDWPTRHNICIG 554
LL + + + + E + I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 555 IARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEEDNTHISTR-VAG 612
+ GL Y+H R I+H DIK NVL++ D + +A L
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 613 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR 647
T Y +PE + AD++S + E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 1e-21
Identities = 29/158 (18%), Positives = 47/158 (29%), Gaps = 21/158 (13%)
Query: 450 VANKIGEGGFGPVYKGLLADGTLIAVKQLSAKS----------KQGNREFVNEIGTISAL 499
+ +GEG V+ VK G+ F +
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 500 QHPHLVKLYGCCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGL 559
+ L KL G + Y + E N++ L +E + I +
Sbjct: 64 EFRALQKLQGLAVPKV-----YAW-EGNAVLMELIDAKELYRVRVENPDE-VLDMILEEV 116
Query: 560 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597
A + IVH D+ NVL+ + I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 19/57 (33%), Positives = 27/57 (47%), Gaps = 2/57 (3%)
Query: 70 LRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGN-LLTG 125
LR+ + G LP L ++ + L++SFN L G IP+ L D N L G
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.0 bits (115), Expect = 1e-06
Identities = 27/152 (17%), Positives = 56/152 (36%), Gaps = 6/152 (3%)
Query: 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANS------VWHYFSESLTDLRISDLNGPE 54
+ T NR+SG +P+ GS + + + + +L + +S
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG 211
Query: 55 ATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVD 114
+ I + N +G + LDL N++ GT+P+ +L +
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271
Query: 115 FIYLTGNLLTGKVPQWMFGRGPENIDLSYNNF 146
+ ++ N L G++PQ + + + N
Sbjct: 272 SLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 5e-05
Identities = 18/98 (18%), Positives = 30/98 (30%), Gaps = 12/98 (12%)
Query: 39 SESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGE----LPHFLGEVSEMKVLDL 94
E L+D R ++L LP L+ + + L C LT + L + L+L
Sbjct: 11 CEELSDARWAEL------LPLLQQ--CQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 95 SFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMF 132
N+L + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 8e-05
Identities = 23/157 (14%), Positives = 51/157 (32%), Gaps = 12/157 (7%)
Query: 5 VQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDL 60
+ N+L L SL + N + + LT+L++ + L
Sbjct: 226 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISN--ISPL 281
Query: 61 RNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTG 120
T + + N E + + + L L FN ++ P + L + ++
Sbjct: 282 AGLTALTNLELNEN-QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFAN 338
Query: 121 NLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQN 157
N ++ V + +N +D + ++
Sbjct: 339 NKVSD-VSSLANLTNINWLSAGHNQISDLTPLANLTR 374
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 9e-05
Identities = 12/117 (10%), Positives = 32/117 (27%), Gaps = 6/117 (5%)
Query: 7 SNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEAT-LPDLRN-RT 64
+ G + +L +L L + + + +
Sbjct: 271 GANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTK 330
Query: 65 FKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGN 121
+ L + ++ L ++ + L N+++ P A L + + L
Sbjct: 331 LQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 16/78 (20%), Positives = 30/78 (38%)
Query: 55 ATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVD 114
+P L L++ +T + + L L NK++ P +FA L ++
Sbjct: 23 EKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 115 FIYLTGNLLTGKVPQWMF 132
+YL+ N L +
Sbjct: 83 RLYLSKNQLKELPEKMPK 100
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 37.7 bits (86), Expect = 0.003
Identities = 26/146 (17%), Positives = 50/146 (34%), Gaps = 1/146 (0%)
Query: 21 LIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEAT-LPDLRNRTFKNLILRSCNLTGEL 79
++ G ++ + + + + L + T +P + L L +T
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVD 187
Query: 80 PHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENI 139
L ++ + L LSFN ++ S A + ++L N L + + +
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVV 247
Query: 140 DLSYNNFADESSGSDCQNGAVNLFAS 165
L NN + S C G AS
Sbjct: 248 YLHNNNISAIGSNDFCPPGYNTKKAS 273
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.002
Identities = 21/81 (25%), Positives = 34/81 (41%), Gaps = 15/81 (18%)
Query: 66 KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTG 125
+ L + + L ELP ++ L SFN L +PE L +++ N L
Sbjct: 287 EELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNLK---QLHVEYNPLR- 337
Query: 126 KVPQWMFGRGPENI-DLSYNN 145
+ P PE++ DL N+
Sbjct: 338 EFPDI-----PESVEDLRMNS 353
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 790 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.74 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.72 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.7 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.66 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.62 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.61 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.53 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.51 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.51 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.48 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.46 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.37 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.34 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.32 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.31 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.28 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.27 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.24 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.2 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.18 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.18 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.17 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.15 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.12 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.97 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.9 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.78 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.62 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.54 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.5 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.26 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.17 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.05 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.87 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.84 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.78 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.24 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.86 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.79 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.59 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.57 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.18 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 93.84 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=426.27 Aligned_cols=254 Identities=26% Similarity=0.478 Sum_probs=199.3
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
++|++.+.||+|+||.||+|.+.+++.||||++... ....++|.+|+.++++++|||||+++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 579999999999999999999988899999999753 3445789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+|+|.+++.. ....++|..+..++.|||+||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 9999999853 3356899999999999999999999985 999999999999999999999999999877655444
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCC-CccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSN-IMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
......||+.|+|||++.+..++.++|||||||++|||+|+..| +......+ +... ... +. ....
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~---i~~-~~--~~~~----- 223 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVED---IST-GF--RLYK----- 223 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHH---HHH-TC--CCCC-----
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHH---HHh-cC--CCCC-----
Confidence 44456799999999999999999999999999999999996544 43322211 1111 111 11 1111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
+.....++.+++..||+.||++||||+||++.|+++
T Consensus 224 --p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 224 --PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 112235678999999999999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=426.24 Aligned_cols=257 Identities=30% Similarity=0.465 Sum_probs=210.2
Q ss_pred HhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
..++|++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 356899999999999999999999888999999997543 345789999999999999999999998865 567899999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++|+|.+++.... ...++|..+++|+.|||+||+|||+.+ |+||||||+||||++++.+||+|||+|+......
T Consensus 89 ~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999885432 346999999999999999999999974 9999999999999999999999999999876655
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
........||+.|+|||++.++.++.++|||||||++|||+||..|+....... .+... ...+ ..+...
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~~----i~~~-----~~~~~p 232 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQN----LERG-----YRMVRP 232 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH----HHTT-----CCCCCC
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHhc-----CCCCCc
Confidence 444455679999999999999999999999999999999999766554322211 11111 1111 111111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
. ....++.+++.+||+.||++||||+||+++|+..
T Consensus 233 ~----~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 233 D----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c----cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 2 2334688999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-51 Score=429.57 Aligned_cols=263 Identities=22% Similarity=0.387 Sum_probs=216.8
Q ss_pred HHHHHhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 440 QIKAATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
+++...++|++.+.||+|+||+||+|.+. +|+.||||+++.. ....++|.+|+.+|++++|||||+++|+|.+++..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34455678999999999999999999965 5889999998754 334678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++|+|.+++... ....++|..+..|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 90 iv~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 999999999999998532 2357899999999999999999999985 99999999999999999999999999998
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
.............||+.|+|||++.+..++.|+|||||||++|||++|+.|+........ +.. ....+
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~----~i~~~------ 232 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE----LLEKD------ 232 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH----HHHTT------
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHH----HHhcC------
Confidence 766555445556689999999999999999999999999999999998777654322211 111 11111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.....+.....++.+++..||+.||.+||||.||++.|+...
T Consensus 233 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 233 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111122233456889999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-50 Score=426.47 Aligned_cols=257 Identities=26% Similarity=0.455 Sum_probs=198.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CC---cEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DG---TLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 520 (790)
++|++.+.||+|+||+||+|.+. ++ ..||||++... .....++|.+|+.+|++++|||||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45778899999999999999864 23 36899998654 344456899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
||||++|+|.+++.. ....++|.++..++.|||+||+|||+.+ |+||||||+||||+.++++||+|||+|+...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998843 2346899999999999999999999974 9999999999999999999999999998765
Q ss_pred CCCcce----eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 601 EDNTHI----STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 601 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
...... .....||+.|||||++.++.++.++|||||||++|||+| |+.||......+. ... ... +.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~~~---i~~-~~-- 250 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---INA---IEQ-DY-- 250 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH---HHT-TC--
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---HHH---HHc-CC--
Confidence 433221 122458999999999999999999999999999999998 8999975443221 111 111 11
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
....+......+.+++.+||+.||.+||||.||++.|+....
T Consensus 251 -------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 -------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111122334568899999999999999999999999987643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=411.44 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=213.3
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEecc
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLE 525 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 525 (790)
++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++|||||+++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999999888899999987643 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcc
Q 040908 526 NNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 605 (790)
Q Consensus 526 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 605 (790)
+|+|.+++... ...+++..+.+++.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999998433 357899999999999999999999985 999999999999999999999999999876655444
Q ss_pred eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 606 ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 606 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
......||+.|+|||++.+..++.|+|||||||++|||+| |+.||......+.. ... ..+. ...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~------~~i-~~~~--~~~------ 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHI-AQGL--RLY------ 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HHH-HTTC--CCC------
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH------HHH-HhCC--CCC------
Confidence 4455679999999999999999999999999999999998 89999765433211 111 1111 111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
.+.....++.+++..||+.||++|||+.|+++.|.+
T Consensus 222 -~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 -RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 112233568899999999999999999999998864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=418.12 Aligned_cols=259 Identities=30% Similarity=0.504 Sum_probs=202.8
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.+.||+|+||+||+|++.+ .||||+++.. .....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4688999999999999999998753 5999998654 34456789999999999999999999999865 56899999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+++|+|.+++... ...++|..+..++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999533 346999999999999999999999984 999999999999999999999999999876543
Q ss_pred Cc-ceeeccccCCCcccHHHhhc---CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 603 NT-HISTRVAGTFGYMAPEYAMR---GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 603 ~~-~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
.. .......||+.|||||++.. ..++.++|||||||++|||+||+.||.......... .....+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~------~~~~~~~~---- 227 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------FMVGRGYL---- 227 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHHTSC----
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCCC----
Confidence 22 23345679999999999964 358899999999999999999999997544322111 11111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.+.+ ...+......+.+++.+||+.||.+||||.||++.|+...
T Consensus 228 ~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 228 SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111 0111223456889999999999999999999999998654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=412.05 Aligned_cols=251 Identities=28% Similarity=0.393 Sum_probs=202.2
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|+||+||+|.. .+|+.||||++.... .+..+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 6799999999999999999996 468999999986543 23345689999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999942 346999999999999999999999985 9999999999999999999999999998765433
Q ss_pred c-ceeeccccCCCcccHHHhhcCCC-CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 604 T-HISTRVAGTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 604 ~-~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
. ......+||+.|||||++.+..+ +.++|||||||++|||+||+.||......... ... .......
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~----~~~~~~~------- 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD----WKEKKTY------- 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHH----HHTTCTT-------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHH----HhcCCCC-------
Confidence 2 23345789999999999988776 56899999999999999999999755432211 111 1111100
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.........++.+++.+||+.||.+|||+.|+++
T Consensus 226 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011122346778899999999999999999854
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=414.36 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=196.1
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEe--CCeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIE--GNQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 520 (790)
++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999985 468999999986543 3345678999999999999999999999965 4568999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC--CCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
|||+++|+|.+++.........+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999544444567999999999999999999999864 23599999999999999999999999999987
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
...... ......||+.|||||++.+..++.++|||||||++|||+||+.||......+.. . . ...+....
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~---~---~-i~~~~~~~-- 233 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---G---K-IREGKFRR-- 233 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---H---H-HHHTCCCC--
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHH---H---H-HHcCCCCC--
Confidence 654332 234577999999999999999999999999999999999999999754332211 1 1 11122211
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+...+ ..++.+++.+||+.||.+|||+.|+++
T Consensus 234 ---~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ---IPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12222 346788999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=415.91 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=201.9
Q ss_pred hcCcceeeeecccCcEEEEeeeecCC-----cEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADG-----TLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
.++|++.++||+|+||.||+|.+... ..||||++.... .....+|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 46789999999999999999996542 479999986543 334567999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+.+|++.+++. .....++|.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 86 ~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999873 33357999999999999999999999984 99999999999999999999999999987
Q ss_pred cCCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 599 DEEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 599 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
....... ......||+.|||||++.++.++.++|||||||++|||+||..|+........ +.. . ...+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~---~-i~~~---- 229 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMK---A-INDG---- 229 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH---H-HHTT----
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHH---H-Hhcc----
Confidence 6543322 22345689999999999999999999999999999999997666543322211 111 1 1111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
.....+......+.+++.+||+.||++||||.||+++|+....
T Consensus 230 -----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1111222344568899999999999999999999999987654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=411.78 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=206.6
Q ss_pred hcCcceeee-ecccCcEEEEeeeec---CCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANK-IGEGGFGPVYKGLLA---DGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~-LG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.++|.+.+. ||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|+|.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 356777774 999999999999753 35579999987543 3445789999999999999999999999865 56899
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++.. .+..+++..+..++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 86 vmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999999843 2357999999999999999999999984 999999999999999999999999999976
Q ss_pred CCCCcce--eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccc
Q 040908 600 EEDNTHI--STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLME 676 (790)
Q Consensus 600 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 676 (790)
....... .....||+.|+|||++..+.++.++|||||||++|||+| |+.||......+.. . ....+...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~---~----~i~~~~~~- 231 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A----FIEQGKRM- 231 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---H----HHHTTCCC-
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH---H----HHHcCCCC-
Confidence 5543322 234568999999999999999999999999999999998 89999755432211 1 11112111
Q ss_pred ccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 677 LVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 677 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
. .+.....++.+++.+||+.+|++||||.+|++.|+..
T Consensus 232 ----~----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 232 ----E----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ----C----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----C----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 1222345678999999999999999999999988753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=406.63 Aligned_cols=245 Identities=25% Similarity=0.431 Sum_probs=205.3
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999964 6889999998653 2334567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999993 2357999999999999999999999985 99999999999999999999999999986554
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
.. .....||+.|||||++.+..++.++|||||||++|||+||+.||......+... .. .... ..
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-----~i--~~~~------~~ 222 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-----RI--SRVE------FT 222 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----HH--HTTC------CC
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH-----HH--HcCC------CC
Confidence 32 234679999999999999999999999999999999999999997554322111 11 1111 11
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. +.....++.+++.+||+.||.+|||+.|+++
T Consensus 223 ~----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 F----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1 1122356788999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=411.33 Aligned_cols=249 Identities=26% Similarity=0.468 Sum_probs=207.6
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999985 568999999997665556678999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.......
T Consensus 100 ~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 9999999873 246899999999999999999999985 99999999999999999999999999987654332
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
......||+.|+|||++.+..++.++|||||||++|||+||+.||.......... .....+.. ..
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~~-~~------- 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTP-EL------- 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCSC-CC-------
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCCCC-CC-------
Confidence 2345679999999999999999999999999999999999999997543322111 11111110 11
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+......+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112223456788999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=413.36 Aligned_cols=258 Identities=28% Similarity=0.445 Sum_probs=204.5
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
.++|++.+.||+|+||.||+|++.+++.||||++... ....+.|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 4689999999999999999999988889999999654 3445789999999999999999999999854 5678999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++|+|..++... ....++|.+++.++.|||.||+|||+.+ |+||||||+||||+.++++||+|||+|+.......
T Consensus 94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999998532 2346999999999999999999999985 99999999999999999999999999987655444
Q ss_pred ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCCC
Q 040908 605 HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGS 684 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 684 (790)
.......||+.|+|||++..+.++.++|||||||++|||+||..|+........ +..+.. .+. .+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i~----~~~-----~~---- 233 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVE----RGY-----RM---- 233 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHH----TTC-----CC----
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHH----hcC-----CC----
Confidence 444556799999999999999999999999999999999997766654332211 111111 111 11
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 685 NVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 685 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
..+....+++.+++.+||+.||++||+|.+|+++|+....
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 1122334568899999999999999999999999998654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=406.35 Aligned_cols=247 Identities=28% Similarity=0.394 Sum_probs=197.9
Q ss_pred eeecccCcEEEEeeeecC---CcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEeccC
Q 040908 452 NKIGEGGFGPVYKGLLAD---GTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYLEN 526 (790)
Q Consensus 452 ~~LG~G~fG~Vy~g~~~~---g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 526 (790)
++||+|+||.||+|.+.+ ++.||||+++... ....++|.+|+.+|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998643 4689999986542 2335679999999999999999999999865 567899999999
Q ss_pred CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCcce
Q 040908 527 NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 606 (790)
Q Consensus 527 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 606 (790)
|+|.+++. ....++|..+..++.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.........
T Consensus 92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999984 3356999999999999999999999984 9999999999999999999999999998765443332
Q ss_pred --eeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCCC
Q 040908 607 --STRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLG 683 (790)
Q Consensus 607 --~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 683 (790)
.....||+.|||||++.+..++.++|||||||++|||+| |+.||......+.. . . ...+..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~---~---~-i~~~~~--------- 228 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---A---M-LEKGER--------- 228 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---H---H-HHTTCC---------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH---H---H-HHcCCC---------
Confidence 234579999999999999999999999999999999998 89999754432211 1 1 111111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 684 SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 684 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
...+.....++.+++.+||+.||.+||||.+|+++|+..
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 111222345688999999999999999999999988753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=410.25 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=206.1
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEec
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEYL 524 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 524 (790)
+.|++.+.||+|+||.||+|.. .+|+.||||++........+.|.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5789999999999999999996 468999999997766666778999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++|+|.+++. .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 92 ~~g~L~~~~~---~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 92 AGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp TTEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 9999999883 23356999999999999999999999985 99999999999999999999999999975433211
Q ss_pred ceeeccccCCCcccHHHhh-----cCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 605 HISTRVAGTFGYMAPEYAM-----RGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 605 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
......||+.|+|||++. ...++.++|||||||++|||+||+.||......+... .. . .+....+
T Consensus 166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~-----~i-~-~~~~~~~-- 235 (288)
T d2jfla1 166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-----KI-A-KSEPPTL-- 235 (288)
T ss_dssp -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-----HH-H-HSCCCCC--
T ss_pred -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH-----HH-H-cCCCCCC--
Confidence 123467999999999984 4568899999999999999999999997654333211 00 1 1111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+.....++.+++.+||+.||.+|||+.|+++
T Consensus 236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112233456889999999999999999999865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=416.83 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=206.7
Q ss_pred HhcCcceeeeecccCcEEEEeeeecC-C-----cEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCC
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLAD-G-----TLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGN 515 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~-g-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 515 (790)
..++|++.+.||+|+||+||+|++.. + ..||||++.... ......|.+|+.++.++ +|||||+++++|.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34689999999999999999998542 2 369999986543 33456789999999998 8999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCcc-------------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEE-------------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIK 576 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk 576 (790)
..++|||||++|+|.++++.... ....++|..++.++.||++||+|||+++ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999964321 1235899999999999999999999984 9999999
Q ss_pred CCcEEecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCcccc
Q 040908 577 ATNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKT 654 (790)
Q Consensus 577 ~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~ 654 (790)
|+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999866544333 3345668999999999999999999999999999999998 899997544
Q ss_pred ccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040908 655 KEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLE 720 (790)
Q Consensus 655 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 720 (790)
..... .. ....+. ....+.....++.+++.+||+.||++||||+||++.|.
T Consensus 272 ~~~~~--~~----~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDANF--YK----LIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHHH--HH----HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHH--HH----HHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 33221 11 111111 11122223457889999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=416.94 Aligned_cols=265 Identities=22% Similarity=0.365 Sum_probs=204.4
Q ss_pred HhcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
..++|++.+.||+|+||+||+|.. .+|+.||+|+++... ......+.+|+.+|++++|||||+++++|.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 467899999999999999999995 478999999987543 333567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++. ....+++..+..++.|++.||.|||++. +|+||||||+|||++.++++||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999994 2356999999999999999999999752 499999999999999999999999999986533
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH---------HhhC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL---------KEQG 672 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~---------~~~~ 672 (790)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.................. ....
T Consensus 158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2 223468999999999999999999999999999999999999999765432211100000000 0000
Q ss_pred C--------------cccc----cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 N--------------LMEL----VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~--------------~~~~----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ..+. ...............++.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 0000 0000000000112346788999999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=399.00 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=196.3
Q ss_pred cceeeeecccCcEEEEeeeec-CCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEe----CCeEEEE
Q 040908 448 FDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIE----GNQLLLI 520 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV 520 (790)
|++.++||+|+||+||+|... +++.||+|++... .....+.|.+|+++|++++|||||++++++.. ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999964 6889999998654 23345679999999999999999999999875 3567999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec-CCCCeEEeecCCcccc
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLD 599 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~ 599 (790)
|||+++|+|.+++. ....+++..+..++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999993 2357899999999999999999999874 4599999999999996 5789999999999865
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD 679 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 679 (790)
.... .....||+.|||||++.+ .++.++|||||||++|||+||+.||......... . .. ...+.....
T Consensus 166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~--~---~~-i~~~~~~~~-- 233 (270)
T d1t4ha_ 166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--Y---RR-VTSGVKPAS-- 233 (270)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--H---HH-HTTTCCCGG--
T ss_pred cCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH--H---HH-HHcCCCCcc--
Confidence 4332 245679999999998865 6999999999999999999999999643322111 1 01 111111111
Q ss_pred CCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 PNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.+.....++.+++.+||+.||++|||+.|+++
T Consensus 234 ------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 ------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11112345788999999999999999999865
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-47 Score=408.74 Aligned_cols=267 Identities=27% Similarity=0.446 Sum_probs=213.3
Q ss_pred HHHHHHHhcCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeE
Q 040908 438 LRQIKAATNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGC 510 (790)
Q Consensus 438 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~ 510 (790)
+.+++...++|++.+.||+|+||.||+|++. +++.||||++..... +..++|.+|+.++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4455556789999999999999999999853 357899999976433 335679999999999999999999999
Q ss_pred EEeCCeEEEEEEeccCCChhhhhcCCc--------------------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcE
Q 040908 511 CIEGNQLLLIYEYLENNSLARALFGPE--------------------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKI 570 (790)
Q Consensus 511 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 570 (790)
|...+..++||||+++|+|.++++... .....++|..++.|+.|+|.||+|||+.+ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999985321 11235899999999999999999999984 9
Q ss_pred EeccCCCCcEEecCCCCeEEeecCCccccCCCC-cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCC-C
Q 040908 571 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN-THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR-S 648 (790)
Q Consensus 571 iHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~-~ 648 (790)
+||||||+|||++.++.+||+|||+|+...... ....+...||+.|+|||++.+..++.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998654432 22334567899999999999999999999999999999999996 4
Q ss_pred CCccccccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 649 NIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 649 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
||......+.. .. ...+...+ .+...+.++.+++..||+.+|++||||.||+++|+.+.
T Consensus 242 p~~~~~~~e~~---~~----v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEEVI---YY----VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHHHH---HH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHHHHH---HH----HHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 66544332211 11 11222211 12223356889999999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=402.83 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=202.9
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999996 46899999998653 2334567999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999883 3357999999999999999999999985 99999999999999999999999999997654
Q ss_pred CCc-ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 602 DNT-HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 602 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+... .. ..+..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-----~i--~~~~~------ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ-----KI--IKLEY------ 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HH--HTTCC------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH-----HH--HcCCC------
Confidence 332 23345679999999999999999999999999999999999999997654322111 00 11111
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..... ...++.+++.+||+.||.+|||+.|+++
T Consensus 228 ~~p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPEK----FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCTT----CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCcc----CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11122 2346788999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.6e-47 Score=408.80 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=208.3
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
-++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999995 46899999999776655667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC--CCCeEEeecCCccccCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK--DLNPKISDFGLAKLDEE 601 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~~~~ 601 (790)
|++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999843 2346999999999999999999999985 999999999999964 67899999999997655
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... .....||+.|||||++.+..++.++|||||||++|||+||+.||......+... ..........
T Consensus 179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-----~i~~~~~~~~------ 245 (350)
T d1koaa2 179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-----NVKSCDWNMD------ 245 (350)
T ss_dssp TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHHHTCCCSC------
T ss_pred ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH-----HHHhCCCCCC------
Confidence 433 344679999999999999999999999999999999999999997554322211 1111111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.........++.+++.+||+.||.+|||+.|+++
T Consensus 246 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 246 --DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp --CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111122346788999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-47 Score=406.91 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=190.2
Q ss_pred HhcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
..+.|++.+.||+|+||+||+|... +|+.||||++..... .....+.+|+.+|++++|||||++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3577999999999999999999964 689999999875432 23456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec---CCCCeEEeecCCccc
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKL 598 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGla~~ 598 (790)
|||++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+|+.
T Consensus 87 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999943 356999999999999999999999985 99999999999994 578999999999986
Q ss_pred cCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
..... .....+||+.|||||++.+..++.++|||||||++|||+||+.||......+.. . .... +.. . .
T Consensus 160 ~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~--~i~~--~~~-~-~ 228 (307)
T d1a06a_ 160 EDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---E--QILK--AEY-E-F 228 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---H--HHHT--TCC-C-C
T ss_pred ccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---H--HHhc--cCC-C-C
Confidence 64433 224467999999999999999999999999999999999999999754332211 1 1111 111 0 1
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ........++.+++..||+.||.+|||+.|+++
T Consensus 229 ~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 DS----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11 111123356789999999999999999999977
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-47 Score=405.71 Aligned_cols=245 Identities=26% Similarity=0.435 Sum_probs=200.6
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
+.|+..+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4599999999999999999985 578999999986543 233457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
|||.+|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999977662 3357999999999999999999999985 99999999999999999999999999986543
Q ss_pred CCcceeeccccCCCcccHHHhhc---CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMR---GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
. ....||+.|||||++.+ +.++.++|||||||++|||++|+.||......+.. ... ..+......
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~-----~~i--~~~~~~~~~ 235 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHI--AQNESPALQ 235 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHH--HHSCCCCCS
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH-----HHH--HhCCCCCCC
Confidence 2 33579999999999864 46899999999999999999999999754322211 011 111111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. . .....+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~----~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S----G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C----C----CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 1 12346788999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-46 Score=406.90 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=208.1
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 36799999999999999999995 57999999999766555567788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec--CCCCeEEeecCCccccCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD--KDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGla~~~~~ 601 (790)
|++|+|.+++.. ....+++..+..|+.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999988742 3356899999999999999999999985 99999999999998 678999999999997765
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+... . ...+.. .
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~-i~~~~~------~ 246 (352)
T d1koba_ 182 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ------N-VKRCDW------E 246 (352)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------H-HHHCCC------C
T ss_pred CCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-HHhCCC------C
Confidence 432 344679999999999999999999999999999999999999997544322111 0 011111 0
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...........++.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111122346788999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=397.51 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=196.5
Q ss_pred hcCcceeeeecccCcEEEEeeeecC----CcEEEEEEccccch-hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLAD----GTLIAVKQLSAKSK-QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
.++|++.+.||+|+||.||+|++.. +..||||+++.... ...+.|.+|+.++++++|||||+++|+|. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999998642 35789999865433 33567999999999999999999999996 467899
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
||||+++|+|.+++. .....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999873 33457899999999999999999999985 999999999999999999999999999976
Q ss_pred CCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCccccc
Q 040908 600 EEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELV 678 (790)
Q Consensus 600 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 678 (790)
............||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. .. . ..+...
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~~---i-~~~~~~--- 228 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GR---I-ENGERL--- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HH---H-HTTCCC---
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---HH---H-HcCCCC---
Confidence 6554444556678999999999999999999999999999999998 88888765443321 11 1 111111
Q ss_pred CCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 679 DPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 679 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
. .+......+.+++..||+.||.+|||+.||++.|+.+
T Consensus 229 --~----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 --P----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp --C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --C----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 1222345688999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=396.97 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=197.9
Q ss_pred hcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-CeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEG-NQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 523 (790)
-++|++.+.||+|+||.||+|.++ |+.||||+++.. ...+.|.+|++++++++|||||+++|+|.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 357889999999999999999984 789999999653 3456799999999999999999999999654 568999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+++|+|.++++.. ....++|..+++|+.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence 9999999999532 2245899999999999999999999974 9999999999999999999999999998654322
Q ss_pred cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccccCCCC
Q 040908 604 THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPNL 682 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 682 (790)
....+|..|+|||++.++.++.++|||||||++|||+| |+.|+......+. ..+. ..+. .+
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i----~~~~-----~~-- 219 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EKGY-----KM-- 219 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHH----TTTC-----CC--
T ss_pred ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHH----HcCC-----CC--
Confidence 23468899999999999999999999999999999998 6777765433221 2211 1111 11
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 683 GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 683 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
..+.....++.+++.+||+.||.+||||.||+++|+..
T Consensus 220 --~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 220 --DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 12222335678999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=401.85 Aligned_cols=254 Identities=27% Similarity=0.458 Sum_probs=201.4
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCc----EEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGT----LIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 519 (790)
++|++.+.||+|+||+||+|.+. +|+ +||+|++... .....++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 443 6899988653 344567899999999999999999999999865 5678
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCcccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 599 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 599 (790)
++||+.+|+|.+++. .....++|..++.++.|||.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999884 33467999999999999999999999984 999999999999999999999999999976
Q ss_pred CCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 600 EEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 600 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+....+ ..+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-------~~~~~--- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGER--- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-------HHTCC---
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcCCC---
Confidence 554333 2334568999999999999999999999999999999999 78888755433321111 11110
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
...+......+.+++.+||+.||.+|||+.||++.|+..
T Consensus 232 ------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 ------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 111222345688999999999999999999999988754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=395.62 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=205.0
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc------hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS------KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 517 (790)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.|.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46899999999999999999996 478999999986432 12356799999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC----CeEEeec
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDF 593 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DF 593 (790)
++|||||++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhc----cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 99999999999999993 2357999999999999999999999985 99999999999998776 4999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGN 673 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 673 (790)
|+|+....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+... ........
T Consensus 162 G~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-----~i~~~~~~ 234 (293)
T d1jksa_ 162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-----NVSAVNYE 234 (293)
T ss_dssp TTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHHTTCCC
T ss_pred hhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH-----HHHhcCCC
Confidence 99987654332 244679999999999999999999999999999999999999997654332211 00000001
Q ss_pred cccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 674 LMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 674 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.... ........+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 FEDE--------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCHH--------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCch--------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00112346788999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=395.55 Aligned_cols=254 Identities=24% Similarity=0.438 Sum_probs=196.0
Q ss_pred cCcceeeeecccCcEEEEeeeec--CC--cEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA--DG--TLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~--~g--~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
++|++.+.||+|+||.||+|++. ++ ..||||++... ..+..++|.+|+.+|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 67999999999999999999853 22 37899998654 23335689999999999999999999999975 4678
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++|++.+++. .....+++..+..++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHH---HHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhh---cccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999999884 23456999999999999999999999974 99999999999999999999999999997
Q ss_pred cCCCCcc--eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 599 DEEDNTH--ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 599 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. .+ ....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---~~---i~~~~~~- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HK---IDKEGER- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HH---HHTSCCC-
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH---HH---HHhCCCC-
Confidence 6554332 2234568899999999999999999999999999999998 89999754433211 11 1111111
Q ss_pred cccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040908 676 ELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEG 721 (790)
Q Consensus 676 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 721 (790)
+ ..+......+.+++.+||+.||++||||.||+++|++
T Consensus 234 ----~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 ----L----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----C----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 1112223468899999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=396.84 Aligned_cols=267 Identities=26% Similarity=0.310 Sum_probs=201.6
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC----eEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN----QLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 521 (790)
++|.+.+.||+|+||.||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++|+|.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5678899999999999999997 5889999998653221 222334555667889999999999998654 689999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC-----CCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES-----RLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
|||++|+|.++++ ...++|..+++++.|+|.||+|||+.+ ..+|+||||||+||||+.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~l~-----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999994 246899999999999999999999742 357999999999999999999999999999
Q ss_pred cccCCCCcc---eeeccccCCCcccHHHhhcCC------CCChhhHHHHHHHHHHHHhCCCCCccccccchh--------
Q 040908 597 KLDEEDNTH---ISTRVAGTFGYMAPEYAMRGH------LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF-------- 659 (790)
Q Consensus 597 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-------- 659 (790)
+........ ......||+.|+|||++.+.. ++.|+|||||||++|||+||..|+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876543322 223467999999999987643 567999999999999999999887543221110
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 660 YLLDWALLLKEQGNLMELVDPNLGSNV-DKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 660 ~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
........... .+..+|.+.... +.+....+.+++.+||+.||.+||||.||++.|+.+.
T Consensus 236 ~~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 236 PSVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 00111111111 112223332222 2356677999999999999999999999999998653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=399.95 Aligned_cols=269 Identities=25% Similarity=0.355 Sum_probs=202.0
Q ss_pred cHHHHHHHhcCcceeeeecccCcEEEEeeeec------CCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeee
Q 040908 437 TLRQIKAATNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLY 508 (790)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~ 508 (790)
...+++...++|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|+..+.++ +|+|||.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 33444455678999999999999999999853 34689999997543 33456788888888887 689999999
Q ss_pred eEEEeC-CeEEEEEEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccC
Q 040908 509 GCCIEG-NQLLLIYEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDI 575 (790)
Q Consensus 509 g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDl 575 (790)
+++.+. +..++|||||++|+|.++++.... ....++|..+..++.||++||+|||+++ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 998764 468999999999999999954322 1245899999999999999999999985 999999
Q ss_pred CCCcEEecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCC-CCCccc
Q 040908 576 KATNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR-SNIMCK 653 (790)
Q Consensus 576 k~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~-~p~~~~ 653 (790)
||+||||++++++||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999866543332 234467999999999999999999999999999999999975 566543
Q ss_pred cccchhhHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 654 TKEEKFYLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 654 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
...+.. ......+... .. +.....++.+++.+||+.||.+|||+.||++.|+.++
T Consensus 241 ~~~~~~------~~~~~~~~~~-----~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 241 KIDEEF------CRRLKEGTRM-----RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp CCSHHH------HHHHHHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHH------HHHHhcCCCC-----CC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 322211 1111122111 11 1122346789999999999999999999999998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=398.69 Aligned_cols=258 Identities=28% Similarity=0.402 Sum_probs=203.9
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCc--EEEEEEcccc-chhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCCeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGT--LIAVKQLSAK-SKQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 520 (790)
++|++.+.||+|+||.||+|.+. +|. .||||++... .....++|.+|+++|+++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 68889999999999999999965 344 4788887543 334456799999999998 799999999999999999999
Q ss_pred EEeccCCChhhhhcCCc------------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCe
Q 040908 521 YEYLENNSLARALFGPE------------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 588 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 588 (790)
|||+++|+|.++++... .....++|..++.++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999996542 23457999999999999999999999984 9999999999999999999
Q ss_pred EEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCC-CCccccccchhhHHHHHHH
Q 040908 589 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRS-NIMCKTKEEKFYLLDWALL 667 (790)
Q Consensus 589 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~~ 667 (790)
||+|||+|+....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||......+. ...
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---~~~--- 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEK--- 238 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH---
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH---HHH---
Confidence 9999999985543222 233568999999999999999999999999999999999765 5654332221 111
Q ss_pred HHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 668 LKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 668 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
...+. .+. .+.....++.+++.+||+.||++||||.||++.|+....
T Consensus 239 -i~~~~-----~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 239 -LPQGY-----RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -GGGTC-----CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHhcC-----CCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111 111 122234578899999999999999999999999987653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-46 Score=395.12 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=201.2
Q ss_pred eeeecccCcEEEEeeeecCC----cEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-CeEEEEEEec
Q 040908 451 ANKIGEGGFGPVYKGLLADG----TLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIEG-NQLLLIYEYL 524 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~g----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 524 (790)
.++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|+++|++++|||||+++|+|.+. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999996432 36899998753 444557899999999999999999999998764 5889999999
Q ss_pred cCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCCc
Q 040908 525 ENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 604 (790)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 604 (790)
++|+|.+++.. ....+++..+++++.|+|+||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999853 3346788999999999999999999884 99999999999999999999999999987654322
Q ss_pred c---eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 605 H---ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 605 ~---~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
. ......||+.|+|||++..+.++.++||||||+++|||+||+.|+....... .+..+. . .+.. ...
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i---~-~g~~--~~~-- 255 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL---L-QGRR--LLQ-- 255 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---H-TTCC--CCC--
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH---H-cCCC--CCC--
Confidence 2 2233568999999999999999999999999999999999888876432211 111111 1 1111 111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
+.....++.+++.+||+.||++||+|.||++.|+.+..
T Consensus 256 -----p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 -----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11223568899999999999999999999999987653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=397.89 Aligned_cols=265 Identities=25% Similarity=0.417 Sum_probs=212.4
Q ss_pred HHHHhcCcceeeeecccCcEEEEeeeec------CCcEEEEEEcccc-chhcHHHHHHHHHHhhccCCCceeeeeeEEEe
Q 040908 441 IKAATNHFDVANKIGEGGFGPVYKGLLA------DGTLIAVKQLSAK-SKQGNREFVNEIGTISALQHPHLVKLYGCCIE 513 (790)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fG~Vy~g~~~------~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 513 (790)
++...++|++.+.||+|+||+||+|.+. +++.||||+++.. .......|.+|+.++++++|||||+++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3444588999999999999999999863 3578999999754 33344579999999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCcc------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEE------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 587 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 587 (790)
.+..++||||+++|+|.+++..... ....++|..+.+++.|+|+||.|||++ +|+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 9999999999999999999853321 123578999999999999999999998 4999999999999999999
Q ss_pred eEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCC-CCCccccccchhhHHHHH
Q 040908 588 PKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGR-SNIMCKTKEEKFYLLDWA 665 (790)
Q Consensus 588 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~ 665 (790)
+||+|||+|+........ ......||+.|+|||.+.++.++.++|||||||++|||+||+ .|+......+..
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------ 245 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------ 245 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH------
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH------
Confidence 999999999866543332 223456899999999999999999999999999999999985 566543322211
Q ss_pred HHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcC
Q 040908 666 LLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRVG 724 (790)
Q Consensus 666 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 724 (790)
... ..+...+ .+......+.+++.+||+.+|.+||||.||+++|++...
T Consensus 246 ~~i-~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 RFV-MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHH-HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHH-HhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 1122111 111233568999999999999999999999999987643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-45 Score=391.51 Aligned_cols=244 Identities=24% Similarity=0.369 Sum_probs=203.5
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999996 46899999998653 2334567999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999883 3456888999999999999999999985 99999999999999999999999999997654
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
.. ....||+.|||||++.+..++.++|||||||++|||+||+.||......+... .. ..+.. .
T Consensus 157 ~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-----~i--~~~~~------~ 219 (316)
T d1fota_ 157 VT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE-----KI--LNAEL------R 219 (316)
T ss_dssp CB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----HH--HHCCC------C
T ss_pred cc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH-----HH--HcCCC------C
Confidence 32 34679999999999999999999999999999999999999997654322111 11 11111 1
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
.... ...++.+++.+|++.||.+|| |+.|+++
T Consensus 220 ~p~~----~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 FPPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1112 234578899999999999996 8888865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=394.73 Aligned_cols=247 Identities=27% Similarity=0.335 Sum_probs=205.4
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++.+.||+|+||.||+|+. .+|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 6799999999999999999995 57899999999754 2334577899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
|||++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999983 3356899999999999999999999985 99999999999999999999999999986543
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+... . ...+.+ .
T Consensus 158 ~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~------~-i~~~~~------~ 223 (337)
T d1o6la_ 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------L-ILMEEI------R 223 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H-HHHCCC------C
T ss_pred CCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH------H-HhcCCC------C
Confidence 322 2345679999999999999999999999999999999999999997654332211 1 111111 1
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPL-----MSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 717 (790)
....+ ..++.+++..||+.||.+||+ +.|+++
T Consensus 224 ~p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11222 345788999999999999995 677764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=395.54 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=210.0
Q ss_pred HhcCcceeeeecccCcEEEEeeee------cCCcEEEEEEccccc-hhcHHHHHHHHHHhhcc-CCCceeeeeeEEEeCC
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLL------ADGTLIAVKQLSAKS-KQGNREFVNEIGTISAL-QHPHLVKLYGCCIEGN 515 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 515 (790)
..++|++.+.||+|+||.||+|++ .+++.||||+++... .....+|.+|+.+++++ +|||||+++|+|.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 457899999999999999999975 245789999997643 33456799999999999 6999999999999999
Q ss_pred eEEEEEEeccCCChhhhhcCCc--------------cccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEE
Q 040908 516 QLLLIYEYLENNSLARALFGPE--------------EHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVL 581 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 581 (790)
..++|||||++|+|.++++... .....+++..+..++.|||+||+|||+++ ++||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999985332 12346899999999999999999999985 999999999999
Q ss_pred ecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhC-CCCCccccccchh
Q 040908 582 LDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSG-RSNIMCKTKEEKF 659 (790)
Q Consensus 582 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~ 659 (790)
++.++.+|++|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+|+ ++|+......+..
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999977654433 33456799999999999999999999999999999999995 4445433332221
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 660 YLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 660 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
. . ....+. ....+......+.+++.+||+.||.+||||.||+++|++..
T Consensus 258 ~--~----~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 258 Y--K----MIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp H--H----HHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--H----HHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1 1 111111 11111223456889999999999999999999999998653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=391.20 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=206.0
Q ss_pred HhcCcceeeeecccCcEEEEeeeecC--------CcEEEEEEccccch-hcHHHHHHHHHHhhcc-CCCceeeeeeEEEe
Q 040908 444 ATNHFDVANKIGEGGFGPVYKGLLAD--------GTLIAVKQLSAKSK-QGNREFVNEIGTISAL-QHPHLVKLYGCCIE 513 (790)
Q Consensus 444 ~~~~y~~~~~LG~G~fG~Vy~g~~~~--------g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 513 (790)
..++|++.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34689999999999999999998532 34799999976543 3457889999999888 89999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhcCCcc------------ccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEE
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEE------------HRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVL 581 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 581 (790)
++..++||||+++|+|.+++..... ....+++.++++++.|||.||+|||+.+ |+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 9999999999999999999954321 1246899999999999999999999985 999999999999
Q ss_pred ecCCCCeEEeecCCccccCCCCcc-eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHh-CCCCCccccccchh
Q 040908 582 LDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVS-GRSNIMCKTKEEKF 659 (790)
Q Consensus 582 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 659 (790)
++.++.+||+|||+++........ ......||+.|+|||++.++.++.|+|||||||++|||+| |+.||........
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~- 246 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 246 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH-
Confidence 999999999999999866543322 2344678999999999999999999999999999999998 6778765433221
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 660 YLLDWALLLKEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 660 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
.. ....+.. +.. +.....++.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 247 --~~----~i~~~~~-----~~~----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 247 --FK----LLKEGHR-----MDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp --HH----HHHTTCC-----CCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HH----HHHcCCC-----CCC----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 11 1111111 111 1122346889999999999999999999999998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.9e-45 Score=380.77 Aligned_cols=250 Identities=20% Similarity=0.334 Sum_probs=203.6
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch---------hcHHHHHHHHHHhhccC-CCceeeeeeEEEeC
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK---------QGNREFVNEIGTISALQ-HPHLVKLYGCCIEG 514 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 514 (790)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.++++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999995 5789999999865321 11245889999999997 99999999999999
Q ss_pred CeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecC
Q 040908 515 NQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 594 (790)
Q Consensus 515 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 594 (790)
+..++||||+++|+|.+++. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999994 3357999999999999999999999985 9999999999999999999999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhc------CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHH
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMR------GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLL 668 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 668 (790)
+++....... .....||+.|+|||++.+ ..++.++||||+||++|||+||+.||.......... .
T Consensus 156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~-----~-- 226 (277)
T d1phka_ 156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-----M-- 226 (277)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----H--
T ss_pred heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH-----H--
Confidence 9997655332 244679999999999863 356889999999999999999999998654322111 1
Q ss_pred HhhCCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 669 KEQGNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 669 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+... ...........++.+++.+||+.||++|||+.||++
T Consensus 227 i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 227 IMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111111 011111123356889999999999999999999854
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.2e-45 Score=381.66 Aligned_cols=257 Identities=21% Similarity=0.298 Sum_probs=199.8
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc---hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC----e
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS---KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN----Q 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 516 (790)
.++|++.+.||+|+||.||+|.. .+|+.||||+++... ......|.+|+.+++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 47899999999999999999995 578999999997542 233457999999999999999999999997653 4
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+++|+|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++..+|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 799999999999999883 3357999999999999999999999885 999999999999999999999999998
Q ss_pred cccCCCC--cceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 597 KLDEEDN--THISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 597 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
+...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+.. .........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcCCC
Confidence 7553322 22334567999999999999999999999999999999999999999754432211 111111111
Q ss_pred -ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcC
Q 040908 675 -MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRP-LMSSVVSMLEGR 722 (790)
Q Consensus 675 -~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~L~~~ 722 (790)
..... . ....++.+++.+|++.||.+|| |++++...|...
T Consensus 233 ~~~~~~----~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 PPSARH----E----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CGGGTS----S----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCchhc----c----CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 11111 1 1234678899999999999999 899998877653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=385.28 Aligned_cols=251 Identities=17% Similarity=0.246 Sum_probs=204.7
Q ss_pred hcCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.++|++.+.||+|+||+||+|... +|+.||||+++.... ....+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999964 688999999976433 345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC--CCeEEeecCCccccCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD--LNPKISDFGLAKLDEE 601 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~kl~DFGla~~~~~ 601 (790)
|++|+|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999943 2346899999999999999999999985 9999999999999854 5799999999987654
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
... .....||+.|+|||.+.+..++.++||||+||++|||++|+.||......+... ..............+
T Consensus 157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~-----~i~~~~~~~~~~~~~- 228 (321)
T d1tkia_ 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE-----NIMNAEYTFDEEAFK- 228 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----HHHHTCCCCCHHHHT-
T ss_pred CCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhCCCCCChhhcc-
Confidence 332 344568999999999999999999999999999999999999997654332111 111111111110000
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
....++.+++..|++.||.+|||+.|+++
T Consensus 229 -------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 -------EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12345789999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-44 Score=392.71 Aligned_cols=248 Identities=26% Similarity=0.324 Sum_probs=198.1
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHH---HHHhhccCCCceeeeeeEEEeCCeEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNE---IGTISALQHPHLVKLYGCCIEGNQLL 518 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~~ 518 (790)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999964 68999999986432 2223334444 66777888999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999993 2356899999999999999999999985 99999999999999999999999999987
Q ss_pred cCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccc
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMEL 677 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 677 (790)
..... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||..........+.. ....
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~------~~~~---- 223 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------MTLT---- 223 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH------HSSS----
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hccc----
Confidence 65432 234679999999999975 468999999999999999999999997654333211110 0000
Q ss_pred cCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040908 678 VDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL-----MSSVVS 717 (790)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 717 (790)
........+ ..++.+++..||+.||.+||| +.|+++
T Consensus 224 ~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 MAVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 011111222 346788999999999999999 577764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-44 Score=390.34 Aligned_cols=244 Identities=22% Similarity=0.326 Sum_probs=203.3
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc---chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK---SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 521 (790)
++|++++.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5899999999999999999996 46999999998643 2234567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 601 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 601 (790)
||+.+|+|.+++. ....+++..+..++.||+.||.|||+.+ ||||||||+|||++.++++||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999983 2356899999999999999999999985 99999999999999999999999999997654
Q ss_pred CCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCCC
Q 040908 602 DNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDPN 681 (790)
Q Consensus 602 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 681 (790)
. .....||+.|||||++.+..++.++|||||||++|||+||+.||......... .. . ..+.. .
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~--i--~~~~~------~ 256 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY---EK--I--VSGKV------R 256 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH--H--HHCCC------C
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH---HH--H--hcCCC------C
Confidence 2 23467999999999999999999999999999999999999999754332211 10 1 11111 1
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040908 682 LGSNVDKEQVRVMINVALLCADVSPTNRP-----LMSSVVS 717 (790)
Q Consensus 682 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 717 (790)
.... ...++.+++..||+.||.+|+ |+.|+++
T Consensus 257 ~p~~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCcc----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1112 234678899999999999994 8888865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=387.17 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=202.0
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc---hhcHHHHHHHHHHhh-ccCCCceeeeeeEEEeCCeEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS---KQGNREFVNEIGTIS-ALQHPHLVKLYGCCIEGNQLLLI 520 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 520 (790)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999964 68999999997532 334456777777765 68999999999999999999999
Q ss_pred EEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccC
Q 040908 521 YEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 600 (790)
Q Consensus 521 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 600 (790)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999993 3356899999999999999999999985 9999999999999999999999999998654
Q ss_pred CCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccCC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVDP 680 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 680 (790)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+... .. ..+. +
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~-----~i--~~~~------~ 220 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH-----SI--RMDN------P 220 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HH--HHCC------C
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH-----HH--HcCC------C
Confidence 4332 2344679999999999999999999999999999999999999997654332211 11 1111 1
Q ss_pred CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 040908 681 NLGSNVDKEQVRVMINVALLCADVSPTNRPLMS-SVV 716 (790)
Q Consensus 681 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-ev~ 716 (790)
...... ..++.+++.+||+.||.+||++. |++
T Consensus 221 ~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 221 FYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 111222 34578999999999999999985 664
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=381.07 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=195.2
Q ss_pred eeeeecccCcEEEEeeee-cCCcEEEEEEccccchhc-----HHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 450 VANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQG-----NREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 450 ~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
.+++||+|+||+||+|.. .+|+.||||+++...... .+.+.+|+.++++++|||||++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468999999999999995 468999999996543221 24688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+.++++..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 99987776662 2356899999999999999999999985 9999999999999999999999999998665433
Q ss_pred cceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh---CCccccc-
Q 040908 604 THISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ---GNLMELV- 678 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~- 678 (790)
.. ....+||+.|+|||++... .++.++|||||||++|||+||+.||......+....+ ...... .......
T Consensus 155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i---~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCTTTSSSTTS
T ss_pred cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH---HHhcCCCChhhccchhc
Confidence 22 2345799999999998754 5799999999999999999999999765433321111 000000 0000000
Q ss_pred --CC---CCCCCCcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 679 --DP---NLGSNVDK-----EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 679 --d~---~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+. ......+. ....++.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 00001111 12356889999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=386.20 Aligned_cols=250 Identities=21% Similarity=0.247 Sum_probs=197.9
Q ss_pred hcCcceee-eecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhcc-CCCceeeeeeEEEe----CCeE
Q 040908 445 TNHFDVAN-KIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISAL-QHPHLVKLYGCCIE----GNQL 517 (790)
Q Consensus 445 ~~~y~~~~-~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~ 517 (790)
.++|++.+ .||+|+||.||+|.. .+|+.||||+++. ...+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898875 599999999999985 5789999999854 24567899987655 89999999999875 4668
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC---CCCeEEeecC
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFG 594 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFG 594 (790)
++|||||++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 9999999999999999532 2246899999999999999999999985 999999999999985 5679999999
Q ss_pred CccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 595 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 595 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
+|+....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||............ .
T Consensus 160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~------~----- 226 (335)
T d2ozaa1 160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------K----- 226 (335)
T ss_dssp TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH------H-----
Confidence 9987654432 24467999999999999989999999999999999999999999765432211000 0
Q ss_pred ccccCCC--CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 675 MELVDPN--LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 675 ~~~~d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
..+.... ...........++.+++.+|++.||.+|||+.|+++
T Consensus 227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0011111 111111234567899999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=377.44 Aligned_cols=260 Identities=23% Similarity=0.373 Sum_probs=199.0
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch--hcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK--QGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999995 5789999999965432 235678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
|+.++.+..... .....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 998654443332 22356999999999999999999999985 999999999999999999999999999866543
Q ss_pred CcceeeccccCCCcccHHHhhcCC-CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcccccC--
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGH-LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLMELVD-- 679 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-- 679 (790)
.. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+... ......+...+...
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~-----~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPG 229 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----HHHHHHCCCCTTTSTT
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH-----HHHHhcCCCchhhccc
Confidence 32 223457999999999987765 5789999999999999999999997654322211 11111111111000
Q ss_pred ----CCC--------CCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 680 ----PNL--------GSNVD---KEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 680 ----~~l--------~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+.. ..... .....++.+++.+|++.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 00000 011256788999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-43 Score=373.68 Aligned_cols=264 Identities=25% Similarity=0.363 Sum_probs=200.1
Q ss_pred cCcceeeeecccCcEEEEeeeecCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|+||+||+|...+|+.||||++.... ....+.+.+|+.+|++++|||||++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999899999999986543 23357899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCCC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 603 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 603 (790)
+.++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.|.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 99887777662 2357999999999999999999999874 9999999999999999999999999998664432
Q ss_pred cceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC---Cccccc-
Q 040908 604 THISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG---NLMELV- 678 (790)
Q Consensus 604 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~- 678 (790)
. ......|++.|+|||.+... .++.++|||||||++|||++|+.||......+...-+.......... ...+..
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 2 22335689999999998754 56899999999999999999999997654322211110000000000 000000
Q ss_pred -CCCC----C---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 679 -DPNL----G---SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 679 -d~~l----~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
+... . ..........+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0 0011112346789999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=374.54 Aligned_cols=240 Identities=23% Similarity=0.382 Sum_probs=195.0
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccch------hcHHHHHHHHHHhhccC--CCceeeeeeEEEeCC
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSK------QGNREFVNEIGTISALQ--HPHLVKLYGCCIEGN 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~ 515 (790)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... .....+.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36899999999999999999995 5789999999865321 11234678999999996 899999999999999
Q ss_pred eEEEEEEeccC-CChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCC-CCeEEeec
Q 040908 516 QLLLIYEYLEN-NSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDF 593 (790)
Q Consensus 516 ~~~lV~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DF 593 (790)
..++||||+.+ +++.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999986 57777772 3457999999999999999999999985 9999999999999854 78999999
Q ss_pred CCccccCCCCcceeeccccCCCcccHHHhhcCCC-CChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC
Q 040908 594 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHL-TDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG 672 (790)
Q Consensus 594 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 672 (790)
|+|+..... ..+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||..... . ..+
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i--------~~~ 219 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I--------IRG 219 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H--------HHC
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H--------hhc
Confidence 999865433 2345679999999999987765 5678999999999999999999964210 0 011
Q ss_pred CcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 NLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. .....+ ..++.+++.+||+.||.+|||+.|+++
T Consensus 220 ~~------~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 QV------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc------CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11 111222 346788999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=378.20 Aligned_cols=265 Identities=22% Similarity=0.347 Sum_probs=197.2
Q ss_pred hcCcceeeeecccCcEEEEeeee-cC-CcEEEEEEccccch--hcHHHHHHHHHHhhcc---CCCceeeeeeEEEe----
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-AD-GTLIAVKQLSAKSK--QGNREFVNEIGTISAL---QHPHLVKLYGCCIE---- 513 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~-g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---- 513 (790)
.++|++.+.||+|+||+||+|.. .+ ++.||||+++.... .....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999985 34 67799999865422 2233566788777666 79999999999863
Q ss_pred -CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEee
Q 040908 514 -GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 592 (790)
Q Consensus 514 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 592 (790)
....+++|||+.++.+..... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 346899999999987765542 23356899999999999999999999985 99999999999999999999999
Q ss_pred cCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh-
Q 040908 593 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ- 671 (790)
Q Consensus 593 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~- 671 (790)
||+++...... ......||+.|+|||++.+..++.++||||+||++|||+||+.||......+....+.........
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 99998654332 234567999999999999999999999999999999999999999765433322111100000000
Q ss_pred -----CCcccccCCCC----CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 672 -----GNLMELVDPNL----GSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 672 -----~~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........... ...........+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000000 00111122346788999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-41 Score=361.41 Aligned_cols=259 Identities=22% Similarity=0.264 Sum_probs=196.4
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeee-eeEEEeCCeEEEEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKL-YGCCIEGNQLLLIYEY 523 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lV~Ey 523 (790)
++|++.+.||+|+||.||+|.. .+|+.||||++..... ..++..|++++++++|+|++.. .+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999985 5689999998765432 3457889999999987765555 5555777889999999
Q ss_pred ccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEec---CCCCeEEeecCCccccC
Q 040908 524 LENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKLDE 600 (790)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGla~~~~ 600 (790)
+. +++.+.+. .....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+...
T Consensus 85 ~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 LG-PSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred cC-Cchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 85 56666552 23357999999999999999999999985 99999999999875 45679999999998765
Q ss_pred CCCcc------eeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 601 EDNTH------ISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 601 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
..... ......||+.|||||.+.+..++.++|||||||++|||+||+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 43221 234467999999999999999999999999999999999999999765433322211111111111111
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040908 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGR 722 (790)
Q Consensus 675 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 722 (790)
... ...+ +.++.+++..||+.+|++||++.++.+.|+..
T Consensus 238 ~~~-----~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 238 EVL-----CKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHH-----TTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hHh-----ccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 111 1122 24678899999999999999999999888764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-41 Score=359.45 Aligned_cols=261 Identities=20% Similarity=0.247 Sum_probs=205.7
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccCC-CceeeeeeEEEeCCeEEEEEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQH-PHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 522 (790)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+.+|+++++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46899999999999999999995 4689999998754322 2356788999999865 899999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecC-----CCCeEEeecCCcc
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDK-----DLNPKISDFGLAK 597 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGla~ 597 (790)
|+ +++|.+++. .....+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~---~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHH---hhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 98 689999884 23356899999999999999999999985 999999999999974 5789999999998
Q ss_pred ccCCCCc------ceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhh
Q 040908 598 LDEEDNT------HISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQ 671 (790)
Q Consensus 598 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 671 (790)
....... .......||+.|||||++.+..++.++|||||||++|||+||+.||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 7643221 1223467999999999999999999999999999999999999999765443332222211111111
Q ss_pred CCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 040908 672 GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVSMLEGRV 723 (790)
Q Consensus 672 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 723 (790)
....++ ...++ .++.+++..|++.+|++||++..+.+.|++..
T Consensus 235 ~~~~~l-----~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 235 TPLREL-----CAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp SCHHHH-----TTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CChHHh-----cCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 222221 11222 45788889999999999999999988887653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=365.59 Aligned_cols=266 Identities=20% Similarity=0.294 Sum_probs=195.9
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEe--------
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIE-------- 513 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 513 (790)
.++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999995 57999999998654 22345678999999999999999999999865
Q ss_pred CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeec
Q 040908 514 GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 593 (790)
Q Consensus 514 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 593 (790)
.+..++||||+.++.+..... ....++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 345799999999887765552 2356888899999999999999999985 999999999999999999999999
Q ss_pred CCccccCCCCcc---eeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHH
Q 040908 594 GLAKLDEEDNTH---ISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLK 669 (790)
Q Consensus 594 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 669 (790)
|+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...................
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999865432221 12235699999999998765 68999999999999999999999997654333222111110000
Q ss_pred hhCCcccc--------cCCCCCCCCcH-H------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 670 EQGNLMEL--------VDPNLGSNVDK-E------QVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 670 ~~~~~~~~--------~d~~l~~~~~~-~------~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
........ +.......... + ....+++++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00000000 00000001111 1 1235678999999999999999999876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-41 Score=362.36 Aligned_cols=265 Identities=20% Similarity=0.323 Sum_probs=195.1
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEcccc--chhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC------
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAK--SKQGNREFVNEIGTISALQHPHLVKLYGCCIEGN------ 515 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 515 (790)
.++|++++.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47899999999999999999995 46999999999753 2333567899999999999999999999997654
Q ss_pred eEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCC
Q 040908 516 QLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 595 (790)
Q Consensus 516 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 595 (790)
..++||||+ +.+|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 579999999 557777662 346999999999999999999999985 99999999999999999999999999
Q ss_pred ccccCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHH-----HH
Q 040908 596 AKLDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALL-----LK 669 (790)
Q Consensus 596 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~~ 669 (790)
|+...... +...||+.|+|||++.+. .++.++||||+||++|||++|+.||................. ..
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 98665432 346799999999998764 568999999999999999999999976543222111100000 00
Q ss_pred hh----------CCcccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCc
Q 040908 670 EQ----------GNLMELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGRV 723 (790)
Q Consensus 670 ~~----------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~~ 723 (790)
.. ..+.+.....+ ..........+.+++.+|++.||.+|||+.|+++ .+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00 00000000000 0001112345678999999999999999999987 455543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=368.35 Aligned_cols=261 Identities=24% Similarity=0.288 Sum_probs=193.0
Q ss_pred CcceeeeecccCcEEEEeeeec-CCcEEEEEEccccchhcHHHHHHHHHHhhccCCCceeeeeeEEEeC------CeEEE
Q 040908 447 HFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHLVKLYGCCIEG------NQLLL 519 (790)
Q Consensus 447 ~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 519 (790)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++|||||+++++|... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888999999999999999964 689999999865432 234799999999999999999998643 34789
Q ss_pred EEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-CeEEeecCCccc
Q 040908 520 IYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKL 598 (790)
Q Consensus 520 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~ 598 (790)
||||++++.+..+. ........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~-~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVAR-HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHH-HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHH-hhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999876444333 22233457999999999999999999999885 99999999999999775 899999999987
Q ss_pred cCCCCcceeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHH-------HHHHh
Q 040908 599 DEEDNTHISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWA-------LLLKE 670 (790)
Q Consensus 599 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-------~~~~~ 670 (790)
...... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+... .....
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 654332 234579999999998875 57899999999999999999999999765433222111000 00000
Q ss_pred hCCcccccCCCCC-----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 671 QGNLMELVDPNLG-----SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 671 ~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.....+..-+... .........++.+++.+|++.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000001100 0011123346788999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=366.82 Aligned_cols=264 Identities=22% Similarity=0.291 Sum_probs=195.1
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc-hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCC----eEE
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS-KQGNREFVNEIGTISALQHPHLVKLYGCCIEGN----QLL 518 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 518 (790)
+++|+++++||+|+||+||+|+. .+|+.||||++.... ....+.+++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999984 579999999996543 334567899999999999999999999997543 235
Q ss_pred EEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 519 LIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 519 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
++++|+.+|+|.+++. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~l~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 5566788999999993 246899999999999999999999985 99999999999999999999999999986
Q ss_pred cCCCCcc--eeeccccCCCcccHHHhhc-CCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHh----h
Q 040908 599 DEEDNTH--ISTRVAGTFGYMAPEYAMR-GHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKE----Q 671 (790)
Q Consensus 599 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----~ 671 (790)
....... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+............. .
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 5432221 2244679999999999854 5678899999999999999999999976543222111110000000 0
Q ss_pred CC----ccc--ccCCCCCCCCcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 672 GN----LME--LVDPNLGSNVDK-----EQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 672 ~~----~~~--~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
.. ... ...+.. ...+. ....++.+++..|++.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000 000000 00010 11235789999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=353.01 Aligned_cols=262 Identities=19% Similarity=0.280 Sum_probs=202.4
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeCCeEEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEGNQLLLIYE 522 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 522 (790)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ......+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999995 578999999986543 2335778999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCccccCCC
Q 040908 523 YLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 602 (790)
Q Consensus 523 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 602 (790)
++.+++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988873 2356889999999999999999999985 999999999999999999999999999876543
Q ss_pred CcceeeccccCCCcccHHHhhcCC-CCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhC---C---cc
Q 040908 603 NTHISTRVAGTFGYMAPEYAMRGH-LTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQG---N---LM 675 (790)
Q Consensus 603 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~---~~ 675 (790)
... .....+++.|+|||++.... ++.++|||||||++|||++|+.||......... ..-........ . ..
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGG
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhhh
Confidence 322 23345788999999987665 689999999999999999999997543322211 11111100000 0 00
Q ss_pred cccCC---------CCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 676 ELVDP---------NLGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 676 ~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
...+. .............+.+++.+|++.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0001111223356788999999999999999999865
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=360.79 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=200.7
Q ss_pred cCcceeeeecccCcEEEEeeee----cCCcEEEEEEccccc----hhcHHHHHHHHHHhhccCC-CceeeeeeEEEeCCe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL----ADGTLIAVKQLSAKS----KQGNREFVNEIGTISALQH-PHLVKLYGCCIEGNQ 516 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 516 (790)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999974 247899999986532 2234568899999999976 899999999999999
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+.+|+|.+++. ....++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999983 2345778889999999999999999984 999999999999999999999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhcC--CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCc
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMRG--HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNL 674 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 674 (790)
+..............|++.|+|||.+... .++.++|||||||+||||+||+.||...........+. .... ...
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~-~~~- 252 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRIL-KSE- 252 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHH-HCC-
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhcc-cCC-
Confidence 87655444444556799999999999764 46889999999999999999999997654433222111 1000 010
Q ss_pred ccccCCCCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040908 675 MELVDPNLGSNVDKEQVRVMINVALLCADVSPTNRPL-----MSSVVS 717 (790)
Q Consensus 675 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 717 (790)
+. .+.....++.+++.+||+.||.+||| ++|+++
T Consensus 253 -----~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -----PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11 12223457788999999999999995 677754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-40 Score=356.29 Aligned_cols=257 Identities=16% Similarity=0.253 Sum_probs=196.6
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccC-CCceeeeeeEEEeC--CeEEEEE
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPHLVKLYGCCIEG--NQLLLIY 521 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 521 (790)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+.+.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999995 57899999998643 3467889999999995 99999999999743 5689999
Q ss_pred EeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCC-CeEEeecCCccccC
Q 040908 522 EYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDE 600 (790)
Q Consensus 522 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~ 600 (790)
||+.+++|.++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999998765 35899999999999999999999985 99999999999998765 58999999998765
Q ss_pred CCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhH-H-H-----HHHHHHhhC
Q 040908 601 EDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYL-L-D-----WALLLKEQG 672 (790)
Q Consensus 601 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~-~-----~~~~~~~~~ 672 (790)
.... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||........... + . .........
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4432 2446789999999998765 479999999999999999999999975443221100 0 0 000000000
Q ss_pred C------cccccCCC--------CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 673 N------LMELVDPN--------LGSNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 673 ~------~~~~~d~~--------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
. ........ ...........++.+++.+|++.||.+|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00010000 001111122356789999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=354.69 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=189.7
Q ss_pred cCcceeeeecccCcEEEEeeeec-CCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEe------CCe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLLA-DGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIE------GNQ 516 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 516 (790)
++|++.++||+|+||+||+|... +|+.||||++.... ......+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999954 69999999997542 3344578899999999999999999999964 368
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.++||||+.++.+. .+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 89999999765554 442 35789999999999999999999985 999999999999999999999999998
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHH----------H--
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLD----------W-- 664 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~----------~-- 664 (790)
+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...........+. |
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 8654432 2344679999999999999999999999999999999999999996543221110000 0
Q ss_pred ----HHHHHhh-CCc-----ccccCCCCC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040908 665 ----ALLLKEQ-GNL-----MELVDPNLG---SNVDKEQVRVMINVALLCADVSPTNRPLMSSVVS 717 (790)
Q Consensus 665 ----~~~~~~~-~~~-----~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 717 (790)
....... ... ......... .........++.+++.+|++.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 000 000100110 1112244567899999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=352.90 Aligned_cols=261 Identities=21% Similarity=0.326 Sum_probs=196.7
Q ss_pred hcCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccc--hhcHHHHHHHHHHhhccCCCceeeeeeEEEeC-----Ce
Q 040908 445 TNHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKS--KQGNREFVNEIGTISALQHPHLVKLYGCCIEG-----NQ 516 (790)
Q Consensus 445 ~~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 516 (790)
+++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999994 579999999997542 33446788999999999999999999998643 34
Q ss_pred EEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeEEeecCCc
Q 040908 517 LLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 596 (790)
Q Consensus 517 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 596 (790)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 5677888999999999832 36899999999999999999999985 999999999999999999999999999
Q ss_pred cccCCCCcceeeccccCCCcccHHHhhcC-CCCChhhHHHHHHHHHHHHhCCCCCccccccchhhHHHHHHHHHhhCCcc
Q 040908 597 KLDEEDNTHISTRVAGTFGYMAPEYAMRG-HLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKFYLLDWALLLKEQGNLM 675 (790)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 675 (790)
...... .....||+.|+|||...+. .++.++|||||||++|||++|+.||...........+. ...+...
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~-----~~~~~~~ 239 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL-----RLVGTPG 239 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-----HHHCCCC
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-----HhcCCCC
Confidence 754332 2345689999999987765 46889999999999999999999997654322221110 0000000
Q ss_pred -cc------------cC--CCCC-CCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 040908 676 -EL------------VD--PNLG-SNVD---KEQVRVMINVALLCADVSPTNRPLMSSVVS--MLEGR 722 (790)
Q Consensus 676 -~~------------~d--~~l~-~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~ 722 (790)
+. .. +... .... .....++.+++.+|++.||.+|||+.|+++ .+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00 00 0000 0000 012346788999999999999999999987 55544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-35 Score=318.41 Aligned_cols=264 Identities=19% Similarity=0.218 Sum_probs=190.5
Q ss_pred cCcceeeeecccCcEEEEeeee-cCCcEEEEEEccccchhcHHHHHHHHHHhhccC-----------CCceeeeeeEEEe
Q 040908 446 NHFDVANKIGEGGFGPVYKGLL-ADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-----------HPHLVKLYGCCIE 513 (790)
Q Consensus 446 ~~y~~~~~LG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 513 (790)
.+|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999995 579999999997543 23456788998888775 5789999998864
Q ss_pred --CCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCC----
Q 040908 514 --GNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---- 587 (790)
Q Consensus 514 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---- 587 (790)
....+++++++..+........ ......+++..+..++.||+.||+|||+.. +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCccccc
Confidence 3566777777766544333211 123356788999999999999999999832 5999999999999987654
Q ss_pred --eEEeecCCccccCCCCcceeeccccCCCcccHHHhhcCCCCChhhHHHHHHHHHHHHhCCCCCccccccchh----hH
Q 040908 588 --PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVSGRSNIMCKTKEEKF----YL 661 (790)
Q Consensus 588 --~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~----~l 661 (790)
++++|||.+....... ....||+.|+|||++....++.++||||+||+++||++|+.||......... .+
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 8999999998554322 3467999999999999999999999999999999999999999754321111 11
Q ss_pred HHHHHHH-------Hhh-CCcccccC---------CC----------CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 040908 662 LDWALLL-------KEQ-GNLMELVD---------PN----------LGSNVDKEQVRVMINVALLCADVSPTNRPLMSS 714 (790)
Q Consensus 662 ~~~~~~~-------~~~-~~~~~~~d---------~~----------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 714 (790)
....... ... .......+ .. ...........++.+++.+|++.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1111110 000 00000000 00 012234566778999999999999999999999
Q ss_pred HHH
Q 040908 715 VVS 717 (790)
Q Consensus 715 v~~ 717 (790)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=3.2e-22 Score=196.52 Aligned_cols=164 Identities=19% Similarity=0.155 Sum_probs=121.4
Q ss_pred cceeeeecccCcEEEEeeeecCCcEEEEEEccccch------------------hcHHHHHHHHHHhhccCCCceeeeee
Q 040908 448 FDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSK------------------QGNREFVNEIGTISALQHPHLVKLYG 509 (790)
Q Consensus 448 y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g 509 (790)
+.+.++||+|+||.||+|...+|+.||||+++.... .....+..|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346799999999999999988899999998653210 11233556888999999999998876
Q ss_pred EEEeCCeEEEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcCCCcEEeccCCCCcEEecCCCCeE
Q 040908 510 CCIEGNQLLLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 589 (790)
Q Consensus 510 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 589 (790)
+. ..+++|||+++..+. .++......++.|++++|+|||+.+ |+||||||+|||+++++ ++
T Consensus 82 ~~----~~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EE
T ss_pred ec----CCEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EE
Confidence 53 237999999875443 2445566789999999999999985 99999999999999764 89
Q ss_pred EeecCCccccCCCCcceeeccccCCCccc------HHHhhcCCCCChhhHHHHHHHH
Q 040908 590 ISDFGLAKLDEEDNTHISTRVAGTFGYMA------PEYAMRGHLTDKADVYSFGIVA 640 (790)
Q Consensus 590 l~DFGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~ksDV~S~Gvvl 640 (790)
|+|||+|+........ .|.. .|. ..+.|..++||||..--+
T Consensus 143 liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9999999865432211 1111 122 235678899999975443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=9e-18 Score=173.35 Aligned_cols=167 Identities=14% Similarity=-0.008 Sum_probs=138.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCcccccCcccEEEecccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLT 76 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~ 76 (790)
++|||++|+|++..+..|.++++|+.|+|++|+|+...+ .+|+.|++++|.+...+......++|+.|+|++|.+.
T Consensus 34 ~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~ 113 (266)
T d1p9ag_ 34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT 113 (266)
T ss_dssp CEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCC
T ss_pred CEEECcCCcCCCcCHHHhhccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 579999999985555678999999999999999886543 4788999999988766544333488999999999998
Q ss_pred ccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCC
Q 040908 77 GELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDC 155 (790)
Q Consensus 77 ~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~ 155 (790)
+..+..+..+.+|++|++++|.+++..+..+..+++|+.|++++|+|++..+..+.. .+|+.|||++|+|+ .+|..+.
T Consensus 114 ~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~ 192 (266)
T d1p9ag_ 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192 (266)
T ss_dssp CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT
T ss_pred eeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHC
Confidence 777778888999999999999998666677888999999999999999887777766 88999999999998 7888888
Q ss_pred CCCcceeeecCCC
Q 040908 156 QNGAVNLFASSSK 168 (790)
Q Consensus 156 ~~~~l~~~~~~~~ 168 (790)
.+..|+.+..+.+
T Consensus 193 ~~~~L~~L~L~~N 205 (266)
T d1p9ag_ 193 GSHLLPFAFLHGN 205 (266)
T ss_dssp TTCCCSEEECCSC
T ss_pred CCCCCCEEEecCC
Confidence 8888888887644
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.72 E-value=5.7e-18 Score=179.11 Aligned_cols=167 Identities=19% Similarity=0.190 Sum_probs=92.2
Q ss_pred EEEccCCcCcc--cCChhhhcccccCcccccC-ccccccccc------cccceeccccCCCCCCCccccc-CcccEEEec
Q 040908 2 YRTVQSNRLSG--ELPEELGSLIHSGKWFGWA-NSVWHYFSE------SLTDLRISDLNGPEATLPDLRN-RTFKNLILR 71 (790)
Q Consensus 2 ~L~Ls~N~l~g--~iP~~~~~L~~L~~L~l~~-N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~ 71 (790)
.|||++|+++| .+|++|++|++|++|+|++ |++++.+|. +|+.|++++|.+.......+.. ..|+.|+++
T Consensus 54 ~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~ 133 (313)
T d1ogqa_ 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133 (313)
T ss_dssp EEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECC
T ss_pred EEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccc
Confidence 45666666655 3556666666666666654 555554442 5555556666555444443333 445555555
Q ss_pred cccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCC----------------------------------------
Q 040908 72 SCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLA---------------------------------------- 111 (790)
Q Consensus 72 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~---------------------------------------- 111 (790)
+|++.+.+|..|++++.|+++++++|.++|.+|..+..+.
T Consensus 134 ~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~ 213 (313)
T d1ogqa_ 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDA 213 (313)
T ss_dssp SSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECC
T ss_pred cccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5555555555555555555555555555555554444443
Q ss_pred --------CCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 112 --------DVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 112 --------~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
+|+.|++++|.+++.+|.....++|+.|+|++|+|+|.+|..++.+++|+.++.+.+
T Consensus 214 ~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N 278 (313)
T d1ogqa_ 214 SVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp GGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred cccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCC
Confidence 344444444444444433222256667777777777777777777777777666544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=2.3e-17 Score=171.89 Aligned_cols=170 Identities=15% Similarity=0.153 Sum_probs=128.0
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceec-cccCCCCCCCccccc-CcccEEEecc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRI-SDLNGPEATLPDLRN-RTFKNLILRS 72 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l-~~n~~~~~~~~~~~~-~~L~~L~L~~ 72 (790)
++|+|++|+|++..|..|.++++|+.|++++|++....+. .+..+.. ..+.+...+...+.. ++|++|+|++
T Consensus 35 ~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~ 114 (284)
T d1ozna_ 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114 (284)
T ss_dssp SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTT
T ss_pred CEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCC
Confidence 5899999999944445799999999999999999866543 3333333 344555555555665 7788888888
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCC
Q 040908 73 CNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESS 151 (790)
Q Consensus 73 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p 151 (790)
|.+....+..+..+.+|+.+++++|+|++..+..|..+++|+.|+|++|++++..|..+.. ++|+.+++++|++++..|
T Consensus 115 n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~ 194 (284)
T d1ozna_ 115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194 (284)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred cccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccCh
Confidence 8887666667777888888888888887555667778888888888888888777776666 778888888888888778
Q ss_pred CCCCCCCcceeeecCCCCC
Q 040908 152 GSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 152 ~~~~~~~~l~~~~~~~~~~ 170 (790)
..|..+.++..++.+.+..
T Consensus 195 ~~f~~l~~L~~L~l~~N~i 213 (284)
T d1ozna_ 195 HAFRDLGRLMTLYLFANNL 213 (284)
T ss_dssp TTTTTCTTCCEEECCSSCC
T ss_pred hHhhhhhhccccccccccc
Confidence 8888888888887766543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.66 E-value=5.7e-17 Score=171.27 Aligned_cols=142 Identities=20% Similarity=0.266 Sum_probs=121.1
Q ss_pred ccCcccccCcccccc--ccc------cccceeccc-cCCCCCCCccccc-CcccEEEeccccccccCCccccCCCCCCEE
Q 040908 23 HSGKWFGWANSVWHY--FSE------SLTDLRISD-LNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVL 92 (790)
Q Consensus 23 ~L~~L~l~~N~l~~~--~~~------~L~~L~l~~-n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 92 (790)
+++.|+|++|.+.+. +|. +|+.|+|++ |++....++.+.. ++|++|+|++|+|.+..|..+.++..|+++
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 588999999999863 333 788888986 6666444445555 999999999999999999999999999999
Q ss_pred EccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CC-CcEEeccCCccccCCCCCCCCCCcceeeec
Q 040908 93 DLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RG-PENIDLSYNNFADESSGSDCQNGAVNLFAS 165 (790)
Q Consensus 93 ~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~-L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~ 165 (790)
++++|++.+.+|.++.++++|+.+++++|.++|.+|..+.. .. ++.+++++|+++|..|..+..+..+ .++.
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l 204 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDL 204 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEEC
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccc
Confidence 99999999999999999999999999999999999998877 44 5899999999999999888776554 3443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=1.4e-15 Score=156.67 Aligned_cols=164 Identities=20% Similarity=0.228 Sum_probs=142.4
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCCCCCcccccCcccEEEeccccc
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNL 75 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l 75 (790)
..|.++++|+ .+|+.|. ++|+.|+|++|+|++.++. +|+.|+|++|.+...+.. ...++|+.|+|++|+|
T Consensus 14 ~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~-~~l~~L~~L~Ls~N~l 89 (266)
T d1p9ag_ 14 EVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLGTLDLSHNQL 89 (266)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCCEEECCSSCC
T ss_pred EEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccccc-cccccccccccccccc
Confidence 4689999999 7998775 5799999999999977653 789999999998865432 2238899999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
+ .+|..+.++++|++|+|++|++.+..+..+..+.+|+.|++++|.+++..+..+.. .+|+.|++++|+|++..+..+
T Consensus 90 ~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~ 168 (266)
T d1p9ag_ 90 Q-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLL 168 (266)
T ss_dssp S-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTT
T ss_pred c-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcccc
Confidence 8 67888999999999999999999878888999999999999999999777777666 889999999999999888999
Q ss_pred CCCCcceeeecCCCCC
Q 040908 155 CQNGAVNLFASSSKGS 170 (790)
Q Consensus 155 ~~~~~l~~~~~~~~~~ 170 (790)
..+.+|+.++.+.+.-
T Consensus 169 ~~l~~L~~L~Ls~N~L 184 (266)
T d1p9ag_ 169 NGLENLDTLLLQENSL 184 (266)
T ss_dssp TTCTTCCEEECCSSCC
T ss_pred ccccccceeecccCCC
Confidence 9999999999987643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.61 E-value=2.6e-16 Score=153.85 Aligned_cols=126 Identities=21% Similarity=0.255 Sum_probs=73.9
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCcccccccc-ccccceeccccCCCCCCCcccccCcccEEEeccccccccCC
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS-ESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELP 80 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~-~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p 80 (790)
.++.++|+|+ .+|..+. +++++|+|++|+|++.++ ..+..| ++|+.|+|++|++.+..+
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l-----------------~~L~~L~L~~N~i~~~~~ 71 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRL-----------------PHLVKLELKRNQLTGIEP 71 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGC-----------------TTCCEEECCSSCCCCBCT
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCC-----------------ceEeeeeccccccccccc
Confidence 4788888888 7887664 567777777777764332 211111 455555555555555555
Q ss_pred ccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccc
Q 040908 81 HFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFA 147 (790)
Q Consensus 81 ~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~ 147 (790)
..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|.+|.. ++|++|+|++|++.
T Consensus 72 ~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 72 NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp TTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred cccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 55555555555555555555444445555555555555555555555555444 55555555555554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=9.3e-15 Score=151.79 Aligned_cols=168 Identities=14% Similarity=0.059 Sum_probs=144.9
Q ss_pred CEEEccCCcCcccCChhhhcccccCccccc-Ccccccccc------ccccceeccccCCCCCCCccccc-CcccEEEecc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGW-ANSVWHYFS------ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRS 72 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~-~N~l~~~~~------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~ 72 (790)
++|++++|+|.+..+..+..+..+..+... .|.++...+ .+|+.|++++|.+.......+.. .+|+.+++++
T Consensus 59 ~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~ 138 (284)
T d1ozna_ 59 TILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138 (284)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcc
Confidence 579999999997777778888888888765 555655443 37888899999888777666665 8899999999
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCC
Q 040908 73 CNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESS 151 (790)
Q Consensus 73 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p 151 (790)
|+|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|++++|++++..|..+.. ++|+.||+++|++++..|
T Consensus 139 N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~ 218 (284)
T d1ozna_ 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218 (284)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred ccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccc
Confidence 9999766778999999999999999999877889999999999999999999999998887 899999999999999888
Q ss_pred CCCCCCCcceeeecCCC
Q 040908 152 GSDCQNGAVNLFASSSK 168 (790)
Q Consensus 152 ~~~~~~~~l~~~~~~~~ 168 (790)
..+..+.+|..+..+.+
T Consensus 219 ~~~~~~~~L~~L~l~~N 235 (284)
T d1ozna_ 219 EALAPLRALQYLRLNDN 235 (284)
T ss_dssp HHHTTCTTCCEEECCSS
T ss_pred cccccccccCEEEecCC
Confidence 88999999999988655
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.51 E-value=7.2e-14 Score=146.38 Aligned_cols=164 Identities=15% Similarity=0.165 Sum_probs=120.6
Q ss_pred CEEEccCCcCcccCCh-hhhcccccCcccccCccccccccc------cccceeccccCCCCCC-----------------
Q 040908 1 MYRTVQSNRLSGELPE-ELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPEAT----------------- 56 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~-~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~~~----------------- 56 (790)
++|+|++|+|+ .+|+ .|.++++|+.|++++|.+....|. .|+.|++++|++...+
T Consensus 34 ~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n~l 112 (305)
T d1xkua_ 34 ALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEI 112 (305)
T ss_dssp CEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSCC
T ss_pred CEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccchhhhhhhhhccccch
Confidence 36777777777 4544 577777777777777777655442 3444455544332111
Q ss_pred ------------------------------Cccccc-CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcch
Q 040908 57 ------------------------------LPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPE 105 (790)
Q Consensus 57 ------------------------------~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~ 105 (790)
...+.. ++|+.+++++|+++ .+|..+ +++|+.|++++|.+++..|.
T Consensus 113 ~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~ 189 (305)
T d1xkua_ 113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAA 189 (305)
T ss_dssp CBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTG
T ss_pred hhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChh
Confidence 001222 46788899999888 677654 68899999999999888888
Q ss_pred hccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcceeeecCCCC
Q 040908 106 SFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 106 ~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
.|.+++.++.|++++|++++..|.++.. ++|+.|+|++|+|+ .+|.++..++.|+.++.+++.
T Consensus 190 ~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~ 253 (305)
T d1xkua_ 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN 253 (305)
T ss_dssp GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSC
T ss_pred Hhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCc
Confidence 8999999999999999999888877776 88999999999997 567888888999999887754
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.51 E-value=2.4e-14 Score=139.62 Aligned_cols=125 Identities=16% Similarity=0.163 Sum_probs=106.2
Q ss_pred ceeccccCCCCCCCcccccCcccEEEeccccccccC-CccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCc
Q 040908 44 DLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGEL-PHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNL 122 (790)
Q Consensus 44 ~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~ 122 (790)
.++.+++++..+|... .+++++|+|++|+|++.+ +..|.++++|++|+|++|++.+..+..|..+++|+.|+|++|+
T Consensus 12 ~v~Cs~~~L~~iP~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 12 TVDCTGRGLKEIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EEECTTSCCSSCCSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEEeCCCcCccCCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 3455555555444321 257999999999998755 5578999999999999999998889999999999999999999
Q ss_pred ccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcceeeecCCCCC
Q 040908 123 LTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFASSSKGS 170 (790)
Q Consensus 123 l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~~~ 170 (790)
|++..|..|.. ++|+.|+|++|+|++..|+.|..+.+|..+..+.+.-
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~ 138 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred ccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccc
Confidence 99888888877 9999999999999999999999999999999876643
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.48 E-value=1.5e-13 Score=143.89 Aligned_cols=152 Identities=21% Similarity=0.211 Sum_probs=118.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccc----------------------------------------
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE---------------------------------------- 40 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~---------------------------------------- 40 (790)
++|++++|.++...|..|.++++|+.|++++|+++..+..
T Consensus 58 ~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~ 137 (305)
T d1xkua_ 58 HTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 137 (305)
T ss_dssp CEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC
T ss_pred cccccccccccccchhhhhCCCccCEecccCCccCcCccchhhhhhhhhccccchhhhhhhhhhcccccccccccccccc
Confidence 4789999999966677899999999999988877532211
Q ss_pred -------------cccceeccccCCCCCCCcccccCcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhc
Q 040908 41 -------------SLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESF 107 (790)
Q Consensus 41 -------------~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~ 107 (790)
+|+.+++.+|.+...+.. ..++|+.|++++|.+++..+..|.+++.+++|++++|++++..|..|
T Consensus 138 ~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~ 215 (305)
T d1xkua_ 138 SSGIENGAFQGMKKLSYIRIADTNITTIPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 215 (305)
T ss_dssp GGGBCTTGGGGCTTCCEEECCSSCCCSCCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTG
T ss_pred ccCCCccccccccccCccccccCCccccCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccc
Confidence 355566666666554332 23689999999999998888889999999999999999997778888
Q ss_pred cCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCC
Q 040908 108 ARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDC 155 (790)
Q Consensus 108 ~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~ 155 (790)
.++++|+.|+|++|+|+ .+|..+.. ++|+.|+|++|+|+......|.
T Consensus 216 ~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~ 263 (305)
T d1xkua_ 216 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263 (305)
T ss_dssp GGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred cccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhcc
Confidence 99999999999999998 45767766 8899999999999865444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.46 E-value=1.5e-13 Score=135.78 Aligned_cols=154 Identities=17% Similarity=0.196 Sum_probs=115.7
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|++++|+|+ .++ .+..+++|+.|+|++|++++..+ .+|+.|++++|.+...+ .+.. ++|+.|++++|.+
T Consensus 49 ~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~~~~ 124 (210)
T d1h6ta2 49 DQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLSLEHNGI 124 (210)
T ss_dssp CEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEECTTSCC
T ss_pred cEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccCccccccCccccccccccccccccc--cccccccccccccccccc
Confidence 46888888888 454 37888889999999998886553 37888888888776543 3444 7888888888888
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
. .++ .+.++++|+.++++.|.+++ +..+..+++|+.+++++|++++. +. +.. ++|+.|+|++|+|+. +| .+
T Consensus 125 ~-~~~-~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~~-l~~l~~L~~L~Ls~N~i~~-l~-~l 196 (210)
T d1h6ta2 125 S-DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-VP-LAGLTKLQNLYLSKNHISD-LR-AL 196 (210)
T ss_dssp C-CCG-GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCB-CG-GG
T ss_pred c-ccc-cccccccccccccccccccc--ccccccccccccccccccccccc-cc-ccCCCCCCEEECCCCCCCC-Ch-hh
Confidence 6 443 57888888888888888873 33577888888899988888864 33 444 788888998888874 44 57
Q ss_pred CCCCcceeeecC
Q 040908 155 CQNGAVNLFASS 166 (790)
Q Consensus 155 ~~~~~l~~~~~~ 166 (790)
..+++|+.++.+
T Consensus 197 ~~l~~L~~L~Ls 208 (210)
T d1h6ta2 197 AGLKNLDVLELF 208 (210)
T ss_dssp TTCTTCSEEEEE
T ss_pred cCCCCCCEEEcc
Confidence 777778777664
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.46 E-value=2e-13 Score=133.78 Aligned_cols=149 Identities=17% Similarity=0.183 Sum_probs=94.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|+|++|+|+ .++ .+..|++|++|++++|++++..+ .+|+.|++++|.+...+ .+.. +.|+.|++++|.+
T Consensus 43 ~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~ 118 (199)
T d2omxa2 43 TTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQI 118 (199)
T ss_dssp CEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECCSSCC
T ss_pred CEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCcccccCCccccccccccccccccc--cccccccccccccccccc
Confidence 35777777777 454 46777777777777777776543 26677777776655443 2333 6677777777777
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSD 154 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~ 154 (790)
.. + ..+.++++|+.|++++|++. .+| .+..+++|+.|++++|++++. +. +.. ++|+.|+|++|+++. +| .+
T Consensus 119 ~~-~-~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~~-l~~l~~L~~L~ls~N~i~~-i~-~l 190 (199)
T d2omxa2 119 TD-I-DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-KP-LANLTTLERLDISSNKVSD-IS-VL 190 (199)
T ss_dssp CC-C-GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GG
T ss_pred cc-c-cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCC-cc-ccCCCCCCEEECCCCCCCC-Cc-cc
Confidence 63 2 23667777777777777776 344 467777777777777777653 22 333 677777777777764 22 34
Q ss_pred CCCCcce
Q 040908 155 CQNGAVN 161 (790)
Q Consensus 155 ~~~~~l~ 161 (790)
+.+++|+
T Consensus 191 ~~L~~L~ 197 (199)
T d2omxa2 191 AKLTNLE 197 (199)
T ss_dssp GGCTTCS
T ss_pred cCCCCCC
Confidence 4444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=2.3e-13 Score=122.45 Aligned_cols=82 Identities=23% Similarity=0.248 Sum_probs=49.4
Q ss_pred cccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCC-ccccC-CCCcEEec
Q 040908 64 TFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVP-QWMFG-RGPENIDL 141 (790)
Q Consensus 64 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~-~~L~~l~l 141 (790)
+|++|+|++|+|+ .+|+.|+.+++|++|+|++|+|+ .+| .+.++++|+.|++++|+++.... ..+.. ++|+.|++
T Consensus 21 ~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l 97 (124)
T d1dcea3 21 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL 97 (124)
T ss_dssp TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEEC
T ss_pred CCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEEC
Confidence 4566666666665 55666666666666666666666 344 36666666666666666664322 23333 56666666
Q ss_pred cCCcccc
Q 040908 142 SYNNFAD 148 (790)
Q Consensus 142 s~N~l~g 148 (790)
++|+++.
T Consensus 98 ~~N~i~~ 104 (124)
T d1dcea3 98 QGNSLCQ 104 (124)
T ss_dssp TTSGGGG
T ss_pred CCCcCCc
Confidence 6666653
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.37 E-value=1.6e-12 Score=129.87 Aligned_cols=155 Identities=13% Similarity=0.140 Sum_probs=96.5
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|++++|+|+ .++ .+..|++|+.|++++|.+++..+ .+++.|.+++|.+... +.+.. ++|+.|++++|.+
T Consensus 44 ~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~ 119 (227)
T d1h6ua2 44 TTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQI 119 (227)
T ss_dssp CEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCC
T ss_pred CEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccccccccccccccccccccccc--ccccccccccccccccccc
Confidence 47899999998 664 58999999999999999887654 3677777777766543 23333 6777777777766
Q ss_pred cccCC--------------------ccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-C
Q 040908 76 TGELP--------------------HFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-R 134 (790)
Q Consensus 76 ~~~~p--------------------~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~ 134 (790)
.+..+ ..+.++++|+.|++++|+++.. + .+.++++|+.|+|++|++++ +|. +.. +
T Consensus 120 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~ 195 (227)
T d1h6ua2 120 TDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISD-ISP-LASLP 195 (227)
T ss_dssp CCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CGG-GGGCT
T ss_pred cccchhccccchhhhhchhhhhchhhhhccccccccccccccccccc-h-hhcccccceecccCCCccCC-Chh-hcCCC
Confidence 53221 1244555566666666666522 2 25666666666666666654 232 323 5
Q ss_pred CCcEEeccCCccccCCCCCCCCCCcceeeec
Q 040908 135 GPENIDLSYNNFADESSGSDCQNGAVNLFAS 165 (790)
Q Consensus 135 ~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~ 165 (790)
+|+.|+|++|+|++..| +..++.|..++.
T Consensus 196 ~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~l 224 (227)
T d1h6ua2 196 NLIEVHLKNNQISDVSP--LANTSNLFIVTL 224 (227)
T ss_dssp TCCEEECTTSCCCBCGG--GTTCTTCCEEEE
T ss_pred CCCEEECcCCcCCCCcc--cccCCCCCEEEe
Confidence 66666666666664322 445555555543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.34 E-value=2.5e-12 Score=138.40 Aligned_cols=140 Identities=15% Similarity=0.203 Sum_probs=73.2
Q ss_pred hhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccccccCCccccCCCCCCEE
Q 040908 18 LGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVL 92 (790)
Q Consensus 18 ~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 92 (790)
+..+++|+.|++++|.+++..+ .+|+.|+++++.+...+ .+.. ..++.++++.|++++ + ..+..+++|+.|
T Consensus 237 l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L 312 (384)
T d2omza2 237 LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-I-SPISNLKNLTYL 312 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEE
T ss_pred hhcccccchhccccCccCCCCcccccccCCEeeccCcccCCCC--cccccccccccccccccccc-c-cccchhcccCeE
Confidence 4444444444444444443322 13444444444433221 1111 344444555554442 1 235566667777
Q ss_pred EccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCCccccCCCCCCCCCCcceeeecCC
Q 040908 93 DLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYNNFADESSGSDCQNGAVNLFASSS 167 (790)
Q Consensus 93 ~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~ 167 (790)
+|++|++++. + .+..+++|+.|+|++|++++ +| .+.. ++|+.|+|++|+|++..| +..+++|+.++.+.
T Consensus 313 ~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~ 382 (384)
T d2omza2 313 TLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382 (384)
T ss_dssp ECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCC
T ss_pred ECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCC
Confidence 7777777643 2 26667777777777777664 33 2433 667777777777766543 55666666666544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=6.7e-13 Score=125.32 Aligned_cols=99 Identities=13% Similarity=0.075 Sum_probs=58.0
Q ss_pred CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCC-ccccC-CCCcEEe
Q 040908 63 RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVP-QWMFG-RGPENID 140 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~-~~L~~l~ 140 (790)
++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|+.|+|++|+++.... ..+.. ++|+.|+
T Consensus 41 ~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~ 118 (162)
T d1a9na_ 41 DQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 118 (162)
T ss_dssp TCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEE
T ss_pred ccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhh
Confidence 45677777777776 443 36667777777777777764333345567777777777777663211 22333 6677777
Q ss_pred ccCCccccCCCC----CCCCCCcceeee
Q 040908 141 LSYNNFADESSG----SDCQNGAVNLFA 164 (790)
Q Consensus 141 ls~N~l~g~~p~----~~~~~~~l~~~~ 164 (790)
+++|+++.. |. .+..+++|..++
T Consensus 119 l~~N~i~~~-~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 119 ILRNPVTNK-KHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCSSGGGGS-TTHHHHHHHHCTTCSEET
T ss_pred cCCCccccc-cchHHHHHHHCCCcCeeC
Confidence 777776542 21 234445555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.31 E-value=4.5e-12 Score=125.04 Aligned_cols=133 Identities=20% Similarity=0.287 Sum_probs=110.1
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|+|++|+|++ +| .++.|++|+.|++++|+++.... .+|+.|++++|..... +.+.. +.|+.+++++|.+
T Consensus 71 ~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~l~~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l 146 (210)
T d1h6ta2 71 TKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKI 146 (210)
T ss_dssp CEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCGGGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCC
T ss_pred CEEeCCCccccC-cc-ccccCcccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccc
Confidence 579999999994 55 37899999999999999987542 4788999998887653 34444 8899999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSY 143 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~ 143 (790)
++ +..+.++++|+++++++|++++ ++ .+.++++|+.|+|++|+++. +|. +.. ++|+.|+|++
T Consensus 147 ~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~~-l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 147 TD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFS 209 (210)
T ss_dssp CC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEEEEE
T ss_pred cc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCC-Chh-hcCCCCCCEEEccC
Confidence 84 3457889999999999999985 55 38999999999999999985 564 555 8999999974
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.28 E-value=4.6e-12 Score=136.28 Aligned_cols=134 Identities=17% Similarity=0.239 Sum_probs=111.9
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCcccccccc----ccccceeccccCCCCCCCccccc-CcccEEEeccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFS----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNL 75 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l 75 (790)
++|++++|++++..| ++.+++|+.|++++|.+++..+ ..+..+.+.+|.+... ..+.. .+++.|+|++|+|
T Consensus 244 ~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l 319 (384)
T d2omza2 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNI 319 (384)
T ss_dssp SEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCC
T ss_pred chhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccc--cccchhcccCeEECCCCCC
Confidence 478999999995443 8889999999999999987654 3677888888877653 23343 8899999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCC
Q 040908 76 TGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYN 144 (790)
Q Consensus 76 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N 144 (790)
++. + .+..+++|++|+|++|+|+ .+| .|.+|++|++|+|++|++++.+| +.. ++|+.|+|++|
T Consensus 320 ~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 320 SDI-S-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCC-G-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCC-c-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 964 3 3889999999999999998 566 69999999999999999998765 555 89999999998
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=7.4e-12 Score=125.98 Aligned_cols=167 Identities=11% Similarity=0.050 Sum_probs=109.7
Q ss_pred CEEEccCCcCcccCCh-hhhcccccCcccccCcccccccc-------ccccceecc-ccCCCCCCCccccc-CcccEEEe
Q 040908 1 MYRTVQSNRLSGELPE-ELGSLIHSGKWFGWANSVWHYFS-------ESLTDLRIS-DLNGPEATLPDLRN-RTFKNLIL 70 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~-~~~~L~~L~~L~l~~N~l~~~~~-------~~L~~L~l~-~n~~~~~~~~~~~~-~~L~~L~L 70 (790)
++|||++|+|+ .+|. .|.++++|++|++++|.+...++ ..+..|.+. .|++.......+.. ++|+.|++
T Consensus 32 ~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l 110 (242)
T d1xwdc1 32 IELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 110 (242)
T ss_dssp SEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEE
T ss_pred CEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccccc
Confidence 58999999999 5555 68999999999999999876443 245666654 35565555565665 88999999
Q ss_pred ccccccccCCc-cccCCCCCCEEEccCCcCCcCcchhccCCC-CCcEEEeeCCcccccCCccccCCCCcEE-eccCCccc
Q 040908 71 RSCNLTGELPH-FLGEVSEMKVLDLSFNKLNGTIPESFARLA-DVDFIYLTGNLLTGKVPQWMFGRGPENI-DLSYNNFA 147 (790)
Q Consensus 71 ~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~-~L~~L~ls~N~l~g~~p~~~~~~~L~~l-~ls~N~l~ 147 (790)
++|++....+. .+..+..|..+..+++++...-+..|.+++ .++.|++++|+++...+..+...++..+ ++++|+|+
T Consensus 111 ~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~ 190 (242)
T d1xwdc1 111 SNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE 190 (242)
T ss_dssp ESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCC
T ss_pred chhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccc
Confidence 99988733222 234456666666666677644445555554 5677777777777544444433444333 45666666
Q ss_pred cCCCCCCCCCCcceeeecCCC
Q 040908 148 DESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 148 g~~p~~~~~~~~l~~~~~~~~ 168 (790)
...+..|..+++|+.++.+.+
T Consensus 191 ~l~~~~f~~l~~L~~L~Ls~N 211 (242)
T d1xwdc1 191 ELPNDVFHGASGPVILDISRT 211 (242)
T ss_dssp CCCTTTTTTSCCCSEEECTTS
T ss_pred cccHHHhcCCCCCCEEECCCC
Confidence 444445666677777776554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.24 E-value=2.1e-11 Score=118.99 Aligned_cols=155 Identities=13% Similarity=0.166 Sum_probs=119.9
Q ss_pred EccCCcCcccCChhhhcccccCcccccCccccccc----cccccceeccccCCCCCCCccccc-CcccEEEecccccccc
Q 040908 4 TVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYF----SESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGE 78 (790)
Q Consensus 4 ~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~----~~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~ 78 (790)
.++.+.+++.++ ...+.+|+.|++++|.+.... ..+|+.|++++|.+..... +.. ++|+.|++++|.+. .
T Consensus 24 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~ 98 (199)
T d2omxa2 24 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-D 98 (199)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-C
T ss_pred HhCCCCCCCccC--HHHhcCCCEEECCCCCCCCccccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-c
Confidence 467788886655 356788999999999887542 2488899999998776442 444 88999999999987 5
Q ss_pred CCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCCCCCC
Q 040908 79 LPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNG 158 (790)
Q Consensus 79 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~ 158 (790)
+| .+++++.|+.|++++|.+.. ++ .+..+++|+.|++++|++.. +|......+|+.|++++|++++.. .+..++
T Consensus 99 ~~-~l~~l~~L~~L~l~~~~~~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~ 172 (199)
T d2omxa2 99 IT-PLANLTNLTGLTLFNNQITD-ID-PLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTDLK--PLANLT 172 (199)
T ss_dssp CG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCCCG--GGTTCT
T ss_pred cc-cccccccccccccccccccc-cc-ccchhhhhHHhhhhhhhhcc-cccccccccccccccccccccCCc--cccCCC
Confidence 55 38899999999999999874 33 47889999999999999874 443333388999999999998643 477888
Q ss_pred cceeeecCCCC
Q 040908 159 AVNLFASSSKG 169 (790)
Q Consensus 159 ~l~~~~~~~~~ 169 (790)
.|+.++.+.+.
T Consensus 173 ~L~~L~ls~N~ 183 (199)
T d2omxa2 173 TLERLDISSNK 183 (199)
T ss_dssp TCCEEECCSSC
T ss_pred CCCEEECCCCC
Confidence 88888887653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.20 E-value=1.8e-11 Score=109.85 Aligned_cols=98 Identities=22% Similarity=0.260 Sum_probs=83.6
Q ss_pred cEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEeccCC
Q 040908 66 KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDLSYN 144 (790)
Q Consensus 66 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~ls~N 144 (790)
+.|+|++|+|+ .+|. ++++++|++|+|++|+|+ .+|..|+.+++|+.|++++|++++ +|. +.. ++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~-~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cCc-cccccccCeEECCCC
Confidence 57999999999 6664 899999999999999998 789899999999999999999995 454 444 89999999999
Q ss_pred ccccCC-CCCCCCCCcceeeecCCC
Q 040908 145 NFADES-SGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 145 ~l~g~~-p~~~~~~~~l~~~~~~~~ 168 (790)
+|+... ...+..+++|..++.+.+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N 100 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGN 100 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCC
Confidence 998643 246777888888887544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.18 E-value=2e-13 Score=133.53 Aligned_cols=126 Identities=13% Similarity=0.205 Sum_probs=80.5
Q ss_pred EEccCC--cCcccCChhhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccCC
Q 040908 3 RTVQSN--RLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELP 80 (790)
Q Consensus 3 L~Ls~N--~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p 80 (790)
++++++ .++ .+|..|..|++|+.|+|++|+|+... .|..| ++|+.|+|++|+|+ .+|
T Consensus 28 ~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i~--~l~~l-----------------~~L~~L~Ls~N~i~-~i~ 86 (198)
T d1m9la_ 28 VELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKIS--SLSGM-----------------ENLRILSLGRNLIK-KIE 86 (198)
T ss_dssp EECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCCC--CHHHH-----------------TTCCEEECCEEEEC-SCS
T ss_pred eeeecccCchh-hhhhHHhcccccceeECcccCCCCcc--cccCC-----------------ccccChhhcccccc-ccc
Confidence 344433 344 56678999999999999999887542 23322 46777777777776 566
Q ss_pred ccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCC-ccccC-CCCcEEeccCCccccCCC
Q 040908 81 HFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVP-QWMFG-RGPENIDLSYNNFADESS 151 (790)
Q Consensus 81 ~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~-~~L~~l~ls~N~l~g~~p 151 (790)
..+..+++|++|+|++|+|+ .++ .+.++++|+.|+|++|+++.... ..+.. ++|+.|+|++|+++...+
T Consensus 87 ~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 87 NLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccccccccccccccccccc-ccc-cccccccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 55555566777777777776 343 46667777777777777764321 23333 667777777777665433
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=8.4e-12 Score=117.59 Aligned_cols=104 Identities=13% Similarity=0.127 Sum_probs=56.9
Q ss_pred hhcccccCcccccCcccccccc-----ccccceeccccCCCCCCCccccc-CcccEEEeccccccccCCccccCCCCCCE
Q 040908 18 LGSLIHSGKWFGWANSVWHYFS-----ESLTDLRISDLNGPEATLPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKV 91 (790)
Q Consensus 18 ~~~L~~L~~L~l~~N~l~~~~~-----~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 91 (790)
+.++.+|+.|+|++|+|+.+.. .+|+.|++++|.+.... .+.. ++|+.|+|++|+|+...+..+..+++|++
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l~--~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD--GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEEC--CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred ccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCccC--CcccCcchhhhhcccccccCCCcccccccccccc
Confidence 4455556666666666654321 25566666666555432 2222 55666666666666333333445666666
Q ss_pred EEccCCcCCcCcc--hhccCCCCCcEEEeeCCccc
Q 040908 92 LDLSFNKLNGTIP--ESFARLADVDFIYLTGNLLT 124 (790)
Q Consensus 92 L~Ls~N~l~g~ip--~~~~~l~~L~~L~ls~N~l~ 124 (790)
|+|++|+|+ .++ ..+..+++|+.|++++|.++
T Consensus 92 L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 92 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ceecccccc-ccccccccccccccchhhcCCCccc
Confidence 666666665 333 24556666666666666665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.17 E-value=4.9e-11 Score=118.79 Aligned_cols=135 Identities=16% Similarity=0.199 Sum_probs=100.5
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccc----cccccceeccccCCCCC--------------------C
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYF----SESLTDLRISDLNGPEA--------------------T 56 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~----~~~L~~L~l~~n~~~~~--------------------~ 56 (790)
++|+|++|+|++..| +..+++|+.|++++|.++... ..+|+.|.++++..... .
T Consensus 66 ~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 143 (227)
T d1h6ua2 66 IGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITN 143 (227)
T ss_dssp CEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred cEeecCCceeecccc--ccccccccccccccccccccccccccccccccccccccccccchhccccchhhhhchhhhhch
Confidence 478899999885433 788888888888888876433 13555666655543211 1
Q ss_pred Cccccc-CcccEEEeccccccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-C
Q 040908 57 LPDLRN-RTFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-R 134 (790)
Q Consensus 57 ~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~ 134 (790)
...+.. ++|+.|++++|.+.+. + .++++++|+.|+|++|++++ +| .+.++++|+.|+|++|++++..| +.. +
T Consensus 144 ~~~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~ 217 (227)
T d1h6ua2 144 ISPLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTS 217 (227)
T ss_dssp CGGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCT
T ss_pred hhhhccccccccccccccccccc-h-hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCC
Confidence 122233 7799999999999843 3 38999999999999999984 55 38999999999999999996543 445 8
Q ss_pred CCcEEeccC
Q 040908 135 GPENIDLSY 143 (790)
Q Consensus 135 ~L~~l~ls~ 143 (790)
+|+.|+|++
T Consensus 218 ~L~~L~lsn 226 (227)
T d1h6ua2 218 NLFIVTLTN 226 (227)
T ss_dssp TCCEEEEEE
T ss_pred CCCEEEeeC
Confidence 999999973
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=2.7e-11 Score=113.27 Aligned_cols=85 Identities=18% Similarity=0.135 Sum_probs=53.8
Q ss_pred CcccEEEeccc-cccccCCccccCCCCCCEEEccCCcCCcCcchhccCCCCCcEEEeeCCcccccCCccccCCCCcEEec
Q 040908 63 RTFKNLILRSC-NLTGELPHFLGEVSEMKVLDLSFNKLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFGRGPENIDL 141 (790)
Q Consensus 63 ~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~l 141 (790)
++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|..|..+++|+.|+|++|+|+...+..+...+|+.|+|
T Consensus 31 ~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L 110 (156)
T d2ifga3 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVL 110 (156)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEEC
T ss_pred cccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcccccccccc
Confidence 45666666544 36644445567777777777777777655566677777777777777777644444444456777777
Q ss_pred cCCccc
Q 040908 142 SYNNFA 147 (790)
Q Consensus 142 s~N~l~ 147 (790)
++|+|.
T Consensus 111 ~~Np~~ 116 (156)
T d2ifga3 111 SGNPLH 116 (156)
T ss_dssp CSSCCC
T ss_pred CCCccc
Confidence 777663
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.12 E-value=9e-11 Score=109.62 Aligned_cols=104 Identities=13% Similarity=0.054 Sum_probs=78.8
Q ss_pred cccEEEeccccccccCCccccCCCCCCEEEccCC-cCCcCcchhccCCCCCcEEEeeCCcccccCCccccC-CCCcEEec
Q 040908 64 TFKNLILRSCNLTGELPHFLGEVSEMKVLDLSFN-KLNGTIPESFARLADVDFIYLTGNLLTGKVPQWMFG-RGPENIDL 141 (790)
Q Consensus 64 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~g~ip~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-~~L~~l~l 141 (790)
..+.++++++.+. .+|..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|..|.. ++|+.|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3456788888887 67888888888999998766 477555567888999999999999998777777766 88899999
Q ss_pred cCCccccCCCCCCCCCCcceeeecCCCC
Q 040908 142 SYNNFADESSGSDCQNGAVNLFASSSKG 169 (790)
Q Consensus 142 s~N~l~g~~p~~~~~~~~l~~~~~~~~~ 169 (790)
++|+|+...+..+ ....|..+..+.+.
T Consensus 88 s~N~l~~l~~~~~-~~~~l~~L~L~~Np 114 (156)
T d2ifga3 88 SFNALESLSWKTV-QGLSLQELVLSGNP 114 (156)
T ss_dssp CSSCCSCCCSTTT-CSCCCCEEECCSSC
T ss_pred cCCCCcccChhhh-ccccccccccCCCc
Confidence 9999885444444 44467777776553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.97 E-value=1.6e-11 Score=119.75 Aligned_cols=117 Identities=16% Similarity=0.181 Sum_probs=90.6
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccccccccceeccccCCCCCCCcccccCcccEEEeccccccccCC
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGELP 80 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~~p 80 (790)
++|+|++|+|+ .++ .|..|++|+.|+|++|.++...+ +.. ...+|+.|+|++|+|+ .++
T Consensus 51 ~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~--~~~----------------~~~~L~~L~l~~N~i~-~l~ 109 (198)
T d1m9la_ 51 KHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIEN--LDA----------------VADTLEELWISYNQIA-SLS 109 (198)
T ss_dssp CEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSS--HHH----------------HHHHCCEEECSEEECC-CHH
T ss_pred ceeECcccCCC-Ccc-cccCCccccChhhcccccccccc--ccc----------------cccccccccccccccc-ccc
Confidence 58999999999 676 59999999999999998865321 100 0146899999999998 444
Q ss_pred ccccCCCCCCEEEccCCcCCcCcc--hhccCCCCCcEEEeeCCcccccCCcc----------ccC-CCCcEEe
Q 040908 81 HFLGEVSEMKVLDLSFNKLNGTIP--ESFARLADVDFIYLTGNLLTGKVPQW----------MFG-RGPENID 140 (790)
Q Consensus 81 ~~~~~l~~L~~L~Ls~N~l~g~ip--~~~~~l~~L~~L~ls~N~l~g~~p~~----------~~~-~~L~~l~ 140 (790)
.+.++++|++|+|++|+|+ .++ ..+..|++|+.|+|++|.+....+.. +.. ++|+.||
T Consensus 110 -~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 110 -GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp -HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred -cccccccccccccccchhc-cccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 4888999999999999998 555 46899999999999999987665542 222 6677766
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.90 E-value=3.2e-09 Score=106.20 Aligned_cols=157 Identities=12% Similarity=0.044 Sum_probs=106.4
Q ss_pred EEEccCCcCcccCChhhhcccccCcccccCccccccccc------cccceeccccCCCC-CCCccccc-CcccEEEec-c
Q 040908 2 YRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYFSE------SLTDLRISDLNGPE-ATLPDLRN-RTFKNLILR-S 72 (790)
Q Consensus 2 ~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~~~------~L~~L~l~~n~~~~-~~~~~~~~-~~L~~L~L~-~ 72 (790)
.++.++++++ .+|..+. +++++|+|++|+|+..++. +|+.|++++|.+.. .+...+.. +.+++|.+. .
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 5788888998 8997664 5789999999999866542 67777888877664 34444554 677777765 4
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCcCcc-hhccCCCCCcEEEeeCCcccccCCccccC--CCCcEEeccCCccccC
Q 040908 73 CNLTGELPHFLGEVSEMKVLDLSFNKLNGTIP-ESFARLADVDFIYLTGNLLTGKVPQWMFG--RGPENIDLSYNNFADE 149 (790)
Q Consensus 73 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~--~~L~~l~ls~N~l~g~ 149 (790)
|++....+..|.++++|++|++++|++....+ ..+..+..|..+..+++++....+..+.. ..+..|++++|+++..
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i 168 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 168 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence 67776667778888888888888888863222 23445666666677777777555555543 4677788888888754
Q ss_pred CCCCCCCCCccee
Q 040908 150 SSGSDCQNGAVNL 162 (790)
Q Consensus 150 ~p~~~~~~~~l~~ 162 (790)
.+..+ ....+..
T Consensus 169 ~~~~~-~~~~l~~ 180 (242)
T d1xwdc1 169 HNCAF-NGTQLDE 180 (242)
T ss_dssp CTTTT-TTCCEEE
T ss_pred ccccc-cchhhhc
Confidence 44433 3344333
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.82 E-value=1.9e-08 Score=105.69 Aligned_cols=114 Identities=25% Similarity=0.275 Sum_probs=88.0
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCccccccc--cccccceeccccCCCCCCCcccccCcccEEEecccccccc
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWANSVWHYF--SESLTDLRISDLNGPEATLPDLRNRTFKNLILRSCNLTGE 78 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~N~l~~~ 78 (790)
..|||++|.|+ .+|+. +++|+.|+|++|+|+..+ +.+|+.|++++|.+...+. + ...|++|+|++|.|. .
T Consensus 41 ~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~~~~L~~L~l~~n~l~~l~~--l-p~~L~~L~L~~n~l~-~ 112 (353)
T d1jl5a_ 41 HELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKALSD--L-PPLLEYLGVSNNQLE-K 112 (353)
T ss_dssp SEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCCCTTCCEEECCSSCCSCCCS--C-CTTCCEEECCSSCCS-S
T ss_pred CEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccchhhhhhhhhhhcccchhhh--h-ccccccccccccccc-c
Confidence 37999999998 79964 468899999999998654 3589999999998886542 1 257999999999998 7
Q ss_pred CCccccCCCCCCEEEccCCcCCcCcch-------------------hccCCCCCcEEEeeCCccc
Q 040908 79 LPHFLGEVSEMKVLDLSFNKLNGTIPE-------------------SFARLADVDFIYLTGNLLT 124 (790)
Q Consensus 79 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~-------------------~~~~l~~L~~L~ls~N~l~ 124 (790)
+|. ++++++|++|++++|.+.. .|. .+..++.++.|++++|.+.
T Consensus 113 lp~-~~~l~~L~~L~l~~~~~~~-~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 113 LPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CCC-CTTCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS
T ss_pred ccc-hhhhccceeeccccccccc-cccccccccchhhccccccccccccccccceeccccccccc
Confidence 775 6889999999999999873 332 2344555566666666554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.78 E-value=2.7e-08 Score=104.36 Aligned_cols=52 Identities=15% Similarity=0.188 Sum_probs=35.7
Q ss_pred CCCCcEEEeeCCcccccCCccccCCCCcEEeccCCccccCCCCCCCCCCcceeeecCCC
Q 040908 110 LADVDFIYLTGNLLTGKVPQWMFGRGPENIDLSYNNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 110 l~~L~~L~ls~N~l~g~~p~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
+++|+.|+|++|+|+ .+|..+ ++|+.|+|++|+|+ .+|.. +.+|+.++.+.+
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~~--~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N 334 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPALP--PRLERLIASFNHLA-EVPEL---PQNLKQLHVEYN 334 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCCC--TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSS
T ss_pred CCCCCEEECCCCccC-cccccc--CCCCEEECCCCcCC-ccccc---cCCCCEEECcCC
Confidence 367888888888887 456432 57888888888887 45643 345666666554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=2.6e-09 Score=109.89 Aligned_cols=168 Identities=14% Similarity=0.090 Sum_probs=111.2
Q ss_pred CEEEccCCcCccc-CChhhhcccccCcccccCcccccccc------ccccceeccccC-CCCCCCccc-cc-CcccEEEe
Q 040908 1 MYRTVQSNRLSGE-LPEELGSLIHSGKWFGWANSVWHYFS------ESLTDLRISDLN-GPEATLPDL-RN-RTFKNLIL 70 (790)
Q Consensus 1 ~~L~Ls~N~l~g~-iP~~~~~L~~L~~L~l~~N~l~~~~~------~~L~~L~l~~n~-~~~~~~~~~-~~-~~L~~L~L 70 (790)
++|||++|.+++. ++.-+.++++|++|+|++|.++...+ .+|+.|+++++. ++......+ .. ++|++|+|
T Consensus 49 ~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~l 128 (284)
T d2astb2 49 QHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL 128 (284)
T ss_dssp CEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEEC
T ss_pred CEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccc
Confidence 5789999988755 34456788999999999998764322 368888887753 332222222 22 77888988
Q ss_pred ccc-ccccc-CCccccC-CCCCCEEEccCC--cCCc-CcchhccCCCCCcEEEeeCC-cccccCCccccC-CCCcEEecc
Q 040908 71 RSC-NLTGE-LPHFLGE-VSEMKVLDLSFN--KLNG-TIPESFARLADVDFIYLTGN-LLTGKVPQWMFG-RGPENIDLS 142 (790)
Q Consensus 71 ~~N-~l~~~-~p~~~~~-l~~L~~L~Ls~N--~l~g-~ip~~~~~l~~L~~L~ls~N-~l~g~~p~~~~~-~~L~~l~ls 142 (790)
+++ +++.. ++..+.. .++|+.|+|++. .++. .+..-+.++++|+.|+|++| .+++.....+.. ++|++|+|+
T Consensus 129 s~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~ 208 (284)
T d2astb2 129 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 208 (284)
T ss_dssp CCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred ccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECC
Confidence 885 45422 2233333 467888888864 3442 23444467888899999875 466555555555 788889998
Q ss_pred C-CccccCCCCCCCCCCcceeeecCCC
Q 040908 143 Y-NNFADESSGSDCQNGAVNLFASSSK 168 (790)
Q Consensus 143 ~-N~l~g~~p~~~~~~~~l~~~~~~~~ 168 (790)
+ +.++......+..+++|+.++.+..
T Consensus 209 ~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 209 RCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 8 4677766666777778888776543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.54 E-value=9.1e-09 Score=108.67 Aligned_cols=62 Identities=23% Similarity=0.259 Sum_probs=29.3
Q ss_pred CcccEEEecccccccc-----CCccccCCCCCCEEEccCCcCCcC----cchhccCCCCCcEEEeeCCccc
Q 040908 63 RTFKNLILRSCNLTGE-----LPHFLGEVSEMKVLDLSFNKLNGT----IPESFARLADVDFIYLTGNLLT 124 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~ls~N~l~ 124 (790)
.+|+.|+|++|+|+.. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|.++
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 3455555555554421 223344455555555555554311 2334445555555555555554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=4e-07 Score=91.60 Aligned_cols=149 Identities=13% Similarity=0.092 Sum_probs=104.6
Q ss_pred HHHHHHhcCcceeeeecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccC-CCceeeeeeEEEeCCeE
Q 040908 439 RQIKAATNHFDVANKIGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQ-HPHLVKLYGCCIEGNQL 517 (790)
Q Consensus 439 ~~~~~~~~~y~~~~~LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 517 (790)
.+++..-..|++.+..+.+....||+... +++.+++|+...........+.+|...+..+. +--+.+++.++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35666667888777665555678999875 45567788876554444456778888887774 43456788888888899
Q ss_pred EEEEEeccCCChhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhhcC-------------------------------
Q 040908 518 LLIYEYLENNSLARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHEES------------------------------- 566 (790)
Q Consensus 518 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------- 566 (790)
++||+++++.++.+.... ......++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999999887655411 1123335556666666666421
Q ss_pred -------------------------CCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 567 -------------------------RLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 567 -------------------------~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
...++|+|+.|.|||++++..+-|.||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1227999999999999987767799998776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=1.8e-08 Score=103.46 Aligned_cols=144 Identities=15% Similarity=0.094 Sum_probs=108.4
Q ss_pred CEEEccCCcCcccCChhhhcccccCcccccCc-cccccc-------cccccceeccccCC-CCCCCc-cc-c-cCcccEE
Q 040908 1 MYRTVQSNRLSGELPEELGSLIHSGKWFGWAN-SVWHYF-------SESLTDLRISDLNG-PEATLP-DL-R-NRTFKNL 68 (790)
Q Consensus 1 ~~L~Ls~N~l~g~iP~~~~~L~~L~~L~l~~N-~l~~~~-------~~~L~~L~l~~n~~-~~~~~~-~~-~-~~~L~~L 68 (790)
++|+|++|++++..+..++.+++|+.|+++++ .++... -.+|+.|+++++.. ...... .+ . .++|+.|
T Consensus 74 ~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L 153 (284)
T d2astb2 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQL 153 (284)
T ss_dssp SEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEE
T ss_pred ccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchh
Confidence 58999999999889999999999999999995 565211 24799999987533 221111 11 1 2689999
Q ss_pred Eeccc--ccccc-CCccccCCCCCCEEEccCC-cCCcCcchhccCCCCCcEEEeeC-CcccccCCccccC-CCCcEEecc
Q 040908 69 ILRSC--NLTGE-LPHFLGEVSEMKVLDLSFN-KLNGTIPESFARLADVDFIYLTG-NLLTGKVPQWMFG-RGPENIDLS 142 (790)
Q Consensus 69 ~L~~N--~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~g~ip~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~-~~L~~l~ls 142 (790)
+|+++ .++.. +..-+.++++|++|+|++| .+++..+..+.++++|+.|+|++ +.++......+.. ++|+.|+++
T Consensus 154 ~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~ 233 (284)
T d2astb2 154 NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233 (284)
T ss_dssp ECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred hhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeee
Confidence 99975 34432 3334467899999999986 58877888999999999999999 4677655555555 899999998
Q ss_pred CC
Q 040908 143 YN 144 (790)
Q Consensus 143 ~N 144 (790)
++
T Consensus 234 ~~ 235 (284)
T d2astb2 234 GI 235 (284)
T ss_dssp TS
T ss_pred CC
Confidence 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.26 E-value=7.3e-08 Score=104.69 Aligned_cols=84 Identities=17% Similarity=0.284 Sum_probs=36.1
Q ss_pred cccEEEeccccccccCCc----cccCCCCCCEEEccCCcCCc----Ccchhcc-CCCCCcEEEeeCCccccc----CCcc
Q 040908 64 TFKNLILRSCNLTGELPH----FLGEVSEMKVLDLSFNKLNG----TIPESFA-RLADVDFIYLTGNLLTGK----VPQW 130 (790)
Q Consensus 64 ~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~g----~ip~~~~-~l~~L~~L~ls~N~l~g~----~p~~ 130 (790)
.|+.+++++|.++..-.. .+....+|++|+|++|+|+. .++..+. ..+.|+.|+|++|+|+.. ++..
T Consensus 313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 392 (460)
T d1z7xw1 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 392 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred ccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHH
Confidence 455555555555432211 22233445555555555532 1222222 234455555555555421 1222
Q ss_pred ccC-CCCcEEeccCCccc
Q 040908 131 MFG-RGPENIDLSYNNFA 147 (790)
Q Consensus 131 ~~~-~~L~~l~ls~N~l~ 147 (790)
+.. ++|++|||++|+|+
T Consensus 393 l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 393 LLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHHCCCCCEEECCSSSCC
T ss_pred HhcCCCCCEEECCCCcCC
Confidence 222 44555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.17 E-value=1.6e-07 Score=98.81 Aligned_cols=62 Identities=13% Similarity=0.155 Sum_probs=29.7
Q ss_pred CCCCCEEEccCCcCCc----CcchhccCCCCCcEEEeeCCccccc-----CCccccC-CCCcEEeccCCccc
Q 040908 86 VSEMKVLDLSFNKLNG----TIPESFARLADVDFIYLTGNLLTGK-----VPQWMFG-RGPENIDLSYNNFA 147 (790)
Q Consensus 86 l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~ls~N~l~g~-----~p~~~~~-~~L~~l~ls~N~l~ 147 (790)
.+.|+.|++++|+++. .+...+..++.|+.|+|++|++... +...+.. ++|+.|+|++|.++
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence 4455555555555541 1222344455566666666655421 1111222 45566666666554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.05 E-value=9.3e-08 Score=89.19 Aligned_cols=85 Identities=22% Similarity=0.194 Sum_probs=56.9
Q ss_pred cEEEeccccccccCCccccCCCCCCEEEccCCcCCcC--cchhccCCCCCcEEEeeCCcccccCCccc-cCCCCcEEecc
Q 040908 66 KNLILRSCNLTGELPHFLGEVSEMKVLDLSFNKLNGT--IPESFARLADVDFIYLTGNLLTGKVPQWM-FGRGPENIDLS 142 (790)
Q Consensus 66 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~--ip~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~~~L~~l~ls 142 (790)
..|++.+|.+. .++..+.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|+++...+-.. ....|+.|+|+
T Consensus 45 ~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~ 123 (162)
T d1koha1 45 VVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLD 123 (162)
T ss_dssp CCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCT
T ss_pred hhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecC
Confidence 33444444443 4555556788888888888888742 34556778888888888888885433222 23678888888
Q ss_pred CCccccCCC
Q 040908 143 YNNFADESS 151 (790)
Q Consensus 143 ~N~l~g~~p 151 (790)
+|+++....
T Consensus 124 ~Npl~~~~~ 132 (162)
T d1koha1 124 GNSLSDTFR 132 (162)
T ss_dssp TSTTSSSSS
T ss_pred CCCcCcCcc
Confidence 888876443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.87 E-value=8.9e-07 Score=95.83 Aligned_cols=85 Identities=19% Similarity=0.254 Sum_probs=54.4
Q ss_pred CcccEEEeccccccc----cCCccccCCCCCCEEEccCCcCCc----Ccchhcc-CCCCCcEEEeeCCccccc----CCc
Q 040908 63 RTFKNLILRSCNLTG----ELPHFLGEVSEMKVLDLSFNKLNG----TIPESFA-RLADVDFIYLTGNLLTGK----VPQ 129 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g----~ip~~~~-~l~~L~~L~ls~N~l~g~----~p~ 129 (790)
++|+.|+|++|.|+. .++..+..+++|++|||++|+|+. .+...+. ...+|+.|+|++|+++.. ++.
T Consensus 27 ~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~ 106 (460)
T d1z7xw1 27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 106 (460)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccc
Confidence 567778888887762 345556777888888888887752 1222222 234688888888877643 233
Q ss_pred cccC-CCCcEEeccCCccc
Q 040908 130 WMFG-RGPENIDLSYNNFA 147 (790)
Q Consensus 130 ~~~~-~~L~~l~ls~N~l~ 147 (790)
.+.. ++|+.|+|++|+++
T Consensus 107 ~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 107 TLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp HTTSCTTCCEEECCSSBCH
T ss_pred hhhccccccccccccccch
Confidence 3333 67888888888775
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.84 E-value=2.9e-07 Score=85.77 Aligned_cols=77 Identities=19% Similarity=0.212 Sum_probs=59.8
Q ss_pred CcccEEEecccccccc--CCccccCCCCCCEEEccCCcCCcCcch-hccCCCCCcEEEeeCCcccccCCcc-------cc
Q 040908 63 RTFKNLILRSCNLTGE--LPHFLGEVSEMKVLDLSFNKLNGTIPE-SFARLADVDFIYLTGNLLTGKVPQW-------MF 132 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~~p~~-------~~ 132 (790)
++|++|+|++|+|+.. ++..+..+++|+.|+|++|+++ .+++ .+....+|+.|+|++|.+....... +.
T Consensus 65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~ 143 (162)
T d1koha1 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE 143 (162)
T ss_dssp TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHT
T ss_pred CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHH
Confidence 6899999999999853 3455778999999999999998 4554 4455567999999999998765532 22
Q ss_pred C-CCCcEEe
Q 040908 133 G-RGPENID 140 (790)
Q Consensus 133 ~-~~L~~l~ 140 (790)
. ++|+.||
T Consensus 144 ~~P~L~~LD 152 (162)
T d1koha1 144 RFPKLLRLD 152 (162)
T ss_dssp TSTTCCEET
T ss_pred HCCCCCEEC
Confidence 3 7788776
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.78 E-value=9e-05 Score=73.27 Aligned_cols=131 Identities=15% Similarity=0.141 Sum_probs=85.8
Q ss_pred eeecccCc-EEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCC--CceeeeeeEEEeCCeEEEEEEeccCCC
Q 040908 452 NKIGEGGF-GPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQH--PHLVKLYGCCIEGNQLLLIYEYLENNS 528 (790)
Q Consensus 452 ~~LG~G~f-G~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gs 528 (790)
+.+..|.. ..||+....++..+++|...... ...+..|+..++.+.. -.+.++++++.+++..++||+|+++.+
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EEcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 34555553 67999988888888889765432 2346678888877743 335667888888888999999998866
Q ss_pred hhhhhcCCccccCCCChhhHHHHHHHHHHHHHHhhh--------------------------------------------
Q 040908 529 LARALFGPEEHRLKLDWPTRHNICIGIARGLAYLHE-------------------------------------------- 564 (790)
Q Consensus 529 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-------------------------------------------- 564 (790)
+.+... ....++.++++.|+-||+
T Consensus 93 ~~~~~~------------~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 93 LLSSHL------------APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TTTSCC------------CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccccc------------cHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 543210 001112222222222221
Q ss_pred -----------cCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 565 -----------ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 565 -----------~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
...+.++|+|+.|.|||++++..+-|.||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 112338999999999999988767899998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.24 E-value=0.00075 Score=71.30 Aligned_cols=77 Identities=13% Similarity=0.166 Sum_probs=48.1
Q ss_pred eeeecccCcEEEEeeeecC-CcEEEEEEccccc-------hhcHHHHHHHHHHhhccC-C--CceeeeeeEEEeCCeEEE
Q 040908 451 ANKIGEGGFGPVYKGLLAD-GTLIAVKQLSAKS-------KQGNREFVNEIGTISALQ-H--PHLVKLYGCCIEGNQLLL 519 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~-------~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~l 519 (790)
.+.||.|..-.||+....+ ++.++||.-.... .........|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998654 6788888643211 112234556888887663 2 234455544 4455688
Q ss_pred EEEeccCCCh
Q 040908 520 IYEYLENNSL 529 (790)
Q Consensus 520 V~Ey~~~gsL 529 (790)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.86 E-value=0.00016 Score=66.75 Aligned_cols=84 Identities=10% Similarity=0.105 Sum_probs=53.6
Q ss_pred CcccEEEecccccccc----CCccccCCCCCCEEEccCCcCCcC----cchhccCCCCCcEEEeeCCccccc-------C
Q 040908 63 RTFKNLILRSCNLTGE----LPHFLGEVSEMKVLDLSFNKLNGT----IPESFARLADVDFIYLTGNLLTGK-------V 127 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~-------~ 127 (790)
++|+.|+|++|.+... +.+.+...+.|++|+|++|.|+.. +-..+...+.|+.|+|++|.+... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 5688888888887632 233445567788888888887632 223566677788888888865521 1
Q ss_pred Ccccc-CCCCcEEeccCCcc
Q 040908 128 PQWMF-GRGPENIDLSYNNF 146 (790)
Q Consensus 128 p~~~~-~~~L~~l~ls~N~l 146 (790)
...+. +++|+.|+++++..
T Consensus 124 ~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCCccEeeCcCCCc
Confidence 12222 26777888776643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.79 E-value=0.0015 Score=66.90 Aligned_cols=136 Identities=15% Similarity=0.114 Sum_probs=78.7
Q ss_pred EEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCce--eeee-----eEEEeCCeEEEEEEeccCCChhh-
Q 040908 460 GPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL--VKLY-----GCCIEGNQLLLIYEYLENNSLAR- 531 (790)
Q Consensus 460 G~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~-----g~~~~~~~~~lV~Ey~~~gsL~~- 531 (790)
=.||++..++|+.+++|+.... .....++..|...+..+....+ +..+ ......+..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999997543 2345667788888877753322 1111 12345667889999998754321
Q ss_pred ----------hh---c----CC-ccccCCCChh-------------------hHHHHHHHHHHHHHHhh----hcCCCcE
Q 040908 532 ----------AL---F----GP-EEHRLKLDWP-------------------TRHNICIGIARGLAYLH----EESRLKI 570 (790)
Q Consensus 532 ----------~l---~----~~-~~~~~~l~~~-------------------~~~~i~~~ia~aL~yLH----~~~~~~i 570 (790)
.+ | .. ...+...++. .+..+...+.+.++.+. +.....+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 1 00 0011111111 11112222223333332 2234468
Q ss_pred EeccCCCCcEEecCCCCeEEeecCCccc
Q 040908 571 VHRDIKATNVLLDKDLNPKISDFGLAKL 598 (790)
Q Consensus 571 iHrDlk~~NILl~~~~~~kl~DFGla~~ 598 (790)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899997763
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.59 E-value=0.00034 Score=64.50 Aligned_cols=83 Identities=7% Similarity=-0.003 Sum_probs=56.4
Q ss_pred cccceeccccCCCCCCCc----ccc-cCcccEEEecccccccc----CCccccCCCCCCEEEccCCcCCcC-------cc
Q 040908 41 SLTDLRISDLNGPEATLP----DLR-NRTFKNLILRSCNLTGE----LPHFLGEVSEMKVLDLSFNKLNGT-------IP 104 (790)
Q Consensus 41 ~L~~L~l~~n~~~~~~~~----~~~-~~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~-------ip 104 (790)
.|+.|++++|.+...... .+. ++.|+.|+|++|.|+.. +-..+...+.|++|+|++|++... +-
T Consensus 45 ~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~ 124 (167)
T d1pgva_ 45 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMM 124 (167)
T ss_dssp CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHH
T ss_pred ccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHH
Confidence 456666665555421111 122 27899999999999853 334567778899999999976521 34
Q ss_pred hhccCCCCCcEEEeeCCcc
Q 040908 105 ESFARLADVDFIYLTGNLL 123 (790)
Q Consensus 105 ~~~~~l~~L~~L~ls~N~l 123 (790)
..+...+.|+.|+++.+..
T Consensus 125 ~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 125 MAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHCSSCCEEECCCCCH
T ss_pred HHHHhCCCccEeeCcCCCc
Confidence 5566678999999987754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.21 E-value=0.011 Score=61.86 Aligned_cols=74 Identities=20% Similarity=0.257 Sum_probs=49.6
Q ss_pred eeeecccCcEEEEeeeecCC--------cEEEEEEccccchhcHHHHHHHHHHhhccCCCce-eeeeeEEEeCCeEEEEE
Q 040908 451 ANKIGEGGFGPVYKGLLADG--------TLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL-VKLYGCCIEGNQLLLIY 521 (790)
Q Consensus 451 ~~~LG~G~fG~Vy~g~~~~g--------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 521 (790)
++.|+.|-.=.+|+....++ ..|.+++... ........+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 46788888889999886432 4566666542 2233455688889888854455 467777643 5799
Q ss_pred EeccCCChh
Q 040908 522 EYLENNSLA 530 (790)
Q Consensus 522 Ey~~~gsL~ 530 (790)
||+++..+.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999875443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.57 E-value=0.073 Score=53.25 Aligned_cols=159 Identities=14% Similarity=0.064 Sum_probs=84.4
Q ss_pred ccHHHHHHHhcCcceeee-----ecccCcEEEEeeeecCCcEEEEEEccccchhcHHHHHHHHHHhhccCCCce--eeee
Q 040908 436 FTLRQIKAATNHFDVANK-----IGEGGFGPVYKGLLADGTLIAVKQLSAKSKQGNREFVNEIGTISALQHPHL--VKLY 508 (790)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~-----LG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~ 508 (790)
.+.++++....+|.+.+. |..|---+.|+....+|+ +++|+...... ..+...|+.++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 466788888888877443 345555778999877665 88888754322 2334456666666643222 1111
Q ss_pred e------EEEeCCeEEEEEEeccCCChhhhh--------------c------CCccccC-----------------CCCh
Q 040908 509 G------CCIEGNQLLLIYEYLENNSLARAL--------------F------GPEEHRL-----------------KLDW 545 (790)
Q Consensus 509 g------~~~~~~~~~lV~Ey~~~gsL~~~l--------------~------~~~~~~~-----------------~l~~ 545 (790)
- +.........++.++.+......- + ....... ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 122345567777777664332100 0 0000000 0011
Q ss_pred hhHHHHHHHHHHHHHHhhh-cCCCcEEeccCCCCcEEecCCCCeEEeecCCcc
Q 040908 546 PTRHNICIGIARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 597 (790)
Q Consensus 546 ~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 597 (790)
......+..+...+.-.+. ..+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1112222222222332222 223469999999999999998777899999875
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.18 E-value=0.0009 Score=61.35 Aligned_cols=84 Identities=11% Similarity=0.145 Sum_probs=52.4
Q ss_pred CcccEEEecccccccc----CCccccCCCCCCEEEccCCcCCcC----cchhccCCCCCcEEEe--eCCccccc----CC
Q 040908 63 RTFKNLILRSCNLTGE----LPHFLGEVSEMKVLDLSFNKLNGT----IPESFARLADVDFIYL--TGNLLTGK----VP 128 (790)
Q Consensus 63 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~l--s~N~l~g~----~p 128 (790)
++|++|+|++|.++.. +-+.+...+.|+.|++++|.+... +-..+...++|+.++| ++|.+... +.
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 5688888888877643 233455667888888888887532 2345667777876555 45556432 22
Q ss_pred ccccC-CCCcEEeccCCcc
Q 040908 129 QWMFG-RGPENIDLSYNNF 146 (790)
Q Consensus 129 ~~~~~-~~L~~l~ls~N~l 146 (790)
..+.. ++|+.|+++.|..
T Consensus 126 ~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCCCcCEEeCcCCCC
Confidence 22223 6788888876654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.84 E-value=0.0045 Score=56.40 Aligned_cols=84 Identities=15% Similarity=0.127 Sum_probs=55.2
Q ss_pred cccceeccccCCCCCCCcc----cc-cCcccEEEecccccccc----CCccccCCCCCCEEEc--cCCcCCc----Ccch
Q 040908 41 SLTDLRISDLNGPEATLPD----LR-NRTFKNLILRSCNLTGE----LPHFLGEVSEMKVLDL--SFNKLNG----TIPE 105 (790)
Q Consensus 41 ~L~~L~l~~n~~~~~~~~~----~~-~~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~g----~ip~ 105 (790)
.|+.|++++|.+....... +. .+.|+.|++++|.+... +-..+...++|+.++| ++|.+.. .+-.
T Consensus 47 ~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~ 126 (166)
T d1io0a_ 47 YVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIAN 126 (166)
T ss_dssp SCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHH
T ss_pred ccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHH
Confidence 4555555555444222111 11 26799999999998743 3456777899987666 4677753 3455
Q ss_pred hccCCCCCcEEEeeCCccc
Q 040908 106 SFARLADVDFIYLTGNLLT 124 (790)
Q Consensus 106 ~~~~l~~L~~L~ls~N~l~ 124 (790)
.+...+.|+.|+++.|...
T Consensus 127 ~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 127 MLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCcCEEeCcCCCCc
Confidence 6778899999999887653
|